Citrus Sinensis ID: 040257
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1254 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.275 | 0.370 | 0.334 | 1e-47 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.205 | 0.314 | 0.386 | 7e-45 | |
| Q55A09 | 1331 | Probable serine/threonine | yes | no | 0.202 | 0.190 | 0.362 | 7e-44 | |
| P18161 | 1155 | Dual specificity protein | no | no | 0.236 | 0.257 | 0.354 | 1e-43 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.226 | 0.174 | 0.368 | 1e-43 | |
| P18160 | 2410 | Dual specificity protein | no | no | 0.206 | 0.107 | 0.375 | 9e-43 | |
| Q6XHB2 | 1726 | Probable serine/threonine | no | no | 0.205 | 0.149 | 0.367 | 3e-42 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.189 | 0.184 | 0.378 | 9e-42 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.204 | 0.279 | 0.367 | 1e-41 | |
| Q54RB7 | 527 | Dual specificity protein | no | no | 0.196 | 0.466 | 0.402 | 1e-41 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 192 bits (488), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 125/374 (33%), Positives = 186/374 (49%), Gaps = 28/374 (7%)
Query: 867 PSIIQNKDQNKQEPLVIVGDVTGSMPSEHQFSPEVVSHLDATSSDEMSTNETESESIFPE 926
PSI+++ ++N L + + + + H TS D++ST
Sbjct: 579 PSIVEDMNRNTNNELDLQPHTAAVVHGQQNDESHIHDHRKYTS-DDISTGCDPRLKDHES 637
Query: 927 SLSQDSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWR 986
+ S R+ + DA + E E L I + + G G+YG VYH W
Sbjct: 638 TSSSLDSTSYRNDPQVLDDADVGECEIPWNDLVIAERI--------GLGSYGEVYHADWH 689
Query: 987 GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLAT 1046
G++VA+K+ F+G + +F E I+ L HPNVV F G V L+
Sbjct: 690 GTEVAVKKFLDQDFSGAA------LAEFRSEVRIMRRLRHPNVVFFLGAV--TRPPNLSI 741
Query: 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKN--IVHFDLKCENLLVN 1104
VTEF+ GSL +L + +D R+++ +A+D A GM LH+ IVH DLK NLLV+
Sbjct: 742 VTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVD 801
Query: 1105 LRDPQRPICKVGDFGLSRIKRNTLVSG-GVRGTLPWMAPELL-NGSSNRVSEKVDVFSFG 1162
KVGDFGLSR+K NT +S GT WMAPE+L N SN EK DV+SFG
Sbjct: 802 ----NNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN---EKCDVYSFG 854
Query: 1163 ISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSF 1222
+ +WE+ T P+ M+ ++G + R IP+ DP +++ +CW DP RPSF
Sbjct: 855 VILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSF 914
Query: 1223 TEITSRLRTISAAI 1236
++T L+ ++ +
Sbjct: 915 AQLTEVLKPLNRLV 928
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 183 bits (465), Expect = 7e-45, Method: Compositional matrix adjust.
Identities = 107/277 (38%), Positives = 158/277 (57%), Gaps = 19/277 (6%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
I DL ++G+G++GTV+ +W GSDVA+K + + F ER+ +F RE I
Sbjct: 546 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-----HAERVN-EFLREVAI 599
Query: 1021 LSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD--RSLDRRKKLIIAMD 1078
+ L HPN+V F G V L+ VTE++ GSL +L K LD R++L +A D
Sbjct: 600 MKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 657
Query: 1079 AAFGMEYLHSKN--IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG-GVRG 1135
A GM YLH++N IVH DLK NLLV+ ++ KV DFGLSR+K +T +S G
Sbjct: 658 VAKGMNYLHNRNPPIVHRDLKSPNLLVD----KKYTVKVCDFGLSRLKASTFLSSKSAAG 713
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT 1195
T WMAPE+L + +EK DV+SFG+ +WE+ T ++P+ +++ ++ + R
Sbjct: 714 TPEWMAPEVLRDEPS--NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE 771
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
IP +P+ ++E CW +P RPSF I LR +
Sbjct: 772 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 808
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 180 bits (456), Expect = 7e-44, Method: Compositional matrix adjust.
Identities = 102/281 (36%), Positives = 157/281 (55%), Gaps = 27/281 (9%)
Query: 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
+ +I D++ +E+G G + V G W+G DVA+K++ + + +E + ++F E
Sbjct: 1065 VTMINYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLN----SNKDKAREEMIQEFKAE 1120
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK------DRSLDRRK 1071
+L +L HPN+V YG + + V EF+ +G+L ++ K LD
Sbjct: 1121 VELLGSLQHPNLVTCYGY----SLNPMCIVMEFLPSGNLFELIHSKPSEQQQSIKLDSTL 1176
Query: 1072 KLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG 1131
L IA D A GM++LH++NI+H DLK NLL+ D I K+ D G++R T
Sbjct: 1177 ILAIAFDIARGMQHLHTRNIIHRDLKSSNLLM---DKHFNI-KIADLGIARETSFTQTMT 1232
Query: 1132 GVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD---MHCGAIIGGIV 1188
+ GT+ W APE+L S ++K DV+S+ I ++E+LTGEEPY M+ G ++
Sbjct: 1233 TI-GTVAWTAPEILRHES--YNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVAS-- 1287
Query: 1189 KNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
LRP +P+ CDP W+KL+ CW+ DP RPSF EIT+ L
Sbjct: 1288 -KGLRPELPDNCDPNWKKLVVWCWSEDPNKRPSFEEITNYL 1327
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 179 bits (454), Expect = 1e-43, Method: Compositional matrix adjust.
Identities = 116/327 (35%), Positives = 173/327 (52%), Gaps = 30/327 (9%)
Query: 920 SESIFPESLSQDSKADVRDKDES--FSDAMIAEMEASIYGLQ--IIKNVDLEELRELGSG 975
SES+ ++++S D++ ES E++ SI G + II D++ ++++G G
Sbjct: 804 SESLIMSPINKESLNDIQRAIESEKIKKTKFEELK-SILGEREYIIDINDIQFIQKVGEG 862
Query: 976 TYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGV 1035
+ V+ G W+G VAIK++K G ++E+ + F RE L +H N+V F G
Sbjct: 863 AFSEVWEGWWKGIHVAIKKLK---IIG---DEEQFKERFIREVQNLKKGNHQNIVMFIGA 916
Query: 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKK-----LIIAMDAAFGMEYLHSKN 1090
+TE+M GSL ++L + S + K L +A D A G+ +LHS
Sbjct: 917 CYKPA----CIITEYMAGGSLYNILHNPNSSTPKVKYSFPLVLKMATDMALGLLHLHSIT 972
Query: 1091 IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN----TLVSGGVRGTLPWMAPELLN 1146
IVH DL +N+L++ + K+ DFGLSR K T+ +GG+ W PEL
Sbjct: 973 IVHRDLTSQNILLD----ELGNIKISDFGLSREKSREGSMTMTNGGICNPR-WRPPELTK 1027
Query: 1147 GSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRK 1206
SEKVDV+ F + +WEILTGE P++D+ + LRP IPE CDPE +
Sbjct: 1028 NLG-HYSEKVDVYCFSLVVWEILTGEIPFSDLDGSQASAQVAYAGLRPPIPEYCDPELKL 1086
Query: 1207 LMEQCWAADPEARPSFTEITSRLRTIS 1233
L+ QCW ADP RP FT I ++L+ IS
Sbjct: 1087 LLTQCWEADPNDRPPFTYIVNKLKEIS 1113
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 179 bits (454), Expect = 1e-43, Method: Compositional matrix adjust.
Identities = 115/312 (36%), Positives = 173/312 (55%), Gaps = 28/312 (8%)
Query: 931 DSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDV 990
D AD+ DK++SF + ++ II ++ +++G G+YG V++GKW+G DV
Sbjct: 1337 DYMADI-DKEDSF-------LTSANMCRWIINYDEISIGKQIGLGSYGIVFNGKWKGVDV 1388
Query: 991 AIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEF 1050
A+K+ K + SE + L +F E LS L H N+V F G + VTE+
Sbjct: 1389 AVKKFVKQ----KLSETQLL--EFRAEMAFLSELKHSNIVTFIGACIKKPN--ICIVTEY 1440
Query: 1051 MVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKN--IVHFDLKCENLLVNLRDP 1108
M G+L+ VL D + KL + AA G++YLHS N IVH D+K N+LV+
Sbjct: 1441 MRMGNLRDVLKNPDIKITFANKLKLLYGAAMGIDYLHSSNPMIVHRDIKPANILVD---- 1496
Query: 1109 QRPICKVGDFGLSRIKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWE 1167
+ K+ DFG +RIK NT ++ GT W APE++ G + EK DVFSFG+ MWE
Sbjct: 1497 EHFNVKIADFGFARIKEDNTTMTRC--GTPCWTAPEVIRGE--KYCEKADVFSFGVVMWE 1552
Query: 1168 ILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITS 1227
+LTG+EP+A+ + + I++ RP IP C E+ KL+++CW A RP+ TE+
Sbjct: 1553 VLTGKEPFAECNFMKVSLDILEGG-RPIIPSDCPHEFAKLIKKCWHAKAHKRPTMTEVVQ 1611
Query: 1228 RLRTISAAIESK 1239
+L I+ + K
Sbjct: 1612 QLMLITEQFDHK 1623
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 176 bits (447), Expect = 9e-43, Method: Compositional matrix adjust.
Identities = 107/285 (37%), Positives = 157/285 (55%), Gaps = 26/285 (9%)
Query: 964 VDLEEL---RELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
+D EL + +G G +G V G WR +DVAIK I + F +SS F E I
Sbjct: 2110 IDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSS-----LVMFQNEVGI 2164
Query: 1021 LSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK--KLIIAMD 1078
LS L HPNVV F G G VTE+M GSL+ L L++ +L +A+D
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 1079 AAFGMEYLHSKN--IVHFDLKCENLLVNLR-DPQRPI--------CKVGDFGLSRIK--R 1125
A GM YLH I+H DL N+L++ DP+ P+ CK+ DFGLSR+K +
Sbjct: 2225 IAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKMEQ 2284
Query: 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIG 1185
+ ++ V G +P+MAPE+ G SN SEK DV+S+G+ ++E+LT +EP DM +
Sbjct: 2285 ASQMTQSV-GCIPYMAPEVFKGDSN--SEKSDVYSYGMVLFELLTSDEPQQDMKPMKMAH 2341
Query: 1186 GIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230
+ RP IP +W++++ QCW ++P++RP+F +I L+
Sbjct: 2342 LAAYESYRPPIPLTTSSKWKEILTQCWDSNPDSRPTFKQIIVHLK 2386
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q6XHB2|ROCO4_DICDI Probable serine/threonine-protein kinase roco4 OS=Dictyostelium discoideum GN=roco4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 175 bits (443), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 100/272 (36%), Positives = 149/272 (54%), Gaps = 14/272 (5%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTK--DFWREAHILS 1022
++E +++G G +G V+ G+ D ++ IK E E + K +F RE I+S
Sbjct: 1025 EIEYEKQIGKGGFGLVHKGR-LVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 1083
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
NL+HPN+V YG++ + V EF+ G L H LL K + KL + +D A G
Sbjct: 1084 NLNHPNIVKLYGLMHNPP----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 1139
Query: 1083 MEYLHSKN--IVHFDLKCENLLVNLRDPQRPIC-KVGDFGLSRIKRNTLVSGGVRGTLPW 1139
+EY+ ++N IVH DL+ N+ + D P+C KV DFGLS+ +++ G+ G W
Sbjct: 1140 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV--SGLLGNFQW 1197
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAI--IGGIVKNTLRPTIP 1197
MAPE + +EK D +SF + ++ ILTGE P+ + G I I I + LRPTIP
Sbjct: 1198 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 1257
Query: 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
E C P R ++E CW+ DP+ RP F+ I L
Sbjct: 1258 EDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 1289
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 173 bits (438), Expect = 9e-42, Method: Compositional matrix adjust.
Identities = 97/256 (37%), Positives = 145/256 (56%), Gaps = 18/256 (7%)
Query: 972 LGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVA 1031
+G G YG V+ G WRG++VA+K + + +L D +E +L L HPN+V
Sbjct: 857 IGRGGYGQVFRGSWRGTEVAVKML------FNDNVNLKLISDLRKEVDLLCKLRHPNIVL 910
Query: 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKN- 1090
F G + + + VTE++ GSL ++LL + +D +L + D A GM YLHS+N
Sbjct: 911 FMGACTEPSSPCI--VTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYLHSRNP 968
Query: 1091 -IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSS 1149
I+H DLK +NLLV+ D + KV DFGL+ +K +T + + GT W+APE+L +
Sbjct: 969 IIIHRDLKTDNLLVD--DSWQ--VKVADFGLATVKSHTF-AKTMCGTTGWVAPEVL--AE 1021
Query: 1150 NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLME 1209
+EK DV+S+ I +WE+LT PYA + ++ I + P +P C P++ LM
Sbjct: 1022 EGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSIDRGERLP-MPAWCPPKYAALMN 1080
Query: 1210 QCWAADPEARPSFTEI 1225
+CW DP RPSF EI
Sbjct: 1081 RCWETDPTHRPSFPEI 1096
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (437), Expect = 1e-41, Method: Compositional matrix adjust.
Identities = 100/272 (36%), Positives = 146/272 (53%), Gaps = 16/272 (5%)
Query: 964 VDLEELR---ELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
+ EL+ +LG GT+G VY G WRGS VAIK+IK + ++ ++F +E I
Sbjct: 657 ISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKIN-----EDVNNQVLEEFRKELTI 711
Query: 1021 LSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
LS L HPN+V L +TE++ GSL L K ++ + +A+ A
Sbjct: 712 LSRLRHPNIVLLMAAC--TAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIA 769
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWM 1140
GM YLH ++H D+K NLL++ + K+ DFGLS++K + G+ WM
Sbjct: 770 QGMNYLHLSGVIHRDIKSLNLLLD----EHMNVKICDFGLSKLKSKSTEMTKSIGSPIWM 825
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
+PELL G +EKVDV++FGI +WE+ TGE PY+ + + + +LRP IP
Sbjct: 826 SPELLMGED--YTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAW 883
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+ L++ CW DP RPSFTEI + L I
Sbjct: 884 PYQLSHLIQACWHQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54RB7|SHKA_DICDI Dual specificity protein kinase shkA OS=Dictyostelium discoideum GN=shkA PE=2 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (437), Expect = 1e-41, Method: Compositional matrix adjust.
Identities = 108/268 (40%), Positives = 152/268 (56%), Gaps = 22/268 (8%)
Query: 972 LGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVA 1031
LG G++GTVY G+ R DVA+K + K +Q+ LT DF +E I+S + HPN+V
Sbjct: 51 LGDGSFGTVYKGRCRLKDVAVKVMLKQV------DQKTLT-DFRKEVAIMSKIFHPNIVL 103
Query: 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKN- 1090
F G T G L TE M G+L+ +LL L ++ +A DAA G+ +LHS N
Sbjct: 104 FLGAC-TSTPGKLMICTELM-KGNLESLLLDPMVKLPLITRMRMAKDAALGVLWLHSSNP 161
Query: 1091 -IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN--TLVSG--GVRGTLPWMAPELL 1145
+H DLK NLLV+ KV DFGLS+IK+ L G G +GT WMAPE+L
Sbjct: 162 VFIHRDLKTSNLLVD----ANLTVKVCDFGLSQIKQRGENLKDGQDGAKGTPLWMAPEVL 217
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILTGEEPYADM-HCGAIIGGIVKNTLRPTIPERCDPEW 1204
G +EK DV+SFG+ +W+I T +E + + + + I + LRP+IP+ C
Sbjct: 218 QG--RLFNEKADVYSFGLVLWQIFTRQELFPEFDNFFKFVAAICEKQLRPSIPDDCPKSL 275
Query: 1205 RKLMEQCWAADPEARPSFTEITSRLRTI 1232
++L+++CW +PE RPSF I S L I
Sbjct: 276 KELIQKCWDPNPEVRPSFEGIVSELEEI 303
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1254 | ||||||
| 255560213 | 1325 | serine/threonine protein kinase, putativ | 0.956 | 0.905 | 0.528 | 0.0 | |
| 356566433 | 1292 | PREDICTED: uncharacterized protein LOC10 | 0.954 | 0.926 | 0.486 | 0.0 | |
| 356524535 | 1290 | PREDICTED: uncharacterized protein LOC10 | 0.409 | 0.398 | 0.620 | 1e-178 | |
| 359477846 | 1188 | PREDICTED: uncharacterized protein LOC10 | 0.358 | 0.378 | 0.662 | 1e-168 | |
| 297741916 | 952 | unnamed protein product [Vitis vinifera] | 0.282 | 0.371 | 0.793 | 1e-167 | |
| 255554200 | 1132 | serine/threonine protein kinase, putativ | 0.331 | 0.367 | 0.672 | 1e-165 | |
| 147841871 | 1230 | hypothetical protein VITISV_040388 [Viti | 0.304 | 0.310 | 0.721 | 1e-165 | |
| 186510389 | 1117 | octicosapeptide/Phox/Bem1p domain-contai | 0.283 | 0.318 | 0.736 | 1e-162 | |
| 297613457 | 1133 | Os12g0594300 [Oryza sativa Japonica Grou | 0.283 | 0.313 | 0.753 | 1e-161 | |
| 297831338 | 1122 | hypothetical protein ARALYDRAFT_319179 [ | 0.293 | 0.327 | 0.710 | 1e-161 |
| >gi|255560213|ref|XP_002521124.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223539693|gb|EEF41275.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1208 bits (3125), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 714/1351 (52%), Positives = 864/1351 (63%), Gaps = 151/1351 (11%)
Query: 5 APGPSGQWIQL--ESSYVVPNTVKDVHTNVSVRTGEEFSMEFLQDRTAARGIPAMTNTVQ 62
+P PS QWIQ E + VP T K+V N+S++TGEEFSMEFLQDR A G+ + TVQ
Sbjct: 15 SPSPSSQWIQQQQELASFVPKTGKNVR-NLSMQTGEEFSMEFLQDRVATGGVSPLIGTVQ 73
Query: 63 NNEMMVGQ-HYNQNNQMRYEDLARILGLKRMDSESASDISDIGSTKGSLKEMENGAYGDK 121
E +G+ H ++N+Q YEDLA ILGL+RMDSE D SD S KGSLKE E+G Y DK
Sbjct: 74 TFENGIGRNHDDRNHQRGYEDLANILGLRRMDSECTDDFSDFVSAKGSLKETESGFYVDK 133
Query: 122 VSRYRKEDADSKHGERKAFGELNGDRAAGLVSTSPPTHVIEPSCSSNFNGPRVLGRSQSG 181
+++ + ED D+ H K FG L+ DR AGL +++ +V+E CS+ + V RSQ G
Sbjct: 134 LNKLKMEDNDTVHRSGKGFGNLDSDRRAGLGTSASAVNVLESPCSAKSDATNVSDRSQPG 193
Query: 182 KMKFLCSFGGKILPRPSDGKLRYVGGETRIISLRTNLSWEELVKKTSNICNQPHLIKYQL 241
KMKFLCS GGKILPRPSDGKLRYVGGETRIIS+ N++WEELVKKT IC QPH IKYQL
Sbjct: 194 KMKFLCSSGGKILPRPSDGKLRYVGGETRIISISKNVTWEELVKKTKGICTQPHSIKYQL 253
Query: 242 PGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRLFLIPLSESENTASLEANTIQPN 301
PGEDLD+LISVSSD+DLQNMI+EY GLERL+GSQRLR+FLIPLSES+ ++S + TIQ +
Sbjct: 254 PGEDLDSLISVSSDEDLQNMIEEYYGLERLDGSQRLRIFLIPLSESDTSSSFDGTTIQQD 313
Query: 302 SPDYEYVVAVNGMLGSSPRKSAGGQTLGNEASRMGTILDLNPSFQKLAPTSVVPLEVKGG 361
SP+Y+YVVAVNG+L SPRKS+GGQ APT E K G
Sbjct: 314 SPNYQYVVAVNGILDPSPRKSSGGQCS--------------------APT----WENKSG 349
Query: 362 LNAFHPTQFINESSDTTRHPN----------------QLHGNNSSIESGSSFITAQLPPE 405
NAFH +F NES + + P + H ++SS ES SSF TA LPPE
Sbjct: 350 FNAFHFNKFSNESLNMHQSPPISPLTLQHRDSKNAHVKFHADSSSTESSSSFSTALLPPE 409
Query: 406 DAGTNTANFNYPPQEPVTLTNYLQPYKQVDNKQPDQPHGVQFLYCNSIEDTNPSALDHNA 465
+ TA + P Q + L N+ P + QPDQP + E +++ H +
Sbjct: 410 NC-DKTAFYKQPCQGLMALMNHHHPCNNDEIVQPDQPQMQSHNHNLGTELVATASVFHQS 468
Query: 466 -FDFDGFTCERPVHKERIFHSEKHLSHPEEAMGFFSGSFDSIDPLLGMPHAFSDSKLQEY 524
F+ CE+P+ + R+FHSEK L PE+ MG SGS D+I GMPHAFSDSKLQE+
Sbjct: 469 EVSFNSSFCEKPMIRGRMFHSEKPLG-PEDPMGLSSGSVDTIYSHHGMPHAFSDSKLQEH 527
Query: 525 GGTSAYCSVEGVSPSSPLIFAKTQLPSLPVTNASPEMPMQLLENVKPLDPRVPELLLDID 584
GG SAYCS EG+SPSSPL F+KTQL SL V+N+S E +QL EN+ ++P + L+DI+
Sbjct: 528 GGLSAYCSQEGMSPSSPLNFSKTQLCSL-VSNSSQEKSVQLQENINFVNPTLQGKLVDIE 586
Query: 585 TTASQGNML---HSPCPEFASRNGPICKVVSNINEKSQTAKDDVSKSSFMKPVPSGGNST 641
T SQ + S P+ A RN P KV +N ++SQ + N
Sbjct: 587 ATDSQRRLDLLDFSSSPKSARRNDPTEKVTTNAGDQSQISNK------------CKENVL 634
Query: 642 TSKTMDQVDERVLFLHEGGNFYAEQLPATNMEYRKNLPNINSNQTVASGDNTNAQDMRFS 701
TM+ +D+ L++G E+ +EY LP +N N T +S +T Q M S
Sbjct: 635 GLDTMNTIDKSNFLLNQGEK-PCEEKSLAGVEYMNILPYVNCN-TRSSAVDTLGQSMNIS 692
Query: 702 RDMLSAST------------------HCESSST-----------VVGGQKCNVSWTKNSD 732
D LSAS+ H + T V Q+ N+ +
Sbjct: 693 EDKLSASSAFDFRPSVNILINHPQNYHAKDQRTANDQYGSLSGKVNREQESNIPRASIPE 752
Query: 733 VAGPFPNTREGSGDENSLADLTSGSCNGLASQEPVHMQPVVNQTNADLREAKLIVSADSS 792
V F NT+ S E+S DL SGS + EP +QP+ NQ + +E+ LI S+ S
Sbjct: 753 VVELFQNTKLRSRGEDSSVDLISGSSSNPFFPEPTQVQPLENQNDISNKESTLISSSKSY 812
Query: 793 PSPVQNDAVPSSHLLKGDLDAKLQNLTADVALKREVSPLDNDFLNCSDKMAEKLGFGESV 852
PS V +D+ P+ L DLDA N D + + +V PLD D + EK GF S
Sbjct: 813 PSAVLDDSGPNKSLPLSDLDASANNAANDASYEGKVYPLD-DHGSYPHLRVEKCGFRGSS 871
Query: 853 SKKSNVEDVAYIQTPSIIQNKDQNKQEPLVIVGDVTGSMP----SEHQFSPEVVS----- 903
+ +NV D+ QT + +N QN+ EPLVIV VT +P S H P V S
Sbjct: 872 CENTNVLDIMLAQTNAPSKNNIQNQLEPLVIVEAVTSDVPHIGQSSHAVFPRVASPHSCD 931
Query: 904 -----HLDATSS-------------DEMSTNETE-------------------------- 919
LDA S ++MS + TE
Sbjct: 932 FISPTALDAGSVMPHVAMHGTDPTINDMSPSATELECIVPHVCPHIANLTSSDFIFPTAS 991
Query: 920 -SESIFPESLSQDSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYG 978
SES+ PE+ D + DKD S SDA+IAEMEASIYGLQIIKN DLEEL+ELGSGTYG
Sbjct: 992 ISESLMPETDFDDINDENGDKDNSISDAVIAEMEASIYGLQIIKNADLEELKELGSGTYG 1051
Query: 979 TVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038
TVYHGKWRG+DVAIKRIKKSCF+GRSSEQERLTKDFWREA ILSNLHHPNVVAFYGVVPD
Sbjct: 1052 TVYHGKWRGTDVAIKRIKKSCFSGRSSEQERLTKDFWREAQILSNLHHPNVVAFYGVVPD 1111
Query: 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKC 1098
G GGTLATVTE+MVNGSL+HVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKC
Sbjct: 1112 GAGGTLATVTEYMVNGSLRHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKC 1171
Query: 1099 ENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDV 1158
+NLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDV
Sbjct: 1172 DNLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDV 1231
Query: 1159 FSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEA 1218
FSFGIS+WEILTGEEPYADMHCGAIIGGIVKNTLRP IP+ CDPEWRKLMEQCW+ DP++
Sbjct: 1232 FSFGISLWEILTGEEPYADMHCGAIIGGIVKNTLRPPIPDSCDPEWRKLMEQCWSPDPDS 1291
Query: 1219 RPSFTEITSRLRTISAAIESKCINSEPKQTK 1249
RPSFTE+T+RLRT+S +++K N +P+Q K
Sbjct: 1292 RPSFTEVTNRLRTMS--LQAKGHNIQPRQMK 1320
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356566433|ref|XP_003551436.1| PREDICTED: uncharacterized protein LOC100809991 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 997 bits (2578), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 628/1292 (48%), Positives = 788/1292 (60%), Gaps = 95/1292 (7%)
Query: 8 PSGQWIQLESSYVVPNTVKDVHTN-VSVRTGEEFSMEFLQDRTAARGIPAMTNTVQNNEM 66
P Q E S V NT + V+ N ++++ GEEFS D AA +P + + E
Sbjct: 22 PKHAQAQPELSSGVSNTGRHVNNNNIAIQAGEEFSTNVGCDGIAAGRVPVSPDIPRYCEN 81
Query: 67 MVGQHYNQNNQMRYEDLARILGLKRMDSESASDISDIGSTKGSLKEMENGAYGDKVSRYR 126
+ G + +N +RYEDL ILGL+RMDSES+SDISD + K +EMENGA + +S+ +
Sbjct: 82 VFGLN-RENGHVRYEDLTNILGLRRMDSESSSDISDFVAIKQPAQEMENGASANILSKIQ 140
Query: 127 KEDADSKHGERKAFGELNGDRAAGLVSTSPPTHVIEPSCSSNFNGPRVLGRSQSGKMKFL 186
K D S RK F E G +++ L S P E S S+ F+G +L QSGKMKFL
Sbjct: 141 KRDGVS----RKVFQEPVGVQSS-LASAVSPLRRYEASQSNGFSGLGILDDFQSGKMKFL 195
Query: 187 CSFGGKILPRPSDGKLRYVGGETRIISLRTNLSWEELVKKTSNICNQPHLIKYQLPGEDL 246
CSFGGKILPRPSDGKLRYVGG+T IIS+R ++SWE+L+KKT ICNQPH IKYQLPGEDL
Sbjct: 196 CSFGGKILPRPSDGKLRYVGGDTHIISIRKDISWEQLMKKTLGICNQPHTIKYQLPGEDL 255
Query: 247 DALISVSSDDDLQNMIDEYCGLERLEGSQRLRLFLIPLSESENTASLEANTIQPNSPDYE 306
DALISV SD+DLQNM +EY GLER EGSQ+LR+FL+PL ESE T+S E + ++ N PDY+
Sbjct: 256 DALISVFSDEDLQNMKEEYHGLERHEGSQKLRIFLVPLGESEETSSTEVSAVRQNDPDYQ 315
Query: 307 YVVAVNGMLGSSPRKSAGGQTLGNEASRMGTILDLNPSFQKLAPTSVVPLEVKGGLNAFH 366
YVVAVNGM G R + GGQ+L NEAS GT +L P F K P + LE++ +NA +
Sbjct: 316 YVVAVNGM-GDPTRTNIGGQSLTNEASSFGTEPNLAPVFSKF-PNASSLLEIRDAINALN 373
Query: 367 PTQFINESSDTTRH----PN------------QLHGNNS---SIESGSSFITAQLPPEDA 407
P +N+S + R P QL GNNS SIES +SF TAQL E +
Sbjct: 374 PDGILNDSLNFQRPLPIPPTPIQVTGSSTGYIQLLGNNSCQGSIESNASFATAQLHTEYS 433
Query: 408 GTNTANFNYPPQEPVTLTNYLQPYKQVDNKQPDQPHGVQFLYCNSIEDTNPSALDHNAFD 467
TA+ YP Q TL++ PY+ D P + +G Y E P ++ +
Sbjct: 434 NIRTADCRYPQQVAATLSSDTHPYQHGDVGWPKKLNG-HLDYNPGNELVTPLCVNPS--- 489
Query: 468 FDGFTCE----RPVHKERIFHSEKHLSHPEEAMGFFSGSFDSIDPLLGMPHAFSDSKLQE 523
DG++ E R + KER +SE LS ++ + S+ D GMPHA SD +L +
Sbjct: 490 -DGYSDEIFGGRSMQKERRVYSENPLSCLDDLIYQQGESYGITDSPHGMPHALSDPQLNK 548
Query: 524 YGGTSAYCSVEGVSPSSPLIFAKTQLPSLPVTNASPEMPMQLLENVKPLDPRVPELLLDI 583
G S Y S +G S + K QL S+ S + L EN P++
Sbjct: 549 SGARSGYISQDGFGQSFSINLEKCQLSSMLPPKVSQ---VNLKENQHESIVHHPQMQSKT 605
Query: 584 DTTAS-----QGNMLHSPCPEFASRNGPICKVVSNINEKSQ-TAKDDVSKSSFMKPVPSG 637
S + ++ SP + N P+ + S I EK A+ D+S S++
Sbjct: 606 PKVESSEPHKRQDLASSPYYDSLGMNDPVHMMDSIITEKKNLIAQTDLSGPSYVAE-DIQ 664
Query: 638 GNSTTSKTMDQVDER---------------------VLFLHEGGNFYAEQLPA-TNMEYR 675
NS + M ++E+ V LH +F A A NM+
Sbjct: 665 ENSVKLERMKLIEEKNPIFIDNKVHEVKSAVIDMGHVPELHLLESFPANNFNAMINMQKN 724
Query: 676 KNLPN-----INSNQTVASGDNTNAQDMRFSRDM---LSASTHCESSSTVVGGQKCNVSW 727
LP+ ++S S +N + R DM S C + + G Q + S
Sbjct: 725 WELPSEGIVPVSSGMMGLSLNNLVGK-ARSDLDMSQRTSDHKKCALAEGLNGEQGIDFSL 783
Query: 728 TKNSDVAGPFPNTREGSGDENSLADLTSGSCNGLASQEPVHMQPVVNQTNADLREAKLIV 787
T+N D+ P N GS D+ S D S + + P NQ A +E +
Sbjct: 784 TRNFDLNAPILNCEVGSCDKFSQGDHMFKQSIHPDSLKAKQIHPCKNQRAAGFQENPTVS 843
Query: 788 SADSSPSPVQNDAVPSSHLLKGDLDAKLQNLTADVALKREVSPLDNDFLNCSDKMAEKLG 847
SA PS ++D P+ ++ D D N + ++ K S LD DF+ + +M ++
Sbjct: 844 SASLYPSAFRDDLSPNLNMPLNDQD----NSSNIMSFKIAPSYLD-DFIISTGQMVSQII 898
Query: 848 FGESVSKKSNVEDVAYIQTPSIIQNKDQNKQEPLVIVGDVTGSMPSEHQFSPEVVSHLDA 907
S S S VED Q+ D N+ EP V+V D+ G + P + + +
Sbjct: 899 PEYSASGMSKVEDKISEQSRRC---NDVNRVEPFVVVEDMNGVV------CPYISEDVGS 949
Query: 908 TSSDEMSTNETESESIFPESLSQDSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLE 967
+S + TE+ESI PES S+D + DK+E SDAMIAEMEASIYGLQII+N DLE
Sbjct: 950 VV---VSLSHTEAESIVPESESEDFNDNQTDKNEFLSDAMIAEMEASIYGLQIIRNADLE 1006
Query: 968 ELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
+L ELGSGTYGTVYHGKWRG+DVAIKRIKKSCFAGRSSEQERL KDFWREA ILSNLHHP
Sbjct: 1007 DLTELGSGTYGTVYHGKWRGTDVAIKRIKKSCFAGRSSEQERLAKDFWREAQILSNLHHP 1066
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLH 1087
NVVAFYG+VPDG GGTLATVTE+MVNGSL+HVL+K +R LDRRKKLIIAMDAAFGMEYLH
Sbjct: 1067 NVVAFYGIVPDGAGGTLATVTEYMVNGSLRHVLVKNNRLLDRRKKLIIAMDAAFGMEYLH 1126
Query: 1088 SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNG 1147
SKNIVHFDLKC+NLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNG
Sbjct: 1127 SKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNG 1186
Query: 1148 SSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKL 1207
+S+RVSEKVDVFSFGISMWE+LTGEEPYADMHCGAIIGGIVKNTLRP +PERCD EWRKL
Sbjct: 1187 NSSRVSEKVDVFSFGISMWELLTGEEPYADMHCGAIIGGIVKNTLRPPVPERCDSEWRKL 1246
Query: 1208 MEQCWAADPEARPSFTEITSRLRTISAAIESK 1239
ME+CW+ DPE+RPSFTEITSRLR++S A+++K
Sbjct: 1247 MEECWSPDPESRPSFTEITSRLRSMSMALQAK 1278
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356524535|ref|XP_003530884.1| PREDICTED: uncharacterized protein LOC100790135 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1632), Expect = e-178, Method: Compositional matrix adjust.
Identities = 330/532 (62%), Positives = 385/532 (72%), Gaps = 18/532 (3%)
Query: 719 GGQKCNVSWTKNSDVAGPFPNTREGSGDENSLADLTSGSCNGLASQEPVHMQPVVNQTNA 778
G Q + S T+N D+ P N GS D+ S D S + + P NQ A
Sbjct: 773 GEQGVDFSLTRNFDLNAPTLNCEVGSCDKISQGDHMFKLSIHPDSLKAEQIHPSKNQMTA 832
Query: 779 DLREAKLIVSADSSPSPVQNDAVPSSHLLKGDLDAKLQNLTADVALKREVSPLDNDFLNC 838
+E + SA P+ +D PS ++ D D N + ++ K S LD DF+
Sbjct: 833 GFQENPTVSSASLYPAAFHDDLSPSPNMPLNDQD----NSSNIMSFKIAPSYLD-DFIIS 887
Query: 839 SDKMAEKLGFGESVSKKSNVEDVAYIQTPSIIQNKDQNKQEPLVIVGDVTGSMPSEHQFS 898
+ +M ++ S S S VED Q+ D N+ EP V+V D+TG +
Sbjct: 888 TGQMVNQIIPEHSASGMSKVEDKISEQSRRC---NDANRVEPFVVVEDMTGVV------R 938
Query: 899 PEVVSHLDATSSDEMSTNETESESIFPESLSQDSKADVRDKDESFSDAMIAEMEASIYGL 958
P + + S +S + E+ESI PES D D DK+E SDAMIAEMEASIYGL
Sbjct: 939 PYIS---EDVGSAVVSPSHMEAESIVPESEPADFNDDQTDKNEFLSDAMIAEMEASIYGL 995
Query: 959 QIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
QII+N DLE+L ELGSGTYGTVYHGKWRG+DVAIKRIKKSCFAGRSSEQERL KDFWREA
Sbjct: 996 QIIRNADLEDLTELGSGTYGTVYHGKWRGTDVAIKRIKKSCFAGRSSEQERLAKDFWREA 1055
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
ILSNLHHPNVVAFYG+VPDG GGTLATVTE+MVNGSL+HVL+K +R LDRRKKLI+AMD
Sbjct: 1056 QILSNLHHPNVVAFYGIVPDGAGGTLATVTEYMVNGSLRHVLVKNNRLLDRRKKLIVAMD 1115
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP 1138
AAFGMEYLHSKNIVHFDLKC+NLLVNLRDPQRPICKVGDFGLSRIK NTLVSGGVRGTLP
Sbjct: 1116 AAFGMEYLHSKNIVHFDLKCDNLLVNLRDPQRPICKVGDFGLSRIKCNTLVSGGVRGTLP 1175
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198
WMAPELLNG+S+RVSEKVDVFSFGISMWE+LTGEEPYADMHCGAIIGGIVKNTLRP +PE
Sbjct: 1176 WMAPELLNGNSSRVSEKVDVFSFGISMWELLTGEEPYADMHCGAIIGGIVKNTLRPHVPE 1235
Query: 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCINSEPKQTKP 1250
RCD EWRKLME+CW+ DPE+RPSFTEIT RLR++S A+++K N + Q +P
Sbjct: 1236 RCDSEWRKLMEECWSPDPESRPSFTEITGRLRSMSMALQAKG-NHQTYQLRP 1286
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477846|ref|XP_003632032.1| PREDICTED: uncharacterized protein LOC100264925 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 599 bits (1545), Expect = e-168, Method: Compositional matrix adjust.
Identities = 308/465 (66%), Positives = 357/465 (76%), Gaps = 15/465 (3%)
Query: 781 REAKLIVSADSSPSPVQNDAVPSSHLLKG---DLDAKLQNLTADVALKREVSPLDNDFLN 837
+EA + SA +PS N + PS +L K ++ +N + + D D LN
Sbjct: 726 QEAAVPSSASLTPS-AGNKSDPSLNLQKNYPLSTESSFENPDKKAVMSGVSTLKDEDPLN 784
Query: 838 --CSDKMAEKLGFGESVSKKSNVEDVAYIQTPSIIQNKDQNKQEPLVIVGDVTGSMPSEH 895
C + + F E + N D ++Q+ + + N VIV DVT +P
Sbjct: 785 FPCHEVDGPEGHFYERL----NPGDAIFVQSQPSDNHHNGNTPGAAVIVEDVTDILPPGI 840
Query: 896 QFSPEVVSHLDATSSDEM-STNETESESIFPESLSQDSKADVRDKDESFSDAMIAEMEAS 954
S ++ ++ +SD + S+ E E+ES ES ++ RD ES SDA +AEMEAS
Sbjct: 841 PSSSPLIPQVEDEASDVITSSGEAEAESDIQESEGEEG----RDLGESISDAAMAEMEAS 896
Query: 955 IYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDF 1014
IYGLQIIKN DLEEL+ELGSGT+GTVYHGKWRG+DVAIKRIKKSCFAGRSSEQERLTKDF
Sbjct: 897 IYGLQIIKNADLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCFAGRSSEQERLTKDF 956
Query: 1015 WREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI 1074
WREA ILSNLHHPNVVAFYGVVPDG GGTLATVTE+MVNGSL+HVLL+KDRSLDRRK+LI
Sbjct: 957 WREARILSNLHHPNVVAFYGVVPDGPGGTLATVTEYMVNGSLRHVLLRKDRSLDRRKRLI 1016
Query: 1075 IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR 1134
IAMDAAFGMEYLH KNIVHFDLKC+NLLVN+RD QRPICKVGDFGLSRIKRNTLVSGGVR
Sbjct: 1017 IAMDAAFGMEYLHLKNIVHFDLKCDNLLVNMRDTQRPICKVGDFGLSRIKRNTLVSGGVR 1076
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194
GTLPWMAPELLNGSSNRVSEKVDVFSFG++MWEILTGEEPYA+MHCGAIIGGIV NTLRP
Sbjct: 1077 GTLPWMAPELLNGSSNRVSEKVDVFSFGVAMWEILTGEEPYANMHCGAIIGGIVSNTLRP 1136
Query: 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239
IPERCDP+WRKLME+CW+ DP ARPSFTEIT+RLR +S AI++K
Sbjct: 1137 PIPERCDPDWRKLMEECWSPDPAARPSFTEITNRLRVMSMAIQTK 1181
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741916|emb|CBI33351.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 596 bits (1536), Expect = e-167, Method: Compositional matrix adjust.
Identities = 285/359 (79%), Positives = 316/359 (88%), Gaps = 5/359 (1%)
Query: 882 VIVGDVTGSMPSEHQFSPEVVSHLDATSSDEM-STNETESESIFPESLSQDSKADVRDKD 940
VIV DVT +P S ++ ++ +SD + S+ E E+ES ES ++ RD
Sbjct: 591 VIVEDVTDILPPGIPSSSPLIPQVEDEASDVITSSGEAEAESDIQESEGEEG----RDLG 646
Query: 941 ESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCF 1000
ES SDA +AEMEASIYGLQIIKN DLEEL+ELGSGT+GTVYHGKWRG+DVAIKRIKKSCF
Sbjct: 647 ESISDAAMAEMEASIYGLQIIKNADLEELKELGSGTFGTVYHGKWRGTDVAIKRIKKSCF 706
Query: 1001 AGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL 1060
AGRSSEQERLTKDFWREA ILSNLHHPNVVAFYGVVPDG GGTLATVTE+MVNGSL+HVL
Sbjct: 707 AGRSSEQERLTKDFWREARILSNLHHPNVVAFYGVVPDGPGGTLATVTEYMVNGSLRHVL 766
Query: 1061 LKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120
L+KDRSLDRRK+LIIAMDAAFGMEYLH KNIVHFDLKC+NLLVN+RD QRPICKVGDFGL
Sbjct: 767 LRKDRSLDRRKRLIIAMDAAFGMEYLHLKNIVHFDLKCDNLLVNMRDTQRPICKVGDFGL 826
Query: 1121 SRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC 1180
SRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFG++MWEILTGEEPYA+MHC
Sbjct: 827 SRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGVAMWEILTGEEPYANMHC 886
Query: 1181 GAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239
GAIIGGIV NTLRP IPERCDP+WRKLME+CW+ DP ARPSFTEIT+RLR +S AI++K
Sbjct: 887 GAIIGGIVSNTLRPPIPERCDPDWRKLMEECWSPDPAARPSFTEITNRLRVMSMAIQTK 945
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255554200|ref|XP_002518140.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223542736|gb|EEF44273.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1521), Expect = e-165, Method: Compositional matrix adjust.
Identities = 284/422 (67%), Positives = 334/422 (79%), Gaps = 6/422 (1%)
Query: 819 TADVALKREVSPLDNDFLNCSDKMAEKLGFGESVSKKSNVEDVAYIQTPSIIQNKDQNK- 877
A A R VSP D +N E + + + + D P + + QN+
Sbjct: 709 VATAASGRVVSPYYEDPVNYPGNNVEDVSIRGQLQMELKIRDA-----PKWLDDLHQNRV 763
Query: 878 QEPLVIVGDVTGSMPSEHQFSPEVVSHLDATSSDEMSTNETESESIFPESLSQDSKADVR 937
+V+V DVTG+ P + + ++ H++ +SDE ++ TE ES PES S+D++AD
Sbjct: 764 LGSVVLVEDVTGTTPPDIPLASRIIPHVEEDASDEFESHITEVESTAPESESEDAEADGG 823
Query: 938 DKDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKK 997
D+S +D I E+EA IYGLQIIKN D+EELRELGSGT+GTVY+GKWRG+DVAIKRIKK
Sbjct: 824 GTDDSINDVAITEIEAGIYGLQIIKNTDIEELRELGSGTFGTVYYGKWRGTDVAIKRIKK 883
Query: 998 SCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLK 1057
SCF+GR SEQERLTKDFWREA ILSNLHHPNVVAFYGVVPDG GGT+ATVTE+MVNGSL+
Sbjct: 884 SCFSGRISEQERLTKDFWREAKILSNLHHPNVVAFYGVVPDGPGGTMATVTEYMVNGSLR 943
Query: 1058 HVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117
H L KKD+ LD RK+LIIA+DAAFGMEYLH K+IVHFDLKC+NLLVNLRD QRPICKVGD
Sbjct: 944 HALQKKDKVLDHRKRLIIALDAAFGMEYLHLKDIVHFDLKCDNLLVNLRDSQRPICKVGD 1003
Query: 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177
FGLSRIKRNTLVSGGVRGTLPWMAPELL+G+SNRVSEKVDV+SFGI MWE+LTGEEPYA+
Sbjct: 1004 FGLSRIKRNTLVSGGVRGTLPWMAPELLDGNSNRVSEKVDVYSFGIVMWEVLTGEEPYAN 1063
Query: 1178 MHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237
MHCGAIIGGIV NTLRP IPERCDPEWRKLME+CW+ P ARPSFTEIT+RLR +S A++
Sbjct: 1064 MHCGAIIGGIVSNTLRPPIPERCDPEWRKLMEECWSFYPSARPSFTEITNRLRVMSMALQ 1123
Query: 1238 SK 1239
K
Sbjct: 1124 PK 1125
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147841871|emb|CAN78098.1| hypothetical protein VITISV_040388 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1516), Expect = e-165, Method: Compositional matrix adjust.
Identities = 288/399 (72%), Positives = 327/399 (81%), Gaps = 17/399 (4%)
Query: 854 KKSNVEDVAYIQTPSIIQNKDQNKQEPLVIVGDVTGSMPSEHQFSPEVVSHLDATSSDEM 913
++ N D ++Q+ + + N VIV DVT +P S ++ ++ +SD +
Sbjct: 829 ERLNPGDAIFVQSQPSDNHHNGNTPGGAVIVEDVTDILPPGIPSSSPLIPQVEDEASDVI 888
Query: 914 -STNETESESIFPESLSQDSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLEELREL 972
S+ E E+ES ES ++ RD ES SDA +AEMEASIYGLQ+IKN DLEEL+EL
Sbjct: 889 TSSGEAEAESDIQESEGEEG----RDLGESISDAAMAEMEASIYGLQMIKNADLEELKEL 944
Query: 973 GSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAF 1032
GSGT+GTVYHGKWRG+DVAIKRIKKSCFAGRSSEQERLTKDFWREA ILSNLHHPNVVAF
Sbjct: 945 GSGTFGTVYHGKWRGTDVAIKRIKKSCFAGRSSEQERLTKDFWREARILSNLHHPNVVAF 1004
Query: 1033 YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIV 1092
YGVVPDG GGTLATVTE+MVNGSL+HVLL+KDRSLDRRK+LIIAMDAAFGMEYLH KNIV
Sbjct: 1005 YGVVPDGPGGTLATVTEYMVNGSLRHVLLRKDRSLDRRKRLIIAMDAAFGMEYLHLKNIV 1064
Query: 1093 HFDLKCENLLVNLRDPQRPICK------------VGDFGLSRIKRNTLVSGGVRGTLPWM 1140
HFDLKC+NLLVN+RD QRPICK VGDFGLSRIKRNTLVSGGVRGTLPWM
Sbjct: 1065 HFDLKCDNLLVNMRDTQRPICKLEMHFIKRLPFQVGDFGLSRIKRNTLVSGGVRGTLPWM 1124
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
APELLNGSSNRVSEKVDVFSFG++MWEILTGEEPYA+MHCGAIIGGIV NTLRP IPERC
Sbjct: 1125 APELLNGSSNRVSEKVDVFSFGVAMWEILTGEEPYANMHCGAIIGGIVSNTLRPPIPERC 1184
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239
DP+WRKLME+CW+ DP ARPSFTEIT+RLR +S AI++K
Sbjct: 1185 DPDWRKLMEECWSPDPAARPSFTEITNRLRVMSMAIQTK 1223
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|186510389|ref|NP_189115.3| octicosapeptide/Phox/Bem1p domain-containing protein kinase [Arabidopsis thaliana] gi|11994655|dbj|BAB02883.1| unnamed protein product [Arabidopsis thaliana] gi|332643418|gb|AEE76939.1| octicosapeptide/Phox/Bem1p domain-containing protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 579 bits (1493), Expect = e-162, Method: Compositional matrix adjust.
Identities = 274/372 (73%), Positives = 309/372 (83%), Gaps = 16/372 (4%)
Query: 879 EPLVIVGDVTGSMPSEHQFSPEVVSHLDATSSDEMSTNETESESIFPESLSQDSKADVRD 938
+P T S+ + + SP+ + H TS D +IF LS++++A+
Sbjct: 762 QPAPATASETYSLKTPREDSPQSIPHAKITSGD----------TIF---LSEEAEANTGQ 808
Query: 939 KDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKS 998
K+ SF D + EMEAS+YGLQIIKN DLE+L ELGSGTYGTVYHG WRG+DVAIKRI+ S
Sbjct: 809 KENSFKDTLFVEMEASVYGLQIIKNADLEDLTELGSGTYGTVYHGTWRGTDVAIKRIRNS 868
Query: 999 CFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKH 1058
CFAGRSSEQERLTKDFWREA ILSNLHHPNVVAFYG+VPDGTGGTLATVTEFMVNGSL+H
Sbjct: 869 CFAGRSSEQERLTKDFWREAQILSNLHHPNVVAFYGIVPDGTGGTLATVTEFMVNGSLRH 928
Query: 1059 VLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118
LLKKDR LD RKK+IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD
Sbjct: 929 ALLKKDRLLDTRKKIIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDL 988
Query: 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADM 1178
GLSRIKRNTLVSGGVRGTLPWMAPELLNGSS RVSEKVDVFS+GIS+WEILTGEEPYADM
Sbjct: 989 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSTRVSEKVDVFSYGISLWEILTGEEPYADM 1048
Query: 1179 HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238
HCGAIIGGIVKNTLRP IP+ C PEW+KLMEQCW+ DP++RP FTEIT RLR++S + +
Sbjct: 1049 HCGAIIGGIVKNTLRPPIPKSCSPEWKKLMEQCWSVDPDSRPPFTEITCRLRSMSMEVVT 1108
Query: 1239 KCINSEPKQTKP 1250
K S+ ++ KP
Sbjct: 1109 K---SKRRENKP 1117
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297613457|ref|NP_001067178.2| Os12g0594300 [Oryza sativa Japonica Group] gi|255670446|dbj|BAF30197.2| Os12g0594300 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1488), Expect = e-161, Method: Compositional matrix adjust.
Identities = 272/361 (75%), Positives = 311/361 (86%), Gaps = 6/361 (1%)
Query: 882 VIVGDVTGSMPSEHQFSPEVVSHLDATSSDEM-----STNETESESIFPESLSQDSKADV 936
VIV D T + P S +V ++ + ++ S + ++ S PE L+ + D
Sbjct: 767 VIVEDATDNAPLGILSSRPLVPLVEVAAEEQQQVIISSLKDDDARSDVPE-LANEDHDDE 825
Query: 937 RDKDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIK 996
D S SDA +AE+EAS+YGLQII+N DLEELRELGSGT+GTVYHGKWRG+DVAIKRIK
Sbjct: 826 PAADGSISDAAVAELEASMYGLQIIRNADLEELRELGSGTFGTVYHGKWRGTDVAIKRIK 885
Query: 997 KSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSL 1056
KSCFAGRSSEQE+LTKDFWREA ILS LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSL
Sbjct: 886 KSCFAGRSSEQEKLTKDFWREAQILSKLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSL 945
Query: 1057 KHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116
++VLL+KDR LDRRK+LIIAMDAAFGMEYLHSK+IVHFDLKC+NLLVNLRDPQRPICKVG
Sbjct: 946 RNVLLRKDRMLDRRKRLIIAMDAAFGMEYLHSKSIVHFDLKCDNLLVNLRDPQRPICKVG 1005
Query: 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYA 1176
DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSS+RVSEKVDVFSFGI++WEILTGEEPYA
Sbjct: 1006 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSSRVSEKVDVFSFGIALWEILTGEEPYA 1065
Query: 1177 DMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236
+MHCGAIIGGIV NTLRP IP+ C+PEWR+LMEQCW+ADP+ RPSFTE+T RLR +S+A+
Sbjct: 1066 NMHCGAIIGGIVNNTLRPPIPKNCEPEWRQLMEQCWSADPDIRPSFTEVTDRLRAMSSAL 1125
Query: 1237 E 1237
+
Sbjct: 1126 K 1126
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297831338|ref|XP_002883551.1| hypothetical protein ARALYDRAFT_319179 [Arabidopsis lyrata subsp. lyrata] gi|297329391|gb|EFH59810.1| hypothetical protein ARALYDRAFT_319179 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1487), Expect = e-161, Method: Compositional matrix adjust.
Identities = 277/390 (71%), Positives = 315/390 (80%), Gaps = 22/390 (5%)
Query: 861 VAYIQTPSIIQNKDQNKQEPLVIVGDVTGSMPSEHQFSPEVVSHLDATSSDEMSTNETES 920
+ +++ PS+ N +P T S+ + + SP+ + H S D
Sbjct: 755 LGHVRIPSMDLN------QPAPATASETYSLKTPREDSPQSIPHTKMNSGD--------- 799
Query: 921 ESIFPESLSQDSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTV 980
+IF LS++++A++ K+ SF DA EMEAS+YGLQIIKN DLE+L ELGSGTY TV
Sbjct: 800 -TIF---LSEEAEANIGQKENSFKDARFVEMEASVYGLQIIKNADLEDLTELGSGTYETV 855
Query: 981 YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040
YHG WRG+DVAIKRI+ SCFAGRSSEQERLTKDFWREA ILSNLHHPNVVAFYG+VPDGT
Sbjct: 856 YHGTWRGTDVAIKRIRNSCFAGRSSEQERLTKDFWREAQILSNLHHPNVVAFYGIVPDGT 915
Query: 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCEN 1100
GGTLATVTEFMVNGSL+H LLKKDR LD RKK+IIAMDAAFGMEYLHSKNIVHFDLKCEN
Sbjct: 916 GGTLATVTEFMVNGSLRHALLKKDRLLDTRKKIIIAMDAAFGMEYLHSKNIVHFDLKCEN 975
Query: 1101 LLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFS 1160
LLVNLRDPQRPICKVGD GLSRIKRNTLVSGGVRGTLPWMAPELLNGSS RVSEKVDVFS
Sbjct: 976 LLVNLRDPQRPICKVGDLGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSTRVSEKVDVFS 1035
Query: 1161 FGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARP 1220
+GIS+WEILTGEEPYADMHCGAIIGGIVKNTLRP IP+ C PEW+KLMEQCW+ DP++RP
Sbjct: 1036 YGISLWEILTGEEPYADMHCGAIIGGIVKNTLRPPIPKSCSPEWKKLMEQCWSVDPDSRP 1095
Query: 1221 SFTEITSRLRTISAAIESKCINSEPKQTKP 1250
FTEIT RLR++S I +K S+ + KP
Sbjct: 1096 PFTEITCRLRSMSMEIVTK---SKRRDNKP 1122
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1254 | ||||||
| TAIR|locus:2093146 | 1117 | AT3G24715 [Arabidopsis thalian | 0.283 | 0.318 | 0.706 | 1.9e-234 | |
| TAIR|locus:2197788 | 1042 | AT1G04700 [Arabidopsis thalian | 0.287 | 0.345 | 0.696 | 1.2e-190 | |
| TAIR|locus:2044702 | 1257 | AT2G35050 [Arabidopsis thalian | 0.270 | 0.269 | 0.668 | 1.1e-169 | |
| TAIR|locus:2206350 | 1248 | AT1G79570 [Arabidopsis thalian | 0.264 | 0.266 | 0.717 | 4e-169 | |
| TAIR|locus:2032895 | 1147 | AT1G16270 [Arabidopsis thalian | 0.281 | 0.307 | 0.662 | 4.5e-165 | |
| TAIR|locus:2174552 | 1054 | AT5G57610 [Arabidopsis thalian | 0.270 | 0.321 | 0.636 | 1.1e-146 | |
| TAIR|locus:2102787 | 1171 | AT3G46920 [Arabidopsis thalian | 0.286 | 0.306 | 0.590 | 2.4e-140 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.405 | 0.545 | 0.286 | 1.1e-42 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.213 | 0.350 | 0.378 | 6e-42 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.257 | 0.417 | 0.347 | 6.1e-41 |
| TAIR|locus:2093146 AT3G24715 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1365 (485.6 bits), Expect = 1.9e-234, Sum P(2) = 1.9e-234
Identities = 263/372 (70%), Positives = 297/372 (79%)
Query: 879 EPLVIVGDVTGSMPSEHQFSPEVVSHLDATSSDEMSTNETESESIFPESLSQDSKADVRD 938
+P T S+ + + SP+ + H TS D +IF LS++++A+
Sbjct: 762 QPAPATASETYSLKTPREDSPQSIPHAKITSGD----------TIF---LSEEAEANTGQ 808
Query: 939 KDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKS 998
K+ SF D + EMEAS+YGLQIIKN DLE+L ELGSGTYGTVYHG WRG+DVAIKRI+ S
Sbjct: 809 KENSFKDTLFVEMEASVYGLQIIKNADLEDLTELGSGTYGTVYHGTWRGTDVAIKRIRNS 868
Query: 999 CFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKH 1058
CFAGRSSEQERLTKDFWREA ILSNLHHPNVVAFYG+VPDGTGGTLATVTEFMVNGSL+H
Sbjct: 869 CFAGRSSEQERLTKDFWREAQILSNLHHPNVVAFYGIVPDGTGGTLATVTEFMVNGSLRH 928
Query: 1059 VXXXXXXXXXXXXXXIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118
IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD
Sbjct: 929 ALLKKDRLLDTRKKIIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDL 988
Query: 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADM 1178
GLSRIKRNTLVSGGVRGTLPWMAPELLNGSS RVSEKVDVFS+GIS+WEILTGEEPYADM
Sbjct: 989 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSTRVSEKVDVFSYGISLWEILTGEEPYADM 1048
Query: 1179 HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238
HCGAIIGGIVKNTLRP IP+ C PEW+KLMEQCW+ DP++RP FTEIT RLR++S + +
Sbjct: 1049 HCGAIIGGIVKNTLRPPIPKSCSPEWKKLMEQCWSVDPDSRPPFTEITCRLRSMSMEVVT 1108
Query: 1239 KCINSEPKQTKP 1250
K S+ ++ KP
Sbjct: 1109 K---SKRRENKP 1117
|
|
| TAIR|locus:2197788 AT1G04700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1326 (471.8 bits), Expect = 1.2e-190, Sum P(3) = 1.2e-190
Identities = 252/362 (69%), Positives = 291/362 (80%)
Query: 880 PLVIVGDVTGSMPSEHQFSPEVVSHLDATSSDEMS--TNETESESIFPESLSQDSKADVR 937
P +IV DVT + S++ S +V ++ S D+ T E E + ES ++ R
Sbjct: 678 PQLIVEDVTNEVISDNLLSATIVPQVNRESDDDHKSYTREKEITNADHESEMEEKYKKSR 737
Query: 938 DKDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKK 997
+ D+SFS+A + E+EA IYGLQIIKN DLE+L ELGSGT+GTVY+GKWRG+DVAIKRIK
Sbjct: 738 NTDDSFSEAAMVEIEAGIYGLQIIKNTDLEDLHELGSGTFGTVYYGKWRGTDVAIKRIKN 797
Query: 998 SCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLK 1057
SCF+G SSEQ R TKDFWREA IL+NLHHPNVVAFYGVVPDG GGT+ATVTE+MVNGSL+
Sbjct: 798 SCFSGGSSEQARQTKDFWREARILANLHHPNVVAFYGVVPDGPGGTMATVTEYMVNGSLR 857
Query: 1058 HVXXXXXXXXXXXXXXIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117
HV +I +D+AFGMEYLH KNIVHFDLKC+NLLVNLRDPQRPICKVGD
Sbjct: 858 HVLQRKDRLLDRRKKLMITLDSAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGD 917
Query: 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177
FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGI MWEILTGEEPYA+
Sbjct: 918 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGIVMWEILTGEEPYAN 977
Query: 1178 MHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237
+HCGAIIGGIV NTLRP +PERC+ EWRKLMEQCW+ DP RPSFTEI RLR+++ A++
Sbjct: 978 LHCGAIIGGIVNNTLRPPVPERCEAEWRKLMEQCWSFDPGVRPSFTEIVERLRSMTVALQ 1037
Query: 1238 SK 1239
K
Sbjct: 1038 PK 1039
|
|
| TAIR|locus:2044702 AT2G35050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1185 (422.2 bits), Expect = 1.1e-169, Sum P(4) = 1.1e-169
Identities = 236/353 (66%), Positives = 273/353 (77%)
Query: 896 QFSPEVVSHLDATSSDEMST------NETESESIFPESLSQDSKADVRDKDESFSDAMIA 949
Q P++ H D ++ST N +++ + S SQ A+ D + +I
Sbjct: 900 QIHPQI--HFDGNIKPDVSTITIPDLNTVDTQEDY--SQSQIKGAESTDATLNAGVPLID 955
Query: 950 EMEAS--IYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQ 1007
M A + LQ+IKN DLEEL+ELGSGT+GTVYHGKWRG+DVAIKRIK+SCF GRSSEQ
Sbjct: 956 FMAADSGMRSLQVIKNDDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKRSCFIGRSSEQ 1015
Query: 1008 ERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVXXXXXXXX 1067
ERLT +FW EA ILS LHHPNV+AFYGVV DG GGTLATVTE+MVNGSL+HV
Sbjct: 1016 ERLTSEFWHEAEILSKLHHPNVMAFYGVVKDGPGGTLATVTEYMVNGSLRHVLLSNRHLD 1075
Query: 1068 XXXXXXIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT 1127
IIAMDAAFGMEYLHSK+IVHFDLKC+NLLVNL+DP RPICKVGDFGLS+IKRNT
Sbjct: 1076 RRKRL-IIAMDAAFGMEYLHSKSIVHFDLKCDNLLVNLKDPARPICKVGDFGLSKIKRNT 1134
Query: 1128 LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGI 1187
LV+GGVRGTLPWMAPELL+GSS++VSEKVDVFSFGI +WEILTGEEPYA+MH GAIIGGI
Sbjct: 1135 LVTGGVRGTLPWMAPELLSGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGI 1194
Query: 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA-AIESK 1239
V NTLRPT+P CDPEWR LMEQCWA DP RP+F EI RLRT+S+ A+ +K
Sbjct: 1195 VNNTLRPTVPNYCDPEWRMLMEQCWAPDPFVRPAFPEIARRLRTMSSSAVHTK 1247
|
|
| TAIR|locus:2206350 AT1G79570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1216 (433.1 bits), Expect = 4.0e-169, Sum P(3) = 4.0e-169
Identities = 239/333 (71%), Positives = 263/333 (78%)
Query: 907 ATSSDEMSTNETESESIFPESLSQDSKADVRDKDESFSDAMIA-EMEASIYGLQIIKNVD 965
A +++M E+E E+L +K E+ A+ E GLQIIKN D
Sbjct: 904 ALENEQMKVTESEEFGAMVENLRTPDSEPKDEKTETRHAALPPLGSEFDYSGLQIIKNED 963
Query: 966 LEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
LEELRELGSGT+GTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLT +FW EA ILS LH
Sbjct: 964 LEELRELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTGEFWGEAEILSKLH 1023
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVXXXXXXXXXXXXXXIIAMDAAFGMEY 1085
HPNVVAFYGVV DG GGTLATVTE+MV+GSL+HV IIAMDAAFGMEY
Sbjct: 1024 HPNVVAFYGVVKDGPGGTLATVTEYMVDGSLRHVLVRKDRHLDRRKRLIIAMDAAFGMEY 1083
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELL 1145
LHSKN VHFDLKC+NLLVNL+DP RPICKVGDFGLS+IKRNTLVSGGVRGTLPWMAPELL
Sbjct: 1084 LHSKNTVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWMAPELL 1143
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205
NGSS++VSEKVDVFSFGI +WEILTGEEPYA+MH GAIIGGIV NTLRPTIP CD EWR
Sbjct: 1144 NGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGAIIGGIVNNTLRPTIPGFCDDEWR 1203
Query: 1206 KLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238
LME+CWA +P ARPSFTEI RLR +S+A S
Sbjct: 1204 TLMEECWAPNPMARPSFTEIAGRLRVMSSAATS 1236
|
|
| TAIR|locus:2032895 AT1G16270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1208 (430.3 bits), Expect = 4.5e-165, Sum P(2) = 4.5e-165
Identities = 243/367 (66%), Positives = 276/367 (75%)
Query: 889 GSMPSEHQFSPEVVSHLDATSSDEMSTNETESESIFPESL------SQDSKADVRDKDES 942
G + HQ +P + +D +M E+E E+L +D K++ R+
Sbjct: 786 GEIARLHQVAPLTENRVDP----QMKVTESEEFDAMVENLRTSDCEQEDEKSETRNAGLP 841
Query: 943 FSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAG 1002
+A+ + S GLQII N DLEEL+ELGSGT+GTVYHGKWRGSDVAIKRIKKSCFAG
Sbjct: 842 PVGPSLADYDTS--GLQIIMNDDLEELKELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAG 899
Query: 1003 RSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVXXX 1062
RSSEQERLT +FW EA ILS LHHPNVVAFYGVV DG G TLATVTE+MV+GSL+HV
Sbjct: 900 RSSEQERLTGEFWGEAEILSKLHHPNVVAFYGVVKDGPGATLATVTEYMVDGSLRHVLVR 959
Query: 1063 XXXXXXXXXXXIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122
IIAMDAAFGMEYLH+KNIVHFDLKC+NLLVNL+DP RPICKVGDFGLS+
Sbjct: 960 KDRHLDRRKRLIIAMDAAFGMEYLHAKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSK 1019
Query: 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA 1182
IKRNTLVSGGVRGTLPWMAPELLNGSS++VSEKVDVFSFGI +WEILTGEEPYA+MH GA
Sbjct: 1020 IKRNTLVSGGVRGTLPWMAPELLNGSSSKVSEKVDVFSFGIVLWEILTGEEPYANMHYGA 1079
Query: 1183 IIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCIN 1242
IIGGIV NTLRPTIP CD +WR LME+CWA +P ARPSFTEI RLR +S A S
Sbjct: 1080 IIGGIVNNTLRPTIPSYCDSDWRILMEECWAPNPTARPSFTEIAGRLRVMSTAATSN--Q 1137
Query: 1243 SEPKQTK 1249
S+P K
Sbjct: 1138 SKPPAHK 1144
|
|
| TAIR|locus:2174552 AT5G57610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1145 (408.1 bits), Expect = 1.1e-146, Sum P(2) = 1.1e-146
Identities = 217/341 (63%), Positives = 259/341 (75%)
Query: 900 EVVSHLDATSSDEMSTNETESESIFPESLSQDSKADVRDKDESFS-DAMIAEMEASIYGL 958
EV +H + + D++ E+ES + + D +F + AE EA GL
Sbjct: 715 EVKAHPEE-AKDQVRPELVENESEHMNAQDEPEIDSDSDNPNNFKIEQTKAEAEAKSRGL 773
Query: 959 QIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
Q I+N DLEE+RELG GTYG+VYHGKW+GSDVAIKRIK SCFAG+ SE+ERL +DFW+EA
Sbjct: 774 QSIRNDDLEEIRELGHGTYGSVYHGKWKGSDVAIKRIKASCFAGKPSERERLIEDFWKEA 833
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVXXXXXXXXXXXXXXIIAMD 1078
+LS+LHHPNVV+FYG+V DG G+LATV EFMVNGSLK IIAMD
Sbjct: 834 LLLSSLHHPNVVSFYGIVRDGPDGSLATVAEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 893
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP 1138
AFGMEYLH KNIVHFDLKCENLLVN+RDPQRPICK+GD GLS++K+ TLVSGGVRGTLP
Sbjct: 894 TAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGDLGLSKVKQKTLVSGGVRGTLP 953
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198
WMAPELL+G SN VSEK+DV+SFGI MWE+LTGEEPYADMHC +IIGGIV N LRP IP+
Sbjct: 954 WMAPELLSGKSNMVSEKIDVYSFGIVMWELLTGEEPYADMHCASIIGGIVNNALRPKIPQ 1013
Query: 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239
CDPEW+ LME CW ++P RPSFTEI+ +LRT++AA+ K
Sbjct: 1014 WCDPEWKGLMESCWTSEPTERPSFTEISQKLRTMAAAMNLK 1054
|
|
| TAIR|locus:2102787 AT3G46920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1072 (382.4 bits), Expect = 2.4e-140, Sum P(2) = 2.4e-140
Identities = 219/371 (59%), Positives = 264/371 (71%)
Query: 870 IQNKDQNKQEPLVIVGDVTGSMPSEHQFSPEVVSHLDATSSDEMSTN-ETESESIFPESL 928
I+ + QN E V + S PS H+ P V S E+S N E + +S + +
Sbjct: 802 IKQELQNVAEG-VAASVLQSSTPSYHE-PPIKVDEYAFNSKGEVSRNDEMKQQSTHFKDI 859
Query: 929 SQDSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGS 988
++ + + S SD S+ LQIIK+ DLEELRELGSGT+GTVYHGKWRG+
Sbjct: 860 -RNQLLERLNFGYSGSD--------SLDQLQIIKDSDLEELRELGSGTFGTVYHGKWRGT 910
Query: 989 DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVT 1048
DVAIKRI CFAG+ SEQER+ DFW EA L+ LHHPNVVAFYGVV D GG++ATVT
Sbjct: 911 DVAIKRINDRCFAGKPSEQERMIDDFWNEAQNLAGLHHPNVVAFYGVVLDSPGGSVATVT 970
Query: 1049 EFMVNGSLKHVXXXXXXXXXXXXXXIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDP 1108
E+MVNGSL++ +IAMD AFGMEYLH K IVHFDLK +NLLVNLRDP
Sbjct: 971 EYMVNGSLRNALQKNVRNFDRCKRQLIAMDIAFGMEYLHGKKIVHFDLKSDNLLVNLRDP 1030
Query: 1109 QRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEI 1168
RPICKVGD GLS++K TL+SGGVRGTLPWMAPELLNG+S+ VSEKVDVFSFGI +WE+
Sbjct: 1031 HRPICKVGDLGLSKVKCQTLISGGVRGTLPWMAPELLNGTSSLVSEKVDVFSFGIVLWEL 1090
Query: 1169 LTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228
TGEEPYAD+H GAIIGGIV NTLRP IP+ CD +W+ LME+CW+A+P RPSFTEI +
Sbjct: 1091 FTGEEPYADLHYGAIIGGIVSNTLRPQIPDFCDMDWKLLMERCWSAEPSERPSFTEIVNE 1150
Query: 1229 LRTISAAIESK 1239
LRT++ + SK
Sbjct: 1151 LRTMATKLPSK 1161
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 486 (176.1 bits), Expect = 1.1e-42, P = 1.1e-42
Identities = 158/551 (28%), Positives = 247/551 (44%)
Query: 701 SRDMLSASTHCES-SSTVVG-GQK-CNVSWTKNSDVAGPFPNTREGSGDENSLADLTSGS 757
S +++ST E+ SST +G G + + ++ + P+ N +N ADL
Sbjct: 405 SPSSVTSSTQLENNSSTAIGKGSRGAIIECSRTNMNIVPY-NQNSEEDPKNLFADLNPFQ 463
Query: 758 CNGLASQEPVHMQPVVNQTNAD-LREAKLIVSADSSPSPVQNDAVPSSHLLKGDLDAKLQ 816
G + ++M N D + K SP+P+ + K ++ ++
Sbjct: 464 NKGA---DKLYMPTKSGLNNVDDFHQQKNNPLVGRSPAPMMWKNYSCNEAPKRKENSYIE 520
Query: 817 NLTADVALKREVSPLDNDFLNCSDKMAEKLGFGESVSKKSNVEDVAYIQTPSIIQNKDQN 876
NL + + + S A +V + NV V+ + PS + + N
Sbjct: 521 NLLPKLHRDPRYGNTQSSYATSSSNGA----ISSNVHGRDNVTFVSPVAVPSSFTSTE-N 575
Query: 877 KQEPLVIVGDVTGSMPSEHQFSPEVVSHLDATSSDEMS-------TNETESESIFPESLS 929
+ P IV D+ + +E P + + +DE T++ S P
Sbjct: 576 QFRPS-IVEDMNRNTNNELDLQPHTAAVVHGQQNDESHIHDHRKYTSDDISTGCDPRLKD 634
Query: 930 QDSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSD 989
+S + D +D + + +A + +I N DL +G G+YG VYH W G++
Sbjct: 635 HESTSSSLDSTSYRNDPQVLD-DADVGECEIPWN-DLVIAERIGLGSYGEVYHADWHGTE 692
Query: 990 VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTE 1049
VA+K+ F+G + +F E I+ L HPNVV F G V L+ VTE
Sbjct: 693 VAVKKFLDQDFSGAA------LAEFRSEVRIMRRLRHPNVVFFLGAVTRPPN--LSIVTE 744
Query: 1050 FMVNGSLKHVXXXXXXXXXXXXXXIIAMDAAFGMEYLHSKN--IVHFDLKCENLLVNLRD 1107
F+ GSL + +A+D A GM LH+ IVH DLK NLLV D
Sbjct: 745 FLPRGSLYRILHRPKSHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLV---D 801
Query: 1108 PQRPICKVGDFGLSRIKRNTLVSG-GVRGTLPWMAPELL-NGSSNRVSEKVDVFSFGISM 1165
+ KVGDFGLSR+K NT +S GT WMAPE+L N SN EK DV+SFG+ +
Sbjct: 802 NNWNV-KVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN---EKCDVYSFGVIL 857
Query: 1166 WEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
WE+ T P+ M+ ++G + R IP+ DP +++ +CW DP RPSF ++
Sbjct: 858 WELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQL 917
Query: 1226 TSRLRTISAAI 1236
T L+ ++ +
Sbjct: 918 TEVLKPLNRLV 928
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 473 (171.6 bits), Expect = 6.0e-42, Sum P(2) = 6.0e-42
Identities = 108/285 (37%), Positives = 156/285 (54%)
Query: 950 EMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQER 1009
+M++ +I+ DL ++G G+ GTVYHG W GSDVA+K K ++ E
Sbjct: 472 DMDSDCLDYEILWE-DLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYS------EE 524
Query: 1010 LTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVXXXXXXXXXX 1069
+ F +E ++ L HPNV+ F G V + L VTEF+ GSL +
Sbjct: 525 IITSFKQEVSLMKRLRHPNVLLFMGAV--ASPQRLCIVTEFLPRGSLFRLLQRNKSKLDL 582
Query: 1070 XXXXIIAMDAAFGMEYLH--SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT 1127
+A D A GM YLH S I+H DLK NLLV+ + KV DFGLSRIK T
Sbjct: 583 RRRIHMASDIARGMNYLHHCSPPIIHRDLKSSNLLVD----RNWTVKVADFGLSRIKHET 638
Query: 1128 LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGI 1187
++ RGT WMAPE+L + EK DV+SFG+ +WE++T + P+ +++ +IG +
Sbjct: 639 YLTTNGRGTPQWMAPEVLRNEA--ADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAV 696
Query: 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
R +P+ DP+W LME CW ++P+ RPSF E+ +LR +
Sbjct: 697 GFMNQRLEVPKDVDPQWIALMESCWHSEPQCRPSFQELMDKLREL 741
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 467 (169.5 bits), Expect = 6.1e-41, P = 6.1e-41
Identities = 119/342 (34%), Positives = 177/342 (51%)
Query: 895 HQFSPEVVSHLDATSSDEMSTNETESESIFPESLSQDSKADVRDKDESFSDAMIAEMEAS 954
HQ +P ++ + + E+ S++ ++ +S + S S +++ +++
Sbjct: 423 HQINPSAGVQYESHAFESNKPINNEASSLWSSPINANSTSSASSCG-STSSSVMNKVDTD 481
Query: 955 IYGLQI-IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKD 1013
GL+ I DL ++G G+ GTVYHG W GSDVA+K K + S+E + +
Sbjct: 482 SEGLEYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSKQEY---SAE---VIES 535
Query: 1014 FWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVXXXXXXXXXXXXXX 1073
F +E ++ L HPNV+ F G V L V+EF+ GSL +
Sbjct: 536 FKQEVLLMKRLRHPNVLLFMGAVTSPQ--RLCIVSEFLPRGSLFRLLQKSTSKLDWRRRI 593
Query: 1074 IIAMDAAFGMEYLH--SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT-LVS 1130
+A+D A GM YLH S I+H DLK NLLV D + KV DFGLSRIK T L S
Sbjct: 594 HMALDIARGMNYLHHCSPPIIHRDLKSSNLLV---DKNWTV-KVADFGLSRIKHETYLTS 649
Query: 1131 GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN 1190
+GT WMAPE+L S EK D++SFG+ +WE+ T + P+ ++ +IG +
Sbjct: 650 KSGKGTPQWMAPEVLRNES--ADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGFM 707
Query: 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
R IP+ DP W LME CW +D + RP+F E+ +LR +
Sbjct: 708 DQRLEIPKDIDPRWISLMESCWHSDTKLRPTFQELMDKLRDL 749
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00020465001 | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (1106 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1254 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-81 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-80 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-80 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-74 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-62 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-59 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-58 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-51 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-49 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-49 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-48 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-47 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-46 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-46 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-46 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-45 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-44 | |
| cd06410 | 97 | cd06410, PB1_UP2, Uncharacterized protein 2 | 2e-44 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-43 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-43 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-42 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-42 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-41 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-40 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-40 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-40 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-39 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-39 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-39 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-38 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-37 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-37 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-36 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-36 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-36 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-36 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-36 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-35 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-35 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-35 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-35 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-35 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-34 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-34 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-34 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-33 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-33 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-33 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-32 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-32 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-32 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-32 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-31 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-31 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-31 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-31 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-31 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-30 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-30 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-30 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-29 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-29 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-29 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-29 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-28 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-28 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-28 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-28 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-28 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-28 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-28 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-27 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-27 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-26 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-26 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-25 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-25 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-25 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-25 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-25 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-25 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-23 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-23 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-22 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-21 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-21 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-21 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-21 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-21 | |
| pfam00564 | 84 | pfam00564, PB1, PB1 domain | 2e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-20 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-19 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-19 | |
| smart00666 | 81 | smart00666, PB1, PB1 domain | 2e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-19 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-19 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-19 | |
| cd05992 | 81 | cd05992, PB1, The PB1 domain is a modular domain m | 7e-19 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-18 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-18 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-17 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-16 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-15 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-13 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-06 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 6e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 265 bits (681), Expect = 5e-81
Identities = 107/274 (39%), Positives = 144/274 (52%), Gaps = 26/274 (9%)
Query: 966 LEELRELGSGTYGTVYHGKWRGS------DVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
LE ++LG G +G VY G +G VA+K +K+ +SE+ER ++F EA
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG-----ASEEER--EEFLEEAS 53
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
I+ L HPN+V GV G L VTE+M G L L K L + L +A+
Sbjct: 54 IMKKLSHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQI 111
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGT 1136
A GMEYL SKN VH DL N LV + + K+ DFGLSR GG +
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVT----ENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195
+ WMAPE L + + K DV+SFG+ +WEI T GE+PY M ++ + ++ R
Sbjct: 168 IKWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLP 224
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
PE C E +LM QCWA DPE RP+F+E+ L
Sbjct: 225 RPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 263 bits (675), Expect = 3e-80
Identities = 107/274 (39%), Positives = 141/274 (51%), Gaps = 26/274 (9%)
Query: 966 LEELRELGSGTYGTVYHGKWRGS------DVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
L ++LG G +G VY G +G +VA+K +K+ +SEQ+ ++F REA
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-----ASEQQI--EEFLREAR 53
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLK-KDRSLDRRKKLIIAMD 1078
I+ L HPN+V GV L V E+M G L L K + + L L A+
Sbjct: 54 IMRKLDHPNIVKLLGVC--TEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ 111
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP 1138
A GMEYL SKN +H DL N LV + + K+ DFGLSR + G LP
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 1139 --WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195
WMAPE L + + K DV+SFG+ +WEI T GEEPY M ++ +K R
Sbjct: 168 IRWMAPESLK--EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLE-YLKKGYRLP 224
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
P C PE KLM QCWA DPE RP+F+E+ L
Sbjct: 225 KPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 263 bits (674), Expect = 4e-80
Identities = 107/273 (39%), Positives = 140/273 (51%), Gaps = 25/273 (9%)
Query: 966 LEELRELGSGTYGTVYHGKWRGS------DVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
L ++LG G +G VY GK +G +VA+K +K+ SEQ+ ++F REA
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-----SEQQI--EEFLREAR 53
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
I+ L HPNVV GV + + V E+M G L L K L L A+
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEPLYI--VMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQI 111
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP- 1138
A GMEYL SKN +H DL N LV + + K+ DFGLSR + G LP
Sbjct: 112 ARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDFGLSRDLYDDDYYRKRGGKLPI 167
Query: 1139 -WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTI 1196
WMAPE L + + K DV+SFG+ +WEI T GE+PY M ++ +KN R
Sbjct: 168 RWMAPESLK--EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEY-LKNGYRLPQ 224
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
P C PE LM QCWA DPE RP+F+E+ L
Sbjct: 225 PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 246 bits (630), Expect = 5e-74
Identities = 103/278 (37%), Positives = 138/278 (49%), Gaps = 33/278 (11%)
Query: 970 RELGSGTYGTVYHGKWRGS-----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
++LG G +G VY GK +G +VA+K +K+ +SE+ER KDF +EA ++ L
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-----ASEEER--KDFLKEARVMKKL 53
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK--------DRSLDRRKKLIIA 1076
HPNVV GV + L V E+M G L L K +L + L A
Sbjct: 54 GHPNVVRLLGVCTEE--EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 1077 MDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLV-SGGVRG 1135
+ A GMEYL SK VH DL N LV + + K+ DFGLSR + G
Sbjct: 112 IQIAKGMEYLASKKFVHRDLAARNCLVG----EDLVVKISDFGLSRDVYDDDYYRKKTGG 167
Query: 1136 TLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL 1192
LP WMAPE L + K DV+SFG+ +WEI T G PY + ++ ++
Sbjct: 168 KLPIRWMAPESLK--DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE-YLRKGY 224
Query: 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230
R PE C E +LM CW DPE RP+F+E+ RL
Sbjct: 225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 2e-62
Identities = 89/266 (33%), Positives = 128/266 (48%), Gaps = 26/266 (9%)
Query: 967 EELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E L +LG G++G VY + + + VAIK IKK + ++ + RE IL L
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK-------KIKKDRERILREIKILKKL 54
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR-SLDRRKKLI--IAMDAAF 1081
HPN+V Y V D L V E+ G L +L K+ R S D + + I
Sbjct: 55 KHPNIVRLYDVFEDED--KLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILS---- 108
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMA 1141
+EYLHSK IVH DLK EN+L++ + K+ DFGL+R GT +MA
Sbjct: 109 ALEYLHSKGIVHRDLKPENILLD----EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMA 164
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY-ADMHCGAIIGGIVKNTLRPTIPE-R 1199
PE+L G + VD++S G+ ++E+LTG+ P+ D + I K PE
Sbjct: 165 PEVLLG--KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD 222
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEI 1225
PE + L+ + DPE R + E
Sbjct: 223 ISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 1e-59
Identities = 90/269 (33%), Positives = 139/269 (51%), Gaps = 24/269 (8%)
Query: 966 LEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
E LR+LGSG++GTVY K +G+ VA+K +KK S++++ RE IL
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKR---SEKSKKDQT---ARREIRILRR 54
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR-SLDRRKKLIIAMDAAFG 1082
L HPN+V L V E+ G L L + S D KK+ + + G
Sbjct: 55 LSHPNIVRLIDAF--EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQI--LRG 110
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK-RNTLVSGGVRGTLPWMA 1141
+EYLHS I+H DLK EN+L++ + + K+ DFGL++ +++ GT +MA
Sbjct: 111 LEYLHSNGIIHRDLKPENILLD----ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMA 166
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY--ADMHCG-AIIGGIVKNTLRPTIPE 1198
PE+L G N KVDV+S G+ ++E+LTG+ P+ ++ +I I+ L P+
Sbjct: 167 PEVLLG-GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPK 225
Query: 1199 RCD--PEWRKLMEQCWAADPEARPSFTEI 1225
E + L+++C DP RP+ EI
Sbjct: 226 WSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 3e-58
Identities = 85/261 (32%), Positives = 124/261 (47%), Gaps = 49/261 (18%)
Query: 972 LGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG G +GTVY + + + VAIK IKK + L ++ RE IL L+HPN+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE-------DSSSLLEELLREIEILKKLNHPNI 53
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK 1089
V YGV L V E+ GSLK +L + + L + L I + G+EYLHS
Sbjct: 54 VKLYGVF--EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN 111
Query: 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSGGVRGTLPWMAPELLNGS 1148
I+H DLK EN+L++ + + K+ DFGLS+ + + + + GT +MAPE+L G
Sbjct: 112 GIIHRDLKPENILLDSDNGK---VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK 168
Query: 1149 SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLM 1208
SEK D++S G+ ++E+ PE + L+
Sbjct: 169 GY-YSEKSDIWSLGVILYEL---------------------------------PELKDLI 194
Query: 1209 EQCWAADPEARPSFTEITSRL 1229
+ DPE RPS EI L
Sbjct: 195 RKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 8e-51
Identities = 99/272 (36%), Positives = 138/272 (50%), Gaps = 26/272 (9%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+L+ +G G +G V G +RG VA+K +K A ++ F EA +++ L
Sbjct: 7 ELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQA---------FLAEASVMTTL 57
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS-LDRRKKLIIAMDAAFGM 1083
HPN+V GVV G L VTE+M GSL L + R+ + ++L A+D GM
Sbjct: 58 RHPNLVQLLGVVLQGNP--LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGM 115
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP--WMA 1141
EYL KN VH DL N+LV+ + KV DFGL++ SG LP W A
Sbjct: 116 EYLEEKNFVHRDLAARNVLVSEDL----VAKVSDFGLAKEASQGQDSG----KLPVKWTA 167
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
PE L + S K DV+SFGI +WEI + G PY + ++ + K R PE C
Sbjct: 168 PEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGC 224
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
PE K+M+ CW DP RP+F ++ +L I
Sbjct: 225 PPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 3e-49
Identities = 92/266 (34%), Positives = 133/266 (50%), Gaps = 23/266 (8%)
Query: 969 LRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
R+LG+G +G V+ G W G+ VA+K +K + + F +EA I+ L H
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---------PEAFLQEAQIMKKLRHD 61
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAMDAAFGMEYL 1086
+V Y V + + VTE+M GSL L + R +L+ +A A GM YL
Sbjct: 62 KLVQLYAVCSEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVS-GGVRGTLPWMAPEL 1144
S+N +H DL N+LV + +CK+ DFGL+R I+ + + G + + W APE
Sbjct: 120 ESRNYIHRDLAARNILVG----ENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEA 175
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPE 1203
N R + K DV+SFGI + EI+T G PY M ++ + + R P C E
Sbjct: 176 AN--YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPRPPNCPEE 232
Query: 1204 WRKLMEQCWAADPEARPSFTEITSRL 1229
LM QCW DPE RP+F + S L
Sbjct: 233 LYDLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 3e-49
Identities = 95/277 (34%), Positives = 136/277 (49%), Gaps = 27/277 (9%)
Query: 962 KNVDLEELRELGSGTYGTVYHGKWRGS-----DVAIKRIKKSCFAGRSSEQERLTKDFWR 1016
V +E+ +G G +G V G+ + DVAIK +K S+++RL DF
Sbjct: 4 SYVTIEK--VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-----SDKQRL--DFLT 54
Query: 1017 EAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIA 1076
EA I+ HPN++ GVV + +TE+M NGSL L + D + + +
Sbjct: 55 EASIMGQFDHPNIIRLEGVVTKSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGML 112
Query: 1077 MDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN---TLVSGGV 1133
A GM+YL N VH DL N+LVN +CKV DFGLSR + T + G
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSDFGLSRRLEDSEATYTTKGG 168
Query: 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL 1192
+ + W APE + + + + DV+SFGI MWE+++ GE PY DM +I +
Sbjct: 169 KIPIRWTAPEAI--AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR 226
Query: 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
P P C +LM CW D RP+F++I S L
Sbjct: 227 LPP-PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 6e-48
Identities = 97/273 (35%), Positives = 136/273 (49%), Gaps = 22/273 (8%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
I +L L+ELGSG +G V+ GKWRG DVAIK I++ G SE DF EA
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIRE----GAMSED-----DFIEEAK 51
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
++ L HPN+V YGV + VTE+M NG L + L ++ L L + D
Sbjct: 52 VMMKLSHPNLVQLYGVCTKQ--RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDV 109
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSGGVRGTL 1137
MEYL S +H DL N LV + + KV DFGL+R + S G + +
Sbjct: 110 CEAMEYLESNGFIHRDLAARNCLVG----EDNVVKVSDFGLARYVLDDQYTSSQGTKFPV 165
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTI 1196
W PE+ + +R S K DV+SFG+ MWE+ + G+ PY ++ + R
Sbjct: 166 KWAPPEVFD--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YRLYR 222
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
P+ E +M CW PE RP+F ++ S+L
Sbjct: 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 8e-48
Identities = 85/266 (31%), Positives = 129/266 (48%), Gaps = 29/266 (10%)
Query: 970 RELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
LG G++G+VY K G +A+K ++ S + E RE ILS+L HP
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE------REIRILSSLQHP 59
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLD-----RRKKLIIAMDAAFG 1082
N+V +YG D TL E++ GSL LLKK L + + I+ G
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQILE-----G 113
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG---VRGTLPW 1139
+ YLHS IVH D+K N+LV+ + K+ DFG ++ + G VRGT W
Sbjct: 114 LAYLHSNGIVHRDIKGANILVDSDG----VVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH-CGAIIGGIVKNTLRPTIPE 1198
MAPE++ G D++S G ++ E+ TG+ P++++ A + I + P IPE
Sbjct: 170 MAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE 227
Query: 1199 RCDPEWRKLMEQCWAADPEARPSFTE 1224
E + + +C DP+ RP+ E
Sbjct: 228 HLSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 92/268 (34%), Positives = 133/268 (49%), Gaps = 21/268 (7%)
Query: 969 LRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
R+LGSG +G V+ G W+ VAIK +K S+ +DF +E L L H
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILK--------SDDLLKQQDFQKEVQALKRLRHK 62
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYL 1086
++++ + V G + +TE M GSL L + + L + +A A GM YL
Sbjct: 63 HLISLFAVCSVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSGGVRGTLPWMAPELL 1145
+N +H DL N+LV + +CKV DFGL+R IK + +S + W APE
Sbjct: 121 EEQNSIHRDLAARNILVG----EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEW 1204
+ S K DV+SFGI ++E+ T G+ PY M+ + I P P +C E
Sbjct: 177 S--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC-PAKCPQEI 233
Query: 1205 RKLMEQCWAADPEARPSFTEITSRLRTI 1232
K+M +CWAA+PE RPSF + L I
Sbjct: 234 YKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 92/269 (34%), Positives = 129/269 (47%), Gaps = 23/269 (8%)
Query: 966 LEELRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
++ LR+LG+G +G V+ G W + VA+K +K G KDF EA I+ L
Sbjct: 8 IQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLK----PGTMDP-----KDFLAEAQIMKKL 58
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAMDAAFGM 1083
HP ++ Y V + VTE M GSL L + +LI +A A GM
Sbjct: 59 RHPKLIQLYAVCTLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP--WMA 1141
YL ++N +H DL N+LV + ICKV DFGL+R+ + + P W A
Sbjct: 117 AYLEAQNYIHRDLAARNVLVG----ENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA 172
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
PE NR S K DV+SFGI + EI+T G PY M ++ + + P P C
Sbjct: 173 PEAAL--YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC-PPGC 229
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEITSRL 1229
E +M CW DP+ RP+F + +L
Sbjct: 230 PKELYDIMLDCWKEDPDDRPTFETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 3e-46
Identities = 102/266 (38%), Positives = 139/266 (52%), Gaps = 23/266 (8%)
Query: 970 RELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN 1028
++G G +G VY G +G+ +VA+K +C RS+ L + F +EA IL HPN
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVK----TC---RSTLPPDLKRKFLQEAEILKQYDHPN 53
Query: 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS 1088
+V GV + V E + GSL L KK L +K L +++DAA GMEYL S
Sbjct: 54 IVKLIGVCVQKQ--PIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL--VSGGVRGTLP--WMAPEL 1144
KN +H DL N LV + + K+ DFG+SR + + VS G +P W APE
Sbjct: 112 KNCIHRDLAARNCLVGENN----VLKISDFGMSREEEGGIYTVSDG-LKQIPIKWTAPEA 166
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPE 1203
LN R + + DV+S+GI +WE + G+ PY M I P P+ C E
Sbjct: 167 LN--YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA-PQLCPEE 223
Query: 1204 WRKLMEQCWAADPEARPSFTEITSRL 1229
+LM QCWA DPE RPSF+EI + L
Sbjct: 224 IYRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 9e-46
Identities = 95/275 (34%), Positives = 133/275 (48%), Gaps = 32/275 (11%)
Query: 970 RELGSGTYGTVYHGKWR---GS--DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ELG G +G+V G + G +VA+K +K+ K+F REA +++ L
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQE-------HIAAGKKEFLREASVMAQL 53
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
HP +V GV G L V E G L LKK R + +A A GM
Sbjct: 54 DHPCIVRLIGVC---KGEPLMLVMELAPLGPL-LKYLKKRREIPVSDLKELAHQVAMGMA 109
Query: 1085 YLHSKNIVHFDLKCEN-LLVNLRDPQRPICKVGDFGLSRIKRN-----TLVSGGVRGTLP 1138
YL SK+ VH DL N LLVN R K+ DFG+SR + G R L
Sbjct: 110 YLESKHFVHRDLAARNVLLVN-----RHQAKISDFGMSRALGAGSDYYRATTAG-RWPLK 163
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIP 1197
W APE +N + S K DV+S+G+++WE + G +PY +M GA + ++++ R P
Sbjct: 164 WYAPECIN--YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-GAEVIAMLESGERLPRP 220
Query: 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
E C E +M CW PE RP+F+E+ S R
Sbjct: 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 5e-45
Identities = 85/284 (29%), Positives = 145/284 (51%), Gaps = 31/284 (10%)
Query: 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRGS------DVAIKRIKKSCFAGRSSEQERLT 1011
L+I+K +LE+++ LGSG +GTVY G W VAIK +++ + +E L
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEIL- 57
Query: 1012 KDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSL-KHVLLKKDRSLDRR 1070
EA++++++ HP+VV G+ + +T+ M G L +V KD + +
Sbjct: 58 ----DEAYVMASVDHPHVVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKDN-IGSQ 109
Query: 1071 KKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI---KRNT 1127
L + A GM YL K +VH DL N+LV + PQ K+ DFGL+++
Sbjct: 110 YLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLDVDEKE 165
Query: 1128 LVSGGVRGTLPWMAPE-LLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIG 1185
+ G + + WMA E +L+ + K DV+S+G+++WE++T G +PY + I
Sbjct: 166 YHAEGGKVPIKWMALESILHR---IYTHKSDVWSYGVTVWELMTFGAKPYEGIP-AVEIP 221
Query: 1186 GIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
+++ R P C + ++ +CW D E+RP+F E+ +
Sbjct: 222 DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 91/278 (32%), Positives = 135/278 (48%), Gaps = 24/278 (8%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
++ D+ +LG G YG VY G W+ VA+K +K E ++F +EA
Sbjct: 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEA 53
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS-LDRRKKLIIAM 1077
++ + HPN+V GV +TEFM G+L L + +R ++ L +A
Sbjct: 54 AVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG--GVRG 1135
+ MEYL KN +H DL N LV + + KV DFGLSR+ + G +
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAKF 167
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRP 1194
+ W APE L + N+ S K DV++FG+ +WEI T G PY + + +++ R
Sbjct: 168 PIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKGYRM 224
Query: 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
PE C P+ +LM CW +P RPSF EI T+
Sbjct: 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|99731 cd06410, PB1_UP2, Uncharacterized protein 2 | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 60/100 (60%), Positives = 79/100 (79%), Gaps = 6/100 (6%)
Query: 186 LCSFGGKILPRPSDGKLRYVGGETRIISLRTNLSWEELVKKTSNICNQPHL--IKYQLPG 243
LCS+GG+ILPRP DG+LRYVGGETRI+S+ ++S++ELV K S + + +KYQLP
Sbjct: 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPD 60
Query: 244 EDLDALISVSSDDDLQNMIDEYCGLERLE-GSQRLRLFLI 282
EDLDALISVS+D+DL+NM++EY +RL GS RLR+FL
Sbjct: 61 EDLDALISVSNDEDLKNMMEEY---DRLSGGSARLRVFLF 97
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. Length = 97 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 95/271 (35%), Positives = 132/271 (48%), Gaps = 22/271 (8%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
I DL L+ELG+G +G V +GKWRG DVAIK IK+ G SE E F EA
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE----GSMSEDE-----FIEEAK 51
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
++ L H +V YGV + VTE+M NG L + L + + + L + D
Sbjct: 52 VMMKLSHEKLVQLYGVCT--KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDV 109
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP- 1138
GM YL SK +H DL N LV+ + KV DFGLSR + + V P
Sbjct: 110 CEGMAYLESKQFIHRDLAARNCLVD----DQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 1139 -WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTI 1196
W PE+L S + S K DV++FG+ MWE+ + G+ PY + + + + LR
Sbjct: 166 RWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-LRLYR 222
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITS 1227
P + +M CW E RP+F ++ S
Sbjct: 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 8e-43
Identities = 93/286 (32%), Positives = 136/286 (47%), Gaps = 38/286 (13%)
Query: 965 DLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
+ +RELG G++G VY G +G + VAIK + +S +ER+ +F E
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-----ENASMRERI--EFLNE 59
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS----------L 1067
A ++ + +VV GVV TG V E M G LK L+ R
Sbjct: 60 ASVMKEFNCHHVVRLLGVV--STGQPTLVVMELMAKGDLKS-YLRSRRPEAENNPGLGPP 116
Query: 1068 DRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRN 1126
+K + +A + A GM YL +K VH DL N +V K+GDFG++R I
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL----TVKIGDFGMTRDIYET 172
Query: 1127 TLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAI 1183
G +G LP WMAPE L + K DV+SFG+ +WE+ T E+PY + +
Sbjct: 173 DYYRKGGKGLLPVRWMAPESL--KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV 230
Query: 1184 IGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
+ ++ +PE C + +LM CW +P+ RP+F EI S L
Sbjct: 231 LKFVIDGGHLD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 95/299 (31%), Positives = 140/299 (46%), Gaps = 48/299 (16%)
Query: 960 IIKNVDLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTK 1012
++ + RELG G +G V+ G+ VA+K +K++ K
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-------SNDARK 53
Query: 1013 DFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL---------LKK 1063
DF REA +L+N H N+V FYGV + G V E+M +G L L LK
Sbjct: 54 DFEREAELLTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKS 111
Query: 1064 DRS----LDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLV--NLRDPQRPICKVGD 1117
S L + L IA+ A GM YL S++ VH DL N LV +L + K+GD
Sbjct: 112 PDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL------VVKIGD 165
Query: 1118 FGLSR-IKRNTLVSGGVRGTLP--WMAPE-LLNGSSNRVSEKVDVFSFGISMWEILT-GE 1172
FG+SR + G LP WM PE ++ + + + DV+SFG+ +WEI T G+
Sbjct: 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVVLWEIFTYGK 222
Query: 1173 EPYADMHCGAIIGGIVKNT-LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230
+P+ + +I I + L+ P C E +M CW DP+ R + +I RL+
Sbjct: 223 QPWYGLSNEEVIECITQGRLLQR--PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 92/283 (32%), Positives = 132/283 (46%), Gaps = 53/283 (18%)
Query: 971 ELGSGTYGTVYHGKWRGS-----DVAIKRIKKSCFAGRSSEQERLTK---DFWREAHILS 1022
+LG G++G V G+W S VA+K +K ++L+ DF +EA I+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS----------DKLSDIMDDFLKEAAIMH 51
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKK---------- 1072
+L H N++ YGVV L VTE GSL LDR +K
Sbjct: 52 SLDHENLIRLYGVVLTHP---LMMVTELAPLGSL----------LDRLRKDALGHFLIST 98
Query: 1073 -LIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR----IKRNT 1127
A+ A GM YL SK +H DL N+L+ D K+GDFGL R + +
Sbjct: 99 LCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD----KVKIGDFGLMRALPQNEDHY 154
Query: 1128 LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGG 1186
++ ++ W APE L + S DV+ FG+++WE+ T GEEP+A + I+
Sbjct: 155 VMEEHLKVPFAWCAPESLR--TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK 212
Query: 1187 IVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
I K R PE C + +M QCWA +P RP+F + L
Sbjct: 213 IDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 8e-41
Identities = 92/277 (33%), Positives = 133/277 (48%), Gaps = 27/277 (9%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
D+ R +G G +G VY G + + VA+K K + F +EA+
Sbjct: 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSV-------REKFLQEAY 59
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
I+ HP++V GV+ + + V E G L+ L SLD ++ +
Sbjct: 60 IMRQFDHPHIVKLIGVITENP---VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQL 116
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC-KVGDFGLSRIKRNTLVSGGVRGTLP 1138
+ + YL SK VH D+ N+LV+ P C K+GDFGLSR + +G LP
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVS-----SPDCVKLGDFGLSRYLEDESYYKASKGKLP 171
Query: 1139 --WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195
WMAPE +N R + DV+ FG+ MWEIL G +P+ + +IG I +N R
Sbjct: 172 IKWMAPESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-ENGERLP 228
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+P C P LM +CWA DP RP FTE+ ++L I
Sbjct: 229 MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 95/273 (34%), Positives = 136/273 (49%), Gaps = 25/273 (9%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
+L ++ELGSG +G V+ GKWR VAIK I + G SE+ DF EA ++
Sbjct: 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE----GAMSEE-----DFIEEAKVMMK 55
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGM 1083
L HP +V YGV L VTEFM NG L + L ++ L + L + D GM
Sbjct: 56 LSHPKLVQLYGVCTQQK--PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGM 113
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSGGVRGTLPWMA 1141
EYL + +H DL N LV+ + KV DFG++R + S G + + W
Sbjct: 114 EYLERNSFIHRDLAARNCLVS----STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSP 169
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
PE+ N ++ S K DV+SFG+ MWE+ T G+ P+ ++ I + R P+
Sbjct: 170 PEVFN--FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRPKLA 226
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233
++M CW PE RP+F E+ LR I+
Sbjct: 227 SMTVYEVMYSCWHEKPEGRPTFAEL---LRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 87/270 (32%), Positives = 131/270 (48%), Gaps = 33/270 (12%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
E L ++G G +G VY + + G +VAIK IK +E+ K E IL
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK-------LESKEKKEKII-NEIQILK 52
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
HPN+V +YG L V EF GSLK +L +++L + + + G
Sbjct: 53 KCKHPNIVKYYGSYLKK--DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKG 110
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-----RIKRNTLVSGGVRGTL 1137
+EYLHS I+H D+K N+L+ K+ DFGLS RNT+V GT
Sbjct: 111 LEYLHSNGIIHRDIKAANILLT----SDGEVKLIDFGLSAQLSDTKARNTMV-----GTP 161
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN---TLRP 1194
WMAPE++NG K D++S GI+ E+ G+ PY+++ + I N LR
Sbjct: 162 YWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR- 218
Query: 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTE 1224
PE+ E++ +++C +PE RP+ +
Sbjct: 219 -NPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 96/272 (35%), Positives = 139/272 (51%), Gaps = 26/272 (9%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+L+ L+ +G G +G V G +RG+ VA+K IK A + F EA +++ L
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA----------QAFLAEASVMTQL 56
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS-LDRRKKLIIAMDAAFGM 1083
H N+V GV+ + GG L VTE+M GSL L + RS L L ++D M
Sbjct: 57 RHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP--WMA 1141
EYL + N VH DL N+LV+ + + KV DFGL++ +T +G LP W A
Sbjct: 116 EYLEANNFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASSTQDTG----KLPVKWTA 167
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
PE L + S K DV+SFGI +WEI + G PY + ++ V+ + P+ C
Sbjct: 168 PEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGC 224
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
P +M+QCW D RPSF ++ +L I
Sbjct: 225 PPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 6e-40
Identities = 79/254 (31%), Positives = 123/254 (48%), Gaps = 19/254 (7%)
Query: 971 ELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN 1028
+G G +G VY G G VAIK+I E K +E +L NL HPN
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLE---KIKEEA---LKSIMQEIDLLKNLKHPN 60
Query: 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS 1088
+V + G + T +L + E+ NGSL ++KK + G+ YLH
Sbjct: 61 IVKYIGSIE--TSDSLYIILEYAENGSL-RQIIKKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-RIKRNTLVSGGVRGTLPWMAPELLNG 1147
+ ++H D+K N+L + K+ DFG++ ++ + V GT WMAPE++
Sbjct: 118 QGVIHRDIKAANILTTKDG----VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 1148 SSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKL 1207
S S D++S G ++ E+LTG PY D++ A + IV++ P +PE PE +
Sbjct: 174 SG--ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDF 230
Query: 1208 MEQCWAADPEARPS 1221
+ QC+ DP RP+
Sbjct: 231 LMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 83/291 (28%), Positives = 139/291 (47%), Gaps = 37/291 (12%)
Query: 966 LEELRELGSGTYGTVYHGKW------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
L+ +++LG G +G V ++ G VA+K + S +E+ DF RE
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-------EEQHRSDFEREIE 58
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
IL L H N+V + GV G +L + E++ +GSL+ L + ++ ++ L+ +
Sbjct: 59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--KRNTLVSGGVRGTL 1137
GM+YL S+ +H DL N+LV + + + K+ DFGL+++ + G
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILV---ESEDLV-KISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 1138 P--WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEP-------YADMHCGAIIGGIV 1188
P W APE L +++ S DV+SFG++++E+ T +P + M A IV
Sbjct: 175 PIFWYAPECL--RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV 232
Query: 1189 -------KNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
K R P C E LM+ CW A+P+ RPSF ++ + +
Sbjct: 233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 5e-39
Identities = 97/278 (34%), Positives = 138/278 (49%), Gaps = 30/278 (10%)
Query: 964 VDLEELRELGSGTYGTVYHGKW-----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
V +EE+ +G+G +G V G+ R VAIK +K +G + +Q R DF EA
Sbjct: 6 VKIEEV--IGAGEFGEVCRGRLKLPGKREIFVAIKTLK----SGYTEKQRR---DFLSEA 56
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
I+ HPN++ GVV + +TEFM NG+L L + D + + +
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSR--PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG 114
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI----KRNTLVSGGVR 1134
A GM+YL N VH DL N+LVN +CKV DFGLSR + + +
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170
Query: 1135 GTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNT 1191
G +P W APE + + + + DV+S+GI MWE+++ GE PY DM +I I ++
Sbjct: 171 GKIPIRWTAPEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY 228
Query: 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
P P C +LM CW D ARP F +I S L
Sbjct: 229 RLPP-PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 9e-39
Identities = 88/271 (32%), Positives = 137/271 (50%), Gaps = 27/271 (9%)
Query: 964 VDLEEL---RELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
++L++L +G G +G V G++ G VA+K IK A + F E +
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTA----------QAFLEETAV 52
Query: 1021 LSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAMDA 1079
++ LHH N+V GV+ L V E M G+L + L + R+L +L+ ++D
Sbjct: 53 MTKLHHKNLVRLLGVI---LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDV 109
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPW 1139
A GMEYL SK +VH DL N+LV+ + + KV DFGL+R+ + + + + W
Sbjct: 110 AEGMEYLESKKLVHRDLAARNILVS----EDGVAKVSDFGLARVGSMGVDNS--KLPVKW 163
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPE 1198
APE L + S K DV+S+G+ +WE+ + G PY M + + K R PE
Sbjct: 164 TAPEALK--HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPPE 220
Query: 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
C + LM CW +P+ RPSF ++ +L
Sbjct: 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 97/278 (34%), Positives = 137/278 (49%), Gaps = 33/278 (11%)
Query: 972 LGSGTYGTVYHGKWRGSD--------VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
LGSG +G VY G VA+K ++K +++QE+ K+F +EAH++SN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-----ATDQEK--KEFLKEAHLMSN 55
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS------LDRRKKLIIAM 1077
+HPN+V GV + + E M G L L L ++ L I +
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRP-ICKVGDFGLSR-IKRNTLVSGGVRG 1135
D A G YL + +H DL N LV+ + + K+GDFGL+R I ++ G
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 1136 TLP--WMAPE-LLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNT 1191
LP WMAPE LL+G S DV+SFG+ MWEILT G++PY ++ ++ V
Sbjct: 174 LLPVRWMAPESLLDGKFTTQS---DVWSFGVLMWEILTLGQQPYPALNNQEVLQ-HVTAG 229
Query: 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
R PE C + +LM CWA DP RP+F I L
Sbjct: 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 1e-37
Identities = 88/269 (32%), Positives = 133/269 (49%), Gaps = 22/269 (8%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
+L ++E+GSG +G V+ G W VAIK I++ G SE+ DF EA ++
Sbjct: 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE----GAMSEE-----DFIEEAQVMMK 55
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGM 1083
L HP +V YGV + + + V EFM +G L L + + L + +D GM
Sbjct: 56 LSHPKLVQLYGVCTERS--PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--KRNTLVSGGVRGTLPWMA 1141
YL S N++H DL N LV + + KV DFG++R S G + + W +
Sbjct: 114 AYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSS 169
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
PE+ S ++ S K DV+SFG+ MWE+ + G+ PY + ++ I R P
Sbjct: 170 PEVF--SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-NAGFRLYKPRLA 226
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEITSRL 1229
+LM+ CW PE RPSF+ + +L
Sbjct: 227 SQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 90/270 (33%), Positives = 138/270 (51%), Gaps = 26/270 (9%)
Query: 966 LEELRELGSGTYGTVYHGKWRG-SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
L+ +++LG+G +G V+ G + G + VAIK +K+ + + F EA+++ L
Sbjct: 8 LKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---------FLAEANLMKQL 58
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA--AFG 1082
HP +V Y VV T + +TE+M NGSL LK + +I M A A G
Sbjct: 59 QHPRLVRLYAVV---TQEPIYIITEYMENGSLVD-FLKTPEGIKLTINKLIDMAAQIAEG 114
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT--LVSGGVRGTLPWM 1140
M ++ KN +H DL+ N+LV+ + CK+ DFGL+R+ + G + + W
Sbjct: 115 MAFIERKNYIHRDLRAANILVS----ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT 170
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPER 1199
APE +N + + K DV+SFGI + EI+T G PY M +I + + P P+
Sbjct: 171 APEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR-PDN 227
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
C E +LM CW PE RP+F + S L
Sbjct: 228 CPEELYELMRLCWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 95/285 (33%), Positives = 138/285 (48%), Gaps = 34/285 (11%)
Query: 966 LEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
+ LR LG G +G VY G +RG D VA+K + +SC SEQ+ DF EA
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-----SEQDES--DFLMEA 60
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR-------SLDRRK 1071
I+S +H N+V GV + + + E M G LK L+++R SL +
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFI--LLELMAGGDLKS-FLRENRPRPERPSSLTMKD 117
Query: 1072 KLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVS 1130
L A D A G +YL + +H D+ N L+ + P R + K+ DFG++R I R +
Sbjct: 118 LLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGR-VAKIADFGMARDIYRASYYR 176
Query: 1131 GGVRGTLP--WMAPE-LLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGG 1186
G R LP WM PE L+G + K DV+SFG+ +WEI + G PY ++
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGI---FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
Query: 1187 IVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231
+ R P+ C ++M CW PE RP+F I R++
Sbjct: 234 VTGGG-RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 85/281 (30%), Positives = 137/281 (48%), Gaps = 34/281 (12%)
Query: 970 RELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
R +G G +G VYHG SD A+K + R ++ E + + F +E I+ +
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN------RITDLEEVEQ-FLKEGIIMKDF 53
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
HPNV++ G+ G L V +M +G L++ + + + + + + A GME
Sbjct: 54 SHPNVLSLLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGME 112
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---------IKRNTLVSGGVRG 1135
YL SK VH DL N +++ + KV DFGL+R + +T G +
Sbjct: 113 YLASKKFVHRDLAARNCMLD----ESFTVKVADFGLARDIYDKEYYSVHNHT----GAKL 164
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRP 1194
+ WMA E L + + + K DV+SFG+ +WE++T G PY D+ I +++ R
Sbjct: 165 PVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RL 221
Query: 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235
PE C ++M CW PE RP+F+E+ SR+ I +
Sbjct: 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 77/268 (28%), Positives = 131/268 (48%), Gaps = 27/268 (10%)
Query: 967 EELRELGSGTYGTVYHGKWRGSD---VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
E ++++G G++G VY + R SD +K I S SE+ER +D E IL
Sbjct: 3 EIIKQIGKGSFGKVYLVR-RKSDGKLYVLKEIDLS----NMSEKER--EDALNEVKILKK 55
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK---KLIIAM--D 1078
L+HPN++ +Y + G L V E+ G L + K + + + + I+
Sbjct: 56 LNHPNIIKYYESFEEK--GKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWFVQ 111
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG-VRGTL 1137
++YLHS+ I+H D+K +N+ + + K+GDFG+S++ +T+ V GT
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVLSSTVDLAKTVVGTP 167
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197
+++PEL + K D++S G ++E+ T + P+ + + I+K P IP
Sbjct: 168 YYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-IP 224
Query: 1198 ERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ E R L+ DPE RPS +I
Sbjct: 225 SQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 93/270 (34%), Positives = 131/270 (48%), Gaps = 26/270 (9%)
Query: 970 RELGSGTYGTVYHGKW-----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ +G+G +G V G+ R VAIK +K AG + +Q R DF EA I+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLK----AGYTEKQRR---DFLSEASIMGQF 62
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
HPN++ GVV + VTE+M NGSL L K D + + + A GM+
Sbjct: 63 DHPNIIHLEGVVTKSK--PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN----TLVSGGVRGTLPWM 1140
YL VH DL N+LVN +CKV DFGLSR+ + + G + + W
Sbjct: 121 YLSDMGYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPER 1199
APE + + + + DV+S+GI MWE+++ GE PY +M +I I + P P
Sbjct: 177 APEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA-PMD 233
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
C +LM CW D RP F +I S L
Sbjct: 234 CPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 75/257 (29%), Positives = 122/257 (47%), Gaps = 15/257 (5%)
Query: 972 LGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVA 1031
LGSG++G+VY G D +K+ A + K +E +LS L HPN+V
Sbjct: 8 LGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM---DAAFGMEYLHS 1088
+ G + L E + GSL LLKK S + +I + G+EYLH
Sbjct: 67 YLGTEREE--DNLYIFLELVPGGSL-AKLLKKYGSFP---EPVIRLYTRQILLGLEYLHD 120
Query: 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGS 1148
+N VH D+K N+LV D + K+ DFG+++ + +G+ WMAPE++
Sbjct: 121 RNTVHRDIKGANILV---DTNGVV-KLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA-Q 175
Query: 1149 SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLM 1208
D++S G ++ E+ TG+ P++ + A + I ++ P IP+ E + +
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235
Query: 1209 EQCWAADPEARPSFTEI 1225
+C DP RP+ E+
Sbjct: 236 LKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 95/294 (32%), Positives = 138/294 (46%), Gaps = 44/294 (14%)
Query: 965 DLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
+ L ELG G +G VY G+ G + VAIK +K++ + ++ ++F +E
Sbjct: 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-------AEPKVQQEFRQE 58
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD------------- 1064
A ++S+L HPN+V GV + E++ +G L L++
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQ--PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 1065 --RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122
SLD L IA+ A GMEYL S + VH DL N LV + K+ DFGLSR
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTV-KISDFGLSR 172
Query: 1123 -IKRNTLVSGGVRGTLP--WMAPE-LLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYAD 1177
I + LP WM PE +L G + + + D++SFG+ +WEI + G +PY
Sbjct: 173 DIYSADYYRVQSKSLLPVRWMPPEAILYG---KFTTESDIWSFGVVLWEIFSYGLQPYYG 229
Query: 1178 MHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231
+I I L P PE C LM +CW P RP F +I +RLR+
Sbjct: 230 FSNQEVIEMIRSRQLLPC-PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 80/270 (29%), Positives = 131/270 (48%), Gaps = 33/270 (12%)
Query: 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
+ L ++G G G VY R G +VAIK+++ + + L E I+ +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK------QNKELII---NEILIMKD 71
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGM 1083
HPN+V +Y G L V E+M GSL ++ + ++ + + + G+
Sbjct: 72 CKHPNIVDYYDSYLVG--DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS------RIKRNTLVSGGVRGTL 1137
EYLHS+N++H D+K +N+L++ + K+ DFG + + KRN++V GT
Sbjct: 130 EYLHSQNVIHRDIKSDNILLS----KDGSVKLADFGFAAQLTKEKSKRNSVV-----GTP 180
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI- 1196
WMAPE++ KVD++S GI E+ GE PY + I + P +
Sbjct: 181 YWMAPEVI--KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-PPLK 237
Query: 1197 -PERCDPEWRKLMEQCWAADPEARPSFTEI 1225
PE+ PE++ + +C DPE RPS E+
Sbjct: 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 91/268 (33%), Positives = 129/268 (48%), Gaps = 26/268 (9%)
Query: 972 LGSGTYGTVYHG--KWRG---SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
+G+G +G V+ G K G VAIK +K G + +Q +DF EA I+ H
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLK----PGYTEKQR---QDFLSEASIMGQFSH 65
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
N++ GVV + +TE+M NG+L L D + + + A GM+YL
Sbjct: 66 HNIIRLEGVVTKFKPAMI--ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN----TLVSGGVRGTLPWMAP 1142
N VH DL N+LVN CKV DFGLSR+ + T + G + + W AP
Sbjct: 124 SDMNYVHRDLAARNILVN----SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201
E + + + + DV+SFGI MWE+++ GE PY DM ++ I P P C
Sbjct: 180 EAI--AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA-PMDCP 236
Query: 1202 PEWRKLMEQCWAADPEARPSFTEITSRL 1229
+LM QCW D RP F +I + L
Sbjct: 237 SAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 97/296 (32%), Positives = 140/296 (47%), Gaps = 47/296 (15%)
Query: 966 LEELRELGSGTYGTV----YH--GKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
L+ +++LG G +G+V Y G VA+K+++ S ++E R DF RE
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLR---DFEREIE 57
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
IL +L H N+V + GV L V E++ GSL+ L K LD RK L+ A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI----KRNTLVSGGVRG 1135
GMEYL SK VH DL N+LV K+GDFGL+++ K V
Sbjct: 118 CKGMEYLGSKRYVHRDLATRNILVE----SENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC--------------- 1180
+ W APE L ++ S DV+SFG+ ++E+ T Y+D C
Sbjct: 174 PIFWYAPESLT--ESKFSVASDVWSFGVVLYELFT----YSDKSCSPPAEFMRMMGNDKQ 227
Query: 1181 GAIIG----GIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
G +I ++KN R P C E +M++CW DP RPSF+E+ ++ I
Sbjct: 228 GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 4e-35
Identities = 92/273 (33%), Positives = 133/273 (48%), Gaps = 28/273 (10%)
Query: 970 RELGSGTYGTVYHGKWRG---SD----VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
+ LG+G +G V G SD VA+K +K + SSE+E L E I+S
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT---AHSSEREALMS----ELKIMS 93
Query: 1023 NL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS-LDRRKKLIIAMDAA 1080
+L +H N+V G GG + +TE+ G L + L +K S L L + A
Sbjct: 94 HLGNHENIVNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKR--NTLVSGGVRGTL 1137
GM +L SKN +H DL N+L+ I K+ DFGL+R I N +V G R +
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLT----HGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTI 1196
WMAPE + + + + DV+S+GI +WEI + G PY M + ++K R
Sbjct: 208 KWMAPESI--FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
PE E +M+ CW ADP RP+F +I +
Sbjct: 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 87/265 (32%), Positives = 132/265 (49%), Gaps = 18/265 (6%)
Query: 971 ELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVV 1030
+G G +G V+ G+ R + + KSC R + L F +EA IL HPN+V
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVA--VKSC---RETLPPDLKAKFLQEARILKQYSHPNIV 56
Query: 1031 AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKN 1090
GV + V E + G L + L ++ + + +AA GMEYL SK+
Sbjct: 57 RLIGVCTQKQ--PIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 1091 IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL--VSGGVRGT-LPWMAPELLNG 1147
+H DL N LV ++ + K+ DFG+SR + + + +GG++ + W APE LN
Sbjct: 115 CIHRDLAARNCLVT----EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN- 169
Query: 1148 SSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRK 1206
R S + DV+SFGI +WE + G PYA++ I + +R PE C +
Sbjct: 170 -YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VRLPCPELCPDAVYR 227
Query: 1207 LMEQCWAADPEARPSFTEITSRLRT 1231
LME+CW DP RPSF+ + L++
Sbjct: 228 LMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 9e-35
Identities = 86/281 (30%), Positives = 129/281 (45%), Gaps = 31/281 (11%)
Query: 966 LEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
L+E+ LG G +G V+ K +G + A + ++ E L +F RE + L
Sbjct: 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS 66
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLL--------KKDRSLDRRKKLIIAM 1077
H NVV G+ + + + E+ G LK L K L ++K+ +
Sbjct: 67 HKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK--------RNTLV 1129
A GM++L + VH DL N LV+ QR KV LS+ RN L+
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVS---SQR-EVKVSLLSLSKDVYNSEYYKLRNALI 180
Query: 1130 SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIV 1188
L W+APE + + S K DV+SFG+ MWE+ T GE P+ + ++ +
Sbjct: 181 P------LRWLAPEAV--QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ 232
Query: 1189 KNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
L +PE C KLM +CWA +P+ RPSF+E+ S L
Sbjct: 233 AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 81/265 (30%), Positives = 123/265 (46%), Gaps = 32/265 (12%)
Query: 969 LRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
L +G G++G VY + ++ VAIK I +E E +D +E LS
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-----EAEDE--IEDIQQEIQFLSQCRS 58
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
P + +YG G+ L + E+ GS +L K LD I + G+EYL
Sbjct: 59 PYITKYYGSFLKGS--KLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYL 114
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS------RIKRNTLVSGGVRGTLPWM 1140
H + +H D+K N+L++ + K+ DFG+S KRNT V GT WM
Sbjct: 115 HEEGKIHRDIKAANILLS----EEGDVKLADFGVSGQLTSTMSKRNTFV-----GTPFWM 165
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
APE++ S EK D++S GI+ E+ GE P +D+H ++ I KN P++
Sbjct: 166 APEVIKQSG--YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP-PSLEGNK 222
Query: 1201 -DPEWRKLMEQCWAADPEARPSFTE 1224
++ + C DP+ RPS E
Sbjct: 223 FSKPFKDFVSLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 85/274 (31%), Positives = 128/274 (46%), Gaps = 37/274 (13%)
Query: 965 DLEELRELGSGTYGTVY---HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHIL 1021
DLE ++ LG G+ G VY H K G A+K+I G +++L RE L
Sbjct: 2 DLERVKVLGQGSSGVVYKVRH-KPTGKIYALKKIH---VDGDEEFRKQLL----RELKTL 53
Query: 1022 SNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
+ P VV YG G ++ V E+M GSL LLKK + IA
Sbjct: 54 RSCESPYVVKCYGAFYKE--GEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILK 110
Query: 1082 GMEYLHSK-NIVHFDLKCENLLVNLR-DPQRPICKVGDFGLSRI------KRNTLVSGGV 1133
G++YLH+K +I+H D+K NLL+N + + K+ DFG+S++ + NT V
Sbjct: 111 GLDYLHTKRHIIHRDIKPSNLLINSKGEV-----KIADFGISKVLENTLDQCNTFV---- 161
Query: 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG---AIIGGIVKN 1190
GT+ +M+PE + G S S D++S G+++ E G+ P+ ++ I
Sbjct: 162 -GTVTYMSPERIQGESY--SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG 218
Query: 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTE 1224
E PE+R + C DP+ RPS E
Sbjct: 219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 6e-34
Identities = 88/262 (33%), Positives = 126/262 (48%), Gaps = 20/262 (7%)
Query: 972 LGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVV 1030
LG G +G V+ G + + VA+K K+ + L F EA IL HPN+V
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDL-------PQELKIKFLSEARILKQYDHPNIV 55
Query: 1031 AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKN 1090
GV + V E + G L KK L ++ + A+DAA GM YL SKN
Sbjct: 56 KLIGVCTQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 1091 IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP--WMAPELLNGS 1148
+H DL N LV + + K+ DFG+SR + + + S +P W APE LN
Sbjct: 114 CIHRDLAARNCLVG----ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN-- 167
Query: 1149 SNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKL 1207
R S + DV+S+GI +WE + G PY M V+ R + P++C + K+
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRMSCPQKCPDDVYKV 226
Query: 1208 MEQCWAADPEARPSFTEITSRL 1229
M++CW PE RP F+E+ L
Sbjct: 227 MQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 7e-34
Identities = 91/270 (33%), Positives = 136/270 (50%), Gaps = 26/270 (9%)
Query: 966 LEELRELGSGTYGTVYHGKWRG-SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
L+ +++LG+G +G V+ G W G + VA+K +K + S F EA I+ L
Sbjct: 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---------FLEEAQIMKKL 58
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGM 1083
H +V Y VV + + VTE+M GSL L + R+L + +A A GM
Sbjct: 59 RHDKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGM 115
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG--GVRGTLPWMA 1141
Y+ N +H DL+ N+LV +CK+ DFGL+R+ + + G + + W A
Sbjct: 116 AYIERMNYIHRDLRSANILVG----DGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA 171
Query: 1142 PEL-LNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPER 1199
PE L G R + K DV+SFGI + E++T G PY M+ ++ V+ R P+
Sbjct: 172 PEAALYG---RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ-VERGYRMPCPQD 227
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
C +LM QCW DPE RP+F + S L
Sbjct: 228 CPISLHELMLQCWKKDPEERPTFEYLQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 93/282 (32%), Positives = 133/282 (47%), Gaps = 33/282 (11%)
Query: 970 RELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
R LG G +G+V + + D VA+K +K F+ E+ F REA +
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEE------FLREAACMKEF 58
Query: 1025 HHPNVVAFYGVV----PDGTGGTLATVTEFMVNGSLKHVLLKKDR------SLDRRKKLI 1074
HPNV+ GV G + FM +G L H L R +L + +
Sbjct: 59 DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL-HTFLLMSRIGEEPFTLPLQTLVR 117
Query: 1075 IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSGGV 1133
+D A GMEYL SKN +H DL N ++N +C V DFGLS+ I G
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVC-VADFGLSKKIYSGDYYRQGC 173
Query: 1134 RGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKN 1190
LP W+A E L + N + DV++FG++MWEI+T G+ PYA + I ++K
Sbjct: 174 ASKLPVKWLALESL--ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231
Query: 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
R P C + +LM QCW+ +P+ RPSF + +L I
Sbjct: 232 N-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-33
Identities = 91/286 (31%), Positives = 133/286 (46%), Gaps = 41/286 (14%)
Query: 970 RELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ LG G +G+V G+ D VA+K +K E +F EA + +
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIE------EFLSEAACMKDF 58
Query: 1025 HHPNVVAFYGVVPDGTG-GTLAT---VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM--- 1077
HPNV+ GV + + + + FM +G L H L R +KL +
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDL-HSFLLYSRLGGLPEKLPLQTLLK 117
Query: 1078 ---DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG--- 1131
D A GMEYL ++N +H DL N + LR+ +C V DFGLS+ + SG
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCM--LREDMT-VC-VADFGLSK----KIYSGDYY 169
Query: 1132 --GVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGG 1186
G +P W+A E L + + K DV++FG++MWEI T G+ PY + I
Sbjct: 170 RQGRIAKMPVKWIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-NHEIYD 226
Query: 1187 IVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+++ R PE C E LM CW ADP+ RP+FT++ L I
Sbjct: 227 YLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 83/271 (30%), Positives = 127/271 (46%), Gaps = 38/271 (14%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D+ E LG G+YG+VY + G VAIK + E ++ +E IL
Sbjct: 6 DILEK--LGEGSYGSVYKAIHKETGQVVAIKVV----------PVEEDLQEIIKEISILK 53
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
P +V +YG L V E+ GS+ ++ +++L + I G
Sbjct: 54 QCDSPYIVKYYGSYF--KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI------KRNTLVSGGVRGT 1136
+EYLHS +H D+K N+L+N + K+ DFG+S KRNT++ GT
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLN----EEGQAKLADFGVSGQLTDTMAKRNTVI-----GT 162
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN---TLR 1193
WMAPE++ + K D++S GI+ E+ G+ PY+D+H I I TL
Sbjct: 163 PFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS 220
Query: 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTE 1224
PE+ PE+ +++C DPE RPS +
Sbjct: 221 --DPEKWSPEFNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 89/272 (32%), Positives = 127/272 (46%), Gaps = 30/272 (11%)
Query: 971 ELGSGTYGTVYHGKWRGS----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
ELGSG +G V G ++ DVAIK +K + ++ + + REA I+ L +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK-------NENEKSVRDEMMREAEIMHQLDN 54
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
P +V GV L V E G L L K + + + + GM+YL
Sbjct: 55 PYIVRMIGVC---EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL 111
Query: 1087 HSKNIVHFDLKCEN-LLVNLRDPQRPICKVGDFGLSRI-----KRNTLVSGGVRGTLPWM 1140
KN VH DL N LLVN + K+ DFGLS+ S G + L W
Sbjct: 112 EGKNFVHRDLAARNVLLVN-----QHYAKISDFGLSKALGADDSYYKARSAG-KWPLKWY 165
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPER 1199
APE +N + S + DV+S+GI+MWE + G++PY M ++ I + R P
Sbjct: 166 APECIN--FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RLDCPAE 222
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231
C PE LM+ CW E RP+F ++ R+RT
Sbjct: 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 86/266 (32%), Positives = 133/266 (50%), Gaps = 23/266 (8%)
Query: 969 LRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
+++LG+G +G V+ G + S VA+K +K G S Q F EA+++ L H
Sbjct: 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLK----PGTMSVQA-----FLEEANLMKTLQHD 61
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAMDAAFGMEYL 1086
+V Y VV + +TE+M GSL L + KLI + A GM Y+
Sbjct: 62 KLVRLYAVVTKEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG--GVRGTLPWMAPEL 1144
KN +H DL+ N+LV+ + +CK+ DFGL+R+ + + G + + W APE
Sbjct: 120 ERKNYIHRDLRAANVLVS----ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPE 1203
+N S + K DV+SFGI ++EI+T G+ PY M ++ + + P E C E
Sbjct: 176 INFGSFTI--KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR-MENCPDE 232
Query: 1204 WRKLMEQCWAADPEARPSFTEITSRL 1229
+M+ CW E RP+F + S L
Sbjct: 233 LYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 31/275 (11%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E ++ +GSGTYG VY + + VAIK IK + + +E +L
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIK-------LEPGDDF-EIIQQEISMLK 55
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
HPN+VA++G L V E+ GSL+ + L + + + G
Sbjct: 56 ECRHPNIVAYFGSYL--RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKG 113
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-RI-----KRNTLVSGGVRGT 1136
+ YLH +H D+K N+L+ + K+ DFG+S ++ KR + + GT
Sbjct: 114 LAYLHETGKIHRDIKGANILLT----EDGDVKLADFGVSAQLTATIAKRKSFI-----GT 164
Query: 1137 LPWMAPELLNGSSN-RVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP- 1194
WMAPE+ K D+++ GI+ E+ + P D+H + I K+ P
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP 224
Query: 1195 --TIPERCDPEWRKLMEQCWAADPEARPSFTEITS 1227
E+ P + +++C DP+ RP+ T++
Sbjct: 225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 83/295 (28%), Positives = 132/295 (44%), Gaps = 45/295 (15%)
Query: 966 LEELRELGSGTYGTVY------HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
L+ +R+LG G +G V G G VA+K +K D +E
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-------PESGGNHIADLKKEIE 58
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
IL NL+H N+V + G+ + G + + EF+ +GSLK L + ++ +++L A+
Sbjct: 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI 118
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNT---LVSGGVRG 1135
GM+YL S+ VH DL N+LV K+GDFGL++ I+ + V +
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG------AIIG---- 1185
+ W APE L S ++ DV+SFG++++E+LT Y D +IG
Sbjct: 175 PVFWYAPECLIQSKFYIAS--DVWSFGVTLYELLT----YCDSESSPMTLFLKMIGPTHG 228
Query: 1186 --------GIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+++ R P C E +LM +CW P R +F + I
Sbjct: 229 QMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 88/276 (31%), Positives = 128/276 (46%), Gaps = 26/276 (9%)
Query: 962 KNVDLEELRELGSGTYGTVYHG-----KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWR 1016
K++ +E R LG+G +G + G R VAI ++ C S +Q R F
Sbjct: 5 KSIKIE--RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----SDKQRR---GFLA 55
Query: 1017 EAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIA 1076
EA L H N+V GV+ G T+ VTE+M NG+L L K + L + + +
Sbjct: 56 EALTLGQFDHSNIVRLEGVIT--RGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGML 113
Query: 1077 MDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGT 1136
A GM+YL VH L +LVN +CK+ F + ++ + + G
Sbjct: 114 PGLASGMKYLSEMGYVHKGLAAHKVLVN----SDLVCKISGFRRLQEDKSEAIYTTMSGK 169
Query: 1137 LP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLR 1193
P W APE + + S DV+SFGI MWE+++ GE PY DM +I V++ R
Sbjct: 170 SPVLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA-VEDGFR 226
Query: 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
P C +LM CW + RP F++I S L
Sbjct: 227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 90/271 (33%), Positives = 132/271 (48%), Gaps = 27/271 (9%)
Query: 967 EELR---ELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
E LR +LG G +G V+ G W G+ VAIK +K + F +EA I+
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---------FLQEAQIMK 56
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAMDAAF 1081
L H +V Y VV + + VTEFM GSL L + D + +L+ +A A
Sbjct: 57 KLRHDKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG--GVRGTLPW 1139
GM Y+ N +H DL+ N+LV +CK+ DFGL+R+ + + G + + W
Sbjct: 114 GMAYIERMNYIHRDLRAANILVG----DNLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPE 1198
APE R + K DV+SFGI + E++T G PY M ++ + + P P+
Sbjct: 170 TAPEA--ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC-PQ 226
Query: 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
C +LM+ CW DP+ RP+F I S L
Sbjct: 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 91/265 (34%), Positives = 130/265 (49%), Gaps = 29/265 (10%)
Query: 967 EELR---ELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
E LR +LG G +G V+ G W G+ VAIK +K + + F +EA ++
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---------FLQEAQVMK 56
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAMDAAF 1081
L H +V Y VV + + VTE+M GSL L + R +L+ +A A
Sbjct: 57 KLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG--GVRGTLPW 1139
GM Y+ N VH DL+ N+LV + +CKV DFGL+R+ + + G + + W
Sbjct: 114 GMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 1140 MAPEL-LNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIP 1197
APE L G R + K DV+SFGI + E+ T G PY M ++ + + P P
Sbjct: 170 TAPEAALYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 226
Query: 1198 ERCDPEWRKLMEQCWAADPEARPSF 1222
E C LM QCW +PE RP+F
Sbjct: 227 E-CPESLHDLMCQCWRKEPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 81/269 (30%), Positives = 125/269 (46%), Gaps = 26/269 (9%)
Query: 971 ELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
ELGSG +GTV G ++ VA+K +K + L + REA+++ L +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND------NNDPALKDELLREANVMQQLDN 55
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
P +V G+ + V E G L + L+K++ + + + + GM+YL
Sbjct: 56 PYIVRMIGIC---EAESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKYL 111
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR--NTLVSGGVRGTLP--WMAP 1142
N VH DL N+L+ + K+ DFGLS+ G P W AP
Sbjct: 112 EETNFVHRDLAARNVLL----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201
E +N + S K DV+SFG+ MWE + G++PY M + ++++ R P+RC
Sbjct: 168 ECMN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-MIESGERMECPQRCP 224
Query: 1202 PEWRKLMEQCWAADPEARPSFTEITSRLR 1230
PE LM+ CW + RP F + RLR
Sbjct: 225 PEMYDLMKLCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 2e-31
Identities = 84/292 (28%), Positives = 138/292 (47%), Gaps = 41/292 (14%)
Query: 966 LEELRELGSGTYGTVYHGKW------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
L+++R LG G +G V + G VA+K +K+ C ++ T + +E +
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-------GQQNTSGWKKEIN 58
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
IL L+H N+V + G + G L + E++ GSL+ L K +L + L+ A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLA--QLLLFAQQI 116
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR--GTL 1137
GM YLHS++ +H DL N+L+ D R + K+GDFGL++ VR G
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLL---DNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 1138 P--WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY---------------ADMHC 1180
P W A E L N+ S DV+SFG++++E+LT + M
Sbjct: 173 PVFWYAVECLK--ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230
Query: 1181 GAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+I +++ +R P+ C E LM+ CW + + RP+F + L+ +
Sbjct: 231 VRLI-ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 77/267 (28%), Positives = 127/267 (47%), Gaps = 18/267 (6%)
Query: 972 LGSGTYGTVYHG--KWRGSDVAIKRIK-KSCFAGRSSEQERLTKDFWR-EAHILSNLHHP 1027
+G GTYG VY G +A+K+++ + AGR +++ R E L +L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLH 1087
N+V + G + T L+ E++ GS+ L R + + G+ YLH
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGR-FEEQLVRFFTEQVLEGLAYLH 125
Query: 1088 SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG---VRGTLPWMAPEL 1144
SK I+H DLK +NLLV+ ICK+ DFG+S+ + + ++G++ WMAPE+
Sbjct: 126 SKGILHRDLKADNLLVD----ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE----RC 1200
++ S S KVD++S G + E+ G P++D A + + P IP
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEITS 1227
P + C+ +P+ RP+ E+
Sbjct: 242 SPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 97/303 (32%), Positives = 137/303 (45%), Gaps = 47/303 (15%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKD 1013
IK D+ RELG G +G V+ + VA+K +K A R KD
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--------KD 53
Query: 1014 FWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL------------- 1060
F REA +L+NL H ++V FYGV DG L V E+M +G L L
Sbjct: 54 FQREAELLTNLQHEHIVKFYGVCGDGD--PLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 111
Query: 1061 --LKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118
+ L + L IA A GM YL S++ VH DL N LV + K+GDF
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLLVKIGDF 167
Query: 1119 GLSR-IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEP 1174
G+SR + G LP WM PE + + + + DV+SFG+ +WEI T G++P
Sbjct: 168 GMSRDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIFTYGKQP 225
Query: 1175 YADMHCGAIIGGIVKNTL--RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+ + +I I + + RP + C E +M CW +P+ R + EI L +
Sbjct: 226 WFQLSNTEVIECITQGRVLERPRV---CPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
Query: 1233 SAA 1235
A
Sbjct: 283 GKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 99/295 (33%), Positives = 137/295 (46%), Gaps = 42/295 (14%)
Query: 961 IKNVDLEELRELGSGTYGTVY----HGKWRGSD---VAIKRIKKSCFAGRSSEQERLTKD 1013
IK D+ ELG G +G V+ H D VA+K +K++ SE R D
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESARQ--D 53
Query: 1014 FWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL---------LKKD 1064
F REA +L+ L H ++V FYGV +G L V E+M +G L L L
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 1065 R-----SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119
L + L IA A GM YL S + VH DL N LV Q + K+GDFG
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG----QGLVVKIGDFG 167
Query: 1120 LSR-IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPY 1175
+SR I G R LP WM PE + + + + D++SFG+ +WEI T G++P+
Sbjct: 168 MSRDIYSTDYYRVGGRTMLPIRWMPPESI--LYRKFTTESDIWSFGVVLWEIFTYGKQPW 225
Query: 1176 ADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230
+ I I + P C PE +M+ CW +P+ R +I SRL+
Sbjct: 226 YQLSNTEAIECITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 90/295 (30%), Positives = 134/295 (45%), Gaps = 54/295 (18%)
Query: 969 LRELGSGTYGTVYHGKWR--GSD----VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
+ ELG +G +Y G G D VAIK +K ++ Q+ +F +EA +++
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-----NNPQQ--WGEFQQEASLMA 62
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD----------------RS 1066
LHHPN+V GVV + + E++ G L L+ + S
Sbjct: 63 ELHHPNIVCLLGVVTQEQ--PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 1067 LDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---- 1122
LD L IA+ A GMEYL S VH DL N+L+ ++ K+ D GLSR
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG----EQLHVKISDLGLSREIYS 176
Query: 1123 -----IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYA 1176
++ +L+ + WM PE + + S D++SFG+ +WEI + G +PY
Sbjct: 177 ADYYRVQPKSLLP------IRWMPPEAI--MYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228
Query: 1177 DMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231
+I + K L P E C P LM +CW P RP F +I +RLR+
Sbjct: 229 GFSNQEVIEMVRKRQLLPC-SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 94/287 (32%), Positives = 139/287 (48%), Gaps = 46/287 (16%)
Query: 969 LRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHIL 1021
LRELG G++G VY G R + VA+K + +S +S +ER+ +F EA ++
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-----ASLRERI--EFLNEASVM 63
Query: 1022 SNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL--LKKD------RSLDRRKKL 1073
+VV GVV G TL V E M +G LK L L+ + R +++
Sbjct: 64 KGFTCHHVVRLLGVVSKGQP-TL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 1074 I-IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSG 1131
I +A + A GM YL++K VH DL N +V K+GDFG++R I
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMV----AHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 1132 GVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAII---- 1184
G +G LP WMAPE L + D++SFG+ +WEI + E+PY + ++
Sbjct: 178 GGKGLLPVRWMAPESLKDGV--FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235
Query: 1185 -GGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230
GG + P+ C LM CW +P+ RP+F EI + L+
Sbjct: 236 DGGYLDQ------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 2e-30
Identities = 85/275 (30%), Positives = 132/275 (48%), Gaps = 33/275 (12%)
Query: 969 LRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHP 1027
LR+LG G++G VY + VA+K + K + + + F RE IL++L H P
Sbjct: 5 LRKLGEGSFGEVYLAR-DRKLVALKVLAKK-----LESKSKEVERFLREIQILASLNHPP 58
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR--SLDRRKKLIIAMDAAFGMEY 1085
N+V Y D L V E++ GSL+ +L K R L + L I +EY
Sbjct: 59 NIVKLYDFFQDEGSLYL--VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR-------GTLP 1138
LHSK I+H D+K EN+L+ D + K+ DFGL+++ + + + GT
Sbjct: 117 LHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 1139 WMAPELLNGSSN-RVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK-------- 1189
+MAPE+L G S S D++S GI+++E+LTG P+ + +K
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233
Query: 1190 ---NTLRPTIPERCDPEWRKLMEQCWAADPEARPS 1221
+ L P+ PE L+++ A DP+ R S
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268
|
Length = 384 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 7e-30
Identities = 94/281 (33%), Positives = 142/281 (50%), Gaps = 36/281 (12%)
Query: 970 RELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
RELG G++G VY G +G + VAIK + ++ +S +ER+ +F EA ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-----ASMRERI--EFLNEASVMK 64
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL--LKKD------RSLDRRKKLI 1074
+ +VV GVV G TL + E M G LK L L+ + ++ KK+I
Sbjct: 65 EFNCHHVVRLLGVVSQGQP-TL-VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 1075 -IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSGG 1132
+A + A GM YL++ VH DL N +V + K+GDFG++R I G
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 1133 VRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189
+G LP WM+PE L + DV+SFG+ +WEI T E+PY M ++ +++
Sbjct: 179 GKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236
Query: 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230
L P+ C +LM CW +P+ RPSF EI S ++
Sbjct: 237 GGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 84/283 (29%), Positives = 138/283 (48%), Gaps = 21/283 (7%)
Query: 958 LQIIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFW 1015
++I+K +L++++ LGSG +GTVY G W G +V +I + R + + K+
Sbjct: 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENV---KIPVAIKVLRENTSPKANKEIL 57
Query: 1016 REAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGS-LKHVLLKKDRSLDRRKKLI 1074
EA++++ + P V G+ T+ VT+ M G L +V KDR + + L
Sbjct: 58 DEAYVMAGVGSPYVCRLLGIC---LTSTVQLVTQLMPYGCLLDYVRENKDR-IGSQDLLN 113
Query: 1075 IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---IKRNTLVSG 1131
+ A GM YL +VH DL N+LV + P K+ DFGL+R I +
Sbjct: 114 WCVQIAKGMSYLEEVRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLDIDETEYHAD 169
Query: 1132 GVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKN 1190
G + + WMA E + R + + DV+S+G+++WE++T G +PY + I + K
Sbjct: 170 GGKVPIKWMALESI--LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG 227
Query: 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233
P P C + +M +CW D E RP F E+ ++
Sbjct: 228 ERLPQ-PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 90/262 (34%), Positives = 122/262 (46%), Gaps = 46/262 (17%)
Query: 990 VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTE 1049
VA+K ++ +S+ R +DF +E ILS L PN+ GV L + E
Sbjct: 49 VAVKVLRPD-----ASDNAR--EDFLKEVKILSRLSDPNIARLLGVCT--VDPPLCMIME 99
Query: 1050 FMVNGSL-----KHVLLKKD-----RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCE 1099
+M NG L KHV +SL L +A A GM YL S N VH DL
Sbjct: 100 YMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159
Query: 1100 NLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG---VRGTLP----WMAPE-LLNGSSNR 1151
N LV I K+ DFG+SR L S V+G P WMA E +L G +
Sbjct: 160 NCLVG---KNYTI-KIADFGMSR----NLYSSDYYRVQGRAPLPIRWMAWESVLLG---K 208
Query: 1152 VSEKVDVFSFGISMWEILT--GEEPYADMHCGAII---GGIVKNTLRPTI---PERCDPE 1203
+ K DV++FG+++WEILT E+PY + +I G ++ R P C +
Sbjct: 209 FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKD 268
Query: 1204 WRKLMEQCWAADPEARPSFTEI 1225
+LM +CW D E RP+F EI
Sbjct: 269 IYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 84/265 (31%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 970 RELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN 1028
++LG+G +G V+ + + + VA+K +K + + F EA+++ L H
Sbjct: 12 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---------VEAFLAEANVMKTLQHDK 62
Query: 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAMDAAFGMEYLH 1087
+V + VV T + +TEFM GSL L + S KLI + A GM ++
Sbjct: 63 LVKLHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 1088 SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT--LVSGGVRGTLPWMAPELL 1145
+N +H DL+ N+LV+ +CK+ DFGL+R+ + G + + W APE +
Sbjct: 120 QRNYIHRDLRAANILVS----ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEW 1204
N S + K DV+SFGI + EI+T G PY M +I + + P E C E
Sbjct: 176 NFGSFTI--KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP-ENCPEEL 232
Query: 1205 RKLMEQCWAADPEARPSFTEITSRL 1229
+M +CW PE RP+F I S L
Sbjct: 233 YNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 8e-29
Identities = 82/276 (29%), Positives = 141/276 (51%), Gaps = 23/276 (8%)
Query: 958 LQIIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFW 1015
L+I+K + ++++ LGSG +GTVY G W G V I K R + + K+
Sbjct: 1 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEIL 57
Query: 1016 REAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGS-LKHVLLKKDRSLDRRKKLI 1074
EA++++++ +P+V G+ T+ +T+ M G L +V KD + + L
Sbjct: 58 DEAYVMASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLN 113
Query: 1075 IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI----KRNTLVS 1130
+ A GM YL + +VH DL N+LV + PQ K+ DFGL+++ ++
Sbjct: 114 WCVQIAKGMNYLEERRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLGADEKEYHAE 169
Query: 1131 GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189
GG + + WMA E + + + DV+S+G+++WE++T G +PY D + I I++
Sbjct: 170 GG-KVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPY-DGIPASEISSILE 225
Query: 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
R P C + +M +CW D ++RP F E+
Sbjct: 226 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 74/266 (27%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 971 ELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVV 1030
ELG G +G VY + + + + K E E DF E ILS HPN+V
Sbjct: 12 ELGDGAFGKVYKAQHKETGL--FAAAKIIQIESEEELE----DFMVEIDILSECKHPNIV 65
Query: 1031 AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKN 1090
Y L + EF G+L ++L+ +R L + + + +LHS
Sbjct: 66 GLYEAY--FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 1091 IVHFDLKCENLLVNLRDPQRPICKVGDFGLS------RIKRNTLVSGGVRGTLPWMAPEL 1144
++H DLK N+L+ L K+ DFG+S KR+T + GT WMAPE+
Sbjct: 124 VIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFI-----GTPYWMAPEV 174
Query: 1145 L---NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI--PER 1199
+ N K D++S GI++ E+ E P+ +++ ++ I+K+ PT+ P +
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE-PPTLDQPSK 233
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEI 1225
+ ++ C DP+ RP+ E+
Sbjct: 234 WSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 91/275 (33%), Positives = 132/275 (48%), Gaps = 34/275 (12%)
Query: 965 DLEELRELGSGTYGTVY---HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHIL 1021
DLE L ELG+G G V H + G +A+K I R E + K RE IL
Sbjct: 2 DLEYLGELGAGNSGVVSKVLH-RPTGKIMAVKTI-------RLEINEAIQKQILRELDIL 53
Query: 1022 SNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRR--KKLIIAMDA 1079
+ P +V FYG + G ++ E+M GSL +L + + R K+ +A+
Sbjct: 54 HKCNSPYIVGFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAV-- 109
Query: 1080 AFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP 1138
G+ YLH K I+H D+K N+LVN R Q +C DFG+S N+L V GT
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLC---DFGVSGQLVNSLAKTFV-GTSS 164
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGI------VKNTL 1192
+MAPE + G+ V K D++S G+S+ E+ TG PY GI + N
Sbjct: 165 YMAPERIQGNDYSV--KSDIWSLGLSLIELATGRFPYPP--ENDPPDGIFELLQYIVNEP 220
Query: 1193 RPTIP-ERCDPEWRKLMEQCWAADPEARPSFTEIT 1226
P +P + P+++ + C DP RPS+ E+
Sbjct: 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-28
Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 37/275 (13%)
Query: 972 LGSGTYGTVYHGKWRGS----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HH 1026
+G G +G V + + D AIKR+K+ +A + +DF E +L L HH
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDH-----RDFAGELEVLCKLGHH 67
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSL-----KHVLLKKD----------RSLDRRK 1071
PN++ G G L E+ +G+L K +L+ D +L ++
Sbjct: 68 PNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 1072 KLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG 1131
L A D A GM+YL K +H DL N+LV + + K+ DFGLSR + +
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSRGQEVYVKKT 181
Query: 1132 GVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKN 1190
R + WMA E LN S + DV+S+G+ +WEI++ G PY M C + + +
Sbjct: 182 MGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239
Query: 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
R P CD E LM QCW P RPSF +I
Sbjct: 240 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 85/281 (30%), Positives = 141/281 (50%), Gaps = 31/281 (11%)
Query: 959 QIIKNVDLEELRELGSGTYGTVYHGKW--RGSD----VAIKRIKKSCFAGRSSEQERLTK 1012
+I+K +L +L+ LGSG +GTV+ G W G VAIK I+ +GR + QE +T
Sbjct: 2 RILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQE-ITD 58
Query: 1013 DFWREAHILS--NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRR 1070
H+L+ +L H +V G+ P G +L VT+ GSL + + SLD +
Sbjct: 59 ------HMLAMGSLDHAYIVRLLGICP---GASLQLVTQLSPLGSLLDHVRQHRDSLDPQ 109
Query: 1071 KKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI---KRNT 1127
+ L + A GM YL +VH +L N+L L+ I ++ DFG++ +
Sbjct: 110 RLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL--LKSDS--IVQIADFGVADLLYPDDKK 165
Query: 1128 LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGG 1186
+ + WMA E + R + + DV+S+G+++WE+++ G EPYA M +
Sbjct: 166 YFYSEHKTPIKWMALESIL--FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPD 222
Query: 1187 IVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITS 1227
+++ R P+ C + +M +CW D RP+F E+ +
Sbjct: 223 LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 97/298 (32%), Positives = 144/298 (48%), Gaps = 40/298 (13%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRG----SD---VAIKRIKKSCFAGRSSEQERLTKD 1013
IK ++ RELG G +G V+ + D VA+K +K + S+ R KD
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA------SDNAR--KD 53
Query: 1014 FWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKH---------VLLKKD 1064
F REA +L+NL H ++V FYGV +G L V E+M +G L VL+ +
Sbjct: 54 FHREAELLTNLQHEHIVKFYGVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 1065 R---SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121
L + + L IA A GM YL S++ VH DL N LV + + K+GDFG+S
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG----ENLLVKIGDFGMS 167
Query: 1122 RIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYAD 1177
R +T V G + WM PE + + + + DV+S G+ +WEI T G++P+
Sbjct: 168 RDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225
Query: 1178 MHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235
+ +I I + + P C E LM CW +P R + EI S L+ ++ A
Sbjct: 226 LSNNEVIECITQGRVLQR-PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 91/295 (30%), Positives = 138/295 (46%), Gaps = 39/295 (13%)
Query: 962 KNVDLEELRELGSGTYGTVYHGKWRGS----DVAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
+++ E++ +G G +G V + + AIK +K+ +SE + +DF E
Sbjct: 2 EDIKFEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-----ASENDH--RDFAGE 52
Query: 1018 AHILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSL-----KHVLLKKD------- 1064
+L L HHPN++ G + G L E+ G+L K +L+ D
Sbjct: 53 LEVLCKLGHHPNIINLLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH 110
Query: 1065 ---RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121
+L ++ L A D A GM+YL K +H DL N+LV + K+ DFGLS
Sbjct: 111 GTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG----ENLASKIADFGLS 166
Query: 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHC 1180
R + + R + WMA E LN S + K DV+SFG+ +WEI++ G PY M C
Sbjct: 167 RGEEVYVKKTMGRLPVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224
Query: 1181 GAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235
+ + + R P CD E +LM QCW P RP F +I+ +L + A
Sbjct: 225 AELYEKLPQG-YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 83/263 (31%), Positives = 128/263 (48%), Gaps = 24/263 (9%)
Query: 972 LGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG G +G VY + G ++A+K++ F S E ++ E +L NL H +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVP---FDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK---DRSLDRRKKLIIAMDAAFGMEYL 1086
V +YG + D TL+ E+M GS+K L ++ R+ I G+EYL
Sbjct: 67 VQYYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE----GVEYL 120
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG----VRGTLPWMAP 1142
HS IVH D+K N+L RD + K+GDFG S+ + SG V GT WM+P
Sbjct: 121 HSNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDP 1202
E+++G K DV+S G ++ E+LT + P+A+ A I I P +P P
Sbjct: 177 EVISGEGY--GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSP 234
Query: 1203 EWRKLMEQCWAADPEARPSFTEI 1225
+ R + + + + + RPS E+
Sbjct: 235 DARNFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 88/296 (29%), Positives = 132/296 (44%), Gaps = 54/296 (18%)
Query: 965 DLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
++E +R++G G +G V+ + G + VA+K +K+ +S + DF RE
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-----ASAD--MQADFQRE 58
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS----------- 1066
A +++ HPN+V GV G + + E+M G L L + RS
Sbjct: 59 AALMAEFDHPNIVKLLGVC--AVGKPMCLLFEYMAYGDLNEFL--RHRSPRAQCSLSHST 114
Query: 1067 ------------LDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114
L ++L IA A GM YL + VH DL N LV + + K
Sbjct: 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG----ENMVVK 170
Query: 1115 VGDFGLSR-IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170
+ DFGLSR I +P WM PE + NR + + DV+++G+ +WEI +
Sbjct: 171 IADFGLSRNIYSADYYKASENDAIPIRWMPPESI--FYNRYTTESDVWAYGVVLWEIFSY 228
Query: 1171 GEEPYADMHCGAIIGGIVK-NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
G +PY M +I + N L + P+ C E LM CW+ P RPSF I
Sbjct: 229 GMQPYYGMAHEEVIYYVRDGNVL--SCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 7e-28
Identities = 89/279 (31%), Positives = 130/279 (46%), Gaps = 37/279 (13%)
Query: 972 LGSGTYGTVYHGKWRGS----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HH 1026
+G G +G V + + D AIKR+K+ +S+ + +DF E +L L HH
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDDH--RDFAGELEVLCKLGHH 55
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSL-----KHVLLKKD----------RSLDRRK 1071
PN++ G G L E+ +G+L K +L+ D +L ++
Sbjct: 56 PNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 1072 KLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG 1131
L A D A GM+YL K +H DL N+LV + + K+ DFGLSR + +
Sbjct: 114 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSRGQEVYVKKT 169
Query: 1132 GVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKN 1190
R + WMA E LN S + DV+S+G+ +WEI++ G PY M C + + +
Sbjct: 170 MGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227
Query: 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
R P CD E LM QCW P RPSF +I L
Sbjct: 228 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (284), Expect = 9e-28
Identities = 78/266 (29%), Positives = 121/266 (45%), Gaps = 35/266 (13%)
Query: 972 LGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG G++G V + + + A+K +KK + + + + E +ILS ++HP +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKK-----KKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 1030 V----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
V AF T L V E+ G L L K+ R + R + A + +EY
Sbjct: 56 VKLHYAFQ------TEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEY 108
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR-----GTLPWM 1140
LHS I++ DLK EN+L++ K+ DFGL++ L S G R GT ++
Sbjct: 109 LHSLGIIYRDLKPENILLD----ADGHIKLTDFGLAKE----LSSEGSRTNTFCGTPEYL 160
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
APE+L G + VD +S G+ ++E+LTG+ P+ I I+K+ PE
Sbjct: 161 APEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--PLRFPEFL 216
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEIT 1226
PE R L+ DP R
Sbjct: 217 SPEARDLISGLLQKDPTKRLGSGGAE 242
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 72/269 (26%), Positives = 125/269 (46%), Gaps = 21/269 (7%)
Query: 967 EELRELGSGTYG--TVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+R LG G +G T+Y S V K + + R SE+ER +D E ILS L
Sbjct: 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLT----RLSEKER--RDALNEIVILSLL 56
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM--DAAFG 1082
HPN++A+Y D TL E+ G+L ++++ L +++++
Sbjct: 57 QHPNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSA 113
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI-KRNTLVSGGVRGTLPWMA 1141
+ Y+H I+H D+K N+ + + K+GDFG+S+I ++ V GT +M+
Sbjct: 114 VSYIHKAGILHRDIKTLNIFLTKAG----LIKLGDFGISKILGSEYSMAETVVGTPYYMS 169
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201
PEL G + K D+++ G ++E+LT + + + ++ IV+ P +
Sbjct: 170 PELCQGVK--YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYS 226
Query: 1202 PEWRKLMEQCWAADPEARPSFTEITSRLR 1230
E L+ DPE RP+ E+ +
Sbjct: 227 SELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 75/261 (28%), Positives = 127/261 (48%), Gaps = 21/261 (8%)
Query: 965 DLEELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E L ++G G++G V+ K A+K+I S R +E + EA +L+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAI-----DEARVLA 54
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI--IAMDAA 1080
L ++ +Y D G L V E+ NG L H LLK R + + +
Sbjct: 55 KLDSSYIIRYYESFLDK--GKLNIVMEYAENGDL-HKLLKMQRGRPLPEDQVWRFFIQIL 111
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI-KRNTLVSGGVRGTLPW 1139
G+ +LHSK I+H D+K NL ++ D K+GD G++++ NT + + GT +
Sbjct: 112 LGLAHLHSKKILHRDIKSLNLFLDAYDN----VKIGDLGVAKLLSDNTNFANTIVGTPYY 167
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199
++PEL +EK DV++ G+ ++E TG+ P+ + GA+I I++ P + +
Sbjct: 168 LSPELC--EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-VSQM 224
Query: 1200 CDPEWRKLMEQCWAADPEARP 1220
+ +L++QC D RP
Sbjct: 225 YSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 7e-27
Identities = 80/281 (28%), Positives = 133/281 (47%), Gaps = 50/281 (17%)
Query: 972 LGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQER-LTKDFWREAHILSNLHHPN 1028
+GSG++G+VY G G +A+K+++ + S +++R + RE +L L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 1029 VVAFYGVVPDGT----------GGTLATVTEFMVN--GSLKHVLLKKDRSLDRRKKLIIA 1076
+V + G D GG++A ++N G+ + L+ R+ R+ I+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAA----LLNNYGAFEETLV---RNFVRQ---ILK 117
Query: 1077 MDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGT 1136
G+ YLH++ I+H D+K N+LV D + I K+ DFG+S+ +S G
Sbjct: 118 -----GLNYLHNRGIIHRDIKGANILV---DNKGGI-KISDFGISKKLEANSLSTKTNGA 168
Query: 1137 LP-------WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADM-HCGAI--IGG 1186
P WMAPE++ +S + K D++S G + E+LTG+ P+ D AI IG
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSY--TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226
Query: 1187 IVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITS 1227
P IP E +E+ + D RP+ E+
Sbjct: 227 NA----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 84/292 (28%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
L + LG G +G V + G D VA+K +K +E++ D E
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-----TEKD--LSDLVSE 65
Query: 1018 AHILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL---------LKKDRSL 1067
++ + H N++ GV G L V E+ +G+L+ L D
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQE--GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123
Query: 1068 DRRKKLI------IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121
+ L A A GME+L SK +H DL N+LV + + K+ DFGL+
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT----EDHVMKIADFGLA 179
Query: 1122 R-IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYAD 1177
R I G LP WMAPE L + + DV+SFG+ +WEI T G PY
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237
Query: 1178 MHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
+ + ++K R P+ C E LM CW P RP+F ++ L
Sbjct: 238 IPVEELFK-LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 79/280 (28%), Positives = 140/280 (50%), Gaps = 15/280 (5%)
Query: 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
L+I+K +L+ ++ LGSG +GTVY G W +K I + + + +F E
Sbjct: 1 LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVK-IPVAIKILNETTGPKANVEFMDE 59
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM 1077
A I++++ HP++V GV T+ VT+ M +G L + + ++ + L +
Sbjct: 60 ALIMASMDHPHLVRLLGVC---LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCV 116
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI---KRNTLVSGGVR 1134
A GM YL + +VH DL N+LV + P K+ DFGL+R+ + G +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLEGDEKEYNADGGK 172
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLR 1193
+ WMA E ++ + + + DV+S+G+++WE++T G +PY + I + K
Sbjct: 173 MPIKWMALECIH--YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL 230
Query: 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233
P P C + +M +CW D ++RP F E+ + ++
Sbjct: 231 PQ-PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 85/295 (28%), Positives = 130/295 (44%), Gaps = 59/295 (20%)
Query: 971 ELGSGTYGTVYHGKWRG--SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN 1028
E G T + K R + VA+K +K+ SS + R D E ++L ++HP+
Sbjct: 12 EFGKVVKATAFRLKGRAGYTTVAVKMLKE----NASSSELR---DLLSEFNLLKQVNHPH 64
Query: 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK-----------------------DR 1065
V+ YG G L + E+ GSL+ L + +R
Sbjct: 65 VIKLYGAC--SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 1066 SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--- 1122
+L + A + GM+YL +VH DL N+LV + K+ DFGLSR
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV----AEGRKMKISDFGLSRDVY 178
Query: 1123 -----IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEP 1174
+KR+ +G +P WMA E L + + + DV+SFG+ +WEI+T G P
Sbjct: 179 EEDSYVKRS-------KGRIPVKWMAIESL--FDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
Query: 1175 YADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
Y + + ++K R PE C E LM CW +P+ RP+F +I+ L
Sbjct: 230 YPGIAPERLFN-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 76/265 (28%), Positives = 122/265 (46%), Gaps = 22/265 (8%)
Query: 972 LGSGTYGTVYHGK--WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG+G + + Y + G+ +A+K++ SSEQE + + +E +++ L+HP++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYV--RNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 1030 VAFYG-VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS 1088
+ G D E+M GS+ H LL K + + G+ YLH
Sbjct: 66 IRMLGATCEDSHFNLFV---EWMAGGSVSH-LLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGL-----SRIKRNTLVSGGVRGTLPWMAPE 1143
I+H D+K NLL+ D ++ DFG ++ G + GT+ +MAPE
Sbjct: 122 NQIIHRDVKGANLLI---DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 1144 LLNGSSNRVSEKVDVFSFGISMWEILTGEEPY-ADMHCG--AIIGGIVKNTLRPTIPERC 1200
+L G S DV+S G + E+ T + P+ A+ H A+I I T P+IPE
Sbjct: 179 VLRGEQYGRS--CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEI 1225
P R + +C PE RP E+
Sbjct: 237 SPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 2e-26
Identities = 73/216 (33%), Positives = 107/216 (49%), Gaps = 31/216 (14%)
Query: 967 EELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E+L +LG GTYG VY + + + VA+K+I+ +E+E + RE +L L
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD------NEEEGIPSTALREISLLKEL 55
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK-KLIIAMDAAF-- 1081
HPN+V V+ T L V E+ + LK L K+ L K I +
Sbjct: 56 KHPNIVKLLDVIH--TERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSI-----MYQL 107
Query: 1082 --GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---IKRNTLVSGGVRGT 1136
G+ Y HS I+H DLK +N+L+N + K+ DFGL+R I T V T
Sbjct: 108 LRGLAYCHSHRILHRDLKPQNILINR----DGVLKLADFGLARAFGIPLRTYTHEVV--T 161
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
L + APE+L GS + S VD++S G E++TG+
Sbjct: 162 LWYRAPEILLGSKH-YSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 83/284 (29%), Positives = 125/284 (44%), Gaps = 47/284 (16%)
Query: 965 DLEELRELGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWR-EAHIL 1021
D E + +G G VY VAIKRI E+ + + D R E +
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRI--------DLEKCQTSVDELRKEVQAM 53
Query: 1022 SNLHHPNVVAFYG--VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM-- 1077
S +HPNVV +Y VV G L V ++ GSL ++ K + IIA
Sbjct: 54 SQCNHPNVVKYYTSFVV----GDELWLVMPYLSGGSLLDIM-KSSYPRGGLDEAIIATVL 108
Query: 1078 -DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS----------RIKRN 1126
+ G+EYLHS +H D+K N+L+ + K+ DFG+S R R
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLG----EDGSVKIADFGVSASLADGGDRTRKVRK 164
Query: 1127 TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGG 1186
T V GT WMAPE++ + K D++SFGI+ E+ TG PY+ ++
Sbjct: 165 TFV-----GTPCWMAPEVME-QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML 218
Query: 1187 IVKNTLRPTIPE-----RCDPEWRKLMEQCWAADPEARPSFTEI 1225
++N P++ + +RK++ C DP RP+ E+
Sbjct: 219 TLQND-PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEEL 261
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 85/282 (30%), Positives = 129/282 (45%), Gaps = 45/282 (15%)
Query: 968 ELREL-GSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
EL E+ G GTYG VY + + G VAIK + E+E + + E +IL
Sbjct: 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-----IEDEEEEIKE----EYNILRKY 59
Query: 1025 -HHPNVVAFYGV----VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKK--LI--I 1075
+HPN+ FYG P G L V E GS+ L+K R +R K I I
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAYI 118
Query: 1076 AMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR------IKRNTLV 1129
+ G+ YLH ++H D+K +N+L+ ++ + + DFG+S +RNT +
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLT-KNAEVKLV---DFGVSAQLDSTLGRRNTFI 174
Query: 1130 SGGVRGTLPWMAPELLNGSSNR---VSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGG 1186
GT WMAPE++ + DV+S GI+ E+ G+ P DMH +
Sbjct: 175 -----GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK 229
Query: 1187 IVKN---TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
I +N TL+ PE ++ + +C + E RP E+
Sbjct: 230 IPRNPPPTLKS--PENWSKKFNDFISECLIKNYEQRPFMEEL 269
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 65/223 (29%), Positives = 109/223 (48%), Gaps = 42/223 (18%)
Query: 967 EELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQER----LTKDFWREAHI 1020
E++ ++G GTYG VY + + + VA+K+I+ E E+ +T RE +
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRM--------ENEKEGFPIT--AIREIKL 51
Query: 1021 LSNLHHPNVVAFYGVVPDGTGGTLATVTEFM---VNGSLKHVLLKKDRSLDRRK----KL 1073
L L HPN+V +V G++ V E+M + G L +K + + K +L
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK--FTESQIKCYMKQL 109
Query: 1074 IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI----KRNTLV 1129
+ G++YLHS I+H D+K N+L+N + K+ DFGL+R
Sbjct: 110 LE------GLQYLHSNGILHRDIKGSNILIN----NDGVLKLADFGLARPYTKRNSADYT 159
Query: 1130 SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
+ + TL + PELL G++ R +VD++S G + E+ G+
Sbjct: 160 NRVI--TLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 73/265 (27%), Positives = 133/265 (50%), Gaps = 19/265 (7%)
Query: 967 EELRELGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E++R +G G +G V+ K V IK+I + ++ ERL E +L L
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVE----QMTKDERLAAQ--NECQVLKLL 56
Query: 1025 HHPNVVAFY-GVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS-LDRRKKLIIAMDAAFG 1082
HPN++ +Y + D L V E+ G+L + K+ S LD L +
Sbjct: 57 SHPNIIEYYENFLEDKA---LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA 113
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAP 1142
+ ++H+K I+H DLK +N+L++ + + K+GDFG+S+I + + V GT +++P
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKH---KMVVKIGDFGISKILSSKSKAYTVVGTPCYISP 170
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDP 1202
EL G ++K D+++ G ++E+ + + + + A++ I+ T P I +R P
Sbjct: 171 ELCEGKP--YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP-ISDRYSP 227
Query: 1203 EWRKLMEQCWAADPEARPSFTEITS 1227
+ R+L+ DP RP ++I +
Sbjct: 228 DLRQLILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 67/260 (25%), Positives = 116/260 (44%), Gaps = 21/260 (8%)
Query: 969 LRELGSGTYGTVYHGKWRGSD--VAIKRI-KKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
LR +G G +G V + R + A+K + K+ C S ++ E IL L+
Sbjct: 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGS------VRNVLNERRILQELN 58
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
HP +V + D + V + ++ G L++ L +K + + + K I + +EY
Sbjct: 59 HPFLVNLWYSFQDEE--NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEY 115
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELL 1145
LHSK I+H D+K +N+L++ ++ + DF ++ ++ GT +MAPE+L
Sbjct: 116 LHSKGIIHRDIKPDNILLD----EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVL 171
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIV--KNTLRPTIPERCDPE 1203
V+ VD +S G++ +E L G+ PY H I I + T P E
Sbjct: 172 CRQGYSVA--VDWWSLGVTAYECLRGKRPY-RGHSRTIRDQIRAKQETADVLYPATWSTE 228
Query: 1204 WRKLMEQCWAADPEARPSFT 1223
+ + DP+ R
Sbjct: 229 AIDAINKLLERDPQKRLGDN 248
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 76/275 (27%), Positives = 124/275 (45%), Gaps = 35/275 (12%)
Query: 972 LGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH--- 1026
+G G YG VY GK G VA+K I + + + D RE +LS L
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLD-----TPDDD--VSDIQREVALLSQLRQSQP 61
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
PN+ +YG G L + E+ GS++ L K + + +I + ++Y+
Sbjct: 62 PNITKYYGSYLKGP--RLWIIMEYAEGGSVR--TLMKAGPIAEKYISVIIREVLVALKYI 117
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS------RIKRNTLVSGGVRGTLPWM 1140
H ++H D+K N+LV +C DFG++ KR+T V GT WM
Sbjct: 118 HKVGVIHRDIKAANILVT-NTGNVKLC---DFGVAALLNQNSSKRSTFV-----GTPYWM 168
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
APE++ K D++S GI+++E+ TG PY+D+ + I K+ P + +
Sbjct: 169 APEVITEGKY-YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK-PPRLEDNG 226
Query: 1201 -DPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234
R+ + C +P+ R S E+ + + I A
Sbjct: 227 YSKLLREFVAACLDEEPKERLSAEELL-KSKWIKA 260
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 82/253 (32%), Positives = 114/253 (45%), Gaps = 39/253 (15%)
Query: 1003 RSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLK 1062
R + DF +E I+S L PN++ V T L +TE+M NG L L +
Sbjct: 55 REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI--TSDPLCMITEYMENGDLNQFLSR 112
Query: 1063 ---KDRSLDRRKKLI-------IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPI 1112
++ + I +A A GM+YL S N VH DL N LV +
Sbjct: 113 HEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG----KNYT 168
Query: 1113 CKVGDFGLSRIKRNTLVSGGV-----RGTLP--WMAPE-LLNGSSNRVSEKVDVFSFGIS 1164
K+ DFG+SR L SG R LP WM+ E +L G S DV++FG++
Sbjct: 169 IKIADFGMSR----NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS---DVWAFGVT 221
Query: 1165 MWEILT--GEEPYADMHCGAII---GGIVKNTLRPTI---PERCDPEWRKLMEQCWAADP 1216
+WEILT E+PY+ + +I G ++ R P C KLM CW +
Sbjct: 222 LWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNA 281
Query: 1217 EARPSFTEITSRL 1229
+ RPSF EI + L
Sbjct: 282 KERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 77/262 (29%), Positives = 119/262 (45%), Gaps = 23/262 (8%)
Query: 972 LGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG GTYG VY + + V AIK I + R + E + S L H N+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPE--------RDSRYVQPLHEEIALHSYLKHRNI 67
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF--GMEYLH 1087
V + G D G E + GSL +L K L ++ II G++YLH
Sbjct: 68 VQYLG--SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 1088 SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-RIKRNTLVSGGVRGTLPWMAPELLN 1146
IVH D+K +N+LVN + K+ DFG S R+ + GTL +MAPE+++
Sbjct: 126 DNQIVHRDIKGDNVLVNTYSG---VVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVID 182
Query: 1147 GSSNRVSEKVDVFSFGISMWEILTGEEPYADM---HCGAIIGGIVKNTLRPTIPERCDPE 1203
D++S G ++ E+ TG+ P+ ++ G+ K + P IPE E
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--IHPEIPESLSAE 240
Query: 1204 WRKLMEQCWAADPEARPSFTEI 1225
+ + +C+ DP+ R S ++
Sbjct: 241 AKNFILRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 92/283 (32%), Positives = 126/283 (44%), Gaps = 34/283 (12%)
Query: 970 RELGSGTYGTVYHGKWRGSD----VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+ LG G +G+V G+ D VA+K +K + SE E DF EA +
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT--RSEME----DFLSEAVCMKEFD 58
Query: 1026 HPNVVAFYGVVPDGTGG----TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM---- 1077
HPNV+ GV + + FM +G L H L R D + L M
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDL-HSFLLYSRLGDCPQYLPTQMLVKF 117
Query: 1078 --DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-RIKRNTLVSGGVR 1134
D A GMEYL SK+ +H DL N ++N +C V DFGLS +I G
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVC-VADFGLSKKIYNGDYYRQGRI 173
Query: 1135 GTLP--WMAPELLNGSSNRV-SEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKN 1190
+P W+A E L ++RV + K DV+SFG++MWEI T G+ PY + I + +
Sbjct: 174 AKMPVKWIAIESL---ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG 230
Query: 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233
R P C LM CW +P+ RPSF + L
Sbjct: 231 N-RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 85/272 (31%), Positives = 134/272 (49%), Gaps = 26/272 (9%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
DLE + ELG G YG V + + +A+KRI+ + S EQ+RL D + + S
Sbjct: 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDL--DISMRS 56
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSL----KHVLLKKDRSLDRRKKLIIAMD 1078
P V FYG + G + E M + SL K V K ++ IA+
Sbjct: 57 V-DCPYTVTFYGAL--FREGDVWICMEVM-DTSLDKFYKKVY-DKGLTIPEDILGKIAVS 111
Query: 1079 AAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTL 1137
+EYLHSK +++H D+K N+L+N R+ Q +C DFG+S +++ G
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLIN-RNGQVKLC---DFGISGYLVDSVAKTIDAGCK 167
Query: 1138 PWMAPELLNGSSNR--VSEKVDVFSFGISMWEILTGEEPYADMHCG-AIIGGIVKNTLRP 1194
P+MAPE +N N+ K DV+S GI+M E+ TG PY + +V+ P
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-SP 226
Query: 1195 TIP-ERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+P E+ PE++ + +C + + RP++ E+
Sbjct: 227 QLPAEKFSPEFQDFVNKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 77/282 (27%), Positives = 131/282 (46%), Gaps = 53/282 (18%)
Query: 969 LRELGSGTYGTVYHGKWRGSDV------AIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
++G GT+G VY ++ A+K I+ + K+ E +L
Sbjct: 5 GNKIGGGTFGKVY----TAVNLDTGELMAVKEIRIQ------DNDPKTIKEIADEMKVLE 54
Query: 1023 NLHHPNVVAFYGV-VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
L HPN+V +YGV V + E+ G+L+ LL+ R LD + +
Sbjct: 55 LLKHPNLVKYYGVEVHR---EKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLE 110
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-RIKRNTLVSG----GVRGT 1136
G+ YLHS IVH D+K N+ ++ + K+GDFG + ++K NT G + GT
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFLDHNG----VIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 1137 LPWMAPELLNGSSNRVSEK---VDVFSFGISMWEILTGEEPYADM--------HCGAIIG 1185
+MAPE++ G + D++S G + E+ TG+ P++++ H GA
Sbjct: 167 PAYMAPEVITG--GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--- 221
Query: 1186 GIVKNTLRPTIPER--CDPEWRKLMEQCWAADPEARPSFTEI 1225
+ P IP+ PE + +++C +DP+ RP+ +E+
Sbjct: 222 ---GHK--PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 75/295 (25%), Positives = 132/295 (44%), Gaps = 41/295 (13%)
Query: 960 IIKNVDLEELRELGSGTYGTVYHGKWRGS------DVAIKRIKKSCFAGRSSEQERLTKD 1013
+ ++ E GT+G +++G +V +K +K S Q L
Sbjct: 9 TLSDLLQE-------GTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTL--- 54
Query: 1014 FWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLK-------KDRS 1066
+E+ +L L H N++ V + + +M G+LK L + ++
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPF-VLYPYMNWGNLKLFLQQCRLGEANNPQA 113
Query: 1067 LDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---- 1122
L ++ + +A+ A GM YLH + ++H D+ N +++ + + K+ D LSR
Sbjct: 114 LSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID--EELQ--VKITDNALSRDLFP 169
Query: 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCG 1181
+ + L R + WMA E L + S DV+SFG+ +WE++T G+ PY ++
Sbjct: 170 MDYHCLGDNENR-PVKWMALESL--VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF 226
Query: 1182 AIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236
+ +K+ R P C E +M CWA DPE RPSF+++ L A +
Sbjct: 227 EMAA-YLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 79/271 (29%), Positives = 118/271 (43%), Gaps = 37/271 (13%)
Query: 972 LGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
+ G YG V+ K + G AIK IKK+ ++ + LT E ILS P V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLT-----ERDILSQAQSPYV 55
Query: 1030 VAFY----GVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
V Y G L V E++ G L LL+ SLD I + +EY
Sbjct: 56 VKLYYSFQGK------KNLYLVMEYLPGGDLAS-LLENVGSLDEDVARIYIAEIVLALEY 108
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---IKRNTLVSGG------VRGT 1136
LHS I+H DLK +N+L++ K+ DFGLS+ ++R ++ + GT
Sbjct: 109 LHSNGIIHRDLKPDNILID----SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196
++APE++ G + S+ VD +S G ++E L G P+ I I+ +
Sbjct: 165 PDYIAPEVILGQGH--SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW-- 220
Query: 1197 PERCD--PEWRKLMEQCWAADPEARPSFTEI 1225
PE + E L+ + DPE R I
Sbjct: 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 90/279 (32%), Positives = 130/279 (46%), Gaps = 39/279 (13%)
Query: 967 EELRELGSGTYGTVYH--GKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E + +G GTYG VY K GS A+K + + ++ E +IL +L
Sbjct: 25 EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---------SDVDEEIEAEYNILQSL 75
Query: 1025 -HHPNVVAFYGVVPDG---TGGTLATVTEFMVNGSLKHV---LLKKDRSLDRRKKLIIAM 1077
+HPNVV FYG+ GG L V E GS+ + LL + LD I
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS------RIKRNTLVSG 1131
A G+++LH+ I+H D+K N+L+ K+ DFG+S R++RNT V
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTSTRLRRNTSV-- 189
Query: 1132 GVRGTLPWMAPELLNGSSN---RVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIV 1188
GT WMAPE++ + DV+S GI+ E+ G+ P DMH + I
Sbjct: 190 ---GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246
Query: 1189 KNTLRPTI--PERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+N PT+ PE+ + + QC D EARPS T +
Sbjct: 247 RNP-PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHL 284
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 86/293 (29%), Positives = 134/293 (45%), Gaps = 31/293 (10%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
++N DLE + +LG+G G+V K + + KK G S + K RE I
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMA--KKVVHIGAKSS---VRKQILRELQI 56
Query: 1021 LSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR-SLDRRKKLIIAMDA 1079
+ P +V+FYG + + EFM GSL + K ++ K+ +A+
Sbjct: 57 MHECRSPYIVSFYGAFLNE--NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV-- 112
Query: 1080 AFGMEYLHSKN-IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP 1138
G+ YL++ + I+H D+K N+LVN R Q +C DFG+S N++ V GT
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLC---DFGVSGELINSIADTFV-GTST 167
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD-----------MHCGAIIGGI 1187
+M+PE + G V K DV+S GIS+ E+ G+ P+A M ++ I
Sbjct: 168 YMSPERIQGGKYTV--KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225
Query: 1188 VKNTLRPTIPERCDPE-WRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239
V P +P PE R ++ C DP RP+ ++ + I A S
Sbjct: 226 V-QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 79/259 (30%), Positives = 131/259 (50%), Gaps = 14/259 (5%)
Query: 969 LRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN 1028
+R +G G+YG V + R +D IKK S + + + +EA +LS L HPN
Sbjct: 5 VRVVGKGSYGEVSLVRHR-TDGKQYVIKKLNLRNASRRERKAAE---QEAQLLSQLKHPN 60
Query: 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLL-KKDRSLDRRKKLIIAMDAAFGMEYLH 1087
+VA Y +G G L V F G L H L +K + L + + + A ++YLH
Sbjct: 61 IVA-YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 1088 SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL-VSGGVRGTLPWMAPELLN 1146
K+I+H DLK +N+ + + I KVGD G++R+ N ++ + GT +M+PEL
Sbjct: 120 EKHILHRDLKTQNVFLT----RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF- 174
Query: 1147 GSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRK 1206
S+ + K DV++ G ++E+ T + + +++ I++ L P +P+ PE +
Sbjct: 175 -SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDYSPELGE 232
Query: 1207 LMEQCWAADPEARPSFTEI 1225
L+ + PE RPS I
Sbjct: 233 LIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 84/260 (32%), Positives = 122/260 (46%), Gaps = 17/260 (6%)
Query: 972 LGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG G +G VY + G ++A K+++ F S E + E +L NL H +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQ---FDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK 1089
V +YG + D TL E+M GS+K LK +L GM YLHS
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKD-QLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG-GVR---GTLPWMAPELL 1145
IVH D+K N+ LRD + K+GDFG S+ + +SG G+R GT WM+PE++
Sbjct: 126 MIVHRDIKGANI---LRDSAGNV-KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205
+G K DV+S G ++ E+LT + P+A+ A I I P +P R
Sbjct: 182 SGEG--YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR 239
Query: 1206 KLMEQCWAADPEARPSFTEI 1225
+ C + RPS E+
Sbjct: 240 DFL-GCIFVEARHRPSAEEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 82/266 (30%), Positives = 132/266 (49%), Gaps = 31/266 (11%)
Query: 968 ELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+L +G G++G VY G + VAIK I E E +D +E +LS
Sbjct: 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCD 60
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
P + +YG GT L + E++ GS +L K L+ I + G++Y
Sbjct: 61 SPYITRYYGSYLKGT--KLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDY 116
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL------SRIKRNTLVSGGVRGTLPW 1139
LHS+ +H D+K N+L++ ++ K+ DFG+ ++IKRNT V GT W
Sbjct: 117 LHSERKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199
MAPE++ S+ K D++S GI+ E+ GE P +D+H ++ I KN+ PT+ +
Sbjct: 168 MAPEVIKQSAYDF--KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-PPTLEGQ 224
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEI 1225
+++ +E C DP RP+ E+
Sbjct: 225 YSKPFKEFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 69/260 (26%), Positives = 113/260 (43%), Gaps = 34/260 (13%)
Query: 972 LGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG G +G V K + + A+K +KK R + + + E IL +HP +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKK-----RHIVETGQQEHIFSEKEILEECNHPFI 55
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK 1089
V Y D + + E+ + G L +L + + + IA EYLH++
Sbjct: 56 VKLYRTFKDKK--YIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEYLHNR 112
Query: 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR-----GTLPWMAPEL 1144
I++ DLK ENLL++ K+ DFG ++ + G + GT ++APE+
Sbjct: 113 GIIYRDLKPENLLLD----SNGYVKLVDFGFAKK-----LKSGQKTWTFCGTPEYVAPEI 163
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILTGEEPYA-----DMHCGAIIGGIVKNTLRPTIPER 1199
+ S VD +S GI ++E+LTG P+ M I I+K + P
Sbjct: 164 ILNKGYDFS--VDYWSLGILLYELLTGRPPFGEDDEDPM---EIYNDILKGNGKLEFPNY 218
Query: 1200 CDPEWRKLMEQCWAADPEAR 1219
D + L++Q +PE R
Sbjct: 219 IDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-23
Identities = 80/260 (30%), Positives = 124/260 (47%), Gaps = 17/260 (6%)
Query: 972 LGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG G +G VY + G ++A+K+++ F S E + E +L NL H +
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQ---FDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK 1089
V +YG + D TL+ E M GS+K LK +L G+ YLHS
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKD-QLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG----GVRGTLPWMAPELL 1145
IVH D+K N+ LRD + K+GDFG S+ + +SG V GT WM+PE++
Sbjct: 126 MIVHRDIKGANI---LRDSVGNV-KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205
+G K D++S G ++ E+LT + P+A+ A I I P +P R
Sbjct: 182 SGEG--YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239
Query: 1206 KLMEQCWAADPEARPSFTEI 1225
+++ + + + RPS E+
Sbjct: 240 DFLKRIF-VEAKLRPSADEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 70/213 (32%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
++L ++G GTYG VY + + G VAIK+IK E E + K RE +L L
Sbjct: 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIK------LRFESEGIPKTALREIKLLKEL 55
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
+HPN++ V G L V EFM + L ++ + R L G+
Sbjct: 56 NHPNIIKLLDVFRHK--GDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR------GTLP 1138
+ HS I+H DLK ENLL+N + K+ DFGL+R VR T
Sbjct: 113 FCHSHGILHRDLKPENLLIN----TEGVLKLADFGLAR-----SFGSPVRPYTHYVVTRW 163
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
+ APELL G S VD++S G E+L+
Sbjct: 164 YRAPELLLGDK-GYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 78/291 (26%), Positives = 115/291 (39%), Gaps = 64/291 (21%)
Query: 970 RELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQE------------RLTKDFWRE 1017
LG GT+ +Y G R +S QE R + F+
Sbjct: 1 EHLGQGTFTNIYKGVLR---------VQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET 51
Query: 1018 AHILSNLHHPNVVAFYGV-VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIA 1076
A ++S L H ++V YGV V D V E++ G L L ++ ++ KL +A
Sbjct: 52 ASLMSQLSHKHLVKLYGVCVRDEN----IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVA 107
Query: 1077 MDAAFGMEYLHSKNIVHFDLKCENLLV---NLRDPQRPICKVGDFGLSR--IKRNTLVSG 1131
A + YL K +VH ++ +N+LV L + P K+ D G+ + R V
Sbjct: 108 KQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE- 166
Query: 1132 GVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEP------------YADM 1178
+PW+APE + ++ D +SFG ++ EI + GEEP Y D
Sbjct: 167 ----RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ 222
Query: 1179 HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
H +P E L+ QCW DP RPSF I L
Sbjct: 223 H---------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 87/270 (32%), Positives = 125/270 (46%), Gaps = 49/270 (18%)
Query: 990 VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGV-VPDGTGGTLATVT 1048
VA+K + R+ + DF +E I+S L +PN++ GV V D L +T
Sbjct: 47 VAVKML-------RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP---LCMIT 96
Query: 1049 EFMVNGSLKHVLLKKD-----------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLK 1097
E+M NG L L +++ S+ L +A+ A GM+YL S N VH DL
Sbjct: 97 EYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA 156
Query: 1098 CENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGV-----RGTLP--WMAPE-LLNGSS 1149
N LV K+ DFG+SR L SG R LP WMA E +L G
Sbjct: 157 TRNCLVG----NHYTIKIADFGMSR----NLYSGDYYRIQGRAVLPIRWMAWESILLGKF 208
Query: 1150 NRVSEKVDVFSFGISMWEI--LTGEEPYADMHCGAII---GGIVKNTLRP---TIPERCD 1201
S DV++FG+++WE+ L E+PY+ + +I G +N R + C
Sbjct: 209 TTAS---DVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCP 265
Query: 1202 PEWRKLMEQCWAADPEARPSFTEITSRLRT 1231
KLM +CW+ D + RP+F +I LR
Sbjct: 266 SPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 78/260 (30%), Positives = 123/260 (47%), Gaps = 17/260 (6%)
Query: 972 LGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG G +G VY + G ++A+K++ F S E + E +L NL H +
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVP---FDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK 1089
V +YG + D L+ E+M GS+K LK +L G+ YLHS
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKD-QLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG----GVRGTLPWMAPELL 1145
IVH D+K N+ LRD + K+GDFG S+ + +SG V GT WM+PE++
Sbjct: 126 MIVHRDIKGANI---LRDSAGNV-KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205
+G K DV+S ++ E+LT + P+A+ A I I +P +P+ R
Sbjct: 182 SGEG--YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR 239
Query: 1206 KLMEQCWAADPEARPSFTEI 1225
++Q + + + RP+ +
Sbjct: 240 DFLKQIFVEE-KRRPTAEFL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 79/278 (28%), Positives = 125/278 (44%), Gaps = 36/278 (12%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQER--LTKDFWREAHILS 1022
D E L +G G++GTV + R SD I K+ + G +E+E+ L E +IL
Sbjct: 1 DYEVLETIGKGSFGTVRKVR-RKSDGKILVWKEIDY-GNMTEKEKQQLVS----EVNILR 54
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL--LKKDRS-LDRRKKLIIAMDA 1079
L HPN+V +Y + D + TL V E+ G L ++ KK+R ++ I
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 1080 AFGMEYLH-----SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN------TL 1128
+ H ++H DLK N+ ++ K+GDFGL++I + T
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLD----ANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 1129 VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY-ADMHCGAIIGGI 1187
V GT +M+PE LN S EK D++S G ++E+ P+ A +
Sbjct: 171 V-----GTPYYMSPEQLNHMS--YDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASK 221
Query: 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+K IP R E ++++ DP+ RPS E+
Sbjct: 222 IKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 967 EELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ L +G G +G V+ K R + VA+K++ A R E + RE L
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKV-----ALRRLE-GGIPNQALREIKALQAC 56
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK-KLIIAMDAAFGM 1083
HP VV V P G+G V E+M L VL ++R L + K + M G+
Sbjct: 57 QHPYVVKLLDVFPHGSG--FVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK-GV 112
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI---KRNTLVSGGVRGTLPWM 1140
Y+H+ I+H DLK NLL++ + K+ DFGL+R+ + L S V T +
Sbjct: 113 AYMHANGIMHRDLKPANLLISADG----VLKIADFGLARLFSEEEPRLYSHQV-ATRWYR 167
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
APELL G + + VD+++ G E+L G
Sbjct: 168 APELLYG-ARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-22
Identities = 88/298 (29%), Positives = 131/298 (43%), Gaps = 49/298 (16%)
Query: 970 RELGSGTYGTVYHGKWRGSD---------VAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
+ LG G +G V + G D VA+K +K + ++ D E +
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-------DNATDKDLADLISEMEL 70
Query: 1021 LSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK-----DRSLDRRKK-- 1072
+ + H N++ GV G L + E+ G+L+ L + D + D K
Sbjct: 71 MKLIGKHKNIINLLGVCTQE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 1073 --------LIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-- 1122
+ A A GMEYL S+ +H DL N+LV + + K+ DFGL+R
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN----VMKIADFGLARGV 184
Query: 1123 --IKRNTLVSGGVRGTLPWMAPELLNGSSNRV-SEKVDVFSFGISMWEILT-GEEPYADM 1178
I S G R + WMAPE L +RV + + DV+SFGI MWEI T G PY +
Sbjct: 185 HDIDYYKKTSNG-RLPVKWMAPEAL---FDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240
Query: 1179 HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236
+ +++ R P C E LM +CW A P RP+F ++ L + AA+
Sbjct: 241 PVEELFK-LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 1e-22
Identities = 85/251 (33%), Positives = 116/251 (46%), Gaps = 47/251 (18%)
Query: 1013 DFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLK-----HVLLKKDR-- 1065
DF +E ILS L PN++ GV D L +TE+M NG L H L K+
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENG 122
Query: 1066 -----------SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114
++ L +A+ A GM+YL S N VH DL N LV I K
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG---ENLTI-K 178
Query: 1115 VGDFGLSRIKRNTLVSGGV-----RGTLP--WMAPE-LLNGSSNRVSEKVDVFSFGISMW 1166
+ DFG+SR L +G R LP WMA E +L G S DV++FG+++W
Sbjct: 179 IADFGMSR----NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTAS---DVWAFGVTLW 231
Query: 1167 EILT--GEEPYADMHCGAII---GGIVKNTLRPTI---PERCDPEWRKLMEQCWAADPEA 1218
EIL E+PY ++ +I G ++ R P C +LM QCW+ D
Sbjct: 232 EILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRE 291
Query: 1219 RPSFTEITSRL 1229
RPSF++I + L
Sbjct: 292 RPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-22
Identities = 80/266 (30%), Positives = 129/266 (48%), Gaps = 31/266 (11%)
Query: 968 ELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+L +G G++G V+ G VAIK I E E +D +E +LS
Sbjct: 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIID-------LEEAEDEIEDIQQEITVLSQCD 60
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
P V +YG GT L + E++ GS +L + D + + + G++Y
Sbjct: 61 SPYVTKYYGSYLKGT--KLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILKGLDY 116
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL------SRIKRNTLVSGGVRGTLPW 1139
LHS+ +H D+K N+L++ ++ K+ DFG+ ++IKRNT V GT W
Sbjct: 117 LHSEKKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199
MAPE++ S+ K D++S GI+ E+ GE P +DMH ++ I KN PT+
Sbjct: 168 MAPEVIQQSA--YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTLTGE 224
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEI 1225
+++ ++ C DP RP+ E+
Sbjct: 225 FSKPFKEFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 61/171 (35%), Positives = 85/171 (49%), Gaps = 12/171 (7%)
Query: 1064 DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123
+ +LD L + A GM +L SKN +H DL N+L+ I K+ DFGL+R
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKICDFGLARD 263
Query: 1124 KR---NTLVSGGVRGTLPWMAPE-LLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADM 1178
R N +V G R + WMAPE + N S DV+S+GI +WEI + G PY M
Sbjct: 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFES---DVWSYGILLWEIFSLGSSPYPGM 320
Query: 1179 HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
+ ++K R PE E +M+ CW ADP RP+F +I +
Sbjct: 321 PVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 6e-22
Identities = 75/291 (25%), Positives = 125/291 (42%), Gaps = 42/291 (14%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D + + +G G++ TV K + ++ AIK + K R +E+ K E +L+
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDK-----RQLIKEKKVKYVKIEKEVLT 56
Query: 1023 NL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
L HP ++ Y D L V E+ NG L ++K SLD + A +
Sbjct: 57 RLNGHPGIIKLYYTFQDEE--NLYFVLEYAPNGELLQ-YIRKYGSLDEKCTRFYAAEILL 113
Query: 1082 GMEYLHSKNIVHFDLKCENLLVN---------------LRDPQRPICKVGDFGL------ 1120
+EYLHSK I+H DLK EN+L++ L P GD
Sbjct: 114 ALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 1121 -SRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH 1179
+R + + V GT +++PELLN + D+++ G ++++LTG+ P+ +
Sbjct: 174 KNRRRFASFV-----GTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226
Query: 1180 CGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230
I+K + P P+ + L+E+ DP+ R E L+
Sbjct: 227 EYLTFQKILKLEY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-21
Identities = 82/271 (30%), Positives = 132/271 (48%), Gaps = 31/271 (11%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E + ELG G +G VY K + G+ A K I+ SE+E +D+ E IL+
Sbjct: 15 EIIGELGDGAFGKVYKAKNKETGALAAAKVIETK------SEEE--LEDYMVEIEILATC 66
Query: 1025 HHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
+HP +V AFY G L + EF G++ ++L+ DR L + +I
Sbjct: 67 NHPYIVKLLGAFY------WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML 120
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVS-GGVRGTLPW 1139
++YLHS I+H DLK N+L+ L K+ DFG+S TL GT W
Sbjct: 121 EALQYLHSMKIIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYW 176
Query: 1140 MAPELLNGSSNRVSE---KVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196
MAPE++ + + + K D++S GI++ E+ E P+ +++ ++ I K+ PT+
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPTL 235
Query: 1197 --PERCDPEWRKLMEQCWAADPEARPSFTEI 1225
P + E+R ++ PE RPS ++
Sbjct: 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-21
Identities = 85/295 (28%), Positives = 125/295 (42%), Gaps = 47/295 (15%)
Query: 970 RELGSGTYGTVYHGKWRGSD---------VAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
+ LG G +G V + G D VA+K +K S E+ D E +
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLK-------SDATEKDLSDLISEMEM 76
Query: 1021 LSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK---------------D 1064
+ + H N++ G G L + E+ G+L+ L + +
Sbjct: 77 MKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPE 134
Query: 1065 RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-I 1123
L + + A A GMEYL SK +H DL N+LV + + K+ DFGL+R I
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT----EDNVMKIADFGLARDI 190
Query: 1124 KRNTLVSGGVRGTLP--WMAPELLNGSSNRV-SEKVDVFSFGISMWEILT-GEEPYADMH 1179
G LP WMAPE L +R+ + + DV+SFG+ +WEI T G PY +
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEAL---FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247
Query: 1180 CGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234
+ ++K R P C E +M CW A P RP+F ++ L I A
Sbjct: 248 VEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 1e-21
Identities = 70/213 (32%), Positives = 100/213 (46%), Gaps = 28/213 (13%)
Query: 967 EELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E+ ++LG GTY VY + + + VAIK+IK R ++ + RE +L L
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLG---ERKEAKDGINFTALREIKLLQEL 59
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK---KLIIAMDAAF 1081
HPN++ V G + V EFM L+ V+ KD+S+ K + M
Sbjct: 60 KHPNIIGLLDVF--GHKSNINLVFEFM-ETDLEKVI--KDKSIVLTPADIKSYMLM-TLR 113
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGT----L 1137
G+EYLHS I+H DLK NLL+ + K+ DFGL+R S + T
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLARS----FGSPNRKMTHQVVT 165
Query: 1138 PWM-APELLNGSSNRVSEKVDVFSFGISMWEIL 1169
W APELL G + VD++S G E+L
Sbjct: 166 RWYRAPELLFG-ARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-21
Identities = 83/293 (28%), Positives = 122/293 (41%), Gaps = 47/293 (16%)
Query: 970 RELGSGTYGTVYHGKWRGSD---------VAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
+ LG G +G V + G D VA+K +K E+ D E +
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEM 73
Query: 1021 LSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK---------------D 1064
+ + H N++ G G L + E+ G+L+ L + D
Sbjct: 74 MKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131
Query: 1065 RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK 1124
+ + + A GMEYL S+ +H DL N+LV + + K+ DFGL+R
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIADFGLARDV 187
Query: 1125 RNT-LVSGGVRGTLP--WMAPELLNGSSNRV-SEKVDVFSFGISMWEILT-GEEPYADMH 1179
N G LP WMAPE L +RV + + DV+SFG+ MWEI T G PY +
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEAL---FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244
Query: 1180 CGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+ ++K R P C E +M CW A P RP+F ++ L I
Sbjct: 245 VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-21
Identities = 80/264 (30%), Positives = 122/264 (46%), Gaps = 30/264 (11%)
Query: 967 EELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+LRE+G G++G VY VAIK K ++G+ S E+ +D +E L L
Sbjct: 18 TDLREIGHGSFGAVYFARDVRTNEVVAIK---KMSYSGKQS-NEKW-QDIIKEVRFLQQL 72
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
HPN + + G L V E+ + GS +L + L + I A G+
Sbjct: 73 RHPNTIEYKGCYLREHTAWL--VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLA 129
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR--NTLVSGGVRGTLPWMAP 1142
YLHS +H D+K N+L L +P K+ DFG + + N+ V GT WMAP
Sbjct: 130 YLHSHERIHRDIKAGNIL--LTEPG--TVKLADFGSASLVSPANSFV-----GTPYWMAP 180
Query: 1143 E-LLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201
E +L + KVDV+S GI+ E+ + P +M+ + + I +N PT+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLSSN-- 237
Query: 1202 PEW----RKLMEQCWAADPEARPS 1221
+W R ++ C P+ RPS
Sbjct: 238 -DWSDYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 2e-21
Identities = 71/212 (33%), Positives = 104/212 (49%), Gaps = 37/212 (17%)
Query: 975 GTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAF 1032
GTYG VY + + + VA+K++K E+E RE +IL L HPN+V
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLK------MEKEKEGFPITSLREINILLKLQHPNIVTV 69
Query: 1033 YGVVPDGTGGTLATVTEFMVNGSLKHVL------LKKDRSLDRRKKLIIAMDAAFGMEYL 1086
VV G L + +MV ++H L +K+ K L++ + + G+ +L
Sbjct: 70 KEVV---VGSNLDKI--YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS--GVAHL 122
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-----IKRNT-LVSGGVRGTLPWM 1140
H I+H DLK NLL+N R I K+ DFGL+R +K T LV TL +
Sbjct: 123 HDNWILHRDLKTSNLLLN----NRGILKICDFGLAREYGSPLKPYTQLVV-----TLWYR 173
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
APELL G+ S +D++S G E+LT +
Sbjct: 174 APELLLGAK-EYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-21
Identities = 87/294 (29%), Positives = 131/294 (44%), Gaps = 52/294 (17%)
Query: 969 LRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWREAHIL 1021
+ ELG +G VY G G+ VAIK +K + L ++F EA +
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMR 62
Query: 1022 SNLHHPNVVAFYGVVPDG-------TGGTLATVTEFMVNGSLKHVLLKKD------RSLD 1068
S L HPN+V GVV + + + + EF+V S + D +L+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 1069 RRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR------ 1122
+ I A GME+L S ++VH DL N+LV + K+ D GL R
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF----DKLNVKISDLGLFREVYAAD 178
Query: 1123 ---IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADM 1178
+ N+L+ + WM+PE + + S D++S+G+ +WE+ + G +PY
Sbjct: 179 YYKLMGNSLLP------IRWMSPEAI--MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230
Query: 1179 HCGAIIGGIVKNTLRPTIPERCDPEW-RKLMEQCWAADPEARPSFTEITSRLRT 1231
+I I + P P+ C P W LM +CW P RP F +I SRLRT
Sbjct: 231 SNQDVIEMIRNRQVLPC-PDDC-PAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|215996 pfam00564, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-21
Identities = 33/88 (37%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 197 PSDGKLRYVGGETRIISLRTNLSWEELVKKTSNICNQP-HLIKYQLPGEDLDALISVSSD 255
KLRY GG R +S+ +S+EEL K K + P ED D L+S++SD
Sbjct: 1 TVRVKLRYGGGIRRFLSVSPGISFEELRSKVEQRFGLDRVDFKLKYPDEDGD-LVSITSD 59
Query: 256 DDLQNMIDEYCGLERLEGSQRLRLFLIP 283
+DL+ I+E R GS+ LRL + P
Sbjct: 60 EDLEEAIEEA----RSLGSKTLRLHVFP 83
|
Length = 84 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 3e-21
Identities = 84/279 (30%), Positives = 131/279 (46%), Gaps = 39/279 (13%)
Query: 967 EELRELGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E + +G GTYG V+ K GS A+K + + ++ E +IL L
Sbjct: 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---------HDIDEEIEAEYNILKAL 71
Query: 1025 H-HPNVVAFYGVVPDG---TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM--- 1077
HPNVV FYG+ G L V E GS+ ++ + +R ++ IIA
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS------RIKRNTLVSG 1131
+A G+++LH +H D+K N+L+ K+ DFG+S R++RNT V
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTSTRLRRNTSV-- 185
Query: 1132 GVRGTLPWMAPELLNGSSNRVS---EKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIV 1188
GT WMAPE++ S + DV+S GI+ E+ G+ P AD+H + I
Sbjct: 186 ---GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242
Query: 1189 KNTLRPTI--PERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+N PT+ PE E+ + +C D E RP+ +++
Sbjct: 243 RNP-PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-21
Identities = 77/267 (28%), Positives = 127/267 (47%), Gaps = 30/267 (11%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
+LE + +GSG GTVY R + A+K I + ++ + + RE IL
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI-------YGNHEDTVRRQICREIEILR 127
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
+++HPNVV + + G + + EFM GSL+ + ++ L + I++ G
Sbjct: 128 DVNHPNVVKCHDMFDHN--GEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-----G 180
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL--VSGGVRGTLPWM 1140
+ YLH ++IVH D+K NLL+N K+ DFG+SRI T+ + V GT+ +M
Sbjct: 181 IAYLHRRHIVHRDIKPSNLLIN----SAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYM 235
Query: 1141 APELLNGSSNRVSEK---VDVFSFGISMWEILTGEEPYADMHCG---AIIGGIVKNTLRP 1194
+PE +N N + D++S G+S+ E G P+ G +++ I + P
Sbjct: 236 SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-PP 294
Query: 1195 TIPERCDPEWRKLMEQCWAADPEARPS 1221
P E+R + C +P R S
Sbjct: 295 EAPATASREFRHFISCCLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 9e-21
Identities = 79/266 (29%), Positives = 130/266 (48%), Gaps = 31/266 (11%)
Query: 968 ELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+L ++G G++G V+ G + VAIK I E E +D +E +LS
Sbjct: 8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-------LEEAEDEIEDIQQEITVLSQCD 60
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
P V +YG T L + E++ GS +L + LD + I + G++Y
Sbjct: 61 SPYVTKYYGSYLKDT--KLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDY 116
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL------SRIKRNTLVSGGVRGTLPW 1139
LHS+ +H D+K N+L++ + K+ DFG+ ++IKRNT V GT W
Sbjct: 117 LHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199
MAPE++ S+ K D++S GI+ E+ GE P++++H ++ I KN PT+
Sbjct: 168 MAPEVIKQSA--YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-PPTLEGN 224
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEI 1225
++ +E C +P RP+ E+
Sbjct: 225 YSKPLKEFVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 68/218 (31%), Positives = 105/218 (48%), Gaps = 35/218 (16%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQE--RLTKDFWREAHILS 1022
+ +++LG GT+G+VY + + G VAIK++KK F S +E L RE L
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK-FY---SWEECMNL-----REVKSLR 52
Query: 1023 NL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSL--DRRKKLIIAMDA 1079
L HPN+V V + L V E+M G+L ++ + + + II
Sbjct: 53 KLNEHPNIVKLKEVFREN--DELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN-----TLVSGGVR 1134
G+ ++H H DLK ENLLV+ + + K+ DFGL+R R+ VS
Sbjct: 110 Q-GLAHIHKHGFFHRDLKPENLLVSGPE----VVKIADFGLAREIRSRPPYTDYVS---- 160
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
T + APE+L S++ S VD+++ G M E+ T
Sbjct: 161 -TRWYRAPEILLRSTS-YSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 4e-20
Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 32/269 (11%)
Query: 972 LGSGTYGTVYHG-KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVV 1030
LG G YGTVY G +G +A+K+++ ++E+E + E +L +L H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKE--YEKLQEEVDLLKSLKHVNIV 65
Query: 1031 AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLK----KDRSLDRRKKLIIAMDAAFGMEYL 1086
+ G D T++ EF+ GS+ +L + + + K I+ G+ YL
Sbjct: 66 QYLGTCLDDN--TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-----GVAYL 118
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---------IKRNTLVSGGVRGTL 1137
H+ +VH D+K N+++ I K+ DFG +R N L S + GT
Sbjct: 119 HNNCVVHRDIKGNNVMLM----PNGIIKLIDFGCARRLAWVGLHGTHSNMLKS--MHGTP 172
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGI-VKNTLRPTI 1196
WMAPE++N S K D++S G +++E+ TG+ P A M A + I L P +
Sbjct: 173 YWMAPEVINESGY--GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL 230
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEI 1225
P+ + C D RPS ++
Sbjct: 231 PDSFSAAAIDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 65/231 (28%), Positives = 99/231 (42%), Gaps = 59/231 (25%)
Query: 967 EELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQER--LTKDFWREAHILS 1022
E+L +G GTYG VY + S VA+K+++ + ER + RE +L
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVR--------MDNERDGIPISSLREITLLL 61
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF- 1081
NL HPN+V VV G L ++ F+V + L L+ M F
Sbjct: 62 NLRHPNIVELKEVV---VGKHLDSI--FLVMEYCEQDL----------ASLLDNMPTPFS 106
Query: 1082 -------------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN-- 1126
G++YLH I+H DLK NLL+ + K+ DFGL+R
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT----DKGCLKIADFGLARTYGLPA 162
Query: 1127 -----TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
+V TL + APELL G + + +D+++ G + E+L +
Sbjct: 163 KPMTPKVV------TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 75/272 (27%), Positives = 121/272 (44%), Gaps = 31/272 (11%)
Query: 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
+ EL LG G G+V + + G A+K I + L K RE I +
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTIT-------TDPNPDLQKQILRELEINKS 55
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRR--KKLI--IAMDA 1079
P +V +YG D + ++ E+ GSL + KK + R +K++ IA
Sbjct: 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESV 114
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPW 1139
G+ YLHS+ I+H D+K N+L+ R Q +C DFG+S N+L +G GT +
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLC---DFGVSGELVNSL-AGTFTGTSFY 169
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY-ADMHCGAIIGGIVKNTLRPTIPE 1198
MAPE + G ++ DV+S G+++ E+ P+ + ++ + PE
Sbjct: 170 MAPERIQGKPYSITS--DVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE 227
Query: 1199 RCDPE-----W----RKLMEQCWAADPEARPS 1221
D W + ++QC DP RP+
Sbjct: 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 5e-20
Identities = 77/261 (29%), Positives = 121/261 (46%), Gaps = 28/261 (10%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E ++ LG+G++G V + +GS A+K + K+ +Q + E IL
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV--KLKQVEHVLN---EKRILQ 56
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
++ HP +V YG D + L V E++ G L L+K A
Sbjct: 57 SIRHPFLVNLYGSFQDDS--NLYLVMEYVPGGELFS-HLRKSGRFPEPVARFYAAQVVLA 113
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-RIKRN--TLVSGGVRGTLPW 1139
+EYLHS +IV+ DLK ENLL+ D I K+ DFG + R+K TL GT +
Sbjct: 114 LEYLHSLDIVYRDLKPENLLL---DSDGYI-KITDFGFAKRVKGRTYTLC-----GTPEY 164
Query: 1140 MAPE-LLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198
+APE +L+ + VD ++ GI ++E+L G P+ D + I I++ +R P
Sbjct: 165 LAPEIILSKGYGK---AVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR--FPS 219
Query: 1199 RCDPEWRKLMEQCWAADPEAR 1219
P+ + L+ D R
Sbjct: 220 FFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 78/273 (28%), Positives = 132/273 (48%), Gaps = 35/273 (12%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD---VAIKRIKKSCFAGRSSEQERLTKDFWREAHIL 1021
D + L++LG G+YG+VY K R SD A+K + G S++ER D E IL
Sbjct: 1 DFKVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVD----LGSMSQKERE--DAVNEIRIL 53
Query: 1022 SNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI------- 1074
++++HPN++++ DG L V E+ G L + K+ + ++KLI
Sbjct: 54 ASVNHPNIISYKEAFLDGN--KLCIVMEYAPFGDLSKAISKRKK----KRKLIPEQEIWR 107
Query: 1075 IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR 1134
I + G++ LH + I+H DLK N+L+ D + K+GD G+S++ + + +
Sbjct: 108 IFIQLLRGLQALHEQKILHRDLKSANILLVAND----LVKIGDLGISKVLKKNMAKTQI- 162
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY--ADMHCGAIIGGIVKNTL 1192
GT +MAPE+ G S K D++S G ++E+ T P+ M + V+
Sbjct: 163 GTPHYMAPEVWKGRP--YSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKVQRGK 217
Query: 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
P IP + + + P+ RP+ +I
Sbjct: 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 9e-20
Identities = 53/155 (34%), Positives = 82/155 (52%), Gaps = 12/155 (7%)
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNT--LVSGGVRGT 1136
A GME+L S+ +H DL N+L++ + + K+ DFGL+R I ++ + G R
Sbjct: 189 AKGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 1137 LPWMAPELLNGSSNRV-SEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRP 1194
L WMAPE + +RV + + DV+SFG+ +WEI + G PY + +K R
Sbjct: 245 LKWMAPETI---FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
P+ PE + M CW +P RP+F+E+ L
Sbjct: 302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 1e-19
Identities = 78/258 (30%), Positives = 124/258 (48%), Gaps = 20/258 (7%)
Query: 968 ELRELGSGTYGTVYHGK-WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
+LRE+G G++G VY + R S+V IKK ++G+ S ++ +D +E L L H
Sbjct: 19 DLREIGHGSFGAVYFARDVRNSEVVA--IKKMSYSGKQSNEK--WQDIIKEVRFLQKLRH 74
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
PN + + G L V E+ + GS +L + L + + A G+ YL
Sbjct: 75 PNTIQYRGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--KRNTLVSGGVRGTLPWMAPE- 1143
HS N++H D+K N+L L +P + K+GDFG + I N V GT WMAPE
Sbjct: 132 HSHNMIHRDVKAGNIL--LSEPG--LVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 182
Query: 1144 LLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPE 1203
+L + KVDV+S GI+ E+ + P +M+ + + I +N
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242
Query: 1204 WRKLMEQCWAADPEARPS 1221
+R ++ C P+ RP+
Sbjct: 243 FRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-19
Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 12/155 (7%)
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNT--LVSGGVRGT 1136
A GME+L S+ +H DL N+L++ + + K+ DFGL+R I ++ + G R
Sbjct: 183 ARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 1137 LPWMAPELLNGSSNRV-SEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRP 1194
L WMAPE + ++V + + DV+SFG+ +WEI + G PY + +K R
Sbjct: 239 LKWMAPESI---FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295
Query: 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
PE PE +M CW +PE RP+F+E+ L
Sbjct: 296 RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 80/271 (29%), Positives = 132/271 (48%), Gaps = 31/271 (11%)
Query: 967 EELRELGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E + ELG G +G VY + + + V A K I SE+E +D+ E IL++
Sbjct: 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK------SEEE--LEDYMVEIDILASC 59
Query: 1025 HHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
HPN+V AFY L + EF G++ V+L+ +R L + ++
Sbjct: 60 DHPNIVKLLDAFY------YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL 113
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLV-SGGVRGTLPW 1139
+ YLH I+H DLK N+L L K+ DFG+S T+ GT W
Sbjct: 114 EALNYLHENKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYW 169
Query: 1140 MAPELL--NGSSNRVSE-KVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196
MAPE++ S +R + K DV+S GI++ E+ E P+ +++ ++ I K+ PT+
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPTL 228
Query: 1197 --PERCDPEWRKLMEQCWAADPEARPSFTEI 1225
P R E++ +++C + +AR + T++
Sbjct: 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 23/282 (8%)
Query: 961 IKNVDLEELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
+ N +E +++G G + VY G VA+K+++ F ++ +D +E
Sbjct: 1 LGNFKIE--KKIGKGQFSVVYKAICLLDGRVVALKKVQ--IFEMMDAKAR---QDCLKEI 53
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL---LKKDRSLDRRKKLII 1075
+L L HPNV+ + + L V E G L ++ K+ R + R
Sbjct: 54 DLLKQLDHPNVIKYLASFIENN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 1076 AMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI-KRNTLVSGGVR 1134
+ +E++HSK I+H D+K N+ + + K+GD GL R T + +
Sbjct: 112 FVQLCSALEHMHSKRIMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLV 167
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEP-YAD-MHCGAIIGGIVKNTL 1192
GT +M+PE ++ N + K D++S G ++E+ + P Y D M+ ++ I K
Sbjct: 168 GTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY 225
Query: 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234
P + E R L+ +C DPE RP + + + + A
Sbjct: 226 PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|214770 smart00666, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 2e-19
Identities = 37/88 (42%), Positives = 54/88 (61%), Gaps = 11/88 (12%)
Query: 197 PSDGKLRYVGGETRIISLRTNLSWEELVKKTSNIC---NQPHLIKYQLPGEDLDALISVS 253
D KLRY GGETR +S+ ++S+E+L K + NQ +KYQ ED D L+S++
Sbjct: 1 TVDVKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLT 56
Query: 254 SDDDLQNMIDEYCGLERLEGSQRLRLFL 281
SD+DL+ I+EY GS++LRL +
Sbjct: 57 SDEDLEEAIEEY----DSLGSKKLRLHV 80
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. Length = 81 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-19
Identities = 83/283 (29%), Positives = 136/283 (48%), Gaps = 28/283 (9%)
Query: 968 ELRELGSGTYGTVYHGK-WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
+LRE+G G++G VY + R ++V IKK ++G+ S ++ +D +E L + H
Sbjct: 29 DLREIGHGSFGAVYFARDVRTNEVVA--IKKMSYSGKQSNEK--WQDIIKEVKFLQRIKH 84
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
PN + + G L V E+ + GS +L + L + I A G+ YL
Sbjct: 85 PNSIEYKGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR--NTLVSGGVRGTLPWMAPE- 1143
HS N++H D+K N+L L +P + K+ DFG + I N+ V GT WMAPE
Sbjct: 142 HSHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASIASPANSFV-----GTPYWMAPEV 192
Query: 1144 LLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPE 1203
+L + KVDV+S GI+ E+ + P +M+ + + I +N PT+ E
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPTLQSN---E 248
Query: 1204 W----RKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCIN 1242
W R ++ C P+ RP+ E+ + + E+ I+
Sbjct: 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLID 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 72/255 (28%), Positives = 111/255 (43%), Gaps = 20/255 (7%)
Query: 969 LRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
L+ + G +G+VY K R G AIK +KKS ++ ++T A ++
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN----QVTNVKAERAIMMIQGES 56
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
P V Y + L V E++ NG L+K L + G+E L
Sbjct: 57 PYVAKLYYSFQ--SKDYLYLVMEYL-NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDL 113
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLN 1146
H + I+H D+K ENLL++ Q K+ DFGLS RN L + GT ++APE +
Sbjct: 114 HQRGIIHRDIKPENLLID----QTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETIL 166
Query: 1147 GSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT--IPERCDPEW 1204
G + + D +S G ++E L G P+ A+ I+ + + E C PE
Sbjct: 167 GVGD--DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEA 224
Query: 1205 RKLMEQCWAADPEAR 1219
L+ + DP R
Sbjct: 225 VDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-19
Identities = 85/293 (29%), Positives = 126/293 (43%), Gaps = 47/293 (16%)
Query: 970 RELGSGTYGTVYHGKWRGSD---------VAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
+ LG G +G V + G D VA+K +K ++ D E +
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK-------DDATDKDLSDLVSEMEM 70
Query: 1021 LSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK-----DRSLD------ 1068
+ + H N++ G G L + E+ G+L+ L + D S D
Sbjct: 71 MKMIGKHKNIINLLGACTQD--GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPE 128
Query: 1069 ---RRKKLI-IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK 1124
K L+ A A GMEYL S+ +H DL N+LV + + K+ DFGL+R
Sbjct: 129 EQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT----EDNVMKIADFGLARDV 184
Query: 1125 RNT-LVSGGVRGTLP--WMAPELLNGSSNRV-SEKVDVFSFGISMWEILT-GEEPYADMH 1179
N G LP WMAPE L +RV + + DV+SFG+ +WEI T G PY +
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEAL---FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241
Query: 1180 CGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+ ++K R P C E +M +CW A P RP+F ++ L +
Sbjct: 242 VEELFK-LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-19
Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 12/155 (7%)
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNT--LVSGGVRGT 1136
A GME+L S+ +H DL N+L++ + + K+ DFGL+R I ++ + G R
Sbjct: 184 ARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 1137 LPWMAPELLNGSSNRV-SEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRP 1194
L WMAPE + ++V + + DV+SFG+ +WEI + G PY + +K+ R
Sbjct: 240 LKWMAPESI---FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
PE PE ++M CW DP+ RP+F+ + L
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 69/278 (24%), Positives = 128/278 (46%), Gaps = 37/278 (13%)
Query: 970 RELGSGTYGTVYHGK----WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
E+G+G +G V G+ + V +K ++ S ++ E+L F +E L+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-----ATPDEQLL--FLQEVQPYRELN 53
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSL-----DRRKKLIIAMDAA 1080
HPNV+ G + V EF G LK+ L+ +R + + +A + A
Sbjct: 54 HPNVLQCLGQCIESI--PYLLVLEFCPLGDLKN-YLRSNRGMVAQMAQKDVLQRMACEVA 110
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL--SRIKRNTLVSGGVRGT-L 1137
G+ +LH + +H DL N + K+GD+GL + + ++ L
Sbjct: 111 SGLLWLHQADFIHSDLALRNCQLT----ADLSVKIGDYGLALEQYPEDYYITKDCHAVPL 166
Query: 1138 PWMAPELLNGSSNRV-----SEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNT 1191
W+APEL+ + ++K +++S G++MWE+ T ++PY D+ ++ +V+
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ 226
Query: 1192 L----RPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+P + + W ++M+ CW DPE RP+ E+
Sbjct: 227 DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 972 LGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKD------FWREAHILSN 1023
LG GTYG V G VAIK++K + ++ +L RE I++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGM 1083
+ H N++ V +G + V + M LK V+ +K R + + K I+ + G+
Sbjct: 77 IKHENIMGLVDVYVEG--DFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-LQILNGL 132
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRG-------- 1135
LH +H DL N+ +N + ICK+ DFGL+R S +
Sbjct: 133 NVLHKWYFMHRDLSPANIFIN----SKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 1136 -------TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
TL + APELL G + + VD++S G E+LTG
Sbjct: 189 EMTSKVVTLWYRAPELLMG-AEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 32/215 (14%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+++ ++G GTYG VY + + G VA+K+I+ +E E + RE +L L
Sbjct: 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIR------LETEDEGVPSTAIREISLLKEL 55
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL-LKKDRSLDRR--KKLIIAMDAAF 1081
+HPN+V VV L V EF ++ LK + LD K + +
Sbjct: 56 NHPNIVRLLDVVHSEN--KLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ-- 110
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRG------ 1135
G+ Y HS ++H DLK +NLL++ + K+ DFGL+R VR
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLID----REGALKLADFGLARA-----FGVPVRTYTHEVV 161
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT 1170
TL + APE+L GS + S VD++S G E++
Sbjct: 162 TLWYRAPEILLGSR-QYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 6e-19
Identities = 73/220 (33%), Positives = 104/220 (47%), Gaps = 42/220 (19%)
Query: 968 ELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+L +LG GTY TVY G+ R G VA+K I G S RE ++ L
Sbjct: 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA-------IREISLMKELK 56
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF---- 1081
H N+V + V+ T L V E+M + LK + D R A+D
Sbjct: 57 HENIVRLHDVI--HTENKLMLVFEYM-DKDLKKYM---DTHGVRG-----ALDPNTVKSF 105
Query: 1082 ------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---IKRNTLVSGG 1132
G+ + H ++H DLK +NLL+N +R K+ DFGL+R I NT +
Sbjct: 106 TYQLLKGIAFCHENRVLHRDLKPQNLLIN----KRGELKLADFGLARAFGIPVNTFSNEV 161
Query: 1133 VRGTLPWMAPELLNGSSNRV-SEKVDVFSFGISMWEILTG 1171
V TL + AP++L GS R S +D++S G M E++TG
Sbjct: 162 V--TLWYRAPDVLLGS--RTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 6e-19
Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 38/220 (17%)
Query: 969 LRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
L+ +GSG YG V K G VAIK+I + K RE +L +L H
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKI------SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 1027 PNVVAFYGVVPDGTG---GTLATVTEFMVNGSLKHVLLKKDRSL--DRRKKLIIAMDAAF 1081
N++ ++ + + VTE M + H ++K + L D + + +
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQPLTDDHIQYFLYQI--LR 114
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRI-----KRNTLVSGGV- 1133
G++YLHS N++H DLK N+LVN + C K+ DFGL+R ++ V
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVN-SN-----CDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 1134 -RGTLPWM-APELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
R W APELL SS+R ++ +D++S G E+LT
Sbjct: 169 TR----WYRAPELL-LSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|99716 cd05992, PB1, The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 7e-19
Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 6/84 (7%)
Query: 199 DGKLRYVGGETRIISLRTNLSWEELVKKTSNICNQP-HLIKYQLPGEDLDALISVSSDDD 257
K++Y G R + + ++S+E+L K + K + P ED D L+++SSD+D
Sbjct: 2 RVKVKYGGEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYPDEDGD-LVTISSDED 60
Query: 258 LQNMIDEYCGLERLEGSQRLRLFL 281
L+ I+E R GS++LRLF+
Sbjct: 61 LEEAIEEA----RRSGSKKLRLFV 80
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. Length = 81 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-18
Identities = 55/168 (32%), Positives = 87/168 (51%), Gaps = 12/168 (7%)
Query: 1064 DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLV-NLRDPQRPICKVGDFGLSR 1122
LD L + A GM++L SKN +H D+ N+L+ + R + K+ DFGL+R
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-----VAKICDFGLAR 260
Query: 1123 I---KRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADM 1178
N +V G R + WMAPE + V DV+S+GI +WEI + G+ PY +
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQS--DVWSYGILLWEIFSLGKSPYPGI 318
Query: 1179 HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEIT 1226
+ +VK + + P+ PE +M+ CW +P RP+F++I+
Sbjct: 319 LVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 34/226 (15%)
Query: 973 GSGTYGTVYHGKW----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN 1028
G GTYG VY K G + AIK+ K G + +++ RE +L L H N
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFK-----GDKEQYTGISQSACREIALLRELKHEN 63
Query: 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLL--------KKDRSLDRR--KKLIIAMD 1078
VV+ V + ++ + ++ +H L K S+ K L+ +
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI- 117
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVS----GGVR 1134
G+ YLHS ++H DLK N+LV P+R + K+GD GL+R+ L V
Sbjct: 118 -LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC 1180
T+ + APELL G+ + +D+++ G E+LT E +
Sbjct: 177 VTIWYRAPELLLGARHYTK-AIDIWAIGCIFAELLTLEPIF---KG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 68/217 (31%), Positives = 108/217 (49%), Gaps = 31/217 (14%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D ++ ++G GTYG VY G+ + G VA+K+I+ SE+E + RE +L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIR------LESEEEGVPSTAIREISLLK 54
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL--LKKDRSLDRRKKLIIAMDAA 1080
L HPN+V V+ + L + EF+ + LK L L K + +D
Sbjct: 55 ELQHPNIVCLQDVLMQES--RLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQIL 111
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-------RIKRNTLVSGGV 1133
G+ + HS+ ++H DLK +NLL++ + + K+ DFGL+ R+ + +V
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLID----NKGVIKLADFGLARAFGIPVRVYTHEVV---- 163
Query: 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT 1170
TL + APE+L GS R S VD++S G E+ T
Sbjct: 164 --TLWYRAPEVLLGSP-RYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-18
Identities = 58/158 (36%), Positives = 84/158 (53%), Gaps = 12/158 (7%)
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSGGVRGTL 1137
A GME+L SKN VH DL N+L+ Q I K+ DFGL+R + + VS G L
Sbjct: 247 ARGMEFLASKNCVHRDLAARNVLLA----QGKIVKICDFGLARDIMHDSNYVSKG-STFL 301
Query: 1138 P--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRP 1194
P WMAPE + N + DV+S+GI +WEI + G PY M + +K+ R
Sbjct: 302 PVKWMAPESI--FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM 359
Query: 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
P+ E +M +CW ++PE RPSF ++ + ++
Sbjct: 360 AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-18
Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 26/264 (9%)
Query: 969 LRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN 1028
L E+G G++G VY ++ + +KK ++G+ + ++ +D +E L L HPN
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVA-VKKMSYSGKQTNEK--WQDIIKEVKFLQQLKHPN 82
Query: 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS 1088
+ + G L V E+ + GS +L + L + I A G+ YLHS
Sbjct: 83 TIEYKGCYLKEHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR--NTLVSGGVRGTLPWMAPE-LL 1145
N++H D+K N+L L +P + K+ DFG + N+ V GT WMAPE +L
Sbjct: 140 HNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASKSSPANSFV-----GTPYWMAPEVIL 190
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEW- 1204
+ KVDV+S GI+ E+ + P +M+ + + I +N PT+ EW
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPTLQSN---EWT 246
Query: 1205 ---RKLMEQCWAADPEARPSFTEI 1225
R ++ C P+ RP+ E+
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-18
Identities = 62/275 (22%), Positives = 114/275 (41%), Gaps = 29/275 (10%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
++D + ++Y G + +V I+ KK + L E
Sbjct: 17 SDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKF-----HKGHKVLIDITENEIKN 71
Query: 1021 LSNLHHPNVVAFYGVVPDGTGG--TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
L + N++ YG + D L+ + E+ G L+ VL K++ L + KL +A+D
Sbjct: 72 LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLDMAID 130
Query: 1079 AAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI-------KRNTLVS 1130
G+ L+ N + +L + LV + K+ GL +I N +V
Sbjct: 131 CCKGLYNLYKYTNKPYKNLTSVSFLVT----ENYKLKIICHGLEKILSSPPFKNVNFMV- 185
Query: 1131 GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN 1190
+ + ++LN + + K D++S G+ +WEI TG+ P+ ++ I I+
Sbjct: 186 --------YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK 237
Query: 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+P C E + ++E C + D RP+ EI
Sbjct: 238 NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-18
Identities = 68/240 (28%), Positives = 105/240 (43%), Gaps = 48/240 (20%)
Query: 969 LRELGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
+R +G G G VY + VA+K+I++ SE L K F REA I ++L H
Sbjct: 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-----SENPLLKKRFLREAKIAADLIH 61
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNG-SLKHVLLKKDRSLDRRKK-----------LI 1074
P +V Y + D G T + G +LK LLK + K L
Sbjct: 62 PGIVPVYSICSD---GDPVYYTMPYIEGYTLKS-LLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 1075 IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR--------- 1125
I +EY+HSK ++H DLK +N+L+ L + D+G + K+
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE----VVILDWGAAIFKKLEEEDLLDI 173
Query: 1126 ----------NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
+ + G + GT +MAPE L G SE D+++ G+ ++++LT PY
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 64/267 (23%), Positives = 127/267 (47%), Gaps = 20/267 (7%)
Query: 967 EELRELGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E ++++G G++G +Y K IK I + + E + +E +L+ +
Sbjct: 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK------KEVILLAKM 56
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSL-KHVLLKKDRSLDRRKKLIIAMDAAFGM 1083
HPN+V F+ + G L V E+ G L K + ++ + L + + G+
Sbjct: 57 KHPNIVTFFASFQEN--GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL 114
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL-VSGGVRGTLPWMAP 1142
+++H + I+H D+K +N+ ++ + K+GDFG++R +++ ++ GT +++P
Sbjct: 115 KHIHDRKILHRDIKSQNIFLS---KNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
Query: 1143 ELLNGSSNR-VSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201
E+ NR + K D++S G ++E+ T + P+ + ++ I + P P
Sbjct: 172 EI---CQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNF-S 227
Query: 1202 PEWRKLMEQCWAADPEARPSFTEITSR 1228
+ R L+ Q + P RPS T I R
Sbjct: 228 RDLRSLISQLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.2 bits (210), Expect = 1e-17
Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 32/264 (12%)
Query: 971 ELGSGTYGTVYHGK--WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN 1028
++G G GTV+ G +VAIK+I + ++E + E ++ L +PN
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQ----KQPKKELIIN----EILVMKELKNPN 77
Query: 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS 1088
+V F G L V E++ GSL V+ + +D + + + +E+LH+
Sbjct: 78 IVNFLDSFL--VGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHA 133
Query: 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGL------SRIKRNTLVSGGVRGTLPWMAP 1142
++H D+K +N+L+ + K+ DFG + KR+T+V GT WMAP
Sbjct: 134 NQVIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAP 184
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN-TLRPTIPERCD 1201
E++ + KVD++S GI E++ GE PY + + + I N T PE+
Sbjct: 185 EVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
Query: 1202 PEWRKLMEQCWAADPEARPSFTEI 1225
P +R + +C D E R S E+
Sbjct: 243 PIFRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-17
Identities = 55/150 (36%), Positives = 78/150 (52%), Gaps = 10/150 (6%)
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKR--NTLVSGGVRGT 1136
A GME+L SKN VH DL N+L+ + + K+ DFGL+R I R N + G
Sbjct: 249 ANGMEFLASKNCVHRDLAARNVLIC----EGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195
L WMAPE + +N + DV+SFGI +WEI T G PY ++ +K R
Sbjct: 305 LKWMAPESI--FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
P E ++M++CW E RP F+++
Sbjct: 363 KPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 75/299 (25%), Positives = 111/299 (37%), Gaps = 62/299 (20%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E L +G G YG V + + G VAIK+ K+S + E + K RE +L L
Sbjct: 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES------EDDEDVKKTALREVKVLRQL 57
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
H N+V G L V E+ V +L +L L +
Sbjct: 58 RHENIVNLKEAFR--RKGRLYLVFEY-VERTLLELLEASPGGLPPDAVRSYIWQLLQAIA 114
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR------GTLP 1138
Y HS NI+H D+K EN+LV+ + K+ DFG +R L + T
Sbjct: 115 YCHSHNIIHRDIKPENILVSESG----VLKLCDFGFAR----ALRARPASPLTDYVATRW 166
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE----------EPYADMHCGAIIGGIV 1188
+ APELL G +N + VDV++ G M E+L GE + Y C +G +
Sbjct: 167 YRAPELLVGDTN-YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKC---LGPLP 222
Query: 1189 K------------NTLR-PTIPER----------CDPEWRKLMEQCWAADPEARPSFTE 1224
+ P + ++ C DP+ R + E
Sbjct: 223 PSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 39/274 (14%)
Query: 965 DLEELRELGSGTYGTVY-----HGKWRGSDVAIKRIKKSCFAGRSSEQE-----RLTKDF 1014
+ E LR LG+G YG V+ G G A+K +KK+ ++ E R +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 1015 WREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI 1074
R L LH+ AF T L + +++ G L L +++ + ++
Sbjct: 61 VRRCPFLVTLHY----AFQ------TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVY 110
Query: 1075 IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR 1134
IA + +++LH I++ D+K EN+L+ D + + + DFGLS+ L R
Sbjct: 111 IA-EIVLALDHLHQLGIIYRDIKLENILL---DSEGHV-VLTDFGLSKE---FLAEEEER 162
Query: 1135 -----GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY----ADMHCGAIIG 1185
GT+ +MAPE++ G S + VD +S G+ +E+LTG P+ I
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR 222
Query: 1186 GIVKNTLRPTIPERCDPEWRKLMEQCWAADPEAR 1219
I+K+ +P P+ E R +++ DP+ R
Sbjct: 223 RILKS--KPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 77/265 (29%), Positives = 131/265 (49%), Gaps = 39/265 (14%)
Query: 969 LRELGSGTYGTVYH-GKWRGSDV----AIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
L+ LG G++G V+ K G D A+K +KK+ R + ++ +D IL+
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERD------ILAE 54
Query: 1024 LHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
++HP +V AF T G L + +F+ G L L K+ + K +A +
Sbjct: 55 VNHPFIVKLHYAFQ------TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-EL 107
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR----- 1134
A +++LHS I++ DLK EN+L+ D + I K+ DFGLS+ + +
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILL---DEEGHI-KLTDFGLSK----ESIDHEKKAYSFC 159
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194
GT+ +MAPE++N + ++ D +SFG+ M+E+LTG P+ + I+K L
Sbjct: 160 GTVEYMAPEVVNRRGH--TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-- 215
Query: 1195 TIPERCDPEWRKLMEQCWAADPEAR 1219
+P+ PE + L+ + +P R
Sbjct: 216 GMPQFLSPEAQSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 72/294 (24%), Positives = 118/294 (40%), Gaps = 58/294 (19%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
++++ LG G G V+ + +G+ A+K + K R+ + LT E IL+
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT-----EQEILA 56
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF- 1081
L HP + Y T L V ++ G L LL++ + K + A F
Sbjct: 57 TLDHPFLPTLYASFQ--TETYLCLVMDYCPGGEL-FRLLQR-----QPGKCLSEEVARFY 108
Query: 1082 ------GMEYLHSKNIVHFDLKCENLLVN------LRD---------PQRPICKVGDFGL 1120
+EYLH IV+ DLK EN+L++ L D P+ K G
Sbjct: 109 AAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 1121 SRIKRNTLV------SGGVR-----GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEIL 1169
R N++ R GT ++APE+++G + VD ++ GI ++E+L
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH--GSAVDWWTLGILLYEML 226
Query: 1170 TGEEPYADMHCGAIIGGIVKNTLR----PTIPERCDPEWRKLMEQCWAADPEAR 1219
G P+ + I+K + P + RKL+ + DP R
Sbjct: 227 YGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVK----DPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 64/270 (23%), Positives = 132/270 (48%), Gaps = 33/270 (12%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+++++G G++G K + G IK I S + + E+ R +E +LSN+
Sbjct: 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR------KEVAVLSNM 56
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSL-------KHVLLKKDRSLDRRKKLIIAM 1077
HPN+V + + G L V ++ G L + VL +D+ LD ++ +A
Sbjct: 57 KHPNIVQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA- 113
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL-VSGGVRGT 1136
++++H + I+H D+K +N+ + + K+GDFG++R+ +T+ ++ GT
Sbjct: 114 -----LKHVHDRKILHRDIKSQNIFLT----KDGTIKLGDFGIARVLNSTVELARTCIGT 164
Query: 1137 LPWMAPELLNGSSNR-VSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT 1195
+++PE+ NR + K D+++ G ++E+ T + + + ++ I++ + P
Sbjct: 165 PYYLSPEIC---ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PP 220
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ + R L+ Q + +P RPS I
Sbjct: 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 75/268 (27%), Positives = 125/268 (46%), Gaps = 40/268 (14%)
Query: 971 ELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN 1028
++G G GTVY G +VAIK++ + ++E + E ++ HPN
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQ----QQPKKELIIN----EILVMRENKHPN 77
Query: 1029 VVAF---YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
+V + Y V G L V E++ GSL V+ + +D + + + +E+
Sbjct: 78 IVNYLDSYLV-----GDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEF 130
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL------SRIKRNTLVSGGVRGTLPW 1139
LHS ++H D+K +N+L+ + K+ DFG + KR+T+V GT W
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPYW 181
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI--P 1197
MAPE++ + KVD++S GI E++ GE PY + + + I N P + P
Sbjct: 182 MAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNP 238
Query: 1198 ERCDPEWRKLMEQCWAADPEARPSFTEI 1225
E+ +R + +C D E R S E+
Sbjct: 239 EKLSAIFRDFLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 70/273 (25%), Positives = 109/273 (39%), Gaps = 40/273 (14%)
Query: 972 LGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG G +G V + + G A K++ K R EQ L E IL + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN-----EKKILEKVSSRFI 55
Query: 1030 V----AFYGVVPDGTGGTLATVTEFMVNGSLK-HVLLKKDRSLDRRKKLIIAMDAAFGME 1084
V AF T L V M G LK H+ + + + A G+E
Sbjct: 56 VSLAYAFE------TKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLE 109
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-RIKRNTLVSGGVRGTLPWMAPE 1143
+LH + IV+ DLK EN+L++ ++ D GL+ +K + G GT +MAPE
Sbjct: 110 HLHQRRIVYRDLKPENVLLD----DHGNVRISDLGLAVELKGGKKIKGRA-GTPGYMAPE 164
Query: 1144 LLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN--------TLRPT 1195
+L G VD F+ G +++E++ G P+ V+ +
Sbjct: 165 VLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQR------KEKVEKEELKRRTLEMAVE 216
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228
P++ PE + L E DPE R ++
Sbjct: 217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSAD 249
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 8e-17
Identities = 70/212 (33%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
EEL E+G G YGTVY + G VA+K+++ +E + RE +L L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP------LSEEGIPLSTLREIALLKQL 55
Query: 1025 ---HHPNVVAFYGV--VPDGTGGT-LATVTEFMVNGSLKHVLLKK--DRSLDRRKKLIIA 1076
HPN+V V P L V E V+ L L K L +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDL-ATYLSKCPKPGLPPETIKDLM 113
Query: 1077 MDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGT 1136
G+++LHS IVH DLK +N+LV D Q K+ DFGL+RI + V T
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVT-SDGQ---VKIADFGLARIYSFEMALTSVVVT 169
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEI 1168
L + APE+L SS VD++S G E+
Sbjct: 170 LWYRAPEVLLQSSYATP--VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 70/275 (25%), Positives = 125/275 (45%), Gaps = 25/275 (9%)
Query: 970 RELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
+++G G + VY G VA+K+++ + D +E +L L+HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA-----DCIKEIDLLKQLNHP 62
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL--LKKDRSLDRRK---KLIIAMDAAFG 1082
NV+ +Y + L V E G L ++ KK + L K K + + +A
Sbjct: 63 NVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA-- 118
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI-KRNTLVSGGVRGTLPWMA 1141
+E++HS+ ++H D+K N+ + + K+GD GL R T + + GT +M+
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILTGEEP-YAD-MHCGAIIGGIVKNTLRPTIPER 1199
PE ++ N + K D++S G ++E+ + P Y D M+ ++ I + P +
Sbjct: 175 PERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 232
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234
E R+L+ C DPE RP T + + + A
Sbjct: 233 YSEELRQLVNMCINPDPEKRPDITYVYDVAKRMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-16
Identities = 77/276 (27%), Positives = 125/276 (45%), Gaps = 36/276 (13%)
Query: 968 ELREL-GSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
EL EL G+GTYG VY G+ G AIK + + E+E + + E ++L
Sbjct: 9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEEEIKQ----EINMLKKY 59
Query: 1025 -HHPNVVAFYGVV----PDGTGGTLATVTEFMVNGSLKHVLLK-KDRSLDRRKKLIIAMD 1078
HH N+ +YG P G L V EF GS+ ++ K +L I +
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI------KRNTLVSGG 1132
G+ +LH ++H D+K +N+L+ + K+ DFG+S +RNT +
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDRTVGRRNTFI--- 172
Query: 1133 VRGTLPWMAPELLNGSSNRVSE---KVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK 1189
GT WMAPE++ N + K D++S GI+ E+ G P DMH + I +
Sbjct: 173 --GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 230
Query: 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
N ++ +++ +E C + RP+ ++
Sbjct: 231 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 69/236 (29%), Positives = 112/236 (47%), Gaps = 23/236 (9%)
Query: 944 SDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFA 1001
+ M + + S + L D E LG+G++G V K +G+ AIK +KK
Sbjct: 3 AAYMFTKPDTSSWKLS-----DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL 57
Query: 1002 GRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLL 1061
+ + + + + E IL L HP +V D + + EF+V G L L
Sbjct: 58 -KMKQVQHVAQ----EKSILMELSHPFIVNMMCSFQDEN--RVYFLLEFVVGGELFTHLR 110
Query: 1062 KKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121
K R + K A + EYLHSK+I++ DLK ENLL+ D + + KV DFG +
Sbjct: 111 KAGRFPNDVAKFYHA-ELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHV-KVTDFGFA 165
Query: 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177
K+ + + GT ++APE++ S + VD ++ G+ ++E + G P+ D
Sbjct: 166 --KKVPDRTFTLCGTPEYLAPEVIQ--SKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217
|
Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 80/262 (30%), Positives = 130/262 (49%), Gaps = 31/262 (11%)
Query: 969 LRELGSGTYGTVY-----HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
L+ LG G YG V+ G G A+K +KK+ R+ + TK E +IL
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKDTAHTK---AERNILEA 56
Query: 1024 LHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
+ HP +V AF TGG L + E++ G L L ++ ++ ++ +
Sbjct: 57 VKHPFIVDLIYAFQ------TGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-EI 109
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSGGVRGTL 1137
+ +E+LH + I++ DLK EN+L+ D Q + K+ DFGL + I T V+ GT+
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILL---DAQGHV-KLTDFGLCKESIHEGT-VTHTFCGTI 164
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197
+MAPE+L S + + VD +S G M+++LTG P+ + I I+K L +P
Sbjct: 165 EYMAPEILMRSGH--GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL--NLP 220
Query: 1198 ERCDPEWRKLMEQCWAADPEAR 1219
PE R L+++ +P +R
Sbjct: 221 PYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 73/286 (25%), Positives = 126/286 (44%), Gaps = 67/286 (23%)
Query: 972 LGSGTYGTVYHG---------KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
LG GT+ ++ G + ++V +K + KS ++ F+ A ++S
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMS 54
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
L H ++V YGV G + V E++ GSL L K ++ KL +A A+
Sbjct: 55 QLSHKHLVLNYGVCVCGDESIM--VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWA 112
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQR-----PICKVGDFGLS--RIKRNTLVSGGVRG 1135
+ +L K + H ++ +N+L+ +R+ R P K+ D G+S + + L+
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLL-IREEDRKTGNPPFIKLSDPGISITVLPKEILLE----- 166
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG-EEP------------YADMHCGA 1182
+PW+ PE + N +S D +SFG ++WEI +G ++P Y D H
Sbjct: 167 RIPWVPPECIENPQN-LSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRH--- 222
Query: 1183 IIGGIVKNTLRPTIPERCDPEWRKL---MEQCWAADPEARPSFTEI 1225
+P P+W +L + QC +P+ RPSF I
Sbjct: 223 ------------QLPA---PKWTELANLINQCMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 72/275 (26%), Positives = 132/275 (48%), Gaps = 42/275 (15%)
Query: 965 DLEELRELGSGTYGTV--YHGKWRGSDVAIKR--IKKSCFAGRSSEQERLTKDFWREAHI 1020
L+ ++G G+ G V K G VA+K+ ++K Q+R F E I
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---------QQRRELLF-NEVVI 69
Query: 1021 LSNLHHPNVVAFYG--VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
+ + HPN+V Y +V D L V EF+ G+L ++ + ++ + +A+
Sbjct: 70 MRDYQHPNIVEMYSSYLVGD----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVL 125
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL-SRI-----KRNTLVSGG 1132
A + +LH++ ++H D+K +++L+ D + K+ DFG +++ +R +LV
Sbjct: 126 KA--LSFLHAQGVIHRDIKSDSILLT-SDGR---VKLSDFGFCAQVSKEVPRRKSLV--- 176
Query: 1133 VRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192
GT WMAPE++ S +VD++S GI + E++ GE PY + + I ++ L
Sbjct: 177 --GTPYWMAPEVI--SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-RDNL 231
Query: 1193 RPTI--PERCDPEWRKLMEQCWAADPEARPSFTEI 1225
P + + P R +++ DP R + E+
Sbjct: 232 PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 74/275 (26%), Positives = 122/275 (44%), Gaps = 29/275 (10%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
DL++L E+G G +GTV + S A+KRI+ S + EQ+RL D + + S
Sbjct: 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEK--EQKRLLMDL--DVVMRS 59
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSL----KHVLLKKDRSLDRRKKLIIAMD 1078
+ P +V FYG + G E M + SL K+V + IA+
Sbjct: 60 S-DCPYIVKFYGAL--FREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVA 115
Query: 1079 AAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTL 1137
+ YL + I+H D+K N+L++ K+ DFG+S +++ G
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGN----IKLCDFGISGQLVDSIAKTRDAGCR 171
Query: 1138 PWMAPELLNGSSNRVSE-KVDVFSFGISMWEILTGEEPYA------DMHCGAIIGGIVKN 1190
P+MAPE ++ S+ + + DV+S GI+++E+ TG+ PY D + G
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPI- 230
Query: 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
L + P + + C D RP + E+
Sbjct: 231 -LSNSEEREFSPSFVNFINLCLIKDESKRPKYKEL 264
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 68/262 (25%), Positives = 122/262 (46%), Gaps = 19/262 (7%)
Query: 970 RELGSGTYGTVYHGKWRGSDVAIKRIK--KSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
+ LG G++GTVY K + + A +R+K K G + E + + +EA +LS L HP
Sbjct: 6 QRLGKGSFGTVYLVKDKKAV-AEERLKVLKEIPVGELNPNETVQAN--QEAQLLSKLDHP 62
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLK---HVLLKKDRSLDRRKKLIIAMDAAFGME 1084
+V F+ + +TE+ L L ++L + + G+
Sbjct: 63 AIVKFHASFLERD--AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL-VSGGVRGTLPWMAPE 1143
Y+H + I+H DLK +N+ + + + K+GDFG+SR+ + ++ GT +M+PE
Sbjct: 121 YMHQRRILHRDLKAKNIFL-----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175
Query: 1144 LLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPE 1203
L K D++S G ++E+ + + +++ IV+ P++PE +
Sbjct: 176 AL--KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP-TPSLPETYSRQ 232
Query: 1204 WRKLMEQCWAADPEARPSFTEI 1225
+M+ DP RPS EI
Sbjct: 233 LNSIMQSMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-16
Identities = 68/219 (31%), Positives = 110/219 (50%), Gaps = 21/219 (9%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSD---VAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
+K D +R LG+G++G V ++ D VAIKR +KS + +Q+++ F E
Sbjct: 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS----KIIKQKQVDHVF-SE 81
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM 1077
IL+ ++HP V YG D + L V EF++ G L++++ A
Sbjct: 82 RKILNYINHPFCVNLYGSFKDES--YLYLVLEFVIGGEF-FTFLRRNKRFPNDVGCFYAA 138
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTL 1137
EYL S NIV+ DLK ENLL++ + K+ DFG +++ + + GT
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLD----KDGFIKMTDFGFAKVVDTRTYT--LCGTP 192
Query: 1138 PWMAPE-LLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
++APE LLN + + D ++ GI ++EIL G P+
Sbjct: 193 EYIAPEILLNVGHGKAA---DWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 968 ELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+L +LG GTY TVY G+ + +D VA+K I R +E RE +L +L
Sbjct: 10 KLDKLGEGTYATVYKGRSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLLKDLK 62
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
H N+V + ++ T +L V E++ + LK L S++ + G+ Y
Sbjct: 63 HANIVTLHDII--HTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNY 119
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR-NTLVSGGVRGTLPWMAPEL 1144
H + ++H DLK +NLL+N +R K+ DFGL+R K T TL + P++
Sbjct: 120 CHRRKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILTG 1171
L GS++ S ++D++ G +E+ TG
Sbjct: 176 LLGSTD-YSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 69/268 (25%), Positives = 124/268 (46%), Gaps = 20/268 (7%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
LR +G G++G + SD A+K I R + +D +EA +L+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI-------RLPKSSSAVEDSRKEAVLLA 53
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSL-KHVLLKKDRSLDRRKKLIIAMDAAF 1081
+ HPN+VAF G L V E+ G L + + L++ + L +
Sbjct: 54 KMKHPNIVAFKESFE--ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR-GTLPWM 1140
G++++H K ++H D+K +N+ + Q K+GDFG +R+ + GT ++
Sbjct: 112 GVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYV 167
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
PE+ + K D++S G ++E+ T + P+ +I + + + +P +P
Sbjct: 168 PPEIWENMP--YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSHY 224
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228
E R L++Q + +P +RPS T I SR
Sbjct: 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 81/292 (27%), Positives = 130/292 (44%), Gaps = 53/292 (18%)
Query: 961 IKNVDLEELRE----------LGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQE 1008
+ ++DL LR+ +G+GTYG VY G+ G AIK + + E+E
Sbjct: 3 LDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEE 57
Query: 1009 RLTKDFWREAHILSNL-HHPNVVAFYGVV----PDGTGGTLATVTEFMVNGSLKHVLLK- 1062
+ E ++L HH N+ +YG P G L V EF GS+ ++
Sbjct: 58 EIKL----EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT 113
Query: 1063 KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122
K +L I + G+ +LH+ ++H D+K +N+L+ + K+ DFG+S
Sbjct: 114 KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSA 169
Query: 1123 I------KRNTLVSGGVRGTLPWMAPELLNGSSNRVSE---KVDVFSFGISMWEILTGEE 1173
+RNT + GT WMAPE++ N + + D++S GI+ E+ G
Sbjct: 170 QLDRTVGRRNTFI-----GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
Query: 1174 PYADMHCGAIIGGIVKNTLRPTIPERCDPEWRK----LMEQCWAADPEARPS 1221
P DMH + I +N P P+ +W K +E C + +RPS
Sbjct: 225 PLCDMHPMRALFLIPRNP--P--PKLKSKKWSKKFIDFIEGCLVKNYLSRPS 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 967 EELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
++L +LG G+Y TVY G+ + + VA+K I R +E REA +L +L
Sbjct: 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEI-------RLEHEEGAPFTAIREASLLKDL 60
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
H N+V + ++ T TL V E++ LK + L + G+
Sbjct: 61 KHANIVTLHDII--HTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR---NTLVSGGVRGTLPWMA 1141
Y H + ++H DLK +NLL++ R K+ DFGL+R K T + V TL +
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGE----LKLADFGLARAKSVPSKTYSNEVV--TLWYRP 171
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
P++L GS+ S +D++ G +E+ TG
Sbjct: 172 PDVLLGSTE-YSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 967 EELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E++ ++G GTYG VY + R ++ +A+K+I+ E E + RE +L +
Sbjct: 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIR------LEQEDEGVPSTAIREISLLKEM 58
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
H N+V VV + L V E++ KH+ D + + R G+
Sbjct: 59 QHGNIVRLQDVV--HSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---IKRNTLVSGGVRGTLPWMA 1141
Y HS ++H DLK +NLL+ D + K+ DFGL+R I T V TL + A
Sbjct: 117 YCHSHRVLHRDLKPQNLLI---DRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRA 171
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILT 1170
PE+L GS + S VD++S G E++
Sbjct: 172 PEILLGSRH-YSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 967 EELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ + +GSG YG V G VAIK+I + + L K RE IL +
Sbjct: 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKI------PHAFDVPTLAKRTLRELKILRHF 61
Query: 1025 HHPNVVAFYGVV--PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF- 1081
H N++A ++ P + V + M L H++ S + L F
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHII----HS---DQPLTEEHIRYFL 113
Query: 1082 -----GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR------IKRNTLVS 1130
G++Y+HS N++H DLK NLLVN + ++GDFG++R + ++
Sbjct: 114 YQLLRGLKYIHSANVIHRDLKPSNLLVN----EDCELRIGDFGMARGLSSSPTEHKYFMT 169
Query: 1131 GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFG 1162
V T + APELL S + +D++S G
Sbjct: 170 EYV-ATRWYRAPELLL-SLPEYTTAIDMWSVG 199
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-15
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 968 ELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+L +LG GTY TV+ G K + VA+K I R +E RE +L NL
Sbjct: 9 KLDKLGEGTYATVFKGRSKLTENLVALKEI-------RLEHEEGAPCTAIREVSLLKNLK 61
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
H N+V + ++ T L V E++ + LK L + I G+ Y
Sbjct: 62 HANIVTLHDII--HTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK-------RNTLVSGGVRGTLP 1138
H + I+H DLK +NLL+N ++ K+ DFGL+R K N +V TL
Sbjct: 119 CHKRKILHRDLKPQNLLIN----EKGELKLADFGLARAKSVPTKTYSNEVV------TLW 168
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
+ P++L GS+ S +D++ G ++E+ TG
Sbjct: 169 YRPPDVLLGST-EYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 4e-15
Identities = 71/266 (26%), Positives = 122/266 (45%), Gaps = 32/266 (12%)
Query: 969 LRELGSGTYGTVYHGK--WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
++G G GTVY G +VAIK++ + +Q+ + E ++ +
Sbjct: 24 FEKIGQGASGTVYTAIDIATGQEVAIKQM--------NLQQQPKKELIINEILVMRENKN 75
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
PN+V + G L V E++ GSL V+ + +D + + + +++L
Sbjct: 76 PNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFL 131
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL------SRIKRNTLVSGGVRGTLPWM 1140
HS ++H D+K +N+L+ + K+ DFG + KR+T+V GT WM
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPYWM 182
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN-TLRPTIPER 1199
APE++ + KVD++S GI E++ GE PY + + + I N T PER
Sbjct: 183 APEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER 240
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEI 1225
+R + +C D + R S E+
Sbjct: 241 LSAVFRDFLNRCLEMDVDRRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 70/233 (30%), Positives = 107/233 (45%), Gaps = 47/233 (20%)
Query: 962 KNVD-LEELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
+ VD + + ++G GTYG VY K G VA+K+++ +E+E RE
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR------LDNEKEGFPITAIREI 57
Query: 1019 HILSNLHHPNVVAFYGVVPDGTG--------GTLATVTEFM---VNGSLKH--VLLKKDR 1065
IL L+H N+V +V D G V E+M + G L+ V +D
Sbjct: 58 KILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH 117
Query: 1066 SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI-- 1123
K+L ++ G+ Y H KN +H D+KC N+L+N + K+ DFGL+R+
Sbjct: 118 IKSFMKQL---LE---GLNYCHKKNFLHRDIKCSNILLN----NKGQIKLADFGLARLYN 167
Query: 1124 ---KR---NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT 1170
R N ++ TL + PELL G R +DV+S G + E+ T
Sbjct: 168 SEESRPYTNKVI------TLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 9e-15
Identities = 68/269 (25%), Positives = 121/269 (44%), Gaps = 30/269 (11%)
Query: 965 DLEELRELGSGTYGTVY-----HGKWRGSDVAIKRIKKSCFAGRSSEQE-----RLTKDF 1014
+ E L+ LG+G YG V+ G G A+K ++K+ ++ E R +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 1015 WREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI 1074
R++ L LH+ AF T L + +++ G + L ++D + +
Sbjct: 61 VRQSPFLVTLHY----AFQ------TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY 110
Query: 1075 IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSGG 1132
+ +E+LH IV+ D+K EN+L+ D + + + DFGLS+ + +
Sbjct: 111 SG-EIILALEHLHKLGIVYRDIKLENILL---DSEGHVV-LTDFGLSKEFLSEEKERTYS 165
Query: 1133 VRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192
GT+ +MAPE++ G + VD +S GI ++E+LTG P+ + + L
Sbjct: 166 FCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224
Query: 1193 R--PTIPERCDPEWRKLMEQCWAADPEAR 1219
+ P P PE + L+ + DP+ R
Sbjct: 225 KCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 68/271 (25%), Positives = 128/271 (47%), Gaps = 33/271 (12%)
Query: 965 DLEELRELGSGTYGTVY-----HGKWRGSDVAIKRIKKSCFAGRS-----SEQERLTKDF 1014
+ E L+ LG+G YG V+ G G A+K +KK+ ++ + ER +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 1015 WREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI 1074
R++ L LH+ AF T L + +++ G L L +++R ++ ++
Sbjct: 61 IRQSPFLVTLHY----AFQ------TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 1075 IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSGG 1132
+ +E+LH I++ D+K EN+L+ D + + DFGLS+ + +
Sbjct: 111 SG-EIVLALEHLHKLGIIYRDIKLENILL---DSNGHVV-LTDFGLSKEFHEDEVERAYS 165
Query: 1133 VRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY---ADMHCGAIIGG-IV 1188
GT+ +MAP+++ G + VD +S G+ M+E+LTG P+ + + A I I+
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL 225
Query: 1189 KNTLRPTIPERCDPEWRKLMEQCWAADPEAR 1219
K+ P P+ + ++++ DP+ R
Sbjct: 226 KS--EPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 69/253 (27%), Positives = 121/253 (47%), Gaps = 23/253 (9%)
Query: 972 LGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
+G G++G V + R + A+K I+K+ RS L E +L+ ++ P +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLA-----ERTVLAQVNCPFI 55
Query: 1030 V--AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLH 1087
V F P L V F+ G L H L ++ R R + A + +E LH
Sbjct: 56 VPLKFSFQSP----EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLH 110
Query: 1088 SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK-RNTLVSGGVRGTLPWMAPELLN 1146
N+++ DLK EN+L++ + +C DFGL ++ ++ + GT ++APELL
Sbjct: 111 KFNVIYRDLKPENILLDYQG-HIALC---DFGLCKLNMKDDDKTNTFCGTPEYLAPELLL 166
Query: 1147 GSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRK 1206
G ++ VD ++ G+ ++E+LTG P+ D + + I++ LR P+ D + +
Sbjct: 167 GHG--YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR--FPDGFDRDAKD 222
Query: 1207 LMEQCWAADPEAR 1219
L+ + DP R
Sbjct: 223 LLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-14
Identities = 71/266 (26%), Positives = 122/266 (45%), Gaps = 32/266 (12%)
Query: 969 LRELGSGTYGTVYHGK--WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
++G G GTVY G +VAI+++ + +Q+ + E ++ +
Sbjct: 25 FEKIGQGASGTVYTAMDVATGQEVAIRQM--------NLQQQPKKELIINEILVMRENKN 76
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
PN+V + G L V E++ GSL V+ + +D + + + +E+L
Sbjct: 77 PNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFL 132
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL------SRIKRNTLVSGGVRGTLPWM 1140
HS ++H D+K +N+L+ + K+ DFG + KR+T+V GT WM
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPYWM 183
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN-TLRPTIPER 1199
APE++ + KVD++S GI E++ GE PY + + + I N T PE+
Sbjct: 184 APEVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEI 1225
+R + +C D E R S E+
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 72/245 (29%), Positives = 106/245 (43%), Gaps = 36/245 (14%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKR------IKKSCFAGRSSEQERLTKDFWREA 1018
D E+L ELG+G G V R S + + R IK + + RE
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPA-----------IRNQIIREL 50
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
+L + P +V FYG G ++ E M GSL V LKK + I++
Sbjct: 51 KVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQV-LKKAGRIPENILGKISIA 107
Query: 1079 AAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTL 1137
G+ YL K I+H D+K N+LVN R K+ DFG+S +++ + V GT
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSFV-GTR 162
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEP--------YADMHCGAIIGGIVK 1189
+M+PE L G+ V D++S G+S+ E+ G P M + G K
Sbjct: 163 SYMSPERLQGTHYTVQS--DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAK 220
Query: 1190 NTLRP 1194
+ RP
Sbjct: 221 ESHRP 225
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 76/281 (27%), Positives = 130/281 (46%), Gaps = 43/281 (15%)
Query: 970 RELGSGTYGTVYHGK----WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+E+G+G +G V G+ + + V +K ++ S +S QE++ F EA +L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS-----ASVQEQM--KFLEEAQPYRSLQ 53
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL--LKKDRSL--DRRKKLIIAMDAAF 1081
H N++ G + T L V EF G LK L +K + D +A + A
Sbjct: 54 HSNLLQCLGQCTEVTPYLL--VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLP 1138
G+ +LH N +H DL N L+ K+GD+GLS K + + L
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLT----ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR 167
Query: 1139 WMAPELLNG-SSNRV----SEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNT- 1191
W+APEL++ N + +++ +V+S G+++WE+ G +PY + ++ V+
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227
Query: 1192 -------LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
L+ + +R W ++M+ CW PE RPS E+
Sbjct: 228 LKLPKPRLKLPLSDR----WYEVMQFCW-LQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 68/273 (24%), Positives = 122/273 (44%), Gaps = 22/273 (8%)
Query: 969 LRELGSGTYGTVYHGKWR---GSDVAIKRI--KKSCFAGRSSEQERLTKDFWREAHIL-S 1022
L LGSG +G VY + + + +A+K I F E+++ D E I+
Sbjct: 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSL-KHVLLKKDR----SLDRRKKLIIAM 1077
L HPN+V +Y + L V + + L +H K++ + +R + + M
Sbjct: 65 QLRHPNIVRYYKTFLEND--RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 1078 DAAFGMEYLH-SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGT 1136
A + YLH K IVH DL N+++ D + DFGL++ K+ V GT
Sbjct: 123 VLA--LRYLHKEKRIVHRDLTPNNIMLGEDDK----VTITDFGLAKQKQPESKLTSVVGT 176
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196
+ + PE++ EK DV++FG ++++ T + P+ + ++ IV+ P
Sbjct: 177 ILYSCPEIVKNEP--YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP 234
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
+ ++ C D EARP ++++ +
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 967 EELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ L +GSG YG V + VAIK++ R + K +RE +L ++
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS------RPFQSAIHAKRTYRELRLLKHM 71
Query: 1025 HHPNVVAFYGV-VPDGTGGTLAT---VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
H NV+ V P + VT M L +++ + S D + L+ +
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQI--L 128
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRIKRNTLVSGGVRGTLP 1138
G++Y+HS I+H DLK N+ VN D C K+ DFGL+R + ++G V T
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVN-ED-----CELKILDFGLAR-HTDDEMTGYV-ATRW 180
Query: 1139 WMAPE-LLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
+ APE +LN ++ VD++S G M E+LTG+
Sbjct: 181 YRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-14
Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 22/196 (11%)
Query: 987 GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY--GVVPDGTGGTL 1044
G +VAIK ++ + E+E F RE + + L+HPN+VA G P G L
Sbjct: 3 GHEVAIKLLRTD-----APEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP---GLL 54
Query: 1045 ATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVN 1104
V E++ +L+ V L D +L + + + + H++ IVH DLK +N++V+
Sbjct: 55 FAVFEYVPGRTLREV-LAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVS 113
Query: 1105 LRDPQRPICKVGDFGLS-------RIKRNTLV-SGGVRGTLPWMAPELLNGSSNRVSEKV 1156
RP KV DFG+ TL + V GT + APE L G V+
Sbjct: 114 QTG-VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP--VTPNS 170
Query: 1157 DVFSFGISMWEILTGE 1172
D++++G+ E LTG+
Sbjct: 171 DLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 78/267 (29%), Positives = 112/267 (41%), Gaps = 32/267 (11%)
Query: 965 DLEELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D++ LG G GTVY +A+K I L K E IL
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV-------ELQKQIMSELEILY 54
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
P ++ FYG ++ TEFM GSL + L R IA+ G
Sbjct: 55 KCDSPYIIGFYGAF--FVENRISICTEFMDGGSLDVYRKIPEHVLGR-----IAVAVVKG 107
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAP 1142
+ YL S I+H D+K N+LVN R Q +C DFG+S N++ V GT +MAP
Sbjct: 108 LTYLWSLKILHRDVKPSNMLVNTRG-QVKLC---DFGVSTQLVNSIAKTYV-GTNAYMAP 162
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADM---HCG----AIIGGIVKNTLRPT 1195
E ++G + DV+S GIS E+ G PY + ++ IV P
Sbjct: 163 ERISGEQYGIHS--DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-PPV 219
Query: 1196 IPE-RCDPEWRKLMEQCWAADPEARPS 1221
+P + ++ + QC P+ RP+
Sbjct: 220 LPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 89/298 (29%), Positives = 135/298 (45%), Gaps = 60/298 (20%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E L +G G+YG V K + G VAIK+ +S + + + K RE +L L
Sbjct: 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLES------EDDKMVKKIAMREIRMLKQL 57
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLD--RRKKLIIAMDAAFG 1082
H N+V V L V EF+ + L L K LD R +K + + G
Sbjct: 58 RHENLVNLIEVFRRKK--RLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQI--LRG 112
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG-----VRGTL 1137
+E+ HS NI+H D+K EN+LV+ Q + K+ DFG +R TL + G T
Sbjct: 113 IEFCHSHNIIHRDIKPENILVS----QSGVVKLCDFGFAR----TLAAPGEVYTDYVATR 164
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY----ADM----HCGAIIGGIV- 1188
+ APELL G + + VD+++ G + E+LTG EP +D+ H +G ++
Sbjct: 165 WYRAPELLVGDT-KYGRAVDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYHIIKCLGNLIP 222
Query: 1189 -------KNTL---------RPTIP-ERCDPEWRK----LMEQCWAADPEARPSFTEI 1225
KN L + P E+ P+ L +QC DP+ RPS +++
Sbjct: 223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 32/215 (14%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+++ ++G GTYG VY + + G VA+K+I+ +E E + RE +L L
Sbjct: 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLLKEL 56
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF--- 1081
+HPN+V V+ T L V EF+ H LKK + + + ++
Sbjct: 57 NHPNIVKLLDVI--HTENKLYLVFEFL------HQDLKKFMDASPLSGIPLPLIKSYLFQ 108
Query: 1082 ---GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---IKRNTLVSGGVRG 1135
G+ + HS ++H DLK +NLL+N K+ DFGL+R + T V
Sbjct: 109 LLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRTYTHEVV-- 162
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT 1170
TL + APE+L G S VD++S G E++T
Sbjct: 163 TLWYRAPEILLG-CKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 5e-14
Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 57/229 (24%)
Query: 969 LRELGSGTYGTVYHGKWRGSD------VAIKRIKKSCF-AGRSSEQERLTKDFWREAHIL 1021
L++LG G YG V W+ D VA+K+I F A R++ + T +RE L
Sbjct: 12 LQKLGKGAYGIV----WKAIDRRTKEVVALKKI----FDAFRNATDAQRT---FREIMFL 60
Query: 1022 SNL-HHPNVVAFYGVVPDGTGGTLATVTEFM---VNGSLKHVLLKKDRSLDRRKKLII-- 1075
L HPN+V V+ + V E+M ++ ++ +L+ D K+ I+
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILE-----DVHKRYIMYQ 115
Query: 1076 ---AMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG 1132
A+ +Y+HS N++H DLK N+L+N D + K+ DFGL+R +L
Sbjct: 116 LLKAL------KYIHSGNVIHRDLKPSNILLN-SDCR---VKLADFGLAR----SLSELE 161
Query: 1133 VRGTLPWM----------APELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
P + APE+L G S R ++ VD++S G + E+L G
Sbjct: 162 ENPENPVLTDYVATRWYRAPEILLG-STRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 6e-14
Identities = 70/212 (33%), Positives = 113/212 (53%), Gaps = 24/212 (11%)
Query: 968 ELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+L+++GSG YGTV R G+ VAIK++ R + E K +RE +L ++
Sbjct: 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLY------RPFQSELFAKRAYRELRLLKHMK 72
Query: 1026 HPNVVAFYGV-VPDGTGGTLAT---VTEFMVNGSLKHVLLKKDR-SLDRRKKLIIAMDAA 1080
H NV+ V PD + V FM G+ L+K ++ S DR + L+ M
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQM--L 128
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWM 1140
G++Y+H+ I+H DLK NL VN + K+ DFGL+R + ++ ++G V T +
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLAR-QTDSEMTGYVV-TRWYR 182
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
APE++ + ++ VD++S G M E+LTG+
Sbjct: 183 APEVIL-NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 30/221 (13%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRS---SEQERL--TKDFWREAH 1019
DLE ++ +G+GT+G V+ + RI + +A + E RL + E
Sbjct: 2 DLERIKTVGTGTFGRVH--------LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKR 53
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
+L + HP ++ + D L + E++ G L L+ L A +
Sbjct: 54 VLKEVSHPFIIRLFWTEHDQR--FLYMLMEYVPGGEL-FSYLRNSGRFSNSTGLFYASEI 110
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN---TLVSGGVRGT 1136
+EYLHSK IV+ DLK EN+L++ ++ K+ DFG ++ R+ TL GT
Sbjct: 111 VCALEYLHSKEIVYRDLKPENILLD-KEGH---IKLTDFGFAKKLRDRTWTLC-----GT 161
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177
++APE++ + ++ VD ++ GI ++E+L G P+ D
Sbjct: 162 PEYLAPEVIQSKGH--NKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-14
Identities = 67/253 (26%), Positives = 110/253 (43%), Gaps = 23/253 (9%)
Query: 972 LGSGTYGTV--YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG GT+G V K G A+K ++K + +T E+ +L N HP +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-----ESRVLQNTRHPFL 57
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK 1089
A T L V E+ NG L ++R + + +EYLHS+
Sbjct: 58 TALKYAFQ--THDRLCFVMEY-ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 114
Query: 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR---GTLPWMAPELLN 1146
++V+ D+K ENL+++ +D K+ DFGL K ++ GT ++APE+L
Sbjct: 115 DVVYRDIKLENLMLD-KDGH---IKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVL- 167
Query: 1147 GSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRK 1206
N VD + G+ M+E++ G P+ + + I+ +R P PE +
Sbjct: 168 -EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKS 224
Query: 1207 LMEQCWAADPEAR 1219
L+ DP+ R
Sbjct: 225 LLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
R LG G +G V + R G A K+++K R E L E IL ++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-----EKQILEKVNSR 60
Query: 1028 NVVAF-YGVVPDGTGGTLATVTEFMVNGSLK-HVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
VV+ Y T L V M G LK H+ + D + + A + G+E
Sbjct: 61 FVVSLAYAY---ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED 117
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-RIKRNTLVSGGVRGTLPWMAPEL 1144
LH + IV+ DLK EN+L++ R + D GL+ I + G V GT+ +MAPE+
Sbjct: 118 LHRERIVYRDLKPENILLDDYGHIR----ISDLGLAVEIPEGETIRGRV-GTVGYMAPEV 172
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
+ + R + D + G ++E++ G+ P+
Sbjct: 173 VK--NERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-14
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 968 ELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+L +LG GTY TV+ G+ + ++ VA+K I R +E RE +L +L
Sbjct: 10 KLEKLGEGTYATVFKGRSKLTENLVALKEI-------RLEHEEGAPCTAIREVSLLKDLK 62
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
H N+V + +V T +L V E++ + LK + + I G+ Y
Sbjct: 63 HANIVTLHDIV--HTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR-NTLVSGGVRGTLPWMAPEL 1144
H + ++H DLK +NLL+N +R K+ DFGL+R K T TL + P++
Sbjct: 120 CHRRKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILTG 1171
L GSS S ++D++ G +E+ +G
Sbjct: 176 LLGSS-EYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 39/216 (18%)
Query: 969 LRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQ-ERLTKDFWREAHILSNL- 1024
L ++G GT+ V + R G AIK +KK +S EQ L RE L L
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF---KSLEQVNNL-----REIQALRRLS 55
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
HPN++ V+ D G LA V E M + +L ++ + R L ++ ++
Sbjct: 56 PHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLD 114
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP------ 1138
++H I H D+K EN+L+ I K+ DFG R G+ P
Sbjct: 115 HMHRNGIFHRDIKPENILIK-----DDILKLADFGSCR---------GIYSKPPYTEYIS 160
Query: 1139 --WM-APE-LLNGSSNRVSEKVDVFSFGISMWEILT 1170
W APE LL + K+D+++ G +EIL+
Sbjct: 161 TRWYRAPECLL--TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 50/158 (31%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E+L ++G GTYGTV+ K R VA+KR++ + E + RE +L L
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKEL 56
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
H N+V Y V+ TL V E+ + LK + +D G+
Sbjct: 57 KHKNIVRLYDVLHSDKKLTL--VFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122
+ HS N++H DLK +NLL+N + K+ DFGL+R
Sbjct: 114 FCHSHNVLHRDLKPQNLLIN----KNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 68/281 (24%), Positives = 129/281 (45%), Gaps = 33/281 (11%)
Query: 970 RELGSGTYGTVYHGK-WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN 1028
+E+G+G +G V + + + VA +K+ S EQ +F ++ L HPN
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN----EFLQQGDPYRILQHPN 56
Query: 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLII---AMDAAFGMEY 1085
++ G + L V E+ G LK L ++ + L++ A + A G+ +
Sbjct: 57 ILQCLGQCVEAIPYLL--VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH 114
Query: 1086 LHSKNIVHFDLKCEN--LLVNLRDPQRPICKVGDFGL--SRIKRNTLVS-GGVRGTLPWM 1140
+H N +H DL N L +L KVGD+G+ SR K + + + L W+
Sbjct: 115 MHKHNFLHSDLALRNCFLTSDLT------VKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168
Query: 1141 APELLNGSSNRV-----SEKVDVFSFGISMWEIL-TGEEPYADMHCGAIIGGIVKNT--- 1191
APEL+ + ++ +V++ G+++WE+ +PY+ + ++ ++K+
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK 228
Query: 1192 -LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231
+P + W ++++ CW + PE R + E+ RL T
Sbjct: 229 LFKPQLELPYSERWYEVLQFCWLS-PEKRATAEEV-HRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 70/253 (27%), Positives = 109/253 (43%), Gaps = 23/253 (9%)
Query: 972 LGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG GT+G V K G A+K +KK + LT E+ +L N HP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLT-----ESRVLQNTRHPFL 57
Query: 1030 VAF-YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS 1088
A Y T L V E+ NG L ++R + + + YLHS
Sbjct: 58 TALKYSF---QTHDRLCFVMEY-ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS 113
Query: 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSGGVRGTLPWMAPELLN 1146
++V+ DLK ENL+++ +D K+ DFGL + I + GT ++APE+L
Sbjct: 114 CDVVYRDLKLENLMLD-KDGH---IKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLE 168
Query: 1147 GSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRK 1206
N VD + G+ M+E++ G P+ + + I+ +R P PE +
Sbjct: 169 --DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEAKS 224
Query: 1207 LMEQCWAADPEAR 1219
L+ DP+ R
Sbjct: 225 LLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-13
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 969 LRELGSGTYGTV---YHGKWRGSDVAIKRI---KKSCFAGRSSEQERLTKDFWREAHILS 1022
L +G G YG V H K G VAIK+I + F R+ RE IL
Sbjct: 10 LSYIGEGAYGMVCSATH-KPTGVKVAIKKISPFEHQTFCQRT----------LREIKILR 58
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATV---TEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
H N++ ++ + + V E M L ++ + S D + + +
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQI-- 115
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRIKRNTLVSGGVR--- 1134
G++Y+HS N++H DLK NLL+N C K+ DFGL+RI G
Sbjct: 116 LRGLKYIHSANVLHRDLKPSNLLLNTN------CDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 1135 -GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
T + APE++ +S ++ +D++S G + E+L+
Sbjct: 170 VATRWYRAPEIML-NSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 69/284 (24%), Positives = 121/284 (42%), Gaps = 52/284 (18%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
DLE L E+GSGT G VY +++ G +A+K+++++ G E +R+ D ++
Sbjct: 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT---GNKEENKRILMDL----DVVL 68
Query: 1023 NLHH-PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI------- 1074
H P +V YG F+ + + + LD+ K I
Sbjct: 69 KSHDCPYIVKCYGY--------------FITDSDVFICMELMSTCLDKLLKRIQGPIPED 114
Query: 1075 ----IAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLV 1129
+ + + YL K ++H D+K N+L++ K+ DFG+S LV
Sbjct: 115 ILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG----NVKLCDFGIS----GRLV 166
Query: 1130 SGGVR----GTLPWMAPELLNGSSNRVSEKV--DVFSFGISMWEILTGEEPYADMHCGAI 1183
+ G +MAPE ++ + DV+S GIS+ E+ TG+ PY +
Sbjct: 167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE 226
Query: 1184 IGGIVKNTLRPTIP--ERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ + P++P E P++ ++ C D RP + E+
Sbjct: 227 VLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 66/232 (28%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 968 ELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+LR LG G+ G V+ D VA+K+I + K RE I+ L
Sbjct: 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKI--------VLTDPQSVKHALREIKIIRRLD 60
Query: 1026 HPNVVAFYGVVPDGTG------------GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKL 1073
H N+V Y V+ ++ V E+M L +VL + S + +
Sbjct: 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHAR-- 117
Query: 1074 IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI------KRNT 1127
+ G++Y+HS N++H DLK N+ +N D + K+GDFGL+RI +
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTED---LVLKIGDFGLARIVDPHYSHKGY 174
Query: 1128 LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH 1179
L G V T + +P LL S N ++ +D+++ G E+LTG+ +A H
Sbjct: 175 LSEGLV--TKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 73/254 (28%), Positives = 111/254 (43%), Gaps = 24/254 (9%)
Query: 972 LGSGTYGTV--YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG GT+G V K G A+K +KK + LT E +L N HP +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-----ENRVLQNSRHPFL 57
Query: 1030 VAF-YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS 1088
A Y T L V E+ NG L ++R + + ++YLHS
Sbjct: 58 TALKYSF---QTHDRLCFVMEY-ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 113
Query: 1089 -KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSGGVRGTLPWMAPELL 1145
KN+V+ DLK ENL+++ +D K+ DFGL + IK + GT ++APE+L
Sbjct: 114 EKNVVYRDLKLENLMLD-KDGH---IKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVL 168
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205
N VD + G+ M+E++ G P+ + + I+ +R P PE +
Sbjct: 169 --EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLSPEAK 224
Query: 1206 KLMEQCWAADPEAR 1219
L+ DP+ R
Sbjct: 225 SLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 78/278 (28%), Positives = 117/278 (42%), Gaps = 35/278 (12%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
++E L ELG G YG+VY R + V A+K I R E E IL
Sbjct: 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEI-------RLELDESKFNQIIMELDILH 54
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHV------LLKKDRSLDRRKKLIIA 1076
P +V FYG G + E+M GSL + + RR I
Sbjct: 55 KAVSPYIVDFYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR----IT 108
Query: 1077 MDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRG 1135
G+++L + NI+H D+K N+LVN Q +C DFG+S +L + G
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLC---DFGVSGNLVASLAKTNI-G 163
Query: 1136 TLPWMAPELLN--GSSNRVSEKV--DVFSFGISMWEILTGEEPYADMHCGAI---IGGIV 1188
+MAPE + G + + V DV+S G+S+ E+ G PY I + IV
Sbjct: 164 CQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV 223
Query: 1189 KNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEIT 1226
PT+P + + + +C P RP++ ++
Sbjct: 224 DGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 64/229 (27%), Positives = 108/229 (47%), Gaps = 31/229 (13%)
Query: 1014 FWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS-LDRRKK 1072
F+ A ++S + H ++ +GV G+ + V EF+ +G L V L+K++ + K
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIM--VEEFVEHGPLD-VCLRKEKGRVPVAWK 119
Query: 1073 LIIAMDAAFGMEYLHSKNIVHFDLKCENLLV---NLRDPQRPICKVGDFGLS-------- 1121
+ +A A + YL KN+VH ++ +N+L+ L + P K+ D G+S
Sbjct: 120 ITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE 179
Query: 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEI-LTGEEPYADMHC 1180
R++R +PW+APE + G ++ +S D +SFG ++ EI GE P +
Sbjct: 180 RVER-----------IPWIAPECVPGGNS-LSTAADKWSFGTTLLEICFDGEVPLKE-RT 226
Query: 1181 GAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
+ + R +PE E L+ QC +P RPSF I L
Sbjct: 227 PSEKERFYEKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-13
Identities = 70/270 (25%), Positives = 121/270 (44%), Gaps = 34/270 (12%)
Query: 966 LEELRELGSGTYGTV--YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
LE ++G G+ G V K G VA+K + R ++ L + E I+ +
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDL-----RKQQRREL---LFNEVVIMRD 74
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGM 1083
H NVV Y G L + EF+ G+L ++ L+ + + +
Sbjct: 75 YQHQNVVEMYKSYL--VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQAL 130
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL-SRIKRNTLVSGGVRGTLPWMAP 1142
YLHS+ ++H D+K +++L+ L K+ DFG ++I ++ + GT WMAP
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGR----VKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY-ADMHCGAIIGGIVKNTLRPTIP---- 1197
E++ S +VD++S GI + E++ GE PY +D A+ LR + P
Sbjct: 187 EVI--SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------KRLRDSPPPKLK 238
Query: 1198 --ERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ P R +E+ +P+ R + E+
Sbjct: 239 NAHKISPVLRDFLERMLTREPQERATAQEL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDF-WREAHILSN 1023
E+L ++G G+YG V+ + R G VAIK+ +S E + + K RE +L
Sbjct: 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVES-------EDDPVIKKIALREIRMLKQ 56
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGM 1083
L HPN+V V L V E+ + ++ + L K R + I +
Sbjct: 57 LKHPNLVNLIEVFRRKR--KLHLVFEY-CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAV 113
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR-----GTLP 1138
+ H N +H D+K EN+L+ + K+ DFG +RI L G T
Sbjct: 114 NFCHKHNCIHRDVKPENILITKQG----QIKLCDFGFARI----LTGPGDDYTDYVATRW 165
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
+ APELL G + + VDV++ G E+LTG+
Sbjct: 166 YRAPELLVGDT-QYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 34/223 (15%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E+L ++G GTYG VY + + G VA+K+ + ++E + RE +L L
Sbjct: 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE------MDEEGIPPTALREISLLQML 57
Query: 1025 HH-PNVVAFYGVV---PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
+V V +L V E++ + LK + R R
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 1081 F----GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-----IKRNT--LV 1129
+ G+ + H ++H DLK +NLLV D Q+ + K+ D GL R +K T +V
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 1130 SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
TL + APE+L GS++ S VD++S G E+ +
Sbjct: 174 ------TLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-13
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 28/221 (12%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKR------IKKSCFAGRSSEQERLTKDF 1014
+K+ D E + ELG+G G V + + S + + R IK + +
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPA-----------IRNQI 50
Query: 1015 WREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI 1074
RE +L + P +V FYG + G ++ E M GSL V LK+ + +
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQV-LKEAKRIPEEILGK 107
Query: 1075 IAMDAAFGMEYLHSKN-IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGV 1133
+++ G+ YL K+ I+H D+K N+LVN R K+ DFG+S +++ + V
Sbjct: 108 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSFV 163
Query: 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEP 1174
GT +M+PE L G+ V D++S G+S+ E+ G P
Sbjct: 164 -GTRSYMSPERLQGTHYSVQS--DIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 72/270 (26%), Positives = 108/270 (40%), Gaps = 31/270 (11%)
Query: 972 LGSGTYGTVYHGKWR----------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHIL 1021
LG GT +Y G + IK I K ++ F+ A ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVL----DPSHRDISLAFFETASMM 58
Query: 1022 SNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
+ H ++V YGV + V EF+ G L + +K L K +A A
Sbjct: 59 RQVSHKHIVLLYGVCVRDVENIM--VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLAS 116
Query: 1082 GMEYLHSKNIVHFDLKCENLLV---NLRDPQRPICKVGDFG--LSRIKRNTLVSGGVRGT 1136
+ YL K++VH ++ +N+L+ + P K+ D G ++ + R V
Sbjct: 117 ALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-----R 171
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEI-LTGEEPYADMHCGAIIGGIVKNTLRPT 1195
+PW+APE + S N +S D +SFG ++WEI GE P D A +
Sbjct: 172 IPWIAPECVEDSKN-LSIAADKWSFGTTLWEICYNGEIPLKDKTL-AEKERFYEGQCMLV 229
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
P C E LM C DP RP F I
Sbjct: 230 TPS-CK-ELADLMTHCMNYDPNQRPFFRAI 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-13
Identities = 47/153 (30%), Positives = 81/153 (52%), Gaps = 9/153 (5%)
Query: 1017 EAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIA 1076
EA +L N++HP+V+ + G T + + + L L K+ R L + LII
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSG-AITCMVLPHY--SSDLYTYLTKRSRPLPIDQALIIE 163
Query: 1077 MDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGT 1136
G+ YLH++ I+H D+K EN+ +N D +C +GD G ++ G+ GT
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVD---QVC-IGDLGAAQFPVVAPAFLGLAGT 219
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEIL 1169
+ APE+L + ++ + K D++S GI ++E+L
Sbjct: 220 VETNAPEVL--ARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-13
Identities = 83/292 (28%), Positives = 136/292 (46%), Gaps = 56/292 (19%)
Query: 968 ELRELGSGTYGTVYHGK--WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+L+ +G G +G V + G +VAIK+I K F+ L K +RE +L +L
Sbjct: 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPV-----LAKRTYRELKLLKHLR 67
Query: 1026 HPNVVA----FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
H N+++ F + D + VTE + G+ H LL R L+++
Sbjct: 68 HENIISLSDIFISPLED-----IYFVTELL--GTDLHRLLTS-RPLEKQFIQYFLYQILR 119
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMA 1141
G++Y+HS +VH DLK N+L+N + IC DFGL+RI+ + G T + A
Sbjct: 120 GLKYVHSAGVVHRDLKPSNILIN-ENCDLKIC---DFGLARIQDPQMT--GYVSTRYYRA 173
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILTGEE--PYAD-MHCGAIIGGIV---------- 1188
PE++ + + +VD++S G E+L G+ P D ++ +II ++
Sbjct: 174 PEIML-TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232
Query: 1189 ---KNTLR--PTIPER-----------CDPEWRKLMEQCWAADPEARPSFTE 1224
+NTLR ++P+R DP L+E+ DP+ R S E
Sbjct: 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 969 LRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
L +LG G+Y TVY G R G VA+K I +E + REA +L L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKT-------EEGVPFTAIREASLLKGLKH 62
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
N+V + ++ T TL V E+M + L +++ L + G+ Y+
Sbjct: 63 ANIVLLHDIIH--TKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR---NTLVSGGVRGTLPWMAPE 1143
H ++I+H DLK +NLL++ K+ DFGL+R K T S V TL + P+
Sbjct: 120 HGQHILHRDLKPQNLLISYLGE----LKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD 173
Query: 1144 LLNGSSNRVSEKVDVFSFGISMWEILTGEEPYA 1176
+L G+++ S +D++ G E+L G+ +
Sbjct: 174 VLLGATDYSSA-LDIWGAGCIFIEMLQGQPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-12
Identities = 81/293 (27%), Positives = 128/293 (43%), Gaps = 55/293 (18%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKR------IKKSCFAGRSSEQERLTKDF 1014
+K+ D E++ ELG+G G V+ + S + + R IK + +
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA-----------IRNQI 50
Query: 1015 WREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDR-RKKL 1073
RE +L + P +V FYG + G ++ E M GSL VL K R ++ K+
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 108
Query: 1074 IIAMDAAFGMEYLHSKN-IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG 1132
IA+ G+ YL K+ I+H D+K N+LVN R K+ DFG+S +++ +
Sbjct: 109 SIAVIK--GLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSF 162
Query: 1133 VRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192
V GT +M+PE L G+ V D++S G+S+ E+ G P
Sbjct: 163 V-GTRSYMSPERLQGTHYSVQS--DIWSMGLSLVEMAIGRYP------------------ 201
Query: 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCINSEP 1245
IP P K +E + E P+ +E + R R + S +S P
Sbjct: 202 ---IP----PPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRP 247
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 67/254 (26%), Positives = 116/254 (45%), Gaps = 24/254 (9%)
Query: 972 LGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS-NLHHPN 1028
LG G++G V + +G++ AIK +KK + + E +L+ HP
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMV-----ERRVLALAWEHPF 57
Query: 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS 1088
+ + T L V E++ G L + R D + A + G+++LH
Sbjct: 58 LTHLFCTFQ--TKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHK 114
Query: 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR---GTLPWMAPELL 1145
K I++ DLK +N+L++ +D K+ DFG+ K N G GT ++APE+L
Sbjct: 115 KGIIYRDLKLDNVLLD-KDGH---IKIADFGMC--KENMNGEGKASTFCGTPDYIAPEIL 168
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205
G + +E VD +SFG+ ++E+L G+ P+ + I+ + RP P E +
Sbjct: 169 KGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFPRWISKEAK 224
Query: 1206 KLMEQCWAADPEAR 1219
+ + + DP R
Sbjct: 225 DCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 69/308 (22%), Positives = 111/308 (36%), Gaps = 71/308 (23%)
Query: 964 VDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
+ + + K + VA+K+I S +E L +E
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLD-----SCSKEDLKLLQ-QEIITSRQ 55
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM---DAA 1080
L HPN++ + L V+ M GS + L K + +L IA D
Sbjct: 56 LQHPNILPYVTSFIVD--SELYVVSPLMAYGSCE--DLLKTHFPEGLPELAIAFILKDVL 111
Query: 1081 FGMEYLHSKNIVHFDLKCENLLV---------NLRDPQRPI------CKVGDFGLSRIKR 1125
++Y+HSK +H +K ++L+ LR I V DF S +K
Sbjct: 112 NALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK- 170
Query: 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC----- 1180
LPW++PE+L + +EK D++S GI+ E+ G P+ DM
Sbjct: 171 ----------NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL 220
Query: 1181 ----GAIIGGIVKNTL---------------RPTIPERCD--------PEWRKLMEQCWA 1213
G + + K+T P + D + + +E C
Sbjct: 221 EKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQ 280
Query: 1214 ADPEARPS 1221
DPE+RPS
Sbjct: 281 RDPESRPS 288
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 68/221 (30%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E+L +LG G+Y TVY GK + G VA+K I R E+E REA +L L
Sbjct: 8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVI-------RLQEEEGTPFTAIREASLLKGL 60
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
H N+V + ++ T TL V E+ V+ L + K L + G+
Sbjct: 61 KHANIVLLHDII--HTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK-------RNTLVSGGVRGTL 1137
Y+H + I+H DLK +NLL++ K+ DFGL+R K N +V TL
Sbjct: 118 YIHQRYILHRDLKPQNLLIS----DTGELKLADFGLARAKSVPSHTYSNEVV------TL 167
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADM 1178
+ P++L GS+ S +D++ G E++ G + M
Sbjct: 168 WYRPPDVLLGST-EYSTCLDMWGVGCIFVEMIQGVAAFPGM 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 966 LEELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
L+ ++G G+ G V K G VA+K++ R ++ L + E I+ +
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRREL---LFNEVVIMRD 75
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGM 1083
HH NVV Y G L V EF+ G+L ++ ++ + + + +
Sbjct: 76 YHHENVVDMYNSYL--VGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRAL 131
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL-SRIKRNTLVSGGVRGTLPWMAP 1142
YLH++ ++H D+K +++L L R K+ DFG +++ + + GT WMAP
Sbjct: 132 SYLHNQGVIHRDIKSDSIL--LTSDGR--IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAP 187
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
E++ S +VD++S GI + E++ GE PY
Sbjct: 188 EVI--SRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 69/231 (29%), Positives = 99/231 (42%), Gaps = 40/231 (17%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E L +LG GT+G VY + G VA+K+I +E++ RE IL
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMH------NEKDGFPITALREIKILK 62
Query: 1023 NLHHPNVVAFYGVV---PDGTGGTLA---TVTEFMV---NGSLKHVLLKKDRSLDRRKKL 1073
L HPNVV + PD + VT +M +G L++ +K S + K
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES---QIKC 119
Query: 1074 IIAMDAAF-GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN---TLV 1129
M G+ YLH +I+H D+K N+L++ + I K+ DFGL+R
Sbjct: 120 Y--MLQLLEGINYLHENHILHRDIKAANILID----NQGILKIADFGLARPYDGPPPNPK 173
Query: 1130 SGGVRGTLP--------WM-APELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
GG GT W PELL G + VD++ G E+ T
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 970 RELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HH 1026
+ LG G++G V + +G+D A+K +KK + +T E +L+ H
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMT-----EKRVLALAGKH 55
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLK-HVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
P + + T L V E++ G L H+ + D + A + G+++
Sbjct: 56 PFLTQLHSCFQ--TKDRLFFVMEYVNGGDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQF 111
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR-----GTLPWM 1140
LH + I++ DLK +N+L++ K+ DFG+ K L GGV GT ++
Sbjct: 112 LHERGIIYRDLKLDNVLLD----SEGHIKIADFGMC--KEGIL--GGVTTSTFCGTPDYI 163
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
APE+L+ + VD ++ G+ ++E+L G+ P+
Sbjct: 164 APEILSYQPYGPA--VDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 65/265 (24%), Positives = 125/265 (47%), Gaps = 24/265 (9%)
Query: 966 LEELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
L+ ++G G+ G V K G VA+K++ R ++ L + E I+ +
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQRREL---LFNEVVIMRD 73
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGM 1083
H NVV Y G L V EF+ G+L ++ + ++ + +A+ A +
Sbjct: 74 YQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSV 131
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL-SRIKRNTLVSGGVRGTLPWMAP 1142
LH++ ++H D+K +++L+ D + K+ DFG +++ + + GT WMAP
Sbjct: 132 --LHAQGVIHRDIKSDSILLT-HDGR---VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP--ERC 1200
EL+ S +VD++S GI + E++ GE PY + + ++++ L P + +
Sbjct: 186 ELI--SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPKLKNLHKV 242
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEI 1225
P + +++ DP R + E+
Sbjct: 243 SPSLKGFLDRLLVRDPAQRATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-12
Identities = 68/256 (26%), Positives = 116/256 (45%), Gaps = 28/256 (10%)
Query: 972 LGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS-NLHHPN 1028
LG G++G V+ + +G++ AIK +KK + + E +LS HP
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-----EKRVLSLAWEHPF 57
Query: 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS 1088
+ Y T L V E++ G L + + D + A + G+++LHS
Sbjct: 58 LTHLYCTFQ--TKENLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQFLHS 114
Query: 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR-----GTLPWMAPE 1143
K IV+ DLK +N+L++ K+ DFG+ K N L G + GT ++APE
Sbjct: 115 KGIVYRDLKLDNILLDTDGH----IKIADFGMC--KENML--GDAKTCTFCGTPDYIAPE 166
Query: 1144 LLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPE 1203
+L G + + VD +SFG+ ++E+L G+ P+ + I P P E
Sbjct: 167 ILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--RMDNPCYPRWLTRE 222
Query: 1204 WRKLMEQCWAADPEAR 1219
+ ++ + + +PE R
Sbjct: 223 AKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 71/274 (25%), Positives = 120/274 (43%), Gaps = 42/274 (15%)
Query: 965 DLEELRELGSGTYGTVYHGK--WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E ++ +GSGTYG VY + G AIK IK + Q+ + ++
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEII--------MMK 61
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
+ H N+VA++G L EF GSL+ + L + ++ + G
Sbjct: 62 DCKHSNIVAYFGSYL--RRDKLWICMEFCGGGSLQDI-YHVTGPLSESQIAYVSRETLQG 118
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR------IKRNTLVSGGVRGT 1136
+ YLHSK +H D+K N+L+ K+ DFG+S KR + + GT
Sbjct: 119 LYYLHSKGKMHRDIKGANILLT----DNGHVKLADFGVSAQITATIAKRKSFI-----GT 169
Query: 1137 LPWMAPELL----NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192
WMAPE+ G N++ D+++ GI+ E+ + P D+H + + K+
Sbjct: 170 PYWMAPEVAAVERKGGYNQL---CDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF 226
Query: 1193 RPTIPERCDP-EW----RKLMEQCWAADPEARPS 1221
+P P+ D +W ++ +P+ RP+
Sbjct: 227 QP--PKLKDKMKWSNSFHHFVKMALTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
+ R LG G +G V + R G A KR++K R E L E IL
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-----EKQILEK 56
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLK-HVLLKKDRSLDRRKKLIIAMDAAFG 1082
++ VV T L V M G LK H+ + + + L A + G
Sbjct: 57 VNSQFVVNLAYAYE--TKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG 114
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-RIKRNTLVSGGVRGTLPWMA 1141
+E LH +N V+ DLK EN+L+ D I ++ D GL+ +I + G V GT+ +MA
Sbjct: 115 LEDLHRENTVYRDLKPENILL---DDYGHI-RISDLGLAVKIPEGESIRGRV-GTVGYMA 169
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
PE+LN + R + D + G ++E++ G+ P+
Sbjct: 170 PEVLN--NQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 6e-12
Identities = 73/293 (24%), Positives = 116/293 (39%), Gaps = 59/293 (20%)
Query: 964 VDLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHIL 1021
D + L ++G G YG V+ K + + VA+KR+KKS + + LT E IL
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLT-----ERDIL 55
Query: 1022 SNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK------KLII 1075
+ +V D LA E++ G + LL L ++
Sbjct: 56 TTTKSEWLVKLLYAFQDDEYLYLAM--EYVPGGDFR-TLLNNLGVLSEDHARFYMAEMFE 112
Query: 1076 AMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---IKRNTLVSGG 1132
A+DA LH +H DLK EN L++ K+ DFGLS+ N++V
Sbjct: 113 AVDA------LHELGYIHRDLKPENFLID----ASGHIKLTDFGLSKGIVTYANSVV--- 159
Query: 1133 VRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192
G+ +MAPE+L G VD +S G ++E L G P+ G+ +N
Sbjct: 160 --GSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPF----SGSTPNETWENLK 211
Query: 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCINSEP 1245
W++ ++ RP + + L + + +K IN
Sbjct: 212 Y----------WKETLQ---------RPVYDDPRFNLSDEAWDLITKLINDPS 245
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 64/260 (24%), Positives = 116/260 (44%), Gaps = 23/260 (8%)
Query: 970 RELGSGTYGTVYHGK--WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
+++G G + VY VA+K+++ + Q D +E +L L+HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ-----DCVKEIDLLKQLNHP 62
Query: 1028 NVVAFY-GVVPDGTGGTLATVTEFMVNGSLKHVLL---KKDRSLDRRKKLIIAMDAAFGM 1083
NV+ + + D L V E G L ++ K+ R + R + +
Sbjct: 63 NVIKYLDSFIEDNE---LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSGGVRGTLPWMAP 1142
E++HS+ ++H D+K N+ + + K+GD GL R T + + GT +M+P
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEP-YAD-MHCGAIIGGIVKNTLRPTIPERC 1200
E ++ N + K D++S G ++E+ + P Y D M+ ++ I + P E
Sbjct: 176 ERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHY 233
Query: 1201 DPEWRKLMEQCWAADPEARP 1220
+ R+L+ C DP+ RP
Sbjct: 234 SEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 1e-11
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 10/117 (8%)
Query: 1060 LLKKDRSLDRRK-KLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118
LLKK+ L + K II + LH NI+H D+K EN+L + + +C D+
Sbjct: 99 LLKKEGKLSEAEVKKII-RQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC---DY 154
Query: 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
GL +I T GTL + +PE + G + VS D ++ G+ +E+LTG+ P+
Sbjct: 155 GLCKI-IGT--PSCYDGTLDYFSPEKIKGHNYDVS--FDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 42/297 (14%)
Query: 972 LGSGTYGTVYHG--KWRGSDVAIKRIKKSCF-----AGRSSEQERLTKDFWREAHILSNL 1024
LG G++G V K +G A+K +KK + ++R+ W E L++L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW-ENPFLTHL 61
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
+ F T L V EF+ G L + K R D + A + G++
Sbjct: 62 Y----CTFQ------TKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQ 110
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR-----GTLPW 1139
+LHSK I++ DLK +N++++ RD K+ DFG+ K N V G R GT +
Sbjct: 111 FLHSKGIIYRDLKLDNVMLD-RDGH---IKIADFGMC--KEN--VFGDNRASTFCGTPDY 162
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199
+APE+L G S VD +SFG+ ++E+L G+ P+ + I +T P P
Sbjct: 163 IAPEILQGLKYTFS--VDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--PHYPRW 218
Query: 1200 CDPEWRKLMEQCWAADPEARPSFT---EITSRLRTIS-AAIESKCINS--EPKQTKP 1250
E + ++E+ + DP R +TI+ A+E + ++ +PK P
Sbjct: 219 ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSP 275
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-11
Identities = 68/254 (26%), Positives = 109/254 (42%), Gaps = 25/254 (9%)
Query: 972 LGSGTYGTV--YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG GT+G V K G A+K +KK + LT E+ +L N HP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-----ESRVLKNTRHPFL 57
Query: 1030 VAF-YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS 1088
+ Y T L V E+ VNG L ++R + + ++YLHS
Sbjct: 58 TSLKYSF---QTKDRLCFVMEY-VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS 113
Query: 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR---GTLPWMAPELL 1145
IV+ DLK ENL+++ +D K+ DFGL K + ++ GT ++APE+L
Sbjct: 114 GKIVYRDLKLENLMLD-KDGH---IKITDFGLC--KEGITDAATMKTFCGTPEYLAPEVL 167
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205
N VD + G+ M+E++ G P+ + + I+ ++ P + +
Sbjct: 168 --EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK--FPRTLSADAK 223
Query: 1206 KLMEQCWAADPEAR 1219
L+ DP R
Sbjct: 224 SLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 970 RELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-H 1026
R LG G++G V + + S A+K +KK + +T E ILS H
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMT-----EKRILSLARNH 55
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
P + Y T L V EF VNG ++K R D + A + + +L
Sbjct: 56 PFLTQLYCCFQ--TPDRLFFVMEF-VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFL 112
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK-RNTLVSGGVRGTLPWMAPELL 1145
H K I++ DLK +N+L++ + CK+ DFG+ + N + GT ++APE+L
Sbjct: 113 HDKGIIYRDLKLDNVLLD-HEGH---CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL 168
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
S VD ++ G+ ++E+L G P+
Sbjct: 169 QEMLYGPS--VDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E + E+G G YGTVY + G VA+K ++ + ++ L RE +L L
Sbjct: 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQ------TNEDGLPLSTVREVALLKRL 56
Query: 1025 H---HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA- 1080
HPN+V V T T E V +HV LD+ + +
Sbjct: 57 EAFDHPNIVRLMDVC-----ATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK 111
Query: 1081 -------FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGV 1133
G+++LH+ IVH DLK EN+LV K+ DFGL+RI + V
Sbjct: 112 DLMRQFLRGLDFLHANCIVHRDLKPENILVT----SGGQVKLADFGLARIYSCQMALTPV 167
Query: 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFG 1162
TL + APE+L S+ + VD++S G
Sbjct: 168 VVTLWYRAPEVLLQST--YATPVDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 972 LGSGTYGTV--YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG G +G V K G A K++ K +S E+ L E IL ++ P +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL-----EKEILEKVNSPFI 55
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLK-HVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS 1088
V T L V M G LK H+ +R L+ + + + G+ +LHS
Sbjct: 56 VNLAYAFESKT--HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113
Query: 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGS 1148
+IV+ D+K EN+L++ + C++ D GL+ ++ GT +MAPE+L
Sbjct: 114 MDIVYRDMKPENVLLDDQGN----CRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEE 169
Query: 1149 SNRVSEKVDVFSFGISMWEILTGEEPYAD 1177
VD F+ G S++E++ G P+ D
Sbjct: 170 PYSYP--VDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 70/269 (26%), Positives = 111/269 (41%), Gaps = 22/269 (8%)
Query: 972 LGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG G +G V + R G A K++ K R + + E IL+ +H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-----EKRILAKVHSRFI 55
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS---LDRRKKLIIAMDAAFGMEYL 1086
V+ T L V M G L++ + D + G+E+L
Sbjct: 56 VSLAYAFQ--TKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-RIKRNTLVSGGVRGTLPWMAPELL 1145
H + I++ DLK EN+L++ R + D GL+ +K + G GT +MAPELL
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVR----ISDLGLAVELKDGQSKTKGYAGTPGFMAPELL 169
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP--TIPERCDPE 1203
G S VD F+ G++++E++ P+ + + L T P++ P
Sbjct: 170 QGEEYDFS--VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPA 227
Query: 1204 WRKLMEQCWAADPEARPSFTEIT-SRLRT 1231
+ E A DPE R F + LRT
Sbjct: 228 SKSFCEALLAKDPEKRLGFRDGNCDGLRT 256
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-11
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 25/223 (11%)
Query: 971 ELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
++G GTYG VY K + G D + +A + E ++ RE +L L HPNV
Sbjct: 8 KVGRGTYGHVYKAKRKDGKD-------EKEYALKQIEGTGISMSACREIALLRELKHPNV 60
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLL--------KKDRSLDRRKKLIIAMDAAF 1081
+A V + + + ++ L H++ KK L R +
Sbjct: 61 IALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVS----GGVRGTL 1137
G+ YLH+ ++H DLK N+LV P+R K+ D G +R+ + L V T
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC 1180
+ APELL G+ + ++ +D+++ G E+LT E + HC
Sbjct: 180 WYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIF---HC 218
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 4e-11
Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 45/225 (20%)
Query: 969 LRELGSGTYGTVYHGKWRGSD----VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
++ELG G YG V + + VAIK+I ++ L K RE +L +
Sbjct: 5 IKELGQGAYGIVCSARNAETSEEETVAIKKIT------NVFSKKILAKRALRELKLLRHF 58
Query: 1025 H-HPNVVAFYG---VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
H N+ Y V P + E ++ L H +++ + L DA
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELY--LYEELMEADL-HQIIRSGQPLT---------DAH 106
Query: 1081 F---------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVS 1130
F G++Y+HS N++H DLK NLLVN D + IC DFGL+R N +
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA-DCELKIC---DFGLARGFSENPGEN 162
Query: 1131 GGVR----GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
G T + APE++ S ++ +DV+S G + E+L
Sbjct: 163 AGFMTEYVATRWYRAPEIML-SFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 967 EELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E+L ++G GT+G V+ + + + VA+K++ +E+E RE IL L
Sbjct: 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVL------MENEKEGFPITALREIKILQLL 68
Query: 1025 HHPNVVAFYGVV------PDGTGGTLATVTEFM---VNGSLKHVLLKKDRSLDRRKKLII 1075
H NVV + + G+ V EF + G L + +K +L KK++
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK--FTLSEIKKVMK 126
Query: 1076 AMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI-------KRNTL 1128
+ G+ Y+H I+H D+K N+L+ +D I K+ DFGL+R K N
Sbjct: 127 MLLN--GLYYIHRNKILHRDMKAANILIT-KD---GILKLADFGLARAFSLSKNSKPNRY 180
Query: 1129 VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT 1170
+ V TL + PELL G + +D++ G M E+ T
Sbjct: 181 TNRVV--TLWYRPPELLLGERD-YGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 36/231 (15%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGS--DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E ++ + +G YG VY + + + A+K+I K R+ Q+ E IL+
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-----ERDILT 56
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
+P VV+ + T L V E+ V G LLK +L + +
Sbjct: 57 FAENPFVVSMFCSFE--TKRHLCMVMEY-VEGGDCATLLKNIGALPVDMARMYFAETVLA 113
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI---KRNTLVSGG------- 1132
+EYLH+ IVH DLK +NLL+ K+ DFGLS+I T + G
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLIT----SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 1133 ------VRGTLPWMAPE--LLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
V GT ++APE L G + VD ++ GI ++E L G P+
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQG----YGKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
R LG G +G V + R G A K+++K R E L E IL ++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-----EKRILEKVNSR 60
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLK-HVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
VV+ T L V M G LK H+ + D ++ + A + G+E L
Sbjct: 61 FVVSLAYAYE--TKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-RIKRNTLVSGGVRGTLPWMAPELL 1145
+ IV+ DLK EN+L++ R R + D GL+ +I V G V GT+ +MAPE++
Sbjct: 119 QRERIVYRDLKPENILLDDRGHIR----ISDLGLAVQIPEGETVRGRV-GTVGYMAPEVI 173
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
N S D + G ++E++ G+ P+
Sbjct: 174 NNEKYTFSP--DWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 8e-11
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 31/226 (13%)
Query: 971 ELGSGTYGTVYHGKWRG----SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
++G GTYG VY K + D A+K+I E ++ RE +L L H
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI----------EGTGISMSACREIALLRELKH 57
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLL--------KKDRSLDRRKKLIIAMD 1078
PNV++ V + + ++ L H++ KK L R +
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVS----GGVR 1134
G+ YLH+ ++H DLK N+LV P+R K+ D G +R+ + L V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC 1180
T + APELL G+ + ++ +D+++ G E+LT E + HC
Sbjct: 177 VTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIF---HC 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 9e-11
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 972 LGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
+G G YG V K VAIK+I + F R + L RE +L +L H NV
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-FDNRIDAKRTL-----REIKLLRHLDHENV 66
Query: 1030 VAFYGVVPDGTGGT---LATVTEFMVNGSLKHVLLKKDRSL--DRRKKLIIAMDAAFGME 1084
+A ++P + V E M + L H +++ ++L D + + + G++
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELM-DTDL-HQIIRSSQTLSDDHCQYFLYQL--LRGLK 122
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRIKRNTLVSGGVRG----TLP 1138
Y+HS N++H DLK NLL+N C K+ DFGL+R T G T
Sbjct: 123 YIHSANVLHRDLKPSNLLLNAN------CDLKICDFGLART---TSEKGDFMTEYVVTRW 173
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
+ APELL S + +DV+S G E+L +
Sbjct: 174 YRAPELLLNCSEYTT-AIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 969 LRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
L+++GSG YG+V K G VAIK++ R + E K +RE +L ++ H
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLS------RPFQSEIFAKRAYRELTLLKHMQH 73
Query: 1027 PNVVAFYGVVPDGTGG----TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
NV+ V G V +M K ++ S D+ + L+ M G
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQK--IMGHPLSEDKVQYLVYQM--LCG 129
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAP 1142
++Y+HS I+H DLK NL VN D + K+ DFGL+R + ++G V T + AP
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVN-EDCE---LKILDFGLAR-HADAEMTGYVV-TRWYRAP 183
Query: 1143 E-LLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
E +LN ++ VD++S G M E+LTG+
Sbjct: 184 EVILNWM--HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-10
Identities = 64/240 (26%), Positives = 107/240 (44%), Gaps = 36/240 (15%)
Query: 1017 EAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIA 1076
EA +L L HP V+A V G G T + ++ L L + R L + +A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVG-GLTCLVLPKY--RSDLYTYLGARLRPLGLAQVTAVA 266
Query: 1077 MDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG---LSRIKRNTLVSGGV 1133
++Y+H + I+H D+K EN+LVN P+ IC +GDFG +R +T G+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVN--GPED-IC-LGDFGAACFARGSWSTPFHYGI 322
Query: 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193
GT+ APE+L G + + VD++S G+ ++E A +H ++
Sbjct: 323 AGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFE--------AAVHTASLFSA------- 365
Query: 1194 PTIPER--CDPEWRKLMEQCWA-ADPEARPSFTEITSRLRTISAAIESKCINSEPKQTKP 1250
ER D + +++ Q D + + + + S+ R +A N P T+P
Sbjct: 366 SRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAAR------NRRPAYTRP 419
|
Length = 461 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
+ R LG G +G V + R G A K+++K R E L E IL
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-----EKQILEK 56
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLK-HVLLKKDRSLDRRKKLIIAMDAAFG 1082
++ VV+ T L V M G LK H+ + + + + A + G
Sbjct: 57 VNSRFVVSLAYAYE--TKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-RIKRNTLVSGGVRGTLPWMA 1141
+E LH + IV+ DLK EN+L+ D I ++ D GL+ + + G V GT+ +MA
Sbjct: 115 LEDLHQERIVYRDLKPENILL---DDHGHI-RISDLGLAVHVPEGQTIKGRV-GTVGYMA 169
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
PE++ + R + D ++ G ++E++ G+ P+
Sbjct: 170 PEVVK--NERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 972 LGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS-NLHHPN 1028
LG G++G V + +G+D AIK +KK +T E IL+ HP
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMT-----EKRILALAAKHPF 57
Query: 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS 1088
+ A + T L V E+ VNG +++ R D + A + + +LH
Sbjct: 58 LTALHCCFQ--TKDRLFFVMEY-VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114
Query: 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSGGVRGTLPWMAPELLN 1146
+++ DLK +N+L++ CK+ DFG+ + I + GT ++APE+L
Sbjct: 115 HGVIYRDLKLDNILLD----AEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEILQ 169
Query: 1147 GSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
S VD ++ G+ M+E++ G+ P+
Sbjct: 170 ELEYGPS--VDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 72/280 (25%), Positives = 125/280 (44%), Gaps = 55/280 (19%)
Query: 970 RELGSGTYGTVYHGKWRGSD---VAIKRIKKSCFAGRSSEQER----------LTKDFW- 1015
R LGSG GTV K R SD A+K + SE ++ L DF+
Sbjct: 38 RVLGSGATGTVLCAK-RVSDGEPFAVKVVDMEGM----SEADKNRAQAEVCCLLNCDFFS 92
Query: 1016 ----REAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL---LKKDRSLD 1068
E + +P V +A V ++ G L+ + K +R+
Sbjct: 93 IVKCHEDFAKKDPRNPENVLM-----------IALVLDYANAGDLRQEIKSRAKTNRTFR 141
Query: 1069 RRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL 1128
+ ++ + + ++HSK+++H D+K N+L+ + K+GDFG S++ T
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC----SNGLVKLGDFGFSKMYAAT- 196
Query: 1129 VSGGVR----GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAII 1184
VS V GT ++APE+ S+K D+FS G+ ++E+LT + P+ G +
Sbjct: 197 VSDDVGRTFCGTPYYVAPEIWRRKP--YSKKADMFSLGVLLYELLTLKRPFD----GENM 250
Query: 1185 GGIVKNTLR---PTIPERCDPEWRKLMEQCWAADPEARPS 1221
++ TL +P PE ++++ ++DP+ RPS
Sbjct: 251 EEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 967 EELRELGSGTYGTVYHG---KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
E + E+G G YG V+ K G VA+KR++ + +E + RE +L +
Sbjct: 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ------TGEEGMPLSTIREVAVLRH 57
Query: 1024 LH---HPNVVAFYGV--VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
L HPNVV + V V T T+ V+ L L K + + M
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 1079 AAF-GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTL 1137
G+++LHS +VH DLK +N+LV K+ DFGL+RI + V TL
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYSFQMALTSVVVTL 173
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFG 1162
+ APE+L SS + VD++S G
Sbjct: 174 WYRAPEVLLQSS--YATPVDLWSVG 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-10
Identities = 68/264 (25%), Positives = 121/264 (45%), Gaps = 20/264 (7%)
Query: 972 LGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
+G G++G V + + + A+K ++K + E+ +++ +L N+ HP +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSE----RNVLLKNVKHPFL 58
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK 1089
V + T L V +++ G L + L ++ L+ R + A + A + YLHS
Sbjct: 59 VGLHFSFQ--TADKLYFVLDYINGGELFYHLQRERCFLEPRARFY-AAEIASALGYLHSL 115
Query: 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSGGVRGTLPWMAPELLNG 1147
NIV+ DLK EN+L+ D Q I + DFGL + I+ N S GT ++APE+L+
Sbjct: 116 NIVYRDLKPENILL---DSQGHIV-LTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLH- 169
Query: 1148 SSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN--TLRPTIPERCDPEWR 1205
VD + G ++E+L G P+ + + I+ L+P I
Sbjct: 170 -KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 228
Query: 1206 KLMEQCWAADPEARPSFTEITSRL 1229
L+++ A+ F EI + +
Sbjct: 229 GLLQKDRTKRLGAKDDFMEIKNHI 252
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 70/277 (25%), Positives = 120/277 (43%), Gaps = 32/277 (11%)
Query: 965 DLEELRELGSGTYGTVYHGK--WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E ++ +GSGTYG VY + G A+K IK S Q+ E ++
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ--------EIFMVK 61
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
H N+VA++G + L E+ GSL+ + L + + + G
Sbjct: 62 ECKHCNIVAYFGSYL--SREKLWICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQG 118
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL-SRIKRNTLVSGGVRGTLPWMA 1141
+ YLHSK +H D+K N+L+ K+ DFG+ ++I GT WMA
Sbjct: 119 LAYLHSKGKMHRDIKGANILLT----DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174
Query: 1142 PELL----NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197
PE+ NG N++ D+++ GI+ E+ + P D+H + + K+ +P P
Sbjct: 175 PEVAAVEKNGGYNQL---CDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP--P 229
Query: 1198 ERCD-----PEWRKLMEQCWAADPEARPSFTEITSRL 1229
+ D + ++ +P+ RP+ + + L
Sbjct: 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 5e-10
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 972 LGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG G +G V +++ + AIK +KK R E E L + R ++ HP +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD-EVESLMCE-KRIFETANSERHPFL 64
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSL-KHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS 1088
V + T + V E+ G L H+ D + R A G++YLH
Sbjct: 65 VNLFACFQ--TEDHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFYAA-CVVLGLQYLHE 119
Query: 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR------IKRNTLVSGGVRGTLPWMAP 1142
IV+ DLK +NLL+ D + + K+ DFGL + + +T GT ++AP
Sbjct: 120 NKIVYRDLKLDNLLL---DTEGFV-KIADFGLCKEGMGFGDRTSTFC-----GTPEFLAP 170
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
E+L +S + VD + G+ ++E+L GE P+
Sbjct: 171 EVLTETS--YTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-10
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 966 LEELRELGSGTYGTV---YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
+ L +GSG YG+V Y + R VA+K++ + +S R T +RE +L
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLR-QKVAVKKLSRPF---QSLIHARRT---YRELRLLK 69
Query: 1023 NLHHPNVVAFYGVVPDGTGGT----LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
++ H NV+ V T + VT M G+ + ++K + D + +I
Sbjct: 70 HMKHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLI-YQ 126
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP 1138
G++Y+HS I+H DLK N+ VN D + ++ DFGL+R + + G T
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVN-EDCE---LRILDFGLARQADDEMT--GYVATRW 180
Query: 1139 WMAPE-LLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
+ APE +LN ++ VD++S G M E+L G+
Sbjct: 181 YRAPEIMLNWM--HYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 75/292 (25%), Positives = 118/292 (40%), Gaps = 52/292 (17%)
Query: 972 LGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
+G G+YG V G VAIK+I F S L RE +L L HP++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRIL-----REIKLLRLLRHPDI 61
Query: 1030 VAFYGVV--PD-GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
V ++ P + V E M S H ++K + L ++Y+
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN----TLVSGGVRGTLPWMAP 1142
H+ N+ H DLK +N+L N D + IC DFGL+R+ N + T + AP
Sbjct: 120 HTANVFHRDLKPKNILAN-ADCKLKIC---DFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGE------------EPYADMHCGA----IIGG 1186
EL ++ + +D++S G E+LTG+ + D+ G I
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL-LGTPSPETISR 234
Query: 1187 IVK-------NTLRPTIP-------ERCDPEWRKLMEQCWAADPEARPSFTE 1224
+ +++R P DP +L+E+ A DP+ RP+ E
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-09
Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 32/220 (14%)
Query: 965 DLEELRELGSGTYGTVYHGKWR------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
D+E R +G G +G V W G VA+K++ F S K +RE
Sbjct: 1 DVEPDRPIGYGAFGVV----WSVTDPRDGKRVALKKMPN-VFQNLVS-----CKRVFREL 50
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGG---TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLII 1075
+L H NV++ ++ + VTE M L +++ K+ +
Sbjct: 51 KMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFL 109
Query: 1076 AMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK----RNTLVSG 1131
G++YLHS I+H D+K NLLVN + IC DFGL+R++ +
Sbjct: 110 -YQILRGLKYLHSAGILHRDIKPGNLLVN-SNCVLKIC---DFGLARVEEPDESKHMTQE 164
Query: 1132 GVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
V T + APE+L GS + VD++S G E+L
Sbjct: 165 VV--TQYYRAPEILMGSR-HYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 967 EELRELGSGTYGTV---YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
+ L +GSG YG+V + K G VA+K++ R + K +RE +L +
Sbjct: 20 QNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 72
Query: 1024 LHHPNVVAFYGVVPDGTG----GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
+ H NV+ V + VT M G+ + ++K + D + +I
Sbjct: 73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLI-YQI 129
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPW 1139
G++Y+HS +I+H DLK NL VN D + K+ DFGL+R + + G T +
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVN-EDCE---LKILDFGLARHTDDEMT--GYVATRWY 183
Query: 1140 MAPE-LLNGSSNRVSEKVDVFSFGISMWEILTG 1171
APE +LN + VD++S G M E+LTG
Sbjct: 184 RAPEIMLNWMHYNQT--VDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 967 EELRELGSGTYGTV--YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ L+ +GSG G V + G +VAIK++ R + K +RE ++ +
Sbjct: 19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLS------RPFQNVTHAKRAYRELVLMKLV 72
Query: 1025 HHPNVVAFYGV-VPDGTGGTLAT---VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
+H N++ V P + V E M + +L V+ + D +R L+ M
Sbjct: 73 NHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVI-QMDLDHERMSYLLYQM--L 128
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRIKRNTLVSGGVRGTLP 1138
G+++LHS I+H DLK N++V C K+ DFGL+R + + T
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
+ APE++ G E VD++S G M E++ G
Sbjct: 183 YRAPEVILGMG--YKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-09
Identities = 65/269 (24%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 927 SLSQDSKADVRDKDESFSDAMIAEMEA---SIYGLQIIKNVDLEELRELGSGTYGTVYHG 983
+L D K+++ D ++ E I L++ K D + ++ +G G +G V
Sbjct: 5 ALVYDCDIPALRKNKNI-DNFLSRYEKAAEKITKLRM-KAEDFDVIKVIGRGAFGEVQLV 62
Query: 984 KWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041
+ + S A+K + K RS + FW E I+++ + +V + D
Sbjct: 63 RHKSSKQVYAMKLLSKFEMIKRSD-----SAFFWEERDIMAHANSEWIVQLHYAFQDDK- 116
Query: 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRK----KLIIAMDAAFGMEYLHSKNIVHFDLK 1097
L V E+M G L +++ D + ++++A+DA +HS +H D+K
Sbjct: 117 -YLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDA------IHSMGFIHRDVK 169
Query: 1098 CENLLVNLRDPQRPICKVGDFGLS-RIKRNTLV-SGGVRGTLPWMAPELL--NGSSNRVS 1153
+N+L++ K+ DFG ++ N +V GT +++PE+L G
Sbjct: 170 PDNMLLDKSGH----LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
Query: 1154 EKVDVFSFGISMWEILTGEEP-YADMHCG 1181
+ D +S G+ ++E+L G+ P YAD G
Sbjct: 226 RECDWWSVGVFLYEMLVGDTPFYADSLVG 254
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 65/261 (24%), Positives = 100/261 (38%), Gaps = 70/261 (26%)
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI--IAMDAAFGM 1083
HPN++ + V TG L ++ FM GS LLK + LI I A G+
Sbjct: 58 HPNIMTSWTVFT--TGSWLWVISPFMAYGSANS-LLKTYFPEGMSEALIGNILFGALRGL 114
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR--------- 1134
YLH +H ++K ++L++ V GLS + +LV G +
Sbjct: 115 NYLHQNGYIHRNIKASHILISGDG------LVSLSGLSHL--YSLVRNGQKAKVVYDFPQ 166
Query: 1135 ---GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAII------- 1184
LPW++PELL + K D++S GI+ E+ TG P+ DM ++
Sbjct: 167 FSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGP 226
Query: 1185 -------------GGIVKNT-------------------------LRPTIPERCDPEWRK 1206
+KN+ LR + P ++
Sbjct: 227 PYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQN 286
Query: 1207 LMEQCWAADPEARPSFTEITS 1227
L+E C DPE RPS + + S
Sbjct: 287 LVELCLQQDPEKRPSASSLLS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 62/271 (22%), Positives = 103/271 (38%), Gaps = 73/271 (26%)
Query: 1017 EAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIA 1076
E H+ +HPN+V + L VT FM GS K ++ +D +L IA
Sbjct: 49 ELHVSKLFNHPNIVPYRATFI--ADNELWVVTSFMAYGSAKDLICT--HFMDGMSELAIA 104
Query: 1077 ---MDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN-TLVSGG 1132
++Y+H VH +K ++L+++ G LS ++ N ++++ G
Sbjct: 105 YILQGVLKALDYIHHMGYVHRSVKASHILISVD---------GKVYLSGLRSNLSMINHG 155
Query: 1133 VRG------------TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADM-- 1178
R LPW++PE+L + K D++S GI+ E+ G P+ DM
Sbjct: 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 215
Query: 1179 -------------------------------HCGAIIG---GIVKNTLRPTIPERC---- 1200
GA G +T RP+ E
Sbjct: 216 TQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPY 275
Query: 1201 ----DPEWRKLMEQCWAADPEARPSFTEITS 1227
P + +EQC +P+ARPS + + +
Sbjct: 276 NRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 61/243 (25%), Positives = 110/243 (45%), Gaps = 20/243 (8%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E L+ +G G +G V K + +D A+K + K R+ T F E +L
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE-----TACFREERDVLV 56
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLK-KDRSLDRRKKLIIAMDAAF 1081
N + + + D L V ++ V G L +L K +DR + + +A +
Sbjct: 57 NGDNQWITTLHYAFQDEN--NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVI 113
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG--LSRIKRNTLVSGGVRGTLPW 1139
++ +H + VH D+K +N+L+++ R + DFG L ++ T+ S GT +
Sbjct: 114 AIDSVHQLHYVHRDIKPDNILMDMNGHIR----LADFGSCLKLMEDGTVQSSVAVGTPDY 169
Query: 1140 MAPELLNGSSN---RVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196
++PE+L + + + D +S G+ M+E+L GE P+ G I+ + R
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 229
Query: 1197 PER 1199
P +
Sbjct: 230 PAQ 232
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-09
Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 27/234 (11%)
Query: 949 AEMEASIYGLQIIKNV-----DLEELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFA 1001
+E ++ Y +Q+ + ++L+ +GSG G V G +VA+K++
Sbjct: 1 SEEDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL------ 54
Query: 1002 GRSSEQERLTKDFWREAHILSNLHHPNVVAFYGV-VPDGT---GGTLATVTEFMVNGSLK 1057
R + + K +RE +L ++H N+++ V P + + V E M + +L
Sbjct: 55 SRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLC 113
Query: 1058 HVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117
V+ LD + + G+++LHS I+H DLK N++V K+ D
Sbjct: 114 QVI---HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILD 166
Query: 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
FGL+R + T + APE++ G + E VD++S G M E++ G
Sbjct: 167 FGLARTACTNFMMTPYVVTRYYRAPEVILGMGYK--ENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 6e-09
Identities = 45/138 (32%), Positives = 72/138 (52%), Gaps = 9/138 (6%)
Query: 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCE 1099
T L VT++M G L L K+ R + R K IA + +E+LH +IV+ DLK E
Sbjct: 67 TDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKYDIVYRDLKPE 125
Query: 1100 NLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVD 1157
N+L++ +C DFGLS+ + N + GT ++APE+L ++ VD
Sbjct: 126 NILLD-ATGHIALC---DFGLSKANLTDNKT-TNTFCGTTEYLAPEVLLDEKG-YTKHVD 179
Query: 1158 VFSFGISMWEILTGEEPY 1175
+S G+ ++E+ G P+
Sbjct: 180 FWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-09
Identities = 70/299 (23%), Positives = 124/299 (41%), Gaps = 54/299 (18%)
Query: 966 LEELRELGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
L+E + G G Y GK + + +K I +S D +
Sbjct: 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV-----NSIPSSEIADMGK------- 739
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGM 1083
L HPN+V G+ G L + E++ +L VL ++ S +RR+K+ I + A +
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYL--IHEYIEGKNLSEVL--RNLSWERRRKIAIGIAKA--L 793
Query: 1084 EYLH---SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWM 1140
+LH S +V +L E ++++ +D P ++ GL +S ++
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKD--EPHLRLSLPGLLCTDTKCFISSA------YV 845
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEP------------------YADMHCGA 1182
APE + ++EK D++ FG+ + E+LTG+ P Y+D H
Sbjct: 846 APE--TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903
Query: 1183 IIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCI 1241
I ++ + ++ + E L C A DP ARP ++ L + S + S C+
Sbjct: 904 WIDPSIRGDV--SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS-SSSCV 959
|
Length = 968 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 972 LGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
+G G++G V K + G A+K ++K R EQ+ + + +L N+ HP +
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK-EQKHIMAE---RNVLLKNVKHPFL 58
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK 1089
V + T L V +F VNG L+++RS + A + A + YLHS
Sbjct: 59 VGLHYSFQ--TTEKLYFVLDF-VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR---GTLPWMAPELLN 1146
NIV+ DLK EN+L+ D Q + + DFGL K S GT ++APE++
Sbjct: 116 NIVYRDLKPENILL---DSQGHVV-LTDFGLC--KEGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 1147 GSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
VD + G ++E+L G P+
Sbjct: 170 --KQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-08
Identities = 64/237 (27%), Positives = 109/237 (45%), Gaps = 27/237 (11%)
Query: 955 IYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTK 1012
I LQ+ K D + ++ +G G +G V + + S A+K + K RS +
Sbjct: 35 IRKLQM-KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSD-----SA 88
Query: 1013 DFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKK 1072
FW E I++ + P VV + D L V E+M G L +++ D ++ K
Sbjct: 89 FFWEERDIMAFANSPWVVQLFCAFQDDK--YLYMVMEYMPGGDLVNLMSNYDVP-EKWAK 145
Query: 1073 LIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG 1132
A + ++ +HS ++H D+K +N+L++ + K+ DFG T G
Sbjct: 146 FYTA-EVVLALDAIHSMGLIHRDVKPDNMLLD----KHGHLKLADFGTCMKMDET---GM 197
Query: 1133 VR-----GTLPWMAPELL--NGSSNRVSEKVDVFSFGISMWEILTGEEP-YADMHCG 1181
VR GT +++PE+L G + D +S G+ ++E+L G+ P YAD G
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG 254
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 18/226 (7%)
Query: 972 LGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
+G G++G V K + GS A+K ++K + EQ + + +L NL HP +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQNHIMAE---RNVLLKNLKHPFL 58
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK 1089
V + T L V ++ VNG L+++R + A + A + YLHS
Sbjct: 59 VGLHYSFQ--TAEKLYFVLDY-VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSGGVRGTLPWMAPELLNG 1147
NI++ DLK EN+L+ D Q + + DFGL + ++ S GT ++APE+L
Sbjct: 116 NIIYRDLKPENILL---DSQGHVV-LTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLR- 169
Query: 1148 SSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193
VD + G ++E+L G P+ + I+ L+
Sbjct: 170 -KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ 214
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-08
Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 970 RELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFW--REAHILSNL- 1024
R +G G+Y V + + ++ A+K +KK ++ E + W E H+
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV----NDDEDID---WVQTEKHVFEQAS 53
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
+HP +V + T L V E+ VNG +++ R L + + + +
Sbjct: 54 NHPFLVGLHSCFQ--TESRLFFVIEY-VNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK-RNTLVSGGVRGTLPWMAPE 1143
YLH + I++ DLK +N+L+ D + I K+ D+G+ + R + GT ++APE
Sbjct: 111 YLHERGIIYRDLKLDNVLL---DSEGHI-KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 166
Query: 1144 LLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
+L G S VD ++ G+ M+E++ G P+
Sbjct: 167 ILRGEDYGFS--VDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-08
Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 26/231 (11%)
Query: 961 IKNVDLEELRELGSGTYGTV--YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
+K D E ++ +G G +G V K A+K + K RS + FW E
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD-----SAFFWEER 94
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
I++ + P VV + D L V E+M G L +++ D + + +
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDR--YLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAE 150
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR---- 1134
++ +HS +H D+K +N+L++ + K+ DFG + +K N G VR
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLADFG-TCMKMNK--EGMVRCDTA 203
Query: 1135 -GTLPWMAPELL--NGSSNRVSEKVDVFSFGISMWEILTGEEP-YADMHCG 1181
GT +++PE+L G + D +S G+ ++E+L G+ P YAD G
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 972 LGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
+G G++G V K + A+K ++K + ++ + + R +L N+ HP +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAE---RNV-LLKNVKHPFL 58
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK 1089
V + T L V ++ VNG L+++RS + A + A + YLHS
Sbjct: 59 VGLHYSFQ--TADKLYFVLDY-VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115
Query: 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSGGVRGTLPWMAPELLNG 1147
NI++ DLK EN+L+ D Q + + DFGL + I+ + S GT ++APE+L
Sbjct: 116 NIIYRDLKPENILL---DSQGHV-VLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEVLR- 169
Query: 1148 SSNRVSEKVDVFSFGISMWEILTGEEPY 1175
VD + G ++E+L G P+
Sbjct: 170 -KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 970 RELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFW--REAHIL---S 1022
R +G G+Y V + + + A+K IKK ++ E + W E H+ S
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV----NDDEDID---WVQTEKHVFETAS 53
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLK-HVLLKKDRSLDRRKKLIIAMDAAF 1081
N HP +V + T L V EF+ G L H +++ R L + + +
Sbjct: 54 N--HPFLVGLHSCFQ--TESRLFFVIEFVSGGDLMFH--MQRQRKLPEEHARFYSAEISL 107
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSGGVRGTLPW 1139
+ +LH + I++ DLK +N+L+ D + I K+ D+G+ + I+ S GT +
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLL---DAEGHI-KLTDYGMCKEGIRPGDTTSTFC-GTPNY 162
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
+APE+L G S VD ++ G+ M+E++ G P+
Sbjct: 163 IAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-07
Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 40/173 (23%)
Query: 1017 EAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSL-----DRRK 1071
EAHIL ++HP+++ G F N +L + L +R
Sbjct: 133 EAHILRAINHPSIIQLKGT--------------FTYNKFTCLILPRYKTDLYCYLAAKRN 178
Query: 1072 -----KLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRP--ICKVGDFGLS--- 1121
L I ++YLH I+H D+K EN+ +N P +C +GDFG +
Sbjct: 179 IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN-----HPGDVC-LGDFGAACFP 232
Query: 1122 -RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEE 1173
I N G GT+ APELL + + VD++S GI ++E+ T +
Sbjct: 233 VDINANKYY--GWAGTIATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCHD 281
|
Length = 391 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQ----ERLTKDFWREA 1018
D L LG G++G V + +G+D AIK +KK + E+ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
L+ LH F T L V E++ G L + + + R + A +
Sbjct: 61 PFLTQLHS----CFQ------TMDRLYFVMEYVNGGDLMYQIQQVGR-FKEPHAVFYAAE 109
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRG 1135
A G+ +LHSK I++ DLK +N+++ D + I K+ DFG+ K N + G
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVML---DSEGHI-KIADFGMC--KENMWDGVTTKTFCG 163
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
T ++APE++ + + VD ++FG+ ++E+L G+ P+
Sbjct: 164 TPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-07
Identities = 44/178 (24%), Positives = 87/178 (48%), Gaps = 18/178 (10%)
Query: 1072 KLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL--- 1128
++++A+D +HS+ ++H DLK N+ + I K+GDFG S+ +++
Sbjct: 177 QIVLALDE------VHSRKMMHRDLKSANIFLM----PTGIIKLGDFGFSKQYSDSVSLD 226
Query: 1129 VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIV 1188
V+ GT ++APEL R S+K D++S G+ ++E+LT P+ I+ ++
Sbjct: 227 VASSFCGTPYYLAPELW--ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284
Query: 1189 KNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI--TSRLRTISAAIESKCINSE 1244
P P + L++ + +P RP+ ++ T L+ ++ + +SE
Sbjct: 285 YGKYDP-FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHSE 341
|
Length = 478 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 56/219 (25%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E ++ +G G +G V K + ++ A+K + K R+ T F E ++L
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAE-----TACFREERNVLV 56
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLK-KDRSLDRRKKLIIAMDAAF 1081
N + + D L V ++ V G L +L K +DR + + IA +
Sbjct: 57 NGDCQWITTLHYAFQDEN--YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA-EMVL 113
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG--LSRIKRNTLVSGGVRGTLPW 1139
+ +H + VH D+K +N+L+++ R + DFG L + T+ S GT +
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIR----LADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 1140 MAPELLNGSSN---RVSEKVDVFSFGISMWEILTGEEPY 1175
++PE+L + + + D +S G+ M+E+L GE P+
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 3e-07
Identities = 60/246 (24%), Positives = 103/246 (41%), Gaps = 48/246 (19%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E ++ +G G +G V+ + + + A+K ++KS R Q E IL+
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKR--NQIAH---VRAERDILA 56
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIA-MDAAF 1081
+ P +V Y D L V E+M G L ++L++KD + + IA + A
Sbjct: 57 DADSPWIVKLYYSFQDEE--HLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA- 113
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS---------------RIKRN 1126
++ +H +H D+K +N+L+ D I K+ DFGL
Sbjct: 114 -LDSVHKLGFIHRDIKPDNILI---DADGHI-KLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 1127 TLVSGGVR---------------GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
+ VR GT ++APE+L G+ + D +S G+ ++E+L G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP--YGLECDWWSLGVILYEMLYG 226
Query: 1172 EEPYAD 1177
P+
Sbjct: 227 FPPFYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-07
Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 967 EELRELGSGTYGTV--YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ L+ +GSG G V + +VAIK++ R + + K +RE ++ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS------RPFQNQTHAKRAYRELVLMKCV 73
Query: 1025 HHPNVVAFYGV-VPDGTGGTLATVTEFM--VNGSLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
+H N+++ V P + V M ++ +L V+ LD + +
Sbjct: 74 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLC 130
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMA 1141
G+++LHS I+H DLK N++V K+ DFGL+R + + T + A
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEIL 1169
PE++ G + E VD++S G M E++
Sbjct: 187 PEVILGMGYK--ENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-07
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D L LG G++G V + +G+D AIK +KK + + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMV-----EKRVLA 55
Query: 1023 NLHHPN-VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
P + + T L V E+ VNG +++ + A + A
Sbjct: 56 LPGKPPFLTQLHSCFQ--TMDRLYFVMEY-VNGGDLMYHIQQVGKFKEPHAVFYAAEIAI 112
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR---GTLP 1138
G+ +LHSK I++ DLK +N+++ D + I K+ DFG+ K N R GT
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVML---DAEGHI-KIADFGMC--KENIFGGKTTRTFCGTPD 166
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
++APE++ + + VD ++FG+ ++E+L G+ P+
Sbjct: 167 YIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 967 EELRELGSGTYGTV--YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ L+ +GSG G V + +VAIK++ R + + K +RE ++ +
Sbjct: 27 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLS------RPFQNQTHAKRAYRELVLMKCV 80
Query: 1025 HHPNVVAFYGVVPDGTG----GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
+H N++ V + V E M + +L V+ LD + +
Sbjct: 81 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI---QMELDHERMSYLLYQML 136
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWM 1140
G+++LHS I+H DLK N++V K+ DFGL+R + + T +
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
APE++ G + E VD++S G M E++ G
Sbjct: 193 APEVILGMGYK--ENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 39/231 (16%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDVA-----------IKRIKKSCFAGRSSEQERLTKD 1013
D E L+ +G G +G V K + + +KR + +CF E++ L
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACF---REERDVLVNG 58
Query: 1014 FWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLK-KDRSLDRRKK 1072
+ ++NLH+ AF L V ++ V G L +L K +DR + +
Sbjct: 59 ---DRRWITNLHY----AFQ------DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 105
Query: 1073 LIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG--LSRIKRNTLVS 1130
+A + ++ +H VH D+K +N+L++ R + DFG L + T+ S
Sbjct: 106 FYLA-EMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIR----LADFGSCLRLLADGTVQS 160
Query: 1131 GGVRGTLPWMAPELLN---GSSNRVSEKVDVFSFGISMWEILTGEEP-YAD 1177
GT +++PE+L R + D +S G+ M+E+L GE P YA+
Sbjct: 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-06
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 38/216 (17%)
Query: 972 LGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
+G+G++G VY VAIK++ Q+ K+ RE I+ NL+H N+
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVL----------QDPQYKN--RELLIMKNLNHINI 121
Query: 1030 V---AFY---GVVPDGTGGTLATVTEFM---VNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
+ +Y + L V EF+ V+ +KH + + +L + +
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKH-YARNNHALPLFLVKLYSYQLC 180
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRG----- 1135
+ Y+HSK I H DLK +NLL+ DP K+ DFG + +N L G R
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLI---DPNTHTLKLCDFGSA---KNLL--AGQRSVSYIC 232
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
+ + APEL+ G++N + +D++S G + E++ G
Sbjct: 233 SRFYRAPELMLGATNYTTH-IDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 8/137 (5%)
Query: 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCE 1099
T L V E+ VNG +++ R L A + + +LH + I++ DLK +
Sbjct: 67 TTSRLFLVIEY-VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLD 125
Query: 1100 NLLVNLRDPQRPICKVGDFGLSRIK-RNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDV 1158
N+L++ K+ D+G+ + + GT ++APE+L G S VD
Sbjct: 126 NVLLD----ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS--VDW 179
Query: 1159 FSFGISMWEILTGEEPY 1175
++ G+ M+E++ G P+
Sbjct: 180 WALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 13/173 (7%)
Query: 1051 MVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQR 1110
++NG H L + ++ A + G+E++H++ +V+ DLK N+L++ +
Sbjct: 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD----EH 133
Query: 1111 PICKVGDFGLS--RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEI 1168
++ D GL+ K+ S G G +MAPE+L + S D FS G ++++
Sbjct: 134 GHVRISDLGLACDFSKKKPHASVGTHG---YMAPEVLQKGTAYDSS-ADWFSLGCMLFKL 189
Query: 1169 LTGEEPYADMHCGAIIGGIVKNTLRPTI--PERCDPEWRKLMEQCWAADPEAR 1219
L G P+ H I + TL + P+ PE + L+E D R
Sbjct: 190 LRGHSPFRQ-HKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 47/175 (26%), Positives = 71/175 (40%), Gaps = 33/175 (18%)
Query: 969 LRELGSGTYGTVYHGKWRGSDVAIK-RIKKSCFAGRSSE------QERLTKDFWREAHIL 1021
++ + G +Y G + G IK RI K R E +ER T+ REA I+
Sbjct: 1 MKLIKRGAEAEIYLGDFLGIKAVIKWRIPKRY---RHPELDERIRRER-TR---REARIM 53
Query: 1022 SNLHHP--NVVAFYGVVPDGTGGTLATVTEFMVNG-SLKHVLLKKDRSLDRRKKLIIAMD 1078
S NV A Y V P+ V E+ + G LK ++ + + +L +
Sbjct: 54 SRARKAGVNVPAVYFVDPENF----IIVMEY-IEGEPLKDLI---NSNGMEELELSREIG 105
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGV 1133
G LHS I+H DL N++++ I + DFGL+ L V
Sbjct: 106 RLVGK--LHSAGIIHGDLTTSNMILSGGK----IYLI-DFGLAEFS-KDLEDRAV 152
|
Length = 211 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 23/178 (12%)
Query: 1051 MVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQR 1110
++NG H L + + A + G+E++H++ +V+ DLK N+L++ R
Sbjct: 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 137
Query: 1111 PICKVGDFGL----SRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMW 1166
+ D GL S+ K + V GT +MAPE+L S D FS G ++
Sbjct: 138 ----ISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLF 187
Query: 1167 EILTGEEPY-----ADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEAR 1219
++L G P+ D H I + T+ +P+ PE R L+E D R
Sbjct: 188 KLLRGHSPFRQHKTKDKH--EIDRMTL--TMAVELPDSFSPELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 966 LEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
E L +G G YG V + + + VAIK+ K S E E + + RE +L
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS------EENEEVKETTLRELKMLRT 56
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSL-DRRKKLIIAMDAAFG 1082
L N+V G L V E++ L+ + + ++ + I + A
Sbjct: 57 LKQENIVELKEAFR--RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKA-- 112
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMA- 1141
+ + H +IVH D+K ENLL++ D + K+ DFG +R L G ++A
Sbjct: 113 IHWCHKNDIVHRDIKPENLLISHND----VLKLCDFGFAR----NLSEGSNANYTEYVAT 164
Query: 1142 -----PELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
PELL G+ + VD++S G + E+ G+
Sbjct: 165 RWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (116), Expect = 2e-05
Identities = 55/239 (23%), Positives = 104/239 (43%), Gaps = 37/239 (15%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKS-CFAGRSSE--QERLTKDFWREAHIL 1021
+ E ++++G+G +G V+ V KR ++ C+ S +ER E +++
Sbjct: 14 EYEVIKKIGNGRFGEVFL-------VKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVM 66
Query: 1022 SNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR---SLDRRKKLIIAMD 1078
L H N+V + + L + EF G L + K + ++ + I
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126
Query: 1079 AAFGMEYLHS-------KNIVHFDLKCENLLV---------------NLRDPQRPICKVG 1116
+ Y H+ + ++H DLK +N+ + NL RPI K+G
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG--RPIAKIG 184
Query: 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
DFGLS+ ++ GT + +PELL + +K D+++ G ++E+ +G+ P+
Sbjct: 185 DFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 3e-05
Identities = 57/277 (20%), Positives = 109/277 (39%), Gaps = 35/277 (12%)
Query: 908 TSSDEMSTNETESESIFPESLSQDSKADVRDKDESFSD-AMIAEMEASIYGLQIIKNVDL 966
+ S + + ++A ++ DE + +I ++ A +G I +
Sbjct: 112 AEDSDASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRA 171
Query: 967 EELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
+ GK + + KR+K A E E L L L+H
Sbjct: 172 STEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEIL---------ALGRLNH 222
Query: 1027 PNVVAFYGVVPDGTGGTLAT------VTEFMVNGSLK---HVLLKKDRSLDRRKKLIIAM 1077
N++ ++ + T + FM + + LLK+ R++ K+L+ A+
Sbjct: 223 ENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI--MKQLLCAV 280
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG--GVRG 1135
EY+H K ++H D+K EN+ +N +GDFG + + G G
Sbjct: 281 ------EYIHDKKLIHRDIKLENIFLNCDGK----IVLGDFGTAMPFEKEREAFDYGWVG 330
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
T+ +PE+L G E D++S G+ + ++L+ +
Sbjct: 331 TVATNSPEILAGDG--YCEITDIWSCGLILLDMLSHD 365
|
Length = 501 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 27/103 (26%), Positives = 58/103 (56%), Gaps = 11/103 (10%)
Query: 1076 AMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR- 1134
A + + G+ +LH + I++ DLK +N++++ K+ DFG+ K + + R
Sbjct: 107 AAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH----IKIADFGMC--KEHMVDGVTTRT 160
Query: 1135 --GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
GT ++APE++ + + VD +++G+ ++E+L G+ P+
Sbjct: 161 FCGTPDYIAPEII--AYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 6e-05
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 26/165 (15%)
Query: 965 DLEELRELGSGTYGTV--YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH--- 1019
D E ++ +G G +G V K G A+K+++KS E L K+ + AH
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS---------EMLEKE--QVAHVRA 50
Query: 1020 ---ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIA 1076
IL+ +P VV Y D L + E++ G + +L+KKD + + IA
Sbjct: 51 ERDILAEADNPWVVKLYYSFQDEN--YLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA 108
Query: 1077 MDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121
+ ++ +H +H D+K +NLL++ + K+ DFGL
Sbjct: 109 -ETILAIDSIHKLGYIHRDIKPDNLLLD----AKGHIKLSDFGLC 148
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 58/250 (23%), Positives = 99/250 (39%), Gaps = 54/250 (21%)
Query: 965 DLEELRELGSGTYGTV--YHGKWRGSDVAIKRIKKSCFAGRSSEQE-RLTKDFWREAHIL 1021
D E L+ +G G +G V K G A+K ++K+ + R +D EA L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 1022 SNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
VV + D L + EF+ G + +L+KKD + + IA +
Sbjct: 62 W------VVKMFYSFQDKL--NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVL 112
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL--------------------- 1120
++ +H +H D+K +NLL++ + K+ DFGL
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLD----SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP 168
Query: 1121 ---------SRIKRNTL------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISM 1165
S+ K T ++ GT ++APE+ ++ D +S G+ M
Sbjct: 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF--MQTGYNKLCDWWSLGVIM 226
Query: 1166 WEILTGEEPY 1175
+E+L G P+
Sbjct: 227 YEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-04
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 14/154 (9%)
Query: 975 GTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAF 1032
G +G VY G K A+K +KK+ ++ + + R+A LS P +V
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAE---RDALALSK--SPFIVHL 69
Query: 1033 YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIV 1092
Y + L V E+++ G +K LL D + + A ++YLH I+
Sbjct: 70 YYSLQSANNVYL--VMEYLIGGDVKS-LLHIYGYFDEEMAVKYISEVALALDYLHRHGII 126
Query: 1093 HFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN 1126
H DLK +N+L++ K+ DFGLS++ N
Sbjct: 127 HRDLKPDNMLIS----NEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-04
Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 19/214 (8%)
Query: 972 LGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
+G G +G V K G A+K +KKS + F E ILS + P +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKS-----VLLAQETVSFFEEERDILSISNSPWI 63
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK 1089
D L V E+ G L +L + + D + + +H
Sbjct: 64 PQLQYAFQDKD--NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121
Query: 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-RIKRN-TLVSGGVRGTLPWMAPELL-- 1145
VH D+K EN+L+ D I K+ DFG + R+ N + S GT ++APE+L
Sbjct: 122 GYVHRDIKPENVLI---DRTGHI-KLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 1146 -NGSSNRVSE-KVDVFSFGISMWEILTGEEPYAD 1177
NG + D +S G+ +E++ G P+ +
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 41/176 (23%), Positives = 69/176 (39%), Gaps = 26/176 (14%)
Query: 1054 GSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113
SL +L + R L+ + + + + LH + L + L+ L
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL-------- 52
Query: 1114 KVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEE 1173
G K T R +MAPE++ G S +EK D++S GI+++E L E
Sbjct: 53 ----DGSVAFK--TPEQS--RPDPYFMAPEVIQGQS--YTEKADIYSLGITLYEALDYEL 102
Query: 1174 PYADMHCGAIIGGIVKNTLRPTIPE-RCDPE-------WRKLMEQCWAADPEARPS 1221
PY + + I I+ N + P R + E + M C + P+ R +
Sbjct: 103 PYNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREA 158
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 58/250 (23%), Positives = 99/250 (39%), Gaps = 54/250 (21%)
Query: 965 DLEELRELGSGTYGTV--YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E L+ +G G +G V K G A+K ++K+ E+E++ E IL
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML----EKEQVAH-IRAERDILV 56
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
VV + D L + EF+ G + +L+KKD + + IA +
Sbjct: 57 EADGAWVVKMFYSFQDKR--NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLA 113
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS--------------------- 1121
++ +H +H D+K +NLL++ + K+ DFGL
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGH----VKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169
Query: 1122 ----------------RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISM 1165
+ R L V GT ++APE+ + ++ D +S G+ M
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTV-GTPDYIAPEVFMQTG--YNKLCDWWSLGVIM 226
Query: 1166 WEILTGEEPY 1175
+E+L G P+
Sbjct: 227 YEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1254 | |||
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06410 | 97 | PB1_UP2 Uncharacterized protein 2. The PB1 domain | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.17 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.04 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.96 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.92 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.91 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.91 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.83 | |
| smart00666 | 81 | PB1 PB1 domain. Phox and Bem1p domain, present in | 98.78 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.73 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.6 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.6 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.27 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.21 | |
| PF00564 | 84 | PB1: PB1 domain; InterPro: IPR000270 The Phox and | 98.13 | |
| cd05992 | 81 | PB1 The PB1 domain is a modular domain mediating s | 98.13 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.07 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.06 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.84 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.83 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.82 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.78 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.67 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.65 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.6 | |
| cd06407 | 82 | PB1_NLP A PB1 domain is present in NIN like protei | 97.56 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.51 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.48 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.46 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.3 | |
| cd06408 | 86 | PB1_NoxR The PB1 domain is present in the Epichloe | 97.27 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.26 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.22 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.13 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.11 | |
| cd06405 | 79 | PB1_Mekk2_3 The PB1 domain is present in the two m | 96.98 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.83 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.4 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.37 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.33 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.19 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.15 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.05 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.04 | |
| cd06401 | 81 | PB1_TFG The PB1 domain found in TFG protein, an on | 95.97 | |
| cd06404 | 83 | PB1_aPKC PB1 domain is an essential modular domain | 95.93 | |
| cd06398 | 91 | PB1_Joka2 The PB1 domain is present in the Nicotia | 95.8 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.47 | |
| cd06396 | 81 | PB1_NBR1 The PB1 domain is an essential part of NB | 95.4 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.39 | |
| PLN02236 | 344 | choline kinase | 95.38 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.17 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 94.82 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.64 | |
| cd06397 | 82 | PB1_UP1 Uncharacterized protein 1. The PB1 domain | 94.63 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.32 | |
| cd06402 | 87 | PB1_p62 The PB1 domain is an essential part of p62 | 93.63 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.57 |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=411.66 Aligned_cols=271 Identities=48% Similarity=0.804 Sum_probs=238.0
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECCce-EEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSD-VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~-VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
.+...++.+.+.||+|+||+||++.|+++. ||||++....... . ..+.|.+|+.+|.+++|||||+++|++.+
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~-----~-~~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDD-----E-SRKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcCh-----H-HHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 344445666677999999999999999999 9999998653221 1 16789999999999999999999999976
Q ss_pred CCCCceEEEEEecccCchhhhhhc-cCCCCCHHHHHHHHHHhhhhhHHhhhCC-cccccCCCCceEeccCCCCCC-eEEE
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLK-KDRSLDRRKKLIIAMDAAFGMEYLHSKN-IVHFDLKCENLLVNLRDPQRP-ICKV 1115 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~k-re~~LSe~~~lkIa~QIAeALaYLHSkG-IIHRDLKPeNILLDsdd~snG-~VKL 1115 (1254)
... .+++||||+++|+|.+++.+ +.+.+++..++.|+.||++||.|||+++ ||||||||+||||+ ..+ ++||
T Consensus 111 ~~~-~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~----~~~~~~KI 185 (362)
T KOG0192|consen 111 PPG-SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD----LKGKTLKI 185 (362)
T ss_pred CCC-ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc----CCCCEEEE
Confidence 542 68999999999999999987 4788999999999999999999999999 99999999999999 665 9999
Q ss_pred EeccccccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC
Q 040257 1116 GDFGLSRIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1116 iDFGLAr~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
||||+++..... ...+...||..|||||++++....|+.|+||||||++||||+||+.||...........+.....++
T Consensus 186 ~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp 265 (362)
T KOG0192|consen 186 ADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP 265 (362)
T ss_pred CCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 999999877654 3344467999999999999542359999999999999999999999999999888888888888999
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCI 1241 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk~~ 1241 (1254)
.++..+++.+..|+.+||..||.+||++.+++..|+.+...+.....
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~ 312 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGP 312 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCc
Confidence 99999999999999999999999999999999999999887665433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=410.49 Aligned_cols=252 Identities=35% Similarity=0.540 Sum_probs=222.5
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+++.++.||+|..|+||+++|+ ++.+|+|++... .+....+++.+|+++|+.++|||||++||.|..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-------~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-------IDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-------CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 33447788899999999999999996 777999999533 245678899999999999999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
... .++|+||||.+|||..++... +.+++.....|+.++++||.|||+ ++||||||||+|||++ +.|.|||||
T Consensus 149 ~~~-~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN----skGeVKicD 222 (364)
T KOG0581|consen 149 NGE-EISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN----SKGEVKICD 222 (364)
T ss_pred CCc-eEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec----cCCCEEecc
Confidence 653 699999999999999998544 679999999999999999999995 9999999999999999 899999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----ChhhHHHHhhhccC
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADM-----HCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~-----n~~eliqsIlk~~L 1192 (1254)
||.++...++ ...++.||..|||||++.+.. |+.++||||||++|+|+.+|++||... ...+++..|+.+.
T Consensus 223 FGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~--Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p- 298 (364)
T KOG0581|consen 223 FGVSGILVNS-IANTFVGTSAYMSPERISGES--YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP- 298 (364)
T ss_pred ccccHHhhhh-hcccccccccccChhhhcCCc--CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC-
Confidence 9999987777 667788999999999999885 788899999999999999999999764 4566777777654
Q ss_pred CCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1193 RPTIPER-CDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1193 rp~ipe~-iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
.+.+|.. ++++++.||..||++||.+||+++||++|=
T Consensus 299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 4567765 999999999999999999999999999873
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=411.96 Aligned_cols=262 Identities=28% Similarity=0.369 Sum_probs=224.4
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
+..|.+.+.||+|+||.|-+|.. +++.||||++.+......... ..-.....+|+++|++|+|||||+++++|..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~-~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRA-IAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhccccccc-ccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34688889999999999999987 478899999998765543321 111233579999999999999999999998776
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
..||||||+.||+|.+.+... +.+.+.....+++|++.||.|||++||+||||||+|||+..+. ....+||+|||+
T Consensus 250 --s~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~-e~~llKItDFGl 325 (475)
T KOG0615|consen 250 --SSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA-EDCLLKITDFGL 325 (475)
T ss_pred --ceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC-cceEEEecccch
Confidence 789999999999999998654 5688999999999999999999999999999999999998443 668999999999
Q ss_pred cccccCccccCCCCCCCCccCcccccCCCCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCChhh-HHHHhhhccCCCC--C
Q 040257 1121 SRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSE-KVDVFSFGISMWEILTGEEPYADMHCGA-IIGGIVKNTLRPT--I 1196 (1254)
Q Consensus 1121 Ar~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~-KSDIWSLGVILYELLTGk~PF~~~n~~e-liqsIlk~~Lrp~--i 1196 (1254)
|+...+.....++|||+.|.|||++.+....+.. ++|||||||+||-+++|.+||.+...+. ..+.+.++.+... .
T Consensus 326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 9998888888899999999999999877655444 8999999999999999999998766655 7778888776543 3
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
...++.+.++||++||..||++|||+.|+|++=
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 456899999999999999999999999999863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=402.88 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=222.0
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|+++++||+|+||+||.++. +++.||+|++++..+... ...+....|..||.+++||+||+++-.|++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-----~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-----KEVRHTKAERNILSKIKHPFIVKLIYSFQT 96 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-----hhHHHHHHHHHHHHhCCCCcEeeeEEeccc
Confidence 4456899999999999999999987 477799999998765533 234667889999999999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. .+|+|+||+.||.|...|. +++.|++..+..++.+|+.||.|||++|||||||||+||||| ..|+|+|+||
T Consensus 97 ~~--kLylVld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd----~~GHi~LtDF 169 (357)
T KOG0598|consen 97 EE--KLYLVLDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD----EQGHIKLTDF 169 (357)
T ss_pred CC--eEEEEEeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec----CCCcEEEecc
Confidence 65 8999999999999999984 557899999999999999999999999999999999999999 8999999999
Q ss_pred cccccc-cCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1119 GLSRIK-RNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1119 GLAr~~-~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
|+|+.. .....+.++|||+.|||||++.+.+ |+..+||||||++||||++|.+||...+....+..+....+ ...+
T Consensus 170 gL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g--y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-~~~p 246 (357)
T KOG0598|consen 170 GLCKEDLKDGDATRTFCGTPEYMAPEILLGKG--YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-PLPP 246 (357)
T ss_pred ccchhcccCCCccccccCCccccChHHHhcCC--CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-CCCC
Confidence 999854 3445566789999999999999874 88999999999999999999999999999999999988763 3456
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCC----CHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARP----SFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRP----SArELLe~ 1228 (1254)
..++.+.++|++++|++||++|. ++.+|.+|
T Consensus 247 ~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 247 GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 66899999999999999999995 55555443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=416.68 Aligned_cols=249 Identities=29% Similarity=0.469 Sum_probs=226.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|...+.||+|+|++||.+++ +|..||+|++.+..+. .....+++.+|++|.++|+|||||+++++|+|.+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~-----k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~- 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK-----KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN- 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc-----CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-
Confidence 4699999999999999999987 5888999999886554 3345678899999999999999999999998877
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+|||+|+|..++|.++++ +.+.+++..++.+++||+.||.|||+++|||||||..||||+ ++.+|||+|||||
T Consensus 92 -nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~----~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 92 -NVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN----ENMNVKIGDFGLA 165 (592)
T ss_pred -ceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec----CcCcEEeccccee
Confidence 8999999999999999886 667899999999999999999999999999999999999999 8889999999999
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
...... ....+.|||+.|.|||++.... .++.+||||+||+||-||.|++||......+.+..+....+. +|..+
T Consensus 166 t~le~~~Erk~TlCGTPNYIAPEVl~k~g--HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~--~P~~l 241 (592)
T KOG0575|consen 166 TQLEYDGERKKTLCGTPNYIAPEVLNKSG--HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS--MPSHL 241 (592)
T ss_pred eeecCcccccceecCCCcccChhHhccCC--CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc--ccccc
Confidence 876644 5667799999999999999664 788999999999999999999999999999999999887664 56789
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+.++++||.++|+.+|.+|||+.+||.+
T Consensus 242 s~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 242 SAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999999999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=387.90 Aligned_cols=254 Identities=28% Similarity=0.497 Sum_probs=219.3
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|.+.++||+|+|++||+|+++ +..||||.+.+..+ ..+..+-+..|+.+|+.++|||||.+++++.+++
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~- 82 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL------NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD- 82 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-
Confidence 37889999999999999999984 67899999986543 2345666789999999999999999999998776
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCC--CeEEEEecc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQR--PICKVGDFG 1119 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~sn--G~VKLiDFG 1119 (1254)
.+|+|||||.||+|.++|++++ .+++..++.++.||+.||++||+++||||||||+||||+...... ..+||+|||
T Consensus 83 -~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 83 -FIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred -eEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 9999999999999999997664 699999999999999999999999999999999999998542233 789999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-CCCCCC
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL-RPTIPE 1198 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L-rp~ipe 1198 (1254)
+|+...+.....+.||++.|||||+++.+ +|+-|+|+||+|+|||+|++|+.||......+++..+.++.. .+..+.
T Consensus 161 fAR~L~~~~~a~tlcGSplYMAPEV~~~~--~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~ 238 (429)
T KOG0595|consen 161 FARFLQPGSMAETLCGSPLYMAPEVIMSQ--QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPA 238 (429)
T ss_pred hhhhCCchhHHHHhhCCccccCHHHHHhc--cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhh
Confidence 99999888888889999999999999855 589999999999999999999999999988888876655433 344556
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++....+++...|++++..|-++.+-+.+
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 667777899999999999998877665443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=365.26 Aligned_cols=262 Identities=30% Similarity=0.527 Sum_probs=211.6
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVA 1031 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVk 1031 (1254)
.+...+|++.++||+|+||.||+|.+. ++.||||+++... .......+.+|+.+|+++ +||||++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv~ 75 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-------TASEHKALMSELKILIHIGNHLNVVN 75 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-------chHHHHHHHHHHHHHHHhccCcceee
Confidence 455568999999999999999999752 3569999987431 122345688999999999 8999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccC-----------------------------------------------
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD----------------------------------------------- 1064 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre----------------------------------------------- 1064 (1254)
+++++.... ..+++||||+.+|+|.+++....
T Consensus 76 ~~~~~~~~~-~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (338)
T cd05102 76 LLGACTKPN-GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTS 154 (338)
T ss_pred EEeEecCCC-CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccC
Confidence 999886543 46889999999999999885421
Q ss_pred --------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCc---
Q 040257 1065 --------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT--- 1127 (1254)
Q Consensus 1065 --------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s--- 1127 (1254)
..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++.....
T Consensus 155 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~----~~~~~kl~DfG~a~~~~~~~~~ 230 (338)
T cd05102 155 GSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDY 230 (338)
T ss_pred cccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc----CCCcEEEeecccccccccCcch
Confidence 2477888899999999999999999999999999999998 6789999999999754221
Q ss_pred cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHH
Q 040257 1128 LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRK 1206 (1254)
Q Consensus 1128 ~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrd 1206 (1254)
.......++..|+|||++.+.. ++.++|||||||+||||++ |..||.....................+..+++.+.+
T Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 308 (338)
T cd05102 231 VRKGSARLPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYR 308 (338)
T ss_pred hcccCCCCCccccCcHHhhcCC--CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 1122334667899999997653 7899999999999999997 999998765544443333333344556778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1207 LMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1207 LIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
|+.+||+.||.+||++.++++.|+.++.+
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=397.28 Aligned_cols=245 Identities=26% Similarity=0.426 Sum_probs=217.0
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVP 1037 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~ 1037 (1254)
+.-.+|.++++||+|+||+|+++..+ ++.||||++++..+..++. .+....|.+|+... +||+++.++.+|+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~-----Ve~~~~EkrI~~la~~HPFL~~L~~~fQ 439 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE-----VESLMCEKRIFELANRHPFLVNLFSCFQ 439 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc-----HHHHHHHHHHHHHhccCCeEeecccccc
Confidence 44458999999999999999999985 5679999999988776543 45566788888776 5999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
..+ ++|+||||+.||++..++ +.+.|++..+..|+.+|+.||.|||++||||||||.+||||| ..|++||+|
T Consensus 440 T~~--~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD----~eGh~kiAD 511 (694)
T KOG0694|consen 440 TKE--HLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD----TEGHVKIAD 511 (694)
T ss_pred cCC--eEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc----ccCcEEecc
Confidence 665 999999999999965554 446799999999999999999999999999999999999999 889999999
Q ss_pred cccccccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1118 FGLSRIKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1118 FGLAr~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
||+++... ....+.++|||+.|||||++.++. |+.++|||||||+|||||.|+.||.+.+.+++...|+... +.+
T Consensus 512 FGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~--Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~--~~y 587 (694)
T KOG0694|consen 512 FGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS--YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE--VRY 587 (694)
T ss_pred cccccccCCCCCccccccCChhhcChhhhccCc--ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCC
Confidence 99998644 444677899999999999999875 8999999999999999999999999999999999998764 468
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSF 1222 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSA 1222 (1254)
|..++.+..+|++++|.++|++|..+
T Consensus 588 P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 588 PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCcccHHHHHHHHHHhccCcccccCC
Confidence 99999999999999999999999744
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=391.81 Aligned_cols=252 Identities=29% Similarity=0.435 Sum_probs=222.2
Q ss_pred cccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeec
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPD 1038 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~D 1038 (1254)
...||..++.||+|+|++|++|+. .++.||||++.+..+.. +...+-+.+|..+|.+| .||.|++||-.|+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-----e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD 145 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-----EKKVKYVTREKEALTQLSGHPGIVKLYFTFQD 145 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-----hcccchhhHHHHHHHHhhCCCCeEEEEEEeec
Confidence 345899999999999999999987 47789999998775542 22345567899999999 89999999999998
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
+. .+|+|+||+++|+|.++|.+. +.|++...+.++.+|+.||+|||++|||||||||+||||+ .++++||+||
T Consensus 146 ~~--sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd----~dmhikITDF 218 (604)
T KOG0592|consen 146 EE--SLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD----KDGHIKITDF 218 (604)
T ss_pred cc--ceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc----CCCcEEEeec
Confidence 77 899999999999999999665 6799999999999999999999999999999999999999 8999999999
Q ss_pred cccccccCcc------------c--cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 040257 1119 GLSRIKRNTL------------V--SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAII 1184 (1254)
Q Consensus 1119 GLAr~~~~s~------------~--sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eli 1184 (1254)
|.|+...... . ...+.||..|.+||++.... .+..+|||+||||||+|+.|++||...+..-..
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~--~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF 296 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP--AGPSSDLWALGCILYQMLAGQPPFRAANEYLIF 296 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC--CCcccchHHHHHHHHHHhcCCCCCccccHHHHH
Confidence 9998643211 1 14588999999999999764 778899999999999999999999999999999
Q ss_pred HHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1185 GGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1185 qsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
+.|+...+ .++..+++.+++||+++|..||.+|+++.||.+|.
T Consensus 297 qkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 297 QKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 99987655 57888999999999999999999999999998874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=355.56 Aligned_cols=263 Identities=24% Similarity=0.357 Sum_probs=221.8
Q ss_pred cccccCceEE--EEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEEL--RELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiL--kkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.+...+++.. ..||+|+++.||+|+++++.||||+++... .......+.+.+|+.+|++++||||+++++++.
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 88 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFH-----KGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccc-----cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence 3333444444 679999999999999999999999987542 123344577889999999999999999999987
Q ss_pred c--CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCCCCCeEE
Q 040257 1038 D--GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1038 D--dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
+ +....+++||||+.+|+|.+++.+. +.+++...+.++.+++.||.|||+ .+++||||||+|||++ .++.+|
T Consensus 89 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~----~~~~~k 163 (283)
T PHA02988 89 DIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT----ENYKLK 163 (283)
T ss_pred ecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC----CCCcEE
Confidence 6 4445789999999999999998654 568999999999999999999998 4999999999999998 778999
Q ss_pred EEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC
Q 040257 1115 VGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
|+|||+++...... ....++..|+|||++.+....++.++|||||||++|||++|+.||......+....+.....++
T Consensus 164 l~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~ 241 (283)
T PHA02988 164 IICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL 241 (283)
T ss_pred EcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99999987543322 2345889999999998643458999999999999999999999999888777777776666666
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
..+..+++.+++|+.+||+.||++|||+.++++.|+.+..
T Consensus 242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 6776789999999999999999999999999999998753
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=389.80 Aligned_cols=263 Identities=38% Similarity=0.654 Sum_probs=230.7
Q ss_pred cccccccccCceEEEEEeeeCcEEEEEEEECCc-eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 956 YGLQIIKNVDLEELRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 956 ~glq~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs-~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
...+.+....+..++.||+|.||.||+|.|+++ .||+|.++...+. .+.|.+|+++|++|+|++||++++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---------~~~f~~Ea~iMk~L~H~~lV~l~g 268 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---------PEAFLREAQIMKKLRHEKLVKLYG 268 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---------hhHHHHHHHHHHhCcccCeEEEEE
Confidence 344566777788889999999999999999877 8999999865322 367889999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhc-cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLK-KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~k-re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
+|..+. .++||||||..|+|.+++.. ....+...+.+.++.|||+|++||+++++|||||-..||||+ ++..|
T Consensus 269 V~~~~~--piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~----~~~~v 342 (468)
T KOG0197|consen 269 VCTKQE--PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD----EDLVV 342 (468)
T ss_pred EEecCC--ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec----cCceE
Confidence 998755 79999999999999999976 456799999999999999999999999999999999999999 78899
Q ss_pred EEEeccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhc
Q 040257 1114 KVGDFGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKN 1190 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~ 1190 (1254)
||+|||||+...+.. ..........|.|||.+... +++.|||||||||+||||+| |+.||..+...+++..+..
T Consensus 343 KIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~--~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~- 419 (468)
T KOG0197|consen 343 KISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYG--KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER- 419 (468)
T ss_pred EEcccccccccCCCceeecCCCCCCceecCHHHHhhC--CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc-
Confidence 999999999644332 33344456779999999855 59999999999999999999 9999999999999887765
Q ss_pred cCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1191 ~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
.++...|..||.++.+++..||+.+|++|||++.+...|+++....
T Consensus 420 GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 420 GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 4677789999999999999999999999999999999999887643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=378.65 Aligned_cols=254 Identities=31% Similarity=0.467 Sum_probs=221.0
Q ss_pred cccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeec
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPD 1038 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~D 1038 (1254)
....|.+.+.||+|+||+|++|.+ ++..||+|++.+....... ....+.+.+|+.++++++ ||||++++.++..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 345799999999999999999988 4788999977764222111 123455668999999999 9999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCC-CeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQR-PICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~sn-G~VKLiD 1117 (1254)
.+ .+++||||+.+|+|.+++.. .+++.+..+..++.||+.||+|||++||+||||||+|||++ .+ +++||+|
T Consensus 92 ~~--~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld----~~~~~~Kl~D 164 (370)
T KOG0583|consen 92 PT--KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD----GNEGNLKLSD 164 (370)
T ss_pred CC--eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec----CCCCCEEEec
Confidence 66 69999999999999999977 67799999999999999999999999999999999999999 55 8999999
Q ss_pred ccccccc-cCccccCCCCCCCCccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1118 FGLSRIK-RNTLVSGGVRGTLPWMAPELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1118 FGLAr~~-~~s~~sts~~GT~~YmAPEVLrG~~-~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
||++... .......+.|||+.|+|||++.+.. |. ..++||||+|++||.|++|+.||...+...+...+....+ .
T Consensus 165 FG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~-g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~--~ 241 (370)
T KOG0583|consen 165 FGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYS-GKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF--K 241 (370)
T ss_pred cccccccCCCCCcccCCCCCcccCCHHHhCCCCCcC-CchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc--c
Confidence 9999877 4555677899999999999999875 32 6889999999999999999999999888888888776654 4
Q ss_pred CCCCC-cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1196 IPERC-DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1196 ipe~i-S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+|..+ +++++.|+.+||..+|.+|+++.+++++
T Consensus 242 ~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 242 IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 67777 9999999999999999999999999944
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=376.10 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=219.4
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|+++++||+|+||+||++.. ++..+|.|.++...+ +...++++..|+.+|++|+|||||++|++-..++..
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m------d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM------DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc------cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 688999999999999999876 688899999984422 345577889999999999999999999943333444
Q ss_pred ceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhh--CC--cccccCCCCceEeccCCCCCCeEEE
Q 040257 1043 TLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHS--KN--IVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHS--kG--IIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
.++||||||.+|+|..+|+. ..+.+++..+|+++.|++.||.++|. .. |+||||||.||+|+ .+|.|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~----~~gvvKL 169 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT----ANGVVKL 169 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc----CCCceee
Confidence 69999999999999998843 34669999999999999999999999 45 99999999999999 8899999
Q ss_pred EeccccccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC
Q 040257 1116 GDFGLSRIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1116 iDFGLAr~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
+|||+++..... .....+.|||.||+||++.+.+ |++++|||||||++|||+.-++||.+.+..++..+|..+.+.+
T Consensus 170 GDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~--Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 170 GDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESG--YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP 247 (375)
T ss_pred ccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCC--CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC
Confidence 999999976554 3456678999999999999775 8999999999999999999999999999999999998887654
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
.....++.+++.||..|+..||+.||+.-.++..++.
T Consensus 248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 3337789999999999999999999986555555443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=362.43 Aligned_cols=241 Identities=27% Similarity=0.453 Sum_probs=217.2
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
..-.+|+.++.||.|+||+|.+++.+ +..||+|++.+..+. ..+..+...+|..+|+.+.||+++++++.|.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV-----klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV-----KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHH-----HHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 34458999999999999999999884 778999999876432 34556778899999999999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. .+++||||++||.|..++++ .++|++..++.++.||+.||+|||+++||+|||||+||||| .+|++||+||
T Consensus 116 ~~--~lymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD----~~G~iKitDF 188 (355)
T KOG0616|consen 116 NS--NLYMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD----QNGHIKITDF 188 (355)
T ss_pred CC--eEEEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec----cCCcEEEEec
Confidence 66 89999999999999999854 46799999999999999999999999999999999999999 8999999999
Q ss_pred cccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCC
Q 040257 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1119 GLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe 1198 (1254)
|.|+..... +.+.|||+.|+|||+++..+ |..++|||||||++|||+.|.+||...+....+.+|+...+. +|.
T Consensus 189 GFAK~v~~r--T~TlCGTPeYLAPEii~sk~--ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~--fP~ 262 (355)
T KOG0616|consen 189 GFAKRVSGR--TWTLCGTPEYLAPEIIQSKG--YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK--FPS 262 (355)
T ss_pred cceEEecCc--EEEecCCccccChHHhhcCC--CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc--CCc
Confidence 999876554 45689999999999999876 788899999999999999999999999999999999988764 688
Q ss_pred CCcHHHHHHHHHhhhcCCCCC
Q 040257 1199 RCDPEWRKLMEQCWAADPEAR 1219 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKR 1219 (1254)
-++.++++||+++|+.|-.+|
T Consensus 263 ~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 263 YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccCHHHHHHHHHHHhhhhHhh
Confidence 899999999999999999999
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=380.72 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=217.1
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.+...+|+++++||+|+||.||+|+- +|..||+|++++..+.. ....+.+..|-.+|....+|+||+||-.|+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~-----~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK-----KNQVEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh-----hhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 45567999999999999999999987 57789999999876543 334567788999999999999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. .+|+||||++||++..+|.+ .+.+++..+..++.+++.||.-||+.|||||||||+|+||| ..||+||+|
T Consensus 212 D~~--~LYLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD----~~GHiKLSD 284 (550)
T KOG0605|consen 212 DKE--YLYLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID----AKGHIKLSD 284 (550)
T ss_pred CCC--eeEEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec----CCCCEeecc
Confidence 876 99999999999999999854 46799999999999999999999999999999999999999 899999999
Q ss_pred ccccccccC-----------------------cc-------------------------ccCCCCCCCCccCcccccCCC
Q 040257 1118 FGLSRIKRN-----------------------TL-------------------------VSGGVRGTLPWMAPELLNGSS 1149 (1254)
Q Consensus 1118 FGLAr~~~~-----------------------s~-------------------------~sts~~GT~~YmAPEVLrG~~ 1149 (1254)
||||..... .. ......|||.|||||++.+..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 999852100 00 011246999999999999885
Q ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc--CCCCCCCCCcHHHHHHHHHhhhcCCCCCC---CHHH
Q 040257 1150 NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT--LRPTIPERCDPEWRKLMEQCWAADPEARP---SFTE 1224 (1254)
Q Consensus 1150 ~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~--Lrp~ipe~iS~eLrdLIkKCLqkDPeKRP---SArE 1224 (1254)
|+..+|||||||||||||.|.+||......+....++... +..+-...++.++++||.+||+ ||++|. ++.|
T Consensus 365 --Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 365 --YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred --CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 8889999999999999999999999999999999998765 4444445678999999999999 999997 4666
Q ss_pred HHHH
Q 040257 1225 ITSR 1228 (1254)
Q Consensus 1225 LLe~ 1228 (1254)
|.+|
T Consensus 442 IK~H 445 (550)
T KOG0605|consen 442 IKKH 445 (550)
T ss_pred HhcC
Confidence 6544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=371.02 Aligned_cols=256 Identities=28% Similarity=0.475 Sum_probs=214.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|...+.||+|+||+||++... +..+|||.+.... . . ..+.+.+|+.+|++|+|||||+++|.......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~----~---~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED----S---P-TSESLEREIRILSRLNHPNIVQYYGSSSSREN 88 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc----c---h-hHHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence 35778889999999999999985 5889999987541 0 1 15678899999999999999999997433321
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCC-CCeEEEEeccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQ-RPICKVGDFGL 1120 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~s-nG~VKLiDFGL 1120 (1254)
..+++.|||+.+|+|.+++.+.++.+++..++.+.+||++||+|||++|||||||||+||||+ . ++.+||+|||+
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~----~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD----PSNGDVKLADFGL 164 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe----CCCCeEEeccCcc
Confidence 368999999999999999977655799999999999999999999999999999999999998 5 68999999999
Q ss_pred cccccC----ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChhhHHHHhhhccCCCC
Q 040257 1121 SRIKRN----TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD-MHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1121 Ar~~~~----s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~-~n~~eliqsIlk~~Lrp~ 1195 (1254)
++.... ......+.||+.|||||++... .....++|||||||++.||+||+.||.. ......+..+......+.
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ 243 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPE 243 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCC
Confidence 986553 2233457799999999999952 1233589999999999999999999998 455555555555556678
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
+|..++.+.++||.+|++++|++|||+.++|++...-
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 8999999999999999999999999999999987643
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=385.84 Aligned_cols=257 Identities=35% Similarity=0.625 Sum_probs=227.3
Q ss_pred hcccccccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 955 IYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 955 ~~glq~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
...+|.|....+..++.||.|+.|.||+|++.++.||||+++.. -..+|+-|++|+|+||+.+.|
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------------kETdIKHLRkLkH~NII~FkG 179 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------------KETDIKHLRKLKHPNIITFKG 179 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------------hhhhHHHHHhccCcceeeEee
Confidence 33455666667778899999999999999999999999987632 124788899999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
+|.... .+|||||||..|-|..+++ .++.+.......|..+|+.|+.|||.+.|||||||.-||||. .+..||
T Consensus 180 VCtqsP--cyCIiMEfCa~GqL~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs----~~d~VK 252 (904)
T KOG4721|consen 180 VCTQSP--CYCIIMEFCAQGQLYEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS----YDDVVK 252 (904)
T ss_pred eecCCc--eeEEeeeccccccHHHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee----ccceEE
Confidence 997655 8999999999999999995 456789999999999999999999999999999999999999 667899
Q ss_pred EEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC
Q 040257 1115 VGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
|+|||-++........-.|+||..|||||+|+.++ .+.|+|||||||||||||||..||.+.+...++..+-.+.+..
T Consensus 253 IsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrneP--csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~L 330 (904)
T KOG4721|consen 253 ISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEP--CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHL 330 (904)
T ss_pred eccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCC--cccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccc
Confidence 99999998766655566789999999999999886 8999999999999999999999999988877777777777778
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
..|..++..|+-||+.||+..|.+||++++++.||+....+
T Consensus 331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 88999999999999999999999999999999999765443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.84 Aligned_cols=262 Identities=21% Similarity=0.343 Sum_probs=209.7
Q ss_pred ceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
|+..+.||+|+||+||++.+ +++.||+|++.+.... .......+.+|+.++++++|+||+++++++.+.. .
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~--~ 74 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD--A 74 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-----hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--e
Confidence 77889999999999999987 4788999998754321 1122345778999999999999999999987665 7
Q ss_pred eEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
+++||||+.+|+|...+... ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++.
T Consensus 75 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~----~~~~~kl~Dfg~~~ 150 (285)
T cd05631 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD----DRGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeCCCcE
Confidence 99999999999998877543 34689999999999999999999999999999999999998 77889999999997
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh--ccCCCCCCCCC
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK--NTLRPTIPERC 1200 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk--~~Lrp~ipe~i 1200 (1254)
............||..|+|||++.+. .++.++|||||||+||+|++|+.||...........+.. ......++..+
T Consensus 151 ~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd05631 151 QIPEGETVRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKF 228 (285)
T ss_pred EcCCCCeecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccC
Confidence 65443333455799999999999866 478899999999999999999999987554322222211 11223456678
Q ss_pred cHHHHHHHHHhhhcCCCCCCC-----HHHHHHH--HHHH-HHHHhhcc
Q 040257 1201 DPEWRKLMEQCWAADPEARPS-----FTEITSR--LRTI-SAAIESKC 1240 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPS-----ArELLe~--Le~L-l~eLEsk~ 1240 (1254)
+.++.+||++||+.||.+||+ +.+++++ ++.+ ...++.+.
T Consensus 229 s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~ 276 (285)
T cd05631 229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANM 276 (285)
T ss_pred CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCc
Confidence 999999999999999999997 8999985 3333 33344443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=350.66 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=211.1
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||++.+. ++.||||++..... ......+.+.+|+.++++++||||+++++++.+..
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 74 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-----IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR-- 74 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-----hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC--
Confidence 6889999999999999999985 78899999975321 11223456889999999999999999999987655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~----~~~~~kl~Dfg~~~ 149 (291)
T cd05612 75 FLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD----KEGHIKLTDFGFAK 149 (291)
T ss_pred eEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEEecCcch
Confidence 899999999999999998554 5689999999999999999999999999999999999998 77899999999987
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcH
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDP 1202 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~ 1202 (1254)
..... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+..... .++..++.
T Consensus 150 ~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~ 223 (291)
T cd05612 150 KLRDR--TWTLCGTPEYLAPEVIQSKG--HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL--EFPRHLDL 223 (291)
T ss_pred hccCC--cccccCChhhcCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc--CCCccCCH
Confidence 65432 22356999999999998764 78899999999999999999999998877777777665543 45667789
Q ss_pred HHHHHHHHhhhcCCCCCCC-----HHHHHHHH
Q 040257 1203 EWRKLMEQCWAADPEARPS-----FTEITSRL 1229 (1254)
Q Consensus 1203 eLrdLIkKCLqkDPeKRPS-----ArELLe~L 1229 (1254)
.+++||++||+.||.+||+ +.+++++-
T Consensus 224 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 224 YAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred HHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 9999999999999999995 89988773
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.55 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=212.2
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|++.+.||+|+||+||+|+++ ++.||||++++.... .....+.+.+|+.++++++||||+++++++.++.
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-----KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence 357999999999999999999984 678999999754211 1233467889999999999999999999998765
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 92 --~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kl~Dfg~ 164 (329)
T PTZ00263 92 --RVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD----NKGHVKVTDFGF 164 (329)
T ss_pred --EEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC----CCCCEEEeeccC
Confidence 899999999999999988654 5689999999999999999999999999999999999998 778999999999
Q ss_pred cccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1121 SRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1121 Ar~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
++...... ...+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.... ..++..+
T Consensus 165 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~p~~~ 238 (329)
T PTZ00263 165 AKKVPDRT--FTLCGTPEYLAPEVIQSKG--HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPNWF 238 (329)
T ss_pred ceEcCCCc--ceecCChhhcCHHHHcCCC--CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--cCCCCCC
Confidence 97654332 2357999999999998764 7889999999999999999999998877777666666543 3456778
Q ss_pred cHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPS-----FTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPS-----ArELLe~ 1228 (1254)
+..+++||++||+.||.+|++ +++++++
T Consensus 239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 999999999999999999986 7888866
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=355.97 Aligned_cols=243 Identities=26% Similarity=0.395 Sum_probs=205.5
Q ss_pred EEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEE
Q 040257 970 RELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATV 1047 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LV 1047 (1254)
+.||+|+||+||++++ .++.||||++++.... .......+.+|+.++++++||||+++++++.... .+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv 73 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-----AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD--RLCFV 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC--EEEEE
Confidence 3699999999999987 4778999999864221 2233456788999999999999999999997655 89999
Q ss_pred EEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccC-
Q 040257 1048 TEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN- 1126 (1254)
Q Consensus 1048 MEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~- 1126 (1254)
|||+.+++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 74 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~----~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 74 MEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD----KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEeeCCCCcccccC
Confidence 999999999988854 45789999999999999999999999999999999999998 778999999999875322
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHH
Q 040257 1127 TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRK 1206 (1254)
Q Consensus 1127 s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrd 1206 (1254)
.......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+.... ..++..++.++.+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~ 224 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAKS 224 (323)
T ss_pred CCcccceecCccccChhhhcCCC--CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHH
Confidence 22234467999999999998664 7899999999999999999999998877776666665443 3456778999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1207 LMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1207 LIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
||++||++||++|| ++.+++++
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 225 LLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 99999999999999 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=338.19 Aligned_cols=256 Identities=31% Similarity=0.575 Sum_probs=213.3
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC-----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR-----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGV 1035 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r-----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGv 1035 (1254)
+.+.+|++.+.||+|+||.||+|.+. +..||+|.++... .......+.+|+.++++++||||++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-------SDKQRRGFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 44567999999999999999999763 4579999987542 12234678899999999999999999999
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
+.... .+++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||
T Consensus 75 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~----~~~~~~l 148 (266)
T cd05064 75 ITRGN--TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN----SDLVCKI 148 (266)
T ss_pred EecCC--CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc----CCCcEEE
Confidence 97654 79999999999999999876666789999999999999999999999999999999999998 7789999
Q ss_pred EeccccccccCcccc--CCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccC
Q 040257 1116 GDFGLSRIKRNTLVS--GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1116 iDFGLAr~~~~s~~s--ts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~L 1192 (1254)
+|||.+......... ....++..|+|||.+.+. .++.++|||||||++|||++ |..||........+..+... .
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~ 225 (266)
T cd05064 149 SGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-F 225 (266)
T ss_pred CCCcccccccccchhcccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-C
Confidence 999987643222111 122356789999999865 48899999999999999875 99999988777666665443 3
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
....+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 3446777899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=352.13 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=208.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||.||+|++. ++.||||++++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-- 74 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-----KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE-- 74 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC--
Confidence 6899999999999999999984 678999999864221 1223466888999999999999999999998665
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kL~Dfg~a~ 149 (333)
T cd05600 75 YLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID----ASGHIKLTDFGLSK 149 (333)
T ss_pred EEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEEEeCcCCc
Confidence 89999999999999999854 35689999999999999999999999999999999999998 77899999999997
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC-----
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP----- 1197 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip----- 1197 (1254)
.... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||......+....+.........+
T Consensus 150 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 225 (333)
T cd05600 150 GIVT--YANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDP 225 (333)
T ss_pred cccc--ccCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCcc
Confidence 5543 23446799999999999876 48899999999999999999999998877766655554322111111
Q ss_pred -CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 -ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 -e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..++.++.+||.+||..+|.+||++++++++
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 2458899999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=377.79 Aligned_cols=252 Identities=29% Similarity=0.371 Sum_probs=215.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn 1040 (1254)
.+|.++++||.|+||.||+|+. ++..||||++++.... .++.. -+||++.|++|+ ||||++|.+++.+..
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-----~ee~~--nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-----WEECM--NLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-----HHHHH--HHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 4789999999999999999987 4778999999876422 22221 368999999998 999999999998876
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
. .++|||||| ..+|.++++.+++.|++..++.|+.||++||+|+|.+|+.||||||+|||+. ....|||+|||+
T Consensus 83 ~-~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~----~~~~iKiaDFGL 156 (538)
T KOG0661|consen 83 R-ILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS----GNDVIKIADFGL 156 (538)
T ss_pred c-eEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec----ccceeEeccccc
Confidence 5 899999999 7799999999999999999999999999999999999999999999999998 678999999999
Q ss_pred cccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC-------
Q 040257 1121 SRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR------- 1193 (1254)
Q Consensus 1121 Ar~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr------- 1193 (1254)
||........+.+..|.+|+|||++.... .|+.++||||+|||++|+.+-++.|.+.+.-+.+.+++.-.-.
T Consensus 157 ARev~SkpPYTeYVSTRWYRAPEvLLrs~-~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 157 AREVRSKPPYTEYVSTRWYRAPEVLLRSG-YYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred ccccccCCCcchhhhcccccchHHhhhcc-ccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 99888777777788999999999998654 5899999999999999999999999988876666555421000
Q ss_pred ----------CC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1194 ----------PT-----------IPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1194 ----------p~-----------ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
.. +...++.++.++|.+||+|||.+|||+.|.|++-
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 00 1123678899999999999999999999999874
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=354.21 Aligned_cols=249 Identities=26% Similarity=0.436 Sum_probs=210.5
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||+|++. ++.||||++++.... .......+.+|+.++..++|+||+++++++.+..
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 74 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-----KRNQIAHVRAERDILADADSPWIVKLYYSFQDEE-- 74 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-----hccHHHHHHHHHHHHHhcCCCCccchhhheecCC--
Confidence 6899999999999999999985 788999999864321 1123456788999999999999999999998665
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~----~~~~~kL~Dfg~~~ 149 (350)
T cd05573 75 HLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID----ADGHIKLADFGLCK 149 (350)
T ss_pred eEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEeecCCCCc
Confidence 899999999999999998655 6799999999999999999999999999999999999998 77899999999987
Q ss_pred cccCcc------------------------------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCC
Q 040257 1123 IKRNTL------------------------------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172 (1254)
Q Consensus 1123 ~~~~s~------------------------------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk 1172 (1254)
...... ......||+.|+|||++.+. .++.++|||||||+||||++|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCC
Confidence 543322 22345699999999999876 4889999999999999999999
Q ss_pred CCCCCCChhhHHHHhhh--ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 040257 1173 EPYADMHCGAIIGGIVK--NTLRPTIPERCDPEWRKLMEQCWAADPEARPS-FTEITSR 1228 (1254)
Q Consensus 1173 ~PF~~~n~~eliqsIlk--~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPS-ArELLe~ 1228 (1254)
.||...........+.. ..+.......+++++.+||.+||. +|.+||+ +.+++++
T Consensus 228 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 228 PPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 99998877666666655 222222233469999999999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=382.53 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=226.5
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
-|++++.||.|+.|.|.+|++ +|+.+|||++.+..-. .......+.+|+-||+.|.|||++++|++|....
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-----s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~-- 85 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-----SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ-- 85 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeecccccc-----ccccccchhhhhHHHHHhcCCCeeeeeeeeccCc--
Confidence 488899999999999999998 6899999999865311 2233456788999999999999999999997655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+|+|+||+++|.|.+++.++ +++++..+.++++||+.|+.|+|..+|+||||||+|+||+ ..+++||+|||+|.
T Consensus 86 ~lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd----~~~nIKIADFGMAs 160 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD----VKNNIKIADFGMAS 160 (786)
T ss_pred eEEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh----cccCEeeeccceee
Confidence 899999999999999999766 5699999999999999999999999999999999999999 66679999999999
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcH
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDP 1202 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~ 1202 (1254)
...+.....+.||++.|.|||+++|.+|. +.++||||.|||||.||||+.||++.+...++.++..+.+ .+|..++.
T Consensus 161 Le~~gklLeTSCGSPHYA~PEIV~G~pYd-G~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--~MPs~Is~ 237 (786)
T KOG0588|consen 161 LEVPGKLLETSCGSPHYAAPEIVSGRPYD-GRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--EMPSNISS 237 (786)
T ss_pred cccCCccccccCCCcccCCchhhcCCCCC-CCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--cCCCcCCH
Confidence 88888888889999999999999999865 7899999999999999999999999988888888888765 47799999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1203 EWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1203 eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
++++||.+||..||++|.|++||++|--
T Consensus 238 eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 238 EAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HHHHHHHHHhccCccccccHHHHhhCch
Confidence 9999999999999999999999999853
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=360.21 Aligned_cols=250 Identities=26% Similarity=0.361 Sum_probs=206.3
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|+.+.++|+|+||+||+|+++ |+.||||++... +++....+-.+||+++|++|+|+|+|.|+.+|... .
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es------edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk--r 74 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES------EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK--R 74 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccC------CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc--c
Confidence 5788899999999999999984 778999999754 33456677789999999999999999999999754 4
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++|+|||.. ++.+-+......++...+..++.|++.|+.|+|++++|||||||+||||+ .++.+||||||+|+
T Consensus 75 klhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit----~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 75 KLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT----QNGVVKLCDFGFAR 149 (396)
T ss_pred eeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe----cCCcEEeccchhhH
Confidence 89999999955 45555656666799999999999999999999999999999999999999 88999999999999
Q ss_pred ccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc--cCC------
Q 040257 1123 IKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN--TLR------ 1193 (1254)
Q Consensus 1123 ~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~--~Lr------ 1193 (1254)
... .....+.+..|.+|+|||.+.|.. .|+..+||||+||++.||++|.+.|.+...-+.+..|... .+.
T Consensus 150 ~L~~pgd~YTDYVATRWYRaPELLvGDt-qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 150 TLSAPGDNYTDYVATRWYRAPELLVGDT-QYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred hhcCCcchhhhhhhhhhccChhhhcccC-cCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence 766 444455677899999999999854 5899999999999999999999999987654444333211 110
Q ss_pred -----------CCCC----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 -----------PTIP----------ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 -----------p~ip----------e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+.+ ..++..+.+|+++||+.||.+|++.+|++.+
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0000 1245568899999999999999999999854
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=373.40 Aligned_cols=264 Identities=34% Similarity=0.572 Sum_probs=224.0
Q ss_pred cccccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 958 lq~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.|.|..+++.++..||+|+||+||+|+|-| +||||+++.... ..+..+.|.+|+.+|++-+|.||+-+.|+|.
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~p------t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDP------TPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCC------CHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 356667788889999999999999999986 699999986532 2336789999999999999999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
.+. +.||..||+|.+|+.+++-.+.+|.+...+.|+.||++|+.|||.++|||||||..||+|. +++.|||+|
T Consensus 459 ~p~---~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~----~~~kVkIgD 531 (678)
T KOG0193|consen 459 NPP---LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH----EDLKVKIGD 531 (678)
T ss_pred CCc---eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc----cCCcEEEec
Confidence 664 5899999999999999988888899999999999999999999999999999999999998 678999999
Q ss_pred ccccccccCc---cccCCCCCCCCccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC
Q 040257 1118 FGLSRIKRNT---LVSGGVRGTLPWMAPELLNGS-SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1118 FGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~-~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
||++...... .....-.|...|||||+++.+ ...|++.+||||||||+|||++|..||...+.+.++..+-.+-+.
T Consensus 532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~ 611 (678)
T KOG0193|consen 532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM 611 (678)
T ss_pred ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC
Confidence 9999754322 112233478889999999743 456999999999999999999999999966666666555555333
Q ss_pred CC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1194 PT---IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1194 p~---ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
+. ....++.++++|+..||+.++++||.+.+|+..|+.+..+
T Consensus 612 pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 612 PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 32 3456788999999999999999999999999999888765
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=341.59 Aligned_cols=251 Identities=26% Similarity=0.355 Sum_probs=202.0
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|+++++||+|+||+||+|.+. ++.||+|+++..... .....+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-------GAPCTAIREVSLLKNLKHANIVTLHDIIHTER 76 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-------CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 347999999999999999999874 678999998754211 11245678999999999999999999997654
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 77 --~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~DfG~ 149 (288)
T cd07871 77 --CLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN----EKGELKLADFGL 149 (288)
T ss_pred --eEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEECcCcc
Confidence 7999999996 589888866666689999999999999999999999999999999999998 778999999999
Q ss_pred cccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-------
Q 040257 1121 SRIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL------- 1192 (1254)
Q Consensus 1121 Ar~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L------- 1192 (1254)
++..... .......++..|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07871 150 ARAKSVPTKTYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228 (288)
T ss_pred eeeccCCCccccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 8754322 122334689999999998754 2478999999999999999999999987665554433321100
Q ss_pred -------------CC--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 -------------RP--------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 -------------rp--------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+ .....++.++++||++||++||.+|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0112457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=340.08 Aligned_cols=254 Identities=32% Similarity=0.518 Sum_probs=203.5
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC------------------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhc
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR------------------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r------------------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkr 1023 (1254)
...+|++.++||+|+||.||+|.+. +..||+|++.... .......+.+|+.+|++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~ 75 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-------NKNARNDFLKEVKILSR 75 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-------CHHHHHHHHHHHHHHhh
Confidence 3458999999999999999999752 2359999887531 12335678899999999
Q ss_pred CCCCceeEEeeeeecCCCCceEEEEEecccCchhhhhhccC------------------CCCCHHHHHHHHHHhhhhhHH
Q 040257 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD------------------RSLDRRKKLIIAMDAAFGMEY 1085 (1254)
Q Consensus 1024 LnHPNIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre------------------~~LSe~~~lkIa~QIAeALaY 1085 (1254)
++||||+++++++.+.. ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|
T Consensus 76 l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 153 (304)
T cd05096 76 LKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKY 153 (304)
T ss_pred cCCCCeeEEEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 99999999999998765 7899999999999999875421 236778899999999999999
Q ss_pred hhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHH
Q 040257 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFG 1162 (1254)
Q Consensus 1086 LHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLG 1162 (1254)
||++||+||||||+|||++ .++.+||+|||+++..... .......++..|+|||++.+. .++.++||||||
T Consensus 154 lH~~~ivH~dlkp~Nill~----~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG 227 (304)
T cd05096 154 LSSLNFVHRDLATRNCLVG----ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFG 227 (304)
T ss_pred HHHCCccccCcchhheEEc----CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC--CCCchhhhHHHH
Confidence 9999999999999999998 7789999999998754222 112233457889999998765 388999999999
Q ss_pred HHHHHHHc--CCCCCCCCChhhHHHHhhhc------cCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1163 ISMWEILT--GEEPYADMHCGAIIGGIVKN------TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1163 VILYELLT--Gk~PF~~~n~~eliqsIlk~------~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
|++|||++ +..||........+..+... ......+..++..+.+|+.+||..+|.+|||+.+|.+.|+
T Consensus 228 ~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 228 VTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 99999986 67888876655554433211 1112234567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=353.98 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=205.0
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||++++. ++.||||++.+... ........+.+|+.++.+++|+||+++++++.+..
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~-- 74 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-----LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL-- 74 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--
Confidence 7899999999999999999884 67899999975421 12334466788999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+|+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++++||+|||+++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~----~~~~vkL~DFGla~ 149 (363)
T cd05628 75 NLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD----SKGHVKLSDFGLCT 149 (363)
T ss_pred eEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCCEEEeeccCcc
Confidence 899999999999999998654 5699999999999999999999999999999999999998 67899999999987
Q ss_pred cccCcc------------------------------------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHH
Q 040257 1123 IKRNTL------------------------------------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMW 1166 (1254)
Q Consensus 1123 ~~~~s~------------------------------------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILY 1166 (1254)
...... .....+||+.|+|||++.+.. ++.++|||||||+||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~~DvwSlGvil~ 227 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG--YNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC--CCCchhhhhhHHHHH
Confidence 432110 012357999999999998764 788999999999999
Q ss_pred HHHcCCCCCCCCChhhHHHHhhhccCCCCCC--CCCcHHHHHHHHHhhhcCCC---CCCCHHHHHHH
Q 040257 1167 EILTGEEPYADMHCGAIIGGIVKNTLRPTIP--ERCDPEWRKLMEQCWAADPE---ARPSFTEITSR 1228 (1254)
Q Consensus 1167 ELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip--e~iS~eLrdLIkKCLqkDPe---KRPSArELLe~ 1228 (1254)
||++|+.||......+....+........++ ..+++++++||.+|+. +|. .||++.||+++
T Consensus 228 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 228 EMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 9999999999887777776666432222233 2468899999999775 344 46899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=353.37 Aligned_cols=249 Identities=24% Similarity=0.415 Sum_probs=206.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||++++. ++.||||++++.... .......+.+|+.+|+.++||||+++++++.+..
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-- 74 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-----EKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN-- 74 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--
Confidence 7899999999999999999984 778999999854211 2233456788999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 75 ~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl~Dfg~~~ 149 (364)
T cd05599 75 YLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD----AKGHIKLSDFGLCT 149 (364)
T ss_pred eEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEeecccce
Confidence 899999999999999998654 4699999999999999999999999999999999999998 78899999999986
Q ss_pred cccCcc---------------------------------------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHH
Q 040257 1123 IKRNTL---------------------------------------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGI 1163 (1254)
Q Consensus 1123 ~~~~s~---------------------------------------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGV 1163 (1254)
...... .....+||+.|+|||++.+. .++.++|||||||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~ 227 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGV 227 (364)
T ss_pred eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchh
Confidence 432110 01124699999999999865 4789999999999
Q ss_pred HHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 040257 1164 SMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP--ERCDPEWRKLMEQCWAADPEARPS---FTEITSR 1228 (1254)
Q Consensus 1164 ILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip--e~iS~eLrdLIkKCLqkDPeKRPS---ArELLe~ 1228 (1254)
++|||++|..||...........+.........+ ..+++++++||.+||. +|.+|++ +.+++++
T Consensus 228 il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999999999999887766666665433222233 2468999999999997 8999997 9999885
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.01 Aligned_cols=252 Identities=35% Similarity=0.642 Sum_probs=210.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEECC-------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeee
Q 040257 964 VDLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~rG-------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf 1036 (1254)
.+|++++.||+|+||.||+|.+.+ ..||+|.++... .......+.+|+.++++++||||+++++++
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 77 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-------EPKVQQEFRQEAELMSDLQHPNIVCLLGVC 77 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-------CHHHHHHHHHHHHHHHhcCCcccceEEEEE
Confidence 478899999999999999998743 358999886431 233456788999999999999999999998
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCce
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENL 1101 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNI 1101 (1254)
.+.. ..+++|||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 78 ~~~~--~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni 155 (283)
T cd05048 78 TKEQ--PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNC 155 (283)
T ss_pred cCCC--ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceE
Confidence 7654 7899999999999999885431 4578899999999999999999999999999999999
Q ss_pred EeccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 040257 1102 LVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYAD 1177 (1254)
Q Consensus 1102 LLDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~ 1177 (1254)
|++ .++.+||+|||+++..... .......+++.|+|||.+.+. .++.++|||||||++|||++ |..||..
T Consensus 156 l~~----~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05048 156 LVG----EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYG 229 (283)
T ss_pred EEc----CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 998 6788999999998753221 122334567889999998765 47899999999999999998 9999998
Q ss_pred CChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1178 MHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1178 ~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
....+....+.... ....+..++.++.+|+.+||+.+|.+||++.+|+++|+.
T Consensus 230 ~~~~~~~~~i~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 230 FSNQEVIEMIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCHHHHHHHHHcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 87777766665443 345677889999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=341.29 Aligned_cols=250 Identities=28% Similarity=0.354 Sum_probs=197.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|+. +++.||||+++.... ......+.+|+.+++.++||||+++++++.++.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 76 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-------EGTPFTAIREASLLKGLKHANIVLLHDIIHTKE- 76 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-------cccchhHHHHHHHHhhCCCCCcCeEEEEEecCC-
Confidence 5799999999999999999998 477899999875421 111235678999999999999999999998665
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+ .++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 77 -~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~ 150 (303)
T cd07869 77 -TLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS----DTGELKLADFGLA 150 (303)
T ss_pred -eEEEEEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECCCCcc
Confidence 899999999 4678887766666789999999999999999999999999999999999998 7789999999998
Q ss_pred ccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-hHHHHhhhcc--------
Q 040257 1122 RIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG-AIIGGIVKNT-------- 1191 (1254)
Q Consensus 1122 r~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~-eliqsIlk~~-------- 1191 (1254)
+.... ........+|+.|+|||++.+.. .++.++|||||||++|+|++|+.||...... ..+..+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
T cd07869 151 RAKSVPSHTYSNEVVTLWYRPPDVLLGST-EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229 (303)
T ss_pred eeccCCCccCCCCcccCCCCChHHHcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhc
Confidence 74332 22223456899999999987543 4788999999999999999999999875432 2222111100
Q ss_pred -------------CCCCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 -------------LRPTIP---------ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 -------------Lrp~ip---------e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+....+ ...+..+.+||.+||+.||++|||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000 1234678899999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=357.29 Aligned_cols=261 Identities=31% Similarity=0.522 Sum_probs=214.0
Q ss_pred cccccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCce
Q 040257 958 LQIIKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNV 1029 (1254)
Q Consensus 958 lq~Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNI 1029 (1254)
.+.+...+|++.+.||+|+||.||++.+. ...||||+++... .......+.+|+.+++.+ +|+||
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~il~~l~~h~nI 104 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-------HTDEREALMSELKILSHLGQHKNI 104 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-------CHHHHHHHHHHHHHHHhhccCCce
Confidence 34455668999999999999999998862 2469999997532 112346788999999999 89999
Q ss_pred eEEeeeeecCCCCceEEEEEecccCchhhhhhccC---------------------------------------------
Q 040257 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD--------------------------------------------- 1064 (1254)
Q Consensus 1030 VkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre--------------------------------------------- 1064 (1254)
+++++++.+.. .+++||||+.+|+|.+++....
T Consensus 105 v~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (374)
T cd05106 105 VNLLGACTHGG--PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYV 182 (374)
T ss_pred eeEeeEecCCC--CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccc
Confidence 99999997655 7899999999999999875321
Q ss_pred ------------------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1065 ------------------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1065 ------------------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~----~~~~~kL~DfGl 258 (374)
T cd05106 183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT----DGRVAKICDFGL 258 (374)
T ss_pred ccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe----CCCeEEEeecee
Confidence 2478888999999999999999999999999999999998 678999999999
Q ss_pred cccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1121 SRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1121 Ar~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
++...... ......++..|+|||++.+. .++.++|||||||++|||++ |+.||........+............
T Consensus 259 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 336 (374)
T cd05106 259 ARDIMNDSNYVVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR 336 (374)
T ss_pred eeeccCCcceeeccCCCCccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC
Confidence 87543321 11223356679999999765 48899999999999999997 99999877665555555555555556
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
+...++++.+++.+||+.||.+||++.++++.|++++
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 6677899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=349.14 Aligned_cols=243 Identities=25% Similarity=0.410 Sum_probs=204.5
Q ss_pred EEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEE
Q 040257 970 RELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATV 1047 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LV 1047 (1254)
+.||+|+||.||+++. .++.||+|++++.... .......+.+|+.+++.++||||++++++|.... .+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~~lv 73 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFV 73 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--EEEEE
Confidence 3699999999999987 4778999999864321 1223456778999999999999999999997655 89999
Q ss_pred EEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccC-
Q 040257 1048 TEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN- 1126 (1254)
Q Consensus 1048 MEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~- 1126 (1254)
|||+.+++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 74 ~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 74 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc----CCCCEEecccHHhccccCC
Confidence 999999999888754 45689999999999999999999999999999999999998 778999999999875322
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHH
Q 040257 1127 TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRK 1206 (1254)
Q Consensus 1127 s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrd 1206 (1254)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+..... .++..+++++++
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~ 224 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RFPRTLSPEAKS 224 (323)
T ss_pred CCccccccCCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHH
Confidence 2223346799999999999865 478999999999999999999999988777766666654433 456778999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1207 LMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1207 LIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
||.+||+.||++|+ ++.+++++
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 225 LLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 99999999999998 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.99 Aligned_cols=249 Identities=24% Similarity=0.291 Sum_probs=199.5
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||+++++ ++.||||+++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE------NEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-- 73 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc------cccchhhHHHHHHHHHhCCCccccchhhhEecCC--
Confidence 6899999999999999999985 66799999975421 1233466788999999999999999999997654
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.++.+..+. .....+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~----~~~~~kl~Dfg~~~ 148 (287)
T cd07848 74 KLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS----HNDVLKLCDFGFAR 148 (287)
T ss_pred EEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEEeeccCcc
Confidence 899999999887666544 4445689999999999999999999999999999999999998 77899999999997
Q ss_pred cccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc---------
Q 040257 1123 IKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT--------- 1191 (1254)
Q Consensus 1123 ~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~--------- 1191 (1254)
...... ......|+..|+|||++.+.. ++.++|||||||++|||++|+.||...........+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07848 149 NLSEGSNANYTEYVATRWYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK 226 (287)
T ss_pred cccccccccccccccccccCCcHHHcCCC--CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence 643221 223356899999999998664 7889999999999999999999998765433222211100
Q ss_pred ----------CC-C----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 ----------LR-P----------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 ----------Lr-p----------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.. + .....++.++.+||++||++||++|||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 0 0112367889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=344.65 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=206.1
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|++++.||+|+||.||++++. +..+|+|++.... ......++.+|+++|++++||||+++++++.+
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 34568999999999999999999985 6679999987531 23345678999999999999999999999976
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC-CcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk-GIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+. .+++||||+.+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~----~~~~~kl~D 147 (331)
T cd06649 75 DG--EISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN----SRGEIKLCD 147 (331)
T ss_pred CC--EEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc----CCCcEEEcc
Confidence 55 799999999999999988543 4689999999999999999999986 699999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHh----------
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGI---------- 1187 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsI---------- 1187 (1254)
||++...... ......|+..|+|||++.+.. ++.++|||||||+||||++|+.||......+....+
T Consensus 148 fg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (331)
T cd06649 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEG 224 (331)
T ss_pred Cccccccccc-ccccCCCCcCcCCHhHhcCCC--CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccC
Confidence 9998754332 233456999999999998764 789999999999999999999999765433322111
Q ss_pred ------------------------------------hhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1188 ------------------------------------VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1188 ------------------------------------lk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
............++.++++||.+||++||++|||+++++++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 1111111112246789999999999999999999999998853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=341.21 Aligned_cols=259 Identities=29% Similarity=0.581 Sum_probs=213.2
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--Cc----eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GS----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs----~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
++...+|++++.||+|+||+||+|++. +. .||||+++... .....+++.+|+.+++.++||||++++
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~ 75 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRLL 75 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 456678999999999999999999873 33 38999886421 123356788999999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
+++... ..++++||+.+|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+
T Consensus 76 g~~~~~---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~----~~~~~ 148 (316)
T cd05108 76 GICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK----TPQHV 148 (316)
T ss_pred EEEcCC---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec----CCCcE
Confidence 998754 46789999999999999977666789999999999999999999999999999999999998 67889
Q ss_pred EEEeccccccccCccc---cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhh
Q 040257 1114 KVGDFGLSRIKRNTLV---SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~~---sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk 1189 (1254)
||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|||++ |..||.+....+... +..
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~ 225 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILE 225 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHh
Confidence 9999999985433221 1223346789999999865 47899999999999999998 999998766555433 333
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
.......+..++.++.+++.+||..+|.+||++.+++..|..+...
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 226 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 4444445667889999999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=342.23 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=197.6
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC-
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG- 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~- 1041 (1254)
+|++.+.||+|+||.||+|++ ++..||||++..... ......++.+|+.++++++||||+++++++.....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE------HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc------cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 488999999999999999987 467899999874311 11223467899999999999999999998764332
Q ss_pred --CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1042 --GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1042 --~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
..+++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~~~~lv~e~~-~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kL~Dfg 148 (338)
T cd07859 75 EFKDIYVVFELM-ESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN----ADCKLKICDFG 148 (338)
T ss_pred CCceEEEEEecC-CCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEccCc
Confidence 3589999999 5688888754 35689999999999999999999999999999999999998 78899999999
Q ss_pred ccccccCc----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh------
Q 040257 1120 LSRIKRNT----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK------ 1189 (1254)
Q Consensus 1120 LAr~~~~s----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk------ 1189 (1254)
+++..... .......||..|+|||++.+....++.++|||||||++|+|++|+.||...........+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99753221 11234569999999999876434588999999999999999999999976543222111100
Q ss_pred --------------------ccCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1190 --------------------NTLRPT---IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1190 --------------------~~Lrp~---ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
...... ....+++.+.+||.+||+.||++||++.+++++
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 012357788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=346.51 Aligned_cols=241 Identities=25% Similarity=0.403 Sum_probs=203.2
Q ss_pred EeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEE
Q 040257 972 LGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTE 1049 (1254)
Q Consensus 972 LGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVME 1049 (1254)
||+|+||+||++++. ++.||+|++++.... .......+.+|+.++++++||||+++++++.+.. .+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-----SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE--KLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC--eEEEEEc
Confidence 699999999999984 667999999754211 2233466788999999999999999999997655 8999999
Q ss_pred ecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccC-cc
Q 040257 1050 FMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN-TL 1128 (1254)
Q Consensus 1050 Ym~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~-s~ 1128 (1254)
|+.+++|.+++.. .+.+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++.... ..
T Consensus 74 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~----~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 74 FINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD----YQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC----CCCcEEEEECcccccCccCCC
Confidence 9999999998854 45689999999999999999999999999999999999998 778999999999875322 22
Q ss_pred ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHH
Q 040257 1129 VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLM 1208 (1254)
Q Consensus 1129 ~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLI 1208 (1254)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+.... ..++..+++++++||
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 224 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--LRFPDGFDRDAKDLL 224 (312)
T ss_pred ccccccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--CCCCCcCCHHHHHHH
Confidence 33446799999999999876 47899999999999999999999999877777766665543 345677899999999
Q ss_pred HHhhhcCCCCCCC---HHHHHHH
Q 040257 1209 EQCWAADPEARPS---FTEITSR 1228 (1254)
Q Consensus 1209 kKCLqkDPeKRPS---ArELLe~ 1228 (1254)
.+||..||.+||+ +.+++++
T Consensus 225 ~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 225 IGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHcCCCHHHcCCCCCHHHHHcC
Confidence 9999999999974 6777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=327.13 Aligned_cols=249 Identities=36% Similarity=0.634 Sum_probs=208.7
Q ss_pred ccCceEEEEEeeeCcEEEEEEEECC-ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWRG-SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~rG-s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
..+|++++.||+|+||.||+++++. ..+|+|.++.... ....+.+|+.+|++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK- 72 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---------cHHHHHHHHHHHHHCCCCCceeEEEEEccCC-
Confidence 3478899999999999999999854 4799998764321 1346788999999999999999999987654
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++......+++..++.++.|++.||.|||+++|+||||||+||+++ .++.+||+|||++
T Consensus 73 -~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~d~g~~ 147 (256)
T cd05114 73 -PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS----STGVVKVSDFGMT 147 (256)
T ss_pred -CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc----CCCeEEECCCCCc
Confidence 78999999999999999876556689999999999999999999999999999999999998 6789999999998
Q ss_pred ccccCccc--cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCC
Q 040257 1122 RIKRNTLV--SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1122 r~~~~s~~--sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe 1198 (1254)
+....... .....++..|+|||++.+. .++.++||||||+++|+|++ |+.||......+....+.... ....+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~ 224 (256)
T cd05114 148 RYVLDDEYTSSSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRPK 224 (256)
T ss_pred cccCCCceeccCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCCCC
Confidence 75432221 1223356689999999865 37889999999999999999 999998887777766665543 334456
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
..+.++.+|+.+||+.+|.+||++.++++.|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 6788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=349.94 Aligned_cols=243 Identities=25% Similarity=0.392 Sum_probs=204.8
Q ss_pred EEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEE
Q 040257 970 RELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATV 1047 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LV 1047 (1254)
+.||+|+||.||++++ .++.||||++.+.... .......+.+|+.+++.++||||+++++++.+.. .+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv 73 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-----AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD--RLCFV 73 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--EEEEE
Confidence 3699999999999987 4778999999864321 1233467788999999999999999999997655 89999
Q ss_pred EEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccC-
Q 040257 1048 TEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN- 1126 (1254)
Q Consensus 1048 MEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~- 1126 (1254)
|||+.+++|..++.. .+.+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 ~Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~----~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 74 MEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD----KDGHIKITDFGLCKEGITD 148 (328)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC----CCCcEEEecCcCCccCCCc
Confidence 999999999888754 45689999999999999999999999999999999999998 778999999999875322
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHH
Q 040257 1127 TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRK 1206 (1254)
Q Consensus 1127 s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrd 1206 (1254)
.......+||+.|+|||++.+. .++.++|||||||+||+|++|+.||...........+.... ..++..++.++.+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~ 224 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPRTLSADAKS 224 (328)
T ss_pred ccccccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--ccCCCCCCHHHHH
Confidence 2223446799999999999865 37889999999999999999999998877666665554433 3456778999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1207 LMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1207 LIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
||++||++||++|+ ++.+++++
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 225 LLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 99999999999997 89999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=356.06 Aligned_cols=258 Identities=33% Similarity=0.534 Sum_probs=209.8
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE-------CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW-------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVA 1031 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~-------rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVk 1031 (1254)
.+...+|++.+.||+|+||+||+|++ .+..||||+++... .....+.+.+|+.+|+.+ +||||++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~Ei~il~~l~~HpnIv~ 103 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-------HLTEREALMSELKVLSYLGNHINIVN 103 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-------CcHHHHHHHHHHHHHHHhcCCcceee
Confidence 34455789999999999999999975 24469999986432 112245788999999999 8999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccC-----------------------------------------------
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD----------------------------------------------- 1064 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre----------------------------------------------- 1064 (1254)
+++++.+.. ..++||||+.+|+|.+++....
T Consensus 104 l~~~~~~~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 181 (375)
T cd05104 104 LLGACTVGG--PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT 181 (375)
T ss_pred eeeeeccCC--cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence 999997765 7899999999999998885421
Q ss_pred ---------------------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1065 ---------------------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1065 ---------------------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
..+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+||+|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~----~~~~~kl~D 257 (375)
T cd05104 182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKICD 257 (375)
T ss_pred ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE----CCCcEEEec
Confidence 2467888999999999999999999999999999999998 677899999
Q ss_pred ccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCC
Q 040257 1118 FGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1118 FGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
||+++...... ......++..|+|||++.+.. ++.++|||||||++|||++ |..||..................
T Consensus 258 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 335 (375)
T cd05104 258 FGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335 (375)
T ss_pred CccceeccCcccccccCCCCCCcceeChhHhcCCC--CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc
Confidence 99987543321 112233566799999998664 7899999999999999998 99999877655544555555455
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
...+...+.++++||.+||+.||++||++.+|++.|+..
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 555666789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.26 Aligned_cols=250 Identities=28% Similarity=0.456 Sum_probs=212.1
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEECC---ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWRG---SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~rG---s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
+...+|++++.||+|+||.||+|++++ ..||+|++.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-----KQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 344579999999999999999998742 46999998754221 2233456889999999999999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. .+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 102 ~~~--~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~ikL~D 174 (340)
T PTZ00426 102 DES--YLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD----KDGFIKMTD 174 (340)
T ss_pred eCC--EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEEec
Confidence 765 899999999999999998543 5689999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
||+++..... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+..... .++
T Consensus 175 FG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~p 248 (340)
T PTZ00426 175 FGFAKVVDTR--TYTLCGTPEYIAPEILLNVG--HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--YFP 248 (340)
T ss_pred CCCCeecCCC--cceecCChhhcCHHHHhCCC--CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CCC
Confidence 9999765432 23457999999999998654 78899999999999999999999998877666666665433 356
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
..++..++++|++||+.+|++|+ ++++++++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 77899999999999999999995 89999887
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=353.68 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=203.0
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|++++.||+|+||+||+|++ +++.||||++.+.... .......+.+|+.++++++|+||+++++++.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-- 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-----NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-- 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC--
Confidence 588999999999999999988 4667999999754221 2334567889999999999999999999998755
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||||+ ..+++||+|||+++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~----~~~~~kL~DFGl~~ 149 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID----LDGHIKLTDFGLCT 149 (381)
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC----CCCCEEEeeCcCCc
Confidence 899999999999999988544 4689999999999999999999999999999999999998 77899999999975
Q ss_pred cccCc------------------------------------------------cccCCCCCCCCccCcccccCCCCCCCc
Q 040257 1123 IKRNT------------------------------------------------LVSGGVRGTLPWMAPELLNGSSNRVSE 1154 (1254)
Q Consensus 1123 ~~~~s------------------------------------------------~~sts~~GT~~YmAPEVLrG~~~kyS~ 1154 (1254)
..... ......+||+.|+|||++.+.. ++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~ 227 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG--YTQ 227 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC--CCC
Confidence 32100 0112356999999999998654 788
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC--CCCCcHHHHHHHHHhhhc--CCCCCCCHHHHHHH
Q 040257 1155 KVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI--PERCDPEWRKLMEQCWAA--DPEARPSFTEITSR 1228 (1254)
Q Consensus 1155 KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i--pe~iS~eLrdLIkKCLqk--DPeKRPSArELLe~ 1228 (1254)
++|||||||++|||++|+.||...........+......... ...+++++.+||.+|+.. ++..|+++.+++++
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999999999999999887665555555432222222 235789999999996544 55559999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=365.42 Aligned_cols=261 Identities=28% Similarity=0.423 Sum_probs=221.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCc------hhHHHHHHHHHHHHHHHhcCCCCceeEEeee
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRS------SEQERLTKDFWREAHILSNLHHPNVVAFYGV 1035 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~------~e~ee~~eqFlrEIeILkrLnHPNIVkLyGv 1035 (1254)
+.|++++.||+|.||+|.+++. .++.||||++.+..+.... .....-.++..+||.||++|.|||||+|+.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 3799999999999999999998 5788999999865433211 1111123578899999999999999999999
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccCCC-CCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKDRS-LDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~-LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
..+.....+|||+|||..|.+.+.- ..+. +++.++++|+++++.||+|||.+|||||||||.|+||+ ++|+||
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~----~~g~VK 250 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS----SDGTVK 250 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc----CCCcEE
Confidence 9999989999999999999887754 2334 89999999999999999999999999999999999999 789999
Q ss_pred EEecccccccc------CccccCCCCCCCCccCcccccCCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHH
Q 040257 1115 VGDFGLSRIKR------NTLVSGGVRGTLPWMAPELLNGSS--NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGG 1186 (1254)
Q Consensus 1115 LiDFGLAr~~~------~s~~sts~~GT~~YmAPEVLrG~~--~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqs 1186 (1254)
|+|||.+.... .........||+.|+|||.+.+.. ...+++.|||||||+||.|+.|+.||-+....+++.+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 99999987541 111223367999999999998743 2356889999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1187 IVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1187 Ilk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
|+...+.......+.+.+++||++||++||++|.++.+|..|..
T Consensus 331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 99988876666678999999999999999999999999988764
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.81 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=204.0
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||++++ .++.||||++.+... ......+.+.+|++++++++||||++++++|.+..
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-- 74 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-----FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ-- 74 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--
Confidence 689999999999999999987 477899999875321 12334567888999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+|+||||+.+|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~----~~~~~kl~DfGla~ 149 (377)
T cd05629 75 YLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID----RGGHIKLSDFGLST 149 (377)
T ss_pred eeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCCEEEeeccccc
Confidence 89999999999999998854 35689999999999999999999999999999999999998 77899999999985
Q ss_pred cccCcc------------------------------------------------ccCCCCCCCCccCcccccCCCCCCCc
Q 040257 1123 IKRNTL------------------------------------------------VSGGVRGTLPWMAPELLNGSSNRVSE 1154 (1254)
Q Consensus 1123 ~~~~s~------------------------------------------------~sts~~GT~~YmAPEVLrG~~~kyS~ 1154 (1254)
...... .....+||+.|+|||++.+.. ++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ 227 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG--YGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC--CCC
Confidence 321100 001246999999999998664 789
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCC--CCcHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 040257 1155 KVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE--RCDPEWRKLMEQCWAADPEAR---PSFTEITSR 1228 (1254)
Q Consensus 1155 KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe--~iS~eLrdLIkKCLqkDPeKR---PSArELLe~ 1228 (1254)
++|||||||+||||++|+.||...........+........++. .++.++++||.+||+ +|.+| +++.+++++
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999999999999988776666665554322223333 478899999999998 66665 599999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=343.75 Aligned_cols=246 Identities=25% Similarity=0.433 Sum_probs=203.9
Q ss_pred ceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHH---hcCCCCceeEEeeeeecCC
Q 040257 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHIL---SNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeIL---krLnHPNIVkLyGvf~Ddn 1040 (1254)
|++++.||+|+||.||++.+. ++.||||++++.... .....+.+.+|+.++ +.++||||+++++++.+..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-----ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 678899999999999999884 678999999864321 112234566666554 5678999999999997655
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+|+||||+.+++|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 76 --~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~----~~~~~kL~Dfg~ 147 (324)
T cd05589 76 --HVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD----TEGFVKIADFGL 147 (324)
T ss_pred --EEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCcEEeCcccC
Confidence 89999999999999988743 4699999999999999999999999999999999999998 778999999999
Q ss_pred cccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1121 SRIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1121 Ar~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
++.... .......+|++.|+|||++.+. .++.++|||||||++|+|++|+.||...........+..... ..+..
T Consensus 148 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~--~~p~~ 223 (324)
T cd05589 148 CKEGMGFGDRTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV--RYPRF 223 (324)
T ss_pred CccCCCCCCcccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCC
Confidence 874322 2223446799999999999876 478899999999999999999999998877777766655433 45677
Q ss_pred CcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
++..+.+||.+||..||.+|| ++.+++++
T Consensus 224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 899999999999999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=326.83 Aligned_cols=254 Identities=35% Similarity=0.633 Sum_probs=212.6
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC-----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR-----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r-----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
..+|++.+.||+|+||+||+|.+. ...||||+++... .......+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-------SDKQRLDFLTEASIMGQFDHPNIIRLEGVVT 75 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-------ChHHHHHHHHHHHHHHhCCCCCcceEeEEEe
Confidence 457899999999999999999884 2369999886432 2233567889999999999999999999987
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. ..++||||+.+++|.+++......+++..++.++.|++.||.|||+++|+|+||||+|||++ .++.+||+|
T Consensus 76 ~~~--~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~----~~~~~~l~d 149 (266)
T cd05033 76 KSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSD 149 (266)
T ss_pred cCC--ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc----CCCCEEECc
Confidence 654 78999999999999999977666799999999999999999999999999999999999998 778999999
Q ss_pred ccccccccC---ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCC
Q 040257 1118 FGLSRIKRN---TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1118 FGLAr~~~~---s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
||+++.... ........++..|+|||.+.+. .++.++||||||+++|+|++ |..||...........+... ..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~ 226 (266)
T cd05033 150 FGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YR 226 (266)
T ss_pred cchhhcccccccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CC
Confidence 999986531 1111223356789999999865 47889999999999999998 99999887766666555443 33
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
...+..++..+.+|+.+||+.+|++||++.+++++|+++
T Consensus 227 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 345567899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=345.53 Aligned_cols=250 Identities=25% Similarity=0.424 Sum_probs=203.4
Q ss_pred CceEEEEEeeeCcEEEEEEEE-----CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeec
Q 040257 965 DLEELRELGSGTYGTVYHGKW-----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPD 1038 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~-----rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~D 1038 (1254)
+|++++.||+|+||+||+++. +++.||+|++.+.... ......+.+.+|+.+++++ +|+||+++++++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV----QKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh----hhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 488999999999999999876 4678999999754221 1223346678899999999 59999999999876
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. .+++||||+.+++|.+++.++ ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 77 ~~--~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~----~~~~~kl~Df 149 (332)
T cd05614 77 EA--KLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD----SEGHVVLTDF 149 (332)
T ss_pred CC--EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC----CCCCEEEeeC
Confidence 55 799999999999999988554 4689999999999999999999999999999999999998 6789999999
Q ss_pred cccccccC--ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----hhHHHHhhhccC
Q 040257 1119 GLSRIKRN--TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC----GAIIGGIVKNTL 1192 (1254)
Q Consensus 1119 GLAr~~~~--s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~----~eliqsIlk~~L 1192 (1254)
|+++.... .......+||..|+|||++.+.. .++.++|||||||+||||++|+.||..... ......+.. .
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~ 226 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG-GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--C 226 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCC-CCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--C
Confidence 99875322 12233467999999999998642 367899999999999999999999964322 222222222 3
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
.+.++..++..+++||.+||+.||++|| ++++++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 3456677899999999999999999999 78888875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=334.60 Aligned_cols=251 Identities=29% Similarity=0.374 Sum_probs=198.5
Q ss_pred CceEEEEEeeeCcEEEEEEEEC---CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC---CCCceeEEeeeeec
Q 040257 965 DLEELRELGSGTYGTVYHGKWR---GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL---HHPNVVAFYGVVPD 1038 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r---Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL---nHPNIVkLyGvf~D 1038 (1254)
+|++++.||+|+||+||+|++. ++.||||+++..... ......+.+|+.+++.+ +||||+++++++..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~ 75 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE------EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 75 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC------CCchHHHHHHHHHHHhhcccCCCCcceEEEEEec
Confidence 6889999999999999999873 567999998754211 11123445666666655 79999999998852
Q ss_pred ---CCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1039 ---GTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1039 ---dn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
.....+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~----~~~~~k 150 (290)
T cd07862 76 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQIK 150 (290)
T ss_pred ccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc----CCCCEE
Confidence 23347899999995 6888887553 34589999999999999999999999999999999999998 778999
Q ss_pred EEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC
Q 040257 1115 VGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
|+|||+++............||..|+|||++.+.. ++.++|||||||++|||++|++||......+.+..+......+
T Consensus 151 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~ 228 (290)
T cd07862 151 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 228 (290)
T ss_pred EccccceEeccCCcccccccccccccChHHHhCCC--CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 99999998655444445567899999999997653 7889999999999999999999998877655555544221000
Q ss_pred -------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 -------------------------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 -------------------------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.....++..+++|+.+||+.||++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0112467788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.73 Aligned_cols=244 Identities=28% Similarity=0.443 Sum_probs=204.5
Q ss_pred EEEeeeCcEEEEEEEE-----CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCce
Q 040257 970 RELGSGTYGTVYHGKW-----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTL 1044 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~-----rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L 1044 (1254)
+.||+|+||.||+++. .++.||||++++.... ........+.+|+.+|+.++||||++++++|.++. .+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV----RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG--KL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH----hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC--eE
Confidence 5799999999999976 3677999999864221 11223456778999999999999999999997655 79
Q ss_pred EEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccc
Q 040257 1045 ATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1045 ~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~ 1124 (1254)
++||||+.+++|.+++.. .+.+.+..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 76 YLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD----AQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEeeCcCCeec
Confidence 999999999999998854 35688899999999999999999999999999999999998 7789999999998743
Q ss_pred c-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHH
Q 040257 1125 R-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPE 1203 (1254)
Q Consensus 1125 ~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~e 1203 (1254)
. .........||+.|+|||++.+.. ++.++|||||||+||||++|+.||...........+.... ..++..+++.
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~ 226 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMRSG--HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--LNLPPYLTPE 226 (323)
T ss_pred ccCCCcccccCCCccccChhhccCCC--CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHH
Confidence 2 222334467999999999998654 7889999999999999999999999887777666666543 3456778999
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1204 WRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1204 LrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
+.+||++||+++|++|| ++.+++++
T Consensus 227 ~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 227 ARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 99999999999999999 89998875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=372.51 Aligned_cols=246 Identities=29% Similarity=0.494 Sum_probs=213.5
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|....+||+|+.|.||.++. +++.||||++...... -.+-+++|+.+|+.++|+|||.+++.|...+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--------~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-- 343 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--------KKELLLNEILVMRDLHHPNIVNFLDSYLVGD-- 343 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--------chhhhHHHHHHHHhccchHHHHHHHHhcccc--
Confidence 578888999999999999887 4667999999865322 1355789999999999999999999887664
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++|||||+||+|.+++.. ..+++.++..|+++++.||+|||.+||||||||.+|||++ .++.|||+|||+|.
T Consensus 344 eLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~----~~g~vKltDFGFca 417 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT----MDGSVKLTDFGFCA 417 (550)
T ss_pred eeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec----cCCcEEEeeeeeee
Confidence 79999999999999998843 3599999999999999999999999999999999999999 78889999999998
Q ss_pred cccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhh-hccCCCCCCCCC
Q 040257 1123 IKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIV-KNTLRPTIPERC 1200 (1254)
Q Consensus 1123 ~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIl-k~~Lrp~ipe~i 1200 (1254)
...... ...+..||+.|||||++.... |++++||||||++++||+.|.+||...+....+..+. .+......++.+
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~--YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~kl 495 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKP--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKL 495 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcc--cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCcccc
Confidence 665443 445677999999999998764 8999999999999999999999999877666555554 344555667889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++++++|+.+||+.|+++|+++.|||+|
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 9999999999999999999999999976
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=372.38 Aligned_cols=246 Identities=30% Similarity=0.508 Sum_probs=216.3
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|-+.+.||+|+||+||+|+.+ .+.||||.+.+..- .++..+.+.+|++|++.|+||||+.++++|....
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr------~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~-- 74 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR------NEKELKNLRQEVRILRSLKHPNIVEMLESFETSA-- 74 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCC------chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc--
Confidence 5667778999999999999875 55799999986531 2334567889999999999999999999997655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++|.||+.| +|..++ ..++.++++.+..|+.+++.||.|||+++|+|||+||+|||+. ..+++|+||||+|+
T Consensus 75 ~~~vVte~a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~----~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 75 HLWVVTEYAVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE----KGGTLKLCDFGLAR 148 (808)
T ss_pred eEEEEehhhhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec----CCCceeechhhhhh
Confidence 89999999966 999988 4557799999999999999999999999999999999999999 88999999999998
Q ss_pred ccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1123 IKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1123 ~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
... +....+.+.||+.|||||++.+.+ |+..+|+||||||+|||++|++||.......+...|..+... .|...+
T Consensus 149 ~m~~~t~vltsikGtPlYmAPElv~e~p--yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~--~p~~~S 224 (808)
T KOG0597|consen 149 AMSTNTSVLTSIKGTPLYMAPELVEEQP--YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK--PPSTAS 224 (808)
T ss_pred hcccCceeeeeccCcccccCHHHHcCCC--ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC--Cccccc
Confidence 543 344566788999999999999876 788899999999999999999999998888888888877544 455889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+.+|++.+|.+||.+|.+..+++.|
T Consensus 225 ~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 225 SSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 999999999999999999999999876
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=352.73 Aligned_cols=249 Identities=20% Similarity=0.302 Sum_probs=204.0
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||++++. ++.||||++.+.... .......+.+|+.+|++++|+||+++++++.+..
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-- 74 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-----MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD-- 74 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-----hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--
Confidence 6899999999999999999874 678999998753211 1223456788999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+|+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+|||++.
T Consensus 75 ~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----~~~~ikL~DFG~a~ 149 (376)
T cd05598 75 NLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGLCT 149 (376)
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC----CCCCEEEEeCCCCc
Confidence 899999999999999998554 5689999999999999999999999999999999999998 77899999999974
Q ss_pred cccC--------------------------------------------ccccCCCCCCCCccCcccccCCCCCCCchhHH
Q 040257 1123 IKRN--------------------------------------------TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDV 1158 (1254)
Q Consensus 1123 ~~~~--------------------------------------------s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDI 1158 (1254)
.... .......+||+.|+|||++.+.. ++.++||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di 227 (376)
T cd05598 150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG--YTQLCDW 227 (376)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC--CCcceee
Confidence 2210 00112356999999999998764 7889999
Q ss_pred HHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC--CCCCCCcHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 040257 1159 FSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP--TIPERCDPEWRKLMEQCWAADPEARP---SFTEITSR 1228 (1254)
Q Consensus 1159 WSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp--~ipe~iS~eLrdLIkKCLqkDPeKRP---SArELLe~ 1228 (1254)
|||||+||||++|+.||......+....+....... .....+++++.++|.+|+ .+|.+|+ ++.+++++
T Consensus 228 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999999999999877666555544322222 223457899999999977 5999999 89999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=342.41 Aligned_cols=248 Identities=23% Similarity=0.365 Sum_probs=206.3
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCC-ceeEEeeeeecCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP-NVVAFYGVVPDGTG 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHP-NIVkLyGvf~Ddn~ 1041 (1254)
+|++++.||+|+||.||+|++. ++.||||++.+.... .....+.+..|+.++..+.|+ +|+++++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-----QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD- 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-
Confidence 5889999999999999999985 567999999864321 122345677899999998765 5888998887655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~~ 148 (324)
T cd05587 75 -RLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----AEGHIKIADFGMC 148 (324)
T ss_pred -EEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc----CCCCEEEeecCcc
Confidence 799999999999999888544 5689999999999999999999999999999999999998 7789999999998
Q ss_pred cccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1122 RIKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1122 r~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
.... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........+..+.... ..++..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~~~~~ 224 (324)
T cd05587 149 KENIFGGKTTRTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSL 224 (324)
T ss_pred eecCCCCCceeeecCCccccChhhhcCCC--CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCC
Confidence 6422 222233457999999999998764 7889999999999999999999999888777777766543 3456778
Q ss_pred cHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSF-----TEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSA-----rELLe~ 1228 (1254)
+.++.+|+.+||.++|.+|++. .+++++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 225 SKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999999999976 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=325.31 Aligned_cols=254 Identities=31% Similarity=0.595 Sum_probs=211.2
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
+...+|+++++||+|+||.||+|.+. +..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---------MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---------hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45568999999999999999999874 5679999876431 1245788999999999999999999998765
Q ss_pred CCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
. ..+++|||+.+++|.+++... ...+++..++.++.|++.||.|||+.+++||||||+||+++ ..+.+||+||
T Consensus 74 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df 147 (261)
T cd05072 74 E--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS----ESLMCKIADF 147 (261)
T ss_pred C--CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec----CCCcEEECCC
Confidence 4 789999999999999998653 35688999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCccc--cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1119 GLSRIKRNTLV--SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1119 GLAr~~~~s~~--sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
|++........ .....++..|+|||++.+. .++.++|||||||++|+|++ |+.||...........+... ....
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~ 224 (261)
T cd05072 148 GLARVIEDNEYTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMP 224 (261)
T ss_pred ccceecCCCceeccCCCccceecCCHHHhccC--CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCC
Confidence 99986543221 2223456789999998765 37889999999999999998 99999887666665555433 3334
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
....++.++.+|+.+||..+|++||+++++++.|+++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 4456889999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=351.89 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=203.9
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|+++++||+|+||+||+|++ .++.||||++.+... ........+.+|+.++++++|+||++++++|.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-- 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-----LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-- 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--
Confidence 588999999999999999988 467799999875321 12334567889999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+|+|.+++.+. +.+++..+..++.||+.||.|||+++|+||||||+|||++ .++++||+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~----~~g~~kL~DFGla~ 149 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGLCT 149 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEEeECCCCc
Confidence 899999999999999988544 5689999999999999999999999999999999999998 78899999999975
Q ss_pred cccC------------------------------------------------ccccCCCCCCCCccCcccccCCCCCCCc
Q 040257 1123 IKRN------------------------------------------------TLVSGGVRGTLPWMAPELLNGSSNRVSE 1154 (1254)
Q Consensus 1123 ~~~~------------------------------------------------s~~sts~~GT~~YmAPEVLrG~~~kyS~ 1154 (1254)
.... .......+||+.|+|||++.+.. ++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~ 227 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG--YTQ 227 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC--CCC
Confidence 2110 00112346999999999998764 788
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 040257 1155 KVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI--PERCDPEWRKLMEQCWAADPEARPS---FTEITSR 1228 (1254)
Q Consensus 1155 KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i--pe~iS~eLrdLIkKCLqkDPeKRPS---ArELLe~ 1228 (1254)
++|||||||+||||++|+.||......+....+......... ...+++++.++|.+|+ .+|++|++ +.+++++
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 999999999999999999999987766655555543222222 3457899999999976 59999987 8888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=331.32 Aligned_cols=247 Identities=37% Similarity=0.674 Sum_probs=203.4
Q ss_pred eEEEEEeeeCcEEEEEEEEC------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 967 EELRELGSGTYGTVYHGKWR------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 967 eiLkkLGeGsFGtVYlAk~r------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
.+.+.||.|.||.||+|.+. +..|+||.++... .....+.+.+|++++++++||||+++++++....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-------SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-------SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-------ccccceeeeecccccccccccccccccccccccc
Confidence 46788999999999999997 5679999995421 2233678899999999999999999999998544
Q ss_pred CCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
.+++||||+.+|+|.+++... ...+++..++.|+.||+.||.|||+++|+|++|+++|||++ .++.+||+|||
T Consensus 75 --~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~----~~~~~Kl~~f~ 148 (259)
T PF07714_consen 75 --PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD----SNGQVKLSDFG 148 (259)
T ss_dssp --SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE----TTTEEEEESTT
T ss_pred --ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccccccc
Confidence 689999999999999999776 56799999999999999999999999999999999999999 78899999999
Q ss_pred ccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1120 LSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1120 LAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
++...... ...........|+|||.+.+.. ++.++||||||+++|||++ |+.||...........+... .+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~-~~~~ 225 (259)
T PF07714_consen 149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE--YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG-QRLP 225 (259)
T ss_dssp TGEETTTSSSEEESTTSESGGGGS-HHHHHHSE--ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT-EETT
T ss_pred ccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc-ccce
Confidence 99765221 1223344677899999998664 7999999999999999999 78999988877777777443 4455
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
.+..++..+.++|.+||..+|++||++.++++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 6778899999999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.73 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=209.6
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|+||+||++++ .++.||||++++... ......+.+.+|+.+++.++|+||+++++++.+..
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~-- 74 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-----LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD-- 74 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--
Confidence 689999999999999999988 477899999986421 12234566788999999999999999999987655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|.+++.+....+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+||+|||++.
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~----~~~~~kL~Dfg~a~ 150 (330)
T cd05601 75 NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID----RTGHIKLADFGSAA 150 (330)
T ss_pred eEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC----CCCCEEeccCCCCe
Confidence 79999999999999999977667799999999999999999999999999999999999998 78899999999997
Q ss_pred cccCcc--ccCCCCCCCCccCcccccCC----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1123 IKRNTL--VSGGVRGTLPWMAPELLNGS----SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1123 ~~~~s~--~sts~~GT~~YmAPEVLrG~----~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
...... ......||+.|+|||++... ...++.++|||||||++|+|++|+.||........+..+.........
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 230 (330)
T cd05601 151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKF 230 (330)
T ss_pred ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCC
Confidence 543322 22234689999999998732 224788999999999999999999999887776666666543322222
Q ss_pred C--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1197 P--ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1197 p--e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+ ..++.++.+||.+||+ +|.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 231 PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 2 3578999999999998 99999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.14 Aligned_cols=258 Identities=36% Similarity=0.614 Sum_probs=214.6
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
|+..+|.+.+.||+|+||+||++... +..+|+|.+... .......+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--------SDNARKDFHREAELLTNLQHEHIVKFY 73 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--------CHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 45668999999999999999999752 345899988643 123456788999999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccC------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCce
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKD------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENL 1101 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNI 1101 (1254)
+++.... .+++||||+.+++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 74 ~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Ni 151 (288)
T cd05093 74 GVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 151 (288)
T ss_pred EEEecCC--ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceE
Confidence 9997654 7899999999999999885432 2489999999999999999999999999999999999
Q ss_pred EeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 040257 1102 LVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYAD 1177 (1254)
Q Consensus 1102 LLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~ 1177 (1254)
|++ .++.+||+|||+++...... ......++..|+|||++.+. .++.++|||||||++|+|++ |..||..
T Consensus 152 li~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 152 LVG----ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred EEc----cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 998 77899999999987542211 12223357789999999865 47899999999999999998 9999988
Q ss_pred CChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1178 MHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1178 ~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
.........+..... ...+..++.++.+|+.+||+.+|.+|||+.++++.|+++..+
T Consensus 226 ~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 226 LSNNEVIECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 877777666665443 334556889999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=325.54 Aligned_cols=254 Identities=35% Similarity=0.643 Sum_probs=212.6
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|.+.+.||+|+||.||+|.++ ++.||+|++.... .....+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---------hHHHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence 44567899999999999999999884 6789999886431 123568899999999999999999999876
Q ss_pred CCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+. .++++|||+.+++|.+++... ...+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 74 ~~--~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~d 147 (263)
T cd05052 74 EP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVAD 147 (263)
T ss_pred CC--CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCcEEeCC
Confidence 55 789999999999999998653 34589999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCcccc--CCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCC
Q 040257 1118 FGLSRIKRNTLVS--GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1118 FGLAr~~~~s~~s--ts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
||++......... ....++..|+|||.+.+. .++.++|||||||++|||++ |..||......+....+. ..+..
T Consensus 148 f~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~ 224 (263)
T cd05052 148 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRM 224 (263)
T ss_pred CccccccccceeeccCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCC
Confidence 9998765433221 122346679999998765 47889999999999999998 999998876665555443 33455
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
..+..++.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 66778899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=342.09 Aligned_cols=248 Identities=23% Similarity=0.377 Sum_probs=206.6
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~ 1041 (1254)
+|++++.||+|+||+||+|++. ++.||||++++.... .......+..|..++..+ +|++|+++++++.+..
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD- 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-
Confidence 5889999999999999999885 567999999864321 122234566788888776 5899999999987655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+|+|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kL~DfG~~ 148 (323)
T cd05616 75 -RLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKIADFGMC 148 (323)
T ss_pred -EEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC----CCCcEEEccCCCc
Confidence 899999999999999888544 5689999999999999999999999999999999999998 7789999999998
Q ss_pred cccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1122 RIKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1122 r~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
+... ........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+..... .++..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--~~p~~~ 224 (323)
T cd05616 149 KENMWDGVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--AYPKSM 224 (323)
T ss_pred eecCCCCCccccCCCChhhcCHHHhcCCC--CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCcC
Confidence 7532 222334567999999999998764 78999999999999999999999998887777777765443 456778
Q ss_pred cHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSF-----TEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSA-----rELLe~ 1228 (1254)
+.++.+|+.+||+.+|.+|++. .+++++
T Consensus 225 s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 225 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 9999999999999999999974 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=366.72 Aligned_cols=257 Identities=26% Similarity=0.379 Sum_probs=214.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
......|+.+.+||+|.||.||++++ +++.||+|++.... +.+.+.....|||.||++|+||||++|.++..
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~------~~~~~~~t~~REI~ILr~l~HpNIikL~eivt 186 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN------EKEGFPITAIREIKILRRLDHPNIIKLEEIVT 186 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc------CCCcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence 34445788899999999999999998 57779999998643 23445666789999999999999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+...+.+|+|+|||+ -+|.-++....-.|++.++..|++||+.||+|||.+||+|||||..||||| .+|.+||+|
T Consensus 187 ~~~~~siYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid----n~G~LKiaD 261 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID----NNGVLKIAD 261 (560)
T ss_pred ecCCceEEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc----CCCCEEecc
Confidence 876679999999994 577777766666899999999999999999999999999999999999999 899999999
Q ss_pred ccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc-----
Q 040257 1118 FGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN----- 1190 (1254)
Q Consensus 1118 FGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~----- 1190 (1254)
||||++..... ..+...-|.+|+|||.+.|.. .|+.++|+||+||||.||++|++.|.+...-+.+..|.+.
T Consensus 262 FGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t-~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 262 FGLARFYTPSGSAPYTSRVVTLWYRPPELLLGAT-SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT 340 (560)
T ss_pred ccceeeccCCCCcccccceEEeeccChHHhcCCc-ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence 99999654433 345566899999999999975 6999999999999999999999999998876666555432
Q ss_pred -cCCC--CC-------------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1191 -TLRP--TI-------------------PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1191 -~Lrp--~i-------------------pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+++ .+ -..++....+|+..+|+.||.+|.|+.++|+.
T Consensus 341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 341 EDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred hhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1111 01 12356778899999999999999999988754
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.37 Aligned_cols=243 Identities=27% Similarity=0.410 Sum_probs=203.7
Q ss_pred EEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEE
Q 040257 970 RELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATV 1047 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LV 1047 (1254)
+.||+|+||+||++++ +++.||+|++++.... .......+.+|+++++.++||||+++++++.+.. .+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~--~~~lv 73 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCFV 73 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC--EEEEE
Confidence 3699999999999987 4778999999864321 1223456778999999999999999999987655 89999
Q ss_pred EEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCCCCCeEEEEecccccccc-
Q 040257 1048 TEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR- 1125 (1254)
Q Consensus 1048 MEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~- 1125 (1254)
|||+.+++|..++.. .+.+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 ~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~----~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 74 MEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD----KDGHIKITDFGLCKEGIK 148 (325)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC----CCCCEEEecCCCCeecCC
Confidence 999999999888754 3568999999999999999999997 7999999999999998 77899999999987432
Q ss_pred CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHH
Q 040257 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205 (1254)
Q Consensus 1126 ~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLr 1205 (1254)
.........||+.|+|||++.+. .++.++|||||||+||+|++|+.||...........+.... ..++..+++++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~ 224 (325)
T cd05594 149 DGATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAK 224 (325)
T ss_pred CCcccccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 22223345699999999999865 47889999999999999999999998877766666555433 345677899999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1206 KLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1206 dLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
+||++||+.||++|+ ++.+++++
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 999999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=352.15 Aligned_cols=255 Identities=20% Similarity=0.341 Sum_probs=212.0
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|++++.||+|+||+||++++. ++.||+|++.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 44568999999999999999999884 678999999753211 12223457789999999999999999999976
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
+. .+++||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 115 ~~--~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~~kL~Df 186 (370)
T cd05596 115 DK--YLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLADF 186 (370)
T ss_pred CC--EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc----CCCCEEEEec
Confidence 55 89999999999999998854 3588999999999999999999999999999999999998 7889999999
Q ss_pred cccccccCcc--ccCCCCCCCCccCcccccCCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC
Q 040257 1119 GLSRIKRNTL--VSGGVRGTLPWMAPELLNGSS--NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1119 GLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~--~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
|++....... .....+||+.|+|||++.+.. ..++.++|||||||+||||++|+.||........+..+.......
T Consensus 187 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05596 187 GTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred cceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC
Confidence 9987543321 223467999999999987542 247889999999999999999999999887777777776543333
Q ss_pred CCCC--CCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 040257 1195 TIPE--RCDPEWRKLMEQCWAADPEA--RPSFTEITSR 1228 (1254)
Q Consensus 1195 ~ipe--~iS~eLrdLIkKCLqkDPeK--RPSArELLe~ 1228 (1254)
.++. .++.++++||.+||+.+|.+ |+++.+++++
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 3343 57899999999999999988 9999999887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=334.71 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=206.1
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|++.+.||+|+||+||++.+ +++.||||++...... .......+.+|+.+++.++||||+++++++.++.
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-----hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--
Confidence 378899999999999999987 4778999999754221 1223455778999999999999999999987655
Q ss_pred ceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++ .++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~~l~Dfg~~ 149 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD----DYGHIRISDLGLA 149 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 899999999999999887543 34689999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc--cCCCCCCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN--TLRPTIPER 1199 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~--~Lrp~ipe~ 1199 (1254)
.............|+..|+|||++.+. .++.++|||||||++|+|++|+.||...........+... .....++..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05605 150 VEIPEGETIRGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227 (285)
T ss_pred eecCCCCccccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcc
Confidence 765433333445789999999999865 4788999999999999999999999876543332222211 122345566
Q ss_pred CcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
++..+.+||.+||..||.+|| ++++++++
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 889999999999999999999 88899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=320.98 Aligned_cols=252 Identities=31% Similarity=0.495 Sum_probs=211.1
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|++.+.||+|++|.||++.. .++.||||.+...... .........+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 77 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS---PETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE-- 77 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc---hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC--
Confidence 588899999999999999986 4788999998754211 112233467889999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||+++ .++.++|+|||+++
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~----~~~~~~l~dfg~~~ 152 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGASK 152 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeecccce
Confidence 899999999999999988543 5688999999999999999999999999999999999998 67899999999987
Q ss_pred cccCcccc----CCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCC
Q 040257 1123 IKRNTLVS----GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1123 ~~~~s~~s----ts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe 1198 (1254)
........ ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||.....................+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (263)
T cd06625 153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEG--YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPS 230 (263)
T ss_pred eccccccccccccCCCcCccccCcceeccCC--CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCc
Confidence 54322111 2345788999999998764 78999999999999999999999987766555555555555556777
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++..+.++|.+||..+|.+||++.+++++
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 231 HVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 889999999999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.88 Aligned_cols=252 Identities=36% Similarity=0.647 Sum_probs=210.9
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
+...+|++.+.||+|+||.||++..+++.+|+|.++... ..+.+.+|+.++++++|+|++++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 71 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE- 71 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-
Confidence 344589999999999999999999999999999886431 235688999999999999999999976533
Q ss_pred CCceEEEEEecccCchhhhhhccCC-CCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDR-SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~-~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
...++++|||+.+++|.+++.+... .+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~dfg 147 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS----EDNVAKVSDFG 147 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc----CCCcEEecCCc
Confidence 2368999999999999999866443 488999999999999999999999999999999999998 77899999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCC
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe 1198 (1254)
++....... ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||...........+.. ......+.
T Consensus 148 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 222 (256)
T cd05082 148 LTKEASSTQ--DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPD 222 (256)
T ss_pred cceeccccC--CCCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCC
Confidence 987543322 233456789999999865 47889999999999999997 9999987766665555433 34445667
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
.+++.+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 7899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=346.49 Aligned_cols=245 Identities=31% Similarity=0.486 Sum_probs=198.1
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|+.+++||+|+||+||++++. ++.||||++.... .......+.+|+.+++.++|+||+++++++.+..
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 145 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-------EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG-- 145 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-------cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC--
Confidence 5777889999999999999984 7789999986431 2334567889999999999999999999997654
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|.... ...+..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++
T Consensus 146 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~~~~kL~DfG~~~ 216 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN----SAKNVKIADFGVSR 216 (353)
T ss_pred eEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEEEcccccce
Confidence 799999999999987543 356778889999999999999999999999999999998 77899999999997
Q ss_pred cccCcc-ccCCCCCCCCccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh---HHHHhhhccCCCC
Q 040257 1123 IKRNTL-VSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA---IIGGIVKNTLRPT 1195 (1254)
Q Consensus 1123 ~~~~s~-~sts~~GT~~YmAPEVLrG~---~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e---liqsIlk~~Lrp~ 1195 (1254)
...... ......||..|+|||++... ....+.++|||||||+||||++|+.||....... ....+. ......
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~ 295 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPE 295 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCC
Confidence 654322 22345699999999998532 1224568999999999999999999997433222 222221 223344
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+..++.++++||.+||+.||++||++.|++++
T Consensus 296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 566788999999999999999999999999987
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.47 Aligned_cols=250 Identities=36% Similarity=0.627 Sum_probs=208.7
Q ss_pred ccCceEEEEEeeeCcEEEEEEEECCc-eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~rGs-~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
..+|++++.||+|+||+||++++.+. .+|||.++.... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 72 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR- 72 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-
Confidence 45789999999999999999988654 599998874321 1246788999999999999999999987654
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++......+++..++.++.||+.||.|||+.+|+|+||||.|||++ .++.+||+|||++
T Consensus 73 -~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~d~g~~ 147 (256)
T cd05113 73 -PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD----DQGCVKVSDFGLS 147 (256)
T ss_pred -CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCCEEECCCccc
Confidence 78999999999999999876555789999999999999999999999999999999999998 6789999999998
Q ss_pred ccccCccc--cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCC
Q 040257 1122 RIKRNTLV--SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1122 r~~~~s~~--sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe 1198 (1254)
+....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |+.||...........+... .....+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 224 (256)
T cd05113 148 RYVLDDEYTSSVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-LRLYRPH 224 (256)
T ss_pred eecCCCceeecCCCccChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-CCCCCCC
Confidence 75433221 1123356789999999865 37889999999999999998 99999887766666655543 3344556
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
..+..+++++.+||..+|.+||++.+|++.|+
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 67899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=327.71 Aligned_cols=252 Identities=36% Similarity=0.611 Sum_probs=209.8
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeee
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGV 1035 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGv 1035 (1254)
..+|.+.+.||+|+||.||+|++. +..||||+++... ..+..+.+.+|+++|+.++|+||++++++
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 76 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-------SNDARKDFEREAELLTNFQHENIVKFYGV 76 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-------CHHHHHHHHHHHHHHHhcCCCCchheeeE
Confidence 446888899999999999999863 3569999987431 12235678899999999999999999999
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccC-------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceE
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKD-------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLL 1102 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre-------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNIL 1102 (1254)
+.... .+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||
T Consensus 77 ~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nil 154 (280)
T cd05049 77 CTEGD--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCL 154 (280)
T ss_pred EecCC--CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEE
Confidence 98764 8999999999999999986432 34788899999999999999999999999999999999
Q ss_pred eccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 040257 1103 VNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADM 1178 (1254)
Q Consensus 1103 LDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~ 1178 (1254)
++ .++.+||+|||+++...... ......++..|+|||++.+.. ++.++|||||||++|||++ |..||...
T Consensus 155 i~----~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 155 VG----YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred Ec----CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCC--cchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 98 77899999999987432211 122334578899999998654 8899999999999999998 99999887
Q ss_pred ChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1179 HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1179 n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
........+..... ...+..++..+.+|+.+||+.+|.+||++.|+++.|+
T Consensus 229 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 229 SNEEVIECITQGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 77776666654433 3345678899999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=342.55 Aligned_cols=242 Identities=24% Similarity=0.411 Sum_probs=203.7
Q ss_pred EEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCCCceEEE
Q 040257 971 ELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTGGTLATV 1047 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~~~L~LV 1047 (1254)
.||+|+||+||+|++. ++.||||++++.... .......+..|+.++..+ +||||+++++++.+.. .+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~--~~~lv 74 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-----QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD--RLFFV 74 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-----hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--eEEEE
Confidence 6999999999999985 568999999864221 122345567788888865 7999999999998655 79999
Q ss_pred EEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc-C
Q 040257 1048 TEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR-N 1126 (1254)
Q Consensus 1048 MEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~-~ 1126 (1254)
|||+.+++|...+.+. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.... .
T Consensus 75 ~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~----~~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 75 MEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD----AEGHCKLADFGMCKEGILN 149 (321)
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEeecccceecccC
Confidence 9999999999888543 5689999999999999999999999999999999999998 77899999999987532 2
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHH
Q 040257 1127 TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRK 1206 (1254)
Q Consensus 1127 s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrd 1206 (1254)
........||..|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..+..... ..+..++.++.+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~ 225 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQELE--YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV--LYPVWLSKEAVS 225 (321)
T ss_pred CccccccccCccccCHHHHcCCC--CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHH
Confidence 22334467999999999998654 78899999999999999999999998888777777765443 345668999999
Q ss_pred HHHHhhhcCCCCCC-------CHHHHHHH
Q 040257 1207 LMEQCWAADPEARP-------SFTEITSR 1228 (1254)
Q Consensus 1207 LIkKCLqkDPeKRP-------SArELLe~ 1228 (1254)
||++||+.||++|+ ++.+++++
T Consensus 226 ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 99999999999999 88888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=343.27 Aligned_cols=243 Identities=26% Similarity=0.425 Sum_probs=202.7
Q ss_pred EEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCCCceEE
Q 040257 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+.||+|+||+||+++++ ++.||||++++.... .......+..|+.++..+ +||||+++++++.+.. .+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~--~~~i 73 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-----QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD--RLFF 73 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC--EEEE
Confidence 36999999999999984 678999999764221 122345667888888766 7999999999997655 8999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc-
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR- 1125 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~- 1125 (1254)
||||+.+++|..++.+. +.+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~----~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 74 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD----HEGHCKLADFGMCKEGIF 148 (320)
T ss_pred EEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeeCCCCeecCc
Confidence 99999999999888544 5699999999999999999999999999999999999998 77899999999987432
Q ss_pred CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHH
Q 040257 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205 (1254)
Q Consensus 1126 ~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLr 1205 (1254)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..+.... ...+..++.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 224 (320)
T cd05590 149 NGKTTSTFCGTPDYIAPEILQEML--YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYPTWLSQDAV 224 (320)
T ss_pred CCCcccccccCccccCHHHHcCCC--CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 222334467999999999998654 7889999999999999999999999888777777766543 345667899999
Q ss_pred HHHHHhhhcCCCCCCCH------HHHHHH
Q 040257 1206 KLMEQCWAADPEARPSF------TEITSR 1228 (1254)
Q Consensus 1206 dLIkKCLqkDPeKRPSA------rELLe~ 1228 (1254)
+||++||++||.+||++ ++++++
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 225 DILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 99999999999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=344.68 Aligned_cols=261 Identities=31% Similarity=0.523 Sum_probs=211.6
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVA 1031 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVk 1031 (1254)
.+...+|++++.||+|+||.||+|.+. ++.||+|+++... .....+.+.+|+.+++++ +|+||++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~E~~~~~~l~~h~niv~ 75 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-------TASEYKALMTELKILIHIGHHLNVVN 75 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-------CHHHHHHHHHHHHHHHhhccCcchhh
Confidence 455668999999999999999999753 3569999886431 112235677899999999 8999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccC-----------------------------------------------
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD----------------------------------------------- 1064 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre----------------------------------------------- 1064 (1254)
+++++.... ..++++|||+.+++|.+++....
T Consensus 76 ~~~~~~~~~-~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (337)
T cd05054 76 LLGACTKPG-GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLS 154 (337)
T ss_pred eeeeEecCC-CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchh
Confidence 999886443 47889999999999998875321
Q ss_pred -------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCc---c
Q 040257 1065 -------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT---L 1128 (1254)
Q Consensus 1065 -------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s---~ 1128 (1254)
..+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++..... .
T Consensus 155 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~----~~~~vkL~DfG~a~~~~~~~~~~ 230 (337)
T cd05054 155 DVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYV 230 (337)
T ss_pred hcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe----CCCcEEEeccccchhcccCcchh
Confidence 2578899999999999999999999999999999999998 6788999999999754221 1
Q ss_pred ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHH
Q 040257 1129 VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKL 1207 (1254)
Q Consensus 1129 ~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdL 1207 (1254)
......++..|+|||++.+.. ++.++|||||||+||||++ |..||......+..............+..+++++.+|
T Consensus 231 ~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 308 (337)
T cd05054 231 RKGDARLPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSI 308 (337)
T ss_pred hccCCCCCccccCcHHhcCCC--CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHH
Confidence 122334567899999998654 8899999999999999998 9999987655444444444444455566788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1208 MEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1208 IkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
+.+||+.+|++||++.+++++|++++.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.52 Aligned_cols=259 Identities=34% Similarity=0.567 Sum_probs=211.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEECC--c--eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeec
Q 040257 964 VDLEELRELGSGTYGTVYHGKWRG--S--DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPD 1038 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~rG--s--~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~D 1038 (1254)
.+|++.+.||+|+||.||+|.+.. . .+++|.++... .....+.+.+|+.++.++ +||||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-------SENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-------CHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 478899999999999999998742 2 36888776321 122345688899999999 79999999999876
Q ss_pred CCCCceEEEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLV 1103 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILL 1103 (1254)
.. .++++|||+.+++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill 152 (297)
T cd05089 75 RG--YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV 152 (297)
T ss_pred CC--cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE
Confidence 54 7899999999999999985432 248889999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhh
Q 040257 1104 NLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGA 1182 (1254)
Q Consensus 1104 Dsdd~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~e 1182 (1254)
+ .++.+||+|||++..............+..|+|||++.+.. ++.++|||||||++|||++ |..||.......
T Consensus 153 ~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~ 226 (297)
T cd05089 153 G----ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE 226 (297)
T ss_pred C----CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 8 67889999999986433222222223356799999987654 7889999999999999997 999998877766
Q ss_pred HHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1183 IIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1183 liqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
....+... .....+..++..+++|+.+||+.+|.+||++.++++.|+.+....+.
T Consensus 227 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 227 LYEKLPQG-YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 66655433 34455667899999999999999999999999999999988876544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=321.71 Aligned_cols=257 Identities=22% Similarity=0.403 Sum_probs=209.3
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||+|+||.||+|++ +++.||||.++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM-----DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN- 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC-----CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-
Confidence 3789999999999999999987 5788999988643211 2334567889999999999999999999987654
Q ss_pred CceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1042 GTLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.++++|||+.+++|..++.. ....+++..++.++.||+.||.|||+++|+|+||||+|||++ .++.++|+||
T Consensus 76 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~----~~~~~~l~d~ 150 (267)
T cd08228 76 -ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred -eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc----CCCCEEECcc
Confidence 78999999999999988743 234588999999999999999999999999999999999998 6778999999
Q ss_pred cccccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--hhHHHHhhhccCCCC
Q 040257 1119 GLSRIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC--GAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1119 GLAr~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~--~eliqsIlk~~Lrp~ 1195 (1254)
|++....... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..... ......+......+.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08228 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL 228 (267)
T ss_pred ccceeccchhHHHhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC
Confidence 9987543322 12234688899999999865 378899999999999999999999965432 333333333333333
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
....++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 34567889999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=325.45 Aligned_cols=258 Identities=30% Similarity=0.571 Sum_probs=210.5
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--Cc----eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GS----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs----~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
.+...+|++++.||+|+||+||+|++. ++ .||+|+++... .......+.+|+.+++.++|+||++++
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-------SPKANKEILDEAYVMAGVGSPYVCRLL 75 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-------CHHHHHHHHHHHHHHHhcCCCCCceEE
Confidence 355668999999999999999999873 33 37999886431 123346788999999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
+++... ..+++|||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+
T Consensus 76 ~~~~~~---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~----~~~~~ 148 (279)
T cd05109 76 GICLTS---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK----SPNHV 148 (279)
T ss_pred EEEcCC---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc----CCCcE
Confidence 998643 46789999999999999976666799999999999999999999999999999999999998 67789
Q ss_pred EEEeccccccccCccc---cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhh
Q 040257 1114 KVGDFGLSRIKRNTLV---SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~~---sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk 1189 (1254)
||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|||++ |..||...........+.
T Consensus 149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~- 225 (279)
T cd05109 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE- 225 (279)
T ss_pred EECCCCceeecccccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 9999999875432211 1122356789999999765 48899999999999999998 999998766555444333
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
.......+..++.++.+++.+||..||++||++.++++.|+.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 226 KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 333344556788999999999999999999999999999877644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=321.75 Aligned_cols=254 Identities=36% Similarity=0.646 Sum_probs=210.6
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
+...+|++.+.||+|++|.||+|.+. ++.||||.++.... ..+.+.+|+.++++++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---------cHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 44567999999999999999999874 55799999875321 135578899999999999999999998765
Q ss_pred CCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
. .++++|||+.+++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++ .++.+||+||
T Consensus 74 ~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~df 147 (261)
T cd05068 74 E--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG----ENNICKVADF 147 (261)
T ss_pred C--CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc----CCCCEEECCc
Confidence 5 7899999999999999986543 4689999999999999999999999999999999999998 7788999999
Q ss_pred cccccccCcccc--CCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1119 GLSRIKRNTLVS--GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1119 GLAr~~~~s~~s--ts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
|+++........ .....+..|+|||++.+. .++.++||||||+++|||++ |+.||...........+... ....
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~ 224 (261)
T cd05068 148 GLARVIKEDIYEAREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMP 224 (261)
T ss_pred ceEEEccCCcccccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCC
Confidence 999765432211 112234579999998865 47899999999999999999 99999887766666555433 3344
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
.+..++..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 5667889999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=326.00 Aligned_cols=252 Identities=34% Similarity=0.608 Sum_probs=207.3
Q ss_pred cCceEEEEEeeeCcEEEEEEEE------CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 964 VDLEELRELGSGTYGTVYHGKW------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~------rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.+|++.+.||+|+||+||+|.+ .+..+|+|.++... .......+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 77 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-------NPQQWGEFQQEASLMAELHHPNIVCLLGVVT 77 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-------CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe
Confidence 4789999999999999999985 24569999887431 1223457888999999999999999999987
Q ss_pred cCCCCceEEEEEecccCchhhhhhcc----------------CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCce
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKK----------------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENL 1101 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kr----------------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNI 1101 (1254)
... ..++||||+.+++|.+++..+ ...+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 78 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ni 155 (283)
T cd05090 78 QEQ--PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNI 155 (283)
T ss_pred cCC--ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceE
Confidence 655 789999999999999988432 12478889999999999999999999999999999999
Q ss_pred EeccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 040257 1102 LVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYAD 1177 (1254)
Q Consensus 1102 LLDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~ 1177 (1254)
|++ ..+.+||+|||+++..... .......++..|+|||++.+. .++.++|||||||++|||++ |..||..
T Consensus 156 li~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 156 LIG----EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred EEc----CCCcEEeccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 998 6778999999999754221 122334467789999999765 37899999999999999998 9999987
Q ss_pred CChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1178 MHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1178 ~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
.........+.... ....+..++..+.+++.+||+.+|.+||++.+|+++|+.
T Consensus 230 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 230 FSNQEVIEMVRKRQ-LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 76655555444433 344667789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=316.67 Aligned_cols=245 Identities=40% Similarity=0.687 Sum_probs=209.0
Q ss_pred EEEeeeCcEEEEEEEEC-----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCce
Q 040257 970 RELGSGTYGTVYHGKWR-----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTL 1044 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r-----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L 1044 (1254)
+.||+|+||.||++.+. +..|++|+++.... ....+.+.+|+.+++.++|+||+++++++.+. ..+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~ 71 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS-------EEERKDFLKEARVMKKLGHPNVVRLLGVCTEE--EPL 71 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc-------hhHHHHHHHHHHHHhhcCCCChheeeeeecCC--Cce
Confidence 36999999999999985 66799999875421 11456788999999999999999999999864 489
Q ss_pred EEEEEecccCchhhhhhcc--------CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1045 ATVTEFMVNGSLKHVLLKK--------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1045 ~LVMEYm~GGSL~d~L~kr--------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
++||||+.+++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||+++ .++.+||+
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~----~~~~~~l~ 147 (262)
T cd00192 72 YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG----EDLVVKIS 147 (262)
T ss_pred EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC----CCCcEEEc
Confidence 9999999999999999765 46799999999999999999999999999999999999998 77899999
Q ss_pred eccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccC
Q 040257 1117 DFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1117 DFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~L 1192 (1254)
|||.+...... .......++..|+|||.+... .++.++||||||+++|+|++ |..||...........+.. ..
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~ 224 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GY 224 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CC
Confidence 99999865432 223345578899999999865 48899999999999999999 6999998877666666654 33
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
....+..++.++.+++.+||+.+|.+||++.+++++|+
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 44567778999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.44 Aligned_cols=248 Identities=37% Similarity=0.656 Sum_probs=206.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.+|++.+.||+|+||.||++++. +..+|+|++.+... ....+.+|+.++++++|+||+++++++.+..
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR-- 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--
Confidence 46888999999999999999885 44699998864321 1245778999999999999999999987654
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
..++||||+++++|.+++......+++..++.++.||+.||.|||+++|+||||||+||+++ .++.+||+|||+++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~dfg~~~ 148 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG----EDNVVKVSDFGLAR 148 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC----CCCcEEECCcccce
Confidence 78999999999999999876666789999999999999999999999999999999999998 77899999999987
Q ss_pred cccCcccc--CCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1123 IKRNTLVS--GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1123 ~~~~s~~s--ts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
........ ....++..|+|||.+.+. .++.++||||||+++|+|++ |+.||......+....+.. ......+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (256)
T cd05059 149 YVLDDQYTSSQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-GYRLYRPKL 225 (256)
T ss_pred ecccccccccCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-CCcCCCCCC
Confidence 54332211 112244579999999865 37889999999999999999 8999987766665555443 344455667
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
++.++.+|+.+||..+|++||++.++++.|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.20 Aligned_cols=252 Identities=35% Similarity=0.620 Sum_probs=211.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.+|+++++||.|+||.||+|.+. +..+|+|++.... ......+.+|+.+++.++|+||+++++++.+..
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 75 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--------LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-- 75 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--------hhhHHHHHHHHHHHhcCCCcchhheeeeEecCC--
Confidence 46888999999999999999985 5679999987542 222456788999999999999999999997665
Q ss_pred ceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~----~~~~~kl~d~g~~ 151 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG----EDLVCKVADFGLA 151 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc----CCceEEEccccch
Confidence 789999999999999998653 35689999999999999999999999999999999999998 7789999999998
Q ss_pred ccccCccc-cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1122 RIKRNTLV-SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1122 r~~~~s~~-sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
........ .....++..|+|||++.+. .++.++||||||+++|+|++ |+.||......+.+..+.. ......+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 228 (261)
T cd05148 152 RLIKEDVYLSSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-GYRMPCPAK 228 (261)
T ss_pred hhcCCccccccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-CCcCCCCCC
Confidence 75433221 2223456789999998765 47889999999999999998 8999988776666665553 344555677
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
++..+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 229 CPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 899999999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=317.19 Aligned_cols=249 Identities=27% Similarity=0.492 Sum_probs=210.5
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|.+.+.||+|++|.||++.+ .++.|++|.+..... .......+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM------NRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC------CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC--
Confidence 578889999999999999988 467899999875322 1233567889999999999999999999987654
Q ss_pred ceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++... ...+++..++.++.+++.||.|||++||+|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~----~~~~~~l~df~~~ 148 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD----AYDNVKIGDLGVA 148 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe----CCCCEEEcccccc
Confidence 899999999999999998664 45689999999999999999999999999999999999998 7789999999998
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
+..... .......++..|+|||++.+.. ++.++||||||+++|+|++|+.||...........+..... +..+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 225 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCEDKP--YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF-PPVSQMY 225 (256)
T ss_pred eeccCccchhhccccCccccCHHHhcCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCcccc
Confidence 754332 2223456889999999998664 78899999999999999999999988776666666655433 3455578
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+..+.+++.+||+.+|++||++.+++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 8999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=342.21 Aligned_cols=242 Identities=28% Similarity=0.416 Sum_probs=202.4
Q ss_pred EEEeeeCcEEEEEEEE-----CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCce
Q 040257 970 RELGSGTYGTVYHGKW-----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTL 1044 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~-----rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L 1044 (1254)
+.||+|+||.||+++. .++.||+|++++... .......+.+|+.+|++++||||+++++++.+.. .+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 73 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL------KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG--KL 73 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--EE
Confidence 5799999999999875 367899999986421 1122345678999999999999999999997655 89
Q ss_pred EEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccc
Q 040257 1045 ATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1045 ~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~ 1124 (1254)
++||||+.+++|.+++.+ ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++..
T Consensus 74 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 74 YLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD----EEGHIKLTDFGLSKES 148 (318)
T ss_pred EEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC----CCCcEEEeeccCCccc
Confidence 999999999999998854 35689999999999999999999999999999999999998 7789999999998754
Q ss_pred cCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHH
Q 040257 1125 RNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPE 1203 (1254)
Q Consensus 1125 ~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~e 1203 (1254)
... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+.... ..++..+++.
T Consensus 149 ~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--~~~p~~~~~~ 224 (318)
T cd05582 149 IDHEKKAYSFCGTVEYMAPEVVNRRG--HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--LGMPQFLSPE 224 (318)
T ss_pred CCCCCceecccCChhhcCHHHHcCCC--CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHH
Confidence 333 2334467999999999998654 6889999999999999999999999877766666665443 3456778999
Q ss_pred HHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 040257 1204 WRKLMEQCWAADPEARPS-----FTEITSR 1228 (1254)
Q Consensus 1204 LrdLIkKCLqkDPeKRPS-----ArELLe~ 1228 (1254)
+.+||++||+.||++||+ +.+++++
T Consensus 225 ~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 225 AQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred HHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 999999999999999999 5556543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=324.97 Aligned_cols=254 Identities=33% Similarity=0.567 Sum_probs=206.6
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
+...+|++.+.||+|+||.||++.+. +..||||++.... ......++.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~iv~~~ 75 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 34457999999999999999998864 2459999875421 112345688999999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccC---------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEec
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVN 1104 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLD 1104 (1254)
+++.+.. ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+++||||||+|||++
T Consensus 76 ~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~ 153 (277)
T cd05062 76 GVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 153 (277)
T ss_pred EEEcCCC--CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc
Confidence 9997655 7899999999999999885422 2357788899999999999999999999999999999998
Q ss_pred cCCCCCCeEEEEeccccccccCccc---cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 040257 1105 LRDPQRPICKVGDFGLSRIKRNTLV---SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHC 1180 (1254)
Q Consensus 1105 sdd~snG~VKLiDFGLAr~~~~s~~---sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~ 1180 (1254)
.++.+||+|||+++....... .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.....
T Consensus 154 ----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 154 ----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred ----CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC--cCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 678999999999874332211 11223577899999998653 7899999999999999999 7899988776
Q ss_pred hhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1181 GAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1181 ~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
......+..... ...+..++..+.+|+.+||+.+|++||++.++++.|+
T Consensus 228 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 228 EQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 666655544332 3456678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=319.17 Aligned_cols=244 Identities=34% Similarity=0.625 Sum_probs=201.2
Q ss_pred EEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEE
Q 040257 971 ELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVT 1048 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVM 1048 (1254)
.||+|+||.||+|++ .++.+|+|.+.... .......+.+|++++++++||||+++++++.... .+++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 72 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL-------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIYIVM 72 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--CeEEEE
Confidence 599999999999988 57789999876421 2334567889999999999999999999997655 789999
Q ss_pred EecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCcc
Q 040257 1049 EFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL 1128 (1254)
Q Consensus 1049 EYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~ 1128 (1254)
||+.+++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++.......
T Consensus 73 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 73 ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT----EKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred eeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc----CCCcEEECccccCccccccc
Confidence 99999999999866556689999999999999999999999999999999999998 67789999999987543221
Q ss_pred cc---CCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHH
Q 040257 1129 VS---GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEW 1204 (1254)
Q Consensus 1129 ~s---ts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eL 1204 (1254)
.. .....+..|+|||.+.+.. ++.++||||||+++|||++ |..||...........+.. ......+..++..+
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 225 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGR--YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLPCPELCPDAV 225 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCC--CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCcccCCHHH
Confidence 11 1112345699999997654 7889999999999999998 9999987665544443333 33445667788999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1205 RKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1205 rdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
.+|+.+||+.+|++||++.++++.|+
T Consensus 226 ~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 226 YRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 99999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=340.53 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=197.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||.||++.+ .+..||||++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ------NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS 94 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc------chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence 3799999999999999999987 477899999875421 12234567789999999999999999999864431
Q ss_pred ----CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1042 ----GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1042 ----~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
..+++||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~----~~~~~kl~D 166 (359)
T cd07876 95 LEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILD 166 (359)
T ss_pred ccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEec
Confidence 357999999965 5655553 2478899999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc-------
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN------- 1190 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~------- 1190 (1254)
||+++............||..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+...
T Consensus 167 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 167 FGLARTACTNFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244 (359)
T ss_pred CCCccccccCccCCCCcccCCCCCchhccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence 99997654444444567899999999998764 788999999999999999999999876543322211110
Q ss_pred ---------------c--CC----------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1191 ---------------T--LR----------------PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1191 ---------------~--Lr----------------p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
. +. .......+.++++||.+||..||++|||+.|++++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0 00 001112457889999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=357.06 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=197.3
Q ss_pred cccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
...+|++++.||+|+||+||+|.+ .++.||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------------QYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 345799999999999999999988 46789999886431 1234699999999999999999876432
Q ss_pred ------CCCceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCC
Q 040257 1040 ------TGGTLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQR 1110 (1254)
Q Consensus 1040 ------n~~~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~sn 1110 (1254)
....+++||||+.+ +|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||||+. ..
T Consensus 132 ~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~---~~ 207 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP---NT 207 (440)
T ss_pred ccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC---CC
Confidence 22357799999964 66665532 3457999999999999999999999999999999999999972 33
Q ss_pred CeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc
Q 040257 1111 PICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN 1190 (1254)
Q Consensus 1111 G~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~ 1190 (1254)
+.+||+|||+++............||+.|+|||++.+.. .++.++|||||||+||||++|++||.+....+.+..+...
T Consensus 208 ~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 208 HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGAT-NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred CceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 479999999998654443344567899999999987642 4789999999999999999999999876654444333221
Q ss_pred c---------------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1191 T---------------------------LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1191 ~---------------------------Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
. +...++...+.++++||.+||++||.+|||+.|++++
T Consensus 287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 0011234567899999999999999999999999966
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=349.35 Aligned_cols=255 Identities=21% Similarity=0.355 Sum_probs=210.3
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|++++.||+|+||.||++++. ++.||+|++.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 44568999999999999999999984 677999999753211 12223457789999999999999999999986
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
+. .+++||||+.+|+|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++ ..+.+||+||
T Consensus 115 ~~--~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~----~~~~~kL~DF 186 (370)
T cd05621 115 DK--YLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD----KHGHLKLADF 186 (370)
T ss_pred CC--EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEEEEec
Confidence 55 89999999999999998854 3588999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCcc--ccCCCCCCCCccCcccccCCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC
Q 040257 1119 GLSRIKRNTL--VSGGVRGTLPWMAPELLNGSS--NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1119 GLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~--~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
|++....... .....+||+.|+|||++.+.. ..++.++|||||||+||+|++|+.||...........+.......
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc
Confidence 9998653322 223567999999999997643 237889999999999999999999999887777777666544333
Q ss_pred CCCC--CCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 040257 1195 TIPE--RCDPEWRKLMEQCWAADPEA--RPSFTEITSR 1228 (1254)
Q Consensus 1195 ~ipe--~iS~eLrdLIkKCLqkDPeK--RPSArELLe~ 1228 (1254)
..+. .++..+++++.+||..++.+ |+++.+++++
T Consensus 267 ~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 3443 46889999999999865544 8899999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=339.04 Aligned_cols=250 Identities=28% Similarity=0.460 Sum_probs=202.3
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|++.+.||+|+||.||++.+. +..+|+|++.... ......++.+|++++++++|+||++++++|.+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 44568999999999999999999985 6679999886531 12345678899999999999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC-CcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk-GIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
.. .+++||||+.+++|.+++... +.+++..+..++.+++.||.|||+. +|+||||||+|||++ .++.+||+|
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~----~~~~~kL~D 147 (333)
T cd06650 75 DG--EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCD 147 (333)
T ss_pred CC--EEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc----CCCCEEEee
Confidence 65 899999999999999998543 5689999999999999999999975 799999999999998 678899999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHH-----------
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGG----------- 1186 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqs----------- 1186 (1254)
||++...... ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||...........
T Consensus 148 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (333)
T cd06650 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE 224 (333)
T ss_pred CCcchhhhhh-ccccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccc
Confidence 9998754332 22345689999999999865 478899999999999999999999975433222110
Q ss_pred ---------------------------------hhhccCCCCC-CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1187 ---------------------------------IVKNTLRPTI-PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1187 ---------------------------------Ilk~~Lrp~i-pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+... ..+.. ...++.++++||.+||++||++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE-PPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cccCcccCCccchhhhhcccccccccHHHHHHHHhcC-CCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0011 11111 12357889999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=327.40 Aligned_cols=258 Identities=36% Similarity=0.589 Sum_probs=213.0
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
++..+|.+.+.||+|+||.||++++. +..+++|.++.. .....+.+.+|+.++++++|+||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--------TLAARKDFQREAELLTNLQHEHIVKFY 73 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--------cHHHHHHHHHHHHHHhcCCCCCcceEE
Confidence 45568899999999999999999853 234888887643 122345688999999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCC
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKC 1098 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKP 1098 (1254)
+++.... ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||
T Consensus 74 ~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 151 (291)
T cd05094 74 GVCGDGD--PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLAT 151 (291)
T ss_pred EEEccCC--ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCc
Confidence 9997654 7899999999999999985432 3478999999999999999999999999999999
Q ss_pred CceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 040257 1099 ENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEP 1174 (1254)
Q Consensus 1099 eNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~P 1174 (1254)
+|||++ .++.+||+|||++....... ......++..|+|||.+.+. .++.++|||||||++|||++ |+.|
T Consensus 152 ~Nil~~----~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p 225 (291)
T cd05094 152 RNCLVG----ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP 225 (291)
T ss_pred ceEEEc----cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999998 77899999999987543221 12234467889999999865 47889999999999999999 9999
Q ss_pred CCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1175 YADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1175 F~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
|...........+.... ....+..++..+.+|+.+||+.+|.+||++.++++.|+++...
T Consensus 226 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 226 WFQLSNTEVIECITQGR-VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCCHHHHHHHHhCCC-CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 98877766666554433 3344556788999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=332.38 Aligned_cols=260 Identities=34% Similarity=0.579 Sum_probs=209.5
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--Cc--eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GS--DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGV 1035 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs--~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGv 1035 (1254)
++-.+|++.+.||+|+||.||+|.++ +. .+|+|.++... .......+.+|+.++.++ +|+||++++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~ 76 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGA 76 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-------CHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 44568999999999999999999874 33 35777665321 123346788899999999 89999999999
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCc
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCEN 1100 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeN 1100 (1254)
+.+.. .+++||||+.+++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 77 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~N 154 (303)
T cd05088 77 CEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 154 (303)
T ss_pred ECCCC--CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchhe
Confidence 97655 7999999999999999885432 257899999999999999999999999999999999
Q ss_pred eEeccCCCCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 040257 1101 LLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMH 1179 (1254)
Q Consensus 1101 ILLDsdd~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n 1179 (1254)
||++ .++.+||+|||++.............++..|+|||.+.+.. ++.++|||||||++|||+| |..||....
T Consensus 155 ili~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 155 ILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred EEec----CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccC--CcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 9998 67899999999986432221222223466799999987653 7889999999999999998 999998776
Q ss_pred hhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1180 CGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1180 ~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
..+....+.. ......+..++.++.+|+.+||+.+|++||++.++++.|+.+...-
T Consensus 229 ~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 229 CAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred hHHHHHHHhc-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 6665554432 3334455667899999999999999999999999999998876553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=345.68 Aligned_cols=249 Identities=23% Similarity=0.378 Sum_probs=204.6
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||++++. ++.||||++++.... .......+.+|+.++..++|++|+++++++.+..
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-- 74 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-----EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR-- 74 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--
Confidence 6899999999999999999884 678999999753211 2234567788999999999999999999998665
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~----~~~~vkL~DfG~~~ 149 (360)
T cd05627 75 NLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD----AKGHVKLSDFGLCT 149 (360)
T ss_pred EEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEEeeccCCc
Confidence 899999999999999998544 5689999999999999999999999999999999999998 77899999999986
Q ss_pred cccCc------------------------------------cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHH
Q 040257 1123 IKRNT------------------------------------LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMW 1166 (1254)
Q Consensus 1123 ~~~~s------------------------------------~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILY 1166 (1254)
..... ......+||+.|+|||++.+.. ++.++|||||||+||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~~~~~DiwSlGvily 227 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG--YNKLCDWWSLGVIMY 227 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC--CCCcceeccccceee
Confidence 43211 0112356999999999998764 788999999999999
Q ss_pred HHHcCCCCCCCCChhhHHHHhhhccCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 040257 1167 EILTGEEPYADMHCGAIIGGIVKNTLRPTIP--ERCDPEWRKLMEQCWAADPEARPS---FTEITSR 1228 (1254)
Q Consensus 1167 ELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip--e~iS~eLrdLIkKCLqkDPeKRPS---ArELLe~ 1228 (1254)
||++|+.||...........+........++ ..++.++++||.+|+ .+|.+|++ +.+++++
T Consensus 228 el~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 228 EMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred ecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 9999999999887777666665432222223 236889999999977 49999984 7788776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=355.50 Aligned_cols=251 Identities=27% Similarity=0.453 Sum_probs=225.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||+|.||+|-++.. .|+.||||.|++..+. .+...-.+.+||+||..|+||||+.+|.+|.. .
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk-----deqDlvhIRREIeIMSsLNHPhII~IyEVFEN--k 125 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK-----DEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN--K 125 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc-----cHHHHHHHHHHHHHHhhcCCCceeehhhhhcC--C
Confidence 4788899999999999999876 4889999999876542 23345578899999999999999999999964 4
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..+.|||||..+|.|.+++.++ +.+++..++.+++||..|+.|+|.++++|||||.+||||| .++++||+|||++
T Consensus 126 dKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD----~N~NiKIADFGLS 200 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD----QNNNIKIADFGLS 200 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec----CCCCeeeeccchh
Confidence 4899999999999999999655 5699999999999999999999999999999999999999 8899999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
..........++||++-|.+||++.|.+|+ .+.+|.||||++||-|+.|..||++.+...++.+|..+.++.. .-+
T Consensus 201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~-GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP---~~P 276 (668)
T KOG0611|consen 201 NLYADKKFLQTFCGSPLYASPEIVNGTPYK-GPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP---ETP 276 (668)
T ss_pred hhhccccHHHHhcCCcccCCccccCCCCCC-CCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC---CCC
Confidence 988888888899999999999999999865 7789999999999999999999999999999999998887643 235
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
....-||++||-.+|++|.|+.+|..++.
T Consensus 277 SdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 277 SDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred chHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 56789999999999999999999999874
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.41 Aligned_cols=243 Identities=26% Similarity=0.463 Sum_probs=199.6
Q ss_pred EEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhc-CCCCceeEEeeeeecCCCCceEE
Q 040257 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN-LHHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkr-LnHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+.||+|+||+||+|++. ++.||||++++.... .....+.+..|..++.. ++||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-----EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE--HLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEE
Confidence 36999999999999984 567999999864321 11223445567777764 48999999999997654 8999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccC
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN 1126 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~ 1126 (1254)
||||+.+++|..++... ..+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 74 VMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD----KDGHIKIADFGMCKENMN 148 (316)
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC----CCCCEEEccCcCCeECCC
Confidence 99999999999888544 5689999999999999999999999999999999999998 778999999999975322
Q ss_pred -ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHH
Q 040257 1127 -TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205 (1254)
Q Consensus 1127 -s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLr 1205 (1254)
.......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+....+... .+.++..++.++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 224 (316)
T cd05592 149 GEGKASTFCGTPDYIAPEILKGQK--YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--RPHFPRWISKEAK 224 (316)
T ss_pred CCCccccccCCccccCHHHHcCCC--CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHH
Confidence 23334567999999999998764 788999999999999999999999988777766666543 3456777899999
Q ss_pred HHHHHhhhcCCCCCCCHH-HHHHH
Q 040257 1206 KLMEQCWAADPEARPSFT-EITSR 1228 (1254)
Q Consensus 1206 dLIkKCLqkDPeKRPSAr-ELLe~ 1228 (1254)
+||.+||..+|.+||++. +++++
T Consensus 225 ~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 225 DCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHcC
Confidence 999999999999999875 56553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.86 Aligned_cols=253 Identities=32% Similarity=0.551 Sum_probs=208.7
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeee
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGV 1035 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGv 1035 (1254)
..+|++++.||+|+||+||+|.+. +..||||+++... .......+.+|+.+++.++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 346778889999999999999873 3569999987431 12345678899999999999999999999
Q ss_pred eecCCCCceEEEEEecccCchhhhhhcc---------------CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCc
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKK---------------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCEN 1100 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kr---------------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeN 1100 (1254)
+.+.. .+++++||+.+++|.+++..+ ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 77 ~~~~~--~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~N 154 (283)
T cd05091 77 VTKEQ--PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN 154 (283)
T ss_pred EcCCC--ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhh
Confidence 97665 788999999999999887432 2347888899999999999999999999999999999
Q ss_pred eEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 040257 1101 LLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYA 1176 (1254)
Q Consensus 1101 ILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~ 1176 (1254)
||++ .++.+||+|||+++...... ......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.
T Consensus 155 il~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~ 228 (283)
T cd05091 155 VLVF----DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYC 228 (283)
T ss_pred eEec----CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCC--CCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 9998 67789999999987542211 122334677899999987553 7889999999999999998 889998
Q ss_pred CCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1177 DMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1177 ~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
.....+....+..... ...+..++..+.+|+.+||+.+|.+||++++|+..|+.
T Consensus 229 ~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 229 GYSNQDVIEMIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 8777766666655443 34567889999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=317.63 Aligned_cols=250 Identities=37% Similarity=0.659 Sum_probs=212.3
Q ss_pred cccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
...+|++.+.||.|+||.||++...++.||||.++... . ..+++.+|+.+++.++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~--------~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 73 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS--------T-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN- 73 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEecCcEEEEEEeccch--------h-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC-
Confidence 44578999999999999999999999999999987531 1 3567889999999999999999999987644
Q ss_pred CceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++|+|+||||+||+++ .++.+||+|||.
T Consensus 74 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~----~~~~~~l~d~g~ 148 (256)
T cd05039 74 -PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS----EDLVAKVSDFGL 148 (256)
T ss_pred -CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe----CCCCEEEccccc
Confidence 7899999999999999986554 2689999999999999999999999999999999999998 778999999999
Q ss_pred cccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1121 SRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1121 Ar~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
++....... ....+..|+|||.+... .++.++||||||+++|+|++ |..||...........+.. ......+..
T Consensus 149 ~~~~~~~~~--~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 223 (256)
T cd05039 149 AKEASQGQD--SGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEG 223 (256)
T ss_pred ccccccccc--cCCCcccccCchhhcCC--cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCCCccC
Confidence 976533222 23356779999998755 47889999999999999997 9999988776665554443 334455667
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
+++.+.+||.+||..+|++||++.++++.|+.
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 88999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=324.71 Aligned_cols=253 Identities=30% Similarity=0.535 Sum_probs=202.2
Q ss_pred ceEEEEEeeeCcEEEEEEEE------CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 966 LEELRELGSGTYGTVYHGKW------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~------rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
|++++.||+|+||+||++.. .+..||+|.++... .......+.+|+++|++++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-------GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 48899999999999988653 35679999987532 112345678899999999999999999998765
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
....+++||||+.+++|.+++.. ..+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg 152 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD----NDRLVKIGDFG 152 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc----CCCcEEEeecc
Confidence 55578999999999999999854 3589999999999999999999999999999999999998 67899999999
Q ss_pred ccccccCccc----cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh--------------
Q 040257 1120 LSRIKRNTLV----SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG-------------- 1181 (1254)
Q Consensus 1120 LAr~~~~s~~----sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~-------------- 1181 (1254)
+++....... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccch
Confidence 9875433211 1222356679999998765 4788999999999999999999998643211
Q ss_pred hHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1182 AIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1182 eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
...............+..++.++.+|+.+||+.+|++||+++++++.|+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0111111122223345667899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.89 Aligned_cols=243 Identities=22% Similarity=0.416 Sum_probs=203.2
Q ss_pred EEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCCCceEE
Q 040257 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+.||+|+||+||++++. ++.||||++++.... .......+.+|+.+++.+ +||||+++++++.+.. .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~--~~~l 73 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-----QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD--RLFF 73 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEE
Confidence 36999999999999984 567999999864321 122345667888898877 7999999999997655 8999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc-
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR- 1125 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~- 1125 (1254)
||||+.+++|..++.+. ..+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 74 VMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD----SEGHIKIADFGMCKEGIL 148 (318)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC----CCCcEEecccCCCeecCc
Confidence 99999999999888543 5699999999999999999999999999999999999998 77899999999986432
Q ss_pred CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHH
Q 040257 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205 (1254)
Q Consensus 1126 ~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLr 1205 (1254)
........+||..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.... ...+..++..+.
T Consensus 149 ~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 224 (318)
T cd05570 149 GGVTTSTFCGTPDYIAPEILSYQP--YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--VRYPRWLSKEAK 224 (318)
T ss_pred CCCcccceecCccccCHHHhcCCC--CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCcCCHHHH
Confidence 222233456999999999998764 7889999999999999999999998877777666665443 345667899999
Q ss_pred HHHHHhhhcCCCCCCCH-----HHHHHH
Q 040257 1206 KLMEQCWAADPEARPSF-----TEITSR 1228 (1254)
Q Consensus 1206 dLIkKCLqkDPeKRPSA-----rELLe~ 1228 (1254)
+||++||..||.+||++ .+++++
T Consensus 225 ~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 225 SILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 99999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=355.12 Aligned_cols=247 Identities=21% Similarity=0.351 Sum_probs=207.8
Q ss_pred CceEEEEEeeeCcEEEEEEEEC---CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR---GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r---Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.|.+.+.||+|+||.||++... +..||+|.+... .......+.+|+.+|+.++||||++++++|....
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~- 138 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--------DERQAAYARSELHCLAACDHFGIVKHFDDFKSDD- 138 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC-
Confidence 4899999999999999999873 456888876432 1223356778999999999999999999998665
Q ss_pred CceEEEEEecccCchhhhhhcc---CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKK---DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kr---e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.+++||||+.+|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++ ..+.+||+||
T Consensus 139 -~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~~kL~DF 213 (478)
T PTZ00267 139 -KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM----PTGIIKLGDF 213 (478)
T ss_pred -EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC----CCCcEEEEeC
Confidence 899999999999999887532 34689999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1119 GLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1119 GLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
|+++...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||........+..+...... .
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~ 290 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-P 290 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-C
Confidence 9998654321 23456799999999999865 4889999999999999999999999887777777766655443 3
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+..++.++++||.+||..+|++||++.+++.+
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 456688999999999999999999999998754
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=321.91 Aligned_cols=254 Identities=34% Similarity=0.598 Sum_probs=209.4
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEECC-------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~rG-------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
+...+|++.+.||+|+||.||++.+++ ..||+|.+.... .......+.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-------SMRERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-------CHHHHHHHHHHHHHHHhCCCCceeEEE
Confidence 445689999999999999999998742 569999976431 122345678899999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccC---------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEec
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVN 1104 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLD 1104 (1254)
+++.... ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++
T Consensus 76 ~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~ 153 (277)
T cd05032 76 GVVSTGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA 153 (277)
T ss_pred EEEcCCC--CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc
Confidence 9987664 7899999999999999985422 2367889999999999999999999999999999999998
Q ss_pred cCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 040257 1105 LRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHC 1180 (1254)
Q Consensus 1105 sdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~ 1180 (1254)
.++.+||+|||+++...... ......++..|+|||.+.+. .++.++|||||||++|||++ |..||.....
T Consensus 154 ----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 227 (277)
T cd05032 154 ----EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227 (277)
T ss_pred ----CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence 77899999999987543221 12233467889999998755 37889999999999999998 9999988776
Q ss_pred hhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1181 GAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1181 ~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
......+... .....+..++.++.+|+.+||+.+|++|||+.++++.|+
T Consensus 228 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 228 EEVLKFVIDG-GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 6666655533 334566778999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.12 Aligned_cols=243 Identities=24% Similarity=0.414 Sum_probs=197.9
Q ss_pred EEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCCCceEE
Q 040257 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+.||+|+||+||++++. ++.||||++++.... .......+.+|+.+++.+ +||||++++++|.+.. .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~--~~~l 73 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-----DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES--RLFF 73 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC--EEEE
Confidence 36999999999999984 678999999864221 223345678899999888 7999999999997665 8999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccc-c
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK-R 1125 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~-~ 1125 (1254)
||||+.+++|..++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~e~~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 74 VIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD----AEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEECcCcccccccc
Confidence 9999999999888754 35799999999999999999999999999999999999998 7789999999998742 2
Q ss_pred CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---------hhHHHHhhhccCCCCC
Q 040257 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC---------GAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1126 ~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~---------~eliqsIlk~~Lrp~i 1196 (1254)
........+||..|+|||++.+.. ++.++|||||||++|+|++|+.||..... ......+... ...+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 224 (329)
T cd05588 149 PGDTTSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRI 224 (329)
T ss_pred CCCccccccCCccccCHHHHcCCC--CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCC
Confidence 222334567999999999998764 78899999999999999999999963211 1122333332 2346
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPS------FTEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPS------ArELLe~ 1228 (1254)
+..++..+.++|++||+.||.+|++ +.+++++
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 6778999999999999999999987 6777765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=326.33 Aligned_cols=258 Identities=30% Similarity=0.551 Sum_probs=212.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECC-------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVA 1031 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVk 1031 (1254)
.+...+|++.+.||+|+||.||++.+.+ ..+|+|.+.... .......+.+|+.+++++ +|+||++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i~~ 80 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNIIN 80 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-------CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 4556689999999999999999998742 468999887431 122345688999999999 8999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhcc---------------CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccC
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK---------------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDL 1096 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kr---------------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDL 1096 (1254)
+++++.... .++++|||+.+++|..++..+ ...+++..++.++.||+.||.|||+++|+||||
T Consensus 81 ~~~~~~~~~--~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dl 158 (293)
T cd05053 81 LLGVCTQEG--PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDL 158 (293)
T ss_pred EEEEEcCCC--CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 999987654 789999999999999998532 346889999999999999999999999999999
Q ss_pred CCCceEeccCCCCCCeEEEEeccccccccCccc---cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CC
Q 040257 1097 KCENLLVNLRDPQRPICKVGDFGLSRIKRNTLV---SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GE 1172 (1254)
Q Consensus 1097 KPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~---sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk 1172 (1254)
||+|||++ .++.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|||++ |.
T Consensus 159 kp~Nil~~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~ 232 (293)
T cd05053 159 AARNVLVT----EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGG 232 (293)
T ss_pred ceeeEEEc----CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCC
Confidence 99999998 778999999999975433211 1122345679999998765 37889999999999999998 99
Q ss_pred CCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1173 EPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1173 ~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
.||......+....+... .....+..++..+.+|+.+||..+|.+|||+.++++.|+.+.
T Consensus 233 ~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 233 SPYPGIPVEELFKLLKEG-YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 999887766666555433 344556678899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=319.70 Aligned_cols=254 Identities=32% Similarity=0.537 Sum_probs=207.6
Q ss_pred ceEEEEEeeeCcEEEEEEEEC-----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 966 LEELRELGSGTYGTVYHGKWR-----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r-----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
|++++.||+|+||.||+|.+. +..||||+++.... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH------TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC------CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 567789999999999999873 25699999875321 1223467889999999999999999999876543
Q ss_pred C----CceEEEEEecccCchhhhhhcc-----CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCC
Q 040257 1041 G----GTLATVTEFMVNGSLKHVLLKK-----DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRP 1111 (1254)
Q Consensus 1041 ~----~~L~LVMEYm~GGSL~d~L~kr-----e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG 1111 (1254)
. ...+++|||+.+++|..++... ...+++..++.++.|++.||.|||+++|+||||||+||+++ +++
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~----~~~ 150 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR----EDM 150 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC----CCC
Confidence 2 2478999999999999887432 23589999999999999999999999999999999999998 778
Q ss_pred eEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHh
Q 040257 1112 ICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGI 1187 (1254)
Q Consensus 1112 ~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsI 1187 (1254)
.+||+|||+++...... ......++..|+|||.+.+. .++.++|||||||++|||++ |..||......+....+
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05035 151 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228 (273)
T ss_pred eEEECCccceeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999997543221 11123356789999998755 47889999999999999999 99999887776666655
Q ss_pred hhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1188 lk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
... .....+..++..+.+++.+||..||.+||++.++++.|+.+
T Consensus 229 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 544 34456777899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=321.91 Aligned_cols=253 Identities=36% Similarity=0.635 Sum_probs=209.4
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--C---ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--G---SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--G---s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
.+|++.+.||+|+||.||+|.+. + ..||||.++... ......+|.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 46889999999999999999874 2 259999986431 23345678999999999999999999999876
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
+. .+++||||+.+++|.+++....+.+++..++.++.|++.||.|||++|++|+||||+||+++ .++.+||+||
T Consensus 77 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~----~~~~~kl~df 150 (269)
T cd05065 77 SR--PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSDF 150 (269)
T ss_pred CC--ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc----CCCcEEECCC
Confidence 55 78999999999999999876666789999999999999999999999999999999999998 6789999999
Q ss_pred cccccccCcccc----CCCC--CCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhcc
Q 040257 1119 GLSRIKRNTLVS----GGVR--GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNT 1191 (1254)
Q Consensus 1119 GLAr~~~~s~~s----ts~~--GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~ 1191 (1254)
|++......... .... .+..|+|||.+.+. .++.++|||||||++|||++ |..||...........+.. .
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~-~ 227 (269)
T cd05065 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-D 227 (269)
T ss_pred ccccccccCccccccccccCCCcceeecCHhHhccC--cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-C
Confidence 998754332111 1111 24579999999865 47889999999999999887 9999988776666655533 3
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1192 Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
.....+..++..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 34445567889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.51 Aligned_cols=248 Identities=37% Similarity=0.551 Sum_probs=201.2
Q ss_pred ceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
|++++.||+|+||+||+++.. ++.||+|++.... ..........+|+.++++++||||+++++++.+.. .
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~ 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE------IEEEEREENIREIKILRRLRHPNIVQILDVFQDDN--Y 72 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS--E
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc------ccccccchhhhhhhccccccccccccccccccccc--c
Confidence 688999999999999999995 4469999998652 12233334566999999999999999999998754 8
Q ss_pred eEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
+++||||+.+++|.+++. ....+++..++.++.||++||.+||+++|+|+||||+|||++ .++.++|+|||.+..
T Consensus 73 ~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~----~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD----ENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES----TTSEEEESSGTTTEE
T ss_pred cccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc----ccccccccccccccc
Confidence 899999999999999986 446789999999999999999999999999999999999999 788999999999875
Q ss_pred c-cCccccCCCCCCCCccCccccc-CCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---hhHHHHhhhccCCCCC--
Q 040257 1124 K-RNTLVSGGVRGTLPWMAPELLN-GSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC---GAIIGGIVKNTLRPTI-- 1196 (1254)
Q Consensus 1124 ~-~~s~~sts~~GT~~YmAPEVLr-G~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~---~eliqsIlk~~Lrp~i-- 1196 (1254)
. ..........++..|+|||++. +. .++.++||||||+++|+|++|..||..... ...+............
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T PF00069_consen 148 LSENNENFNPFVGTPEYMAPEVLQQGK--KYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ 225 (260)
T ss_dssp STSTTSEBSSSSSSGGGSCHHHHTTTS--SBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS
T ss_pred ccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc
Confidence 2 3333445567899999999988 44 478999999999999999999999998732 2222222221111111
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.......+.++|.+||+.||++||++.+++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11224899999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=325.63 Aligned_cols=254 Identities=31% Similarity=0.545 Sum_probs=207.8
Q ss_pred CceEEEEEeeeCcEEEEEEEECC-------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 965 DLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~rG-------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
+|++.+.||+|+||+||+|.+.. ..+++|.+.... ......++.+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-------SSSELRDLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-------CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 46788899999999999998742 358888876432 1122467889999999999999999999987
Q ss_pred cCCCCceEEEEEecccCchhhhhhcc-----------------------CCCCCHHHHHHHHHHhhhhhHHhhhCCcccc
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKK-----------------------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHF 1094 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kr-----------------------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHR 1094 (1254)
... ..+++|||+.+++|.+++... ...+++..++.++.|++.||.|||+++|+||
T Consensus 74 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~ 151 (290)
T cd05045 74 QDG--PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151 (290)
T ss_pred cCC--CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehh
Confidence 655 788999999999999987532 1347889999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 040257 1095 DLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170 (1254)
Q Consensus 1095 DLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT- 1170 (1254)
||||+|||++ .++.+||+|||+++...... ......++..|+|||.+.+. .++.++||||||+++|||++
T Consensus 152 dikp~nill~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~ 225 (290)
T cd05045 152 DLAARNVLVA----EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTL 225 (290)
T ss_pred hhhhheEEEc----CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhc
Confidence 9999999998 67899999999987532211 12223456789999998765 47899999999999999998
Q ss_pred CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1171 GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1171 Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
|..||...........+ ........+..++.++.+|+.+||+.+|++||++.++++.|++++.
T Consensus 226 g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 226 GGNPYPGIAPERLFNLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 99999877665555443 3334555677789999999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=351.54 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=215.8
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|++..+||.|..++||+|+. ++..||||++..... + ...+.+.+|+..++.++||||++++..|..
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc------~-~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC------N-NDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh------h-hhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 4456899999999999999999987 578899999985432 1 125778999999999999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+. .+++||.||.+||+.++++.. ...+.+..+..|++++++||.|||++|.||||||+.||||+ ++|.|||+|
T Consensus 96 ~~--~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~----~dG~VkLad 169 (516)
T KOG0582|consen 96 DS--ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID----SDGTVKLAD 169 (516)
T ss_pred cc--eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc----CCCcEEEcC
Confidence 76 899999999999999999654 34499999999999999999999999999999999999999 899999999
Q ss_pred ccccccccCc-----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC
Q 040257 1118 FGLSRIKRNT-----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1118 FGLAr~~~~s-----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L 1192 (1254)
||.+-..... .....+.||+.|||||+++..-..|++|+||||||++.+||.+|+.||..+..-+++...+++..
T Consensus 170 Fgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~p 249 (516)
T KOG0582|consen 170 FGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDP 249 (516)
T ss_pred ceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCC
Confidence 9976532111 11256789999999999877777899999999999999999999999999888777666555543
Q ss_pred CCC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 RPT--------IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 rp~--------ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+.. ....++..++.+|..||.+||.+|||+.++|++
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 211 113356789999999999999999999999965
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=322.37 Aligned_cols=255 Identities=35% Similarity=0.571 Sum_probs=203.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEE------CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 964 VDLEELRELGSGTYGTVYHGKW------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~------rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.+|++++.||+|+||+||++.. .+..||||++... .....+.+.+|++++++++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 75 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--------TAEHLRDFEREIEILKSLQHDNIVKYKGVCY 75 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEc
Confidence 4788999999999999999875 3567999998643 1233467889999999999999999999876
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
......+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~----~~~~~~l~d 151 (284)
T cd05081 76 SAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE----SENRVKIGD 151 (284)
T ss_pred cCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC----CCCeEEECC
Confidence 5555578999999999999999866556689999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccc----cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh------------
Q 040257 1118 FGLSRIKRNTLV----SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG------------ 1181 (1254)
Q Consensus 1118 FGLAr~~~~s~~----sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~------------ 1181 (1254)
||+++....... .....++..|+|||++.+. .++.++|||||||++|||++|..++......
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05081 152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQ 229 (284)
T ss_pred CcccccccCCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccc
Confidence 999985432211 1112234569999999765 4788999999999999999988776432111
Q ss_pred ---hHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1182 ---AIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1182 ---eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
..+............+..++.++.+|+.+||..+|++|||+.+|++.|+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 001112222333344567889999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=350.29 Aligned_cols=261 Identities=31% Similarity=0.506 Sum_probs=212.8
Q ss_pred cccccccCceEEEEEeeeCcEEEEEEEECC-------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCce
Q 040257 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNV 1029 (1254)
Q Consensus 958 lq~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNI 1029 (1254)
.+.+...+|+++++||+|+||.||+|++.+ ..||||+++... .....+.+.+|+++|+++. ||||
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~Ei~~l~~l~~HpnI 103 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-------RSSEKQALMSELKIMTHLGPHLNI 103 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhcCCCCCe
Confidence 345567789999999999999999998732 359999986431 1223467899999999996 9999
Q ss_pred eEEeeeeecCCCCceEEEEEecccCchhhhhhccC---------------------------------------------
Q 040257 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD--------------------------------------------- 1064 (1254)
Q Consensus 1030 VkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre--------------------------------------------- 1064 (1254)
+++++++.+.. .+++||||+.+|+|.+++.+..
T Consensus 104 v~l~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (400)
T cd05105 104 VNLLGACTKSG--PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMK 181 (400)
T ss_pred eeEEEEEccCC--ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccc
Confidence 99999997654 7999999999999998875421
Q ss_pred --------------------------------------------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccc
Q 040257 1065 --------------------------------------------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHF 1094 (1254)
Q Consensus 1065 --------------------------------------------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHR 1094 (1254)
..+++..++.++.||+.||.|||+.+|+||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~ 261 (400)
T cd05105 182 QADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHR 261 (400)
T ss_pred cccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 236788889999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 040257 1095 DLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170 (1254)
Q Consensus 1095 DLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT- 1170 (1254)
||||+|||++ .++.+||+|||+++...... ......++..|+|||++.+. .++.++|||||||+||||++
T Consensus 262 dikp~Nill~----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~ 335 (400)
T cd05105 262 DLAARNVLLA----QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSL 335 (400)
T ss_pred CCChHhEEEe----CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHC
Confidence 9999999998 67889999999987543221 12233467889999999865 37899999999999999997
Q ss_pred CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1171 GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1171 Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
|..||.....................+..++.++.+++.+||+.+|++||++.+|.+.|+.+.
T Consensus 336 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 336 GGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred CCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 999998765554444444444455566778999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=317.78 Aligned_cols=248 Identities=25% Similarity=0.430 Sum_probs=208.3
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|+||.||++++. +..+|+|.++... .....+.+.+|+.+++.++|+||+++++.+.+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-------SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG-- 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-------chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--
Confidence 5788999999999999999884 6779999986432 1223466788999999999999999999997665
Q ss_pred ceEEEEEecccCchhhhhhc-cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLK-KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~k-re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.++++|||+++++|.+++.. ....+++..++.++.||+.||.|||+++|+|+||||+|||++ .++.++|+|||++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~----~~~~~~l~dfg~~ 147 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFGSA 147 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC----CCCcEEEcccCcc
Confidence 89999999999999988754 345589999999999999999999999999999999999998 7789999999998
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
...... .......++..|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+..... ...+..+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 224 (255)
T cd08219 148 RLLTSPGAYACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-KPLPSHY 224 (255)
T ss_pred eeecccccccccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-CCCCccc
Confidence 754332 222345688999999999865 378899999999999999999999988776666655554433 3355678
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+..+++||.+||..+|++||++.++++.
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 8999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.30 Aligned_cols=243 Identities=26% Similarity=0.409 Sum_probs=199.0
Q ss_pred EEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHH-HHhcCCCCceeEEeeeeecCCCCceEE
Q 040257 970 RELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH-ILSNLHHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIe-ILkrLnHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+.||+|+||+||++++ +++.||||++.+.... .......+.+|.. +++.++||||+++++++.+.. .+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~--~~~l 73 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-----KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD--KLYF 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC--EEEE
Confidence 3699999999999998 4778999999754221 1122234555554 567899999999999997655 8999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc-
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR- 1125 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~- 1125 (1254)
||||+.+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~----~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 74 VLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred EEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeccCCCccccc
Confidence 9999999999988854 45789999999999999999999999999999999999998 77899999999987432
Q ss_pred CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHH
Q 040257 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205 (1254)
Q Consensus 1126 ~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLr 1205 (1254)
........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+..... ..+..++..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (323)
T cd05575 149 HSKTTSTFCGTPEYLAPEVLRKQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--RLKPNISVSAR 224 (323)
T ss_pred CCCccccccCChhhcChhhhcCCC--CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 222334467999999999998764 78899999999999999999999998877777766665433 34556799999
Q ss_pred HHHHHhhhcCCCCCCCHH----HHHHH
Q 040257 1206 KLMEQCWAADPEARPSFT----EITSR 1228 (1254)
Q Consensus 1206 dLIkKCLqkDPeKRPSAr----ELLe~ 1228 (1254)
+||++||+.||.+||+++ +++++
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 225 HLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 999999999999999874 55543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=321.81 Aligned_cols=254 Identities=35% Similarity=0.626 Sum_probs=210.0
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC-----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR-----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r-----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
..+|++.+.||+|+||.||+|++. +..+|+|.++... .....+.+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 347889999999999999999873 2258999886431 1223567889999999999999999999997
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
++. ..++||||+.+++|.+++.+....+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 76 ~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~----~~~~~~l~d 149 (267)
T cd05066 76 KSK--PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN----SNLVCKVSD 149 (267)
T ss_pred cCC--ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC----CCCeEEeCC
Confidence 654 78999999999999999977666789999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccc----cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccC
Q 040257 1118 FGLSRIKRNTLV----SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1118 FGLAr~~~~s~~----sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~L 1192 (1254)
||++........ .....++..|+|||.+.+. .++.++|+|||||++|++++ |..||......+....+... .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~ 226 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-Y 226 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-C
Confidence 999875433211 1112235679999999865 37899999999999999887 99999887766655555443 3
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
....+..+++.+.+++.+||+.+|.+||++.++++.|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 3445566789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=324.15 Aligned_cols=257 Identities=29% Similarity=0.551 Sum_probs=208.5
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEE--CCce----EEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKW--RGSD----VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~----VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
+...+|++++.||+|+||+||+|.+ .+.. +++|.+... .......++..|+.+++++.||||+++++
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~~~~~l~~l~h~~iv~~~~ 76 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-------SGRQTFQEITDHMLAMGSLDHAYIVRLLG 76 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-------cchHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 4456899999999999999999998 3443 566665421 11233456778888999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
++... ..++++||+.+|+|.+++......+++..++.++.||+.||.|||+++++||||||+|||++ .++.+|
T Consensus 77 ~~~~~---~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~----~~~~~k 149 (279)
T cd05111 77 ICPGA---SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK----SDSIVQ 149 (279)
T ss_pred EECCC---ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEE
Confidence 98533 57789999999999999977667799999999999999999999999999999999999998 778999
Q ss_pred EEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhc
Q 040257 1115 VGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKN 1190 (1254)
Q Consensus 1115 LiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~ 1190 (1254)
|+|||+++..... .......++..|+|||.+.+.. ++.++|||||||++|||++ |+.||...........+ ..
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~ 226 (279)
T cd05111 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR--YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EK 226 (279)
T ss_pred EcCCccceeccCCCcccccCCCCCcccccCHHHhccCC--cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HC
Confidence 9999999754322 1223345677899999997653 7899999999999999998 99999877655543333 33
Q ss_pred cCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1191 ~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
......+..++..+.+++.+||..+|.+||++.++++.|..+..
T Consensus 227 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 227 GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 33444556678899999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=319.39 Aligned_cols=252 Identities=35% Similarity=0.643 Sum_probs=208.8
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
+...+|+++++||+|+||.||++.+. +..+|+|.+...... .+.+.+|+.++++++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---------PESFLEEAQIMKKLRHDKLVQLYAVVSE- 72 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---------HHHHHHHHHHHHhcCCCceEEEEeEECC-
Confidence 44558999999999999999999874 567999998753211 2457889999999999999999998853
Q ss_pred CCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
...+++|||+.+++|.+++... ...+++..++.++.+++.||.|||+++|+||||||+||+++ .++.+||+||
T Consensus 73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~----~~~~~~l~df 146 (260)
T cd05070 73 --EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG----DGLVCKIADF 146 (260)
T ss_pred --CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe----CCceEEeCCc
Confidence 2578999999999999998653 34589999999999999999999999999999999999998 6789999999
Q ss_pred cccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1119 GLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1119 GLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
|++....... ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+.. .....
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~ 223 (260)
T cd05070 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYRMP 223 (260)
T ss_pred eeeeeccCcccccccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCC
Confidence 9997543321 11223356689999998755 47889999999999999999 9999988776666655543 33445
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
.+...+..+.+|+.+||+.+|++|||+.++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 667788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=352.27 Aligned_cols=256 Identities=28% Similarity=0.402 Sum_probs=220.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECC--ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRG--SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rG--s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.+....|++++.||.|.-|+||+++.++ ..+|+|++.+..+.. +....+...|.+||+.+.||.++.||+.|.
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-----rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe 147 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-----RKKLKRAQTEREILSLLDHPFLPTLYASFE 147 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-----hhHHHHHHHHHHHHHhcCCCccchhhheee
Confidence 3445578899999999999999999976 679999999876543 333566778999999999999999999997
Q ss_pred cCCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.+. .+|++||||.||+|...++++ ++.|++..++.++.+++.||+|||-.|||+|||||+||||. ++|||.|+
T Consensus 148 t~~--~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr----edGHIMLs 221 (459)
T KOG0610|consen 148 TDK--YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR----EDGHIMLS 221 (459)
T ss_pred ccc--eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe----cCCcEEee
Confidence 665 899999999999999888654 46799999999999999999999999999999999999999 89999999
Q ss_pred eccccccc-------c---------------------------C-c----------------------cccCCCCCCCCc
Q 040257 1117 DFGLSRIK-------R---------------------------N-T----------------------LVSGGVRGTLPW 1139 (1254)
Q Consensus 1117 DFGLAr~~-------~---------------------------~-s----------------------~~sts~~GT~~Y 1139 (1254)
||.|+... . . . ..+..+.||-.|
T Consensus 222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEY 301 (459)
T KOG0610|consen 222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEY 301 (459)
T ss_pred eccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccc
Confidence 99987410 0 0 0 112346799999
Q ss_pred cCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 040257 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEAR 1219 (1254)
Q Consensus 1140 mAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKR 1219 (1254)
+|||+++|.. -+.++|||+|||+|||||.|..||.+.+..+.+..++.+.+...-...++..+++||+++|.+||.+|
T Consensus 302 lAPEvI~G~G--HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 302 LAPEVIRGEG--HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred ccceeeecCC--CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence 9999999885 67889999999999999999999999999999999998877665555788999999999999999999
Q ss_pred CC----HHHHHHH
Q 040257 1220 PS----FTEITSR 1228 (1254)
Q Consensus 1220 PS----ArELLe~ 1228 (1254)
.. +.||.+|
T Consensus 380 lg~~rGA~eIK~H 392 (459)
T KOG0610|consen 380 LGSKRGAAEIKRH 392 (459)
T ss_pred hccccchHHhhcC
Confidence 87 7777765
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.33 Aligned_cols=242 Identities=26% Similarity=0.443 Sum_probs=199.2
Q ss_pred EEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhc-CCCCceeEEeeeeecCCCCceEE
Q 040257 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN-LHHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkr-LnHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+.||+|+||.||+++++ ++.||||++++.... .......+..|..++.. ++||||+++++++.+.. .+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-----IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE--HLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC--EEEE
Confidence 36999999999999984 678999999864321 11123455677888765 48999999999997655 8999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc-
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR- 1125 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~- 1125 (1254)
||||+.+++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~----~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 74 VMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD----RDGHIKIADFGMCKENVF 148 (316)
T ss_pred EECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEeCccCCCeeccc
Confidence 99999999999888543 5689999999999999999999999999999999999998 77899999999987422
Q ss_pred CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHH
Q 040257 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205 (1254)
Q Consensus 1126 ~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLr 1205 (1254)
........+||..|+|||++.+.. ++.++|||||||++|||++|+.||...........+... .+.++..++.+++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 224 (316)
T cd05620 149 GDNRASTFCGTPDYIAPEILQGLK--YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPHYPRWITKESK 224 (316)
T ss_pred CCCceeccCCCcCccCHHHHcCCC--CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHH
Confidence 122234467999999999998764 788999999999999999999999887776666655443 2445677899999
Q ss_pred HHHHHhhhcCCCCCCCHH-HHHH
Q 040257 1206 KLMEQCWAADPEARPSFT-EITS 1227 (1254)
Q Consensus 1206 dLIkKCLqkDPeKRPSAr-ELLe 1227 (1254)
+||++||..||++||++. ++++
T Consensus 225 ~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 225 DILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHc
Confidence 999999999999999974 6664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.56 Aligned_cols=251 Identities=27% Similarity=0.355 Sum_probs=195.8
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC---CCCceeEEeeeeecC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL---HHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL---nHPNIVkLyGvf~Dd 1039 (1254)
+|++++.||+|+||+||+++++ ++.||+|.++...... .....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED------GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC------CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 4889999999999999999884 6789999987532111 1112344566666554 799999999987643
Q ss_pred ---CCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1040 ---TGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1040 ---n~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
....++++|||+. ++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~kl 149 (288)
T cd07863 75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT----SGGQVKL 149 (288)
T ss_pred cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEE
Confidence 2346899999996 58888775533 3589999999999999999999999999999999999998 7789999
Q ss_pred EeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc----
Q 040257 1116 GDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT---- 1191 (1254)
Q Consensus 1116 iDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~---- 1191 (1254)
+|||+++............+|..|+|||++.+. .++.++|||||||++|+|++|++||...........+....
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07863 150 ADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 227 (288)
T ss_pred CccCccccccCcccCCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC
Confidence 999999865544344445689999999999865 37899999999999999999999998766554443332210
Q ss_pred ---CC-----------C-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 ---LR-----------P-------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 ---Lr-----------p-------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+. . .....++..+++||.+||+.||++|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0 0112467789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=319.98 Aligned_cols=245 Identities=33% Similarity=0.589 Sum_probs=203.2
Q ss_pred EEeeeCcEEEEEEEE----CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEE
Q 040257 971 ELGSGTYGTVYHGKW----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~----rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+||+|+||.||+|.+ ++..+|+|+++... ......+.+.+|+.+++.+.|+||+++++++..+ ..++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~l 72 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN------NDPALKDELLREANVMQQLDNPYIVRMIGICEAE---SWML 72 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---CcEE
Confidence 589999999999976 35679999986432 1234567788999999999999999999998543 5789
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccC
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN 1126 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~ 1126 (1254)
||||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||.|||++ .++.+||+|||+++....
T Consensus 73 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~----~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 73 VMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV----TQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc----CCCeEEECCCccccccCC
Confidence 99999999999988543 5689999999999999999999999999999999999998 678999999999875433
Q ss_pred ccc----cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1127 TLV----SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1127 s~~----sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
... .....++..|+|||.+... .++.++|||||||++|||++ |+.||...........+... ..+..+..++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~ 224 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNYY--KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-ERMECPQRCP 224 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCC
Confidence 211 1122345789999998754 47889999999999999998 99999887766666655443 3455677889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
+++.+||.+||+.||++||++.+|.+.|+.+
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=313.83 Aligned_cols=251 Identities=27% Similarity=0.434 Sum_probs=211.6
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||.|+||.||++.+ ++..+|+|++..... .....+++.+|+.++++++|+||+++++++......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM------TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC------CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 478899999999999999987 467799999875422 123346788899999999999999999988766666
Q ss_pred ceEEEEEecccCchhhhhhcc---CCCCCHHHHHHHHHHhhhhhHHhh-----hCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK---DRSLDRRKKLIIAMDAAFGMEYLH-----SKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr---e~~LSe~~~lkIa~QIAeALaYLH-----SkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
.++++|||+.+++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||+++ .++.+|
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~----~~~~~k 150 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD----ANNNVK 150 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe----cCCCEE
Confidence 789999999999999998553 457899999999999999999999 89999999999999998 678999
Q ss_pred EEeccccccccCccc-cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC
Q 040257 1115 VGDFGLSRIKRNTLV-SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~~-sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
|+|||++........ .....++..|+|||++.+.. ++.++|+||||+++|+|++|+.||...........+.... .
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~ 227 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS--YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK-F 227 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcCCC--CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC-C
Confidence 999999886544332 33456899999999998653 7889999999999999999999998877655555554443 3
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+..+..++..+.+++.+||..+|.+||++.+|+++
T Consensus 228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 45667788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=331.09 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=200.3
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|.+++.||+|+||+||+|++. ++.||+|+++..... .....+.+|+.++++++||||+++++++..+.
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 77 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-------GAPCTAIREVSLLKDLKHANIVTLHDIVHTDK- 77 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-------CcchhHHHHHHHHHhCCCCCcceEEEEEeeCC-
Confidence 47999999999999999999874 667999998754211 11234678999999999999999999997655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||++
T Consensus 78 -~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~ 151 (309)
T cd07872 78 -SLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN----ERGELKLADFGLA 151 (309)
T ss_pred -eEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECccccc
Confidence 7999999996 488888766666689999999999999999999999999999999999998 7789999999998
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc---------
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT--------- 1191 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~--------- 1191 (1254)
+..... .......++..|+|||++.+.. .++.++|||||||++|+|++|+.||......+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 152 RAKSVPTKTYSNEVVTLWYRPPDVLLGSS-EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230 (309)
T ss_pred eecCCCccccccccccccccCCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 754322 2223345789999999987542 47889999999999999999999998766544333222110
Q ss_pred ------------CCC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 ------------LRP-------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 ------------Lrp-------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
... .....++.++++||.+||+.||.+|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000 0112467889999999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=327.94 Aligned_cols=243 Identities=26% Similarity=0.367 Sum_probs=194.2
Q ss_pred EeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEE
Q 040257 972 LGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTE 1049 (1254)
Q Consensus 972 LGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVME 1049 (1254)
||+|+||+||+++.. ++.||+|++....... ......+..|++++++++||||+++++++.++. .+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~--~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-----KSGEKMALLEKEILEKVNSPFIVNLAYAFESKT--HLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-----chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC--eEEEEEe
Confidence 699999999999874 7889999987532211 111234566999999999999999999997655 8999999
Q ss_pred ecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCcc
Q 040257 1050 FMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL 1128 (1254)
Q Consensus 1050 Ym~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~ 1128 (1254)
|+.+++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++.......
T Consensus 74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD----DQGNCRLSDLGLAVELKDGK 149 (277)
T ss_pred cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc----CCCCEEEeeceeeeecCCCc
Confidence 999999988875433 3588999999999999999999999999999999999998 67889999999987654443
Q ss_pred ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh----hHHHHhhhccCCCCCCCCCcHHH
Q 040257 1129 VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG----AIIGGIVKNTLRPTIPERCDPEW 1204 (1254)
Q Consensus 1129 ~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~----eliqsIlk~~Lrp~ipe~iS~eL 1204 (1254)
......|+..|+|||++.+.. ++.++|||||||++|||++|+.||...... ............ .....++.++
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 226 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEP--YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEES 226 (277)
T ss_pred eeeccCCCCCccCHHHHccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHH
Confidence 334456899999999998764 889999999999999999999999765432 222222222211 1224578999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1205 RKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1205 rdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++||.+||+.||++||+++|+++.
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchhh
Confidence 999999999999999999766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.52 Aligned_cols=257 Identities=33% Similarity=0.611 Sum_probs=212.3
Q ss_pred cccCceEEEEEeeeCcEEEEEEEECC-----ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeee
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWRG-----SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~rG-----s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf 1036 (1254)
...+|.+.+.||+|+||.||+|.+.. ..||||.+.... .....+.+.+|+.+++++.||||+++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 76 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-------SPSVREKFLQEAYIMRQFDHPHIVKLIGVI 76 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCchhceeEEE
Confidence 44578899999999999999998742 358999876431 123456788999999999999999999998
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.+. ..++||||+.+++|.+++.+....+++..++.++.+++.||.|||+.+++||||||+|||++ ..+.+||+
T Consensus 77 ~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~l~ 149 (270)
T cd05056 77 TEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS----SPDCVKLG 149 (270)
T ss_pred cCC---CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe----cCCCeEEc
Confidence 653 46899999999999999976656689999999999999999999999999999999999998 67899999
Q ss_pred eccccccccCccc--cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCC
Q 040257 1117 DFGLSRIKRNTLV--SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1117 DFGLAr~~~~s~~--sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
|||+++....... .....++..|+|||.+.+. .++.++||||||+++|||++ |..||......+....+.... .
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~ 226 (270)
T cd05056 150 DFGLSRYLEDESYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-R 226 (270)
T ss_pred cCceeeecccccceecCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-c
Confidence 9999875433221 1122345679999998765 37899999999999999986 999998877666655554432 3
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
...+..++..+.+|+.+||..+|.+||++.++++.|+.++.+
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 227 LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 345677899999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=318.93 Aligned_cols=253 Identities=32% Similarity=0.507 Sum_probs=202.8
Q ss_pred eEEEEEeeeCcEEEEEEEECCc----eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC---
Q 040257 967 EELRELGSGTYGTVYHGKWRGS----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG--- 1039 (1254)
Q Consensus 967 eiLkkLGeGsFGtVYlAk~rGs----~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd--- 1039 (1254)
.+.+.||+|+||.||+|++... .+|+|.++.... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC------TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence 4567899999999999998532 589998875321 123356788899999999999999999976432
Q ss_pred -CCCceEEEEEecccCchhhhhhc-----cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1040 -TGGTLATVTEFMVNGSLKHVLLK-----KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1040 -n~~~L~LVMEYm~GGSL~d~L~k-----re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
.....+++|||+.+++|..++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~ 151 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN----ENMNV 151 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc----CCCCE
Confidence 12357899999999999888732 223478999999999999999999999999999999999998 77899
Q ss_pred EEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhh
Q 040257 1114 KVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk 1189 (1254)
||+|||+++...... ......++..|++||.+.+. .++.++|||||||++|||++ |+.||...........+..
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 229 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999987543321 11223467789999999865 47899999999999999999 8999987766655555544
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
.. ....+..++..+.++|.+||+.+|++|||+.+|++.|+.+
T Consensus 230 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GN-RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 33 2334556888999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=322.30 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=203.0
Q ss_pred cccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
...+|++++.||+|+||.||+|++ .++.||+|++.... ......+.+|+.++++++||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--------~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--------GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--------cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 345799999999999999999997 46779999986431 11124577899999999999999999999765
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
. .+++||||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++ .++.+||+|||
T Consensus 79 ~--~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~----~~~~~~l~dfg 151 (267)
T cd06646 79 E--KLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT----DNGDVKLADFG 151 (267)
T ss_pred C--EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEECcCc
Confidence 4 789999999999999988543 5689999999999999999999999999999999999998 77889999999
Q ss_pred ccccccCcc-ccCCCCCCCCccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC--
Q 040257 1120 LSRIKRNTL-VSGGVRGTLPWMAPELLNGS-SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT-- 1195 (1254)
Q Consensus 1120 LAr~~~~s~-~sts~~GT~~YmAPEVLrG~-~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~-- 1195 (1254)
++....... ......++..|+|||.+.+. ...++.++|||||||++|||++|+.||...........+....+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06646 152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL 231 (267)
T ss_pred cceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC
Confidence 987543221 22345688999999998532 22367899999999999999999999976544333322222222211
Q ss_pred -CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1196 -IPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1196 -ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
....++..+.+||++||..+|++||++.+++++|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1234678999999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.24 Aligned_cols=255 Identities=35% Similarity=0.619 Sum_probs=210.3
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC--Cc---eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeee
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR--GS---DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r--Gs---~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf 1036 (1254)
...+|+..+.||+|+||.||+|++. +. .+|+|.++... .....+.+.+|+.++++++|+||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-------TEKQRQDFLSEASIMGQFSHHNIIRLEGVV 75 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence 4457888999999999999999874 22 58999886431 122346788999999999999999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.+.. ..++||||+.+++|.+++......+++..+..++.|++.||.|||+.+|+||||||+||+++ .++.+||+
T Consensus 76 ~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~----~~~~~kl~ 149 (268)
T cd05063 76 TKFK--PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN----SNLECKVS 149 (268)
T ss_pred ccCC--CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc----CCCcEEEC
Confidence 7655 78999999999999999976667789999999999999999999999999999999999998 67889999
Q ss_pred eccccccccCccc----cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhcc
Q 040257 1117 DFGLSRIKRNTLV----SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNT 1191 (1254)
Q Consensus 1117 DFGLAr~~~~s~~----sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~ 1191 (1254)
|||++........ ......+..|+|||++.+. .++.++|||||||++|||++ |+.||...........+...
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~- 226 (268)
T cd05063 150 DFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG- 226 (268)
T ss_pred CCccceecccccccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-
Confidence 9999875432211 1112234579999999765 47899999999999999997 99999877766666665443
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1192 Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
.....+..++.++.+|+.+||+.+|.+||++.++++.|+++
T Consensus 227 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 33344556789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=337.15 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=205.8
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||++++. ++.||||++.+... ......+.+.+|+.+++.++|+||+++++++.++.
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 74 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-----LKRAETACFREERDVLVNGDRRWITNLHYAFQDEN-- 74 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC--
Confidence 7899999999999999999984 67899999975321 12223456788999999999999999999998665
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|.+++.+....+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~~ 150 (331)
T cd05597 75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD----KNGHIRLADFGSCL 150 (331)
T ss_pred eEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC----CCCCEEEEECCcee
Confidence 89999999999999999976566799999999999999999999999999999999999998 77899999999986
Q ss_pred cccCcc--ccCCCCCCCCccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC-
Q 040257 1123 IKRNTL--VSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI- 1196 (1254)
Q Consensus 1123 ~~~~s~--~sts~~GT~~YmAPEVLrG~---~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i- 1196 (1254)
...... ......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||......+....+.........
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 230 (331)
T cd05597 151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230 (331)
T ss_pred ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence 543221 22234699999999999742 224788999999999999999999999887766666555443222222
Q ss_pred --CCCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 040257 1197 --PERCDPEWRKLMEQCWAADPEA--RPSFTEITSR 1228 (1254)
Q Consensus 1197 --pe~iS~eLrdLIkKCLqkDPeK--RPSArELLe~ 1228 (1254)
...++..+++||++||+.++.+ |+++++++++
T Consensus 231 ~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 231 PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 2347899999999999764444 7899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=329.42 Aligned_cols=257 Identities=32% Similarity=0.534 Sum_probs=211.2
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEE
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAF 1032 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkL 1032 (1254)
+...+|++.+.||+|+||.||++.+. +..+|||+++... .....+.+.+|+.+++++ +|+||+++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-------HSSEREALMSELKIMSHLGNHENIVNL 104 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-------ChHHHHHHHHHHHHHHhccCCCCcceE
Confidence 34457899999999999999998752 3368999886431 122346788999999999 79999999
Q ss_pred eeeeecCCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCC
Q 040257 1033 YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRP 1111 (1254)
Q Consensus 1033 yGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG 1111 (1254)
++++.... .++++|||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+|||++ ..+
T Consensus 105 ~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~----~~~ 178 (302)
T cd05055 105 LGACTIGG--PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT----HGK 178 (302)
T ss_pred EEEEecCC--ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc----CCC
Confidence 99987655 7899999999999999986533 3489999999999999999999999999999999999998 677
Q ss_pred eEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHh
Q 040257 1112 ICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGI 1187 (1254)
Q Consensus 1112 ~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsI 1187 (1254)
.+||+|||+++...... ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||............
T Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~ 256 (302)
T cd05055 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL 256 (302)
T ss_pred eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC--CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH
Confidence 89999999987543221 122234677899999998664 7899999999999999998 99999877665555455
Q ss_pred hhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1188 lk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
.........+...+.++.+|+.+||..+|++||++.++++.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 444444445566789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=351.51 Aligned_cols=253 Identities=30% Similarity=0.417 Sum_probs=223.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn~ 1041 (1254)
.|++.+.||+|.||+||+++.+ ++.+|+|++.+...... ...+.+.+|+.+|+++. |||||.++++|.+..
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~-----~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~- 109 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK-----EDREDVRREVAILQQLSGHPNIVQLKDAFEDPD- 109 (382)
T ss_pred cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc-----ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-
Confidence 5888899999999999999984 77899999987654321 13467889999999998 999999999998766
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++|||++.||.|.+.+.+. .+++..+..++.||+.++.|||+.||+||||||+|+|+.......+.+|++|||++
T Consensus 110 -~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 110 -SVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred -eEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 899999999999999999776 39999999999999999999999999999999999999865544578999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC--CCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT--IPER 1199 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~--ipe~ 1199 (1254)
............+||+.|+|||++...+ |+..+||||+|+++|.|++|..||...........+....+... ....
T Consensus 187 ~~~~~~~~~~~~~Gtp~y~APEvl~~~~--y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 187 KFIKPGERLHTIVGTPEYVAPEVLGGRP--YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD 264 (382)
T ss_pred eEccCCceEeeecCCccccCchhhcCCC--CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence 9877766677889999999999999654 89999999999999999999999999998888888887766443 3355
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++..+++||+.||..||.+|+++.++|+|
T Consensus 265 is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred cCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 78999999999999999999999999996
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=338.01 Aligned_cols=249 Identities=24% Similarity=0.313 Sum_probs=198.4
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
.+|++++.||+|+||.||++.+ .++.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 90 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS 90 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc------ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence 3799999999999999999987 477899999875421 2223456788999999999999999999886432
Q ss_pred ---CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1041 ---GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1041 ---~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
...+++||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 91 ~~~~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~----~~~~~kl~D 162 (355)
T cd07874 91 LEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILD 162 (355)
T ss_pred ccccceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC----CCCCEEEee
Confidence 2357999999954 6666653 2488899999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-----
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL----- 1192 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L----- 1192 (1254)
||+++............||..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.....
T Consensus 163 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred CcccccCCCccccCCccccCCccCHHHHcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99998665554445567999999999998764 78899999999999999999999987654333222111000
Q ss_pred -----------------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 -----------------------------------RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 -----------------------------------rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
........+.++++||.+||..||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000112235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=337.92 Aligned_cols=262 Identities=30% Similarity=0.526 Sum_probs=209.7
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE-------CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW-------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVA 1031 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~-------rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVk 1031 (1254)
.+...+|++.+.||+|+||+||+|.+ .++.||||+++... .......+.+|+.+|.++ +|+||++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv~ 75 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNVVN 75 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-------ChHHHHHHHHHHHHHHhccCCccHhh
Confidence 45566899999999999999999974 25679999987532 112245688899999999 6899999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccC-----------------------------------------------
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD----------------------------------------------- 1064 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre----------------------------------------------- 1064 (1254)
+++++.... ..++++|||+.+|+|.+++....
T Consensus 76 ~~~~~~~~~-~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (343)
T cd05103 76 LLGACTKPG-GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVE 154 (343)
T ss_pred hcceeecCC-CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccC
Confidence 999886543 36889999999999999885421
Q ss_pred -------------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1065 -------------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1065 -------------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
..+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~----~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 155 EKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIY 230 (343)
T ss_pred CCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc----CCCcEEEEecccccccc
Confidence 2367788889999999999999999999999999999998 67899999999987532
Q ss_pred Cc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1126 NT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1126 ~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
.. .......++..|+|||++.+. .++.++||||||+++|+|++ |..||.....................+...+
T Consensus 231 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (343)
T cd05103 231 KDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 308 (343)
T ss_pred cCcchhhcCCCCCCcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCC
Confidence 21 111223356789999998765 47899999999999999997 9999987654433333343444445566678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
+++.+++.+||+.+|.+||++.+|+++|+.++++
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 8999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=326.92 Aligned_cols=244 Identities=24% Similarity=0.380 Sum_probs=196.4
Q ss_pred EeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEE
Q 040257 972 LGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTE 1049 (1254)
Q Consensus 972 LGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVME 1049 (1254)
||+|+||+||++++ +++.||+|++.+.... .....+.+..|+.+++.++|+||+++++++.... .+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-----KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT--DLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-----hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC--eEEEEEe
Confidence 69999999999987 4678999998754211 2223456788999999999999999999987654 7999999
Q ss_pred ecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccC
Q 040257 1050 FMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN 1126 (1254)
Q Consensus 1050 Ym~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~ 1126 (1254)
|+.+++|...+.. ....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++.....
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD----NDGNVRISDLGLAVELKD 149 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEeeCccceecCC
Confidence 9999999887643 335689999999999999999999999999999999999998 678899999999875433
Q ss_pred c-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc--CCCCCCCCCcHH
Q 040257 1127 T-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT--LRPTIPERCDPE 1203 (1254)
Q Consensus 1127 s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~--Lrp~ipe~iS~e 1203 (1254)
. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.... ....++..++..
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQGEE--YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPA 227 (280)
T ss_pred CCccccccCCCcCccCHHHhcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHH
Confidence 2 2233457899999999998764 7889999999999999999999997654322211111111 122345668999
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1204 WRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1204 LrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
+.+|+.+||+.||++|| ++++++++
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 228 SKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=345.20 Aligned_cols=257 Identities=21% Similarity=0.338 Sum_probs=209.7
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.+...+|++++.||+|+||.||+++++ ++.||+|++.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 344568999999999999999999984 677999998753211 1223455778999999999999999999997
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
++. .+++||||+.+++|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 114 ~~~--~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~----~~~~ikL~D 185 (371)
T cd05622 114 DDR--YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLAD 185 (371)
T ss_pred cCC--EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC----CCCCEEEEe
Confidence 655 89999999999999998854 3588999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCcc--ccCCCCCCCCccCcccccCCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC
Q 040257 1118 FGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSS--NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1118 FGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~--~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
||+++...... .....+||+.|+|||++.+.. ..++.++|||||||+||||++|+.||...+.......+......
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 99997653321 223567999999999997643 23788999999999999999999999988777666666654322
Q ss_pred CCC--CCCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 040257 1194 PTI--PERCDPEWRKLMEQCWAADPEA--RPSFTEITSRL 1229 (1254)
Q Consensus 1194 p~i--pe~iS~eLrdLIkKCLqkDPeK--RPSArELLe~L 1229 (1254)
..+ ...++..+++||.+||..++.+ |+++.+++++.
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 266 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 223 3468999999999999844443 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.49 Aligned_cols=239 Identities=25% Similarity=0.385 Sum_probs=195.6
Q ss_pred EEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHH-HHHhcCCCCceeEEeeeeecCCCCceEE
Q 040257 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREA-HILSNLHHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEI-eILkrLnHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+.||+|+||+||++++. ++.||+|++.+.... .......+..|. .+++.++||||+++++++.+.. .+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~--~~~l 73 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL-----KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--KLYF 73 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH-----hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC--eEEE
Confidence 36999999999999984 567999999754221 111123344444 4578899999999999997665 7999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc-
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR- 1125 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~- 1125 (1254)
||||+.+++|.+++.. ...+.+..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~----~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 74 VLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD----SQGHIVLTDFGLCKENIE 148 (325)
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEEccCCCCccccc
Confidence 9999999999998854 35688999999999999999999999999999999999998 67899999999987432
Q ss_pred CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHH
Q 040257 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205 (1254)
Q Consensus 1126 ~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLr 1205 (1254)
........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+.+..+..... ..+..++..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 224 (325)
T cd05602 149 HNGTTSTFCGTPEYLAPEVLHKQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QLKPNITNSAR 224 (325)
T ss_pred CCCCcccccCCccccCHHHHcCCC--CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--CCCCCCCHHHH
Confidence 222334567999999999998764 78899999999999999999999998877777766655433 34556889999
Q ss_pred HHHHHhhhcCCCCCCCHHH
Q 040257 1206 KLMEQCWAADPEARPSFTE 1224 (1254)
Q Consensus 1206 dLIkKCLqkDPeKRPSArE 1224 (1254)
++|.+||+.+|.+|+++.+
T Consensus 225 ~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 225 HLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHHcccCHHHCCCCCC
Confidence 9999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=335.58 Aligned_cols=248 Identities=21% Similarity=0.365 Sum_probs=204.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn~ 1041 (1254)
+|+..+.||+|+||+||+++++ ++.||||++.+.... .....+.+..|+.++..+. |++|+++++++.+..
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD- 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-
Confidence 4788899999999999999884 678999999864221 1223456677888888775 577888999887655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~----~~~~ikL~Dfg~~ 148 (323)
T cd05615 75 -RLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD----SEGHIKIADFGMC 148 (323)
T ss_pred -EEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEeccccc
Confidence 799999999999999988543 5699999999999999999999999999999999999998 7789999999998
Q ss_pred ccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1122 RIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1122 r~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
+.... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+..... ..+..+
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--~~p~~~ 224 (323)
T cd05615 149 KEHMVDGVTTRTFCGTPDYIAPEIIAYQP--YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--SYPKSL 224 (323)
T ss_pred cccCCCCccccCccCCccccCHHHHcCCC--CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCccC
Confidence 75322 22233456999999999998764 78899999999999999999999998887777777765443 456778
Q ss_pred cHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSF-----TEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSA-----rELLe~ 1228 (1254)
+.++.+++.+||+++|.+|++. ++++++
T Consensus 225 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 225 SKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred CHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 9999999999999999999974 455544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.08 Aligned_cols=260 Identities=30% Similarity=0.520 Sum_probs=211.1
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEECC---------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCcee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWRG---------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVV 1030 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~rG---------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIV 1030 (1254)
+...+|.+.+.||+|+||.||++++.+ ..+|+|.++... .......+.+|+.+++.+ +|+||+
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKNII 87 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-------ChHHHHHHHHHHHHHHHhcCCCCEe
Confidence 334579999999999999999998632 359999887431 112245688899999999 799999
Q ss_pred EEeeeeecCCCCceEEEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCccccc
Q 040257 1031 AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFD 1095 (1254)
Q Consensus 1031 kLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRD 1095 (1254)
++++++.+.. .+++||||+.+++|.+++..+. ..+++..++.++.||+.||+|||++||+|||
T Consensus 88 ~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 165 (307)
T cd05098 88 NLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRD 165 (307)
T ss_pred eEEEEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 9999997655 7899999999999999986532 2478899999999999999999999999999
Q ss_pred CCCCceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-C
Q 040257 1096 LKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-G 1171 (1254)
Q Consensus 1096 LKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-G 1171 (1254)
|||+|||++ .++.+||+|||+++...... ......++..|+|||++.+. .++.++|||||||++|||++ |
T Consensus 166 lkp~Nill~----~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g 239 (307)
T cd05098 166 LAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLG 239 (307)
T ss_pred ccHHheEEc----CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCC
Confidence 999999998 67899999999987543211 11112245689999999865 37899999999999999998 8
Q ss_pred CCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1172 EEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1172 k~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
..||......+....+. .......+..++.++.+|+.+||..+|.+||++.++++.|+.+....
T Consensus 240 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 240 GSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred CCCCCcCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 99998766555554443 33344566778899999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=336.59 Aligned_cols=242 Identities=26% Similarity=0.444 Sum_probs=199.1
Q ss_pred EEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhc-CCCCceeEEeeeeecCCCCceEE
Q 040257 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN-LHHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkr-LnHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+.||+|+||+||+|++. ++.||||+++..... .......+..|..+++. ++||||+++++++.+.. .+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~--~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-----MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE--NLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC--EEEE
Confidence 36999999999999984 567999999864321 11223455667778775 58999999999997655 7999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc-
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR- 1125 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~- 1125 (1254)
||||+.+|+|..++... ..+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~----~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 74 VMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD----TDGHIKIADFGMCKENML 148 (316)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEccCCcceECCC
Confidence 99999999999988543 5689999999999999999999999999999999999998 77899999999987432
Q ss_pred CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHH
Q 040257 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205 (1254)
Q Consensus 1126 ~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLr 1205 (1254)
.........||..|+|||++.+.. ++.++|||||||++|||++|+.||......+....+.... +.++..++.+++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 224 (316)
T cd05619 149 GDAKTCTFCGTPDYIAPEILLGQK--YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAK 224 (316)
T ss_pred CCCceeeecCCccccCHHHHcCCC--CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHH
Confidence 122233456999999999998664 7899999999999999999999998877766666654432 345667899999
Q ss_pred HHHHHhhhcCCCCCCCHH-HHHH
Q 040257 1206 KLMEQCWAADPEARPSFT-EITS 1227 (1254)
Q Consensus 1206 dLIkKCLqkDPeKRPSAr-ELLe 1227 (1254)
+||.+||+.+|++||++. ++++
T Consensus 225 ~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 225 DILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHhccCHhhcCCChHHHHc
Confidence 999999999999999997 6655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.89 Aligned_cols=252 Identities=35% Similarity=0.628 Sum_probs=210.0
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
+...+|+++++||+|+||.||+|.. .++.||+|.+..... ...++.+|+.++++++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---------SPEAFLAEANLMKQLQHPRLVRLYAVVTQ- 72 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---------cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-
Confidence 4556899999999999999999987 467899999875421 13467889999999999999999998743
Q ss_pred CCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
..++++|||+.+++|.+++... ...+++..++.++.|++.||+|||+.||+||||||+||+++ .++.++|+||
T Consensus 73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~l~df 146 (260)
T cd05067 73 --EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS----ETLCCKIADF 146 (260)
T ss_pred --CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc----CCCCEEEccC
Confidence 3689999999999999988543 34689999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1119 GLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1119 GLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
|++....... ......++..|+|||++.+.. ++.++||||||+++|||++ |+.||...........+.. .....
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~ 223 (260)
T cd05067 147 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-GYRMP 223 (260)
T ss_pred cceeecCCCCcccccCCcccccccCHHHhccCC--cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCCCC
Confidence 9987544221 122334567899999997653 7889999999999999999 9999988776665555433 34445
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
.+...+.++.+++.+||..+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 667788999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=375.20 Aligned_cols=264 Identities=37% Similarity=0.625 Sum_probs=229.3
Q ss_pred cccccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCcee
Q 040257 958 LQIIKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVV 1030 (1254)
Q Consensus 958 lq~Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIV 1030 (1254)
..+|...+.+..+.||+|+||+||+|+.. ...||||.++... ...++.+|.+|+++|..|+|||||
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-------~~~~~~dF~REaeLla~l~H~nIV 552 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-------ENQARQDFRREAELLAELQHPNIV 552 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-------cHHHHHHHHHHHHHHHhccCCCeE
Confidence 34667778888999999999999999863 3459999998642 344688999999999999999999
Q ss_pred EEeeeeecCCCCceEEEEEecccCchhhhhhccC---------C----CCCHHHHHHHHHHhhhhhHHhhhCCcccccCC
Q 040257 1031 AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------R----SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLK 1097 (1254)
Q Consensus 1031 kLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------~----~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLK 1097 (1254)
+|+|+|.+++ .+|+|+|||..|+|.++|..+. . +++..+.+.|+.||+.||.||-++.+|||||-
T Consensus 553 rLlGVC~~~~--P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLA 630 (774)
T KOG1026|consen 553 RLLGVCREGD--PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLA 630 (774)
T ss_pred EEEEEEccCC--eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchh
Confidence 9999998776 8999999999999999986431 2 28889999999999999999999999999999
Q ss_pred CCceEeccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCC
Q 040257 1098 CENLLVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEE 1173 (1254)
Q Consensus 1098 PeNILLDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~ 1173 (1254)
.+|+||. ++..|||+|||+++..-.. .......-..+||+||.|... +||.+|||||+||+|||+++ |+.
T Consensus 631 TRNCLVg----e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~--kFTteSDVWs~GVvLWEIFsyG~Q 704 (774)
T KOG1026|consen 631 TRNCLVG----ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG--KFTTESDVWSFGVVLWEIFSYGKQ 704 (774)
T ss_pred hhhceec----cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC--cccchhhhhhhhhhhhhhhccccC
Confidence 9999998 8899999999999843221 111122346789999999854 59999999999999999999 999
Q ss_pred CCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 040257 1174 PYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1174 PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLE 1237 (1254)
||.+..+.++++.+..+.+ ...|+.++.++.+|+..||+.+|.+||+++||-..|+....+-+
T Consensus 705 Py~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 705 PYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred cccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 9999999999999988888 78999999999999999999999999999999999998865533
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=336.51 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=207.7
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|+++++||+|+||+||+++++ ++.||+|++.+... ........+.+|+.++..++|++|+++++++.+..
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 74 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-----LKRAETACFREERDVLVNGDNQWITTLHYAFQDEN-- 74 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC--
Confidence 7899999999999999999985 56799999875321 12223445778999999999999999999997665
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+|+|.+++.+....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++.
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~----~~~~~kL~DfG~a~ 150 (332)
T cd05623 75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD----MNGHIRLADFGSCL 150 (332)
T ss_pred EEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEEEeecchhe
Confidence 89999999999999999976566799999999999999999999999999999999999998 77899999999986
Q ss_pred cccC--ccccCCCCCCCCccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC-
Q 040257 1123 IKRN--TLVSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI- 1196 (1254)
Q Consensus 1123 ~~~~--s~~sts~~GT~~YmAPEVLrG~---~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i- 1196 (1254)
.... ........||+.|+|||++.+. ...++.++|||||||+||||++|+.||......+.+..+.....+...
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (332)
T cd05623 151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230 (332)
T ss_pred ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCC
Confidence 4322 2222345799999999998632 224788999999999999999999999988777777766654332222
Q ss_pred --CCCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 040257 1197 --PERCDPEWRKLMEQCWAADPEA--RPSFTEITSR 1228 (1254)
Q Consensus 1197 --pe~iS~eLrdLIkKCLqkDPeK--RPSArELLe~ 1228 (1254)
...+++++++||++||+.++.+ |+++.+++++
T Consensus 231 ~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 231 AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 2457899999999999765554 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.08 Aligned_cols=254 Identities=34% Similarity=0.604 Sum_probs=209.1
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEECC-ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWRG-SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~rG-s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
+...+|++.++||+|+||.||+|++.+ ..||+|+++.... ..+.+.+|+.++++++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 72 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---------CHHHHHHHHHHHHhCCCCCcceEEEEECC-
Confidence 455689999999999999999998853 4699999875321 12467889999999999999999998753
Q ss_pred CCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
...++||||+.+++|.+++.+. ...+++..++.++.|++.||.|||+.+|+||||||+||+++ .++.+||+||
T Consensus 73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~----~~~~~~L~df 146 (262)
T cd05071 73 --EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADF 146 (262)
T ss_pred --CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc----CCCcEEeccC
Confidence 2578999999999999998653 34578999999999999999999999999999999999998 6788999999
Q ss_pred cccccccCccc--cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1119 GLSRIKRNTLV--SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1119 GLAr~~~~s~~--sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
|.++....... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...........+... ....
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~ 223 (262)
T cd05071 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 223 (262)
T ss_pred CceeeccccccccccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-CCCC
Confidence 99975433221 1223466789999998755 37899999999999999999 89899877666655554432 2334
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
.+..++..+.+|+.+||+.+|++||++.++++.|++++
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 45668899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.84 Aligned_cols=256 Identities=24% Similarity=0.427 Sum_probs=209.0
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|+||.||+|.+. ++.||+|.++..... .....+.+.+|++++++++|+||+++++++.+..
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~-- 75 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-----DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN-- 75 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-----chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC--
Confidence 6889999999999999999984 788999998743221 1223567889999999999999999999998754
Q ss_pred ceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1043 TLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
..++||||+.+++|..++.. ....+++..++.++.+|+.||.|||+.||+||||||+||+++ .++.++|+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~----~~~~~~l~d~~ 151 (267)
T cd08224 76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDLG 151 (267)
T ss_pred eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC----CCCcEEEeccc
Confidence 78999999999999988753 234589999999999999999999999999999999999998 67889999999
Q ss_pred ccccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--hhhHHHHhhhccCCCCC
Q 040257 1120 LSRIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH--CGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1120 LAr~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n--~~eliqsIlk~~Lrp~i 1196 (1254)
++....... ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||.... .......+......+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd08224 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP 229 (267)
T ss_pred eeeeccCCCcccceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCC
Confidence 987543322 22334688899999999865 47889999999999999999999996543 22333333333333222
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
...++..+.++|.+||..+|.+||++.+|++.|+.+.
T Consensus 230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 3367889999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.17 Aligned_cols=255 Identities=32% Similarity=0.580 Sum_probs=205.9
Q ss_pred ccCceEEEEEeeeCcEEEEEEEECC-------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeee
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGV 1035 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~rG-------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGv 1035 (1254)
...|.+.+.||+|+||.||+|.+.+ ..||+|.+.... .......+.+|+.+++.++|+||++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 77 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-------SEQDESDFLMEALIMSKFNHQNIVRLIGV 77 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3468999999999999999998854 458888775321 12233568889999999999999999998
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccC------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCC
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKD------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQ 1109 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~s 1109 (1254)
+.+.. ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++++||||||+|||++..+ .
T Consensus 78 ~~~~~--~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~-~ 154 (277)
T cd05036 78 SFERL--PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG-P 154 (277)
T ss_pred EccCC--CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC-C
Confidence 87654 6789999999999999985542 2589999999999999999999999999999999999998332 3
Q ss_pred CCeEEEEeccccccccCccc---cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHH
Q 040257 1110 RPICKVGDFGLSRIKRNTLV---SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIG 1185 (1254)
Q Consensus 1110 nG~VKLiDFGLAr~~~~s~~---sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliq 1185 (1254)
...+||+|||+++....... ......+..|+|||++.+. .++.++|||||||++|||++ |+.||..........
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~ 232 (277)
T cd05036 155 GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232 (277)
T ss_pred CcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 45799999999975432211 1122235679999999765 48999999999999999997 999998877666554
Q ss_pred HhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1186 GIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1186 sIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
.+.. ......+..++..+.+|+.+||+.+|++||++.+|+++|+
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVTG-GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 4433 3344556778899999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.97 Aligned_cols=250 Identities=34% Similarity=0.650 Sum_probs=208.0
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
..+|++.+.||+|+||.||++.+. ++.+|+|++...... ...+.+|++++++++||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---------EEDFIEEAQVMMKLSHPKLVQLYGVCTERS- 72 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---------HHHHHHHHHHHHhCCCCCeeeEEEEEccCC-
Confidence 357899999999999999999885 678999988754221 245788999999999999999999987655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..++||||+.+++|.+++......+++..++.++.+++.||.|||+++|+|+||||+||+++ .++.+||+|||++
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~ 147 (256)
T cd05112 73 -PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMT 147 (256)
T ss_pred -ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc----CCCeEEECCCcce
Confidence 78999999999999999876666789999999999999999999999999999999999998 6789999999998
Q ss_pred ccccCccc--cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCC
Q 040257 1122 RIKRNTLV--SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1122 r~~~~s~~--sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe 1198 (1254)
........ .....++..|+|||.+.+. .++.++||||||+++|||++ |..||...........+... .....+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 224 (256)
T cd05112 148 RFVLDDQYTSSTGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPR 224 (256)
T ss_pred eecccCcccccCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCC
Confidence 75432211 1223356789999999865 47889999999999999998 99999877766666555433 2333455
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
..+..+.+|+.+||+.+|++||++.++++.|.
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 67899999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=355.35 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=211.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||+|+||+||++++ +++.||||++..... .......+.+|+.++..++|+||++++..+.....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~------~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM------SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC------CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 4899999999999999999987 578899999975432 12234567889999999999999999887653321
Q ss_pred ------CceEEEEEecccCchhhhhhcc---CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCe
Q 040257 1042 ------GTLATVTEFMVNGSLKHVLLKK---DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPI 1112 (1254)
Q Consensus 1042 ------~~L~LVMEYm~GGSL~d~L~kr---e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~ 1112 (1254)
..+++||||+.+|+|.+++..+ ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++.
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~----~~~~ 181 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC----SNGL 181 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe----CCCC
Confidence 1478999999999999988543 34689999999999999999999999999999999999998 7789
Q ss_pred EEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh
Q 040257 1113 CKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1113 VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk 1189 (1254)
+||+|||+++..... ......+||+.|+|||++.+.. ++.++|||||||+||||++|+.||........+..+..
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~ 259 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP--YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA 259 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 999999998754322 2234467999999999998754 88999999999999999999999998877777766665
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.... ..+..+++++.+|+.+||+.+|.+||++.+++++
T Consensus 260 ~~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRYD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 5443 4567789999999999999999999999999875
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=318.57 Aligned_cols=256 Identities=23% Similarity=0.434 Sum_probs=208.9
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|+||.||++.+ .++.+|||.+..... .......++.+|+.+++.++|+||+++++++.++.
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 75 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-----MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-- 75 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-----hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC--
Confidence 677888999999999999986 577899998875321 12334567889999999999999999999997655
Q ss_pred ceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1043 TLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
.++++|||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~dfg 151 (267)
T cd08229 76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDLG 151 (267)
T ss_pred eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEECcch
Confidence 78999999999999998753 234589999999999999999999999999999999999998 67789999999
Q ss_pred ccccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--hhHHHHhhhccCCCCC
Q 040257 1120 LSRIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC--GAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1120 LAr~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~--~eliqsIlk~~Lrp~i 1196 (1254)
++....... ......++..|+|||++.+.. ++.++||||||+++|+|++|..||..... ......+......+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd08229 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP 229 (267)
T ss_pred hhhccccCCcccccccCCcCccCHHHhcCCC--ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCC
Confidence 987543322 223456889999999997653 78899999999999999999999975433 2333333333333333
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
...++..+++++.+||..+|.+|||+.+|++.++++.
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 230 SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 4567889999999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=336.28 Aligned_cols=238 Identities=25% Similarity=0.377 Sum_probs=195.7
Q ss_pred EEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHH-HHhcCCCCceeEEeeeeecCCCCceEE
Q 040257 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH-ILSNLHHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIe-ILkrLnHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
++||+|+||+||++++. ++.||+|++.+.... .......+.+|.. +++.++||||+++++++.+.. .+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~--~~~l 73 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-----KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE--KLYF 73 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--EEEE
Confidence 36999999999999984 678999999754221 1222344555554 678899999999999987655 8999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc-
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR- 1125 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~- 1125 (1254)
||||+.+++|...+.. ...+++..++.++.||+.||.|||+++|+||||||+||||+ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~----~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 74 VLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred EEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEccCCCCccCCC
Confidence 9999999999888754 45688999999999999999999999999999999999998 77899999999987532
Q ss_pred CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHH
Q 040257 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205 (1254)
Q Consensus 1126 ~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLr 1205 (1254)
........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+.... ..++...+..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 224 (321)
T cd05603 149 PEETTSTFCGTPEYLAPEVLRKEP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP--LQLPGGKTVAAC 224 (321)
T ss_pred CCCccccccCCcccCCHHHhcCCC--CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 222334467999999999998654 7889999999999999999999999887766666665543 345667789999
Q ss_pred HHHHHhhhcCCCCCCCHH
Q 040257 1206 KLMEQCWAADPEARPSFT 1223 (1254)
Q Consensus 1206 dLIkKCLqkDPeKRPSAr 1223 (1254)
++|.+||+++|.+|+++.
T Consensus 225 ~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 225 DLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHccCCHhhcCCCC
Confidence 999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=337.83 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=199.2
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
.+|++++.||+|+||.||++.+ .++.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 97 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc------CchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence 4799999999999999999987 467899999875421 1223456788999999999999999999875432
Q ss_pred ---CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1041 ---GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1041 ---~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
...+++||||+. ++|...+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~D 169 (364)
T cd07875 98 LEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILD 169 (364)
T ss_pred ccccCeEEEEEeCCC-CCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC----CCCcEEEEe
Confidence 235799999995 46766663 2478899999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC----
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR---- 1193 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr---- 1193 (1254)
||+++............+|..|+|||++.+.. ++.++|||||||+||+|++|+.||...+.......+......
T Consensus 170 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247 (364)
T ss_pred CCCccccCCCCcccCCcccCCcCCHHHHhCCC--CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99998665544445567999999999998764 788999999999999999999999876654443333221000
Q ss_pred ------------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 ------------------------------------PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 ------------------------------------p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.......+..+++||.+||+.||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00011234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.80 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=203.5
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|+..+.||+|+||.||++.+. ++.||+|.+...... .......+.+|+.++++++|++|+.+++.+.+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-----chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--
Confidence 3678889999999999999884 678999998754221 1223355678999999999999999999987655
Q ss_pred ceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+||+++ ..+.++|+|||++
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~----~~~~~~l~Dfg~~ 149 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD----DHGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeccce
Confidence 899999999999999887543 34589999999999999999999999999999999999998 6788999999998
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---hHHHHhhhccCCCCCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG---AIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~---eliqsIlk~~Lrp~ipe 1198 (1254)
.............|+..|+|||++.+. .++.++|||||||++|+|++|+.||...... .....+.. ......+.
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (285)
T cd05630 150 VHVPEGQTIKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVQEEYSE 226 (285)
T ss_pred eecCCCccccCCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hhhhhcCc
Confidence 754433333345689999999999865 4788999999999999999999999864332 12222221 12234556
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPS-----FTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPS-----ArELLe~ 1228 (1254)
.+++++++|+.+||+.||++||| ++|++++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 78899999999999999999999 8999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.99 Aligned_cols=256 Identities=30% Similarity=0.538 Sum_probs=205.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEE------CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 964 VDLEELRELGSGTYGTVYHGKW------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~------rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.-|++++.||+|+||.||++++ .+..||+|.++... .......+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-------GGNHIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 3578899999999999999975 35679999986431 1233467889999999999999999999988
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.....+++||||+++++|.+++.+....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~----~~~~~~l~d 152 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGD 152 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc----CCCCEEECC
Confidence 7655678999999999999999866555689999999999999999999999999999999999998 678899999
Q ss_pred ccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-------------
Q 040257 1118 FGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC------------- 1180 (1254)
Q Consensus 1118 FGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~------------- 1180 (1254)
||+++...... ......++..|+|||++.+. .++.++|||||||++|+|++++.|+.....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM 230 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccc
Confidence 99987543221 12234567789999998765 478899999999999999998776532110
Q ss_pred -hhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1181 -GAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1181 -~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
................+..++..+.+|+.+||+.+|.+||++.++++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 231 TVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0111111222223344566889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.44 Aligned_cols=253 Identities=36% Similarity=0.607 Sum_probs=208.6
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEE-------CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKW-------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~-------rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
|+..+|+..++||+|+||.||+++. .+..+|+|.++.. .......+.+|+++++.++|+||++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--------SESARQDFQREAELLTVLQHQHIVRFY 73 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--------CHHHHHHHHHHHHHHhcCCCCCCceEE
Confidence 4556889999999999999999864 2446888887643 223456789999999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccC--------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCC
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKD--------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCE 1099 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre--------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPe 1099 (1254)
+++.+.. ..+++|||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+
T Consensus 74 ~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ 151 (280)
T cd05092 74 GVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATR 151 (280)
T ss_pred EEEecCC--ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHh
Confidence 9987655 7899999999999999986532 24789999999999999999999999999999999
Q ss_pred ceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 040257 1100 NLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPY 1175 (1254)
Q Consensus 1100 NILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF 1175 (1254)
|||++ .++.+||+|||+++...... ......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||
T Consensus 152 nil~~----~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~ 225 (280)
T cd05092 152 NCLVG----QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQPW 225 (280)
T ss_pred hEEEc----CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC--cCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99998 67899999999987442211 112233567899999998664 7899999999999999998 99999
Q ss_pred CCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1176 ADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1176 ~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
...........+... .....+..+++.+.+||.+||+.||.+||++.+|++.|+
T Consensus 226 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 226 YQLSNTEAIECITQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ccCCHHHHHHHHHcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 877666666555443 233456678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.02 Aligned_cols=253 Identities=34% Similarity=0.547 Sum_probs=205.8
Q ss_pred ccCceEEEEEeeeCcEEEEEEEECC------------------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWRG------------------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~rG------------------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL 1024 (1254)
..+|+++++||+|+||.||++++.. ..||+|++.... .....+.+.+|+++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~l 76 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-------SDNAREDFLKEVKILSRL 76 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-------CHHHHHHHHHHHHHHHhc
Confidence 3578999999999999999988642 348999887532 123457788999999999
Q ss_pred CCCceeEEeeeeecCCCCceEEEEEecccCchhhhhhccC----------CCCCHHHHHHHHHHhhhhhHHhhhCCcccc
Q 040257 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD----------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHF 1094 (1254)
Q Consensus 1025 nHPNIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre----------~~LSe~~~lkIa~QIAeALaYLHSkGIIHR 1094 (1254)
+||||+++++++..+. ..+++|||+.+++|..++.... ..+++..++.++.|++.||.|||+++|+||
T Consensus 77 ~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~ 154 (296)
T cd05051 77 SDPNIARLLGVCTVDP--PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHR 154 (296)
T ss_pred CCCCEeEEEEEEecCC--CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence 9999999999997654 7899999999999999986543 258999999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 040257 1095 DLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170 (1254)
Q Consensus 1095 DLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT- 1170 (1254)
||||+||+++ ..+.++|+|||+++...... ......++..|+|||.+.+. .++.++|||||||++|||++
T Consensus 155 dlkp~Nili~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~ 228 (296)
T cd05051 155 DLATRNCLVG----KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTL 228 (296)
T ss_pred ccchhceeec----CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhc
Confidence 9999999998 67899999999987543221 22234467789999998865 37899999999999999998
Q ss_pred -CCCCCCCCChhhHHHHhhhc------cCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1171 -GEEPYADMHCGAIIGGIVKN------TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1171 -Gk~PF~~~n~~eliqsIlk~------~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
+..||........+...... ......+..++.++.+|+.+||+.+|.+||++.+|++.|+
T Consensus 229 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 229 CREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 78899876665555544322 1112234456789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.11 Aligned_cols=260 Identities=29% Similarity=0.504 Sum_probs=212.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC---------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCce
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR---------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNV 1029 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r---------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNI 1029 (1254)
.+...+|.+.+.||+|+||.||++++. +..||+|.+.... .......+.+|+.+++.+ +||||
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i 83 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNI 83 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-------chHHHHHHHHHHHHHHhhccCCCc
Confidence 345568899999999999999999752 2358999876431 122346788999999999 89999
Q ss_pred eEEeeeeecCCCCceEEEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccc
Q 040257 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHF 1094 (1254)
Q Consensus 1030 VkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHR 1094 (1254)
+++++++.... ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||
T Consensus 84 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 84 INLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred hheeEEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 99999997654 7899999999999999986531 347888899999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 040257 1095 DLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170 (1254)
Q Consensus 1095 DLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT- 1170 (1254)
||||+|||++ .++.+||+|||+++...... ......++..|+|||++.+. .++.++||||||+++|+|++
T Consensus 162 dlkp~Nili~----~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~ 235 (304)
T cd05101 162 DLAARNVLVT----ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTL 235 (304)
T ss_pred ccccceEEEc----CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcC
Confidence 9999999998 67899999999997543321 12223356789999999765 47899999999999999998
Q ss_pred CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1171 GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1171 Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
|..||......+....+.. ......+..++.++++|+.+||..+|.+||++.++++.|+.+..-
T Consensus 236 g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 236 GGSPYPGIPVEELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CCCCcccCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 8899988776666655543 334445667889999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=349.77 Aligned_cols=254 Identities=31% Similarity=0.559 Sum_probs=201.9
Q ss_pred CceEEEEEeeeCcEEEEEEEECC-ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 965 DLEELRELGSGTYGTVYHGKWRG-SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~rG-s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
.|..-+.||+|+||.||+|...+ +.||||++..... .. ..+|.+|+.+|.+++|||+|+|+|||.+... .
T Consensus 76 ~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~------~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~ 146 (361)
T KOG1187|consen 76 NFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSG------QG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-H 146 (361)
T ss_pred CCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCC------cc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-e
Confidence 56666789999999999999965 8899998765421 11 2459999999999999999999999987663 5
Q ss_pred eEEEEEecccCchhhhhhccCC-CCCHHHHHHHHHHhhhhhHHhhhCC---cccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDR-SLDRRKKLIIAMDAAFGMEYLHSKN---IVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~-~LSe~~~lkIa~QIAeALaYLHSkG---IIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
.++|+|||.+|+|.++++.... .++|..+++|+.+++.||+|||+.. |||||||+.||||| ++...||+|||
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD----~~~~aKlsDFG 222 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD----EDFNAKLSDFG 222 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC----CCCCEEccCcc
Confidence 8999999999999999987766 8999999999999999999999853 99999999999999 88999999999
Q ss_pred ccccccC-ccccCCC-CCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hhhHHH---Hhh---
Q 040257 1120 LSRIKRN-TLVSGGV-RGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH---CGAIIG---GIV--- 1188 (1254)
Q Consensus 1120 LAr~~~~-s~~sts~-~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n---~~eliq---sIl--- 1188 (1254)
+|+.... ....... .||.+|+|||++... ..+.|+||||||++|+||+||+.+..... ...... ..+
T Consensus 223 La~~~~~~~~~~~~~~~gt~gY~~PEy~~~g--~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 223 LAKLGPEGDTSVSTTVMGTFGYLAPEYASTG--KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred CcccCCccccceeeecCCCCccCChhhhccC--CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 9976654 3222222 799999999999753 48999999999999999999998887432 111111 111
Q ss_pred --hccCCCCCC-CCCc--H---HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1189 --KNTLRPTIP-ERCD--P---EWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1189 --k~~Lrp~ip-e~iS--~---eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
.....+.+. ...+ . .+..+..+|++.+|.+||+|.|+++.|+.+.
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 112223332 2233 2 3557788999999999999999988885543
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=316.06 Aligned_cols=252 Identities=35% Similarity=0.630 Sum_probs=207.7
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEECC-ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWRG-SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~rG-s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
+...+|++...||+|++|.||++.+.+ ..+|+|++.... ...+.+.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---------MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE- 72 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---------ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 334578999999999999999998854 469999876431 123567889999999999999999998853
Q ss_pred CCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
...+++|||+.+++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||||+||+++ .++.+||+||
T Consensus 73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~----~~~~~~l~df 146 (260)
T cd05069 73 --EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG----DNLVCKIADF 146 (260)
T ss_pred --CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCeEEECCC
Confidence 25789999999999999986543 3488999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1119 GLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1119 GLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
|++....... ......++..|+|||.+.+. .++.++||||||+++|+|++ |+.||.+.........+.. .....
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~ 223 (260)
T cd05069 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMP 223 (260)
T ss_pred ccceEccCCcccccCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCC
Confidence 9997543321 11223456789999998755 47899999999999999999 9999988776666555543 34445
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
.+...+..+.+|+++||.++|.+||+++++++.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.10 Aligned_cols=245 Identities=34% Similarity=0.609 Sum_probs=202.7
Q ss_pred EEeeeCcEEEEEEEEC----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEE
Q 040257 971 ELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~r----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
.||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.++++++|+||+++++++.. ...++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~l 71 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALML 71 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEE
Confidence 3899999999999774 3458999886431 23345678899999999999999999998853 26889
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccC
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN 1126 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~ 1126 (1254)
||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 72 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 72 VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV----NQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc----CCCcEEeccCCccccccC
Confidence 9999999999999876666799999999999999999999999999999999999998 678899999999874322
Q ss_pred cc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1127 TL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1127 s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
.. ......++..|+|||.+.+.. ++.++|||||||++|+|++ |+.||...........+.. ......+..++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 224 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ-GKRLDCPAECP 224 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCC--CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CCCCCCCCCCC
Confidence 21 111122357899999987653 7889999999999999996 9999988776665544433 34455677789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
+++.++|.+||..+|++||++.+|++.|+.+
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=337.66 Aligned_cols=243 Identities=23% Similarity=0.405 Sum_probs=196.1
Q ss_pred EEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCCCceEE
Q 040257 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+.||+|+||+||++++. ++.||+|++++.... .......+.+|+.++.++ +||||+++++++.+.. .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~l 73 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-----DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFF 73 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-----chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC--EEEE
Confidence 36999999999999884 667999999865321 122345677888888776 8999999999998765 8999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccC
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN 1126 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~ 1126 (1254)
||||+.+++|..++.. .+.+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~E~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~----~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 74 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCCEEEeeCCccccccC
Confidence 9999999999888744 45699999999999999999999999999999999999998 778999999999875322
Q ss_pred -ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---------hhhHHHHhhhccCCCCC
Q 040257 1127 -TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH---------CGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1127 -s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n---------~~eliqsIlk~~Lrp~i 1196 (1254)
........||..|+|||++.+.. ++.++|||||||++|+|++|+.||.... .......+... ...+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~ 224 (329)
T cd05618 149 PGDTTSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRI 224 (329)
T ss_pred CCCccccccCCccccCHHHHcCCC--CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCC
Confidence 22234467999999999998764 7889999999999999999999995311 11122223322 2346
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPS------FTEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPS------ArELLe~ 1228 (1254)
+..++..+.+||++||..||.+||+ +.+++++
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 7788999999999999999999998 4677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=354.90 Aligned_cols=267 Identities=26% Similarity=0.415 Sum_probs=233.8
Q ss_pred ceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
|++.+.||+|.|++|.++++ +|..||||++.+..+. ......++.|+++|+.+.|||||+||.+...++ .
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD------~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT--K 91 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT--K 91 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc------hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc--e
Confidence 66778899999999999987 7999999999876542 334567889999999999999999999986555 8
Q ss_pred eEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
+|+|+|.-.+|+|.++|.+++..+.+..+.+++.||+.||.|+|+..+|||||||+||.+. ..-|.|||+|||++..
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF---EKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF---EKLGLVKLTDFGFSNK 168 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe---eecCceEeeecccccc
Confidence 9999999999999999999999999999999999999999999999999999999999887 3678999999999987
Q ss_pred ccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHH
Q 040257 1124 KRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPE 1203 (1254)
Q Consensus 1124 ~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~e 1203 (1254)
+......++.||+..|-|||++.|..|. .+++||||||||||.|++|++||...+..+.+..|+.-.+ ..|..++.+
T Consensus 169 f~PG~kL~TsCGSLAYSAPEILLGDsYD-APAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--tvPshvS~e 245 (864)
T KOG4717|consen 169 FQPGKKLTTSCGSLAYSAPEILLGDSYD-APAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--TVPSHVSKE 245 (864)
T ss_pred CCCcchhhcccchhhccCchhhhcCccC-CcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--cCchhhhHH
Confidence 7777777889999999999999998754 5789999999999999999999999999998888887665 468889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhcccCCCCCCCCCCCC
Q 040257 1204 WRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCINSEPKQTKPIVS 1253 (1254)
Q Consensus 1204 LrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk~~k~~p~t~~Pi~S 1253 (1254)
.++||..||..||.+|.+.++|...-. -....+...|.-|+||
T Consensus 246 CrdLI~sMLvRdPkkRAslEeI~s~~W-------lq~~D~~~sT~iPLvs 288 (864)
T KOG4717|consen 246 CRDLIQSMLVRDPKKRASLEEIVSTSW-------LQAGDRGLSTAIPLVS 288 (864)
T ss_pred HHHHHHHHHhcCchhhccHHHHhcccc-------ccCCCCCccccCceee
Confidence 999999999999999999999986522 1223445555577765
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.47 Aligned_cols=251 Identities=29% Similarity=0.451 Sum_probs=206.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||.|+||.||++.+. ++.+++|++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--------GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD- 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--------hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC-
Confidence 47899999999999999999884 6779999987531 113467889999999999999999999987655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.++++|||+.+++|.+++......+++..++.++.|++.||.|||+++|+|+||||+||+++ .++.+||+|||++
T Consensus 74 -~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~ 148 (262)
T cd06613 74 -KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT----EDGDVKLADFGVS 148 (262)
T ss_pred -EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC----CCCCEEECccccc
Confidence 79999999999999998866656799999999999999999999999999999999999999 6788999999998
Q ss_pred ccccCcc-ccCCCCCCCCccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC---C
Q 040257 1122 RIKRNTL-VSGGVRGTLPWMAPELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT---I 1196 (1254)
Q Consensus 1122 r~~~~s~-~sts~~GT~~YmAPEVLrG~~-~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~---i 1196 (1254)
....... ......++..|+|||.+.+.. ..++.++||||||+++|+|++|+.||...........+....+.+. .
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (262)
T cd06613 149 AQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD 228 (262)
T ss_pred hhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccc
Confidence 7544322 223456888999999987541 1478899999999999999999999987765554444433322221 2
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
...++.++.+|+++||..+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 23456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.56 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=204.0
Q ss_pred ceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
|+..+.||+|+||+||++.+. ++.||+|++...... .......+.+|+.++++++|+||+.+++++.+++ .
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~ 74 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-----KRKGESMALNEKQILEKVNSQFVVNLAYAYETKD--A 74 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-----hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--E
Confidence 677889999999999999884 678999998754221 1223355778999999999999999999987655 8
Q ss_pred eEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
++++|||+.+++|.+.+... ...+++..+..++.|++.||.|||+++|+||||||+||+++ .++.+||+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~----~~~~~kl~Dfg~~~ 150 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD----DYGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC----CCCCEEEecCCcce
Confidence 99999999999999887543 34699999999999999999999999999999999999998 67789999999987
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc--CCCCCCCCC
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT--LRPTIPERC 1200 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~--Lrp~ipe~i 1200 (1254)
............|+..|+|||++.+. .++.++|||||||++|+|++|..||...........+.... ....++..+
T Consensus 151 ~~~~~~~~~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd05632 151 KIPEGESIRGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKF 228 (285)
T ss_pred ecCCCCcccCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccC
Confidence 54333233345689999999999865 47889999999999999999999998766544333332211 122345668
Q ss_pred cHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPS-----FTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPS-----ArELLe~ 1228 (1254)
+.++.+|+.+||..+|++||+ +.+++++
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 889999999999999999999 7788775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=313.65 Aligned_cols=253 Identities=36% Similarity=0.632 Sum_probs=210.6
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
+...+|.+.+.||+|+||.||++.+. +..+|||.+..... ..+++.+|+.++++++|+||+++++++...
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---------CHHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 44568999999999999999999875 45699998874321 135678899999999999999999998764
Q ss_pred CCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
. .+++||||+.+++|.+++.... ..+++..++.++.+|+.||.|||+++|+|+||||+||+++ .++.+||+||
T Consensus 74 ~--~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~----~~~~~~l~d~ 147 (261)
T cd05034 74 E--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG----ENLVCKIADF 147 (261)
T ss_pred C--ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc----CCCCEEECcc
Confidence 4 7899999999999999986643 4689999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCccc--cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1119 GLSRIKRNTLV--SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1119 GLAr~~~~s~~--sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
|++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++ |+.||...........+... +...
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~ 224 (261)
T cd05034 148 GLARLIEDDEYTAREGAKFPIKWTAPEAANYGR--FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMP 224 (261)
T ss_pred ccceeccchhhhhhhccCCCccccCHHHhccCC--cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCC
Confidence 99875432211 11223456899999998653 7889999999999999998 99999887766666655443 3444
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
.+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 566678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.58 Aligned_cols=260 Identities=27% Similarity=0.458 Sum_probs=212.1
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEECC------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWRG------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~rG------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
+...+|++.+.||+|+||.||+|.+.. ..|++|+++... .......+.+|+.++++++|+||+++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-------SEIQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 445689999999999999999999853 668999876321 2233567889999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccC-------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKD-------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD 1107 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre-------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd 1107 (1254)
++.... ...+++++|+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++
T Consensus 76 ~~~~~~-~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~--- 151 (280)
T cd05043 76 VCIEDG-EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID--- 151 (280)
T ss_pred EEecCC-CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---
Confidence 876542 46789999999999999885532 4588999999999999999999999999999999999998
Q ss_pred CCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhH
Q 040257 1108 PQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAI 1183 (1254)
Q Consensus 1108 ~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~el 1183 (1254)
..+.+||+|||+++...... ......++..|+|||++.+. .++.++|||||||++||+++ |+.||...+....
T Consensus 152 -~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 228 (280)
T cd05043 152 -EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228 (280)
T ss_pred -CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH
Confidence 67899999999997442211 11223467789999999765 47899999999999999999 9999987765554
Q ss_pred HHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1184 IGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1184 iqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
...+. .......+..+++++.+++.+||..+|++|||+.++++.|+++..+
T Consensus 229 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 229 AAYLK-DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 44333 3334444556789999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=315.29 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=207.5
Q ss_pred CceEEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 965 DLEELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
+|.+.+.||+|+||.||+|.. .++.+|+|.++..... ..........+.+|++++++++|+||+++++++.+.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSN--VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN--T 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccc--hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC--e
Confidence 477888999999999999987 5677999998754211 1123344567899999999999999999999998764 8
Q ss_pred eEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
++++|||+.+++|.+++.+. ..+++..+..++.|++.||.|||+.+|+|+||||+||+++ .++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~~ 151 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM----PNGIIKLIDFGCARR 151 (265)
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC----CCCeEEeccchhhHh
Confidence 99999999999999998544 4688999999999999999999999999999999999998 778999999999874
Q ss_pred ccC-------ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc-cCCCC
Q 040257 1124 KRN-------TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN-TLRPT 1195 (1254)
Q Consensus 1124 ~~~-------s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~-~Lrp~ 1195 (1254)
... ........++..|+|||++.+.. ++.++|+||||+++|+|++|+.||...........+... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG--YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCC--CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC
Confidence 321 11223356889999999998653 788999999999999999999999876654444333322 33445
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+..++.++.++|++||+.+|.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 667789999999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=312.36 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=211.2
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|+.++.||.|+||.||.++. ++..+++|.+..... ......++.+|+.++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL------SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-- 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc------chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC--
Confidence 488999999999999998877 467899999865421 1233456789999999999999999999998754
Q ss_pred ceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.++++|||+.+++|.+++... ...+++..+..++.|++.+|.|||+.+++|+||+|+||+++ .++.+||+|||++
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~----~~~~~kl~d~~~~ 148 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT----KAGLIKLGDFGIS 148 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe----CCCCEEECcCcce
Confidence 899999999999999998654 45689999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1122 RIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1122 r~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
....... ......++..|+|||++.+.. ++.++||||||+++|+|++|..||......+....+....+.+ .+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 225 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQGVK--YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVY 225 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCCCC--CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-Ccccc
Confidence 7553332 233456899999999998653 7888999999999999999999998877777776666555443 34667
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
+.++.+++.+||..+|.+||++.++++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 89999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=311.26 Aligned_cols=250 Identities=30% Similarity=0.494 Sum_probs=207.2
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|++|.||++++. ++.||+|++..... .....+.+.+|+.++++++|+|++++++.+... ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA------SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc------CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CC
Confidence 4889999999999999999874 66799999875321 122345678899999999999999999887533 23
Q ss_pred ceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.++++|||+.+++|.+++... ...+++..++.++.+++.||.|||++||+||||||+||+++ ..+.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~----~~~~~~l~df~~~ 149 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT----RTNIIKVGDLGIA 149 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe----cCCcEEEecccce
Confidence 689999999999999988653 34589999999999999999999999999999999999998 7789999999998
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
...... .......+++.|+|||++.+. .++.++||||||+++|+|++|+.||...+.......+....+ +..+..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 226 (257)
T cd08223 150 RVLENQCDMASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDY 226 (257)
T ss_pred EEecccCCccccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCcccc
Confidence 754322 222345688999999999865 478899999999999999999999987766555555544433 3456678
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++++.+|+.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 227 SPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 8999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=335.85 Aligned_cols=253 Identities=22% Similarity=0.319 Sum_probs=206.6
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||+++++ ++.||+|++.+... ........+.+|+.++..++|+||+++++++.+..
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~-- 74 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-----LKRAETACFREERNVLVNGDCQWITTLHYAFQDEN-- 74 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--
Confidence 7899999999999999999884 56799999875321 12223455778999999999999999999998655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+|+|.+++.+....+++..+..++.||+.||+|||+++|+||||||+|||++ ..+.+||+|||++.
T Consensus 75 ~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~----~~~~~kl~DfG~a~ 150 (331)
T cd05624 75 YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD----MNGHIRLADFGSCL 150 (331)
T ss_pred EEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc----CCCCEEEEecccee
Confidence 89999999999999999976566799999999999999999999999999999999999998 77899999999987
Q ss_pred cccCcc--ccCCCCCCCCccCcccccCCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1123 IKRNTL--VSGGVRGTLPWMAPELLNGSS---NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1123 ~~~~s~--~sts~~GT~~YmAPEVLrG~~---~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
...... ......||+.|+|||++.+.. ..++.++|||||||+||+|++|+.||...+..+....+.....+...+
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCC
Confidence 543322 123356999999999987521 247889999999999999999999998877766666665443322222
Q ss_pred ---CCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 040257 1198 ---ERCDPEWRKLMEQCWAADPEA--RPSFTEITSR 1228 (1254)
Q Consensus 1198 ---e~iS~eLrdLIkKCLqkDPeK--RPSArELLe~ 1228 (1254)
..++.++++||.+||+..+++ |+++++++++
T Consensus 231 ~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 346899999999999876554 4688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.67 Aligned_cols=248 Identities=26% Similarity=0.365 Sum_probs=189.6
Q ss_pred EEEEeeeCcEEEEEEEEC----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCce
Q 040257 969 LRELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTL 1044 (1254)
Q Consensus 969 LkkLGeGsFGtVYlAk~r----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L 1044 (1254)
.++||+|+||+||+|++. ++.||+|.+..... ...+.+|+.+|++++||||+++++++.......+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSHADRKV 75 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEE
Confidence 457999999999999863 46799999864321 2346689999999999999999999876666688
Q ss_pred EEEEEecccCchhhhhhcc--------CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1045 ATVTEFMVNGSLKHVLLKK--------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1045 ~LVMEYm~GGSL~d~L~kr--------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
+++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++..+...+.+||+
T Consensus 76 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 76 WLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 9999998 45777776421 23588999999999999999999999999999999999996444467899999
Q ss_pred eccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---------hH
Q 040257 1117 DFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG---------AI 1183 (1254)
Q Consensus 1117 DFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~---------el 1183 (1254)
|||+++...... ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...... ..
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcCCC-CcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence 999997643321 223456899999999998643 4788999999999999999999999643321 11
Q ss_pred HHHhhhc-----------------------cCC-------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040257 1184 IGGIVKN-----------------------TLR-------------PTIPERCDPEWRKLMEQCWAADPEARPSFTEITS 1227 (1254)
Q Consensus 1184 iqsIlk~-----------------------~Lr-------------p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe 1227 (1254)
+..+... .+. .......+..+.+||.+||++||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111000 000 0001123457889999999999999999999987
Q ss_pred H
Q 040257 1228 R 1228 (1254)
Q Consensus 1228 ~ 1228 (1254)
+
T Consensus 314 h 314 (317)
T cd07868 314 D 314 (317)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=358.02 Aligned_cols=251 Identities=26% Similarity=0.458 Sum_probs=224.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
..|..++++|+|+||.+++++++ ++.|++|.+....... ..+.....|+.+++++.|||||.+.+.|.++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~------~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~- 76 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE------PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG- 76 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc------hhhHHHHHHHHHHHhccCCCeeeeccchhcCC-
Confidence 36888999999999999988875 5679999998653322 22346778999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
..++|||+||+||+|.+.|.+.. ..|+++.++.|+.||+.||.|||+++|+|||||+.||+++ .+..|||+|||+
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt----k~~~VkLgDfGl 152 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT----KDKKVKLGDFGL 152 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc----ccCceeecchhh
Confidence 24999999999999999997654 6799999999999999999999999999999999999999 778899999999
Q ss_pred cccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1121 SRIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1121 Ar~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
|+...... ...+..||+.||.||++.+.+ |..|+|||||||++|||++-+++|...+...++.++....+ ..++..
T Consensus 153 aK~l~~~~~~a~tvvGTp~YmcPEil~d~p--Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~-~Plp~~ 229 (426)
T KOG0589|consen 153 AKILNPEDSLASTVVGTPYYMCPEILSDIP--YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY-SPLPSM 229 (426)
T ss_pred hhhcCCchhhhheecCCCcccCHHHhCCCC--CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC-CCCCcc
Confidence 99887765 666788999999999999886 88999999999999999999999999999999999988764 457888
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++.+++.+|+.||..+|+.||++.+||.+
T Consensus 230 ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 230 YSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 99999999999999999999999999987
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=314.15 Aligned_cols=249 Identities=31% Similarity=0.582 Sum_probs=199.8
Q ss_pred EEeeeCcEEEEEEEEC-----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceE
Q 040257 971 ELGSGTYGTVYHGKWR-----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~r-----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~ 1045 (1254)
.||+|+||.||+|.+. ...+|||.+.... .....+.+.+|+.+++.++||||+++++++...+ ...+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 73 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-------DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPL 73 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccC-------CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcE
Confidence 5899999999999863 2458999875321 1223467888999999999999999999775433 3578
Q ss_pred EEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1046 TVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
++|||+.+++|.+++.+....+++..++.++.||+.||.|||+.+|+||||||+|||++ ..+.+||+|||+++...
T Consensus 74 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~----~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 74 VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD----ESFTVKVADFGLARDIY 149 (262)
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEECCcccccccc
Confidence 99999999999999976656678888899999999999999999999999999999998 67889999999987432
Q ss_pred Ccc-----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1126 NTL-----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1126 ~s~-----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
... ......++..|+|||.+.+. .++.++|||||||++|||++ |.+||...........+... ..+..+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG-RRLLQPEY 226 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCCCc
Confidence 211 11233467789999998765 48899999999999999999 56677766655554444332 23344566
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
++..+.+++.+||..+|++||++.++++.|+.+..
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 78899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.30 Aligned_cols=265 Identities=30% Similarity=0.520 Sum_probs=214.6
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC---------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCce
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR---------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNV 1029 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r---------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNI 1029 (1254)
.+...+|.+.+.||+|+||.||++++. ...+|+|+++... .......+.+|+.+++++ +||||
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i 80 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-------TDKDLADLISEMELMKLIGKHKNI 80 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhccCCCCe
Confidence 445568999999999999999999752 3358999876431 122345688899999999 69999
Q ss_pred eEEeeeeecCCCCceEEEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccc
Q 040257 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHF 1094 (1254)
Q Consensus 1030 VkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHR 1094 (1254)
+++++++.+.. .++++|||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||
T Consensus 81 v~~~~~~~~~~--~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 158 (314)
T cd05099 81 INLLGVCTQEG--PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHR 158 (314)
T ss_pred eeEEEEEccCC--ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 99999987654 7899999999999999985532 348889999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEEeccccccccCccc---cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 040257 1095 DLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLV---SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170 (1254)
Q Consensus 1095 DLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~---sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT- 1170 (1254)
||||+|||++ .++.+||+|||+++....... .....++..|+|||++.+. .++.++||||||+++|+|++
T Consensus 159 dlkp~Nill~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~~ 232 (314)
T cd05099 159 DLAARNVLVT----EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFTL 232 (314)
T ss_pred cccceeEEEc----CCCcEEEccccccccccccccccccccCCCCccccCHHHHccC--CcCccchhhHHHHHHHHHHhC
Confidence 9999999998 678999999999975432211 1112244679999999865 47889999999999999999
Q ss_pred CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 040257 1171 GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKC 1240 (1254)
Q Consensus 1171 Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk~ 1240 (1254)
|..||......+....+... .....+..++.++++|+.+||..+|++||++.++++.|+.+...+....
T Consensus 233 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 301 (314)
T cd05099 233 GGSPYPGIPVEELFKLLREG-HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEY 301 (314)
T ss_pred CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCc
Confidence 89999887766666555433 3344566788899999999999999999999999999999987665543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=314.21 Aligned_cols=253 Identities=26% Similarity=0.466 Sum_probs=207.8
Q ss_pred ceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCC-chhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 966 LEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGR-SSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~-~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
|.+...||+|++|.||+|.+ .++.+|+|.+........ ........+.+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD-- 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--
Confidence 66778999999999999987 467899999875432211 1223445677889999999999999999999987655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
..+++|||+.+++|..++... +.+++..+..++.|++.||.|||+++|+||||+|+||+++ .++.+||+|||+++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~----~~~~~~l~dfg~~~ 154 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD----NKGGIKISDFGISK 154 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc----CCCCEEecccCCCc
Confidence 788999999999999998544 5688999999999999999999999999999999999998 77899999999987
Q ss_pred cccCcc-------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1123 IKRNTL-------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1123 ~~~~s~-------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
...... ......|+..|+|||.+.+. .++.++|||||||++|+|++|+.||........+..+.. ...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~ 231 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPE 231 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCc
Confidence 553211 11234588899999999865 378899999999999999999999987665544444333 33455
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+..++..+.++|++||+.+|.+||++.+++++
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 232 IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 667789999999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=321.98 Aligned_cols=253 Identities=29% Similarity=0.447 Sum_probs=207.2
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
.+..|+++++||+|+||.||+|++. ++.+++|.+... .....+.+.+|+.+++.++|+||+++++++..+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--------SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 3456999999999999999999984 677999998643 223356788899999999999999999998765
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
. .+++||||+.+++|..++.+....+++..++.++.||+.+|.|||+++|+||||||+||+++ .++.+||+|||
T Consensus 82 ~--~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~kl~dfg 155 (292)
T cd06644 82 G--KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT----LDGDIKLADFG 155 (292)
T ss_pred C--eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc----CCCCEEEccCc
Confidence 5 89999999999999888866666799999999999999999999999999999999999998 67899999999
Q ss_pred ccccccCc-cccCCCCCCCCccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-CC
Q 040257 1120 LSRIKRNT-LVSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL-RP 1194 (1254)
Q Consensus 1120 LAr~~~~s-~~sts~~GT~~YmAPEVLrG~---~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L-rp 1194 (1254)
++...... .......++..|+|||++.+. ...++.++|||||||++|+|++|..||...........+..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T cd06644 156 VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 235 (292)
T ss_pred cceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccC
Confidence 98643222 222345588899999998632 22468899999999999999999999987665554444433222 12
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+..++.++.+||.+||..+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 2345678899999999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=311.16 Aligned_cols=244 Identities=36% Similarity=0.637 Sum_probs=202.5
Q ss_pred EEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEE
Q 040257 971 ELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTE 1049 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVME 1049 (1254)
.||+|+||.||++... ++.+|+|+++... .......+.+|+.++++++||||+++++++.... ..++|||
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 72 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--PIYIVME 72 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--ccEEEEE
Confidence 6899999999999874 5679999886432 1223456889999999999999999999997655 7899999
Q ss_pred ecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCccc
Q 040257 1050 FMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLV 1129 (1254)
Q Consensus 1050 Ym~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~ 1129 (1254)
|+.+++|.+++......+++..++.++.+++.+|.|||++|++||||||+||+++ .++.+||+|||++........
T Consensus 73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSRQEDDGIY 148 (250)
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc----CCCeEEECCCccceecccccc
Confidence 9999999999876666789999999999999999999999999999999999998 778999999999875433221
Q ss_pred c--CCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHH
Q 040257 1130 S--GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRK 1206 (1254)
Q Consensus 1130 s--ts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrd 1206 (1254)
. ....++..|+|||++.+. .++.++||||||+++|+|++ |..||...........+.. ......+..++..+.+
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 225 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-GYRMSCPQKCPDDVYK 225 (250)
T ss_pred ccCCCCCCcccccCHHHhccC--CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHH
Confidence 1 122345679999999765 47889999999999999998 9999988766655554443 3344556678899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1207 LMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1207 LIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
|+.+||..+|++||++.++++.|.
T Consensus 226 li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 226 VMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.15 Aligned_cols=244 Identities=36% Similarity=0.614 Sum_probs=205.2
Q ss_pred EEeeeCcEEEEEEEECC---c--eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceE
Q 040257 971 ELGSGTYGTVYHGKWRG---S--DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~rG---s--~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~ 1045 (1254)
.||+|++|.||++.+.. + .||||.+..... ....+.+.+|+.++++++||||+++++++.+ ..++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 71 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-------SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLM 71 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCccc-------HHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEE
Confidence 58999999999998732 2 589999876421 1456788999999999999999999999876 4789
Q ss_pred EEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccc
Q 040257 1046 TVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~ 1124 (1254)
+||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++|+|+||||+|||++ .++.+||+|||+++..
T Consensus 72 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~----~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA----SDDKVKIGDFGLMRAL 147 (257)
T ss_pred EEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe----cCCEEEeccccccccc
Confidence 9999999999999987654 5689999999999999999999999999999999999998 6789999999998754
Q ss_pred cCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1125 RNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1125 ~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
.... ......++..|+|||.+.+.. ++.++|||||||++|+|++ |+.||......+....+.........+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRT--FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA 225 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcccC--cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCcc
Confidence 3311 112345678899999988653 7889999999999999999 99999887777666665544444445567
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
++..+.+++.+||+.+|++||++.++++.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 7899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=333.11 Aligned_cols=250 Identities=29% Similarity=0.399 Sum_probs=208.9
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|..+++||+|.||.||+|++ +++.||||+++.... .+.......||+++|+.++|+||+.++++|...+
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~------kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-- 74 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA------KDGINRTALREIKLLQELKHPNIIELIDVFPHKS-- 74 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc------ccCccHHHHHHHHHHHHccCcchhhhhhhccCCC--
Confidence 678889999999999999998 478899999986532 2223455789999999999999999999997665
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+.+|+||+ ..+|..+|+.+...++..++..|+.++++||+|||++.|+||||||.|+||+ ++|.+||+|||+++
T Consensus 75 ~l~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis----~~g~lKiADFGLAr 149 (318)
T KOG0659|consen 75 NLSLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS----SDGQLKIADFGLAR 149 (318)
T ss_pred ceEEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc----CCCcEEeecccchh
Confidence 899999998 6799999988888899999999999999999999999999999999999999 88999999999999
Q ss_pred cccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC-------
Q 040257 1123 IKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP------- 1194 (1254)
Q Consensus 1123 ~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp------- 1194 (1254)
...... ......-|.+|+|||.+.|.. .|+..+||||.|||+.||+-|.+-|.+.+.-+.+..+....-.+
T Consensus 150 ~f~~p~~~~~~~V~TRWYRAPELLfGsr-~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 150 FFGSPNRIQTHQVVTRWYRAPELLFGSR-QYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred ccCCCCcccccceeeeeccChHHhccch-hcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence 765433 223336899999999999864 68999999999999999999999998877655554443211000
Q ss_pred --------------C-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 --------------T-----IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 --------------~-----ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
. +-...+.++.+|+.+||..||.+|+++.|.+++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 112246678899999999999999999999886
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.67 Aligned_cols=254 Identities=30% Similarity=0.463 Sum_probs=208.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|+..+.||+|+||.||++.+ +++.||+|++...... .........+.+|+.++++++||||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPES---PETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCC---chhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence 3688899999999999999987 4678999998754211 1223345678899999999999999999999876555
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..++++|||+.+++|.+++... ..+++...+.++.|++.||.|||+.+|+||||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~----~~~~~~l~dfg~~ 153 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 153 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEccCCCc
Confidence 6889999999999999988543 4589999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCc----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1122 RIKRNT----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1122 r~~~~s----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
+..... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||........+.........+.++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCc
Confidence 754321 111234588899999999865 47899999999999999999999998776555555554444455667
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+++.+++++ +||..+|++||++++++++
T Consensus 232 ~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 232 SHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred hhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 77888999999 6777899999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=335.73 Aligned_cols=239 Identities=26% Similarity=0.387 Sum_probs=196.2
Q ss_pred EEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHH-HHhcCCCCceeEEeeeeecCCCCceEE
Q 040257 970 RELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH-ILSNLHHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIe-ILkrLnHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+.||+|+||+||++++ +++.||||++.+.... .......+.+|.. +++.++||||+++++++.... .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~--~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-----NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE--KLYF 73 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC--EEEE
Confidence 3699999999999988 4778999999754221 1122344555654 567899999999999987655 8999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc-
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR- 1125 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~- 1125 (1254)
||||+.+++|...+.+ ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~----~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 74 VLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD----SQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred EEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEeecCCcccCCC
Confidence 9999999999888754 45799999999999999999999999999999999999998 77899999999987432
Q ss_pred CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHH
Q 040257 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205 (1254)
Q Consensus 1126 ~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLr 1205 (1254)
........+||..|+|||++.+.. ++.++|||||||++|+|++|+.||......+....+..... ..+...+..+.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 224 (325)
T cd05604 149 QSDTTTTFCGTPEYLAPEVIRKQP--YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--VLRPGASLTAW 224 (325)
T ss_pred CCCCcccccCChhhCCHHHHcCCC--CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--cCCCCCCHHHH
Confidence 222334567999999999998764 78899999999999999999999998877777666665433 33446789999
Q ss_pred HHHHHhhhcCCCCCCCHHH
Q 040257 1206 KLMEQCWAADPEARPSFTE 1224 (1254)
Q Consensus 1206 dLIkKCLqkDPeKRPSArE 1224 (1254)
++|++||+.+|.+||++++
T Consensus 225 ~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 225 SILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHHHhccCHHhcCCCCC
Confidence 9999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.39 Aligned_cols=247 Identities=35% Similarity=0.601 Sum_probs=200.6
Q ss_pred EEeeeCcEEEEEEEECC--c--eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCCCceE
Q 040257 971 ELGSGTYGTVYHGKWRG--S--DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~rG--s--~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~~~L~ 1045 (1254)
.||+|+||.||+|++.+ . .+++|.++... .....+.+.+|+.++.++ +||||+++++++.... .++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~ 72 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLY 72 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC--Cce
Confidence 58999999999998843 2 46888776421 122345688899999999 8999999999997654 789
Q ss_pred EEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCC
Q 040257 1046 TVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQR 1110 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~sn 1110 (1254)
++|||+.+++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++ .+
T Consensus 73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~----~~ 148 (270)
T cd05047 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----EN 148 (270)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc----CC
Confidence 9999999999999985432 2478999999999999999999999999999999999998 78
Q ss_pred CeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhh
Q 040257 1111 PICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1111 G~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk 1189 (1254)
+.+||+|||++..............+..|+|||++.+. .++.++|||||||++|||++ |..||...........+..
T Consensus 149 ~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~ 226 (270)
T cd05047 149 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226 (270)
T ss_pred CeEEECCCCCccccchhhhccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC
Confidence 89999999998633222112222345679999998765 37889999999999999997 9999988776666555543
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
. .....+..++.++.+|+.+||..+|.+||++.+++..|+.++
T Consensus 227 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 G-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C-CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 2 333455667899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.11 Aligned_cols=257 Identities=32% Similarity=0.559 Sum_probs=207.5
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
+...+|++.+.||+|+||.||+|.++ +..||+|.+.... .......+.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 75 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-------SLRERIEFLNEASVMKGFTCHHVVRLL 75 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-------CHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 44568999999999999999998753 3369999876431 112234578899999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccC---------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEec
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVN 1104 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLD 1104 (1254)
+++.+.. ..++||||+.+|+|.+++.+.. ..++...++.++.||+.||.|||+++|+||||||+|||++
T Consensus 76 ~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~ 153 (288)
T cd05061 76 GVVSKGQ--PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA 153 (288)
T ss_pred EEEcCCC--CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc
Confidence 9987665 7899999999999999986432 2346678889999999999999999999999999999998
Q ss_pred cCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 040257 1105 LRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHC 1180 (1254)
Q Consensus 1105 sdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~ 1180 (1254)
.++.+||+|||+++...... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||.....
T Consensus 154 ----~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~DvwslG~~l~el~~~~~~p~~~~~~ 227 (288)
T cd05061 154 ----HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV--FTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227 (288)
T ss_pred ----CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCC--CChHhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 67899999999987432211 111223567899999998653 7899999999999999998 7899988776
Q ss_pred hhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1181 GAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1181 ~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
.+....+..... ...+..+++.+++|+.+||+.+|++|||+.++++.|++..
T Consensus 228 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 228 EQVLKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 666655544332 3345667899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=333.63 Aligned_cols=243 Identities=22% Similarity=0.381 Sum_probs=197.0
Q ss_pred EEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCCCceEE
Q 040257 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+.||+|+||+||++++. ++.||+|++++.... .....+.+.+|+.++.++ +||||+++++++.+.. .+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~l 73 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-----DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS--RLFL 73 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC--EEEE
Confidence 36999999999999884 677999999864221 223356678899999888 6999999999997655 8999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc-
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR- 1125 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~- 1125 (1254)
||||+.+++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 74 VIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD----ADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe----CCCCEEEeccccceeccC
Confidence 9999999999988754 35699999999999999999999999999999999999998 77899999999987432
Q ss_pred CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC------hh-hHHHHhhhccCCCCCCC
Q 040257 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH------CG-AIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1126 ~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n------~~-eliqsIlk~~Lrp~ipe 1198 (1254)
........+||+.|+|||++.+. .++.++|||||||+||+|++|+.||.... .. .....+... ...++.
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~ 224 (327)
T cd05617 149 PGDTTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPR 224 (327)
T ss_pred CCCceecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCC
Confidence 22233456799999999999866 47889999999999999999999996321 11 222223222 234677
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSF------TEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSA------rELLe~ 1228 (1254)
.++..+.++|++||..||.+|+++ .+++++
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 789999999999999999999984 566655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=317.03 Aligned_cols=258 Identities=31% Similarity=0.582 Sum_probs=213.8
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--Cc----eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GS----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs----~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
+++..+|++++.||+|+||+||+|.+. +. .+|+|.+.... .......+.+|+.++++++||||++++
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 75 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-------SPKANKEILDEAYVMASVDHPHVVRLL 75 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-------CHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 456678999999999999999999873 22 48888876542 133456788999999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
+++.. ...++||||+.+++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++ ..+.+
T Consensus 76 ~~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~----~~~~~ 148 (279)
T cd05057 76 GICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK----TPQHV 148 (279)
T ss_pred EEEec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc----CCCeE
Confidence 99875 378999999999999999977666799999999999999999999999999999999999998 67789
Q ss_pred EEEeccccccccCccc---cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhh
Q 040257 1114 KVGDFGLSRIKRNTLV---SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~~---sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk 1189 (1254)
||+|||+++....... .....++..|+|||.+... .++.++||||||+++|||++ |+.||......+....+..
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 226 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR--IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhhcC--CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Confidence 9999999975432211 1112235679999998754 47889999999999999998 9999988776666555544
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
. .....+..++..+.+++.+||..+|.+||++.++++.|..+..
T Consensus 227 ~-~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 227 G-ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred C-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 3 3334556678899999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=357.45 Aligned_cols=268 Identities=39% Similarity=0.626 Sum_probs=233.9
Q ss_pred cccccccCceEEEEEeeeCcEEEEEEEECC-----ce-EEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeE
Q 040257 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRG-----SD-VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVA 1031 (1254)
Q Consensus 958 lq~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-----s~-VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVk 1031 (1254)
.|.+...+..+.++||+|+||.||+|+++- .. ||||..+.... ..+....+|.+|++++++++|||||+
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~-----~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE-----LTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc-----ccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 355666777778999999999999998842 13 89998875321 23556788999999999999999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCC
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRP 1111 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG 1111 (1254)
+||+..+.. .+++|||+|.||+|.+++.+....++..+.+.++.+.+.||+|||++++|||||-.+|+|++ ...
T Consensus 226 ~yGVa~~~~--Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~----~~~ 299 (474)
T KOG0194|consen 226 FYGVAVLEE--PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS----KKG 299 (474)
T ss_pred EEEEEcCCC--ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec----CCC
Confidence 999998776 89999999999999999988777799999999999999999999999999999999999998 667
Q ss_pred eEEEEeccccccccCccccC-CCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhh
Q 040257 1112 ICKVGDFGLSRIKRNTLVSG-GVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1112 ~VKLiDFGLAr~~~~s~~st-s~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk 1189 (1254)
.+||+|||+++......... ...-...|+|||.+... .|++++|||||||++||+++ |..||.+....+....+..
T Consensus 300 ~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~--~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 300 VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG--IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK 377 (474)
T ss_pred eEEeCccccccCCcceeeccccccCcceecChhhhccC--ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence 79999999998664322222 12356789999999865 59999999999999999999 8999999999999999988
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
..++...+...+.++..++.+||..+|++||+|.++.+.|+.+....+.
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 8888888889999999999999999999999999999999999887664
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=314.23 Aligned_cols=254 Identities=29% Similarity=0.448 Sum_probs=207.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||+|+||.||++.+ +++.||||.+...... .......+.+.+|+.++++++||||+++++++.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES---PETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCC---cccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 4789999999999999999987 4678999988643111 1122345678899999999999999999999877655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..++++|||+.+++|.+++... ..+++...+.++.|++.||.|||+++|+|+||||+|||++ .++.+||+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~l~Dfg~~ 153 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD----SVGNVKLGDFGAS 153 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec----CCCCEEECcCccc
Confidence 6788999999999999988544 4588999999999999999999999999999999999998 7789999999998
Q ss_pred ccccCc----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1122 RIKRNT----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1122 r~~~~s----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
+..... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||........+.........+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP 231 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCc
Confidence 754321 112234688999999999865 47889999999999999999999998765555554444443445566
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
...+..+.++|.+||. +|++||++.+++++
T Consensus 232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 232 PHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 6778889999999994 89999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.30 Aligned_cols=253 Identities=32% Similarity=0.589 Sum_probs=207.9
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
...+|++++.||+|+||.||++++. +..||+|++.... .......+.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~iv~~~~ 75 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDHPNIVKLLG 75 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-------CHHHHHHHHHHHHHHHhcCCCchheEEE
Confidence 3458999999999999999999863 4679999886431 1233467889999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccC---------------------CCCCHHHHHHHHHHhhhhhHHhhhCCccc
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVH 1093 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------------------~~LSe~~~lkIa~QIAeALaYLHSkGIIH 1093 (1254)
++.++. .++++|||+.+++|.+++.... ..+++..++.++.||+.||.|||+++++|
T Consensus 76 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H 153 (288)
T cd05050 76 VCAVGK--PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVH 153 (288)
T ss_pred EEcCCC--ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 987655 7899999999999999985421 24678889999999999999999999999
Q ss_pred ccCCCCceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 040257 1094 FDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT 1170 (1254)
Q Consensus 1094 RDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT 1170 (1254)
|||||+|||++ .++.+||+|||++....... .......+..|+|||.+.+. .++.++|||||||++|+|++
T Consensus 154 ~dl~p~nil~~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~ 227 (288)
T cd05050 154 RDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFS 227 (288)
T ss_pred ccccHhheEec----CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHh
Confidence 99999999998 77899999999987432221 11222346679999998765 48899999999999999998
Q ss_pred -CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1171 -GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1171 -Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
|..||......+....+..... ...+..++.++.+||.+||+.+|.+||++.|+++.|+
T Consensus 228 ~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 228 YGMQPYYGMAHEEVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 8889988777666665554433 2345667899999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.70 Aligned_cols=254 Identities=31% Similarity=0.528 Sum_probs=203.0
Q ss_pred cccCceEEEEEeeeCcEEEEEEEECC----------------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWRG----------------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~rG----------------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn 1025 (1254)
...+|++.++||+|+||.||++++.+ ..||+|++.... .......+.+|++++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~ei~~l~~l~ 75 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-------TKTARNDFLKEIKIMSRLK 75 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-------CHHHHHHHHHHHHHHHhCC
Confidence 44589999999999999999987632 248999886431 1233567889999999999
Q ss_pred CCceeEEeeeeecCCCCceEEEEEecccCchhhhhhccC-----------CCCCHHHHHHHHHHhhhhhHHhhhCCcccc
Q 040257 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD-----------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHF 1094 (1254)
Q Consensus 1026 HPNIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre-----------~~LSe~~~lkIa~QIAeALaYLHSkGIIHR 1094 (1254)
|+||+++++++.... ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++|+||
T Consensus 76 h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~ 153 (295)
T cd05097 76 NPNIIRLLGVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHR 153 (295)
T ss_pred CCCcCeEEEEEcCCC--ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 999999999997654 7899999999999999885432 236888999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 040257 1095 DLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170 (1254)
Q Consensus 1095 DLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT- 1170 (1254)
||||+|||++ .++.+||+|||++....... ......++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 154 dlkp~Nill~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 154 DLATRNCLVG----NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred ccChhhEEEc----CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC--CcCchhhHHHHHHHHHHHHHc
Confidence 9999999998 67789999999987432211 11223356789999998865 37999999999999999988
Q ss_pred -CCCCCCCCChhhHHHHhhh------ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1171 -GEEPYADMHCGAIIGGIVK------NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1171 -Gk~PF~~~n~~eliqsIlk------~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
|..||........+..+.. .......+..++..+.+|+.+||+.+|.+||++.++++.|+
T Consensus 228 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 228 CKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 6788887666555444321 11112234557889999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=357.13 Aligned_cols=249 Identities=31% Similarity=0.491 Sum_probs=214.9
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
...|..+..||+|+||.||+|.+ +++.||||++.... .+...+.+.+|+.+|.+++++||.++|+.+..++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-------~~deIediqqei~~Ls~~~~~~it~yygsyl~g~ 84 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-------AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT 84 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh-------cchhhHHHHHHHHHHHhcCcchHHhhhhheeecc
Confidence 34577778999999999999998 47789999998643 2334577889999999999999999999998877
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.++++||||.||++.+.+. .+..+.+..+..++++++.||.|||.++.||||||+.|||+. ..|.|||+|||.
T Consensus 85 --~LwiiMey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s----~~g~vkl~DfgV 157 (467)
T KOG0201|consen 85 --KLWIIMEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS----ESGDVKLADFGV 157 (467)
T ss_pred --cHHHHHHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe----ccCcEEEEecce
Confidence 8999999999999999884 444568899999999999999999999999999999999998 678999999999
Q ss_pred cccccCccc-cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1121 SRIKRNTLV-SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1121 Ar~~~~s~~-sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
+........ ..++.||+.|||||++++. .|+.|+||||||++.+||.+|.+||.......++..|-+ ..+|.+...
T Consensus 158 a~ql~~~~~rr~tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-~~PP~L~~~ 234 (467)
T KOG0201|consen 158 AGQLTNTVKRRKTFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-SAPPRLDGD 234 (467)
T ss_pred eeeeechhhccccccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-CCCCccccc
Confidence 987655433 3678899999999999965 489999999999999999999999998877555444433 345666778
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++.+++|+..||.+||+.||+|.++|++
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 99999999999999999999999999975
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=319.71 Aligned_cols=250 Identities=28% Similarity=0.445 Sum_probs=204.8
Q ss_pred ceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
|++++.||+|+||.||++.+. +..+++|.+... .....+.+.+|+++++.++||||+++++++..+. .
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--~ 76 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--------SEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--N 76 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--------CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC--E
Confidence 577888999999999999985 566888888543 1223467888999999999999999999987655 7
Q ss_pred eEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
.++||||+.+++|..++.+....+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~----~~~~~kl~dfg~~~~ 152 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT----LDGDIKLADFGVSAK 152 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc----cCCCEEEcccccccc
Confidence 8999999999999988866666799999999999999999999999999999999999998 778899999999865
Q ss_pred ccCc-cccCCCCCCCCccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-CCCCCC
Q 040257 1124 KRNT-LVSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL-RPTIPE 1198 (1254)
Q Consensus 1124 ~~~s-~~sts~~GT~~YmAPEVLrG~---~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L-rp~ipe 1198 (1254)
.... .......++..|+|||++... ...++.++|||||||++|+|++|+.||...........+..... ....+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd06643 153 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPS 232 (282)
T ss_pred ccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCcc
Confidence 4322 222345689999999998532 22477899999999999999999999987766555544443322 223455
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
.++.++++||.+||..+|.+||++.+++++-
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 6788999999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.71 Aligned_cols=254 Identities=32% Similarity=0.576 Sum_probs=209.7
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
.+...+|++.+.||+|+||.||++.+. +..+|+|.+... ....+.+.+|+.++++++|+||+++++++.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence 345668999999999999999999874 566999987643 1124578889999999999999999999876
Q ss_pred CCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
...+++|||+.+++|.+++.+. ...+++..++.++.||+.||.|||+.|++|+||||+||+++ ..+.+||+|
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~d 145 (260)
T cd05073 73 ---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIAD 145 (260)
T ss_pred ---CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEECC
Confidence 3688999999999999998653 34578889999999999999999999999999999999998 778999999
Q ss_pred ccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCC
Q 040257 1118 FGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1118 FGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
||++....... ......++..|+|||++.+. .++.++|+|||||++|+|++ |+.||...........+.. ....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~ 222 (260)
T cd05073 146 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRM 222 (260)
T ss_pred CcceeeccCCCcccccCCcccccccCHhHhccC--CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-CCCC
Confidence 99987543221 12223356779999999765 37889999999999999999 9999988776665554443 3344
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
..+...+.++.+++.+||..+|++||++.++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 45567889999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.74 Aligned_cols=251 Identities=26% Similarity=0.428 Sum_probs=202.7
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCC-
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn- 1040 (1254)
.|++.+.||+|+||.||+|.+ .++.||+|++.... .....+.+|+.+++++ +|+||+++++++....
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 577788899999999999988 46779999987431 1124567899999988 7999999999986532
Q ss_pred ---CCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1041 ---GGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1041 ---~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
...++++|||+.+++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++ .++.+||+
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~----~~~~~~l~ 153 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVKLV 153 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC----CCCCEEEc
Confidence 23688999999999999988653 35689999999999999999999999999999999999998 67889999
Q ss_pred eccccccccCc-cccCCCCCCCCccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC
Q 040257 1117 DFGLSRIKRNT-LVSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1117 DFGLAr~~~~s-~~sts~~GT~~YmAPEVLrG~---~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L 1192 (1254)
|||++...... .......|+..|+|||++.+. ...++.++|||||||++|||++|..||...........+.....
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 233 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 233 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCC
Confidence 99998754332 223345689999999998632 22478899999999999999999999987655444443333333
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.......++.++.+|+.+||..+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 333445678899999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=315.87 Aligned_cols=254 Identities=32% Similarity=0.569 Sum_probs=209.5
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
...+|++++.||+|+||+||+++.+ .+.+++|.+.... .......+.+|++++++++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 75 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-------DENLQSEFRRELDMFRKLSHKNVVRLLG 75 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-------chHHHHHHHHHHHHHHhcCCcceeeeEE
Confidence 3457999999999999999999863 3458888775421 2234567889999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccC--------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccC
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKD--------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLR 1106 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre--------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsd 1106 (1254)
++.+.. ..++||||+.+++|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 76 ~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~-- 151 (275)
T cd05046 76 LCREAE--PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS-- 151 (275)
T ss_pred EECCCC--cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe--
Confidence 987654 7899999999999999986433 1589999999999999999999999999999999999998
Q ss_pred CCCCCeEEEEeccccccccCc--cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhH
Q 040257 1107 DPQRPICKVGDFGLSRIKRNT--LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAI 1183 (1254)
Q Consensus 1107 d~snG~VKLiDFGLAr~~~~s--~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~el 1183 (1254)
..+.++|+|||++...... .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||........
T Consensus 152 --~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~ 227 (275)
T cd05046 152 --SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD--FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227 (275)
T ss_pred --CCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCccccchHHH
Confidence 6789999999998643221 1122334677899999987653 7889999999999999998 8899987766666
Q ss_pred HHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1184 IGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1184 iqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
...+.........+..++..+.+++.+||+.+|.+||++.+++..|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 228 LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 66665555444456678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=336.65 Aligned_cols=243 Identities=24% Similarity=0.351 Sum_probs=197.3
Q ss_pred EeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC---CCCceeEEeeeeecCCCCceEE
Q 040257 972 LGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL---HHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 972 LGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL---nHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
||+|+||+||+|++. ++.||||++.+.... .......+..|..++..+ +||||+++++++.+.. .+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~--~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-----AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS--DLYL 73 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-----hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC--eEEE
Confidence 799999999999884 778999999754221 122234455677777655 6999999999997765 8999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc-
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR- 1125 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~- 1125 (1254)
||||+.+++|..++.+ ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 74 VTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD----ATGHIALCDFGLSKANLT 148 (330)
T ss_pred EEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEecCCcCcCCCC
Confidence 9999999999988854 45699999999999999999999999999999999999998 77899999999987432
Q ss_pred CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHH
Q 040257 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205 (1254)
Q Consensus 1126 ~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLr 1205 (1254)
........+||..|+|||++.+.. .++.++|||||||++|+|++|+.||......+.+..+....... ....++.+++
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~ 226 (330)
T cd05586 149 DNKTTNTFCGTTEYLAPEVLLDEK-GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF-PKNVLSDEGR 226 (330)
T ss_pred CCCCccCccCCccccCHHHHcCCC-CCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC-CCccCCHHHH
Confidence 222334567999999999997542 37889999999999999999999999887777666665544322 1234789999
Q ss_pred HHHHHhhhcCCCCCC----CHHHHHHH
Q 040257 1206 KLMEQCWAADPEARP----SFTEITSR 1228 (1254)
Q Consensus 1206 dLIkKCLqkDPeKRP----SArELLe~ 1228 (1254)
+||++||++||.+|| ++.+++++
T Consensus 227 ~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 227 QFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 999999999999998 57777764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=342.65 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=193.2
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.+...+|++++.||+|+||.||++.+ +++.||||.... ..+.+|+++|++|+||||++++++|.
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------------~~~~~E~~il~~l~HpnIv~~~~~~~ 153 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------------GGTATEAHILRAINHPSIIQLKGTFT 153 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------------hhhHHHHHHHHhCCCCCCCCEeEEEE
Confidence 34556899999999999999999988 467899996432 24568999999999999999999997
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
... ..++|||++ .++|..++... ..+++..++.++.||+.||.|||++|||||||||+|||++ ..+.+||+|
T Consensus 154 ~~~--~~~lv~e~~-~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~----~~~~vkL~D 225 (391)
T PHA03212 154 YNK--FTCLILPRY-KTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN----HPGDVCLGD 225 (391)
T ss_pred ECC--eeEEEEecC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc----CCCCEEEEe
Confidence 654 789999998 57888877543 5689999999999999999999999999999999999998 778899999
Q ss_pred ccccccccCc--cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-------hhhHHHHhh
Q 040257 1118 FGLSRIKRNT--LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH-------CGAIIGGIV 1188 (1254)
Q Consensus 1118 FGLAr~~~~s--~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n-------~~eliqsIl 1188 (1254)
||+++..... .......||+.|+|||++.+.. ++.++|||||||+||||++|+.||.... ....+..+.
T Consensus 226 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~ 303 (391)
T PHA03212 226 FGAACFPVDINANKYYGWAGTIATNAPELLARDP--YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303 (391)
T ss_pred CCcccccccccccccccccCccCCCChhhhcCCC--CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHH
Confidence 9998743221 1223457999999999998764 7899999999999999999998875321 111111111
Q ss_pred h--------------------------ccC-CC-CCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1189 K--------------------------NTL-RP-TIP-----ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1189 k--------------------------~~L-rp-~ip-----e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
. ... .+ ..+ ..++.++.+||.+||++||++|||++|+|++
T Consensus 304 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 000 00 000 1245688999999999999999999999975
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=336.51 Aligned_cols=251 Identities=26% Similarity=0.366 Sum_probs=199.5
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC-
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG- 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~- 1041 (1254)
+|++++.||+|+||+||++.+ .++.||||++..... .....+++.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ------NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc------chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 478889999999999999987 478899999864311 12234568899999999999999999999875431
Q ss_pred --CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1042 --GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1042 --~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
..+++||||+. ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg 148 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFG 148 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC----CCCCEEecccc
Confidence 26899999985 677777643 45689999999999999999999999999999999999998 77899999999
Q ss_pred ccccccCc--cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh--------
Q 040257 1120 LSRIKRNT--LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK-------- 1189 (1254)
Q Consensus 1120 LAr~~~~s--~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk-------- 1189 (1254)
+++..... .......++..|+|||++.+.. .++.++|||||||++|||++|+.||...+....+..+..
T Consensus 149 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 149 LARVEEPDESKHMTQEVVTQYYRAPEILMGSR-HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227 (372)
T ss_pred ceeecccCccccCCCCCcCCCcCCHHHHcCCC-CCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 99754322 1223345789999999998643 478899999999999999999999987655443332211
Q ss_pred ---------------ccCCC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1190 ---------------NTLRP-------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1190 ---------------~~Lrp-------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
....+ ......++++.+||.+||+.||++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 01110 1223457889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=309.57 Aligned_cols=250 Identities=26% Similarity=0.467 Sum_probs=209.5
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|+..+.||+|+||.||++.. .++.+|||.+...... ......+.+|+.++++++||||+++++.+....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT------KDERLAAQNECQVLKLLSHPNIIEYYENFLEDK-- 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc------cHHHHHHHHHHHHHhhCCCCchhheeeeEecCC--
Confidence 488899999999999999887 4677999998754321 223467889999999999999999999987554
Q ss_pred ceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++.... ..+++..++.++.+++.+|.|||+++|+|+||||+||+++ ..+..+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~---~~~~~~~l~d~~~~ 149 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD---KHKMVVKIGDFGIS 149 (256)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEEccCCCc
Confidence 8999999999999999996643 4589999999999999999999999999999999999997 23457899999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
.............++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+.......+..... ...+..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-APISDRYS 226 (256)
T ss_pred eecCCCccccccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-CCCCCCcC
Confidence 866544444445688999999999865 378899999999999999999999988776665555544332 34566789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++++++.+||..+|.+|||+.+++++
T Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 227 PDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=323.14 Aligned_cols=251 Identities=27% Similarity=0.378 Sum_probs=201.1
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|++++.||+|+||.||+++++ ++.||+|.++..... .....+.+|+.+++.++||||+++++++.++.
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~ 77 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-------GAPCTAIREVSLLKDLKHANIVTLHDIIHTEK 77 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-------CchhHHHHHHHHHHhcCCCCcceEEEEEecCC
Confidence 347999999999999999999884 678999998754211 11235678999999999999999999997655
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+. ++|..++......+++..++.++.||+.||.|||+++|+|+||||+|||++ .++.+||+|||+
T Consensus 78 --~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~dfg~ 150 (301)
T cd07873 78 --SLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN----ERGELKLADFGL 150 (301)
T ss_pred --eEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC----CCCcEEECcCcc
Confidence 7999999996 688888876666789999999999999999999999999999999999998 778999999999
Q ss_pred cccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-------
Q 040257 1121 SRIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL------- 1192 (1254)
Q Consensus 1121 Ar~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L------- 1192 (1254)
+...... .......++..|+|||++.+.. .++.++|||||||++|+|++|+.||......+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 229 (301)
T cd07873 151 ARAKSIPTKTYSNEVVTLWYRPPDILLGST-DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229 (301)
T ss_pred hhccCCCCCcccccceeecccCcHHHhCCC-CCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhc
Confidence 8753322 1222345788999999987643 478899999999999999999999987665443332211000
Q ss_pred ----------C---C--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 ----------R---P--------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 ----------r---p--------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
. + .....++..+++||.+||+.||.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 0 0113467889999999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=312.39 Aligned_cols=245 Identities=35% Similarity=0.613 Sum_probs=202.1
Q ss_pred EEEeeeCcEEEEEEEEC--C---ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCce
Q 040257 970 RELGSGTYGTVYHGKWR--G---SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTL 1044 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r--G---s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L 1044 (1254)
++||+|+||.||+|++. + ..+|+|.+..... ....+++.+|+.+++.+.|+||+++++++... ..
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~ 70 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI-------AAGKKEFLREASVMAQLDHPCIVRLIGVCKGE---PL 70 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc-------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC---ce
Confidence 36999999999999873 2 5699999875421 13346788999999999999999999987532 57
Q ss_pred EEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccc
Q 040257 1045 ATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1045 ~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~ 1124 (1254)
++||||+.+++|.+++.... .+++..++.++.|++.||.|||..+|+|+||||+|||++ .++.+||+|||+++..
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~----~~~~~kl~df~~~~~~ 145 (257)
T cd05060 71 MLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV----NRHQAKISDFGMSRAL 145 (257)
T ss_pred EEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc----CCCcEEecccccccee
Confidence 89999999999999986543 689999999999999999999999999999999999998 7789999999998754
Q ss_pred cCccc----cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1125 RNTLV----SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1125 ~~s~~----sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
..... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+... .....+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 222 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ERLPRPEE 222 (257)
T ss_pred ecCCcccccccCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CcCCCCCC
Confidence 32211 1111234679999999765 48889999999999999998 99999887766655555433 33456677
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
++..+++||.+||..+|.+||++.+|++.|+.+
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=318.53 Aligned_cols=244 Identities=30% Similarity=0.429 Sum_probs=198.2
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||.||+|.+ .+..||+|++.... ......++.+|++++++++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 72 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-------TVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-- 72 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC--
Confidence 678889999999999999987 46779999987531 1223457889999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
..++||||+.+++|..+. .+++..+..++.|++.||.|||+.+|+|+||||+|||++ .++.+||+|||++.
T Consensus 73 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~----~~~~~~l~dfg~~~ 143 (279)
T cd06619 73 RISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN----TRGQVKLCDFGVST 143 (279)
T ss_pred EEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC----CCCCEEEeeCCcce
Confidence 788999999999986542 478889999999999999999999999999999999998 77899999999987
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-------hHHHHhhhccCCCC
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG-------AIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~-------eliqsIlk~~Lrp~ 1195 (1254)
..... ......++..|+|||++.+. .++.++|||||||++|+|++|+.||...... .....+........
T Consensus 144 ~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (279)
T cd06619 144 QLVNS-IAKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL 220 (279)
T ss_pred ecccc-cccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC
Confidence 54333 23345789999999999865 3788999999999999999999999653221 11222222221111
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
.....++++++|+.+||+.+|++||++++++++-
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 2344788999999999999999999999998863
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=342.98 Aligned_cols=259 Identities=31% Similarity=0.508 Sum_probs=211.9
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECC-------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVA 1031 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVk 1031 (1254)
.+...+|.+.+.||+|+||.||+|++.+ +.||||+++... .....+.+.+|+.+|.++. ||||++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~E~~~l~~l~~H~niv~ 105 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-------RSSEKQALMSELKIMSHLGPHLNIVN 105 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-------ChhHHHHHHHHHHHHHhcCCCCCeEE
Confidence 3445568888999999999999998743 469999997532 1122356889999999997 999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccC-----------------------------------------------
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD----------------------------------------------- 1064 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre----------------------------------------------- 1064 (1254)
+++++.... .+++||||+.+|+|.+++.+..
T Consensus 106 ~~~~~~~~~--~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (401)
T cd05107 106 LLGACTKGG--PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSK 183 (401)
T ss_pred EEEEEccCC--CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCC
Confidence 999997654 7899999999999999885421
Q ss_pred --------------------------------------------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccc
Q 040257 1065 --------------------------------------------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHF 1094 (1254)
Q Consensus 1065 --------------------------------------------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHR 1094 (1254)
..+++..++.++.||+.||.|||+.+|+||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr 263 (401)
T cd05107 184 DESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR 263 (401)
T ss_pred ccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcc
Confidence 135677788999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 040257 1095 DLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170 (1254)
Q Consensus 1095 DLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT- 1170 (1254)
||||+|||++ ..+.+||+|||+++..... .......++..|+|||.+.+.. ++.++|||||||++|||++
T Consensus 264 dlkp~NiLl~----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGvil~e~l~~ 337 (401)
T cd05107 264 DLAARNVLIC----EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL--YTTLSDVWSFGILLWEIFTL 337 (401)
T ss_pred cCCcceEEEe----CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC--CCcHhHHHHHHHHHHHHHHc
Confidence 9999999998 6789999999999754221 1122345678899999998653 7889999999999999998
Q ss_pred CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1171 GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1171 Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
|..||......+..........++..+..++.++.+|+.+||..+|.+||++++|++.|+.++
T Consensus 338 g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 338 GGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 899998766555555555555555667778999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.63 Aligned_cols=246 Identities=34% Similarity=0.634 Sum_probs=207.2
Q ss_pred cCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 964 VDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
.+|++.+.||+|+||.||+++..++.||+|.++... ....+.+|+.++++++||||+++++++... .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~ 72 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----------TAQAFLEETAVMTKLHHKNLVRLLGVILHN---G 72 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc----------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---C
Confidence 468999999999999999999999999999986421 235688899999999999999999998653 4
Q ss_pred eEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+|||++ .++.+||+|||++.
T Consensus 73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~----~~~~~kl~Dfg~~~ 148 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS----EDGVAKVSDFGLAR 148 (254)
T ss_pred cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCcEEECCCccce
Confidence 689999999999999986543 3588999999999999999999999999999999999998 67889999999987
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
..... ......+..|+|||.+.+. .++.++|+|||||++|+|++ |+.||......+....+... .....+..++
T Consensus 149 ~~~~~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 223 (254)
T cd05083 149 VGSMG--VDNSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPPEGCP 223 (254)
T ss_pred ecccc--CCCCCCCceecCHHHhccC--CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-CCCCCCCcCC
Confidence 54322 1223346779999998755 47889999999999999997 99999887766655555433 4444566788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 224 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 224 ADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=315.43 Aligned_cols=257 Identities=30% Similarity=0.555 Sum_probs=208.6
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeee
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf 1036 (1254)
..+|++.+.||+|+||.||++++. ++.+|||+++.... ....+.+.+|+++++.+.|+||+++++++
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~ei~~l~~l~~~~i~~~~~~~ 75 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-------EQHRSDFEREIEILRTLDHENIVKYKGVC 75 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc-------hHHHHHHHHHHHHHHhCCCCChheEEeee
Confidence 346888899999999999999864 56799999875421 13456789999999999999999999998
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
........+++|||+.+++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~ 151 (284)
T cd05038 76 EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE----SEDLVKIS 151 (284)
T ss_pred ecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEc
Confidence 77556689999999999999999976655699999999999999999999999999999999999998 67899999
Q ss_pred eccccccccCccc----cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh----------
Q 040257 1117 DFGLSRIKRNTLV----SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA---------- 1182 (1254)
Q Consensus 1117 DFGLAr~~~~s~~----sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e---------- 1182 (1254)
|||++........ .....++..|++||.+.+. .++.++||||||+++|||++|+.||.......
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05038 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229 (284)
T ss_pred ccccccccccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence 9999986542211 1122345679999998765 47889999999999999999999986532211
Q ss_pred ----HHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1183 ----IIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1183 ----liqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
..............+..++.++.+|+.+||..+|++||++.++++.|+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11122223333344566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=308.60 Aligned_cols=253 Identities=28% Similarity=0.480 Sum_probs=208.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|+..+.||+|++|+||+|... ++.|++|.+....... ...+..+.+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQ---TGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED-- 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccc---cchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC--
Confidence 3667789999999999999884 7789999987542111 12334567889999999999999999999987654
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.++++|||+.+++|.+++.+. ..+++..++.++.||+.||.|||+.+|+|+||+|+||+++ ..+.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~----~~~~~kl~d~~~~~ 150 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD----TNGVVKLADFGMAK 150 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccCccce
Confidence 789999999999999988543 4588999999999999999999999999999999999998 67899999999987
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcH
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDP 1202 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~ 1202 (1254)
............++..|++||.+.... .++.++|+||||+++|+|++|+.||...........+......+..+..+++
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T cd06632 151 QVVEFSFAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229 (258)
T ss_pred eccccccccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCH
Confidence 654433334566899999999987543 3788999999999999999999999876654444444432334456677889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1203 EWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1203 eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+.+|+.+||..+|.+||++.+++.+
T Consensus 230 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 230 EAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.32 Aligned_cols=251 Identities=29% Similarity=0.471 Sum_probs=208.3
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||.|+||.||++++. +..+|+|++... .....+.+.+|+.++++++|+||+++++++..+.
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--------SEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN- 75 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC-
Confidence 36888899999999999999884 678999998643 1223467889999999999999999999997654
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|..++.+....+++..++.++.|++.||.|||+++|+|+||||+||+++ .++.++|+|||++
T Consensus 76 -~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~----~~~~~~l~d~g~~ 150 (280)
T cd06611 76 -KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT----LDGDVKLADFGVS 150 (280)
T ss_pred -eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC----CCCCEEEccCccc
Confidence 88999999999999999877667799999999999999999999999999999999999998 7789999999988
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-CCCC
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL-RPTI 1196 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~---~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L-rp~i 1196 (1254)
...... .......++..|+|||++... ...++.++||||||+++|+|++|+.||...........+..... ....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQ 230 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCC
Confidence 644322 222335689999999998632 22367899999999999999999999988766555555443322 1223
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+..++.++.++|.+||+.+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 45678999999999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=316.17 Aligned_cols=250 Identities=29% Similarity=0.377 Sum_probs=197.1
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|++|.||+|++ ++..||||+++.... .......+.+|+.++++++||||+++++++.++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE------EEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-- 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc------cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC--
Confidence 588899999999999999988 467899999864321 1122356778999999999999999999998655
Q ss_pred ceEEEEEecccCchhhhhhcc--CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK--DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr--e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+. ++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~ 147 (285)
T cd07861 73 RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID----NKGVIKLADFGL 147 (285)
T ss_pred eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc----CCCcEEECcccc
Confidence 8999999996 6888777543 25689999999999999999999999999999999999998 778999999999
Q ss_pred cccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc--------
Q 040257 1121 SRIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT-------- 1191 (1254)
Q Consensus 1121 Ar~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~-------- 1191 (1254)
+...... .......+++.|+|||++.+.. .++.++|||||||++|+|++|+.||...........+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd07861 148 ARAFGIPVRVYTHEVVTLWYRAPEVLLGSP-RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226 (285)
T ss_pred eeecCCCcccccCCcccccccChHHhcCCC-CcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 8744322 1122335788999999987643 46889999999999999999999998654332222111000
Q ss_pred -------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 -------------------LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 -------------------Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
........+++++.+||.+||..||.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0001123468899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=322.10 Aligned_cols=261 Identities=30% Similarity=0.593 Sum_probs=210.9
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEEC--Cc----eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEE
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWR--GS----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAF 1032 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs----~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkL 1032 (1254)
..++..+|+.++.||+|+||.||++.+. +. .+|+|.+.... .......+.+|+.+++.++||||+++
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~niv~~ 74 (303)
T cd05110 2 RILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-------GPKANVEFMDEALIMASMDHPHLVRL 74 (303)
T ss_pred cccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCcccE
Confidence 3466678999999999999999999873 33 46888775431 12233468889999999999999999
Q ss_pred eeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCe
Q 040257 1033 YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPI 1112 (1254)
Q Consensus 1033 yGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~ 1112 (1254)
++++... ..++++||+.+|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.
T Consensus 75 ~~~~~~~---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~----~~~~ 147 (303)
T cd05110 75 LGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK----SPNH 147 (303)
T ss_pred EEEEcCC---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec----CCCc
Confidence 9998653 46789999999999999877666789999999999999999999999999999999999998 6678
Q ss_pred EEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhh
Q 040257 1113 CKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIV 1188 (1254)
Q Consensus 1113 VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIl 1188 (1254)
+||+|||+++...... ......++..|+|||.+.+.. ++.++|||||||++|||++ |+.||.+........ +.
T Consensus 148 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~ 224 (303)
T cd05110 148 VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LL 224 (303)
T ss_pred eEEccccccccccCcccccccCCCccccccCCHHHhccCC--CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HH
Confidence 9999999997543221 122234567899999998653 7899999999999999997 999998765444433 33
Q ss_pred hccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1189 KNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1189 k~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
........+..++..+.+++.+||..+|++||++.++++.|+.+...-
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 225 EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 333334445567889999999999999999999999999999886553
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.47 Aligned_cols=253 Identities=28% Similarity=0.422 Sum_probs=223.8
Q ss_pred ccCceEEEEEeeeCcEEEEEEEECCc--eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWRGS--DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~rGs--~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
-.+|++.+.||+|-||.||+|+.+.+ .||+|++.+..+. ......++.+|++|-..|+||||+++|++|.|..
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~-----~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL-----KTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH-----HhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 34899999999999999999998643 5999999876432 3445677899999999999999999999999876
Q ss_pred CCceEEEEEecccCchhhhhhc-cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLK-KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~k-re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
.+|+++||...|+|...+.. +...+++...+.++.|++.||.|+|.++||||||||+|+|++ ..+.+||+|||
T Consensus 96 --riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg----~~~~lkiAdfG 169 (281)
T KOG0580|consen 96 --RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG----SAGELKIADFG 169 (281)
T ss_pred --eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC----CCCCeeccCCC
Confidence 89999999999999999863 345699999999999999999999999999999999999999 78899999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
.+.... .....+.|||..|.+||+..+.. ++..+|+|++|++.||++.|.+||......+.++.+.+-.+ .+|..
T Consensus 170 wsV~~p-~~kR~tlcgt~dyl~pEmv~~~~--hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~--~~p~~ 244 (281)
T KOG0580|consen 170 WSVHAP-SNKRKTLCGTLDYLPPEMVEGRG--HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL--KFPST 244 (281)
T ss_pred ceeecC-CCCceeeecccccCCHhhcCCCC--ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc--cCCcc
Confidence 997665 44456789999999999999775 78889999999999999999999999999999998876544 46788
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
++.+.+++|.+||.++|.+|....|++++-..
T Consensus 245 is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 245 ISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred cChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 99999999999999999999999999987543
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=309.38 Aligned_cols=244 Identities=39% Similarity=0.669 Sum_probs=202.8
Q ss_pred EEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEE
Q 040257 971 ELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTE 1049 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVME 1049 (1254)
+||+|+||.||++.+. ++.||+|++..... ......+.+|++++++++|+||+++++++.+.. ..++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e 72 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-------PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ--PIYIVME 72 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCC-------HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--CeEEEEE
Confidence 6999999999999885 78899998875421 134567889999999999999999999987665 7899999
Q ss_pred ecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCccc
Q 040257 1050 FMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLV 1129 (1254)
Q Consensus 1050 Ym~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~ 1129 (1254)
|+.+++|.+++.+....+++..++.++.+++.||.|||+++|+||||||+|||++ .++.+||+|||++........
T Consensus 73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~----~~~~~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSREEEGGIY 148 (251)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc----CCCcEEEeeccccccccCCcc
Confidence 9999999999876656789999999999999999999999999999999999998 778999999999875432111
Q ss_pred c---CCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHH
Q 040257 1130 S---GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205 (1254)
Q Consensus 1130 s---ts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLr 1205 (1254)
. ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||...........+.. ......+..++.++.
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 225 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIY 225 (251)
T ss_pred eeccccCcceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHHH
Confidence 1 112345679999998765 37889999999999999999 8999987765554444433 233445667889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1206 KLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1206 dLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
+|+.+||..+|.+||++.++++.|+
T Consensus 226 ~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 226 RLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHhccChhhCcCHHHHHHHhh
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=322.40 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=188.5
Q ss_pred EEEEeeeCcEEEEEEEEC----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCce
Q 040257 969 LRELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTL 1044 (1254)
Q Consensus 969 LkkLGeGsFGtVYlAk~r----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L 1044 (1254)
..+||+|+||+||+|++. +..||+|.+..... ...+.+|+.++++++||||+++++++.......+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----------SMSACREIALLRELKHPNVIALQKVFLSHSDRKV 75 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeE
Confidence 367999999999999874 35699998864321 2346789999999999999999999876666688
Q ss_pred EEEEEecccCchhhhhhcc--------CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1045 ATVTEFMVNGSLKHVLLKK--------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1045 ~LVMEYm~GGSL~d~L~kr--------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
++||||+. ++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||+...+...+.+||+
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 76 WLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 99999985 5777766321 23488899999999999999999999999999999999996444467899999
Q ss_pred eccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh---------H
Q 040257 1117 DFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA---------I 1183 (1254)
Q Consensus 1117 DFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e---------l 1183 (1254)
|||+++...... ......+|..|+|||++.+.. .++.++|||||||++|||+||+.||....... .
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcCCC-ccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence 999998653321 123456899999999997642 47899999999999999999999996432210 0
Q ss_pred HHHhhhc-----------------------cC-------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040257 1184 IGGIVKN-----------------------TL-------------RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITS 1227 (1254)
Q Consensus 1184 iqsIlk~-----------------------~L-------------rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe 1227 (1254)
+..+... .. ........+..+.+||.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 00 00001123456889999999999999999999987
Q ss_pred H
Q 040257 1228 R 1228 (1254)
Q Consensus 1228 ~ 1228 (1254)
+
T Consensus 314 h 314 (317)
T cd07867 314 D 314 (317)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=307.89 Aligned_cols=248 Identities=42% Similarity=0.705 Sum_probs=206.1
Q ss_pred ceEEEEEeeeCcEEEEEEEECC------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 966 LEELRELGSGTYGTVYHGKWRG------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~rG------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
+++.+.||.|+||.||++++.. ..||+|+++.... ....+.+..|+.+++.++|+||+++++++.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-------EQQIEEFLREARIMRKLDHPNIVKLLGVCTEE 73 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-------hHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 3466789999999999999864 6799999865421 11356788999999999999999999999876
Q ss_pred CCCceEEEEEecccCchhhhhhccCCC-CCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRS-LDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~-LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
. ..+++|||+.+++|.+++...... +++..++.++.||+.||.|||+.+++|+||||+||+++ ..+.++|+||
T Consensus 74 ~--~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~----~~~~~~l~df 147 (258)
T smart00219 74 E--PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDF 147 (258)
T ss_pred C--eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc----cCCeEEEccc
Confidence 4 799999999999999998654444 89999999999999999999999999999999999998 7779999999
Q ss_pred cccccccCccccC--CCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1119 GLSRIKRNTLVSG--GVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1119 GLAr~~~~s~~st--s~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
|++.......... ...++..|+|||.+.+. .++.++||||||+++|+|++ |+.||...........+.... ...
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~ 224 (258)
T smart00219 148 GLSRDLYDDDYYKKKGGKLPIRWMAPESLKDG--KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLP 224 (258)
T ss_pred CCceecccccccccccCCCcccccChHHhccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCC
Confidence 9997554331111 12367899999998654 47889999999999999998 899998877666666655443 344
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
.+..++.++.+++.+||..+|++|||+.++++.|
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 5566899999999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=320.33 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=208.3
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|++|+||++... ++.||||.+...... .....+.+.+|+++++.++|+||+++++++.+..
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 74 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-----KRNKVKRVLTEQEILATLDHPFLPTLYASFQTET-- 74 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-----hHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC--
Confidence 6899999999999999999984 678999999764221 2234567889999999999999999999987655
Q ss_pred ceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+|||++ .++.++|+|||++
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg~~ 150 (316)
T cd05574 75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH----ESGHIMLSDFDLS 150 (316)
T ss_pred EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc----CCCCEEEeecchh
Confidence 899999999999999988653 35689999999999999999999999999999999999998 6789999999998
Q ss_pred ccccCcc------------------------------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcC
Q 040257 1122 RIKRNTL------------------------------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG 1171 (1254)
Q Consensus 1122 r~~~~s~------------------------------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTG 1171 (1254)
....... ......|+..|+|||++.+. .++.++||||||+++|+|++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhC
Confidence 6432110 11234578899999999865 378899999999999999999
Q ss_pred CCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC----HHHHHHH
Q 040257 1172 EEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPS----FTEITSR 1228 (1254)
Q Consensus 1172 k~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPS----ArELLe~ 1228 (1254)
+.||...+.......+.............+..+++||++||..+|++||+ +.+++++
T Consensus 229 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 229 TTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 99998887776666665544333333337899999999999999999999 8888875
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=325.91 Aligned_cols=261 Identities=28% Similarity=0.509 Sum_probs=212.6
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC---------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCce
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR---------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNV 1029 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r---------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNI 1029 (1254)
.+...+|++++.||+|+||.||++++. ...||+|.++... .......+.+|+.+++++ +||||
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i 80 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-------TDKDLSDLVSEMEMMKMIGKHKNI 80 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-------CHHHHHHHHHHHHHHHhhcCCCCe
Confidence 455567999999999999999999762 1258999876431 223356788999999999 79999
Q ss_pred eEEeeeeecCCCCceEEEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccc
Q 040257 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHF 1094 (1254)
Q Consensus 1030 VkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHR 1094 (1254)
+++++++.+.. .++++|||+.+++|.+++.++. ..+++..++.++.||+.||.|||++||+||
T Consensus 81 v~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~ 158 (334)
T cd05100 81 INLLGACTQDG--PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHR 158 (334)
T ss_pred eeeeEEEccCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 99999997654 7899999999999999986431 247888899999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEEeccccccccCccc---cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 040257 1095 DLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLV---SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170 (1254)
Q Consensus 1095 DLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~---sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT- 1170 (1254)
||||+|||++ .++.+||+|||+++....... .....++..|+|||++.+.. ++.++|||||||+||||++
T Consensus 159 dlkp~Nill~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~ 232 (334)
T cd05100 159 DLAARNVLVT----EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTL 232 (334)
T ss_pred ccccceEEEc----CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC--cCchhhhHHHHHHHHHHHhc
Confidence 9999999998 678999999999875433211 11223456799999998653 7889999999999999998
Q ss_pred CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1171 GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1171 Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
|..||......+....+... .....+..++.++.+|+.+||..+|.+||++.++++.|+.+....
T Consensus 233 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 233 GGSPYPGIPVEELFKLLKEG-HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 89999887766666555433 334456677899999999999999999999999999999997544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.50 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=200.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||+|+||.||++++ .++.||+|+++... ......+.+|+.+++.++||||+++++++.+..
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~- 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--------GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD- 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--------hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-
Confidence 3677888999999999999988 46789999987431 112345778999999999999999999987655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++... +.+++..++.++.|++.||.|||++||+|+||||+||+++ ..+.+||+|||++
T Consensus 80 -~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~~~l~dfg~~ 153 (267)
T cd06645 80 -KLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT----DNGHVKLADFGVS 153 (267)
T ss_pred -EEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECcceee
Confidence 889999999999999988544 5689999999999999999999999999999999999998 7788999999998
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC-C--
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGS-SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT-I-- 1196 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~-~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~-i-- 1196 (1254)
...... .......|+..|+|||++... ...++.++|||||||++|+|++|..||..................+. .
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06645 154 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233 (267)
T ss_pred eEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccc
Confidence 644322 122345689999999997421 22478899999999999999999999976554433333322222221 1
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
...++..+.+||.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 12467889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=330.34 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=197.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
.+|++++.||+|+||+||++.+ .++.||||++.... ........+.+|+.+|++++||||+++++++....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF------QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh------hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 4799999999999999999987 46679999987532 11223456778999999999999999999876432
Q ss_pred ---CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1041 ---GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1041 ---~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
...++++|+++ +++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~----~~~~~kl~D 161 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN----EDCELRILD 161 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC----CCCCEEEcC
Confidence 13578999987 788888774 34699999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-----
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL----- 1192 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L----- 1192 (1254)
||+++..... .....||..|+|||++.+.. .++.++|||||||++|+|++|+.||...+....+..+.....
T Consensus 162 fg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 162 FGLARQADDE--MTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred CccceecCCC--cCCccccccccCchHhcCCc-cCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999865433 23456899999999997632 478899999999999999999999987654433332221000
Q ss_pred ----------------CCC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 ----------------RPT--------IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 ----------------rp~--------ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+. .....++.+.+||.+||..||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 012356678899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=340.07 Aligned_cols=252 Identities=29% Similarity=0.373 Sum_probs=211.3
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|+.++.|++|+||.||+|+++ ++.||+|+++... +.+.+.-..+|||.+|.+++|||||.+-.+....+.+
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek------ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK------EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc------ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 6899999999999999999985 5569999998542 2334445568999999999999999999999888888
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+|+||||| .-+|..++.....+|....+..++.|++.||+|||.++|+|||||++|+|++ ..|.+||+|||+|+
T Consensus 151 ~iy~VMe~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~----~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 151 KIYIVMEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS----HKGILKIADFGLAR 225 (419)
T ss_pred eeeeeHHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec----cCCcEEecccchhh
Confidence 899999999 4578888877777899999999999999999999999999999999999999 88999999999999
Q ss_pred cccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc------CCC-
Q 040257 1123 IKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT------LRP- 1194 (1254)
Q Consensus 1123 ~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~------Lrp- 1194 (1254)
...... ..+...-|.+|+|||.+.|.. .|+.++|+||+|||+.||+++++.|.+...-+.+..|.... .++
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~-tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAK-TYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCc-ccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 776542 334556899999999999875 68999999999999999999999999877655555543210 000
Q ss_pred ----------------------CCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 ----------------------TIPE-RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 ----------------------~ipe-~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++. .++..-.+|+..+|..||.+|.|+.+.|++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111 145777899999999999999999999876
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=317.36 Aligned_cols=246 Identities=28% Similarity=0.452 Sum_probs=208.8
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|+||.||++.+ .++.+|+|++.+.... .....+.+.+|+++++++.||||+++++++.+..
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 74 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-----KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS-- 74 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--
Confidence 688999999999999999988 4678999998754211 2233567889999999999999999999997665
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|.+++.+. ..+++..+..++.||+.||.|||++||+|+||+|.|||++ .++.+||+|||++.
T Consensus 75 ~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~dfg~~~ 149 (290)
T cd05580 75 NLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD----SDGYIKITDFGFAK 149 (290)
T ss_pred eEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC----CCCCEEEeeCCCcc
Confidence 799999999999999998554 5789999999999999999999999999999999999998 67899999999987
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcH
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDP 1202 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~ 1202 (1254)
..... .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...........+... ...++..++.
T Consensus 150 ~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~ 223 (290)
T cd05580 150 RVKGR--TYTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KVRFPSFFSP 223 (290)
T ss_pred ccCCC--CCCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CccCCccCCH
Confidence 65443 3345689999999999765 3788899999999999999999999877765555555533 2345667799
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1203 EWRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1203 eLrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
.++++|.+||..+|.+|+ ++++++++
T Consensus 224 ~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 224 DAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 999999999999999999 78888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=318.39 Aligned_cols=253 Identities=31% Similarity=0.526 Sum_probs=201.4
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC------------------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR------------------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r------------------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL 1024 (1254)
..+|++.+.||+|+||.||++++. ...+|+|++.... ......++.+|+.+++.+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~E~~~l~~l 76 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-------NKNARNDFLKEIKIMSRL 76 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHhC
Confidence 347999999999999999998643 2358999886431 223456788999999999
Q ss_pred CCCceeEEeeeeecCCCCceEEEEEecccCchhhhhhccC----------CCCCHHHHHHHHHHhhhhhHHhhhCCcccc
Q 040257 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD----------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHF 1094 (1254)
Q Consensus 1025 nHPNIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre----------~~LSe~~~lkIa~QIAeALaYLHSkGIIHR 1094 (1254)
+|+||+++++++.+.. ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||
T Consensus 77 ~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~ 154 (296)
T cd05095 77 KDPNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHR 154 (296)
T ss_pred CCCCcceEEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 9999999999997665 7899999999999999886532 236778899999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 040257 1095 DLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170 (1254)
Q Consensus 1095 DLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT- 1170 (1254)
||||+|||++ .++.+||+|||+++...... ......++..|++||+..+. .++.++|||||||++|||++
T Consensus 155 dlkp~Nili~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~DiwSlG~~l~el~~~ 228 (296)
T cd05095 155 DLATRNCLVG----KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTL 228 (296)
T ss_pred cCChheEEEc----CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC--CccchhhhhHHHHHHHHHHHh
Confidence 9999999998 67899999999987542221 11223346789999988765 48899999999999999998
Q ss_pred -CCCCCCCCChhhHHHHhhh---c---cCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1171 -GEEPYADMHCGAIIGGIVK---N---TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1171 -Gk~PF~~~n~~eliqsIlk---~---~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
|..||......+.+..... . ......+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 229 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 229 CKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 7889977655554432211 0 1112234567899999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=326.60 Aligned_cols=249 Identities=23% Similarity=0.388 Sum_probs=194.5
Q ss_pred EEEEEeee--CcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 968 ELRELGSG--TYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 968 iLkkLGeG--sFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
++++||+| +|++||++.+ +++.||||++..... .......+.+|+.+++.++||||++++++|..++ .
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~ 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC------TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--E 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc------cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--E
Confidence 45689999 7889999987 477899999875421 1233456778999999999999999999998765 7
Q ss_pred eEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
+++||||+.+++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++.++++||+...
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~----~~~~~~l~~~~~~~ 149 (327)
T cd08227 74 LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS----VDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe----cCCcEEEcccchhh
Confidence 89999999999999998653 34589999999999999999999999999999999999998 67789999998653
Q ss_pred cccCcc--------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC-
Q 040257 1123 IKRNTL--------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR- 1193 (1254)
Q Consensus 1123 ~~~~s~--------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr- 1193 (1254)
...... ......++..|+|||++.+....++.++|||||||++|||++|+.||..................
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 229 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccc
Confidence 221100 11123467789999999864345889999999999999999999999865443332222211100
Q ss_pred -------------------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 -------------------------------------------PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 -------------------------------------------p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
......+++++.+||.+||+.||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00112356789999999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=313.98 Aligned_cols=246 Identities=30% Similarity=0.482 Sum_probs=206.5
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||.|++|.||++++ .++.||+|++.... .......+.+|+.+++.++|+||+++++++.++.
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-------AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS-- 72 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-------cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC--
Confidence 678889999999999999988 46789999987431 1122356788999999999999999999988764
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++|+||+.+++|.+++... .+++..++.++.|++.||.|||+++|+|+||+|+||+++ .++.++|+|||+++
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~~ 146 (274)
T cd06609 73 KLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS----EEGDVKLADFGVSG 146 (274)
T ss_pred eEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEcccccce
Confidence 899999999999999998543 789999999999999999999999999999999999998 78899999999997
Q ss_pred cccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCC-C
Q 040257 1123 IKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER-C 1200 (1254)
Q Consensus 1123 ~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~-i 1200 (1254)
..... .......++..|+|||++.+.. ++.++||||||+++|+|++|+.||...+.......+... ..+..+.. +
T Consensus 147 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 223 (274)
T cd06609 147 QLTSTMSKRNTFVGTPFWMAPEVIKQSG--YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNKF 223 (274)
T ss_pred eecccccccccccCCccccChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCccccc
Confidence 65443 2233456888999999998764 889999999999999999999999876655554444333 33344444 7
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+..+.+++.+||..+|++||++++++++
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 8899999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=313.23 Aligned_cols=250 Identities=27% Similarity=0.353 Sum_probs=199.7
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||.||++++. ++.||+|++..... .....+.+.+|+.++++++|+||+++++++....
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 73 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED------DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-- 73 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc------CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC--
Confidence 6889999999999999999984 67899999875321 1112345778999999999999999999997655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.++.|..++. ....+++..++.++.||+.||.|||+.+|+||||||+||+++ .++.+||+|||++.
T Consensus 74 ~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~ 148 (286)
T cd07847 74 KLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT----KQGQIKLCDFGFAR 148 (286)
T ss_pred EEEEEEeccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc----CCCcEEECccccce
Confidence 7899999999888877664 345689999999999999999999999999999999999998 77899999999997
Q ss_pred cccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc----------
Q 040257 1123 IKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT---------- 1191 (1254)
Q Consensus 1123 ~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~---------- 1191 (1254)
...... ......++..|+|||++.+.. .++.++||||||+++|+|++|+.||.+....+....+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 149 ILTGPGDDYTDYVATRWYRAPELLVGDT-QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred ecCCCcccccCcccccccCCHHHHhCCC-CcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 654332 223345788999999987642 47889999999999999999999998766544332221100
Q ss_pred ----------CCCC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 ----------LRPT---------IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 ----------Lrp~---------ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+. ....++..+.+|+.+||+.+|++||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 012457889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=307.74 Aligned_cols=247 Identities=32% Similarity=0.530 Sum_probs=205.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||+|+||.||++.+. ++.+++|.+.... ..+++.+|++++++++|+||+++++++.+..
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~- 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----------DLQEIIKEISILKQCDSPYIVKYYGSYFKNT- 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-
Confidence 47888999999999999999985 5789999986431 1567889999999999999999999998764
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++++||+.+++|.+++......+++..++.++.|++.||.|||+.+|+|+||+|+||+++ .++.+||+|||++
T Consensus 72 -~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~----~~~~~~l~dfg~~ 146 (256)
T cd06612 72 -DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN----EEGQAKLADFGVS 146 (256)
T ss_pred -cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC----CCCcEEEcccccc
Confidence 89999999999999999876667799999999999999999999999999999999999998 6788999999998
Q ss_pred ccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-CCCCCCC
Q 040257 1122 RIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL-RPTIPER 1199 (1254)
Q Consensus 1122 r~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L-rp~ipe~ 1199 (1254)
....... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...........+..... ....+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd06612 147 GQLTDTMAKRNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEK 224 (256)
T ss_pred hhcccCccccccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhh
Confidence 7554332 22334588899999999866 478999999999999999999999987655443333222111 1123345
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++..+.+||.+||+.+|.+||++.+++++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 67899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=335.15 Aligned_cols=245 Identities=25% Similarity=0.347 Sum_probs=192.0
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|++++.||+|+||.||+|++. +..||+|+..+. ....|+.++++++|+||+++++++.+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------------~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------------TTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence 33457999999999999999999985 457999975432 22458999999999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. ..++||||+ .++|..++......+++..++.|+.||+.||.|||++|||||||||+|||++ ..+.+||+||
T Consensus 129 ~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kl~Df 201 (357)
T PHA03209 129 GA--ITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN----DVDQVCIGDL 201 (357)
T ss_pred CC--eeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEecC
Confidence 65 788999998 5688888877667899999999999999999999999999999999999998 7788999999
Q ss_pred cccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCC-CCCChh---------hHHHHhh
Q 040257 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY-ADMHCG---------AIIGGIV 1188 (1254)
Q Consensus 1119 GLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF-~~~n~~---------eliqsIl 1188 (1254)
|+++............||..|+|||++.+.. ++.++|||||||++|||+++..++ ...... ..+..+.
T Consensus 202 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~ 279 (357)
T PHA03209 202 GAAQFPVVAPAFLGLAGTVETNAPEVLARDK--YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279 (357)
T ss_pred ccccccccCcccccccccccccCCeecCCCC--CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHH
Confidence 9997544333334567999999999998764 789999999999999999865554 321110 0111111
Q ss_pred hc--cCCCCC------------------------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1189 KN--TLRPTI------------------------------PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1189 k~--~Lrp~i------------------------------pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.. .....+ ...++.++.+||.+||+.||.+|||+.|++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 280 STLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00 000000 11345667789999999999999999999976
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.29 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=203.0
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|+||.||+|++ .++.||+|++...... ......+.+|+.++++++||||+++++++.++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE------GGIPNQALREIKALQACQHPYVVKLLDVFPHGS-- 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc------chhhHHHHHHHHHHHhCCCCCCcceeeEEecCC--
Confidence 488999999999999999998 4678999998754221 223467889999999999999999999998754
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+ +++|.+++......+++..++.++.||+.||.|||+++|+|+||||+||+++ ..+.++|+|||++.
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~----~~~~~~l~dfg~~~ 147 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS----ADGVLKIADFGLAR 147 (286)
T ss_pred eeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc----CCCcEEEeeeeecc
Confidence 889999999 9999999876667799999999999999999999999999999999999998 67899999999987
Q ss_pred cccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC-------
Q 040257 1123 IKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR------- 1193 (1254)
Q Consensus 1123 ~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr------- 1193 (1254)
...... ......++..|+|||++.+.. .++.++||||||+++|+|++|+++|...........+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGAR-KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred cccCCCCCccccccCcccccCceeeeccc-cCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHh
Confidence 554322 123346899999999987542 3688999999999999999998888765544333332211000
Q ss_pred --------------C-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 --------------P-------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 --------------p-------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
. ......+..+.+||.+||..+|++||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0112456889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.65 Aligned_cols=250 Identities=27% Similarity=0.368 Sum_probs=196.5
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||.||++++ +++.||+|+++.... .......+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~------~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKNIVRLYDVLHSDK-- 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc------cccCccchhHHHHHHHhcCCCCeeeHHHHhccCC--
Confidence 478899999999999999998 477899999875321 1122345678999999999999999999997655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++|+||+. ++|..++......+++..++.++.||+.||.|||+++|+||||||+||+++ .++.+||+|||+++
T Consensus 73 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~----~~~~~~l~dfg~~~ 147 (284)
T cd07839 73 KLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN----KNGELKLADFGLAR 147 (284)
T ss_pred ceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc----CCCcEEECccchhh
Confidence 7999999996 578877766566799999999999999999999999999999999999998 67899999999987
Q ss_pred cccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChhhHHHHhhhcc---------
Q 040257 1123 IKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD-MHCGAIIGGIVKNT--------- 1191 (1254)
Q Consensus 1123 ~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~-~n~~eliqsIlk~~--------- 1191 (1254)
..... .......++..|+|||++.+.. .++.++|||||||++|+|++|..||.. ....+.+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCCc-ccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 54322 1122345788999999987643 368899999999999999999888643 33222222221100
Q ss_pred ---------CCC---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 ---------LRP---------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 ---------Lrp---------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+ .....++.++++||.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 1112467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=309.58 Aligned_cols=252 Identities=29% Similarity=0.460 Sum_probs=204.2
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn 1040 (1254)
.+|++.+.||+|++|.||+|+++ ++.+++|++.... ...+.+.+|+.+++++ .|+||+++++++.+..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKN 76 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---------hhHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence 47999999999999999999984 5679999887531 1235688999999998 7999999999987543
Q ss_pred ----CCceEEEEEecccCchhhhhhcc---CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1041 ----GGTLATVTEFMVNGSLKHVLLKK---DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1041 ----~~~L~LVMEYm~GGSL~d~L~kr---e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
...+++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+|+|+||+|+||+++ .++.+
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~----~~~~~ 152 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT----KNAEV 152 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc----cCCeE
Confidence 34689999999999999887542 35789999999999999999999999999999999999998 67899
Q ss_pred EEEeccccccccCcc-ccCCCCCCCCccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh
Q 040257 1114 KVGDFGLSRIKRNTL-VSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~-~sts~~GT~~YmAPEVLrG~---~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk 1189 (1254)
||+|||++....... ......++..|+|||++... ...++.++|||||||+||+|++|+.||...........+..
T Consensus 153 ~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 232 (275)
T cd06608 153 KLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR 232 (275)
T ss_pred EECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc
Confidence 999999987543322 22335588999999998643 23467899999999999999999999987655555554443
Q ss_pred ccCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1190 NTLRP-TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1190 ~~Lrp-~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..... ..+..++.++++||.+||..||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 32211 1223467899999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=344.01 Aligned_cols=250 Identities=21% Similarity=0.282 Sum_probs=189.8
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC------CCceeEEee
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH------HPNVVAFYG 1034 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn------HPNIVkLyG 1034 (1254)
..+|+++++||+|+||+||+|.+ .++.||||+++... .....+..|+.+++.++ |.+|+++++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---------hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 45799999999999999999987 46779999996421 11233445666666554 556899999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCC-----
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDP----- 1108 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~----- 1108 (1254)
+|.... ..+|+||+++ +++|.+++.+. +.+++..++.|+.||+.||.|||+ .|||||||||+|||++..+.
T Consensus 199 ~~~~~~-~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 199 YFQNET-GHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EEEcCC-ceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccc
Confidence 987543 4789999987 77888887554 569999999999999999999998 59999999999999984321
Q ss_pred -------CCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 040257 1109 -------QRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG 1181 (1254)
Q Consensus 1109 -------snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~ 1181 (1254)
....+||+|||.+..... .....+||+.|+|||++.+.. |+.++|||||||+||||++|+.||...+..
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~--~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLG--WMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 123699999998864322 234567999999999998764 889999999999999999999999876654
Q ss_pred hHHHHhhhcc-------------------------CCCCC---------------CCCCcHHHHHHHHHhhhcCCCCCCC
Q 040257 1182 AIIGGIVKNT-------------------------LRPTI---------------PERCDPEWRKLMEQCWAADPEARPS 1221 (1254)
Q Consensus 1182 eliqsIlk~~-------------------------Lrp~i---------------pe~iS~eLrdLIkKCLqkDPeKRPS 1221 (1254)
+.+..+.... +.+.. ....++.+.+||.+||++||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 3332221100 00000 0012456789999999999999999
Q ss_pred HHHHHHH
Q 040257 1222 FTEITSR 1228 (1254)
Q Consensus 1222 ArELLe~ 1228 (1254)
++|+|+|
T Consensus 432 a~e~L~H 438 (467)
T PTZ00284 432 ARQMTTH 438 (467)
T ss_pred HHHHhcC
Confidence 9999984
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.43 Aligned_cols=253 Identities=29% Similarity=0.465 Sum_probs=201.1
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeec--
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPD-- 1038 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~D-- 1038 (1254)
.+|++++.||+|+||+||++++ .++.+|+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---------DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---------chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 4799999999999999999988 46789999876421 1124567899999998 69999999998743
Q ss_pred -CCCCceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1039 -GTGGTLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1039 -dn~~~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
.....+++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++|+||||||+||+++ ..+.+|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~~k 164 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT----TEGGVK 164 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC----CCCCEE
Confidence 233478999999999999988742 335688999999999999999999999999999999999998 677899
Q ss_pred EEeccccccccCc-cccCCCCCCCCccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc
Q 040257 1115 VGDFGLSRIKRNT-LVSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN 1190 (1254)
Q Consensus 1115 LiDFGLAr~~~~s-~~sts~~GT~~YmAPEVLrG~---~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~ 1190 (1254)
|+|||+++..... .......|+..|+|||++... ...++.++|||||||++|+|++|+.||........+..+...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 9999998754322 222334689999999998642 124788999999999999999999999876554433333222
Q ss_pred cC-CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1191 TL-RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1191 ~L-rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
.. ....+..++..+.+||.+||+.+|++||++.++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11 1123445678999999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.59 Aligned_cols=258 Identities=25% Similarity=0.440 Sum_probs=210.1
Q ss_pred CceEEEEEeeeCcEEEEEEEEC---CceEEEEEEeccccCCC--chhHHHHHHHHHHHHHHHhc-CCCCceeEEeeeeec
Q 040257 965 DLEELRELGSGTYGTVYHGKWR---GSDVAIKRIKKSCFAGR--SSEQERLTKDFWREAHILSN-LHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r---Gs~VAIKvIkk~~~~~~--~~e~ee~~eqFlrEIeILkr-LnHPNIVkLyGvf~D 1038 (1254)
.|++.+.||+|+||.||++.+. ++.+|+|.+........ .........++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 3677889999999999999985 46799999864322111 11223345667889988864 799999999999976
Q ss_pred CCCCceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCCCCCeEE
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
.. ..+++|||+.+++|.+++.. ....+++..++.++.|++.||.|||+ .+|+|+||||+|||++ ..+.+|
T Consensus 81 ~~--~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~----~~~~~~ 154 (269)
T cd08528 81 ND--RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG----EDDKVT 154 (269)
T ss_pred CC--eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC----CCCcEE
Confidence 55 89999999999999888733 34568999999999999999999996 7899999999999998 778999
Q ss_pred EEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC
Q 040257 1115 VGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
|+|||++.............++..|++||.+.+. .++.++|+||||+++|+|++|+.||...........+......+
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcCC--CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc
Confidence 9999999765444333456689999999999865 37899999999999999999999998776666665555554444
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
.....++..+.+||.+||+.||++||++.|+..+|.
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 344467899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.13 Aligned_cols=245 Identities=27% Similarity=0.516 Sum_probs=191.8
Q ss_pred EEeeeCcEEEEEEEEC----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEE
Q 040257 971 ELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~r----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+||+|+||+||+|... ...+|+|.+.... .......+.+|+.+++.++|+||+++++++.+.. .+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~--~~~l 72 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI--PYLL 72 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC--ceEE
Confidence 5999999999999752 2357777665321 1233456888999999999999999999987654 7899
Q ss_pred EEEecccCchhhhhhccC----CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1047 VTEFMVNGSLKHVLLKKD----RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre----~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
||||+.+++|.+++.... ...++...+.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++.
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~dfg~~~ 148 (269)
T cd05042 73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT----ADLSVKIGDYGLAL 148 (269)
T ss_pred EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec----CCCcEEEecccccc
Confidence 999999999999986542 2246778889999999999999999999999999999998 77899999999986
Q ss_pred cccCcc---ccCCCCCCCCccCcccccCC-----CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccC-
Q 040257 1123 IKRNTL---VSGGVRGTLPWMAPELLNGS-----SNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL- 1192 (1254)
Q Consensus 1123 ~~~~s~---~sts~~GT~~YmAPEVLrG~-----~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~L- 1192 (1254)
...... ......++..|+|||++... ...++.++|||||||++|||++ |..||......+.+........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 228 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc
Confidence 432211 11223456789999997532 1246889999999999999999 8889987766555544433221
Q ss_pred ---CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1193 ---RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1193 ---rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
.+..+..++..+.+++..|| .||++||++++|++.|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 22344567889999999999 5999999999999987
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.42 Aligned_cols=249 Identities=25% Similarity=0.297 Sum_probs=197.3
Q ss_pred ceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCCCC
Q 040257 966 LEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn~~ 1042 (1254)
|++++.||+|+||.||+++. .++.||+|+++..... . ......+|+.+++++. |+||+++++++.+....
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~------~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS------L-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC------c-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 57789999999999999987 4678999998754211 0 1123457888888885 99999999999877556
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+. ++|.+.+......+++..++.++.||+.||.|||+++|+||||||+||+++ . +.+||+|||+++
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~----~-~~~kl~dfg~~~ 147 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK----D-DILKLADFGSCR 147 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc----C-CCeEEEeccccc
Confidence 8999999996 588887766556789999999999999999999999999999999999998 5 899999999998
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc-----------
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT----------- 1191 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~----------- 1191 (1254)
............++..|+|||++.... .++.++|||||||++|||++|..||...+..+.+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLTDG-YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhcCC-CCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 654443334456889999999875432 36889999999999999999999998766544333322100
Q ss_pred -----CCCC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 -----LRPT-----------IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 -----Lrp~-----------ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.... ....++..+.+||.+||..+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 112457899999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=308.48 Aligned_cols=242 Identities=28% Similarity=0.470 Sum_probs=190.9
Q ss_pred EEeeeCcEEEEEEEECCce------------EEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 971 ELGSGTYGTVYHGKWRGSD------------VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~rGs~------------VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
.||+|+||.||++.+.... +++|.+.... .. ...+.+|+.++++++||||+++++++..
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--------~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH--------RD-SLAFFETASLMSQLSHKHLVKLYGVCVR 72 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccch--------hh-HHHHHHHHHHHHcCCCcchhheeeEEec
Confidence 6899999999999985332 6777665321 11 4678899999999999999999999876
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC---CCCCeEEE
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD---PQRPICKV 1115 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd---~snG~VKL 1115 (1254)
. ..++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++ .....+||
T Consensus 73 -~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 73 -D--ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred -C--CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEe
Confidence 3 57899999999999999876655789999999999999999999999999999999999998322 01227999
Q ss_pred EeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCC
Q 040257 1116 GDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1116 iDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
+|||++..... .....++..|+|||++.+....++.++||||||+++|+|++ |..||............... .
T Consensus 150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~---~ 223 (259)
T cd05037 150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ---H 223 (259)
T ss_pred CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC---C
Confidence 99999875433 22344677899999998763458899999999999999999 68888766533332222211 1
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
..+......+.+||.+||..+|.+||++.++++.|+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 122223478999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.62 Aligned_cols=250 Identities=28% Similarity=0.454 Sum_probs=200.4
Q ss_pred ceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
+.....||+|+||.||+|++. +..||+|.+.... ....+.+.+|+.++++++|+||+++++++..+. .
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~ 79 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--------SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG--F 79 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--------HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC--E
Confidence 334467999999999999874 5679999886531 123457889999999999999999999987665 8
Q ss_pred eEEEEEecccCchhhhhhccCCCC--CHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSL--DRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~L--Se~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
+++|+||+.+++|.+++......+ ++..+..++.||+.||.|||+++|+||||||+||+++. ..+.+||+|||++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~---~~~~~~l~dfg~~ 156 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT---YSGVVKISDFGTS 156 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC---CCCeEEEecchhh
Confidence 999999999999999987654455 88889999999999999999999999999999999972 3568999999998
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh-HHHHhhhccCCCCCCCC
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA-IIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e-liqsIlk~~Lrp~ipe~ 1199 (1254)
...... .......++..|+|||++.+....++.++||||||+++|+|++|+.||....... ...........+.++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06624 157 KRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES 236 (268)
T ss_pred eecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcc
Confidence 754321 2222345889999999987655557889999999999999999999997654322 11111111233456677
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++++++|+.+||..+|.+||++.+++++
T Consensus 237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 237 LSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 88999999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.93 Aligned_cols=257 Identities=28% Similarity=0.501 Sum_probs=205.7
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCC--CchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAG--RSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~--~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
.|.+.+.||+|+||.||+|.. .++.+|||.++...... .........+.+.+|+.++++++|+||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477888999999999999986 47789999986432111 11122334567889999999999999999999987654
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+.+++|.+++.+. ..+++..+..++.||+.||.|||+++++||||+|+||+++ .++.+||+|||+
T Consensus 82 --~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~----~~~~~~l~d~~~ 154 (272)
T cd06629 82 --YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD----ADGICKISDFGI 154 (272)
T ss_pred --ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc----CCCeEEEeeccc
Confidence 889999999999999998654 5689999999999999999999999999999999999998 778999999999
Q ss_pred cccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC--
Q 040257 1121 SRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT-- 1195 (1254)
Q Consensus 1121 Ar~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~-- 1195 (1254)
++...... ......++..|+|||++......++.++|+||||+++|+|++|..||...........+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP 234 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCC
Confidence 87543211 1233468899999999886544578899999999999999999999976554443333322222222
Q ss_pred --CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1196 --IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1196 --ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
....++..+.++|.+||..+|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 223468899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.76 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=201.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDG- 1039 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Dd- 1039 (1254)
..|++.+.||+|+||.||++++ .++.+|+|++... .....++..|+.+++++ +|+||+++++++...
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 4688889999999999999998 4678999988643 11235677899999988 799999999998532
Q ss_pred ---CCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1040 ---TGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1040 ---n~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
....++++|||+.+++|.+++... ...+++..++.++.||+.||.|||+++|+|+||||+||+++ ..+.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~----~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT----ENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEE
Confidence 235789999999999999988553 34588889999999999999999999999999999999998 6778999
Q ss_pred EeccccccccCc-cccCCCCCCCCccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc
Q 040257 1116 GDFGLSRIKRNT-LVSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT 1191 (1254)
Q Consensus 1116 iDFGLAr~~~~s-~~sts~~GT~~YmAPEVLrG~---~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~ 1191 (1254)
+|||++...... .......|+..|+|||.+... ...++.++|||||||++|+|++|..||...........+....
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 242 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 242 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC
Confidence 999998754322 122345689999999998632 2247889999999999999999999997765444443333322
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
........++.++.+||.+||..||.+||++.+|+++
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 243 PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 2223344678999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.18 Aligned_cols=246 Identities=29% Similarity=0.513 Sum_probs=192.1
Q ss_pred EEeeeCcEEEEEEEEC----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEE
Q 040257 971 ELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~r----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
.||+|+||.||+|++. +..+|+|.++... .......+.+|+.++++++||||+++++++.+.. .+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 72 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-------SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--PYLL 72 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--CcEE
Confidence 5899999999999864 3458999876431 1122346888999999999999999999987655 7899
Q ss_pred EEEecccCchhhhhhccC----CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1047 VTEFMVNGSLKHVLLKKD----RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre----~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
||||+.+++|.+++.... ...++..++.++.|++.||.|||+++|+||||||+||+++ ..+.+||+|||++.
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~----~~~~~kL~dfg~~~ 148 (269)
T cd05087 73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT----ADLTVKIGDYGLSH 148 (269)
T ss_pred EEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEEECCccccc
Confidence 999999999999985432 2456778888999999999999999999999999999998 67899999999987
Q ss_pred cccCcc---ccCCCCCCCCccCcccccCCCC-----CCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhcc-C
Q 040257 1123 IKRNTL---VSGGVRGTLPWMAPELLNGSSN-----RVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNT-L 1192 (1254)
Q Consensus 1123 ~~~~s~---~sts~~GT~~YmAPEVLrG~~~-----kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~-L 1192 (1254)
...... ......++..|+|||++.+... .++.++||||||+++|||++ |..||......+......... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (269)
T cd05087 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL 228 (269)
T ss_pred cccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC
Confidence 433221 1223457788999999864321 35789999999999999996 999998766555443332221 1
Q ss_pred ---CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1193 ---RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1193 ---rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
.+......+..+.+++.+|| .+|.+|||+++|+..|.
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 12223356788999999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=315.66 Aligned_cols=249 Identities=29% Similarity=0.460 Sum_probs=203.6
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||.||++++. +..||+|.++... .......+.+|+.++++++|+||+++++++....
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-------DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG-- 72 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC--
Confidence 6888999999999999999985 7789999886431 1223467889999999999999999999987654
Q ss_pred ceEEEEEecccCchhhhhhcc--CCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK--DRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr--e~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
.+++||||+.+++|..++... ...+++..+..++.+|+.||.|||+ .+|+||||||+||+++ .++.+||+|||
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~dfg 148 (286)
T cd06622 73 AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN----GNGQVKLCDFG 148 (286)
T ss_pred eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC----CCCCEEEeecC
Confidence 899999999999998888553 2368999999999999999999996 5999999999999998 67899999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCCC----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHH---hhhccC
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSS----NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGG---IVKNTL 1192 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~~----~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqs---Ilk~~L 1192 (1254)
++....... .....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||........... +.. ..
T Consensus 149 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~ 226 (286)
T cd06622 149 VSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD-GD 226 (286)
T ss_pred CcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh-cC
Confidence 987543322 23345888999999986532 2358899999999999999999999976544333222 222 22
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+..+..++.++.+||.+||..+|.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 344566689999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=368.84 Aligned_cols=261 Identities=22% Similarity=0.328 Sum_probs=209.9
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
....+|++++.||+|+||+||++++. +..+|+|++..... .......+..|+.+|++|+||||++++++|.+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l------~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL------KEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc------CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 34458999999999999999999984 56799999875422 12335678899999999999999999999877
Q ss_pred CCCCceEEEEEecccCchhhhhhcc---CCCCCHHHHHHHHHHhhhhhHHhhhC-------CcccccCCCCceEeccCC-
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKK---DRSLDRRKKLIIAMDAAFGMEYLHSK-------NIVHFDLKCENLLVNLRD- 1107 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kr---e~~LSe~~~lkIa~QIAeALaYLHSk-------GIIHRDLKPeNILLDsdd- 1107 (1254)
.....+||||||+.+++|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+||||+...
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 6666899999999999999988542 35699999999999999999999984 499999999999996321
Q ss_pred ------------CCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 040257 1108 ------------PQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175 (1254)
Q Consensus 1108 ------------~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF 1175 (1254)
...+.+||+|||++.............||+.|+|||++.+....++.++||||||||||+|++|+.||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 12456999999999865444444456799999999999765556889999999999999999999999
Q ss_pred CCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1176 ADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1176 ~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
........+...+..... ......+.++.+||..||..+|.+||++.|+|.+
T Consensus 244 ~~~~~~~qli~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcCCcHHHHHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 865544333333322211 1123468899999999999999999999999964
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=317.16 Aligned_cols=247 Identities=27% Similarity=0.440 Sum_probs=202.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||.||++.+ .+..||+|.+..... ...+.+.+|+.+++.++|+||+++++++.++.
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~- 90 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--------PKKELIINEILVMRENKNPNIVNYLDSYLVGD- 90 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--------chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-
Confidence 4899999999999999999987 467899999875421 12356788999999999999999999987654
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..++||||+.+++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+|||++ .++.+||+|||++
T Consensus 91 -~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~----~~~~~kl~dfg~~ 163 (296)
T cd06654 91 -ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFC 163 (296)
T ss_pred -EEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc----CCCCEEECccccc
Confidence 89999999999999998843 4588999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc-cCCCCCCCC
Q 040257 1122 RIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN-TLRPTIPER 1199 (1254)
Q Consensus 1122 r~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~-~Lrp~ipe~ 1199 (1254)
....... ......+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...........+... ......+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06654 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (296)
T ss_pred hhccccccccCcccCCccccCHHHHcCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccc
Confidence 7543221 123346889999999998653 788999999999999999999999876543333222222 112233456
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++..+.+|+.+||..+|++||++.+++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 78899999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.37 Aligned_cols=246 Identities=29% Similarity=0.485 Sum_probs=205.5
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|+.++.||.|+||.||+|.+ .+..||||++.... .......+.+|+.+++++.|+||+++++++.+..
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT-- 75 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-------cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--
Confidence 577788899999999999987 46789999987532 1223467889999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
..++||||+.+++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++ .++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~----~~~~~~l~dfg~~~ 149 (277)
T cd06640 76 KLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS----EQGDVKLADFGVAG 149 (277)
T ss_pred EEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc----CCCCEEEcccccce
Confidence 89999999999999998853 4688999999999999999999999999999999999998 67889999999987
Q ss_pred cccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1123 IKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1123 ~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
...... ......++..|+|||++.+.. ++.++|+|||||++|||++|+.||...........+ .....+..+..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~apE~~~~~~--~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 226 (277)
T cd06640 150 QLTDTQIKRNTFVGTPFWMAPEVIQQSA--YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEFS 226 (277)
T ss_pred eccCCccccccccCcccccCHhHhccCC--CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCCCchhhh
Confidence 543322 223345788999999998653 789999999999999999999999877655544433 2233445556678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+.+|+.+||+.+|++||++.+++++
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 899999999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=298.63 Aligned_cols=247 Identities=32% Similarity=0.565 Sum_probs=206.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|+..+.||+|++|.||++.+. ++.+++|++..... .....+.+|+.++++++|+||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-- 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence 5788899999999999999985 77899999975421 24567889999999999999999999997764
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
..++++||+.+++|.+++......+++..++.++.|++.||.|||+++++||||+|+||+++ .++.++|+|||.+.
T Consensus 71 ~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~~~~~ 146 (253)
T cd05122 71 ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT----SDGEVKLIDFGLSA 146 (253)
T ss_pred eEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc----cCCeEEEeeccccc
Confidence 78999999999999999876656799999999999999999999999999999999999998 67899999999987
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC--CCC
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP--ERC 1200 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip--e~i 1200 (1254)
............++..|++||.+.+.. ++.++|+||||+++|+|++|+.||................ .+..+ ..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 223 (253)
T cd05122 147 QLSDTKARNTMVGTPYWMAPEVINGKP--YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG-PPGLRNPEKW 223 (253)
T ss_pred cccccccccceecCCcccCHHHHcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC-CCCcCccccc
Confidence 654433234456889999999998654 7889999999999999999999998775544444333322 22222 224
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+..+.++|.+||+.+|.+|||+.+++++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 8899999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.53 Aligned_cols=242 Identities=29% Similarity=0.458 Sum_probs=192.6
Q ss_pred EEeeeCcEEEEEEEEC--------------------------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC
Q 040257 971 ELGSGTYGTVYHGKWR--------------------------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~r--------------------------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL 1024 (1254)
+||+|+||.||+|.+. ...||+|++... .......+.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--------HRDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--------HHHHHHHHHHHHHHHhcC
Confidence 5999999999998752 124788887532 233456788899999999
Q ss_pred CCCceeEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEec
Q 040257 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVN 1104 (1254)
Q Consensus 1025 nHPNIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLD 1104 (1254)
+||||+++++++.+.. ..++||||+.+++|..++.+....+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 74 ~h~niv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 74 SHIHLAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred CCCCeeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 9999999999998665 78899999999999998876666789999999999999999999999999999999999997
Q ss_pred cCC---CCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHH-cCCCCCCCCCh
Q 040257 1105 LRD---PQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEIL-TGEEPYADMHC 1180 (1254)
Q Consensus 1105 sdd---~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELL-TGk~PF~~~n~ 1180 (1254)
..+ .....+||+|||++...... ....++..|+|||.+.+. ..++.++|||||||++|||+ +|+.||.....
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred ccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 322 12345899999987543221 223477889999998754 35789999999999999985 79999987654
Q ss_pred hhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1181 GAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1181 ~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
.+.... .... ...+...++.+.+||.+||+.+|++||++.++++.|
T Consensus 228 ~~~~~~-~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEKERF-YEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHH-HHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 443222 2221 223444567899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=335.49 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=221.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
..|++..+||+|.|+.||++.+ +|+.+|+|++....+... -.+++.+|+.|.+.|+|||||+|++.+....
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~------~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~- 83 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQEES- 83 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc------cHHHHHHHHHHHHhcCCCcEeehhhhhcccc-
Confidence 3577777899999999999877 578899999987655433 3467889999999999999999999887554
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..|+|+|+|.|++|..-|.++ ..+++..+-.++.||+++|.|+|.++|||||+||+|+|+-..+ ..--|||+|||++
T Consensus 84 -~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~-~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 84 -FHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKA-KGAAVKLADFGLA 160 (355)
T ss_pred -eeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeecc-CCCceeecccceE
Confidence 899999999999998887666 4588999999999999999999999999999999999997554 4457999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC--CCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT--IPER 1199 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~--ipe~ 1199 (1254)
..........++.||+.|||||+++..+ |+..+|||+.|+|||-|+.|++||.+.+...+++.|..+.+... ....
T Consensus 161 i~l~~g~~~~G~~GtP~fmaPEvvrkdp--y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~ 238 (355)
T KOG0033|consen 161 IEVNDGEAWHGFAGTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDT 238 (355)
T ss_pred EEeCCccccccccCCCcccCHHHhhcCC--CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCc
Confidence 9877777778889999999999999776 88889999999999999999999999999999999998876544 3456
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++++.++|+++||..||.+|.|+.|.|++
T Consensus 239 is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 239 VTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 89999999999999999999999998864
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=338.55 Aligned_cols=253 Identities=27% Similarity=0.413 Sum_probs=218.8
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.+.-.+|+.+++||+|.||+|.+++- +++.||||++++..+..++ ....-+.|-++|+..+||++..|--.|+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakd-----EVAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKD-----EVAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehH-----HhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 34455899999999999999999987 4788999999988765432 2345567889999999999998877776
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
.. .++|+||||..||.|..++ .+.+.|++...+.+..+|+.||.|||+++||+||||.+|+|+| .+|++||+|
T Consensus 239 t~--drlCFVMeyanGGeLf~HL-srer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD----kDGHIKitD 311 (516)
T KOG0690|consen 239 TQ--DRLCFVMEYANGGELFFHL-SRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD----KDGHIKITD 311 (516)
T ss_pred cC--ceEEEEEEEccCceEeeeh-hhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec----cCCceEeee
Confidence 44 4999999999999999988 4567799999999999999999999999999999999999999 899999999
Q ss_pred cccccccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1118 FGLSRIKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1118 FGLAr~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
||+|+..- ......++|||+.|+|||++... .|..++|||.+||+||||++|+.||...++..+..-|+...+ .+
T Consensus 312 FGLCKE~I~~g~t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--kF 387 (516)
T KOG0690|consen 312 FGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--KF 387 (516)
T ss_pred cccchhcccccceeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--cC
Confidence 99998533 33345679999999999999865 589999999999999999999999999999999888887655 46
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
|..++++.+.|+..+|.+||.+|. +++||.++
T Consensus 388 Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 388 PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 888999999999999999999995 46666554
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.84 Aligned_cols=250 Identities=28% Similarity=0.452 Sum_probs=201.6
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|+||.||++++. +..+|+|.+.... ......++.+|++++++++||||++++++|.++.
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 72 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-- 72 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--
Confidence 6899999999999999999884 5678989886431 2334567889999999999999999999998755
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++.+. +.+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||++
T Consensus 73 ~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~ 147 (308)
T cd06615 73 EISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVS 147 (308)
T ss_pred EEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe----cCCcEEEccCCCc
Confidence 899999999999999998654 568999999999999999999997 6999999999999998 6788999999998
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh------------
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK------------ 1189 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk------------ 1189 (1254)
...... ......++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+..
T Consensus 148 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 148 GQLIDS-MANSFVGTRSYMSPERLQGTH--YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred cccccc-ccccCCCCcCccChhHhcCCC--CCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence 754332 223456899999999987653 78899999999999999999999965432222111100
Q ss_pred -----------------------ccCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1190 -----------------------NTLRPTIP-ERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1190 -----------------------~~Lrp~ip-e~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
....+..+ ..++.++++|+.+||..+|++||++.+++++.--
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 00111111 2367789999999999999999999999988543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=298.43 Aligned_cols=251 Identities=32% Similarity=0.523 Sum_probs=210.8
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|...+.||+|++|.||+|.+. ++.|++|++...... ....+.+.+|+.++++++|+||+++++++.+....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS------EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 4778899999999999999985 778999998754211 23457788999999999999999999999876335
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++++||+.+++|.+++.... .+++..++.++.+++.||.|||+.+++|+||+|+||+++ .++.+||+|||.+.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~----~~~~~~l~d~~~~~ 149 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD----SDGVVKLADFGCAK 149 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEcccccEE
Confidence 8999999999999999986554 799999999999999999999999999999999999998 67899999999988
Q ss_pred cccCccc---cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hhhHHHHhhhccCCCCCCC
Q 040257 1123 IKRNTLV---SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH-CGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1123 ~~~~s~~---sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n-~~eliqsIlk~~Lrp~ipe 1198 (1254)
....... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||.... .......+........++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVIRGEE--YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE 227 (260)
T ss_pred ecccccccccccCCCCCccccCHhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCc
Confidence 6655432 34456889999999998664 7889999999999999999999998765 2233333333234455677
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++..+++||.+||..+|.+||++.+++++
T Consensus 228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 228 HLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 789999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=317.63 Aligned_cols=252 Identities=30% Similarity=0.497 Sum_probs=205.4
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|++++.||+|+||+||++.+. ++.||+|++.... .....+.+.+|+++++.++||||+++++++.+
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-------KSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-------cchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence 34568899999999999999999985 7789999886431 23345678899999999999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
.. .+++||||+.+++|.+++.+ .+.+++..+..++.+++.||.|||+ ++|+||||||+||+++ ..+.++|+|
T Consensus 75 ~~--~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~d 147 (284)
T cd06620 75 EN--NICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN----SRGQIKLCD 147 (284)
T ss_pred CC--EEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC----CCCcEEEcc
Confidence 64 89999999999999988754 3568999999999999999999997 6999999999999998 678899999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-----------hHHHH
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG-----------AIIGG 1186 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~-----------eliqs 1186 (1254)
||++...... ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||...... .....
T Consensus 148 ~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd06620 148 FGVSGELINS-IADTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224 (284)
T ss_pred CCcccchhhh-ccCccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence 9998644222 22345689999999998765 4788999999999999999999999864431 22222
Q ss_pred hhhccCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1187 IVKNTLRPTIP-ERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1187 Ilk~~Lrp~ip-e~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
+..... +..+ ..++.++.+|+.+||+.||.+||++.|++++..
T Consensus 225 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 225 IVQEPP-PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred HhhccC-CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 222221 2222 237789999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.30 Aligned_cols=250 Identities=30% Similarity=0.459 Sum_probs=196.2
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHH-HhcCCCCceeEEeeeeecCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI-LSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeI-LkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
+|++++.||+|+||.||++++. ++.||||+++..... ....++..|+.+ ++.++||||+++++++..+.
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~- 73 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-------QEQKRLLMDLDISMRSVDCPYTVTFYGALFREG- 73 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-------HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-
Confidence 7899999999999999999984 788999998754211 112345556654 66779999999999997655
Q ss_pred CceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhhC-CcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1042 GTLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHSk-GIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
.++++|||+. ++|..++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|
T Consensus 74 -~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~----~~~~~kl~d 147 (283)
T cd06617 74 -DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN----RNGQVKLCD 147 (283)
T ss_pred -cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC----CCCCEEEee
Confidence 7899999995 677766643 335689999999999999999999997 999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hhhHHHHhhhccCCC
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSS--NRVSEKVDVFSFGISMWEILTGEEPYADMH-CGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~--~kyS~KSDIWSLGVILYELLTGk~PF~~~n-~~eliqsIlk~~Lrp 1194 (1254)
||++.............++..|+|||.+.+.. ..++.++|+|||||++|+|++|+.||.... ..+.+..........
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd06617 148 FGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQ 227 (283)
T ss_pred cccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCC
Confidence 99987654433333456889999999986521 246889999999999999999999997533 223333333322222
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.....++.++.+||.+||..+|.+||++.+++++
T Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 228 LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2234578999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=308.49 Aligned_cols=243 Identities=27% Similarity=0.428 Sum_probs=204.4
Q ss_pred EeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEE
Q 040257 972 LGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTE 1049 (1254)
Q Consensus 972 LGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVME 1049 (1254)
||.|++|.||++++. ++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.++. .++++||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-----ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK--YIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch-----hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC--ccEEEEe
Confidence 689999999999996 788999999754321 2233567889999999999999999999987665 7899999
Q ss_pred ecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCccc
Q 040257 1050 FMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLV 1129 (1254)
Q Consensus 1050 Ym~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~ 1129 (1254)
|+.+++|.+++.+. ..+++..+..++.||+.||.|||+++++|+||||+||+++ .++.+||+|||++........
T Consensus 74 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~----~~~~~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 74 YCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD----SNGYVKLVDFGFAKKLKSGQK 148 (262)
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc----CCCCEEEeeCCcccccCcccc
Confidence 99999999998554 4589999999999999999999999999999999999998 678999999999986544333
Q ss_pred cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--hhhHHHHhhhccCCCCCCCCCcHHHHHH
Q 040257 1130 SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH--CGAIIGGIVKNTLRPTIPERCDPEWRKL 1207 (1254)
Q Consensus 1130 sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n--~~eliqsIlk~~Lrp~ipe~iS~eLrdL 1207 (1254)
.....++..|++||.+.+. .++.++|+||||+++|+|++|..||.... .......+.........+...+.++++|
T Consensus 149 ~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDL 226 (262)
T ss_pred cccccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 3345688999999998755 47889999999999999999999998766 4555555554444556666678999999
Q ss_pred HHHhhhcCCCCCCC-----HHHHHHH
Q 040257 1208 MEQCWAADPEARPS-----FTEITSR 1228 (1254)
Q Consensus 1208 IkKCLqkDPeKRPS-----ArELLe~ 1228 (1254)
|.+||..+|++||+ ++|++++
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 227 IKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred HHHHccCChhhCcCCcccCHHHHhcC
Confidence 99999999999999 8888873
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=307.78 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=210.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||+|+||.||++++ .++.||+|++...... .........+.+|+.++++++|+||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS---QETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCccc---chhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 4789999999999999999987 4678999987532111 1123345678899999999999999999999877666
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..++++|||+.+++|.+++... ..+++...+.++.||+.||.|||+.+|+|+||||+||+++ .++.++|+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~l~dfg~~ 153 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 153 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEECccccc
Confidence 6789999999999999988544 4588999999999999999999999999999999999998 6778999999999
Q ss_pred ccccCc----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1122 RIKRNT----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1122 r~~~~s----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
+..... .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||........+..+......+.++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p 231 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCC
Confidence 754321 112235688999999999865 47889999999999999999999998876665555555555556678
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+++.+.+++.+||.. +.+||++.+++++
T Consensus 232 ~~~~~~~~~~i~~~l~~-~~~r~~~~~~~~~ 261 (264)
T cd06653 232 DGVSDACRDFLKQIFVE-EKRRPTAEFLLRH 261 (264)
T ss_pred cccCHHHHHHHHHHhcC-cccCccHHHHhcC
Confidence 88999999999999994 7999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=310.73 Aligned_cols=247 Identities=34% Similarity=0.557 Sum_probs=204.3
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|+..+.||+|++|.||++.++ ++.+|+|++.... ......++.+|++++++++||||+++++++....
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 72 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-------NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-- 72 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-------ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC--
Confidence 5778889999999999999985 6789999987542 1234567889999999999999999999987764
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++++||+.+++|.+++......+++..+..++.|++.||.|||+ .+++|+||||+||+++ ..+.+||+|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~----~~~~~~l~d~g~~ 148 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN----SRGQIKLCDFGVS 148 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC----CCCCEEEeecccc
Confidence 8999999999999999987655778999999999999999999999 9999999999999998 6788999999998
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----hhhHHHHhhhccCCCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH-----CGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n-----~~eliqsIlk~~Lrp~i 1196 (1254)
.......... ..++..|+|||.+.+. .++.++||||||+++|+|++|+.||.... .......+... ..+..
T Consensus 149 ~~~~~~~~~~-~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 224 (265)
T cd06605 149 GQLVNSLAKT-FVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-PPPRL 224 (265)
T ss_pred hhhHHHHhhc-ccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC-CCCCC
Confidence 7543322222 6688999999999876 47899999999999999999999997642 22233333322 22333
Q ss_pred CCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1197 PER-CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1197 pe~-iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+.. ++.++++||.+||..+|++||++.+++.+
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 333 78899999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=367.60 Aligned_cols=265 Identities=37% Similarity=0.636 Sum_probs=227.2
Q ss_pred cccccccCceEEEEEeeeCcEEEEEEEEC---Cc----eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCcee
Q 040257 958 LQIIKNVDLEELRELGSGTYGTVYHGKWR---GS----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVV 1030 (1254)
Q Consensus 958 lq~Ik~~dYeiLkkLGeGsFGtVYlAk~r---Gs----~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIV 1030 (1254)
+..+.......++.||+|.||.||.|... +. .||||.+++.. ......+|++|..+|+.++|||||
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-------~~~~~~~Fl~Ea~~m~~f~HpNiv 758 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-------SEQEVSDFLKEALLMSKFDHPNIV 758 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCccee
Confidence 44466677888999999999999999873 32 38999887642 234467899999999999999999
Q ss_pred EEeeeeecCCCCceEEEEEecccCchhhhhhcc------CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEec
Q 040257 1031 AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVN 1104 (1254)
Q Consensus 1031 kLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kr------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLD 1104 (1254)
+++|++.+. ...+|++|||++|+|..+|++. ...++..+.+.++.+|++|+.||+++++|||||-.+|+||+
T Consensus 759 ~liGv~l~~--~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~ 836 (1025)
T KOG1095|consen 759 SLIGVCLDS--GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD 836 (1025)
T ss_pred eEEEeecCC--CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec
Confidence 999999874 3788999999999999999776 56799999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEEEeccccccc-cCcccc-CC-CCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 040257 1105 LRDPQRPICKVGDFGLSRIK-RNTLVS-GG-VRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHC 1180 (1254)
Q Consensus 1105 sdd~snG~VKLiDFGLAr~~-~~s~~s-ts-~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~ 1180 (1254)
....|||+|||+|+.+ +..... .. ..-...|||||.+... .++.|+|||||||+|||++| |..||...++
T Consensus 837 ----~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~--iFtskSDvWsFGVllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 837 ----ERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG--IFTSKSDVWSFGVLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred ----ccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc--ccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence 6789999999999932 222211 11 1234679999999954 59999999999999999999 9999999999
Q ss_pred hhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1181 GAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1181 ~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
.+++..++.+. +...|..|+..+.++|..||+.+|++||++..|++.+..+...+..
T Consensus 911 ~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 911 FEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred HHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 99888777666 6778899999999999999999999999999999999999886554
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=305.12 Aligned_cols=249 Identities=29% Similarity=0.490 Sum_probs=205.0
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||.|+||+||+|.+ .+..+|+|++..... ......+.+|+.+++.++|+||+++++.+.+..
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC-------QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-- 72 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc-------chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC--
Confidence 689999999999999999987 466799999864321 113567889999999999999999999987655
Q ss_pred ceEEEEEecccCchhhhhhcc--CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK--DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr--e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
..++||||+.+++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+||+++ .++.+||+|||+
T Consensus 73 ~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~----~~~~~~l~df~~ 148 (267)
T cd06610 73 ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG----EDGSVKIADFGV 148 (267)
T ss_pred EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEcccch
Confidence 889999999999999998653 24689999999999999999999999999999999999998 677899999999
Q ss_pred cccccCcc-----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1121 SRIKRNTL-----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1121 Ar~~~~s~-----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
+....... ......|+..|+|||++... ..++.++|+|||||++|+|++|+.||................. +.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~ 226 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-PS 226 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC-CC
Confidence 87543321 12334688999999998765 2478899999999999999999999987766555554443321 11
Q ss_pred CC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1196 IP-----ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1196 ip-----e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.. ..++..+.+|+.+||.++|++||++.+|+++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11 2567899999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=313.69 Aligned_cols=243 Identities=28% Similarity=0.512 Sum_probs=193.1
Q ss_pred EEeeeCcEEEEEEEECC---------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 971 ELGSGTYGTVYHGKWRG---------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~rG---------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.||+|+||.||+|.+.. ..+|+|.+... .....+.+.+|+.+++.+.||||+++++++..+.
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~- 72 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD- 72 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch--------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-
Confidence 58999999999998732 23777776432 2334567888999999999999999999998655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC----CCCCeEEEEe
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD----PQRPICKVGD 1117 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd----~snG~VKLiD 1117 (1254)
..++||||+.+|+|..++......+++..++.++.||+.||.|||+++|+||||||+|||++..+ ...+.++++|
T Consensus 73 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 73 -ESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred -CcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 68899999999999999977666789999999999999999999999999999999999997322 1223489999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCC-CCCCCCChhhHHHHhhhccCCCCC
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE-EPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk-~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
||++...... ....++..|+|||++.+.. .++.++||||||+++|+|++|. .||.......... .... ...+
T Consensus 152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~--~~~~ 224 (258)
T cd05078 152 PGISITVLPK---EILLERIPWVPPECIENPQ-NLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED--RHQL 224 (258)
T ss_pred cccccccCCc---hhccccCCccCchhccCCC-CCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc--cccC
Confidence 9998644322 2345888999999997632 4788999999999999999984 6665554433322 2222 2345
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
+...+.++.+||.+||+.+|++|||++++++.|+
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 225 PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 5566789999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=303.69 Aligned_cols=251 Identities=29% Similarity=0.521 Sum_probs=203.4
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|+||.||++.. .++.|++|.++.... .......+.+|+.++++++|+||+++++++....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN------DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc------chHHHHHHHHHHHHHHhCCCCChhheeeeEecCC--
Confidence 478889999999999999987 467899999875421 1345677899999999999999999999987554
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++|+||+.+++|.+++... ..+++..++.++.+++.||.|||+.+|+|+||+|+||+++ ..+.+||+|||++.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~----~~~~~kl~d~g~~~ 147 (264)
T cd06626 73 KVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD----HNGVIKLGDFGCAV 147 (264)
T ss_pred EEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccccccc
Confidence 899999999999999998654 4588999999999999999999999999999999999998 67899999999987
Q ss_pred cccCccc-----cCCCCCCCCccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1123 IKRNTLV-----SGGVRGTLPWMAPELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1123 ~~~~s~~-----sts~~GT~~YmAPEVLrG~~-~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
....... .....++..|+|||++.+.. ..++.++||||||+++|+|++|+.||..................+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 227 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPI 227 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCC
Confidence 5433221 12346788999999998653 34788999999999999999999999765432222222222223334
Q ss_pred CCC--CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1197 PER--CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1197 pe~--iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+.. ++..+.+||.+||+.+|.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 228 PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 443 48899999999999999999999998863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.11 Aligned_cols=243 Identities=27% Similarity=0.442 Sum_probs=190.2
Q ss_pred EEeeeCcEEEEEEEECC--------------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeee
Q 040257 971 ELGSGTYGTVYHGKWRG--------------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~rG--------------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf 1036 (1254)
.||+|+||.||+|++.. ..+++|.+... .......+.+|+.+++.++||||+++++++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~ 73 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--------HRDISLAFFETASMMRQVSHKHIVLLYGVC 73 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--------hhhHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 58999999999998531 23777776532 233456788899999999999999999998
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCC---CCCeE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDP---QRPIC 1113 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~---snG~V 1113 (1254)
.+.. ..++||||+.+++|..++..+...+++..++.++.||+.||.|||+++|+||||||+|||++..+. ....+
T Consensus 74 ~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 74 VRDV--ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred ecCC--CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCcee
Confidence 7654 678999999999999888766667999999999999999999999999999999999999973221 12248
Q ss_pred EEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHH-cCCCCCCCCChhhHHHHhhhccC
Q 040257 1114 KVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEIL-TGEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELL-TGk~PF~~~n~~eliqsIlk~~L 1192 (1254)
|++|||++...... ....++..|+|||.+... ..++.++|||||||+||||+ +|..||......+... ......
T Consensus 152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~ 226 (262)
T cd05077 152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQC 226 (262)
T ss_pred EeCCCCCCccccCc---ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCc
Confidence 99999998644221 234578889999998643 24788999999999999998 5888987654433222 222221
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
......+.++.+||.+||+.||.+||++.+|++.|+
T Consensus 227 --~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 227 --MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred --cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 122234678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=304.51 Aligned_cols=249 Identities=22% Similarity=0.439 Sum_probs=208.1
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||.||+++. .++.||+|.+...... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS------PKEREESRKEVAVLSNMKHPNIVQYQESFEENG-- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC------hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC--
Confidence 488999999999999999887 4678999998753211 223457889999999999999999999997654
Q ss_pred ceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+++++|+||+|+|||++ .++.++|+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~----~~~~~~l~d~~~~ 148 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT----KDGTIKLGDFGIA 148 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEEeeccce
Confidence 899999999999999988653 33578999999999999999999999999999999999998 6778999999998
Q ss_pred ccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1122 RIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1122 r~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
....... ......|+..|+|||++.+.. ++.++|+|||||++|+|++|+.||...........+..+.. +..+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 225 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICENRP--YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPVSSHY 225 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCCCC--CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-CCCcccC
Confidence 7543322 122345788999999998653 78899999999999999999999987776666666654443 3456678
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+.++.++|.+||+.+|.+||++.+++++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 8999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=309.87 Aligned_cols=247 Identities=25% Similarity=0.404 Sum_probs=206.6
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|++.+.||.|+||.||++++. ++.||+|++.+.... .....+.+.+|++++++++||||+++++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-----EKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE-- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-----chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC--
Confidence 4789999999999999999985 778999999754221 2234567889999999999999999999987655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++|+||+.+++|..++... ..+++..+..++.||++||.|||+++|+|+||+|+||+++ .++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~----~~~~~~l~d~~~~~ 148 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD----EQGHVHITDFNIAT 148 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc----CCCCEEEeeccccc
Confidence 899999999999999998554 5789999999999999999999999999999999999998 77899999999987
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---hhHHHHhhhccCCCCCCCC
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC---GAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~---~eliqsIlk~~Lrp~ipe~ 1199 (1254)
............++..|+|||++.+.. ++.++|+||||+++|+|++|..||..... ....... .. .....+..
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~-~~~~~~~~ 224 (258)
T cd05578 149 KVTPDTLTTSTSGTPGYMAPEVLCRQG--YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ-ET-ADVLYPAT 224 (258)
T ss_pred ccCCCccccccCCChhhcCHHHHcccC--CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh-cc-ccccCccc
Confidence 655443444566889999999998654 78899999999999999999999987663 2222222 21 33456677
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCH--HHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSF--TEITS 1227 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSA--rELLe 1227 (1254)
++..+.++|.+||..+|.+||++ +++++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 225 WSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred CcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 88999999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=335.29 Aligned_cols=251 Identities=27% Similarity=0.364 Sum_probs=205.6
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec---C
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD---G 1039 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D---d 1039 (1254)
.|..++.||+|+||.|..+.+ +++.||||++... .......++..||+++|+.++|+||+.+++++.. +
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~------F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP------FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhh------hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 455678999999999999888 4778999998743 2244556788999999999999999999999875 3
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
....+|+|+|+| +.+|..+++ .+..++..++..++.||+.||+|+|+.+|+||||||.|+|++ .+..+||||||
T Consensus 97 ~f~DvYiV~elM-etDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n----~~c~lKI~DFG 170 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN----ADCDLKICDFG 170 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeec----cCCCEEecccc
Confidence 445799999999 677777774 445599999999999999999999999999999999999999 88899999999
Q ss_pred ccccccC---ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc------
Q 040257 1120 LSRIKRN---TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN------ 1190 (1254)
Q Consensus 1120 LAr~~~~---s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~------ 1190 (1254)
+|+.... ....+.+.-|.+|.|||++... ..|+.++||||+||||.||++|++.|.+.+....+..++.-
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 9997753 3334556789999999999654 46999999999999999999999999887654433322211
Q ss_pred ------------------cCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1191 ------------------TLRPT-----IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1191 ------------------~Lrp~-----ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
...+. +-...++.+.+|+.+||..||.+|+|++|.|++
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111 112567889999999999999999999999987
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.32 Aligned_cols=248 Identities=35% Similarity=0.613 Sum_probs=198.1
Q ss_pred EEeeeCcEEEEEEEECC--------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 971 ELGSGTYGTVYHGKWRG--------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~rG--------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.||+|+||.||+|++.. ..+|||.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 72 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-------TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-- 72 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-------chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--
Confidence 58999999999998742 468999876431 1123456888999999999999999999987655
Q ss_pred ceEEEEEecccCchhhhhhcc------CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC-CCCCeEEE
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD-PQRPICKV 1115 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd-~snG~VKL 1115 (1254)
..++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+++|+||||+|||++..+ .....+||
T Consensus 73 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 73 PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEE
Confidence 789999999999999998542 23478899999999999999999999999999999999998321 11238999
Q ss_pred EeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhcc
Q 040257 1116 GDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNT 1191 (1254)
Q Consensus 1116 iDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~ 1191 (1254)
+|||+++...... ......++..|+|||++.+. .++.++|||||||++|+|++ |+.||...........+.. .
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~ 229 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-G 229 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccC--CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-C
Confidence 9999987443221 11223456789999999865 47899999999999999998 9999987766555444432 2
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1192 Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
.....+..++..+.+||.+||..+|.+||++.++++.|+
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 334455678899999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.82 Aligned_cols=252 Identities=29% Similarity=0.379 Sum_probs=202.7
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||.|+||.||+|++. ++.+|+|.++..... ......+.+|+.++++++||||+++++++...+..
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence 6888899999999999999984 678999999754221 22334567899999999999999999998876556
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+. ++|.+++......+++..++.++.||+.||.|||+++|+|+||||+|||++ .++.+||+|||++.
T Consensus 80 ~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~----~~~~~~l~d~g~~~ 154 (293)
T cd07843 80 KIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN----NRGILKICDFGLAR 154 (293)
T ss_pred cEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC----CCCcEEEeecCcee
Confidence 8999999996 588888866556799999999999999999999999999999999999998 77899999999987
Q ss_pred cccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc-----------
Q 040257 1123 IKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN----------- 1190 (1254)
Q Consensus 1123 ~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~----------- 1190 (1254)
..... .......++..|+|||++.+.. .++.++||||||+++|+|++|..||...........+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 155 EYGSPLKPYTQLVVTLWYRAPELLLGAK-EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred eccCCccccccccccccccCchhhcCCc-cccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence 54432 2223345788999999987643 3688999999999999999999999876554433332211
Q ss_pred ------------------cCCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1191 ------------------TLRPTIPER-CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1191 ------------------~Lrp~ipe~-iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+...++.. +++.+.+||++||+.+|++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 001112222 57889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=337.15 Aligned_cols=259 Identities=26% Similarity=0.381 Sum_probs=209.1
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|...+++|.|+||.||.|+.. +..||||++.... +--.+|+.+|+.+.|||||+|.-+|......
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------------RYKNRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 5788899999999999999984 5679999886431 0113699999999999999999888755444
Q ss_pred ---ceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1043 ---TLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1043 ---~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
++.+||||| ..+|.++++. .+..++...+..+..||++||.|||+.||+||||||+|||+| +..+.+|||
T Consensus 93 d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD---~~tg~LKic 168 (364)
T KOG0658|consen 93 DEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD---PDTGVLKIC 168 (364)
T ss_pred chhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc---CCCCeEEec
Confidence 677899999 5688888753 256789999999999999999999999999999999999998 577999999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC----
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL---- 1192 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L---- 1192 (1254)
|||.|+..........+..|..|+|||.+.|.. .|+.+.||||.|||+.||+-|++.|.+.+....+..+.+-.-
T Consensus 169 DFGSAK~L~~~epniSYicSRyYRaPELifga~-~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred cCCcceeeccCCCceeEEEeccccCHHHHcCcc-ccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 999999876666666677899999999999875 689999999999999999999999998766554443332100
Q ss_pred -----------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 040257 1193 -----------------------RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCIN 1242 (1254)
Q Consensus 1193 -----------------------rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk~~k 1242 (1254)
........++++.+|+.++|+.+|.+|.++.|++.+ .+.++++...-+
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h--~fFdelr~~~~~ 318 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH--PFFDELRDPNTK 318 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc--hhhHHhhCcCcc
Confidence 001234568899999999999999999999999975 444444443333
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.52 Aligned_cols=253 Identities=26% Similarity=0.337 Sum_probs=201.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||.||+|.+. ++.||+|+++..... ......+.+|+.++++++|+||+++++++.+...
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER------DGIPISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC------CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 47999999999999999999984 778999998754211 1112345679999999999999999999987655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..+++||||+. ++|.+++......+++..++.++.||+.||.|||+.||+||||||+||+++ ..+.+||+|||++
T Consensus 81 ~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~kL~dfg~~ 155 (309)
T cd07845 81 DSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT----DKGCLKIADFGLA 155 (309)
T ss_pred CeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEECcccee
Confidence 67899999995 578888766556799999999999999999999999999999999999998 7789999999998
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC-------
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR------- 1193 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr------- 1193 (1254)
...... .......++..|+|||++.+.. .++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 156 RTYGLPAKPMTPKVVTLWYRAPELLLGCT-TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred eecCCccCCCCcccccccccChhhhcCCC-CcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence 754432 1122234578899999987542 4788999999999999999999999877665555444321000
Q ss_pred ----------CCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 ----------PTI-----------PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 ----------p~i-----------pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
... ....++.+.+||.+||..||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 01257888999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=314.32 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=203.3
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||.||++.+. ++.||||.+..... ........+.+|+++++.++||||+++++.+..+.
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 74 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-----ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR-- 74 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC--
Confidence 6889999999999999999884 56799999875421 12233467889999999999999999999987654
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|.+++... +.+++..+..++.|++.||.|||+++|+||||||+||+++ ..+.+||+|||+++
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~----~~~~~~l~dfg~~~ 149 (305)
T cd05609 75 HLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT----SMGHIKLTDFGLSK 149 (305)
T ss_pred EEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC----CCCCEEEeeCCCcc
Confidence 899999999999999998554 5689999999999999999999999999999999999998 77899999999986
Q ss_pred cccCc----------------cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHH
Q 040257 1123 IKRNT----------------LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGG 1186 (1254)
Q Consensus 1123 ~~~~s----------------~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqs 1186 (1254)
..... .......++..|+|||.+.+. .++.++|||||||++|||++|..||.+....+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~ 227 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 32110 011124578899999998765 478999999999999999999999988776666666
Q ss_pred hhhccCC-CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1187 IVKNTLR-PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1187 Ilk~~Lr-p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
....... +.....++.++++||.+||+.+|++||+..++++.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 228 VISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred HHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 5544322 222335789999999999999999999854444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=314.02 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=204.4
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||.|++|+||++.+ .++.||||.+..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--------PKKELIINEILVMKELKNPNIVNFLDSFLVGD- 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--------chHHHHHHHHHHHHhcCCCceeeeeeeEecCc-
Confidence 3699999999999999999986 577899999864321 12356788999999999999999999997655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++|+||+.+++|..++.. ..+++..++.++.+++.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~----~~~~~kl~dfg~~ 162 (296)
T cd06655 90 -ELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG----MDGSVKLTDFGFC 162 (296)
T ss_pred -eEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccCccc
Confidence 89999999999999998843 3589999999999999999999999999999999999998 6788999999998
Q ss_pred ccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc-CCCCCCCC
Q 040257 1122 RIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT-LRPTIPER 1199 (1254)
Q Consensus 1122 r~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~-Lrp~ipe~ 1199 (1254)
....... ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+.... .....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06655 163 AQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240 (296)
T ss_pred hhcccccccCCCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCccc
Confidence 7543221 22334688999999999865 37889999999999999999999998776544443333222 12234566
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++..+.+||.+||..+|.+||++.+++++
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 88999999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=331.57 Aligned_cols=243 Identities=23% Similarity=0.311 Sum_probs=193.4
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
..+|++++.||+|+||.||++... +..||+|.+... ..+.+|+.+|++++||||+++++++..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------~~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------KTPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------ccHHHHHHHHHhcCCCCccceeeeEee
Confidence 457999999999999999998763 356888887642 124579999999999999999999876
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. .++++||++. ++|.+++ .....+++..++.|+.||+.||.|||++|||||||||+|||++ ..+.+||+||
T Consensus 158 ~~--~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~----~~~~~~l~Df 229 (392)
T PHA03207 158 KS--TVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD----EPENAVLGDF 229 (392)
T ss_pred CC--EEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEccC
Confidence 54 7999999984 6888877 4446799999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---hHHHHhhhc--
Q 040257 1119 GLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG---AIIGGIVKN-- 1190 (1254)
Q Consensus 1119 GLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~---eliqsIlk~-- 1190 (1254)
|+++...... ......||..|+|||++.+.. ++.++|||||||+||||++|+.||.+.... ..+..+...
T Consensus 230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~ 307 (392)
T PHA03207 230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDP--YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ 307 (392)
T ss_pred ccccccCcccccccccccccccCccCHhHhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhc
Confidence 9987543321 223456999999999998664 788999999999999999999999764321 111111110
Q ss_pred -----------------------cCCCC--C-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1191 -----------------------TLRPT--I-----PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1191 -----------------------~Lrp~--i-----pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..++. . ...++.++++||.+||..||++||++.+++.+
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 308 VHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 0 12346788899999999999999999999987
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=306.32 Aligned_cols=253 Identities=28% Similarity=0.497 Sum_probs=204.8
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|+..+.||+|++|.||+++. +++.||+|++..... ....+....+.+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~--~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRN--TSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccC--CchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC--
Confidence 367788999999999999987 577899999874321 11223445678899999999999999999999997655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCC-CeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQR-PICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~sn-G~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++.+ .+.+++..++.++.||+.||.|||++||+|+||||+||+++ .+ ..+||+|||++
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~----~~~~~~~l~dfg~~ 151 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID----STGQRLRIADFGAA 151 (268)
T ss_pred eEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEEcccccc
Confidence 78999999999999998854 35689999999999999999999999999999999999997 33 46999999998
Q ss_pred ccccCcc-----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---hHHHHhhhccCC
Q 040257 1122 RIKRNTL-----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG---AIIGGIVKNTLR 1193 (1254)
Q Consensus 1122 r~~~~s~-----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~---eliqsIlk~~Lr 1193 (1254)
....... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...... .....+......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (268)
T cd06630 152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA 229 (268)
T ss_pred cccccccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC
Confidence 7543321 12234578899999999765 3788999999999999999999999754432 222222223334
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+..+..+++++.+++.+||..+|.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 230 PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 55666788999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=301.51 Aligned_cols=247 Identities=32% Similarity=0.551 Sum_probs=207.7
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|++|.||++++. ++.|+||++..... ......+.+|+.++.+++|+||+++++++....
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD-------EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG-- 72 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc-------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC--
Confidence 6889999999999999999884 77899999875421 134567889999999999999999999997664
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++... ..+++..++.++.|+++||.|||+ .+++|+||+|+||+++ .++.++|+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~----~~~~~~l~df~~~ 147 (264)
T cd06623 73 EISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN----SKGEVKIADFGIS 147 (264)
T ss_pred eEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC----CCCCEEEccCccc
Confidence 899999999999999998654 678999999999999999999999 9999999999999998 7889999999998
Q ss_pred ccccCcccc-CCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hhhHHHHhhhccCCCCCC
Q 040257 1122 RIKRNTLVS-GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH---CGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1122 r~~~~s~~s-ts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n---~~eliqsIlk~~Lrp~ip 1197 (1254)
......... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.... .......+... ..+..+
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 224 (264)
T cd06623 148 KVLENTLDQCNTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-PPPSLP 224 (264)
T ss_pred eecccCCCcccceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-CCCCCC
Confidence 765433222 245688999999998866 47889999999999999999999997763 33444444432 233444
Q ss_pred CC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 ER-CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 e~-iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.. ++..+.++|.+||..+|.+||++.+++++
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 55 88999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=309.06 Aligned_cols=249 Identities=29% Similarity=0.472 Sum_probs=201.5
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|+..+.||.|++|.||++.+ .++.+|+|.+.... ......++.+|++++++++||||++++++|.+....
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-------NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS 74 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-------chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC
Confidence 688999999999999999998 46789999987531 113456788999999999999999999999776666
Q ss_pred ceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1043 TLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
.+++||||+.+++|.+++.. ....+++..+..++.||+.||.|||+.+++|+||+|+||+++ ..+.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~----~~~~~~l~dfg 150 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT----RKGQVKLCDFG 150 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe----cCCeEEEeecc
Confidence 89999999999999887643 345688999999999999999999999999999999999998 67789999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----hhhHHHHhhhccCCC
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH-----CGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n-----~~eliqsIlk~~Lrp 1194 (1254)
++........ ....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||.... ..+....+.... .+
T Consensus 151 ~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 226 (287)
T cd06621 151 VSGELVNSLA-GTFTGTSFYMAPERIQGKP--YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP-NP 226 (287)
T ss_pred cccccccccc-ccccCCccccCHHHhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-ch
Confidence 9875433221 2345788999999998653 7889999999999999999999997652 122222222211 11
Q ss_pred CCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 TIP------ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 ~ip------e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+ ..+++.+.+||.+||..+|.+|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 111 2346789999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=309.45 Aligned_cols=252 Identities=32% Similarity=0.466 Sum_probs=202.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn 1040 (1254)
.+|++.+.||+|+||.||++.. .++.+|+|++.... .....+.+|+.+++++ +||||+++++++....
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 4799999999999999999988 47789999986431 1234567889999988 8999999999986533
Q ss_pred ---CCceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1041 ---GGTLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1041 ---~~~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
...+++||||+.+++|.+++.. ....+++..++.++.|++.||.|||+.+|+||||||+||+++ ..+.+|
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~----~~~~~k 168 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT----TEGGVK 168 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----CCCCEE
Confidence 2468999999999999988753 345689999999999999999999999999999999999998 677899
Q ss_pred EEeccccccccCcc-ccCCCCCCCCccCcccccCCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc
Q 040257 1115 VGDFGLSRIKRNTL-VSGGVRGTLPWMAPELLNGSS---NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN 1190 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~-~sts~~GT~~YmAPEVLrG~~---~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~ 1190 (1254)
|+|||++....... ......++..|+|||++.... ..++.++|||||||++|+|++|+.||........+..+...
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 248 (291)
T cd06639 169 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248 (291)
T ss_pred EeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence 99999987543322 223456889999999986432 13678999999999999999999999877655544444332
Q ss_pred cCC-CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1191 TLR-PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1191 ~Lr-p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
... ...+..++..+.+||.+||..+|++||++.+++++
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 211 12244567889999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=356.32 Aligned_cols=258 Identities=20% Similarity=0.300 Sum_probs=210.2
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeee-e
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGV-V 1036 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGv-f 1036 (1254)
+....+++.+.|.+|+|+.||+|++. +..||+|++... ++...+.+.+|+++|++|+ |+|||.+++. .
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--------de~~L~~v~~EI~~MK~L~gh~nIV~yidss~ 105 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--------DEEALNAVKREIDIMKLLSGHKNIVSYIDSSA 105 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--------CHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence 44557889999999999999999984 378999998743 4556788899999999996 9999999993 2
Q ss_pred ec---CC-CCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCC--cccccCCCCceEeccCCCC
Q 040257 1037 PD---GT-GGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKN--IVHFDLKCENLLVNLRDPQ 1109 (1254)
Q Consensus 1037 ~D---dn-~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkG--IIHRDLKPeNILLDsdd~s 1109 (1254)
.. .. ...++|+||||.||+|.++|.++ ...|++..+++|+.++++||.+||... |||||||-+||||. .
T Consensus 106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls----~ 181 (738)
T KOG1989|consen 106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS----A 181 (738)
T ss_pred ccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc----C
Confidence 21 12 24578999999999999999754 345999999999999999999999997 99999999999999 7
Q ss_pred CCeEEEEeccccccccCcc-ccC---------CCCCCCCccCcccccC-CCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 040257 1110 RPICKVGDFGLSRIKRNTL-VSG---------GVRGTLPWMAPELLNG-SSNRVSEKVDVFSFGISMWEILTGEEPYADM 1178 (1254)
Q Consensus 1110 nG~VKLiDFGLAr~~~~s~-~st---------s~~GT~~YmAPEVLrG-~~~kyS~KSDIWSLGVILYELLTGk~PF~~~ 1178 (1254)
+++.||||||.+...-... ... ...-|+.|+|||++.- ....+++|+|||+|||+||-|+....||...
T Consensus 182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 8899999999987432111 000 1136899999999841 1124899999999999999999999999875
Q ss_pred ChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1179 HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1179 n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
.. ..|+...+.......++..+++||+.||+.||++||++.|++.++..+..
T Consensus 262 g~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 262 GK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred cc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 32 23555666555556789999999999999999999999999999988754
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=298.24 Aligned_cols=249 Identities=29% Similarity=0.539 Sum_probs=211.5
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|+||.||++.+. +..+++|++..... .......+.+|+++++.++|+|++++++.+.+. .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~ 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM------SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--G 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC------ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--C
Confidence 4788999999999999999985 77899999875421 123456678899999999999999999998776 4
Q ss_pred ceEEEEEecccCchhhhhhcc---CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK---DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr---e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
..++|+||+++++|.+++... ...+++..++.++.+|+.||.|||++|++|+||+|+||+++ .++.++|+|||
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~----~~~~~~l~d~~ 148 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFG 148 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc----CCCcEEECCcc
Confidence 899999999999999998664 36799999999999999999999999999999999999998 67899999999
Q ss_pred ccccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCC
Q 040257 1120 LSRIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1120 LAr~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe 1198 (1254)
.+....... ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||................ ...++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 225 (258)
T cd08215 149 ISKVLSSTVDLAKTVVGTPYYLSPELCQNKP--YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPS 225 (258)
T ss_pred ceeecccCcceecceeeeecccChhHhccCC--CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CCCCCC
Confidence 987654432 233456888999999987654 7889999999999999999999998877666666555443 344566
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++..+.+++.+||..+|++||++.+++++
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=314.18 Aligned_cols=247 Identities=27% Similarity=0.437 Sum_probs=202.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||.||++.. .++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++..+.
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 89 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--------PKKELIINEILVMRENKNPNIVNYLDSYLVGD- 89 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--------chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 4799999999999999999987 478899999874321 12355788999999999999999999997655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++.+ ..+++..+..++.|++.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~----~~~~~~l~Dfg~~ 162 (297)
T cd06656 90 -ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFC 162 (297)
T ss_pred -EEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEECcCccc
Confidence 89999999999999998843 4588999999999999999999999999999999999998 6789999999998
Q ss_pred ccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc-cCCCCCCCC
Q 040257 1122 RIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN-TLRPTIPER 1199 (1254)
Q Consensus 1122 r~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~-~Lrp~ipe~ 1199 (1254)
....... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+... ......+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T cd06656 163 AQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER 240 (297)
T ss_pred eEccCCccCcCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccc
Confidence 7543322 22334688999999999865 3788999999999999999999999765543332222221 112234556
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++..+++|+.+||..+|.+||++.+++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 78899999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=327.11 Aligned_cols=258 Identities=25% Similarity=0.337 Sum_probs=226.6
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~ 1041 (1254)
.|+..+.||+|..++|.++.+ ++..+|+|++.............++.+.-.+|+.||+++ .||+|+++.+++..+.
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s- 96 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA- 96 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc-
Confidence 355566799999999999877 477899999986655444555677888889999999998 6999999999997655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++|+|.|+.|.|.+++... -.++++..+.|++|+++|+.|||.++||||||||+|||++ ++.++||+|||.+
T Consensus 97 -F~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld----dn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 -FVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD----DNMNIKISDFGFA 170 (411)
T ss_pred -hhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec----cccceEEecccee
Confidence 899999999999999999543 5699999999999999999999999999999999999999 8889999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSN----RVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~----kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
+...........|||++|+|||.+...-+ .|+..+|+|++|+|||.|+.|.+||+....--++..+..+.+....+
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 98877777778999999999999875432 58899999999999999999999999888778888888888877666
Q ss_pred C--CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1198 E--RCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1198 e--~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
+ +++...++||.+||+.||.+|.|++|.|.|=
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 4 4678899999999999999999999999864
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=310.61 Aligned_cols=253 Identities=28% Similarity=0.351 Sum_probs=201.0
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||.||+|.+. ++.||||.++...... ........+.+|++++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE---AKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS-- 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc---ccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC--
Confidence 4788899999999999999984 6789999997653221 11233456778999999999999999999998744
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+ +++|.+++......+++..++.++.||++||.|||++||+|+||||+|||++ .++.+||+|||+++
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~----~~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc----CCCCEEEccceeee
Confidence 899999999 9999999865544799999999999999999999999999999999999998 77899999999997
Q ss_pred cccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC--------
Q 040257 1123 IKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR-------- 1193 (1254)
Q Consensus 1123 ~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr-------- 1193 (1254)
...... ......++..|+|||.+.+.. .++.++|||||||++|+|++|.++|........+..+......
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGAR-HYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCC-CCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 654321 222334678899999986532 4788999999999999999998888765544433333211000
Q ss_pred -------------C-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 -------------P-----TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 -------------p-----~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
. ......+..+.+||.+||+++|++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 0112346789999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=313.39 Aligned_cols=249 Identities=28% Similarity=0.457 Sum_probs=203.7
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|+..+.||+|+||+||++++ .++.||+|++...... .......+.+|+.+++.++||||+++++++.+..
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-- 88 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-- 88 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-----cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC--
Confidence 588899999999999999987 4778999998643211 2233456889999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
..++||||+. ++|.+.+......+++..+..++.||+.||.|||+.+|+||||+|+||+++ .++.+||+|||++.
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~----~~~~~kL~dfg~~~ 163 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT----EPGTVKLADFGSAS 163 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC----CCCCEEEeecCcce
Confidence 7899999985 677777755556799999999999999999999999999999999999998 77899999999987
Q ss_pred cccCccccCCCCCCCCccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGS-SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~-~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
..... ....++..|+|||++.+. ...++.++||||||+++|||++|+.||...+.......+.........+..++
T Consensus 164 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (307)
T cd06607 164 LVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWS 240 (307)
T ss_pred ecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhC
Confidence 54332 235688899999998532 23478899999999999999999999988766555444443332222334578
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+.++|.+||..+|.+||++.+++.+
T Consensus 241 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 241 DYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 899999999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=307.53 Aligned_cols=250 Identities=28% Similarity=0.364 Sum_probs=200.3
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|+||.||+|.+. ++.||||+++.... .....+.+.+|++++++++|+||+++++++.++.
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 73 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED------DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG-- 73 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc------cccchhHHHHHHHHHHhcCCCCeeehhheEEECC--
Confidence 6899999999999999999884 67899998875321 2234567889999999999999999999997654
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.++.+..++ .+...+++..++.++.||+.||.|||+++|+|+||+|+||+++ .++.+||+|||++.
T Consensus 74 ~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~----~~~~~kl~d~g~~~ 148 (288)
T cd07833 74 RLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS----ESGVLKLCDFGFAR 148 (288)
T ss_pred EEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEEeeeccc
Confidence 799999999876665544 4445689999999999999999999999999999999999998 68899999999987
Q ss_pred cccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc----------
Q 040257 1123 IKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN---------- 1190 (1254)
Q Consensus 1123 ~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~---------- 1190 (1254)
...... ......++..|+|||++.+.. .++.++||||||+++|+|++|+.||........+..+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 149 ALRARPASPLTDYVATRWYRAPELLVGDT-NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred ccCCCccccccCcccccCCcCCchhcCCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 654432 233456788999999998652 4788999999999999999999999865443322221110
Q ss_pred -----------cC---------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1191 -----------TL---------RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1191 -----------~L---------rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+ ....+..++.++++||++||..+|++||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 001233458889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=308.67 Aligned_cols=250 Identities=28% Similarity=0.413 Sum_probs=195.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|++|.||+++.+ ++.||||.+....... ....+.+|+.++++++|+||+++++++.+..
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 76 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-------APFTAIREASLLKDLKHANIVTLHDIIHTKK- 76 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-------CchhHHHHHHHHhhCCCcceeeEEEEEecCC-
Confidence 47999999999999999999874 6789999987542111 1234568999999999999999999997655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..++||||+. ++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 77 -~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~ 150 (291)
T cd07844 77 -TLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS----ERGELKLADFGLA 150 (291)
T ss_pred -eEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc----CCCCEEECccccc
Confidence 8999999997 589988866666789999999999999999999999999999999999998 7789999999998
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hhhHHHHhhhc-------c-
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH-CGAIIGGIVKN-------T- 1191 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n-~~eliqsIlk~-------~- 1191 (1254)
+..... .......++..|+|||++.+.. .++.++||||||+++|+|++|+.||.... ..+....+... .
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07844 151 RAKSVPSKTYSNEVVTLWYRPPDVLLGST-EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229 (291)
T ss_pred cccCCCCccccccccccccCCcHHhhcCc-ccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhh
Confidence 753221 1112234688899999987542 36889999999999999999999997654 22211111100 0
Q ss_pred -------------CCC-------CCCCCCc--HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 -------------LRP-------TIPERCD--PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 -------------Lrp-------~ipe~iS--~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
... .....++ ..+.+++.+||+.+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 0001233 778899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.42 Aligned_cols=246 Identities=30% Similarity=0.479 Sum_probs=202.9
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|+.++.||+|+||.||+|.+ .+..||+|.+.... .....+.+.+|+.++++++||||+++++++....
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT-- 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-------chHHHHHHHHHHHHHHcCCCCccHhhhcccccCC--
Confidence 456667799999999999987 46779999886431 1223467889999999999999999999997655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|.+++.. ..+++..++.++.||+.||.|||+++|+|+||+|+||+++ .++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~----~~~~~~l~dfg~~~ 149 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS----EQGDVKLADFGVAG 149 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe----CCCCEEEccccccc
Confidence 78999999999999998843 4689999999999999999999999999999999999998 67889999999987
Q ss_pred cccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1123 IKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1123 ~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
...... ......++..|+|||.+.+. .++.++|+|||||++|||++|+.||...........+. ....+.....++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 226 (277)
T cd06642 150 QLTDTQIKRNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYS 226 (277)
T ss_pred cccCcchhhhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccC
Confidence 543322 22234588899999999865 47889999999999999999999997665544443332 223344556678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++.++|.+||..+|.+||++.+++++
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 899999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.63 Aligned_cols=254 Identities=33% Similarity=0.557 Sum_probs=201.9
Q ss_pred ceEEEEEeeeCcEEEEEEEEC-----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 966 LEELRELGSGTYGTVYHGKWR-----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r-----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
|.+.+.||+|+||.||+|.++ +..||||+++.... .....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF------SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC------ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 456788999999999999863 46799999875421 1223566889999999999999999999876432
Q ss_pred C----CceEEEEEecccCchhhhhhcc-----CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCC
Q 040257 1041 G----GTLATVTEFMVNGSLKHVLLKK-----DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRP 1111 (1254)
Q Consensus 1041 ~----~~L~LVMEYm~GGSL~d~L~kr-----e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG 1111 (1254)
. ...+++++|+.+++|..++... ...+++..++.++.||+.||+|||+++|+||||||+||+++ .++
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~----~~~ 150 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN----ENM 150 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc----CCC
Confidence 2 1347889999999998776421 22478899999999999999999999999999999999998 678
Q ss_pred eEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHh
Q 040257 1112 ICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGI 1187 (1254)
Q Consensus 1112 ~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsI 1187 (1254)
.+||+|||+++...... ......++..|++||.+.+.. ++.++|||||||++|+|++ |+.||...........+
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05074 151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV--YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228 (273)
T ss_pred CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCc--cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 89999999987543221 112233567899999987653 7889999999999999999 89999877665555444
Q ss_pred hhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1188 lk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
.... ....+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 229 ~~~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 4332 2234456788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.38 Aligned_cols=246 Identities=23% Similarity=0.487 Sum_probs=191.6
Q ss_pred EEeeeCcEEEEEEEEC-Cc---eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEE
Q 040257 971 ELGSGTYGTVYHGKWR-GS---DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~r-Gs---~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+||+|+||+||++++. +. .+++|.++... .....+.+.+|+.+++.++||||+++++++.+.. ..++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~l 72 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-------SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI--PYLL 72 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-------ChHHHHHHHHHHHHHhccCCcchhheEEEecCCC--ccEE
Confidence 5999999999999763 32 34555554321 1223567899999999999999999999998654 7899
Q ss_pred EEEecccCchhhhhhccC---CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1047 VTEFMVNGSLKHVLLKKD---RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre---~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
||||+.+++|.+++.+.. ..+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++..
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~----~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT----SDLTVKVGDYGIGPS 148 (268)
T ss_pred EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc----CCccEEecccccccc
Confidence 999999999999986532 3466777889999999999999999999999999999998 778899999999863
Q ss_pred ccCc---cccCCCCCCCCccCcccccCCC-----CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhcc---
Q 040257 1124 KRNT---LVSGGVRGTLPWMAPELLNGSS-----NRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNT--- 1191 (1254)
Q Consensus 1124 ~~~s---~~sts~~GT~~YmAPEVLrG~~-----~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~--- 1191 (1254)
.... .......++..|+|||++.... ..++.++|||||||++|||++ |..||......+.+..+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK 228 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc
Confidence 2111 1223456888999999985321 235788999999999999997 677887766655555444332
Q ss_pred -CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1192 -LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1192 -Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
..+..+..+++.+.+++..|| .+|.+||+++++++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 223445567889999999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=306.64 Aligned_cols=247 Identities=28% Similarity=0.508 Sum_probs=200.6
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC---CCceeEEeeeeecC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH---HPNVVAFYGVVPDG 1039 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn---HPNIVkLyGvf~Dd 1039 (1254)
.|+.++.||+|+||.||+|.+ .++.||+|.+.... ......++.+|+.++++++ |||++++++++.+.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-------PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 367778999999999999998 46789999986432 1122456778999999886 99999999998765
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
. ..++||||+.+++|.+++.. ..+++..++.++.|++.||.|||+.||+|+||+|+||+++ ..+.++|+|||
T Consensus 75 ~--~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~----~~~~~~l~dfg 146 (277)
T cd06917 75 P--RLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT----NTGNVKLCDFG 146 (277)
T ss_pred C--EEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc----CCCCEEEccCC
Confidence 4 78999999999999998844 3689999999999999999999999999999999999998 67899999999
Q ss_pred ccccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCC
Q 040257 1120 LSRIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1120 LAr~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe 1198 (1254)
++....... ......|+..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...........+... ..+.++.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 224 (277)
T cd06917 147 VAALLNQNSSKRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLED 224 (277)
T ss_pred ceeecCCCccccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCc
Confidence 987543322 22334688999999998753 24688999999999999999999999876554444333222 2223333
Q ss_pred -CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 -RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 -~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++.++.+|+.+||..+|.+||++.+++.+
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 378899999999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=308.44 Aligned_cols=250 Identities=30% Similarity=0.390 Sum_probs=199.0
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||.||+|.++ ++.||+|++.+... .....+.+.+|+++++.++||||+++++++.++.
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED------DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK-- 73 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC------cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC--
Confidence 6889999999999999999984 67899998865321 1123456788999999999999999999997654
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|..++.. ...+++..++.++.||+.||.|||+.+|+|+||+|+||+++ .++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~----~~~~~~l~dfg~~~ 148 (286)
T cd07846 74 RLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS----QSGVVKLCDFGFAR 148 (286)
T ss_pred eEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCcEEEEeeeeee
Confidence 89999999999888876643 34589999999999999999999999999999999999998 77899999999987
Q ss_pred cccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc-----------
Q 040257 1123 IKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN----------- 1190 (1254)
Q Consensus 1123 ~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~----------- 1190 (1254)
..... .......++..|+|||++.+.. .++.++||||||+++|||++|+.||......+....+...
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 149 TLAAPGEVYTDYVATRWYRAPELLVGDT-KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred eccCCccccCcccceeeccCcHHhcccc-ccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence 54332 2223355788999999987543 4678999999999999999999999765433322221110
Q ss_pred ---------cCCC---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1191 ---------TLRP---------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1191 ---------~Lrp---------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
...+ .....++..+.+|+.+||..+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000 0123467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=310.97 Aligned_cols=257 Identities=27% Similarity=0.376 Sum_probs=197.3
Q ss_pred CceEEEEEeeeCcEEEEEEEEC----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
.|++.+.||+|+||.||+|.+. ++.||||.+..... ........+.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-----QYTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-----cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 4788999999999999999983 57899999986321 11223356778999999999999999999998875
Q ss_pred CCceEEEEEecccCchhhhhhcc----CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKK----DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kr----e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
...+++||||+.+ +|...+... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++...+.+||+
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 76 DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 5689999999864 666655321 23688999999999999999999999999999999999998434348999999
Q ss_pred eccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh---------H
Q 040257 1117 DFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA---------I 1183 (1254)
Q Consensus 1117 DFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e---------l 1183 (1254)
|||+++...... ......++..|+|||++.+.. .++.++|||||||+||+|++|+.||....... .
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCC-CCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 999987543321 223446788999999987642 47889999999999999999999997544321 0
Q ss_pred HHHhhh------------------------ccCCCCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1184 IGGIVK------------------------NTLRPTIP-----------ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1184 iqsIlk------------------------~~Lrp~ip-----------e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+..+.. .......+ ...+.++.+++.+||..||++|||+.+++++
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 00000111 1456788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=347.14 Aligned_cols=248 Identities=27% Similarity=0.337 Sum_probs=204.8
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-C-----CceeEEeeee
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-H-----PNVVAFYGVV 1036 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-H-----PNIVkLyGvf 1036 (1254)
+|++++.||+|+||.|.+|.+ +++.||||+++.. ..+..+...|+.+|..|+ | -|||+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 789999999999999999988 4678999999864 345667778999999997 3 4899999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
...+ ++|||+|.+ ..+|.++++.. ...++...++.|+.||+.||.+||+.+|||+||||+||||.. .....|||
T Consensus 258 ~fr~--HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~--~~r~~vKV 332 (586)
T KOG0667|consen 258 YFRN--HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKD--PKRSRIKV 332 (586)
T ss_pred cccc--ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeecc--CCcCceeE
Confidence 8766 999999987 78999999654 356999999999999999999999999999999999999983 34568999
Q ss_pred EeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc----
Q 040257 1116 GDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT---- 1191 (1254)
Q Consensus 1116 iDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~---- 1191 (1254)
+|||.|+....... .+..+..|+|||+|.|.+ |+.+.||||||||++||++|.+.|.+.+..+.+..|..-.
T Consensus 333 IDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlp--Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY--TYIQSRFYRAPEVILGLP--YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred EecccccccCCcce--eeeeccccccchhhccCC--CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 99999987655543 567889999999999986 8999999999999999999999998877655544332100
Q ss_pred ----------------------------------------------CCCCCC-----------CCCcHHHHHHHHHhhhc
Q 040257 1192 ----------------------------------------------LRPTIP-----------ERCDPEWRKLMEQCWAA 1214 (1254)
Q Consensus 1192 ----------------------------------------------Lrp~ip-----------e~iS~eLrdLIkKCLqk 1214 (1254)
.....| ......+.+||++||.+
T Consensus 409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~ 488 (586)
T KOG0667|consen 409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW 488 (586)
T ss_pred HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence 000011 01234678999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 040257 1215 DPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1215 DPeKRPSArELLe~Le 1230 (1254)
||.+|+|+.|.|+|=.
T Consensus 489 dP~~R~tp~qal~Hpf 504 (586)
T KOG0667|consen 489 DPAERITPAQALNHPF 504 (586)
T ss_pred CchhcCCHHHHhcCcc
Confidence 9999999999998743
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.79 Aligned_cols=248 Identities=26% Similarity=0.487 Sum_probs=208.1
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|+||.||++++ .+..+|+|.+..... .......+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM------SQKEREDAVNEIRILASVNHPNIISYKEAFLDGN-- 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc------cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC--
Confidence 478899999999999999987 466799999875432 1223456778999999999999999999987664
Q ss_pred ceEEEEEecccCchhhhhhcc---CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK---DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr---e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
..++||||+.+++|..++... ...+++..++.++.+++.||.|||+.|++|+||+|+||+++ ..+.+||+|||
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~----~~~~~kl~d~g 148 (256)
T cd08530 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV----ANDLVKIGDLG 148 (256)
T ss_pred EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe----cCCcEEEeecc
Confidence 899999999999999988552 34689999999999999999999999999999999999998 67789999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
++...... ......++..|++||.+.+.. ++.++|+||||+++|+|++|+.||...........+..... +..+..
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~--~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 224 (256)
T cd08530 149 ISKVLKKN-MAKTQIGTPHYMAPEVWKGRP--YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY-PPIPPI 224 (256)
T ss_pred chhhhccC-CcccccCCccccCHHHHCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCchh
Confidence 99765444 333355889999999998654 78899999999999999999999988776665555544433 344557
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++.++++++.+||..+|.+||++.+++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 225 YSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 88999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.20 Aligned_cols=250 Identities=27% Similarity=0.368 Sum_probs=193.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|.+++.||+|+||.||+|.. +++.||||++...... .....+.+|+.+++.++|+||+++++++.++.
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~- 76 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-------GVPFTAIREASLLKGLKHANIVLLHDIIHTKE- 76 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-------CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC-
Confidence 3789999999999999999987 4778999998754211 11235678999999999999999999997654
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..++||||+. ++|...+......+.+..+..++.||+.||.|||+++|+|+||||+|||++ .++.+||+|||++
T Consensus 77 -~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~Dfg~~ 150 (291)
T cd07870 77 -TLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS----YLGELKLADFGLA 150 (291)
T ss_pred -eEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc----CCCcEEEeccccc
Confidence 7899999995 677777655555678888999999999999999999999999999999998 6789999999998
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-hHHHHhhh----------
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG-AIIGGIVK---------- 1189 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~-eliqsIlk---------- 1189 (1254)
+..... .......++..|+|||++.+.. .++.++|||||||++|+|++|+.||...... +.+..+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07870 151 RAKSIPSQTYSSEVVTLWYRPPDVLLGAT-DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229 (291)
T ss_pred cccCCCCCCCCCccccccccCCceeecCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhh
Confidence 753222 1223345788999999987542 3688999999999999999999999765432 11111100
Q ss_pred -----------ccCCCCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1190 -----------NTLRPTIP---------ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1190 -----------~~Lrp~ip---------e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.......+ ...+..+.+|+.+||..||.+|||+.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000 1125688999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.79 Aligned_cols=256 Identities=30% Similarity=0.400 Sum_probs=206.8
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCc-eeEEeeeeecCC-
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN-VVAFYGVVPDGT- 1040 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPN-IVkLyGvf~Ddn- 1040 (1254)
.|+.+++||+|+||+||+|+. +|+.||+|++....- .+.......+|+.+|+.|+|+| |+.|++++...+
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~------~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE------EEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc------ccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 456667799999999999987 577899999986421 1224455689999999999999 999999998654
Q ss_pred ---CCceEEEEEecccCchhhhhhccC---CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1041 ---GGTLATVTEFMVNGSLKHVLLKKD---RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1041 ---~~~L~LVMEYm~GGSL~d~L~kre---~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
...+++|+||+ ..+|..++.... ..++...+..++.||+.||+|||+++|+||||||+||||+ ..|.+|
T Consensus 86 ~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~----~~G~lK 160 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS----SSGVLK 160 (323)
T ss_pred ccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC----CCCcEe
Confidence 24789999997 778888886655 3578889999999999999999999999999999999999 789999
Q ss_pred EEecccccccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC
Q 040257 1115 VGDFGLSRIKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1115 LiDFGLAr~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
|+|||+|+... .....+...+|.+|+|||++.|.. .|+..+||||+|||++||++++..|.+....+.+..+....-.
T Consensus 161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~-~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt 239 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGST-SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT 239 (323)
T ss_pred eeccchHHHhcCCcccccccEEEeeccCHHHhcCCC-cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence 99999999654 233344556899999999999885 4899999999999999999999999988776555544321110
Q ss_pred C----------------CCC------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 040257 1194 P----------------TIP------------ERCDPEWRKLMEQCWAADPEARPSFTEITSR--LRTI 1232 (1254)
Q Consensus 1194 p----------------~ip------------e~iS~eLrdLIkKCLqkDPeKRPSArELLe~--Le~L 1232 (1254)
+ .++ ...++...+++.+||+.+|.+|.|++..+++ +..+
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 0 011 1123478899999999999999999999997 5444
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=350.68 Aligned_cols=246 Identities=30% Similarity=0.495 Sum_probs=209.5
Q ss_pred EEEeeeCcEEEEEEEECC--ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEE
Q 040257 970 RELGSGTYGTVYHGKWRG--SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATV 1047 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~rG--s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LV 1047 (1254)
-+||+|.||+||-|++.. ..+|||.+... ..+..+-+..||.+-++|+|.|||+++|.+.++. ++-|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--------dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG--f~kIF 650 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--------DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG--FFKIF 650 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc--------cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC--eEEEE
Confidence 479999999999999854 45899988643 2334556788999999999999999999986544 88899
Q ss_pred EEecccCchhhhhhccCCCC--CHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1048 TEFMVNGSLKHVLLKKDRSL--DRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1048 MEYm~GGSL~d~L~kre~~L--Se~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
||.++||+|...+..+-+++ .+...-.+.+||++||+|||++.|||||||-+||||++ -.|.+||+|||-++...
T Consensus 651 MEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT---ySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 651 MEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT---YSGVLKISDFGTSKRLA 727 (1226)
T ss_pred eecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee---ccceEEecccccchhhc
Confidence 99999999999998887887 78889999999999999999999999999999999983 57899999999987543
Q ss_pred C-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh-HHHHhhhccCCCCCCCCCcHH
Q 040257 1126 N-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA-IIGGIVKNTLRPTIPERCDPE 1203 (1254)
Q Consensus 1126 ~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e-liqsIlk~~Lrp~ipe~iS~e 1203 (1254)
. +..+.++.||..|||||++...+..|+.++|||||||++.||.||++||....... .+.++-.-..-+.+|+.++.+
T Consensus 728 ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsae 807 (1226)
T KOG4279|consen 728 GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAE 807 (1226)
T ss_pred cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHH
Confidence 3 44567789999999999999888899999999999999999999999998765433 222222223457789999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1204 WRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1204 LrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++||.+|+..+|.+||+++++|+.
T Consensus 808 ak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 808 AKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHcCCCcccCccHHHhccC
Confidence 9999999999999999999999864
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.65 Aligned_cols=249 Identities=25% Similarity=0.348 Sum_probs=198.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
.+|++++.||+|+||+||++.+ +++.||||++.+... .......+.+|+.++++++|+||++++++|....
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ------NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKS 89 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc------ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCC
Confidence 4799999999999999999987 477899999864321 1223456778999999999999999999886432
Q ss_pred ---CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1041 ---GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1041 ---~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
....++||||+. ++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 90 ~~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~----~~~~~kL~D 161 (353)
T cd07850 90 LEEFQDVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILD 161 (353)
T ss_pred ccccCcEEEEEeccC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEcc
Confidence 235799999995 578877743 288999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC----
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR---- 1193 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr---- 1193 (1254)
||+++............++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...+.......+......
T Consensus 162 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 162 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred CccceeCCCCCCCCCCcccccccCHHHHhCCC--CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99998665544444456889999999998764 789999999999999999999999866543332222110000
Q ss_pred ----------------C---------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 ----------------P---------------------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 ----------------p---------------------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+ ..+...+..+++||.+||+.||++||++.|+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0011245678999999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.37 Aligned_cols=251 Identities=28% Similarity=0.404 Sum_probs=201.4
Q ss_pred ceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
|++++.||.|++|.||++++. ++.+|+|++.... ........+.+|+.++++++|+|++++++++.+.....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN------EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc------ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 678899999999999999985 5789999998642 11223456788999999999999999999998763358
Q ss_pred eEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
+++||||+. ++|..++......+++..++.++.||+.||.|||+.+++|+||||+|||++ .++.+||+|||++..
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~----~~~~~~l~d~g~~~~ 149 (287)
T cd07840 75 IYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN----NDGVLKLADFGLARP 149 (287)
T ss_pred EEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc----CCCCEEEccccceee
Confidence 999999996 588888866656799999999999999999999999999999999999999 788999999999875
Q ss_pred ccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC--------
Q 040257 1124 KRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR-------- 1193 (1254)
Q Consensus 1124 ~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr-------- 1193 (1254)
..... ......++..|+|||.+.+.. .++.++||||||+++|+|++|+.||........+..+......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 150 YTKRNSADYTNRVITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred ccCCCcccccccccccccCCceeeEccc-cCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccc
Confidence 54432 123345688899999887542 4788999999999999999999999876654444333221000
Q ss_pred ---------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 ---------------------PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 ---------------------p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+...++..+.+++++||..+|.+||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00111137889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=344.61 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=207.8
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVV 1036 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf 1036 (1254)
-.+++..|+++++||+|+.+.||++... .+.||+|++.... .+.....-|.+|+.+|.+|+ |.+|++||+|-
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~------~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE 429 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE------ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE 429 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh------cCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence 3577888999999999999999999884 4668888776432 23456778999999999995 99999999997
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
..+. .+|+|||| ...+|..+|.++........++.+..|++.|+.++|++||||.||||.|+|+- .|.+||+
T Consensus 430 v~d~--~lYmvmE~-Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-----kG~LKLI 501 (677)
T KOG0596|consen 430 VTDG--YLYMVMEC-GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-----KGRLKLI 501 (677)
T ss_pred ccCc--eEEEEeec-ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-----eeeEEee
Confidence 7644 99999997 57899999988776666568889999999999999999999999999999994 7899999
Q ss_pred eccccccccCcc---ccCCCCCCCCccCcccccCCCC---------CCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hhH
Q 040257 1117 DFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSN---------RVSEKVDVFSFGISMWEILTGEEPYADMHC-GAI 1183 (1254)
Q Consensus 1117 DFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~---------kyS~KSDIWSLGVILYELLTGk~PF~~~n~-~el 1183 (1254)
|||+|......+ .....+||+.||+||.+..... ++++++||||||||||+|+.|+.||..... ...
T Consensus 502 DFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aK 581 (677)
T KOG0596|consen 502 DFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAK 581 (677)
T ss_pred eechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHH
Confidence 999998765543 3455689999999999865432 378899999999999999999999987653 233
Q ss_pred HHHhhhccCCCCCCCCCc-HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1184 IGGIVKNTLRPTIPERCD-PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1184 iqsIlk~~Lrp~ipe~iS-~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+..+..-....+++..-+ .++.++++.||++||.+||++.+||++
T Consensus 582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 334433323334443322 248999999999999999999999975
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.44 Aligned_cols=249 Identities=29% Similarity=0.418 Sum_probs=198.2
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||.|++|.||+|++. ++.||||+++..... .....+.+|+.++++++|+||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-------GTPSTAIREISLMKELKHENIVRLHDVIHTEN-- 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-------cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--
Confidence 4889999999999999999984 778999998754211 12345678999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccC--CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKD--RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre--~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+||+++ .++.+||+|||+
T Consensus 72 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~----~~~~~~l~d~g~ 146 (284)
T cd07836 72 KLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN----KRGELKLADFGL 146 (284)
T ss_pred cEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCcEEEeecch
Confidence 7899999997 48888775543 4689999999999999999999999999999999999998 778999999999
Q ss_pred cccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc--------
Q 040257 1121 SRIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT-------- 1191 (1254)
Q Consensus 1121 Ar~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~-------- 1191 (1254)
+....... ......++..|++||++.+.. .++.++|||||||++|+|++|+.||......+....+....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 147 ARAFGIPVNTFSNEVVTLWYRAPDVLLGSR-TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhhcCCccccccccccccccChHHhcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 87543221 122345788999999987643 46889999999999999999999998766554433332110
Q ss_pred --------CCCC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 --------LRPT-----------IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 --------Lrp~-----------ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+... +...++..+++++.+||+.+|.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 112356788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=334.94 Aligned_cols=245 Identities=24% Similarity=0.400 Sum_probs=214.4
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECCce--EEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVV 1036 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~--VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf 1036 (1254)
.|+..+|..+.+||+|+||+|.++..+|+. ||||++++..+...+..... ..|.++|... +-|.++.++.+|
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvect-----m~EKrvLAL~~kppFL~qlHScF 419 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECT-----MVEKRVLALPGKPPFLVQLHSCF 419 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccce-----ehhhhheecCCCCchHHHHHHHh
Confidence 455668999999999999999999987654 99999999887765544333 3466777655 578999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
+.-+ ++|+||||+.||+|...|++- +++.+..+..++.+|+.||-|||++|||+||||.+||||+ .+|+|||+
T Consensus 420 QTmD--RLyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd----~eGHiKi~ 492 (683)
T KOG0696|consen 420 QTMD--RLYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKIA 492 (683)
T ss_pred hhhh--heeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec----cCCceEee
Confidence 7554 899999999999999999665 5689999999999999999999999999999999999999 89999999
Q ss_pred eccccccc-cCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1117 DFGLSRIK-RNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1117 DFGLAr~~-~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
|||+++.. -....+.++|||+.|+|||++.-++ |+.++||||+|++||||+.|++||.+.+.+++.+.|..... .
T Consensus 493 DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqP--YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--s 568 (683)
T KOG0696|consen 493 DFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--S 568 (683)
T ss_pred ecccccccccCCcceeeecCCCcccccceEEecc--cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--c
Confidence 99999853 2334566799999999999999776 78889999999999999999999999999999999987654 5
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCC
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARP 1220 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRP 1220 (1254)
+|..++.+...+.+..|.+.|.+|.
T Consensus 569 yPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 569 YPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred CcccccHHHHHHHHHHhhcCCcccc
Confidence 7889999999999999999999995
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.28 Aligned_cols=246 Identities=29% Similarity=0.470 Sum_probs=204.7
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
-|++++.||+|+||.||+|.+ .+..||||++.... .......+.+|+.++++++||||+++++++.++.
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-- 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-------chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC--
Confidence 477888999999999999987 46789999876431 1223467889999999999999999999998665
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
..++||||+.+++|..++.. ..+++..+..++.+++.+|.|||+++|+|+||||+||+++ .++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~----~~~~~~l~dfg~~~ 149 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAG 149 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC----CCCCEEEeecccce
Confidence 78999999999999998843 4689999999999999999999999999999999999998 67889999999987
Q ss_pred cccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1123 IKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1123 ~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
...... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+.. ...+..+..++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 226 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-NNPPTLEGNYS 226 (277)
T ss_pred ecccchhhhccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-CCCCCCCcccC
Confidence 543321 22334588899999998755 478899999999999999999999987665554444332 33445566788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++.+++.+||..+|.+||++.+++++
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.34 Aligned_cols=250 Identities=28% Similarity=0.368 Sum_probs=196.8
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||.|++|.||+|++ .++.||||+++.... .......+.+|++++++++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE------TEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-- 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc------ccccchHHHHHHHHHHhcCCCCCcchhhhcccCC--
Confidence 478899999999999999988 477899998864321 1122356788999999999999999999987654
Q ss_pred ceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+. ++|..++... ...+++..++.++.|++.||+|||+++|+|+||+|+||+++ .++.+||+|||++
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~----~~~~~~l~dfg~~ 147 (284)
T cd07860 73 KLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLA 147 (284)
T ss_pred cEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEeeccch
Confidence 8899999995 6788877543 35689999999999999999999999999999999999998 7789999999998
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC------
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP------ 1194 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp------ 1194 (1254)
...... .......++..|+|||.+.+.. .++.++||||||+++|+|+||+.||...........+....-.+
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 148 RAFGVPVRTYTHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred hhcccCccccccccccccccCCeEEecCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 754322 1122334688899999987543 35888999999999999999999997665433332222110000
Q ss_pred ---------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 ---------------------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 ---------------------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.....++.+++++|.+||+.||.+||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0112467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=310.97 Aligned_cols=251 Identities=28% Similarity=0.461 Sum_probs=207.2
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|+..+.||+|+||.||++++ .+..+|+|++...... .......+.+|+.++++++|+|++++++++.++.
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 98 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-- 98 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-----chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--
Confidence 477888999999999999987 4678999998753211 2234567889999999999999999999997665
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
..++||||+. |+|.+.+......+++..+..++.+|+.||.|||+++|+||||+|+||+++ .++.+||+|||++.
T Consensus 99 ~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~----~~~~~kl~dfg~~~ 173 (317)
T cd06635 99 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSAS 173 (317)
T ss_pred eEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC----CCCCEEEecCCCcc
Confidence 7889999996 577777766566799999999999999999999999999999999999998 67899999999986
Q ss_pred cccCccccCCCCCCCCccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGS-SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~-~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
.... .....++..|+|||++... ...++.++|||||||++|+|++|+.||...........+............++
T Consensus 174 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (317)
T cd06635 174 IASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWS 250 (317)
T ss_pred ccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCcccc
Confidence 5432 2335688899999998531 22478899999999999999999999988766666665555544444455678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
..+++||.+||+.+|.+||++.++++++.
T Consensus 251 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 89999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=297.80 Aligned_cols=249 Identities=23% Similarity=0.468 Sum_probs=204.3
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|.+.+.||+|+||.||++.++ +..+|+|.+...... ....+.+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-- 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP------VKEKEASKKEVILLAKMKHPNIVTFFASFQENG-- 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc------chhhHHHHHHHHHHHhCCCCChhhhhheeccCC--
Confidence 4788999999999999999984 678999998753221 112356778999999999999999999987654
Q ss_pred ceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCC-CeEEEEeccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQR-PICKVGDFGL 1120 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~sn-G~VKLiDFGL 1120 (1254)
.+++|+||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+|+|+||||+||+++ .+ ..+||+|||.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~----~~~~~~~l~d~~~ 148 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS----KNGMVAKLGDFGI 148 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc----CCCCeEEeccccc
Confidence 8999999999999999886543 3578999999999999999999999999999999999998 34 4679999999
Q ss_pred cccccCccc-cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1121 SRIKRNTLV-SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1121 Ar~~~~s~~-sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
+........ .....|+..|+|||++.+. .++.++|+||||+++|+|++|+.||...........+..... ......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 225 (257)
T cd08225 149 ARQLNDSMELAYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-APISPN 225 (257)
T ss_pred chhccCCcccccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-CCCCCC
Confidence 875543321 2234588899999998755 378899999999999999999999987766665555544333 234456
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++.++.++|.+||..+|++||++.+++.+
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 78899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.78 Aligned_cols=244 Identities=25% Similarity=0.389 Sum_probs=196.3
Q ss_pred EeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEE
Q 040257 972 LGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTE 1049 (1254)
Q Consensus 972 LGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVME 1049 (1254)
||+|+||+||++.+ +++.||+|++.+.... .......+.+|+.+|++++||||+++++++.... .+|+|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-----KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD--DLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-----hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC--eEEEEEe
Confidence 68999999999987 4778999998754211 1223445678999999999999999999987654 7899999
Q ss_pred ecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCcc
Q 040257 1050 FMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL 1128 (1254)
Q Consensus 1050 Ym~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~ 1128 (1254)
|+.+++|.+++.+.. ..+++..++.++.|++.||.|||++||+||||+|+||+++ .++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~----~~~~~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD----DHGNVRISDLGLAVELKGGK 149 (277)
T ss_pred cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEccCcchhhhccCC
Confidence 999999999886543 3689999999999999999999999999999999999998 67899999999987654333
Q ss_pred ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc--cCCCCCCCCCcHHHHH
Q 040257 1129 VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN--TLRPTIPERCDPEWRK 1206 (1254)
Q Consensus 1129 ~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~--~Lrp~ipe~iS~eLrd 1206 (1254)
......++..|+|||++.+.. ++.++||||||+++|+|++|+.||...........+... ......+..+++.+.+
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEV--YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKD 227 (277)
T ss_pred ccccccCCCCcCCHHHhcCCC--CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHH
Confidence 333455788999999998654 788999999999999999999999765432111112111 1233455667999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1207 LMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1207 LIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
+|.+||+.+|.+|| ++.+++++
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHhC
Confidence 99999999999999 77777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.43 Aligned_cols=243 Identities=30% Similarity=0.429 Sum_probs=199.4
Q ss_pred EeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEE
Q 040257 972 LGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTE 1049 (1254)
Q Consensus 972 LGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVME 1049 (1254)
||.|+||.||++++. ++.+++|++..... ......+.+.+|++++++++|+||+++++.+.... .++++||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-----IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK--NLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-----hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc--EEEEEEe
Confidence 689999999999985 78899999875421 12344567889999999999999999999887654 8999999
Q ss_pred ecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCcc-
Q 040257 1050 FMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL- 1128 (1254)
Q Consensus 1050 Ym~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~- 1128 (1254)
|+.+++|.+++.+. +.+++..++.++.||+.||.|||+.+|+|+||+|+||+++ .++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~----~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 74 YLPGGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID----SNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc----CCCCEEEEecccchhcccCcc
Confidence 99999999988654 3789999999999999999999999999999999999998 77899999999987533221
Q ss_pred --------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1129 --------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1129 --------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
......++..|++||.+.+.. ++.++||||||+++|+|++|..||...........+............+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQG--HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEV 226 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccC
Confidence 223345788999999987654 7889999999999999999999998887777666665544332222234
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+..+.+|+.+||+.+|.+||++..+.+.
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~ 254 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEEI 254 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence 8999999999999999999999444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=292.02 Aligned_cols=248 Identities=31% Similarity=0.557 Sum_probs=207.6
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|++|.||++++. ++.|++|.+...... ......+.+|++++++++|+|++++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK------EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-- 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC--
Confidence 4788899999999999999874 678999999765321 234567899999999999999999999987654
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.++++|||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++ ..+.+||+|||++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~d~~~~~ 147 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT----KDGVVKLADFGVAT 147 (254)
T ss_pred EEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC----CCCCEEEeccccce
Confidence 899999999999999988554 5789999999999999999999999999999999999998 67899999999987
Q ss_pred cccCccc-cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1123 IKRNTLV-SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1123 ~~~~s~~-sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
....... .....++..|+|||.+.+.. ++.++|||+||+++|+|++|+.||............... ..+..+..++
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 224 (254)
T cd06627 148 KLNDVSKDDASVVGTPYWMAPEVIEMSG--ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-DHPPLPEGIS 224 (254)
T ss_pred ecCCCcccccccccchhhcCHhhhcCCC--CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-CCCCCCCCCC
Confidence 5543322 23356888999999987654 788999999999999999999999876654444444332 2344566788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+.+++.+||..+|++||++.+++.+
T Consensus 225 ~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 225 PELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 999999999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=305.47 Aligned_cols=252 Identities=26% Similarity=0.308 Sum_probs=195.5
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn~ 1041 (1254)
+|++.+.||+|+||.||+|.+ +++.||||++..... .......+.+|+.+++.+. |+||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 75 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD------EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK 75 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc------ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC
Confidence 688999999999999999998 477899998865321 1122356778999999995 6999999998875432
Q ss_pred ---CceEEEEEecccCchhhhhhcc----CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCC-CCeE
Q 040257 1042 ---GTLATVTEFMVNGSLKHVLLKK----DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQ-RPIC 1113 (1254)
Q Consensus 1042 ---~~L~LVMEYm~GGSL~d~L~kr----e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~s-nG~V 1113 (1254)
..+++||||+.+ +|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||+++ . ++.+
T Consensus 76 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~----~~~~~~ 150 (295)
T cd07837 76 NGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD----KQKGLL 150 (295)
T ss_pred CCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe----cCCCeE
Confidence 237999999975 788877543 23589999999999999999999999999999999999998 4 7899
Q ss_pred EEEeccccccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC
Q 040257 1114 KVGDFGLSRIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L 1192 (1254)
||+|||+++..... .......+++.|+|||++.+.. .++.++||||||+++|+|++|..||...........+.....
T Consensus 151 kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 229 (295)
T cd07837 151 KIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST-HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229 (295)
T ss_pred EEeecccceecCCCccccCCcccccCCCChHHhhCCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999998754322 1112234688899999987542 478899999999999999999999987654443333221100
Q ss_pred ----------------------CC----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 ----------------------RP----TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 ----------------------rp----~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+ .....++.++.+||.+||..+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0113467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.75 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=194.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC--
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT-- 1040 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn-- 1040 (1254)
+|++++.||+|+||.||+++.. ++.||||++..... .......+.+|+.++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE------KEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC------cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 6999999999999999999984 77899999864321 1112334567999999999999999999876543
Q ss_pred ----CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1041 ----GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1041 ----~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
....++||||+. ++|...+......+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~ 161 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT----KDGILKLA 161 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC----CCCcEEEC
Confidence 235799999985 578887766655789999999999999999999999999999999999998 77899999
Q ss_pred eccccccccCcc-----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh--
Q 040257 1117 DFGLSRIKRNTL-----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK-- 1189 (1254)
Q Consensus 1117 DFGLAr~~~~s~-----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk-- 1189 (1254)
|||++....... ......++..|+|||.+.+.. .++.++||||||+++|+|++|+.||...........+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER-DYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCc-ccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999987543221 112345788899999987542 367899999999999999999999976654332221111
Q ss_pred ccCCC---------------CC-------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1190 NTLRP---------------TI-------------PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1190 ~~Lrp---------------~i-------------pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+...+ .. ....+..+.+||.+||..||.+||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 00 11135677899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=335.66 Aligned_cols=243 Identities=26% Similarity=0.336 Sum_probs=192.1
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
...|.+.+.||+|+||.||++.+. ++.||||.... ..+.+|+++|++|+|+||+++++++....
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------------ASSVHEARLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------------cCHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 447999999999999999999985 56799996431 23467999999999999999999987654
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
..++|||++ .++|..++......+++..++.|+.||+.||.|||++|||||||||+||||+ ..+.+||+|||+
T Consensus 234 --~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~----~~~~vkL~DFGl 306 (461)
T PHA03211 234 --LTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN----GPEDICLGDFGA 306 (461)
T ss_pred --EEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC----CCCCEEEcccCC
Confidence 789999998 5788888866666799999999999999999999999999999999999998 678899999999
Q ss_pred cccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------hhhHHHHhhh
Q 040257 1121 SRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH--------CGAIIGGIVK 1189 (1254)
Q Consensus 1121 Ar~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n--------~~eliqsIlk 1189 (1254)
++...... ......||..|+|||++.+.. ++.++|||||||+||||++|..++.... ...+...+..
T Consensus 307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~ 384 (461)
T PHA03211 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDP--YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQ 384 (461)
T ss_pred ceecccccccccccccCCCcCCcCHHHHcCCC--CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHh
Confidence 97543321 223456999999999998764 8899999999999999999876653221 1112211111
Q ss_pred ccC-------------------------CCCCC-------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1190 NTL-------------------------RPTIP-------ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1190 ~~L-------------------------rp~ip-------e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+ .+... ..++..+.+||.+||+.||.+|||+.|+|++
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 385 AQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 110 00000 1245578899999999999999999999986
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.01 Aligned_cols=250 Identities=26% Similarity=0.447 Sum_probs=194.6
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn~ 1041 (1254)
+|+..+.||+|+||.||++++. ++.||||.+..... ......+.+|+.++.++. |+||+++++++..+.
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~- 76 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-------EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG- 76 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC-------hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-
Confidence 5666778999999999999884 67899999875321 123456888999999996 999999999887654
Q ss_pred CceEEEEEecccCchhhh---hh-ccCCCCCHHHHHHHHHHhhhhhHHhhhC-CcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1042 GTLATVTEFMVNGSLKHV---LL-KKDRSLDRRKKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~---L~-kre~~LSe~~~lkIa~QIAeALaYLHSk-GIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
..+++|||+. ++|..+ +. .....+++..+..++.+++.||+|||+. +|+||||||+|||++ ..+.+||+
T Consensus 77 -~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~----~~~~~kl~ 150 (288)
T cd06616 77 -DCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD----RNGNIKLC 150 (288)
T ss_pred -cEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc----cCCcEEEe
Confidence 7789999975 454443 22 2235799999999999999999999974 999999999999998 67889999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-hHHHHhhhcc---
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHCG-AIIGGIVKNT--- 1191 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~-~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~-eliqsIlk~~--- 1191 (1254)
|||+++............|+..|+|||++.+.. ..++.++|||||||++|+|++|+.||...... ..+..+....
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd06616 151 DFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPI 230 (288)
T ss_pred ecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCc
Confidence 999987554443334456889999999987542 24788999999999999999999999765421 1222222211
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+....+..++.++.+||.+||.++|.+||++++++++
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112223478899999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=304.17 Aligned_cols=251 Identities=26% Similarity=0.331 Sum_probs=196.1
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|.+|+||+|+++ ++.||||++..... .....+.+.+|++++++++||||+++++++.+..
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 74 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE------DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-- 74 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc------cccchHHHHHHHHHHHhccCCCEeeEEEEEecCC--
Confidence 6899999999999999999874 67899998865321 1223456788999999999999999999998655
Q ss_pred ceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+. ++|...+.... ..+++..++.++.||+.||.|||+++|+||||||+||+++. .++.+||+|||++
T Consensus 75 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~---~~~~~kl~dfg~~ 150 (294)
T PLN00009 75 RLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RTNALKLADFGLA 150 (294)
T ss_pred eEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC---CCCEEEEcccccc
Confidence 8999999995 57777764433 33688888999999999999999999999999999999972 3457999999999
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC--------
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL-------- 1192 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L-------- 1192 (1254)
...... .......++..|+|||++.+.. .++.++|||||||++|+|++|+.||........+..+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (294)
T PLN00009 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSR-HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWP 229 (294)
T ss_pred cccCCCccccccCceeecccCHHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 754322 1122345788999999987642 478899999999999999999999987654443333221100
Q ss_pred ---------------CC----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 ---------------RP----TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 ---------------rp----~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.. .....+++.+.+++.+||+.+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0113467889999999999999999999999974
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=305.98 Aligned_cols=256 Identities=23% Similarity=0.408 Sum_probs=201.0
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVV 1036 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf 1036 (1254)
.+...+|++.+.||+|+||.||++++. ++.||||++++... ......+.+|+.++.++ .|+||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 83 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-------KEENKRILMDLDVVLKSHDCPYIVKCYGYF 83 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-------hHHHHHHHHHHHHHHhccCCCchHhhheee
Confidence 344567999999999999999999996 78899999975421 11234556677766665 599999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
.+.. .++++|||+ .++|...+......+++..+..++.||+.||.|||+ .+|+||||+|+||+++ .++.+||
T Consensus 84 ~~~~--~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~----~~~~~kL 156 (296)
T cd06618 84 ITDS--DVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD----ASGNVKL 156 (296)
T ss_pred ecCC--eEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc----CCCCEEE
Confidence 8765 799999998 457777765555679999999999999999999997 5999999999999998 7789999
Q ss_pred EeccccccccCccccCCCCCCCCccCcccccCCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hhHHHHhhhccC
Q 040257 1116 GDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSS--NRVSEKVDVFSFGISMWEILTGEEPYADMHC-GAIIGGIVKNTL 1192 (1254)
Q Consensus 1116 iDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~--~kyS~KSDIWSLGVILYELLTGk~PF~~~n~-~eliqsIlk~~L 1192 (1254)
+|||++.............++..|+|||.+.+.. ..++.++||||||+++|+|++|+.||..... .+.+..+.....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (296)
T cd06618 157 CDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP 236 (296)
T ss_pred CccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC
Confidence 9999987554433333345788999999997553 3478899999999999999999999976433 233333333221
Q ss_pred C-CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1193 R-PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1193 r-p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
. ......++.++.+|+.+||..+|.+||++.+++++-
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 1 112234688999999999999999999999998773
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.98 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=207.3
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn~ 1041 (1254)
+|.+.+.||+|+||.||+++. .++.||+|++.+.... .......+.+|+.+++++. |+||+++++++.+..
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~- 75 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-----KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE- 75 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-----chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc-
Confidence 689999999999999999998 4788999998764221 1223466788999999998 999999999987655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++.+. ..+++..++.++.|++.||.|||++|++|+||||+||+++ .++.++|+|||++
T Consensus 76 -~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~----~~~~~~l~df~~~ 149 (280)
T cd05581 76 -NLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD----KDMHIKITDFGTA 149 (280)
T ss_pred -eEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEecCCccc
Confidence 899999999999999998654 4699999999999999999999999999999999999998 7789999999998
Q ss_pred ccccCcc---------------------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 040257 1122 RIKRNTL---------------------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC 1180 (1254)
Q Consensus 1122 r~~~~s~---------------------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~ 1180 (1254)
....... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP--AGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC--CChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 7543221 122345788999999987653 78899999999999999999999988776
Q ss_pred hhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH----HHHHHH
Q 040257 1181 GAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSF----TEITSR 1228 (1254)
Q Consensus 1181 ~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSA----rELLe~ 1228 (1254)
......+... ....+..+++.+.+||.+||..+|.+||++ ++++++
T Consensus 228 ~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 YLTFQKILKL--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHHHhc--CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 5655555432 234566779999999999999999999999 887764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.65 Aligned_cols=244 Identities=24% Similarity=0.451 Sum_probs=198.7
Q ss_pred ceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
|.....||+|+||.||++.. ++..||||.+... .....+.+.+|+.+++.++|+||+++++.+.... .
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--~ 93 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--------KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD--E 93 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--------hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC--e
Confidence 33455799999999999987 4778999988643 1223466889999999999999999999987655 8
Q ss_pred eEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
.++||||+.+++|.+++.. ..+++..++.++.||+.||.|||+++|+||||||+||+++ .++.+||+|||++..
T Consensus 94 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~kL~dfg~~~~ 167 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT----SDGRIKLSDFGFCAQ 167 (292)
T ss_pred EEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEEEccCcchhh
Confidence 8999999999999988743 3588999999999999999999999999999999999998 678999999999864
Q ss_pred ccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC--CCCCC
Q 040257 1124 KRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT--IPERC 1200 (1254)
Q Consensus 1124 ~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~--ipe~i 1200 (1254)
.... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||........+..+.. ..... ....+
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 244 (292)
T cd06658 168 VSKEVPKRKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPPRVKDSHKV 244 (292)
T ss_pred cccccccCceeecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCcccccccc
Confidence 3222 122334688999999999765 378899999999999999999999987665544443322 12222 22346
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+..+.+++.+||..+|.+|||+++++++
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 8899999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=304.42 Aligned_cols=245 Identities=24% Similarity=0.472 Sum_probs=201.1
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|...+.||+|++|.||++.+ .++.+++|++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-- 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--------QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-- 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--------hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC--
Confidence 456667999999999999987 46779999886431 122356788999999999999999999987655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
..++++||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||+|+||+++ .++.++|+|||.+.
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~d~g~~~ 163 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT----SDGRVKLSDFGFCA 163 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc----CCCcEEEcccccch
Confidence 78999999999999998855 4689999999999999999999999999999999999998 77899999999876
Q ss_pred cccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC--CCC
Q 040257 1123 IKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI--PER 1199 (1254)
Q Consensus 1123 ~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i--pe~ 1199 (1254)
...... ......|+..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+.... .+.. +..
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 240 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPKLKNLHK 240 (285)
T ss_pred hhccCCcccccccCCccccCHHHhcCCC--CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCCCccccc
Confidence 433221 223345889999999998654 7889999999999999999999998766555555444332 1222 233
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++..+.+|+.+||..+|++||++.+++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 78899999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=304.57 Aligned_cols=253 Identities=27% Similarity=0.359 Sum_probs=198.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
.+|++.+.||+|+||.||+|.+. ++.||||+++.... .......+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE------KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc------ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 47889999999999999999984 67899999875421 1112345678999999999999999999886543
Q ss_pred -------CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1041 -------GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1041 -------~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
...+++|+||+.+ +|...+......+++..++.++.||+.||.|||+.+|+|+||||+||+++ .++.+
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~----~~~~~ 155 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN----NKGQI 155 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCcE
Confidence 3378999999975 67777765556799999999999999999999999999999999999998 78899
Q ss_pred EEEeccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc
Q 040257 1114 KVGDFGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT 1191 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~ 1191 (1254)
||+|||++....... ......++..|+|||.+.+.. .++.++|||||||++|+|++|+.||........+..+....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 999999987543322 112234677899999986542 36889999999999999999999998665444333322210
Q ss_pred CCC----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 LRP----------------------------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 Lrp----------------------------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+ .....++..+.+++.+||..+|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0112367899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=297.21 Aligned_cols=241 Identities=27% Similarity=0.396 Sum_probs=192.7
Q ss_pred EEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHH-HhcCCCCceeEEeeeeecCCCCceEE
Q 040257 970 RELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI-LSNLHHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeI-LkrLnHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+.||+|+||.||+|.+ .++.||||++.+.... .......+..|..+ ...++|+||+++++++...+ .+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-----AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD--YLYL 74 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-----HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC--eEEE
Confidence 4699999999999988 4678999998754211 11122334455444 45568999999999997654 8999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccC
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN 1126 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~ 1126 (1254)
||||+.+++|..++... ..+++..+..++.||+.||.|||+.+|+||||+|+||+++ ..+.+||+|||+++....
T Consensus 75 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 75 VMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID----QTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEeecccceeccc
Confidence 99999999999988543 5689999999999999999999999999999999999998 678899999999875433
Q ss_pred ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC--CCCCCCCCcHHH
Q 040257 1127 TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL--RPTIPERCDPEW 1204 (1254)
Q Consensus 1127 s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L--rp~ipe~iS~eL 1204 (1254)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...........+..... .......++..+
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVG--DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEA 224 (260)
T ss_pred ---cccCCCCcCccChhhhcCCC--CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHH
Confidence 23356889999999998764 78999999999999999999999988776666555544332 223344678999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 040257 1205 RKLMEQCWAADPEARPSFTEITS 1227 (1254)
Q Consensus 1205 rdLIkKCLqkDPeKRPSArELLe 1227 (1254)
.+++.+||..+|++||++.++.+
T Consensus 225 ~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 225 VDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred HHHHHHHccCCHHHccCCCcHHH
Confidence 99999999999999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=301.37 Aligned_cols=249 Identities=28% Similarity=0.360 Sum_probs=196.8
Q ss_pred ceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
|++++.||.|++|.||+|.+ .++.||+|++...... ......+.+|+.++++++||||+++++++.++. .
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~--~ 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED------EGVPSTAIREISLLKELNHPNIVRLLDVVHSEN--K 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc------ccchhHHHHHHHHHHhcCCCCccCHhheeccCC--e
Confidence 56788999999999999987 4788999998754211 122356778999999999999999999997654 8
Q ss_pred eEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++|||+ .++|..++.... ..+++..++.++.|++.||.|||+++++||||+|+||+++ .++.++|+|||++.
T Consensus 73 ~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df~~~~ 147 (283)
T cd07835 73 LYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID----REGALKLADFGLAR 147 (283)
T ss_pred EEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc----CCCcEEEeeccccc
Confidence 99999999 468988885543 3689999999999999999999999999999999999998 67899999999987
Q ss_pred cccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC---------
Q 040257 1123 IKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL--------- 1192 (1254)
Q Consensus 1123 ~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L--------- 1192 (1254)
...... ......++..|+|||++.+.. .++.++||||||+++|+|++|+.||........+..+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 148 AFGVPVRTYTHEVVTLWYRAPEILLGSR-QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred ccCCCccccCccccccCCCCCceeecCc-ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhh
Confidence 543221 112234688899999887542 368899999999999999999999986654333322221100
Q ss_pred ------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 ------------------RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 ------------------rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.......++..+.++|.+||+.+|.+||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 001124567889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=347.68 Aligned_cols=260 Identities=35% Similarity=0.616 Sum_probs=229.8
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--C---ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--G---SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--G---s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
+|......+.++||.|.||.|++|+++ + ..||||.+|... .++.+.+|+.|+.||-++.||||++|-|
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-------tekqrrdFL~EAsIMGQFdHPNIIrLEG 697 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-------TEKQRRDFLSEASIMGQFDHPNIIRLEG 697 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-------cHHHHhhhhhhhhhcccCCCCcEEEEEE
Confidence 455667788899999999999999984 3 359999998653 4566789999999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
+..... .+.||.|||++|+|..+|+++++.|...++.-+++.|+.|++||-++++|||||-.+|||++ ++..+|
T Consensus 698 VVTks~--PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN----snLvCK 771 (996)
T KOG0196|consen 698 VVTKSK--PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN----SNLVCK 771 (996)
T ss_pred EEecCc--eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec----cceEEE
Confidence 997654 78899999999999999999999999999999999999999999999999999999999999 899999
Q ss_pred EEeccccccccCccc----cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhh
Q 040257 1115 VGDFGLSRIKRNTLV----SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~~----sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk 1189 (1254)
++|||+++...+... +.+-.-..+|.|||.|.-. +++.++||||+|++|||.++ |..||+++.+.+++..+..
T Consensus 772 VsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~R--KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~ 849 (996)
T KOG0196|consen 772 VSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ 849 (996)
T ss_pred eccccceeecccCCCccccccCCccceeecChhHhhhc--ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh
Confidence 999999997644331 1111234689999999854 59999999999999999987 9999999999999988865
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
.++...|-+|+..+.+|+..||++|-.+||.+.||+..|++|+..
T Consensus 850 -gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 850 -GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred -ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 467777889999999999999999999999999999999999763
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=303.10 Aligned_cols=251 Identities=25% Similarity=0.425 Sum_probs=201.0
Q ss_pred CceEEEEEeeeCcEEEEEEEE-----CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeec
Q 040257 965 DLEELRELGSGTYGTVYHGKW-----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPD 1038 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~-----rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~D 1038 (1254)
.|++.+.||+|+||.||+++. ++..||+|+++..... ......+.+.+|+.+++++ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV----QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhh----hcchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 378889999999999999986 4678999998754211 1223346678899999999 59999999999876
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
+. .+++||||+.+++|.+++... ..+++..+..++.||+.||.|||+.+++||||||+|||++ .++.+||+||
T Consensus 77 ~~--~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~df 149 (290)
T cd05613 77 DT--KLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVVLTDF 149 (290)
T ss_pred CC--eEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC----CCCCEEEeeC
Confidence 54 789999999999999998654 5688999999999999999999999999999999999998 6789999999
Q ss_pred cccccccCc--cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh----hHHHHhhhccC
Q 040257 1119 GLSRIKRNT--LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG----AIIGGIVKNTL 1192 (1254)
Q Consensus 1119 GLAr~~~~s--~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~----eliqsIlk~~L 1192 (1254)
|++...... .......|+..|+|||.+.+....++.++||||||+++|+|++|..||...... .....+.. .
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~ 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK--S 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc--c
Confidence 998754332 122235688999999998764444678899999999999999999999643221 22222222 1
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
.+..+..+++.+.+|+.+||..+|.+|| ++++++++
T Consensus 228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 2345667889999999999999999997 78888875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=350.88 Aligned_cols=258 Identities=27% Similarity=0.389 Sum_probs=205.1
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|+++++||+|+||.||+|.+. ++.||||++..... ......+++.+|+.++++++||||+++++++.+..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-----~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~- 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-----ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD- 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-----cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-
Confidence 37999999999999999999884 77899999875321 12345677899999999999999999999997655
Q ss_pred CceEEEEEecccCchhhhhhcc----------CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCC
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKK----------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRP 1111 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kr----------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG 1111 (1254)
..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ ..+
T Consensus 76 -~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd----~dg 150 (932)
T PRK13184 76 -PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG----LFG 150 (932)
T ss_pred -EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc----CCC
Confidence 789999999999999988531 12356677889999999999999999999999999999998 778
Q ss_pred eEEEEeccccccccCc-------------------cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCC
Q 040257 1112 ICKVGDFGLSRIKRNT-------------------LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172 (1254)
Q Consensus 1112 ~VKLiDFGLAr~~~~s-------------------~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk 1172 (1254)
.+||+|||+++..... .......||+.|+|||++.+.. ++.++|||||||++|||+||+
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~--~S~kSDIWSLGVILyELLTG~ 228 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP--ASESTDIYALGVILYQMLTLS 228 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC--CCcHhHHHHHHHHHHHHHHCC
Confidence 8999999999754110 0112346999999999998764 789999999999999999999
Q ss_pred CCCCCCChhhHHHHh-hhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHH
Q 040257 1173 EPYADMHCGAIIGGI-VKNTLRPTIPERCDPEWRKLMEQCWAADPEARP-SFTEITSRLRTISA 1234 (1254)
Q Consensus 1173 ~PF~~~n~~eliqsI-lk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRP-SArELLe~Le~Ll~ 1234 (1254)
.||............ ............+++.+.+++.+||..||++|+ +++++++.|+.++.
T Consensus 229 ~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 229 FPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred CCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999875443322211 111111111235788999999999999999996 67888888887765
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=299.93 Aligned_cols=249 Identities=30% Similarity=0.393 Sum_probs=200.7
Q ss_pred ceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
|++.+.||+|++|.||++.+ .++.+++|+++.... .......+.+|+.++++++|+||+++++++.++. .
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~ 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE------SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG--D 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc------cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC--C
Confidence 56778999999999999987 477799999875422 1123467788999999999999999999987664 8
Q ss_pred eEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
+++||||+. ++|.+++..+...+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.+||+|||.+..
T Consensus 73 ~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df~~~~~ 147 (283)
T cd05118 73 LYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN----TEGVLKLADFGLARS 147 (283)
T ss_pred EEEEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC----CCCcEEEeeeeeeEe
Confidence 999999996 488888877667899999999999999999999999999999999999998 678999999999875
Q ss_pred ccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC---------
Q 040257 1124 KRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR--------- 1193 (1254)
Q Consensus 1124 ~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr--------- 1193 (1254)
..... ......++..|+|||.+.+. ..++.++||||||+++|+|++|+.||...+..+.+..+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 54432 22234578899999998765 24789999999999999999999999876654443332211000
Q ss_pred -------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 -------------------PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 -------------------p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
......++.++++||.+||++||.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00112467889999999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=302.56 Aligned_cols=248 Identities=31% Similarity=0.525 Sum_probs=205.8
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|+..+.||+|++|.||++.+. +..+++|++..... ..+.+.+|+++++.++|+||+++++++....
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 88 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------NKELIINEILIMKDCKHPNIVDYYDSYLVGD-- 88 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC--
Confidence 4777889999999999999985 77899999875321 3466788999999999999999999998764
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
..++|+||+.+++|.+++......+++..++.++.+++.||.|||+.||+|+||+|+||+++ .++.++|+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~----~~~~~~l~d~~~~~ 164 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS----KDGSVKLADFGFAA 164 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc----CCCCEEECccchhh
Confidence 89999999999999999976554799999999999999999999999999999999999998 77899999999876
Q ss_pred cccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC-CCCCCC
Q 040257 1123 IKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP-TIPERC 1200 (1254)
Q Consensus 1123 ~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp-~ipe~i 1200 (1254)
..... .......++..|++||.+.+.. ++.++|+||||+++|+|++|+.||...........+....... .....+
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd06614 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKD--YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW 242 (286)
T ss_pred hhccchhhhccccCCcccCCHhHhcCCC--CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhC
Confidence 43322 1122345788999999988654 7889999999999999999999998776655544444333222 122347
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
+..+.+||.+||+.+|.+||++.+++++-
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 88999999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=312.72 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=197.4
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.++++++|+||+++++++.....
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-------HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-------cchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence 4799999999999999999987 47789999986321 12234567889999999999999999998764432
Q ss_pred ---CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1042 ---GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1042 ---~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
..+++|+||+. ++|...+. ...+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+||
T Consensus 78 ~~~~~~~lv~e~~~-~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~----~~~~~kl~df 150 (336)
T cd07849 78 ESFNDVYIVQELME-TDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TNCDLKICDF 150 (336)
T ss_pred cccceEEEEehhcc-cCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCCEEECcc
Confidence 35799999985 57777763 34689999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh-----
Q 040257 1119 GLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK----- 1189 (1254)
Q Consensus 1119 GLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk----- 1189 (1254)
|++....... ......|+..|+|||.+.+. ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~ 229 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP 229 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9987543221 11234688999999987643 2478899999999999999999999976543222211110
Q ss_pred ----------c---------cCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 040257 1190 ----------N---------TLRPT-----IPERCDPEWRKLMEQCWAADPEARPSFTEITSR--LRTI 1232 (1254)
Q Consensus 1190 ----------~---------~Lrp~-----ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~--Le~L 1232 (1254)
. ..... .....+.++.+||.+||+.+|++||++.+++++ ++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0 00000 012356789999999999999999999999998 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.66 Aligned_cols=245 Identities=24% Similarity=0.435 Sum_probs=199.9
Q ss_pred ceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
|+....||+|+||.||++.. .++.||||++.... ....+.+.+|+.+++.++||||+++++++..+. .
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~ 92 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--------QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE--E 92 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--------cchHHHHHHHHHHHHhCCCCchhhhhhheeeCC--e
Confidence 44555799999999999987 47889999986431 112355788999999999999999999987655 7
Q ss_pred eEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
+++||||+.+++|..++.. ..+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++..
T Consensus 93 ~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~----~~~~~kL~dfg~~~~ 166 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT----LDGRVKLSDFGFCAQ 166 (297)
T ss_pred EEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc----cCCcEEEeechhHhh
Confidence 8999999999999987743 4689999999999999999999999999999999999998 778999999999864
Q ss_pred ccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-CCCCCCCCc
Q 040257 1124 KRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL-RPTIPERCD 1201 (1254)
Q Consensus 1124 ~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L-rp~ipe~iS 1201 (1254)
..... ......++..|+|||++.+.. ++.++|||||||++|||++|+.||...........+..... .......++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (297)
T cd06659 167 ISKDVPKRKSLVGTPYWMAPEVISRTP--YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKIS 244 (297)
T ss_pred cccccccccceecCccccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCC
Confidence 43221 223456899999999998653 78899999999999999999999987665554443332211 112234568
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+.++|.+||+.+|.+||++.+++++
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 899999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.00 Aligned_cols=243 Identities=23% Similarity=0.352 Sum_probs=189.9
Q ss_pred EEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHH---HHHhcCCCCceeEEeeeeecCCCCceE
Q 040257 971 ELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREA---HILSNLHHPNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEI---eILkrLnHPNIVkLyGvf~Ddn~~~L~ 1045 (1254)
.||+|+||.||++.+ +++.+|+|.+.+....... . ...+.+|. .++...+||||+.+++++.... ..+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--G---ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD--KLC 73 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccch--H---HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC--eEE
Confidence 389999999999987 4678999998764322111 1 12223343 3444457999999999987654 789
Q ss_pred EEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1046 TVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
+||||+.+++|.+++... +.+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++....
T Consensus 74 lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~----~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 74 FILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFS 148 (279)
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC----CCCCEEEccCCcceecc
Confidence 999999999999888544 5699999999999999999999999999999999999998 77899999999987543
Q ss_pred CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh--hHHHHhhhccCCCCCCCCCcHH
Q 040257 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG--AIIGGIVKNTLRPTIPERCDPE 1203 (1254)
Q Consensus 1126 ~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~--eliqsIlk~~Lrp~ipe~iS~e 1203 (1254)
... .....|+..|+|||.+... ..++.++|||||||++|+|++|..||...... ..+... ........+..++.+
T Consensus 149 ~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 225 (279)
T cd05633 149 KKK-PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPE 225 (279)
T ss_pred ccC-ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHH
Confidence 322 2334689999999998642 23788999999999999999999999754321 111111 122334566778999
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1204 WRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1204 LrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
++++|.+||..||.+|| ++++++++
T Consensus 226 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 226 LKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 99999999999999999 69999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=303.79 Aligned_cols=253 Identities=27% Similarity=0.360 Sum_probs=195.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||.||++++. ++.+|||++....... .....+.+|++++++++|+||+++++++.+...
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD------GFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC------CcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 47999999999999999999984 6789999987542111 112345689999999999999999998765432
Q ss_pred ------CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1042 ------GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1042 ------~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
..+++||||+. ++|...+......+++..++.++.||++||.|||++||+|+||||+|||++ .++.+||
T Consensus 82 ~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~----~~~~~~l 156 (311)
T cd07866 82 KSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID----NQGILKI 156 (311)
T ss_pred cccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEE
Confidence 35799999985 467776655556799999999999999999999999999999999999998 7889999
Q ss_pred EeccccccccCccc------------cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 040257 1116 GDFGLSRIKRNTLV------------SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAI 1183 (1254)
Q Consensus 1116 iDFGLAr~~~~s~~------------sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~el 1183 (1254)
+|||+++....... .....+++.|+|||.+.+.. .++.++|||||||++|+|++|+.||........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~ 235 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER-RYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCC-ccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999875332111 12234688899999987542 478899999999999999999999987655443
Q ss_pred HHHhhhccCC---------------------CCC-------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1184 IGGIVKNTLR---------------------PTI-------PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1184 iqsIlk~~Lr---------------------p~i-------pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
...+...... ... ...+.+.+.+||.+||..+|.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 3332211000 000 02244678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=342.67 Aligned_cols=250 Identities=25% Similarity=0.424 Sum_probs=213.2
Q ss_pred CceEEEEEeeeCcEEEEEEEECCc--eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWRGS--DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~rGs--~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
-|+++..||.|+||+||++..+.+ ..|-|+|... .++..++++-||+||..+.||+||+|++.|..++
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--------seEELEDylVEIeILa~CdHP~ivkLl~ayy~en-- 102 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--------SEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-- 102 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC--
Confidence 478899999999999999988643 3566777543 3445688999999999999999999999776555
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.++|+.|||.||-...++..-++.+.+.++..+++|++.||.|||+++|||||||..|||++ .+|.|+|+|||.+.
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T----ldGdirLADFGVSA 178 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT----LDGDIRLADFGVSA 178 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE----ecCcEeeecccccc
Confidence 79999999999999999998889999999999999999999999999999999999999999 78899999999875
Q ss_pred ccc-CccccCCCCCCCCccCcccccCCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC-CCCC
Q 040257 1123 IKR-NTLVSGGVRGTLPWMAPELLNGSS---NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR-PTIP 1197 (1254)
Q Consensus 1123 ~~~-~s~~sts~~GT~~YmAPEVLrG~~---~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr-p~ip 1197 (1254)
... .......+.||+.|||||+..... ..|+.++||||||++|.||..+.+|....+.-.++..+.+...+ ...|
T Consensus 179 Kn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP 258 (1187)
T KOG0579|consen 179 KNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP 258 (1187)
T ss_pred cchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc
Confidence 322 223346688999999999986532 24888999999999999999999999998887777777654332 2346
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..++..+.+|+++||.+||+.||++.+|++|
T Consensus 259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 7789999999999999999999999999865
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=307.67 Aligned_cols=251 Identities=28% Similarity=0.458 Sum_probs=204.0
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|+..+.||+|+||.||+|++ .+..+|+|.+...... ......++.+|+.+++.++|+|++++++++....
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 88 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-- 88 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-----ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--
Confidence 577788899999999999998 4667999988643111 1223456788999999999999999999987654
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
..++||||+. ++|.+.+......+++..++.++.|++.||.|||+++++||||||+|||++ .++.+||+|||++.
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~~ 163 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSAS 163 (308)
T ss_pred eeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC----CCCcEEECCcccce
Confidence 7889999995 688777765556789999999999999999999999999999999999998 67899999999987
Q ss_pred cccCccccCCCCCCCCccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGS-SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~-~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
..... ....++..|+|||.+.+. ...++.++|||||||++|+|++|+.||...........+............++
T Consensus 164 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (308)
T cd06634 164 IMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240 (308)
T ss_pred eecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCccccc
Confidence 54332 235688899999998532 22478899999999999999999999987765555544444433333345678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
..+++||++||..+|.+||++.+++++-.
T Consensus 241 ~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 89999999999999999999999987743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=298.06 Aligned_cols=250 Identities=29% Similarity=0.348 Sum_probs=196.1
Q ss_pred ceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC---CCCceeEEeeeeecCC
Q 040257 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL---HHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL---nHPNIVkLyGvf~Ddn 1040 (1254)
|++.+.||+|+||.||+++++ ++.||+|+++.... .......+.+|+.+++++ +|+||+++++++.+..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS------EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc------cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678899999999999999985 67899999975321 112234556677776655 6999999999987654
Q ss_pred C---CceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1041 G---GTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1041 ~---~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
. ..++++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+|+|+||+|+||+++ .++.+||+
T Consensus 75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~----~~~~~~l~ 149 (287)
T cd07838 75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT----SDGQVKIA 149 (287)
T ss_pred CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc----cCCCEEEe
Confidence 2 23899999996 57888775533 3589999999999999999999999999999999999998 67899999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC---
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR--- 1193 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr--- 1193 (1254)
|||++.............++..|+|||++.+.. ++.++|||||||++|+|++|+.||......+.+..+......
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 150 DFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS--YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE 227 (287)
T ss_pred ccCcceeccCCcccccccccccccChHHhccCC--CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCCh
Confidence 999987654433333445788999999998764 788999999999999999999999877665555444321100
Q ss_pred ---------------C-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 ---------------P-------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 ---------------p-------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
. .....++..+.+||.+||+.||.+||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 0011345778899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.11 Aligned_cols=248 Identities=27% Similarity=0.451 Sum_probs=202.8
Q ss_pred ceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
|...+.||+|+||+||+|++ .+..|++|++...... .......+.+|+.+++.++|||++++++++.+.. .
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-----TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH--T 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-----chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--E
Confidence 66677899999999999987 4778999998754211 2233456788999999999999999999998765 7
Q ss_pred eEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
.++||||+. ++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++ .++.+||+|||++..
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~----~~~~~kL~dfg~~~~ 170 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSASK 170 (313)
T ss_pred EEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC----CCCCEEEeecCCCcc
Confidence 899999995 677777766666799999999999999999999999999999999999998 678899999999864
Q ss_pred ccCccccCCCCCCCCccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcH
Q 040257 1124 KRNTLVSGGVRGTLPWMAPELLNGS-SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDP 1202 (1254)
Q Consensus 1124 ~~~s~~sts~~GT~~YmAPEVLrG~-~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~ 1202 (1254)
.. ......|+..|+|||++... ...++.++|||||||++|+|++|..||...+.......+............++.
T Consensus 171 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
T cd06633 171 SS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTD 247 (313)
T ss_pred cC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCH
Confidence 32 22345688999999998531 234788999999999999999999999887665555555444333333445678
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1203 EWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1203 eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+++|+.+||+.+|.+||++.+++.+
T Consensus 248 ~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 248 SFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=305.19 Aligned_cols=247 Identities=28% Similarity=0.448 Sum_probs=200.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||++.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++....
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~- 89 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--------QPKKELIINEILVMRENKHPNIVNYLDSYLVGD- 89 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--------chHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-
Confidence 4789999999999999999986 46789999885321 122456788999999999999999999997655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..++|+||+.+++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||||+||+++ .++.+||+|||++
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~----~~~~~kL~dfg~~ 162 (293)
T cd06647 90 -ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFC 162 (293)
T ss_pred -cEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc----CCCCEEEccCcce
Confidence 78999999999999998854 3578999999999999999999999999999999999998 6778999999987
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc-cCCCCCCCC
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN-TLRPTIPER 1199 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~-~Lrp~ipe~ 1199 (1254)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+....+..+... ......+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd06647 163 AQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240 (293)
T ss_pred ecccccccccccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccc
Confidence 643322 222334688899999998765 4788999999999999999999999876543333222211 111123345
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++..++++|.+||..+|++||++.+++.+
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 67889999999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=310.52 Aligned_cols=247 Identities=25% Similarity=0.412 Sum_probs=192.1
Q ss_pred EEeee--CcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEE
Q 040257 971 ELGSG--TYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 971 kLGeG--sFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
.||+| +||+||++++ .++.||||++..... .....+.+.+|+.+++.++||||++++++|..+. .+++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~~~ 76 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC------TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--WLWV 76 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccC------CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--ceEE
Confidence 46666 9999999988 578999999874321 1223467889999999999999999999998765 7899
Q ss_pred EEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1047 VTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
||||+.+++|.+++.+. ...+++..+..++.||+.||.|||+++|+||||||+|||++ ..+.+|++||+.+....
T Consensus 77 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~----~~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 77 ISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS----GDGLVSLSGLSHLYSLV 152 (328)
T ss_pred EEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe----CCCcEEEechHHHhhhh
Confidence 99999999999988653 24589999999999999999999999999999999999998 67899999998643211
Q ss_pred Cccc--------cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc------
Q 040257 1126 NTLV--------SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT------ 1191 (1254)
Q Consensus 1126 ~s~~--------sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~------ 1191 (1254)
.... .....++..|+|||++.+....++.++|||||||++|+|++|+.||................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD 232 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcc
Confidence 1000 11123456799999998765568899999999999999999999998765443332221110
Q ss_pred ---------------------------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1192 ---------------------------------------LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1192 ---------------------------------------Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
+.......++..+.+||++||+.||++|||+.+++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 01111233567899999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.83 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=201.9
Q ss_pred CceEEEEEeeeCcEEEEEEEE-----CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeec
Q 040257 965 DLEELRELGSGTYGTVYHGKW-----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPD 1038 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~-----rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~D 1038 (1254)
+|++.+.||+|++|.||++++ +++.||||++++... .......+.+.+|+.++.++ +||||+++++++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~----~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI----VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH----HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 478899999999999999875 356799999875421 11233456788999999999 59999999999876
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. .+++||||+.+++|..++... ..+++..++.++.|++.+|.|||+.+++||||||+||+++ .++.++|+||
T Consensus 77 ~~--~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df 149 (288)
T cd05583 77 DT--KLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD----SEGHVVLTDF 149 (288)
T ss_pred CC--EEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEEEC
Confidence 54 789999999999999988543 4689999999999999999999999999999999999998 6788999999
Q ss_pred cccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----hhHHHHhhhccC
Q 040257 1119 GLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC----GAIIGGIVKNTL 1192 (1254)
Q Consensus 1119 GLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~----~eliqsIlk~~L 1192 (1254)
|+++...... ......|+..|+|||.+.+.....+.++||||||+++|+|++|..||..... ......+.. .
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~ 227 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--S 227 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc--c
Confidence 9987543221 2223468899999999876543468899999999999999999999964322 122222222 2
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
....+..++..+.++|.+||+.+|++|||+.++.+.|+.
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 234566788999999999999999999998777665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=311.93 Aligned_cols=256 Identities=27% Similarity=0.353 Sum_probs=200.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|.+++.||+|+||+||++++ +++.||||.+..... .......+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD------NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc------ccchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 3799999999999999999987 477899999875321 11123456789999999999999999998864422
Q ss_pred ---CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1042 ---GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1042 ---~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
..+++||||+. ++|.+++.. .+.+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~----~~~~~kL~Df 152 (337)
T cd07858 79 EAFNDVYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDF 152 (337)
T ss_pred cccCcEEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEECcC
Confidence 35899999995 788887754 35699999999999999999999999999999999999998 6789999999
Q ss_pred cccccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh--------
Q 040257 1119 GLSRIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK-------- 1189 (1254)
Q Consensus 1119 GLAr~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk-------- 1189 (1254)
|++...... .......++..|+|||.+.... .++.++|||||||++|+|++|+.||...+.......+..
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLNCS-EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhcCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 999754332 2223446788999999987532 378899999999999999999999976543222211110
Q ss_pred ---------------cc---CC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 040257 1190 ---------------NT---LR---PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR--LRTI 1232 (1254)
Q Consensus 1190 ---------------~~---Lr---p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~--Le~L 1232 (1254)
.. .. ......+++++.+||++||+.+|++||++++++++ +..+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00 00 01123578889999999999999999999999998 6554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.97 Aligned_cols=248 Identities=28% Similarity=0.394 Sum_probs=196.5
Q ss_pred ceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCCCC
Q 040257 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn~~ 1042 (1254)
|++.+.||+|++|+||+|+.. ++.|+||++...... .......+|+..+++++ |+||+++++++.++.
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~-- 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-------WEECMNLREVKSLRKLNEHPNIVKLKEVFREND-- 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-------hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC--
Confidence 567889999999999999984 677999998754211 11123456899999999 999999999997744
Q ss_pred ceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..++||||+ +++|.+.+.... ..+++..++.++.|++.+|.|||+++|+|+||+|+||+++ .++.++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~----~~~~~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS----GPEVVKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc----CCCCEEEeecccc
Confidence 899999999 889988886553 4689999999999999999999999999999999999998 7889999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc-----------
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN----------- 1190 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~----------- 1190 (1254)
.............++..|+|||++.+.. .++.++|+||||+++|+|++|+.||...........+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 147 REIRSRPPYTDYVSTRWYRAPEILLRST-SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225 (283)
T ss_pred eeccCCCCcCCCCCcccccCceeeecCc-CcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh
Confidence 8655443334456888999999986532 4788999999999999999999999766544333222110
Q ss_pred ------cCCC-----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1191 ------TLRP-----------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1191 ------~Lrp-----------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.... ......+..+.+||.+||+.+|++||+++|++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000 0011236789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.87 Aligned_cols=255 Identities=18% Similarity=0.217 Sum_probs=185.2
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEECCc-----eEEEEEEeccccCCCchhHHHH------HHHHHHHHHHHhcCCCCce
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWRGS-----DVAIKRIKKSCFAGRSSEQERL------TKDFWREAHILSNLHHPNV 1029 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~rGs-----~VAIKvIkk~~~~~~~~e~ee~------~eqFlrEIeILkrLnHPNI 1029 (1254)
+...+|++.++||+|+||+||+|.+.+. .+|+|+..... .....+.. ......++..+..+.|++|
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~---~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN---ETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccC---CchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 4445899999999999999999998543 46666543221 11001100 1122334455667799999
Q ss_pred eEEeeeeecCCC--CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC
Q 040257 1030 VAFYGVVPDGTG--GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD 1107 (1254)
Q Consensus 1030 VkLyGvf~Ddn~--~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd 1107 (1254)
+++++++..... ...+++++++ ..++.+.+.. ...+++..++.++.||+.||.|||+++|+||||||+|||++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~--- 160 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD--- 160 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---
Confidence 999987654332 1345677775 3456555533 33467888999999999999999999999999999999998
Q ss_pred CCCCeEEEEeccccccccCc--------cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 040257 1108 PQRPICKVGDFGLSRIKRNT--------LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH 1179 (1254)
Q Consensus 1108 ~snG~VKLiDFGLAr~~~~s--------~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n 1179 (1254)
..+.+||+|||+++..... .......||+.|+|||++.+.. ++.++|||||||+||||++|+.||....
T Consensus 161 -~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~--~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 161 -GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC--VTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred -CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC--CCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 6778999999999754211 1122346999999999998764 8999999999999999999999998763
Q ss_pred h-hhHH--------HHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1180 C-GAII--------GGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1180 ~-~eli--------qsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
. ...+ ..+..... ....+++++.++++.||+.+|++||++.+|++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 238 HNGNLIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred cchHHHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 2 2211 11111111 2345688999999999999999999999999876
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=359.40 Aligned_cols=255 Identities=25% Similarity=0.343 Sum_probs=218.5
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
++..||+++++||+|+||.|.+++++ ++.||+|++.+-.+.. .....-|+.|-.+|...+.+.|+.++-.|+|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-----r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-----RAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-----chhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 45679999999999999999999985 5679999998743322 1224568889999999999999999999988
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
+. ++|+|||||+||+|...+.+.+ .+++..+++|+.+|+.||.-||+.|+|||||||+||||| ..||+||+||
T Consensus 147 ~~--~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld----~~GHikLADF 219 (1317)
T KOG0612|consen 147 ER--YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD----KSGHIKLADF 219 (1317)
T ss_pred cc--ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec----ccCcEeeccc
Confidence 76 9999999999999999997776 899999999999999999999999999999999999999 8999999999
Q ss_pred ccccccc--CccccCCCCCCCCccCcccccCC--C-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC
Q 040257 1119 GLSRIKR--NTLVSGGVRGTLPWMAPELLNGS--S-NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1119 GLAr~~~--~s~~sts~~GT~~YmAPEVLrG~--~-~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
|.|-... .........|||.|.+||+++.. . +.|+..+|||||||++|||+.|..||....-.+.+..|+...-.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 9886443 33345567799999999999632 2 46899999999999999999999999998888888888876444
Q ss_pred CCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 040257 1194 PTIP--ERCDPEWRKLMEQCWAADPEARPS---FTEITSR 1228 (1254)
Q Consensus 1194 p~ip--e~iS~eLrdLIkKCLqkDPeKRPS---ArELLe~ 1228 (1254)
..+| ..+|+++++||.++++. |+.|.. +.++-.|
T Consensus 300 l~FP~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 300 LSFPDETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNH 338 (1317)
T ss_pred cCCCcccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhC
Confidence 4455 56899999999999974 788877 8888766
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=305.52 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=194.1
Q ss_pred eEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEE
Q 040257 967 EELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 967 eiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
.+.+.+|.|+++.||+++.+++.||||++..... .....+.+.+|+.+++.++|+||+++++++.+.. ..++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~--~~~~ 76 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC------SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS--ELYV 76 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEecccc------chhHHHHHHHHHHHHHhcCCcchhhhhheeecCC--eEEE
Confidence 3444566667777777777889999999975421 1223567889999999999999999999998665 7899
Q ss_pred EEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1047 VTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
+|||+.+++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||.+....
T Consensus 77 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~----~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 77 VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS----GDGKVVLSGLRYSVSMI 152 (314)
T ss_pred EEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe----cCCceEEecCccceeec
Confidence 99999999999998653 34588999999999999999999999999999999999998 67899999999886432
Q ss_pred Cc--------cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC----
Q 040257 1126 NT--------LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR---- 1193 (1254)
Q Consensus 1126 ~s--------~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr---- 1193 (1254)
.. .......++..|+|||++.+....++.++|||||||++|||++|+.||..................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (314)
T cd08216 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLD 232 (314)
T ss_pred cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccc
Confidence 11 112234577889999999765445788999999999999999999999865543322211111000
Q ss_pred ----------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1194 ----------------------------PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1194 ----------------------------p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
......++.++.+|+.+||.+||++|||+++++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 001122346788999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.83 Aligned_cols=263 Identities=23% Similarity=0.335 Sum_probs=210.7
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf 1036 (1254)
-.|.+.+|++.+.||+|+|+.||+++. ++..||+|++.-.. .+..+..++|++..++++|||+++++++.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--------~~~~e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--------QEDIEEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--------hHHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence 357788999999999999999999986 57779999997542 22356778999999999999999999876
Q ss_pred ecC---CCCceEEEEEecccCchhhhhhcc---CCCCCHHHHHHHHHHhhhhhHHhhhCC--cccccCCCCceEeccCCC
Q 040257 1037 PDG---TGGTLATVTEFMVNGSLKHVLLKK---DRSLDRRKKLIIAMDAAFGMEYLHSKN--IVHFDLKCENLLVNLRDP 1108 (1254)
Q Consensus 1037 ~Dd---n~~~L~LVMEYm~GGSL~d~L~kr---e~~LSe~~~lkIa~QIAeALaYLHSkG--IIHRDLKPeNILLDsdd~ 1108 (1254)
..+ .....|+++.|...|+|.+.+... +..+++.+.++|+.+|++||++||+.. +.||||||.|||+.
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---- 163 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---- 163 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec----
Confidence 533 234689999999999999998543 346999999999999999999999998 99999999999998
Q ss_pred CCCeEEEEeccccccccCcc----------ccCCCCCCCCccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 040257 1109 QRPICKVGDFGLSRIKRNTL----------VSGGVRGTLPWMAPELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYAD 1177 (1254)
Q Consensus 1109 snG~VKLiDFGLAr~~~~s~----------~sts~~GT~~YmAPEVLrG~~-~kyS~KSDIWSLGVILYELLTGk~PF~~ 1177 (1254)
+.+.++|.|||.++...-.. .......|..|+|||.+.-+. ..++.++|||||||+||.|+.|..||..
T Consensus 164 ~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 164 DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 67899999999987432111 111224788999999997543 2478999999999999999999999964
Q ss_pred CCh--hhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1178 MHC--GAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1178 ~n~--~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
.-. ..+...+....+.......+++.+.+||++||+.||.+||++.+++.+++++.
T Consensus 244 ~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 244 IYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 221 11112222333333333458999999999999999999999999999999874
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.01 Aligned_cols=245 Identities=23% Similarity=0.338 Sum_probs=190.7
Q ss_pred EEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEE
Q 040257 971 ELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVT 1048 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVM 1048 (1254)
.||+|+||.||++.+ .++.||||.+.+....... ...........+.+++...||+|+++++++.+.. .+++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch--hHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC--EEEEEE
Confidence 389999999999987 4678999998765322111 1111111122334555668999999999997655 799999
Q ss_pred EecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCcc
Q 040257 1049 EFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL 1128 (1254)
Q Consensus 1049 EYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~ 1128 (1254)
||+.+++|..++.. ...+++..++.++.|++.||.|||+.+|+||||||+||+++ .++.+||+|||++......
T Consensus 77 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~----~~~~~kl~dfg~~~~~~~~- 150 (278)
T cd05606 77 DLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKK- 150 (278)
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC----CCCCEEEccCcCccccCcc-
Confidence 99999999988854 45699999999999999999999999999999999999998 6788999999998754332
Q ss_pred ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---hhHHHHhhhccCCCCCCCCCcHHHH
Q 040257 1129 VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC---GAIIGGIVKNTLRPTIPERCDPEWR 1205 (1254)
Q Consensus 1129 ~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~---~eliqsIlk~~Lrp~ipe~iS~eLr 1205 (1254)
......|+..|+|||++.+.. .++.++||||||+++|+|++|+.||..... ....... .......+..++.++.
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~ 227 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELR 227 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCC-CCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCCHHHH
Confidence 223456899999999987432 378899999999999999999999976532 2221111 1223455666789999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1206 KLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1206 dLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
+++.+||..+|.+|| ++.+++++
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 228 SLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 999999999999999 99999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.30 Aligned_cols=256 Identities=29% Similarity=0.366 Sum_probs=205.1
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC--
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT-- 1040 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn-- 1040 (1254)
+|++.+.||+|++|.||+|++. ++.||||++..... .....+.+.+|+.+++.++|+||+++++++.+..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD------DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc------cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 4788999999999999999984 67899999875421 1233467889999999999999999999987653
Q ss_pred -CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1041 -GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1041 -~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
...++++|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.++|+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~----~~~~~~L~dfg 148 (330)
T cd07834 75 DFNDVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN----SNCDLKICDFG 148 (330)
T ss_pred cccceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEcccC
Confidence 246899999996 5888887543 4799999999999999999999999999999999999998 67899999999
Q ss_pred ccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC-
Q 040257 1120 LSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP- 1194 (1254)
Q Consensus 1120 LAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp- 1194 (1254)
++....... ......++..|+|||++.+.. .++.++||||||+++|+|++|+.||......+.+..+....-.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 227 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS-RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeeccc-CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence 998654432 233445788999999998763 47899999999999999999999998776554444333211000
Q ss_pred ----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHHH
Q 040257 1195 ----------------------------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR--LRTIS 1233 (1254)
Q Consensus 1195 ----------------------------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~--Le~Ll 1233 (1254)
.....++..+.+||.+||+++|.+||++.+++++ ++.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0112357889999999999999999999999986 45443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=289.06 Aligned_cols=240 Identities=30% Similarity=0.432 Sum_probs=200.9
Q ss_pred EeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEE
Q 040257 972 LGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTE 1049 (1254)
Q Consensus 972 LGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVME 1049 (1254)
||+|+||.||++.+. ++.+|+|++.+.... .......+.+|+.++++++|+||+++++.+..+. .+++|||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII-----KRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE--KLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhc-----chHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC--eeEEEEe
Confidence 689999999999984 678999998765322 1224567888999999999999999999987654 8999999
Q ss_pred ecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCc-c
Q 040257 1050 FMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT-L 1128 (1254)
Q Consensus 1050 Ym~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s-~ 1128 (1254)
|+.+++|.+++... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++ ..+.++|+|||++...... .
T Consensus 74 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~----~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 74 YAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD----ADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc----CCCcEEEeecCcceecccCCC
Confidence 99999999998544 4689999999999999999999999999999999999998 6788999999998765433 2
Q ss_pred ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHH
Q 040257 1129 VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLM 1208 (1254)
Q Consensus 1129 ~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLI 1208 (1254)
......++..|++||.+.+.. ++.++|+||||+++|+|++|+.||...........+.. .....+...+..+.+|+
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~--~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i 224 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKG--YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLI 224 (250)
T ss_pred cccCCcCCccccChHHhCCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHH
Confidence 234456888999999998653 78899999999999999999999987766565555554 23456677789999999
Q ss_pred HHhhhcCCCCCCCH---HHHHH
Q 040257 1209 EQCWAADPEARPSF---TEITS 1227 (1254)
Q Consensus 1209 kKCLqkDPeKRPSA---rELLe 1227 (1254)
++||..||++||++ +++++
T Consensus 225 ~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 225 SGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHhcCCHhhCCCcccHHHHHh
Confidence 99999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=337.31 Aligned_cols=249 Identities=29% Similarity=0.476 Sum_probs=211.9
Q ss_pred ceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
|.-++.||.|+||.||.+++ +...||||++.... . ...+-..+++.|+..|++++|||++.+-|||..+. .
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySG---K--Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--T 100 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG---K--QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--T 100 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccc---c--ccHHHHHHHHHHHHHHHhccCCCcccccceeeccc--h
Confidence 55667899999999999987 45679999986442 1 12334678899999999999999999999998766 7
Q ss_pred eEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
.++||||| -||-.+++.-..+++-+..+..|+.+.+.||.|||+++.||||||..||||+ +.|.|||+|||.+.+
T Consensus 101 aWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs----e~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 101 AWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS----EPGLVKLADFGSASI 175 (948)
T ss_pred HHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec----CCCeeeeccccchhh
Confidence 78899999 6777777766667899999999999999999999999999999999999999 889999999999976
Q ss_pred ccCccccCCCCCCCCccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcH
Q 040257 1124 KRNTLVSGGVRGTLPWMAPELLNGS-SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDP 1202 (1254)
Q Consensus 1124 ~~~s~~sts~~GT~~YmAPEVLrG~-~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~ 1202 (1254)
... .+.|.||+.|||||++... .+.|+-++||||||++..||...++|+..++.-..+.-|..+.-+......++.
T Consensus 176 ~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~ 252 (948)
T KOG0577|consen 176 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD 252 (948)
T ss_pred cCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHH
Confidence 543 3558899999999998643 235899999999999999999999999999877777777666554444567889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1203 EWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1203 eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
.|++|+..||++-|.+|||..+++.+-
T Consensus 253 ~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 253 YFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred HHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 999999999999999999999998764
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=293.26 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=200.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|.+.+.||+|+||.||++++. +..+++|+++........ .....++.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN---PNETVQANQEAQLLSKLDHPAIVKFHASFLERD-- 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccC---cchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--
Confidence 4788899999999999999885 344677776643221111 111234667899999999999999999987655
Q ss_pred ceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1043 TLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
..++||||+.+++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++ . +.+||+|||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~-~~~~l~d~g 150 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----N-NLLKIGDFG 150 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----c-CCEeecccC
Confidence 78999999999999988753 345689999999999999999999999999999999999997 2 469999999
Q ss_pred ccccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCC
Q 040257 1120 LSRIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1120 LAr~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe 1198 (1254)
++..... ........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+... ..+..+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 227 (260)
T cd08222 151 VSRLLMGSCDLATTFTGTPYYMSPEALKHQG--YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-PTPSLPE 227 (260)
T ss_pred ceeecCCCcccccCCCCCcCccCHHHHccCC--CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCCcc
Confidence 9875432 22233456888999999987653 788899999999999999999999876665555554433 3344566
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++.++.++|.+||..+|++||++.+++++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred hhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.91 Aligned_cols=250 Identities=27% Similarity=0.384 Sum_probs=197.5
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~ 1041 (1254)
+|++.+.||+|+||.||+|.+. ++.+|||++..... .......+.+|+.+++++ +||||++++++|.....
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~------~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR------NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC------cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 6888899999999999999874 67899998864311 111234567899999999 99999999999876655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..+++||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~----~~~~~kl~d~g~~ 154 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN----SDCRVKLADFGLA 154 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEEeeccch
Confidence 67899999996 5888887543 688999999999999999999999999999999999998 7889999999998
Q ss_pred ccccCc------cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc----
Q 040257 1122 RIKRNT------LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT---- 1191 (1254)
Q Consensus 1122 r~~~~s------~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~---- 1191 (1254)
...... .......|+..|+|||++.+.. .++.++||||||+++|+|++|+.||...........+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccc-cccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 744321 1223346889999999886532 46889999999999999999999997654433222211110
Q ss_pred -----------------------CC--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 -----------------------LR--PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 -----------------------Lr--p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.. ......++.++.+||.+||+.+|.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 01112368899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.77 Aligned_cols=253 Identities=26% Similarity=0.368 Sum_probs=198.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC--
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG-- 1039 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd-- 1039 (1254)
.+|++.+.||+|+||.||++.. +++.||+|++..... .......+.+|+.+|++++||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD------VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc------cccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 4789999999999999999987 477899999875321 112345677899999999999999999987643
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~dfg 152 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN----EDCELRIGDFG 152 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEecccc
Confidence 2347899999995 6888887543 5599999999999999999999999999999999999998 78899999999
Q ss_pred ccccccCcc-----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc----
Q 040257 1120 LSRIKRNTL-----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN---- 1190 (1254)
Q Consensus 1120 LAr~~~~s~-----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~---- 1190 (1254)
++....... ......++..|+|||++.+.. .++.++|||||||++|+|++|+.||........+..+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~ 231 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP-EYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCc-ccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC
Confidence 987543221 112346889999999986532 4788999999999999999999999766543222211110
Q ss_pred ------------------cCC--CC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1191 ------------------TLR--PT-----IPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1191 ------------------~Lr--p~-----ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
... .. .....+.++.++|++||+.+|++||++.+++.+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 000 00 1134678999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.96 Aligned_cols=250 Identities=24% Similarity=0.453 Sum_probs=207.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn 1040 (1254)
.+++.+..||.|+.|+||+++++ +..+|||.+.+.. +.+..++++..+.++... ..|+||+.+|+|..+.
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-------Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-------NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-------CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 46677888999999999999986 4779999998652 334457788888876655 4999999999998766
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
..++.||.| ...+..++..-.+++++..+-++..-++.||.||.+ ++|||||+||+|||+| ..|++||||||
T Consensus 165 --dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD----e~GniKlCDFG 237 (391)
T KOG0983|consen 165 --DVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGNIKLCDFG 237 (391)
T ss_pred --hHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc----cCCCEEeeccc
Confidence 677789987 455566665556789999999999999999999986 5999999999999999 88999999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hhHHHHhhhccCCCCCC
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGS-SNRVSEKVDVFSFGISMWEILTGEEPYADMHC-GAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~-~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~-~eliqsIlk~~Lrp~ip 1197 (1254)
++....++...+...|.+.|||||.+.-. ..+|+.++||||||++|+||.||+.||.+.+. -+.+..++. ..++.++
T Consensus 238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~ 316 (391)
T KOG0983|consen 238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLP 316 (391)
T ss_pred ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCC
Confidence 99887777777777899999999999754 34689999999999999999999999988543 345555555 3445554
Q ss_pred --CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 --ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 --e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+++.+++|+..||.+|+.+||.+.+|+++
T Consensus 317 ~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 3489999999999999999999999999875
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=333.53 Aligned_cols=249 Identities=28% Similarity=0.479 Sum_probs=220.3
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
-|.+++.||+|.|++|.++++ ++..||||.+.+.... ......+.+|+++|+.|+|||||+++.+...+.
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln------~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~-- 128 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN------PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA-- 128 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC------hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc--
Confidence 588999999999999999998 5888999999876532 233455889999999999999999999987554
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+|+||||+.+|.+.+++.+.++ ..+..+..++.|+..|++|||+++|||||||.+||||+ .+.++||+|||++.
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~----~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD----ENMNIKIADFGFST 203 (596)
T ss_pred eeEEEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc----cccceeeeccccce
Confidence 89999999999999999977655 55689999999999999999999999999999999999 77789999999999
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcH
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDP 1202 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~ 1202 (1254)
+........++||++.|.|||++.|..| .++.+|+||||++||-|+.|..||++....++....+.+.++ ++.-++.
T Consensus 204 ~~~~~~~lqt~cgsppyAaPEl~~g~~y-~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r--Ip~~ms~ 280 (596)
T KOG0586|consen 204 FFDYGLMLQTFCGSPPYAAPELFNGKKY-DGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR--IPFYMSC 280 (596)
T ss_pred eecccccccccCCCCCccChHhhcCccc-CCcceehhhhhhhheeeeecccccCCcccccccchheeeeec--ccceeec
Confidence 8888888888999999999999999874 578999999999999999999999988877777777776665 4555677
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1203 EWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1203 eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
+..++|+++|-++|.+|++++++-.+-
T Consensus 281 dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 281 DCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred hhHHHHHHhhccCccccCCHHHhhhhc
Confidence 899999999999999999999987654
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=303.95 Aligned_cols=255 Identities=27% Similarity=0.345 Sum_probs=196.4
Q ss_pred CceE-EEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchh------HHHHHHHHHHHHHHHhcCCCCceeEEeee
Q 040257 965 DLEE-LRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSE------QERLTKDFWREAHILSNLHHPNVVAFYGV 1035 (1254)
Q Consensus 965 dYei-LkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e------~ee~~eqFlrEIeILkrLnHPNIVkLyGv 1035 (1254)
+|.. .+.||.|+||+||++.+ .++.||||+++.......... .......+.+|+.++++++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 4544 46799999999999987 477899999875432210000 00112356789999999999999999999
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
+.... ..++||||+. ++|.+++.. ...+++...+.++.||+.||.|||++||+|+||||+||+++ ..+.+||
T Consensus 89 ~~~~~--~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~----~~~~~kl 160 (335)
T PTZ00024 89 YVEGD--FINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN----SKGICKI 160 (335)
T ss_pred EecCC--cEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC----CCCCEEE
Confidence 97655 8999999996 688888744 45689999999999999999999999999999999999998 6789999
Q ss_pred EeccccccccC---------------ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 040257 1116 GDFGLSRIKRN---------------TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC 1180 (1254)
Q Consensus 1116 iDFGLAr~~~~---------------s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~ 1180 (1254)
+|||++..... ........++..|+|||.+.+.. .++.++|||||||++|+|++|+.||.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999875431 11112234678899999997643 468899999999999999999999987766
Q ss_pred hhHHHHhhhccCCC--------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1181 GAIIGGIVKNTLRP--------------------------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1181 ~eliqsIlk~~Lrp--------------------------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
...+..+......+ ......+.++.++|.+||+.+|++||++.+++.+
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 55444332210000 0112347789999999999999999999999975
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=337.15 Aligned_cols=248 Identities=31% Similarity=0.515 Sum_probs=210.8
Q ss_pred EEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceE
Q 040257 968 ELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~ 1045 (1254)
.-.+||+|+|-+||+|.+. |-.||--.++...+. ......++|..|+++|+.|+||||+++|.+|.+.....+.
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~----q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVT----QSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhh----cChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 3457999999999999885 444554444322222 1344468899999999999999999999999988878899
Q ss_pred EEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC--CcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1046 TVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK--NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk--GIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
+|.|.+..|+|..++++. +..+.+.+..|++||++||.|||++ -|||||||-+||+|+ ...|.|||+|+|||..
T Consensus 120 ~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin---G~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN---GNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc---CCcCceeecchhHHHH
Confidence 999999999999999655 5689999999999999999999998 599999999999998 4678999999999998
Q ss_pred ccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChhhHHHHhhhccCCCCCCCCCcH
Q 040257 1124 KRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD-MHCGAIIGGIVKNTLRPTIPERCDP 1202 (1254)
Q Consensus 1124 ~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~-~n~~eliqsIlk~~Lrp~ipe~iS~ 1202 (1254)
.+...... ..|||.|||||++... |...+||||||++|+||+|+..||.. .+..++++++..+..+..+..--++
T Consensus 196 ~r~s~aks-vIGTPEFMAPEmYEE~---YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 196 LRKSHAKS-VIGTPEFMAPEMYEEN---YNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred hhccccce-eccCccccChHHHhhh---cchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence 87776655 6799999999999844 89999999999999999999999976 4566777777777665555566689
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1203 EWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1203 eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++++||.+||.. ..+|||+.|||.+
T Consensus 272 evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 272 EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 999999999999 9999999999974
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=329.78 Aligned_cols=255 Identities=34% Similarity=0.611 Sum_probs=219.7
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC----Cc--eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeee
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR----GS--DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r----Gs--~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf 1036 (1254)
...+...+.||.|-||.||+|... |. .||||.-+..+.. ...+.|+.|..+++.++||||++|+|+|
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-------d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-------DDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-------hhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 334455678999999999999873 22 3899988876422 2367899999999999999999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.+. ..+||||.+..|.|..+++.+...++......++.||+.||.|||+..+|||||-.+|||+. +..-|||+
T Consensus 461 ~e~---P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs----Sp~CVKLa 533 (974)
T KOG4257|consen 461 VEQ---PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS----SPQCVKLA 533 (974)
T ss_pred ecc---ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec----Ccceeeec
Confidence 765 58999999999999999988888899999999999999999999999999999999999998 67789999
Q ss_pred eccccccccCccccCCCC--CCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCC
Q 040257 1117 DFGLSRIKRNTLVSGGVR--GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~--GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
|||+++............ -..-|||||.+.-. +++.++|||.|||+|||++. |..||.+..+.+++..+.++ -+
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfR--rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG-eR 610 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFR--RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG-ER 610 (974)
T ss_pred ccchhhhccccchhhccccccceeecCccccchh--cccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC-CC
Confidence 999999766544322222 34569999999744 59999999999999999987 99999999888888776655 45
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
...|..|++.+..|+.+||..+|.+||.+.+|...|.+++.
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 67899999999999999999999999999999999998877
|
|
| >cd06410 PB1_UP2 Uncharacterized protein 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=274.00 Aligned_cols=95 Identities=62% Similarity=1.044 Sum_probs=91.4
Q ss_pred EeecCCccccCCCCCCceeecCceEEEeccCCCChHHHHHHHHhhcCCCc--eEEEecCCCCcCcEEeecChHHHHHHHH
Q 040257 186 LCSFGGKILPRPSDGKLRYVGGETRIISLRTNLSWEELVKKTSNICNQPH--LIKYQLPGEDLDALISVSSDDDLQNMID 263 (1254)
Q Consensus 186 mcSyGG~I~pr~~d~~l~YvGG~triv~V~r~~~f~~l~~kl~~~~~~~~--~lkYqLP~edLD~LiSVt~DeDL~~m~~ 263 (1254)
||||||||+|||+||+|+|+||+|||++|+|++||+||+.||+++++... +||||||+||||+||||++||||+|||+
T Consensus 1 ~cs~GG~i~pr~~dg~l~Y~GG~tr~i~V~r~~s~~el~~kl~~~~~~~~~~~lky~Lp~edld~Lisv~~DeDl~~M~~ 80 (97)
T cd06410 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPDEDLDALISVSNDEDLKNMME 80 (97)
T ss_pred CcccCCEEeCcCCCCCEEEcCCceEEEEEcCCCCHHHHHHHHHHHhCCCCceEEEEEcCCCCcceeEEecCcHHHHHHHH
Confidence 79999999999999999999999999999999999999999999998875 8999999999999999999999999999
Q ss_pred HhhcccccCCCceEEEEEe
Q 040257 264 EYCGLERLEGSQRLRLFLI 282 (1254)
Q Consensus 264 Eydr~~~~~~~~rlR~FLF 282 (1254)
||+|+ ...++|+|||||
T Consensus 81 e~~~~--~~~~~rirvflf 97 (97)
T cd06410 81 EYDRL--SGGSARLRVFLF 97 (97)
T ss_pred hhccc--cCCCceEEEEEC
Confidence 99998 456789999998
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=305.06 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=199.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||.||++.+ .++.||||++.+.. ........+.+|+.++++++||||+++++++.....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF------QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 3799999999999999999987 47789999986432 122334567899999999999999999998865432
Q ss_pred ----CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1042 ----GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1042 ----~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
..+++||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~----~~~~~kl~d 161 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN----EDCELKILD 161 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEee
Confidence 2468999998 7788887743 4689999999999999999999999999999999999998 678899999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC----
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR---- 1193 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr---- 1193 (1254)
||++...... .....++..|+|||.+.+.. .++.++||||||+++|+|++|+.||...........+......
T Consensus 162 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 162 FGLARQTDSE--MTGYVVTRWYRAPEVILNWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccccC--ccccccCCcccCHHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9998754332 22346789999999987532 3788999999999999999999999876544333322211000
Q ss_pred -------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 -------------------------PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 -------------------------p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
......++..+.++|.+||..||.+||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01123567889999999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=329.20 Aligned_cols=256 Identities=19% Similarity=0.279 Sum_probs=183.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEECC---ceEEEEEEecc---------ccCCCchhHHHHHHHHHHHHHHHhcCCCCceeE
Q 040257 964 VDLEELRELGSGTYGTVYHGKWRG---SDVAIKRIKKS---------CFAGRSSEQERLTKDFWREAHILSNLHHPNVVA 1031 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~rG---s~VAIKvIkk~---------~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVk 1031 (1254)
.+|+++++||+|+||+||+|.++. ..+++|.+... .+.............+.+|+.+|++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 379999999999999999987642 12222211100 000001112234566889999999999999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhcc----CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK----DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD 1107 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kr----e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd 1107 (1254)
+++++.+.. ..++|++++ .++|..++... ........++.|+.||+.||.|||++|||||||||+||||+
T Consensus 228 l~~~~~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~--- 301 (501)
T PHA03210 228 IEEILRSEA--NTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN--- 301 (501)
T ss_pred EeEEEEECC--eeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---
Confidence 999998765 788999998 45666665332 12234667788999999999999999999999999999998
Q ss_pred CCCCeEEEEeccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCC--hhh
Q 040257 1108 PQRPICKVGDFGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEP-YADMH--CGA 1182 (1254)
Q Consensus 1108 ~snG~VKLiDFGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~P-F~~~n--~~e 1182 (1254)
.++.+||+|||+++...... ......||..|+|||++.+.. ++.++|||||||+||||++|..+ |.... ...
T Consensus 302 -~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 302 -CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG--YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred -CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC--CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 77899999999997654322 223467999999999998764 88999999999999999998764 43221 111
Q ss_pred HHHHhhhc------cCC---------------C----C-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1183 IIGGIVKN------TLR---------------P----T-----IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1183 liqsIlk~------~Lr---------------p----~-----ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+..+... .+. . . ....++..+.++|.+||++||.+|||+.|++++
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111110 000 0 0 011245677888999999999999999999975
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=323.16 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=209.6
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf 1036 (1254)
+.+....|..-++||+|+||.||-++. +|+-||.|.+.+..+..+. -..-.++|..||.+++.++||.+--.|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~-----ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRK-----GETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhh-----hhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 456667899999999999999997665 6888999998776543222 223457899999999999999997666
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
.. ...+|+||..|.||+|..+|...+ ..|++..++.++.+|+.||++||+.+||+|||||+||||| +.|+|+|
T Consensus 255 eT--kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD----d~GhvRI 328 (591)
T KOG0986|consen 255 ET--KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD----DHGHVRI 328 (591)
T ss_pred cC--CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec----cCCCeEe
Confidence 54 448999999999999999886654 4599999999999999999999999999999999999999 8999999
Q ss_pred EeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc--cCC
Q 040257 1116 GDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN--TLR 1193 (1254)
Q Consensus 1116 iDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~--~Lr 1193 (1254)
+|+|+|.............||.+|||||++.+.. |+...|||||||+||||+.|+.||...........+... ...
T Consensus 329 SDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~--Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~ 406 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV--YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP 406 (591)
T ss_pred eccceEEecCCCCccccccCcccccCHHHHcCCc--ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch
Confidence 9999999877766666678999999999999875 788899999999999999999999865443322222221 123
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFT 1223 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSAr 1223 (1254)
..+++.+++++++|.+.+|++||.+|...+
T Consensus 407 ~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 407 EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 457788999999999999999999997543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=306.15 Aligned_cols=250 Identities=28% Similarity=0.387 Sum_probs=195.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||.|+||.||+|..+ ++.||+|++..... ...+.+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--------chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 47999999999999999999884 67899999865421 224567789999999999999999987654322
Q ss_pred ------------CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCC
Q 040257 1042 ------------GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQ 1109 (1254)
Q Consensus 1042 ------------~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~s 1109 (1254)
..+++||||+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. .
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~---~ 150 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT---E 150 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC---C
Confidence 25789999996 588877743 46899999999999999999999999999999999999972 4
Q ss_pred CCeEEEEeccccccccCccc----cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 040257 1110 RPICKVGDFGLSRIKRNTLV----SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIG 1185 (1254)
Q Consensus 1110 nG~VKLiDFGLAr~~~~s~~----sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliq 1185 (1254)
++.+||+|||+++....... .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||..........
T Consensus 151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred CceEEECCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 56789999999875432211 1223478899999987643 247889999999999999999999997665433333
Q ss_pred Hhhhc-----------------------cCCC-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1186 GIVKN-----------------------TLRP-----TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1186 sIlk~-----------------------~Lrp-----~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+... .... .....++.++.+||.+||+.||++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 22211 0000 0112467889999999999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=326.58 Aligned_cols=259 Identities=36% Similarity=0.640 Sum_probs=224.4
Q ss_pred cccccccCceEEEEEeeeCcEEEEEEEECC--ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeee
Q 040257 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRG--SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGV 1035 (1254)
Q Consensus 958 lq~Ik~~dYeiLkkLGeGsFGtVYlAk~rG--s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGv 1035 (1254)
.|.+...++.+-++||-|.||.||.|.|+. ..||||.++.. ....++|+.|+.+|+.++|||+|+|+|+
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---------tMeveEFLkEAAvMKeikHpNLVqLLGV 331 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---------TMEVEEFLKEAAVMKEIKHPNLVQLLGV 331 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---------chhHHHHHHHHHHHHhhcCccHHHHhhh
Confidence 345666788888999999999999999973 45999998853 2236789999999999999999999999
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccCC-CCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKDR-SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre~-~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
|..+. .+|||.|||..|+|.+++.+.++ .++.-..+.++.||..|++||..+++|||||-..|+|+. ++..||
T Consensus 332 CT~Ep--PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg----EnhiVK 405 (1157)
T KOG4278|consen 332 CTHEP--PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHIVK 405 (1157)
T ss_pred hccCC--CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc----ccceEE
Confidence 98765 79999999999999999976554 367778889999999999999999999999999999998 888999
Q ss_pred EEeccccccccCcccc--CCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhcc
Q 040257 1115 VGDFGLSRIKRNTLVS--GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNT 1191 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~~s--ts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~ 1191 (1254)
|+|||++++....+.+ .+.....-|.|||-+.- +.++.|+|||+|||+|||+.| |-.||.+.+...++. ++...
T Consensus 406 vADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~-LLEkg 482 (1157)
T KOG4278|consen 406 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG-LLEKG 482 (1157)
T ss_pred eeccchhhhhcCCceecccCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH-HHhcc
Confidence 9999999987665433 33445678999999974 358999999999999999998 999999988766654 55667
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1192 Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
++...|+.|++.+.+|++.||+|.|.+||++.|+-+.++.++.
T Consensus 483 yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 483 YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 8888999999999999999999999999999999999988764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=311.01 Aligned_cols=246 Identities=22% Similarity=0.372 Sum_probs=203.5
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVV 1036 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf 1036 (1254)
.+.-.+|+++++||+|+|++|.+++++ .+.||+|++++..+... +...-...|..+..+. +||++|.++.+|
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd-----edidwvqtek~vfe~asn~pflvglhscf 320 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD-----EDIDWVQTEKHVFEQASNNPFLVGLHSCF 320 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc-----ccchhHHhhHHHHHhccCCCeEEehhhhh
Confidence 344458999999999999999999885 45699999998755432 1234455677777665 799999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
+.+. ++++|.||++||+|...++ +.+++++++++.+..+|+.||.|||++|||+||||.+|+||+ ..|++||+
T Consensus 321 qtes--rlffvieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld----aeghiklt 393 (593)
T KOG0695|consen 321 QTES--RLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD----AEGHIKLT 393 (593)
T ss_pred cccc--eEEEEEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc----cCCceeec
Confidence 7665 8999999999999999884 557899999999999999999999999999999999999999 89999999
Q ss_pred ecccccccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-------Chhh-HHHHh
Q 040257 1117 DFGLSRIKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADM-------HCGA-IIGGI 1187 (1254)
Q Consensus 1117 DFGLAr~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~-------n~~e-liqsI 1187 (1254)
|+|+++..- ....+.++|||+.|.|||+++|.. |.+.+|||+||++|+||+.|+.||+-. +..+ +.+-+
T Consensus 394 dygmcke~l~~gd~tstfcgtpnyiapeilrgee--ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi 471 (593)
T KOG0695|consen 394 DYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE--YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI 471 (593)
T ss_pred ccchhhcCCCCCcccccccCCCcccchhhhcccc--cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH
Confidence 999998543 334567799999999999999885 777899999999999999999999631 2222 33444
Q ss_pred hhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 040257 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPS 1221 (1254)
Q Consensus 1188 lk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPS 1221 (1254)
+... ..+|..++-....+++..|.+||.+|..
T Consensus 472 lekq--iriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 472 LEKQ--IRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred hhhc--ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 4443 3467777888889999999999999953
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=291.52 Aligned_cols=249 Identities=32% Similarity=0.414 Sum_probs=198.8
Q ss_pred ceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
|+..+.||+|.+|.||+|+.. ++.||+|++..... .....+.+.+|+.++++++|+||+++++++.+.. .
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~ 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE------EEGIPSTALREISLLKELKHPNIVKLLDVIHTER--K 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc------cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC--c
Confidence 566788999999999999984 67899999986421 2233456778999999999999999999987654 8
Q ss_pred eEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
+++||||+. ++|.+++.+....+++..++.++.+++.||.|||+++|+||||+|+||+++ .++.+||+|||+++.
T Consensus 73 ~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~----~~~~~~l~d~g~~~~ 147 (282)
T cd07829 73 LYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN----RDGVLKLADFGLARA 147 (282)
T ss_pred eEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc----CCCCEEEecCCcccc
Confidence 999999996 589999976656799999999999999999999999999999999999998 678999999999875
Q ss_pred ccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc-----------
Q 040257 1124 KRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT----------- 1191 (1254)
Q Consensus 1124 ~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~----------- 1191 (1254)
..... ......++..|+|||.+.+. ..++.++|||||||++|||++|+.||........+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 43322 22234467889999998754 247889999999999999999999998765444333222100
Q ss_pred ---------CCC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 ---------LRP-------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 ---------Lrp-------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+.. ......+..+.++|++||..+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000 0011246789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=299.15 Aligned_cols=242 Identities=24% Similarity=0.435 Sum_probs=197.5
Q ss_pred EEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceE
Q 040257 968 ELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~ 1045 (1254)
...+||+|+||.||++.. +++.||||++.... ......+.+|+.+++.++|+||+++++++.... ..+
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 93 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--------QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELW 93 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--------hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC--EEE
Confidence 345799999999999988 46789999875321 123456889999999999999999999998665 899
Q ss_pred EEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1046 TVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
+||||+.+++|.+++.. ..+++..++.++.|++.||+|||+.||+|+||+|+||+++ .++.++|+|||++....
T Consensus 94 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~----~~~~~~l~dfg~~~~~~ 167 (292)
T cd06657 94 VVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFCAQVS 167 (292)
T ss_pred EEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEcccccceecc
Confidence 99999999999987743 3588999999999999999999999999999999999998 67889999999886443
Q ss_pred Cc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC--CCCCCcH
Q 040257 1126 NT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT--IPERCDP 1202 (1254)
Q Consensus 1126 ~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~--ipe~iS~ 1202 (1254)
.. .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+... +... ....++.
T Consensus 168 ~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (292)
T cd06657 168 KEVPRRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPKLKNLHKVSP 244 (292)
T ss_pred cccccccccccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-CCcccCCcccCCH
Confidence 22 122335688999999998754 4788999999999999999999999876655544433322 2221 2345788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1203 EWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1203 eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+.+++.+||+.+|.+||++.+++++
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 99999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.27 Aligned_cols=245 Identities=28% Similarity=0.478 Sum_probs=211.1
Q ss_pred ceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
|+++.+||+|+||.||++.++ |..+|||.+... ...+++..|+.|+.+++.|++|++||.+...+ .
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--D 102 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--D 102 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----------chHHHHHHHHHHHHHcCCchhhhhhhhhccCC--c
Confidence 677889999999999999884 778999998753 22567889999999999999999999776544 7
Q ss_pred eEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
++||||||..|+..++++.+.+++++..+..+++..+.||+|||...=||||||..||||+ .+|+.||+|||.+..
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN----T~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN----TDGIAKLADFGVAGQ 178 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc----ccchhhhhhccccch
Confidence 9999999999999999998999999999999999999999999999999999999999999 788999999999986
Q ss_pred ccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc-CCCCCCCCCc
Q 040257 1124 KRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT-LRPTIPERCD 1201 (1254)
Q Consensus 1124 ~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~-Lrp~ipe~iS 1201 (1254)
..... -.+++.||+.|||||++.... |..++||||||++..||..|++||.+...-..+..+-... .....|+.++
T Consensus 179 LTDTMAKRNTVIGTPFWMAPEVI~EIG--Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS 256 (502)
T KOG0574|consen 179 LTDTMAKRNTVIGTPFWMAPEVIEEIG--YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWS 256 (502)
T ss_pred hhhhHHhhCccccCcccccHHHHHHhc--cchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhh
Confidence 55443 245677999999999998764 8889999999999999999999999877655444333222 1223467789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++.+|+++||-+.|++|.|+.+++++
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 999999999999999999999999976
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.10 Aligned_cols=238 Identities=22% Similarity=0.340 Sum_probs=185.6
Q ss_pred ceEEEE--EeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhc-CCCCceeEEeeeeecCC
Q 040257 966 LEELRE--LGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN-LHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 966 YeiLkk--LGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkr-LnHPNIVkLyGvf~Ddn 1040 (1254)
|++.+. ||+|+||.||++.. .+..+|+|.+....... .|+.+... .+|+||+++++++....
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 344444 59999999999987 46779999987542110 01222221 27999999999998765
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCC-eEEEEecc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRP-ICKVGDFG 1119 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG-~VKLiDFG 1119 (1254)
.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+||+++ ..+ .++|+|||
T Consensus 83 --~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~~l~dfg 155 (267)
T PHA03390 83 --GHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD----RAKDRIYLCDYG 155 (267)
T ss_pred --eeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe----CCCCeEEEecCc
Confidence 899999999999999998554 4799999999999999999999999999999999999998 555 89999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH-HHHhhh-ccCCCCCC
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAI-IGGIVK-NTLRPTIP 1197 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~el-iqsIlk-~~Lrp~ip 1197 (1254)
++...... ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||........ ...+.. .......+
T Consensus 156 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T PHA03390 156 LCKIIGTP---SCYDGTLDYFSPEKIKGHN--YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI 230 (267)
T ss_pred cceecCCC---ccCCCCCcccChhhhcCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcc
Confidence 98755332 2345889999999998654 78899999999999999999999975433221 111111 11222344
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPS-FTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPS-ArELLe~ 1228 (1254)
..+++.+.+||.+||+.+|.+||+ +++++++
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 568999999999999999999995 6998864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.68 Aligned_cols=251 Identities=27% Similarity=0.341 Sum_probs=193.6
Q ss_pred CceEEEEEeeeCcEEEEEEEEC----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Dd 1039 (1254)
+|++.+.||+|+||.||++++. ++.||||++..... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS------KKILAKRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc------cchhHHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 4788999999999999999985 45799999864311 122345677899999999 599999999875422
Q ss_pred --CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1040 --TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1040 --n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
....++++++|+. ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 75 ~~~~~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~----~~~~~kl~D 148 (332)
T cd07857 75 PGNFNELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN----ADCELKICD 148 (332)
T ss_pred cccCCcEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc----CCCCEEeCc
Confidence 2245788889884 688888743 45689999999999999999999999999999999999998 678999999
Q ss_pred ccccccccCcc-----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc-
Q 040257 1118 FGLSRIKRNTL-----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT- 1191 (1254)
Q Consensus 1118 FGLAr~~~~s~-----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~- 1191 (1254)
||+++...... ......|+..|+|||++.+. ..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 99987543211 12335689999999988653 247899999999999999999999998755433322211100
Q ss_pred ------------------------CC----CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 ------------------------LR----PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 ------------------------Lr----p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.. .......+..+.+|+.+||+.+|++|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 01112357889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=301.88 Aligned_cols=249 Identities=26% Similarity=0.357 Sum_probs=196.2
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
.+|++++.||+|+||.||++.+ .++.||+|+++.... .....+.+.+|+.++++++||||+++++++....
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch------hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 4799999999999999999986 477899999875311 1222456778999999999999999999875432
Q ss_pred ---CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1041 ---GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1041 ---~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
....+++++++ +++|.+++.. ..+++..++.++.||+.||.|||+++|+||||||+||+++ .++.+||+|
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kl~d 163 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILD 163 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc----CCCCEEEec
Confidence 23477888876 7889887743 3589999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-----
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL----- 1192 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L----- 1192 (1254)
||+++..... .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||........+..+.....
T Consensus 164 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 164 FGLARHTDDE--MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred cccccccccc--ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9998754332 2335688999999998753 2478899999999999999999999976554433332211100
Q ss_pred -------------------CC-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 -------------------RP-----TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 -------------------rp-----~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+ ......++++.+||.+||+.||.+||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 0012357789999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.25 Aligned_cols=252 Identities=28% Similarity=0.404 Sum_probs=197.2
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC-
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG- 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~- 1041 (1254)
+|.+.+.||+|+||.||+|.+ +++.||||++++... .......+.+|+.+++.++||||+++++++.....
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ------SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc------cccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 799999999999999999987 477899999875421 12234567889999999999999999999864421
Q ss_pred ---CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1042 ---GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1042 ---~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
..+++|+||+. .+|..++ ...+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+||+||
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~----~~~~~kL~df 161 (342)
T cd07879 90 DEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN----EDCELKILDF 161 (342)
T ss_pred CCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEeeC
Confidence 35689999985 4666554 23589999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC------
Q 040257 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL------ 1192 (1254)
Q Consensus 1119 GLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L------ 1192 (1254)
|+++..... .....++..|+|||++.+.. .++.++|||||||++|||++|+.||...+....+..+....-
T Consensus 162 g~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 162 GLARHADAE--MTGYVVTRWYRAPEVILNWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CCCcCCCCC--CCCceeeecccChhhhcCcc-ccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 998754322 23346788999999987532 378899999999999999999999987654433332221000
Q ss_pred ---------------CCCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHHH
Q 040257 1193 ---------------RPTI--------PERCDPEWRKLMEQCWAADPEARPSFTEITSR--LRTIS 1233 (1254)
Q Consensus 1193 ---------------rp~i--------pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~--Le~Ll 1233 (1254)
.+.. ....+..+.+||.+||+.||.+||++.+++.+ ++.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000 12356789999999999999999999999966 66553
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=304.26 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=199.1
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||+|++|.||+|++. ++.||||++.... ........+.+|+.++++++|+||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF------QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc------chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 47999999999999999999984 6789999886431 112234567789999999999999999988765432
Q ss_pred ----CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1042 ----GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1042 ----~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
..+++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~----~~~~~kL~d 161 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN----EDCELKILD 161 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEcc
Confidence 3589999998 6799888753 4689999999999999999999999999999999999998 678899999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC---
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP--- 1194 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp--- 1194 (1254)
||++...... .....++..|+|||.+.+.. .++.++|||||||++|+|++|+.||........+..+......+
T Consensus 162 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 162 FGLARHTDDE--MTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccccc--ccCCcccccccCHHHHhCCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 9998754332 23356888999999986532 47889999999999999999999998765544433332211000
Q ss_pred --------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 --------------------------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 --------------------------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.....++..+.+||.+||..+|.+|||+.+|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0112357899999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=357.92 Aligned_cols=251 Identities=30% Similarity=0.465 Sum_probs=212.7
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|+....||.|.||.||.+.. +|...|+|.++-... .......+.+|+.+|..|+|||+|++||+-.+.+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~------~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-- 1307 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS------DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-- 1307 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc------ccccCcchHHHHHHHHhccCccccccCceeecHH--
Confidence 577788999999999999887 577799998874311 1444566788999999999999999999977665
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.++|.||||.+|+|.+.+ ++++-.++.....+..|++.||.|||++|||||||||.||||+ .+|.+|++|||.|.
T Consensus 1308 kv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld----~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD----FNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee----cCCcEEeeccccee
Confidence 678899999999999987 5556688888889999999999999999999999999999999 78899999999998
Q ss_pred cccCcc-----ccCCCCCCCCccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1123 IKRNTL-----VSGGVRGTLPWMAPELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1123 ~~~~s~-----~sts~~GT~~YmAPEVLrG~~-~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
...+.. ......||+.|||||++.+.. .+-..+.||||||||+.||+||+.||...++.-.+.--+.....|.+
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC
Confidence 655442 223457999999999998764 23456899999999999999999999988776555444555567889
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
|+.++.+-++||..||..||++|.++.||+++
T Consensus 1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 99999999999999999999999999988876
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=316.97 Aligned_cols=261 Identities=30% Similarity=0.516 Sum_probs=216.2
Q ss_pred cccccccCceEEEEEeeeCcEEEEEEEECC-ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeee
Q 040257 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRG-SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 958 lq~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf 1036 (1254)
++++....+.+.++||+|-||.|.+|+..+ ..||+|.++... ....+.+|.+|+++|.+|+||||++|+|+|
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-------~~~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-------TKNARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-------chhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 345556677888999999999999999976 889999997542 344578899999999999999999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCC-CHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSL-DRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~L-Se~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
..++ .+++|+|||++|+|.+++.++..+. .-.....|+.||+.||+||.+.++|||||.+.|+|++ .++++||
T Consensus 605 ~~De--PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~----~e~~iKi 678 (807)
T KOG1094|consen 605 VQDD--PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD----GEFTIKI 678 (807)
T ss_pred ecCC--chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec----CcccEEe
Confidence 8766 8999999999999999997765443 5566678999999999999999999999999999999 8999999
Q ss_pred Eeccccccc---cCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCChhhHHHHhh--
Q 040257 1116 GDFGLSRIK---RNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT--GEEPYADMHCGAIIGGIV-- 1188 (1254)
Q Consensus 1116 iDFGLAr~~---~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT--Gk~PF~~~n~~eliqsIl-- 1188 (1254)
+|||+++.. ........+.-..+|||+|.+... +++.++|+|+||++|||+++ ...||.....++.+...-
T Consensus 679 adfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg--kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~ 756 (807)
T KOG1094|consen 679 ADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEF 756 (807)
T ss_pred cCcccccccccCCceeeecceeeeeeehhHHHHHhc--cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhh
Confidence 999999832 112223334456889999998744 59999999999999999876 788998887776665432
Q ss_pred -hcc---CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1189 -KNT---LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1189 -k~~---Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
... .-+..|..++..+.++|.+||..|-++||++++|..+|++..
T Consensus 757 ~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 757 FRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred cCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 111 112456778999999999999999999999999999998763
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=329.09 Aligned_cols=147 Identities=25% Similarity=0.454 Sum_probs=129.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|.++++||+|+||+||+|.+. ++.||||+++..... .......+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~- 77 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-----NKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN- 77 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-----CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC-
Confidence 37999999999999999999986 788999999754321 2334567889999999999999999999887655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+|+||||+.+++|..++... +.+++..++.|+.||+.||.|||+++||||||||+||||+ ..+.+||+|||++
T Consensus 78 -~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~----~~g~vkL~DFGls 151 (669)
T cd05610 78 -NVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS----NEGHIKLTDFGLS 151 (669)
T ss_pred -EEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc----CCCCEEEEeCCCC
Confidence 899999999999999988543 4688999999999999999999999999999999999998 6789999999987
Q ss_pred c
Q 040257 1122 R 1122 (1254)
Q Consensus 1122 r 1122 (1254)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=297.14 Aligned_cols=249 Identities=28% Similarity=0.394 Sum_probs=195.1
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|++++.||+|+||.||++.. +++.||||++.+... .....+.+.+|+.++++++||||++++++|....
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS------TPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc------ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 34799999999999999999987 467799998865321 1123456778999999999999999999986533
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
...+++|||+ +++|..++.. ..+++..+..++.||+.||.|||+++|+||||||.|||++ ..+.+||+|||+
T Consensus 83 -~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~----~~~~~~l~dfg~ 154 (328)
T cd07856 83 -EDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN----ENCDLKICDFGL 154 (328)
T ss_pred -CcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC----CCCCEEeCcccc
Confidence 3688999998 6688887743 4578888999999999999999999999999999999998 678999999999
Q ss_pred cccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh-----------
Q 040257 1121 SRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK----------- 1189 (1254)
Q Consensus 1121 Ar~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk----------- 1189 (1254)
+...... .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||...........+..
T Consensus 155 ~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 155 ARIQDPQ--MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccccCCC--cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 8754332 2234578899999998652 2478999999999999999999999976543221111100
Q ss_pred -------------ccCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1190 -------------NTLRPT-----IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1190 -------------~~Lrp~-----ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
...... ....++..++++|.+||+.+|++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 112467899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=328.24 Aligned_cols=250 Identities=34% Similarity=0.582 Sum_probs=213.1
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC---Cc--eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR---GS--DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r---Gs--~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
.++...++||+|+||+|++|.|+ |+ .||||.++..... ....+|++|+.+|.+|+|+|+++|||++.+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-------~~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-------AIMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-------hhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 34556678999999999999996 33 4999999865322 257889999999999999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhc-cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLK-KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~k-re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
. .+.+|||.+..|+|.+.+.+ ....|-....-.|+.||+.||.||..+++|||||-..||||- ....|||||
T Consensus 183 q---p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla----sprtVKI~D 255 (1039)
T KOG0199|consen 183 Q---PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA----SPRTVKICD 255 (1039)
T ss_pred c---hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec----ccceeeeec
Confidence 3 58899999999999999977 455688888889999999999999999999999999999998 677899999
Q ss_pred ccccccccCccc----cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccC
Q 040257 1118 FGLSRIKRNTLV----SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1118 FGLAr~~~~s~~----sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~L 1192 (1254)
|||.+....... .....-...|+|||.++.. +++.++|+|++||+||||+| |..||.+.....+++.+. ..-
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~--kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~e 332 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHR--KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGE 332 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhccc--cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccc
Confidence 999985543322 2223345679999999965 59999999999999999999 999999999888888887 444
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
+...++.|++++.++++.||+.+|.+||++..|.+.+-
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 55678889999999999999999999999999975543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-33 Score=321.85 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=226.7
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECCce--EEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~--VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.++-.+++.+-.||-|+||.|=+++..++. +|+|++++..+.. ....+.+..|.+||..++.|+||++|-.|.
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-----tkQqeHv~sEr~Im~~~~s~fIvrLYrTfr 490 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-----TKQQEHVFSERNIMMECRSDFIVRLYRTFR 490 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-----hhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence 344457788889999999999999887655 8999998765432 233567788999999999999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. ++|++||-|-||.|+.++..+ +.|+......++..+++|++|||++|||+|||||+|+||+ .+|.+||.|
T Consensus 491 d~k--yvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd----~~Gy~KLVD 563 (732)
T KOG0614|consen 491 DSK--YVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD----NRGYLKLVD 563 (732)
T ss_pred cch--hhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec----cCCceEEee
Confidence 765 899999999999999999665 5699999999999999999999999999999999999999 889999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
||+|+.......+.++|||+.|.|||++.... -+.++|.||||+++|||++|.+||.+.+.-..+..|+++.-...+|
T Consensus 564 FGFAKki~~g~KTwTFcGTpEYVAPEIILnKG--HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P 641 (732)
T KOG0614|consen 564 FGFAKKIGSGRKTWTFCGTPEYVAPEIILNKG--HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP 641 (732)
T ss_pred hhhHHHhccCCceeeecCCcccccchhhhccC--cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc
Confidence 99999888888888899999999999999775 5778999999999999999999999999999999998887777888
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPS-----FTEITSRL 1229 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPS-----ArELLe~L 1229 (1254)
..++....+||++++..+|.+|.. +.+|..|-
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 999999999999999999999975 56666553
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-33 Score=302.80 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=205.6
Q ss_pred CceEE-EEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeec--
Q 040257 965 DLEEL-RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPD-- 1038 (1254)
Q Consensus 965 dYeiL-kkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~D-- 1038 (1254)
+|.+- ++||-|-.|+|..+.++ +..+|+|++... .+..+|+++--.. .|||||.++++|..
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------------~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------------PKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------------HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 44432 57999999999999884 677999988632 3345677765444 69999999999853
Q ss_pred CCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
....++.+|||.|+||.|...|..++ ..|++..+..|++||+.||.|||+.+|.||||||+|+|..... .+..+||+|
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~-~na~lKLtD 207 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS-PNAPLKLTD 207 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC-CCcceEecc
Confidence 23457889999999999999997654 5699999999999999999999999999999999999998554 677899999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----hhHHHHhhhccCC
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC----GAIIGGIVKNTLR 1193 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~----~eliqsIlk~~Lr 1193 (1254)
||+|+.........+-|.|+.|.|||++..+ +|+..+|+|||||+||-|++|.+||..... ......|..+.+.
T Consensus 208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 208 FGFAKETQEPGDLMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred cccccccCCCccccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence 9999977766666678899999999999866 488889999999999999999999987653 3455566666665
Q ss_pred CCCCC--CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 PTIPE--RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 p~ipe--~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..-++ .+++..+++|+++|+.+|.+|.|+.+++++
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 54443 478899999999999999999999998765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=335.02 Aligned_cols=249 Identities=31% Similarity=0.518 Sum_probs=191.9
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee-----
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP----- 1037 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~----- 1037 (1254)
+|+++..||+|+||.||+++. +|+.||||+|.... .......+.+|+.+|.+|+|||||++|..|.
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-------SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 678888999999999999987 69999999997542 3455678899999999999999999852110
Q ss_pred -------------------------------------------------------------------------cC-----
Q 040257 1038 -------------------------------------------------------------------------DG----- 1039 (1254)
Q Consensus 1038 -------------------------------------------------------------------------Dd----- 1039 (1254)
++
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence 00
Q ss_pred ----------------------------------CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHH
Q 040257 1040 ----------------------------------TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085 (1254)
Q Consensus 1040 ----------------------------------n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaY 1085 (1254)
....+||-||||+...|.+++......-.....|+++++|++||.|
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence 0025788999998888888875432222578889999999999999
Q ss_pred hhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc-------------------CccccCCCCCCCCccCccccc
Q 040257 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR-------------------NTLVSGGVRGTLPWMAPELLN 1146 (1254)
Q Consensus 1086 LHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~-------------------~s~~sts~~GT~~YmAPEVLr 1146 (1254)
+|++|||||||||.||+|+ +...|||+|||+++... +....+...||.-|+|||++.
T Consensus 713 IH~~giIHRDLKP~NIFLd----~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLD----SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHhCceeeccCCcceeEEc----CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 9999999999999999999 78899999999997510 111335567999999999998
Q ss_pred CCCC-CCCchhHHHHHHHHHHHHHcCCCCCCC-CChhhHHHHhhhccCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 040257 1147 GSSN-RVSEKVDVFSFGISMWEILTGEEPYAD-MHCGAIIGGIVKNTLRPT--IPERCDPEWRKLMEQCWAADPEARPSF 1222 (1254)
Q Consensus 1147 G~~~-kyS~KSDIWSLGVILYELLTGk~PF~~-~n~~eliqsIlk~~Lrp~--ipe~iS~eLrdLIkKCLqkDPeKRPSA 1222 (1254)
+... .|+.|+|+||||+|||||+. ||.. +.....+..+.+..++.. +...--+.-..+|++||+.||.+||||
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA 865 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA 865 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH
Confidence 7642 69999999999999999984 5754 334444444444443333 011112345689999999999999999
Q ss_pred HHHHH
Q 040257 1223 TEITS 1227 (1254)
Q Consensus 1223 rELLe 1227 (1254)
.|||+
T Consensus 866 ~eLL~ 870 (1351)
T KOG1035|consen 866 TELLN 870 (1351)
T ss_pred HHHhh
Confidence 99985
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=279.00 Aligned_cols=218 Identities=22% Similarity=0.247 Sum_probs=175.9
Q ss_pred eCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEEecc
Q 040257 975 GTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMV 1052 (1254)
Q Consensus 975 GsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVMEYm~ 1052 (1254)
|.+|+||++++ +++.||+|++.... .+.+|...+....||||+++++++.+.. ..++||||+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~ 68 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------------EYSRERLTIIPHCVPNMVCLHKYIVSED--SVFLVLQHAE 68 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------------hhhhHHHHHHhcCCCceeehhhheecCC--eEEEEEecCC
Confidence 89999999998 46789999987541 1223445555567999999999987654 8999999999
Q ss_pred cCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCccccCC
Q 040257 1053 NGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG 1132 (1254)
Q Consensus 1053 GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~sts 1132 (1254)
+++|.+++.+. ..+++..+..++.|++.||.|||+++|+||||||+||+++ .++.++|+|||.+...... ...
T Consensus 69 ~~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~df~~~~~~~~~--~~~ 141 (237)
T cd05576 69 GGKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD----DRGHIQLTYFSRWSEVEDS--CDG 141 (237)
T ss_pred CCCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----CCCCEEEecccchhccccc--ccc
Confidence 99999988654 4589999999999999999999999999999999999998 6788999999987644332 123
Q ss_pred CCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 040257 1133 VRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCW 1212 (1254)
Q Consensus 1133 ~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCL 1212 (1254)
..++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ........++..+++.+++||.+||
T Consensus 142 ~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 142 EAVENMYCAPEVGGISE--ETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred CCcCccccCCcccCCCC--CCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHc
Confidence 44677899999987553 788999999999999999999887643211 1111122355678899999999999
Q ss_pred hcCCCCCCCH
Q 040257 1213 AADPEARPSF 1222 (1254)
Q Consensus 1213 qkDPeKRPSA 1222 (1254)
+.||.+||++
T Consensus 214 ~~dp~~R~~~ 223 (237)
T cd05576 214 QFNPTERLGA 223 (237)
T ss_pred cCCHHHhcCC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=264.92 Aligned_cols=237 Identities=34% Similarity=0.497 Sum_probs=193.9
Q ss_pred CcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEEeccc
Q 040257 976 TYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVN 1053 (1254)
Q Consensus 976 sFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVMEYm~G 1053 (1254)
+||.||++++. ++.+|+|++...... ...+.+.+|+.++++++|+||+++++++.... ..++++||+.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK-------KKRERILREISILKKLKHPNIVRLYDVFEDED--KLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc-------cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC--EEEEEEeCCCC
Confidence 58999999985 578999998754221 11567889999999999999999999987654 78999999999
Q ss_pred CchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCccccCCC
Q 040257 1054 GSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGV 1133 (1254)
Q Consensus 1054 GSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~sts~ 1133 (1254)
++|..++.... .+++..++.++.+++.+|.|||+.+|+|+||+|.||+++ .++.++|+|||.+............
T Consensus 72 ~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~----~~~~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 72 GDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD----EDGHVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred CCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC----CCCcEEEccccceeeeccccccccc
Confidence 99999885543 389999999999999999999999999999999999998 6689999999999866554344456
Q ss_pred CCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChhhHHHHhhhccCCCCCCCC-CcHHHHHHHHHh
Q 040257 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD-MHCGAIIGGIVKNTLRPTIPER-CDPEWRKLMEQC 1211 (1254)
Q Consensus 1134 ~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~-~n~~eliqsIlk~~Lrp~ipe~-iS~eLrdLIkKC 1211 (1254)
.++..|++||.+.+. .++.++|||+||+++|+|++|..||.. .........+............ ++.++.+++.+|
T Consensus 147 ~~~~~~~~pE~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 147 VGTPEYMAPEVLLGK--GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKL 224 (244)
T ss_pred cCCcCCCCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHH
Confidence 688999999999855 378899999999999999999999987 4444444433333322222222 788999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 040257 1212 WAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1212 LqkDPeKRPSArELLe~ 1228 (1254)
|..+|.+||++.+++++
T Consensus 225 l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 225 LVKDPEKRLTAEEALQH 241 (244)
T ss_pred ccCCchhccCHHHHhhC
Confidence 99999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=314.04 Aligned_cols=247 Identities=30% Similarity=0.444 Sum_probs=205.4
Q ss_pred EEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEE
Q 040257 970 RELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATV 1047 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LV 1047 (1254)
++||.|.||+||-|++ +|+.||||+|.+..+.... ..++.+|+.||.++.||.||.+--.|...+ .++.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq------esqlR~EVaILq~l~HPGiV~le~M~ET~e--rvFVV 641 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ------ESQLRNEVAILQNLHHPGIVNLECMFETPE--RVFVV 641 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCch------HHHHHHHHHHHHhcCCCCeeEEEEeecCCc--eEEEE
Confidence 5799999999999988 4889999999988765432 256788999999999999999998887655 89999
Q ss_pred EEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCc
Q 040257 1048 TEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT 1127 (1254)
Q Consensus 1048 MEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s 1127 (1254)
||-+.|.=|.-++....+++++.....++.||+.||.|||-++|+|.||||+|||+...+ ...++||||||.|+++.+.
T Consensus 642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~-~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS-PFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC-CCCceeeccccceeecchh
Confidence 999854444444445567899999999999999999999999999999999999998543 6789999999999999888
Q ss_pred cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hhhHHHHhhhccCCCCCCCCCcHHHHH
Q 040257 1128 LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH-CGAIIGGIVKNTLRPTIPERCDPEWRK 1206 (1254)
Q Consensus 1128 ~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n-~~eliqsIlk~~Lrp~ipe~iS~eLrd 1206 (1254)
.......||+.|+|||+++.+. |...-|+||+|+|+|--+.|.+||.... ..+.++... -.+++.....++++..+
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkG--yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa-FMyPp~PW~eis~~Aid 797 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKG--YNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA-FMYPPNPWSEISPEAID 797 (888)
T ss_pred hhhhhhcCCccccCHHHHhhcc--ccccccceeeeEEEEEEecccccCCCccchhHHhhccc-cccCCCchhhcCHHHHH
Confidence 8888899999999999999775 7888999999999999999999996532 222222111 12444455678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 040257 1207 LMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1207 LIkKCLqkDPeKRPSArELLe~ 1228 (1254)
||..+|+..-++|-|..+-+.+
T Consensus 798 lIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 798 LINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHHHHHHHhcchHhhccc
Confidence 9999999999999998776643
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=321.42 Aligned_cols=262 Identities=27% Similarity=0.417 Sum_probs=206.4
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC--
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT-- 1040 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn-- 1040 (1254)
-|..-..||+|+||.||++++ +|+.||||.+++... .+-.++..+|+++|++|+|+|||+++++-.+..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-------~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-------LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG 86 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcc-------cchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence 456667899999999999997 488899999987542 223566788999999999999999999876555
Q ss_pred --CCceEEEEEecccCchhhhhhccC--CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1041 --GGTLATVTEFMVNGSLKHVLLKKD--RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1041 --~~~L~LVMEYm~GGSL~d~L~kre--~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.....+|||||.+|||+..+.+.+ ..+++...+.++..+..||.|||++||+||||||.||++-...+.....||+
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence 456789999999999999996543 4599999999999999999999999999999999999997444456678999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh----hHHHHhhhccC
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG----AIIGGIVKNTL 1192 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~----eliqsIlk~~L 1192 (1254)
|||.|+..........+.||..|.+||++..+ ..|+..+|.|||||++|+++||..||...... +....+..+..
T Consensus 167 DfG~Arel~d~s~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 167 DFGAARELDDNSLFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP 245 (732)
T ss_pred cccccccCCCCCeeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence 99999988887788889999999999999852 24788899999999999999999999643322 22222221110
Q ss_pred -------------------CCCCCCCCcHH----HHHHHHHhhhcCCCCCC--CHHHHHHHHHHHHH
Q 040257 1193 -------------------RPTIPERCDPE----WRKLMEQCWAADPEARP--SFTEITSRLRTISA 1234 (1254)
Q Consensus 1193 -------------------rp~ipe~iS~e----LrdLIkKCLqkDPeKRP--SArELLe~Le~Ll~ 1234 (1254)
..+.+-.+++. +-..+..+|..+|++|. .+.+....+.+++.
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 01122233333 44677788999999998 77777777766654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=314.13 Aligned_cols=259 Identities=35% Similarity=0.565 Sum_probs=215.5
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC---------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCce
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR---------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNV 1029 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r---------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNI 1029 (1254)
.+....+.+.+.||+|.||.|++|... ...||||.++.... ....+.+..|+++|+.+ +|+||
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~-------~~~~~~~~~El~~m~~~g~H~ni 364 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS-------SSEKKDLMSELNVLKELGKHPNI 364 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC-------cHHHHHHHHHHHHHHHhcCCcch
Confidence 444445566679999999999998752 33599999886531 23467789999999988 69999
Q ss_pred eEEeeeeecCCCCceEEEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccc
Q 040257 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHF 1094 (1254)
Q Consensus 1030 VkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHR 1094 (1254)
+.++|++.. .+.+++|+||+..|+|..++.... ..++..+.+.++.||+.|++||+++.+|||
T Consensus 365 v~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHR 442 (609)
T KOG0200|consen 365 VNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHR 442 (609)
T ss_pred hhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccch
Confidence 999999987 458999999999999999997654 248999999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEEeccccccccCcccc--CCCCC--CCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 040257 1095 DLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVS--GGVRG--TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT 1170 (1254)
Q Consensus 1095 DLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~s--ts~~G--T~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT 1170 (1254)
||-.+|||+. .+..+||+|||+++........ ....+ ...|||||.+... .|+.++||||+|++|||++|
T Consensus 443 DLAaRNVLi~----~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~--~ft~kSDVWSfGI~L~Eifs 516 (609)
T KOG0200|consen 443 DLAARNVLIT----KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR--VFTSKSDVWSFGILLWEIFT 516 (609)
T ss_pred hhhhhhEEec----CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC--cccccchhhHHHHHHHHHhh
Confidence 9999999998 7789999999999853332111 11122 3459999999974 59999999999999999999
Q ss_pred -CCCCCCCCC-hhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1171 -GEEPYADMH-CGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1171 -Gk~PF~~~n-~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
|..||.+.. ..++ ...+....+...|..++.++.+|++.||..+|++||++.++.+.|..++.
T Consensus 517 LG~~PYp~~~~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 517 LGGTPYPGIPPTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCCCCCCcHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 999999876 4444 44667777888899999999999999999999999999999999999654
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=297.48 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=201.8
Q ss_pred EEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCCCceEE
Q 040257 970 RELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
..||+|+|+.|--+.. ++..||||++.+. ....+.++++|++++.++ .|+||+.|++||.+++ .+|+
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--------~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYL 153 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--------PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYL 153 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC--------CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEE
Confidence 4699999999998775 6888999999864 234568899999999998 5999999999999887 8999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccC
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN 1126 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~ 1126 (1254)
|||-|.||+|...|+++ +.|++..+..+.++|+.||.|||.+||.||||||+|||....+ .-.-||||||.+......
T Consensus 154 VfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn-~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN-KVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC-CcCceeeecccccccccc
Confidence 99999999999999765 5699999999999999999999999999999999999997444 456689999998763321
Q ss_pred c--------cccCCCCCCCCccCccccc---CCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---------------h
Q 040257 1127 T--------LVSGGVRGTLPWMAPELLN---GSSNRVSEKVDVFSFGISMWEILTGEEPYADMH---------------C 1180 (1254)
Q Consensus 1127 s--------~~sts~~GT~~YmAPEVLr---G~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n---------------~ 1180 (1254)
. ....+-+|+..|||||+.. ++...|+.++|.||||+|||-||.|.+||.+.- .
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 1 1123356889999999863 455568999999999999999999999996421 1
Q ss_pred hhHHHHhhhccCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1181 GAIIGGIVKNTLRPTI--PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1181 ~eliqsIlk~~Lrp~i--pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+...|-.+.+..+- ...++.+.+++|..+|.+++.+|.++.+++++
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 2344455555554322 23478899999999999999999999999984
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=326.96 Aligned_cols=242 Identities=25% Similarity=0.372 Sum_probs=184.2
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.+...+.||+|+||.||+|++ .+..||||+++.... ....|++++++++||||+++++++.+..
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~l~~l~HpnIv~~~~~~~~~~-- 756 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------------IPSSEIADMGKLQHPNIVKLIGLCRSEK-- 756 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------------ccHHHHHHHhhCCCCCcceEEEEEEcCC--
Confidence 355667899999999999997 477899998864310 1123578899999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhh---hCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLH---SKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLH---SkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
..++||||+++|+|.+++. .+++..+..|+.||+.||+||| +.+|+||||||+||+++ ..+..++. |+
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~----~~~~~~~~-~~ 827 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID----GKDEPHLR-LS 827 (968)
T ss_pred CCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC----CCCceEEE-ec
Confidence 7899999999999999984 3889999999999999999999 66999999999999998 55556654 66
Q ss_pred ccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--hhHHHHh---h-----h
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC--GAIIGGI---V-----K 1189 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~--~eliqsI---l-----k 1189 (1254)
........ ....+|..|+|||++.+. .++.++|||||||++|||+||+.||..... ....... . .
T Consensus 828 ~~~~~~~~---~~~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 902 (968)
T PLN00113 828 LPGLLCTD---TKCFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLD 902 (968)
T ss_pred cccccccC---CCccccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchh
Confidence 55432211 223578999999999865 489999999999999999999999853211 1111100 0 0
Q ss_pred ccCCCCCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1190 NTLRPTIP------ERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1190 ~~Lrp~ip------e~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
....+... .....++.+++.+||+.+|++||++.|+++.|+.+..
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 00111111 1112356789999999999999999999999998755
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=310.92 Aligned_cols=238 Identities=28% Similarity=0.362 Sum_probs=194.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn 1040 (1254)
..|+....+|.|+|+.|..+.+ +++..++|++.+.. .+..+|+.++... +||||+++++.+.++.
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~ 389 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------------DDNQDEIPISLLVRDHPNIVKSHDVYEDGK 389 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccc------------cccccccchhhhhcCCCcceeecceecCCc
Confidence 3577777899999999999988 46679999997651 1223456555444 7999999999998765
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
..++|||++.++-|.+.+.... .+. ..+..|+++|+.||.|||++|||||||||+|||++ .+.++++|+|||.
T Consensus 390 --~~~~v~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~---~~~g~lrltyFG~ 462 (612)
T KOG0603|consen 390 --EIYLVMELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD---GSAGHLRLTYFGF 462 (612)
T ss_pred --eeeeeehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec---CCCCcEEEEEech
Confidence 8999999999999988885442 233 77778999999999999999999999999999994 2778999999999
Q ss_pred cccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-hHHHHhhhccCCCCCCCC
Q 040257 1121 SRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG-AIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1121 Ar~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~-eliqsIlk~~Lrp~ipe~ 1199 (1254)
++..... ..+-+-|..|.|||++... .|++++||||||++||+||+|+.||..-... +++..+ ..+.+...
T Consensus 463 a~~~~~~--~~tp~~t~~y~APEvl~~~--~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~~ 534 (612)
T KOG0603|consen 463 WSELERS--CDTPALTLQYVAPEVLAIQ--EYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSEC 534 (612)
T ss_pred hhhCchh--hcccchhhcccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccccc
Confidence 9876555 3334678999999999955 5999999999999999999999999876665 333222 23444588
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+|.++++||.+||+.||.+|+++.+++.+
T Consensus 535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 535 VSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred cCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 99999999999999999999999999876
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=292.33 Aligned_cols=256 Identities=28% Similarity=0.390 Sum_probs=199.3
Q ss_pred CceEEEEEeeeCcEEEEEEEEC------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 965 DLEELRELGSGTYGTVYHGKWR------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
.|+.++.||+|.||.||++..+ .+.+|||.++...- ...+.....||+.+++.|+||||+.|..+|..
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd------~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD------GTGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC------CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 5888999999999999999652 23699999986521 11223456789999999999999999999876
Q ss_pred CCCCceEEEEEecccCchhhhhhc----cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLK----KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~k----re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
. ...+++++||. .-+|+++|+- +.+.++...+..|+.||+.|+.|||++.|+||||||.|||+..+++..|.||
T Consensus 99 ~-d~~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 99 H-DKKVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred c-CceEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 4 45899999997 5578888743 2356899999999999999999999999999999999999998888889999
Q ss_pred EEeccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---------
Q 040257 1115 VGDFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG--------- 1181 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~--------- 1181 (1254)
|+|||+++...+.. ....+.-|.+|+|||.+.|.. .|+.+.|||++|||+.||+|-.+.|.+....
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~-hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR-HYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccc-cccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 99999999776543 334566799999999999874 6999999999999999999988888643211
Q ss_pred hHHHHhhhc------cCCC---CCC--------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040257 1182 AIIGGIVKN------TLRP---TIP--------------------------ERCDPEWRKLMEQCWAADPEARPSFTEIT 1226 (1254)
Q Consensus 1182 eliqsIlk~------~Lrp---~ip--------------------------e~iS~eLrdLIkKCLqkDPeKRPSArELL 1226 (1254)
..+..|..- ..++ .+| ..-++...+|+.+||..||.+|.|+++.+
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 111111100 0000 000 11234467899999999999999999998
Q ss_pred HHH
Q 040257 1227 SRL 1229 (1254)
Q Consensus 1227 e~L 1229 (1254)
++.
T Consensus 336 eh~ 338 (438)
T KOG0666|consen 336 EHP 338 (438)
T ss_pred ccc
Confidence 874
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=304.51 Aligned_cols=243 Identities=21% Similarity=0.342 Sum_probs=196.2
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..-|..++.||-|+||.|.++.. +...||+|.+.+..+. .+........|..||.....+.||+||-.|+|.+
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl-----~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL-----MRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 702 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHH-----hhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence 34577889999999999999875 4456999999865433 2233455678999999999999999999998766
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+||||+|++||++..+|.+. +-|.+..+++++.++..||++.|..|+|||||||+||||| .+|++||+||||
T Consensus 703 --nLYFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID----rdGHIKLTDFGL 775 (1034)
T KOG0608|consen 703 --NLYFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGL 775 (1034)
T ss_pred --ceEEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc----cCCceeeeeccc
Confidence 899999999999999988654 5699999999999999999999999999999999999999 889999999999
Q ss_pred ccccc---------C-c---------------------------------cccCCCCCCCCccCcccccCCCCCCCchhH
Q 040257 1121 SRIKR---------N-T---------------------------------LVSGGVRGTLPWMAPELLNGSSNRVSEKVD 1157 (1254)
Q Consensus 1121 Ar~~~---------~-s---------------------------------~~sts~~GT~~YmAPEVLrG~~~kyS~KSD 1157 (1254)
|.-.. + . .......||+.|+|||++.... |+..+|
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g--~~q~cd 853 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG--YTQLCD 853 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC--ccccch
Confidence 85210 0 0 0011245999999999998764 889999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh--ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 040257 1158 VFSFGISMWEILTGEEPYADMHCGAIIGGIVK--NTLRPTIPERCDPEWRKLMEQCWAADPEARP 1220 (1254)
Q Consensus 1158 IWSLGVILYELLTGk~PF~~~n~~eliqsIlk--~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRP 1220 (1254)
|||.|||||||+.|+.||......+....++. ..+.......++++..++|.++++ .++.|.
T Consensus 854 wws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 99999999999999999987666554444432 334445567889999999988764 366665
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=293.26 Aligned_cols=255 Identities=24% Similarity=0.406 Sum_probs=204.0
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHH-hcCCCCceeEEeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHIL-SNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeIL-krLnHPNIVkLyGvf 1036 (1254)
.+...+++.+..||.|+||+|++..++ ++..|||+|.... .+...++++.|.+.. +.-+.||||++||.+
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-------~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-------IEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-------chHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 455566777889999999999998885 7789999998543 234457788888755 455899999999975
Q ss_pred ecCCCCceEEEEEecccCchhhhhhc----cCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCCCCC
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLK----KDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDPQRP 1111 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~k----re~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~snG 1111 (1254)
..+ +..+|.||.| ..||..+.+. ....+++..+-.|..-++.||.||.. ..|||||+||+||||+ ..|
T Consensus 133 F~E--GdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld----r~G 205 (361)
T KOG1006|consen 133 FSE--GDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD----RHG 205 (361)
T ss_pred hcC--CceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe----cCC
Confidence 433 3678999998 5566554321 34568999999999999999999986 5999999999999999 888
Q ss_pred eEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hhHHHHhhhc
Q 040257 1112 ICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC-GAIIGGIVKN 1190 (1254)
Q Consensus 1112 ~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~-~eliqsIlk~ 1190 (1254)
.|||||||++....++...+...|...|||||.+......|..++|+||||++|||+.||++||...+. -+.+..++.+
T Consensus 206 ~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g 285 (361)
T KOG1006|consen 206 DVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG 285 (361)
T ss_pred CEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC
Confidence 999999999998877777777789999999999987665699999999999999999999999987654 2333334443
Q ss_pred cCCCC-CC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1191 TLRPT-IP---ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1191 ~Lrp~-ip---e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+.. .+ -.++..+..||..||.+|-..||.+.+|+++
T Consensus 286 dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 286 DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 32211 12 2378899999999999999999999999865
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=308.01 Aligned_cols=252 Identities=30% Similarity=0.465 Sum_probs=210.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeec--
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPD-- 1038 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~D-- 1038 (1254)
..|++..+||.|.+|.||+++. .++..|+|+..... ...+++..|.++|+.+ .|||++.+|++|..
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---------d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---------DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---------cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3588999999999999998876 57889999876432 1224455688899877 69999999998752
Q ss_pred -CCCCceEEEEEecccCchhhhhhc-cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1039 -GTGGTLATVTEFMVNGSLKHVLLK-KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1039 -dn~~~L~LVMEYm~GGSL~d~L~k-re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
...+.++||||||.+||.-++++. .+..+.|..+..|+++++.||.+||.+.+||||||-.|||++ .++.|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT----~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT----ENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe----ccCcEEEe
Confidence 344689999999999999998854 356799999999999999999999999999999999999999 88999999
Q ss_pred eccccccccCc-cccCCCCCCCCccCcccccCCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC
Q 040257 1117 DFGLSRIKRNT-LVSGGVRGTLPWMAPELLNGSS---NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1117 DFGLAr~~~~s-~~sts~~GT~~YmAPEVLrG~~---~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L 1192 (1254)
|||++.....+ ....++.||+.|||||++.... ..|+.++|+||||++..||-.|.+|+.++.....+..+-.+..
T Consensus 166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP 245 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 245 (953)
T ss_pred eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC
Confidence 99998765543 3445677999999999997542 3578899999999999999999999999888776666655433
Q ss_pred CC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 RP-TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 rp-~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+. .-+..++.++.+||..||.+|.++||+..++|++
T Consensus 246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 22 2356788999999999999999999999999864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=305.49 Aligned_cols=260 Identities=30% Similarity=0.563 Sum_probs=218.4
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEE--CC----ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEE
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKW--RG----SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAF 1032 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~--rG----s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkL 1032 (1254)
.+++..+++..++||+|+||+||+|.| ++ -+||||++.... ..+...+++.|+-+|.+|.|||+++|
T Consensus 691 rI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-------~~~~s~e~LdeAl~masldHpnl~RL 763 (1177)
T KOG1025|consen 691 RILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-------SPKASIELLDEALRMASLDHPNLLRL 763 (1177)
T ss_pred eechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-------CchhhHHHHHHHHHHhcCCCchHHHH
Confidence 345555677788999999999999998 33 358888886542 22345678899999999999999999
Q ss_pred eeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCe
Q 040257 1033 YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPI 1112 (1254)
Q Consensus 1033 yGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~ 1112 (1254)
++++.... +-||++|++.|+|.++++.+...+..+..+.|+.||++||.|||.++++||||-.+|||+. +-.+
T Consensus 764 Lgvc~~s~---~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk----sP~h 836 (1177)
T KOG1025|consen 764 LGVCMLST---LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK----SPNH 836 (1177)
T ss_pred hhhcccch---HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec----CCCe
Confidence 99997654 7789999999999999988888899999999999999999999999999999999999998 6779
Q ss_pred EEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhh
Q 040257 1113 CKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIV 1188 (1254)
Q Consensus 1113 VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIl 1188 (1254)
|||.|||+++...... ......-.+-|||-|.++.. .|+.++|||||||++||++| |..||.+....++...+
T Consensus 837 vkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~--~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll- 913 (1177)
T KOG1025|consen 837 VKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIR--KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL- 913 (1177)
T ss_pred EEEEecchhhccCcccccccccccccCcHHHHHHHhhcc--CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-
Confidence 9999999998654322 12222345669999999865 48999999999999999999 99999998776665544
Q ss_pred hccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1189 KNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1189 k~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
+...+...|..++.++..++.+||..|+..||+++++...+..+...
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 44445778888999999999999999999999999999998777553
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-31 Score=295.21 Aligned_cols=264 Identities=25% Similarity=0.364 Sum_probs=210.2
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
..+.+|-++.+||+|+|+.||++-+ ..+.||+|+-....-. ++...+...+...+|..|-+.|.||.||++|++|.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~W-rdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNW-RDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccch-hhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 3345788899999999999999877 4678999986543222 233445566778899999999999999999999986
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC--CcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK--NIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk--GIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
++ ..+|-|+|||+|.+|..+++. .+.++++.++.|+.||+.||.||.+. -|||-||||.||||- .+..-|.+||+
T Consensus 539 Dt-dsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv-~GtacGeIKIT 615 (775)
T KOG1151|consen 539 DT-DSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLV-NGTACGEIKIT 615 (775)
T ss_pred cc-ccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEe-cCcccceeEee
Confidence 65 378899999999999998854 46799999999999999999999986 599999999999996 33467899999
Q ss_pred eccccccccCcc--------ccCCCCCCCCccCcccccCC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHH
Q 040257 1117 DFGLSRIKRNTL--------VSGGVRGTLPWMAPELLNGS--SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGG 1186 (1254)
Q Consensus 1117 DFGLAr~~~~s~--------~sts~~GT~~YmAPEVLrG~--~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqs 1186 (1254)
|||++++.+... .+....||.+|++||.+--. +.+++.|+||||+|||+|..+.|+.||........+..
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 999998754422 34456799999999998633 56789999999999999999999999987544332211
Q ss_pred ---hhhc-cCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1187 ---IVKN-TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1187 ---Ilk~-~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
|++. .........++.+.+.||++||+.--++|.+..+|..+
T Consensus 696 eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 696 ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 1111 11222334578999999999999999999999888764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=289.85 Aligned_cols=251 Identities=24% Similarity=0.286 Sum_probs=198.2
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCC--C----ceeEE
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH--P----NVVAF 1032 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnH--P----NIVkL 1032 (1254)
+...+|.++..||+|.||+|..+.+. +..||||+++. .....+...-|+++|.++.+ | -++.+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---------V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---------VDKYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---------HHHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 33458999999999999999999874 56799999974 34566777889999999942 1 36777
Q ss_pred eeeeecCCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccC-----
Q 040257 1033 YGVVPDGTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLR----- 1106 (1254)
Q Consensus 1033 yGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsd----- 1106 (1254)
.+||.- .+++|||+|.+ |.|+.+++... ..+++..+++.|+.|++++++|||+.+++|.||||+|||+...
T Consensus 157 ~~wFdy--rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 157 RDWFDY--RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred ehhhhc--cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence 788854 45899999987 77999999663 4579999999999999999999999999999999999998521
Q ss_pred -----------CCCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 040257 1107 -----------DPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175 (1254)
Q Consensus 1107 -----------d~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF 1175 (1254)
...+..|+|+|||.|+...+.. .....|..|.|||++.|-+ ++.++||||+||||+||+||...|
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLG--wS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLG--WSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccC--cCCccCceeeeeEEEEeeccceec
Confidence 1235689999999998765544 4567899999999999875 899999999999999999999999
Q ss_pred CCCChhh---HHHHhhhccCC-----------------CCCC-------------------------CCCcHHHHHHHHH
Q 040257 1176 ADMHCGA---IIGGIVKNTLR-----------------PTIP-------------------------ERCDPEWRKLMEQ 1210 (1254)
Q Consensus 1176 ~~~n~~e---liqsIlk~~Lr-----------------p~ip-------------------------e~iS~eLrdLIkK 1210 (1254)
+.-.+.+ +.+.++. .++ ...+ .....++.+||++
T Consensus 310 qtHen~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred ccCCcHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 8765444 2222221 000 0000 0012357899999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 040257 1211 CWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1211 CLqkDPeKRPSArELLe~ 1228 (1254)
||..||.+|+|++|+|.+
T Consensus 389 mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSH 406 (415)
T ss_pred HHccCccccccHHHHhcC
Confidence 999999999999999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=291.01 Aligned_cols=263 Identities=19% Similarity=0.178 Sum_probs=182.3
Q ss_pred cccCceEEEEEeeeCcEEEEEEEE------------------CCceEEEEEEeccccCCCch-hH-----HHHHHHHHHH
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKW------------------RGSDVAIKRIKKSCFAGRSS-EQ-----ERLTKDFWRE 1017 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~------------------rGs~VAIKvIkk~~~~~~~~-e~-----ee~~eqFlrE 1017 (1254)
...+|++.++||+|+||+||+|.+ .++.||||+++......... .. ....+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 455899999999999999999864 24569999986431100000 00 0011233457
Q ss_pred HHHHhcCCCCce-----eEEeeeeecC------CCCceEEEEEecccCchhhhhhccC----------------------
Q 040257 1018 AHILSNLHHPNV-----VAFYGVVPDG------TGGTLATVTEFMVNGSLKHVLLKKD---------------------- 1064 (1254)
Q Consensus 1018 IeILkrLnHPNI-----VkLyGvf~Dd------n~~~L~LVMEYm~GGSL~d~L~kre---------------------- 1064 (1254)
+.++.+++|.++ ++++++|... .....++||||+.+++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 6677776532 2246789999999999998885421
Q ss_pred -CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCccccCC--CCCCCCccC
Q 040257 1065 -RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG--VRGTLPWMA 1141 (1254)
Q Consensus 1065 -~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~sts--~~GT~~YmA 1141 (1254)
..+++..++.++.|++.+|.|||+.+|+||||||+|||++ .++.+||+|||++........... ..+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~----~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT----VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC----CCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 1245677888999999999999999999999999999998 677899999999875433222222 234789999
Q ss_pred cccccCCC--------------------CCCCchhHHHHHHHHHHHHHcCCC-CCCCCChh-----------hHHHHhhh
Q 040257 1142 PELLNGSS--------------------NRVSEKVDVFSFGISMWEILTGEE-PYADMHCG-----------AIIGGIVK 1189 (1254)
Q Consensus 1142 PEVLrG~~--------------------~kyS~KSDIWSLGVILYELLTGk~-PF~~~n~~-----------eliqsIlk 1189 (1254)
||.+.... +....+.||||+||+||+|++|.. ||...... .....+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99986321 112235799999999999999876 77532111 00111112
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCC---CCCCCHHHHHHH
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADP---EARPSFTEITSR 1228 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDP---eKRPSArELLe~ 1228 (1254)
..+........++..++|+.+||.++| .+|+|+.|+|+|
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 222333345578899999999999866 689999999986
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=283.80 Aligned_cols=253 Identities=32% Similarity=0.579 Sum_probs=203.9
Q ss_pred CceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhc--CCCCceeEEeeeeec--CC
Q 040257 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN--LHHPNVVAFYGVVPD--GT 1040 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkr--LnHPNIVkLyGvf~D--dn 1040 (1254)
++.+.+.||+|.||.||+|+|+|..||||++.... ...+++|.+|+.. |+|+||+.+++.-.. +.
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred eeEEEEEecCccccceeeccccCCceEEEEecccc-----------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 57788999999999999999999999999997431 2456788888875 599999999876432 34
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC--------CcccccCCCCceEeccCCCCCCe
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK--------NIVHFDLKCENLLVNLRDPQRPI 1112 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk--------GIIHRDLKPeNILLDsdd~snG~ 1112 (1254)
..++++|.+|.+.|||.+++.+ ..++....++++..++.||+|||-. .|.|||||..|||+. .++.
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK----kn~~ 354 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGT 354 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc----cCCc
Confidence 4589999999999999999965 5799999999999999999999963 499999999999998 8999
Q ss_pred EEEEeccccccccCc-----cccCCCCCCCCccCcccccCCCCC--C-C-chhHHHHHHHHHHHHHc----------CCC
Q 040257 1113 CKVGDFGLSRIKRNT-----LVSGGVRGTLPWMAPELLNGSSNR--V-S-EKVDVFSFGISMWEILT----------GEE 1173 (1254)
Q Consensus 1113 VKLiDFGLAr~~~~s-----~~sts~~GT~~YmAPEVLrG~~~k--y-S-~KSDIWSLGVILYELLT----------Gk~ 1173 (1254)
+-|+|+|||...... ...+..+||.+|||||++...-+. + + ..+||||||+||||+.- -+.
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 999999999755443 223556799999999999754221 0 1 35899999999999974 267
Q ss_pred CCCCC-----ChhhHHHHhhhccCCCCCCCCCc-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1174 PYADM-----HCGAIIGGIVKNTLRPTIPERCD-----PEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1174 PF~~~-----n~~eliqsIlk~~Lrp~ipe~iS-----~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
||.+. ..+++..-+....++|.+|..+. ..+.+|++.||..+|.-|.|+--+.+.|.++..
T Consensus 435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 88653 33455555666778887775542 246689999999999999999999998888764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=299.16 Aligned_cols=252 Identities=16% Similarity=0.179 Sum_probs=167.1
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
+...+|++.+.||+|+||.||+|++. +..||||++.... .. +....| .++...+.++..++.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~----e~~~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AV----EIWMNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hh----HHHHHH--HHHhhchhhHHHHHH
Confidence 34558999999999999999999984 5679999876421 01 111111 111122222222221
Q ss_pred eee----cCCCCceEEEEEecccCchhhhhhccCCC-------------------CCHHHHHHHHHHhhhhhHHhhhCCc
Q 040257 1035 VVP----DGTGGTLATVTEFMVNGSLKHVLLKKDRS-------------------LDRRKKLIIAMDAAFGMEYLHSKNI 1091 (1254)
Q Consensus 1035 vf~----Ddn~~~L~LVMEYm~GGSL~d~L~kre~~-------------------LSe~~~lkIa~QIAeALaYLHSkGI 1091 (1254)
.+. ......+++||||+.+++|.+++...... .....+..++.||+.||.|||+++|
T Consensus 197 ~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI 276 (566)
T PLN03225 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276 (566)
T ss_pred hhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE
Confidence 111 12344789999999999999988643211 1233456799999999999999999
Q ss_pred ccccCCCCceEeccCCCCCCeEEEEeccccccccC--ccccCCCCCCCCccCcccccCCCC-------------------
Q 040257 1092 VHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN--TLVSGGVRGTLPWMAPELLNGSSN------------------- 1150 (1254)
Q Consensus 1092 IHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~--s~~sts~~GT~~YmAPEVLrG~~~------------------- 1150 (1254)
+||||||+|||++. ..+.+||+|||+++.... ......+.+++.|+|||.+.....
T Consensus 277 iHRDLKP~NILl~~---~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~ 353 (566)
T PLN03225 277 VHRDVKPQNIIFSE---GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353 (566)
T ss_pred EeCcCCHHHEEEeC---CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence 99999999999982 357899999999975432 223345678999999997643221
Q ss_pred -CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc---------CCCC----------CCCCCcHHHHHHHHH
Q 040257 1151 -RVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT---------LRPT----------IPERCDPEWRKLMEQ 1210 (1254)
Q Consensus 1151 -kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~---------Lrp~----------ipe~iS~eLrdLIkK 1210 (1254)
.++.++|||||||+||||+++..++..... .....+.... .... ..........+||.+
T Consensus 354 ~~~~~k~DVwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 354 LNLPDRFDIYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred ccCCCCcccHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 234567999999999999998776543211 1111110000 0000 011123345689999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 040257 1211 CWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1211 CLqkDPeKRPSArELLe~ 1228 (1254)
||++||++|||++++++|
T Consensus 433 mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 433 MMRFKGRQRISAKAALAH 450 (566)
T ss_pred HccCCcccCCCHHHHhCC
Confidence 999999999999999986
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=262.65 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=202.7
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|+..++||+|.||+||+++.+ ...||+|+++... ..+......++|+-+|+.|+|.|||+++++...+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldd------ddegvpssalreicllkelkhknivrl~dvlhsdk-- 74 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD------DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-- 74 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccC------CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc--
Confidence 3556678999999999999875 5569999997542 23344566789999999999999999999987655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+.+|+||| ..+|..+...-++.++.+.++.++.|+++||.|+|+++++||||||+|+||+ .+|.+||+|||+++
T Consensus 75 kltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin----~ngelkladfglar 149 (292)
T KOG0662|consen 75 KLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN----RNGELKLADFGLAR 149 (292)
T ss_pred eeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec----cCCcEEecccchhh
Confidence 789999998 6788888877788899999999999999999999999999999999999999 88999999999998
Q ss_pred cccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccC------CC
Q 040257 1123 IKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL------RP 1194 (1254)
Q Consensus 1123 ~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~L------rp 1194 (1254)
...-+. -.....-|.+|.+|.++.|.. -|+...|+||-|||+.|+.. |++.|.+.+.++.+..+....- ++
T Consensus 150 afgipvrcysaevvtlwyrppdvlfgak-ly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeeeee-hhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence 654332 223345799999999999864 58899999999999999986 8888999887776666543211 11
Q ss_pred ------------CCCC---------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 ------------TIPE---------RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 ------------~ipe---------~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++. .+...-+++++++|.-+|.+|.++++.+++
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 0110 122335689999999999999999998875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-28 Score=234.21 Aligned_cols=211 Identities=41% Similarity=0.661 Sum_probs=180.6
Q ss_pred EeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEE
Q 040257 972 LGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTE 1049 (1254)
Q Consensus 972 LGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVME 1049 (1254)
||+|.+|.||++... ++.+++|++...... .....+.+|+.+++.+.|++|+++++++... ...+++||
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-------SLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch-------hHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEe
Confidence 689999999999996 788999998754211 0346788999999999999999999999765 38899999
Q ss_pred ecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCC-CCeEEEEeccccccccCcc
Q 040257 1050 FMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQ-RPICKVGDFGLSRIKRNTL 1128 (1254)
Q Consensus 1050 Ym~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~s-nG~VKLiDFGLAr~~~~s~ 1128 (1254)
|+.+++|.+++......+++..++.++.+++.+|.+||+.+++|+||+|.||+++ . .+.++|+|||.+.......
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~----~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD----SDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe----CCCCcEEEecCCceEEccCCc
Confidence 9999999999865545689999999999999999999999999999999999998 5 6789999999987554432
Q ss_pred -ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHH
Q 040257 1129 -VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKL 1207 (1254)
Q Consensus 1129 -~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdL 1207 (1254)
......+...|++||.+... ..++.+.|+|+||+++++| ..+.++
T Consensus 148 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~ 193 (215)
T cd00180 148 SLLKTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL---------------------------------PELKDL 193 (215)
T ss_pred chhhcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH---------------------------------HHHHHH
Confidence 12234578889999999764 2478899999999999999 678999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 040257 1208 MEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1208 IkKCLqkDPeKRPSArELLe~L 1229 (1254)
+.+||+.+|.+||++.++++++
T Consensus 194 l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 194 IRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHhhCCcccCcCHHHHhhCC
Confidence 9999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=278.78 Aligned_cols=255 Identities=29% Similarity=0.454 Sum_probs=202.9
Q ss_pred CceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhc--CCCCceeEEeeeeecCC--
Q 040257 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN--LHHPNVVAFYGVVPDGT-- 1040 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkr--LnHPNIVkLyGvf~Ddn-- 1040 (1254)
.++.+++||+|.||.||+|++.++.||||++... ..+.|.+|.+|++. ++|+||+++++.-...+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecCHH-----------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 3556678999999999999999999999998632 34678888888875 58999999998754333
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC---------CcccccCCCCceEeccCCCCCC
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK---------NIVHFDLKCENLLVNLRDPQRP 1111 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk---------GIIHRDLKPeNILLDsdd~snG 1111 (1254)
...+.+|++|.+.|+|.+++.. ..++|....+|+..+++||+|||+. .|+|||||.+||||. +++
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK----~Dl 353 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK----NDL 353 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc----cCC
Confidence 3468899999999999999954 4689999999999999999999974 599999999999998 889
Q ss_pred eEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCC----CchhHHHHHHHHHHHHHcCCCC----------
Q 040257 1112 ICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRV----SEKVDVFSFGISMWEILTGEEP---------- 1174 (1254)
Q Consensus 1112 ~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~ky----S~KSDIWSLGVILYELLTGk~P---------- 1174 (1254)
.+.|+|||+|....... ..-...||.+|||||++.|.-+-- =.+.||||+|.|||||++...-
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 99999999998654322 222356999999999998753211 1468999999999999985433
Q ss_pred --CCC-----CChhhHHHHhhhccCCCCCCCCC-----cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1175 --YAD-----MHCGAIIGGIVKNTLRPTIPERC-----DPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1175 --F~~-----~n~~eliqsIlk~~Lrp~ipe~i-----S~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
|.. -..+++...++....+|.++..+ ...+++.+..||..|++.|.|+.=+-+++..+...-
T Consensus 434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 321 12344555566667777776433 346889999999999999999999999998886644
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-29 Score=287.38 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=202.5
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC------CCceeE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH------HPNVVA 1031 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn------HPNIVk 1031 (1254)
.+...+|.+....|+|-|++|.+|.+ .+..||||+|... +.+.+.=++|++||++|+ --|+++
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---------E~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---------EVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---------hHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 45567899999999999999999998 4678999999863 556677789999999995 347888
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccCC--CCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCC
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR--SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQ 1109 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~--~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~s 1109 (1254)
|+-.|...+ ++|+|+|.+ ..+|.+++.+.+. .+....+..|+.|++.||..|-..||+|.||||+|||++ ..
T Consensus 499 l~r~F~hkn--HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN---E~ 572 (752)
T KOG0670|consen 499 LFRHFKHKN--HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN---ES 572 (752)
T ss_pred HHHHhhhcc--eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec---cC
Confidence 888887655 899999987 7899999977654 377889999999999999999999999999999999998 36
Q ss_pred CCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh
Q 040257 1110 RPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1110 nG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk 1189 (1254)
...+||||||.|.....+..+ .+.-+..|.|||++.|.+ |+...|+||+||+||||+||+..|.+..+..++.-.+.
T Consensus 573 k~iLKLCDfGSA~~~~eneit-PYLVSRFYRaPEIiLG~~--yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEIT-PYLVSRFYRAPEIILGLP--YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred cceeeeccCcccccccccccc-HHHHHHhccCcceeecCc--ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 678999999999877665443 234566799999999997 55569999999999999999999998776665543221
Q ss_pred --ccCC-----------------------------------------C------------CCCCC---CcHHHHHHHHHh
Q 040257 1190 --NTLR-----------------------------------------P------------TIPER---CDPEWRKLMEQC 1211 (1254)
Q Consensus 1190 --~~Lr-----------------------------------------p------------~ipe~---iS~eLrdLIkKC 1211 (1254)
+.++ | .++.. .-.++++||.+|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 1000 0 01110 113578999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 040257 1212 WAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1212 LqkDPeKRPSArELLe~ 1228 (1254)
|..||++|.+..+.|.|
T Consensus 730 l~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKH 746 (752)
T ss_pred hccChhhcCCHHHHhcC
Confidence 99999999999999876
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=261.48 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=200.1
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDG 1039 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Dd 1039 (1254)
..+|++++++|+|.++.||.|.. .+..++||+++.. -.+.+.+|+.||..|. ||||++|+++..++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp 105 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----------KKKKIKREIKILQNLRGGPNIIKLLDIVKDP 105 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----------HHHHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence 34799999999999999999985 5778999999742 2467889999999997 99999999999998
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
......+|+||+.+.+...+. ..++...+..++.+++.||.|+|++||+|||+||.|++|+ .....++|+|||
T Consensus 106 ~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId---h~~rkLrlIDWG 178 (338)
T KOG0668|consen 106 ESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID---HELRKLRLIDWG 178 (338)
T ss_pred cccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec---hhhceeeeeecc
Confidence 888899999999888877665 4588889999999999999999999999999999999998 456789999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChhhHHHHhhh---------
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD-MHCGAIIGGIVK--------- 1189 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~-~n~~eliqsIlk--------- 1189 (1254)
+|.+.......+....+..|--||.+-.-. .|+.+-|+|||||+|..|+..+.||.. .++.+.+-.+.+
T Consensus 179 LAEFYHp~~eYnVRVASRyfKGPELLVdy~-~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 179 LAEFYHPGKEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred hHhhcCCCceeeeeeehhhcCCchheeech-hccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 998877766666666777889999987543 467779999999999999999999852 222221111110
Q ss_pred ------ccCCC--------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1190 ------NTLRP--------------------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1190 ------~~Lrp--------------------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
-.+.+ ......++++.+|+.++|..|-.+|+|++|...+
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00111 1112356889999999999999999999998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=271.35 Aligned_cols=135 Identities=25% Similarity=0.331 Sum_probs=114.7
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC--------CCce
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH--------HPNV 1029 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn--------HPNI 1029 (1254)
.+...+|-+.++||+|-|++||++.++ .+.||+|+.+. .+...+..+.||++|++++ -..|
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---------AQHYTEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---------hhHHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 355579999999999999999999884 67799999984 3456777889999999883 3479
Q ss_pred eEEeeeeec--CCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEec
Q 040257 1030 VAFYGVVPD--GTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVN 1104 (1254)
Q Consensus 1030 VkLyGvf~D--dn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLD 1104 (1254)
|+|++.|.. .+..++|+|+|++ |.+|+.+|...+ +.++...+..|++||+.||.|||. .||||.||||+|||+.
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 999999864 4566899999998 778888876543 569999999999999999999997 5999999999999983
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=290.82 Aligned_cols=258 Identities=31% Similarity=0.456 Sum_probs=194.9
Q ss_pred EEEEeeeCcEE-EEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCCCceEE
Q 040257 969 LRELGSGTYGT-VYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 969 LkkLGeGsFGt-VYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
-+.+|.|+.|+ ||+|...++.||||++-.. ......+|+.+|+.- .|||||++|+.-.++ ..+||
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e-----------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~--qF~YI 580 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEE-----------FFDFAQREIQLLQESDEHPNVIRYYCSEQDR--QFLYI 580 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhH-----------hHHHHHHHHHHHHhccCCCceEEEEeeccCC--ceEEE
Confidence 35689999985 7899999999999988643 345567899999877 699999998765544 49999
Q ss_pred EEEecccCchhhhhhcc--CCCC-CHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCC-CCCeEEEEeccccc
Q 040257 1047 VTEFMVNGSLKHVLLKK--DRSL-DRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDP-QRPICKVGDFGLSR 1122 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kr--e~~L-Se~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~-snG~VKLiDFGLAr 1122 (1254)
+.|.| ..+|.+++... +... .....+.++.|++.||++||+.+||||||||+||||...+. ....++|+|||+|+
T Consensus 581 alELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 581 ALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred EehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99998 67999999663 1111 11445778899999999999999999999999999985432 34689999999998
Q ss_pred cccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChhhHHHHhhhccCCCC-C
Q 040257 1123 IKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG-EEPYADMHCGAIIGGIVKNTLRPT-I 1196 (1254)
Q Consensus 1123 ~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTG-k~PF~~~n~~eliqsIlk~~Lrp~-i 1196 (1254)
...... ...+..||.+|+|||++.... -+.++||||||||+|+.++| .+||.+.... -..|+.+.+... +
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~--~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L 735 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDR--KTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHL 735 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccc--cCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeee
Confidence 543321 234567999999999999764 46689999999999999995 9999864322 122333322211 1
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHH------------HHHHHHHHHHhhcccCCC
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEIT------------SRLRTISAAIESKCINSE 1244 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELL------------e~Le~Ll~eLEsk~~k~~ 1244 (1254)
......+..+||.+|+..+|..||++.+|| ++|+++-+++|.+....+
T Consensus 736 ~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~r~~~ 795 (903)
T KOG1027|consen 736 EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKENRDSP 795 (903)
T ss_pred ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhhccCc
Confidence 111122899999999999999999999987 557777777776655443
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-29 Score=269.25 Aligned_cols=255 Identities=25% Similarity=0.331 Sum_probs=196.8
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC-
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG- 1039 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd- 1039 (1254)
...|+.+.+||+|.||.||+++. .++.||+|++... .+.+.+....++|+++|..|+|+|++.++.+|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme------neKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME------NEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh------ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 34677778899999999999877 4667888876432 22344456678999999999999999999887531
Q ss_pred -----CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1040 -----TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1040 -----n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
.+..+|+||.+|+ -+|.-++..+..+++...+.+++.+++.||.|+|+..|+|||+|+.|+||+ .++.+|
T Consensus 90 Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt----~dgilk 164 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT----KDGILK 164 (376)
T ss_pred CCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc----CCceEE
Confidence 2345899999985 466666766667799999999999999999999999999999999999999 889999
Q ss_pred EEeccccccccCc-----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh
Q 040257 1115 VGDFGLSRIKRNT-----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1115 LiDFGLAr~~~~s-----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk 1189 (1254)
|+|||+++..... ...+...-|.+|++||.+.|.. .|+.+.|||..||||.||+|+.+-|.+......+..|..
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r-~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR-EYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhccc-ccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 9999999743211 1122334699999999999864 689999999999999999999999887665544332211
Q ss_pred -------ccCC-------------CCCC-------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1190 -------NTLR-------------PTIP-------------ERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1190 -------~~Lr-------------p~ip-------------e~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
+.++ ++++ -.-+++..+|+.++|..||.+|+++.+++++-
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 0000 0011 11245677999999999999999999998663
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=253.45 Aligned_cols=213 Identities=31% Similarity=0.447 Sum_probs=172.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhc-CCCCceeEEeeeeecCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN-LHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkr-LnHPNIVkLyGvf~Ddn 1040 (1254)
.++..+..||+|++|.|-+.++ .|+..|+|.+.... ..+..++.++|+++..+ ..+|++|++||.+.+..
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-------n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-------NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-------ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 3555667899999999887777 58889999998642 23345678889987665 47999999999765443
Q ss_pred CCceEEEEEecccCchhhhh---hccCCCCCHHHHHHHHHHhhhhhHHhhhC-CcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1041 GGTLATVTEFMVNGSLKHVL---LKKDRSLDRRKKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L---~kre~~LSe~~~lkIa~QIAeALaYLHSk-GIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.++|.||.| ..||..+. .++++.+++..+-+|+..++.||.|||++ .|||||+||.||||+ ..|+||+|
T Consensus 119 --dvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn----~~GqVKiC 191 (282)
T KOG0984|consen 119 --DVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN----YDGQVKIC 191 (282)
T ss_pred --cEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc----cCCcEEEc
Confidence 688999998 55666553 34677899999999999999999999986 899999999999999 88999999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCC-hhhHHHHhhhc
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSN--RVSEKVDVFSFGISMWEILTGEEPYADMH-CGAIIGGIVKN 1190 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~--kyS~KSDIWSLGVILYELLTGk~PF~~~n-~~eliqsIlk~ 1190 (1254)
|||.+....++...+...|...|||||++..+.+ .|+.++||||||++++||.++++||.... .-+.+.+++..
T Consensus 192 DFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 192 DFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred ccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 9999998877766666678999999999975432 58999999999999999999999998643 34455555543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=231.55 Aligned_cols=210 Identities=35% Similarity=0.536 Sum_probs=172.7
Q ss_pred ceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
|.+.+.||.|++|.||++.+. ++.+|+|.+...... ...+.+.+|+..+++++|+|++++++++.... .
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------KQREEFLREIRILKKLKHPNIVKLYGVFEDPE--P 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCChhhheeeeecCC--c
Confidence 567789999999999999985 578999999764211 24567889999999999999999999987654 7
Q ss_pred eEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
.++++||+.+++|.+++......+++..++.++.+++.+|.+||+++++|+||+|.||+++ ..+.++|+|||.+..
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~----~~~~~~l~d~g~~~~ 147 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG----MDGLVKLADFGLARF 147 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeeCceeeE
Confidence 8899999999999999865433388999999999999999999999999999999999998 668999999999876
Q ss_pred ccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChh-hHHHHhhh
Q 040257 1124 KRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD-MHCG-AIIGGIVK 1189 (1254)
Q Consensus 1124 ~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~-~n~~-eliqsIlk 1189 (1254)
..... ......++..|++||.+. ....++.++|+|+||+++++|++|+.||.. .+.. .....+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 54432 223456788899999985 333577899999999999999999999977 4444 44444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=274.38 Aligned_cols=206 Identities=27% Similarity=0.376 Sum_probs=170.3
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC---CCceeEEeeeee
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH---HPNVVAFYGVVP 1037 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn---HPNIVkLyGvf~ 1037 (1254)
..+|..++.||.|+||.|++|.++ ...|+||.|.+..+..+.=....-.-.+--||.||..|+ |+||++++++|.
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 347999999999999999999996 345999999887544221111111122345999999997 999999999998
Q ss_pred cCCCCceEEEEEecc-cCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1038 DGTGGTLATVTEFMV-NGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~-GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
++. .+|++||... +.+|.++|. ....+++..+..|++|++.|+++||+.||||||||-+|+.++ ++|-+||+
T Consensus 640 ddd--~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd----~~g~~kli 712 (772)
T KOG1152|consen 640 DDD--YYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD----SNGFVKLI 712 (772)
T ss_pred cCC--eeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccccCceecccccccEEEe----cCCeEEEe
Confidence 776 8999999853 568888884 446799999999999999999999999999999999999999 89999999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~ 1177 (1254)
|||.+....+ .....+.||..|.|||++.|..| ....-|||+||++||.++....||.+
T Consensus 713 dfgsaa~~ks-gpfd~f~gtv~~aapevl~g~~y-~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 713 DFGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKY-LGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eccchhhhcC-CCcceeeeeccccchhhhCCCcc-CCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999865433 34556889999999999999875 46778999999999999998888864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-28 Score=260.36 Aligned_cols=253 Identities=28% Similarity=0.395 Sum_probs=192.9
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
|.+--+.||.|+||+||.+.+ +++.||+|++..- ...-...+++++|+++|..++|.|++..+++.+-..-+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv------fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d 127 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV------FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS 127 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH------HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence 445557899999999999988 5888999988642 22445578899999999999999999998876543321
Q ss_pred ---ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1043 ---TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1043 ---~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
.+|.+.|.| ..+|..+|.. ...++..++.-+++||++||+|||+.+|+||||||.|+|++ ++..+||||||
T Consensus 128 fFqEiYV~TELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN----SNCvLKICDFG 201 (449)
T KOG0664|consen 128 FFQELYVLTELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN----SNCILKICDFG 201 (449)
T ss_pred HHHHHHHHHHHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec----cCceEEecccc
Confidence 356677766 4566666643 45689999999999999999999999999999999999999 89999999999
Q ss_pred ccccccCccc--cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh--------
Q 040257 1120 LSRIKRNTLV--SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK-------- 1189 (1254)
Q Consensus 1120 LAr~~~~s~~--sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk-------- 1189 (1254)
+++..+.... .+...-|-.|.|||++.|.. .|+.++||||+|||+.||+..+..|...+.-+.++.+.+
T Consensus 202 LARvee~d~~~hMTqEVVTQYYRAPEiLMGaR-hYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E 280 (449)
T KOG0664|consen 202 LARTWDQRDRLNMTHEVVTQYYRAPELLMGAR-RYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE 280 (449)
T ss_pred cccccchhhhhhhHHHHHHHHhccHHHhhcch-hhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence 9986543322 12223577899999999874 699999999999999999999999976554433332221
Q ss_pred ---------------ccCC-CCCC--------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1190 ---------------NTLR-PTIP--------ERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1190 ---------------~~Lr-p~ip--------e~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
...+ +..+ ..-..+...++.++|..||++|.+..+.+.++.
T Consensus 281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1111 1111 122345667888999999999999998887763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=256.05 Aligned_cols=261 Identities=27% Similarity=0.461 Sum_probs=213.0
Q ss_pred cccCceEEEEEeeeCcEEEEEEEECC-------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~rG-------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
...+++....+-+|.||.||+|.|+. +.|-+|.++... .+-....++.|..+|..+.|||+..+.+
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-------S~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-------SQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-------cHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34467777889999999999998852 235556555321 2333566788999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhc-------cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLK-------KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD 1107 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~k-------re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd 1107 (1254)
++.++. ...+.++.++.-|+|..++.. ..+.++-.+...++.|++.|++|||+++|||.||-.+|++|+
T Consensus 355 V~ie~~-~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId--- 430 (563)
T KOG1024|consen 355 VSIEDY-ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID--- 430 (563)
T ss_pred EEeecc-CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh---
Confidence 987654 467788999999999999862 124477778889999999999999999999999999999999
Q ss_pred CCCCeEEEEeccccccccC---ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhH
Q 040257 1108 PQRPICKVGDFGLSRIKRN---TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAI 1183 (1254)
Q Consensus 1108 ~snG~VKLiDFGLAr~~~~---s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~el 1183 (1254)
+..+|||+|=.+++-.-. ......-.....||+||.+... .|+.++|+||||++||||+| |+.||.+.+..++
T Consensus 431 -d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 431 -DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM 507 (563)
T ss_pred -hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence 778999999999884321 1222223356779999999866 48999999999999999999 9999999988776
Q ss_pred HHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 040257 1184 IGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1184 iqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLE 1237 (1254)
..-+ +..++...|-+|+.++..++..||...|++||++.|+..-|.+....+.
T Consensus 508 ~~yl-kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 508 EHYL-KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred HHHH-hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 6544 5567788899999999999999999999999999999999988877664
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-27 Score=275.91 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=206.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|+.+.++|.|.||.||++++ +++..|+|+++..-- ....-+..|+-+++.++||||+.+++.+....
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--------dd~~~iqqei~~~~dc~h~nivay~gsylr~d- 85 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--------DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD- 85 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCC--------ccccccccceeeeecCCCcChHHHHhhhhhhc-
Confidence 4899999999999999999988 477799999986421 11344567899999999999999999887655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.++++||||.+|+|.++. ...+.+++.++..++++.++||+|||++|=+|||||-.|||++ +.+.|||+|||.+
T Consensus 86 -klwicMEycgggslQdiy-~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt----d~gDvklaDfgvs 159 (829)
T KOG0576|consen 86 -KLWICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT----DEGDVKLADFGVS 159 (829)
T ss_pred -CcEEEEEecCCCccccee-eecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec----ccCceeecccCch
Confidence 789999999999999976 3457899999999999999999999999999999999999999 8899999999998
Q ss_pred ccccCcc-ccCCCCCCCCccCccccc-CCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC---
Q 040257 1122 RIKRNTL-VSGGVRGTLPWMAPELLN-GSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI--- 1196 (1254)
Q Consensus 1122 r~~~~s~-~sts~~GT~~YmAPEVLr-G~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i--- 1196 (1254)
..+.... ....+.||+.|||||+-. +....|...+|||++|+...|+-.-++|-.+......+.-..+..+.+..
T Consensus 160 aqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkD 239 (829)
T KOG0576|consen 160 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKD 239 (829)
T ss_pred hhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccC
Confidence 6544332 234577999999999963 22345899999999999999999888887776666655555554444332
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
...+++.+.+|++.+|.++|++||+++.+|.+
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 34578899999999999999999999988863
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=254.58 Aligned_cols=249 Identities=27% Similarity=0.359 Sum_probs=194.7
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|.-++.+|.|.- .|..+-+ .+++||+|++... +.. ..-.++..+|+.++..++|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n-----~~~akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQN-----QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-ccc-----CccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 347888888999998 5655544 5889999998765 222 122356678999999999999999999986332
Q ss_pred ----CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1041 ----GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1041 ----~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
....|+||||| ..+|...+.. .++-.....|+.|++.|++|||+.||+||||||+||++. .+..+||+
T Consensus 89 ~l~~~~e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~----~~~~lKi~ 160 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN----SDCTLKIL 160 (369)
T ss_pred cHHHHHhHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec----chhheeec
Confidence 13578999998 7788888752 467788899999999999999999999999999999998 88999999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc------
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN------ 1190 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~------ 1190 (1254)
|||+++........+.+..|..|.|||++.+.. |...+||||+||++.||++|+..|.+.+.-+...++...
T Consensus 161 dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~--~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 161 DFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cchhhcccCcccccCchhheeeccCchheeccC--CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 999999777665666778999999999999886 788899999999999999999999765432221111100
Q ss_pred ------------------cC-----CCCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1191 ------------------TL-----RPTIP-----------ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1191 ------------------~L-----rp~ip-----------e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+ ...+| ..-...+++++.+||..+|++|.|++++|+|
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 00000 1123458899999999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=218.79 Aligned_cols=164 Identities=24% Similarity=0.357 Sum_probs=130.5
Q ss_pred CchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCccccCCC
Q 040257 1054 GSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGV 1133 (1254)
Q Consensus 1054 GSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~sts~ 1133 (1254)
|+|.+++..++..+++..++.|+.||+.||.|||+++ ||+|||++ .++.+|+ ||+++...... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~----~~~~~~~--fG~~~~~~~~~----~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT----WDGLLKL--DGSVAFKTPEQ----S 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc----Cccceee--ccceEeecccc----C
Confidence 6889999776677999999999999999999999998 99999998 7788999 99987654422 2
Q ss_pred CCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-hHHHHhhhccCCC-----CCCCCCcH--HHH
Q 040257 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG-AIIGGIVKNTLRP-----TIPERCDP--EWR 1205 (1254)
Q Consensus 1134 ~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~-eliqsIlk~~Lrp-----~ipe~iS~--eLr 1205 (1254)
.||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ..+..+....... ..+..++. ++.
T Consensus 65 ~g~~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (176)
T smart00750 65 RVDPYFMAPEVIQGQS--YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA 142 (176)
T ss_pred CCcccccChHHhcCCC--CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence 5899999999998764 788999999999999999999999765432 2233332221111 11122333 689
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1206 KLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1206 dLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
++|.+||..+|.+||++.++++++..+..+
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 999999999999999999999999877544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-23 Score=209.42 Aligned_cols=251 Identities=32% Similarity=0.495 Sum_probs=198.2
Q ss_pred ceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCC-ceeEEeeeeecCCCCce
Q 040257 966 LEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP-NVVAFYGVVPDGTGGTL 1044 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHP-NIVkLyGvf~Ddn~~~L 1044 (1254)
|.+...||.|+|+.||++.+. ..+++|.+....... ......+.+|+.++..+.|+ +|+++++++.... ..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESK-----SKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--SL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccc-----hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC--EE
Confidence 677889999999999999988 778999987653221 13467788999999999988 7999999995443 57
Q ss_pred EEEEEecccCchhhhhhccC--CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCC-eEEEEecccc
Q 040257 1045 ATVTEFMVNGSLKHVLLKKD--RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRP-ICKVGDFGLS 1121 (1254)
Q Consensus 1045 ~LVMEYm~GGSL~d~L~kre--~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG-~VKLiDFGLA 1121 (1254)
+++++|+.++++.+++.... ..+.......++.|++.++.|+|+.+++||||||+||+++ ..+ .++++|||.+
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~----~~~~~~~l~dfg~~ 149 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD----RDGRVVKLIDFGLA 149 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec----CCCCeEEEeccCcc
Confidence 89999999999997664443 2689999999999999999999999999999999999998 555 7999999998
Q ss_pred ccccCcc-------ccCCCCCCCCccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----hhHHHHhhh
Q 040257 1122 RIKRNTL-------VSGGVRGTLPWMAPELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHC----GAIIGGIVK 1189 (1254)
Q Consensus 1122 r~~~~s~-------~sts~~GT~~YmAPEVLrG~~-~kyS~KSDIWSLGVILYELLTGk~PF~~~n~----~eliqsIlk 1189 (1254)
+...... ......|+..|++||.+.+.. ..++...|+|++|++++++++|..||..... ......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 229 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence 7443322 235667999999999998742 3478899999999999999999999877653 333333333
Q ss_pred ccCC---CCCCCCC----cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1190 NTLR---PTIPERC----DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1190 ~~Lr---p~ipe~i----S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.... ....... ...+.+++.+|+..+|..|.+..+....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 2221 1111111 2578899999999999999988877765
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=276.19 Aligned_cols=201 Identities=20% Similarity=0.238 Sum_probs=145.4
Q ss_pred hcCCC-CceeEEeeeeec----C-CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCccccc
Q 040257 1022 SNLHH-PNVVAFYGVVPD----G-TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFD 1095 (1254)
Q Consensus 1022 krLnH-PNIVkLyGvf~D----d-n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRD 1095 (1254)
+.++| .||++++++|.. . ....++++|||+ +++|.+++......+++..++.|+.||+.||.|||++||||||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 34455 578888887721 1 113577788887 7799999976566799999999999999999999999999999
Q ss_pred CCCCceEeccCC---------------CCCCeEEEEeccccccccCc-----------------cccCCCCCCCCccCcc
Q 040257 1096 LKCENLLVNLRD---------------PQRPICKVGDFGLSRIKRNT-----------------LVSGGVRGTLPWMAPE 1143 (1254)
Q Consensus 1096 LKPeNILLDsdd---------------~snG~VKLiDFGLAr~~~~s-----------------~~sts~~GT~~YmAPE 1143 (1254)
|||+||||+..+ ...+.+||+|||+++..... .......||+.|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 999999996210 13456777788877532110 0011235889999999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 040257 1144 LLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFT 1223 (1254)
Q Consensus 1144 VLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSAr 1223 (1254)
++.+.. |+.++|||||||+||||++|..||.... .....+....+.+.... ..+....++.+||.++|.+||++.
T Consensus 186 ~~~~~~--~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~L~~~P~~Rps~~ 260 (793)
T PLN00181 186 EDNGSS--SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILL-NWPKEASFCLWLLHPEPSCRPSMS 260 (793)
T ss_pred hhccCC--CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhh-cCHHHHHHHHHhCCCChhhCcChH
Confidence 998764 7899999999999999999998876422 12222222222221111 245567899999999999999999
Q ss_pred HHHHH
Q 040257 1224 EITSR 1228 (1254)
Q Consensus 1224 ELLe~ 1228 (1254)
|++++
T Consensus 261 eil~h 265 (793)
T PLN00181 261 ELLQS 265 (793)
T ss_pred HHhhc
Confidence 99875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=235.84 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=187.2
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~ 1041 (1254)
.|.+.+.||+|.||.+.+++++ ++.+++|.+.+.. ....+|.+|...--.| .|.||+.-|++... +.
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---------tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq-t~ 94 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---------TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ-TS 94 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---------hhHHHHHHHhccceeeccchhhhHHHHHHhh-cC
Confidence 5788899999999999999997 4569999987652 2357788998766555 58999988876332 33
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
+.+++++||++.|+|..-+.. ..+.+.....++.|++.||.|+|++++||||||.+||||... +..+|||||||++
T Consensus 95 d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~--df~rvKlcDFG~t 170 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA--DFYRVKLCDFGLT 170 (378)
T ss_pred ceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC--CccEEEeeecccc
Confidence 488999999999999988733 457889999999999999999999999999999999999743 4569999999998
Q ss_pred ccccCccccCCCCCCCCccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh----hHHHHhhhccCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTGEEPYADMHCG----AIIGGIVKNTLRP 1194 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~---~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~----eliqsIlk~~Lrp 1194 (1254)
+....... ....+..|.+||++... .+...+.+|||.||+++|.++||++||+..... ....... +...+
T Consensus 171 ~k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~-~rk~~ 247 (378)
T KOG1345|consen 171 RKVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL-KRKNP 247 (378)
T ss_pred cccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh-cccCc
Confidence 75433211 12356679999987533 234567799999999999999999999743211 1111221 12222
Q ss_pred CCC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1195 TIP---ERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1195 ~ip---e~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
..| ..+++.+.++.++-|..++++|--..+....-
T Consensus 248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 333 34678889999999999999995555444443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-23 Score=229.11 Aligned_cols=260 Identities=22% Similarity=0.270 Sum_probs=199.4
Q ss_pred CceEEEEEeeeCcEEEEEEEECCc---eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC----CCceeEEeeeee
Q 040257 965 DLEELRELGSGTYGTVYHGKWRGS---DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH----HPNVVAFYGVVP 1037 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~rGs---~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn----HPNIVkLyGvf~ 1037 (1254)
.|.+.+.||+|+||.||++..... .+|+|......... ...+..|+.++..+. ..++..+++...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--------~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--------PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--------CccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 799999999999999999998543 58888876532111 114556788888776 358888888874
Q ss_pred cCCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC-CCCCeEEE
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD-PQRPICKV 1115 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd-~snG~VKL 1115 (1254)
.....-++||+.+ |.+|.++..... +.++...++.|+.|++.+|++||+.|+|||||||.|+++.... .....+.|
T Consensus 91 -~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 91 -STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred -CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEE
Confidence 2333778899976 999999875554 7899999999999999999999999999999999999998432 12257999
Q ss_pred Eecccccccc---Cc-------cc-cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 040257 1116 GDFGLSRIKR---NT-------LV-SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAII 1184 (1254)
Q Consensus 1116 iDFGLAr~~~---~s-------~~-sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eli 1184 (1254)
.|||+++... .. .. ...+.||..|+++.+..+.. .+++.|+|||++++.+|+.|..||.........
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e--~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE--QGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc--cCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 9999998211 11 11 23456999999999998774 789999999999999999999999776543333
Q ss_pred HHhhhccCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1185 GGIVKNTLRPT---IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1185 qsIlk~~Lrp~---ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
..+........ .....+.++..++..+-..+...+|.+..+...|+.+..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 33322211111 23445678889999999999999999999999998887765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=245.29 Aligned_cols=244 Identities=20% Similarity=0.319 Sum_probs=188.0
Q ss_pred CceEEEEEeeeCcEEEEEEEE-----CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeec
Q 040257 965 DLEELRELGSGTYGTVYHGKW-----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPD 1038 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~-----rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~D 1038 (1254)
.|..+++||+|.|++||++.+ +.+.||+|.+..... ..++.+|+++|..+ .+.||+++.+++..
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----------p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----------PSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----------chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 688999999999999999876 345699999875432 35688999999988 58999999999975
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.+ ..++||||++.....++. ..++...+.++++.++.||.++|.+|||||||||.|+|.+ ...+.-.|+||
T Consensus 107 nd--~v~ivlp~~~H~~f~~l~----~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n---~~t~rg~LvDF 177 (418)
T KOG1167|consen 107 ND--QVAIVLPYFEHDRFRDLY----RSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN---RRTQRGVLVDF 177 (418)
T ss_pred CC--eeEEEecccCccCHHHHH----hcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc---cccCCceEEec
Confidence 54 899999999999988887 3477899999999999999999999999999999999998 35667789999
Q ss_pred cccccccC---------------cc------------------------------ccCCCCCCCCccCcccccCCCCCCC
Q 040257 1119 GLSRIKRN---------------TL------------------------------VSGGVRGTLPWMAPELLNGSSNRVS 1153 (1254)
Q Consensus 1119 GLAr~~~~---------------s~------------------------------~sts~~GT~~YmAPEVLrG~~~kyS 1153 (1254)
|++...+. .. ......||++|.|||++...+. -+
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~-Qt 256 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR-QT 256 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC-cC
Confidence 99861000 00 0011349999999999987764 47
Q ss_pred chhHHHHHHHHHHHHHcCCCCCCCCChh--------------hHHHH-hhhcc---------------------C-----
Q 040257 1154 EKVDVFSFGISMWEILTGEEPYADMHCG--------------AIIGG-IVKNT---------------------L----- 1192 (1254)
Q Consensus 1154 ~KSDIWSLGVILYELLTGk~PF~~~n~~--------------eliqs-Ilk~~---------------------L----- 1192 (1254)
.++||||.|+|++-+++++.||.....+ ++.+. ...+. +
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 8899999999999999999998532110 00000 00000 0
Q ss_pred ---------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 ---------RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 ---------rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.....+..+..+.+|+.+||..||.+|.|+++.|.+
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 000112234578899999999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=207.94 Aligned_cols=262 Identities=18% Similarity=0.258 Sum_probs=209.6
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVP 1037 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~ 1037 (1254)
+....|+++++||+|+||.++.|+. .+.+||||.-....- .-++.-|...++.| ..+.|..+|-|-.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----------APQLrdEYr~YKlL~g~~GIP~vYYFGq 94 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----------APQLRDEYRTYKLLGGTEGIPQVYYFGQ 94 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC----------cchHHHHHHHHHHHcCCCCCCceeeecc
Confidence 3445799999999999999999987 689999997654321 23455678888877 4788988887765
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCC-CCCeEEEE
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDP-QRPICKVG 1116 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~-snG~VKLi 1116 (1254)
++- +=.+|||.+ |-||.+++.-.++.|+.+.+.-++.|++.-|+|+|++.+|+|||||+|+||...+. ....|.|+
T Consensus 95 eG~--~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 95 EGK--YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred ccc--hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEE
Confidence 554 456799987 89999999888899999999999999999999999999999999999999985443 34568999
Q ss_pred eccccccccCcc--------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---hhHHH
Q 040257 1117 DFGLSRIKRNTL--------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC---GAIIG 1185 (1254)
Q Consensus 1117 DFGLAr~~~~s~--------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~---~eliq 1185 (1254)
|||+|+...... ......||.+||+=.-..|. .-+.+.|+-|||-+++++|-|..||.+... .+.++
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe 249 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE 249 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH
Confidence 999998655432 23345799999998888766 368999999999999999999999987643 34444
Q ss_pred HhhhccCC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 040257 1186 GIVKNTLR---PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1186 sIlk~~Lr---p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLE 1237 (1254)
+|-..... ..+...++.++...++..-..+-.+-|+++-+...+.++++.+.
T Consensus 250 KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 250 KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 44332221 12346788999999999999999999999999999999988653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=214.58 Aligned_cols=163 Identities=21% Similarity=0.140 Sum_probs=123.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC---CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeE-EeeeeecC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR---GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVA-FYGVVPDG 1039 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r---Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVk-LyGvf~Dd 1039 (1254)
.+|++.+.||+|+||+||+|.++ ++.+|||++....... ........+.+|+++|++++|+||+. ++++
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~---~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWW---SKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccccc---ccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 47999999999999999999873 5668999875321100 01223566899999999999999985 5432
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccC-CCCceEeccCCCCCCeEEEEec
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDL-KCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDL-KPeNILLDsdd~snG~VKLiDF 1118 (1254)
...++||||+.|++|.. +. . .. ...++.+++++|.|||++||+|||| ||+|||++ .++.+||+||
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~-~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~----~~~~ikLiDF 156 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-AR-P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG----PDGEAAVIDF 156 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hC-c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc----CCCCEEEEEC
Confidence 25789999999999963 21 1 11 1467889999999999999999999 99999997 6678999999
Q ss_pred cccccccCcc---------ccCCCCCCCCccCcccccC
Q 040257 1119 GLSRIKRNTL---------VSGGVRGTLPWMAPELLNG 1147 (1254)
Q Consensus 1119 GLAr~~~~s~---------~sts~~GT~~YmAPEVLrG 1147 (1254)
|+|+...... ......+++.|+|||.+..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9998543221 1134568888999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=200.60 Aligned_cols=259 Identities=20% Similarity=0.296 Sum_probs=204.4
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCC-CceeEEeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH-PNVVAFYGVV 1036 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnH-PNIVkLyGvf 1036 (1254)
.+....|.++++||.|+||.+|+|.. .|..||||+-....- ..++..|..+++.|++ ..|..+..+.
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----------hpqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----------HPQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----------CcchhHHHHHHHHhccCCCCchhhhhc
Confidence 34456899999999999999999987 588999998764321 1346678888888864 5666776666
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.+.. +-.+||+.+ |-+|.+.+.-..+.++...++-++-|++.-|+|+|.+++|||||||+|+|+.... ....+.|+
T Consensus 81 ~e~~--ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr-h~~kl~LI 156 (341)
T KOG1163|consen 81 TEKD--YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR-HCNKLYLI 156 (341)
T ss_pred cccc--cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc-ccceEEEE
Confidence 5544 667899987 8999999877778899999999999999999999999999999999999997433 45578999
Q ss_pred eccccccccCc--------cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---hHHH
Q 040257 1117 DFGLSRIKRNT--------LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG---AIIG 1185 (1254)
Q Consensus 1117 DFGLAr~~~~s--------~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~---eliq 1185 (1254)
|||+|+..... .......||..|.+-....+.. -+.+.|+-|+|.+|..+.-|..||++.... +..+
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e--qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE 234 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE--QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE 234 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhh--hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence 99999854322 1223456999999988777553 578899999999999999999999986543 3333
Q ss_pred HhhhccCC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1186 GIVKNTLR---PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1186 sIlk~~Lr---p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
.|...... ..+...+|.++.-.+..|-..--++-|+..-+.+.++.|+.
T Consensus 235 kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 235 KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 44433322 23456789999999999999999999999988888877765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-21 Score=231.96 Aligned_cols=250 Identities=26% Similarity=0.342 Sum_probs=184.2
Q ss_pred EEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceE
Q 040257 968 ELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~ 1045 (1254)
....+|.|++|.|+..... .+.++.|.+... .. ...........+..|+.+-..|+|+|++..+..+.+.. ...
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--~~~ 397 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--GIL 397 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--cch
Confidence 3467999999988776652 333444544321 00 11122333333777888888999999988887776544 233
Q ss_pred EEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1046 TVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
-.||||++ +|..++... ..+....+-.++.|++.||+|+|+.||.|||||++|+++. ..+.+||+|||.+....
T Consensus 398 ~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~----~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT----ENGILKIIDFGAASVFR 471 (601)
T ss_pred hhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe----cCCceEEeecCcceeec
Confidence 34999999 999888443 5688999999999999999999999999999999999999 78899999999987543
Q ss_pred Cc-----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH-HHhh-hccC-----C
Q 040257 1126 NT-----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAII-GGIV-KNTL-----R 1193 (1254)
Q Consensus 1126 ~s-----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eli-qsIl-k~~L-----r 1193 (1254)
.. .....++|+..|+|||++.+..++ .+..||||.|++++.|++|+.||.-....+.. .... .... .
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~yd-pr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYD-PRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP 550 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccC-cchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence 22 345678899999999999987643 46799999999999999999999654332221 1110 0000 0
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+...++.+.+.+|.+||+.+|.+|.++++|++.
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 11234467788999999999999999999999863
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-21 Score=231.10 Aligned_cols=233 Identities=28% Similarity=0.408 Sum_probs=189.7
Q ss_pred EeeeCcEEEEEEEE-----CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCCCCceE
Q 040257 972 LGSGTYGTVYHGKW-----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 972 LGeGsFGtVYlAk~-----rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn~~~L~ 1045 (1254)
+|+|+||.|++++. .+.-+|+|+.++......... ....|..++..++ ||.+++++-.|+.+. .++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~------~t~~er~il~~~~~~~f~v~lhyafqt~~--kl~ 73 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT------HTKQERIILAFVHNTPFLVKLHYAFQTDG--KLY 73 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc------ccccHHHHHhhccCCCceeeeeeeecccc--chh
Confidence 79999999997543 466799999987654433222 3445778888886 999999998887655 788
Q ss_pred EEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1046 TVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
+++++..+|.|...+.+. ..+.+.....+..+++.+++++|+.+|+|||+|++||+++ .+|++|+.|||+++...
T Consensus 74 l~ld~~rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld----~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 74 LILDFLRGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL----LEGHIKLTDFGLSKEAV 148 (612)
T ss_pred HhhhhcccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec----ccCccccCCchhhhHhH
Confidence 999999999999887443 5578888888999999999999999999999999999999 88999999999998654
Q ss_pred CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHH
Q 040257 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWR 1205 (1254)
Q Consensus 1126 ~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLr 1205 (1254)
..... |||..|||||++++ ...++|+||||+++|||+||..||.. +....|.+. ....|...+..++
T Consensus 149 ~~~~~---cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~--~~~~p~~l~~~a~ 215 (612)
T KOG0603|consen 149 KEKIA---CGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA--ELEMPRELSAEAR 215 (612)
T ss_pred hhhhc---ccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--ccCCchhhhHHHH
Confidence 44333 89999999999983 46679999999999999999999998 445555543 3456788899999
Q ss_pred HHHHHhhhcCCCCCCCH--HHHHHHHH
Q 040257 1206 KLMEQCWAADPEARPSF--TEITSRLR 1230 (1254)
Q Consensus 1206 dLIkKCLqkDPeKRPSA--rELLe~Le 1230 (1254)
+++..++.++|.+|... .-+.++++
T Consensus 216 ~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 216 SLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred HHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 99999999999999744 44554443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.3e-20 Score=199.16 Aligned_cols=252 Identities=28% Similarity=0.496 Sum_probs=203.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 964 VDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
.++.++.+|.+...|..|+|+|.+..++.|+++...+ ..+...+|..|.-.|+-+.||||+.+++.|..+. .
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~------t~risrdfneefp~lrifshpnilpvlgacnspp--n 261 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREV------TARISRDFNEEFPALRIFSHPNILPVLGACNSPP--N 261 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCcchhhhhhhhhhc------chhhcchhhhhCcceeeecCCchhhhhhhccCCC--C
Confidence 3556667899999999999999999999999875432 2334567888888999999999999999997664 7
Q ss_pred eEEEEEecccCchhhhhhccCC-CCCHHHHHHHHHHhhhhhHHhhhCC-ccc-ccCCCCceEeccCCCCCCeEEEE--ec
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDR-SLDRRKKLIIAMDAAFGMEYLHSKN-IVH-FDLKCENLLVNLRDPQRPICKVG--DF 1118 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~-~LSe~~~lkIa~QIAeALaYLHSkG-IIH-RDLKPeNILLDsdd~snG~VKLi--DF 1118 (1254)
+.+|..||+-|+|..+++.... ..+-.++.+++.+|++|+.|||+.. +|- --|....++|| ++...+|. |-
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid----edltarismad~ 337 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID----EDLTARISMADT 337 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec----chhhhheecccc
Confidence 8999999999999999976543 3677789999999999999999863 443 36888899998 55555543 32
Q ss_pred cccccccCccccCCCCCCCCccCcccccCCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRV-SEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1119 GLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~ky-S~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
-++. ...+..-.+.||+||.++..+... -.++|+|||.++||||.|...||.+...-+.-.++..+.++..+|
T Consensus 338 kfsf------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip 411 (448)
T KOG0195|consen 338 KFSF------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP 411 (448)
T ss_pred eeee------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC
Confidence 2221 112233578899999998765433 357899999999999999999999988777777777788899999
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
..++..+.+|++-|+..||.+||.+..++-.|+++.
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 999999999999999999999999999999888763
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-19 Score=201.01 Aligned_cols=264 Identities=24% Similarity=0.286 Sum_probs=185.2
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEECC-------------------------------------ceEEEEEEeccccCCC
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWRG-------------------------------------SDVAIKRIKKSCFAGR 1003 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~rG-------------------------------------s~VAIKvIkk~~~~~~ 1003 (1254)
+.-++|++...||+|+...||.+.... -+.|||.+..-..
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~--- 230 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH--- 230 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc---
Confidence 344589999999999999999765310 0245665543221
Q ss_pred chhHHHHHHHHHHHHH--------------HHhcC--------CCCceeEEeeeeecC----------------------
Q 040257 1004 SSEQERLTKDFWREAH--------------ILSNL--------HHPNVVAFYGVVPDG---------------------- 1039 (1254)
Q Consensus 1004 ~~e~ee~~eqFlrEIe--------------ILkrL--------nHPNIVkLyGvf~Dd---------------------- 1039 (1254)
......+.+...+|+- ..+.+ +|||||+++++|.+.
T Consensus 231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~ 310 (598)
T KOG4158|consen 231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS 310 (598)
T ss_pred CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence 1223333444444421 11111 599999998876431
Q ss_pred ---CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1040 ---TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1040 ---n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
....+|+||..+ ..+|..++-.+ ..+.....-|+.|+++|+.|||++||.|||+|.+||||..++..-..+.|+
T Consensus 311 g~g~~~tlylvMkrY-~~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRY-RQTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred ccCCCceEEEehhcc-hhhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 224688888876 56788887443 467778888999999999999999999999999999998887788899999
Q ss_pred eccccccccCcc-------ccCCCCCCCCccCcccccCCCCCC----CchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 040257 1117 DFGLSRIKRNTL-------VSGGVRGTLPWMAPELLNGSSNRV----SEKVDVFSFGISMWEILTGEEPYADMHCGAIIG 1185 (1254)
Q Consensus 1117 DFGLAr~~~~s~-------~sts~~GT~~YmAPEVLrG~~~ky----S~KSDIWSLGVILYELLTGk~PF~~~n~~eliq 1185 (1254)
|||++-..+... ..-..-|.-.-||||+..-.+... -.|+|.|+.|.+.||+++...||.......+-.
T Consensus 388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~ 467 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT 467 (598)
T ss_pred ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech
Confidence 999875322211 111233677799999987554321 147999999999999999999998733222111
Q ss_pred HhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1186 GIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1186 sIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
....+...+.++..+++.+++++..+|+.||.+|++.+-..+.|+
T Consensus 468 r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 468 RTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 223333446788999999999999999999999998765555543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.4e-20 Score=225.80 Aligned_cols=243 Identities=20% Similarity=0.209 Sum_probs=176.7
Q ss_pred CceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCce
Q 040257 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTL 1044 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L 1044 (1254)
++...+.||.+.|=+|.+++++...|+||++.+..- .-.-+. .++-++|++ ...+++||++.+.-+...+ ..-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p---~~sL~~-~~qrL~~ik-~~l~~~pn~lPfqk~~~t~--kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDP---TISLRP-FKQRLEEIK-FALMKAPNCLPFQKVLVTD--KAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCC---CCCchH-HHHHHHHHH-HHhhcCCcccchHHHHHhh--HHH
Confidence 677788999999999999999877799999876531 111122 233344555 6667899999987664433 256
Q ss_pred EEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc-
Q 040257 1045 ATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI- 1123 (1254)
Q Consensus 1045 ~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~- 1123 (1254)
|+|-+|. .-+|.+.+..+ .-+...+..+|+.||+.||.-+|..||+|+|||.+||||+ +-..+.|+||..-+.
T Consensus 97 ylvRqyv-khnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT----SWNW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT----SWNWLYLTDFASFKPT 170 (1431)
T ss_pred HHHHHHH-hhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe----eechhhhhcccccCCc
Confidence 6677776 66888888554 2367788889999999999999999999999999999999 778899999986542
Q ss_pred ---ccCccccC----CCCCCCCccCcccccCCC--------CC-CCchhHHHHHHHHHHHHHc-CCCCCCCCCh------
Q 040257 1124 ---KRNTLVSG----GVRGTLPWMAPELLNGSS--------NR-VSEKVDVFSFGISMWEILT-GEEPYADMHC------ 1180 (1254)
Q Consensus 1124 ---~~~s~~st----s~~GT~~YmAPEVLrG~~--------~k-yS~KSDIWSLGVILYELLT-Gk~PF~~~n~------ 1180 (1254)
.+++...+ +......|.|||++.... .. .+++-||||+||+++||++ |++||.-..-
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~ 250 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG 250 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc
Confidence 22222222 222345699999986421 12 5788999999999999988 8999862211
Q ss_pred -hhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1181 -GAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1181 -~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
....+..+. +--+..++++|..|++.||.+|.++++.|+.
T Consensus 251 ~~~~~e~~Le--------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLE--------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHH--------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111111111 1124579999999999999999999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=188.97 Aligned_cols=176 Identities=11% Similarity=0.071 Sum_probs=132.8
Q ss_pred cccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHH------HHHHHHHHhcCCCCceeEEeee
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKD------FWREAHILSNLHHPNVVAFYGV 1035 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eq------FlrEIeILkrLnHPNIVkLyGv 1035 (1254)
-..+|+++++||.|+||.||+....+..+|||++...... .+..... +.+|+..+.++.|++|..+.++
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~-----~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKR-----TERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCc-----hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 3558999999999999999998777778999999754211 2222233 5789999999999999999888
Q ss_pred eecCC------CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCC
Q 040257 1036 VPDGT------GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQ 1109 (1254)
Q Consensus 1036 f~Ddn------~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~s 1109 (1254)
+.+.. ....+++|||++|.+|.++. .+++ ....+++.+|..||+.||+||||||.||+++ .
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~----~ 170 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS----K 170 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe----C
Confidence 66432 13578999999999998863 2332 2456899999999999999999999999998 5
Q ss_pred CCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHH
Q 040257 1110 RPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEIL 1169 (1254)
Q Consensus 1110 nG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELL 1169 (1254)
++ ++|+|||............ .++... .|..++|+|+||+++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~d-----------~~vler--~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAKD-----------RIDLER--HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhHH-----------HHHHHh--HhcccccccceeEeehHHH
Confidence 56 9999999886543221111 122222 2557899999999987654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.7e-19 Score=214.62 Aligned_cols=204 Identities=31% Similarity=0.471 Sum_probs=153.7
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|+.++.|..|+||.||+++++ .+.+|+| +.+..+ +.+- +|.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------------ilRn--ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------------ILRN--ILTFAGNPFVV---------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------------hhhc--cccccCCccee----------
Confidence 348999999999999999999886 6779984 433211 0110 33333333333
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
|+....++ .-+.++... +.+++|||+-||+|||+||+|.||+ .-|++|++|||+
T Consensus 136 -------------gDc~tllk-~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT----~mGhiKlTDfgL 189 (1205)
T KOG0606|consen 136 -------------GDCATLLK-NIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLIT----SMGHIKLTDFGL 189 (1205)
T ss_pred -------------chhhhhcc-cCCCCcchh--------hHHhHhhccCCeecCCCCCCcceee----ecccccccchhh
Confidence 33344332 223344332 7789999999999999999999999 889999999999
Q ss_pred cccccCc----------------cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 040257 1121 SRIKRNT----------------LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAII 1184 (1254)
Q Consensus 1121 Ar~~~~s----------------~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eli 1184 (1254)
++..-.. ......|||+.|.|||++..+. |...+|||++|+|+||++-|+.||.+...++++
T Consensus 190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg--ygkpvdwwamGiIlyeFLVgcvpffGdtpeelf 267 (1205)
T KOG0606|consen 190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG--YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 267 (1205)
T ss_pred hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc--cCCCccHHHHHHHHHHHheeeeeccCCCHHHHH
Confidence 8743211 1123468999999999998664 888899999999999999999999999988888
Q ss_pred HHhhhcc-CCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 040257 1185 GGIVKNT-LRPTIPERCDPEWRKLMEQCWAADPEARP 1220 (1254)
Q Consensus 1185 qsIlk~~-Lrp~ipe~iS~eLrdLIkKCLqkDPeKRP 1220 (1254)
..++... .+++-...++++++++|.++|..+|..|.
T Consensus 268 g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 268 GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 8776543 33444566789999999999999999995
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.5e-18 Score=182.22 Aligned_cols=191 Identities=15% Similarity=0.027 Sum_probs=143.0
Q ss_pred eEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCCCCceE
Q 040257 967 EELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 967 eiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn~~~L~ 1045 (1254)
.+...|++|+||+||++...+..++.+.+....+.. .......+.+|+++|++|. |++|++++++. ..+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~----~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWL----RGVAWWLARREALALRQLDGLPRTPRLLHWD------GRH 74 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhh----hhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEE
Confidence 356789999999999888888888888776543221 1122335789999999995 58899998862 468
Q ss_pred EEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccC-CCCceEeccCCCCCCeEEEEeccccccc
Q 040257 1046 TVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDL-KCENLLVNLRDPQRPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDL-KPeNILLDsdd~snG~VKLiDFGLAr~~ 1124 (1254)
++|||+.|.+|...+.. ....++.|++.+|.++|++||+|||| ||+|||++ .++.++|+|||++...
T Consensus 75 lvmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~----~~g~i~LIDFG~A~~~ 142 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ----EDGSPAVIDFQLAVRG 142 (218)
T ss_pred EEEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc----CCCCEEEEECCCceec
Confidence 99999999888654311 12357789999999999999999999 79999998 6778999999999854
Q ss_pred cCccc--------------cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 040257 1125 RNTLV--------------SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH 1179 (1254)
Q Consensus 1125 ~~s~~--------------sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n 1179 (1254)
..... ......++.|++|+..+-....--.+.+|++.|+-+|.++|+..++.+..
T Consensus 143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 43221 01123678889998765432112267899999999999999999876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-18 Score=178.06 Aligned_cols=145 Identities=22% Similarity=0.184 Sum_probs=107.7
Q ss_pred EEEeeeCcEEEEEEEE-CCceEEEEEEeccccCCCch------------------hHHHHHHHHHHHHHHHhcCCCCcee
Q 040257 970 RELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAGRSS------------------EQERLTKDFWREAHILSNLHHPNVV 1030 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~~~~------------------e~ee~~eqFlrEIeILkrLnHPNIV 1030 (1254)
..||+|+||.||+|.+ +|+.||||+++......... ..........+|+.++.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 5799999999999987 58899999998653211100 0001122335699999999877764
Q ss_pred EEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHh-hhCCcccccCCCCceEeccCCCC
Q 040257 1031 AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL-HSKNIVHFDLKCENLLVNLRDPQ 1109 (1254)
Q Consensus 1031 kLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYL-HSkGIIHRDLKPeNILLDsdd~s 1109 (1254)
....+... ..+|||||+.+++|...+.. ...++...++.++.|++.+|.+| |+.||+||||||+|||++
T Consensus 83 ~p~~~~~~----~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----- 152 (190)
T cd05147 83 CPEPILLK----SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----- 152 (190)
T ss_pred CCcEEEec----CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-----
Confidence 33322211 23799999988777655433 35789999999999999999999 799999999999999997
Q ss_pred CCeEEEEeccccccc
Q 040257 1110 RPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1110 nG~VKLiDFGLAr~~ 1124 (1254)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 257999999998744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=170.71 Aligned_cols=147 Identities=20% Similarity=0.142 Sum_probs=110.0
Q ss_pred EEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCC------------------chhHHHHHHHHHHHHHHHhcCCCCce
Q 040257 969 LRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGR------------------SSEQERLTKDFWREAHILSNLHHPNV 1029 (1254)
Q Consensus 969 LkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~------------------~~e~ee~~eqFlrEIeILkrLnHPNI 1029 (1254)
.+.||+|++|.||+|.+. |+.||||+++....... ..........+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999884 88999999986521100 00111112334679999999999887
Q ss_pred eEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCC
Q 040257 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDP 1108 (1254)
Q Consensus 1030 VkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~ 1108 (1254)
.....+... ..++||||+.++++...+.. ...++......++.|++.+|.+||+ .||+||||||+|||++
T Consensus 82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~---- 152 (190)
T cd05145 82 PVPEPILLK----KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH---- 152 (190)
T ss_pred CCceEEEec----CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----
Confidence 544333322 23799999988865443322 3457888999999999999999999 9999999999999996
Q ss_pred CCCeEEEEecccccccc
Q 040257 1109 QRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1109 snG~VKLiDFGLAr~~~ 1125 (1254)
++.++|+|||+++...
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 3679999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-17 Score=182.55 Aligned_cols=237 Identities=17% Similarity=0.206 Sum_probs=149.3
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCC----------CceeEE
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH----------PNVVAF 1032 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnH----------PNIVkL 1032 (1254)
.+.....||.|+++.||.+++. ++.+|||++.... .......+++.+|.-....+.+ -.++.-
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-----~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-----DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-----TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-----ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 3566788999999999999994 6889999987553 1123335666666654444322 122222
Q ss_pred eeeee---------cCC-CC-----ceEEEEEecccCchhhhhh---ccCCC---CCHHHHHHHHHHhhhhhHHhhhCCc
Q 040257 1033 YGVVP---------DGT-GG-----TLATVTEFMVNGSLKHVLL---KKDRS---LDRRKKLIIAMDAAFGMEYLHSKNI 1091 (1254)
Q Consensus 1033 yGvf~---------Ddn-~~-----~L~LVMEYm~GGSL~d~L~---kre~~---LSe~~~lkIa~QIAeALaYLHSkGI 1091 (1254)
++... ... .. ..+++|+-+ .++|..++. ..... +....++.+..|+++.+++||..||
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 22111 111 00 235677765 667777642 22222 3344556677899999999999999
Q ss_pred ccccCCCCceEeccCCCCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCC------CCCCCchhHHHHHHHHH
Q 040257 1092 VHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGS------SNRVSEKVDVFSFGISM 1165 (1254)
Q Consensus 1092 IHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~------~~kyS~KSDIWSLGVIL 1165 (1254)
+|+||||+|+|++ .+|.++|+||+........... ...+..|.+||..... .-.++.+.|.|+||+++
T Consensus 167 VHgdi~~~nfll~----~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 167 VHGDIKPENFLLD----QDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp EEST-SGGGEEE-----TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred EecccceeeEEEc----CCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 9999999999999 8899999999887654443332 2355789999987432 12478999999999999
Q ss_pred HHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 040257 1166 WEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEAR 1219 (1254)
Q Consensus 1166 YELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKR 1219 (1254)
|.|++|..||........... .+ ..+. .+++.++.||..+|+++|++|
T Consensus 241 y~lWC~~lPf~~~~~~~~~~~----~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEADPEW----DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGSTSGG----GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCccccccc----cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999986543322211 11 1233 789999999999999999988
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1e-16 Score=164.76 Aligned_cols=142 Identities=21% Similarity=0.271 Sum_probs=112.6
Q ss_pred EEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEE
Q 040257 970 RELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTE 1049 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVME 1049 (1254)
+.||+|++|.||+|.+.+..+++|+..................++.+|+.++..+.|++|.....++.+.. ..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIVME 79 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEEEE
Confidence 57999999999999999999999987643222111122223456788999999999988876665554443 5788999
Q ss_pred ecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1050 FMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1050 Ym~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
|++|++|.+++.... . ....++.+++.+|.+||+.+++|+|++|.|||++ .+.++|+|||+++.
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-----~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-----GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-----CCCEEEEECCcccC
Confidence 999999999884321 2 7788999999999999999999999999999997 35799999999854
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.6e-17 Score=202.10 Aligned_cols=252 Identities=20% Similarity=0.273 Sum_probs=181.7
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC---CCceeEEeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH---HPNVVAFYGV 1035 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn---HPNIVkLyGv 1035 (1254)
.+.+..|.+-+.||+|+||+||+|.. +++.||||+=+..+.. +|.--.+++.+|+ -+-|.++...
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-----------EfYI~~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-----------EFYICLQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-----------eeeehHHHHHhhchhhhcchHHHHHH
Confidence 34556788999999999999999987 5778999987754322 1222233444444 1223333333
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEecc---CCCCCCe
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNL---RDPQRPI 1112 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDs---dd~snG~ 1112 (1254)
+.-.+ ..++|+||.+.|+|.+++. ..+.+++..+..++.|++..|++||..+|||+||||+|+||.. .+....-
T Consensus 763 ~~~~~--~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 763 HVFQN--ASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred HccCC--cceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence 32233 4578999999999999996 5567999999999999999999999999999999999999962 2234567
Q ss_pred EEEEeccccc---cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh
Q 040257 1113 CKVGDFGLSR---IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1113 VKLiDFGLAr---~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk 1189 (1254)
++|+|||.+. ...+.......++|-.+-.+|+..|.+ |+..+|.|.|..+++-||.|+.-= ...
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp--WtYq~DyfGlAa~~h~mLFG~y~q-----------~~~ 906 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP--WTYQIDYFGLAATVHVMLFGKYME-----------VKN 906 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC--CchhhhhHHHHHHHHHHHHHHHHH-----------hcC
Confidence 9999999885 233444556677899999999999886 888999999999999999987521 111
Q ss_pred ccCC---CCCCCCC-cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1190 NTLR---PTIPERC-DPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1190 ~~Lr---p~ipe~i-S~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
+..+ ..++..+ -.-|.+|+..+|..|-..=|...+|...|+..+.....
T Consensus 907 g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~ 959 (974)
T KOG1166|consen 907 GSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFT 959 (974)
T ss_pred CcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence 1110 0111111 23477899999985444457888888888777766554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.6e-17 Score=172.60 Aligned_cols=143 Identities=21% Similarity=0.248 Sum_probs=106.3
Q ss_pred ceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-----CCCceeEEeeeeecCC
Q 040257 966 LEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-----HHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-----nHPNIVkLyGvf~Ddn 1040 (1254)
+.-...||+|+|+.||....... .+||++.... ....+.+.+|+.+++.+ .||||+++++++.++.
T Consensus 4 L~~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~--------~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~ 74 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRG--------DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC 74 (210)
T ss_pred cCCcceecCCCceEEEECCCCcC-eEEEEEeccc--------cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC
Confidence 34456899999999996222322 4688876431 11235688999999999 5799999999998754
Q ss_pred C-CceE-EEEEe--cccCchhhhhhccCCCCCHHHHHHHHHHhhhhh-HHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1041 G-GTLA-TVTEF--MVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGM-EYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1041 ~-~~L~-LVMEY--m~GGSL~d~L~kre~~LSe~~~lkIa~QIAeAL-aYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
. +.++ +|||| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++||||||||+|||++..+.....++|
T Consensus 75 g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 75 GTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred CCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence 2 2333 78999 4579999999542 35555 35677888777 99999999999999999999854445568999
Q ss_pred Eecccc
Q 040257 1116 GDFGLS 1121 (1254)
Q Consensus 1116 iDFGLA 1121 (1254)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=160.77 Aligned_cols=137 Identities=22% Similarity=0.264 Sum_probs=105.6
Q ss_pred EeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEEec
Q 040257 972 LGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFM 1051 (1254)
Q Consensus 972 LGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVMEYm 1051 (1254)
||+|+||+||++.+.+..+++|+..................++.+|+++++.+.|+++.....++.+.. ..++||||+
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e~~ 79 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVMEYI 79 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEEEEE
Confidence 899999999999999999999997643322111122233467789999999998876543333333333 568999999
Q ss_pred ccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1052 VNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1052 ~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
+|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ .+.++|+|||++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-----~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-----DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-----CCcEEEEECCCCcC
Confidence 99999987743211 7889999999999999999999999999997 46799999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-16 Score=187.47 Aligned_cols=208 Identities=37% Similarity=0.573 Sum_probs=165.1
Q ss_pred HhcCCCCceeEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCc-ccccCCCC
Q 040257 1021 LSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNI-VHFDLKCE 1099 (1254)
Q Consensus 1021 LkrLnHPNIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGI-IHRDLKPe 1099 (1254)
|+.+.|.|+.+++|.+.++. .+++|.+||..|+|.+.+......+++.....++++|+.||.|||...| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--EMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCC--ceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 46788999999999998874 8999999999999999998877889999999999999999999998766 99999999
Q ss_pred ceEeccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCC--C---CCchhHHHHHHHHHHHHHcC
Q 040257 1100 NLLVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSN--R---VSEKVDVFSFGISMWEILTG 1171 (1254)
Q Consensus 1100 NILLDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~--k---yS~KSDIWSLGVILYELLTG 1171 (1254)
|++++ ..+.+||+|||+....... .......-..-|.|||.+++... . .+.+.||||+|++++|+++.
T Consensus 79 nClvd----~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 79 NCLVD----SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred cceee----eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999 8999999999998765321 11111223456999999987421 1 46789999999999999999
Q ss_pred CCCCCCCC----hhhHHHHhhhcc---CCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1172 EEPYADMH----CGAIIGGIVKNT---LRPTIP--ERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1172 k~PF~~~n----~~eliqsIlk~~---Lrp~ip--e~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
+.||.... ..+++..+.+.. ++|.+. ....+++..+++.||..+|.+||+++++-..++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99997632 234444444312 233332 1355678999999999999999999999888876654
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=5e-16 Score=184.12 Aligned_cols=142 Identities=23% Similarity=0.228 Sum_probs=112.8
Q ss_pred ceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceE
Q 040257 966 LEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~ 1045 (1254)
|...+.||+|+||+||++.+.+..+++|+.................+++.+|+++++.++|++|+..+.++.+.. ..+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--EKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--CCE
Confidence 345678999999999999998777777765433222111122233467889999999999999988776665543 568
Q ss_pred EEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1046 TVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
+||||+++++|.+++. ....++.+++.+|.+||+.+|+||||||+|||++ ++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-----~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-----DDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-----CCcEEEEeCccccc
Confidence 9999999999998874 3567899999999999999999999999999994 45799999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.1e-15 Score=162.53 Aligned_cols=148 Identities=20% Similarity=0.116 Sum_probs=111.2
Q ss_pred CceEEEEEeeeCcEEEEEEE-E--CCceEEEEEEeccccCCC----------------chhHHHHHHHHHHHHHHHhcCC
Q 040257 965 DLEELRELGSGTYGTVYHGK-W--RGSDVAIKRIKKSCFAGR----------------SSEQERLTKDFWREAHILSNLH 1025 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk-~--rGs~VAIKvIkk~~~~~~----------------~~e~ee~~eqFlrEIeILkrLn 1025 (1254)
.|++.+.||+|+||.||+|. + .++.||||+++....... ..........+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57888999999999999998 3 588999999975421100 0011122345678999999997
Q ss_pred CC--ceeEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCC-cccccCCCCceE
Q 040257 1026 HP--NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKN-IVHFDLKCENLL 1102 (1254)
Q Consensus 1026 HP--NIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkG-IIHRDLKPeNIL 1102 (1254)
+. .+.+++++ . ..++||||+.+.+|...+... ..+.......++.||+.+|.+||++| |+||||||+||+
T Consensus 109 ~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe---c---CceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 53 34455543 1 347999999998887665332 34566677899999999999999999 999999999999
Q ss_pred eccCCCCCCeEEEEeccccccc
Q 040257 1103 VNLRDPQRPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1103 LDsdd~snG~VKLiDFGLAr~~ 1124 (1254)
++ .+.++|+|||.+...
T Consensus 182 i~-----~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-----DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-----CCCEEEEEChhhhcc
Confidence 97 357999999998644
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.4e-15 Score=152.61 Aligned_cols=142 Identities=18% Similarity=0.038 Sum_probs=106.4
Q ss_pred ceEEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccCCCch--------------hHHHHHHHHHHHHHHHhcCCCC--c
Q 040257 966 LEELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAGRSS--------------EQERLTKDFWREAHILSNLHHP--N 1028 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~~~~--------------e~ee~~eqFlrEIeILkrLnHP--N 1028 (1254)
|.+.+.||+|+||.||++.+ +++.||||++.......... ........+.+|+.++..+.|. .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 66778899999999999988 58899999987532100000 0011223467789999988777 4
Q ss_pred eeEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCC
Q 040257 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDP 1108 (1254)
Q Consensus 1029 IVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~ 1108 (1254)
++..++. ...++||||+.+++|...... .....++.+|+.++.++|+.||+||||||.||+++
T Consensus 97 v~~~~~~------~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~---- 159 (198)
T cd05144 97 VPKPIDW------NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD---- 159 (198)
T ss_pred CCceeec------CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc----
Confidence 4444442 245899999999998765421 34567888999999999999999999999999998
Q ss_pred CCCeEEEEeccccccc
Q 040257 1109 QRPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1109 snG~VKLiDFGLAr~~ 1124 (1254)
.++.++|+|||++...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 6789999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=8e-16 Score=179.43 Aligned_cols=169 Identities=28% Similarity=0.389 Sum_probs=130.2
Q ss_pred ceEEEEEecccCchhhhhhcc--CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK--DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr--e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
+++|.|++|...+|.++|..+ ....++...+.++.|++.|++| ++.+|||+||.||+.. .+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~----~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS----DDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc----cchhhhhhhhhh
Confidence 688999999999999999643 2446788889999999999999 9999999999999997 666899999999
Q ss_pred cccccCcc-------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccC
Q 040257 1121 SRIKRNTL-------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1121 Ar~~~~s~-------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~L 1192 (1254)
........ ..+...||..||+||.+.+.. |+.++||||||+||+||+. =...|. .......+..+.+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~--y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~i 477 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ--YSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGII 477 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhh--hhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCC
Confidence 86543332 344567999999999999874 8999999999999999987 222222 1222333344444
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTE 1224 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArE 1224 (1254)
++....+.+.+ ..|+.++|...|.+||++.+
T Consensus 478 p~~~~~d~p~e-~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 478 PPEFLQDYPEE-YTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ChHHhhcCcHH-HHHHHHhcCCCcccCchHHH
Confidence 44444444444 58999999999999994443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.2e-14 Score=132.38 Aligned_cols=132 Identities=23% Similarity=0.175 Sum_probs=109.0
Q ss_pred EEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCC--CceeEEeeeeecCCCCceE
Q 040257 968 ELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH--PNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnH--PNIVkLyGvf~Ddn~~~L~ 1045 (1254)
+++.||+|.++.||++...+..+++|.+..... ...+.+|+.+++.+.| .++++++.++... +..+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~ 69 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----------GADREREVAILQLLARKGLPVPKVLASGESD--GWSY 69 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccE
Confidence 356799999999999999888899998864311 3467789999999976 5888988887654 4789
Q ss_pred EEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC---CcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1046 TVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK---NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk---GIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
++|||+.+..+..+ +......++.+++.+|.+||.. +++|+||+|+|||++ ..+.++|+|||.++
T Consensus 70 ~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~----~~~~~~l~Df~~~~ 137 (155)
T cd05120 70 LLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD----DGKILGIIDWEYAG 137 (155)
T ss_pred EEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE----CCcEEEEEeccccc
Confidence 99999988877654 4566677889999999999985 799999999999998 56789999999986
Q ss_pred c
Q 040257 1123 I 1123 (1254)
Q Consensus 1123 ~ 1123 (1254)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 4
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.4e-14 Score=151.75 Aligned_cols=144 Identities=16% Similarity=0.172 Sum_probs=106.7
Q ss_pred EEEe-eeCcEEEEEEEECCceEEEEEEeccccCCCch-----hHHHHHHHHHHHHHHHhcCCCCce--eEEeeeeecCCC
Q 040257 970 RELG-SGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSS-----EQERLTKDFWREAHILSNLHHPNV--VAFYGVVPDGTG 1041 (1254)
Q Consensus 970 kkLG-eGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~-----e~ee~~eqFlrEIeILkrLnHPNI--VkLyGvf~Ddn~ 1041 (1254)
..|| .|+.|+||+++..+..++||.+....+..+.. .......++.+|+.++.+|.|++| +..+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4587 89999999998888999999997543211110 111234567889999999988775 667766443221
Q ss_pred C--ceEEEEEeccc-CchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1042 G--TLATVTEFMVN-GSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1042 ~--~L~LVMEYm~G-GSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
. ..++||||+++ .+|.+++.. ..++.. .+.+|+.+|.+||++||+||||||.|||++ .++.++|+||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~----~~~~v~LIDf 186 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD----PDGKFWLIDF 186 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc----CCCCEEEEEC
Confidence 1 23599999997 688887743 345543 356899999999999999999999999998 5568999999
Q ss_pred ccccc
Q 040257 1119 GLSRI 1123 (1254)
Q Consensus 1119 GLAr~ 1123 (1254)
|.++.
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 99864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=8.7e-14 Score=140.64 Aligned_cols=143 Identities=20% Similarity=0.057 Sum_probs=96.6
Q ss_pred EEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhH----------------HHHHHHHHHHHHHHhcCCCC--ce
Q 040257 969 LRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQ----------------ERLTKDFWREAHILSNLHHP--NV 1029 (1254)
Q Consensus 969 LkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~----------------ee~~eqFlrEIeILkrLnHP--NI 1029 (1254)
.+.||+|+||+||++.+. ++.||||+++........... .........|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 457999999999999886 888999998754211100000 00001113456666665433 24
Q ss_pred eEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCC
Q 040257 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDP 1108 (1254)
Q Consensus 1030 VkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~ 1108 (1254)
.+.+++. ..++||||+.++.+........ ... .....++.+++.++.++|. .+|+||||||+||+++
T Consensus 82 ~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~---- 149 (187)
T cd05119 82 PKPIDLN------RHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD---- 149 (187)
T ss_pred CceEecC------CCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----
Confidence 4555432 3589999999855432211110 011 5678899999999999999 9999999999999997
Q ss_pred CCCeEEEEeccccccc
Q 040257 1109 QRPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1109 snG~VKLiDFGLAr~~ 1124 (1254)
++.++|+|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 467999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.2e-15 Score=179.46 Aligned_cols=250 Identities=23% Similarity=0.267 Sum_probs=188.7
Q ss_pred CceEEEEEeeeCcEEEEEEEEC---CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR---GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r---Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn 1040 (1254)
.|...+.||+|+|+.|-+.... ...+|+|.+.... ......++...|..+-+.+. |.|++++++...+..
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR 94 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCC------CccchhhhcCccccccccccccccccccCCccCCCc
Confidence 5667777999999999877653 3346666665432 12233445556777777776 999999999987665
Q ss_pred CCceEEEEEecccCchhhhh-hccCCCCCHHHHHHHHHHhhhhhHHhh-hCCcccccCCCCceEeccCCCCCC-eEEEEe
Q 040257 1041 GGTLATVTEFMVNGSLKHVL-LKKDRSLDRRKKLIIAMDAAFGMEYLH-SKNIVHFDLKCENLLVNLRDPQRP-ICKVGD 1117 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L-~kre~~LSe~~~lkIa~QIAeALaYLH-SkGIIHRDLKPeNILLDsdd~snG-~VKLiD 1117 (1254)
..+++++|..++++...+ .......+......++.|+..++.|+| ..++.||||||+|.+++ ..+ .+|++|
T Consensus 95 --~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~----~s~~~l~~~d 168 (601)
T KOG0590|consen 95 --SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD----ESGSALKIAD 168 (601)
T ss_pred --ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc----cCCCcccCCC
Confidence 778899999999999988 433325777888899999999999999 99999999999999998 566 899999
Q ss_pred ccccccccC----ccccCCCCC-CCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH-HHhhhcc
Q 040257 1118 FGLSRIKRN----TLVSGGVRG-TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAII-GGIVKNT 1191 (1254)
Q Consensus 1118 FGLAr~~~~----s~~sts~~G-T~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eli-qsIlk~~ 1191 (1254)
||+|..... .......+| ++.|+|||...+.. ......|+||+|+++.-+++|..||......... .......
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~-~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~ 247 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKA-YRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK 247 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchh-hcCCCcccccccccccccccCCCCccccccccccceeecccc
Confidence 999975544 222344568 99999999998753 2467799999999999999999999764432211 1222211
Q ss_pred C--CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040257 1192 L--RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITS 1227 (1254)
Q Consensus 1192 L--rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe 1227 (1254)
. .......++....+++.+++..+|..|.+.+++-.
T Consensus 248 ~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 1 12234557788899999999999999999887654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.8e-12 Score=149.88 Aligned_cols=249 Identities=24% Similarity=0.221 Sum_probs=180.6
Q ss_pred ccCceEEEEEee--eCcEEEEEEEE----CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeee
Q 040257 963 NVDLEELRELGS--GTYGTVYHGKW----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGV 1035 (1254)
Q Consensus 963 ~~dYeiLkkLGe--GsFGtVYlAk~----rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGv 1035 (1254)
...+.+.+.+|. |.+|.||.+.. ....+|+|.-+... .. ......=.+|+...+++ .|++.++.+..
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~-----p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SP-----PLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CC-----ccccccccchhhcccccCccccccccCcc
Confidence 345677788999 99999998765 35668888744321 10 01112223566666666 49999998877
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhh----hhHHhhhCCcccccCCCCceEeccCCCCC-
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF----GMEYLHSKNIVHFDLKCENLLVNLRDPQR- 1110 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAe----ALaYLHSkGIIHRDLKPeNILLDsdd~sn- 1110 (1254)
+.... .+++-+|++ +.+|..+.......++...++.+..+... ||.++|+.+|+|-|+||.||++. .+
T Consensus 187 ~e~~~--~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~----~~~ 259 (524)
T KOG0601|consen 187 WEGSG--ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT----SDW 259 (524)
T ss_pred cccCC--cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc----ccc
Confidence 76544 788888887 68888888777777889999999999999 99999999999999999999998 55
Q ss_pred CeEEEEeccccccccCccccCC------CCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 040257 1111 PICKVGDFGLSRIKRNTLVSGG------VRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAII 1184 (1254)
Q Consensus 1111 G~VKLiDFGLAr~~~~s~~sts------~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eli 1184 (1254)
..++++|||+............ ..|...|++||..++. ++...|||+||.++.+..++..++....... .
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l---~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W 335 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL---ATFASDIFSLGEVILEAILGSHLPSVGKNSS-W 335 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc---cchHhhhcchhhhhHhhHhhcccccCCCCCC-c
Confidence 7899999999875544332211 1477889999999876 7889999999999999998776654321100 0
Q ss_pred HHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1185 GGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1185 qsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+....++.++....+.++...+..|++.+|..|++++.+..+
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 01111113334445567778889999999999999988866543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.5e-10 Score=135.57 Aligned_cols=148 Identities=21% Similarity=0.202 Sum_probs=96.6
Q ss_pred EEEeeeCcEEEEEEEE-CCceEEEEEEeccccCCC--------------------------chhHHHHHH------HHHH
Q 040257 970 RELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAGR--------------------------SSEQERLTK------DFWR 1016 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~~--------------------------~~e~ee~~e------qFlr 1016 (1254)
+.||.|++|.||+|++ +|+.||||+.+....... ....+++.. .|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999998 589999999864320000 000011111 2445
Q ss_pred HHHHHhcC----CCCceeEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhh-hhHHhhhCCc
Q 040257 1017 EAHILSNL----HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF-GMEYLHSKNI 1091 (1254)
Q Consensus 1017 EIeILkrL----nHPNIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAe-ALaYLHSkGI 1091 (1254)
|+..+.++ ++.+-+.+-.++.+-. +..++||||+.|++|.++......... ...++..++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 55555554 2332333333332222 246899999999999887643222222 3345555555 4788999999
Q ss_pred ccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1092 VHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1092 IHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
+|+|+||.||+++ .++.++|+|||++....
T Consensus 279 ~H~D~hPgNilv~----~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVL----KDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEEC----CCCcEEEEeCCCeeECC
Confidence 9999999999998 67889999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.16 E-value=7.5e-11 Score=116.92 Aligned_cols=127 Identities=18% Similarity=0.106 Sum_probs=94.1
Q ss_pred EEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCce-eEEeeeeecCCCCceEEE
Q 040257 969 LRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV-VAFYGVVPDGTGGTLATV 1047 (1254)
Q Consensus 969 LkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNI-VkLyGvf~Ddn~~~L~LV 1047 (1254)
++.|+.|.++.||+++..+..|++|+...... ....+.+|+.+++.+.+.++ .+++.+.. . .-++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~--~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---------LLINRENEAENSKLAAEAGIGPKLYYFDP--E--TGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---------cccCHHHHHHHHHHHHHhCCCCceEEEeC--C--CCeEE
Confidence 46789999999999999989999998754310 11234678888888755443 45555432 2 34789
Q ss_pred EEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCc-----ccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1048 TEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNI-----VHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1048 MEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGI-----IHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
|||++|.++.... . ....++.+++.+|..||..++ +|+|++|.||+++ .+.++|+||+.+.
T Consensus 70 ~e~i~G~~l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-----~~~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-----DGRLWLIDWEYAG 135 (170)
T ss_pred EEecCCCcccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-----CCeEEEEeccccc
Confidence 9999998876531 1 113456789999999999885 9999999999997 3468999999975
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1e-09 Score=116.52 Aligned_cols=136 Identities=21% Similarity=0.242 Sum_probs=102.9
Q ss_pred EEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCC--ceeEEeeeeecCCCCceEEEE
Q 040257 971 ELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP--NVVAFYGVVPDGTGGTLATVT 1048 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHP--NIVkLyGvf~Ddn~~~L~LVM 1048 (1254)
.+++|+-+.+|.+.+.+.++++|.-..+......-+..-..++..+|+.++.+++-- +..-++++. .. ...|+|
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~--~~~I~m 78 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PD--NGLIVM 78 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CC--CCEEEE
Confidence 578999999999999888888886554444433334444566778999999988533 334445443 33 456899
Q ss_pred EecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1049 EFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1049 EYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
||++|..|.+.+... ...++..+-.-+.-||..||||+||.++||++. .+.+.++|||++.+
T Consensus 79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~-----~~~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS-----GGRIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe-----CCcEEEEECCcccc
Confidence 999999999888543 256777788888999999999999999999996 34599999999863
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.5e-10 Score=135.65 Aligned_cols=151 Identities=20% Similarity=0.241 Sum_probs=93.1
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccC--------------------------CCchhHHHHHHHHH-
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFA--------------------------GRSSEQERLTKDFW- 1015 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~--------------------------~~~~e~ee~~eqFl- 1015 (1254)
+|+. +.||.|++|.||+|+++ |+.||||+++..... ......+++.+.+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 68999999999999984 789999999754200 00001112233333
Q ss_pred -----HHHHHHhcC----CCCceeEEeeeeecCCCCceEEEEEecccCchhhhh--hccCC---CCCHHHHHHHHHHhhh
Q 040257 1016 -----REAHILSNL----HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL--LKKDR---SLDRRKKLIIAMDAAF 1081 (1254)
Q Consensus 1016 -----rEIeILkrL----nHPNIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L--~kre~---~LSe~~~lkIa~QIAe 1081 (1254)
+|+..+.++ .+...+.+-.++.+- .+..++||||+.|+.+.++. ...+. .+.+..+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 344333333 233333333333322 12567999999999997742 22211 13333333444444
Q ss_pred hhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccc
Q 040257 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1082 ALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~ 1124 (1254)
...|++|+|+||.||+++.+++..+.++++|||++...
T Consensus 277 -----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 277 -----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred -----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 46899999999999999854444569999999998754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.6e-09 Score=113.82 Aligned_cols=144 Identities=19% Similarity=0.117 Sum_probs=100.2
Q ss_pred EEEeeeCcEEEEEEEEC--------CceEEEEEEecccc--CCC----------------chhHHHHHHHHHHHHHHHhc
Q 040257 970 RELGSGTYGTVYHGKWR--------GSDVAIKRIKKSCF--AGR----------------SSEQERLTKDFWREAHILSN 1023 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r--------Gs~VAIKvIkk~~~--~~~----------------~~e~ee~~eqFlrEIeILkr 1023 (1254)
..||.|--+.||.|... +..+|||+++.... ... ............+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999764 36899999874321 100 01111222223489999998
Q ss_pred CC--CCceeEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHh-hhCCcccccCCCCc
Q 040257 1024 LH--HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL-HSKNIVHFDLKCEN 1100 (1254)
Q Consensus 1024 Ln--HPNIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYL-HSkGIIHRDLKPeN 1100 (1254)
+. .-++..++++. .-++||||+.+..+.....+ +..++......+..+++.+|..| |..||||+||++.|
T Consensus 83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 85 34566777652 35789999976544322211 22355566677889999999999 89999999999999
Q ss_pred eEeccCCCCCCeEEEEecccccccc
Q 040257 1101 LLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1101 ILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
||+. .+.++|+|||.+....
T Consensus 156 IL~~-----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWH-----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEE-----CCcEEEEECCCceeCC
Confidence 9996 3579999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.6e-09 Score=115.04 Aligned_cols=154 Identities=21% Similarity=0.213 Sum_probs=112.1
Q ss_pred EEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEE
Q 040257 968 ELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATV 1047 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LV 1047 (1254)
.+..|-+|+-+.|+++.+.|+.+.||.-......-..-+..-...+..+|+++|.++.--.|.--.-+|.|.. .-+|+
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~--~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY--GGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC--CCeEE
Confidence 5667889999999999999999888865444333333345556777889999999886444432223344444 33568
Q ss_pred EEeccc-CchhhhhhccCCCCCHHHH-HHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccc
Q 040257 1048 TEFMVN-GSLKHVLLKKDRSLDRRKK-LIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1048 MEYm~G-GSL~d~L~kre~~LSe~~~-lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~ 1124 (1254)
|||+.| .++.+++......-..... ..++.+|-+.|.-||.++|||+||..+||+|..++ ....+.|+|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~-~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG-NQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC-CcCceEEEeecchhcc
Confidence 999966 4777777554333333333 78899999999999999999999999999998544 4556689999998643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.3e-10 Score=142.04 Aligned_cols=245 Identities=22% Similarity=0.286 Sum_probs=172.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
++.+.+-+-+|.++.++.++-. +...++|+..+.-..... ..+....+-.++-..++|.++...--+. ...
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~-----~~~s~r~~s~~~i~p~~P~v~~~~~s~~--~rs 877 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN-----DYESIRSKSNILITPRSPAVVRSFPSFP--CRS 877 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccc-----cccccCCccCccccCCCCceecccCCCC--CCC
Confidence 3445556778888888876553 222444443322111000 0111222333333334566665544432 234
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.++++++|..+++|...++.-. ..+..-.+.+...+..+++|||...++|||++|.|+|+. ..++.+++|||...
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~----~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA----YDGHRPLTDFGTLS 952 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhc----ccCCcccCcccccc
Confidence 7889999999999999886543 566667777788899999999999999999999999998 78899999998322
Q ss_pred -cc------c-------------------------CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 040257 1123 -IK------R-------------------------NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT 1170 (1254)
Q Consensus 1123 -~~------~-------------------------~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT 1170 (1254)
.. . +........+|+.|.+||.+.+.. -...+|||++|++++|.++
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~--hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR--HGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc--CCCcchhhhhhhhhhhhhc
Confidence 10 0 001122346899999999998774 4566999999999999999
Q ss_pred CCCCCCCCChhhHHHHhhhccC-CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 040257 1171 GEEPYADMHCGAIIGGIVKNTL-RPTIPERCDPEWRKLMEQCWAADPEARPSFT 1223 (1254)
Q Consensus 1171 Gk~PF~~~n~~eliqsIlk~~L-rp~ipe~iS~eLrdLIkKCLqkDPeKRPSAr 1223 (1254)
|..||...........+..... ++..+...+.+.++++...|..++.+|..+.
T Consensus 1031 g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999888888887776544 3445677889999999999999999997765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.92 E-value=7.3e-09 Score=106.16 Aligned_cols=143 Identities=24% Similarity=0.269 Sum_probs=103.4
Q ss_pred EEEeeeCcEEEEEEEECC-ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCC--CceeEEeeeeecCC-CCceE
Q 040257 970 RELGSGTYGTVYHGKWRG-SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH--PNVVAFYGVVPDGT-GGTLA 1045 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~rG-s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnH--PNIVkLyGvf~Ddn-~~~L~ 1045 (1254)
+.|+.|..+.||++...+ +.+++|+....... .....+.+|+.+++.+.+ ..+.+++.+..... .+..+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF 76 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence 568999999999998865 78999987643210 123456789999998865 34567777664321 12567
Q ss_pred EEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-------------------------------------
Q 040257 1046 TVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS------------------------------------- 1088 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS------------------------------------- 1088 (1254)
+||||++|.++...+.. ..++......++.+++.+|.+||+
T Consensus 77 ~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 77 YVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred EEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 99999999988876532 346666777777777777777773
Q ss_pred -------------------CCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1089 -------------------KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1089 -------------------kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
..++|+|+++.|||++.. ..+.+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~--~~~~~~iID~e~~~~ 206 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD--EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC--CCcEEEEEecccccc
Confidence 236999999999999821 146789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.8e-08 Score=121.64 Aligned_cols=162 Identities=22% Similarity=0.301 Sum_probs=120.3
Q ss_pred CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEEecccCchhhhhhccCC
Q 040257 986 RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR 1065 (1254)
Q Consensus 986 rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~ 1065 (1254)
.+.+|.|+.++... ........+-++-|+.++||||+++++.+.... .+|+|+|-+ ..|..++.+
T Consensus 36 ~~~~vsVF~~~~~~--------~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--~~ylvTErV--~Pl~~~lk~--- 100 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSN--------GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--TLYLVTERV--RPLETVLKE--- 100 (690)
T ss_pred cCCceEEEEEeCCC--------chhhHHHHHHHHHhhhccCchhhhhhhhhcccC--ceEEEeecc--ccHHHHHHH---
Confidence 46778888887542 133445667788999999999999999987655 899999986 456666643
Q ss_pred CCCHHHHHHHHHHhhhhhHHhh-hCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCccc-cCCCCCCCCccCcc
Q 040257 1066 SLDRRKKLIIAMDAAFGMEYLH-SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLV-SGGVRGTLPWMAPE 1143 (1254)
Q Consensus 1066 ~LSe~~~lkIa~QIAeALaYLH-SkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~-sts~~GT~~YmAPE 1143 (1254)
+........+.||+.||.||| ..+++|++|.-..|+++ ..|..||++|.++........ .....---.|..|+
T Consensus 101 -l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn----~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 101 -LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN----ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE 175 (690)
T ss_pred -hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc----CCCcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence 335666777889999999997 57899999999999999 889999999998764332211 11111223467777
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHHcC
Q 040257 1144 LLNGSSNRVSEKVDVFSFGISMWEILTG 1171 (1254)
Q Consensus 1144 VLrG~~~kyS~KSDIWSLGVILYELLTG 1171 (1254)
.+... . ...|.|-|||++++++.|
T Consensus 176 ~~~~s--~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPS--E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCcc--c--cchhhhhHHHHHHHHhCc
Confidence 66532 2 347999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1e-09 Score=123.66 Aligned_cols=196 Identities=21% Similarity=0.305 Sum_probs=136.1
Q ss_pred HHhcCCCCceeEEeeeeecC---CCCceEEEEEecccCchhhhhhcc---CCCCCHHHHHHHHHHhhhhhHHhhhC--Cc
Q 040257 1020 ILSNLHHPNVVAFYGVVPDG---TGGTLATVTEFMVNGSLKHVLLKK---DRSLDRRKKLIIAMDAAFGMEYLHSK--NI 1091 (1254)
Q Consensus 1020 ILkrLnHPNIVkLyGvf~Dd---n~~~L~LVMEYm~GGSL~d~L~kr---e~~LSe~~~lkIa~QIAeALaYLHSk--GI 1091 (1254)
-|-++-|-|||+++.|+.+. +.....|+.|||..|+|..++++- ...+....-.+|+.||+.||.|||+. -|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34455689999999998653 335788999999999999998542 34577788889999999999999997 59
Q ss_pred ccccCCCCceEeccCCCCCCeEEEEecccccccc--C---ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHH
Q 040257 1092 VHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR--N---TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMW 1166 (1254)
Q Consensus 1092 IHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~--~---s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILY 1166 (1254)
+|+++..+-|++. .++-+||.----..... . ........+-++|.+||.=.-. ..+-++|||++|+...
T Consensus 200 ihgnlTc~tifiq----~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t--n~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQ----HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT--NTTGASDIYKFGMCAL 273 (458)
T ss_pred ccCCcchhheeec----CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc--ccccchhhhhhhHHHH
Confidence 9999999999998 77788874321111100 0 0111223466789999874422 3567899999999999
Q ss_pred HHHcCCCCCCCCCh----hhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1167 EILTGEEPYADMHC----GAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1167 ELLTGk~PF~~~n~----~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
||..+..--..... .+.+...... .....-+.++.+||+-+|..||+++.++.|.
T Consensus 274 emailEiq~tnseS~~~~ee~ia~~i~~--------len~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIANVIIG--------LENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHHheeccCCCcceeehhhhhhhheee--------ccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 99876553222111 1111111110 0112235789999999999999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.2e-09 Score=127.81 Aligned_cols=253 Identities=22% Similarity=0.204 Sum_probs=171.8
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC---CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR---GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVV 1036 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r---Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf 1036 (1254)
....+|..+..||.|.|+.|+.+..+ +..|++|.+.+.... ...+ ..-..|+.+...+ .|.+++.++..|
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~-~~~d-----i~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT-FASD-----IFSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc-hHhh-----hcchhhhhHhhHhhcccccCCCCCCc
Confidence 44558999999999999999987653 566898888755321 1110 1123455454444 477788876655
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.... ..++-.|||.++++...+. -...+++...+.+..|++.++.++|+..++|+|+||+||++..+ .+..++.
T Consensus 336 ~~~r--~~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~---~~~~~~~ 409 (524)
T KOG0601|consen 336 SQLR--QGYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISND---GFFSKLG 409 (524)
T ss_pred cccc--cccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccc---hhhhhcc
Confidence 4433 4568899999998877662 22357888899999999999999999999999999999999722 2788999
Q ss_pred eccccccccCccccCCCCCCCCcc-CcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWM-APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~Ym-APEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
|||......- ........-++. ..|++... +.+-.+.|+||||..+.+.+++...-....... .+..+ ..+.
T Consensus 410 ~~~~~t~~~~--~~~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~~-~~p~ 482 (524)
T KOG0601|consen 410 DFGCWTRLAF--SSGVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRSG-DTPN 482 (524)
T ss_pred ccccccccce--ecccccccccccccchhhccc-cccccccccccccccccccccCcccCcccccce---eeecc-cccC
Confidence 9998753111 111122333444 35555543 356788999999999999999865433221111 11111 1222
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
.+.. ..++..+.+.++..++..||.+.++..+..-+.
T Consensus 483 ~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 483 LPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred CCch-HHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 3333 378889999999999999999998877765443
|
|
| >smart00666 PB1 PB1 domain | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.9e-08 Score=90.47 Aligned_cols=75 Identities=45% Similarity=0.715 Sum_probs=65.2
Q ss_pred CCceeecCceEEEeccCCCChHHHHHHHHhhcCC---CceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCce
Q 040257 200 GKLRYVGGETRIISLRTNLSWEELVKKTSNICNQ---PHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQR 276 (1254)
Q Consensus 200 ~~l~YvGG~triv~V~r~~~f~~l~~kl~~~~~~---~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~r 276 (1254)
.+++| ||++|.+.|+++++|.+|+.++.+.++. .+.|||+ .||-| +|++++|+||..|++.+.+.. ...
T Consensus 4 vK~~~-~~~~~~~~~~~~~s~~dL~~~i~~~~~~~~~~~~l~Y~--Dedgd-~v~l~sd~Dl~~a~~~~~~~~----~~~ 75 (81)
T smart00666 4 VKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLTSDEDLEEAIEEYDSLG----SKK 75 (81)
T ss_pred EEEEE-CCEEEEEEECCCCCHHHHHHHHHHHhCCCCCCeEEEEE--CCCCC-EEEecCHHHHHHHHHHHHHcC----Cce
Confidence 45677 8999999999999999999999999987 4889999 67766 999999999999999996643 357
Q ss_pred EEEEEe
Q 040257 277 LRLFLI 282 (1254)
Q Consensus 277 lR~FLF 282 (1254)
||+++|
T Consensus 76 l~l~v~ 81 (81)
T smart00666 76 LRLHVF 81 (81)
T ss_pred EEEEeC
Confidence 888886
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.9e-07 Score=103.73 Aligned_cols=152 Identities=16% Similarity=0.043 Sum_probs=100.3
Q ss_pred EEeeeCcEEEEEEEECCceEEEEEEeccccCCCchh---HHHHHHHHHHHHHHHhcCCCCce--eEEeeeeec---CCCC
Q 040257 971 ELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSE---QERLTKDFWREAHILSNLHHPNV--VAFYGVVPD---GTGG 1042 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e---~ee~~eqFlrEIeILkrLnHPNI--VkLyGvf~D---dn~~ 1042 (1254)
++-.-....|+++.+.|+.|.||......+...... -..-...+.+|...+.+|..-+| +.++++... ....
T Consensus 29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 344444445778888889999998754321100000 00001136788888877742222 334444322 1123
Q ss_pred ceEEEEEecccC-chhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccC---CCCCCeEEEEe
Q 040257 1043 TLATVTEFMVNG-SLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLR---DPQRPICKVGD 1117 (1254)
Q Consensus 1043 ~L~LVMEYm~GG-SL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsd---d~snG~VKLiD 1117 (1254)
.-++|||++++. +|.+++... ....+......++.+++..+.-||..||+|+|+++.|||++.+ +.....+.|+|
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 577999999876 788887432 2345667778899999999999999999999999999999831 12457899999
Q ss_pred ccccc
Q 040257 1118 FGLSR 1122 (1254)
Q Consensus 1118 FGLAr 1122 (1254)
|+.+.
T Consensus 189 l~r~~ 193 (268)
T PRK15123 189 LHRAQ 193 (268)
T ss_pred CCccc
Confidence 99875
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.7e-07 Score=107.19 Aligned_cols=256 Identities=18% Similarity=0.202 Sum_probs=164.6
Q ss_pred eEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhc-CCCCceeEEeee----eecCCC
Q 040257 967 EELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN-LHHPNVVAFYGV----VPDGTG 1041 (1254)
Q Consensus 967 eiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkr-LnHPNIVkLyGv----f~Ddn~ 1041 (1254)
...+.||+|+-+.+|-..--+ ..+-|++.+.-.. ...+ .+..|.. -.||-+-.-+.| ....+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~-d~VAKIYh~Pppa--------~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~ 81 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR-DQVAKIYHAPPPA--------AQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRR 81 (637)
T ss_pred CCCccccCCccceeeecchhh-chhheeecCCCch--------HHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCc
Confidence 345679999999999533222 2345777654211 1111 1222322 245543321222 222222
Q ss_pred C-ceEEEEEecccCchhhhhhc------cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1042 G-TLATVTEFMVNGSLKHVLLK------KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1042 ~-~L~LVMEYm~GGSL~d~L~k------re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
+ .+.++|..+.+.---..+.. .-..+.|...+++++.|+.+.+.||..|.+-+|+.++|+|+. +.+.|.
T Consensus 82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs----d~~~V~ 157 (637)
T COG4248 82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS----DDSKVV 157 (637)
T ss_pred cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee----cCceEE
Confidence 2 37788888766532222211 113378899999999999999999999999999999999998 778899
Q ss_pred EEeccccccccCccccCCCCCCCCccCcccccCC---CCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChh----hHHH-
Q 040257 1115 VGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTG-EEPYADMHCG----AIIG- 1185 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~---~~kyS~KSDIWSLGVILYELLTG-k~PF~~~n~~----eliq- 1185 (1254)
|.|=..-....+......-.|...|.+||...-. ...-+...|.|.||+++|+|+.| +.||.+.... .-.+
T Consensus 158 LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 158 LVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred EEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 9886554444455555556689999999986511 11235668999999999999886 9999754210 0000
Q ss_pred Hhhhc----------cCCC---CCC-CCCcHHHHHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1186 GIVKN----------TLRP---TIP-ERCDPEWRKLMEQCWAA--DPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1186 sIlk~----------~Lrp---~ip-e~iS~eLrdLIkKCLqk--DPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
.|..+ .+.+ ..| ..+++.+..+..+|+.. ++.-||+++.++..|..+.+++.+
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 11111 1111 111 23678899999999965 356899999999999999888754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.4e-07 Score=97.10 Aligned_cols=133 Identities=23% Similarity=0.180 Sum_probs=82.6
Q ss_pred EEEEEEE-CCceEEEEEEeccccC-----------C-------CchhHHHHHHHHHHHHHHHhcCCCC--ceeEEeeeee
Q 040257 979 TVYHGKW-RGSDVAIKRIKKSCFA-----------G-------RSSEQERLTKDFWREAHILSNLHHP--NVVAFYGVVP 1037 (1254)
Q Consensus 979 tVYlAk~-rGs~VAIKvIkk~~~~-----------~-------~~~e~ee~~eqFlrEIeILkrLnHP--NIVkLyGvf~ 1037 (1254)
.||.|.. .+..+|||+.+..... . .............+|.+.|.++..- ++.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3888887 5778999998743110 0 1112233445677899999999755 566777553
Q ss_pred cCCCCceEEEEEecc--cCchhhhhhccCCCCCHHHHHHHHHHhhhhhHH-hhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1038 DGTGGTLATVTEFMV--NGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY-LHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~--GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaY-LHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
.-++||||+. |..+..+. .. .++......++.+++..+.. +|..||||+||.+.|||++ .+ .+.
T Consensus 80 -----~~~ivME~I~~~G~~~~~l~-~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~-~~~ 146 (188)
T PF01163_consen 80 -----RNVIVMEYIGEDGVPLPRLK-DV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DG-KVY 146 (188)
T ss_dssp -----TTEEEEE--EETTEEGGCHH-HC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TT-CEE
T ss_pred -----CCEEEEEecCCCccchhhHH-hc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cc-eEE
Confidence 2368999998 54554433 22 12234455677777775555 5899999999999999997 33 899
Q ss_pred EEecccccccc
Q 040257 1115 VGDFGLSRIKR 1125 (1254)
Q Consensus 1115 LiDFGLAr~~~ 1125 (1254)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999986543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.60 E-value=8.7e-07 Score=105.15 Aligned_cols=215 Identities=15% Similarity=0.164 Sum_probs=150.2
Q ss_pred CcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC--CCceEEEEEec
Q 040257 976 TYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT--GGTLATVTEFM 1051 (1254)
Q Consensus 976 sFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn--~~~L~LVMEYm 1051 (1254)
.-.+.|++.. +|..|++|++........ .....-+++|+++.|+|+|++..+|.... ...+++|++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy 359 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY 359 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc--------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence 3457788876 688899999943221111 11123467899999999999999887322 13688999998
Q ss_pred cc-Cchhhhhhc--------------cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1052 VN-GSLKHVLLK--------------KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1052 ~G-GSL~d~L~k--------------re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
++ ++|.+.... .+...++..+|.++.|+..||.++|+.|+..+-|.|.+||++ ...+++|.
T Consensus 360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~----G~~RIriS 435 (655)
T KOG3741|consen 360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT----GKMRIRIS 435 (655)
T ss_pred CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee----CcceEEEe
Confidence 75 567665422 123478899999999999999999999999999999999998 56689998
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hhhHHHHhhhccCCCC
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH-CGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n-~~eliqsIlk~~Lrp~ 1195 (1254)
..|......+.. . |-+.+. .+-|.=.||.+++.|.||..--...+ ....... .
T Consensus 436 ~C~i~Dvl~~d~-----------~--~~le~~-----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~ 489 (655)
T KOG3741|consen 436 GCGIMDVLQEDP-----------T--EPLESQ-----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------R 489 (655)
T ss_pred cccceeeecCCC-----------C--cchhHH-----hhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------H
Confidence 877765543332 0 122221 34699999999999999865321111 1111111 1
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
+...++.+++++|..+...++++ -++.+++.++
T Consensus 490 I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 490 ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 23346889999999999999987 5777777654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.6e-07 Score=95.31 Aligned_cols=110 Identities=22% Similarity=0.155 Sum_probs=80.5
Q ss_pred HHHHHHHHHHhcCCCC--ceeEEeeeeecCC--CCceEEEEEecccC-chhhhhhccCCCCCHHHHHHHHHHhhhhhHHh
Q 040257 1012 KDFWREAHILSNLHHP--NVVAFYGVVPDGT--GGTLATVTEFMVNG-SLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086 (1254)
Q Consensus 1012 eqFlrEIeILkrLnHP--NIVkLyGvf~Ddn--~~~L~LVMEYm~GG-SL~d~L~kre~~LSe~~~lkIa~QIAeALaYL 1086 (1254)
.+..+|...+..|..- ...+.+++..... ....++|+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 3566777777766422 2344445443321 13457899999874 78888854333 66777889999999999999
Q ss_pred hhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1087 HSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
|..||+|+|+++.|||++..+ ....+.|+||+-++.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~-~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDD-GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCC-CceeEEEEcchhcee
Confidence 999999999999999998433 345899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.8e-07 Score=110.88 Aligned_cols=143 Identities=22% Similarity=0.306 Sum_probs=103.8
Q ss_pred HhhhhhHHhhhC-CcccccCCCCceEeccCCCCCCeEEEEeccccccccCcccc----------CCCCCCCCccCccccc
Q 040257 1078 DAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVS----------GGVRGTLPWMAPELLN 1146 (1254)
Q Consensus 1078 QIAeALaYLHSk-GIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~s----------ts~~GT~~YmAPEVLr 1146 (1254)
+++.||.|+|.. ++||+.|.|++|.++ ..+.+||+.|+.+....+.... ....-...|.|||++.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n----a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVN----ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred cccchhhhhccCcceeecccchhheeec----cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 444899999975 999999999999999 8899999999987644331110 0112456799999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHH-cCCCCCCCCChhhHHHHhhhc---cCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 040257 1147 GSSNRVSEKVDVFSFGISMWEIL-TGEEPYADMHCGAIIGGIVKN---TLRPTIPERCDPEWRKLMEQCWAADPEARPSF 1222 (1254)
Q Consensus 1147 G~~~kyS~KSDIWSLGVILYELL-TGk~PF~~~n~~eliqsIlk~---~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSA 1222 (1254)
+. ..+.++|+||||+++|.+. .|+.-+......... ..... --...+...++.++++=+.+++..+...||++
T Consensus 183 ~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 183 GT--TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred cc--cccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 75 3688999999999999999 455555443322221 11111 11223446789999999999999999999987
Q ss_pred HHHHH
Q 040257 1223 TEITS 1227 (1254)
Q Consensus 1223 rELLe 1227 (1254)
.+++.
T Consensus 260 ~~l~~ 264 (700)
T KOG2137|consen 260 DLLLS 264 (700)
T ss_pred hhhhc
Confidence 76653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=6.5e-06 Score=92.28 Aligned_cols=141 Identities=22% Similarity=0.077 Sum_probs=102.2
Q ss_pred eEEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccC------------C--CchhHHHHHHHHHHHHHHHhcCCCC--ce
Q 040257 967 EELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFA------------G--RSSEQERLTKDFWREAHILSNLHHP--NV 1029 (1254)
Q Consensus 967 eiLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~------------~--~~~e~ee~~eqFlrEIeILkrLnHP--NI 1029 (1254)
.+...||-|--+.||.|.. .+..+|||.-+..... . ........+....+|.++|.+|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4567899999999999998 4889999976532111 0 0001122344567899999999654 67
Q ss_pred eEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCC
Q 040257 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQ 1109 (1254)
Q Consensus 1030 VkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~s 1109 (1254)
.+.+++- +-++||||+.|-.|...- ++....-.++..|++-+..+-..||||+|+.+-|||++ .
T Consensus 174 P~P~~~n------RHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~----~ 237 (304)
T COG0478 174 PKPIAWN------RHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT----E 237 (304)
T ss_pred CCccccc------cceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe----c
Confidence 7777652 568899999887666543 13344455666677777777799999999999999999 7
Q ss_pred CCeEEEEecccccc
Q 040257 1110 RPICKVGDFGLSRI 1123 (1254)
Q Consensus 1110 nG~VKLiDFGLAr~ 1123 (1254)
+|.+.++||-.+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 88999999988754
|
|
| >PF00564 PB1: PB1 domain; InterPro: IPR000270 The Phox and Bem1p domain, is present in many eukaryotic cytoplasmic signalling proteins | Back alignment and domain information |
|---|
Probab=98.13 E-value=5.7e-06 Score=75.61 Aligned_cols=74 Identities=39% Similarity=0.587 Sum_probs=59.3
Q ss_pred eeecCceEEEeccCCCChHHHHHHHHhhcCC---CceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEE
Q 040257 203 RYVGGETRIISLRTNLSWEELVKKTSNICNQ---PHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRL 279 (1254)
Q Consensus 203 ~YvGG~triv~V~r~~~f~~l~~kl~~~~~~---~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~ 279 (1254)
+|.|+.+|++.+++.++|.+|+.++++.++. .+.|+|+ .||- .+|++++|+||..|++.+... +..+|||
T Consensus 7 ~~~~~~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~Y~--D~dg-D~V~i~sd~Dl~~a~~~~~~~----~~~~lrl 79 (84)
T PF00564_consen 7 RYGGDIRRIISLPSDVSFDDLRSKIREKFGLLDEDFQLKYK--DEDG-DLVTISSDEDLQEAIEQAKES----GSKTLRL 79 (84)
T ss_dssp EETTEEEEEEEECSTSHHHHHHHHHHHHHTTSTSSEEEEEE--ETTS-SEEEESSHHHHHHHHHHHHHC----TTSCEEE
T ss_pred EECCeeEEEEEcCCCCCHHHHHHHHHHHhCCCCccEEEEee--CCCC-CEEEeCCHHHHHHHHHHHHhc----CCCcEEE
Confidence 3444344569999999999999999999987 4677886 4333 799999999999999999775 3348999
Q ss_pred EEec
Q 040257 280 FLIP 283 (1254)
Q Consensus 280 FLFp 283 (1254)
|+.+
T Consensus 80 ~v~~ 83 (84)
T PF00564_consen 80 FVQD 83 (84)
T ss_dssp EEEE
T ss_pred EEEe
Confidence 9864
|
The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate.; GO: 0005515 protein binding; PDB: 1IPG_A 1IP9_A 2KFK_A 1WMH_A 1VD2_A 1WI0_A 1OEY_C 1PQS_A 1Q1O_A 1TZ1_A .... |
| >cd05992 PB1 The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.2e-05 Score=73.07 Aligned_cols=73 Identities=36% Similarity=0.585 Sum_probs=56.9
Q ss_pred ceeecCceEEEecc-CCCChHHHHHHHHhhcCCC---ceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceE
Q 040257 202 LRYVGGETRIISLR-TNLSWEELVKKTSNICNQP---HLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRL 277 (1254)
Q Consensus 202 l~YvGG~triv~V~-r~~~f~~l~~kl~~~~~~~---~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rl 277 (1254)
++|- |++|.+.|+ ++++|.+|+.++.+.++.. +.|||. .||- .+|++++|+||..|+..+.+ ....++
T Consensus 5 ~~~~-~~~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~y~--D~e~-d~v~l~sd~Dl~~a~~~~~~----~~~~~l 76 (81)
T cd05992 5 VKYG-GEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYP--DEDG-DLVTISSDEDLEEAIEEARR----SGSKKL 76 (81)
T ss_pred EEec-CCCEEEEEecCCCCHHHHHHHHHHHhCCCCCcEEEEee--CCCC-CEEEeCCHHHHHHHHHHHhh----cCCccE
Confidence 4454 556666676 9999999999999999874 445555 4444 68999999999999999966 344688
Q ss_pred EEEEe
Q 040257 278 RLFLI 282 (1254)
Q Consensus 278 R~FLF 282 (1254)
|+|++
T Consensus 77 ~l~v~ 81 (81)
T cd05992 77 RLFVF 81 (81)
T ss_pred EEEeC
Confidence 88874
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.3e-05 Score=84.13 Aligned_cols=147 Identities=16% Similarity=0.103 Sum_probs=101.1
Q ss_pred EeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCc--eeEEe--eeeecCCCCceEEE
Q 040257 972 LGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN--VVAFY--GVVPDGTGGTLATV 1047 (1254)
Q Consensus 972 LGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPN--IVkLy--Gvf~Ddn~~~L~LV 1047 (1254)
-|+|+-+-|++....|..+-+|.-.......-.. .--...|.+|+..|.+|..-+ +.+.. +.-..+....-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~--P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRY--PFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccC--CCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 5679999999988888888888765221110000 001356888999888885322 33333 11112223357789
Q ss_pred EEeccc-CchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1048 TEFMVN-GSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1048 MEYm~G-GSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
+|-+.+ .+|.+++.... .+.+......++.+|+.+|.-||+.|+.|+|+-+.|||++..+ ...|+++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g--~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG--KAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC--CeeEEEEEhhccc
Confidence 997754 57777764432 3457777889999999999999999999999999999998322 3459999998775
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.06 E-value=6.4e-05 Score=77.15 Aligned_cols=80 Identities=19% Similarity=0.228 Sum_probs=56.2
Q ss_pred EEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCC--ceeEEeeeeecC-CCCceE
Q 040257 969 LRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP--NVVAFYGVVPDG-TGGTLA 1045 (1254)
Q Consensus 969 LkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHP--NIVkLyGvf~Dd-n~~~L~ 1045 (1254)
++.|+.|..+.||++...+..+++|..... .....+.+|..+++.|... .+.+++.+.... .....+
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence 568999999999999998889999987532 2345666788888777422 355666643322 223478
Q ss_pred EEEEecccCchhh
Q 040257 1046 TVTEFMVNGSLKH 1058 (1254)
Q Consensus 1046 LVMEYm~GGSL~d 1058 (1254)
++|+|+.+..+..
T Consensus 72 ~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 72 LLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEESSEEHHH
T ss_pred EEEEEeccccccc
Confidence 9999999887777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00012 Score=79.46 Aligned_cols=72 Identities=18% Similarity=0.242 Sum_probs=49.0
Q ss_pred EEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCc--eeEEeeeeecCCCCceEEE
Q 040257 970 RELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN--VVAFYGVVPDGTGGTLATV 1047 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPN--IVkLyGvf~Ddn~~~L~LV 1047 (1254)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++..+.. ...+|
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~--~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGG--RLGLI 72 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC----------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCC--eeeee
Confidence 56899999999984 35567888775321 1233567888888775332 456666665444 56789
Q ss_pred EEecccCc
Q 040257 1048 TEFMVNGS 1055 (1254)
Q Consensus 1048 MEYm~GGS 1055 (1254)
|||+.|..
T Consensus 73 ~e~i~G~~ 80 (226)
T TIGR02172 73 YELIVGKR 80 (226)
T ss_pred eeecCCcc
Confidence 99998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00012 Score=79.28 Aligned_cols=135 Identities=24% Similarity=0.225 Sum_probs=92.4
Q ss_pred cCceEEEEEeeeCc-EEEEEEEECCceEEEEEEeccccCCCch------hH-------HHHHHHHHHHHHHHhcCC---C
Q 040257 964 VDLEELRELGSGTY-GTVYHGKWRGSDVAIKRIKKSCFAGRSS------EQ-------ERLTKDFWREAHILSNLH---H 1026 (1254)
Q Consensus 964 ~dYeiLkkLGeGsF-GtVYlAk~rGs~VAIKvIkk~~~~~~~~------e~-------ee~~eqFlrEIeILkrLn---H 1026 (1254)
.+++.++.||.|.. |.||+++..|..||||+++.-....... .. .....-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 47889999999999 9999999999999999944211111100 00 123446778888777664 5
Q ss_pred Cce--eEEeeeeecC----------------CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh
Q 040257 1027 PNV--VAFYGVVPDG----------------TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS 1088 (1254)
Q Consensus 1027 PNI--VkLyGvf~Dd----------------n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS 1088 (1254)
.++ |+++||+.-. ......||.||+.... .+... -+.+|.+-|..+|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHHH
Confidence 556 9999987322 1123456777664332 22233 34566777889999
Q ss_pred CCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1089 kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.||+-+|+++.|..=. ||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~~G---------~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYRGG---------KLVDFSSS 206 (207)
T ss_pred CCeeeccCccccccCC---------EEEecccC
Confidence 9999999999998622 89999875
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00027 Score=77.73 Aligned_cols=143 Identities=16% Similarity=0.128 Sum_probs=92.8
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHH------HHHHHHHhcCCC---CceeE
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDF------WREAHILSNLHH---PNVVA 1031 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqF------lrEIeILkrLnH---PNIVk 1031 (1254)
+...+|.+++++-......|.+-...++.+.+|..+.... ..++....| .+++..+.++.. -.+..
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~-----r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~ 102 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENR-----RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD 102 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhh-----hHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence 4456899999999999999999999999999998764321 111111212 223333333322 22222
Q ss_pred Eeeeeec---CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCC
Q 040257 1032 FYGVVPD---GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDP 1108 (1254)
Q Consensus 1032 LyGvf~D---dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~ 1108 (1254)
++.+... .-....+++|||++|..|.+... +++ .+...|.++|.-||+.|+.|+|..|.|++++
T Consensus 103 ~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~---- 169 (229)
T PF06176_consen 103 PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS---- 169 (229)
T ss_pred ceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----
Confidence 2221111 01124568999999988877541 222 2445677789999999999999999999997
Q ss_pred CCCeEEEEeccccc
Q 040257 1109 QRPICKVGDFGLSR 1122 (1254)
Q Consensus 1109 snG~VKLiDFGLAr 1122 (1254)
++.++++||+..+
T Consensus 170 -~~~i~iID~~~k~ 182 (229)
T PF06176_consen 170 -NNGIRIIDTQGKR 182 (229)
T ss_pred -CCcEEEEECcccc
Confidence 3459999998764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00025 Score=79.04 Aligned_cols=148 Identities=22% Similarity=0.114 Sum_probs=97.2
Q ss_pred EEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccCC----------------CchhHHHHHHHHHHHHHHHhcCC--CCc
Q 040257 968 ELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAG----------------RSSEQERLTKDFWREAHILSNLH--HPN 1028 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~----------------~~~e~ee~~eqFlrEIeILkrLn--HPN 1028 (1254)
+...|..|--+.||+|.. .+..+|+|+++...... +.........-..+|..-|+++. +-.
T Consensus 52 ~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 52 LVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 445788999999999886 57889999997532110 01111111122345777777763 455
Q ss_pred eeEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCC
Q 040257 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRD 1107 (1254)
Q Consensus 1029 IVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd 1107 (1254)
+.+-+++. .-.+||||+....+-.-.. ++-.+.......+..++++.+.-|-. .++||+||+.=|||+.
T Consensus 132 vP~Pi~~~------~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~--- 201 (268)
T COG1718 132 VPEPIAFR------NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH--- 201 (268)
T ss_pred CCCceeec------CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE---
Confidence 56666665 2367999986542211111 12223333667777888888888877 8999999999999996
Q ss_pred CCCCeEEEEeccccccccCc
Q 040257 1108 PQRPICKVGDFGLSRIKRNT 1127 (1254)
Q Consensus 1108 ~snG~VKLiDFGLAr~~~~s 1127 (1254)
.+.+.|+|||.|....++
T Consensus 202 --~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 202 --DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred --CCeEEEEECccccccCCC
Confidence 568999999998765443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.67 E-value=8.8e-05 Score=79.30 Aligned_cols=132 Identities=28% Similarity=0.349 Sum_probs=94.0
Q ss_pred ceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCcee-EEeeeeecCCCCce
Q 040257 966 LEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVV-AFYGVVPDGTGGTL 1044 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIV-kLyGvf~Ddn~~~L 1044 (1254)
.+..+.|++|.+|.||+|.|++..+|+|+-+... .+..+..|+++|..+...++. ++|.|- ..
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----------~r~~l~kEakiLeil~g~~~~p~vy~yg------~~ 87 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----------PRRNLEKEAKILEILAGEGVTPEVYFYG------ED 87 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCc----------chhhHHHHHHHHHHhhhcCCCceEEEec------hh
Confidence 4556789999999999999999999999876542 245677899999998876664 455442 23
Q ss_pred EEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCC--CceEeccCCCCCCeEEEEeccccc
Q 040257 1045 ATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKC--ENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1045 ~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKP--eNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
++.|||+.|-.|....... +..+.+ .+++.-.-|-..||-|..|.- .||++. ...+.|+||..|+
T Consensus 88 ~i~me~i~G~~L~~~~~~~----~rk~l~----~vlE~a~~LD~~GI~H~El~~~~k~vlv~-----~~~~~iIDFd~At 154 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG----DRKHLL----RVLEKAYKLDRLGIEHGELSRPWKNVLVN-----DRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhhcCcchhhhhhcc----cHHHHH----HHHHHHHHHHHhccchhhhcCCceeEEec-----CCcEEEEEccchh
Confidence 4569999888888765321 233333 344454556677999998864 566664 4479999999987
Q ss_pred cccC
Q 040257 1123 IKRN 1126 (1254)
Q Consensus 1123 ~~~~ 1126 (1254)
+...
T Consensus 155 ~k~~ 158 (201)
T COG2112 155 FKKK 158 (201)
T ss_pred hccC
Confidence 5433
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00023 Score=86.20 Aligned_cols=147 Identities=19% Similarity=0.194 Sum_probs=91.5
Q ss_pred EEEeeeCcEEEEEEEEC-CceEEEEEEecccc--------------------------CCCchhHHHHHHHH------HH
Q 040257 970 RELGSGTYGTVYHGKWR-GSDVAIKRIKKSCF--------------------------AGRSSEQERLTKDF------WR 1016 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~--------------------------~~~~~e~ee~~eqF------lr 1016 (1254)
.-|+.++-|.||+|++. |+.||||+.+.... .......+++.+.+ .+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 46999999999999996 89999999864310 00111122222222 33
Q ss_pred HHHHHhcCC-----CCceeEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCc
Q 040257 1017 EAHILSNLH-----HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNI 1091 (1254)
Q Consensus 1017 EIeILkrLn-----HPNIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGI 1091 (1254)
|..-+.+++ .+++ .+=.++.+-+ +.-.++|||+.|-.+.++...+...++.+.+.....++. +..+=..|+
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t-~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYT-TRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-Eeceeehhcc-CCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 444444331 3332 2212222212 245789999999999888543434456444443333322 233334899
Q ss_pred ccccCCCCceEeccCCCCCCeEEEEeccccccc
Q 040257 1092 VHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1092 IHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~ 1124 (1254)
+|.|..|.||+++ .++.+.+.|||+....
T Consensus 287 fHaDpHpGNi~v~----~~g~i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVR----SDGRIVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEe----cCCcEEEEcCcceecC
Confidence 9999999999999 7789999999998654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00036 Score=74.67 Aligned_cols=75 Identities=20% Similarity=0.121 Sum_probs=49.9
Q ss_pred EeeeCc-EEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCCCCceEEEEE
Q 040257 972 LGSGTY-GTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGTGGTLATVTE 1049 (1254)
Q Consensus 972 LGeGsF-GtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn~~~L~LVME 1049 (1254)
|-.|.. ..||+....+..+.||+..... ...+.+|+++++.+. +--+.+++++.... +..++|||
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e 72 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTS 72 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEE
Confidence 444544 7899987766778888775321 123556888887773 34456777776543 35788999
Q ss_pred ecccCchhhh
Q 040257 1050 FMVNGSLKHV 1059 (1254)
Q Consensus 1050 Ym~GGSL~d~ 1059 (1254)
+++|.+|...
T Consensus 73 ~i~G~~l~~~ 82 (244)
T cd05150 73 AVPGVPAAAL 82 (244)
T ss_pred eeCCccHhHh
Confidence 9998877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd06407 PB1_NLP A PB1 domain is present in NIN like proteins (NLP), a key enzyme in a process of establishment of symbiosis betweeen legumes and nitrogen fixing bacteria (Rhizobium) | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00044 Score=65.13 Aligned_cols=71 Identities=25% Similarity=0.426 Sum_probs=59.8
Q ss_pred ecCceEEEeccCCCChHHHHHHHHhhcCC----CceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEEE
Q 040257 205 VGGETRIISLRTNLSWEELVKKTSNICNQ----PHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRLF 280 (1254)
Q Consensus 205 vGG~triv~V~r~~~f~~l~~kl~~~~~~----~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~F 280 (1254)
.||+++.+.++.+++|.+|..++++.++. .+.|||. .|| .-.|+++||+||+.-++-|.. ....++|+|
T Consensus 7 ~~~d~~r~~l~~~~~~~~L~~~i~~r~~~~~~~~f~LkY~--Dde-gd~v~ltsd~DL~eai~i~~~----~~~~~v~l~ 79 (82)
T cd06407 7 YGEEKIRFRLPPSWGFTELKQEIAKRFKLDDMSAFDLKYL--DDD-EEWVLLTCDADLEECIDVYRS----SGSHTIRLL 79 (82)
T ss_pred eCCeEEEEEcCCCCCHHHHHHHHHHHhCCCCCCeeEEEEE--CCC-CCeEEeecHHHHHHHHHHHHH----CCCCeEEEE
Confidence 38899999999999999999999999974 4889998 444 789999999999988887754 345689998
Q ss_pred Ee
Q 040257 281 LI 282 (1254)
Q Consensus 281 LF 282 (1254)
+-
T Consensus 80 v~ 81 (82)
T cd06407 80 VH 81 (82)
T ss_pred ee
Confidence 73
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes like osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-inte |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00036 Score=89.54 Aligned_cols=203 Identities=19% Similarity=0.183 Sum_probs=138.6
Q ss_pred HHHHHHHHhcCCCCceeEEeeeeecCCC-C-ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCc
Q 040257 1014 FWREAHILSNLHHPNVVAFYGVVPDGTG-G-TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNI 1091 (1254)
Q Consensus 1014 FlrEIeILkrLnHPNIVkLyGvf~Ddn~-~-~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGI 1091 (1254)
...|+..+.++.|+|++.++.|-.+... + .+.+..+++...++...+.. -...+....+.+..++.+||.|+|+...
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 3457778889999999999988654321 1 23345677777788777743 3568899999999999999999999865
Q ss_pred ccccCCCCceEeccCCCCCCeEEEE--eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHH
Q 040257 1092 VHFDLKCENLLVNLRDPQRPICKVG--DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEIL 1169 (1254)
Q Consensus 1092 IHRDLKPeNILLDsdd~snG~VKLi--DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELL 1169 (1254)
.|.-|...-..-.. ....+.+.++ ||+.+.............-+..|.++|.............|+|.+|..+..+.
T Consensus 308 ~~v~L~~s~~~~~~-~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 308 EHVVLSASSSKEST-VDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred ceeEEecccccccc-cCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 55544443111111 1255667776 88888765544433334456678888888766655666689999999999998
Q ss_pred cCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1170 TGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1170 TGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
.|..+-... .....+ .+........+++.+|+..+.++|+++.+++.+.
T Consensus 387 ~~~~i~~~~---~~~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 387 QGEDISEKS---AVPVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hcCcccccc---cchhhh--------hccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 876542211 111111 1122222678899999999999999999998874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.48 E-value=3.1e-05 Score=94.21 Aligned_cols=181 Identities=18% Similarity=0.161 Sum_probs=127.1
Q ss_pred EEEEeeeCcEEEEEEEECCc-eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCc-eeEEeeeeecCCCCceEE
Q 040257 969 LRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN-VVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 969 LkkLGeGsFGtVYlAk~rGs-~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPN-IVkLyGvf~Ddn~~~L~L 1046 (1254)
.+.+++|+++++++.+...+ ....+.+... ....-++++|.+++||| .+..++-+. ......+
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~-------------l~~rl~~eLLdK~n~P~~~v~~~~d~~--~E~~~~i 311 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------------LSRRLAIELLDKVNNPNPVVRYLEDYD--GEDYLWI 311 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc-------------hhhHHHHHHHHHccCCCCcccccccCC--cccccch
Confidence 34578999999998765422 2223333211 22334788999999999 444444443 3348889
Q ss_pred EEEecccC-chhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1047 VTEFMVNG-SLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1047 VMEYm~GG-SL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
+|+++.++ +-...+...+-.+...+...+++.-++++++||+..=+||| ||+.. ++.+|..||+......
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-----~~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-----EEEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-----ccccccccccCCcccC
Confidence 99999777 32222212222355555666778889999999998778999 88875 4678999999987665
Q ss_pred CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 040257 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175 (1254)
Q Consensus 1126 ~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF 1175 (1254)
.......+.+++.++|||+..... +....|.|+++.--.+|--|-+|-
T Consensus 383 ~~~~~~t~~~~~~~~~pev~~~~~--~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 383 RTMKPRTAIGTPEPLAPEVIQENT--IDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccccccCCCCCCCCCchhhcccc--cccCCCccCCCcchhhcCCCCCCC
Confidence 555566778999999999887653 778899999998777777776664
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0012 Score=83.92 Aligned_cols=82 Identities=16% Similarity=0.254 Sum_probs=56.2
Q ss_pred EEEEEeeeCcEEEEEEEECC----ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCce--eEEeeeeecCC
Q 040257 968 ELRELGSGTYGTVYHGKWRG----SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNV--VAFYGVVPDGT 1040 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~rG----s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNI--VkLyGvf~Ddn 1040 (1254)
.++.|+.|.+..+|+..+.+ ..+++|+........ ....+.+|+.+|+.|. |.++ .+++.++.+..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-------~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~ 114 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-------SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS 114 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-------cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC
Confidence 36778999999999987754 357777654321110 1235678999999885 6654 78888776532
Q ss_pred -CCceEEEEEecccCch
Q 040257 1041 -GGTLATVTEFMVNGSL 1056 (1254)
Q Consensus 1041 -~~~L~LVMEYm~GGSL 1056 (1254)
.+..|+||||+.|..+
T Consensus 115 v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 115 VIGTAFYIMEYLEGRIF 131 (822)
T ss_pred cCCCceEEEEecCCccc
Confidence 2357899999987654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0022 Score=69.15 Aligned_cols=141 Identities=21% Similarity=0.225 Sum_probs=92.9
Q ss_pred EEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchh--------HHHHHHHHHHHHHHHhcCC------CCceeEEe
Q 040257 968 ELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSE--------QERLTKDFWREAHILSNLH------HPNVVAFY 1033 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e--------~ee~~eqFlrEIeILkrLn------HPNIVkLy 1033 (1254)
....||+|+.=.||.--. .....||+............ .....++..+|+.-+..+. +.+|.+++
T Consensus 5 ~~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CCcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 345799999999997433 34568888875530000000 0112345566766666555 88999999
Q ss_pred eeeecCCCCceEEEEEeccc------CchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC
Q 040257 1034 GVVPDGTGGTLATVTEFMVN------GSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD 1107 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~G------GSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd 1107 (1254)
|+...+- .+.+|+|.+.+ -+|.+++.. ..++. . +...+-+-..||-+++|+.+||+|.||++...+
T Consensus 84 G~veT~~--G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 84 GFVETNL--GLGLVVELIRDADGNISPTLEDYLKE--GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEEecCC--ceEEEEEEEECCCCCcCccHHHHHHc--CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 9997655 67888888753 267777732 33554 2 233344456788999999999999999998665
Q ss_pred CCCCeEEEEe
Q 040257 1108 PQRPICKVGD 1117 (1254)
Q Consensus 1108 ~snG~VKLiD 1117 (1254)
.....+.|+|
T Consensus 156 ~~~~~lvlID 165 (199)
T PF10707_consen 156 SGEFRLVLID 165 (199)
T ss_pred CCceEEEEEe
Confidence 4444788888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd06408 PB1_NoxR The PB1 domain is present in the Epichloe festucae NoxR protein (NADPH oxidase regulator), a key regulator of NADPH oxidase isoform, NoxA | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0013 Score=62.86 Aligned_cols=72 Identities=21% Similarity=0.352 Sum_probs=58.3
Q ss_pred cCceEEEeccCCCChHHHHHHHHhhcCCC--ceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCC--CceEEEEE
Q 040257 206 GGETRIISLRTNLSWEELVKKTSNICNQP--HLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEG--SQRLRLFL 281 (1254)
Q Consensus 206 GG~triv~V~r~~~f~~l~~kl~~~~~~~--~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~--~~rlR~FL 281 (1254)
+|++|++.|+.+|+|.+|..|+.+.|+.. +.|||+ .| ...|++++++||+-.+.-+....+..+ -+|+-+.+
T Consensus 10 ~~Dv~~i~v~~~i~f~dL~~kIrdkf~~~~~~~iKyk--DE--GD~iti~sq~DLd~Ai~~a~~~~~~~~~~~~~~e~w~ 85 (86)
T cd06408 10 QDDTRYIMIGPDTGFADFEDKIRDKFGFKRRLKIKMK--DD--GDMITMGDQDDLDMAIDTARSEARKQGSDMGKLEIWV 85 (86)
T ss_pred cCcEEEEEcCCCCCHHHHHHHHHHHhCCCCceEEEEE--cC--CCCccccCHHHHHHHHHHHHHHHHhhcccccceeeec
Confidence 78899999999999999999999999864 788998 22 789999999999999988854333222 25766554
|
NoxA is essential for growth control of the fungal endophyte in plant tissue in the process of symbiotic interaction between a fungi and its plant host. The Epichloe festucae p67(phox)-like regulator, NoxR, dispensable in culture but essential in plants for the symbiotic interaction. Plants infected with a noxR deletion mutant show severe stunting and premature senescence, whereas hyphae in the meristematic tissues show increased branching leading to increased fungal colonization of pseudostem and leaf blade tissue. The PB1 domain is a modular domain mediating specific protein-protein interactions which a play role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0014 Score=70.41 Aligned_cols=75 Identities=16% Similarity=0.187 Sum_probs=44.1
Q ss_pred EEEeeeCcE-EEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCC---ceeEEeeeeecCCC-Cce
Q 040257 970 RELGSGTYG-TVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP---NVVAFYGVVPDGTG-GTL 1044 (1254)
Q Consensus 970 kkLGeGsFG-tVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHP---NIVkLyGvf~Ddn~-~~L 1044 (1254)
..|+.|+.. .||+. +..+++|..... .....+.+|.++|..|... -+.++++....... ...
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~----------~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~ 69 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA----------GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP 69 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc----------chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence 456766666 58875 245777765421 1134577888888877421 34444444332211 245
Q ss_pred EEEEEecccCchh
Q 040257 1045 ATVTEFMVNGSLK 1057 (1254)
Q Consensus 1045 ~LVMEYm~GGSL~ 1057 (1254)
+++|+++.|.++.
T Consensus 70 ~~l~~~i~G~~l~ 82 (235)
T cd05155 70 WSVYRWLEGETAT 82 (235)
T ss_pred eEEEEeecCCCCC
Confidence 7899999987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0012 Score=80.45 Aligned_cols=150 Identities=16% Similarity=0.143 Sum_probs=91.0
Q ss_pred EEEeeeCcEEEEEEEEC-CceEEEEEEeccccCC-----------------------CchhHHHHHHHH------HHHHH
Q 040257 970 RELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAG-----------------------RSSEQERLTKDF------WREAH 1019 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~-----------------------~~~e~ee~~eqF------lrEIe 1019 (1254)
+.||.-+.|.||+++.+ |+.||||+-+...-.. -.--.+++.+.+ .+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 35999999999999985 7789999876431000 000011222222 23332
Q ss_pred HH----hcCCCCc------eeEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC
Q 040257 1020 IL----SNLHHPN------VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK 1089 (1254)
Q Consensus 1020 IL----krLnHPN------IVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk 1089 (1254)
-. +.+.|-+ |.++|--+. ..-.++||||.|..+.+.-.-....++...+..-+.++..- -+=..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~--qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLE--QIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHH--HHHhc
Confidence 22 2223444 444443332 25678999999987776643344456666544443333221 12236
Q ss_pred CcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1090 GIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
|++|.|=.|.||+++........+.+-|||+.....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 899999999999998544457889999999987543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0013 Score=69.98 Aligned_cols=98 Identities=19% Similarity=0.107 Sum_probs=77.5
Q ss_pred HHHHHHhcCCC-CceeEEeeeeecCCCCceEEEEEecccCchhhhhh--ccCCCCCHHHHHHHHHHhhhhhHHhhh---C
Q 040257 1016 REAHILSNLHH-PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLL--KKDRSLDRRKKLIIAMDAAFGMEYLHS---K 1089 (1254)
Q Consensus 1016 rEIeILkrLnH-PNIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~--kre~~LSe~~~lkIa~QIAeALaYLHS---k 1089 (1254)
.|.-+++.+.+ +++++++|+|- -+++.||...+++..... ..-...+|..+.+|+.++++.+.+|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 47778888865 69999999992 356899998776653210 011246899999999999999999997 4
Q ss_pred CcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1090 GIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
.+...|++++|+-++ .++++|++|......
T Consensus 82 ~~~lcDv~~~nfgv~----~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVN----DDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEe----CCCcEEEEechhcch
Confidence 688899999999998 778999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.00012 Score=95.30 Aligned_cols=190 Identities=17% Similarity=0.130 Sum_probs=131.5
Q ss_pred EEEEEEECCc---eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEEecccCc
Q 040257 979 TVYHGKWRGS---DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGS 1055 (1254)
Q Consensus 979 tVYlAk~rGs---~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVMEYm~GGS 1055 (1254)
.-++++|-++ .+.+|+++...+... .+-..+-...|.+-++...|+++...+.-.........+..++|+.+|.
T Consensus 1241 ~~~R~k~Lr~kid~Fk~~I~ke~d~e~L---sePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~ 1317 (2724)
T KOG1826|consen 1241 FHFRNKWLRSKIDWFKFSIYKEYDFENL---SEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGK 1317 (2724)
T ss_pred eeeccchHhhhhceeEEEeehhhhHHHH---hhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhH
Confidence 3446666322 356777664322111 1222333445566666778999988877666666667888999999999
Q ss_pred hhhhhhccCCC---CCHHHHHHHHHHhhhhhHHhhhC-----CcccccCCCCceEeccCCCCCCeEEEEeccccccccCc
Q 040257 1056 LKHVLLKKDRS---LDRRKKLIIAMDAAFGMEYLHSK-----NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT 1127 (1254)
Q Consensus 1056 L~d~L~kre~~---LSe~~~lkIa~QIAeALaYLHSk-----GIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s 1127 (1254)
+.++|.+.-.. +...-+.....+.+.+..-+|+. -.+|++||+-|.+|. .+..||+.++|+.++..+.
T Consensus 1318 ~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIV----tny~v~~gk~gLdKIknp~ 1393 (2724)
T KOG1826|consen 1318 LFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIV----TNYNVKLGKGGLDKIKNPV 1393 (2724)
T ss_pred HHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhcccee----cCCcccccccccccccCch
Confidence 99998664322 33333333334446666666653 279999999999998 7778999999999854443
Q ss_pred -cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 040257 1128 -LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177 (1254)
Q Consensus 1128 -~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~ 1177 (1254)
.......+++.|+.|+..... +++.++|+|.+|+.+|++..|..+|..
T Consensus 1394 ~sf~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1394 LSFFGLELCSPIYVLQLIKNEI--KFTKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred HhhhhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHHHHHHhcccHHHHH
Confidence 233445688889999998765 378889999999999999988887753
|
|
| >cd06405 PB1_Mekk2_3 The PB1 domain is present in the two mitogen-activated protein kinase kinases MEKK2 and MEKK3 which are two members of the signaling kinase cascade involved in angiogenesis and early cardiovascular development | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0033 Score=58.61 Aligned_cols=70 Identities=26% Similarity=0.413 Sum_probs=59.7
Q ss_pred cCceEEEeccCCCChHHHHHHHHhhcCCCceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEEEEe
Q 040257 206 GGETRIISLRTNLSWEELVKKTSNICNQPHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRLFLI 282 (1254)
Q Consensus 206 GG~triv~V~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~FLF 282 (1254)
-||.||+.++|.+.|.||..|+...||..+.+-|-.-. -||.+.|.|||+.-|+-.|+. +.-..||+.|-
T Consensus 8 ~gEKRIi~f~RPvkf~dl~~kv~~afGq~mdl~ytn~e----L~iPl~~Q~DLDkAie~ld~s---~~~ksLRilL~ 77 (79)
T cd06405 8 NGEKRIIQFPRPVKFKDLQQKVTTAFGQPMDLHYTNNE----LLIPLKNQEDLDRAIELLDRS---PHMKSLRILLS 77 (79)
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeEEEeccc----EEEeccCHHHHHHHHHHHccC---ccccceeEeEe
Confidence 58999999999999999999999999999999997432 799999999999999999982 22235777664
|
The PB1 domain of MEKK2 (and/or MEKK3) interacts with the PB1 domain of another member of the kinase cascade Map2k5. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, f |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0031 Score=68.47 Aligned_cols=134 Identities=17% Similarity=0.113 Sum_probs=75.2
Q ss_pred EeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCce-eEEeeeeecCCCCceEEEEEe
Q 040257 972 LGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV-VAFYGVVPDGTGGTLATVTEF 1050 (1254)
Q Consensus 972 LGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNI-VkLyGvf~Ddn~~~L~LVMEY 1050 (1254)
+..|-...+|+....+..+++|+...... ...-...+|..+++.+....+ .+++.+. . -++||||
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~--------~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~ 69 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCK--------ALGVDRQREYQILQALSALGLAPKPILVN--E----HWLLVEW 69 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccc--------cccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEe
Confidence 55688889999887777888887543210 000123467788887753323 3444443 1 2579999
Q ss_pred cccCchhhh-----------------hhcc---CCCCCHHH-HHHHHHHh---------hhhhHHhhh--------CCcc
Q 040257 1051 MVNGSLKHV-----------------LLKK---DRSLDRRK-KLIIAMDA---------AFGMEYLHS--------KNIV 1092 (1254)
Q Consensus 1051 m~GGSL~d~-----------------L~kr---e~~LSe~~-~lkIa~QI---------AeALaYLHS--------kGII 1092 (1254)
++|..+... ++.. ...++... ...+..++ ...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 988765421 1111 11122221 11221111 111222211 2589
Q ss_pred cccCCCCceEeccCCCCCCeEEEEeccccccc
Q 040257 1093 HFDLKCENLLVNLRDPQRPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1093 HRDLKPeNILLDsdd~snG~VKLiDFGLAr~~ 1124 (1254)
|+|+.|.||+++ .++ +.|+||..+...
T Consensus 150 H~Dl~~~Nil~~----~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 150 HMDVHAYNLVVT----PQG-LKLIDWEYASDG 176 (256)
T ss_pred cCCCCcCcEEEe----CCC-CEEEeccccCcC
Confidence 999999999998 444 789999988643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.015 Score=61.86 Aligned_cols=73 Identities=15% Similarity=0.154 Sum_probs=46.1
Q ss_pred EEEEeeeCcEEEEEEEEC---CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCC-CceeEEeeeeecCCCCce
Q 040257 969 LRELGSGTYGTVYHGKWR---GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH-PNVVAFYGVVPDGTGGTL 1044 (1254)
Q Consensus 969 LkkLGeGsFGtVYlAk~r---Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnH-PNIVkLyGvf~Ddn~~~L 1044 (1254)
++.|..|-...+|++... +..|++|+....... .....+|+.+++.+.. .-.+++++.+. .
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---------~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~---- 67 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---------IIDRERELRIHKLLSKHGLAPKLYATFQ--N---- 67 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---------eecHHHHHHHHHHHHhCCCCCeEEEEeC--C----
Confidence 456888999999998875 467888976532100 0112357777777743 23445555432 1
Q ss_pred EEEEEecccCch
Q 040257 1045 ATVTEFMVNGSL 1056 (1254)
Q Consensus 1045 ~LVMEYm~GGSL 1056 (1254)
.+||||++|.++
T Consensus 68 ~~l~e~i~G~~l 79 (235)
T cd05157 68 GLIYEFIPGRTL 79 (235)
T ss_pred cEEEEeeCCCcC
Confidence 369999988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.02 Score=63.20 Aligned_cols=140 Identities=19% Similarity=0.166 Sum_probs=80.8
Q ss_pred EEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCC--ceeEEeeeeec----CCC
Q 040257 968 ELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP--NVVAFYGVVPD----GTG 1041 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHP--NIVkLyGvf~D----dn~ 1041 (1254)
.++.|..|....+|+....+..+++|+.... . ...+..|+.++..|.+- .+.+++..... ...
T Consensus 18 ~i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~-----~------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~ 86 (296)
T cd05153 18 SFEGISAGIENTNYFVTTDSGRYVLTLFEKV-----S------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA 86 (296)
T ss_pred heecccCccccceEEEEeCCCcEEEEEcCCC-----C------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence 3567888888999998877778999987531 0 12344566666666322 24444432100 112
Q ss_pred CceEEEEEecccCchhh----h----------hhccCCC----------CCHHHHH----------HHHHHhhhhhHHhh
Q 040257 1042 GTLATVTEFMVNGSLKH----V----------LLKKDRS----------LDRRKKL----------IIAMDAAFGMEYLH 1087 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d----~----------L~kre~~----------LSe~~~l----------kIa~QIAeALaYLH 1087 (1254)
+..++|++|++|..+.. . ++..... ..+.... .....+..++.++.
T Consensus 87 ~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~ 166 (296)
T cd05153 87 GKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQD 166 (296)
T ss_pred CceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHH
Confidence 35688999998876532 0 0100000 0111000 01111233444444
Q ss_pred h-------CCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1088 S-------KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1088 S-------kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
. .+++|+|+.|.|||++ .+..+.|+||+.+.
T Consensus 167 ~~~~~~~~~~l~HgD~~~~Nil~~----~~~~~~iIDfe~a~ 204 (296)
T cd05153 167 AFDPSDLPRGVIHADLFRDNVLFD----GDELSGVIDFYFAC 204 (296)
T ss_pred hhhhhcCCCcCCccCcCcccEEEe----CCceEEEeehhhhc
Confidence 3 4799999999999998 55567899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.036 Score=61.96 Aligned_cols=30 Identities=23% Similarity=0.371 Sum_probs=25.3
Q ss_pred CCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1089 kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.++||+|+.+.|||++ .+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~----~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFE----GDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEE----CCceEEEEeccccc
Confidence 4899999999999997 44455799999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.023 Score=63.66 Aligned_cols=143 Identities=16% Similarity=0.160 Sum_probs=79.7
Q ss_pred ceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCC--CceeEEeeeee----cC
Q 040257 966 LEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH--PNVVAFYGVVP----DG 1039 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnH--PNIVkLyGvf~----Dd 1039 (1254)
...++.++.|....+|+.+..+..+++|+..... . ...+..|+.++..|.. -.+.+++.... ..
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~----~------~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~ 93 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV----K------AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLST 93 (307)
T ss_pred ceeccccCCccccceEEEEeCCCcEEEEEecCCC----C------HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence 3446678888888999988766678889775421 0 1223345566655532 12344433211 11
Q ss_pred CCCceEEEEEecccCchhhh--------------hhccCCCCC-------HHHHH----------------HHHHHhhhh
Q 040257 1040 TGGTLATVTEFMVNGSLKHV--------------LLKKDRSLD-------RRKKL----------------IIAMDAAFG 1082 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~--------------L~kre~~LS-------e~~~l----------------kIa~QIAeA 1082 (1254)
..+..+++++|++|..+... ++.....++ ....+ .....+...
T Consensus 94 ~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~ 173 (307)
T TIGR00938 94 LAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKE 173 (307)
T ss_pred cCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHH
Confidence 12467899999988654211 111000000 00000 001112334
Q ss_pred hHHhh-------hCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1083 MEYLH-------SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1083 LaYLH-------SkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
++++. ..+++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 174 ~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~----~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 174 LDYLDKFWPRDLPRGVIHADLFPDNVLFD----GDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHhhhhhcCCCccCCCCCCcCcEEEE----CCceEEEeeccccc
Confidence 55553 25899999999999998 55567899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.0029 Score=73.29 Aligned_cols=140 Identities=16% Similarity=0.024 Sum_probs=95.1
Q ss_pred ceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCch--------------hHHHHHHHHHHHHHHHhcCCC--Cc
Q 040257 966 LEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSS--------------EQERLTKDFWREAHILSNLHH--PN 1028 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~--------------e~ee~~eqFlrEIeILkrLnH--PN 1028 (1254)
+.+++.||-|--+-||.+-+. |++.++|.-......-+.. .....+-...+|...|+.|.. --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 456788999999999998885 8888888654221110000 001112234568888887742 23
Q ss_pred eeEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCC
Q 040257 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDP 1108 (1254)
Q Consensus 1029 IVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~ 1108 (1254)
+.+.+++. +.++|||.+.+..|....+-. ....+...+..-|.-|..+|+||+|+.-=||+++
T Consensus 174 VPkpiD~~------RH~Vvmelv~g~Pl~~v~~v~-------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~---- 236 (465)
T KOG2268|consen 174 VPKPIDHN------RHCVVMELVDGYPLRQVRHVE-------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK---- 236 (465)
T ss_pred CCCccccc------ceeeHHHhhcccceeeeeecC-------ChHHHHHHHHHHHHHHHHcCceecccchheeEEe----
Confidence 44555443 678899999998887754221 1233445566667788999999999999999998
Q ss_pred CCCeEEEEeccccc
Q 040257 1109 QRPICKVGDFGLSR 1122 (1254)
Q Consensus 1109 snG~VKLiDFGLAr 1122 (1254)
..+.++++||-.+.
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 67889999998654
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.022 Score=63.14 Aligned_cols=74 Identities=23% Similarity=0.365 Sum_probs=45.8
Q ss_pred EEEEeeeCcEEEEEEEEC--------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCc-eeEEeeeeecC
Q 040257 969 LRELGSGTYGTVYHGKWR--------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN-VVAFYGVVPDG 1039 (1254)
Q Consensus 969 LkkLGeGsFGtVYlAk~r--------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPN-IVkLyGvf~Dd 1039 (1254)
++.|..|-...||+.... ++.+++|+...... ......+|..+++.+.... ..++++++..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---------~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---------LLIDRERELVVFARLSERNLGPKLYGIFPN- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---------ceechHHHHHHHHHHHhCCCCCceEEEeCC-
Confidence 456777888899998765 36788998754310 0123346777777764322 3456655532
Q ss_pred CCCceEEEEEecccCchh
Q 040257 1040 TGGTLATVTEFMVNGSLK 1057 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~ 1057 (1254)
.+|++|++|..+.
T Consensus 73 -----~~v~e~i~G~~l~ 85 (302)
T cd05156 73 -----GRIEEFIPSRTLT 85 (302)
T ss_pred -----CchhheeCCCcCC
Confidence 2479999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.035 Score=65.58 Aligned_cols=149 Identities=22% Similarity=0.132 Sum_probs=96.4
Q ss_pred EEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccCC----------------Cch-hHHHHH-HHHHHHHHHHhcCCCCc
Q 040257 968 ELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAG----------------RSS-EQERLT-KDFWREAHILSNLHHPN 1028 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~----------------~~~-e~ee~~-eqFlrEIeILkrLnHPN 1028 (1254)
+-..|..|--+.||.+.- .|..+|||+++...+.- ... ..+.+. --...|++-|++|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345788999999999876 58889999998543210 000 011222 22345777788876544
Q ss_pred eeEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhh-hCCcccccCCCCceEeccCC
Q 040257 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLH-SKNIVHFDLKCENLLVNLRD 1107 (1254)
Q Consensus 1029 IVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLH-SkGIIHRDLKPeNILLDsdd 1107 (1254)
|.----+... .-.+||+++.. +=+-.-.-+...++...+..+-.+++.-+.-|- ..++||.||.-=|+|+.
T Consensus 228 IP~PePIlLk----~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh--- 299 (520)
T KOG2270|consen 228 IPCPEPILLK----NHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH--- 299 (520)
T ss_pred CCCCCceeee----cceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE---
Confidence 4321111111 23689999853 322222223445777777777778888777774 57999999999999995
Q ss_pred CCCCeEEEEeccccccccC
Q 040257 1108 PQRPICKVGDFGLSRIKRN 1126 (1254)
Q Consensus 1108 ~snG~VKLiDFGLAr~~~~ 1126 (1254)
.|.+.|+|-+.+.....
T Consensus 300 --dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 300 --DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred --CCEEEEEEccccccCCC
Confidence 78999999998865443
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.067 Score=63.61 Aligned_cols=82 Identities=18% Similarity=0.067 Sum_probs=52.5
Q ss_pred EEEEEeeeCcEEEEEEEECC--ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC---CCceeEEeeeeecCCCC
Q 040257 968 ELRELGSGTYGTVYHGKWRG--SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH---HPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~rG--s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn---HPNIVkLyGvf~Ddn~~ 1042 (1254)
..+.||.|.+..||++...+ +.++||.-... ............+++..|.+.|+.+. ..++++++.+-. .
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~-~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~----~ 104 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPY-VRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE----E 104 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcc-cccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC----C
Confidence 45789999999999998864 37999985311 00000000122456667888887752 346778887733 2
Q ss_pred ceEEEEEecccC
Q 040257 1043 TLATVTEFMVNG 1054 (1254)
Q Consensus 1043 ~L~LVMEYm~GG 1054 (1254)
..++||||+++.
T Consensus 105 ~~~lVME~L~~~ 116 (401)
T PRK09550 105 LAVTVMEDLSDH 116 (401)
T ss_pred CCEEEEecCCCc
Confidence 467899999764
|
|
| >cd06401 PB1_TFG The PB1 domain found in TFG protein, an oncogenic gene product and fusion partner to nerve growth factor tyrosine kinase receptor TrkA and to the tyrosine kinase ALK | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.028 Score=53.42 Aligned_cols=53 Identities=25% Similarity=0.451 Sum_probs=44.1
Q ss_pred cCceEEEeccC-CCChHHHHHHHHhhcC------CCceEEEecCCCCcCcEEeecChHHHHHH
Q 040257 206 GGETRIISLRT-NLSWEELVKKTSNICN------QPHLIKYQLPGEDLDALISVSSDDDLQNM 261 (1254)
Q Consensus 206 GG~triv~V~r-~~~f~~l~~kl~~~~~------~~~~lkYqLP~edLD~LiSVt~DeDL~~m 261 (1254)
|||.|.+.++. .++|.+|+..+..++. .++.|||.=+. ..||+||+++||.--
T Consensus 8 g~DiR~~~~~~~~~t~~~L~~~v~~~F~~~~~~~~~flIKYkD~d---GDlVTIts~~dL~~A 67 (81)
T cd06401 8 GDDIRRIPIHNEDITYDELLLMMQRVFRGKLGSSDDVLIKYKDED---GDLITIFDSSDLSFA 67 (81)
T ss_pred CCeEEEEeccCccccHHHHHHHHHHHhccccCCcccEEEEEECCC---CCEEEeccHHHHHHH
Confidence 99999999998 5899999999987765 25789998333 348999999999865
|
The PB1 domain is a modular domain mediating specific protein-protein interaction in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The PB1 domains of TFG represent a type I/II PB1 domain. The physiological function of TFG remains unknown. |
| >cd06404 PB1_aPKC PB1 domain is an essential modular domain of the atypical protein kinase C (aPKC) which in complex with Par6 and Par3 proteins is crucial for establishment of apical-basal polarity of animal cells | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.051 Score=51.87 Aligned_cols=72 Identities=25% Similarity=0.443 Sum_probs=56.8
Q ss_pred ecCceEEEeccCCCChHHHHHHHHhhcC----CCceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEEE
Q 040257 205 VGGETRIISLRTNLSWEELVKKTSNICN----QPHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRLF 280 (1254)
Q Consensus 205 vGG~triv~V~r~~~f~~l~~kl~~~~~----~~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~F 280 (1254)
-+|+-+|..++.+++|.+|..|+..+|. .++++||-= || .-+|++++|++|+.-+..|.... ..-|-+-
T Consensus 7 y~gdi~it~~d~~~s~e~L~~~v~~~c~~~~~q~ft~kw~D--EE-GDp~tiSS~~EL~EA~rl~~~n~----~~~l~ih 79 (83)
T cd06404 7 YNGDIMITSIDPSISLEELCNEVRDMCRFHNDQPFTLKWID--EE-GDPCTISSQMELEEAFRLYELNK----DSELNIH 79 (83)
T ss_pred ecCcEEEEEcCCCcCHHHHHHHHHHHhCCCCCCcEEEEEEC--CC-CCceeecCHHHHHHHHHHHHhcC----cccEEEE
Confidence 4677789999999999999999999995 458899982 22 34899999999998888885532 2356677
Q ss_pred Eec
Q 040257 281 LIP 283 (1254)
Q Consensus 281 LFp 283 (1254)
+||
T Consensus 80 vfp 82 (83)
T cd06404 80 VFP 82 (83)
T ss_pred ecC
Confidence 776
|
PB1 domain is a modular domain mediating specific protein-protein interaction which play roles in many critical cell processes. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, |
| >cd06398 PB1_Joka2 The PB1 domain is present in the Nicotiana plumbaginifolia Joka2 protein which interacts with sulfur stress inducible UP9 protein | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.056 Score=52.23 Aligned_cols=71 Identities=20% Similarity=0.407 Sum_probs=54.3
Q ss_pred cCceEEEeccC-----CCChHHHHHHHHhhcCC----CceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCce
Q 040257 206 GGETRIISLRT-----NLSWEELVKKTSNICNQ----PHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQR 276 (1254)
Q Consensus 206 GG~triv~V~r-----~~~f~~l~~kl~~~~~~----~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~r 276 (1254)
||++|-+.++. +++|.+|..|+++++.. .+.|+|. .|=..+|.++||+||+.-|+...+ .+...-
T Consensus 8 ~~~~rRf~l~~~~~~~d~~~~~L~~kI~~~f~l~~~~~~~l~Y~---Dedgd~V~l~~D~DL~~a~~~~~~---~~~~~~ 81 (91)
T cd06398 8 GGTLRRFTFPVAENQLDLNMDGLREKVEELFSLSPDADLSLTYT---DEDGDVVTLVDDNDLTDAIQYFCS---GSRLNP 81 (91)
T ss_pred CCEEEEEEeccccccCCCCHHHHHHHHHHHhCCCCCCcEEEEEE---CCCCCEEEEccHHHHHHHHHHHhc---cCCCce
Confidence 78899999985 79999999999999864 4678997 223449999999999988887433 223345
Q ss_pred EEEEEe
Q 040257 277 LRLFLI 282 (1254)
Q Consensus 277 lR~FLF 282 (1254)
||+++-
T Consensus 82 lrl~v~ 87 (91)
T cd06398 82 LRIDVT 87 (91)
T ss_pred EEEEEE
Confidence 777764
|
The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.03 Score=68.13 Aligned_cols=156 Identities=21% Similarity=0.309 Sum_probs=94.6
Q ss_pred HHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCc
Q 040257 1012 KDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNI 1091 (1254)
Q Consensus 1012 eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGI 1091 (1254)
.+++....+++.+.|+|+..++++-.. ...+..+|||++ +.+|.+.+..+. +-..... -+++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~-~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s~~--------------~~~~ 88 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRG-KHERVIVVMEHY-TMSLEDILKTGN--LKDESLL--------------AHGV 88 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecC-ccceEEEEehhh-ccchHHHHHhcc--cchhhhc--------------cccc
Confidence 345666789999999999999887654 344688999998 889999885543 2111110 1122
Q ss_pred ccccCCCCceEeccCCCCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcC
Q 040257 1092 VHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG 1171 (1254)
Q Consensus 1092 IHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTG 1171 (1254)
.| .|| ++++| -++ |. | |-. ..+|+|||++|.++.++.-|
T Consensus 89 ~~-----~~~-----------~~~td-~~~--------------t~-~--~~~-------~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 89 LH-----LNI-----------IYITD-HFL--------------TK-Y--PSP-------IGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred ce-----ehh-----------hhccc-ccc--------------cc-C--CCC-------CCcchhhhhHHHHHHHHHHh
Confidence 21 122 23333 000 00 0 111 12479999999999999999
Q ss_pred CCCCCCCChhhHHHHhhhccCCC----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040257 1172 EEPYADMHCGAIIGGIVKNTLRP----------TIPERCDPEWRKLMEQCWAADPEARPSFTEIT 1226 (1254)
Q Consensus 1172 k~PF~~~n~~eliqsIlk~~Lrp----------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELL 1226 (1254)
...|......+....+.+-...+ .+-..++..+..+.++|+-..|..||...++.
T Consensus 128 ~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 128 ISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred hHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 88887665544444333221111 01123566677889999999999888655443
|
|
| >cd06396 PB1_NBR1 The PB1 domain is an essential part of NBR1 protein, next to BRCA1, a scaffold protein mediating specific protein-protein interaction with both titin protein kinase and with another scaffold protein p62 | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.096 Score=49.86 Aligned_cols=69 Identities=17% Similarity=0.313 Sum_probs=54.8
Q ss_pred cCceEEEeccC--CCChHHHHHHHHhhcCCC-ceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEEEEe
Q 040257 206 GGETRIISLRT--NLSWEELVKKTSNICNQP-HLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRLFLI 282 (1254)
Q Consensus 206 GG~triv~V~r--~~~f~~l~~kl~~~~~~~-~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~FLF 282 (1254)
||+++...++. +.+|.+|.+.+++.|+.. +.|||= +|=.--|.++||.||+.-++-|.| .+ -.||+|+.
T Consensus 8 ~~d~~rf~~~~~~~~~~~~L~~ev~~rf~l~~f~lKYl---Dde~e~v~lssd~eLeE~~rl~~~----~~-~~l~~~v~ 79 (81)
T cd06396 8 NGESQSFLVSDSENTTWASVEAMVKVSFGLNDIQIKYV---DEENEEVSVNSQGEYEEALKSAVR----QG-NLLQMNVY 79 (81)
T ss_pred CCeEEEEEecCCCCCCHHHHHHHHHHHhCCCcceeEEE---cCCCCEEEEEchhhHHHHHHHHHh----CC-CEEEEEEe
Confidence 56788899988 789999999999999865 778996 233458999999999888777755 22 47888764
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The NBR1 protein contains a type I PB1 domain. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.092 Score=58.09 Aligned_cols=29 Identities=24% Similarity=0.354 Sum_probs=24.8
Q ss_pred CCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1089 kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++|+|+.+.||+++ . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~----~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK----D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe----C-CcEEEEECcccc
Confidence 4789999999999998 3 467899999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.13 Score=59.51 Aligned_cols=139 Identities=17% Similarity=0.240 Sum_probs=77.6
Q ss_pred eEEEEEeeeCcEEEEEEEEC------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCce-eEEeeeeecC
Q 040257 967 EELRELGSGTYGTVYHGKWR------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV-VAFYGVVPDG 1039 (1254)
Q Consensus 967 eiLkkLGeGsFGtVYlAk~r------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNI-VkLyGvf~Dd 1039 (1254)
..+..|-.|-...+|++.+. ++.|++|+..... .....+ .+|..+++.+..-++ .++++.+..+
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--------~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g 109 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--------ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG 109 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--------Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc
Confidence 33455666889999998753 2568888775431 111111 457778777753333 4566666321
Q ss_pred CCCceEEEEEecccCchhhh-----------------hhccC---CC-CC-HHHHHHHHHHh-----------------h
Q 040257 1040 TGGTLATVTEFMVNGSLKHV-----------------LLKKD---RS-LD-RRKKLIIAMDA-----------------A 1080 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~-----------------L~kre---~~-LS-e~~~lkIa~QI-----------------A 1080 (1254)
.|++|+.+.+|... ++... .. .. +.....+..++ .
T Consensus 110 ------~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~ 183 (344)
T PLN02236 110 ------RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLE 183 (344)
T ss_pred ------eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHH
Confidence 47899977665421 01111 00 11 12222222111 1
Q ss_pred hhhHHh--------hhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1081 FGMEYL--------HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1081 eALaYL--------HSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
..+..| +...++|+|+++.|||++. .++.+.|+||..+..
T Consensus 184 ~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~---~~~~~~lID~Eya~~ 231 (344)
T PLN02236 184 DEINLLEKELSGDDQEIGFCHNDLQYGNIMIDE---ETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHHHHHhcccCCCceEEeCCCCcCcEEEeC---CCCcEEEEeehhccc
Confidence 111111 1236899999999999971 246799999998753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.17 Score=58.77 Aligned_cols=153 Identities=18% Similarity=0.153 Sum_probs=84.6
Q ss_pred CceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCC--CceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH--PNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnH--PNIVkLyGvf~Ddn~~ 1042 (1254)
...+++++..|..-.+|....+++.+++. ..... .......+..+|..+++.+.- .-+...+++|.++..+
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~------~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g 98 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRG------DPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLG 98 (321)
T ss_pred CCceeeeccCCcccceEEEecCCceEEEe-cCCcc------ccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCC
Confidence 45556666555555666666667778877 22110 011223445667777777642 2344566777655545
Q ss_pred ceEEEEEecccCchhhhhhccCCC-------------------------------CCHHHHHHHHH--------------
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRS-------------------------------LDRRKKLIIAM-------------- 1077 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~-------------------------------LSe~~~lkIa~-------------- 1077 (1254)
..++||+|++|..+.......... ....++..+..
T Consensus 99 ~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 99 TPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred CceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 778999999884322221100000 00000001110
Q ss_pred HhhhhhHHhhhC--------CcccccCCCCceEeccCCCCCCeEEEEeccccccccCcc
Q 040257 1078 DAAFGMEYLHSK--------NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL 1128 (1254)
Q Consensus 1078 QIAeALaYLHSk--------GIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~ 1128 (1254)
.......||+.+ .++|+|+.+.||+++ ...-+-|.||+++...+...
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~----~~~~~gVlDwe~~~lGDP~~ 233 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIID----PGRPTGVLDWELATLGDPLE 233 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEe----CCCeeEEEeccccccCCcHH
Confidence 112223444432 489999999999998 34448899999998765543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.11 Score=58.72 Aligned_cols=109 Identities=14% Similarity=0.057 Sum_probs=72.6
Q ss_pred CceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCC---CceeEEeeeeecC-C
Q 040257 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH---PNVVAFYGVVPDG-T 1040 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnH---PNIVkLyGvf~Dd-n 1040 (1254)
.....+.||.|..+.||+....+..+.+|..+... ....+.+|...|+.|.- ..+.++++++.+. .
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~----------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGNPMPLMARSFS----------TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCCEEEEEecccc----------cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 34456789999999999987755567777754210 12457788888887742 4678888877543 2
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK 1089 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk 1089 (1254)
.+..++|||++.+.++.+.. ........+..+++++|.-||+.
T Consensus 85 ~g~~~LVmE~i~G~~~~~~~------~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 85 PGPDVLLLERLRGVSVEAPA------RTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred CCCeEEEEeccCCEecCCCC------CCHHHHHHHHHHHHHHHHHHhCC
Confidence 34689999999998776511 22333445556666777777763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.2 Score=56.26 Aligned_cols=31 Identities=19% Similarity=0.353 Sum_probs=25.1
Q ss_pred CcccccCCCCceEeccCCCC-CCeEEEEeccccccc
Q 040257 1090 NIVHFDLKCENLLVNLRDPQ-RPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1090 GIIHRDLKPeNILLDsdd~s-nG~VKLiDFGLAr~~ 1124 (1254)
.++|+|+++.|||++ . ...+-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~----~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILID----EDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEe----CCCCEEEEECcHhcccC
Confidence 489999999999998 3 334679999998644
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd06397 PB1_UP1 Uncharacterized protein 1 | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.12 Score=49.19 Aligned_cols=58 Identities=33% Similarity=0.437 Sum_probs=47.4
Q ss_pred cCceEEEeccCCCChHHHHHHHHhhcCCC---ceEEEecCCCCcC-cEEeecChHHHHHHHHHhhc
Q 040257 206 GGETRIISLRTNLSWEELVKKTSNICNQP---HLIKYQLPGEDLD-ALISVSSDDDLQNMIDEYCG 267 (1254)
Q Consensus 206 GG~triv~V~r~~~f~~l~~kl~~~~~~~---~~lkYqLP~edLD-~LiSVt~DeDL~~m~~Eydr 267 (1254)
||+||=+++++.-+|++|.+||..++..+ +.|+|- |-| -+|++++|+||+.-+.-..+
T Consensus 8 ~g~~RRf~~~~~pt~~~L~~kl~~Lf~lp~~~~~vtYi----DeD~D~ITlssd~eL~d~~~~~~~ 69 (82)
T cd06397 8 LGDTRRIVFPDIPTWEALASKLENLYNLPEIKVGVTYI----DNDNDEITLSSNKELQDFYRLSHR 69 (82)
T ss_pred CCceEEEecCCCccHHHHHHHHHHHhCCChhHeEEEEE----cCCCCEEEecchHHHHHHHHhccc
Confidence 56666677999999999999999999765 778997 445 58999999999987765544
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.19 Score=57.76 Aligned_cols=80 Identities=14% Similarity=0.200 Sum_probs=46.4
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEECCc-----eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCce-eEEee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWRGS-----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV-VAFYG 1034 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~rGs-----~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNI-VkLyG 1034 (1254)
++..++.+. .|..|-...+|+....+. .|++|+.....- .. -.-.+|..+++.+..-++ .++++
T Consensus 12 ~~~~~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--------~~-IdR~~E~~il~~l~~~gl~P~~l~ 81 (330)
T PLN02421 12 LDDSDFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--------YV-IDRERELQAIKYLSAAGFGAKLLG 81 (330)
T ss_pred CCcCceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--------eE-echHHHHHHHHHHHhcCCCCceeE
Confidence 333444444 455588889999876432 688887753210 01 112357778877754444 45666
Q ss_pred eeecCCCCceEEEEEecccCch
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSL 1056 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL 1056 (1254)
++. + . +|.+|+.+..|
T Consensus 82 ~~~--~--G--~i~~fi~g~~l 97 (330)
T PLN02421 82 VFG--N--G--MIQSFINARTL 97 (330)
T ss_pred EeC--C--c--EeehhhcCCCC
Confidence 652 2 1 47899877654
|
|
| >cd06402 PB1_p62 The PB1 domain is an essential part of p62 scaffold protein (alias sequestosome 1,SQSTM) involved in cell signaling, receptor internalization, and protein turnover | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.33 Score=46.84 Aligned_cols=65 Identities=20% Similarity=0.353 Sum_probs=50.0
Q ss_pred ceEEEeccC--CCChHHHHHHHHhhc----CCCceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEEEE
Q 040257 208 ETRIISLRT--NLSWEELVKKTSNIC----NQPHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRLFL 281 (1254)
Q Consensus 208 ~triv~V~r--~~~f~~l~~kl~~~~----~~~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~FL 281 (1254)
|-|-.++++ +++|.+|+.++.++| +..++|||.=. =.-||++++||||.--+.... .+-||||+
T Consensus 15 EIRRf~l~~~~~~s~~~L~~~V~~~f~~l~~~~ftlky~De---eGDlvtIssdeEL~~A~~~~~-------~~~~RlyI 84 (87)
T cd06402 15 EIRRFAIDEDVSTSYEYLVEKVAAVFPSLRGKNFQLFWKDE---EGDLVAFSSDEELVMALGSLN-------DDTFRIYI 84 (87)
T ss_pred ceEEEEecCCCCcCHHHHHHHHHHHccccCCCcEEEEEECC---CCCEEeecCHHHHHHHHHcCC-------CCcEEEEE
Confidence 567778854 469999999999998 45689999822 233899999999988776542 35789987
Q ss_pred e
Q 040257 282 I 282 (1254)
Q Consensus 282 F 282 (1254)
-
T Consensus 85 ~ 85 (87)
T cd06402 85 K 85 (87)
T ss_pred E
Confidence 3
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play roles in many critical cell processes. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.35 Score=54.57 Aligned_cols=30 Identities=17% Similarity=0.138 Sum_probs=26.2
Q ss_pred CcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1090 GIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
+++|+|+.++|||++ .++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~----~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYD----ETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEc----CCCCEEEEEhhhccc
Confidence 799999999999998 566789999988753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1254 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-40 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-40 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-40 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-39 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-39 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-33 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-31 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-30 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-30 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-30 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-30 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-30 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-30 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-30 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-30 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-30 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-30 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-30 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-30 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-30 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-30 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-30 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-29 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-29 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-29 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-29 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-29 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-29 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-29 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-29 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-29 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-29 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-29 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-29 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-29 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-29 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-29 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-29 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-29 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-29 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-29 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-29 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-29 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-29 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-29 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-29 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-29 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-28 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-28 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-28 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-28 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-28 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-28 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-28 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-28 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-28 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-28 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-28 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-28 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-28 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-28 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-28 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-28 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-28 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-28 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-28 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-28 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-28 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-28 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-28 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-28 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-28 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-28 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-28 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-28 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-28 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-28 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-28 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-28 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-28 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-28 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-28 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-28 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-28 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-28 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-28 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-27 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-27 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-27 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-27 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-27 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-27 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-27 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-27 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-27 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-27 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-27 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-27 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-27 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-27 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-27 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-27 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-27 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-26 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-26 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-26 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-26 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-26 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-26 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-26 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-26 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-26 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-26 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-26 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-26 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-26 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-26 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-26 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-26 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-26 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-26 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-26 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-26 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-26 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-26 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-26 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-26 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-26 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-26 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-26 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-26 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-26 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-26 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-26 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-26 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-25 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-25 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-25 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-25 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-25 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-25 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-25 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-25 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-25 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-25 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-25 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-25 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-25 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-25 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-25 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-25 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-25 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-25 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-25 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-25 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-25 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-25 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-25 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-25 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-25 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-25 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-25 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-25 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-25 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-25 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-25 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-25 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-25 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-24 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-24 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-24 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-24 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-24 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-24 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-24 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-24 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-24 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-24 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-24 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-24 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-24 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-24 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-24 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-24 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-24 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-24 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-24 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-24 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-24 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-24 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-24 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-24 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-24 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-24 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-24 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-24 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-24 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-24 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-24 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-24 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-24 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-24 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-24 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-23 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-23 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-23 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-23 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-23 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-23 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-23 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-23 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-23 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-23 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-23 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-23 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-23 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-23 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-23 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-23 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-23 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-23 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-23 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-23 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-23 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-23 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-23 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-23 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-23 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-22 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-22 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-22 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-22 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-22 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-22 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-22 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-22 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-22 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-22 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-22 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-22 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-22 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-22 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-22 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-21 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-21 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-21 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-21 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-21 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-21 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-21 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-21 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-20 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-20 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-20 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-20 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-20 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-20 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-20 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-20 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-20 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-20 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-20 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-20 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-20 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-20 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-20 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-20 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-20 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-20 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-20 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-20 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-20 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-20 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-20 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-20 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-20 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-19 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-19 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-19 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-19 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-19 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-19 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-19 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-19 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-19 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-19 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-19 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-19 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-19 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-19 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-19 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-18 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-18 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-18 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-18 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-18 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-18 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-17 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-17 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-17 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-17 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-17 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-17 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-17 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-17 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-17 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-16 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-16 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-16 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-16 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-16 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-16 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-16 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-14 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-13 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-13 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1254 | |||
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-126 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-122 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-122 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-121 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-118 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-114 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-113 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-102 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-98 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 7e-98 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-93 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-87 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 6e-85 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-75 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-73 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 6e-72 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-71 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 6e-71 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 6e-71 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-70 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-70 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-70 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 7e-70 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 8e-70 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-69 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-69 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 4e-69 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 4e-69 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-69 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 6e-69 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-68 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-68 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-68 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-68 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-68 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 6e-68 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 8e-68 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-67 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-67 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-67 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-67 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-67 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-67 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 8e-67 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 8e-67 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-66 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-66 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-66 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-65 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-65 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-65 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 5e-65 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 5e-65 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-64 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-64 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 6e-64 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-63 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 4e-63 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-63 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-63 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-62 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-62 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-62 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 9e-62 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-61 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 5e-61 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-60 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 9e-60 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-52 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-51 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-49 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-48 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-48 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-47 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-46 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-46 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-46 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 9e-46 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-45 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 8e-44 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 9e-44 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-43 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-42 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 6e-42 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-41 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-41 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-41 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-40 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-39 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-39 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-39 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-39 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-39 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 5e-39 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-38 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-38 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-13 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-38 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-38 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-38 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-38 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-38 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 5e-38 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-37 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-37 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-37 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 5e-37 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-36 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-36 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 4e-36 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-35 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-35 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-35 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-35 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-35 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-34 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-34 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-34 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-34 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-34 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-33 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-33 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-33 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-33 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 7e-33 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 9e-33 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-32 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-32 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-32 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-32 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-32 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-32 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 6e-32 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-31 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-31 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-31 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-31 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-31 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 5e-31 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 6e-31 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-30 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-30 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-30 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-30 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-30 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-30 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 4e-30 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 6e-30 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 9e-30 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-29 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-29 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-29 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-29 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 6e-29 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 9e-29 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-28 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-28 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-28 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-28 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-28 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 4e-28 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-28 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 6e-28 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-27 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-27 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-27 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-27 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 8e-27 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-26 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-26 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-26 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-26 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-26 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 3e-26 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-26 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-25 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-25 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-25 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 7e-25 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-24 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-24 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-23 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-23 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-23 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 4e-23 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 4e-23 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-23 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 7e-23 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-22 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-22 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-22 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 5e-22 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-21 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-21 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-21 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-21 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-21 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-21 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 8e-21 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-20 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-20 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-20 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-20 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-20 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-20 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 6e-20 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 6e-20 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-19 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-19 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-19 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-19 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-19 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-18 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-18 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-18 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-18 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-18 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 3e-18 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 5e-18 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 6e-18 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-17 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-17 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-13 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-11 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-08 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 5e-13 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 5e-11 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 6e-10 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 9e-10 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 4e-09 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 4e-09 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 8e-09 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-08 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 5e-08 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-07 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-07 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-04 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 9e-04 |
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 388 bits (1000), Expect = e-126
Identities = 102/292 (34%), Positives = 155/292 (53%), Gaps = 14/292 (4%)
Query: 948 IAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSS 1005
+ E L + + ++E +++G G +G V+ G+ S VAIK + G +
Sbjct: 3 MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 1006 EQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR 1065
E+ ++F RE I+SNL+HPN+V YG++ + V EF+ G L H LL K
Sbjct: 63 MIEKF-QEFQREVFIMSNLNHPNIVKLYGLMHNP----PRMVMEFVPCGDLYHRLLDKAH 117
Query: 1066 SLDRRKKLIIAMDAAFGMEYLHSKN--IVHFDLKCENLLVNLRDPQRPIC-KVGDFGLSR 1122
+ KL + +D A G+EY+ ++N IVH DL+ N+ + D P+C KV DFGLS+
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
Query: 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG- 1181
++ G+ G WMAPE + +EK D +SF + ++ ILTGE P+ + G
Sbjct: 178 QSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
Query: 1182 -AIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
I I + LRPTIPE C P R ++E CW+ DP+ RP F+ I L +
Sbjct: 236 IKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-122
Identities = 97/279 (34%), Positives = 135/279 (48%), Gaps = 18/279 (6%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
I +L +G G +G VY W G +VA+K + + + ++ +EA +
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARH----DPDEDISQTIENVRQEAKL 59
Query: 1021 LSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
+ L HPN++A GV L V EF G L VL K D + A+ A
Sbjct: 60 FAMLKHPNIIALRGVCLKE--PNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIA 115
Query: 1081 FGMEYLHSKN---IVHFDLKCENLLVN----LRDPQRPICKVGDFGLSRIKRNTLVSGGV 1133
GM YLH + I+H DLK N+L+ D I K+ DFGL+R T
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193
G WMAPE++ S S+ DV+S+G+ +WE+LTGE P+ + A+ G+ N L
Sbjct: 176 -GAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
IP C + KLME CW DP +RPSFT I +L TI
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-122
Identities = 104/284 (36%), Positives = 155/284 (54%), Gaps = 19/284 (6%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
I DL ++G+G++GTV+ +W GSDVA+K + + F +F RE I
Sbjct: 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFH------AERVNEFLREVAI 87
Query: 1021 LSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD--RSLDRRKKLIIAMD 1078
+ L HPN+V F G V L+ VTE++ GSL +L K LD R++L +A D
Sbjct: 88 MKRLRHPNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 1079 AAFGMEYLHSKN--IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG-GVRG 1135
A GM YLH++N IVH +LK NLLV+ ++ KV DFGLSR+K +T +S G
Sbjct: 146 VAKGMNYLHNRNPPIVHRNLKSPNLLVD----KKYTVKVCDFGLSRLKASTFLSSKSAAG 201
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT 1195
T WMAPE+L +EK DV+SFG+ +WE+ T ++P+ +++ ++ + R
Sbjct: 202 TPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE 259
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239
IP +P+ ++E CW +P RPSF I LR + +
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 375 bits (965), Expect = e-121
Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 18/277 (6%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
I L L +L G ++ G+W+G+D+ +K +K ++ R ++DF E
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWS------TRKSRDFNEECPR 60
Query: 1021 LSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLK-KDRSLDRRKKLIIAMDA 1079
L HPNV+ G +T +M GSL +VL + + +D+ + + A+D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 1080 AFGMEYLHSKN--IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTL 1137
A GM +LH+ I L +++++ ++ + ++ G
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMT----ARISMADVKFSFQSP----GRMYAP 172
Query: 1138 PWMAPELLNGS-SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196
W+APE L + D++SF + +WE++T E P+AD+ I + LRPTI
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233
P P KLM+ C DP RP F I L +
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 367 bits (943), Expect = e-118
Identities = 88/281 (31%), Positives = 148/281 (52%), Gaps = 22/281 (7%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
I + + + +GSG++GTVY GKW G DVA+K + + + + + F E +
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT------APTPQQLQAFKNEVGV 73
Query: 1021 LSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
L H N++ F G T LA VT++ SL H L + + +K + IA A
Sbjct: 74 LRKTRHVNILLFMGYS---TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVS---GGVRGTL 1137
GM+YLH+K+I+H DLK N+ ++ + K+GDFGL+ K S + G++
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLH----EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 1138 PWMAPELLNG-SSNRVSEKVDVFSFGISMWEILTGEEPYADMHC-GAIIGGIVKNTLRPT 1195
WMAPE++ SN S + DV++FGI ++E++TG+ PY++++ II + + +L P
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246
Query: 1196 ---IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233
+ C ++LM +C + RPSF I + + ++
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 357 bits (919), Expect = e-114
Identities = 90/281 (32%), Positives = 135/281 (48%), Gaps = 27/281 (9%)
Query: 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
L +I ++E +G G +G V KWR DVAIK+I+ E K F E
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE----------SESERKAFIVE 51
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR--SLDRRKKLII 1075
LS ++HPN+V YG + + V E+ GSL +VL + +
Sbjct: 52 LRQLSRVNHPNIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107
Query: 1076 AMDAAFGMEYLHS---KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG 1132
+ + G+ YLHS K ++H DLK NLL+ + K+ DFG + + + +
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLL---VAGGTVLKICDFGTACDIQTHMTNN- 163
Query: 1133 VRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAI-IGGIVKNT 1191
+G+ WMAPE+ GS SEK DVFS+GI +WE++T +P+ ++ A I V N
Sbjct: 164 -KGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG 220
Query: 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
RP + + LM +CW+ DP RPS EI + +
Sbjct: 221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-113
Identities = 86/321 (26%), Positives = 122/321 (38%), Gaps = 35/321 (10%)
Query: 925 PESLSQDSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGK 984
PE A + S + + E + I LE +G G +G VYHG+
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWD--------IPFEQLEIGELIGKGRFGQVYHGR 53
Query: 985 WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTL 1044
W G +VAI+ I + E K F RE H NVV F G L
Sbjct: 54 WHG-EVAIRLIDIE------RDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP--PHL 104
Query: 1045 ATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVN 1104
A +T +L V+ LD K IA + GM YLH+K I+H DLK +N+ +
Sbjct: 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD 164
Query: 1105 LRDPQRPICKVGDFGLSRIKRNTLVSG------GVRGTLPWMAPELLNGSSNRV------ 1152
+ DFGL I G L +APE++ S
Sbjct: 165 NGK-----VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLP 219
Query: 1153 -SEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQC 1211
S+ DVF+ G +E+ E P+ AII + E ++ C
Sbjct: 220 FSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFC 279
Query: 1212 WAADPEARPSFTEITSRLRTI 1232
WA + E RP+FT++ L +
Sbjct: 280 WAFEQEERPTFTKLMDMLEKL 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = 4e-98
Identities = 86/323 (26%), Positives = 140/323 (43%), Gaps = 58/323 (17%)
Query: 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
+Q ++ ++++G G YG V+ GKWRG VA+K + A ++RE
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-----------SWFRE 79
Query: 1018 AHI--LSNLHHPNVVAFYGVVPDGTGGT--LATVTEFMVNGSLKHVLLKKDRSLDRRKKL 1073
I + H N++ F GTG L +T++ NGSL L K +LD + L
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSML 137
Query: 1074 IIAMDAAFGMEYLHSKN--------IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125
+A + G+ +LH++ I H DLK +N+LV + C + D GL+
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVKFI 193
Query: 1126 NT-----LVSGGVRGTLPWMAPELLNGSSNRVS----EKVDVFSFGISMWEILTGEE--- 1173
+ + GT +M PE+L+ S NR D++SFG+ +WE+
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253
Query: 1174 -------PYADM-----HCGAIIGGIVKNTLRPTIPER-----CDPEWRKLMEQCWAADP 1216
PY D+ + + LRP+ P R C + KLM +CWA +P
Sbjct: 254 IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313
Query: 1217 EARPSFTEITSRLRTISAAIESK 1239
+R + + L +S + + K
Sbjct: 314 ASRLTALRVKKTLAKMSESQDIK 336
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = 7e-98
Identities = 87/297 (29%), Positives = 127/297 (42%), Gaps = 34/297 (11%)
Query: 960 IIKNVDLEELRELGSGTYGTVYHGKWRGS--DVAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
I + DL LG G +G R + + +K + + E + F +E
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--------FDEETQRTFLKE 57
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM 1077
++ L HPNV+ F GV+ L +TE++ G+L+ ++ D +++ A
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKD--KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAK 115
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT---------- 1127
D A GM YLHS NI+H DL N LV + V DFGL+R+ +
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVR----ENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 1128 -----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG- 1181
V G WMAPE++NG EKVDVFSFGI + EI+ D
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
Query: 1182 AIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238
G V+ L P C P + + +C DPE RPSF ++ L T+ +
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 2e-87
Identities = 79/316 (25%), Positives = 127/316 (40%), Gaps = 58/316 (18%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI--LS 1022
+ +G G +G V+ GKWRG +VA+K R + ++REA I
Sbjct: 43 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS-----------SREERSWFREAEIYQTV 91
Query: 1023 NLHHPNVVAFYGVVPDGTGGT--LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
L H N++ F G L V+++ +GSL L ++ + +A+ A
Sbjct: 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTA 149
Query: 1081 FGMEYLHSK--------NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT----- 1127
G+ +LH + I H DLK +N+LV + C + D GL+ +
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVRHDSATDTID 205
Query: 1128 LVSGGVRGTLPWMAPELLNGSSN----RVSEKVDVFSFGISMWEILTGEE---------- 1173
+ GT +MAPE+L+ S N ++ D+++ G+ WEI
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265
Query: 1174 PYADM-----HCGAIIGGIVKNTLRPTIPER-----CDPEWRKLMEQCWAADPEARPSFT 1223
PY D+ + + + LRP IP R K+M +CW A+ AR +
Sbjct: 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325
Query: 1224 EITSRLRTISAAIESK 1239
I L +S K
Sbjct: 326 RIKKTLSQLSQQEGIK 341
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 6e-85
Identities = 79/309 (25%), Positives = 130/309 (42%), Gaps = 58/309 (18%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI--LS 1022
D+ L +G G YG V+ G W+G +VA+K R K ++RE +
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFS-----------SRDEKSWFRETELYNTV 57
Query: 1023 NLHHPNVVAFYGVV--PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
L H N++ F + L +T + GSL L + +LD L I + A
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIA 115
Query: 1081 FGMEYLHSK--------NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT----- 1127
G+ +LH + I H DLK +N+LV ++ Q C + D GL+ + +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-KNGQ---CCIADLGLAVMHSQSTNQLD 171
Query: 1128 LVSGGVRGTLPWMAPELLNGSSN----RVSEKVDVFSFGISMWEILTGEE---------- 1173
+ + GT +MAPE+L+ + ++VD+++FG+ +WE+
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231
Query: 1174 PYADMHCGA-----IIGGIVKNTLRPTIPER-----CDPEWRKLMEQCWAADPEARPSFT 1223
P+ D+ + + + RP IP R KLM++CW +P AR +
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291
Query: 1224 EITSRLRTI 1232
I L I
Sbjct: 292 RIKKTLTKI 300
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 4e-75
Identities = 91/278 (32%), Positives = 130/278 (46%), Gaps = 22/278 (7%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGS--DVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
+ + DL ++G G +G V+ G+ R VA+K +++ + F +EA
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-----LPPDLK--AKFLQEA 163
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
IL HPN+V GV + V E + G L + L + L + D
Sbjct: 164 RILKQYSHPNIVRLIGVCTQK--QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSGGVRGTL 1137
AA GMEYL SK +H DL N LV ++ + K+ DFG+SR + G +
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKN----VLKISDFGMSREEADGVYAASGGLRQV 277
Query: 1138 P--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRP 1194
P W APE LN R S + DV+SFGI +WE + G PY ++ + K R
Sbjct: 278 PVKWTAPEALN--YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRL 334
Query: 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
PE C +LMEQCWA +P RPSF+ I L++I
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 245 bits (629), Expect = 3e-73
Identities = 76/285 (26%), Positives = 138/285 (48%), Gaps = 27/285 (9%)
Query: 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRGSD------VAIKRIKKSCFAGRSSEQERLT 1011
L+I+K + ++++ LGSG +GTVY G W VAIK ++++ +S +
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----TSPKAN-- 61
Query: 1012 KDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK 1071
K+ EA++++++ +P+V G+ T+ +T+ M G L + + ++ +
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 1072 KLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVS 1130
L + A GM YL + +VH DL N+LV K+ DFGL++ +
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAEEKEY 174
Query: 1131 GGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGI 1187
G +P WMA E + + + DV+S+G+++WE++T G +PY + I I
Sbjct: 175 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 231
Query: 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
++ R P C + +M +CW D ++RP F E+ +
Sbjct: 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 6e-72
Identities = 88/280 (31%), Positives = 127/280 (45%), Gaps = 25/280 (8%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDFW 1015
I D+ R LG G +G VY G + VA+K KK + + + F
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-----CTLDNK--EKFM 61
Query: 1016 REAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLII 1075
EA I+ NL HP++V G++ + E G L H L + SL ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGII---EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 1076 AMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRG 1135
++ M YL S N VH D+ N+LV + K+GDFGLSR +
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPE----CVKLGDFGLSRYIEDEDYYKASVT 174
Query: 1136 TLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL 1192
LP WM+PE +N R + DV+ F + MWEIL+ G++P+ + +IG + K
Sbjct: 175 RLPIKWMSPESIN--FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR 232
Query: 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
P P+ C P LM +CW DP RP FTE+ L +
Sbjct: 233 LPK-PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 1e-71
Identities = 94/287 (32%), Positives = 139/287 (48%), Gaps = 25/287 (8%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDFW 1015
I+ +E R +G G +G V+ G + + VAIK K +S+ R + F
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-----TSDSVR--EKFL 64
Query: 1016 REAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLII 1075
+EA + HP++V GV+ T + + E G L+ L + SLD ++
Sbjct: 65 QEALTMRQFDHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 1076 AMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRG 1135
A + + YL SK VH D+ N+LV+ D K+GDFGLSR ++ +G
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 177
Query: 1136 TLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL 1192
LP WMAPE +N R + DV+ FG+ MWEIL G +P+ + +IG I
Sbjct: 178 KLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 235
Query: 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239
P P C P LM +CWA DP RP FTE+ ++L TI +++
Sbjct: 236 LPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 281
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 6e-71
Identities = 91/284 (32%), Positives = 127/284 (44%), Gaps = 24/284 (8%)
Query: 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDF 1014
+I DL L +LG G++G V G+W VA+K +K Q DF
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD-----VLSQPEAMDDF 68
Query: 1015 WREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI 1074
RE + + +L H N++ YGVV + VTE GSL L K
Sbjct: 69 IREVNAMHSLDHRNLIRLYGVV---LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 1075 IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT----LVS 1130
A+ A GM YL SK +H DL NLL+ RD + K+GDFGL R ++
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQ 181
Query: 1131 GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189
+ W APE L + S D + FG+++WE+ T G+EP+ ++ I+ I K
Sbjct: 182 EHRKVPFAWCAPESLK--TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
Query: 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233
R PE C + +M QCWA PE RP+F + L
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 6e-71
Identities = 81/289 (28%), Positives = 132/289 (45%), Gaps = 26/289 (8%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDFW 1015
++ + +G G +G VYHG +D A+K + + E F
Sbjct: 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-----DIGEV--SQFL 74
Query: 1016 REAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLII 1075
E I+ + HPNV++ G+ G+ V +M +G L++ + + + + +
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 1076 AMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNT--LVSGG 1132
+ A GM+YL SK VH DL N +++ ++ KV DFGL+R + V
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 1133 VRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189
LP WMA E L + + + K DV+SFG+ +WE++T G PY D++ I +
Sbjct: 190 TGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-VYLL 246
Query: 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238
R PE C ++M +CW E RPSF+E+ SR+ I +
Sbjct: 247 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 1e-70
Identities = 84/286 (29%), Positives = 129/286 (45%), Gaps = 26/286 (9%)
Query: 964 VDLEELRELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
V R +G G +G VYHG++ AIK + + Q+ + F RE
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-----EMQQV--EAFLREG 73
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
++ L+HPNV+A G++ G + +M +G L + R+ + + +
Sbjct: 74 LLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRN--TLVSGGVRG 1135
A GMEYL + VH DL N +++ + KV DFGL+R I V
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLD----ESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 1136 TLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL 1192
LP W A E L + R + K DV+SFG+ +WE+LT G PY + + +
Sbjct: 189 RLPVKWTALESLQ--TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT-HFLAQGR 245
Query: 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238
R PE C ++M+QCW ADP RP+F + + I +A+
Sbjct: 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 1e-70
Identities = 91/299 (30%), Positives = 130/299 (43%), Gaps = 31/299 (10%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
R LG G +G+V + + D VA+K +K + + ++F REA
Sbjct: 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA----DIIASSDI--EEFLREAA 77
Query: 1020 ILSNLHHPNVVAFYGVV----PDGTGGTLATVTEFMVNGSLKHVLLK-----KDRSLDRR 1070
+ HP+V GV G + FM +G L LL +L +
Sbjct: 78 CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 1071 KKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLV 1129
+ +D A GMEYL S+N +H DL N ++ + V DFGLSR I
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA----EDMTVCVADFGLSRKIYSGDYY 193
Query: 1130 SGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGG 1186
G LP W+A E L N + DV++FG++MWEI+T G+ PYA + I
Sbjct: 194 RQGCASKLPVKWLALESLA--DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN- 250
Query: 1187 IVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCINSEP 1245
+ R P C E LM QCW+ADP+ RPSFT + L I + + +P
Sbjct: 251 YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 3e-70
Identities = 68/314 (21%), Positives = 118/314 (37%), Gaps = 58/314 (18%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
+++ L+ L G +G V+ + VA+K Q++ + E +
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIF---------PIQDKQSWQNEYEVYS 71
Query: 1021 LSNLHHPNVVAFYGVV--PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
L + H N++ F G L +T F GSL L K + + IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAET 129
Query: 1079 AAFGMEYLHSK----------NIVHFDLKCENLLV--NLRDPQRPICKVGDFGLSRIK-- 1124
A G+ YLH I H D+K +N+L+ NL + DFGL+
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT------ACIADFGLALKFEA 183
Query: 1125 -RNTLVSGGVRGTLPWMAPELLNGSSN---RVSEKVDVFSFGISMWEILTGEEPY----- 1175
++ + G GT +MAPE+L G+ N ++D+++ G+ +WE+ +
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 1176 -----------ADMHCGAIIGGIVKNTLRPTIPERCDPE-----WRKLMEQCWAADPEAR 1219
+ +V RP + + + +E+CW D EAR
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 1220 PSFTEITSRLRTIS 1233
S + R+ +
Sbjct: 304 LSAGCVGERITQMQ 317
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 237 bits (605), Expect = 7e-70
Identities = 75/328 (22%), Positives = 114/328 (34%), Gaps = 73/328 (22%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI--LS 1022
+L+ L +G G YG VY G VA+K S R ++F E +I +
Sbjct: 14 NLKLLELIGRGRYGAVYKGSLDERPVAVKVF---------SFANR--QNFINEKNIYRVP 62
Query: 1023 NLHHPNVVAFYGVVPDGTGGT---LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
+ H N+ F T V E+ NGSL L + D +A
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSV 120
Query: 1080 AFGMEYLHS---------KNIVHFDLKCENLLV--NLRDPQRPICKVGDFGLSRIKRNTL 1128
G+ YLH+ I H DL N+LV + C + DFGLS
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT------CVISDFGLSMRLTGNR 174
Query: 1129 VSG---------GVRGTLPWMAPELLNGSSN-----RVSEKVDVFSFGISMWEILTGEE- 1173
+ GT+ +MAPE+L G+ N ++VD+++ G+ WEI
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 1174 ------------PYADMHCGA-----IIGGIVKNTLRPTIPERCDP------EWRKLMEQ 1210
+ + + + RP PE ++ +E
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 1211 CWAADPEARPSFTEITSRLRTISAAIES 1238
CW D EAR + R+ + E
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWER 322
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 8e-70
Identities = 87/276 (31%), Positives = 136/276 (49%), Gaps = 22/276 (7%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
+K ++ L+ELGSG +G V GKW+G DVA+K IK+ S ++ +F++EA
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-----SMSED----EFFQEAQ 55
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
+ L HP +V FYGV + VTE++ NG L + L + L+ + L + D
Sbjct: 56 TMMKLSHPKLVKFYGVCSKE--YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV 113
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP- 1138
GM +L S +H DL N LV+ + KV DFG++R + V P
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVD----RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV 169
Query: 1139 -WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTI 1196
W APE+ + + S K DV++FGI MWE+ + G+ PY ++ + + R
Sbjct: 170 KWSAPEVFH--YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLYR 226
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
P ++M CW PE RP+F ++ S + +
Sbjct: 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-69
Identities = 83/279 (29%), Positives = 130/279 (46%), Gaps = 22/279 (7%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
I +L ++E+GSG +G V+ G W VAIK I++ + +E DF EA
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-----AMSEE----DFIEEAE 55
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
++ L HP +V YGV + + VTEFM +G L L + L + +D
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQ--APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP- 1138
GM YL ++H DL N LV + + KV DFG++R + + P
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 1139 -WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTI 1196
W +PE+ + +R S K DV+SFG+ MWE+ + G+ PY + ++ I
Sbjct: 170 KWASPEVFS--FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK- 226
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235
P ++M CW PE RP+F+ + +L I+ +
Sbjct: 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-69
Identities = 90/276 (32%), Positives = 131/276 (47%), Gaps = 22/276 (7%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
I DL L+ELG+G +G V +GKWRG DVAIK IK+ S ++ +F EA
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-----SMSED----EFIEEAK 71
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
++ NL H +V YGV + +TE+M NG L + L + ++ L + D
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP- 1138
MEYL SK +H DL N LVN + + KV DFGLSR + + V P
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 185
Query: 1139 -WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTI 1196
W PE+L ++ S K D+++FG+ MWEI + G+ PY I +
Sbjct: 186 RWSPPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR- 242
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
P + +M CW + RP+F + S + +
Sbjct: 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 4e-69
Identities = 83/290 (28%), Positives = 128/290 (44%), Gaps = 30/290 (10%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
L + LG G +G+V G + D VA+K +K SS++E ++F EA
Sbjct: 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL----DNSSQREI--EEFLSEAA 88
Query: 1020 ILSNLHHPNVVAFYGVVPDG---TGGTLATVTEFMVNGSLKHVLLK-----KDRSLDRRK 1071
+ + HPNV+ GV + + FM G L LL + + +
Sbjct: 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 1072 KLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVS 1130
L +D A GMEYL ++N +H DL N ++ V DFGLS+ I
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR----DDMTVCVADFGLSKKIYSGDYYR 204
Query: 1131 GGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGI 1187
G +P W+A E L + K DV++FG++MWEI T G PY + +
Sbjct: 205 QGRIAKMPVKWIAIESLA--DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD-Y 261
Query: 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237
+ + R PE C E ++M CW DP RP+F+ + +L + ++
Sbjct: 262 LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 4e-69
Identities = 88/279 (31%), Positives = 129/279 (46%), Gaps = 26/279 (9%)
Query: 970 RELGSGTYGTVYHGKWRGS----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
ELG G +G+V G +R DVAIK +K+ ++ T++ REA I+ L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLD 68
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
+P +V GV L V E G L L+ K + + + GM+Y
Sbjct: 69 NPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 125
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--KRNTLVSGGVRGTLP--WMA 1141
L KN VH DL N+L+ R K+ DFGLS+ ++ + G P W A
Sbjct: 126 LEEKNFVHRDLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 181
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
PE +N + S + DV+S+G++MWE L+ G++PY M ++ I + R P C
Sbjct: 182 PECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPEC 238
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239
PE LM CW E RP F + R+R ++ SK
Sbjct: 239 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 4e-69
Identities = 86/373 (23%), Positives = 151/373 (40%), Gaps = 44/373 (11%)
Query: 871 QNKDQNKQEPLVIVGDVTGSMPSEHQFSPEVVSHLDATSSDEMSTNETESESIFPESLSQ 930
+ + ++V + + S S+ + + I +L+
Sbjct: 14 HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNP 73
Query: 931 DSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSD- 989
+ V+ + ++ + +G G +G VYHG +D
Sbjct: 74 ELVQAVQHV------------------VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDG 115
Query: 990 ----VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLA 1045
A+K + + E F E I+ + HPNV++ G+ G+
Sbjct: 116 KKIHCAVKSLNRIT-----DIGEV--SQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPL 167
Query: 1046 TVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNL 1105
V +M +G L++ + + + + + + A GM++L SK VH DL N +++
Sbjct: 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD- 226
Query: 1106 RDPQRPICKVGDFGLSR-IKRN--TLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFS 1160
++ KV DFGL+R + V LP WMA E L + + + K DV+S
Sbjct: 227 ---EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ--TQKFTTKSDVWS 281
Query: 1161 FGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEAR 1219
FG+ +WE++T G PY D++ I + R PE C ++M +CW E R
Sbjct: 282 FGVLLWELMTRGAPPYPDVNTFDIT-VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 340
Query: 1220 PSFTEITSRLRTI 1232
PSF+E+ SR+ I
Sbjct: 341 PSFSELVSRISAI 353
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 6e-69
Identities = 78/304 (25%), Positives = 144/304 (47%), Gaps = 28/304 (9%)
Query: 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRGSD------VAIKRIKKSCFAGRSSEQERLT 1011
L+I+K + ++++ LGSG +GTVY G W VAIK ++++ +S +
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----TSPKAN-- 61
Query: 1012 KDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK 1071
K+ EA++++++ +P+V G+ T+ +T+ M G L + + ++ +
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 1072 KLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVS 1130
L + A GM YL + +VH DL N+LV K+ DFGL++ +
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAEEKEY 174
Query: 1131 GGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGI 1187
G +P WMA E + + + DV+S+G+++WE++T G +PY + I I
Sbjct: 175 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI 231
Query: 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES-KCINSEPK 1246
++ R P C + +M +CW D ++RP F E+ ++ + I + +
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDER 291
Query: 1247 QTKP 1250
P
Sbjct: 292 MHLP 295
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-68
Identities = 95/288 (32%), Positives = 131/288 (45%), Gaps = 26/288 (9%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGS-----DVAIKRIKKSCFAGRSSEQERLTKDFW 1015
I+ + + +GSG G V +G+ R VAIK +K +E++R +DF
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-----TERQR--RDFL 98
Query: 1016 REAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLII 1075
EA I+ HPN++ GVV G VTE+M NGSL L D + + +
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 1076 AMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--KRNTLVSGGV 1133
GM YL VH DL N+LV+ +CKV DFGLSR+
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVD----SNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 1134 RGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKN 1190
G +P W APE + S DV+SFG+ MWE+L GE PY +M +I + +
Sbjct: 213 GGKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270
Query: 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238
R P C +LM CW D RP F++I S L + + ES
Sbjct: 271 -YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-68
Identities = 86/306 (28%), Positives = 135/306 (44%), Gaps = 45/306 (14%)
Query: 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSD------VAIKRIKKSCFAGRSSEQERLTKD 1013
+ L+ L++LG G +G+V ++ VA+K+++ S E +D
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--------EEHLRD 57
Query: 1014 FWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKL 1073
F RE IL +L H N+V + GV L + E++ GSL+ L K +D K L
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 1074 IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTL---V 1129
GMEYL +K +H DL N+LV K+GDFGL++ + ++ V
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVE----NENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 1130 SGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT----------------G 1171
G P W APE L ++ S DV+SFG+ ++E+ T G
Sbjct: 174 KEP--GESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229
Query: 1172 EEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231
+ M +I ++KN R P+ C E +M +CW + RPSF ++ R+
Sbjct: 230 NDKQGQMIVFHLI-ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
Query: 1232 ISAAIE 1237
I +
Sbjct: 289 IRDNMA 294
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 3e-68
Identities = 89/279 (31%), Positives = 132/279 (47%), Gaps = 24/279 (8%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
L+ + LG+G +G V+ G + G VA+K +K+ S + F EA+++
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-----SMSPD----AFLAEANLMKQ 64
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAMDAAFG 1082
L H +V Y VV T + +TE+M NGSL L KL+ +A A G
Sbjct: 65 LQHQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP--WM 1140
M ++ +N +H DL+ N+LV+ CK+ DFGL+R+ + + P W
Sbjct: 122 MAFIEERNYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPER 1199
APE +N + K DV+SFGI + EI+T G PY M +I + + R P+
Sbjct: 178 APEAIN--YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDN 234
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238
C E +LM CW PE RP+F + S L A E
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 4e-68
Identities = 86/306 (28%), Positives = 136/306 (44%), Gaps = 45/306 (14%)
Query: 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSD------VAIKRIKKSCFAGRSSEQERLTKD 1013
+ L+ L++LG G +G+V ++ VA+K+++ S E +D
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--------EEHLRD 88
Query: 1014 FWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKL 1073
F RE IL +L H N+V + GV L + E++ GSL+ L K +D K L
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 148
Query: 1074 IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNT---LV 1129
GMEYL +K +H DL N+LV + K+GDFGL++ + ++ V
Sbjct: 149 QYTSQICKGMEYLGTKRYIHRDLATRNILVENEN----RVKIGDFGLTKVLPQDKEYYKV 204
Query: 1130 SGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT----------------G 1171
G P W APE L ++ S DV+SFG+ ++E+ T G
Sbjct: 205 KEP--GESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260
Query: 1172 EEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231
+ M +I ++KN R P+ C E +M +CW + RPSF ++ R+
Sbjct: 261 NDKQGQMIVFHLI-ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319
Query: 1232 ISAAIE 1237
I +
Sbjct: 320 IRDQMA 325
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 6e-68
Identities = 83/305 (27%), Positives = 138/305 (45%), Gaps = 42/305 (13%)
Query: 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSD------VAIKRIKKSCFAGRSSEQERLTKD 1013
I + L+ + +LG G +G+V ++ VA+K+++ S +Q+R D
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQR---D 70
Query: 1014 FWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKL 1073
F RE IL LH +V + GV +L V E++ +G L+ L + LD + L
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 1074 IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNT---LV 1129
+ + GMEYL S+ VH DL N+LV K+ DFGL++ + + +V
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILVE----SEAHVKIADFGLAKLLPLDKDYYVV 186
Query: 1130 SGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGG 1186
G P W APE L+ N S + DV+SFG+ ++E+ T ++ + + G
Sbjct: 187 REP--GQSPIFWYAPESLS--DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 242
Query: 1187 IVKNTLRPTI-------------PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233
++ + P C E +LM+ CWA P+ RPSF+ + +L +
Sbjct: 243 CERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302
Query: 1234 AAIES 1238
+
Sbjct: 303 SGSRG 307
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 6e-68
Identities = 93/276 (33%), Positives = 139/276 (50%), Gaps = 26/276 (9%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
+ +L+ L+ +G G +G V G +RG+ VA+K IK ++ Q F EA +
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQ-----AFLAEASV 67
Query: 1021 LSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAMDA 1079
++ L H N+V GV+ + G L VTE+M GSL L + RS+ L+ ++D
Sbjct: 68 MTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP- 1138
MEYL N VH DL N+LV+ + + KV DFGL++ +T G LP
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASST--QDT--GKLPV 178
Query: 1139 -WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTI 1196
W APE L + S K DV+SFGI +WEI + G PY + ++ + K +
Sbjct: 179 KWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 235
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
P+ C P ++M+ CW D RPSF ++ +L I
Sbjct: 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 8e-68
Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 26/279 (9%)
Query: 970 RELGSGTYGTVYHGKWRGS----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+ELGSG +GTV G ++ VA+K +K + + + EA+++ L
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILK----NEANDPALK--DELLAEANVMQQLD 76
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
+P +V G+ + V E G L + L+++R + + + + + GM+Y
Sbjct: 77 NPYIVRMIGIC---EAESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKY 132
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--KRNTLVSGGVRGTLP--WMA 1141
L N VH DL N+L+ + K+ DFGLS+ G P W A
Sbjct: 133 LEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 188
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
PE +N + S K DV+SFG+ MWE + G++PY M + + K R P C
Sbjct: 189 PECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGC 245
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239
E LM CW D E RP F + RLR + ++
Sbjct: 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-67
Identities = 89/291 (30%), Positives = 130/291 (44%), Gaps = 30/291 (10%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
++ +R LG G +G VY G+ G VA+K + + C SEQ+ DF E
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----SEQDE--LDFLME 83
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLK------KDRSLDRRK 1071
A I+S +H N+V GV + E M G LK L + + SL
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQS--LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 1072 KLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVS 1130
L +A D A G +YL + +H D+ N L+ P R + K+GDFG++R I R +
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYRASYYR 200
Query: 1131 GGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGI 1187
G LP WM PE + K D +SFG+ +WEI + G PY ++
Sbjct: 201 KGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE-F 257
Query: 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238
V + R P+ C ++M QCW PE RP+F I R+ + +
Sbjct: 258 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-67
Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 37/292 (12%)
Query: 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRGSD---------VAIKRIKKSCFAGRSSEQE 1008
I+N DL LG GT+ ++ G R V +K + K+
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----HRNYS 56
Query: 1009 RLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLD 1068
+ F+ A ++S L H ++V YGV G V EF+ GSL L K ++
Sbjct: 57 ---ESFFEAASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCIN 111
Query: 1069 RRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQR----PICKVGDFGLSRIK 1124
KL +A A M +L ++H ++ +N+L+ + ++ P K+ D G+S
Sbjct: 112 ILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT- 170
Query: 1125 RNTLVSGGVRGTLPWMAPE-LLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGA 1182
L ++ +PW+ PE + N ++ D +SFG ++WEI + G++P + +
Sbjct: 171 --VLPKDILQERIPWVPPECIENP--KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
Query: 1183 IIGGIVKNTL--RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+ P E L+ C +P+ RPSF I L ++
Sbjct: 227 KLQFYEDRHQLPAP-----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-67
Identities = 91/276 (32%), Positives = 138/276 (50%), Gaps = 26/276 (9%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
+ +L+ L+ +G G +G V G +RG+ VA+K IK A + F EA +
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA----------QAFLAEASV 239
Query: 1021 LSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAMDA 1079
++ L H N+V GV+ + G L VTE+M GSL L + RS+ L+ ++D
Sbjct: 240 MTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP- 1138
MEYL N VH DL N+LV+ + + KV DFGL++ + ++ G LP
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSDFGLTK-EASSTQDTG---KLPV 350
Query: 1139 -WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTI 1196
W APE L + S K DV+SFGI +WEI + G PY + ++ + K +
Sbjct: 351 KWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 407
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
P+ C P +M+ CW D RP+F ++ +L I
Sbjct: 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-67
Identities = 94/289 (32%), Positives = 140/289 (48%), Gaps = 27/289 (9%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGS------DVAIKRIKKSCFAGRSSEQERLTKDF 1014
I + + +G+G +G VY G + S VAIK +K +E++R DF
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-----TEKQR--VDF 93
Query: 1015 WREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI 1074
EA I+ H N++ GV+ + +TE+M NG+L L +KD + +
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVG 151
Query: 1075 IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR 1134
+ A GM+YL + N VH DL N+LVN +CKV DFGLSR+ + +
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 1135 --GTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189
G +P W APE ++ + + DV+SFGI MWE++T GE PY ++ ++ I
Sbjct: 208 SGGKIPIRWTAPEAIS--YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265
Query: 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238
PT P C +LM QCW + RP F +I S L + A +S
Sbjct: 266 GFRLPT-PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 3e-67
Identities = 112/391 (28%), Positives = 176/391 (45%), Gaps = 53/391 (13%)
Query: 869 IIQNKDQNKQEPLVIVGD------------------VTGSMPSEHQFSPEVVSHLDATSS 910
++Q K EPL + V G+ S P+ S
Sbjct: 285 MLQLKIAGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFI-IRPQKEGERALPSI 343
Query: 911 DEMSTNETESESIFPESLS-QDSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLEEL 969
+++ NE + S+S D A++ D++++++ + E I+ +E
Sbjct: 344 PKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYE--------IQRERIELG 395
Query: 970 RELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
R +G G +G V+ G + + VAIK K +S+ R + F +EA +
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-----TSDSVR--EKFLQEALTMRQF 448
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
HP++V GV+ T + + E G L+ L + SLD ++ A + +
Sbjct: 449 DHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP--WMAP 1142
YL SK VH D+ N+LV+ D K+GDFGLSR ++ +G LP WMAP
Sbjct: 506 YLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201
E +N R + DV+ FG+ MWEIL G +P+ + +I G ++N R +P C
Sbjct: 562 ESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-GRIENGERLPMPPNCP 618
Query: 1202 PEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
P LM +CWA DP RP FTE+ ++L TI
Sbjct: 619 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-67
Identities = 92/274 (33%), Positives = 130/274 (47%), Gaps = 24/274 (8%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGS--DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D+ +LG G YG VY G W+ VA+K +K+ + E E +F +EA ++
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVE----EFLKEAAVMK 64
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAMDAAF 1081
+ HPN+V GV +TEFM G+L L + +R L+ +A +
Sbjct: 65 EIKHPNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP--W 1139
MEYL KN +H DL N LV + + KV DFGLSR+ + P W
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPE 1198
APE L N+ S K DV++FG+ +WEI T G PY + + + K+ R PE
Sbjct: 179 TAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPE 235
Query: 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
C + +LM CW +P RPSF EI T+
Sbjct: 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 8e-67
Identities = 74/283 (26%), Positives = 129/283 (45%), Gaps = 27/283 (9%)
Query: 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSD------VAIKRIKKSCFAGRSSEQERLTKD 1013
I K +L +L+ LGSG +GTV+ G W V IK I+ S Q +
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-----SGRQSF--QA 61
Query: 1014 FWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKL 1073
+ +L H ++V G+ G +L VT+++ GSL + + +L + L
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLC---PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLL 118
Query: 1074 IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSGG 1132
+ A GM YL +VH +L N+L+ +V DFG++ + +
Sbjct: 119 NWGVQIAKGMYYLEEHGMVHRNLAARNVLLK----SPSQVQVADFGVADLLPPDDKQLLY 174
Query: 1133 VRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189
P WMA E ++ + + + DV+S+G+++WE++T G EPYA + + +++
Sbjct: 175 SEAKTPIKWMALESIH--FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-DLLE 231
Query: 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
R P+ C + +M +CW D RP+F E+ + +
Sbjct: 232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 8e-67
Identities = 81/300 (27%), Positives = 129/300 (43%), Gaps = 43/300 (14%)
Query: 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSD------VAIKRIKKSCFAGRSSEQERLTKD 1013
+ L+ +R+LG G +G V ++ VA+K +K S D
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-----SGGNHI--AD 69
Query: 1014 FWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKL 1073
+E IL NL+H N+V + G+ + G + + EF+ +GSLK L K ++ +++L
Sbjct: 70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL 129
Query: 1074 IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNT---LV 1129
A+ GM+YL S+ VH DL N+LV K+GDFGL++ I+ + V
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGDFGLTKAIETDKEYYTV 185
Query: 1130 SGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT---------------GE 1172
P W APE L ++ DV+SFG+++ E+LT
Sbjct: 186 KDD--RDSPVFWYAPECLM--QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
Query: 1173 EPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+ M ++ +K R P C E +LM +CW P R SF + +
Sbjct: 242 PTHGQMTVTRLV-NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-66
Identities = 94/347 (27%), Positives = 143/347 (41%), Gaps = 30/347 (8%)
Query: 904 HLDATSSDEMSTNETESESIFPESLSQDSKADVRDKDESFSDAMIAEMEASIYGLQIIKN 963
D +++ + + + + A +SI L+ +
Sbjct: 11 DYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR 70
Query: 964 VDLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWR 1016
++ +R LG G +G VY G+ G VA+K + + C SEQ+ DF
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----SEQDE--LDFLM 123
Query: 1017 EAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLK------KDRSLDRR 1070
EA I+S +H N+V GV + E M G LK L + + SL
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQS--LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181
Query: 1071 KKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLV 1129
L +A D A G +YL + +H D+ N L+ P R + K+GDFG++R I R
Sbjct: 182 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYRAGYY 240
Query: 1130 SGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGG 1186
G LP WM PE + K D +SFG+ +WEI + G PY ++
Sbjct: 241 RKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE- 297
Query: 1187 IVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233
V + R P+ C ++M QCW PE RP+F I R+ +
Sbjct: 298 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-66
Identities = 90/283 (31%), Positives = 129/283 (45%), Gaps = 24/283 (8%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
I L +LG G +G V+ G W G+ VAIK +K + E F +EA
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPE----AFLQEAQ 231
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAMD 1078
++ L H +V Y VV + + VTE+M GSL L + R +L+ +A
Sbjct: 232 VMKKLRHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP 1138
A GM Y+ N VH DL+ N+LV + +CKV DFGL+R+ + + P
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 1139 --WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195
W APE R + K DV+SFGI + E+ T G PY M ++ + + R
Sbjct: 345 IKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 401
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238
P C LM QCW +PE RP+F + + L + E
Sbjct: 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 3e-66
Identities = 86/282 (30%), Positives = 131/282 (46%), Gaps = 26/282 (9%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDFW 1015
+ ++ + +G+G +G V G+ + VAIK +K +E++R +DF
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-----TEKQR--RDFL 94
Query: 1016 REAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLII 1075
EA I+ HPN++ GVV + VTE+M NGSL L K D + + +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 1076 AMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--KRNTLVSGGV 1133
A GM+YL VH DL N+L+N +CKV DFGL R+
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILIN----SNLVCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 1134 RGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKN 1190
G +P W +PE + + + DV+S+GI +WE+++ GE PY +M +I + +
Sbjct: 209 GGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
Query: 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
P P C +LM CW D RP F +I S L +
Sbjct: 267 YRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 1e-65
Identities = 74/307 (24%), Positives = 133/307 (43%), Gaps = 45/307 (14%)
Query: 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSD------VAIKRIKKSCFAGRSSEQERLTKD 1013
+ L+++R+LG G +G V + ++ VA+K +K +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-------GPQHRSG 79
Query: 1014 FWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKL 1073
+ +E IL L+H +++ + G D +L V E++ GSL+ L S+ + L
Sbjct: 80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLL 137
Query: 1074 IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNT---LV 1129
+ A GM YLH+++ +H DL N+L++ + K+GDFGL++ + V
Sbjct: 138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLD----NDRLVKIGDFGLAKAVPEGHEYYRV 193
Query: 1130 SGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT---------------GE 1172
G P W APE L + DV+SFG++++E+LT
Sbjct: 194 RED--GDSPVFWYAPECLK--EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249
Query: 1173 EPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
M + +++ R P++C E LM+ CW + RP+F + L+T+
Sbjct: 250 IAQGQMTVLRLT-ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308
Query: 1233 SAAIESK 1239
+ +
Sbjct: 309 HEKYQGQ 315
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 3e-65
Identities = 93/297 (31%), Positives = 132/297 (44%), Gaps = 43/297 (14%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
D+ RELG G +G V+ + VA+K +K + R KDF RE
Sbjct: 16 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP------TLAAR--KDFQRE 67
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL---------------LK 1062
A +L+NL H ++V FYGV DG L V E+M +G L L +
Sbjct: 68 AELLTNLQHEHIVKFYGVCGDG--DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 1063 KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122
L + L IA A GM YL S++ VH DL N LV + K+GDFG+SR
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLLVKIGDFGMSR 181
Query: 1123 -IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADM 1178
+ G LP WM PE + + + + DV+SFG+ +WEI T G++P+ +
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVILWEIFTYGKQPWFQL 239
Query: 1179 HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235
+I I + P C E +M CW +P+ R + EI L + A
Sbjct: 240 SNTEVIECITQGR-VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 3e-65
Identities = 91/278 (32%), Positives = 132/278 (47%), Gaps = 24/278 (8%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGS--DVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
++ D+ +LG G YG VY G W+ VA+K +K+ + E E +F +EA
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVE----EFLKEA 267
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAM 1077
++ + HPN+V GV +TEFM G+L L + +R L+ +A
Sbjct: 268 AVMKEIKHPNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTL 1137
+ MEYL KN +H +L N LV + + KV DFGLSR+ +
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAKF 381
Query: 1138 P--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRP 1194
P W APE L N+ S K DV++FG+ +WEI T G PY + + + K+ R
Sbjct: 382 PIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRM 438
Query: 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
PE C + +LM CW +P RPSF EI T+
Sbjct: 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 5e-65
Identities = 88/288 (30%), Positives = 128/288 (44%), Gaps = 36/288 (12%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
+ RELG G++G VY G +G VAIK + ++ S +ER +F E
Sbjct: 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-----SMRER--IEFLNE 78
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK---------DRSLD 1068
A ++ + +VV GVV G + E M G LK L
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 1069 RRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNT 1127
K + +A + A GM YL++ VH DL N +V + K+GDFG++R I
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRDIYETD 192
Query: 1128 LVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAII 1184
G +G LP WM+PE L + DV+SFG+ +WEI T E+PY + ++
Sbjct: 193 YYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250
Query: 1185 GGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
V P+ C +LM CW +P+ RPSF EI S ++
Sbjct: 251 R-FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 5e-65
Identities = 91/283 (32%), Positives = 133/283 (46%), Gaps = 24/283 (8%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
I L+ ++LG+G +G V+ + VA+K +K S E F EA+
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVE----AFLAEAN 235
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAMD 1078
++ L H +V + VV T + +TEFM GSL L + S KLI +
Sbjct: 236 VMKTLQHDKLVKLHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP 1138
A GM ++ +N +H DL+ N+LV+ +CK+ DFGL+R+ + + P
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASL----VCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 1139 --WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195
W APE +N + K DV+SFGI + EI+T G PY M +I + + R
Sbjct: 349 IKWTAPEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 405
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238
PE C E +M +CW PE RP+F I S L A ES
Sbjct: 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-64
Identities = 82/293 (27%), Positives = 122/293 (41%), Gaps = 42/293 (14%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
+ + ELG +G VY G G VAIK +K R ++F E
Sbjct: 10 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-----EGPLR--EEFRHE 62
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL---------------LK 1062
A + + L HPNVV GVV L+ + + +G L L
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKD--QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 1063 KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122
+L+ + + A GMEYL S ++VH DL N+LV + K+ D GL R
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY----DKLNVKISDLGLFR 176
Query: 1123 -IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADM 1178
+ LP WMAPE + + S D++S+G+ +WE+ + G +PY
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 234
Query: 1179 HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231
++ +++N P+ C LM +CW P RP F +I SRLR
Sbjct: 235 SNQDVVE-MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 286
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-64
Identities = 91/310 (29%), Positives = 136/310 (43%), Gaps = 26/310 (8%)
Query: 939 KDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGS----DVAIKR 994
F E L + ++ L ELG G +G+V G +R DVAIK
Sbjct: 311 DTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV 370
Query: 995 IKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNG 1054
+K+ ++ T++ REA I+ L +P +V GV L V E G
Sbjct: 371 LKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGG 420
Query: 1055 SLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114
L L+ K + + + GM+YL KN VH +L N+L+ R K
Sbjct: 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH----YAK 476
Query: 1115 VGDFGLSRI--KRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT 1170
+ DFGLS+ ++ + G P W APE +N + S + DV+S+G++MWE L+
Sbjct: 477 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALS 534
Query: 1171 -GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
G++PY M ++ I + R P C PE LM CW E RP F + R+
Sbjct: 535 YGQKPYKKMKGPEVMAFIEQGK-RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 593
Query: 1230 RTISAAIESK 1239
R ++ SK
Sbjct: 594 RACYYSLASK 603
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 6e-64
Identities = 90/283 (31%), Positives = 128/283 (45%), Gaps = 24/283 (8%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGS-DVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
I L +LG G +G V+ G W G+ VAIK +K + E F +EA
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPE----AFLQEAQ 314
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAMD 1078
++ L H +V Y VV + + VTE+M GSL L + R +L+ +A
Sbjct: 315 VMKKLRHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP 1138
A GM Y+ N VH DL+ N+LV +CKV DFGL+R+ + + P
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 1139 --WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPT 1195
W APE R + K DV+SFGI + E+ T G PY M ++ + + R
Sbjct: 428 IKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 484
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238
P C LM QCW +PE RP+F + + L + E
Sbjct: 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-63
Identities = 82/295 (27%), Positives = 125/295 (42%), Gaps = 41/295 (13%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
L+ + LG G +G V G D VA+K +K+ + E + E
Sbjct: 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----THSEH--RALMSE 80
Query: 1018 AHILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK------------- 1063
IL ++ HH NVV G GG L + EF G+L L K
Sbjct: 81 LKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 1064 --DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121
L + + A GME+L S+ +H DL N+L++ ++ + K+ DFGL+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLA 195
Query: 1122 R-IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYAD 1177
R I ++ LP WMAPE + + + DV+SFG+ +WEI + G PY
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 1178 MHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+ +K R P+ PE + M CW +P RP+F+E+ L +
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 4e-63
Identities = 87/308 (28%), Positives = 130/308 (42%), Gaps = 50/308 (16%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
++E +R++G G +G V+ + G VA+K +K+ S + DF RE
Sbjct: 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-----SADMQ--ADFQRE 100
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLK--------------- 1062
A +++ +PN+V GV G + + E+M G L L
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 1063 --------KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114
L ++L IA A GM YL + VH DL N LV + + K
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG----ENMVVK 214
Query: 1115 VGDFGLSR-IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170
+ DFGLSR I +P WM PE + NR + + DV+++G+ +WEI +
Sbjct: 215 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF--YNRYTTESDVWAYGVVLWEIFSY 272
Query: 1171 GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230
G +PY M +I V++ PE C E LM CW+ P RPSF I L+
Sbjct: 273 GLQPYYGMAHEEVIY-YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331
Query: 1231 TISAAIES 1238
+ E
Sbjct: 332 RMCERAEG 339
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 4e-63
Identities = 90/293 (30%), Positives = 133/293 (45%), Gaps = 42/293 (14%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
D+ ELG G +G V+ + VA+K +K++ SE R +DF RE
Sbjct: 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESAR--QDFQRE 93
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL--------------LKK 1063
A +L+ L H ++V F+GV +G L V E+M +G L L
Sbjct: 94 AELLTMLQHQHIVRFFGVCTEG--RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 1064 DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR- 1122
L + L +A A GM YL + VH DL N LV Q + K+GDFG+SR
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG----QGLVVKIGDFGMSRD 207
Query: 1123 IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMH 1179
I G R LP WM PE + + + + DV+SFG+ +WEI T G++P+ +
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPESIL--YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265
Query: 1180 CGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
I + P C PE +M CW +P+ R S ++ +RL+ +
Sbjct: 266 NTEAID-CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 6e-63
Identities = 89/297 (29%), Positives = 132/297 (44%), Gaps = 41/297 (13%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD----VAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
D++ +G G +G V + + AIKR+K+ +S+ + +DF E +
Sbjct: 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDDH--RDFAGELEV 78
Query: 1021 LSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK---------------D 1064
L L HHPN++ G G L E+ +G+L L K
Sbjct: 79 LCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 1065 RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK 1124
+L ++ L A D A GM+YL K +H DL N+LV + + K+ DFGLSR +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSRGQ 192
Query: 1125 RNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCG 1181
+ G LP WMA E LN + + DV+S+G+ +WEI++ G PY M C
Sbjct: 193 EVYVKKTM--GRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248
Query: 1182 AIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238
+ + R P CD E LM QCW P RPSF +I L + ++
Sbjct: 249 ELYE-KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 1e-62
Identities = 81/297 (27%), Positives = 122/297 (41%), Gaps = 45/297 (15%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD---------VAIKRIKKSCFAGRSSEQERLTKDFW 1015
L + LG G +G V + G D VA+K +K +E++ D
Sbjct: 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKDL--SDLV 88
Query: 1016 REAHILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK----------- 1063
E ++ + H N++ G G L + E+ G+L+ L +
Sbjct: 89 SEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 1064 ----DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119
+ + + + A GMEYL S+ +H DL N+LV + + K+ DFG
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIADFG 202
Query: 1120 LSR-IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPY 1175
L+R I G LP WMAPE L + + DV+SFG+ MWEI T G PY
Sbjct: 203 LARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 1176 ADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+ + ++K R P C E +M CW A P RP+F ++ L I
Sbjct: 261 PGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-62
Identities = 83/302 (27%), Positives = 131/302 (43%), Gaps = 50/302 (16%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
+L + LG G +G V VA+K +K++ S E +D E
Sbjct: 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-----SPSEL--RDLLSE 76
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK-------------- 1063
++L ++HP+V+ YG G L + E+ GSL+ L +
Sbjct: 77 FNVLKQVNHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 1064 ---------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114
+R+L + A + GM+YL +VH DL N+LV + K
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA----EGRKMK 190
Query: 1115 VGDFGLSR-IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170
+ DFGLSR + +G +P WMA E L + + + DV+SFG+ +WEI+T
Sbjct: 191 ISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTL 248
Query: 1171 GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230
G PY + + ++K R P+ C E +LM QCW +P+ RP F +I+ L
Sbjct: 249 GGNPYPGIPPERLFN-LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307
Query: 1231 TI 1232
+
Sbjct: 308 KM 309
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-62
Identities = 87/297 (29%), Positives = 129/297 (43%), Gaps = 44/297 (14%)
Query: 965 DLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
L + LG+G +G V G VA+K +K S + ER + E
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTER--EALMSE 76
Query: 1018 AHILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK------------- 1063
+LS L +H N+V G G G +TE+ G L + L +K
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 1064 ----DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119
+ +LD L + A GM +L SKN +H DL N+L+ I K+ DFG
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT----HGRITKICDFG 190
Query: 1120 LSR-IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPY 1175
L+R IK ++ LP WMAPE + + + + DV+S+GI +WE+ + G PY
Sbjct: 191 LARDIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 1176 ADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
M + ++K R PE E +M+ CW ADP RP+F +I +
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 9e-62
Identities = 81/297 (27%), Positives = 122/297 (41%), Gaps = 45/297 (15%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD---------VAIKRIKKSCFAGRSSEQERLTKDFW 1015
L + LG G +G V + G D VA+K +K +E++ D
Sbjct: 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKDL--SDLV 134
Query: 1016 REAHILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK----------- 1063
E ++ + H N++ G G L + E+ G+L+ L +
Sbjct: 135 SEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 1064 ----DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119
+ + + + A GMEYL S+ +H DL N+LV + + K+ DFG
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIADFG 248
Query: 1120 LSR-IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPY 1175
L+R I G LP WMAPE L + + DV+SFG+ MWEI T G PY
Sbjct: 249 LARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPY 306
Query: 1176 ADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+ + ++K R P C E +M CW A P RP+F ++ L I
Sbjct: 307 PGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 4e-61
Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 40/290 (13%)
Query: 965 DLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
+L+ + LG+G +G V G VA+K +K + E+ + E
Sbjct: 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-----HADEK--EALMSE 99
Query: 1018 AHILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRR------ 1070
I+S+L H N+V G G G + +TE+ G L + L +K R L+
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHG--GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 1071 ------KKLI-IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR- 1122
+ L+ + A GM +L SKN +H D+ N+L+ + K+GDFGL+R
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT----NGHVAKIGDFGLARD 213
Query: 1123 IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMH 1179
I ++ LP WMAPE + + + DV+S+GI +WEI + G PY +
Sbjct: 214 IMNDSNYIVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271
Query: 1180 CGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
+ +VK+ + P +M+ CWA +P RP+F +I S L
Sbjct: 272 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 5e-61
Identities = 82/297 (27%), Positives = 124/297 (41%), Gaps = 45/297 (15%)
Query: 965 DLEELRELGSGTYGTVYHGKWRG---------SDVAIKRIKKSCFAGRSSEQERLTKDFW 1015
L + LG G +G V + G + VA+K +K ++E++ D
Sbjct: 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKDL--SDLI 122
Query: 1016 REAHILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK----------- 1063
E ++ + H N++ G G L + E+ G+L+ L +
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 1064 ----DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119
+ L + + A A GMEYL SK +H DL N+LV + + K+ DFG
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT----EDNVMKIADFG 236
Query: 1120 LSR-IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPY 1175
L+R I G LP WMAPE L + + DV+SFG+ +WEI T G PY
Sbjct: 237 LARDIHHIDYYKKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSPY 294
Query: 1176 ADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+ + ++K R P C E +M CW A P RP+F ++ L I
Sbjct: 295 PGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-60
Identities = 86/302 (28%), Positives = 123/302 (40%), Gaps = 49/302 (16%)
Query: 965 DLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
+LE + LGSG +G V + G VA+K +K+ ER + E
Sbjct: 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-----DSSER--EALMSE 98
Query: 1018 AHILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK------------- 1063
+++ L H N+V G G + + E+ G L + L K
Sbjct: 99 LKMMTQLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 1064 ---------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114
L L A A GME+L K+ VH DL N+LV + K
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT----HGKVVK 212
Query: 1115 VGDFGLSR-IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170
+ DFGL+R I ++ LP WMAPE L + K DV+S+GI +WEI +
Sbjct: 213 ICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWSYGILLWEIFSL 270
Query: 1171 GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230
G PY + A +++N + P E +M+ CWA D RPSF +TS L
Sbjct: 271 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330
Query: 1231 TI 1232
Sbjct: 331 CQ 332
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 9e-60
Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 21/261 (8%)
Query: 971 ELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN 1028
E+G G++ TVY G +VA ++ + ++ ER + F EA +L L HPN
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDR----KLTKSER--QRFKEEAEMLKGLQHPN 86
Query: 1029 VVAFYG--VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
+V FY + VTE M +G+LK LK+ + + + G+++L
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 1087 HSKN--IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPEL 1144
H++ I+H DLKC+N+ + K+GD GL+ +KR + V GT +MAPE+
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASFAKA-VIGTPEFMAPEM 201
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP-TIPERCDPE 1203
+ E VDV++FG+ M E+ T E PY++ A I V + ++P + + PE
Sbjct: 202 YE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258
Query: 1204 WRKLMEQCWAADPEARPSFTE 1224
++++E C + + R S +
Sbjct: 259 VKEIIEGCIRQNKDERYSIKD 279
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-52
Identities = 69/256 (26%), Positives = 116/256 (45%), Gaps = 19/256 (7%)
Query: 972 LGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029
LG GTYG VY G +AIK I + R ++ E + +L H N+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPE--------RDSRYSQPLHEEIALHKHLKHKNI 81
Query: 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI--IAMDAAFGMEYLH 1087
V + G + + E + GSL +L K L ++ I G++YLH
Sbjct: 82 VQYLGSFSENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 1088 SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-RIKRNTLVSGGVRGTLPWMAPELLN 1146
IVH D+K +N+L+ + + K+ DFG S R+ + GTL +MAPE+++
Sbjct: 140 DNQIVHRDIKGDNVLI---NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196
Query: 1147 GSSNRVSEKVDVFSFGISMWEILTGEEPYADM-HCGAIIGGIVKNTLRPTIPERCDPEWR 1205
+ D++S G ++ E+ TG+ P+ ++ A + + + P IPE E +
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 256
Query: 1206 KLMEQCWAADPEARPS 1221
+ +C+ DP+ R
Sbjct: 257 AFILKCFEPDPDKRAC 272
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-51
Identities = 69/262 (26%), Positives = 99/262 (37%), Gaps = 22/262 (8%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ L LG G+YG V+ + + G A+KR F G +L E +
Sbjct: 60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP-FRGPKDRARKL-----AEVGSHEKV 113
Query: 1025 -HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGM 1083
HP V GG L TE SL+ SL + D +
Sbjct: 114 GQHPCCVRLEQAWE--EGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPE 1143
+LHS+ +VH D+K N+ + R CK+GDFGL G +MAPE
Sbjct: 171 AHLHSQGLVHLDVKPANIFLG----PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226
Query: 1144 LLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPE 1203
LL GS DVFS G+++ E+ E H G + + L P E
Sbjct: 227 LLQGSYG---TAADVFSLGLTILEVACNMELP---HGGEGWQQLRQGYLPPEFTAGLSSE 280
Query: 1204 WRKLMEQCWAADPEARPSFTEI 1225
R ++ DP+ R + +
Sbjct: 281 LRSVLVMMLEPDPKLRATAEAL 302
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 3e-49
Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 41/278 (14%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D +E+ +GSG +G V+ K R G IKR+K + + RE L+
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------------NEKAEREVKALA 59
Query: 1023 NLHHPNVVAFYG--------------VVPDGTGGTLATVTEFMVNGSLKHVLLK-KDRSL 1067
L H N+V + G L EF G+L+ + K + L
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 1068 DRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT 1127
D+ L + G++Y+HSK +++ DLK N+ + K+GDFGL +N
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK----QVKIGDFGLVTSLKND 175
Query: 1128 LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGI 1187
+GTL +M+PE ++ ++VD+++ G+ + E+L + +
Sbjct: 176 GKRTRSKGTLRYMSPEQISSQD--YGKEVDLYALGLILAELLHVCDTAFETS------KF 227
Query: 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ I + D + + L+++ + PE RP+ +EI
Sbjct: 228 FTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-48
Identities = 66/260 (25%), Positives = 107/260 (41%), Gaps = 30/260 (11%)
Query: 971 ELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN 1028
+G G++G V+ K G A+K++ RL E + L P
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKV-------------RLEVFRVEELVACAGLSSPR 111
Query: 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS 1088
+V YG V +G + E + GSL L+K+ L + L A G+EYLH+
Sbjct: 112 IVPLYGAVREGP--WVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR------IKRNTLVSGGVRGTLPWMAP 1142
+ I+H D+K +N+L+ + DFG + + ++ L + GT MAP
Sbjct: 169 RRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT-LRPTIPERCD 1201
E++ G KVD++S M +L G P+ G + I IP C
Sbjct: 226 EVVMGKP--CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA 283
Query: 1202 PEWRKLMEQCWAADPEARPS 1221
P + +++ +P R S
Sbjct: 284 PLTAQAIQEGLRKEPVHRAS 303
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 5e-48
Identities = 67/280 (23%), Positives = 113/280 (40%), Gaps = 37/280 (13%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
EL ++GSG +G+V+ R G AIKR KK AG EQ L RE + + L
Sbjct: 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP-LAGSVDEQNAL-----REVYAHAVL 67
Query: 1025 -HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS---LDRRKKLIIAMDAA 1080
H +VV ++ + + E+ GSL + + R + + +
Sbjct: 68 GQHSHVVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVN---------------LRDPQRPICKVGDFGLSRIKR 1125
G+ Y+HS ++VH D+K N+ ++ + + K+GD G
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIG 1185
+ V G ++A E+L + K D+F+ +++ E G
Sbjct: 186 SPQV---EEGDSRFLANEVLQENYTH-LPKADIFALALTVVCAAGAEPLP---RNGDQWH 238
Query: 1186 GIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
I + L P IP+ E+ +L++ DPE RPS +
Sbjct: 239 EIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-47
Identities = 59/268 (22%), Positives = 118/268 (44%), Gaps = 29/268 (10%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
L+++G G++G K G IK I S R S +ER ++ RE +L+N+
Sbjct: 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS----RMSSKER--EESRREVAVLANM 80
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLK-KDRSLDRRKKLIIAMDAAFGM 1083
HPN+V + + G+L V ++ G L + K + L + +
Sbjct: 81 KHPNIVQYRESFEEN--GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI------KRNTLVSGGVRGTL 1137
+++H + I+H D+K +N+ + + ++GDFG++R+ + GT
Sbjct: 139 KHVHDRKILHRDIKSQNIFLT----KDGTVQLGDFGIARVLNSTVELARACI-----GTP 189
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197
+++PE+ + K D+++ G ++E+ T + + ++ I+ + P +
Sbjct: 190 YYLSPEICENKP--YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP-VS 246
Query: 1198 ERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ R L+ Q + +P RPS I
Sbjct: 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-46
Identities = 64/291 (21%), Positives = 119/291 (40%), Gaps = 46/291 (15%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D EE+ LG G +G V + AIK+I+ + E E +L+
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---------EEKLSTILSEVMLLA 57
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLAT-----------VTEFMVNGSLKHVLLKKDRSLDRRK 1071
+L+H VV +Y + E+ NG+L ++ ++ + R +
Sbjct: 58 SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 1072 KLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG 1131
+ + Y+HS+ I+H DLK N+ + D R + K+GDFGL++ +L
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV-KIGDFGLAKNVHRSLDIL 173
Query: 1132 GVR---------------GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYA 1176
+ GT ++A E+L+G+ + +EK+D++S GI +E++
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEMIYP--FST 230
Query: 1177 DMHCGAIIGGIVKNTLR--PTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
M I+ + ++ P + +K++ DP RP +
Sbjct: 231 GMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-46
Identities = 70/286 (24%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E ++ LG G +G V+ K + + AIKRI+ + E R + RE L+ L
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-----NRELAR--EKVMREVKALAKL 60
Query: 1025 HHPNVVAFYGV----------VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI 1074
HP +V ++ P L + +LK + + +R + +
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 1075 --IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG 1132
I + A +E+LHSK ++H DLK N+ + D + KVGDFGL
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEEEQT 176
Query: 1133 VR-------------GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH 1179
V GT +M+PE ++G N S KVD+FS G+ ++E+L M
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLYP--FSTQME 232
Query: 1180 CGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ + P + + P +++ + P RP I
Sbjct: 233 RVRTLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-46
Identities = 67/292 (22%), Positives = 124/292 (42%), Gaps = 31/292 (10%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+++G G + VY G VA+K+++ + R D +E +L L
Sbjct: 35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ---IFDLMDAKAR--ADCIKEIDLLKQL 89
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL---LKKDRSLDRRKKLIIAMDAAF 1081
+HPNV+ +Y + L V E G L ++ K+ R + R +
Sbjct: 90 NHPNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI------KRNTLVSGGVRG 1135
+E++HS+ ++H D+K N+ + + K+GD GL R ++LV G
Sbjct: 148 ALEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLV-----G 198
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYA--DMHCGAIIGGIVKNTLR 1193
T +M+PE ++ + + K D++S G ++E+ + P+ M+ ++ I +
Sbjct: 199 TPYYMSPERIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 256
Query: 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCINSEP 1245
P + E R+L+ C DPE RP T + + + A S +
Sbjct: 257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHH 308
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 9e-46
Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 24/279 (8%)
Query: 957 GLQIIKNVDLEELRELGSGTYGTVYH-GKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFW 1015
+ I+ + LG G GT+ + G + DVA+KRI CF
Sbjct: 17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----------SFAD 65
Query: 1016 REAHILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI 1074
RE +L HPNV+ ++ D + E +L+ + +KD + + +
Sbjct: 66 REVQLLRESDEHPNVIRYFCTEKDRQFQYI--AIEL-CAATLQEYVEQKDFAHLGLEPIT 122
Query: 1075 IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC-KVGDFGLSRI----KRNTLV 1129
+ G+ +LHS NIVH DLK N+L+++ + I + DFGL + + +
Sbjct: 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 1130 SGGVRGTLPWMAPELLNGSSN-RVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGI 1187
GV GT W+APE+L+ + VD+FS G + +++ G P+ +
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242
Query: 1188 VKNTL-RPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+L + D R+L+E+ A DP+ RPS +
Sbjct: 243 GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 71/270 (26%), Positives = 121/270 (44%), Gaps = 24/270 (8%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E L +G+G+YG + + G + K + +E E+ + E ++L L
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG----SMTEAEK--QMLVSEVNLLREL 62
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL---LKKDRSLDRRKKLIIAMDAAF 1081
HPN+V +Y + D T TL V E+ G L V+ K+ + LD L +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 1082 GMEYLHSKN-----IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI-KRNTLVSGGVRG 1135
++ H ++ ++H DLK N+ ++ + K+GDFGL+RI +T + G
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLD----GKQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT 1195
T +M+PE +N +EK D++S G ++E+ P+ + G I + R
Sbjct: 179 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR- 235
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
IP R E +++ + RPS EI
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-44
Identities = 60/303 (19%), Positives = 117/303 (38%), Gaps = 41/303 (13%)
Query: 944 SDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAG 1002
S + E + +K L+++GSG V+ AIK +
Sbjct: 8 SSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE---- 63
Query: 1003 RSSEQERLTKDFWREAHILSNLHHPN--VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL 1060
+ + E L+ L + ++ Y + V E N L
Sbjct: 64 --EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--YIYMVMEC-GNIDLNS-W 117
Query: 1061 LKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120
LKK +S+D ++ + + +H IVH DLK N L+ + K+ DFG+
Sbjct: 118 LKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGI 172
Query: 1121 SR--------IKRNTLVSGGVRGTLPWMAPELLNGSSN---------RVSEKVDVFSFGI 1163
+ + +++ V GT+ +M PE + S+ ++S K DV+S G
Sbjct: 173 ANQMQPDTTSVVKDSQV-----GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 227
Query: 1164 SMWEILTGEEPYADM-HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSF 1222
++ + G+ P+ + + + + I+ P+ + + + +++ C DP+ R S
Sbjct: 228 ILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287
Query: 1223 TEI 1225
E+
Sbjct: 288 PEL 290
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 9e-44
Identities = 57/288 (19%), Positives = 112/288 (38%), Gaps = 19/288 (6%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
LG G V+ G+ + G AIK F + RE +L L+H
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQM----REFEVLKKLNHK 67
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS--LDRRKKLIIAMDAAFGMEY 1085
N+V + + + T + EF GSL VL + + L + LI+ D GM +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELL 1145
L IVH ++K N++ + + + + K+ DFG +R + + GT ++ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 1146 NGSSNRV------SEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199
+ R VD++S G++ + TG P+ ++ + P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK-PSG 246
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCINSEPKQ 1247
+K + P ++ L+ + + + + ++ ++
Sbjct: 247 AISGVQKAENGPIDWSGDM-PVSCSLSRGLQVLLTPVLANILEADQEK 293
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-43
Identities = 59/286 (20%), Positives = 114/286 (39%), Gaps = 41/286 (14%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
+K L+++GSG V+ AIK + + + E
Sbjct: 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE------EADNQTLDSYRNEIA 59
Query: 1020 ILSNLHHPN--VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM 1077
L+ L + ++ Y T + V E N L LKK +S+D ++
Sbjct: 60 YLNKLQQHSDKIIRLYDYEI--TDQYIYMVMEC-GNIDLNS-WLKKKKSIDPWERKSYWK 115
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--------IKRNTLV 1129
+ + +H IVH DLK N L+ + K+ DFG++ + +++ V
Sbjct: 116 NMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 1130 SGGVRGTLPWMAPELLNGSSN---------RVSEKVDVFSFGISMWEILTGEEPYADM-H 1179
GT+ +M PE + S+ ++S K DV+S G ++ + G+ P+ + +
Sbjct: 171 -----GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225
Query: 1180 CGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ + I+ P+ + + + +++ C DP+ R S E+
Sbjct: 226 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 78/284 (27%), Positives = 134/284 (47%), Gaps = 39/284 (13%)
Query: 959 QIIKNVDLEE----LRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTK 1012
+ +++D E + ELG G +G VY K G+ A K I+ +E L +
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-------SEEEL-E 61
Query: 1013 DFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKK 1072
D+ E IL+ HP +V G G L + EF G++ ++L+ DR L +
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYY--HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 119
Query: 1073 LIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS------RIKRN 1126
++ + +LHSK I+H DLK N+L+ L ++ DFG+S KR+
Sbjct: 120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG----DIRLADFGVSAKNLKTLQKRD 175
Query: 1127 TLVSGGVRGTLPWMAPELLNGSSNRVS---EKVDVFSFGISMWEILTGEEPYADMHCGAI 1183
+ + GT WMAPE++ + + + K D++S GI++ E+ E P+ +++ +
Sbjct: 176 SFI-----GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230
Query: 1184 IGGIVKN---TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTE 1224
+ I K+ TL P + E+R ++ +PE RPS +
Sbjct: 231 LLKIAKSDPPTLLT--PSKWSVEFRDFLKIALDKNPETRPSAAQ 272
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-42
Identities = 64/291 (21%), Positives = 108/291 (37%), Gaps = 31/291 (10%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
I N +++LG G + V + G A+KRI + + REA
Sbjct: 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----EQQDREEAQ---REA 77
Query: 1019 HILSNLHHPNVVAFYGV--VPDGTGGTLATVTEFMVNGSLKHVL---LKKDRSLDRRKKL 1073
+ +HPN++ G + F G+L + + K L + L
Sbjct: 78 DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137
Query: 1074 IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVS--- 1130
+ + G+E +H+K H DLK N+L+ + D G +
Sbjct: 138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLG----DEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 1131 -------GGVRGTLPWMAPELLNGSSNR-VSEKVDVFSFGISMWEILTGEEPY-ADMHCG 1181
R T+ + APEL + S+ + E+ DV+S G ++ ++ GE PY G
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253
Query: 1182 AIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+ V+N L R +L+ DP RP + S+L +
Sbjct: 254 DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-41
Identities = 58/286 (20%), Positives = 113/286 (39%), Gaps = 41/286 (14%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
+K L+++GSG V+ AIK + + + E
Sbjct: 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE------EADNQTLDSYRNEIA 106
Query: 1020 ILSNLHHPN--VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM 1077
L+ L + ++ Y T + V E N L LKK +S+D ++
Sbjct: 107 YLNKLQQHSDKIIRLYDYEI--TDQYIYMVMEC-GNIDLNS-WLKKKKSIDPWERKSYWK 162
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--------IKRNTLV 1129
+ + +H IVH DLK N L+ + K+ DFG++ + +++ V
Sbjct: 163 NMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 1130 SGGVRGTLPWMAPELLNGSSN---------RVSEKVDVFSFGISMWEILTGEEPYADM-H 1179
G + +M PE + S+ ++S K DV+S G ++ + G+ P+ + +
Sbjct: 218 -----GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272
Query: 1180 CGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ + I+ P+ + + + +++ C DP+ R S E+
Sbjct: 273 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 31/266 (11%)
Query: 967 EELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+L ++G G++G V+ G VAIK I ++ + +D +E +LS
Sbjct: 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE------EAEDEI-EDIQQEITVLSQC 77
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
P V +YG T L + E++ GS +L + LD + I + G++
Sbjct: 78 DSPYVTKYYGSYLKDT--KLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLD 133
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS------RIKRNTLVSGGVRGTLP 1138
YLHS+ +H D+K N+L++ + K+ DFG++ +IKRNT V GT
Sbjct: 134 YLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPF 184
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198
WMAPE++ S+ K D++S GI+ E+ GE P++++H ++ I KN PT+
Sbjct: 185 WMAPEVIKQSA--YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEG 241
Query: 1199 RCDPEWRKLMEQCWAADPEARPSFTE 1224
++ +E C +P RP+ E
Sbjct: 242 NYSKPLKEFVEACLNKEPSFRPTAKE 267
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 8e-41
Identities = 58/293 (19%), Positives = 113/293 (38%), Gaps = 29/293 (9%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
LG G V+ G+ + G AIK F + RE +L L+H
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQM----REFEVLKKLNHK 67
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS--LDRRKKLIIAMDAAFGMEY 1085
N+V + + + T + EF GSL VL + + L + LI+ D GM +
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI-----KRNTLVSGGVRGTLPWM 1140
L IVH ++K N++ + + + + K+ DFG +R + +L GT ++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-----GTEEYL 182
Query: 1141 APELLNGSSNRV------SEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194
P++ + R VD++S G++ + TG P+ ++ +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCINSEPKQ 1247
P +K + P ++ L+ + + + + ++ ++
Sbjct: 243 K-PSGAISGVQKAENGPIDWSGDM-PVSCSLSRGLQVLLTPVLANILEADQEK 293
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 1e-40
Identities = 82/298 (27%), Positives = 133/298 (44%), Gaps = 52/298 (17%)
Query: 966 LEELRE----------LGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDF 1014
L +L E +G G +G VY G R G+ VA+KR S Q ++F
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT------PESSQG--IEEF 82
Query: 1015 WREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR---SLDRRK 1071
E LS HP++V+ G + + + ++M NG+LK L D S+ +
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDER--NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 1072 KLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI---KRNTL 1128
+L I + AA G+ YLH++ I+H D+K N+L++ + + K+ DFG+S+ T
Sbjct: 141 RLEICIGAARGLHYLHTRAIIHRDVKSINILLD----ENFVPKITDFGISKKGTELDQTH 196
Query: 1129 VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY------------- 1175
+S V+GTL ++ PE R++EK DV+SFG+ ++E+L
Sbjct: 197 LSTVVKGTLGYIDPEYF--IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254
Query: 1176 --ADMHCGAIIGGIVKNTLRPTIPERCDPEWR--KLMEQCWAADPEARPSFTEITSRL 1229
+ H + IV L I + +C A E RPS ++ +L
Sbjct: 255 WAVESHNNGQLEQIVDPNLADKIRPES--LRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-39
Identities = 68/207 (32%), Positives = 106/207 (51%), Gaps = 22/207 (10%)
Query: 972 LGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVA 1031
+G G +G VY G + VA+K++ ++E+ L + F +E +++ H N+V
Sbjct: 39 MGEGGFGVVYKGYVNNTTVAVKKLAAMV--DITTEE--LKQQFDQEIKVMAKCQHENLVE 94
Query: 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS--LD--RRKKLIIAMDAAFGMEYLH 1087
G DG L V +M NGSL L D + L R K IA AA G+ +LH
Sbjct: 95 LLGFSSDGDDLCL--VYVYMPNGSLLDRLSCLDGTPPLSWHMRCK--IAQGAANGINFLH 150
Query: 1088 SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI---KRNTLVSGGVRGTLPWMAPEL 1144
+ +H D+K N+L L + K+ DFGL+R T+++ + GT +MAPE
Sbjct: 151 ENHHIHRDIKSANIL--LDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA 206
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILTG 1171
L G ++ K D++SFG+ + EI+TG
Sbjct: 207 LRG---EITPKSDIYSFGVVLLEIITG 230
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 73/215 (33%), Positives = 115/215 (53%), Gaps = 28/215 (13%)
Query: 972 LGSGTYGTVYHGK-WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVV 1030
LG G +G VY G+ G+ VA+KR+K+ G + F E ++S H N++
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ-------FQTEVEMISMAVHRNLL 90
Query: 1031 AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS---LD--RRKKLIIAMDAAFGMEY 1085
G T L V +M NGS+ L ++ S LD +R++ IA+ +A G+ Y
Sbjct: 91 RLRGFCMTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQR--IALGSARGLAY 146
Query: 1086 LHSK---NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--KRNTLVSGGVRGTLPWM 1140
LH I+H D+K N+L L + VGDFGL+++ ++T V+ VRGT+ +
Sbjct: 147 LHDHCDPKIIHRDVKAANIL--LDEEFEA--VVGDFGLAKLMDYKDTHVTTAVRGTIGHI 202
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
APE L S+ + SEK DVF +G+ + E++TG+ +
Sbjct: 203 APEYL--STGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 73/312 (23%), Positives = 132/312 (42%), Gaps = 42/312 (13%)
Query: 929 SQDSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVD----LEELRELGSGTYGTVYHG- 983
S D+ ++ F ++ + ++ D L+ ++G G+ G V
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65
Query: 984 -KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG--VVPDGT 1040
K G VA+K + +Q+R + E I+ + H NVV Y +V
Sbjct: 66 EKHSGRQVAVKMMDLR-------KQQRRE-LLFNEVVIMRDYQHFNVVEMYKSYLV---- 113
Query: 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCEN 1100
G L + EF+ G+L ++ L+ + + + YLH++ ++H D+K ++
Sbjct: 114 GEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDS 171
Query: 1101 LLVNLRDPQRPICKVGDFGLS------RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSE 1154
+L+ L K+ DFG KR +LV GT WMAPE+++ S +
Sbjct: 172 ILLTLDGR----VKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRSL--YAT 220
Query: 1155 KVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI--PERCDPEWRKLMEQCW 1212
+VD++S GI + E++ GE PY + + + P + + P R +E+
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNSHKVSPVLRDFLERML 279
Query: 1213 AADPEARPSFTE 1224
DP+ R + E
Sbjct: 280 VRDPQERATAQE 291
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 72/270 (26%), Positives = 123/270 (45%), Gaps = 38/270 (14%)
Query: 967 EELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
++G G GTVY G +VAI+++ +Q + + E ++
Sbjct: 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-------QQPKK-ELIINEILVMREN 74
Query: 1025 HHPNVVAFYG--VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
+PN+V + +V G L V E++ GSL V+ + +D + + +
Sbjct: 75 KNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQA 128
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS------RIKRNTLVSGGVRGT 1136
+E+LHS ++H D+K +N+L+ + K+ DFG + KR+T+V GT
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GT 179
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196
WMAPE++ + KVD++S GI E++ GE PY + + + I N P +
Sbjct: 180 PYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPEL 236
Query: 1197 --PERCDPEWRKLMEQCWAADPEARPSFTE 1224
PE+ +R + +C D E R S E
Sbjct: 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-39
Identities = 74/287 (25%), Positives = 118/287 (41%), Gaps = 45/287 (15%)
Query: 970 RELGSGTYGTVYH-GKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHP 1027
+ LG G+ GTV G ++G VA+KR+ E +L+ HP
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-----------DIALMEIKLLTESDDHP 69
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI------IAMDAAF 1081
NV+ +Y + E N +L+ ++ K+ S + K + A
Sbjct: 70 NVIRYYCSETTDRFLYI--ALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC---------KVGDFGLSRIKRNTLVSGG 1132
G+ +LHS I+H DLK +N+LV+ + DFGL + + S
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 1133 VR-----GTLPWMAPELLNGSSN-----RVSEKVDVFSFGISMWEILT-GEEPYADMHC- 1180
GT W APELL S+N R++ +D+FS G + IL+ G+ P+ D +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 1181 -GAIIGGIVK-NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
II GI + ++ E L+ Q DP RP+ ++
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-39
Identities = 73/287 (25%), Positives = 118/287 (41%), Gaps = 51/287 (17%)
Query: 965 DLEELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E +GSG V + VAIKRI Q + + +E +S
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE------KCQTSM-DELLKEIQAMS 68
Query: 1023 NLHHPNVVAFYG--VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKL------- 1073
HHPN+V++Y VV L V + + GS+ ++ + + +
Sbjct: 69 QCHHPNIVSYYTSFVV----KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124
Query: 1074 IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-----------R 1122
I + G+EYLH +H D+K N+L+ + ++ DFG+S
Sbjct: 125 TILREVLEGLEYLHKNGQIHRDVKAGNILLG----EDGSVQIADFGVSAFLATGGDITRN 180
Query: 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA 1182
R T V GT WMAPE++ K D++SFGI+ E+ TG PY
Sbjct: 181 KVRKTFV-----GTPCWMAPEVMEQVRG-YDFKADIWSFGITAIELATGAAPYHKYPPMK 234
Query: 1183 IIGGIVKN---TLRPTIPERCD-----PEWRKLMEQCWAADPEARPS 1221
++ ++N +L + ++ +RK++ C DPE RP+
Sbjct: 235 VLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 41/279 (14%)
Query: 967 EELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E + +G+GTYG VY G G AIK + + E ++ +E ++L
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-------VTGDEE--EEIKQEINMLKKY 77
Query: 1025 -HHPNVVAFYG----VVPDGTGGTLATVTEFMVNGSLKHVL-LKKDRSLDRRKKLIIAMD 1078
HH N+ +YG P G L V EF GS+ ++ K +L I +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS------RIKRNTLVSGG 1132
G+ +LH ++H D+K +N+L+ + K+ DFG+S +RNT +
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDRTVGRRNTFI--- 190
Query: 1133 VRGTLPWMAPELLNGSSNRVS---EKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK 1189
GT WMAPE++ N + K D++S GI+ E+ G P DMH + I +
Sbjct: 191 --GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248
Query: 1190 N---TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
N L+ ++ +++ +E C + RP+ ++
Sbjct: 249 NPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQL 284
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-38
Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 10/173 (5%)
Query: 1064 DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR- 1122
L + + A GME+L S+ +H DL N+L++ ++ + K+ DFGL+R
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARD 242
Query: 1123 IKRNTLVSGGVRGTLP--WMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMH 1179
I ++ LP WMAPE + + + DV+SFG+ +WEI + G PY +
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
Query: 1180 CGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+K R P+ PE + M CW +P RP+F+E+ L +
Sbjct: 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 38/165 (23%), Positives = 58/165 (35%), Gaps = 21/165 (12%)
Query: 970 RELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
+ LG G +G V G D VA+K +K+ ++ E + E IL
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-----ATHSEH--RALMSELKILI 80
Query: 1023 NL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
++ HH NVV G GG L + EF G+L L K R + + A
Sbjct: 81 HIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSK-----RNEFVPYKTKGAR 134
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN 1126
+ + DLK + V + LS ++
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 76/280 (27%), Positives = 126/280 (45%), Gaps = 36/280 (12%)
Query: 961 IKNVDLEELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
+K DLE + ELG G YG V G +A+KRI+ + + QE+ K +
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-----VNSQEQ--KRLLMDL 56
Query: 1019 HI-LSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL---LKKDRSLDRRKKLI 1074
I + + P V FYG + G + E M + SL + K +++
Sbjct: 57 DISMRTVDCPFTVTFYGALFR--EGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK 113
Query: 1075 IAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-----IKRNTL 1128
IA+ +E+LHSK +++H D+K N+L+N K+ DFG+S + ++
Sbjct: 114 IAVSIVKALEHLHSKLSVIHRDVKPSNVLIN----ALGQVKMCDFGISGYLVDDVAKDID 169
Query: 1129 VSGGVRGTLPWMAPELLNGSSNRV--SEKVDVFSFGISMWEILTGEEPYADM-HCGAIIG 1185
G P+MAPE +N N+ S K D++S GI+M E+ PY +
Sbjct: 170 A-----GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK 224
Query: 1186 GIVKNTLRPTIP-ERCDPEWRKLMEQCWAADPEARPSFTE 1224
+V+ P +P ++ E+ QC + + RP++ E
Sbjct: 225 QVVEEPS-PQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 75/267 (28%), Positives = 120/267 (44%), Gaps = 27/267 (10%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E R LG G +G VY + + S +A+K + K+ E+ + RE I S
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-----QLEKAGVEHQLRREVEIQS 64
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
+L HPN++ YG D T + + E+ G++ L K + ++R I A
Sbjct: 65 HLRHPNILRLYGYFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN-A 121
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS----RIKRNTLVSGGVRGTLP 1138
+ Y HSK ++H D+K ENLL+ + K+ DFG S +R L GTL
Sbjct: 122 LSYCHSKRVIHRDIKPENLLL---GSAGEL-KIADFGWSVHAPSSRRTDLC-----GTLD 172
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198
++ PE++ G + EKVD++S G+ +E L G+ P+ I + P+
Sbjct: 173 YLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPD 228
Query: 1199 RCDPEWRKLMEQCWAADPEARPSFTEI 1225
R L+ + +P RP E+
Sbjct: 229 FVTEGARDLISRLLKHNPSQRPMLREV 255
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 73/267 (27%), Positives = 117/267 (43%), Gaps = 30/267 (11%)
Query: 967 EELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+LRE+G G++G VY VAIK++ S + +D +E L L
Sbjct: 57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS-----GKQSNEKWQDIIKEVRFLQKL 111
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
HPN + + G T V E+ GS +L + L + + A G+
Sbjct: 112 RHPNTIQYRGCYLREH--TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--KRNTLVSGGVRGTLPWMAP 1142
YLHS N++H D+K N+L++ + + K+GDFG + I N+ V GT WMAP
Sbjct: 169 YLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSASIMAPANSFV-----GTPYWMAP 219
Query: 1143 ELLNGSSNRV-SEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201
E++ KVDV+S GI+ E+ + P +M+ + + I +N + P
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---ES-PALQS 275
Query: 1202 PEWRKLM----EQCWAADPEARPSFTE 1224
W + + C P+ RP+
Sbjct: 276 GHWSEYFRNFVDSCLQKIPQDRPTSEV 302
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-38
Identities = 71/278 (25%), Positives = 119/278 (42%), Gaps = 28/278 (10%)
Query: 961 IKNVDLEELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
DL++L E+G G YG+V K G +A+KRI RS+ E+ K +
Sbjct: 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-------RSTVDEKEQKQLLMDL 71
Query: 1019 HI-LSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRR---KKL- 1073
+ + + P +V FYG + G E M + S LD + L
Sbjct: 72 DVVMRSSDCPYIVQFYGALFRE--GDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG 128
Query: 1074 IIAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG 1132
I + + +L I+H D+K N+L++ + K+ DFG+S +++
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLD----RSGNIKLCDFGISGQLVDSIAKTR 184
Query: 1133 VRGTLPWMAPELLNGSSNRV--SEKVDVFSFGISMWEILTGEEPYADMHC-GAIIGGIVK 1189
G P+MAPE ++ S++R + DV+S GI+++E+ TG PY + + +VK
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244
Query: 1190 N---TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTE 1224
L + P + + C D RP + E
Sbjct: 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 80/268 (29%), Positives = 126/268 (47%), Gaps = 34/268 (12%)
Query: 967 EELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ L +LG G+YG+VY K G VAIK++ E + ++ +E I+
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--------VESD--LQEIIKEISIMQQC 81
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
P+VV +YG T L V E+ GS+ ++ ++++L + I G+E
Sbjct: 82 DSPHVVKYYGSYFKNT--DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS------RIKRNTLVSGGVRGTLP 1138
YLH +H D+K N+L+N K+ DFG++ KRNT++ GT
Sbjct: 140 YLHFMRKIHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVI-----GTPF 190
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI-- 1196
WMAPE++ + D++S GI+ E+ G+ PYAD+H I I N PT
Sbjct: 191 WMAPEVIQEIG--YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PPTFRK 247
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTE 1224
PE + ++QC PE R + T+
Sbjct: 248 PELWSDNFTDFVKQCLVKSPEQRATATQ 275
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-38
Identities = 48/226 (21%), Positives = 88/226 (38%), Gaps = 24/226 (10%)
Query: 969 LRELGSGTYGTVYHGKWRGSDVAIKRIKKSCF---------AGRSSEQERLTKDFWREAH 1019
+R L G + + + A+K+ +KS + DF E
Sbjct: 36 IRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
I++++ + + G++ + + + E+M N S+ I
Sbjct: 96 IITDIKNEYCLTCEGIITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 1080 AF-------GMEYLHS-KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSG 1131
Y+H+ KNI H D+K N+L+ D + K+ DFG S + + G
Sbjct: 154 KCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRV-KLSDFGESEYMVDKKIKG 209
Query: 1132 GVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177
RGT +M PE + S+ KVD++S GI ++ + P++
Sbjct: 210 -SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-37
Identities = 63/287 (21%), Positives = 101/287 (35%), Gaps = 40/287 (13%)
Query: 969 LRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
LG+G +G V + G VAIK+ ++ +ER E I+ L+H
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP---KNRERWC----LEIQIMKKLNH 71
Query: 1027 PNVVAFYGVVPDGTGGTLAT----VTEFMVNGSLKHVLLKKDRS--LDRRKKLIIAMDAA 1080
PNVV+ V E+ G L+ L + + L + D +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWM 1140
+ YLH I+H DLK EN+++ + K+ D G ++ + GTL ++
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIH-KIIDLGYAKELDQGELCTEFVGTLQYL 190
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER- 1199
APELL + + VD +SFG +E +TG P+ G V+ I
Sbjct: 191 APELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 1200 ------------CDPEWRKLMEQC----WAA-----DPEARPSFTEI 1225
P + W R + +
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-37
Identities = 73/310 (23%), Positives = 115/310 (37%), Gaps = 38/310 (12%)
Query: 926 ESLSQDSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHG-- 983
E L D + R + + E++ D E++ ELG+G G V+
Sbjct: 5 EELELDEQQRKRLEAFLTQKQKVGELKDD----------DFEKISELGAGNGGVVFKVSH 54
Query: 984 KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043
K G +A K I + + RE +L + P +V FYG G
Sbjct: 55 KPSGLVMARKLI-------HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGE 105
Query: 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLL 1102
++ E M GSL +LKK + + +++ G+ YL K I+H D+K N+L
Sbjct: 106 ISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 164
Query: 1103 VNLRDPQRPICKVGDFG----LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDV 1158
VN R K+ DFG L N+ V GT +M+PE L G+ S + D+
Sbjct: 165 VN----SRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTH--YSVQSDI 213
Query: 1159 FSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEA 1218
+S G+S+ E+ G P + P + D
Sbjct: 214 WSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRP 273
Query: 1219 RPSFTEITSR 1228
+ E+
Sbjct: 274 PMAIFELLDY 283
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 71/267 (26%), Positives = 117/267 (43%), Gaps = 27/267 (10%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D + R LG G +G VY + + + +A+K + KS E+E + RE I S
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS-----QLEKEGVEHQLRREIEIQS 69
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
+L HPN++ Y D + + EF G L L K R ++R + A
Sbjct: 70 HLRHPNILRMYNYFHDRK--RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD-A 126
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS----RIKRNTLVSGGVRGTLP 1138
+ Y H + ++H D+K ENLL+ + + K+ DFG S ++R T+ GTL
Sbjct: 127 LHYCHERKVIHRDIKPENLLM---GYKGEL-KIADFGWSVHAPSLRRRTMC-----GTLD 177
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198
++ PE++ G ++ EKVD++ G+ +E L G P+ IV L+ P
Sbjct: 178 YLPPEMIEGKTH--DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--FPP 233
Query: 1199 RCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ L+ + P R +
Sbjct: 234 FLSDGSKDLISKLLRYHPPQRLPLKGV 260
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 65/269 (24%), Positives = 106/269 (39%), Gaps = 38/269 (14%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
LG G++ VY + G +VAIK I K + + + + E I L HP
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKK-----AMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLD----RR--KKLIIAMDAAF 1081
+++ Y D + V E NG + L + + R ++I M
Sbjct: 72 SILELYNYFEDSN--YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML--- 126
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR-----GT 1136
YLHS I+H DL NLL+ I K+ DFGL+ L + GT
Sbjct: 127 ---YLHSHGILHRDLTLSNLLL---TRNMNI-KIADFGLA----TQLKMPHEKHYTLCGT 175
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196
+++PE+ S++ + DV+S G + +L G P+ + +V +
Sbjct: 176 PNYISPEIATRSAH--GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE--M 231
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEI 1225
P E + L+ Q +P R S + +
Sbjct: 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSV 260
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-36
Identities = 51/228 (22%), Positives = 86/228 (37%), Gaps = 29/228 (12%)
Query: 967 EELRELGSG--TYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
E L +G G TV K G V ++RI + + E H+
Sbjct: 28 ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN------LEACSNEMVTFLQGELHVSK 81
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM---DA 1079
+HPN+V + L VT FM GS K ++ +D +L IA
Sbjct: 82 LFNHPNIVPYRATFIADN--ELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGV 137
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS------RIKRNTLVSGGV 1133
++Y+H VH +K ++L++ + + ++ +
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILIS----VDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 1134 R--GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH 1179
LPW++PE+L + K D++S GI+ E+ G P+ DM
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 60/275 (21%), Positives = 115/275 (41%), Gaps = 35/275 (12%)
Query: 965 DLEELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHIL- 1021
DLE L E+GSGT G V+ + G +A+K++ R S + K + ++
Sbjct: 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-------RRSGNKEENKRILMDLDVVL 78
Query: 1022 SNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
+ P +V +G T + E M + + + + R + +
Sbjct: 79 KSHDCPYIVQCFGTFI--TNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 1082 GMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-----RIKRNTLVSGGVRG 1135
+ YL K ++H D+K N+L++ +R K+ DFG+S ++ G
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLD----ERGQIKLCDFGISGRLVDDKAKDRSA-----G 186
Query: 1136 TLPWMAPELLNGSSNRV---SEKVDVFSFGISMWEILTGEEPYADMHCG-AIIGGIVKNT 1191
+MAPE ++ + DV+S GIS+ E+ TG+ PY + ++ +++
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE 246
Query: 1192 LRPTIPERCD--PEWRKLMEQCWAADPEARPSFTE 1224
P +P +++ ++ C D RP + +
Sbjct: 247 P-PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 71/267 (26%), Positives = 112/267 (41%), Gaps = 35/267 (13%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
R LG G + + A K + KS + + E I +L H
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQ 75
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR-SLDR-RKKL--IIAMDAAFGM 1083
+VV F+G D + V E SL + ++ + R L I+ G
Sbjct: 76 HVVGFHGFFEDND--FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-----GC 128
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR-----GTLP 1138
+YLH ++H DLK NL + + + K+GDFGL+ + G R GT
Sbjct: 129 QYLHRNRVIHRDLKLGNLFL---NEDLEV-KIGDFGLA----TKVEYDGERKKVLCGTPN 180
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198
++APE+L+ + S +VDV+S G M+ +L G+ P+ I KN IP+
Sbjct: 181 YIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPK 236
Query: 1199 RCDPEWRKLMEQCWAADPEARPSFTEI 1225
+P L+++ DP ARP+ E+
Sbjct: 237 HINPVAASLIQKMLQTDPTARPTINEL 263
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 71/267 (26%), Positives = 112/267 (41%), Gaps = 35/267 (13%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
R LG G + + A K + KS + + E I +L H
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKS-----LLLKPHQREKMSMEISIHRSLAHQ 101
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR-SLDR-RKKL--IIAMDAAFGM 1083
+VV F+G D + V E SL + ++ + R L I+ G
Sbjct: 102 HVVGFHGFFEDND--FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-----GC 154
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR-----GTLP 1138
+YLH ++H DLK NL + + + K+GDFGL+ + G R GT
Sbjct: 155 QYLHRNRVIHRDLKLGNLFL---NEDLEV-KIGDFGLA----TKVEYDGERKKVLCGTPN 206
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198
++APE+L+ + S +VDV+S G M+ +L G+ P+ I KN IP+
Sbjct: 207 YIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPK 262
Query: 1199 RCDPEWRKLMEQCWAADPEARPSFTEI 1225
+P L+++ DP ARP+ E+
Sbjct: 263 HINPVAASLIQKMLQTDPTARPTINEL 289
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 39/240 (16%)
Query: 957 GLQIIKNVDLEEL----RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERL 1010
G++ K +E+ ELGSG + V + + G + A K IKK R
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR- 59
Query: 1011 TKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRR 1070
++ RE IL + H NV+ + V + T L + E + G L D
Sbjct: 60 -EEIEREVSILRQVLHHNVITLHDVYENRTDVVL--ILELVSGGEL----------FDF- 105
Query: 1071 KKLIIAM------DAAF-------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117
+ +A G+ YLH+K I HFDLK EN+++ ++ P K+ D
Sbjct: 106 ---LAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177
FGL+ + + + GT ++APE++N + + D++S G+ + +L+G P+
Sbjct: 163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 67/301 (22%), Positives = 113/301 (37%), Gaps = 42/301 (13%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
+ + L R L G + VY + G + A+KR+ E+ R +E
Sbjct: 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-----NEEEKNRAII---QEV 76
Query: 1019 HILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMV-----NGSLKHVLLKK--DRSLDRR 1070
+ L HPN+V F G + EF++ G L L K L
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD 136
Query: 1071 KKLIIAMDAAFGMEYLHSKN--IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL 1128
L I ++++H + I+H DLK ENLL++ + K+ DFG + +
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG----TIKLCDFGSATTISHYP 192
Query: 1129 VSGG-------------VRGTLPWMAPELLNGSSNR-VSEKVDVFSFGISMWEILTGEEP 1174
T + PE+++ SN + EK D+++ G ++ + + P
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
Query: 1175 YADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234
+ D I+ G T L+ +PE R S E+ +L+ I+A
Sbjct: 253 FEDGAKLRIVNGKYSIPPHDTQYTVF----HSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
Query: 1235 A 1235
A
Sbjct: 309 A 309
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-35
Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 34/224 (15%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
+ LGSG G V R VAI+ I K FA S+ + + E IL L+HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM------DAAF 1081
++ V E M G L D+ ++
Sbjct: 201 CIIKIKNFFDA---EDYYIVLELMEGGEL----------FDK----VVGNKRLKEATCKL 243
Query: 1082 -------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR 1134
++YLH I+H DLK EN+L++ ++ I K+ DFG S+I T + +
Sbjct: 244 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLC 302
Query: 1135 GTLPWMAPELLNGSSNRV-SEKVDVFSFGISMWEILTGEEPYAD 1177
GT ++APE+L + VD +S G+ ++ L+G P+++
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 41/238 (17%)
Query: 960 IIKNVDLEEL----RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKD 1013
+ + ++++ ELGSG + V + + G A K IKK R +D
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR--ED 60
Query: 1014 FWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKL 1073
RE IL + HPNV+ + V + T L + E + G L D
Sbjct: 61 IEREVSILKEIQHPNVITLHEVYENKTDVIL--ILELVAGGEL----------FDF---- 104
Query: 1074 IIAM------DAAF-------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120
+ +A G+ YLHS I HFDLK EN+++ R+ +P K+ DFGL
Sbjct: 105 LAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 1121 SR-IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177
+ I GT ++APE++N + + D++S G+ + +L+G P+
Sbjct: 165 AHKIDFGNEFKNIF-GTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLG 219
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-34
Identities = 74/262 (28%), Positives = 116/262 (44%), Gaps = 29/262 (11%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
++LGSG YG V + + + AIK I+K+ + S+ E +L L HP
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS------KLLEEVAVLKLLDHP 96
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR-SLDRRKKLIIAMDAAFGMEYL 1086
N++ Y D L V E G L ++ + + + +I + + + YL
Sbjct: 97 NIMKLYDFFEDKRNYYL--VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG--VTYL 152
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLN 1146
H NIVH DLK ENLL+ ++ I K+ DFGLS + N GT ++APE+L
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALI-KIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR 211
Query: 1147 GSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRK 1206
+ EK DV+S G+ ++ +L G P+ I+ + K PEW+
Sbjct: 212 KKYD---EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD-----SPEWKN 263
Query: 1207 -------LMEQCWAADPEARPS 1221
L++Q D + R S
Sbjct: 264 VSEGAKDLIKQMLQFDSQRRIS 285
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-34
Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 39/240 (16%)
Query: 957 GLQIIKNVDLEEL----RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERL 1010
G++ K +E+ ELGSG + V + + G + A K IKK R
Sbjct: 1 GMETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR- 59
Query: 1011 TKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRR 1070
++ RE IL + HPN++ + V + T L + E + G L D
Sbjct: 60 -EEIEREVSILRQVLHPNIITLHDVYENRTDVVL--ILELVSGGEL----------FDF- 105
Query: 1071 KKLIIA------MDAAF-------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117
+ +A G+ YLH+K I HFDLK EN+++ ++ P K+ D
Sbjct: 106 ---LAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177
FGL+ + + + GT ++APE++N + + D++S G+ + +L+G P+
Sbjct: 163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 34/224 (15%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
+ LGSG G V R VAIK I K FA S+ + + E IL L+HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM------DAAF 1081
++ V E M G L D+ ++
Sbjct: 76 CIIKIKNFFDA---EDYYIVLELMEGGEL----------FDK----VVGNKRLKEATCKL 118
Query: 1082 -------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR 1134
++YLH I+H DLK EN+L++ ++ I K+ DFG S+I T + +
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLC 177
Query: 1135 GTLPWMAPELLNGSSNRV-SEKVDVFSFGISMWEILTGEEPYAD 1177
GT ++APE+L + VD +S G+ ++ L+G P+++
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-34
Identities = 72/262 (27%), Positives = 118/262 (45%), Gaps = 28/262 (10%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
R LG G++G V K + G + A+K I K ++ ++ RE +L L HP
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE-----SLLREVQLLKQLDHP 86
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR-SLDRRKKLIIAMDAAFGMEYL 1086
N++ Y D L V E G L ++ + R S ++I + + + Y+
Sbjct: 87 NIMKLYEFFEDKGYFYL--VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG--ITYM 142
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLN 1146
H IVH DLK ENLL+ + I ++ DFGLS + GT ++APE+L+
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANI-RIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH 201
Query: 1147 GSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRK 1206
G+ + EK DV+S G+ ++ +L+G P+ + I+ + K P+W+K
Sbjct: 202 GTYD---EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE-----LPQWKK 253
Query: 1207 -------LMEQCWAADPEARPS 1221
L+ + P R S
Sbjct: 254 VSESAKDLIRKMLTYVPSMRIS 275
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 75/286 (26%), Positives = 116/286 (40%), Gaps = 67/286 (23%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
R+LGSG +G V+ + R G + IK I K RS + E +L +L HP
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKD----RSQVPM---EQIEAEIEVLKSLDHP 80
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIA----------M 1077
N++ + V D + V E G L L+R I++
Sbjct: 81 NIIKIFEVFEDYHNMYI--VMETCEGGEL----------LER----IVSAQARGKALSEG 124
Query: 1078 DAAFGM-------EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVS 1130
A M Y HS+++VH DLK EN+L P PI K+ DFGL+ + ++ S
Sbjct: 125 YVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPI-KIIDFGLAELFKSDEHS 183
Query: 1131 GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN 1190
GT +MAPE+ V+ K D++S G+ M+ +LTG P+ +
Sbjct: 184 TNAAGTALYMAPEVFKRD---VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK 240
Query: 1191 TLRPTIPERCDPEW-----------RKLMEQCWAADPEARPSFTEI 1225
E ++++ + DPE RPS ++
Sbjct: 241 EPNY------AVECRPLTPQAVDLLKQMLTK----DPERRPSAAQV 276
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 3e-33
Identities = 73/278 (26%), Positives = 109/278 (39%), Gaps = 63/278 (22%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
LGSG + V+ K R G A+K IKKS E +L + H
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--------SSLENEIAVLKKIKHE 66
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM------DAAF 1081
N+V + T L V + + G L DR I+ DA+
Sbjct: 67 NIVTLEDIYESTTHYYL--VMQLVSGGEL----------FDR----ILERGVYTEKDASL 110
Query: 1082 -------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR 1134
++YLH IVH DLK ENLL + I + DFGLS++++N ++S
Sbjct: 111 VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKI-MITDFGLSKMEQNGIMSTAC- 168
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194
GT ++APE+L S+ VD +S G+ + +L G P+ + + I +
Sbjct: 169 GTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY-- 224
Query: 1195 TIPERCDPEW-----------RKLMEQCWAADPEARPS 1221
E P W L+E+ DP R +
Sbjct: 225 ---EFESPFWDDISESAKDFICHLLEK----DPNERYT 255
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 67/266 (25%), Positives = 107/266 (40%), Gaps = 25/266 (9%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
LG G+YG V A+K +KK + + + +E +L L H
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK----KEIQLLRRLRHK 66
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGS---LKHVLLKKDRSLDRRKKL--IIAMDAAFG 1082
NV+ V+ + + V E+ V G L V K+ +I G
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID-----G 121
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR---GTLPW 1139
+EYLHS+ IVH D+K NLL+ + K+ G++ R G+ +
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLL---TTGGTL-KISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199
PE+ NG KVD++S G++++ I TG P+ + + I K + IP
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA--IPGD 235
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEI 1225
C P L++ +P R S +I
Sbjct: 236 CGPPLSDLLKGMLEYEPAKRFSIRQI 261
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 35/223 (15%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
ELGSG + V + + G + A K IKK + R ++ RE +IL + HP
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR--EEIEREVNILREIRHP 68
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIA------MDAAF 1081
N++ + + + T L + E + G L D + +A
Sbjct: 69 NIITLHDIFENKTDVVL--ILELVSGGEL----------FDF----LAEKESLTEDEATQ 112
Query: 1082 -------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR 1134
G+ YLHSK I HFDLK EN+++ ++ P K+ DFG++ +
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177
GT ++APE++N + + D++S G+ + +L+G P+
Sbjct: 173 GTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLG 213
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-33
Identities = 58/313 (18%), Positives = 102/313 (32%), Gaps = 73/313 (23%)
Query: 970 RELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
+G G+YG V + AIK + K+ + + E ++ LHHP
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE---RIKTEVRLMKKLHHP 88
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM---------- 1077
N+ Y V D + V E G L L + + +
Sbjct: 89 NIARLYEVYEDEQ--YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 1078 ----------------------DAAF-------GMEYLHSKNIVHFDLKCENLLVNLRDP 1108
+ + YLH++ I H D+K EN L + +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS-TNK 205
Query: 1109 QRPICKVGDFGLSRIKRNTLVSGGVR-----GTLPWMAPELLNGSSNRVSEKVDVFSFGI 1163
I K+ DFGLS+ GT ++APE+LN ++ K D +S G+
Sbjct: 206 SFEI-KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 1164 SMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEW-----------RKLMEQCW 1212
+ +L G P+ ++ I ++ + +P + L+ +
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLNK--KLCFE---NPNYNVLSPLARDLLSNLLNR-- 317
Query: 1213 AADPEARPSFTEI 1225
+ + R
Sbjct: 318 --NVDERFDAMRA 328
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 57/220 (25%), Positives = 88/220 (40%), Gaps = 43/220 (19%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
+G G++G V + A K+I K + + F +E I+ +L HP
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY----FVEDVD----RFKQEIEIMKSLDHP 66
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIA------MDAAF 1081
N++ Y D T L V E G L +R ++ DAA
Sbjct: 67 NIIRLYETFEDNTDIYL--VMELCTGGEL----------FER----VVHKRVFRESDAAR 110
Query: 1082 GM-------EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR 1134
M Y H N+ H DLK EN L P P+ K+ DFGL+ + +
Sbjct: 111 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPL-KLIDFGLAARFKPGKMMRTKV 169
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEP 1174
GT +++P++L G + D +S G+ M+ +L G P
Sbjct: 170 GTPYYVSPQVLEGLYG---PECDEWSAGVMMYVLLCGYPP 206
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
LG G++G V K R + A+K I K+ + + RE +L L HP
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS------TILREVELLKKLDHP 81
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIA------MDAAF 1081
N++ + ++ D + + V E G L D II DAA
Sbjct: 82 NIMKLFEILEDSSSFYI--VGELYTGGEL----------FDE----IIKRKRFSEHDAAR 125
Query: 1082 GM-------EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR 1134
+ Y+H NIVH DLK EN+L+ ++ I K+ DFGLS +
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRI 184
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEP 1174
GT ++APE+L G+ + EK DV+S G+ ++ +L+G P
Sbjct: 185 GTAYYIAPEVLRGTYD---EKCDVWSAGVILYILLSGTPP 221
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-32
Identities = 82/279 (29%), Positives = 121/279 (43%), Gaps = 52/279 (18%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKS-----CFAGRSSEQERLTKDFWREAHILS 1022
R+LGSG YG V K + S+ AIK IKKS ++ + E+ ++ + E +L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM----- 1077
+L HPN++ + V D L VTEF G L ++ II
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYL--VTEFYEGGEL----------FEQ----IINRHKFDE 145
Query: 1078 -DAAF-------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLV 1129
DAA G+ YLH NIVH D+K EN+L+ ++ I K+ DFGLS
Sbjct: 146 CDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI-KIVDFGLSSFFSKDYK 204
Query: 1130 SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK 1189
GT ++APE+L N EK DV+S G+ M+ +L G P+ + II + K
Sbjct: 205 LRDRLGTAYYIAPEVLKKKYN---EKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261
Query: 1190 NTLRPTIPERCDPEWRK-------LMEQCWAADPEARPS 1221
+W+ L++ D R +
Sbjct: 262 GKYYFD-----FNDWKNISDEAKELIKLMLTYDYNKRCT 295
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 32/294 (10%), Positives = 64/294 (21%), Gaps = 49/294 (16%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
L G V+ + D A+K + + + L
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTM-----GAENSRSELERLHEATFAAARLLGE 122
Query: 1028 N------------------------VVAFYGVVPDGTGGTLATVTEFMV-----NGSLKH 1058
+ D + S
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 1059 VLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118
+ I+ L SK +VH +NL + +GD
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR----LMLGDV 238
Query: 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADM 1178
+ + + E LN S+ + ++ + G+S++ + P+ +
Sbjct: 239 SALWKVGTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 1179 HCGAIIGGIVKNTLRPTIPERCDPEW-------RKLMEQCWAADPEARPSFTEI 1225
G + P + L+ + D R E
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 40/220 (18%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
ELG G + V + G + A K I + R + REA I L HP
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ------KLEREARICRKLQHP 65
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM------DAAF 1081
N+V + + + + L V + + G L + I+A DA+
Sbjct: 66 NIVRLHDSIQEESFHYL--VFDLVTGGEL----------FED----IVAREFYSEADASH 109
Query: 1082 -------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR 1134
+ Y HS IVH +LK ENLL+ + + K+ DFGL+ ++ G
Sbjct: 110 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFA 168
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEP 1174
GT +++PE+L + S+ VD+++ G+ ++ +L G P
Sbjct: 169 GTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPP 206
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-32
Identities = 71/274 (25%), Positives = 113/274 (41%), Gaps = 53/274 (19%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
LG G++G V K R + A+K I K+ + + RE +L L HP
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS------TILREVELLKKLDHP 81
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM------DAAF 1081
N++ + ++ D + + V E G L D II DAA
Sbjct: 82 NIMKLFEILEDSSSFYI--VGELYTGGEL----------FDE----IIKRKRFSEHDAAR 125
Query: 1082 GM-------EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR 1134
+ Y+H NIVH DLK EN+L+ ++ I K+ DFGLS +
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRI 184
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194
GT ++APE+L G+ + EK DV+S G+ ++ +L+G P+ + I+ +
Sbjct: 185 GTAYYIAPEVLRGTYD---EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF 241
Query: 1195 TIPERCDPEWRK-------LMEQCWAADPEARPS 1221
P+WR L+ + P R +
Sbjct: 242 D-----LPQWRTISDDAKDLIRKMLTFHPSLRIT 270
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-32
Identities = 80/279 (28%), Positives = 113/279 (40%), Gaps = 65/279 (23%)
Query: 970 RELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
ELG G VY K +G+ A+K +KK+ K E +L L HP
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKT----------VDKKIVRTEIGVLLRLSHP 108
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM------DAAF 1081
N++ + T +L V E + G L DR I+ DAA
Sbjct: 109 NIIKLKEIFETPTEISL--VLELVTGGEL----------FDR----IVEKGYYSERDAAD 152
Query: 1082 -------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR 1134
+ YLH IVH DLK ENLL P P+ K+ DFGLS+I + ++ V
Sbjct: 153 AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPL-KIADFGLSKIVEHQVLMKTVC 211
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEP-YADMHCGAIIGGIVKNTLR 1193
GT + APE+L G + +VD++S GI + +L G EP Y + + I+
Sbjct: 212 GTPGYCAPEILRGCA--YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY- 268
Query: 1194 PTIPERCDPEW-----------RKLMEQCWAADPEARPS 1221
P W RKL+ DP+ R +
Sbjct: 269 ----YFISPWWDEVSLNAKDLVRKLIVL----DPKKRLT 299
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 6e-32
Identities = 40/300 (13%), Positives = 84/300 (28%), Gaps = 48/300 (16%)
Query: 950 EMEASIYGLQIIKNVDL-----EELRELGSGTYGTVYHGKWRGSD-------VAIKRIKK 997
E + + ++ L LG G + VY + +K K
Sbjct: 46 EWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP 105
Query: 998 SCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLK 1057
+ E T+ L + FY G L V E G+L
Sbjct: 106 AN----PWEFYIGTQ----LMERLKPSMQHMFMKFYSAHLFQNGSVL--VGELYSYGTLL 155
Query: 1058 HVLLKKDRSLDRRKKLIIAM----DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113
+ + + ++ + + + +E +H I+H D+K +N ++ ++
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215
Query: 1114 -------KVGDFGLSRIKR----NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFG 1162
+ D G S + T+ + T + E+L+ + ++D F
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFT-AKCETSGFQCVEMLSNKP--WNYQIDYFGVA 272
Query: 1163 ISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPE-WRKLMEQCWAADPEARPS 1221
+++ +L G G + W +
Sbjct: 273 ATVYCMLFGTYMKVKNEGGECK-------PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLP 325
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 46/287 (16%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFW------------ 1015
E+G G+YG V + A+K + K ++ R
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 1016 ------REAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSL----KHVLLKKDR 1065
+E IL L HPNVV V+ D L V E + G + L +D+
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 1066 SLDRRKKL--IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123
+ R +I G+EYLH + I+H D+K NLLV I K+ DFG+S
Sbjct: 139 A---RFYFQDLIK-----GIEYLHYQKIIHRDIKPSNLLV---GEDGHI-KIADFGVSNE 186
Query: 1124 --KRNTLVSGGVRGTLPWMAPELLNGSSNRVS-EKVDVFSFGISMWEILTGEEPYADMHC 1180
+ L+S V GT +MAPE L+ + S + +DV++ G++++ + G+ P+ D
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245
Query: 1181 GAIIGGIVKNTLRPTIPERCD--PEWRKLMEQCWAADPEARPSFTEI 1225
+ I L P++ D + + L+ + +PE+R EI
Sbjct: 246 MCLHSKIKSQALE--FPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 72/268 (26%), Positives = 119/268 (44%), Gaps = 36/268 (13%)
Query: 969 LRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
L+ +G G + V + G +VAIK I K+ + ++L RE I+ L+H
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLF----REVRIMKILNH 73
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDR--RKKL--IIAMDAAFG 1082
PN+V + V+ T TL + E+ G + L+ R ++ R K I++
Sbjct: 74 PNIVKLFEVI--ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-----A 126
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-RIKRNTLVSGGVRGTLPWMA 1141
++Y H K IVH DLK ENLL+ D I K+ DFG S + G P+ A
Sbjct: 127 VQYCHQKRIVHRDLKAENLLL---DADMNI-KIADFGFSNEFTVGGKLDAFC-GAPPYAA 181
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA----IIGGIVKNTLRPTIP 1197
PEL G +VDV+S G+ ++ +++G P+ + ++ G IP
Sbjct: 182 PELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY------RIP 234
Query: 1198 ERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ L+++ +P R + +I
Sbjct: 235 FYMSTDCENLLKRFLVLNPIKRGTLEQI 262
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 57/236 (24%), Positives = 97/236 (41%), Gaps = 32/236 (13%)
Query: 957 GLQIIKNVDLEEL-----RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQER 1009
L + +ELG G + V + G + A K +KK R + R
Sbjct: 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKR----RRGQDCR 72
Query: 1010 LTKDFWREAHILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLD 1068
+ E +L P V+ + V + + L + E+ G + L
Sbjct: 73 --AEILHEIAVLELAKSCPRVINLHEVYENTSEIIL--ILEYAAGGEIF------SLCLP 122
Query: 1069 RRKKLIIAMDAAF-------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121
+++ D G+ YLH NIVH DLK +N+L++ P I K+ DFG+S
Sbjct: 123 ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI-KIVDFGMS 181
Query: 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177
R + + GT ++APE+LN + ++ D+++ GI + +LT P+
Sbjct: 182 RKIGHACELREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVG 235
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-31
Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 40/209 (19%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
ELG G + V + G + A K I + R + REA I L HP
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ------KLEREARICRKLQHP 88
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM------DAAF 1081
N+V + + + + L V + + G L + I+A DA+
Sbjct: 89 NIVRLHDSIQEESFHYL--VFDLVTGGEL----------FED----IVAREFYSEADASH 132
Query: 1082 -------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR 1134
+ Y HS IVH +LK ENLL+ + + K+ DFGL+ ++ G
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFA 191
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGI 1163
GT +++PE+L S+ VD+++ G+
Sbjct: 192 GTPGYLSPEVLKKDP--YSKPVDIWACGV 218
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-31
Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 42/225 (18%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
+G G + V R G A+K + + F +D REA I L HP
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST---EDLKREASICHMLKHP 86
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIA----------M 1077
++V G L V EFM L I+
Sbjct: 87 HIVELLETYSSD--GMLYMVFEFMDGADL----------CFE----IVKRADAGFVYSEA 130
Query: 1078 DAAFGM-------EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLV 1129
A+ M Y H NI+H D+K +L+ ++ P+ K+G FG++ + + LV
Sbjct: 131 VASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV-KLGGFGVAIQLGESGLV 189
Query: 1130 SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEP 1174
+GG GT +MAPE++ + VDV+ G+ ++ +L+G P
Sbjct: 190 AGGRVGTPHFMAPEVVKREP--YGKPVDVWGCGVILFILLSGCLP 232
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-31
Identities = 53/255 (20%), Positives = 103/255 (40%), Gaps = 24/255 (9%)
Query: 929 SQDSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLEEL----RELGSGTYGTVYHGK 984
+ + D D+ + D + + +K + + ELGSG +G V+
Sbjct: 16 GKYDGPKINDYDKFYED----IWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 985 WR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042
+ G K I + E I++ LHHP ++ + D
Sbjct: 72 EKATGRVFVAKFINTPYPLDK--------YTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123
Query: 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLL 1102
L + EF+ G L + +D + + + A G++++H +IVH D+K EN++
Sbjct: 124 VL--ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 181
Query: 1103 VNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFG 1162
+ + K+ DFGL+ + T + APE+++ V D+++ G
Sbjct: 182 CETKKAS-SV-KIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP--VGFYTDMWAIG 237
Query: 1163 ISMWEILTGEEPYAD 1177
+ + +L+G P+A
Sbjct: 238 VLGYVLLSGLSPFAG 252
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-31
Identities = 59/275 (21%), Positives = 109/275 (39%), Gaps = 18/275 (6%)
Query: 906 DATSSDEMSTNETESESIFPESLSQDSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVD 965
D+ S + + + + + D A + +
Sbjct: 31 DSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT 90
Query: 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
+ + LG G +G V+ + G +A K IK + ++ E +++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK--------EEVKNEISVMNQ 142
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGM 1083
L H N++ Y L V E++ G L ++ + +L ++ G+
Sbjct: 143 LDHANLIQLYDAFESKNDIVL--VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGI 200
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSGGVRGTLPWMAP 1142
++H I+H DLK EN+L RD + I K+ DFGL+R K + GT ++AP
Sbjct: 201 RHMHQMYILHLDLKPENILCVNRDAK-QI-KIIDFGLARRYKPREKLKVNF-GTPEFLAP 257
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177
E++N VS D++S G+ + +L+G P+
Sbjct: 258 EVVNYDF--VSFPTDMWSVGVIAYMLLSGLSPFLG 290
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 59/300 (19%), Positives = 111/300 (37%), Gaps = 59/300 (19%)
Query: 898 SPEVVSHLDATSSDEMSTNETESESIFPESLSQDSKADVRDKDESFSDAMIAEMEASIYG 957
P ++L A + +E+++ +S+ + + + F Y
Sbjct: 47 DPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQ---------KYD 97
Query: 958 LQIIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFW 1015
+ +G G V R G + A+K ++ + + E + +
Sbjct: 98 PK----------DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 1016 REAHILSNLH-HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI 1074
RE HIL + HP+++ + L V + M G L D +
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFL--VFDLMRKGEL----------FDY----L 191
Query: 1075 IAM------DAAF-------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121
+ + +LH+ NIVH DLK EN+L+ D I ++ DFG S
Sbjct: 192 TEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQI-RLSDFGFS 247
Query: 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRV----SEKVDVFSFGISMWEILTGEEPYAD 1177
+ GT ++APE+L S + ++VD+++ G+ ++ +L G P+
Sbjct: 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 63/273 (23%), Positives = 107/273 (39%), Gaps = 43/273 (15%)
Query: 969 LRELGSGTYGTVYHGKWR--GSDVAIKRIKKS--CFAGRSSEQERLTKDFWREAHILSNL 1024
LG G +GTV+ G VAIK I ++ S+ E +L +
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP----LEVALLWKV 91
Query: 1025 H----HPNVVAFYGVVPDGTGGTLATVTEFMVNGS------LKHVLLKKDRSLDRRKKL- 1073
HP V+ G L V E + + L + S R
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFML--VLERPLPAQDLFDYITEKGPLGEGPS---RCFFG 146
Query: 1074 -IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG 1132
++A +++ HS+ +VH D+K EN+L+ D +R K+ DFG + + +
Sbjct: 147 QVVA-----AIQHCHSRGVVHRDIKDENILI---DLRRGCAKLIDFGSGALLHDEPYTDF 198
Query: 1133 VRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192
GT + PE ++ + V+S GI +++++ G+ P+ I+ +
Sbjct: 199 D-GTRVYSPPEWISRHQYH-ALPATVWSLGILLYDMVCGDIPFERDQ--EILEAEL---- 250
Query: 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
P P+ L+ +C A P +RPS EI
Sbjct: 251 --HFPAHVSPDCCALIRRCLAPKPSSRPSLEEI 281
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 48/210 (22%), Positives = 82/210 (39%), Gaps = 41/210 (19%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
ELG G + V G + A I + R + REA I L HP
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ------KLEREARICRLLKHP 70
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM------DAAF 1081
N+V + + + L + + + G L + I+A DA+
Sbjct: 71 NIVRLHDSISEEGHHYL--IFDLVTGGEL----------FED----IVAREYYSEADASH 114
Query: 1082 GM-------EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSGGV 1133
+ + H +VH +LK ENLL+ + + K+ DFGL+ ++ G
Sbjct: 115 CIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV-KLADFGLAIEVEGEQQAWFGF 173
Query: 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFGI 1163
GT +++PE+L + VD+++ G+
Sbjct: 174 AGTPGYLSPEVLRKDP--YGKPVDLWACGV 201
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 63/329 (19%), Positives = 108/329 (32%), Gaps = 80/329 (24%)
Query: 965 DLEELRELGSGTYGTVYHGK---------------------------------------- 984
D E ++ +G G +G V+ K
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 985 ------------WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAF 1032
+ + + K + + N V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 1033 YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI--IAMDAAFGMEYLHSKN 1090
P L + +LK + ++ DR + I + A +E+LHSK
Sbjct: 127 L--QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 1091 IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--------------KRNTLVSGGVRGT 1136
++H DLK N+ + D + KVGDFGL +G V GT
Sbjct: 185 LMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV-GT 239
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196
+M+PE ++G++ S KVD+FS G+ ++E+L M II + P +
Sbjct: 240 KLYMSPEQIHGNNY--SHKVDIFSLGLILFELLYSFST--QMERVRIITDVRNLKF-PLL 294
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ P+ +++ + P RP T+I
Sbjct: 295 FTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-30
Identities = 43/225 (19%), Positives = 83/225 (36%), Gaps = 47/225 (20%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
+LG G +G V+ K +K + ++Q +E IL+ H
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQV----LVKKEISILNIARHR 61
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIA-------MDAA 1080
N++ + + + EF+ + +R I +
Sbjct: 62 NILHLHESFESMEELVM--IFEFISGLDI----------FER----INTSAFELNEREIV 105
Query: 1081 F-------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSGG 1132
+++LHS NI HFD++ EN++ + + K+ +FG +R +K
Sbjct: 106 SYVHQVCEALQFLHSHNIGHFDIRPENII--YQTRRSSTIKIIEFGQARQLKPGDNFRLL 163
Query: 1133 VRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177
+ APE+ VS D++S G ++ +L+G P+
Sbjct: 164 F-TAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINPFLA 205
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 68/299 (22%), Positives = 119/299 (39%), Gaps = 36/299 (12%)
Query: 969 LRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
+ +LG G TVY + VAIK I + +R F RE H S L H
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKR----FEREVHNSSQLSH 70
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNG-SLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
N+V+ V + V E+ + G +L ++ L + G+++
Sbjct: 71 QNIVSMIDVDEED--DCYYLVMEY-IEGPTLSE-YIESHGPLSVDTAINFTNQILDGIKH 126
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLV--SGGVRGTLPWMAPE 1143
H IVH D+K +N+L++ + K+ DFG+++ T + + V GT+ + +PE
Sbjct: 127 AHDMRIVHRDIKPQNILID-SNKT---LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 1144 LLNGSSNRVSEKVDVFSFGISMWEILTGEEPY--------ADMHCGAIIGGIVKNTLRPT 1195
G + E D++S GI ++E+L GE P+ A H + V +R
Sbjct: 183 QAKGEA--TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PNVTTDVRKD 239
Query: 1196 IPERCDPEWRKLMEQCWAADPEARP-SFTEITSRLRTISAA--IESKCINSEPKQTKPI 1251
IP ++ + D R + E+ L ++ + +T +
Sbjct: 240 IP----QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKMKTIAV 294
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 59/268 (22%), Positives = 111/268 (41%), Gaps = 35/268 (13%)
Query: 969 LRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
+ LGSG +G V+ + +V +K IKK ++ E ILS + H
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGS-LKHVLLKKDR---SLDRRK-KLIIAMDAAF 1081
N++ + G V E +G L + + R L + +++
Sbjct: 89 ANIIKVLDIF--ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS----- 141
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR----GTL 1137
+ YL K+I+H D+K EN+++ I K+ DFG + L G + GT+
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVI---AEDFTI-KLIDFGSA----AYLERGKLFYTFCGTI 193
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197
+ APE+L G+ R E ++++S G++++ ++ E P+ ++ + + P
Sbjct: 194 EYCAPEVLMGNPYRGPE-LEMWSLGVTLYTLVFEENPFCELE--ETVEAAIH------PP 244
Query: 1198 ERCDPEWRKLMEQCWAADPEARPSFTEI 1225
E L+ PE R + ++
Sbjct: 245 YLVSKELMSLVSGLLQPVPERRTTLEKL 272
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-30
Identities = 61/290 (21%), Positives = 109/290 (37%), Gaps = 24/290 (8%)
Query: 890 SMPSEHQFSPEVVSHLDATSSDEMSTNETESESIFPESLSQDSKADVRDKDESFSDAMIA 949
S P E +P ++ + +E ++S + V D + + +
Sbjct: 91 SKPCEPT-APVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 950 EMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQ 1007
+ I ELG+G +G V+ R G++ A K + S++
Sbjct: 150 IKHDHVLDHYDIH-------EELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDK 198
Query: 1008 ERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSL 1067
E +E +S L HP +V + D + + EFM G L + + +
Sbjct: 199 E----TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM--IYEFMSGGELFEKVADEHNKM 252
Query: 1068 DRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT 1127
+ + G+ ++H N VH DLK EN++ + K+ DFGL+
Sbjct: 253 SEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE--LKLIDFGLTAHLDPK 310
Query: 1128 LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177
GT + APE+ G V D++S G+ + +L+G P+
Sbjct: 311 QSVKVTTGTAEFAAPEVAEGKP--VGYYTDMWSVGVLSYILLSGLSPFGG 358
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 72/266 (27%), Positives = 107/266 (40%), Gaps = 29/266 (10%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
+ LG G YG V R VA+K + E + +E I L+H
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIK------KEICINKMLNHE 65
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR---SLDRRK-KLIIAMDAAFGM 1083
NVV FYG G E+ G L + +R ++A G+
Sbjct: 66 NVVKFYGHR--REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GV 118
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR---GTLPWM 1140
YLH I H D+K ENLL+ D + + K+ DFGL+ + R + GTLP++
Sbjct: 119 VYLHGIGITHRDIKPENLLL---DERDNL-KISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH-CGAIIGGIVKNTLRPTIPER 1199
APELL +E VDV+S GI + +L GE P+ + ++
Sbjct: 175 APELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEI 1225
D L+ + +P AR + +I
Sbjct: 234 IDSAPLALLHKILVENPSARITIPDI 259
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 36/298 (12%), Positives = 80/298 (26%), Gaps = 49/298 (16%)
Query: 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSE--------QERLTKD 1013
L LG + G + + ++ + RL +
Sbjct: 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 132
Query: 1014 FWREAHILSNLH------------HPNVVAFYGVVPDGTGGTLATVTEFMVN-----GSL 1056
+ +L ++ D + + M + G +
Sbjct: 133 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 192
Query: 1057 KHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116
+SL +L + + + LH +VH L+ +++++ R +
Sbjct: 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG----VFLT 248
Query: 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSS---------NRVSEKVDVFSFGISMWE 1167
F + V + + PEL + ++ D ++ G+ ++
Sbjct: 249 GFEHLV-RDGARVV--SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 1168 ILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
I + P I ++ IP R L+E E R +
Sbjct: 306 IWCADLPITKDAALGGSEWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQA 357
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 58/229 (25%), Positives = 89/229 (38%), Gaps = 41/229 (17%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQ-ERLTKDFWREAHILSNL-H 1025
LG G V + + A+K I + S+E+ + L + +E IL +
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM------DA 1079
HPN++ T L V + M G L D + +
Sbjct: 83 HPNIIQLKDTYETNTFFFL--VFDLMKKGEL----------FDY----LTEKVTLSEKET 126
Query: 1080 AF-------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG 1132
+ LH NIVH DLK EN+L+ D I K+ DFG S
Sbjct: 127 RKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNI-KLTDFGFSCQLDPGEKLRE 182
Query: 1133 VRGTLPWMAPELLNGSSNRV----SEKVDVFSFGISMWEILTGEEPYAD 1177
V GT ++APE++ S N ++VD++S G+ M+ +L G P+
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 69/285 (24%), Positives = 122/285 (42%), Gaps = 37/285 (12%)
Query: 969 LRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
LG G V+ + DVA+K + ++ A S R F REA + L+H
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLR----FRREAQNAAALNH 71
Query: 1027 PNVVAFY--GVVPDGTGGTLATVTEFMVNG-SLKHVLLKKDRSLDRRKKLIIAMDAAFGM 1083
P +VA Y G G V E+ V+G +L+ ++ + + ++ + + DA +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEY-VDGVTLRD-IVHTEGPMTPKRAIEVIADACQAL 129
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVS----GGVRGTLPW 1139
+ H I+H D+K N+++ + KV DFG++R ++ S V GT +
Sbjct: 130 NFSHQNGIIHRDVKPANIMI---SATNAV-KVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY--------ADMHCGAIIGGIVKNT 1191
++PE G S V + DV+S G ++E+LTGE P+ A H +
Sbjct: 186 LSPEQARGDS--VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP--SA 241
Query: 1192 LRPTIPERCDPEWRKLMEQCWAADPEARP-SFTEITSRLRTISAA 1235
+ + ++ + A +PE R + E+ + L +
Sbjct: 242 RHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 63/271 (23%), Positives = 103/271 (38%), Gaps = 39/271 (14%)
Query: 972 LGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPN 1028
LG G G V R G A+K + S +E P+
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDS-------------PKARQEVDHHWQASGGPH 83
Query: 1029 VVAFYGVVPDGTGGTLAT--VTEFMVNGSL-KHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
+V V + G + E M G L + + D++ R+ I D +++
Sbjct: 84 IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELL 1145
LHS NI H D+K ENLL ++ + K+ DFG ++ + T ++APE+L
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVL-KLTDFGFAKETTQNALQTPC-YTPYYVAPEVL 201
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEW- 1204
+ D++S G+ M+ +L G P+ AI G+ + +PEW
Sbjct: 202 GPEK--YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY-GFPNPEWS 258
Query: 1205 ----------RKLMEQCWAADPEARPSFTEI 1225
R L++ DP R + T+
Sbjct: 259 EVSEDAKQLIRLLLKT----DPTERLTITQF 285
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 61/268 (22%), Positives = 104/268 (38%), Gaps = 35/268 (13%)
Query: 969 LRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCF--AGRSSEQERLTKDFWREAHILSNL 1024
LGSG +G+VY G VAIK ++K G R+ E +L +
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP----MEVVLLKKV 103
Query: 1025 HH--PNVVAFYGVVPDGTGGTLATVTEFMVN-GSLKHVLLKKDR---SLDRRK-KLIIAM 1077
V+ + + E L + ++ L R ++
Sbjct: 104 SSGFSGVIRLLDWF--ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE- 160
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTL 1137
+ + H+ ++H D+K EN+L+ D R K+ DFG + ++T+ + GT
Sbjct: 161 ----AVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYTDFD-GTR 212
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197
+ PE + V+S GI +++++ G+ P+ II G V
Sbjct: 213 VYSPPEWIRYHRYH-GRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRGQV------FFR 263
Query: 1198 ERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+R E + L+ C A P RP+F EI
Sbjct: 264 QRVSSECQHLIRWCLALRPSDRPTFEEI 291
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 71/270 (26%), Positives = 115/270 (42%), Gaps = 41/270 (15%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
LG GT+G V G+ + G VA+K + + ++ RE L HP
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIK----REIQNLKLFRHP 71
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDR--RKKL--IIAMDAAFGM 1083
+++ Y V+ T V E++ G L + K R + R+ I++ +
Sbjct: 72 HIIKLYQVI--STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS-----AV 124
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR----GTLPW 1139
+Y H +VH DLK EN+L+ D K+ DFGLS N + G G+ +
Sbjct: 125 DYCHRHMVVHRDLKPENVLL---DAHMNA-KIADFGLS----NMMSDGEFLRTSCGSPNY 176
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA----IIGGIVKNTLRPT 1195
APE+++G +VD++S G+ ++ +L G P+ D H I GG+
Sbjct: 177 AAPEVISGRL-YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF------Y 229
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
IPE + L+ DP R + +I
Sbjct: 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDI 259
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-28
Identities = 52/278 (18%), Positives = 106/278 (38%), Gaps = 38/278 (13%)
Query: 969 LRELGSGTYGTVYHGKWR---GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+ G G +Y R G V +K + +G + Q E L+ +
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLV---HSGDAEAQAM----AMAERQFLAEVV 137
Query: 1026 HPNVVAFYGVVPDGTGGTLAT---VTEFMVNG-SLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
HP++V + V V E+ V G SLK + L + + ++
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEY-VGGQSLKRSK---GQKLPVAEAIAYLLEILP 193
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMA 1141
+ YLHS +V+ DLK EN+++ ++ K+ D G + G + GT + A
Sbjct: 194 ALSYLHSIGLVYNDLKPENIML---TEEQL--KLIDLGAVSRINSF---GYLYGTPGFQA 245
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201
PE++ + D+++ G ++ + G + G+ ++
Sbjct: 246 PEIVRT---GPTVATDIYTVGRTLAALTLDLPTRN----GRYVDGLPEDDPVLKTY---- 294
Query: 1202 PEWRKLMEQCWAADPEARP-SFTEITSRLRTISAAIES 1238
+ +L+ + DP R + E++++L + + +
Sbjct: 295 DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVA 332
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 71/266 (26%), Positives = 108/266 (40%), Gaps = 29/266 (10%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
+ LG G YG V R VA+K + E + +E I L+H
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIK------KEICINKMLNHE 65
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDR--RKKL--IIAMDAAFGM 1083
NVV FYG G E+ G L + + ++ ++A G+
Sbjct: 66 NVVKFYGHR--REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GV 118
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR---GTLPWM 1140
YLH I H D+K ENLL+ D + + K+ DFGL+ + R + GTLP++
Sbjct: 119 VYLHGIGITHRDIKPENLLL---DERDNL-KISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG-AIIGGIVKNTLRPTIPER 1199
APELL +E VDV+S GI + +L GE P+ + ++
Sbjct: 175 APELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEI 1225
D L+ + +P AR + +I
Sbjct: 234 IDSAPLALLHKILVENPSARITIPDI 259
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 1e-28
Identities = 36/294 (12%), Positives = 78/294 (26%), Gaps = 42/294 (14%)
Query: 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQE------------- 1008
L LG + G + + ++ ++
Sbjct: 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 137
Query: 1009 ----RLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFM--VNGSLKHVL-- 1060
+ K R + P V D + + + +L+
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197
Query: 1061 ----LKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116
+SL +L + + + LH +VH L+ ++++ D + + +
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGV-FLT 253
Query: 1117 DFGLSRI--KRNTLVSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTG 1171
F G A +L ++ D ++ G++++ I
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 1172 EEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ P D I ++ IP R L+E E R +
Sbjct: 314 DLPNTDDAALGGSEWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQA 361
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 66/277 (23%), Positives = 117/277 (42%), Gaps = 36/277 (12%)
Query: 969 LRELGSGTYGTVYHGK--WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
R +G G G VY + R VA+K + ++ + + R REA L
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSET-LSSDPVFRTR----MQREARTAGRLQE 93
Query: 1027 PNVVAFYGVVPDG-TGGTLATVTEFMVNG-SLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
P+VV + G G L +NG L +L++ L + + I ++
Sbjct: 94 PHVVPIHDF---GEIDGQLYVDMRL-INGVDLAA-MLRRQGPLAPPRAVAIVRQIGSALD 148
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLV--SGGVRGTLPWMAP 1142
H+ H D+K EN+LV+ D + DFG++ + + G GTL +MAP
Sbjct: 149 AAHAAGATHRDVKPENILVSADD----FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAP 204
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY-ADMHCGAIIGGIVKN------TLRPT 1195
E + S + + D+++ ++E LTG PY D +++G + T+RP
Sbjct: 205 ERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQ--LSVMGAHINQAIPRPSTVRPG 260
Query: 1196 IPERCDPEWRKLMEQCWAADPEAR-PSFTEITSRLRT 1231
IP + ++ + A +PE R + ++++
Sbjct: 261 IP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHA 293
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 65/273 (23%), Positives = 104/273 (38%), Gaps = 38/273 (13%)
Query: 970 RELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HH 1026
+ LG G G V K A+K ++ RE +
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQC 114
Query: 1027 PNVVAFYGVVPDGTGGTLAT--VTEFMVNGSL-KHVLLKKDRSLDRRKKLIIAMDAAFGM 1083
P++V V + G V E + G L + + D++ R+ I +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPE 1143
+YLHS NI H D+K ENLL + P + K+ DFG ++ + T ++APE
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAIL-KLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 1144 LLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPE 1203
+L + D++S G+ M+ +L G P+ H AI G+ E +PE
Sbjct: 234 VLGPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNPE 290
Query: 1204 W-----------RKLMEQCWAADPEARPSFTEI 1225
W R L++ +P R + TE
Sbjct: 291 WSEVSEEVKMLIRNLLKT----EPTQRMTITEF 319
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 968 ELRELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
E ++G GTYG VY K + D A+K+I+ G S RE +L
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSA-------CREIALLRE 74
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL--LKKDRSLDRRKKLIIAMDAAF 1081
L HPNV++ V + + ++ L H++ + ++ + +L M +
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 1082 ------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-----IKRNTLVS 1130
G+ YLH+ ++H DLK N+LV P+R K+ D G +R +K +
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 1131 GGVRGTLPWM-APELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
V T W APELL G + ++ +D+++ G E+LT E
Sbjct: 194 PVVV-TF-WYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSE 233
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 70/296 (23%), Positives = 112/296 (37%), Gaps = 64/296 (21%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E++ ++G G+YG V+ + R G VAIK+ S + + K RE +L L
Sbjct: 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL------ESEDDPVIKKIALREIRMLKQL 59
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK-KLIIAMDAAFGM 1083
HPN+V V L V E+ + ++ H L + R + K I +
Sbjct: 60 KHPNLVNLLEVFR--RKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQ-AV 115
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---IKRNTL---VSGGVRGTL 1137
+ H N +H D+K EN+L+ + + K+ DFG +R + V+ T
Sbjct: 116 NFCHKHNCIHRDVKPENILIT----KHSVIKLCDFGFARLLTGPSDYYDDEVA-----TR 166
Query: 1138 PWM-APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY----ADMH--------CG--- 1181
W +PELL G + + VDV++ G E+L+G P +D+ G
Sbjct: 167 -WYRSPELLVGDT-QYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDLI 223
Query: 1182 -AIIGGIVKN---------------TLRPTIPERCDPEWRKLMEQCWAADPEARPS 1221
N L P L++ C DP R +
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFP-NISYPALGLLKGCLHMDPTERLT 278
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 67/284 (23%), Positives = 103/284 (36%), Gaps = 68/284 (23%)
Query: 970 RELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HH 1026
+ LG G++ K A+K I K R+ + +E L H
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK-----------RMEANTQKEITALKLCEGH 65
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM------DAA 1080
PN+V + V D L V E + G L +R I +A+
Sbjct: 66 PNIVKLHEVFHDQLHTFL--VMELLNGGEL----------FER----IKKKKHFSETEAS 109
Query: 1081 FGM-------EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR--NTLVSG 1131
+ M ++H +VH DLK ENLL + I K+ DFG +R+K N +
Sbjct: 110 YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEI-KIIDFGFARLKPPDNQPLKT 168
Query: 1132 GVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD---MHCGAIIGGIV 1188
TL + APELLN N E D++S G+ ++ +L+G+ P+ I+
Sbjct: 169 PC-FTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225
Query: 1189 KNTLRPTIPERCDPEW-----------RKLMEQCWAADPEARPS 1221
K + W + L+ DP R
Sbjct: 226 KKIKKGDF-SFEGEAWKNVSQEAKDLIQGLLTV----DPNKRLK 264
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 77/266 (28%), Positives = 116/266 (43%), Gaps = 34/266 (12%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
LG G++G V VA+K I + +S R+ RE L L HP
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVE----REISYLKLLRHP 69
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDR--RKKL--IIAMDAAFGM 1083
+++ Y V+ T + V E+ G L +++K R + R+ II +
Sbjct: 70 HIIKLYDVI--TTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC-----AI 121
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR----GTLPW 1139
EY H IVH DLK ENLL+ D + K+ DFGLS N + G G+ +
Sbjct: 122 EYCHRHKIVHRDLKPENLLL---DDNLNV-KIADFGLS----NIMTDGNFLKTSCGSPNY 173
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199
APE++NG E VDV+S GI ++ +L G P+ D + + +P+
Sbjct: 174 AAPEVINGKLYAGPE-VDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV--MPDF 230
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEI 1225
P + L+ + ADP R + EI
Sbjct: 231 LSPGAQSLIRRMIVADPMQRITIQEI 256
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 112 bits (284), Expect = 2e-27
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E+L ++G GTYGTV+ K R VA+KR++ + E + RE +L L
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKEL 58
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK-KLIIAMDAAFGM 1083
H N+V + V+ TL V EF + LK + LD K + G+
Sbjct: 59 KHKNIVRLHDVLHSDKKLTL--VFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLK-GL 114
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---IKRNTLVSGGVRGTLPWM 1140
+ HS+N++H DLK +NLL+N + K+ +FGL+R I + V TL +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLARAFGIPVRCYSAEVV--TLWYR 168
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175
P++L G + S +D++S G E+ P
Sbjct: 169 PPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 63/299 (21%), Positives = 103/299 (34%), Gaps = 79/299 (26%)
Query: 972 LGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPN 1028
LG G + V + A+K I+K RS +RE +L H N
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS--------RVFREVEMLYQCQGHRN 72
Query: 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM------DAAFG 1082
V+ + V E M GS+ L I +A+
Sbjct: 73 VLELIEFFEEED--RFYLVFEKMRGGSI----------LSH----IHKRRHFNELEASVV 116
Query: 1083 M-------EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR- 1134
+ ++LH+K I H DLK EN+L + P+ K+ DF L + +
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPV-KICDFDLGSGIKLNGDCSPIST 175
Query: 1135 -------GTLPWMAPELLNGSSNRVS---EKVDVFSFGISMWEILTGEEPYADMHCGAII 1184
G+ +MAPE++ S S ++ D++S G+ ++ +L+G P+ CG+
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG-RCGSDC 234
Query: 1185 GGIVKNTLRPTIPE------RC-----DPEW-----------RKLMEQCWAADPEARPS 1221
G D +W KL+ + D + R S
Sbjct: 235 GWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVR----DAKQRLS 289
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 967 EELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
L ++G GTYG VY + G A+K+I+ E E + RE IL L
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKELK 58
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRR--KKLIIAMDAAFGM 1083
H N+V Y V+ L V E + + LK +L + L+ K ++ + G+
Sbjct: 59 HSNIVKLYDVIHTKKRLVL--VFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLN--GI 113
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---IKRNTLVSGGVRGTLPWM 1140
Y H + ++H DLK +NLL+N + K+ DFGL+R I V TL +
Sbjct: 114 AYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLARAFGIPVRKYTHEIV--TLWYR 167
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
AP++L GS + S +D++S G E++ G
Sbjct: 168 APDVLMGSK-KYSTTIDIWSVGCIFAEMVNGT 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 69/295 (23%), Positives = 109/295 (36%), Gaps = 62/295 (21%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E L +G G+YG V + + G VAIK+ S + + + K RE +L L
Sbjct: 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLLKQL 81
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK-KLIIAMDAAFGM 1083
H N+V V L V EF+ + ++ L LD + + + G+
Sbjct: 82 RHENLVNLLEVCKKKKRWYL--VFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIIN-GI 137
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRG------TL 1137
+ HS NI+H D+K EN+LV+ + K+ DFG +R ++ T
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSG----VVKLCDFGFART-----LAAPGEVYDDEVATR 188
Query: 1138 PWM-APELLNGSSNRVSEKVDVFSFGISMWEILTGE------------------------ 1172
W APELL G + + VDV++ G + E+ GE
Sbjct: 189 -WYRAPELLVGDV-KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP 246
Query: 1173 ------EPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPS 1221
+ + L P + L ++C DP+ RP
Sbjct: 247 RHQELFNKNPVFAGVRLPEIKEREPLERRYP-KLSEVVIDLAKKCLHIDPDKRPF 300
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 61/275 (22%), Positives = 93/275 (33%), Gaps = 71/275 (25%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HH 1026
+ LG G G V + A+K ++ RE +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQC 70
Query: 1027 PNVVAFYGVVPDGTGGTLAT--VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGM- 1083
P++V V + G V E + G L R DR + +A+ M
Sbjct: 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELF------SRIQDRGDQAFTEREASEIMK 124
Query: 1084 ------EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTL 1137
+YLHS NI H D+K ENLL + P + K+ DFG
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL-KLTDFGF----------------- 166
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197
A E + + D++S G+ M+ +L G P+ H AI G+
Sbjct: 167 ---AKETTGEKYD---KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY- 219
Query: 1198 ERCDPEW-----------RKLMEQCWAADPEARPS 1221
E +PEW R L++ +P R +
Sbjct: 220 EFPNPEWSEVSEEVKMLIRNLLKT----EPTQRMT 250
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 73/275 (26%), Positives = 115/275 (41%), Gaps = 41/275 (14%)
Query: 967 EELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ ++++GSG +G K VA+K I++ + ++ RE +L
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG---------AAIDENVQREIINHRSL 73
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR---SLDRRK--KLIIAMDA 1079
HPN+V F V+ T LA + E+ G L + R R +L+ +
Sbjct: 74 RHPNIVRFKEVI--LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS- 130
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR-----NTLVSGGVR 1134
Y HS I H DLK EN L L P K+ DFG S+ + V
Sbjct: 131 -----YCHSMQICHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPKSTV----- 178
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR- 1193
GT ++APE+L + DV+S G++++ +L G P+ D ++ L
Sbjct: 179 GTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV 237
Query: 1194 -PTIPERC--DPEWRKLMEQCWAADPEARPSFTEI 1225
+IP+ PE L+ + + ADP R S EI
Sbjct: 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 73/212 (34%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 967 EELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
++L ++G GTYG VY K G VA+KRI+ +E E + RE +L LH
Sbjct: 24 QKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKELH 77
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRR--KKLIIAMDAAFGM 1083
HPN+V+ V+ TL V EFM LK VL + L K + + G+
Sbjct: 78 HPNIVSLIDVIHSERCLTL--VFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLR--GV 132
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---IKRNTLVSGGVRGTLPWM 1140
+ H I+H DLK +NLL+N K+ DFGL+R I + V TL +
Sbjct: 133 AHCHQHRILHRDLKPQNLLIN----SDGALKLADFGLARAFGIPVRSYTHEVV--TLWYR 186
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
AP++L G S + S VD++S G E++TG+
Sbjct: 187 APDVLMG-SKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ +LG GTYG VY VAIKRI+ E+E + RE +L L
Sbjct: 37 RRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLKEL 90
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF--- 1081
H N++ V+ L + E+ LK + D+ + + + +F
Sbjct: 91 QHRNIIELKSVIHHNHRLHL--IFEYA-ENDLKKYM-------DKNPDVSMRVIKSFLYQ 140
Query: 1082 ---GMEYLHSKNIVHFDLKCENLLVNLRD-PQRPICKVGDFGLSR---IKRNTLVSGGVR 1134
G+ + HS+ +H DLK +NLL+++ D + P+ K+GDFGL+R I +
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII- 199
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
TL + PE+L G S S VD++S E+L
Sbjct: 200 -TLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-26
Identities = 62/289 (21%), Positives = 100/289 (34%), Gaps = 74/289 (25%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHIL-SNLHH 1026
++G G+Y + + A+K I KS E IL H
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------------EEIEILLRYGQH 75
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM------DAA 1080
PN++ V DG + VTE M G L LD+ I+ +A+
Sbjct: 76 PNIITLKDVYDDGKYVYV--VTELMKGGEL----------LDK----ILRQKFFSEREAS 119
Query: 1081 F-------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR------NT 1127
+EYLH++ +VH DLK N+L ++ DFG ++ R T
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 1128 LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGI 1187
T ++APE+L D++S G+ ++ +LTG P+A+ I
Sbjct: 180 PC-----YTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFAN-GPDDTPEEI 231
Query: 1188 VKNTLRPTIPERCDPEW-----------RKLMEQCWAADPEARPSFTEI 1225
+ W K++ DP R + +
Sbjct: 232 LARIGSGKF-SLSGGYWNSVSDTAKDLVSKMLHV----DPHQRLTAALV 275
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 73/270 (27%), Positives = 117/270 (43%), Gaps = 41/270 (15%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
LG GT+G V GK G VA+K + + ++ RE L HP
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-RSLDVVGKIR----REIQNLKLFRHP 76
Query: 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDR--RKKL--IIAMDAAFGM 1083
+++ Y V+ T + V E++ G L + K R ++ R+ I++ G+
Sbjct: 77 HIIKLYQVI--STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-----GV 129
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR----GTLPW 1139
+Y H +VH DLK EN+L+ D K+ DFGLS N + G G+ +
Sbjct: 130 DYCHRHMVVHRDLKPENVLL---DAHMNA-KIADFGLS----NMMSDGEFLRTSCGSPNY 181
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA----IIGGIVKNTLRPT 1195
APE+++G E VD++S G+ ++ +L G P+ D H I GI
Sbjct: 182 AAPEVISGRLYAGPE-VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF------Y 234
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
P+ +P L++ DP R + +I
Sbjct: 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDI 264
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E+L LG G + TVY + + VAIK+IK RS ++ + + RE +L L
Sbjct: 13 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLLQEL 69
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK-KLIIAMDAAFGM 1083
HPN++ + +L V +FM L+ ++ L K + M G+
Sbjct: 70 SHPNIIGLLDAFGHKSNISL--VFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQ-GL 125
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---IKRNTLVSGGVRGTLPWM 1140
EYLH I+H DLK NLL++ + + K+ DFGL++ V T W
Sbjct: 126 EYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAYTHQVV--TR-WY 178
Query: 1141 -APELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
APELL G + VD+++ G + E+L
Sbjct: 179 RAPELLFG-ARMYGVGVDMWAVGCILAELLLRV 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 66/263 (25%), Positives = 112/263 (42%), Gaps = 27/263 (10%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D + + LG G++ TV + + AIK ++K + ++ E ++S
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPY-VTR---ERDVMS 85
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIA-MDAAF 1081
L HP V Y D L + NG L + K + + A + +A
Sbjct: 86 RLDHPFFVKLYFTFQDDE--KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 143
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR-----GT 1136
EYLH K I+H DLK EN+L+ + I ++ DFG + K + S R GT
Sbjct: 144 --EYLHGKGIIHRDLKPENILL---NEDMHI-QITDFGTA--KVLSPESKQARANSFVGT 195
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196
+++PELL + D+++ G +++++ G P+ + I I+K
Sbjct: 196 AQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD--F 251
Query: 1197 PERCDPEWRKLMEQCWAADPEAR 1219
PE+ P+ R L+E+ D R
Sbjct: 252 PEKFFPKARDLVEKLLVLDATKR 274
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 72/223 (32%), Positives = 109/223 (48%), Gaps = 41/223 (18%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQER------LTKDFWREA 1018
++L +LG+GTY TVY G + G VA+K +K + E + RE
Sbjct: 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVK--------LDSEEGTPSTAI-----REI 54
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
++ L H N+V Y V+ TL V EFM + LK + + + L + +
Sbjct: 55 SLMKELKHENIVRLYDVIHTENKLTL--VFEFM-DNDLKK-YMDSRTVGNTPRGLELNLV 110
Query: 1079 AAF------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---IKRNTLV 1129
F G+ + H I+H DLK +NLL+N +R K+GDFGL+R I NT
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLIN----KRGQLKLGDFGLARAFGIPVNTFS 166
Query: 1130 SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
S V TL + AP++L G S S +D++S G + E++TG+
Sbjct: 167 SEVV--TLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGK 206
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+L +LG GTY TVY GK + + VA+K I R +E RE +L +L
Sbjct: 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLLKDL 57
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK-KLIIAMDAAFGM 1083
H N+V + ++ TL V E++ + LK L ++ KL + G+
Sbjct: 58 KHANIVTLHDIIHTEKSLTL--VFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLR-GL 113
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR---IKRNTLVSGGVRGTLPWM 1140
Y H + ++H DLK +NLL+N +R K+ DFGL+R I T + V TL +
Sbjct: 114 AYCHRQKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYDNEVV--TLWYR 167
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
P++L G S S ++D++ G +E+ TG
Sbjct: 168 PPDILLG-STDYSTQIDMWGVGCIFYEMATGR 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-24
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 43/223 (19%)
Query: 967 EELRELGSGTYGTVYHGKWRGSD-VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+ +G+G++G V+ K SD VAIK++ Q++ K+ RE I+ +
Sbjct: 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVL----------QDKRFKN--RELQIMRIVK 90
Query: 1026 HPNVVA----FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
HPNVV FY L V E++ ++ R + K+ M
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRAS----RHYAKLKQ---TMPMLL 142
Query: 1082 ----------GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLV 1129
+ Y+HS I H D+K +NLL++ P + K+ DFG ++ I V
Sbjct: 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD---PPSGVLKLIDFGSAKILIAGEPNV 199
Query: 1130 SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
S + + APEL+ G++N + +D++S G M E++ G+
Sbjct: 200 SYIC--SRYYRAPELIFGATN-YTTNIDIWSTGCVMAELMQGQ 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 62/264 (23%), Positives = 112/264 (42%), Gaps = 26/264 (9%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
E LR +G G++G V + + A+K + K R + R +E I+
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER--NEVRNVF---KELQIMQ 70
Query: 1023 NLHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
L HP +V +F + V + ++ G L++ L + + KL I +
Sbjct: 71 GLEHPFLVNLWYSFQ------DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-E 123
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP 1138
++YL ++ I+H D+K +N+L+ D + + DF ++ + + GT P
Sbjct: 124 LVMALDYLQNQRIIHRDMKPDNILL---DEHGHV-HITDFNIAAMLPRETQITTMAGTKP 179
Query: 1139 WMAPELLNGSSNRV-SEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL--RPT 1195
+MAPE+ + S VD +S G++ +E+L G PY + IV T
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY-HIRSSTSSKEIVHTFETTVVT 238
Query: 1196 IPERCDPEWRKLMEQCWAADPEAR 1219
P E L+++ +P+ R
Sbjct: 239 YPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 56/228 (24%), Positives = 93/228 (40%), Gaps = 43/228 (18%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQE--RLTKDFWREAHILS 1022
E+L ++G GT+G V+ + R G VA+K++ +E+E +T RE IL
Sbjct: 20 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITA--LREIKILQ 71
Query: 1023 NLHHPNVVAFYGVV------PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRR--KKLI 1074
L H NVV + + G++ V +F + L +L K+++
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVM 130
Query: 1075 IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR 1134
+ G+ Y+H I+H D+K N+L+ + + K+ DFGL+R S
Sbjct: 131 QMLLN--GLYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLAR-----AFSLAKN 179
Query: 1135 GTLPWM----------APELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
PELL G +D++ G M E+ T
Sbjct: 180 SQPNRYTNRVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRS 226
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-23
Identities = 83/400 (20%), Positives = 140/400 (35%), Gaps = 50/400 (12%)
Query: 833 NDFLNCSDKMAEKLGFGESVSKKSNVEDVAYIQTPSIIQNKDQNKQEPLVIVGDVTGSMP 892
FL ++ L + + +D Q ++ Q L
Sbjct: 73 QQFLRTHEQHGPALQLWKDIEDYDTADDALRPQKAQALRAAYLEPQAQLFC--------- 123
Query: 893 SEHQFSPEVVSHLDATSSDEMSTNETESESIFPESLSQDSKADVRDKDESFSDAMIAEME 952
E V+ A + D + L Q + D +E
Sbjct: 124 --SFLDAETVARARAGAGDGL---FQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLE 178
Query: 953 ASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERL 1010
A G + R LG G +G V+ + + + A K++ K R Q +
Sbjct: 179 AQPMGED-----WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM 233
Query: 1011 TKDFWREAHILSNLHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLK---HVLLKK 1063
E IL+ +H +V AF T L V M G ++ + + +
Sbjct: 234 V-----EKKILAKVHSRFIVSLAYAFE------TKTDLCLVMTIMNGGDIRYHIYNVDED 282
Query: 1064 DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR- 1122
+ + + G+E+LH +NI++ DLK EN+L+ D + ++ D GL+
Sbjct: 283 NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNV-RISDLGLAVE 338
Query: 1123 -IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG 1181
T G GT +MAPELL G S VD F+ G++++E++ P+
Sbjct: 339 LKAGQTKTKGYA-GTPGFMAPELLLGEEYDFS--VDYFALGVTLYEMIAARGPFRARGEK 395
Query: 1182 AIIGGIVKNTLR--PTIPERCDPEWRKLMEQCWAADPEAR 1219
+ + L T P++ P + E DPE R
Sbjct: 396 VENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 65/227 (28%), Positives = 91/227 (40%), Gaps = 43/227 (18%)
Query: 967 EELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFW-----REAH 1019
E + E+G G YGTVY + S VA+K ++ RE
Sbjct: 12 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV--------PNGGGGGGGLPISTVREVA 63
Query: 1020 ILSNLH---HPNVVAFYGVVPDGTGGTLAT---VTEFMVNGSLKHVL-LKKDRSLDRR-- 1070
+L L HPNVV V V E + + L+ L L
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETI 122
Query: 1071 KKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI----KRN 1126
K L+ G+++LH+ IVH DLK EN+LV K+ DFGL+RI
Sbjct: 123 KDLMRQFLR--GLDFLHANCIVHRDLKPENILVT----SGGTVKLADFGLARIYSYQMAL 176
Query: 1127 T-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
T +V V TL + APE+L S + VD++S G E+ +
Sbjct: 177 TPVV---V--TLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRK 216
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 38/219 (17%)
Query: 967 EELRELGSGTYGTVYHG--KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ +R+LG G Y V+ V +K +K +++ K RE IL NL
Sbjct: 39 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------VKKKKIK---REIKILENL 87
Query: 1025 -HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRR---KKLIIAMDAA 1080
PN++ +V D T A V E + N L + D R +++ A+D
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDF-KQLYQTLTDYDIRFYMYEILKALD-- 144
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI-----KRNTLVSGGVRG 1135
Y HS I+H D+K N++++ + + D+GL+ + N V+
Sbjct: 145 ----YCHSMGIMHRDVKPHNVMIDHEHRKLRLI---DWGLAEFYHPGQEYNVRVA----- 192
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEP 1174
+ + PELL +D++S G + ++ +EP
Sbjct: 193 SRYFKGPELLVDYQM-YDYSLDMWSLGCMLASMIFRKEP 230
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-23
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ + +G+G++G VY K G VAIK++ Q++ K+ RE I+ L
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFKN--RELQIMRKL 104
Query: 1025 HHPNVVA----FYGVVPDGTGGTLATVTEFM---VNGSLKHVLLKKDRSLDRRKKLIIAM 1077
H N+V FY L V +++ V +H K KL +
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-- 162
Query: 1078 DAAF----GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSG 1131
+ + Y+HS I H D+K +NLL++ P + K+ DFG ++ ++ VS
Sbjct: 163 ---YQLFRSLAYIHSFGICHRDIKPQNLLLD---PDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 1132 GVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
+ + APEL+ G+++ + +DV+S G + E+L G+
Sbjct: 217 IC--SRYYRAPELIFGATD-YTSSIDVWSAGCVLAELLLGQ 254
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 51/232 (21%)
Query: 967 EELRELGSGTYGTV---YHGKWRGSDVAIKRI--KKSCFAGRSSEQERLTKDFWREAHIL 1021
+L+ LG G G V VAIK+I + RE I+
Sbjct: 14 MDLKPLGCGGNGLVFSAVDND-CDKRVAIKKIVLTDPQSVKHA----------LREIKII 62
Query: 1022 SNLHHPNVVAFYGVV-PDGTGGTLAT-----------VTEFMVNGSLKHVLLKKDRSLDR 1069
L H N+V + ++ P G+ T V E+M + +L++ L+
Sbjct: 63 RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLLEE 120
Query: 1070 RKKLIIAMDAAF----GMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRI 1123
+L + + G++Y+HS N++H DLK NL +N D K+GDFGL+RI
Sbjct: 121 HARLFM-----YQLLRGLKYIHSANVLHRDLKPANLFINTED-----LVLKIGDFGLARI 170
Query: 1124 KRNTLVSGGVR----GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
G T + +P LL S N ++ +D+++ G E+LTG
Sbjct: 171 MDPHYSHKGHLSEGLVTKWYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 52/222 (23%), Positives = 86/222 (38%), Gaps = 31/222 (13%)
Query: 967 EELRELGSGTYGTV---YHGKWRGSDVAIKRIKKSCFAGRSS---EQERLTKDFWREAHI 1020
R + SG+YG V + G VAIKR+ + GR+ L K RE +
Sbjct: 25 TVQRFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 1021 LSNLHHPNVVAFYGVVPDGTGGTLAT---VTEFMVNGSLKHVLLKKDRSL-DRRKKLIIA 1076
L++ HHPN++ + + VTE M L V+ + + + + +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM- 140
Query: 1077 MDAAF----GMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRIKRNTLVS 1130
+ G+ LH +VH DL N+L+ + DF L+R
Sbjct: 141 ----YHILLGLHVLHEAGVVHRDLHPGNILLADN------NDITICDFNLAREDTADANK 190
Query: 1131 GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
+ APEL+ ++ VD++S G M E+ +
Sbjct: 191 THYVTHRWYRAPELV-MQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-22
Identities = 61/231 (26%), Positives = 95/231 (41%), Gaps = 53/231 (22%)
Query: 967 EELRELGSGTYGTVY---HGKWRGSDVAIKRIKKSCFAGRSSEQER-------LTKDFWR 1016
E + E+G G YG V+ K G VA+KR++ + + R
Sbjct: 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--------VQTGEEGMPLSTI-----R 60
Query: 1017 EAHILSNLH---HPNVVAFYGVVPDGTGGTLAT---VTEFMVNGSLKHVLLKKDR---SL 1067
E +L +L HPNVV + V V E + + L L K
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT 119
Query: 1068 DRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR-- 1125
+ K ++ + G+++LHS +VH DLK +N+LV K+ DFGL+RI
Sbjct: 120 ETIKDMMFQLLR--GLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYSFQ 173
Query: 1126 ----NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
+ +V TL + APE+L S + VD++S G E+ +
Sbjct: 174 MALTSVVV------TLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRK 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-22
Identities = 83/398 (20%), Positives = 141/398 (35%), Gaps = 47/398 (11%)
Query: 834 DFLNCSDKMAEKLGFGESVSKKSNVEDVAYIQTPSIIQNKDQNKQEPLVIVGDVTGSMPS 893
+F +++ + F + V++ D + + P +I
Sbjct: 69 EFCATRPELSRCVAFLDGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLI---------- 118
Query: 894 EHQFSPEVVSH-LDATSSDEMSTNETESESIFPESLSQDSKADVRDKDESFSDAMIAEME 952
+ ++V++ E + E LS AD D +E
Sbjct: 119 -PEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLE 177
Query: 953 ASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERL 1010
+ R LG G +G V + R + A K+++K R E L
Sbjct: 178 RQPVTKN-----TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232
Query: 1011 TKDFWREAHILSNLHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS 1066
E IL ++ VV A+ T L V M G LK + ++
Sbjct: 233 N-----EKQILEKVNSRFVVSLAYAYE------TKDALCLVLTLMNGGDLKFHIYHMGQA 281
Query: 1067 L--DRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-I 1123
+ R A + G+E LH + IV+ DLK EN+L+ D I ++ D GL+ +
Sbjct: 282 GFPEARAVFYAA-EICCGLEDLHRERIVYRDLKPENILL---DDHGHI-RISDLGLAVHV 336
Query: 1124 KRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAI 1183
+ G V GT+ +MAPE++ S D ++ G ++E++ G+ P+
Sbjct: 337 PEGQTIKGRV-GTVGYMAPEVVKNERYTFS--PDWWALGCLLYEMIAGQSPFQQRKKKIK 393
Query: 1184 IGGIVKNTLR--PTIPERCDPEWRKLMEQCWAADPEAR 1219
+ + ER P+ R L Q DP R
Sbjct: 394 REEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-22
Identities = 66/258 (25%), Positives = 112/258 (43%), Gaps = 22/258 (8%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
+ ++ LG+G++G V K + S A+K + K + + E T + E IL
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEH-TLN---EKRILQ 96
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
++ P +V D + L V E++ G + L + R + + A
Sbjct: 97 AVNFPFLVKLEFSFKDNS--NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLT 153
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAP 1142
EYLHS ++++ DLK ENLL+ D Q I +V DFG + KR + + GT +AP
Sbjct: 154 FEYLHSLDLIYRDLKPENLLI---DQQGYI-QVTDFGFA--KRVKGRTWTLCGTPEALAP 207
Query: 1143 ELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201
E++ N+ VD ++ G+ ++E+ G P+ I IV +R P
Sbjct: 208 EIILSKGYNKA---VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--FPSHFS 262
Query: 1202 PEWRKLMEQCWAADPEAR 1219
+ + L+ D R
Sbjct: 263 SDLKDLLRNLLQVDLTKR 280
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-21
Identities = 76/344 (22%), Positives = 132/344 (38%), Gaps = 38/344 (11%)
Query: 890 SMPSEHQFSPEVVSHLDATSSDEMSTNETESESI--FPESLSQDSKADVRDKDESFSDAM 947
+ H FS + H+ + + I ++L D + D+
Sbjct: 117 LLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQ 176
Query: 948 IAEMEASI-YGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRS 1004
+E +I + D R +G G +G VY + + A+K + K +
Sbjct: 177 WKNVELNIHLTMN-----DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK- 230
Query: 1005 SEQERLTKDFWREAHIL---SNLHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLK 1057
+ E L + E +L S P +V AF+ T L+ + + M G L
Sbjct: 231 -QGETLALN---ERIMLSLVSTGDCPFIVCMSYAFH------TPDKLSFILDLMNGGDLH 280
Query: 1058 HVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117
+ L + + + A + G+E++H++ +V+ DLK N+L+ D + ++ D
Sbjct: 281 YHLSQHGVFSEADMRFYAA-EIILGLEHMHNRFVVYRDLKPANILL---DEHGHV-RISD 335
Query: 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177
GL+ V GT +MAPE+L D FS G ++++L G P+
Sbjct: 336 LGLACDFSKKKPHASV-GTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393
Query: 1178 MHCGAIIGGIVKNTLR--PTIPERCDPEWRKLMEQCWAADPEAR 1219
H I + TL +P+ PE R L+E D R
Sbjct: 394 -HKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 436
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-21
Identities = 72/267 (26%), Positives = 118/267 (44%), Gaps = 37/267 (13%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D + L+ LG GT+G V + + + A+K ++K + E E+ +L
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVT----ESRVLQ 60
Query: 1023 NLHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
N HP + AF T L V E+ G L L ++ + R + A +
Sbjct: 61 NTRHPFLTALKYAFQ------THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-E 113
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR---- 1134
+EYLHS+++V+ D+K ENL++ D I K+ DFGL K +S G
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLML---DKDGHI-KITDFGLC--KEG--ISDGATMKTF 165
Query: 1135 -GTLPWMAPELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192
GT ++APE+L + R VD + G+ M+E++ G P+ + + I+ +
Sbjct: 166 CGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222
Query: 1193 RPTIPERCDPEWRKLMEQCWAADPEAR 1219
R P PE + L+ DP+ R
Sbjct: 223 R--FPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 3e-21
Identities = 77/270 (28%), Positives = 125/270 (46%), Gaps = 39/270 (14%)
Query: 965 DLEELRELGSGTYGTVY---HGKWRGSDV--AIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
E LR LG G YG V+ + A+K +KK+ + + TK E +
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH-TKA---ERN 73
Query: 1020 ILSNLHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLII 1075
IL + HP +V AF TGG L + E++ G L L ++ ++ +
Sbjct: 74 ILEEVKHPFIVDLIYAFQ------TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127
Query: 1076 AMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR- 1134
A + + + +LH K I++ DLK EN+++ + Q + K+ DFGL K + + G
Sbjct: 128 A-EISMALGHLHQKGIIYRDLKPENIML---NHQGHV-KLTDFGLC--KES--IHDGTVT 178
Query: 1135 ----GTLPWMAPELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK 1189
GT+ +MAPE+L S NR VD +S G M+++LTG P+ + I I+K
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRA---VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235
Query: 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEAR 1219
L +P E R L+++ + +R
Sbjct: 236 CKLN--LPPYLTQEARDLLKKLLKRNAASR 263
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-21
Identities = 88/337 (26%), Positives = 142/337 (42%), Gaps = 41/337 (12%)
Query: 897 FSPEVVSHLDATSSDEMSTNETESESIFPESLSQDSKADVRDKDESFSDAM-IAEMEASI 955
E H++ E T ++ + + L + + A++ + S SD EME S+
Sbjct: 82 TVIERTFHVETPEEREEWTTAIQTVA---DGLKKQAAAEMDFRSGSPSDNSGAEEMEVSL 138
Query: 956 Y-GLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERLTK 1012
+ + E L+ LG GT+G V K + + A+K +KK + LT
Sbjct: 139 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT- 197
Query: 1013 DFWREAHILSNLHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLD 1068
E +L N HP + +F T L V E+ G L L ++ +
Sbjct: 198 ----ENRVLQNSRHPFLTALKYSFQ------THDRLCFVMEYANGGELFFHLSRERVFSE 247
Query: 1069 RRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT 1127
R + A + ++YLHS KN+V+ DLK ENL++ D I K+ DFGL K
Sbjct: 248 DRARFYGA-EIVSALDYLHSEKNVVYRDLKLENLML---DKDGHI-KITDFGLC--KEG- 299
Query: 1128 LVSGGVR-----GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA 1182
+ G GT ++APE+L N VD + G+ M+E++ G P+ +
Sbjct: 300 -IKDGATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 356
Query: 1183 IIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEAR 1219
+ I+ +R P PE + L+ DP+ R
Sbjct: 357 LFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 969 LRELGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
L+ +GSG G V + +VAIK++ + F + + K +RE ++ ++H
Sbjct: 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PF-----QNQTHAKRAYRELVLMKCVNH 83
Query: 1027 PNVVAFYGVV-PDGTGGTLAT---VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
N++ V P + V E M + +++ + +R L+ M G
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM--DANLCQVIQMELDHERMSYLLYQM--LCG 139
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRIKRNTLVSGGVRGTLPWM 1140
+++LHS I+H DLK N++V C K+ DFGL+R + + T +
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTRYYR 193
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
APE++ E VD++S G M E++ G
Sbjct: 194 APEVI--LGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 6e-21
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 967 EELRELGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+GSG YG+V K G VAIK++ + F + E K +RE +L ++
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PF-----QSEIFAKRAYRELLLLKHM 80
Query: 1025 HHPNVVAFYGVV-PDGTGGTLAT---VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
H NV+ V P + V FM + ++ S ++ + L+ M
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM--QTDLQKIMGLKFSEEKIQYLVYQM--L 136
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRIKRNTLVSGGVRGTLP 1138
G++Y+HS +VH DLK NL VN C K+ DFGL+R + +G V T
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNED------CELKILDFGLARHADAEM-TGYV-VTRW 188
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
+ APE++ S ++ VD++S G M E+LTG+
Sbjct: 189 YRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 8e-21
Identities = 37/282 (13%), Positives = 72/282 (25%), Gaps = 65/282 (23%)
Query: 969 LRELGSGTYGTVYHGKWRGSD------VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
L G W+ D VA+ + + LS
Sbjct: 36 LIFHGGVPPLQF----WQALDTALDRQVALTFVD-PQGVLPDDVLQE----TLSRTLRLS 86
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
+ P V VV GG + V E++ GSL+ V D S + A
Sbjct: 87 RIDKPGVARVLDVVHTRAGGLV--VAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAA 141
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAP 1142
+ H + + V++ + M
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVSIDG----DVVLAYPAT-------------------MPD 178
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN---------TLR 1193
+ + D+ G S++ +L P + + + ++ +
Sbjct: 179 ---------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADID 229
Query: 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235
IP + + + D R + T + + + A
Sbjct: 230 RDIP----FQISAVAARSVQGDGGIRSASTLLNLMQQATAVA 267
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 52/252 (20%), Positives = 89/252 (35%), Gaps = 38/252 (15%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E L+ +G G + V K + + A+K + K R F E +L
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE-----VSCFREERDVLV 116
Query: 1023 NLHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
N + AF L V E+ V G L +L K + +
Sbjct: 117 NGDRRWITQLHFAFQ------DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-------RIKRNTLVSG 1131
++ +H VH D+K +N+L+ D I ++ DFG ++ V
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILL---DRCGHI-RLADFGSCLKLRADGTVRSLVAV-- 224
Query: 1132 GVRGTLPWMAPELLNGSSNRVSEK-----VDVFSFGISMWEILTGEEPYADMHCGAIIGG 1186
GT +++PE+L D ++ G+ +E+ G+ P+ G
Sbjct: 225 ---GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK 281
Query: 1187 IVKNTLRPTIPE 1198
IV ++P
Sbjct: 282 IVHYKEHLSLPL 293
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 79/328 (24%), Positives = 141/328 (42%), Gaps = 41/328 (12%)
Query: 913 MSTNETESESIFPESLSQ-DSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLEE--- 968
M+ + E S + AD D E A++ G + V +E
Sbjct: 1 MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHA--EKVGIENFEL 58
Query: 969 LRELGSGTYGTVY-----HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
L+ LG+G YG V+ G G A+K +KK+ ++ E T+ E +L +
Sbjct: 59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH-TRT---ERQVLEH 114
Query: 1024 L-HHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
+ P +V AF T L + +++ G L L +++R + ++ + +
Sbjct: 115 IRQSPFLVTLHYAFQ------TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-E 167
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR---- 1134
+E+LH I++ D+K EN+L+ D + + DFGLS K + R
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILL---DSNGHV-VLTDFGLS--KEF-VADETERAYDF 220
Query: 1135 -GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193
GT+ +MAP+++ G + + VD +S G+ M+E+LTG P+ I + L+
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280
Query: 1194 --PTIPERCDPEWRKLMEQCWAADPEAR 1219
P P+ + L+++ DP+ R
Sbjct: 281 SEPPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 68/311 (21%), Positives = 111/311 (35%), Gaps = 75/311 (24%)
Query: 967 EELRELGSGTYGTV---YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
+ LG G YG V H G VAIK+I F ++ RE IL +
Sbjct: 14 QLKSLLGEGAYGVVCSATHKP-TGEIVAIKKI--EPF-----DKPLFALRTLREIKILKH 65
Query: 1024 LHHPNVVAFYGVVPDGTGGTLAT---VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
H N++ + + + + E M + H ++ D + I
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQYFI----- 118
Query: 1081 F----GMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSR-IKRNTLVSGGV 1133
+ ++ LH N++H DLK NLL+N C KV DFGL+R I + +
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSN------CDLKVCDFGLARIIDESAADNSEP 172
Query: 1134 RGTLPWM----------APELLNGSSNRVSEKVDVFSFGISMWEILTGE----------- 1172
G M APE++ +S + S +DV+S G + E+
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVM-LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231
Query: 1173 ---------EPYADMHCGAIIGGIVKNTLR--PTIPER--------CDPEWRKLMEQCWA 1213
P++D I + ++ P P +P+ L+++
Sbjct: 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV 291
Query: 1214 ADPEARPSFTE 1224
DP R + E
Sbjct: 292 FDPAKRITAKE 302
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 22/258 (8%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D + LR LG+G++G V+ + R + A+K +KK R + E T D E +LS
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEH-TND---ERLMLS 61
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
+ HP ++ +G D + + +++ G L +L K R + K A +
Sbjct: 62 IVTHPFIIRMWGTFQDAQ--QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLA 118
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAP 1142
+EYLHSK+I++ DLK EN+L+ D I K+ DFG + K V+ + GT ++AP
Sbjct: 119 LEYLHSKDIIYRDLKPENILL---DKNGHI-KITDFGFA--KYVPDVTYTLCGTPDYIAP 172
Query: 1143 ELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201
E+++ N+ +D +SFGI ++E+L G P+ D + I+ LR P +
Sbjct: 173 EVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--FPPFFN 227
Query: 1202 PEWRKLMEQCWAADPEAR 1219
+ + L+ + D R
Sbjct: 228 EDVKDLLSRLITRDLSQR 245
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-20
Identities = 63/317 (19%), Positives = 116/317 (36%), Gaps = 47/317 (14%)
Query: 904 HLDATSSDEMSTNETESESIFPESLSQDSKADVRDKDESFSD------AMIAEMEASIYG 957
LD + E+ L + ++++ + ++++
Sbjct: 13 ILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLH 72
Query: 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFW 1015
+ D E L+ +G G +G V K + +D A+K + K R+ T F
Sbjct: 73 RE-----DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE-----TACFR 122
Query: 1016 REAHILSNLHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK 1071
E +L N + AF L V ++ V G L +L K + L
Sbjct: 123 EERDVLVNGDSKWITTLHYAFQ------DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM 176
Query: 1072 KLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-------RIK 1124
+ ++ +H + VH D+K +N+L+ D I ++ DFG ++
Sbjct: 177 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHI-RLADFGSCLKLMEDGTVQ 232
Query: 1125 RNTLVSGGVRGTLPWMAPELLNGSSNRVSE---KVDVFSFGISMWEILTGEEPYADMHCG 1181
+ V GT +++PE+L + D +S G+ M+E+L GE P+
Sbjct: 233 SSVAV-----GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287
Query: 1182 AIIGGIVKNTLRPTIPE 1198
G I+ + R P
Sbjct: 288 ETYGKIMNHKERFQFPT 304
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 3e-20
Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 41/270 (15%)
Query: 965 DLEELRELGSGTYGTVY-----HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
E L+ LG G++G V+ G A+K +KK+ R E
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKM-----ERD 78
Query: 1020 ILSNLHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLII 1075
IL ++HP +V AF T G L + +F+ G L L K+ + K +
Sbjct: 79 ILVEVNHPFIVKLHYAFQ------TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 1076 AMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR- 1134
A + A +++LHS I++ DLK EN+L+ D + I K+ DFGLS K + + +
Sbjct: 133 A-ELALALDHLHSLGIIYRDLKPENILL---DEEGHI-KLTDFGLS--KES--IDHEKKA 183
Query: 1135 ----GTLPWMAPELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK 1189
GT+ +MAPE++N + D +SFG+ M+E+LTG P+ + I+K
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQS---ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240
Query: 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEAR 1219
L +P+ PE + L+ + +P R
Sbjct: 241 AKLG--MPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 6e-20
Identities = 72/370 (19%), Positives = 141/370 (38%), Gaps = 32/370 (8%)
Query: 862 AYIQTPSIIQNKDQNKQEPLVIVGDV----TGSMPSEHQFSPEVVSHLDATSSDEMSTNE 917
+ ++ D + +G + + + +++S + + E
Sbjct: 235 SDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPE 294
Query: 918 TESESIFPESLSQDSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTY 977
+ + +K K A + +K D L LG G++
Sbjct: 295 GSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSF 354
Query: 978 GTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS-NLHHPNVVAFYG 1034
G V + +G+D A+K +KK + E E +L+ P + +
Sbjct: 355 GKVMLSERKGTDELYAVKILKKDVVIQDD-DVECT----MVEKRVLALPGKPPFLTQLHS 409
Query: 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHF 1094
T L V E++ G L + + + R + A + A G+ +L SK I++
Sbjct: 410 CFQ--TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSKGIIYR 466
Query: 1095 DLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR-----GTLPWMAPELLNGSS 1149
DLK +N+++ D + I K+ DFG+ K N + GV GT ++APE++
Sbjct: 467 DLKLDNVML---DSEGHI-KIADFGMC--KEN--IWDGVTTKTFCGTPDYIAPEIIAYQP 518
Query: 1150 NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLME 1209
S VD ++FG+ ++E+L G+ P+ + I+++ + P+ E + +
Sbjct: 519 YGKS--VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAICK 574
Query: 1210 QCWAADPEAR 1219
P R
Sbjct: 575 GLMTKHPGKR 584
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-20
Identities = 57/249 (22%), Positives = 108/249 (43%), Gaps = 37/249 (14%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E ++ +G G +G V + + + A+K + K RS + FW E I++
Sbjct: 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD-----SAFFWEERDIMA 124
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK----KLIIAMD 1078
+ P VV + D L V E+M G L +++ D + ++++A+
Sbjct: 125 FANSPWVVQLFYAFQDDR--YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL- 181
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS-------RIKRNTLVSG 1131
+ +HS +H D+K +N+L+ D + K+ DFG ++ +T V
Sbjct: 182 -----DAIHSMGFIHRDVKPDNMLL---DKSGHL-KLADFGTCMKMNKEGMVRCDTAV-- 230
Query: 1132 GVRGTLPWMAPELL--NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK 1189
GT +++PE+L G + D +S G+ ++E+L G+ P+ I+
Sbjct: 231 ---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 287
Query: 1190 NTLRPTIPE 1198
+ T P+
Sbjct: 288 HKNSLTFPD 296
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 44/227 (19%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI---L 1021
+ R G GT+GTV GK + G VAIK++ Q+ ++ RE I L
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI----------QDPRFRN--RELQIMQDL 73
Query: 1022 SNLHHPNVVA----FYGVVPDGTGGT-LATVTEFM---VNGSLKHVLLKKDRSLDRRKKL 1073
+ LHHPN+V FY + L V E++ ++ ++ ++ K+
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 1074 IIAMDAAF----GMEYLH--SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--KR 1125
+ F + LH S N+ H D+K N+LVN K+ DFG ++
Sbjct: 134 FL-----FQLIRSIGCLHLPSVNVCHRDIKPHNVLVN---EADGTLKLCDFGSAKKLSPS 185
Query: 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
V+ + + APEL+ G+ + + VD++S G E++ GE
Sbjct: 186 EPNVAYIC--SRYYRAPELIFGNQH-YTTAVDIWSVGCIFAEMMLGE 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-19
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 967 EELRELGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ L+ +GSG G V + +VAIK++ + F + + K +RE ++ +
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PF-----QNQTHAKRAYRELVLMKCV 118
Query: 1025 HHPNVVAFYGVV-PDGTGGTLAT---VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
+H N+++ V P T V E M + +++ + +R L+ M
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYLLYQMLC- 175
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRIKRNTLVSGGVRGTLP 1138
G+++LHS I+H DLK N++V C K+ DFGL+R + + T
Sbjct: 176 -GIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
+ APE++ E VD++S G M E++ +
Sbjct: 229 YRAPEVI--LGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 40/219 (18%)
Query: 969 LRELGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
L+ +GSG YG V G+ VAIK++ + F + E K +RE +L ++ H
Sbjct: 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PF-----QSELFAKRAYRELRLLKHMRH 83
Query: 1027 PNVVAFYGVV-PDGTGGTLAT---VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF- 1081
NV+ V PD T V FM G+ L+K ++ + R + ++ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLV-----YQ 136
Query: 1082 ---GMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRIKRNTL---VSGGV 1133
G+ Y+H+ I+H DLK NL VN C K+ DFGL+R + + V
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNED------CELKILDFGLARQADSEMTGYVV--- 187
Query: 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
T + APE++ + R ++ VD++S G M E++TG+
Sbjct: 188 --TRWYRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 967 EELRELGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ L +GSG YG+V G VA+K++ + F + K +RE +L ++
Sbjct: 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PF-----QSIIHAKRTYRELRLLKHM 85
Query: 1025 HHPNVVAFYGVV-PDGTGGTLAT---VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
H NV+ V P + VT M L +++ + + D + LI +
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQI--L 142
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRIKRNTLVSGGVRGTLP 1138
G++Y+HS +I+H DLK NL VN C K+ DFGL+R + + +G V T
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNED------CELKILDFGLARHTADEM-TGYV-ATRW 194
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
+ APE++ + ++ VD++S G M E+LTG
Sbjct: 195 YRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-19
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 967 EELRELGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
L +G G YG V + VAIK+I S F E + + RE IL
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPF-----EHQTYCQRTLREIKILLRF 82
Query: 1025 HHPNVVAFYGVVPDGTGGTLAT---VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
H N++ ++ T + V + M L +L + S D + +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQI--LR 139
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRIKRNTLVSGGVR----G 1135
G++Y+HS N++H DLK NLL+N C K+ DFGL+R+ G
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTT------CDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
T + APE++ +S ++ +D++S G + E+L+
Sbjct: 194 TRWYRAPEIM-LNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 58/250 (23%), Positives = 92/250 (36%), Gaps = 55/250 (22%)
Query: 967 EELRELGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+G G+YG VY + K +VAIK++ + F E K RE IL+ L
Sbjct: 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-MF-----EDLIDCKRILREITILNRL 82
Query: 1025 HHPNVVAFYGVVPDGTGGTLAT---VTEFMVNGSLKHVLLKKDRSL-DRRKKLIIAMDAA 1080
++ Y ++ V E S L K L + K I+
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEEHIKTIL----- 135
Query: 1081 F----GMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRI----------- 1123
+ G ++H I+H DLK N L+N +D C KV DFGL+R
Sbjct: 136 YNLLLGENFIHESGIIHRDLKPANCLLN-QD-----CSVKVCDFGLARTINSEKDTNIVN 189
Query: 1124 --KRNTLVSGGVRGTLPWM----------APELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
+ N + + APEL+ N ++ +D++S G E+L
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN-YTKSIDIWSTGCIFAELLNM 248
Query: 1172 EEPYADMHCG 1181
+ + +
Sbjct: 249 LQSHINDPTN 258
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 71/267 (26%), Positives = 119/267 (44%), Gaps = 36/267 (13%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D + LG G++G V+ +++ ++ AIK +KK + E E +LS
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD-DVECT----MVEKRVLS 72
Query: 1023 -NLHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM 1077
HP + F T L V E++ G L + + + R A
Sbjct: 73 LAWEHPFLTHMFCTFQ------TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA- 125
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR--- 1134
+ G+++LHSK IV+ DLK +N+L+ D I K+ DFG+ K N + G +
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILL---DKDGHI-KIADFGMC--KEN--MLGDAKTNT 177
Query: 1135 --GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192
GT ++APE+L G S VD +SFG+ ++E+L G+ P+ + I +
Sbjct: 178 FCGTPDYIAPEILLGQKYNHS--VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 235
Query: 1193 RPTIPERCDPEWRKLMEQCWAADPEAR 1219
P + E + L+ + + +PE R
Sbjct: 236 F--YPRWLEKEAKDLLVKLFVREPEKR 260
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-18
Identities = 63/253 (24%), Positives = 88/253 (34%), Gaps = 60/253 (23%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E +G+G+YG V + VAIK+I R E K RE IL+ L
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI------LRVFEDLIDCKRILREIAILNRL 109
Query: 1025 HHPNVVAFYGVVPDGTGGTLAT---VTEFMVNGSLKHVLLKKDRSL-DRRKKLIIAMDAA 1080
+H +VV +V V E S L + L + K ++
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLL----- 162
Query: 1081 F----GMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRIKRNTLVSGGVR 1134
+ G++Y+HS I+H DLK N LVN C KV DFGL+R
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQD------CSVKVCDFGLARTVDYPENGNSQL 216
Query: 1135 GTLPWM----------------------------APELLNGSSNRVSEKVDVFSFGISMW 1166
P APEL+ +E +DV+S G
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI-LLQENYTEAIDVWSIGCIFA 275
Query: 1167 EILTGEEPYADMH 1179
E+L + H
Sbjct: 276 ELLNMIKENVAYH 288
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-18
Identities = 63/276 (22%), Positives = 118/276 (42%), Gaps = 45/276 (16%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D + LR +G G+Y V + + +D A+K +KK + + + E H+
Sbjct: 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE-DIDW-VQ---TEKHVFE 64
Query: 1023 -NLHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM 1077
+HP +V F T L V E++ G L + ++ + + + A
Sbjct: 65 QASNHPFLVGLHSCFQ------TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA- 117
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR--- 1134
+ + + YLH + I++ DLK +N+L+ D + I K+ D+G+ K + G
Sbjct: 118 EISLALNYLHERGIIYRDLKLDNVLL---DSEGHI-KLTDYGMC--KEG--LRPGDTTST 169
Query: 1135 --GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGG------ 1186
GT ++APE+L G S VD ++ G+ M+E++ G P+ +
Sbjct: 170 FCGTPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227
Query: 1187 ---IVKNTLRPTIPERCDPEWRKLMEQCWAADPEAR 1219
I++ +R IP + +++ DP+ R
Sbjct: 228 FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 261
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 48/253 (18%), Positives = 91/253 (35%), Gaps = 70/253 (27%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ LG+G++G V G A+K++ Q+ K+ RE I+ L
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVL----------QDPRYKN--RELDIMKVL 57
Query: 1025 HHPNVVA----FYGVVPDGTGGTLAT--------------------------------VT 1048
H N++ FY + +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 1049 EFM---VNGSLKHVLLKKDRSLDRRKKLIIAMDAAF----GMEYLHSKNIVHFDLKCENL 1101
E++ ++ LK + + I + + ++HS I H D+K +NL
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYI-----YQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 1102 LVNLRDPQRPICKVGDFGLSRI--KRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVF 1159
LVN + K+ DFG ++ V+ + + APEL+ G++ + +D++
Sbjct: 173 LVN---SKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATE-YTPSIDLW 226
Query: 1160 SFGISMWEILTGE 1172
S G E++ G+
Sbjct: 227 SIGCVFGELILGK 239
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-18
Identities = 65/267 (24%), Positives = 115/267 (43%), Gaps = 36/267 (13%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D L LG G++G V + +G+D A+K +KK + T E +L+
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD--DDVECTM---VEKRVLA 75
Query: 1023 -NLHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM 1077
P + F T L V E++ G L + + + R + A
Sbjct: 76 LPGKPPFLTQLHSCFQ------TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA- 128
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR--- 1134
+ A G+ +L SK I++ DLK +N+++ D + I K+ DFG+ K N + GV
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHI-KIADFGMC--KEN--IWDGVTTKT 180
Query: 1135 --GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192
GT ++APE++ S VD ++FG+ ++E+L G+ P+ + I+++ +
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKS--VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 238
Query: 1193 RPTIPERCDPEWRKLMEQCWAADPEAR 1219
P+ E + + P R
Sbjct: 239 A--YPKSMSKEAVAICKGLMTKHPGKR 263
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-18
Identities = 65/268 (24%), Positives = 113/268 (42%), Gaps = 38/268 (14%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
+ E +R LG G++G V + + + A+K +KK + E T E ILS
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD-DVEC-TM---TEKRILS 78
Query: 1023 -NLHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM 1077
+HP + F T L V EF+ G L + K R + R + A
Sbjct: 79 LARNHPFLTQLFCCFQ------TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA- 131
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR--- 1134
+ + +LH K I++ DLK +N+L+ D + K+ DFG+ K + GV
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLL---DHEGHC-KLADFGMC--KEG--ICNGVTTAT 183
Query: 1135 --GTLPWMAPELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT 1191
GT ++APE+L VD ++ G+ ++E+L G P+ + + I+ +
Sbjct: 184 FCGTPDYIAPEILQEMLYGPA---VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 240
Query: 1192 LRPTIPERCDPEWRKLMEQCWAADPEAR 1219
+ P + +++ +P R
Sbjct: 241 VV--YPTWLHEDATGILKSFMTKNPTMR 266
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-18
Identities = 62/276 (22%), Positives = 118/276 (42%), Gaps = 45/276 (16%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDV--AIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D + LR +G G+Y V + + +D A++ +KK + + + E H+
Sbjct: 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE-DIDW-VQ---TEKHVFE 107
Query: 1023 -NLHHPNVV----AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM 1077
+HP +V F T L V E++ G L + ++ + + + A
Sbjct: 108 QASNHPFLVGLHSCFQ------TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA- 160
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR--- 1134
+ + + YLH + I++ DLK +N+L+ D + I K+ D+G+ K + G
Sbjct: 161 EISLALNYLHERGIIYRDLKLDNVLL---DSEGHI-KLTDYGMC--KEG--LRPGDTTST 212
Query: 1135 --GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGG------ 1186
GT ++APE+L G S VD ++ G+ M+E++ G P+ +
Sbjct: 213 FCGTPNYIAPEILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270
Query: 1187 ---IVKNTLRPTIPERCDPEWRKLMEQCWAADPEAR 1219
I++ +R IP + +++ DP+ R
Sbjct: 271 FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 304
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 59/237 (24%), Positives = 101/237 (42%), Gaps = 53/237 (22%)
Query: 967 EELRELGSGTYGTV---YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
E +++LG G YG V + G VA+K+I F + + +RE IL+
Sbjct: 12 ELVKKLGKGAYGIVWKSIDRR-TGEVVAVKKIFD-AF-----QNSTDAQRTFREIMILTE 64
Query: 1024 LH-HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF- 1081
L H N+V V+ + V ++M + H +++ + K+ ++ +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVV-----YQ 117
Query: 1082 ---GMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC--KVGDFGLSRI------------K 1124
++YLHS ++H D+K N+L+N C KV DFGLSR
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAE------CHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 1125 RNTLVSGGVRGTLPWM----------APELLNGSSNRVSEKVDVFSFGISMWEILTG 1171
+ P + APE+L GS+ + ++ +D++S G + EIL G
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGST-KYTKGIDMWSLGCILGEILCG 227
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-17
Identities = 74/304 (24%), Positives = 132/304 (43%), Gaps = 36/304 (11%)
Query: 928 LSQDSKADVRDKDESFSDAMIAEMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRG 987
+SQ + ++ + + + A ++ K D L+ +G G++G V + +
Sbjct: 2 ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKA 61
Query: 988 SDV--AIKRIKKSCFAGRSSEQERLTKDFWREAHILS-NLHHPNVV----AFYGVVPDGT 1040
+V A+K ++K + E++ E ++L N+ HP +V +F T
Sbjct: 62 EEVFYAVKVLQKKAILKKK-EEKH-IMS---ERNVLLKNVKHPFLVGLHFSFQ------T 110
Query: 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCEN 1100
L V +++ G L + L ++ L+ R + A + A + YLHS NIV+ DLK EN
Sbjct: 111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSLNIVYRDLKPEN 169
Query: 1101 LLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR-----GTLPWMAPELLNGSSNRVSEK 1155
+L+ D Q I + DFGL K N + GT ++APE+L+ +
Sbjct: 170 ILL---DSQGHI-VLTDFGLC--KEN--IEHNSTTSTFCGTPEYLAPEVLHKQPYDRT-- 219
Query: 1156 VDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAAD 1215
VD + G ++E+L G P+ + + I+ L+ + R L+E D
Sbjct: 220 VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKD 277
Query: 1216 PEAR 1219
R
Sbjct: 278 RTKR 281
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 74.9 bits (183), Expect = 1e-13
Identities = 85/586 (14%), Positives = 155/586 (26%), Gaps = 229/586 (39%)
Query: 92 MDSESASDISDIGSTKGSLKEMENGAYGDKVSRYR---KEDADSKHGERKAFGELNGDRA 148
MD E+ E + Y D +S + ++ D K + D
Sbjct: 7 MDFETG--------------EHQYQ-YKDILSVFEDAFVDNFDCKDVQ---------DMP 42
Query: 149 AGLVSTSPPTHVI-EPSCSSNFNGPRVLGRSQSGKMKFLCSFGGKILPRPSDGKLRYVGG 207
++S H+I +G L F +L + + ++V
Sbjct: 43 KSILSKEEIDHIIMSKD---AVSGTLRL---------FWT-----LLSKQEEMVQKFVEE 85
Query: 208 ETRIISLRTNLSWEELVKKTSNICNQPHLI--KYQLPGEDLDALISVSSDDDLQNMIDEY 265
LR N + L+ QP ++ Y + D L N +
Sbjct: 86 -----VLRINYKF--LMSPIKTEQRQPSMMTRMY------------IEQRDRLYNDNQVF 126
Query: 266 C--GLERLEGSQRLRLFLIPLSESENTASLEANTIQPNSPDYEYVVAVNGMLGSSPRKSA 323
+ RL+ +LR L+ L ++N V ++G+LGS
Sbjct: 127 AKYNVSRLQPYLKLRQALLELRPAKN-------------------VLIDGVLGS------ 161
Query: 324 GGQTLGNEASRMGTILDLNP------SF-QKLAPTSVVPLEVKGGLNAFHPTQFINESSD 376
G + + + + +P +V LE+ L
Sbjct: 162 GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETV--LEM---LQKLL---------- 206
Query: 377 TTRHPNQLHGNNSSIESGSSFITAQLPPEDAGTNTANFNYPPQEPVTLTNYL--QPYKQ- 433
Q+ N +S SS I +L L L +PY+
Sbjct: 207 -----YQIDPNWTSRSDHSSNI--KLRIHSIQAE-------------LRRLLKSKPYENC 246
Query: 434 ---VDNKQPDQPHGVQFLYCNSIEDTNPSALDHNAFDF--------------DGFTCERP 476
+ N VQ N A + AF+ D +
Sbjct: 247 LLVLLN--------VQ----------NAKAWN--AFNLSCKILLTTRFKQVTDFLSAATT 286
Query: 477 VHKERIFHSEKHLSHPEEAMGFFSGSFD-----------SIDPL-LGMPHAFSDSKLQEY 524
H + H L+ P+E D + +P L + +++
Sbjct: 287 TH-ISLDHHSMTLT-PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES----IRDG 340
Query: 525 GGTSAY--------------CSVEGVSPS-------SPLIFAK-TQLPS--LPV--TNAS 558
T S+ + P+ +F +P+ L + +
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVI 400
Query: 559 PEMPMQLLE----------NVKPLDPRVPELLLDIDTTASQGNMLH 594
M ++ K +P + L++ LH
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 4e-11
Identities = 104/732 (14%), Positives = 194/732 (26%), Gaps = 253/732 (34%)
Query: 463 HNAFDFDGFTCERPVHKERIFHSEKHLSHPEEAMGFFSGSFD---------------SID 507
H+ DF+ T E + I LS E+A F +FD ID
Sbjct: 4 HHHMDFE--TGEHQYQYKDI------LSVFEDA---FVDNFDCKDVQDMPKSILSKEEID 52
Query: 508 PLLGMPHAFSDSK-----LQEYGGTSAYCSVEGV-SPSSPLIFAKTQLPSLPVTNASPEM 561
++ A S + L VE V + + + + P M
Sbjct: 53 HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIK-----TEQRQPSM 107
Query: 562 PMQLLENVKPLDPRVPELLLDIDTTASQGNMLHSPCPEFASRNGPICKVVSNINEKSQTA 621
++ Q + L++ FA N + + +
Sbjct: 108 MTRMYI--------------------EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE- 146
Query: 622 KDDVSKSSFMKPVPS------GGNSTTSKTMDQV-DERVLFLHEGGNFYA----EQLPAT 670
++P + G+ T +D +V + F+ P T
Sbjct: 147 ---------LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPET 197
Query: 671 NMEYRKNL-----PNINSNQTVASGDNTNAQDMR-FSRDMLSASTHCESSSTVVGGQKC- 723
+E + L PN S +S ++ R +L + + + C
Sbjct: 198 VLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY----------ENCL 247
Query: 724 ----NVSWTKNSDVAGPFPNTREGSGDENSLADLTSGSCNGLASQEPVHMQPVVNQTNAD 779
NV N+ F +L SC +
Sbjct: 248 LVLLNV-Q--NAKAWNAF--------------NL---SC----------------KI--- 268
Query: 780 LREAKLIVSADSSPSPVQNDAVPSSHLLKGDLDAKLQNLTADVALKREVSPLDNDFLNCS 839
L+ + + D + ++ LD LT EV L L
Sbjct: 269 -----LLTTRFKQVT----DFLSAATTTHISLDHHSMTLT-----PDEVKSL---LLKYL 311
Query: 840 DKMAEKLGFGESVSKKSNVEDVAYIQTPSIIQNKDQNKQEPLVI--VGDVTGSMPSEHQF 897
D + L P + N P + + + +
Sbjct: 312 DCRPQDL--------------------PR--EVLTTN---PRRLSIIAESIRDGLATWDN 346
Query: 898 SPEV----VSHLDATSSDEMSTNET----ESESIFPES-------LS----QDSKADVRD 938
V ++ + +S + + E + S+FP S LS K+DV
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMV 406
Query: 939 -KDESFSDAMIA----EMEASIYGLQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIK 993
++ +++ E SI + + V LE L H +
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL---------H----------R 447
Query: 994 RIKKSCFAGRSSEQERLTKD------FWREAHILSNLHHPNVVAFY-------------- 1033
I ++ + + L + H L N+ HP + +
Sbjct: 448 SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKI 507
Query: 1034 ---GVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK- 1089
+ +G L T+ + ++ D +R I+ + SK
Sbjct: 508 RHDSTAWNASGSILNTLQQL--KFYKPYI-CDNDPKYERLVNAILDFLPKIEENLICSKY 564
Query: 1090 -NIVHFDLKCEN 1100
+++ L E+
Sbjct: 565 TDLLRIALMAED 576
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 1e-10
Identities = 73/464 (15%), Positives = 136/464 (29%), Gaps = 130/464 (28%)
Query: 859 EDVAYIQTPSIIQNKDQNKQEPLVIVGDVTGSMPSEHQFSPEVVSHLDATSSDEMST--- 915
+D+ + + + N D V D+ S+ S E + H+ + T
Sbjct: 19 KDILSVFEDAFVDNFDCKD------VQDMPKSI-----LSKEEIDHIIMSKDAVSGTLRL 67
Query: 916 -------NETESESIFPESLSQD-----SKADVRDKDESFSDAMIAEMEASIY-GLQIIK 962
E + E L + S + S M E +Y Q+
Sbjct: 68 FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA 127
Query: 963 --NVDLEE--------LRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAG---RSSEQER 1009
NV + L EL + G GS K+ A S + +
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLI-DGV-LGSG-------KTWVALDVCLSYKVQC 178
Query: 1010 LTKD--FW------REAH----ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLK 1057
FW +L L + + P+ T + + + S++
Sbjct: 179 KMDFKIFWLNLKNCNSPETVLEMLQKLLYQ-------IDPNWTSRSDHSSNIKLRIHSIQ 231
Query: 1058 HVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIV-HFDLKCENLLVNLRDPQRPICKVG 1116
L + +S L++ ++ + + F+L C+ +L+ R Q V
Sbjct: 232 AELRRLLKSKPYENCLLVLLN-------VQNAKAWNAFNLSCK-ILLTTRFKQ-----VT 278
Query: 1117 DFGLSRIKRNTLVSGGVRGTL-PWMAPEL----LNGSSNRV-SEKVDVFSFGISM-WEIL 1169
DF LS + TL P L L+ + E + +S+ E +
Sbjct: 279 DF-LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI 337
Query: 1170 TGE----EPYADMHCGA---IIGGIVKNTLRPT-----------------IPERCDPEWR 1205
+ + ++C II + N L P IP
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIESSL-NVLEPAEYRKMFDRLSVFPPSAHIPT------- 389
Query: 1206 KLMEQCWAADPEARPSFTEITSRLRTISAAIESKCINSEPKQTK 1249
L+ W ++ + ++L S + +PK++
Sbjct: 390 ILLSLIWFDVIKSDVM--VVVNKLHKYS------LVEKQPKEST 425
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 3e-08
Identities = 96/624 (15%), Positives = 176/624 (28%), Gaps = 215/624 (34%)
Query: 81 EDLARILGLKRMDSESASD-ISDIGSTKGS------LKEMENGAYGDKVSRYRKEDADSK 133
E++ I+ K D+ S + + +K ++E+ Y +S + E
Sbjct: 49 EEIDHIIMSK--DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQ-P 105
Query: 134 HGERKAFGELNGDRAAGLVSTSPPTHVIEPSCSSNFN--------GPRVL--GRSQSGK- 182
+ + E DR +V VL G SGK
Sbjct: 106 SMMTRMYIEQR-DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKT 164
Query: 183 ---------MKFLCSFGGKI--LPRPSDGKLRYVGGETRIISLRTNL------SWEELVK 225
K C KI L L+ ++ + L +W
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWL------NLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218
Query: 226 KTSNICNQPHLIKYQLPGEDL-------DALISVSSDDDLQN------------------ 260
+SNI + H I+ +L L + L+ + ++QN
Sbjct: 219 HSSNIKLRIHSIQAEL--RRLLKSKPYENCLLVL---LNVQNAKAWNAFNLSCKILLTTR 273
Query: 261 -----------------MIDEYCGLERLEGSQRLRLFLIPLSESENTASLEANTIQPNSP 303
+ L E L L L E T P
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEV---KSLLLKYLDCRPQDLPREVLTTNP--- 327
Query: 304 DYEYVVAVNGMLGSSPRKSAGGQTLGNEASRMGTILDLNPSFQKLAPTSVVPLEVKGGLN 363
++ ++ S R + + +N KL ++ LN
Sbjct: 328 ---RRLS---IIAESIR---------DGLATWDNWKHVN--CDKLTTI------IESSLN 364
Query: 364 AFHPTQFINESSDTTRHPNQLHGNNSSIESGSSFITAQLPPEDAGTNTANFNYPPQ---- 419
P ++ + ++L S+ F P A + P
Sbjct: 365 VLEP-------AEYRKMFDRL-----SV-----F------PPSA-------HIPTILLSL 394
Query: 420 --------EPVTLTNYLQPYKQVDNKQPDQP----HGVQFLYCNSIEDT---NPSALDH- 463
+ + + N L Y V+ KQP + + +E+ + S +DH
Sbjct: 395 IWFDVIKSDVMVVVNKLHKYSLVE-KQPKESTISIPSIYLELKVKLENEYALHRSIVDHY 453
Query: 464 ---NAFDFDGFTCERPVHKERIFHSEKHLSH------PEEAMGFFSGSFDSIDPLLGMPH 514
FD D P + ++ F+S H+ H E M F F +D
Sbjct: 454 NIPKTFDSDDLI---PPYLDQYFYS--HIGHHLKNIEHPERMTLFRMVF--LD------F 500
Query: 515 AFSDSKLQEYGGTSAYCSVEGVSPS-SPLIFAKTQLPSLPVTNASPEMPMQLLENVKPLD 573
F + K++ +A+ + + + L F K + + P+ +L+ +
Sbjct: 501 RFLEQKIRHDS--TAWNASGSILNTLQQLKFYKPY-----ICDNDPK-YERLVNAILDFL 552
Query: 574 PRVPELLLDIDTTASQGNMLHSPC 597
P++ E N++ S
Sbjct: 553 PKIEE------------NLICSKY 564
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.1 bits (173), Expect = 5e-13
Identities = 39/244 (15%), Positives = 65/244 (26%), Gaps = 60/244 (24%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
L+ ++G G +G V+ + VAIK I + ++ ++ E I L
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKEL 80
Query: 1025 H---------HPNVVAFYGVV----------------------------PDGTGGTLATV 1047
+ V L V
Sbjct: 81 SLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIV 140
Query: 1048 TEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLR 1106
EF G + K SL K I + + H DL N+L+
Sbjct: 141 LEFEFGGIDLEQMRTKLSSLATAKS--ILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198
Query: 1107 DPQRPICKVG----------------DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSN 1150
++ + D+ LSR++R G V M +L G +
Sbjct: 199 SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER----DGIVVFCDVSMDEDLFTGDGD 254
Query: 1151 RVSE 1154
+
Sbjct: 255 YQFD 258
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-11
Identities = 48/231 (20%), Positives = 89/231 (38%), Gaps = 49/231 (21%)
Query: 969 LRELGSGTYGTVYHGKWR------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
+R+LG G + TV W + VA+K ++ + T+ E +L
Sbjct: 24 VRKLGWGHFSTV----WLAKDMVNNTHVAMKIVRG---------DKVYTEAAEDEIKLLQ 70
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMV-NGSLKHV-------------LLKKDR--- 1065
++ + G L + F + HV L+KK
Sbjct: 71 RVNDADNTKED---SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 127
Query: 1066 -SLDRRKKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQ--RPICKVGDFGLS 1121
L K+ I+ G++Y+H + I+H D+K EN+L+ + D K+ D G +
Sbjct: 128 IPLIYVKQ--ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
Query: 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
+ T + +PE+L G+ D++S ++E++TG+
Sbjct: 186 CWYDEHYTNSIQ--TREYRSPEVLLGAP--WGCGADIWSTACLIFELITGD 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 6e-10
Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 55/227 (24%)
Query: 969 LRELGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
L+ +G G++G V + VA+K ++ ++R + E IL +L
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---------EKRFHRQAAEEIRILEHLRK 152
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHV-------------LLKKDR----SLDR 1069
+ D T + + F H+ L+KK++ SL
Sbjct: 153 QD--------KDNTMNVIHMLENFTFRN---HICMTFELLSMNLYELIKKNKFQGFSLPL 201
Query: 1070 RKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT-- 1127
+K A ++ LH I+H DLK EN+L L+ R KV DFG S +
Sbjct: 202 VRK--FAHSILQCLDALHKNRIIHCDLKPENIL--LKQQGRSGIKVIDFGSSCYEHQRVY 257
Query: 1128 --LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
+ S R APE++ G+ R +D++S G + E+LTG
Sbjct: 258 TYIQSRFYR------APEVILGA--RYGMPIDMWSLGCILAELLTGY 296
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 25/164 (15%)
Query: 970 RELGSGTYGTVYHGK--WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH- 1026
R++GSG++G +Y G G +VAIK ++ +L E+ I +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLEC------VKTKHPQLH----IESKIYKMMQGG 64
Query: 1027 ---PNVVAFYGVVPDGTGGTLATVTEFMVNG-SLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
P + + G G V E + G SL+ + R + L++A
Sbjct: 65 VGIPTIR-WCGA----EGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISR 117
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN 1126
+EY+HSKN +H D+K +N L+ L + + DFGL++ R+
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRD 160
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 32/170 (18%), Positives = 55/170 (32%), Gaps = 25/170 (14%)
Query: 970 RELGSGTYGTVYHG-KWRGSDVAIKRIKKSCFAGRSSEQ--------ERLTK----DFWR 1016
+G G +G +Y V + +R K W
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 1017 EAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMV----NGSLKHVLLKKDRSLDRRKK 1072
L L P G FM+ L+ + + R+
Sbjct: 101 RTRKLKYLGVPKYWGS------GLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 1073 LIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122
L +++ +EY+H VH D+K NLL+N ++P + + D+GL+
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ--VYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 27/184 (14%), Positives = 52/184 (28%), Gaps = 43/184 (23%)
Query: 970 RELGSGTYGTVYHG----------KWRGSDVAIK--RIKKSCFAGRSSEQERLTKDFWRE 1017
G +Y + ++K F ++ Q +
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 1018 AHILSNLHHPNVVAFYG----------VVPDGTGGTLATVTEFMVNG----SLKHVLLKK 1063
L + + G +V G +L + V+ S + VL
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSA--LDVSPKHVLSERSVLQVA 165
Query: 1064 DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123
R LD +E+LH VH ++ EN+ V+ D + + +G +
Sbjct: 166 CRLLDA-------------LEFLHENEYVHGNVTAENIFVDPEDQSQ--VTLAGYGFAFR 210
Query: 1124 KRNT 1127
+
Sbjct: 211 YCPS 214
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 25/165 (15%)
Query: 970 RELGSGTYGTVYHGK--WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH- 1026
+++G G +G + GK + VAIK S +L E L
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQL----HLEYRFYKQLGSG 64
Query: 1027 ---PNVVAFYGVVPDGTGGTLATVTEFMVNG-SLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
P V ++G G A V E + G SL+ + DR+ + L+IA+
Sbjct: 65 DGIPQVY-YFGP----CGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISR 117
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRP-ICKVGDFGLSRIKRN 1126
MEY+HSKN+++ D+K EN L+ + + + DF L++ +
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 36/168 (21%), Positives = 65/168 (38%), Gaps = 31/168 (18%)
Query: 970 RELGSGTYGTVYHGK--WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH- 1026
R +G G++G ++ G VAIK R S+ +L E L
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEP------RRSDAPQLR----DEYRTYKLLAGC 65
Query: 1027 ---PNVVAFYGVVPDGTGGTLATVTEFMV----NGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
PNV ++G +V SL+ +L R + + A
Sbjct: 66 TGIPNVY-YFGQEGLHN---------VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQM 115
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRP-ICKVGDFGLSRIKRN 1126
++ +H K++V+ D+K +N L+ + + + V DFG+ + R+
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 40/175 (22%), Positives = 58/175 (33%), Gaps = 38/175 (21%)
Query: 970 RELGSGTYGTVYHGK--WRGSDVAIKRIKKSCFAGRSSEQE-----RLTK----DFWREA 1018
+++GSG +G +Y + A +K E R+ K W E
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTE---------FMVNG--SLKHVLLKKDRSL 1067
L L P G+ V E NG VL R L
Sbjct: 103 KQLDYLGIPLFY-GSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRML 161
Query: 1068 DRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122
D +EY+H VH D+K NLL+ ++P + + D+GLS
Sbjct: 162 DV-------------LEYIHENEYVHGDIKAANLLLGYKNPDQ--VYLADYGLSY 201
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 25/165 (15%)
Query: 970 RELGSGTYGTVYHGK--WRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH- 1026
R++GSG++G +Y G +VAIK ++ +L E+ I L
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLEN------VKTKHPQLL----YESKIYRILQGG 62
Query: 1027 ---PNVVAFYGVVPDGTGGTLATVTEFMVNG-SLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
PNV ++GV G V + + G SL+ + R L + L++A
Sbjct: 63 TGIPNVR-WFGV----EGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT 1127
+E++HSK+ +H D+K +N L+ + + DFGL++ R+T
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMG-LGRRANQVYIIDFGLAKKYRDT 159
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 51/229 (22%), Positives = 83/229 (36%), Gaps = 57/229 (24%)
Query: 969 LRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
+G G++G V VAIK IK ++ E +L ++
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---------KKAFLNQAQIEVRLLELMNK 109
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHV-------------LLKKDR----SLDR 1069
+ + + FM H+ LL+ SL+
Sbjct: 110 HD--------TEMKYYIVHLKRHFMFRN---HLCLVFEMLSYNLYDLLRNTNFRGVSLNL 158
Query: 1070 RKKLIIAMDAAFGMEYLHSK--NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT 1127
+K A + +L + +I+H DLK EN+L L +P+R K+ DFG S
Sbjct: 159 TRK--FAQQMCTALLFLATPELSIIHCDLKPENIL--LCNPKRSAIKIVDFGSSCQLGQR 214
Query: 1128 ----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE 1172
+ S R +PE+L G +D++S G + E+ TGE
Sbjct: 215 IYQYIQSRFYR------SPEVLLGM--PYDLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 53/270 (19%), Positives = 93/270 (34%), Gaps = 83/270 (30%)
Query: 969 LRELGSGTYGTVY--HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-- 1024
+R+LG G + TV+ VA+K + KS E T+ E +L ++
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKS--------AEHYTETALDEIRLLKSVRN 92
Query: 1025 ---HHPNVVAFYGVVP--------DGTGGT-LATVTEFMVNG-SLKHVLLK-KDRSLDRR 1070
+ PN +V G GT + V E + G L ++K + L
Sbjct: 93 SDPNDPN----REMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLP 146
Query: 1071 KKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDP--------------------- 1108
I G++YLH+K I+H D+K EN+L+++ +
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 1109 ------------------------QRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPEL 1144
++ K+ D G + T + + E+
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEV 264
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILTGEEP 1174
L GS + D++S +E+ TG+
Sbjct: 265 LIGSG--YNTPADIWSTACMAFELATGDYL 292
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 5e-04
Identities = 43/244 (17%), Positives = 79/244 (32%), Gaps = 71/244 (29%)
Query: 969 LRELGSGTYGTVY----HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ LG GT+G V H + S VA+K I+ + + E ++L +
Sbjct: 24 VGNLGEGTFGKVVECLDHAR-GKSQVALKIIRN---------VGKYREAARLEINVLKKI 73
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHV-------------LLKKDR----SL 1067
+ + + F +G H+ LK++ L
Sbjct: 74 KEKD--------KENKFLCVLMSDWFNFHG---HMCIAFELLGKNTFEFLKENNFQPYPL 122
Query: 1068 DRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVN---------------LRDPQRPI 1112
+ +A + +LH + H DLK EN+L + +
Sbjct: 123 PHVRH--MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 1113 CKVGDFGLSRIKRNT----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEI 1168
+V DFG + + + R PE++ ++ DV+S G ++E
Sbjct: 181 IRVADFGSATFDHEHHTTIVATRHYR------PPEVILEL--GWAQPCDVWSIGCILFEY 232
Query: 1169 LTGE 1172
G
Sbjct: 233 YRGF 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 9e-04
Identities = 53/243 (21%), Positives = 85/243 (34%), Gaps = 69/243 (28%)
Query: 969 LRELGSGTYGTV---YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
+ LG G +G V K G VA+K +K +R + E +L +L+
Sbjct: 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---------VDRYCEAARSEIQVLEHLN 69
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHV-------------LLKKDR----SLD 1068
+ P+ T + + F +G H+ +K++ LD
Sbjct: 70 TTD--------PNSTFRCVQMLEWFEHHG---HICIVFELLGLSTYDFIKENGFLPFRLD 118
Query: 1069 RRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVN---------------LRDPQRPIC 1113
+K +A + +LHS + H DLK EN+L R P
Sbjct: 119 HIRK--MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 1114 KVGDFGLSRIKRNT----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEIL 1169
KV DFG + + + R APE++ S+ DV+S G + E
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTRHYR------APEVILAL--GWSQPCDVWSIGCILIEYY 228
Query: 1170 TGE 1172
G
Sbjct: 229 LGF 231
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1254 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.53 | |
| 2cu1_A | 103 | Mitogen-activated protein kinase kinase kinase 2; | 99.34 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.93 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.63 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.26 | |
| 1vd2_A | 89 | Protein kinase C, IOTA type; PB1 domain, OPCA moti | 98.11 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.1 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.96 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.95 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.75 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.73 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.56 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.1 | |
| 2jrh_A | 94 | Mitogen-activated protein kinase kinase kinase 3; | 96.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.81 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.76 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.72 | |
| 2c60_A | 111 | Human mitogen-activated protein kinase kinase kina | 96.7 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.69 | |
| 2npt_B | 100 | Mitogen-activated protein kinase kinase kinase 2; | 96.68 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.36 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.29 | |
| 1q1o_A | 98 | Cell division control protein 24; PB1 domain, PCCR | 96.01 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.93 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.9 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.7 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.63 | |
| 2kkc_A | 102 | Sequestosome-1; P62, PB1, autophagy, ubiquitin-pro | 95.12 | |
| 2ktr_A | 117 | Sequestosome-1; autophagy, NF-KB signaling, HOMO-o | 94.94 | |
| 1pqs_A | 77 | Cell division control protein 24; alpha and beta p | 94.86 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 94.12 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 93.7 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.52 | |
| 1oey_A | 83 | P67-PHOX, neutrophil cytosol factor 2; immune syst | 92.42 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.32 | |
| 1wmh_B | 86 | Partitioning defective-6 homolog alpha; kinase, PB | 90.96 | |
| 2bkf_A | 87 | Zinc-finger protein NBR1 (NEXT to breast cancer 1; | 88.72 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.79 | |
| 1oey_J | 107 | P40-PHOX, neutrophil cytosol factor 4; immune syst | 87.68 | |
| 1ip9_A | 85 | BEM1 protein; ubiquitin alpha/beta roll, signaling | 87.1 | |
| 1wj6_A | 101 | KIAA0049 protein, RSGI RUH-024; PB1 domain, protei | 84.86 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=454.28 Aligned_cols=265 Identities=32% Similarity=0.552 Sum_probs=221.6
Q ss_pred cccccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 958 lq~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.|.|...+|++.++||+|+||+||+|++++ .||||+++.... .....+.|.+|+.+|++++|||||++++++.
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~------~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 102 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDP------TPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSC------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCC------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 456788899999999999999999999875 599999874321 2334578999999999999999999999986
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
++ .++||||||++|+|.+++......+++..++.|+.||+.||.|||+++||||||||+||||+ .++++||+|
T Consensus 103 ~~---~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~----~~~~~Ki~D 175 (307)
T 3omv_A 103 KD---NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH----EGLTVKIGD 175 (307)
T ss_dssp SS---SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE----TTEEEEECC
T ss_pred CC---eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC----CCCcEEEee
Confidence 43 58999999999999999987777899999999999999999999999999999999999999 788999999
Q ss_pred ccccccccC---ccccCCCCCCCCccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-
Q 040257 1118 FGLSRIKRN---TLVSGGVRGTLPWMAPELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL- 1192 (1254)
Q Consensus 1118 FGLAr~~~~---s~~sts~~GT~~YmAPEVLrG~~-~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L- 1192 (1254)
||+|+.... .......+||+.|||||++.+.. ..|+.++|||||||+||||+||+.||.+.+....+..++....
T Consensus 176 FGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~ 255 (307)
T 3omv_A 176 FGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA 255 (307)
T ss_dssp CSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC
T ss_pred ccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence 999986432 22334568999999999997643 3589999999999999999999999998776555544444332
Q ss_pred CC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1193 RP---TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1193 rp---~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
.+ ..+..+++++.+||.+||+.||++|||+.||+++|+.|.+.+
T Consensus 256 ~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 256 SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 22 345678999999999999999999999999999999886544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=451.77 Aligned_cols=259 Identities=34% Similarity=0.597 Sum_probs=219.8
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeE
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVA 1031 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVk 1031 (1254)
..+...+|.+.++||+|+||+||+|+++ ++.||||+++.. .....++|.+|+++|++|+|||||+
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--------~~~~~~~f~~E~~il~~l~HpnIV~ 107 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--------SESARQDFQREAELLTMLQHQHIVR 107 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--------SHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--------CHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 4566678999999999999999999874 567999999743 2334578999999999999999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccC--------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCC
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD--------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLK 1097 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre--------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLK 1097 (1254)
++++|.+.. .++||||||++|+|.+++.+.. .++++..++.|+.||+.||.|||+++|||||||
T Consensus 108 l~g~~~~~~--~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK 185 (329)
T 4aoj_A 108 FFGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLA 185 (329)
T ss_dssp EEEEECSSS--SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred EEEEEEECC--EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccccc
Confidence 999998765 7999999999999999986532 358999999999999999999999999999999
Q ss_pred CCceEeccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCC
Q 040257 1098 CENLLVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEE 1173 (1254)
Q Consensus 1098 PeNILLDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~ 1173 (1254)
|+||||+ .++++||+|||+++..... ......+||+.|||||++.+.. |+.++|||||||+||||+| |+.
T Consensus 186 p~NILl~----~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~--~~~~sDvwS~Gvvl~Ellt~G~~ 259 (329)
T 4aoj_A 186 TRNCLVG----QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQ 259 (329)
T ss_dssp GGGEEEE----TTTEEEECCCC----------------CCCCGGGCCHHHHTTCC--CCHHHHHHHHHHHHHHHHTTSCC
T ss_pred HhhEEEC----CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCC--CCccccccchHHHHHHHHcCCCC
Confidence 9999999 7899999999999854332 2234567999999999999764 8999999999999999999 999
Q ss_pred CCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1174 PYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1174 PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
||......+.+..+..+ .++..|..+++++.+||.+||+.||++|||+.||+++|+.+.+
T Consensus 260 Pf~~~~~~~~~~~i~~g-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 260 PWYQLSNTEAIDCITQG-RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp TTCSSCHHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHcC-CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 99998888887777654 4566788899999999999999999999999999999998865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=449.78 Aligned_cols=260 Identities=35% Similarity=0.604 Sum_probs=224.7
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeE
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVA 1031 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVk 1031 (1254)
+.|+..+|.+.++||+|+||+||+|++. +..||||+++.. .....++|.+|+++|++|+|||||+
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--------~~~~~~~f~~E~~il~~l~HpnIV~ 79 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--------SDNARKDFHREAELLTNLQHEHIVK 79 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--------CHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--------ChHHHHHHHHHHHHHHhCCCCCCcc
Confidence 4677789999999999999999999874 567999999743 2234578999999999999999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhcc------------CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCC
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK------------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCE 1099 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kr------------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPe 1099 (1254)
++++|.++. .+++|||||++|+|.+++.+. ...+++..++.|+.||+.||.|||+++||||||||+
T Consensus 80 l~g~~~~~~--~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~ 157 (299)
T 4asz_A 80 FYGVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATR 157 (299)
T ss_dssp EEEEECSSS--SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEEeeCC--EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHh
Confidence 999998765 799999999999999999653 246999999999999999999999999999999999
Q ss_pred ceEeccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 040257 1100 NLLVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPY 1175 (1254)
Q Consensus 1100 NILLDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF 1175 (1254)
||||+ .++++||+|||+|+..... .......||+.|||||++.+. .|+.++|||||||+||||+| |+.||
T Consensus 158 NILl~----~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf 231 (299)
T 4asz_A 158 NCLVG----ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPW 231 (299)
T ss_dssp GEEEC----GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred hEEEC----CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99998 7789999999999854332 223345689999999999876 48999999999999999999 99999
Q ss_pred CCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1176 ADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1176 ~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
.+....+++..+..+. .+..|..+++++.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 232 ~~~~~~~~~~~i~~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 232 YQLSNNEVIECITQGR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp TTSCHHHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 9998888888777654 4567888999999999999999999999999999999987653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=459.34 Aligned_cols=250 Identities=21% Similarity=0.415 Sum_probs=215.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
++|+++++||+|+||+||+|+++ ++.||||++.+... .....+.+.+|+.+|++|+|||||+++++|.++.
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~- 96 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM------SSKEREESRREVAVLANMKHPNIVQYRESFEENG- 96 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC------CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC-
Confidence 47999999999999999999984 78899999986532 1233578899999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+|||||||.||+|.++|..+ ...+++..++.|+.||+.||.|||++|||||||||+||||+ .++++||+|||+
T Consensus 97 -~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~vKl~DFGl 171 (350)
T 4b9d_A 97 -SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT----KDGTVQLGDFGI 171 (350)
T ss_dssp -EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC----TTCCEEECSTTE
T ss_pred -EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC----CCCCEEEccccc
Confidence 899999999999999999654 34579999999999999999999999999999999999998 788999999999
Q ss_pred cccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1121 SRIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1121 Ar~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
|+..... ......+||+.|||||++.+.. |+.++|||||||+||||++|+.||.+.+..+.+..+....+. ..+..
T Consensus 172 a~~~~~~~~~~~~~~GT~~YmAPE~l~~~~--y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~ 248 (350)
T 4b9d_A 172 ARVLNSTVELARACIGTPYYLSPEICENKP--YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLH 248 (350)
T ss_dssp ESCCCHHHHHHHHHHSCCTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTT
T ss_pred ceeecCCcccccccCCCccccCHHHHCCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCcc
Confidence 9866443 2234567999999999999864 899999999999999999999999999888888888877653 46677
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++++++||.+||++||++|||+.|++++
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 249 YSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=454.52 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=218.7
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|++.++||+|+||+||+|+++ ++.||||+++...+ ..+|+.+|++|+|||||+++++|.++.
T Consensus 59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------------~~~E~~il~~l~HpnIV~l~~~~~~~~-- 123 (336)
T 4g3f_A 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------------RVEELVACAGLSSPRIVPLYGAVREGP-- 123 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------------CTHHHHTTTTCCCTTBCCEEEEEEETT--
T ss_pred heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------------HHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 5888999999999999999985 77899999986432 136999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCC-eEEEEecccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRP-ICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG-~VKLiDFGLA 1121 (1254)
.+|||||||.||+|.+++.+. +.+++..++.|+.||+.||.|||+++||||||||+||||+ .++ ++||+|||+|
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~~vKl~DFGla 198 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS----SDGSRAALCDFGHA 198 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC----TTSCCEEECCCTTC
T ss_pred EEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe----CCCCEEEEeeCCCC
Confidence 899999999999999999654 5699999999999999999999999999999999999998 555 6999999999
Q ss_pred ccccCcc------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC-C
Q 040257 1122 RIKRNTL------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR-P 1194 (1254)
Q Consensus 1122 r~~~~s~------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr-p 1194 (1254)
+...... ....++||+.|||||++.+.. |+.++|||||||+||||++|+.||.+.....++..+...... .
T Consensus 199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~ 276 (336)
T 4g3f_A 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP--CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR 276 (336)
T ss_dssp EEC------------CCCCCCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG
T ss_pred eEccCCCcccceecCCccccCccccCHHHHCCCC--CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch
Confidence 8654321 233468999999999999874 889999999999999999999999987777777766665432 2
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKC 1240 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk~ 1240 (1254)
.++..+++++++||.+||++||.+|||+.||+++|...+.++..-.
T Consensus 277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~ 322 (336)
T 4g3f_A 277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLK 322 (336)
T ss_dssp GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSC
T ss_pred hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhcc
Confidence 4677899999999999999999999999999999999988766533
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=445.35 Aligned_cols=259 Identities=32% Similarity=0.556 Sum_probs=222.2
Q ss_pred cccccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCcee
Q 040257 958 LQIIKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVV 1030 (1254)
Q Consensus 958 lq~Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIV 1030 (1254)
+..+...+++++++||+|+||+||+|++. ++.||||+++... .....++|.+|+.+|++|+|||||
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-------~~~~~~~f~~E~~il~~l~HpNIV 92 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-------EGPLREEFRHEAMLRARLQHPNVV 92 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-------CC-CHHHHHHHHHHHHHCCCTTBC
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-------ChHHHHHHHHHHHHHHhCCCCCCC
Confidence 34566678899999999999999999973 4679999987532 112346799999999999999999
Q ss_pred EEeeeeecCCCCceEEEEEecccCchhhhhhcc---------------CCCCCHHHHHHHHHHhhhhhHHhhhCCccccc
Q 040257 1031 AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK---------------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFD 1095 (1254)
Q Consensus 1031 kLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kr---------------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRD 1095 (1254)
+++|+|.++. .+++|||||++|+|.++|..+ ...+++..++.|+.||+.||.|||+++|||||
T Consensus 93 ~l~g~~~~~~--~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRD 170 (308)
T 4gt4_A 93 CLLGVVTKDQ--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKD 170 (308)
T ss_dssp CEEEEECSSS--SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred CcceEEEECC--EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999998655 789999999999999999643 23589999999999999999999999999999
Q ss_pred CCCCceEeccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-C
Q 040257 1096 LKCENLLVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-G 1171 (1254)
Q Consensus 1096 LKPeNILLDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-G 1171 (1254)
|||+||||+ .++++||+|||+++..... ......+||+.|||||++.+. .|+.++|||||||+||||+| |
T Consensus 171 LK~~NILl~----~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~El~t~g 244 (308)
T 4gt4_A 171 LATRNVLVY----DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYG 244 (308)
T ss_dssp CSGGGEEEC----GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTT
T ss_pred ccccceEEC----CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC--CCCccchhhhHHHHHHHHHhCC
Confidence 999999999 7889999999999854322 234456799999999999866 48999999999999999999 8
Q ss_pred CCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1172 EEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1172 k~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
+.||.+....+++..+..+. .+..+..+++++.+|+.+||+.||++|||+.||+++|+.+
T Consensus 245 ~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 245 LQPYCGYSNQDVVEMIRNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp CCTTTTCCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHcCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99999998888877776554 4567888999999999999999999999999999999753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=452.60 Aligned_cols=250 Identities=27% Similarity=0.409 Sum_probs=220.3
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|+++++||+|+||+||+|+++ ++.||||++.+..+. .....+.+.+|+++|++|+|||||+++++|.++.
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-----KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC-----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 347999999999999999999984 778999999864321 1223467889999999999999999999998765
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+|||||||.||+|.+++.+. +.+++..++.|+.||+.||.|||++|||||||||+||||+ .++++||+|||+
T Consensus 106 --~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~----~~g~vKl~DFGl 178 (311)
T 4aw0_A 106 --KLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGT 178 (311)
T ss_dssp --EEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCCTT
T ss_pred --EEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc----CCCCEEEEEcCC
Confidence 899999999999999999654 5699999999999999999999999999999999999998 788999999999
Q ss_pred cccccC---ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1121 SRIKRN---TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1121 Ar~~~~---s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
|+.... .....+++||+.|||||++.+.. |+.++|||||||+||||++|+.||.+.+..+++..+....+ .++
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~--y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--~~p 254 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY--DFP 254 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSC--BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCC
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCC
Confidence 986532 23345678999999999999765 79999999999999999999999999888888888887654 467
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+++++++||.+||++||++|||++|++.+
T Consensus 255 ~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 255 EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred cccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 7899999999999999999999999997654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=439.52 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=203.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|+++ ++.||||++.+.... ......++.+|+.+|++++|||||++++++.+++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~- 86 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-----KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD- 86 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-----CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-
Confidence 37999999999999999999984 788999999865332 2233567889999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+|+||||+ +|+|.+++.++ +.+++..++.++.||+.||+|||++|||||||||+||||+ .++++||+|||+|
T Consensus 87 -~~~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~----~~~~vkl~DFGla 159 (275)
T 3hyh_A 87 -EIIMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD----EHLNVKIADFGLS 159 (275)
T ss_dssp -EEEEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC----TTCCEEECCSSCC
T ss_pred -EEEEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC----CCCCEEEeecCCC
Confidence 899999999 78999988654 5699999999999999999999999999999999999998 7889999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
+...........+||+.|||||++.+..+ ++.++|||||||+||+|++|+.||.+.+.......+..... .++..++
T Consensus 160 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~y-~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~--~~p~~~s 236 (275)
T 3hyh_A 160 NIMTDGNFLKTSCGSPNYAAPEVISGKLY-AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY--TLPKFLS 236 (275)
T ss_dssp ---------------CTTSCHHHHSSSSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCTTSC
T ss_pred eecCCCCccCCeeECcccCChhhhcCCCC-CCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--CCCCCCC
Confidence 87665555566889999999999997752 46899999999999999999999999888888877776543 4677899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++++||.+||++||++|||+.|++++
T Consensus 237 ~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 237 PGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 999999999999999999999999985
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=452.68 Aligned_cols=247 Identities=24% Similarity=0.416 Sum_probs=215.3
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
..|+++++||+|+||+||+|+++ ++.||||++...... ..+.+.+|+.+|++++|||||+++++|.+++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--------~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~- 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--------RRELLFNEVVIMRDYQHENVVEMYNSYLVGD- 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--------SGGGGHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--------HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 46999999999999999999994 778999999754321 1245788999999999999999999998766
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+|||||||.+|+|.+++.+ ..+++..++.|+.||+.||+|||++|||||||||+||||+ .++++||+|||+|
T Consensus 145 -~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~vKl~DFGla 217 (346)
T 4fih_A 145 -ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFC 217 (346)
T ss_dssp -EEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred -EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC----CCCCEEEecCcCc
Confidence 89999999999999998854 4699999999999999999999999999999999999998 7889999999999
Q ss_pred ccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-CCCCCCC
Q 040257 1122 RIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL-RPTIPER 1199 (1254)
Q Consensus 1122 r~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L-rp~ipe~ 1199 (1254)
+.... .......+||+.|||||++.+.. |+.++|||||||+||||++|+.||.+.+..+.+..+..... ....+..
T Consensus 218 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~--y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 295 (346)
T 4fih_A 218 AQVSKEVPRRKSLVGTPYWMAPELISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK 295 (346)
T ss_dssp EECCSSSCCBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGG
T ss_pred eecCCCCCcccccccCcCcCCHHHHCCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCcccc
Confidence 86543 33456688999999999998764 79999999999999999999999999888777777665432 2233456
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++++++||.+||++||++|||+.|++++
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 89999999999999999999999999885
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=446.83 Aligned_cols=263 Identities=30% Similarity=0.515 Sum_probs=225.2
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEECC-------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCC-Ccee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH-PNVV 1030 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnH-PNIV 1030 (1254)
++|...+|++++.||+|+||+||+|++.+ +.||||+++... .....+.|.+|+.+|++++| ||||
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-------~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-------ChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 35677899999999999999999999853 469999987542 12235678999999999965 8999
Q ss_pred EEeeeeecCCCCceEEEEEecccCchhhhhhcc---------------CCCCCHHHHHHHHHHhhhhhHHhhhCCccccc
Q 040257 1031 AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK---------------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFD 1095 (1254)
Q Consensus 1031 kLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kr---------------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRD 1095 (1254)
+++++|.+.. ..+++|||||.+|+|.++|.+. ...+++..++.|+.||+.||.|||+++|||||
T Consensus 132 ~l~g~~~~~~-~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRD 210 (353)
T 4ase_A 132 NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 210 (353)
T ss_dssp CEEEEECCTT-SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEEEEecC-CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCc
Confidence 9999986543 3689999999999999999653 23489999999999999999999999999999
Q ss_pred CCCCceEeccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-C
Q 040257 1096 LKCENLLVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-G 1171 (1254)
Q Consensus 1096 LKPeNILLDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-G 1171 (1254)
|||+||||+ .++++||+|||+|+..... ......+||+.|||||++.+. .|+.++|||||||+||||+| |
T Consensus 211 LK~~NILl~----~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G 284 (353)
T 4ase_A 211 LAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLG 284 (353)
T ss_dssp CSGGGEEEC----GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTS
T ss_pred cCccceeeC----CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCC
Confidence 999999998 7789999999999864332 233456799999999999876 48999999999999999998 9
Q ss_pred CCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1172 EEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1172 k~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
+.||.+....+.+...+....++..|..+++++.+||.+||+.||++|||+.||+++|+.++++
T Consensus 285 ~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 285 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 9999987766666666666667788889999999999999999999999999999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=435.13 Aligned_cols=250 Identities=28% Similarity=0.494 Sum_probs=209.8
Q ss_pred Cc-eEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC--
Q 040257 965 DL-EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG-- 1039 (1254)
Q Consensus 965 dY-eiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd-- 1039 (1254)
+| ++.++||+|+||+||+|.++ +..||||++..... .....++|.+|+.+|++|+|||||+++++|.+.
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL------TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence 44 67778999999999999985 66799999976532 123357799999999999999999999998652
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCC--cccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKN--IVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkG--IIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
....++||||||.+|+|.+++.+. +.+++..++.|+.||+.||.|||+++ ||||||||+||||+. .++.+||+|
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~---~~g~vKl~D 175 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGD 175 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS---TTSCEEECC
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC---CCCCEEEEe
Confidence 234689999999999999999654 57999999999999999999999998 999999999999971 367999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-hHHHHhhhccCCCCC
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG-AIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~-eliqsIlk~~Lrp~i 1196 (1254)
||+|+..... .....+||+.|||||++.+. |+.++|||||||+||||+||+.||.+.... .+...+.....+...
T Consensus 176 FGla~~~~~~-~~~~~~GTp~YmAPE~~~~~---y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~ 251 (290)
T 3fpq_A 176 LGLATLKRAS-FAKAVIGTPEFMAPEMYEEK---YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 251 (290)
T ss_dssp TTGGGGCCTT-SBEESCSSCCCCCGGGGGTC---CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred CcCCEeCCCC-ccCCcccCccccCHHHcCCC---CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCC
Confidence 9999865443 34457899999999999753 899999999999999999999999875544 444444444444455
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+..+++++++||.+||++||++|||+.|+++|
T Consensus 252 ~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 66788999999999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=457.93 Aligned_cols=247 Identities=24% Similarity=0.416 Sum_probs=215.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
..|+++++||+|+||+||+|+++ ++.||||++...... ..+.+.+|+.+|++|+|||||+++++|.+..
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--------~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~- 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--------RRELLFNEVVIMRDYQHENVVEMYNSYLVGD- 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--------SGGGHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--------HHHHHHHHHHHHHhCCCCCCCceEEEEEECC-
Confidence 46999999999999999999995 788999999754211 1245789999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+|||||||.||+|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+||||+ .+++|||+|||+|
T Consensus 222 -~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~----~~g~vKl~DFGla 294 (423)
T 4fie_A 222 -ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFC 294 (423)
T ss_dssp -EEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC----TTCCEEECCCTTC
T ss_pred -EEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc----CCCCEEEecCccc
Confidence 89999999999999998854 4699999999999999999999999999999999999998 7889999999999
Q ss_pred ccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-CCCCCCC
Q 040257 1122 RIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL-RPTIPER 1199 (1254)
Q Consensus 1122 r~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L-rp~ipe~ 1199 (1254)
+.... .......+||+.|||||++.+.. |+.++|||||||+||||++|+.||.+.+..+.+..+..... ....+..
T Consensus 295 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~--y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 372 (423)
T 4fie_A 295 AQVSKEVPRRKSLVGTPYWMAPELISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK 372 (423)
T ss_dssp EECCSSCCCBCCCEECTTTCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTS
T ss_pred eECCCCCccccccccCcCcCCHHHHCCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCccccc
Confidence 86543 33455678999999999998764 79999999999999999999999999888887777765432 2234567
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++++++||.+||++||++|||+.|+|+|
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 89999999999999999999999999885
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=442.38 Aligned_cols=251 Identities=28% Similarity=0.402 Sum_probs=211.5
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEE-----CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKW-----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGV 1035 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~-----rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGv 1035 (1254)
+...+|++++.||+|+||+||+|++ .++.||||++++....... ..++.+|+.+|++++|||||+++++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~~~ 94 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD------RVRTKMERDILVEVNHPFIVKLHYA 94 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE------CC------CCCCCCCCTTEECEEEE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH------HHHHHHHHHHHHHCCCCCCCeEEEE
Confidence 4456899999999999999999987 2567999999865332111 2357789999999999999999999
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
|.++. .+|+|||||.||+|.+++.+. +.+++..++.|+.||+.||.|||++|||||||||+|||++ .++++||
T Consensus 95 ~~~~~--~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~vKl 167 (304)
T 3ubd_A 95 FQTEG--KLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD----EEGHIKL 167 (304)
T ss_dssp EEETT--EEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC----TTSCEEE
T ss_pred EEECC--EEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc----CCCCEEe
Confidence 98765 899999999999999999654 5799999999999999999999999999999999999998 7889999
Q ss_pred Eecccccccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC
Q 040257 1116 GDFGLSRIKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1116 iDFGLAr~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
+|||+|+... ........+||+.|||||++.+.. |+.++|||||||+||||+||+.||.+.+..+.+..+....+
T Consensus 168 ~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-- 243 (304)
T 3ubd_A 168 TDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG--HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-- 243 (304)
T ss_dssp ESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--
T ss_pred cccccceeccCCCccccccccCcccCCHHHhccCC--CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC--
Confidence 9999998543 333445678999999999998774 88999999999999999999999999988888888877654
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPS-----FTEITSR 1228 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPS-----ArELLe~ 1228 (1254)
.++..+++++++||.+||++||++||| ++|+++|
T Consensus 244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 467789999999999999999999998 4677764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=417.98 Aligned_cols=255 Identities=28% Similarity=0.451 Sum_probs=203.7
Q ss_pred CceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC--C
Q 040257 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG--G 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~--~ 1042 (1254)
+|.+.++||+|+||+||+|+++++.||||+++... .. ...+..|+..+.+++|||||++++++.++.. .
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~-------~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-------ER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG-------HH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-------hh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 67888999999999999999999999999986431 11 1223456777788999999999999976543 3
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC--------CcccccCCCCceEeccCCCCCCeEE
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK--------NIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk--------GIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
.++||||||++|+|.+++.. ..+++..++.++.|++.||.|||++ +||||||||+||||+ .++++|
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~----~~~~~K 148 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTCC 148 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC----TTSCEE
T ss_pred EEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC----CCCCEE
Confidence 58999999999999999964 3689999999999999999999987 999999999999998 788999
Q ss_pred EEeccccccccCcc-----ccCCCCCCCCccCcccccCCCC----CCCchhHHHHHHHHHHHHHcCCCCCCCC-------
Q 040257 1115 VGDFGLSRIKRNTL-----VSGGVRGTLPWMAPELLNGSSN----RVSEKVDVFSFGISMWEILTGEEPYADM------- 1178 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~-----~sts~~GT~~YmAPEVLrG~~~----kyS~KSDIWSLGVILYELLTGk~PF~~~------- 1178 (1254)
|+|||+|+...... .....+||+.|||||++.+..+ .|+.++|||||||+||||+||+.||...
T Consensus 149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~ 228 (303)
T 3hmm_A 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence 99999998654322 2234579999999999986421 3678999999999999999998766422
Q ss_pred --------ChhhHHHHhhhccCCCCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1179 --------HCGAIIGGIVKNTLRPTIPER-----CDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1179 --------n~~eliqsIlk~~Lrp~ipe~-----iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
........+....+++.++.. ++..+.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 112334444555566666543 23578899999999999999999999999998864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=419.96 Aligned_cols=247 Identities=28% Similarity=0.441 Sum_probs=190.3
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC-
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG- 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~- 1041 (1254)
+|++++.||+|+||+||+|+++ ++.||||+++... .....+.+.+|+.+|++|+|||||+++++|.+.+.
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-------RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence 6999999999999999999985 7889999997542 23345678999999999999999999999875432
Q ss_pred ---------CceEEEEEecccCchhhhhhccCC--CCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCC
Q 040257 1042 ---------GTLATVTEFMVNGSLKHVLLKKDR--SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQR 1110 (1254)
Q Consensus 1042 ---------~~L~LVMEYm~GGSL~d~L~kre~--~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~sn 1110 (1254)
..+|+|||||.+|+|.+++..+.. ...+..++.|+.||+.||+|||++|||||||||+||||+ .+
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~----~~ 154 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT----MD 154 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TT
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC----CC
Confidence 247999999999999999965432 345677889999999999999999999999999999998 77
Q ss_pred CeEEEEeccccccccCcc-------------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 040257 1111 PICKVGDFGLSRIKRNTL-------------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177 (1254)
Q Consensus 1111 G~VKLiDFGLAr~~~~s~-------------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~ 1177 (1254)
+++||+|||+|+...... ...+.+||+.|||||++.+.. |+.++|||||||+||||++ ||..
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS--YSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCC--CCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC--CCCHHHHHHHHHHHHHHcc---CCCC
Confidence 899999999998654321 123457999999999999764 8999999999999999996 7765
Q ss_pred CChh-hHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1178 MHCG-AIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1178 ~n~~-eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.... ..+..+..... +......++.+.+||.+||++||.+|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 230 QMERVRTLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHHHHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccHHHHHHHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3221 22222222222 11222345677899999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=428.41 Aligned_cols=252 Identities=25% Similarity=0.332 Sum_probs=210.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC--
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG-- 1039 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd-- 1039 (1254)
.+|++++.||+|+||+||+|+++ ++.||||++++... .....+++.+|+.+|++|+|||||++++++...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD------VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc------chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 47999999999999999999984 78899999975421 223356788999999999999999999998643
Q ss_pred --CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1040 --TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1040 --n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
....+|||||||. |+|.+++.+ .+.+++..++.|+.||+.||.|||++|||||||||+|||++ .++.+||+|
T Consensus 128 ~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~----~~~~~Ki~D 201 (398)
T 4b99_A 128 YGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN----ENCELKIGD 201 (398)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTCCEEECC
T ss_pred cccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC----CCCCEEEee
Confidence 3357999999995 679888854 46799999999999999999999999999999999999998 788999999
Q ss_pred ccccccccC-----ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC
Q 040257 1118 FGLSRIKRN-----TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1118 FGLAr~~~~-----s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L 1192 (1254)
||+|+.... .......+||+.|||||++.+.. .|+.++|||||||+||||++|++||.+.+..+.+..+.....
T Consensus 202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~-~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g 280 (398)
T 4b99_A 202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH-EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280 (398)
T ss_dssp CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCS-CCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred cceeeecccCccccccccccceeChHhcCHHHhcCCC-CCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 999985432 22345678999999999998754 479999999999999999999999998887777666653322
Q ss_pred CCC----------------------C-------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 RPT----------------------I-------PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 rp~----------------------i-------pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+. . ...+++++.+||.+||++||.+|||+.|+|+|
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111 0 12468899999999999999999999999985
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=439.25 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=220.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||+|+++ ++.||||++.+.. ....+.+.+|+.+|+.|+|||||+++++|.+..
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 227 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-- 227 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS--
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--------hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--
Confidence 7999999999999999999984 7789999997542 223466889999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.++||||||.||+|.+++..+...+++..++.|+.||+.||.|||+++|+||||||+|||++.+ ..+.+||+|||+|+
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~--~~~~vKl~DFG~a~ 305 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--RSNELKLIDFGLTA 305 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECCCSSCE
T ss_pred EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC--CCCCEEEeecccee
Confidence 8999999999999999997776789999999999999999999999999999999999999732 34789999999999
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC--CCCCCC
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP--TIPERC 1200 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp--~ipe~i 1200 (1254)
...........+||+.|||||++.+.. |+.++|||||||+||||++|+.||.+.+..+.+..+....+.. .....+
T Consensus 306 ~~~~~~~~~~~~GT~~y~APEv~~~~~--y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 383 (573)
T 3uto_A 306 HLDPKQSVKVTTGTAEFAAPEVAEGKP--VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 383 (573)
T ss_dssp ECCTTSEEEEECSSGGGCCHHHHTTCC--BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTS
T ss_pred EccCCCceeeeEECccccCHHHhCCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCC
Confidence 776655556678999999999999875 7999999999999999999999999998888888887665433 233568
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++++++||.+||++||.+|||+.|+|+|
T Consensus 384 s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 384 SEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999999984
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=408.79 Aligned_cols=245 Identities=19% Similarity=0.240 Sum_probs=196.3
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC-----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeee
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR-----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVP 1037 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r-----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~ 1037 (1254)
.+|+++++||+|+||+||+|+++ ++.||||++.+.. ...++.+|+++|+.+ +||||++++++|.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----------HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----------CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----------CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 47999999999999999999873 4579999986531 124577899999988 6999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.+ .+|+||||+.+|+|.+++ +.+++..++.++.||+.||+|||++|||||||||+|||++. ..+.+||+|
T Consensus 91 ~~~--~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~---~~~~~kl~D 161 (361)
T 4f9c_A 91 KND--HVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR---RLKKYALVD 161 (361)
T ss_dssp ETT--EEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET---TTTEEEECC
T ss_pred ECC--EEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC---CCCeEEECc
Confidence 765 899999999999999988 35899999999999999999999999999999999999982 337999999
Q ss_pred ccccccccCcc-----------------------------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHH
Q 040257 1118 FGLSRIKRNTL-----------------------------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEI 1168 (1254)
Q Consensus 1118 FGLAr~~~~s~-----------------------------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYEL 1168 (1254)
||+|+...... .....+||+.|+|||++.+.. .|+.++||||+||+||||
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~y~~~~DiWSlG~il~el 240 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP-NQTTAIDMWSAGVIFLSL 240 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS-CCCTHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCCccchhhhHHHHHHH
Confidence 99997533211 123457999999999998754 478999999999999999
Q ss_pred HcCCCCCCCCC-hhhHHHHhhhc----------------------------------------------------cCCCC
Q 040257 1169 LTGEEPYADMH-CGAIIGGIVKN----------------------------------------------------TLRPT 1195 (1254)
Q Consensus 1169 LTGk~PF~~~n-~~eliqsIlk~----------------------------------------------------~Lrp~ 1195 (1254)
++|+.||.... ....+..+... .....
T Consensus 241 l~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 320 (361)
T 4f9c_A 241 LSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLE 320 (361)
T ss_dssp HHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------------
T ss_pred HHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccc
Confidence 99999996433 22222221100 00001
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
....+++++++||++||++||++|+|++|+|+|
T Consensus 321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 123578899999999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=383.68 Aligned_cols=264 Identities=39% Similarity=0.700 Sum_probs=219.1
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
.+...+|++.+.||+|+||+||+|+++++.||||++..... .....+.+.+|+.+|++++||||+++++++.+.
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF------HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC------SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 45566899999999999999999999999999999975432 223356788999999999999999999999765
Q ss_pred CCCceEEEEEecccCchhhhhhccCC--CCCHHHHHHHHHHhhhhhHHhhhCC--cccccCCCCceEeccCCCCCCeEEE
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDR--SLDRRKKLIIAMDAAFGMEYLHSKN--IVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~--~LSe~~~lkIa~QIAeALaYLHSkG--IIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
. .+++||||+.+++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||
T Consensus 107 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~----~~~~~kL 180 (309)
T 3p86_A 107 P--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD----KKYTVKV 180 (309)
T ss_dssp T--CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC----TTCCEEE
T ss_pred C--ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe----CCCcEEE
Confidence 5 78999999999999999965432 3899999999999999999999999 99999999999998 7789999
Q ss_pred EeccccccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC
Q 040257 1116 GDFGLSRIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1116 iDFGLAr~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.......
T Consensus 181 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 258 (309)
T 3p86_A 181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP--SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258 (309)
T ss_dssp CCCC-----------------CCTTSCHHHHTTCC--CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC
T ss_pred CCCCCCccccccccccccCCCCccccChhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9999997544332 234467999999999998764 7889999999999999999999999988877777766566666
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLE 1237 (1254)
..+..+++++.+||.+||+.||.+|||+.++++.|+.++....
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 7788899999999999999999999999999999999876543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=434.24 Aligned_cols=255 Identities=23% Similarity=0.327 Sum_probs=211.1
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+.-.+|+++++||+|+||+||+|+++ ++.||||++.+..+.... .........+++.+++.++|||||+++++|.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~--~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhh--hHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 44568999999999999999999984 778999999865432211 11222333455778888999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. .+|||||||.||+|.++|.+. +.+++..++.|+.||+.||.|||++|||||||||+||||+ .+|+|||+||
T Consensus 264 ~~--~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld----~~G~vKL~DF 336 (689)
T 3v5w_A 264 PD--KLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDL 336 (689)
T ss_dssp SS--EEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC----TTSCEEECCC
T ss_pred CC--EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe----CCCCEEeccc
Confidence 66 899999999999999999654 5699999999999999999999999999999999999999 7899999999
Q ss_pred cccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---hhHHHHhhhccCCCC
Q 040257 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC---GAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1119 GLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~---~eliqsIlk~~Lrp~ 1195 (1254)
|+|+...... ..+.+||+.|||||++.+.. .|+.++|||||||+||||++|+.||.+... ..+...+... ...
T Consensus 337 GlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~-~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--~~~ 412 (689)
T 3v5w_A 337 GLACDFSKKK-PHASVGTHGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVE 412 (689)
T ss_dssp TTCEECSSCC-CCSCCSCGGGCCHHHHSTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--CCC
T ss_pred ceeeecCCCC-CCCccCCcCccCHHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--CCC
Confidence 9998665443 34578999999999996432 489999999999999999999999976432 2334444433 345
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPS-----FTEITSR 1228 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPS-----ArELLe~ 1228 (1254)
++..+++++++||.+||++||.+|++ +.||++|
T Consensus 413 ~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 67889999999999999999999997 7888875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=364.61 Aligned_cols=260 Identities=28% Similarity=0.486 Sum_probs=226.4
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
.+...+|++++.||+|+||+||+|+++++.||||+++.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDW------STRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTC------CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEeccccc------CHHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 45566899999999999999999999999999999975421 223346789999999999999999999999877
Q ss_pred CCCceEEEEEecccCchhhhhhccCC-CCCHHHHHHHHHHhhhhhHHhhhCC--cccccCCCCceEeccCCCCCCeEEEE
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDR-SLDRRKKLIIAMDAAFGMEYLHSKN--IVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~-~LSe~~~lkIa~QIAeALaYLHSkG--IIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
....+++||||+.+++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.++|+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~----~~~~~~l~ 155 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID----EDMTARIS 155 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC----TTSCEEEE
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc----CCcceeEE
Confidence 55689999999999999999976543 5899999999999999999999999 99999999999998 77889999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSN-RVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~-kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
|||++..... ....||+.|+|||++.+..+ .++.++|||||||++|+|++|+.||...........+......+.
T Consensus 156 ~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (271)
T 3kmu_A 156 MADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT 231 (271)
T ss_dssp GGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred eccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC
Confidence 9988754322 23468999999999986532 245589999999999999999999999888888777777777778
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
.+..+++++.+||.+||+.||.+|||+.++++.|+.+.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 232 IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 88899999999999999999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=364.99 Aligned_cols=258 Identities=33% Similarity=0.619 Sum_probs=223.6
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
+.+...+|++++.||+|+||+||++++ .++.||||++...... .+++.+|+.++++++||||+++++++.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 75 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCL 75 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---------HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 456778999999999999999999998 5677999999754221 246889999999999999999999997
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. .+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 76 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~kl~D 149 (269)
T 4hcu_A 76 EQA--PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSD 149 (269)
T ss_dssp SSS--SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----GGGCEEECC
T ss_pred cCC--ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc----CCCCEEecc
Confidence 655 79999999999999999977777799999999999999999999999999999999999998 677899999
Q ss_pred ccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCC
Q 040257 1118 FGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1118 FGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
||+++...... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||...........+... ...
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~ 226 (269)
T 4hcu_A 150 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRL 226 (269)
T ss_dssp TTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCC
T ss_pred ccccccccccccccccCcccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-ccC
Confidence 99998654322 22334577889999999865 48999999999999999999 99999988877777666554 445
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
..+..++..+.+|+.+||+.||++||++.+++++|+.+.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 5667789999999999999999999999999999999865
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=381.27 Aligned_cols=263 Identities=36% Similarity=0.600 Sum_probs=223.1
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC-----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR-----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r-----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
.+...+|++.+.||+|+||+||+|++. +..||||+++... .....+.+.+|+.+|++++||||+++++
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 117 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-------TERQRRDFLSEASIMGQFDHPNIIRLEG 117 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-------CHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 455668999999999999999999983 3359999997532 2334567899999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
++.+.. .+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 118 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~k 191 (325)
T 3kul_A 118 VVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD----SNLVCK 191 (325)
T ss_dssp EECGGG--CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEE
T ss_pred EEEeCC--ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC----CCCCEE
Confidence 997655 78999999999999999977767899999999999999999999999999999999999998 778999
Q ss_pred EEeccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhh
Q 040257 1115 VGDFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk 1189 (1254)
|+|||+++...... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...........+..
T Consensus 192 l~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 269 (325)
T 3kul_A 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269 (325)
T ss_dssp ECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred ECCCCcccccccCccceeeccCCCCcccccCHhHhcCCC--CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 99999998653321 222334678899999998654 8899999999999999999 9999999888777776655
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
. .....+..+++.+.+||.+||..||.+||++.+|++.|+.+....+.
T Consensus 270 ~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 270 G-YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred C-CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 4 44556778999999999999999999999999999999999875444
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=376.22 Aligned_cols=263 Identities=33% Similarity=0.551 Sum_probs=218.4
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.+...+|++.+.||+|+||+||++.+. ++.||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 77 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--------DEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCcCcccEEEEEe
Confidence 456679999999999999999999985 778999988542 2344577899999999999999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
++. .+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 78 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~D 151 (310)
T 3s95_A 78 KDK--RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR----ENKNVVVAD 151 (310)
T ss_dssp ETT--EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC----TTSCEEECC
T ss_pred cCC--eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC----CCCCEEEee
Confidence 765 89999999999999999987677899999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCcccc---------------CCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 040257 1118 FGLSRIKRNTLVS---------------GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA 1182 (1254)
Q Consensus 1118 FGLAr~~~~s~~s---------------ts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e 1182 (1254)
||+++........ ....||+.|+|||++.+. .++.++||||||+++|+|++|..||.......
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~ 229 (310)
T 3s95_A 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229 (310)
T ss_dssp CTTCEECC--------------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC
T ss_pred cccceecccccccccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH
Confidence 9999754332211 145799999999999876 48899999999999999999999987543221
Q ss_pred HH-HHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1183 II-GGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1183 li-qsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
.. ............+..+++.+.+||.+||+.||++|||+.++++.|+.+...+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 230 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp TTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 10 000111111224566788999999999999999999999999999999988765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=373.04 Aligned_cols=263 Identities=32% Similarity=0.528 Sum_probs=215.5
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE------CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~------rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
.+...+|++++.||+|+||+||+|++ .++.||||++... .....+.+.+|+.++++++||||++++
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 77 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--------TEEHLRDFEREIEILKSLQHDNIVKYK 77 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--------CHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 45567899999999999999999985 4678999998743 233456788999999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
+++.......+++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+
T Consensus 78 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~----~~~~~ 153 (295)
T 3ugc_A 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE----NENRV 153 (295)
T ss_dssp EEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEE
T ss_pred EEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc----CCCeE
Confidence 99876544578999999999999999977666799999999999999999999999999999999999998 77899
Q ss_pred EEEeccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh-------
Q 040257 1114 KVGDFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA------- 1182 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e------- 1182 (1254)
||+|||+++...... ......++..|+|||++.+.. ++.++||||||+++|+|++|..||.......
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 231 (295)
T 3ugc_A 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231 (295)
T ss_dssp EECCCCSCC-------------CTTCGGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTT
T ss_pred EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCC--CChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCc
Confidence 999999998653321 223344777899999998664 8999999999999999999999986432110
Q ss_pred --------HHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1183 --------IIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1183 --------liqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
..............+..+++++.+||.+||+.||.+|||+.++++.|+.++..+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 232 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 111222333445567789999999999999999999999999999999998765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=364.04 Aligned_cols=261 Identities=36% Similarity=0.626 Sum_probs=212.9
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
+...+|++.+.||+|+||+||+|++.++.||||+++.... .......+.+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPD----EDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-
T ss_pred cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCc----ccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 4556899999999999999999999999999999875421 112233567889999999999999999999997655
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCC---cccccCCCCceEeccCCC----CCCeE
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKN---IVHFDLKCENLLVNLRDP----QRPIC 1113 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkG---IIHRDLKPeNILLDsdd~----snG~V 1113 (1254)
.+++||||+.+++|.+++. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.... ..+.+
T Consensus 80 --~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 80 --NLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp ---CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred --ceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence 7899999999999999884 357999999999999999999999999 999999999999983221 26789
Q ss_pred EEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC
Q 040257 1114 KVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
||+|||+++....... ....||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+......
T Consensus 156 kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 232 (271)
T 3dtc_A 156 KITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232 (271)
T ss_dssp EECCCCC--------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC
T ss_pred EEccCCcccccccccc-cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC
Confidence 9999999975544322 245699999999999865 4899999999999999999999999998887777777777777
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
...+..+++.+.+||.+||+.||.+|||+.+++++|+.+
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 778888999999999999999999999999999999754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=379.54 Aligned_cols=263 Identities=30% Similarity=0.513 Sum_probs=221.5
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVA 1031 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVk 1031 (1254)
.+...+|++++.||+|+||.||+|++. ++.||||+++... .....+.+.+|+.+++++ +||||++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-------CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 455678999999999999999999863 3679999997532 122356789999999999 7999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccCC----------------------------------------------
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR---------------------------------------------- 1065 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~---------------------------------------------- 1065 (1254)
+++++.+.. ..+++||||+.+|+|.+++.....
T Consensus 91 ~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 91 LLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp EEEEECSTT-SCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeecCC-CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 999987644 358899999999999999865432
Q ss_pred -------------------CCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccC
Q 040257 1066 -------------------SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN 1126 (1254)
Q Consensus 1066 -------------------~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~ 1126 (1254)
.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~----~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYK 245 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEECCCGGGSCTTS
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc----CCCcEEEEeccceeeecc
Confidence 189999999999999999999999999999999999998 678999999999975432
Q ss_pred c---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCCcH
Q 040257 1127 T---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDP 1202 (1254)
Q Consensus 1127 s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~ 1202 (1254)
. .......||+.|+|||++.+. .++.++|||||||++|||++ |+.||.....................+..+++
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP 323 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCH
T ss_pred cccchhccccCCCceeEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCH
Confidence 2 223345688899999999865 48999999999999999998 99999887766666556555566677788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1203 EWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1203 eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
++.+||.+||+.||.+|||+.+++++|+.++.+.
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=382.26 Aligned_cols=249 Identities=25% Similarity=0.441 Sum_probs=219.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|++ +++.||||++.+... .....+++.+|+.+|+.++||||+++++++.+..
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~- 87 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL------NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK- 87 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 4799999999999999999998 578899999986532 2234567889999999999999999999997655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 88 -~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~----~~~~~kl~DFG~a 161 (328)
T 3fe3_A 88 -TLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD----ADMNIKIADFGFS 161 (328)
T ss_dssp -EEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECSTTCC
T ss_pred -EEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc----CCCCEEEeeccCc
Confidence 899999999999999998654 5699999999999999999999999999999999999998 7889999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
+...........+||+.|+|||++.+.. ..+.++|||||||+||+|++|+.||.+.+.......+....+ ..+..++
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~p~~~s 238 (328)
T 3fe3_A 162 NEFTVGGKLDAFCGAPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--RIPFYMS 238 (328)
T ss_dssp GGGSSSCGGGTTSSSGGGCCHHHHHTCC-CCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSC
T ss_pred eecCCCCccccccCCcceeCcccccCCC-cCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCCC
Confidence 8665555556678999999999998764 235899999999999999999999999888888887777654 4566789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++.+||++||..||.+|||+.|++++
T Consensus 239 ~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 239 TDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 999999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.29 Aligned_cols=262 Identities=36% Similarity=0.606 Sum_probs=221.7
Q ss_pred cccccccccCceEEEEEeeeCcEEEEEEEECC-ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 956 YGLQIIKNVDLEELRELGSGTYGTVYHGKWRG-SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 956 ~glq~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
.+.+.+...+|++++.||+|+||+||++++.+ ..||||+++..... .+++.+|+.++++++||||+++++
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~ 86 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYG 86 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---------HHHHHHHHHHHhcCCCCCEeeEEE
Confidence 34456777899999999999999999999864 47999999854221 245789999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
++.+.. .+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 87 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~----~~~~~k 160 (283)
T 3gen_A 87 VCTKQR--PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN----DQGVVK 160 (283)
T ss_dssp EECSSS--SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC----TTSCEE
T ss_pred EEecCC--CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc----CCCCEE
Confidence 997655 79999999999999999977667799999999999999999999999999999999999998 778999
Q ss_pred EEeccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhcc
Q 040257 1115 VGDFGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNT 1191 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~ 1191 (1254)
|+|||+++...... ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||...........+...
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~- 237 (283)
T 3gen_A 161 VSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG- 237 (283)
T ss_dssp ECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-
T ss_pred EccccccccccccccccccCCccCcccCCHHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc-
Confidence 99999997554322 223345678899999998654 8999999999999999998 99999988877776666543
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1192 Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
.....+..+++.+.+||.+||+.+|.+|||+.+++++|++++.+
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 238 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 44556677899999999999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=367.96 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=212.5
Q ss_pred cccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCc------------------hhHHHHHHHHHHHHHHH
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRS------------------SEQERLTKDFWREAHIL 1021 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~------------------~e~ee~~eqFlrEIeIL 1021 (1254)
...+|++.+.||+|+||+||+|++ +++.||||++......... .......+.+.+|+.+|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 345899999999999999999988 4778999999765322110 00112245688999999
Q ss_pred hcCCCCceeEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCce
Q 040257 1022 SNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENL 1101 (1254)
Q Consensus 1022 krLnHPNIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNI 1101 (1254)
++++||||+++++++.+.....+++||||+.+++|.+++. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 9999999999999998766668999999999999998763 35799999999999999999999999999999999999
Q ss_pred EeccCCCCCCeEEEEeccccccccCc-cccCCCCCCCCccCcccccCCCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 040257 1102 LVNLRDPQRPICKVGDFGLSRIKRNT-LVSGGVRGTLPWMAPELLNGSSNR-VSEKVDVFSFGISMWEILTGEEPYADMH 1179 (1254)
Q Consensus 1102 LLDsdd~snG~VKLiDFGLAr~~~~s-~~sts~~GT~~YmAPEVLrG~~~k-yS~KSDIWSLGVILYELLTGk~PF~~~n 1179 (1254)
|++ .++.+||+|||+++..... .......||+.|+|||++.+.... ++.++|||||||++|+|++|+.||....
T Consensus 169 l~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 169 LVG----EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EEC----TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEC----CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 998 7789999999999865432 233456799999999999865422 3788999999999999999999999887
Q ss_pred hhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1180 CGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1180 ~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.......+............+++++.+||.+||+.||++||++.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 7776666666555444456789999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=374.45 Aligned_cols=263 Identities=31% Similarity=0.574 Sum_probs=221.0
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECC-------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAF 1032 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkL 1032 (1254)
.+...+|++++.||+|+||+||+|++.+ +.||||+++... .....+.+.+|+.++++++||||+++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~ 115 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDNPNIVKL 115 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3455689999999999999999999864 679999987532 23345678999999999999999999
Q ss_pred eeeeecCCCCceEEEEEecccCchhhhhhccC-----------------------CCCCHHHHHHHHHHhhhhhHHhhhC
Q 040257 1033 YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD-----------------------RSLDRRKKLIIAMDAAFGMEYLHSK 1089 (1254)
Q Consensus 1033 yGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre-----------------------~~LSe~~~lkIa~QIAeALaYLHSk 1089 (1254)
++++.+.. .+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++
T Consensus 116 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 193 (343)
T 1luf_A 116 LGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193 (343)
T ss_dssp EEEECSSS--SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEccCC--ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99997654 7899999999999999986532 5689999999999999999999999
Q ss_pred CcccccCCCCceEeccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHH
Q 040257 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMW 1166 (1254)
Q Consensus 1090 GIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILY 1166 (1254)
||+||||||+|||++ .++.+||+|||+++..... .......+|+.|+|||++.+.. ++.++|||||||++|
T Consensus 194 ~ivH~Dlkp~NIl~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~ 267 (343)
T 1luf_A 194 KFVHRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLW 267 (343)
T ss_dssp TCCCSCCSGGGEEEC----GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHH
T ss_pred CeecCCCCcceEEEC----CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC--cCcccccHHHHHHHH
Confidence 999999999999998 6789999999999754322 1223345788999999998653 899999999999999
Q ss_pred HHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1167 EILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1167 ELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
+|++ |..||......+....+..... ...+..++.++.+||.+||+.||.+||++.+++++|+.+....+.
T Consensus 268 el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 268 EIFSYGLQPYYGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG 339 (343)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred HHHhcCCCcCCCCChHHHHHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence 9999 9999998887777766655443 456778899999999999999999999999999999998776554
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=365.96 Aligned_cols=262 Identities=32% Similarity=0.521 Sum_probs=223.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE-------CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW-------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVA 1031 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~-------rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVk 1031 (1254)
.+...+|++.+.||+|+||+||+|++ .++.||||+++... .....+.+.+|+.+++++ +||||++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i~~ 91 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-------HLTEREALMSELKVLSYLGNHMNIVN 91 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-------hHHHHHHHHHHHHHHhhcccCCCeee
Confidence 45566899999999999999999986 24679999997542 122346788999999999 9999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccCC-----------------CCCHHHHHHHHHHhhhhhHHhhhCCcccc
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR-----------------SLDRRKKLIIAMDAAFGMEYLHSKNIVHF 1094 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~-----------------~LSe~~~lkIa~QIAeALaYLHSkGIIHR 1094 (1254)
+++++.+.. ..++||||+.+++|.+++..... .+++..++.++.||+.||.|||++||+||
T Consensus 92 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 169 (313)
T 1t46_A 92 LLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169 (313)
T ss_dssp EEEEECSSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEEecCC--CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 999997655 78999999999999999866532 48999999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 040257 1095 DLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170 (1254)
Q Consensus 1095 DLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT- 1170 (1254)
||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.++||||||+++|+|++
T Consensus 170 dlkp~Nil~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~ 243 (313)
T 1t46_A 170 DLAARNILLT----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSL 243 (313)
T ss_dssp CCSGGGEEEE----TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTT
T ss_pred CCccceEEEc----CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhC
Confidence 9999999998 77899999999997654332 22334577889999999865 48999999999999999999
Q ss_pred CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1171 GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1171 Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
|+.||.....................+..++.++.+||.+||+.||.+|||+.+++++|+.+..+.
T Consensus 244 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp TCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 999998877666666666666666667788999999999999999999999999999999988764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=361.50 Aligned_cols=258 Identities=33% Similarity=0.614 Sum_probs=220.8
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEECC-ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWRG-SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
..+...+|++++.||+|+||+||++++++ ..||||+++..... .+.+.+|+.++++++||||+++++++.
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 73 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---------EDEFFQEAQTMMKLSHPKLVKFYGVCS 73 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---------HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 34667799999999999999999999864 46999999754321 245789999999999999999999997
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. .+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 74 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~~l~D 147 (268)
T 3sxs_A 74 KEY--PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD----RDLCVKVSD 147 (268)
T ss_dssp SSS--SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC----TTCCEEECC
T ss_pred cCC--ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC----CCCCEEEcc
Confidence 654 79999999999999999977766799999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCC
Q 040257 1118 FGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1118 FGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
||++....... ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||...........+.... ..
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~ 224 (268)
T 3sxs_A 148 FGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK--YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-RL 224 (268)
T ss_dssp TTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSE--EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CC
T ss_pred CccceecchhhhhcccCCCcCcccCCHHHHhccC--CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-CC
Confidence 99997554332 223345677899999998654 7889999999999999999 999999888777666655443 34
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
..+..+++.+.+||.+||+.+|.+|||+.+++++|+.+..
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 5566789999999999999999999999999999988754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=382.41 Aligned_cols=263 Identities=29% Similarity=0.499 Sum_probs=222.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC---------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCce
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR---------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNV 1029 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r---------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNI 1029 (1254)
.+...+|++++.||+|+||+||+|++. +..||||+++... .....+.+.+|+.+|+++ +||||
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hpnI 149 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNI 149 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-------BHHHHHHHHHHHHHHHHSCCCTTB
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-------CHHHHHHHHHHHHHHHHhcCCCCE
Confidence 445668999999999999999999873 2359999987541 233456789999999999 89999
Q ss_pred eEEeeeeecCCCCceEEEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccc
Q 040257 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHF 1094 (1254)
Q Consensus 1030 VkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHR 1094 (1254)
+++++++.+.. .+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||
T Consensus 150 v~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 227 (370)
T 2psq_A 150 INLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 227 (370)
T ss_dssp CCEEEEECSSS--SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred eeEEEEEccCC--CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 99999997655 7999999999999999986543 348899999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 040257 1095 DLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170 (1254)
Q Consensus 1095 DLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT- 1170 (1254)
||||+||||+ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||+||||++
T Consensus 228 Dlkp~NIll~----~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~ 301 (370)
T 2psq_A 228 DLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTL 301 (370)
T ss_dssp CCCGGGEEEC----TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTT
T ss_pred ccchhhEEEC----CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcC
Confidence 9999999998 77899999999998543321 22334578899999999876 48999999999999999999
Q ss_pred CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1171 GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1171 Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
|+.||......+....+... .....+..++.++.+||.+||+.||.+||++.|+++.|+.++.....
T Consensus 302 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 302 GGSPYPGIPVEELFKLLKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp SCCSSTTCCGGGHHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 99999988777766655443 44567778999999999999999999999999999999999876543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=363.15 Aligned_cols=267 Identities=37% Similarity=0.676 Sum_probs=220.1
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf 1036 (1254)
..+...+|++.+.||+|+||+||+|++ +++.||||++....... ........+.+.+|+.++++++||||+++++++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG-ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTC-CHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeecccccc-chhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 346667999999999999999999998 47789999987543211 111111126788999999999999999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCC--cccccCCCCceEeccCC-CCCCeE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKN--IVHFDLKCENLLVNLRD-PQRPIC 1113 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkG--IIHRDLKPeNILLDsdd-~snG~V 1113 (1254)
.+.. ++||||+.+++|.+.+......+++..++.++.||+.||.|||+++ |+||||||+|||++..+ .....+
T Consensus 93 ~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 93 HNPP----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp TTTT----EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred cCCC----eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 6543 6899999999999998777778999999999999999999999999 99999999999998332 122349
Q ss_pred EEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH--HHHhhhcc
Q 040257 1114 KVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAI--IGGIVKNT 1191 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~el--iqsIlk~~ 1191 (1254)
||+|||+++..... .....||+.|+|||++.+....++.++|||||||++|+|++|+.||........ ...+....
T Consensus 169 kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 169 KVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp EECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred EeCCCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 99999999754432 334679999999999965555588999999999999999999999987654433 44555566
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1192 Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
..+..+..+++++.+||.+||+.||.+|||+.++++.|+.+
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 66778888999999999999999999999999999999753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=374.57 Aligned_cols=265 Identities=32% Similarity=0.480 Sum_probs=219.4
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE-------CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW-------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVA 1031 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~-------rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVk 1031 (1254)
.+...+|++.+.||+|+||+||+|++ .+..||||+++... .....+.+.+|+.+++++ +||||++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~ 113 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-------DSSEREALMSELKMMTQLGSHENIVN 113 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-------CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 45567899999999999999999997 23469999997532 122346788999999999 8999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccCC----------------------CCCHHHHHHHHHHhhhhhHHhhhC
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR----------------------SLDRRKKLIIAMDAAFGMEYLHSK 1089 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~----------------------~LSe~~~lkIa~QIAeALaYLHSk 1089 (1254)
+++++.+.. .+++||||+.+++|.+++..... .+++..++.++.||+.||.|||++
T Consensus 114 ~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 191 (344)
T 1rjb_A 114 LLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 191 (344)
T ss_dssp EEEEECSSS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEeeCC--ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 999998654 78999999999999999966532 378999999999999999999999
Q ss_pred CcccccCCCCceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHH
Q 040257 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMW 1166 (1254)
Q Consensus 1090 GIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILY 1166 (1254)
||+||||||+|||++ .++.+||+|||++....... ......+|+.|+|||++.+.. ++.++|||||||+||
T Consensus 192 ~ivH~Dikp~NIll~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~ 265 (344)
T 1rjb_A 192 SCVHRDLAARNVLVT----HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLW 265 (344)
T ss_dssp TEEETTCSGGGEEEE----TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHH
T ss_pred CcccCCCChhhEEEc----CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC--CChhHhHHHHHHHHH
Confidence 999999999999998 77899999999997543221 223445788999999998653 899999999999999
Q ss_pred HHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhc
Q 040257 1167 EILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239 (1254)
Q Consensus 1167 ELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk 1239 (1254)
+|++ |..||.....................+..+++++.+||.+||+.||.+|||+.+++++|+.+....+.+
T Consensus 266 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 266 EIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp HHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred HHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 9998 999999877666666666666666777889999999999999999999999999999999998776654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=369.08 Aligned_cols=248 Identities=26% Similarity=0.436 Sum_probs=211.9
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|++++.||+|+||+||+|.+ +++.||||++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--------CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--------HHHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence 34799999999999999999987 4778999999754211 1356788999999999999999999998765
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 91 --~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~----~~~~~kl~Dfg~ 162 (297)
T 3fxz_A 91 --ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 162 (297)
T ss_dssp --EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTT
T ss_pred --EEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC----CCCCEEEeeCCC
Confidence 799999999999999998553 689999999999999999999999999999999999998 778999999999
Q ss_pred cccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc-CCCCCCC
Q 040257 1121 SRIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT-LRPTIPE 1198 (1254)
Q Consensus 1121 Ar~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~-Lrp~ipe 1198 (1254)
+...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.... .....+.
T Consensus 163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T 3fxz_A 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240 (297)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHHCSC--BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGG
T ss_pred ceecCCcccccCCccCCcCccChhhhcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Confidence 8765432 2334567999999999998764 7899999999999999999999998877666555554332 2334566
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++..+++||.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 789999999999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=380.69 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=216.8
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
...+|++++.||+|+||+||+++++ ++.||||++++.... .......+.+|+.+|+.++||||+++++++.+.
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 77 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-----hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC
Confidence 3458999999999999999999984 778999999864211 112245678899999999999999999999876
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
. .+++||||+.+|+|..++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++++||+|||
T Consensus 78 ~--~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~vkL~DFG 150 (337)
T 1o6l_A 78 D--RLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFG 150 (337)
T ss_dssp S--EEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCCT
T ss_pred C--EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC----CCCCEEEeecc
Confidence 5 899999999999999988544 5699999999999999999999999999999999999998 78899999999
Q ss_pred cccccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCC
Q 040257 1120 LSRIKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1120 LAr~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe 1198 (1254)
+++... ........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+..... .++.
T Consensus 151 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~p~ 226 (337)
T 1o6l_A 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RFPR 226 (337)
T ss_dssp TCBCSCCTTCCBCCCEECGGGCCGGGGSSSC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCT
T ss_pred chhhcccCCCcccccccChhhCChhhhcCCC--CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCC
Confidence 997532 233345678999999999998764 78999999999999999999999998888777777766543 4667
Q ss_pred CCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
.+++++++||.+||+.||.+|| ++.+++++
T Consensus 227 ~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 8899999999999999999999 89999886
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=353.90 Aligned_cols=258 Identities=33% Similarity=0.625 Sum_probs=222.2
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
+.+...+|++++.||+|+||.||++++ .+..||+|++...... .+.+.+|+.++++++||||+++++++.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 73 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCL 73 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---------HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---------HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 456677999999999999999999998 4667999999754211 256789999999999999999999997
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. .+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 74 ~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~----~~~~~kl~d 147 (267)
T 3t9t_A 74 EQA--PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSD 147 (267)
T ss_dssp SSS--SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC----GGGCEEECC
T ss_pred cCC--CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC----CCCCEEEcc
Confidence 654 78999999999999999977767799999999999999999999999999999999999998 678899999
Q ss_pred ccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCC
Q 040257 1118 FGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1118 FGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
||++....... ......++..|+|||++.+. .++.++||||||+++|+|++ |+.||...........+... ...
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-~~~ 224 (267)
T 3t9t_A 148 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRL 224 (267)
T ss_dssp TTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCC
T ss_pred cccccccccccccccccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-CcC
Confidence 99997654321 22334578889999999865 37899999999999999999 99999988777776666544 344
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
..+..++..+.+|+.+||+.||.+||++.+++++|+.+.+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5567789999999999999999999999999999999865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=361.48 Aligned_cols=261 Identities=33% Similarity=0.602 Sum_probs=212.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC-----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR-----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r-----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
.+...+|++.+.||+|+||+||+|.+. +..||||+++... .....+.+.+|+.++++++||||+++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------SHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCccceEEE
Confidence 455678999999999999999999884 3358999876431 2344577899999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
++.+ ..+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 84 ~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~k 156 (281)
T 1mp8_A 84 VITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVK 156 (281)
T ss_dssp EECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEE
T ss_pred EEcc---CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC----CCCCEE
Confidence 9853 368899999999999999977766799999999999999999999999999999999999998 678999
Q ss_pred EEeccccccccCccc--cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhcc
Q 040257 1115 VGDFGLSRIKRNTLV--SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNT 1191 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~~--sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~ 1191 (1254)
|+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|||++ |..||...........+....
T Consensus 157 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~ 234 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 234 (281)
T ss_dssp ECC-------------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred ECccccccccCcccccccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC
Confidence 999999986543321 2233467889999999865 48999999999999999997 999999887777776665543
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 040257 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1192 Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLE 1237 (1254)
....+..+++.+.+||.+||+.||.+|||+.++++.|+.+..+-.
T Consensus 235 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 235 -RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 345667889999999999999999999999999999999987643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=372.30 Aligned_cols=272 Identities=29% Similarity=0.498 Sum_probs=219.1
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE------CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~------rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
.+...+|++++.||+|+||+||++++ .++.||||++... .....+.+.+|+.++++++||||++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--------GPDQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--------CHHHHHHHHHHHHHHHhcCCCceeEEE
Confidence 46667999999999999999999985 4677999998753 123356788999999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
+++.......+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~----~~~~~ 166 (327)
T 3lxl_A 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE----SEAHV 166 (327)
T ss_dssp EEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEE
T ss_pred EEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC----CCCCE
Confidence 99886666689999999999999999977666799999999999999999999999999999999999998 77899
Q ss_pred EEEeccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh--------
Q 040257 1114 KVGDFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG-------- 1181 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~-------- 1181 (1254)
||+|||+++...... ......+|..|+|||++.+.. ++.++|||||||++|+|++|+.||......
T Consensus 167 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~ 244 (327)
T 3lxl_A 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI--FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244 (327)
T ss_dssp EECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC--
T ss_pred EEcccccceecccCCccceeeccCCccccccCHHHhccCC--CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc
Confidence 999999998653322 223345888899999998664 789999999999999999999998653321
Q ss_pred ------hHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhcccCCCC
Q 040257 1182 ------AIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCINSEP 1245 (1254)
Q Consensus 1182 ------eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk~~k~~p 1245 (1254)
...............+..+++++.+||.+||+.||.+|||+.+++++|+.+............+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~ 314 (327)
T 3lxl_A 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT 314 (327)
T ss_dssp --CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------------
T ss_pred cccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccccc
Confidence 1222333344455667789999999999999999999999999999999998766554443333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=384.06 Aligned_cols=261 Identities=34% Similarity=0.579 Sum_probs=222.7
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf 1036 (1254)
+.+...+|++.+.||+|+||.||+|++. ++.||||+++... ......++.+|+.+|++++||||+++++++
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 181 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-------PPDLKAKFLQEARILKQYSHPNIVRLIGVC 181 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-------CHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-------CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3566678999999999999999999995 7789999987431 123346788999999999999999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.+.. .+++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+
T Consensus 182 ~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~----~~~~~kl~ 255 (377)
T 3cbl_A 182 TQKQ--PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT----EKNVLKIS 255 (377)
T ss_dssp CSSS--SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEEC
T ss_pred ecCC--CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc----CCCcEEEC
Confidence 7654 78999999999999999977666799999999999999999999999999999999999998 77899999
Q ss_pred eccccccccCcccc---CCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccC
Q 040257 1117 DFGLSRIKRNTLVS---GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1117 DFGLAr~~~~s~~s---ts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~L 1192 (1254)
|||+++........ ....++..|+|||++.+.. ++.++|||||||+||||++ |..||...........+.. ..
T Consensus 256 DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~ 332 (377)
T 3cbl_A 256 DFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR--YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK-GG 332 (377)
T ss_dssp CGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT-TC
T ss_pred cCCCceecCCCceeecCCCCCCCcCcCCHhHhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CC
Confidence 99999864432211 1123567899999998653 8899999999999999998 9999998877766655543 34
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
+...+..++.++.+||.+||+.||.+|||+.++++.|+.+..+
T Consensus 333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 5566788999999999999999999999999999999998765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=362.68 Aligned_cols=260 Identities=30% Similarity=0.513 Sum_probs=220.4
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAF 1032 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkL 1032 (1254)
.+...+|.+.+.||+|+||.||++++. ++.||||+++... .....+.+.+|+.++++++||||+++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~ 91 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-------SPSELRDLLSEFNVLKQVNHPHVIKL 91 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-------CHHHHHHHHHHHHHHhhCCCCceeeE
Confidence 456678999999999999999999872 3679999987431 23345678899999999999999999
Q ss_pred eeeeecCCCCceEEEEEecccCchhhhhhccC-----------------------CCCCHHHHHHHHHHhhhhhHHhhhC
Q 040257 1033 YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD-----------------------RSLDRRKKLIIAMDAAFGMEYLHSK 1089 (1254)
Q Consensus 1033 yGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre-----------------------~~LSe~~~lkIa~QIAeALaYLHSk 1089 (1254)
++++.+.. .+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++
T Consensus 92 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 169 (314)
T 2ivs_A 92 YGACSQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM 169 (314)
T ss_dssp EEEECSSS--SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEecCC--ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 99997655 7899999999999999986542 2489999999999999999999999
Q ss_pred CcccccCCCCceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHH
Q 040257 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMW 1166 (1254)
Q Consensus 1090 GIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILY 1166 (1254)
||+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++.+.. ++.++|||||||++|
T Consensus 170 ~ivH~dikp~NIli~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ 243 (314)
T 2ivs_A 170 KLVHRDLAARNILVA----EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLW 243 (314)
T ss_dssp TEECCCCSGGGEEEE----TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE--ECHHHHHHHHHHHHH
T ss_pred CCcccccchheEEEc----CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC--cCchhhHHHHHHHHH
Confidence 999999999999999 77899999999997543321 223345788899999998654 789999999999999
Q ss_pred HHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1167 EILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1167 ELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
+|++ |..||...........+... .....+..+++++.+||.+||+.||.+||++.+++++|+.++.+
T Consensus 244 el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 244 EIVTLGGNPYPGIPPERLFNLLKTG-HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHhCCCCCCCCCCHHHHHHHhhcC-CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 9999 99999988777666555443 34556778899999999999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=377.43 Aligned_cols=264 Identities=30% Similarity=0.523 Sum_probs=224.4
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECC---------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCce
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRG---------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNV 1029 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rG---------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNI 1029 (1254)
.+...+|++.+.||+|+||+||+|++.+ ..||||+++... ......++.+|+.+++++ +||||
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hpnI 137 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKNI 137 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-------CHHHHHHHHHHHHHHHHhcCCchh
Confidence 4556689999999999999999999732 469999997542 233456788999999999 99999
Q ss_pred eEEeeeeecCCCCceEEEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccc
Q 040257 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHF 1094 (1254)
Q Consensus 1030 VkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHR 1094 (1254)
+++++++.+.. .+++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||+++|+||
T Consensus 138 v~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 215 (382)
T 3tt0_A 138 INLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 215 (382)
T ss_dssp CCEEEEECSSS--SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred hhheeeeccCC--ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 99999997655 7899999999999999996643 358999999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 040257 1095 DLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170 (1254)
Q Consensus 1095 DLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT- 1170 (1254)
||||+||||+ .++.+||+|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 216 Dlkp~NIll~----~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~ 289 (382)
T 3tt0_A 216 DLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTL 289 (382)
T ss_dssp CCCGGGEEEC----TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCcceEEEc----CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhC
Confidence 9999999998 7789999999999855432 223334578899999999875 48999999999999999999
Q ss_pred CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhc
Q 040257 1171 GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239 (1254)
Q Consensus 1171 Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk 1239 (1254)
|..||......+....+... .....+..++.++.+||.+||+.||++|||+.+|+++|+.+.......
T Consensus 290 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 290 GGSPYPGVPVEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp SCCSSTTCCHHHHHHHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred CCCCCCCCCHHHHHHHHHcC-CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 99999988877766655543 445667789999999999999999999999999999999998765443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=361.41 Aligned_cols=261 Identities=30% Similarity=0.513 Sum_probs=214.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE------CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~------rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
.+....|++++.||+|+||.||+|++ .++.||||+++... .....+.+.+|+.++++++||||++++
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-------GGNHIADLKKEIEILRNLYHENIVKYK 89 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------------CCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-------cchhHHHHHHHHHHHHhCCCCCeeeee
Confidence 34556799999999999999999985 46789999997542 112246688999999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
+++.+.....+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 90 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~ 165 (302)
T 4e5w_A 90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQV 165 (302)
T ss_dssp EEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEE
T ss_pred eEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc----CCCCE
Confidence 99987765689999999999999999977777799999999999999999999999999999999999998 67899
Q ss_pred EEEeccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----------
Q 040257 1114 KVGDFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADM----------- 1178 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~----------- 1178 (1254)
||+|||++....... ......+|..|+|||++.+.. ++.++||||||+++|+|++|..||...
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 243 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK--FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCC--CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCc
Confidence 999999998654332 233456888899999998664 789999999999999999999986422
Q ss_pred ---ChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1179 ---HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1179 ---n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
..................+..+++++.+||.+||+.||.+|||+.++++.|+.++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 244 HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1112222333334455667789999999999999999999999999999999885
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=368.81 Aligned_cols=265 Identities=23% Similarity=0.339 Sum_probs=214.6
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+.+.+|++.+.||+|+||+||+|++. ++.||||+++..... ...+.+.+|+.+|++++||||+++++++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-------RPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-------SCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-------chHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 44568999999999999999999995 778999999754321 124567789999999999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCC--CCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDR--SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~--~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.....+++||||+.+++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+.......+.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence 776788999999999999999965432 389999999999999999999999999999999999983222267789999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCC------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----hhHHHH
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGS------SNRVSEKVDVFSFGISMWEILTGEEPYADMHC----GAIIGG 1186 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~------~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~----~eliqs 1186 (1254)
|||+++............||+.|+|||++... ...++.++|||||||++|||++|+.||..... ...+..
T Consensus 159 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred cCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 99999876655555567799999999998621 23488999999999999999999999974332 333444
Q ss_pred hhhccCCC-----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1187 IVKNTLRP-----------------------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1187 Ilk~~Lrp-----------------------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
+....... .+...++..+.+||.+||+.||++|||+.|++++..+-
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 43322110 11223456788999999999999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=384.00 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=211.6
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVP 1037 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~ 1037 (1254)
+...+|++++.||+|+||+||+|+++ ++.||||++++.... .....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-----~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 94 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-----QDDDVECTMTEKRILSLARNHPFLTQLFCCFQ 94 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-----HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-----chhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence 33458999999999999999999984 678999999864211 222345678899999988 7999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. .+++||||+.+|+|..++.+. +.+++..++.++.||+.||.|||++||+||||||+||||+ .++++||+|
T Consensus 95 ~~~--~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~----~~g~ikL~D 167 (353)
T 3txo_A 95 TPD--RLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD----HEGHCKLAD 167 (353)
T ss_dssp CSS--EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECC
T ss_pred eCC--EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC----CCCCEEEcc
Confidence 765 899999999999999998654 5699999999999999999999999999999999999998 788999999
Q ss_pred cccccccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1118 FGLSRIKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1118 FGLAr~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
||+++... ........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+....+..... .+
T Consensus 168 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~ 243 (353)
T 3txo_A 168 FGMCKEGICNGVTTATFCGTPDYIAPEILQEML--YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--VY 243 (353)
T ss_dssp CTTCBCSCC---------CCGGGCCHHHHHHHH--CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CC
T ss_pred ccceeecccCCccccccCCCcCeEChhhcCCCC--cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CC
Confidence 99998532 233445678999999999998764 78999999999999999999999999988888888877654 45
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSF------TEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSA------rELLe~ 1228 (1254)
+..++.++.+||++||++||.+||++ .+++++
T Consensus 244 p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 244 PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 67789999999999999999999998 778764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=379.74 Aligned_cols=258 Identities=24% Similarity=0.343 Sum_probs=217.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
..|++++.||+|+||+||+|++. ++.||||++++....... .....+.+.+|+.+|++++||||+++++++.+..
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~- 88 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR--RGVCREEIEREVSILRQVLHPNIITLHDVYENRT- 88 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCS--SSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEcccccccc--chhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC-
Confidence 37999999999999999999985 778999999875432111 0112356889999999999999999999998655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+.....+||+|||++
T Consensus 89 -~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 89 -DVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp -EEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred -EEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 89999999999999999854 4569999999999999999999999999999999999999833222338999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC--CCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT--IPER 1199 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~--ipe~ 1199 (1254)
............+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+.+..+....+... ....
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred eEcCCCCccccCCCCccEECchHHcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence 8766555555678999999999998764 78999999999999999999999999888888777766544322 2256
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++.++++||.+||..||.+|||+.|++++
T Consensus 245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 78999999999999999999999999964
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=378.08 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=217.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|.++ ++.||||++..... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~- 101 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL------SARDFQKLEREARICRKLQHPNIVRLHDSIQEES- 101 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 37999999999999999999984 77899999986532 1223467889999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+.+..+ ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|||++
T Consensus 102 -~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~-~~~~~kl~DfG~a 178 (362)
T 2bdw_A 102 -FHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-KGAAVKLADFGLA 178 (362)
T ss_dssp -EEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS-TTCCEEECCCTTC
T ss_pred -EEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-CCCCEEEeecCcc
Confidence 899999999999999988554 5689999999999999999999999999999999999998432 3467999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC--CC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP--ER 1199 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip--e~ 1199 (1254)
.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+....+....+ ..
T Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (362)
T 2bdw_A 179 IEVNDSEAWHGFAGTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 256 (362)
T ss_dssp BCCTTCCSCCCSCSCTTTCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGG
T ss_pred eEecCCcccccCCCCccccCHHHHccCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 8766555555678999999999998764 8899999999999999999999999888888777777665543332 45
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++++++||.+||+.||.+||++.+++++
T Consensus 257 ~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 257 VTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 78999999999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=365.49 Aligned_cols=261 Identities=25% Similarity=0.361 Sum_probs=215.1
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|++++.||+|+||+||++++. ++.||||++..... ......+.+.+|+.++++++||||+++++++.+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 82 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-----EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE 82 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-----CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-----ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence 34568999999999999999999984 77899999875421 133456788999999999999999999999976
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. .+++||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 83 ~~--~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~----~~~~~kl~Df 155 (294)
T 4eqm_A 83 DD--CYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID----SNKTLKIFDF 155 (294)
T ss_dssp SS--EEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECCC
T ss_pred CC--eEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEEeC
Confidence 55 899999999999999998654 4699999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC--
Q 040257 1119 GLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP-- 1194 (1254)
Q Consensus 1119 GLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp-- 1194 (1254)
|+++...... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...................
T Consensus 156 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T 4eqm_A 156 GIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA--TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVT 233 (294)
T ss_dssp SSSTTC-------------CCSSCCHHHHHTCC--CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHH
T ss_pred CCccccccccccccCccccCccccCHhHhcCCC--CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcc
Confidence 9997654322 233456999999999998764 7889999999999999999999999887666555544443321
Q ss_pred -CCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHHH
Q 040257 1195 -TIPERCDPEWRKLMEQCWAADPEARP-SFTEITSRLRTISAA 1235 (1254)
Q Consensus 1195 -~ipe~iS~eLrdLIkKCLqkDPeKRP-SArELLe~Le~Ll~e 1235 (1254)
..+..+++.+.++|.+||++||.+|| ++.++++.|+.+..+
T Consensus 234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 23466889999999999999999998 999999998877544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=373.77 Aligned_cols=251 Identities=20% Similarity=0.232 Sum_probs=217.1
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|.+. ++.||+|+++... .....+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 74 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---------TDQVLVKKEISILNIARHRNILHLHESFESME- 74 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---------ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-
Confidence 47999999999999999999984 6789999987431 12356789999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||++
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~--~~~~~kl~Dfg~a 151 (321)
T 1tki_A 75 -ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKIIEFGQA 151 (321)
T ss_dssp -EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECCCTTC
T ss_pred -EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC--CCCCEEEEECCCC
Confidence 8999999999999999997766679999999999999999999999999999999999999821 2689999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC--CCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI--PER 1199 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i--pe~ 1199 (1254)
+............||+.|+|||++.+.. ++.++|||||||++|+|++|..||........+..+....+.... ...
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (321)
T 1tki_A 152 RQLKPGDNFRLLFTAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229 (321)
T ss_dssp EECCTTCEEEEEESCGGGSCHHHHTTCE--ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred eECCCCCccccccCChhhcCcHHhcCCC--CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhcc
Confidence 8765544444567999999999998764 789999999999999999999999998888888777766544321 246
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
++.++.+||.+||..||.+|||+.|++++-
T Consensus 230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 230 ISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 789999999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=373.05 Aligned_cols=261 Identities=25% Similarity=0.377 Sum_probs=210.4
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
.+...+|+++++||+|+||+||+|++.++.||||++... ......+.+|+.++++++||||+++++++.+.
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---------DKQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG---------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred ccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC---------chHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 455668999999999999999999999999999999643 12234456699999999999999999999765
Q ss_pred C--CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC----------CcccccCCCCceEeccCC
Q 040257 1040 T--GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK----------NIVHFDLKCENLLVNLRD 1107 (1254)
Q Consensus 1040 n--~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk----------GIIHRDLKPeNILLDsdd 1107 (1254)
. ...+++||||+.+|+|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~--- 165 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK--- 165 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC---
T ss_pred CCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC---
Confidence 4 2357999999999999999955 3599999999999999999999999 999999999999998
Q ss_pred CCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-
Q 040257 1108 PQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSS---NRVSEKVDVFSFGISMWEILTGEEPYADMHC- 1180 (1254)
Q Consensus 1108 ~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~---~kyS~KSDIWSLGVILYELLTGk~PF~~~n~- 1180 (1254)
..+.+||+|||+++...... ......||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.....
T Consensus 166 -~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 166 -NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp -TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred -CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 77899999999997543322 233457999999999998632 1356789999999999999999999975321
Q ss_pred ---------------hhHHHHhhhccCCCCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1181 ---------------GAIIGGIVKNTLRPTIPER-----CDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1181 ---------------~eliqsIlk~~Lrp~ipe~-----iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
......+......+..+.. .+.++.+||.+||+.||++|||+.++++.|+.+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1222222233333333321 245699999999999999999999999999998654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=362.18 Aligned_cols=264 Identities=30% Similarity=0.515 Sum_probs=219.9
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVA 1031 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVk 1031 (1254)
.+...+|++.+.||+|+||+||+|++. ++.||||+++... .....+.+.+|+.+++++ +||||++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-------CcHHHHHHHHHHHHHHhcccCCCeee
Confidence 345568999999999999999999862 3679999997542 123346788999999999 7999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccCCC---------------CCHHHHHHHHHHhhhhhHHhhhCCcccccC
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS---------------LDRRKKLIIAMDAAFGMEYLHSKNIVHFDL 1096 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~---------------LSe~~~lkIa~QIAeALaYLHSkGIIHRDL 1096 (1254)
+++++.... ..+++||||+.+++|.+++...... +++..++.++.||+.||.|||++||+||||
T Consensus 96 ~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~di 174 (316)
T 2xir_A 96 LLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 174 (316)
T ss_dssp EEEEECCTT-SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEecCC-CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccC
Confidence 999987543 3689999999999999999665332 899999999999999999999999999999
Q ss_pred CCCceEeccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CC
Q 040257 1097 KCENLLVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GE 1172 (1254)
Q Consensus 1097 KPeNILLDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk 1172 (1254)
||+|||++ ..+.+||+|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++ |.
T Consensus 175 kp~Nil~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 175 AARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp SGGGEEEC----GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccceEEEC----CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCC
Confidence 99999998 6789999999999754332 122344578899999999865 48999999999999999998 99
Q ss_pred CCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 040257 1173 EPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1173 ~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLE 1237 (1254)
.||.....................+..+++++.++|.+||+.||.+|||+.+++++|+.++.+-.
T Consensus 249 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 249 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 99988765554444444444556677789999999999999999999999999999999987643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=357.71 Aligned_cols=264 Identities=18% Similarity=0.260 Sum_probs=216.5
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVV 1036 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf 1036 (1254)
.+...+|++++.||+|+||+||+|++ .++.||||++..... ...+.+|+.+++.+ +|+||+++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~e~~~~~~l~~~~~i~~~~~~~ 75 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----------APQLRDEYRTYKLLAGCTGIPNVYYFG 75 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----------SCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----------cHHHHHHHHHHHHHhcCCCCCeEEeec
Confidence 34456899999999999999999996 578899999875421 13467799999999 799999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC-CCCCeEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD-PQRPICKV 1115 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd-~snG~VKL 1115 (1254)
.+.. ..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++..+ ...+.+||
T Consensus 76 ~~~~--~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 76 QEGL--HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp EETT--EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred CCCc--eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 7655 889999999 9999999977667799999999999999999999999999999999999998432 23445999
Q ss_pred EeccccccccCcc--------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---hhhHH
Q 040257 1116 GDFGLSRIKRNTL--------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH---CGAII 1184 (1254)
Q Consensus 1116 iDFGLAr~~~~s~--------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n---~~eli 1184 (1254)
+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.... ....+
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 230 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE--QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhcCCC--CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence 9999998654322 234567999999999998764 8999999999999999999999998743 23333
Q ss_pred HHhhhccCC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1185 GGIVKNTLR---PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1185 qsIlk~~Lr---p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
..+...... ......+++++.+||.+||+.||.+||++.+|++.|+.+..++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 231 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 333222211 122346789999999999999999999999999999999887654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=361.78 Aligned_cols=263 Identities=27% Similarity=0.468 Sum_probs=209.5
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEECC---------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCce
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWRG---------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV 1029 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~rG---------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNI 1029 (1254)
..+...+|++.+.||+|+||+||+|++.. ..||+|++.... ....+.+.+|+.++++++||||
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i 74 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--------RNYSESFFEAASMMSKLSHKHL 74 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--------GGGHHHHHHHHHHHHTSCCTTB
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--------HHHHHHHHHHHHHHHhCCCCCE
Confidence 35667799999999999999999998742 459999986531 2234678899999999999999
Q ss_pred eEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCC-
Q 040257 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDP- 1108 (1254)
Q Consensus 1030 VkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~- 1108 (1254)
+++++++.+.. ..++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++..+.
T Consensus 75 v~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 152 (289)
T 4fvq_A 75 VLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDR 152 (289)
T ss_dssp CCEEEEECCTT--CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBG
T ss_pred eEEEEEEEeCC--CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcc
Confidence 99999998655 788999999999999999776666999999999999999999999999999999999999983220
Q ss_pred ---CCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChhhHH
Q 040257 1109 ---QRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG-EEPYADMHCGAII 1184 (1254)
Q Consensus 1109 ---snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTG-k~PF~~~n~~eli 1184 (1254)
..+.+||+|||++....... ...||..|+|||++.+. ..++.++|||||||++|+|++| .+||.........
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~ 228 (289)
T 4fvq_A 153 KTGNPPFIKLSDPGISITVLPKD---ILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228 (289)
T ss_dssp GGTBCCEEEECCCCSCTTTSCHH---HHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred cccccceeeeccCcccccccCcc---ccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH
Confidence 11239999999987543322 23478899999999863 2489999999999999999995 4555554444333
Q ss_pred HHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1185 GGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1185 qsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
... .. ....+...+.++.+||.+||+.||.+|||+.+++++|+.+...-..
T Consensus 229 ~~~-~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 229 QFY-ED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp HHH-HT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred HHh-hc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 322 22 2344556688899999999999999999999999999998765444
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.63 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=218.2
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|++++.||+|+||+||+|.+. ++.||+|++..... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL------SARDFQKLEREARICRKLQHPNIVRLHDSIQEES 78 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC------CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence 358999999999999999999984 77899999976532 1233467889999999999999999999997655
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
..++||||+.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|||+
T Consensus 79 --~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 79 --FHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-KGAAVKLADFGL 154 (284)
T ss_dssp --EEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS-TTCCEEECCCTT
T ss_pred --EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC-CCCcEEEeecee
Confidence 789999999999999888654 5699999999999999999999999999999999999997333 345699999999
Q ss_pred cccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC--CC
Q 040257 1121 SRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI--PE 1198 (1254)
Q Consensus 1121 Ar~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i--pe 1198 (1254)
+.............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+......... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T 3kk8_A 155 AIEVNDSEAWHGFAGTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 232 (284)
T ss_dssp CEECCSSCBCCCSCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred eEEcccCccccCCCCCcCCcCchhhcCCC--CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhc
Confidence 98766655555677999999999998764 789999999999999999999999998887777777665544332 24
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+++++.+||.+||+.||.+|||+.|++++
T Consensus 233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 233 TVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 689999999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=368.75 Aligned_cols=262 Identities=29% Similarity=0.571 Sum_probs=215.2
Q ss_pred cccccccCceEEEEEeeeCcEEEEEEEEC--Cce----EEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeE
Q 040257 958 LQIIKNVDLEELRELGSGTYGTVYHGKWR--GSD----VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVA 1031 (1254)
Q Consensus 958 lq~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~----VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVk 1031 (1254)
...++..+|++++.||+|+||+||+|++. ++. ||+|.++... .....+.+.+|+.++++++||||++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~ 81 (327)
T 3poz_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCR 81 (327)
T ss_dssp SEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------------CHHHHHHHHHHHHHCCBTTBCC
T ss_pred HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-------CHHHHHHHHHHHHHHHhCCCCCEeE
Confidence 34567789999999999999999999984 343 5666664321 2233467889999999999999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCC
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRP 1111 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG 1111 (1254)
+++++.+. ..++|+||+.+|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||++ .++
T Consensus 82 ~~~~~~~~---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~----~~~ 154 (327)
T 3poz_A 82 LLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQ 154 (327)
T ss_dssp EEEEEESS---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETT
T ss_pred EEEEEecC---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC----CCC
Confidence 99999864 47889999999999999987777899999999999999999999999999999999999998 778
Q ss_pred eEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHh
Q 040257 1112 ICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGI 1187 (1254)
Q Consensus 1112 ~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsI 1187 (1254)
.+||+|||+++...... ......+|..|+|||++.+. .++.++|||||||++|||++ |+.||...........+
T Consensus 155 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 232 (327)
T 3poz_A 155 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232 (327)
T ss_dssp EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred CEEEccCcceeEccCCcccccccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH
Confidence 99999999998643322 22234568899999999865 48999999999999999999 99999987776665554
Q ss_pred hhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1188 lk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
... .....+..++.++.+|+.+||+.+|.+||++.+++++|+.+....
T Consensus 233 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 233 EKG-ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp HTT-CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred HcC-CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 433 344566778999999999999999999999999999999987643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=356.18 Aligned_cols=266 Identities=33% Similarity=0.566 Sum_probs=225.7
Q ss_pred cccccCceEEE-EEeeeCcEEEEEEEE----CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 960 IIKNVDLEELR-ELGSGTYGTVYHGKW----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 960 ~Ik~~dYeiLk-kLGeGsFGtVYlAk~----rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
.+...+|.++. .||+|+||+||+|.+ .+..||||+++... .....+.+.+|+.++++++||||+++++
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 77 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIG 77 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-------chhHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 35566788887 999999999999986 36679999997531 2334567889999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
++..+ .+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 78 ~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~k 150 (287)
T 1u59_A 78 VCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAK 150 (287)
T ss_dssp EEESS---SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----ETTEEE
T ss_pred EecCC---CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc----CCCCEE
Confidence 99432 58999999999999999977667799999999999999999999999999999999999998 678999
Q ss_pred EEeccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhh
Q 040257 1115 VGDFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk 1189 (1254)
|+|||+++...... ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||...........+..
T Consensus 151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~ 228 (287)
T 1u59_A 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228 (287)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred ECcccceeeeccCcceeeccccccccccccCHHHhccCC--CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc
Confidence 99999998653321 122344688999999998653 7899999999999999998 9999998877776665554
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCIN 1242 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk~~k 1242 (1254)
. ..+..+..+++++.+||.+||..+|.+||++.+++++|+.+..+.......
T Consensus 229 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 229 G-KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp T-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred C-CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 3 345567789999999999999999999999999999999999998876543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=353.90 Aligned_cols=261 Identities=33% Similarity=0.592 Sum_probs=220.6
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
+.+...+|++++.||+|+||.||+|++. +..||||+++.... ..+.+.+|+.++++++||||+++++++.
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---------SPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---------cHHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 3456678999999999999999999986 45799999875421 1356889999999999999999999986
Q ss_pred cCCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
++ .+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 79 ~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~kl~ 151 (279)
T 1qpc_A 79 QE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIA 151 (279)
T ss_dssp SS---SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEEC
T ss_pred CC---CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc----CCCCEEEC
Confidence 43 5889999999999999986542 3689999999999999999999999999999999999998 77899999
Q ss_pred eccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCC
Q 040257 1117 DFGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1117 DFGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
|||++....... ......++..|+|||++.+.. ++.++||||||+++|+|++ |+.||......+....+... ..
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~ 228 (279)
T 1qpc_A 152 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YR 228 (279)
T ss_dssp CCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CC
T ss_pred CCcccccccCcccccccCCCCccCccChhhhccCC--CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-cC
Confidence 999998654332 223345788999999998653 7899999999999999999 99999988777766665443 44
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
...+..++.++.+||.+||..||++|||+.++++.|+.+..+...
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 556678899999999999999999999999999999999887654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=377.58 Aligned_cols=267 Identities=30% Similarity=0.522 Sum_probs=222.5
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeE
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVA 1031 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVk 1031 (1254)
..+...+|++++.||+|+||+||+|++. ++.||||+++... ......++.+|+.++++++||||++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~ 138 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-------SEQDELDFLMEALIISKFNHQNIVR 138 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-------CHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-------ChhhHHHHHHHHHHHHhCCCCCCCe
Confidence 3455678999999999999999999953 4569999986431 1223456889999999999999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccC------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEecc
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNL 1105 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDs 1105 (1254)
+++++.+.. ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 139 ~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 216 (367)
T 3l9p_A 139 CIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 216 (367)
T ss_dssp EEEEECSSS--SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred EEEEEecCC--CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEec
Confidence 999997655 7899999999999999986543 35899999999999999999999999999999999999984
Q ss_pred CCCCCCeEEEEeccccccccC---ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChh
Q 040257 1106 RDPQRPICKVGDFGLSRIKRN---TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCG 1181 (1254)
Q Consensus 1106 dd~snG~VKLiDFGLAr~~~~---s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~ 1181 (1254)
.+ ....+||+|||+++.... ........||+.|+|||++.+. .++.++|||||||+||||++ |..||......
T Consensus 217 ~~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~~ 293 (367)
T 3l9p_A 217 PG-PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 293 (367)
T ss_dssp SS-TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CC-CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 33 345699999999974321 1222335578999999999865 48999999999999999998 99999988877
Q ss_pred hHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1182 AIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1182 eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
+....+.... ....+..++..+.+||.+||+.||.+||++.+|+++|+.+....+.
T Consensus 294 ~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 294 EVLEFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp HHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred HHHHHHHcCC-CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 7776665543 4456778899999999999999999999999999999998876554
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=359.29 Aligned_cols=261 Identities=33% Similarity=0.607 Sum_probs=206.2
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
..+...+|++.+.||+|+||+||+|++.+ .||||+++.... .....+.+.+|+.++++++||||+++++++..
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAP------TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSC------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCC------CHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC
Confidence 45677799999999999999999998765 599999975421 23345678999999999999999999997643
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
..+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 92 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~----~~~~~kl~Df 164 (289)
T 3og7_A 92 ---PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH----EDNTVKIGDF 164 (289)
T ss_dssp ---SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----TTTEEEECCC
T ss_pred ---CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC----CCCCEEEccc
Confidence 268899999999999999977777899999999999999999999999999999999999999 7789999999
Q ss_pred cccccccC---ccccCCCCCCCCccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhh-hccCC
Q 040257 1119 GLSRIKRN---TLVSGGVRGTLPWMAPELLNGS-SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIV-KNTLR 1193 (1254)
Q Consensus 1119 GLAr~~~~---s~~sts~~GT~~YmAPEVLrG~-~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIl-k~~Lr 1193 (1254)
|+++.... ........||+.|+|||++... ...++.++||||||+++|+|++|+.||........+.... .....
T Consensus 165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (289)
T 3og7_A 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244 (289)
T ss_dssp C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC
T ss_pred eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC
Confidence 99975432 2223345699999999998632 2347899999999999999999999998866554444333 33332
Q ss_pred C---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1194 P---TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1194 p---~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
+ .....+++.+.+||.+||+.+|.+|||+.++++.|+.+.
T Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 2 234568899999999999999999999999999998874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=365.43 Aligned_cols=251 Identities=31% Similarity=0.418 Sum_probs=205.2
Q ss_pred cCceEEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.+|++++.||+|+||+||+|++ +++.||||++.... ........+.+|+.++++++||||+++++++.+..
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 92 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA------EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER-- 92 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS--
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccc------ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC--
Confidence 3799999999999999999998 57789999997542 12234567889999999999999999999997655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 93 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~----~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 93 CLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN----SDGALKLADFGLAR 167 (311)
T ss_dssp CEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCTTCE
T ss_pred EEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC----CCCCEEEccCcCce
Confidence 8999999997 488888877667799999999999999999999999999999999999998 77899999999998
Q ss_pred cccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC-------
Q 040257 1123 IKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP------- 1194 (1254)
Q Consensus 1123 ~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp------- 1194 (1254)
..... .......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||........+..+......+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSK-KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp ETTSCCC---CCCCCCTTCCHHHHTTCC-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred ecCCCcccccCCcccCCcCCHHHhcCCC-CCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence 65432 2234456899999999997642 47899999999999999999999998877665555543211100
Q ss_pred ---------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 ---------------------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 ---------------------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.....+++++.+||.+||++||.+|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0113467899999999999999999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=383.88 Aligned_cols=256 Identities=34% Similarity=0.634 Sum_probs=221.2
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+.+...+|++++.||+|+||+||+|+++++.||||+++... ..+.|.+|+.+|++++||||+++++++.+
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----------TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----------HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 45677799999999999999999999999999999997542 23568899999999999999999999865
Q ss_pred CCCCceEEEEEecccCchhhhhhccCC-CCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDR-SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~-~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
.. ..+++||||+.+|+|.+++..... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 258 ~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~----~~~~~kl~D 332 (450)
T 1k9a_A 258 EK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSD 332 (450)
T ss_dssp TT-SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTSCEEECC
T ss_pred CC-CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC----CCCCEEEee
Confidence 43 368999999999999999976544 379999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
||+++...... ....++..|+|||++.+. .++.++|||||||+||||++ |+.||......+....+..+ .+...
T Consensus 333 fG~a~~~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~ 407 (450)
T 1k9a_A 333 FGLTKEASSTQ--DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 407 (450)
T ss_dssp CTTCEECC--------CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-CCCCC
T ss_pred CCCcccccccc--cCCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCC
Confidence 99998543322 223578899999999865 48999999999999999998 99999988877777666543 45667
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
+..+++++.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 78899999999999999999999999999999998865
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=360.30 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=204.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.+|++++.||+|+||+||+|++. ++.||||++..... .......+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE------DEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-- 73 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG------GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc------ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC--
Confidence 37999999999999999999984 77899999975421 1122356778999999999999999999998655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~Dfg~~~ 148 (288)
T 1ob3_A 74 RLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLAR 148 (288)
T ss_dssp CEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECCTTHHH
T ss_pred eEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEEeECcccc
Confidence 89999999965 99998877667899999999999999999999999999999999999998 77899999999997
Q ss_pred cccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC---------
Q 040257 1123 IKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL--------- 1192 (1254)
Q Consensus 1123 ~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L--------- 1192 (1254)
..... .......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||........+..+.....
T Consensus 149 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 149 AFGIPVRKYTHEIVTLWYRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp HHCC---------CCCTTCCHHHHTTCC-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccCccccccccccccccccCchheeCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence 54332 2223456899999999997642 478999999999999999999999998776655554432100
Q ss_pred -------CC-----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 -------RP-----------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 -------rp-----------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+ .....+++++.+||.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 1124578999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=353.12 Aligned_cols=260 Identities=30% Similarity=0.542 Sum_probs=215.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--Cc---eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GS---DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs---~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
..|+..+.||+|+||+||+|++. +. .||+|++.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 93 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-------EMQQVEAFLREGLLMRGLNHPNVLALIGIMLP 93 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-------cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 35777899999999999999873 22 59999986431 22345778899999999999999999999976
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. ...++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 94 ~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~----~~~~~kl~Df 168 (298)
T 3pls_A 94 PE-GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD----ESFTVKVADF 168 (298)
T ss_dssp SS-SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECCT
T ss_pred CC-CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc----CCCcEEeCcC
Confidence 54 345899999999999999987777899999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCc-----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCC-CCCCCChhhHHHHhhhccC
Q 040257 1119 GLSRIKRNT-----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEE-PYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1119 GLAr~~~~s-----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~-PF~~~n~~eliqsIlk~~L 1192 (1254)
|+++..... .......+|..|+|||.+.+. .++.++|||||||++|+|++|.. ||...........+.. ..
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-~~ 245 (298)
T 3pls_A 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-GR 245 (298)
T ss_dssp TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT-TC
T ss_pred CCcccccCCcccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc-CC
Confidence 999754332 122345678899999999865 48999999999999999999554 5555555555444443 33
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
....+..++..+.+||.+||+.||.+|||+.++++.|+.+..++..
T Consensus 246 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 4556777899999999999999999999999999999999988654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=365.57 Aligned_cols=264 Identities=34% Similarity=0.600 Sum_probs=219.0
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECC------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRG------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rG------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
.+...+|.+.+.||+|+||+||+|.+.. ..||||+++... .......+.+|+.++++++||||++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 112 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-------TEKQRVDFLGEAGIMGQFSHHNIIRLE 112 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 5667789999999999999999998742 249999987532 223356788999999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
+++.+.. .+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 113 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~~ 186 (333)
T 1mqb_A 113 GVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVC 186 (333)
T ss_dssp EEECSSS--SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCE
T ss_pred EEEecCC--CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC----CCCcE
Confidence 9997654 89999999999999999977767899999999999999999999999999999999999998 77899
Q ss_pred EEEeccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhh
Q 040257 1114 KVGDFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIV 1188 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIl 1188 (1254)
||+|||+++...... ......+|..|+|||++.+. .++.++|||||||++|||++ |+.||...........+.
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 264 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 999999997653321 12223467889999999865 48999999999999999999 999999888777766665
Q ss_pred hccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhc
Q 040257 1189 KNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239 (1254)
Q Consensus 1189 k~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk 1239 (1254)
.. .....+..++..+.+||.+||+.+|.+||++.++++.|+.+.......
T Consensus 265 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 265 DG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp TT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred CC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 44 344556778999999999999999999999999999999998765543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=365.50 Aligned_cols=265 Identities=30% Similarity=0.527 Sum_probs=224.0
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECC-------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVA 1031 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVk 1031 (1254)
.+...+|++.+.||+|+||+||+|.+.+ ..||+|+++... .....+.+.+|+.+++++ +||||++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~ 114 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-------HADEKEALMSELKIMSHLGQHENIVN 114 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-------ChHHHHHHHHHHHHHHhhcCCCCeee
Confidence 3556689999999999999999999842 369999987532 123356788999999999 8999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhcc-------------CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCC
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK-------------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKC 1098 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kr-------------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKP 1098 (1254)
+++++.+.. .+++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 115 ~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 192 (333)
T 2i1m_A 115 LLGACTHGG--PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAA 192 (333)
T ss_dssp EEEEECSSS--SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEecCC--ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCccc
Confidence 999997655 789999999999999998653 24579999999999999999999999999999999
Q ss_pred CceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCC
Q 040257 1099 ENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEP 1174 (1254)
Q Consensus 1099 eNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~P 1174 (1254)
+|||++ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus 193 ~NIl~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p 266 (333)
T 2i1m_A 193 RNVLLT----NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNP 266 (333)
T ss_dssp GGCEEE----GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred ceEEEC----CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCC
Confidence 999998 77899999999997543221 22334577889999999865 48999999999999999998 9999
Q ss_pred CCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhc
Q 040257 1175 YADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239 (1254)
Q Consensus 1175 F~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk 1239 (1254)
|...........+.........+..++..+.+||.+||+.||.+|||+.+++++|+.+..+.+.+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 331 (333)
T 2i1m_A 267 YPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE 331 (333)
T ss_dssp STTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred CcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhcc
Confidence 98877666666666666666677788999999999999999999999999999999998876653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=354.51 Aligned_cols=260 Identities=34% Similarity=0.575 Sum_probs=217.4
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECC-----ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRG-----SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-----s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
.+...+|++.+.||+|+||+||+|++.+ ..||||++.... .....+.+.+|+.++++++||||+++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 80 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-------TLDNKEKFMSEAVIMKNLDHPHIVKLIG 80 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-------CHHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-------CchHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 4456689999999999999999998742 249999987542 1233567899999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
++.++ ..++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 81 ~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~k 153 (281)
T 3cc6_A 81 IIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA----SPECVK 153 (281)
T ss_dssp EECSS---SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE----ETTEEE
T ss_pred EEcCC---CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC----CCCcEE
Confidence 98653 46899999999999999977767799999999999999999999999999999999999998 678999
Q ss_pred EEeccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhcc
Q 040257 1115 VGDFGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNT 1191 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~ 1191 (1254)
|+|||++....... ......+++.|+|||++.+. .++.++||||||+++|+|++ |+.||...........+...
T Consensus 154 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~- 230 (281)
T 3cc6_A 154 LGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG- 230 (281)
T ss_dssp ECCCCGGGCC---------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-
T ss_pred eCccCCCcccccccccccccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-
Confidence 99999997654322 22334578899999999865 48999999999999999998 99999877776666555443
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1192 Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
.....+..+++.+.+||.+||..||.+||++.+++++|+.+...-
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 231 DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 334556778999999999999999999999999999999987653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.21 Aligned_cols=268 Identities=31% Similarity=0.518 Sum_probs=207.8
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECCc-----eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRGS-----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs-----~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
.+...+|++++.||+|+||+||+|++... .||||+++.... .....+.+.+|+.++++++||||+++++
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 92 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII------ASSDIEEFLREAACMKEFDHPHVAKLVG 92 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------------CHHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc------CHHHHHHHHHHHHHHHHCCCCceehhhc
Confidence 45566899999999999999999987432 699999875422 1223567889999999999999999999
Q ss_pred eeecCCCC----ceEEEEEecccCchhhhhhccC-----CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEecc
Q 040257 1035 VVPDGTGG----TLATVTEFMVNGSLKHVLLKKD-----RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNL 1105 (1254)
Q Consensus 1035 vf~Ddn~~----~L~LVMEYm~GGSL~d~L~kre-----~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDs 1105 (1254)
++.+.... ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~- 171 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA- 171 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc-
Confidence 98765421 2489999999999999985432 2589999999999999999999999999999999999998
Q ss_pred CCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChh
Q 040257 1106 RDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCG 1181 (1254)
Q Consensus 1106 dd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~ 1181 (1254)
.++.+||+|||+++...... ......+++.|+|||++.+. .++.++|||||||++|+|++ |+.||......
T Consensus 172 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 246 (323)
T 3qup_A 172 ---EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246 (323)
T ss_dssp ---TTSCEEECCCCC-----------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred ---CCCCEEEeeccccccccccccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence 77899999999997543322 12234467889999999866 48999999999999999999 99999988877
Q ss_pred hHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 040257 1182 AIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKC 1240 (1254)
Q Consensus 1182 eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk~ 1240 (1254)
.....+.... ....+..++.++.+||.+||+.||.+|||+.++++.|+.++....-..
T Consensus 247 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 247 EIYNYLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp GHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred HHHHHHhcCC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 7777665543 345567789999999999999999999999999999999987654433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=366.72 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=214.8
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|++.+.||+|+||+||+|++. ++.||||+++........ .....+.+.+|+.+|++++||||+++++++.+..
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 87 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR--RGVSREDIEREVSILKEIQHPNVITLHEVYENKT-- 87 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEcccccccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--
Confidence 6899999999999999999985 778999999865322111 0112456889999999999999999999998655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+.....+||+|||+++
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 89999999999999999854 45699999999999999999999999999999999999998433233489999999998
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC--CCCCC
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT--IPERC 1200 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~--ipe~i 1200 (1254)
............||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+.+..+........ ....+
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred ECCCCCccccccCCcCcCCceeecCCC--CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccC
Confidence 765444445567999999999998664 88999999999999999999999998877777666655433221 22467
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+..+++||.+||+.||.+|||+.+++++
T Consensus 245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 245 SALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 8999999999999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=367.73 Aligned_cols=254 Identities=28% Similarity=0.414 Sum_probs=207.1
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE-----CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW-----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~-----rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
.+...+|++++.||+|+||+||++++ .++.||||++++..... .......+.+|+.+|++++||||+++++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR----NAKDTAHTKAERNILEEVKHPFIVDLIY 88 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhh----hhhHHHHHHHHHHHHHhCCCCCccceeE
Confidence 45566899999999999999999987 46789999998653221 1223456788999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
++.+.. .+++||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 89 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~----~~~~~k 161 (327)
T 3a62_A 89 AFQTGG--KLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN----HQGHVK 161 (327)
T ss_dssp EEECSS--CEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC----TTSCEE
T ss_pred EEEcCC--EEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC----CCCcEE
Confidence 998755 899999999999999998654 5689999999999999999999999999999999999998 778999
Q ss_pred EEecccccccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC
Q 040257 1115 VGDFGLSRIKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1115 LiDFGLAr~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
|+|||+++... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........+..+.....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~- 238 (327)
T 3a62_A 162 LTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG--HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL- 238 (327)
T ss_dssp ECCCSCC----------CTTSSCCTTSCHHHHTTSC--CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-
T ss_pred EEeCCcccccccCCccccccCCCcCccCHhhCcCCC--CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-
Confidence 99999987532 223344567999999999998764 78999999999999999999999998888777777766543
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
.++..++.++++||.+||+.||.+|| ++.+++++
T Consensus 239 -~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 -NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 45677899999999999999999999 78888875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=358.21 Aligned_cols=255 Identities=30% Similarity=0.532 Sum_probs=202.5
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhc--CCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN--LHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkr--LnHPNIVkLyGvf~D 1038 (1254)
+...+|++++.||+|+||+||+|+++++.||||++.... ...+.+|.+++.. ++||||+++++++.+
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~ 73 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----------EKSWFRETELYNTVMLRHENILGFIASDMT 73 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----------chhhHHHHHHHHHhhccCcCeeeEEEeecc
Confidence 345689999999999999999999999999999986431 2344556666655 899999999998654
Q ss_pred C--CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhh--------hCCcccccCCCCceEeccCCC
Q 040257 1039 G--TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLH--------SKNIVHFDLKCENLLVNLRDP 1108 (1254)
Q Consensus 1039 d--n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLH--------SkGIIHRDLKPeNILLDsdd~ 1108 (1254)
. ....+++||||+.+++|.+++.. ..+++..++.++.||+.||.||| +++|+||||||+|||++
T Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~---- 147 (301)
T 3q4u_A 74 SRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK---- 147 (301)
T ss_dssp EETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC----
T ss_pred ccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc----
Confidence 3 23468999999999999999943 46999999999999999999999 99999999999999998
Q ss_pred CCCeEEEEeccccccccCccc-----cCCCCCCCCccCcccccCCCC----CCCchhHHHHHHHHHHHHHcC--------
Q 040257 1109 QRPICKVGDFGLSRIKRNTLV-----SGGVRGTLPWMAPELLNGSSN----RVSEKVDVFSFGISMWEILTG-------- 1171 (1254)
Q Consensus 1109 snG~VKLiDFGLAr~~~~s~~-----sts~~GT~~YmAPEVLrG~~~----kyS~KSDIWSLGVILYELLTG-------- 1171 (1254)
.++.+||+|||+++....... .....||+.|+|||++.+... .++.++|||||||++|||++|
T Consensus 148 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~ 227 (301)
T 3q4u_A 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227 (301)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence 778999999999975433221 233479999999999986532 245799999999999999999
Q ss_pred --CCCCCCCCh-----hhHHHHhhhccCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1172 --EEPYADMHC-----GAIIGGIVKNTLRPTIPE-----RCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1172 --k~PF~~~n~-----~eliqsIlk~~Lrp~ipe-----~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
+.||..... .............+..+. .++.++.+||.+||+.||.+|||+.++++.|+.+
T Consensus 228 ~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 888865322 222222222223333332 2457899999999999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=370.19 Aligned_cols=248 Identities=26% Similarity=0.442 Sum_probs=215.6
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|++++.||+|+||+||+++++ ++.||||++++.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-----RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC
Confidence 458999999999999999999984 778999999864211 1122456778999999999999999999998765
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+.+++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++++||+|||+
T Consensus 80 --~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~~kL~Dfg~ 152 (318)
T 1fot_A 80 --QIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGF 152 (318)
T ss_dssp --EEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTSCEEECCCSS
T ss_pred --EEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc----CCCCEEEeecCc
Confidence 899999999999999998654 5699999999999999999999999999999999999998 788999999999
Q ss_pred cccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1121 SRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1121 Ar~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
++..... ....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+....+ .++..+
T Consensus 153 a~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~p~~~ 226 (318)
T 1fot_A 153 AKYVPDV--TYTLCGTPDYIAPEVVSTKP--YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--RFPPFF 226 (318)
T ss_dssp CEECSSC--BCCCCSCTTTCCHHHHTTCC--BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--CCCTTS
T ss_pred ceecCCc--cccccCCccccCHhHhcCCC--CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCC
Confidence 9865443 34567999999999998764 78899999999999999999999998888887777776543 456778
Q ss_pred cHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
+.++++||.+||..||.+|| ++.+++++
T Consensus 227 ~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 99999999999999999999 89999865
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=356.28 Aligned_cols=260 Identities=30% Similarity=0.542 Sum_probs=215.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEECC-----ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 964 VDLEELRELGSGTYGTVYHGKWRG-----SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~rG-----s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
.+|++.+.||+|+||+||+|++.. ..+|+|.+.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-------CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 468999999999999999998732 248999886431 23345678899999999999999999998654
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. ...++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 98 ~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~kl~Df 172 (298)
T 3f66_A 98 SE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD----EKFTVKVADF 172 (298)
T ss_dssp SS-SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECSC
T ss_pred CC-CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC----CCCCEEECcc
Confidence 33 478899999999999999977777799999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCcc-----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccC
Q 040257 1119 GLSRIKRNTL-----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1119 GLAr~~~~s~-----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~L 1192 (1254)
|+++...... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |.+||...........+....
T Consensus 173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~- 249 (298)
T 3f66_A 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR- 249 (298)
T ss_dssp GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-
T ss_pred cccccccccchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-
Confidence 9997543322 22334577889999999865 48999999999999999999 677777766666555554433
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
....+..++..+.+||.+||+.||.+|||+.++++.|+.++..+..
T Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 250 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 3455677899999999999999999999999999999999886654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=357.13 Aligned_cols=251 Identities=27% Similarity=0.353 Sum_probs=204.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|++. ++.||||++..... .......+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS------STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC------cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC-
Confidence 37999999999999999999984 67899999986432 1223466789999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+ +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 75 -~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~----~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 75 -KLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLA 148 (292)
T ss_dssp -EEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred -EEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeecccc
Confidence 89999999965 66666666667899999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCC-CCCChhhHHHHhhhccCC------
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY-ADMHCGAIIGGIVKNTLR------ 1193 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF-~~~n~~eliqsIlk~~Lr------ 1193 (1254)
+..... .......||+.|+|||++.+.. .++.++|||||||++|+|++|..|| ........+..+......
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCS-CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred eecCCccccccCCccccCCcChHHHcCCC-CcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence 865432 2334457899999999998653 3799999999999999999988875 455544444444321110
Q ss_pred ---------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 ---------------------PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 ---------------------p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
......++.++++||.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 01123478899999999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=372.04 Aligned_cols=252 Identities=22% Similarity=0.390 Sum_probs=210.7
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVP 1037 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~ 1037 (1254)
+...+|++++.||+|+||+||+|+++ ++.||||++++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 80 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN-----DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 80 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC-----SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc-----chHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence 34458999999999999999999985 678999999875432 223456678899999987 8999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. .+++||||+.+++|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++++||+|
T Consensus 81 ~~~--~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~~kL~D 153 (345)
T 3a8x_A 81 TES--RLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLTD 153 (345)
T ss_dssp CSS--EEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECC
T ss_pred eCC--EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC----CCCCEEEEe
Confidence 755 899999999999999998654 5699999999999999999999999999999999999998 788999999
Q ss_pred cccccccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---------ChhhHHHHh
Q 040257 1118 FGLSRIKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADM---------HCGAIIGGI 1187 (1254)
Q Consensus 1118 FGLAr~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~---------n~~eliqsI 1187 (1254)
||+++... ........+||+.|+|||++.+.. ++.++|||||||+||||++|+.||... ........+
T Consensus 154 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i 231 (345)
T 3a8x_A 154 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231 (345)
T ss_dssp GGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred ccccccccCCCCcccccCCCccccCccccCCCC--CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence 99998532 233345678999999999998764 789999999999999999999999752 222333444
Q ss_pred hhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 040257 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSF------TEITSR 1228 (1254)
Q Consensus 1188 lk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSA------rELLe~ 1228 (1254)
.... ..++..++.++++||++||+.||.+||++ .+++++
T Consensus 232 ~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 232 LEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 4433 34677889999999999999999999985 677654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=369.60 Aligned_cols=261 Identities=28% Similarity=0.522 Sum_probs=214.6
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEEC--Cce----EEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEE
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWR--GSD----VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAF 1032 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~----VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkL 1032 (1254)
..+...+|++++.||+|+||+||+|++. ++. ||+|.+...... .....+.+|+.++++++||||+++
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~ 80 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-------QSFQAVTDHMLAIGSLDHAHIVRL 80 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC-------SCBCSCCHHHHHHHTCCCTTBCCE
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH-------HHHHHHHHHHHHHhcCCCCCcCeE
Confidence 3566779999999999999999999984 444 677766533211 112346679999999999999999
Q ss_pred eeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCe
Q 040257 1033 YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPI 1112 (1254)
Q Consensus 1033 yGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~ 1112 (1254)
++++.+ ..+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ..+.
T Consensus 81 ~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~----~~~~ 153 (325)
T 3kex_A 81 LGLCPG---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK----SPSQ 153 (325)
T ss_dssp EEEECB---SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES----SSSC
T ss_pred EEEEcC---CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC----CCCe
Confidence 999864 368899999999999999977666799999999999999999999999999999999999998 7789
Q ss_pred EEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhh
Q 040257 1113 CKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIV 1188 (1254)
Q Consensus 1113 VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIl 1188 (1254)
+||+|||+++...... ......+|..|+|||++.+.. ++.++|||||||++|+|++ |+.||...........+.
T Consensus 154 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 231 (325)
T 3kex_A 154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231 (325)
T ss_dssp EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH
T ss_pred EEECCCCcccccCcccccccccCCCCcccccChHHhccCC--CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH
Confidence 9999999998653322 234456888999999998654 8999999999999999999 999999877666665554
Q ss_pred hccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1189 KNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1189 k~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
.. .....+..++.++.+||.+||..||.+||++.+++++|+.+....
T Consensus 232 ~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 232 KG-ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp TT-CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred cC-CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 43 344556678889999999999999999999999999999986543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=377.72 Aligned_cols=262 Identities=32% Similarity=0.592 Sum_probs=212.2
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC-----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR-----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r-----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
.+...+|++.+.||+|+||+||+|++. +..||||+++... .....+.+.+|+.++++++||||+++++
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~ 113 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-------TEKQRRDFLGEASIMGQFDHPNIIRLEG 113 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 455668999999999999999999874 5569999987531 2334567899999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
++.+.. .+++||||+.+++|.+++.+....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+|
T Consensus 114 ~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~k 187 (373)
T 2qol_A 114 VVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN----SNLVCK 187 (373)
T ss_dssp EECSSS--SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEE
T ss_pred EEeeCC--ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc----CCCCEE
Confidence 997654 78999999999999999987777899999999999999999999999999999999999998 778999
Q ss_pred EEeccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhh
Q 040257 1115 VGDFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk 1189 (1254)
|+|||+++...... ......++..|+|||++.+. .++.++|||||||+||||++ |+.||...........+..
T Consensus 188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~ 265 (373)
T 2qol_A 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265 (373)
T ss_dssp ECCC----------------------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT
T ss_pred ECcCccccccccCCccceeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999998654321 11223357789999999865 48999999999999999998 9999998887777666554
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLE 1237 (1254)
. .....+..++..+.+||.+||+.||.+||++.++++.|+.+.....
T Consensus 266 ~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 266 G-YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp T-EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred C-CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 3 3344566789999999999999999999999999999999977543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=366.31 Aligned_cols=261 Identities=21% Similarity=0.257 Sum_probs=211.2
Q ss_pred cccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeec
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPD 1038 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~D 1038 (1254)
...+|++++.||+|+||+||+|++ +++.||||++..... ...+.+|+.+++++ +||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----------APQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----------SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----------hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 446899999999999999999997 578899999875421 13467899999999 99999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC-CCCCeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD-PQRPICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd-~snG~VKLiD 1117 (1254)
.. ..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++..+ .....+||+|
T Consensus 77 ~~--~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~D 153 (330)
T 2izr_A 77 GK--YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIID 153 (330)
T ss_dssp TT--EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECC
T ss_pred CC--ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEE
Confidence 55 889999999 9999999977667899999999999999999999999999999999999998221 1122399999
Q ss_pred ccccccccCcc--------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---hHHHH
Q 040257 1118 FGLSRIKRNTL--------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG---AIIGG 1186 (1254)
Q Consensus 1118 FGLAr~~~~s~--------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~---eliqs 1186 (1254)
||+++...... ......||+.|+|||++.+.. ++.++|||||||+||||++|+.||...... +.+..
T Consensus 154 Fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~ 231 (330)
T 2izr_A 154 FALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE--QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK 231 (330)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred cccceeeecCCCCccccccccCCcCCCccccChHHHcCCC--CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence 99998543322 124567999999999999764 899999999999999999999999875433 33333
Q ss_pred hhhccCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1187 IVKNTLRPT---IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1187 Ilk~~Lrp~---ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
+........ ....++ ++.+||.+||+.+|.+||++.+|++.|+++..++..
T Consensus 232 i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 232 IGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 322221111 123345 999999999999999999999999999999887643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=362.68 Aligned_cols=263 Identities=27% Similarity=0.504 Sum_probs=218.2
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEE------CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKW------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~------rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
+....|++++.||+|+||+||++.+ +++.||||+++... .....+.+.+|+.+|++++||||+++++
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-------GPQHRSGWKQEIDILRTLYHEHIIKYKG 100 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-------ChHHHHHHHHHHHHHHhCCCcchhhEEE
Confidence 3333459999999999999999876 46779999997541 2234567889999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
++.+.....+++||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~----~~~~~k 174 (318)
T 3lxp_A 101 CCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD----NDRLVK 174 (318)
T ss_dssp EEEETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEE
T ss_pred EEecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc----CCCCEE
Confidence 99886666899999999999999999543 489999999999999999999999999999999999998 778999
Q ss_pred EEeccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---------
Q 040257 1115 VGDFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG--------- 1181 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~--------- 1181 (1254)
|+|||+++...... ......+|..|+|||++.+.. ++.++|||||||++|+|++|+.||......
T Consensus 175 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 252 (318)
T 3lxp_A 175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK--FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252 (318)
T ss_dssp ECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred ECCccccccccccccccccccCCCCCceeeChHHhcCCC--CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccc
Confidence 99999998654322 223445888899999998654 789999999999999999999999753211
Q ss_pred -----hHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1182 -----AIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1182 -----eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
...............+..++.++.+||++||+.||.+|||+.++++.|+.+..++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 253 GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred cchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 112223334445566778999999999999999999999999999999999988864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=354.67 Aligned_cols=262 Identities=34% Similarity=0.599 Sum_probs=223.7
Q ss_pred cccccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeee
Q 040257 958 LQIIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGV 1035 (1254)
Q Consensus 958 lq~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGv 1035 (1254)
.+.+...+|++.+.||+|+||+||+|.+. +..||||++.... ...+.+.+|+.++++++||||++++++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~ 77 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLGV 77 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---------THHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---------HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34567779999999999999999999995 6789999987531 124668899999999999999999999
Q ss_pred eecCCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
+.+.. .+++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 78 ~~~~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~~ 151 (288)
T 3kfa_A 78 CTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVK 151 (288)
T ss_dssp ECSSS--SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC----GGGCEE
T ss_pred EccCC--CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc----CCCCEE
Confidence 97655 789999999999999999653 34599999999999999999999999999999999999998 677899
Q ss_pred EEeccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhcc
Q 040257 1115 VGDFGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNT 1191 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~ 1191 (1254)
|+|||++....... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |..||...........+.. .
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~-~ 228 (288)
T 3kfa_A 152 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-D 228 (288)
T ss_dssp ECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-T
T ss_pred EccCccceeccCCccccccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-c
Confidence 99999998654332 22334567889999999865 48999999999999999999 9999998877766655544 3
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 040257 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1192 Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLE 1237 (1254)
.....+..+++.+.+||.+||..||.+|||+.++++.|+.+..+..
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 4556677899999999999999999999999999999999987643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=376.10 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=215.5
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVP 1037 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~ 1037 (1254)
+...+|++++.||+|+||+||+|+++ ++.||||++++.... .....+.+.+|..+|..+ +||||+++++++.
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-----~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 91 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-----QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 91 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence 34568999999999999999999995 567999999864221 112245678899999988 8999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. .+++||||+.+|+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++++||+|
T Consensus 92 ~~~--~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~----~~g~vkL~D 164 (353)
T 2i0e_A 92 TMD--RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD----SEGHIKIAD 164 (353)
T ss_dssp CSS--EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECC
T ss_pred cCC--EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc----CCCcEEEEe
Confidence 755 899999999999999998654 4699999999999999999999999999999999999998 788999999
Q ss_pred cccccccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1118 FGLSRIKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1118 FGLAr~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
||+++... ........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+....+....+ .+
T Consensus 165 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~ 240 (353)
T 2i0e_A 165 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--AY 240 (353)
T ss_dssp CTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC--BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CC
T ss_pred CCcccccccCCcccccccCCccccChhhhcCCC--cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC--CC
Confidence 99998532 233445678999999999998764 78999999999999999999999999888888888877543 46
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPS-----FTEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPS-----ArELLe~ 1228 (1254)
+..+++++++||.+||++||.+||+ +++++++
T Consensus 241 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 241 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 6789999999999999999999995 5788765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=361.06 Aligned_cols=259 Identities=34% Similarity=0.586 Sum_probs=209.5
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
..+...+|++.+.||+|+||+||+++++++.||||++... ...+.+.+|+.+|++++||||+++++++.+
T Consensus 3 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 72 (307)
T 2eva_A 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----------SERKAFIVELRQLSRVNHPNIVKLYGACLN 72 (307)
T ss_dssp CBCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT
T ss_pred CcCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3456678999999999999999999999999999998632 124678899999999999999999999863
Q ss_pred CCCCceEEEEEecccCchhhhhhccCC--CCCHHHHHHHHHHhhhhhHHhhh---CCcccccCCCCceEeccCCCCCC-e
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDR--SLDRRKKLIIAMDAAFGMEYLHS---KNIVHFDLKCENLLVNLRDPQRP-I 1112 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~--~LSe~~~lkIa~QIAeALaYLHS---kGIIHRDLKPeNILLDsdd~snG-~ 1112 (1254)
..++||||+.+++|.+++..... .+++..++.++.||+.||.|||+ +||+||||||+|||++ .++ .
T Consensus 73 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~----~~~~~ 144 (307)
T 2eva_A 73 ----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV----AGGTV 144 (307)
T ss_dssp ----TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE----TTTTE
T ss_pred ----CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe----CCCCE
Confidence 47899999999999999965432 47899999999999999999999 8999999999999998 444 4
Q ss_pred EEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh-HHHHhhhcc
Q 040257 1113 CKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA-IIGGIVKNT 1191 (1254)
Q Consensus 1113 VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e-liqsIlk~~ 1191 (1254)
+||+|||++...... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||....... .........
T Consensus 145 ~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 220 (307)
T 2eva_A 145 LKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG 220 (307)
T ss_dssp EEECCCCC--------------CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT
T ss_pred EEEcccccccccccc--cccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC
Confidence 899999999754332 2234699999999999875 48899999999999999999999998653322 122222233
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhc
Q 040257 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239 (1254)
Q Consensus 1192 Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk 1239 (1254)
..+..+..++..+.+||.+||+.||.+|||+.++++.|+.+...+...
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 445566778999999999999999999999999999999987765443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=372.20 Aligned_cols=256 Identities=22% Similarity=0.376 Sum_probs=208.4
Q ss_pred ccccCceEEEEEeee--CcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeee
Q 040257 961 IKNVDLEELRELGSG--TYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeG--sFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf 1036 (1254)
....+|++++.||+| +||+||+|++. ++.||||+++.... .....+.+.+|+.++++++||||+++++++
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC------SNEMVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc------ChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 345589999999999 99999999995 77899999986432 234567788999999999999999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
.+.. .+++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||
T Consensus 96 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~----~~~~~kl 169 (389)
T 3gni_B 96 IADN--ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS----VDGKVYL 169 (389)
T ss_dssp EETT--EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEE
T ss_pred EECC--EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEE
Confidence 8765 899999999999999998654 35699999999999999999999999999999999999998 7789999
Q ss_pred EeccccccccCc--------cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHh
Q 040257 1116 GDFGLSRIKRNT--------LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGI 1187 (1254)
Q Consensus 1116 iDFGLAr~~~~s--------~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsI 1187 (1254)
+|||++...... .......||+.|+|||++.+....++.++|||||||++|+|++|+.||........+..+
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249 (389)
T ss_dssp CCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred cccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999987632111 112234689999999999875445899999999999999999999999876655544433
Q ss_pred hhccCC--------------------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 040257 1188 VKNTLR--------------------------------------------PTIPERCDPEWRKLMEQCWAADPEARPSFT 1223 (1254)
Q Consensus 1188 lk~~Lr--------------------------------------------p~ipe~iS~eLrdLIkKCLqkDPeKRPSAr 1223 (1254)
...... ...+..+++++.+||.+||+.||.+|||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 322111 113445788999999999999999999999
Q ss_pred HHHHH
Q 040257 1224 EITSR 1228 (1254)
Q Consensus 1224 ELLe~ 1228 (1254)
|++++
T Consensus 330 ell~h 334 (389)
T 3gni_B 330 TLLNH 334 (389)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.90 Aligned_cols=261 Identities=35% Similarity=0.602 Sum_probs=213.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC---Cc--eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR---GS--DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r---Gs--~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
.+...+|++++.||+|+||+||+|++. ++ .||||+++..... .....+.+.+|+.++++++||||+++++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 88 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPEAMDDFIREVNAMHSLDHRNLIRLYG 88 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-----CHHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence 455678999999999999999999873 22 5899998754221 2334577899999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
++.+. ..++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+|
T Consensus 89 ~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~----~~~~~k 161 (291)
T 1u46_A 89 VVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA----TRDLVK 161 (291)
T ss_dssp EECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTEEE
T ss_pred EEccC---CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc----CCCCEE
Confidence 99764 37899999999999999977667799999999999999999999999999999999999998 678999
Q ss_pred EEeccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhh
Q 040257 1115 VGDFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk 1189 (1254)
|+|||++....... ......+|..|+|||++.+.. ++.++||||||+++|+|++ |+.||...........+..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 239 (291)
T 1u46_A 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239 (291)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred EccccccccccccccchhhhccCCCCceeeCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc
Confidence 99999997653322 223345788899999998654 7899999999999999999 9999999888888877776
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
.......+..++.++.+||.+||..||.+||++.+++++|+.+..
T Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 666666777899999999999999999999999999999987753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=354.88 Aligned_cols=256 Identities=35% Similarity=0.637 Sum_probs=212.4
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
.+...+|++++.||+|+||+||+++++++.||||+++... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred cCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 4556689999999999999999999999999999987431 245688999999999999999999987654
Q ss_pred CCCceEEEEEecccCchhhhhhccCC-CCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDR-SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~-~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
. ..+++||||+.+++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 87 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~Df 161 (278)
T 1byg_A 87 K-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSDF 161 (278)
T ss_dssp ---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTSCEEECCC
T ss_pred C-CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe----CCCcEEEeec
Confidence 3 378999999999999999865432 378999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1119 GLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
|++....... ....++..|+|||++.+. .++.++||||||+++|+|++ |+.||...........+... .....+
T Consensus 162 g~~~~~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 236 (278)
T 1byg_A 162 GLTKEASSTQ--DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAP 236 (278)
T ss_dssp CC--------------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCC
T ss_pred cccccccccc--cCCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCc
Confidence 9987544332 234578899999999865 48999999999999999998 99999988776666655443 445667
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
..+++.+.+||.+||..||.+||++.++++.|+.+...
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 78899999999999999999999999999999998653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=381.61 Aligned_cols=252 Identities=22% Similarity=0.397 Sum_probs=209.1
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVP 1037 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~ 1037 (1254)
+...+|+++++||+|+||+||+|+++ ++.||||++++..... ......+.+|..+|+++ +||||++++++|.
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~-----~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND-----DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC---------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-----HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 44558999999999999999999985 6679999998754321 22234577899999876 8999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. .+++||||+.+|+|..++.+. +.+++..++.++.||+.||.|||++||+||||||+||||+ .++++||+|
T Consensus 124 ~~~--~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~----~~g~ikL~D 196 (396)
T 4dc2_A 124 TES--RLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLTD 196 (396)
T ss_dssp CSS--EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECC
T ss_pred ECC--EEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC----CCCCEEEee
Confidence 765 899999999999999988654 5699999999999999999999999999999999999998 788999999
Q ss_pred cccccc-ccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---------hhhHHHHh
Q 040257 1118 FGLSRI-KRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH---------CGAIIGGI 1187 (1254)
Q Consensus 1118 FGLAr~-~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n---------~~eliqsI 1187 (1254)
||+++. ..........+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.... .......+
T Consensus 197 FGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~--~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i 274 (396)
T 4dc2_A 197 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED--YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274 (396)
T ss_dssp CTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH
T ss_pred cceeeecccCCCccccccCCcccCCchhhcCCC--CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH
Confidence 999985 23334455678999999999999764 7899999999999999999999996432 22233444
Q ss_pred hhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 040257 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSF------TEITSR 1228 (1254)
Q Consensus 1188 lk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSA------rELLe~ 1228 (1254)
... ...++..++.++++||++||++||.+||++ .+++++
T Consensus 275 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 275 LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred hcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 443 345677899999999999999999999985 566654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=362.15 Aligned_cols=264 Identities=33% Similarity=0.570 Sum_probs=218.7
Q ss_pred cccccccCceEEEEEeeeCcEEEEEEEEC--Cce--EEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEE
Q 040257 958 LQIIKNVDLEELRELGSGTYGTVYHGKWR--GSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAF 1032 (1254)
Q Consensus 958 lq~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~--VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkL 1032 (1254)
+..+...+|++.+.||+|+||.||+|++. +.. +|||+++... .....+.+.+|+.+++++ +||||+++
T Consensus 19 ~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~~ 91 (327)
T 1fvr_A 19 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINL 91 (327)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCE
T ss_pred cccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-------chHHHHHHHHHHHHHHhccCCCchhhh
Confidence 34556678999999999999999999874 443 5999887431 122345688999999999 89999999
Q ss_pred eeeeecCCCCceEEEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCC
Q 040257 1033 YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLK 1097 (1254)
Q Consensus 1033 yGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLK 1097 (1254)
++++.+.. .+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 92 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk 169 (327)
T 1fvr_A 92 LGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 169 (327)
T ss_dssp EEEEEETT--EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred ceeeeeCC--ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCc
Confidence 99998765 8999999999999999986543 468999999999999999999999999999999
Q ss_pred CCceEeccCCCCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 040257 1098 CENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYA 1176 (1254)
Q Consensus 1098 PeNILLDsdd~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~ 1176 (1254)
|+|||++ .++.+||+|||+++............+++.|+|||++.+.. ++.++|||||||++|+|++ |+.||.
T Consensus 170 p~NIl~~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 170 ARNILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp GGGEEEC----GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cceEEEc----CCCeEEEcccCcCccccccccccCCCCCccccChhhhcccc--CCchhcchHHHHHHHHHHcCCCCCCC
Confidence 9999998 67799999999997544333333445788999999998654 7899999999999999998 999999
Q ss_pred CCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 040257 1177 DMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1177 ~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLE 1237 (1254)
..........+... .....+..+++++.+||.+||+.||.+|||+.+++++|+.+..+..
T Consensus 244 ~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 244 GMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp TCCHHHHHHHGGGT-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCcHHHHHHHhhcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 88877766665543 3445667789999999999999999999999999999999987643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=383.39 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=216.1
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|.+ +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~- 83 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL------SARDHQKLEREARICRLLKHPNIVRLHDSISEEG- 83 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC------HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS-
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC------CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC-
Confidence 3799999999999999999988 477899999986532 2233567889999999999999999999998665
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+|+|.+.+..+ ..+++..++.++.||+.||.|||++||+||||||+|||++... ..+.+||+|||++
T Consensus 84 -~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~-~~~~vkL~DFG~a 160 (444)
T 3soa_A 84 -HHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL-KGAAVKLADFGLA 160 (444)
T ss_dssp -EEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSS-TTCCEEECCCSSC
T ss_pred -EEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccC-CCCcEEEccCcee
Confidence 899999999999999998655 5699999999999999999999999999999999999998432 4578999999999
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC--C
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP--E 1198 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip--e 1198 (1254)
+..... .......||+.|+|||++.+.. ++.++|||||||+||+|++|..||...........+....+....+ .
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (444)
T 3soa_A 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDP--YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD 238 (444)
T ss_dssp BCCCTTCCBCCCSCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred EEecCCCceeecccCCcccCCHHHhcCCC--CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccc
Confidence 765433 2334567999999999998764 7899999999999999999999999988888888887766544333 4
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+++++++||.+||+.||.+|||+.|++++
T Consensus 239 ~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 239 TVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 689999999999999999999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=352.50 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=213.1
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++.+.||+|+||+||+|.+. +..+|+|++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 79 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--------DVDRFKQEIEIMKSLDHPNIIRLYETFEDNT-- 79 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--------CHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--
Confidence 6999999999999999999985 457999999764221 1456889999999999999999999998655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..++ .++.+||+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS-PDSPLKLIDFGLAA 157 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-TTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCC-CCCcEEEEecccce
Confidence 899999999999999988554 5689999999999999999999999999999999999994222 67899999999998
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC--CCC
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP--ERC 1200 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip--e~i 1200 (1254)
............||+.|+|||++.+. ++.++||||||+++|+|++|+.||...........+.......... ..+
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (277)
T 3f3z_A 158 RFKPGKMMRTKVGTPYYVSPQVLEGL---YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNV 234 (277)
T ss_dssp ECCTTSCBCCCCSCTTTCCHHHHTTC---BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTS
T ss_pred eccCccchhccCCCCCccChHHhccc---CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcC
Confidence 76555555567799999999999764 7889999999999999999999999888877777776654432211 257
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++.+.+||.+||+.||.+||++.+++++
T Consensus 235 ~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 235 SPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 8999999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=384.46 Aligned_cols=261 Identities=33% Similarity=0.574 Sum_probs=222.6
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
+.+...+|++.+.||+|+||+||+|++. +..||||+++.... ..+.|.+|+.+|++++||||+++++++.
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~l~~~~~ 253 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---------SVEAFLAEANVMKTLQHDKLVKLHAVVT 253 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB---------CHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc---------cHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 3566678999999999999999999995 66799999975421 1467889999999999999999999986
Q ss_pred cCCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
. ..+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+||||+ .++.+||+
T Consensus 254 ~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~----~~~~~kl~ 326 (454)
T 1qcf_A 254 K---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIA 326 (454)
T ss_dssp S---SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC----TTCCEEEC
T ss_pred C---CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC----CCCcEEEe
Confidence 3 36899999999999999996542 3688999999999999999999999999999999999998 77899999
Q ss_pred eccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCC
Q 040257 1117 DFGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1117 DFGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
|||+++...... ......++..|+|||++.+. .++.++|||||||+||||++ |+.||......+....+... .+
T Consensus 327 DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~ 403 (454)
T 1qcf_A 327 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YR 403 (454)
T ss_dssp STTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-CC
T ss_pred eCCCceEcCCCceeccCCCcccccccCHHHhccC--CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC
Confidence 999998654322 22334567889999999865 48999999999999999999 99999998887777766544 45
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
...+..+++++.+||.+||+.||++|||+.+|++.|+.+..+.+.
T Consensus 404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 556778999999999999999999999999999999988655443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=353.98 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=206.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||+|+||+||++++. +..+|+|++...... ...+.+.+|+.+|++++||||+++++++.+..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 93 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-------VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH- 93 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-------SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-------hhHHHHHHHHHHHHhCCCchHHhHHHheecCC-
Confidence 37999999999999999999984 678999999865311 11456789999999999999999999998655
Q ss_pred CceEEEEEecccCchhhhhhcc---CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKK---DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kr---e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.+++||||+.+++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+||
T Consensus 94 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~-~~~~~kl~Df 171 (285)
T 3is5_A 94 -NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-PHSPIKIIDF 171 (285)
T ss_dssp -EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSS-TTCCEEECCC
T ss_pred -eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCC-CCCCEEEEee
Confidence 899999999999999988542 46799999999999999999999999999999999999996322 5678999999
Q ss_pred cccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC-CC
Q 040257 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT-IP 1197 (1254)
Q Consensus 1119 GLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~-ip 1197 (1254)
|++.............||+.|+|||++.+. ++.++|||||||++|+|++|+.||.................... ..
T Consensus 172 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (285)
T 3is5_A 172 GLAELFKSDEHSTNAAGTALYMAPEVFKRD---VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC 248 (285)
T ss_dssp CCCCC----------CTTGGGCCHHHHTTC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--
T ss_pred ecceecCCcccCcCcccccCcCChHHhccC---CCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc
Confidence 999866555445566799999999998743 79999999999999999999999998877766665544333222 22
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+++++.+||.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3478999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=361.52 Aligned_cols=263 Identities=29% Similarity=0.502 Sum_probs=221.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC---------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCce
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR---------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNV 1029 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r---------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNI 1029 (1254)
.+...+|++++.||+|+||+||+|++. +..||||+++... .......+.+|+.+++++ +||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~i 103 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNI 103 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-------CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-------cHHHHHHHHHHHHHHHHhhcCCCE
Confidence 455678999999999999999999873 4569999987532 223456788999999999 89999
Q ss_pred eEEeeeeecCCCCceEEEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccc
Q 040257 1030 VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHF 1094 (1254)
Q Consensus 1030 VkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHR 1094 (1254)
+++++++.+.. .+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||
T Consensus 104 v~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 181 (334)
T 2pvf_A 104 INLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181 (334)
T ss_dssp CCEEEEECSSS--CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred eeEEEEEccCC--ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 99999997654 7899999999999999986543 248999999999999999999999999999
Q ss_pred cCCCCceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-
Q 040257 1095 DLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170 (1254)
Q Consensus 1095 DLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT- 1170 (1254)
||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 182 Dlkp~NIll~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~ 255 (334)
T 2pvf_A 182 DLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTL 255 (334)
T ss_dssp CCSGGGEEEC----TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTT
T ss_pred CCccceEEEc----CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC--cChHHHHHHHHHHHHHHHhC
Confidence 9999999998 77899999999997654321 223345788899999998654 7899999999999999999
Q ss_pred CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1171 GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1171 Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
|..||......+....+... .....+..++.++.+||.+||+.+|.+||++.+++++|+.+......
T Consensus 256 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 256 GGSPYPGIPVEELFKLLKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp SCCSSTTCCHHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CCCCcCcCCHHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 99999988777766655544 34556778899999999999999999999999999999999876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=373.57 Aligned_cols=250 Identities=23% Similarity=0.380 Sum_probs=217.6
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
....+|++++.||+|+||+||++++. ++.||||++.+.... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-----KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-----cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 44568999999999999999999984 778999999754211 11234678899999999999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. .+++||||+.+++|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++++||+||
T Consensus 113 ~~--~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~~kL~DF 185 (350)
T 1rdq_E 113 NS--NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDF 185 (350)
T ss_dssp SS--EEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCC
T ss_pred CC--EEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC----CCCCEEEccc
Confidence 65 899999999999999998654 4699999999999999999999999999999999999998 7889999999
Q ss_pred cccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCC
Q 040257 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1119 GLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe 1198 (1254)
|+++..... ....+||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+.......+..... .++.
T Consensus 186 g~a~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~p~ 259 (350)
T 1rdq_E 186 GFAKRVKGR--TWTLCGTPEALAPEIILSKG--YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--RFPS 259 (350)
T ss_dssp TTCEECSSC--BCCCEECGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCT
T ss_pred ccceeccCC--cccccCCccccCHHHhcCCC--CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC--CCCC
Confidence 999865443 23467999999999998764 78999999999999999999999999888888887776643 4667
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPS-----FTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPS-----ArELLe~ 1228 (1254)
.++.++.+||.+||+.||.+||+ +.+++++
T Consensus 260 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 88999999999999999999998 8888875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=353.04 Aligned_cols=265 Identities=31% Similarity=0.525 Sum_probs=220.0
Q ss_pred cccccCceEEE-EEeeeCcEEEEEEEEC----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 960 IIKNVDLEELR-ELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 960 ~Ik~~dYeiLk-kLGeGsFGtVYlAk~r----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
.+...+|++.+ .||+|+||+||+|.+. ++.||||+++... ......+.+.+|+.+++.++||||+++++
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 85 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA------NDPALKDELLAEANVMQQLDNPYIVRMIG 85 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc------cCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45566899988 9999999999999652 4679999997542 12334577899999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
++.. ..+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 86 ~~~~---~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~----~~~~~k 157 (291)
T 1xbb_A 86 ICEA---ESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAK 157 (291)
T ss_dssp EEES---SSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEEE
T ss_pred EECC---CCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe----CCCcEE
Confidence 9943 3688999999999999998654 5699999999999999999999999999999999999998 678999
Q ss_pred EEeccccccccCccc----cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhh
Q 040257 1115 VGDFGLSRIKRNTLV----SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~~----sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk 1189 (1254)
|+|||++........ .....++..|+|||++.+.. ++.++||||||+++|+|++ |+.||...........+..
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 235 (291)
T 1xbb_A 158 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235 (291)
T ss_dssp ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred EccCCcceeeccCCCcccccccCCCCceeeChHHhccCC--CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 999999975533211 12234678899999998654 7899999999999999999 9999998877766655544
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhccc
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCI 1241 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk~~ 1241 (1254)
. ..+..+..+++.+.+||.+||+.||.+||++.++++.|+.+.........
T Consensus 236 ~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~ 286 (291)
T 1xbb_A 236 G-ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286 (291)
T ss_dssp T-CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred C-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhccc
Confidence 3 34556778999999999999999999999999999999999988766544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=365.82 Aligned_cols=250 Identities=28% Similarity=0.383 Sum_probs=205.4
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|++. ++.||||++..... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 78 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-------VDCPENIKKEICINKMLNHENVVKFYGHRREGN- 78 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-------cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-
Confidence 48999999999999999999984 77899999975421 122356788999999999999999999998665
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 79 -~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~----~~~~~kl~Dfg~a 152 (323)
T 3tki_A 79 -IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLA 152 (323)
T ss_dssp -EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred -eEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe----CCCCEEEEEeecc
Confidence 88999999999999999854 45699999999999999999999999999999999999998 7789999999999
Q ss_pred ccccC---ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-hHHHHhhhccCCCCCC
Q 040257 1122 RIKRN---TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG-AIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1122 r~~~~---s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~-eliqsIlk~~Lrp~ip 1197 (1254)
+.... .......+||+.|+|||++.+.. .++.++|||||||+||+|++|+.||...... ................
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSS-BCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTG
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCcc
Confidence 75432 22234567999999999998654 2478999999999999999999999876543 2233333332222333
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..++..+.+||.+||+.||.+|||+.|++++
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 5688999999999999999999999999876
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=376.86 Aligned_cols=252 Identities=26% Similarity=0.440 Sum_probs=214.2
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVP 1037 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~ 1037 (1254)
+...+|++++.||+|+||+||+|+++ ++.||||++++.... .......+.+|..+++.+ +||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-----MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh-----hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 34568999999999999999999984 678999999864221 111235577889999876 9999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. .+++||||+.+|+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++++||+|
T Consensus 89 ~~~--~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~vkL~D 161 (345)
T 1xjd_A 89 TKE--NLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIKIAD 161 (345)
T ss_dssp CSS--EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECC
T ss_pred eCC--EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC----CCCCEEEeE
Confidence 765 899999999999999998654 5699999999999999999999999999999999999998 778999999
Q ss_pred cccccccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1118 FGLSRIKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1118 FGLAr~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
||+++... ........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+.... +.+
T Consensus 162 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~ 237 (345)
T 1xjd_A 162 FGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFY 237 (345)
T ss_dssp CTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCC
T ss_pred ChhhhhcccCCCcccCCCCCcccCChhhhcCCC--CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--CCC
Confidence 99997532 233345678999999999998764 7899999999999999999999999988888777776654 346
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFT-EITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSAr-ELLe~ 1228 (1254)
+..+++++++||.+||+.||.+||++. +++++
T Consensus 238 p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 238 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 778899999999999999999999997 77643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=363.41 Aligned_cols=257 Identities=24% Similarity=0.298 Sum_probs=209.2
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||+|.+. +..||||++.+...... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-- 101 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI---NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ-- 101 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhccc---CHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC--
Confidence 7999999999999999999984 66799999976432111 1223567889999999999999999999998655
Q ss_pred ceEEEEEecccCchhhhhhcc---------------------------------------CCCCCHHHHHHHHHHhhhhh
Q 040257 1043 TLATVTEFMVNGSLKHVLLKK---------------------------------------DRSLDRRKKLIIAMDAAFGM 1083 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kr---------------------------------------e~~LSe~~~lkIa~QIAeAL 1083 (1254)
.+++||||+.+++|.+++... ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 899999999999999988421 11246778889999999999
Q ss_pred HHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCc-----cccCCCCCCCCccCcccccCCCCCCCchhHH
Q 040257 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT-----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDV 1158 (1254)
Q Consensus 1084 aYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s-----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDI 1158 (1254)
.|||+++|+||||||+|||++.+ ..+.+||+|||+++..... .......||+.|+|||++.+....++.++||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTN--KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCS--SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHCCccccCCChhhEEEecC--CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999999999999999999721 2348999999999754221 1234456999999999998655568999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1159 FSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP--ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1159 WSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip--e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
|||||+||+|++|+.||......+....+.........+ ..+++++.+||.+||+.||.+||++.+++++
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999999999999988888887777665543333 2478999999999999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=357.46 Aligned_cols=256 Identities=28% Similarity=0.349 Sum_probs=205.5
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC---CCCceeEEeeeee
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL---HHPNVVAFYGVVP 1037 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL---nHPNIVkLyGvf~ 1037 (1254)
..+|++++.||+|+||+||+|++ +++.||||++......... ......+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGG---GGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTS---SCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccc---cccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 45899999999999999999996 4778999999754321111 11123445666666665 5999999999987
Q ss_pred cCCCC---ceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1038 DGTGG---TLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1038 Ddn~~---~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
..... .+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~----~~~~~ 159 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT----SGGTV 159 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC----TTSCE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc----CCCCE
Confidence 65422 5789999996 69999886553 3499999999999999999999999999999999999998 77899
Q ss_pred EEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC
Q 040257 1114 KVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
||+|||+++............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........+..+......
T Consensus 160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC--CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEeeCccccccCCCcccCCccccccccCchHHcCCC--CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999998765555555677999999999998664 789999999999999999999999988877766665432111
Q ss_pred CC-------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 PT-------------------------IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 p~-------------------------ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+. ....+++++.+||.+||++||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00 113578899999999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=376.51 Aligned_cols=251 Identities=21% Similarity=0.338 Sum_probs=216.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|.+. ++.||+|++.... ......+.+|+.+|++++||||+++++++.+..
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~- 121 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--------PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY- 121 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--------hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC-
Confidence 37999999999999999999984 6789999987542 122356889999999999999999999998655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||++
T Consensus 122 -~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~~~vkL~DFG~a 198 (387)
T 1kob_A 122 -EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK--KASSVKIIDFGLA 198 (387)
T ss_dssp -EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TCCCEEECCCTTC
T ss_pred -EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC--CCCceEEEecccc
Confidence 8999999999999999997766679999999999999999999999999999999999999722 3468999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC--CCCCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR--PTIPER 1199 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr--p~ipe~ 1199 (1254)
+...........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........+..+....+. ......
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 276 (387)
T 1kob_A 199 TKLNPDEIVKVTTATAEFAAPEIVDREP--VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 276 (387)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHTTCC--BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred eecCCCcceeeeccCCCccCchhccCCC--CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccc
Confidence 8765544444557999999999998764 789999999999999999999999988877777776655433 233456
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++++++||.+||+.||.+|||+.+++++
T Consensus 277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 89999999999999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=358.33 Aligned_cols=259 Identities=32% Similarity=0.542 Sum_probs=217.6
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAF 1032 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkL 1032 (1254)
.+...+|++.+.||+|+||+||+|++. ++.||||++.... .......+.+|+.++++++||||+++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-------CHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-------CHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 344568999999999999999999875 4679999987431 12234568899999999999999999
Q ss_pred eeeeecCCCCceEEEEEecccCchhhhhhccC---------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEe
Q 040257 1033 YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLV 1103 (1254)
Q Consensus 1033 yGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILL 1103 (1254)
++++.+.. ..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 94 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli 171 (322)
T 1p4o_A 94 LGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 171 (322)
T ss_dssp EEEECSSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred EEEEccCC--ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE
Confidence 99997655 7899999999999999986532 457899999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 040257 1104 NLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMH 1179 (1254)
Q Consensus 1104 Dsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n 1179 (1254)
+ .++.+||+|||+++...... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||....
T Consensus 172 ~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 172 A----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp C----TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred c----CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCC--CCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 8 77899999999997543321 122345688999999998653 8999999999999999999 899999888
Q ss_pred hhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1180 CGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1180 ~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
.......+..... ...+..++..+.+||.+||+.||.+|||+.+++++|+.+..
T Consensus 246 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 246 NEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 7777766655443 34567789999999999999999999999999999987644
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=368.26 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=209.1
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|.++ ++.||||++......... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~- 99 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP---GLSTEDLKREASICHMLKHPHIVELLETYSSDG- 99 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS---SCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc---cchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-
Confidence 47999999999999999999984 778999999754221110 012356889999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhcc---CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKK---DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kr---e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.+++||||+.+++|.+.+.++ ...+++..++.++.||+.||.|||+++|+||||||+|||++..+ ....+||+||
T Consensus 100 -~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~-~~~~vkl~Df 177 (351)
T 3c0i_A 100 -MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE-NSAPVKLGGF 177 (351)
T ss_dssp -EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS-TTCCEEECCC
T ss_pred -EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC-CCCcEEEecC
Confidence 899999999999998887543 23589999999999999999999999999999999999998432 3456999999
Q ss_pred cccccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC--
Q 040257 1119 GLSRIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT-- 1195 (1254)
Q Consensus 1119 GLAr~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~-- 1195 (1254)
|+++...... .....+||+.|+|||++.+.. ++.++|||||||+||+|++|+.||.... ......+....+...
T Consensus 178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREP--YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR 254 (351)
T ss_dssp TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH
T ss_pred cceeEecCCCeeecCCcCCcCccCHHHHcCCC--CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc
Confidence 9998654432 244567999999999998764 7899999999999999999999998753 444555554443221
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
....++.++++||.+||..||.+|||+.+++++
T Consensus 255 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 255 QWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 124678999999999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=355.44 Aligned_cols=265 Identities=29% Similarity=0.508 Sum_probs=212.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC-----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR-----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r-----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
.+...+|.+.+.||+|+||+||+|++. +..||||+++.... .....+.+.+|+.++++++||||+++++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS------SQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC------CHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc------chhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 455668999999999999999999874 23699999875421 2233567889999999999999999999
Q ss_pred eeecCCCC---ceEEEEEecccCchhhhhhc-----cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccC
Q 040257 1035 VVPDGTGG---TLATVTEFMVNGSLKHVLLK-----KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLR 1106 (1254)
Q Consensus 1035 vf~Ddn~~---~L~LVMEYm~GGSL~d~L~k-----re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsd 1106 (1254)
++.+.... ..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~-- 181 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR-- 181 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC--
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc--
Confidence 98765432 46999999999999998842 235699999999999999999999999999999999999998
Q ss_pred CCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhh
Q 040257 1107 DPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGA 1182 (1254)
Q Consensus 1107 d~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~e 1182 (1254)
.++.+||+|||+++..... .......+++.|+|||++.+. .++.++||||||+++|+|++ |..||.......
T Consensus 182 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 257 (313)
T 3brb_A 182 --DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257 (313)
T ss_dssp --TTSCEEECSCSCC----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred --CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 7789999999999754332 122334578899999999865 48999999999999999999 999999887777
Q ss_pred HHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 040257 1183 IIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1183 liqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLE 1237 (1254)
....+.... ....+..++..+.+||.+||..||.+||++.+++++|+.+...+.
T Consensus 258 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 258 MYDYLLHGH-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHHHHTTC-CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHHcCC-CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 776665543 445677889999999999999999999999999999999987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=373.67 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=208.7
Q ss_pred ceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCc
Q 040257 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~ 1043 (1254)
+...+.||+|+||+||+|++. ++.||||+++... ....+.+.+|+.+|++++||||+++++++.+.. .
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~ 160 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--------MKDKEEVKNEISVMNQLDHANLIQLYDAFESKN--D 160 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--E
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--------cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--E
Confidence 344678999999999999984 7789999998542 123467889999999999999999999998765 8
Q ss_pred eEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
+++||||+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||+..+ ..+.+||+|||+++.
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR--DAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET--TTTEEEECCCSSCEE
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC--CCCcEEEEeCCCcee
Confidence 999999999999999987766679999999999999999999999999999999999999421 567899999999987
Q ss_pred ccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC--CCCCCc
Q 040257 1124 KRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT--IPERCD 1201 (1254)
Q Consensus 1124 ~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~--ipe~iS 1201 (1254)
...........||+.|+|||++.+.. ++.++|||||||+||||++|+.||........+..+....+... ....++
T Consensus 239 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 316 (373)
T 2x4f_A 239 YKPREKLKVNFGTPEFLAPEVVNYDF--VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDIS 316 (373)
T ss_dssp CCTTCBCCCCCSSCTTCCHHHHTTCB--CCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSC
T ss_pred cCCccccccccCCCcEeChhhccCCC--CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCC
Confidence 65555555567999999999998653 88999999999999999999999999888777777766544322 224679
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++++||.+||+.||.+||++.|++++
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 999999999999999999999999984
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=361.18 Aligned_cols=264 Identities=32% Similarity=0.528 Sum_probs=217.2
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE------CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~------rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
.+...+|++++.||+|+||.||++++ .++.||||++... .....+.+.+|+.++++++||||++++
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 108 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--------TEEHLRDFEREIEILKSLQHDNIVKYK 108 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--------CSHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 34556899999999999999999985 4678999998753 123356788999999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
+++.......+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 109 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~----~~~~~ 184 (326)
T 2w1i_A 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE----NENRV 184 (326)
T ss_dssp EEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTEE
T ss_pred EEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc----CCCcE
Confidence 99877665678999999999999999977767799999999999999999999999999999999999998 67899
Q ss_pred EEEeccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh--------
Q 040257 1114 KVGDFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG-------- 1181 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~-------- 1181 (1254)
||+|||+++...... ......++..|+|||++.+.. ++.++||||||+++|+|++|..||......
T Consensus 185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~ 262 (326)
T 2w1i_A 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262 (326)
T ss_dssp EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTT
T ss_pred EEecCcchhhccccccccccccCCCCceeEECchhhcCCC--CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccc
Confidence 999999998654332 123345778899999998654 789999999999999999999998643110
Q ss_pred ----h---HHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 040257 1182 ----A---IIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1182 ----e---liqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLE 1237 (1254)
. .+...+........+..++.++.+||.+||+.||.+||++.+|++.|+.+.+.+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 263 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 0 1112223333445677889999999999999999999999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=371.88 Aligned_cols=271 Identities=19% Similarity=0.204 Sum_probs=210.1
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHH-----HHHHHHHHHHHhcCCCCce
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERL-----TKDFWREAHILSNLHHPNV 1029 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~-----~eqFlrEIeILkrLnHPNI 1029 (1254)
...+|++++.||+|+||+||+|.+. ++.||||++...... ....... ...+..|+..++.++||||
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP--LFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH--HHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh--HHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 4458999999999999999999884 367999998754210 0000011 1234456778888999999
Q ss_pred eEEeeeeecCC--CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC
Q 040257 1030 VAFYGVVPDGT--GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD 1107 (1254)
Q Consensus 1030 VkLyGvf~Ddn--~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd 1107 (1254)
+++++++.... ...+++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+..
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~- 188 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK- 188 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS-
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC-
Confidence 99999987542 24689999999 999999997776789999999999999999999999999999999999999732
Q ss_pred CCCCeEEEEeccccccccCccc--------cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 040257 1108 PQRPICKVGDFGLSRIKRNTLV--------SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH 1179 (1254)
Q Consensus 1108 ~snG~VKLiDFGLAr~~~~s~~--------sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n 1179 (1254)
..+.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||+||||++|+.||....
T Consensus 189 -~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 189 -NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA--PSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp -CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred -CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC--CCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 457899999999975433211 13345999999999998764 8999999999999999999999998643
Q ss_pred hhhHHHHhhhccCCC---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhc
Q 040257 1180 CGAIIGGIVKNTLRP---------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239 (1254)
Q Consensus 1180 ~~eliqsIlk~~Lrp---------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk 1239 (1254)
............+.. .....++.++.+||..||..+|.+||++.+|++.|+.++.++...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp TCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 322211111110000 012567899999999999999999999999999999998876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=349.99 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=196.3
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|++++.||+|+||+||++++ +++.||||+++... ......+.+.++...++.++||||+++++++.+
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV------NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc------CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 4566899999999999999999998 57889999997542 122233445556666888999999999999986
Q ss_pred CCCCceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhhC-CcccccCCCCceEeccCCCCCCeEE
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHSk-GIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
.. .+++||||+. ++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++ ..+.+|
T Consensus 78 ~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~----~~~~~k 150 (290)
T 3fme_A 78 EG--DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN----ALGQVK 150 (290)
T ss_dssp SS--SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEEC----TTCCEE
T ss_pred cC--CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC----CCCCEE
Confidence 55 7999999996 588776643 456799999999999999999999998 999999999999998 678999
Q ss_pred EEeccccccccCccccCCCCCCCCccCcccccC--CCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-ChhhHHHHhhhcc
Q 040257 1115 VGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNG--SSNRVSEKVDVFSFGISMWEILTGEEPYADM-HCGAIIGGIVKNT 1191 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG--~~~kyS~KSDIWSLGVILYELLTGk~PF~~~-n~~eliqsIlk~~ 1191 (1254)
|+|||+++............||+.|+|||++.. ....++.++|||||||++|+|++|+.||... .....+.......
T Consensus 151 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 230 (290)
T 3fme_A 151 MCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP 230 (290)
T ss_dssp BCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC
T ss_pred EeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC
Confidence 999999986655555555679999999999742 1234899999999999999999999999863 3334444444444
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
........+++++.+||.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 231 SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 4444456789999999999999999999999999984
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=376.76 Aligned_cols=246 Identities=25% Similarity=0.387 Sum_probs=204.4
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHH-HhcCCCCceeEEeeeeec
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHI-LSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeI-LkrLnHPNIVkLyGvf~D 1038 (1254)
...+|++++.||+|+||+||+++++ ++.||||++++..... ......+.+|..+ ++.++||||++++++|.+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-----~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~ 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-----KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEEEC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-----hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence 4458999999999999999999985 6679999998764332 1223456677776 577899999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. .+|+||||+.+|+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+||||+ .++++||+||
T Consensus 111 ~~--~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~----~~g~ikL~DF 183 (373)
T 2r5t_A 111 AD--KLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD----SQGHIVLTDF 183 (373)
T ss_dssp SS--EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECCC
T ss_pred CC--EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC----CCCCEEEeeC
Confidence 65 899999999999999988654 5689999999999999999999999999999999999998 7889999999
Q ss_pred cccccc-cCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1119 GLSRIK-RNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1119 GLAr~~-~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
|+++.. .........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+....+....+ .++
T Consensus 184 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~~ 259 (373)
T 2r5t_A 184 GLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QLK 259 (373)
T ss_dssp CBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC--CCC
T ss_pred ccccccccCCCccccccCCccccCHHHhCCCC--CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc--CCC
Confidence 999853 2333455678999999999998764 88999999999999999999999999888888888876643 456
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFT 1223 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSAr 1223 (1254)
..++.++++||.+||++||.+||++.
T Consensus 260 ~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 260 PNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp SSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 77899999999999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=381.70 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=207.0
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
...+|++++.||+|+||+||+|++. ++.||||++++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 220 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-----AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH 220 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC------------------CCCCCSCTTSCCEEEEEEET
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-----hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC
Confidence 3458999999999999999999984 778999999864321 122345678899999999999999999999876
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
. .+++||||+.+++|.+++... +.+++..++.++.||+.||.|||+ +|||||||||+||||+ .++.+||+||
T Consensus 221 ~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~----~~~~~kl~DF 293 (446)
T 4ejn_A 221 D--RLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD----KDGHIKITDF 293 (446)
T ss_dssp T--EEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC----SSSCEEECCC
T ss_pred C--EEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC----CCCCEEEccC
Confidence 5 899999999999999988554 569999999999999999999998 9999999999999998 7789999999
Q ss_pred ccccccc-CccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1119 GLSRIKR-NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1119 GLAr~~~-~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
|+++... ........+||+.|+|||++.+.. ++.++|||||||+||||++|+.||...........+..... .++
T Consensus 294 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~p 369 (446)
T 4ejn_A 294 GLCKEGIKDGATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--RFP 369 (446)
T ss_dssp CCCCTTCC-----CCSSSCGGGCCHHHHHTSC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCC
T ss_pred CCceeccCCCcccccccCCccccCHhhcCCCC--CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--CCC
Confidence 9997532 233345578999999999998764 89999999999999999999999999888887777766543 456
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
..+++++.+||.+||+.||.+|| ++++++++
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 370 RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 77899999999999999999999 99999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=372.12 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=198.4
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn 1040 (1254)
.+|++++.||+|+||+||+|.+. ++.||||++.+... ......++.+|+.+|+++. ||||+++++++...+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~------~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ------NSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C------CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc------ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 37999999999999999999884 77899999864321 2233567789999999997 999999999998766
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
...+|+||||+. ++|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----~~~~~kl~DFG~ 155 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN----AECHVKVADFGL 155 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCTT
T ss_pred CCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc----CCCCEEecCCcc
Confidence 668999999996 688888854 4689999999999999999999999999999999999998 788999999999
Q ss_pred cccccC----------------------ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 040257 1121 SRIKRN----------------------TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADM 1178 (1254)
Q Consensus 1121 Ar~~~~----------------------s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~ 1178 (1254)
++.... .......+||+.|+|||++.+. ..++.++|||||||+||||++|+.||.+.
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 975422 1122346799999999999864 25899999999999999999999999987
Q ss_pred ChhhHHHHhhhccCCC---------------------------------------------CCCCCCcHHHHHHHHHhhh
Q 040257 1179 HCGAIIGGIVKNTLRP---------------------------------------------TIPERCDPEWRKLMEQCWA 1213 (1254)
Q Consensus 1179 n~~eliqsIlk~~Lrp---------------------------------------------~ipe~iS~eLrdLIkKCLq 1213 (1254)
+....+..+....-.+ .....+++++.+||.+||+
T Consensus 235 ~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 7666555543211100 0112578899999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 040257 1214 ADPEARPSFTEITSR 1228 (1254)
Q Consensus 1214 kDPeKRPSArELLe~ 1228 (1254)
.||.+|||+.|++++
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=367.07 Aligned_cols=251 Identities=28% Similarity=0.464 Sum_probs=214.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
..|+.++.||+|+||+||+|++ +++.||||++..... ......+.+.+|+.+|++++||||+++++++.+..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 127 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH- 127 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-----cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 3589999999999999999997 477899999975421 13344577899999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+. |+|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 128 -~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~DfG~a 201 (348)
T 1u5q_A 128 -TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSA 201 (348)
T ss_dssp -EEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE----TTTEEEECCCTTC
T ss_pred -eEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEeeccCc
Confidence 8999999996 688888866667899999999999999999999999999999999999999 7789999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGS-SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~-~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
+..... ....||+.|+|||++.+. ...++.++|||||||++|||++|+.||........+..+.........+..+
T Consensus 202 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (348)
T 1u5q_A 202 SIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 278 (348)
T ss_dssp BSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTS
T ss_pred eecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Confidence 765432 345799999999998632 2358899999999999999999999999887777666666655555556678
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
+..+++||.+||+.||.+|||+.+++++.
T Consensus 279 ~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 279 SEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 99999999999999999999999998753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=374.62 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=211.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|.+ +++.||||++.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~- 82 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-----KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT- 82 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-----chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 4799999999999999999998 5778999999754211 1122356889999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+ +|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 83 -~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~----~~~~~kl~DFG~s 155 (336)
T 3h4j_B 83 -DIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD----DNLNVKIADFGLS 155 (336)
T ss_dssp -EEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC----TTCCEEECCSSCT
T ss_pred -EEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc----CCCCEEEEEeccc
Confidence 899999999 78898888654 4699999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
............+||+.|+|||++.+..+ .+.++|||||||++|+|++|+.||...........+... ....+..++
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s 232 (336)
T 3h4j_B 156 NIMTDGNFLKTSCGSPNYAAPEVINGKLY-AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDFLS 232 (336)
T ss_dssp BTTTTSBTTCCCTTSTTTSCGGGSCCSGG-GCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS--CCCCCTTSC
T ss_pred eeccCCcccccccCCcCcCCHHHHcCCCC-CCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCCCcccCC
Confidence 87666555566789999999999987642 378999999999999999999999876555444333322 234567789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
+++.+||++||+.||.+|||+.|++++-
T Consensus 233 ~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 233 PGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 9999999999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=369.65 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=197.1
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
...+|++++.||+|+||+||++++. ++.||||++...... .+.+.+|+.++++++||||+++++++.+.
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---------DENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---------CHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---------cHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 3458999999999999999999984 778999999754211 24577899999999999999999999866
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
. .+++||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||
T Consensus 89 ~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~--~~~~~kl~Dfg 163 (361)
T 3uc3_A 89 T--HLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS--PAPRLKICDFG 163 (361)
T ss_dssp S--EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS--SSCCEEECCCC
T ss_pred C--EEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC--CCceEEEeecC
Confidence 5 899999999999999998654 469999999999999999999999999999999999999721 23459999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCCCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCh----hhHHHHhhhccCCC
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVS-EKVDVFSFGISMWEILTGEEPYADMHC----GAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS-~KSDIWSLGVILYELLTGk~PF~~~n~----~eliqsIlk~~Lrp 1194 (1254)
+++............||+.|+|||++.+.. ++ .++|||||||++|+|++|+.||..... ...+..+.......
T Consensus 164 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (361)
T 3uc3_A 164 YSKSSVLHSQPKSTVGTPAYIAPEVLLRQE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI 241 (361)
T ss_dssp CC---------------CTTSCHHHHHCSS--CCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC
T ss_pred ccccccccCCCCCCcCCCCcCChhhhcCCC--CCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC
Confidence 997544444445567999999999998764 44 459999999999999999999987543 33344444444433
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.....+++++++||.+||+.||.+|||+.|++++
T Consensus 242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 3444689999999999999999999999999987
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=378.18 Aligned_cols=254 Identities=22% Similarity=0.414 Sum_probs=213.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.+...+|++++.||+|+||+||++++. ++.||||++.+.... .......+.+|+.+|+.++||||++++++|.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-----ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-----cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 455568999999999999999999984 667999999754211 1222467889999999999999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. .+++||||+.+|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+ .++++||+|
T Consensus 86 ~~~--~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~----~~g~vkL~D 158 (384)
T 4fr4_A 86 DEE--DMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD----EHGHVHITD 158 (384)
T ss_dssp CSS--EEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECC
T ss_pred eCC--EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC----CCCCEEEec
Confidence 765 89999999999999999854 45699999999999999999999999999999999999998 788999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---hhHHHHhhhccCC
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHC---GAIIGGIVKNTLR 1193 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~-~kyS~KSDIWSLGVILYELLTGk~PF~~~n~---~eliqsIlk~~Lr 1193 (1254)
||+++...........+||+.|+|||++.+.. ..++.++|||||||+||+|++|+.||..... ......+... .
T Consensus 159 FG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--~ 236 (384)
T 4fr4_A 159 FNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--V 236 (384)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--C
T ss_pred cceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--c
Confidence 99998766655566788999999999997532 3478999999999999999999999975432 3333333332 3
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPS-FTEITS 1227 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPS-ArELLe 1227 (1254)
..++..++.++.+||.+||+.||.+||+ +.++++
T Consensus 237 ~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 4567788999999999999999999998 777765
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=358.12 Aligned_cols=248 Identities=27% Similarity=0.436 Sum_probs=196.8
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC-
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG- 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~- 1041 (1254)
+|++++.||+|+||+||+|+++ ++.||||+++... .....+.+.+|+.+|++++||||++++++|.+...
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-------RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-------TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-------chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence 6999999999999999999984 7789999997542 12235678899999999999999999999865432
Q ss_pred ------------------------------------------------------CceEEEEEecccCchhhhhhccC--C
Q 040257 1042 ------------------------------------------------------GTLATVTEFMVNGSLKHVLLKKD--R 1065 (1254)
Q Consensus 1042 ------------------------------------------------------~~L~LVMEYm~GGSL~d~L~kre--~ 1065 (1254)
..+++||||+.+++|.+++.... .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 23899999999999999986643 2
Q ss_pred CCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCc-------------cccCC
Q 040257 1066 SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT-------------LVSGG 1132 (1254)
Q Consensus 1066 ~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s-------------~~sts 1132 (1254)
...+..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..... .....
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe----CCCCEEEeecCcccccccchhhccccccccccccccc
Confidence 356667899999999999999999999999999999998 7789999999999865433 12334
Q ss_pred CCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 040257 1133 VRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCW 1212 (1254)
Q Consensus 1133 ~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCL 1212 (1254)
..||+.|+|||++.+. .++.++|||||||++|+|++|..|+... ......+.... .+......++++.+||.+||
T Consensus 236 ~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l 310 (332)
T 3qd2_B 236 QVGTKLYMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLK-FPLLFTQKYPQEHMMVQDML 310 (332)
T ss_dssp CC-CGGGSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTC-CCHHHHHHCHHHHHHHHHHH
T ss_pred cCCCcCccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccC-CCcccccCChhHHHHHHHHc
Confidence 5799999999999876 4899999999999999999988775321 12222222211 11122334678899999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 040257 1213 AADPEARPSFTEITSR 1228 (1254)
Q Consensus 1213 qkDPeKRPSArELLe~ 1228 (1254)
+.||.+|||+.|++++
T Consensus 311 ~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 311 SPSPTERPEATDIIEN 326 (332)
T ss_dssp CSSGGGSCCHHHHHHS
T ss_pred cCCCCcCCCHHHHhhc
Confidence 9999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.43 Aligned_cols=261 Identities=20% Similarity=0.294 Sum_probs=211.7
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|++.+.||+|+||+||+|++ .++.||||++..... ...+.+|+.+++.++|++++..+.++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~- 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------HPQLHIESKIYKMMQGGVGIPTIRWCGAE- 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----------CCHHHHHHHHHHHHTTSTTCCCEEEEEEE-
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----------hhHHHHHHHHHHHhhcCCCCCccccccCC-
Confidence 45899999999999999999997 578899999875421 13477899999999998877666665432
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
....++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFGL 154 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-GTTCEEECCCTT
T ss_pred CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCC-CCCeEEEeeCCC
Confidence 34789999999 9999999976667899999999999999999999999999999999999994221 567899999999
Q ss_pred cccccCccc--------cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---hhHHHHhhh
Q 040257 1121 SRIKRNTLV--------SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC---GAIIGGIVK 1189 (1254)
Q Consensus 1121 Ar~~~~s~~--------sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~---~eliqsIlk 1189 (1254)
++....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... ...+..+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence 986543321 24567999999999998764 89999999999999999999999986432 223333322
Q ss_pred ccCCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1190 NTLRP---TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1190 ~~Lrp---~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
..... .....+++++.+||.+||+.||.+||++.++++.|+.+..+...
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 22211 12356789999999999999999999999999999999887654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=381.35 Aligned_cols=251 Identities=27% Similarity=0.434 Sum_probs=215.8
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||+|++. ++.||||++.+...... ....+.+|+.+|++++||||+++++++.+..
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-- 94 (486)
T 3mwu_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK------DTSTILREVELLKKLDHPNIMKLFEILEDSS-- 94 (486)
T ss_dssp HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch------HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC--
Confidence 7999999999999999999984 77899999975432211 1356789999999999999999999998755
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|||+++
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-KDCDIKIIDFGLST 172 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSS-TTCCEEECSCSCTT
T ss_pred EEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-CCCCEEEEECCcCe
Confidence 899999999999999988654 5699999999999999999999999999999999999997333 56789999999998
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC--CCC
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP--ERC 1200 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip--e~i 1200 (1254)
............||+.|+|||++.+. ++.++|||||||++|+|++|+.||......+.+..+....+....+ ..+
T Consensus 173 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 249 (486)
T 3mwu_A 173 CFQQNTKMKDRIGTAYYIAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249 (486)
T ss_dssp TBCCC----CCTTGGGGCCGGGGGSC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGS
T ss_pred ECCCCCccCCCcCCCCCCCHHHhCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCC
Confidence 66555555566799999999999864 8999999999999999999999999988888888887766554433 457
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++++++||.+||+.||.+|||+.+++++
T Consensus 250 s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 250 SDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 8999999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=365.37 Aligned_cols=256 Identities=29% Similarity=0.484 Sum_probs=207.4
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.+|++.+.||+|+||+||+|++. ++.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 108 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--------SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN-- 108 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--------SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT--
T ss_pred hccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--
Confidence 47999999999999999999985 7789999876431 112467889999999999999999999997654
Q ss_pred ceEEEEEecccCchhhhhhccC---CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKD---RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre---~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg 184 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD----ENFVPKITDFG 184 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC----TTCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC----CCCCEEEeecc
Confidence 7899999999999999986543 3589999999999999999999999999999999999998 77899999999
Q ss_pred ccccccC---ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH---H----Hhhh
Q 040257 1120 LSRIKRN---TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAII---G----GIVK 1189 (1254)
Q Consensus 1120 LAr~~~~---s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eli---q----sIlk 1189 (1254)
+++.... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||......... . ....
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR--LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCB--CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCC--CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence 9975432 22233456899999999998654 889999999999999999999999764332111 1 0001
Q ss_pred c--------cCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1190 N--------TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1190 ~--------~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
. .+....+..++..+.+|+.+||+.||++|||+.+++++|+.++..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 1 111122233456789999999999999999999999999988753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.30 Aligned_cols=251 Identities=29% Similarity=0.461 Sum_probs=211.6
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
...+|++++.||+|+||+||+|++. +..||||++..... ........+.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc-----chhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence 3458999999999999999999985 55799999975321 1222346688999999999999999999999866
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
. .+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 82 ~--~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~----~~~~~~l~Dfg 154 (279)
T 3fdn_A 82 T--RVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG----SAGELKIADFG 154 (279)
T ss_dssp S--EEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC----TTSCEEECSCC
T ss_pred C--EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc----CCCCEEEEecc
Confidence 5 899999999999999998654 5699999999999999999999999999999999999998 77899999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
++....... .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+.... ...+..
T Consensus 155 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~ 229 (279)
T 3fdn_A 155 WSVHAPSSR-RTDLCGTLDYLPPEMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDF 229 (279)
T ss_dssp EESCC---------CCCCTTCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCTT
T ss_pred ccccCCccc-ccccCCCCCccCHhHhccCC--CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC--CCCCCc
Confidence 986544332 23456999999999998764 7889999999999999999999999888777776665543 346677
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
++..+.+||.+||+.||.+||++.|++++-
T Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 230 VTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred CCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 899999999999999999999999999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=385.85 Aligned_cols=255 Identities=21% Similarity=0.339 Sum_probs=215.5
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|++++.||+|+||+||+|+++ ++.||||++++.... .......+.+|+.+++.++||||++++++|.+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh-----hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 45568999999999999999999994 678999999753211 01112346789999999999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. .+++||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+ .++++||+||
T Consensus 141 ~~--~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~----~~g~ikL~DF 212 (410)
T 3v8s_A 141 DR--YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLADF 212 (410)
T ss_dssp SS--EEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCC
T ss_pred CC--EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC----CCCCEEEecc
Confidence 65 89999999999999998854 3689999999999999999999999999999999999998 7889999999
Q ss_pred cccccccCcc--ccCCCCCCCCccCcccccCCCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc--C
Q 040257 1119 GLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNR--VSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT--L 1192 (1254)
Q Consensus 1119 GLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~k--yS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~--L 1192 (1254)
|+++...... .....+||+.|+|||++.+.... ++.++|||||||+||||++|+.||...+.......+.... +
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc
Confidence 9997654432 33467899999999999865322 7889999999999999999999999988888888777653 2
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEA--RPSFTEITSR 1228 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeK--RPSArELLe~ 1228 (1254)
.......++.++++||.+||+.+|.+ ||++.||++|
T Consensus 293 ~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 22233468999999999999999988 9999999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=358.58 Aligned_cols=246 Identities=26% Similarity=0.328 Sum_probs=199.3
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhc-CCCCceeEEeeeeecCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN-LHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkr-LnHPNIVkLyGvf~Ddn 1040 (1254)
.+|+++++||+|+||+||+|++. ++.||||++..... ......++..|+..+.+ ++||||++++++|.+..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR------GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC------SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc------ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 37999999999999999999994 78899999865321 11223344556655554 49999999999998655
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+ +++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 131 --~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~----~~~~~kl~DFG~ 203 (311)
T 3p1a_A 131 --ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG----PRGRCKLGDFGL 203 (311)
T ss_dssp --EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----GGGCEEECCCTT
T ss_pred --EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC----CCCCEEEcccee
Confidence 899999999 7799999877777899999999999999999999999999999999999998 678999999999
Q ss_pred cccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1121 SRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1121 Ar~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
+.............||+.|+|||++.+. ++.++|||||||++|||++|..||.... ....+......+..+..+
T Consensus 204 a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~ 277 (311)
T 3p1a_A 204 LVELGTAGAGEVQEGDPRYMAPELLQGS---YGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGL 277 (311)
T ss_dssp CEECC------CCCCCGGGCCGGGGGTC---CSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTS
T ss_pred eeecccCCCCcccCCCccccCHhHhcCC---CCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCC
Confidence 9876655555566799999999999863 8999999999999999999977765432 223333333333445678
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++++.+||.+||++||++|||+.|++++
T Consensus 278 ~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 278 SSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 9999999999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=360.29 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=205.6
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|++++.||+|+||+||++++ .++.||||+++.... ........+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-----RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-----TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-----CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 35899999999999999999997 477899999976422 13345677899999999999999999999987544
Q ss_pred CC--ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1041 GG--TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1041 ~~--~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. .+++||||+.+++|.+++... +.+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+||
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Df 160 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS----ATNAVKVMDF 160 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTSCEEECCC
T ss_pred CCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc----CCCCEEEeec
Confidence 22 458999999999999998654 4699999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCc----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC
Q 040257 1119 GLSRIKRNT----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1119 GLAr~~~~s----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
|+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..................+
T Consensus 161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238 (311)
T ss_dssp SCC------------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred cCcccccccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC
Confidence 999754332 122345689999999999876 48999999999999999999999999887776666555543322
Q ss_pred C--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH-HHHHHH
Q 040257 1195 T--IPERCDPEWRKLMEQCWAADPEARPSFTEIT-SRLRTI 1232 (1254)
Q Consensus 1195 ~--ipe~iS~eLrdLIkKCLqkDPeKRPSArELL-e~Le~L 1232 (1254)
. ....++.++.+||.+||+.||.+||+..+++ ..|..+
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 1 2345889999999999999999999655544 444443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=350.54 Aligned_cols=262 Identities=24% Similarity=0.430 Sum_probs=206.3
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||+|+||.||+|.+ +++.||||+++..... .......+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 105 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM-----DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN- 105 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 3799999999999999999997 4788999999753221 2344577889999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1042 GTLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.+++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 106 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~----~~~~~kl~Df 180 (310)
T 2wqm_A 106 -ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDL 180 (310)
T ss_dssp -EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECCC
T ss_pred -cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc----CCCCEEEEec
Confidence 89999999999999998854 345689999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--hhhHHHHhhhccCCCC
Q 040257 1119 GLSRIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH--CGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1119 GLAr~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n--~~eliqsIlk~~Lrp~ 1195 (1254)
|++...... .......|++.|+|||++.+. .++.++||||||+++|+|++|+.||.... .......+....+...
T Consensus 181 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 258 (310)
T 2wqm_A 181 GLGRFFSSKTTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 258 (310)
T ss_dssp ------------------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC
T ss_pred cceeeecCCCccccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC
Confidence 998754332 222345689999999999865 48999999999999999999999997543 2334444444444444
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
....++.++.+||.+||..||.+|||+.++++.|+.+......
T Consensus 259 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 259 PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 4467899999999999999999999999999999999876544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=351.66 Aligned_cols=250 Identities=25% Similarity=0.398 Sum_probs=190.3
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||+|+||.||+|++ .++.||||++..... ......+.+.+|+.++++++||||+++++++.+..
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 84 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM-----YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN- 84 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS-
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh-----hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC-
Confidence 4799999999999999999998 578899999975421 11223467889999999999999999999998755
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 85 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~----~~~~~kl~dfg~~ 159 (278)
T 3cok_A 85 -YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT----RNMNIKIADFGLA 159 (278)
T ss_dssp -EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC----TTCCEEECCCTTC
T ss_pred -eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEEEeecce
Confidence 89999999999999999977767899999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
...... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+.... ...+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~ 235 (278)
T 3cok_A 160 TQLKMPHEKHYTLCGTPNYISPEIATRSA--HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--YEMPSFL 235 (278)
T ss_dssp EECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC--CCCCTTS
T ss_pred eeccCCCCcceeccCCCCcCCcchhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc--cCCcccc
Confidence 765422 2223456899999999998654 7889999999999999999999998766555444443322 2356678
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+.++.+||.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 236 SIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 9999999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=350.14 Aligned_cols=261 Identities=20% Similarity=0.293 Sum_probs=208.5
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|++.+.||+|+||+||+|++ .++.||||++..... ...+.+|+.+++.++|++++..+.++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~- 76 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------HPQLHIESKIYKMMQGGVGIPTIRWCGAE- 76 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------------CCCHHHHHHHHHHHTTSTTCCCEEEEEEE-
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----------chHHHHHHHHHHHhcCCCCCCeeeeecCC-
Confidence 34799999999999999999997 477899998764321 23467899999999988877777665432
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
....++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFGL 154 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGG-GTTCEEECCCTT
T ss_pred CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccC-CCCeEEEecCcc
Confidence 24789999999 9999999976667899999999999999999999999999999999999993111 678899999999
Q ss_pred cccccCcc--------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---hHHHHhhh
Q 040257 1121 SRIKRNTL--------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG---AIIGGIVK 1189 (1254)
Q Consensus 1121 Ar~~~~s~--------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~---eliqsIlk 1189 (1254)
++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... ..+..+..
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCC--CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc
Confidence 98654322 223457999999999998764 899999999999999999999999864332 22222222
Q ss_pred ccCCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1190 NTLRP---TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1190 ~~Lrp---~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
..... .....+++++.+||.+||+.||++||++.++++.|+.+..+...
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred ccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 22211 12356789999999999999999999999999999999988764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=380.98 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=218.4
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|++. ++.||||++.+...... ...+.+.+|+.+|++++||||+++++++.+..
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 99 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK-----TDKESLLREVQLLKQLDHPNIMKLYEFFEDKG- 99 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBS-----SCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccc-----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-
Confidence 47999999999999999999984 77899999976533211 12456889999999999999999999998655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|||++
T Consensus 100 -~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 100 -YFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS-KDANIRIIDFGLS 176 (484)
T ss_dssp -EEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCCEEECCTTHH
T ss_pred -EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCC-CCCcEEEEeeeee
Confidence 899999999999999988654 5699999999999999999999999999999999999996332 5688999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC--CC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP--ER 1199 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip--e~ 1199 (1254)
+............||+.|+|||++.+. ++.++|||||||++|+|++|+.||......+.+..+....+....+ ..
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 253 (484)
T 3nyv_A 177 THFEASKKMKDKIGTAYYIAPEVLHGT---YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253 (484)
T ss_dssp HHBCCCCSHHHHTTGGGTCCHHHHHTC---CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGG
T ss_pred EEcccccccccCCCCccccCceeecCC---CCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccccc
Confidence 866554444456799999999999863 8899999999999999999999999998888888887776654443 46
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++++++||.+||+.||.+|||+.+++++
T Consensus 254 ~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 254 VSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 89999999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=357.17 Aligned_cols=267 Identities=30% Similarity=0.522 Sum_probs=218.4
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEE-------CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeE
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKW-------RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVA 1031 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~-------rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVk 1031 (1254)
..+...+|++++.||+|+||+||+|++ .+..||||++.... ......++.+|+.++++++||||++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~ 97 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-------SEQDELDFLMEALIISKFNHQNIVR 97 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-------CHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-------chhhHHHHHHHHHHHhhCCCCCCCe
Confidence 445667899999999999999999984 35579999986431 1223457889999999999999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccC------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEecc
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNL 1105 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDs 1105 (1254)
+++++.+.. .+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 98 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~ 175 (327)
T 2yfx_A 98 CIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 175 (327)
T ss_dssp EEEEECSSS--SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred EEEEEcCCC--CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEec
Confidence 999998655 7899999999999999996643 34899999999999999999999999999999999999984
Q ss_pred CCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChh
Q 040257 1106 RDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCG 1181 (1254)
Q Consensus 1106 dd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~ 1181 (1254)
.+ ....+||+|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||......
T Consensus 176 ~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 252 (327)
T 2yfx_A 176 PG-PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252 (327)
T ss_dssp SS-TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CC-CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH
Confidence 33 4557999999998743222 122234578899999999865 48999999999999999998 99999988777
Q ss_pred hHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1182 AIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1182 eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
.....+... .....+..++..+.+||.+||+.||.+||++.+++++|+.+...-+.
T Consensus 253 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 253 EVLEFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp HHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred HHHHHHhcC-CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 666655544 33456677899999999999999999999999999999998775544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=381.01 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=214.4
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||+|+++ +..||||++.+...... ....+.+|+.+|+.++||||++++++|.+..
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-- 109 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS------SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR-- 109 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C------TTHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch------HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--
Confidence 6999999999999999999984 67899999986532211 1356789999999999999999999998655
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|||+++
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE-KDALIKIVDFGLSA 187 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-TTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCC-CCCcEEEEECCCCe
Confidence 899999999999999988654 5699999999999999999999999999999999999997332 45679999999998
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC--CCC
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP--ERC 1200 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip--e~i 1200 (1254)
...........+||+.|+|||++.+. ++.++|||||||++|+|++|+.||......+.+..+....+....+ ..+
T Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (494)
T 3lij_A 188 VFENQKKMKERLGTAYYIAPEVLRKK---YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV 264 (494)
T ss_dssp ECBTTBCBCCCCSCTTTCCHHHHTTC---BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTS
T ss_pred ECCCCccccccCCCcCeeCHHHHccc---CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccC
Confidence 76665555667899999999998743 8899999999999999999999999988888888887766554333 468
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR--LRTI 1232 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~--Le~L 1232 (1254)
++.+++||++||+.||.+|||+.+++++ ++..
T Consensus 265 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 265 SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred CHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 9999999999999999999999999976 4444
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=356.35 Aligned_cols=258 Identities=24% Similarity=0.331 Sum_probs=214.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||.||+|++. ++.||||+++........ .....+.+.+|+.++++++||||+++++++.+..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 88 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR--RGVSREEIEREVSILRQVLHHNVITLHDVYENRT- 88 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccc--cchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence 36999999999999999999984 778999999865322111 1112456889999999999999999999998655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+.....+||+|||++
T Consensus 89 -~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 89 -DVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp -EEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred -EEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 89999999999999999854 4568999999999999999999999999999999999999833222238999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC--CCCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP--TIPER 1199 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp--~ipe~ 1199 (1254)
.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+....... .....
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred eecCccccccccCCCCCccCcccccCCC--CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence 8765554445567999999999998664 7899999999999999999999999888777776665543322 12256
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++..+.+||.+||+.||.+|||+.+++++
T Consensus 245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 78999999999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.84 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=201.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|++. ++.||||++.... ......+.+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 75 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE------DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR- 75 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC------C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc------cchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-
Confidence 37999999999999999999985 7789999986542 13344567889999999999999999999998755
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 76 -~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 76 -RLHLVFEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT----KHSVIKLCDFGFA 149 (311)
T ss_dssp -EEEEEEECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred -eEEEEEEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc----CCCCEEEeeCCCc
Confidence 89999999999999887743 45699999999999999999999999999999999999998 7789999999999
Q ss_pred ccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc---------
Q 040257 1122 RIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT--------- 1191 (1254)
Q Consensus 1122 r~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~--------- 1191 (1254)
..... ........||..|+|||++.+.. .++.++||||||+++|+|++|+.||...........+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 150 RLLTGPSDYYDDEVATRWYRSPELLVGDT-QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp EECC------------GGGCCHHHHHTCS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhccCcccccCCCcCCccccChHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence 86543 22234457899999999997642 47999999999999999999999998877655444332210
Q ss_pred ----------CCCCC----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 ----------LRPTI----------PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 ----------Lrp~i----------pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..... ...++.++.+||.+||+.||.+|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 13578889999999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=366.72 Aligned_cols=249 Identities=28% Similarity=0.366 Sum_probs=194.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||+|+||+||+|++. ++.||||+++... ..+.+.+|+.+|++++||||+++++++.+..
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 121 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT- 121 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEECSS-
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----------hHHHHHHHHHHHHhCCCCCCcceeeeEecCC-
Confidence 47999999999999999999995 5679999997531 1345778999999999999999999998655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++..+ .++.+||+|||++
T Consensus 122 -~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~-~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 122 -EISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPA-PDAPLKIADFGLS 198 (349)
T ss_dssp -EEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSS-TTCCEEECCCC--
T ss_pred -eEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCC-CCCCEEEccCccc
Confidence 899999999999999988544 5689999999999999999999999999999999999997322 4789999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh-HHHHhhhccCCC--CCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA-IIGGIVKNTLRP--TIPE 1198 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e-liqsIlk~~Lrp--~ipe 1198 (1254)
+............||+.|+|||++.+.. ++.++|||||||+||||++|+.||....... ....+....... ....
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 276 (349)
T 2w4o_A 199 KIVEHQVLMKTVCGTPGYCAPEILRGCA--YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWD 276 (349)
T ss_dssp --------------CGGGSCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTT
T ss_pred cccCcccccccccCCCCccCHHHhcCCC--CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhh
Confidence 8765554445567999999999998764 8999999999999999999999998765544 444454443322 2335
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++.++.+||.+||+.||++|||+.+++++
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 688999999999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=387.51 Aligned_cols=257 Identities=22% Similarity=0.336 Sum_probs=215.7
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|+++++||+|+||+||+|+++ ++.||||++++.... .......+.+|+.+++.++||||++++++|.+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-----KRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-----HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh-----hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44568999999999999999999985 577999999753211 11112347789999999999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. .+++||||+.+|+|.+++.+....+++..++.++.||+.||.|||++|||||||||+||||+ .++++||+||
T Consensus 146 ~~--~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~----~~g~vkL~DF 219 (437)
T 4aw2_A 146 DN--NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD----MNGHIRLADF 219 (437)
T ss_dssp SS--EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCC
T ss_pred CC--EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc----CCCCEEEcch
Confidence 65 89999999999999999977667899999999999999999999999999999999999998 7889999999
Q ss_pred cccccccCc--cccCCCCCCCCccCcccccC---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC
Q 040257 1119 GLSRIKRNT--LVSGGVRGTLPWMAPELLNG---SSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1119 GLAr~~~~s--~~sts~~GT~~YmAPEVLrG---~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
|+++..... ......+||+.|+|||++.. ....|+.++|||||||+||||++|+.||...+..+....+......
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence 999754332 22344689999999999972 1224889999999999999999999999998888887777654322
Q ss_pred CCCC---CCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 040257 1194 PTIP---ERCDPEWRKLMEQCWAADPEA--RPSFTEITSR 1228 (1254)
Q Consensus 1194 p~ip---e~iS~eLrdLIkKCLqkDPeK--RPSArELLe~ 1228 (1254)
..++ ..+++++++||++||+.+|++ |++++|++++
T Consensus 300 ~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 300 FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 2233 458999999999999998888 9999999876
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=361.25 Aligned_cols=261 Identities=28% Similarity=0.571 Sum_probs=213.3
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEEC--CceE----EEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEE
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWR--GSDV----AIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAF 1032 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~V----AIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkL 1032 (1254)
..+...+|++++.||+|+||+||+|++. ++.+ |+|.+.... .....+.+.+|+.++++++||||+++
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~ 82 (327)
T 3lzb_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRL 82 (327)
T ss_dssp EECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-------SCCCHHHHHHHHHHHTTCCBTTBCCC
T ss_pred cccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-------CHHHHHHHHHHHHHHHhCCCCCeeEE
Confidence 4567789999999999999999999984 4444 556554321 11124568899999999999999999
Q ss_pred eeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCe
Q 040257 1033 YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPI 1112 (1254)
Q Consensus 1033 yGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~ 1112 (1254)
++++.+. ..++|++|+.+++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ ..+.
T Consensus 83 ~~~~~~~---~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~ 155 (327)
T 3lzb_A 83 LGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQH 155 (327)
T ss_dssp CEEEESS---SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETTE
T ss_pred EEEEecC---CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc----CCCC
Confidence 9999764 47889999999999999987777899999999999999999999999999999999999998 7789
Q ss_pred EEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhh
Q 040257 1113 CKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIV 1188 (1254)
Q Consensus 1113 VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIl 1188 (1254)
+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...........+.
T Consensus 156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 233 (327)
T 3lzb_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233 (327)
T ss_dssp EEECCTTC----------------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred EEEccCcceeEccCccccccccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 9999999997643321 22234467889999999865 48999999999999999999 999999887777665554
Q ss_pred hccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1189 KNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1189 k~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
.. .....+..++.++.+||.+||+.||.+||++.++++.|+.+....
T Consensus 234 ~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 234 KG-ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp TT-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred cC-CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 43 344567778999999999999999999999999999999997543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=361.64 Aligned_cols=250 Identities=29% Similarity=0.408 Sum_probs=193.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|.+. ++.||||+++..... .....+.+|+.++++++||||+++++++.++.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 76 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-------GTPSTAIREISLMKELKHENIVRLYDVIHTEN- 76 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTT-------CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT-
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-------ccHHHHHHHHHHHHhcCCCCcceEEEEEEECC-
Confidence 47999999999999999999884 778999999754311 11245778999999999999999999997655
Q ss_pred CceEEEEEecccCchhhhhhccC-----CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKD-----RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre-----~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 77 -~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl~ 150 (317)
T 2pmi_A 77 -KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN----KRGQLKLG 150 (317)
T ss_dssp -EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEEC
T ss_pred -eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc----CCCCEEEC
Confidence 8999999997 69988885432 4589999999999999999999999999999999999998 77899999
Q ss_pred eccccccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC---
Q 040257 1117 DFGLSRIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL--- 1192 (1254)
Q Consensus 1117 DFGLAr~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L--- 1192 (1254)
|||+++..... .......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+.+..+.....
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 229 (317)
T 2pmi_A 151 DFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSR-TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229 (317)
T ss_dssp CCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred cCccceecCCCcccCCCCcccccccCchHhhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99999865432 2233456899999999997642 478999999999999999999999998877665555432100
Q ss_pred -----------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 -----------------------------RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 -----------------------------rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+.....++.++.+||.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 001123578899999999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=351.15 Aligned_cols=253 Identities=27% Similarity=0.442 Sum_probs=213.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||++++. ++.||+|++..... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM------TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 79 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC------CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC
Confidence 47999999999999999999984 77899999975432 12345678999999999999999999998866555
Q ss_pred CceEEEEEecccCchhhhhhcc---CCCCCHHHHHHHHHHhhhhhHHhhhCC-----cccccCCCCceEeccCCCCCCeE
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKK---DRSLDRRKKLIIAMDAAFGMEYLHSKN-----IVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kr---e~~LSe~~~lkIa~QIAeALaYLHSkG-----IIHRDLKPeNILLDsdd~snG~V 1113 (1254)
..+++||||+.+++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~----~~~~~ 155 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQNV 155 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC----SSSCE
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc----CCCCE
Confidence 6899999999999999998653 234899999999999999999999999 99999999999998 77899
Q ss_pred EEEeccccccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC
Q 040257 1114 KVGDFGLSRIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L 1192 (1254)
||+|||+++...... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+.....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~ 233 (279)
T 2w5a_A 156 KLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233 (279)
T ss_dssp EECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred EEecCchheeeccccccccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc
Confidence 999999987554321 12234689999999999876 488999999999999999999999998877776666655543
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
...+..++.++.+||.+||+.||.+||++.++++++
T Consensus 234 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 234 -RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred -ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 356678899999999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=353.38 Aligned_cols=257 Identities=32% Similarity=0.580 Sum_probs=202.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhc--CCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN--LHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkr--LnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||.||+|+++++.||||++.... ...+.+|.+++.. ++||||+++++++.+...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 479999999999999999999999999999986431 1234455555554 499999999999876532
Q ss_pred --CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC--------CcccccCCCCceEeccCCCCCC
Q 040257 1042 --GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK--------NIVHFDLKCENLLVNLRDPQRP 1111 (1254)
Q Consensus 1042 --~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk--------GIIHRDLKPeNILLDsdd~snG 1111 (1254)
..+++||||+.+++|.+++... .+++..++.++.|++.||.|||++ +|+||||||+|||++ .++
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~----~~~ 179 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK----KNG 179 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC----TTS
T ss_pred CCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC----CCC
Confidence 4789999999999999999543 689999999999999999999999 999999999999998 778
Q ss_pred eEEEEeccccccccCccc-----cCCCCCCCCccCcccccCCCCCCC----chhHHHHHHHHHHHHHcC----------C
Q 040257 1112 ICKVGDFGLSRIKRNTLV-----SGGVRGTLPWMAPELLNGSSNRVS----EKVDVFSFGISMWEILTG----------E 1172 (1254)
Q Consensus 1112 ~VKLiDFGLAr~~~~s~~-----sts~~GT~~YmAPEVLrG~~~kyS----~KSDIWSLGVILYELLTG----------k 1172 (1254)
.+||+|||+++....... .....||+.|+|||++.+..+... .++|||||||++|||++| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 999999999975433221 234579999999999986642211 249999999999999999 7
Q ss_pred CCCCCCCh-----hhHHHHhhhccCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 040257 1173 EPYADMHC-----GAIIGGIVKNTLRPTIPE-----RCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1173 ~PF~~~n~-----~eliqsIlk~~Lrp~ipe-----~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLE 1237 (1254)
.||..... ......+......+..+. .+++++.+||.+||+.||.+|||+.+++++|+.+..+.+
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 77754321 222222333333444443 456789999999999999999999999999999976543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=376.05 Aligned_cols=260 Identities=25% Similarity=0.353 Sum_probs=199.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|.+.+.||+|+||+||+|.+. ++.||||++.+................+.+|+.+|++++||||+++++++...
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-- 212 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 212 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS--
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 37999999999999999999984 67899999987543322222223344578999999999999999999998643
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++..+ ....+||+|||++
T Consensus 213 -~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 -DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGHS 289 (419)
T ss_dssp -EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-SSCCEEECCSSTT
T ss_pred -ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCC-CcceEEEeecccc
Confidence 57899999999999998854 45699999999999999999999999999999999999997332 4557999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh-HHHHhhhccCCC--CCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGS-SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA-IIGGIVKNTLRP--TIP 1197 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~-~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e-liqsIlk~~Lrp--~ip 1197 (1254)
+...........+||+.|+|||++.+. ...++.++|||||||+||+|++|+.||....... ....+....... ...
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 876665555667899999999998642 2357899999999999999999999998654432 333333332221 122
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+++.+.+||.+||+.||.+||++.|++++
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 4578999999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=345.10 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=207.2
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|++++.||+|+||.||+|++. ++.||||++..... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-----RSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc-----cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 44568999999999999999999984 78899999975321 112234678899999999999999999999986
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. .+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 83 ~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~df 155 (276)
T 2h6d_A 83 PT--DFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD----AHMNAKIADF 155 (276)
T ss_dssp SS--EEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC----TTSCEEECCC
T ss_pred CC--eEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC----CCCCEEEeec
Confidence 55 899999999999999998654 4689999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCC
Q 040257 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1119 GLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe 1198 (1254)
|++.............||+.|+|||++.+.. ..+.++||||||+++|+|++|+.||...........+.... ...+.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~ 232 (276)
T 2h6d_A 156 GLSNMMSDGEFLRTSCGSPNYAAPEVISGRL-YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--FYIPE 232 (276)
T ss_dssp CGGGCCCC-------------CCTGGGTTSC-CCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCT
T ss_pred ccccccCCCcceecccCCccccCHHHHcCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--ccCch
Confidence 9998665544444567899999999998753 23689999999999999999999999887777666665543 23566
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++..+.+||.+||+.||.+|||+.+++++
T Consensus 233 ~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 233 YLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 789999999999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=347.39 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=211.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||++++. ++.||+|+++........ .....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSR--RGVSREEIEREVNILREIRHPNIITLHDIFENKT- 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccc--cchHHHHHHHHHHHHHhCCCCCeeehhheecCCC-
Confidence 36999999999999999999995 778999999865432211 1112456889999999999999999999998655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.....+||+|||++
T Consensus 82 -~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 82 -DVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp -EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred -eEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 799999999999999998553 569999999999999999999999999999999999999844333458999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC--CCCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP--TIPER 1199 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp--~ipe~ 1199 (1254)
.............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+....... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 160 HKIEAGNEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp EECC--------CCCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred eeccCCCcccccCCCcCccCcceecCCC--CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence 8665544444567999999999998664 7899999999999999999999999887777666655443321 12246
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++..+.+||.+||+.||.+||++.+++++
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 78899999999999999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=382.68 Aligned_cols=257 Identities=22% Similarity=0.316 Sum_probs=213.9
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.+...+|++++.||+|+||+||+++++ ++.||||++++.... .....+.+.+|+.++..++||||++++++|.
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-----~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-----KRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-----hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 345568999999999999999999984 788999999753211 1122345778999999999999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. .+|+||||+.+|+|.+++.+....+++..++.++.||+.||.|||++|||||||||+||||+ .++++||+|
T Consensus 132 ~~~--~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld----~~g~vkL~D 205 (412)
T 2vd5_A 132 DEN--YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD----RCGHIRLAD 205 (412)
T ss_dssp CSS--EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECC
T ss_pred eCC--EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec----CCCCEEEee
Confidence 765 89999999999999999977666799999999999999999999999999999999999998 788999999
Q ss_pred ccccccccCcc--ccCCCCCCCCccCcccccCC-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc
Q 040257 1118 FGLSRIKRNTL--VSGGVRGTLPWMAPELLNGS-----SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN 1190 (1254)
Q Consensus 1118 FGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~-----~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~ 1190 (1254)
||+++...... .....+||+.|+|||++.+. ...|+.++|||||||++|||++|+.||...+..+.+..+...
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 99998654332 23456899999999999731 124789999999999999999999999998888777777653
Q ss_pred c--C-CCCCCCCCcHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 040257 1191 T--L-RPTIPERCDPEWRKLMEQCWAADPEAR---PSFTEITSR 1228 (1254)
Q Consensus 1191 ~--L-rp~ipe~iS~eLrdLIkKCLqkDPeKR---PSArELLe~ 1228 (1254)
. + .+..+..+++++++||++||+ +|.+| |+++++++|
T Consensus 286 ~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 2 2 222346789999999999999 99998 589999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.30 Aligned_cols=260 Identities=24% Similarity=0.345 Sum_probs=193.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVV 1036 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf 1036 (1254)
.+...+|++.++||+|+||+||++++ +++.||||++... .......+.+|+.+++++. ||||+++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 95 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--------EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--------SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--------chHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence 34556899999999999999999998 5788999998653 2233567889999999996 99999999998
Q ss_pred ec------CCCCceEEEEEecccCchhhhhhc--cCCCCCHHHHHHHHHHhhhhhHHhhhCC--cccccCCCCceEeccC
Q 040257 1037 PD------GTGGTLATVTEFMVNGSLKHVLLK--KDRSLDRRKKLIIAMDAAFGMEYLHSKN--IVHFDLKCENLLVNLR 1106 (1254)
Q Consensus 1037 ~D------dn~~~L~LVMEYm~GGSL~d~L~k--re~~LSe~~~lkIa~QIAeALaYLHSkG--IIHRDLKPeNILLDsd 1106 (1254)
.. .....+++||||+. |+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-- 172 (337)
T 3ll6_A 96 SIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-- 172 (337)
T ss_dssp EECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC--
T ss_pred cccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC--
Confidence 42 23346899999995 788888754 3456999999999999999999999999 99999999999998
Q ss_pred CCCCCeEEEEeccccccccCccc-------------cCCCCCCCCccCcccccC-CCCCCCchhHHHHHHHHHHHHHcCC
Q 040257 1107 DPQRPICKVGDFGLSRIKRNTLV-------------SGGVRGTLPWMAPELLNG-SSNRVSEKVDVFSFGISMWEILTGE 1172 (1254)
Q Consensus 1107 d~snG~VKLiDFGLAr~~~~s~~-------------sts~~GT~~YmAPEVLrG-~~~kyS~KSDIWSLGVILYELLTGk 1172 (1254)
.++.+||+|||+++....... .....||+.|+|||++.. ....++.++|||||||++|+|++|+
T Consensus 173 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~ 250 (337)
T 3ll6_A 173 --NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250 (337)
T ss_dssp --TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSS
T ss_pred --CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCC
Confidence 778999999999976543211 113458999999999842 2235889999999999999999999
Q ss_pred CCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1173 EPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1173 ~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
.||........ .............+..+.+||.+||+.||.+||++.+++++|+.+....
T Consensus 251 ~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 251 HPFEDGAKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp CCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCcchhHHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 99976544332 2233333445567788999999999999999999999999999997653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=348.63 Aligned_cols=251 Identities=27% Similarity=0.454 Sum_probs=208.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec---
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD--- 1038 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D--- 1038 (1254)
.+|++++.||+|+||.||+|++. ++.||||+++... +.+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 47999999999999999999995 7889999997541 245679999999999999999998754
Q ss_pred -----------CCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccC
Q 040257 1039 -----------GTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLR 1106 (1254)
Q Consensus 1039 -----------dn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsd 1106 (1254)
.....+++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-- 156 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV-- 156 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc--
Confidence 1233589999999999999999654 35699999999999999999999999999999999999998
Q ss_pred CCCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHH
Q 040257 1107 DPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGG 1186 (1254)
Q Consensus 1107 d~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqs 1186 (1254)
.++.+||+|||++.............||+.|+|||++.+.. ++.++||||||+++|+|++|..||... ......
T Consensus 157 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~ 230 (284)
T 2a19_B 157 --DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD--YGKEVDLYALGLILAELLHVCDTAFET--SKFFTD 230 (284)
T ss_dssp --ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSC--CCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHH
T ss_pred --CCCCEEECcchhheeccccccccccCCcccccChhhhccCC--CcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHH
Confidence 77899999999998765544445567999999999998764 789999999999999999999988532 122222
Q ss_pred hhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1187 IVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1187 Ilk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
+.. ..++..++..+++||.+||..||.+||++.+++++|+.+....+.
T Consensus 231 ~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 231 LRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp HHT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred hhc----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 222 234566889999999999999999999999999999988665544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=357.64 Aligned_cols=264 Identities=27% Similarity=0.410 Sum_probs=202.6
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHH--HHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREA--HILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEI--eILkrLnHPNIVkLyGvf~ 1037 (1254)
.+...+|++++.||+|+||+||+|+++++.||||++.... ...+..|. ..+..++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----------RQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----------hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 3455689999999999999999999999999999997431 12233344 4455689999999997543
Q ss_pred ---cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC---------CcccccCCCCceEecc
Q 040257 1038 ---DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK---------NIVHFDLKCENLLVNL 1105 (1254)
Q Consensus 1038 ---Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk---------GIIHRDLKPeNILLDs 1105 (1254)
......+++||||+.+++|.+++... ..++..++.++.||+.||.|||++ +|+||||||+||||+
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~- 154 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK- 154 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC-
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc-
Confidence 22334678999999999999999544 458899999999999999999999 999999999999998
Q ss_pred CCCCCCeEEEEeccccccccCc---------cccCCCCCCCCccCcccccCCC-----CCCCchhHHHHHHHHHHHHHcC
Q 040257 1106 RDPQRPICKVGDFGLSRIKRNT---------LVSGGVRGTLPWMAPELLNGSS-----NRVSEKVDVFSFGISMWEILTG 1171 (1254)
Q Consensus 1106 dd~snG~VKLiDFGLAr~~~~s---------~~sts~~GT~~YmAPEVLrG~~-----~kyS~KSDIWSLGVILYELLTG 1171 (1254)
.++.+||+|||+++..... .......||+.|+|||++.+.. ..++.++|||||||+||||++|
T Consensus 155 ---~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 231 (336)
T 3g2f_A 155 ---NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231 (336)
T ss_dssp ---TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ---CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence 7789999999999754322 1223456999999999998631 1356789999999999999999
Q ss_pred CCCCCCCCh------------------hhHHHHhhhccCCCCCCCC------CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040257 1172 EEPYADMHC------------------GAIIGGIVKNTLRPTIPER------CDPEWRKLMEQCWAADPEARPSFTEITS 1227 (1254)
Q Consensus 1172 k~PF~~~n~------------------~eliqsIlk~~Lrp~ipe~------iS~eLrdLIkKCLqkDPeKRPSArELLe 1227 (1254)
..||..... ......+.....++.++.. +++++.+||.+||+.||++|||+.|+++
T Consensus 232 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp BGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 777643211 1111112222333444433 3457999999999999999999999999
Q ss_pred HHHHHHHHHhhcc
Q 040257 1228 RLRTISAAIESKC 1240 (1254)
Q Consensus 1228 ~Le~Ll~eLEsk~ 1240 (1254)
.|+.+++..+...
T Consensus 312 ~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 312 RMAELMMIWERNK 324 (336)
T ss_dssp HHHHHHHCCCC--
T ss_pred HHHHHHHHHHhcc
Confidence 9999987766543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=361.38 Aligned_cols=254 Identities=27% Similarity=0.330 Sum_probs=198.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|++ +++.||||+++.... .......+.+|+.++++++||||+++++++.+..
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 106 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE------EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH- 106 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------------CHHHHHHGGGCCCTTBCCEEEEEEETT-
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc------ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC-
Confidence 3799999999999999999987 477899999975421 2334566789999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC-CCCCeEEEEeccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD-PQRPICKVGDFGL 1120 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd-~snG~VKLiDFGL 1120 (1254)
.+++||||+. ++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++..+ ...+.+||+|||+
T Consensus 107 -~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 107 -RLHLIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp -EEEEEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred -EEEEEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 8999999997 5999988554 4699999999999999999999999999999999999996433 2567799999999
Q ss_pred cccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC----
Q 040257 1121 SRIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT---- 1195 (1254)
Q Consensus 1121 Ar~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~---- 1195 (1254)
++..... .......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||........+..+......+.
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccCCcccccCCCcCCccccCHHHhcCCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 9765322 2234456899999999998643 479999999999999999999999998877666655543211110
Q ss_pred ------------C------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1196 ------------I------------PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1196 ------------i------------pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
. +..++.++.+||.+||+.||.+|||+.|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 01167899999999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=357.91 Aligned_cols=246 Identities=24% Similarity=0.411 Sum_probs=208.8
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|+..+.||+|+||+||+|++. ++.||||++..... ...+.+.+|+.++++++||||+++++++....
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 115 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--------QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE-- 115 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--------hHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--
Confidence 4778889999999999999984 78899999975421 12356789999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 116 ~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 116 ELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT----LDGRVKLSDFGFCA 189 (321)
T ss_dssp EEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCcEEEeeeeeee
Confidence 79999999999999998853 4699999999999999999999999999999999999998 77899999999987
Q ss_pred cccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC-CCCCCCC
Q 040257 1123 IKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR-PTIPERC 1200 (1254)
Q Consensus 1123 ~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr-p~ipe~i 1200 (1254)
..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+...... ......+
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2c30_A 190 QISKDVPKRKSLVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV 267 (321)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGS
T ss_pred ecccCccccccccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccC
Confidence 65432 223456799999999999865 4789999999999999999999999987776666655543321 1223457
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++.+.+||.+||+.||++|||+.+++++
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 8999999999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=354.91 Aligned_cols=256 Identities=27% Similarity=0.462 Sum_probs=206.9
Q ss_pred ceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceE
Q 040257 966 LEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~ 1045 (1254)
|...+.||+|+||+||+|+++++.||||++...... ......+.+.+|+.++++++||||+++++++.+.. .++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 106 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDI----TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD--DLC 106 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTS----CTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCE
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCc----chHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC--ceE
Confidence 445588999999999999999999999999754211 12234567889999999999999999999997655 789
Q ss_pred EEEEecccCchhhhhhcc--CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1046 TVTEFMVNGSLKHVLLKK--DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kr--e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~kl~Dfg~~~~ 182 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD----EAFTAKISDFGLARA 182 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc----CCCcEEEeecccccc
Confidence 999999999999998643 34589999999999999999999999999999999999998 778999999999875
Q ss_pred ccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhh----c------
Q 040257 1124 KRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK----N------ 1190 (1254)
Q Consensus 1124 ~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk----~------ 1190 (1254)
.... .......||+.|+|||++.+. ++.++||||||+++|+|++|+.||...........+.. .
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRGE---ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED 259 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTTE---ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred cccccccccccccCCCcCcCChHHhcCC---CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence 4332 223345699999999999764 78899999999999999999999986543322211111 0
Q ss_pred cC---CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1191 TL---RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1191 ~L---rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
.+ ....+...+..+.+++.+||+.+|.+|||+.+++++|+.+..
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 260 YIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 00 111223345779999999999999999999999999998753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=349.60 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=210.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||.||++.+ +++.||||+++...... .......+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR----IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK 80 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH----STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC--
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc----cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Confidence 3799999999999999999998 46789999997542110 11234678899999999999999999999876666
Q ss_pred CceEEEEEecccCchhhhhhc-cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLK-KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~k-re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
..+++||||+.++ |.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~----~~~~~kl~dfg~ 155 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT----TGGTLKISALGV 155 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCTT
T ss_pred CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc----CCCcEEeecccc
Confidence 6899999999776 6665543 345699999999999999999999999999999999999998 778999999999
Q ss_pred cccccC---ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1121 SRIKRN---TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1121 Ar~~~~---s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
+..... ........||+.|+|||++.+....++.++||||||+++|+|++|+.||...........+..... ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~--~~~ 233 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY--AIP 233 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC--CCC
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC--CCC
Confidence 976432 222334569999999999987554458899999999999999999999998887777766665533 456
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+++.+.+||.+||..||.+|||+.+++++
T Consensus 234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 7789999999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=380.59 Aligned_cols=258 Identities=30% Similarity=0.430 Sum_probs=214.3
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCC-----chhHHHHHHHHHHHHHHHhcCCCCceeEEeeee
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGR-----SSEQERLTKDFWREAHILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~-----~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf 1036 (1254)
.+|+++++||+|+||+||+|+++ ++.||||++++...... ....+...+.+.+|+.+|++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 47999999999999999999984 67899999986532210 001113356788999999999999999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.+.. .+++||||+.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ....+||+
T Consensus 116 ~~~~--~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl~ 191 (504)
T 3q5i_A 116 EDKK--YFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN-SLLNIKIV 191 (504)
T ss_dssp ECSS--EEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTT-CCSSEEEC
T ss_pred EcCC--EEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCC-CCccEEEE
Confidence 8655 899999999999999988654 5699999999999999999999999999999999999998332 33479999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
|||+++............||+.|+|||++.+. ++.++|||||||++|+|++|+.||........+..+....+....
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK---YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC---BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhccC---CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 99999876665555667799999999999753 789999999999999999999999999888888888776554332
Q ss_pred C--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1197 P--ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1197 p--e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+ ..+++++++||++||+.||.+|||+.|++++
T Consensus 269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2 5688999999999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=346.60 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=208.2
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC-
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG- 1039 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd- 1039 (1254)
...|++.+.||+|+||+||+|.+. +..||+|++..... .....+.+.+|+.++++++||||+++++++...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL------TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh------CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 345889999999999999999984 56799999975432 123357788999999999999999999988642
Q ss_pred -CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCC--cccccCCCCceEeccCCCCCCeEEEE
Q 040257 1040 -TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKN--IVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1040 -n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkG--IIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
....+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ...+.+||+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~---~~~~~~kl~ 174 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT---GPTGSVKIG 174 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES---STTSCEEEC
T ss_pred CCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE---CCCCCEEEe
Confidence 234689999999999999999654 56899999999999999999999999 99999999999996 246789999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh-HHHHhhhccCCCC
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA-IIGGIVKNTLRPT 1195 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e-liqsIlk~~Lrp~ 1195 (1254)
|||++....... .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||....... ....+........
T Consensus 175 Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (290)
T 1t4h_A 175 DLGLATLKRASF-AKAVIGTPEFMAPEMYEEK---YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 250 (290)
T ss_dssp CTTGGGGCCTTS-BEESCSSCCCCCGGGGGTC---CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred eCCCcccccccc-cccccCCcCcCCHHHHhcc---CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc
Confidence 999997554432 2345699999999998753 7999999999999999999999998755443 3333433333334
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+...++++.+||.+||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 556678999999999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=359.22 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=210.9
Q ss_pred ccccccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 957 GLQIIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 957 glq~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
....+...+|++++.||+|+||+||++++. ++.||+|++.... .....+.+.+|+.++++++||||+++++
T Consensus 26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 98 (360)
T 3eqc_A 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYG 98 (360)
T ss_dssp TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-------CHHHHHHHHHHHGGGGGCCCTTBCCEEE
T ss_pred cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-------CHHHHHHHHHHHHHHHHCCCCCEEEEeE
Confidence 344667779999999999999999999995 7789999997542 2334577899999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC-CcccccCCCCceEeccCCCCCCeE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk-GIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
++.+.. .+++||||+.+++|.+++... +.+++..++.++.||+.||.|||+. ||+||||||+|||++ .++.+
T Consensus 99 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~----~~~~~ 171 (360)
T 3eqc_A 99 AFYSDG--EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEI 171 (360)
T ss_dssp EEEETT--EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC----TTCCE
T ss_pred EEEECC--EEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC----CCCCE
Confidence 998765 799999999999999998654 4689999999999999999999996 999999999999998 77899
Q ss_pred EEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH---------
Q 040257 1114 KVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAII--------- 1184 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eli--------- 1184 (1254)
||+|||++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.........
T Consensus 172 kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 248 (360)
T 3eqc_A 172 KLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248 (360)
T ss_dssp EECCCCCCHHHHHH-C----CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----
T ss_pred EEEECCCCcccccc-cccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccc
Confidence 99999998754332 22345799999999999876 4899999999999999999999999865543321
Q ss_pred ---------------------------------HHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1185 ---------------------------------GGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1185 ---------------------------------qsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
..+............++.++.+||.+||+.||.+|||+.+++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp -------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred cCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 122222222223345789999999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=375.77 Aligned_cols=268 Identities=22% Similarity=0.330 Sum_probs=216.5
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
..+.+|++.+.||+|+||+||+|++. ++.||||+++..... ...+.+.+|+.+|++++||||+++++++.+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-------RPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-------SCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-------chHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 34568999999999999999999995 778999999754321 123567789999999999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCC--CCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDR--SLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~--~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.....+++||||+.+++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+...+...+.+||+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence 776688999999999999999865432 389999999999999999999999999999999999993222367789999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCC----hhhHHHH
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSS------NRVSEKVDVFSFGISMWEILTGEEPYADMH----CGAIIGG 1186 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~------~kyS~KSDIWSLGVILYELLTGk~PF~~~n----~~eliqs 1186 (1254)
|||+++............||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.... ..+.+..
T Consensus 159 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp CGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred cCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 999998766655555677999999999986410 236889999999999999999999997432 2344444
Q ss_pred hhhccCCC-----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1187 IVKNTLRP-----------------------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1187 Ilk~~Lrp-----------------------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
+....... .+...++..+.+||.+||++||++||++.++++.|+.++..
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 44332110 11123456788999999999999999999999999888653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=360.68 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=206.9
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCC--CceeEEeeeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH--PNVVAFYGVVP 1037 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnH--PNIVkLyGvf~ 1037 (1254)
+...+|++++.||+|+||+||++.+ +++.||||++..... .....+.+.+|+.+|++++| +||+++++++.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc------chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 4566899999999999999999988 466799999975421 23345778899999999976 99999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. .+++|||+ .+++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|
T Consensus 80 ~~~--~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-----~~~~kl~D 150 (343)
T 3dbq_A 80 TDQ--YIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLID 150 (343)
T ss_dssp CSS--EEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-----TTEEEECC
T ss_pred eCC--EEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-----CCcEEEee
Confidence 665 89999995 688999998654 5699999999999999999999999999999999999996 46899999
Q ss_pred ccccccccCcc---ccCCCCCCCCccCcccccCC---------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hhHH
Q 040257 1118 FGLSRIKRNTL---VSGGVRGTLPWMAPELLNGS---------SNRVSEKVDVFSFGISMWEILTGEEPYADMHC-GAII 1184 (1254)
Q Consensus 1118 FGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~---------~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~-~eli 1184 (1254)
||+++...... ......||+.|+|||++.+. ...++.++|||||||+||+|++|+.||..... ...+
T Consensus 151 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 230 (343)
T 3dbq_A 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 230 (343)
T ss_dssp CSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred cccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH
Confidence 99998654322 23356799999999998641 13589999999999999999999999987543 3444
Q ss_pred HHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1185 GGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1185 qsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
..+.........+...+.++.+||.+||+.||.+|||+.+++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 445555555667777889999999999999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=364.79 Aligned_cols=257 Identities=23% Similarity=0.361 Sum_probs=217.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~ 1041 (1254)
+|++.+.||+|+||.||+|++. ++.||||++................+.+.+|+.+++++ +||||+++++++....
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~- 173 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS- 173 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS-
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC-
Confidence 6999999999999999999984 78899999976532222233445567889999999999 7999999999997654
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++
T Consensus 174 -~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~----~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 174 -FMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD----DNMQIRLSDFGFS 247 (365)
T ss_dssp -EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred -EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEEEecCcc
Confidence 899999999999999998654 5699999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCC----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGS----SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~----~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
.............||+.|+|||++.+. ...++.++|||||||++|+|++|+.||...........+....+....+
T Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327 (365)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred cccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 876555455567899999999998643 1247889999999999999999999999887777776666655443222
Q ss_pred --CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 --ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 --e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..++..+.+||.+||+.||.+||++.+++++
T Consensus 328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 4678899999999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=368.29 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=206.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn 1040 (1254)
.+|++++.||+|+||+||+|.++ ++.||||++.+... ...+|++++.++ +||||+++++++.+..
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------------DPTEEIEILLRYGQHPNIITLKDVYDDGK 89 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------------CCHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------------ChHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence 37999999999999999999985 77899999976421 123577888777 7999999999998655
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+...+...+.+||+|||+
T Consensus 90 --~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 90 --YVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp --EEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred --EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 899999999999999998554 56999999999999999999999999999999999999964333345799999999
Q ss_pred cccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---ChhhHHHHhhhccCCCC-
Q 040257 1121 SRIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADM---HCGAIIGGIVKNTLRPT- 1195 (1254)
Q Consensus 1121 Ar~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~---n~~eliqsIlk~~Lrp~- 1195 (1254)
++.... .......+||+.|+|||++.+.. ++.++|||||||+||+|++|+.||... ...+....+....+...
T Consensus 167 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 244 (342)
T 2qr7_A 167 AKQLRAENGLLMTPCYTANFVAPEVLERQG--YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244 (342)
T ss_dssp CEECBCTTCCBCCSSCCSSCCCHHHHHHHH--HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS
T ss_pred cccCcCCCCceeccCCCccccCHHHhcCCC--CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc
Confidence 986533 23344567999999999998654 788999999999999999999999863 34455555655544322
Q ss_pred -CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1196 -IPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1196 -ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
....++.++++||++||..||++||++.+++++-
T Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 3356899999999999999999999999999763
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=347.43 Aligned_cols=251 Identities=27% Similarity=0.372 Sum_probs=214.9
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|.+.+.||+|+||+||++++. ++.||+|++...... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-----KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc-----CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 347999999999999999999995 677999999765322 2334567889999999999999999999998655
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 89 --~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~dfg~ 161 (294)
T 2rku_A 89 --FVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN----EDLEVKIGDFGL 161 (294)
T ss_dssp --EEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCTT
T ss_pred --EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc----CCCCEEEEeccC
Confidence 899999999999999988544 5699999999999999999999999999999999999998 778999999999
Q ss_pred cccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1121 SRIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1121 Ar~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
+..... ........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||......+....+.... ...+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~ 237 (294)
T 2rku_A 162 ATKVEYDGERKKVLCGTPNYIAPEVLSKKG--HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPKH 237 (294)
T ss_dssp CEECCSTTCCBCCCCSCCSSCCHHHHTTSC--BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTT
T ss_pred ceecccCccccccccCCCCcCCcchhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc--CCCccc
Confidence 976532 22334466999999999998654 7889999999999999999999999887776666655443 345677
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
++..+.+||.+||+.||++|||+.+++++-
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 238 INPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred cCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 899999999999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=371.03 Aligned_cols=249 Identities=24% Similarity=0.305 Sum_probs=196.0
Q ss_pred CceEE-EEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHH-hcCCCCceeEEeeeeec--
Q 040257 965 DLEEL-RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHIL-SNLHHPNVVAFYGVVPD-- 1038 (1254)
Q Consensus 965 dYeiL-kkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeIL-krLnHPNIVkLyGvf~D-- 1038 (1254)
+|.+. +.||+|+||+||++.+. ++.||||++... ..+.+|+.++ +.++||||++++++|..
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 67776 68999999999999984 678999999642 2456788876 45689999999998864
Q ss_pred CCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
.....+++||||+.+|+|.+++..+. ..+++..++.|+.||+.||.|||++||+||||||+|||++..+ .++.+||+|
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~~~~kl~D 207 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTD 207 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-TTCCEEECC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCC-CCccEEEEe
Confidence 22347899999999999999997653 4699999999999999999999999999999999999998322 368999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh----HHHHhhhccCC
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA----IIGGIVKNTLR 1193 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e----liqsIlk~~Lr 1193 (1254)
||+++...........+||+.|+|||++.+. .++.++|||||||+||+|++|+.||....... ....+....+.
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~ 285 (400)
T 1nxk_A 208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285 (400)
T ss_dssp CTTCEECC-----------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred cccccccCCCCccccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence 9999866554445567899999999999865 48899999999999999999999997654322 33344444333
Q ss_pred CCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1194 PTI--PERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1194 p~i--pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
... ...++.++++||++||+.||.+|||+.+++++-
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 222 246899999999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=389.98 Aligned_cols=270 Identities=33% Similarity=0.552 Sum_probs=224.1
Q ss_pred ccccCceEEE-EEeeeCcEEEEEEEEC----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeee
Q 040257 961 IKNVDLEELR-ELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGV 1035 (1254)
Q Consensus 961 Ik~~dYeiLk-kLGeGsFGtVYlAk~r----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGv 1035 (1254)
+...++.+.. .||+|+||+||+|.++ +..||||+++.... ....+.+.+|+.+|++++||||++++++
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~~E~~il~~l~hpniv~l~~~ 404 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-------KADTEEMMREAQIMHQLDNPYIVRLIGV 404 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-------STTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3444566666 8999999999999873 34699999975421 1124678899999999999999999999
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
+.++ .+++||||+.+|+|.+++......+++..++.|+.||+.||.|||+++||||||||+||||+ .++.+||
T Consensus 405 ~~~~---~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~----~~~~vkL 477 (613)
T 2ozo_A 405 CQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV----NRHYAKI 477 (613)
T ss_dssp EESS---SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEE
T ss_pred eccC---CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc----CCCcEEE
Confidence 9753 58999999999999999977767799999999999999999999999999999999999999 7789999
Q ss_pred EeccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhc
Q 040257 1116 GDFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKN 1190 (1254)
Q Consensus 1116 iDFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~ 1190 (1254)
+|||+++...... ......+++.|+|||++.+. .++.++|||||||+||||++ |+.||......+....+..+
T Consensus 478 ~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~ 555 (613)
T 2ozo_A 478 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 555 (613)
T ss_dssp CCCSTTTTCC--------------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT
T ss_pred eeccCcccccCCCceeeeccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 9999998653221 11223456889999999865 48999999999999999998 99999998887777666544
Q ss_pred cCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhcccCCCCCC
Q 040257 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCINSEPKQ 1247 (1254)
Q Consensus 1191 ~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk~~k~~p~t 1247 (1254)
.+...+..+++++.+||.+||+.+|.+||++.+|++.|+.+..++..+....+..+
T Consensus 556 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~s~le 611 (613)
T 2ozo_A 556 -KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSALE 611 (613)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCSSSCS
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCcccee
Confidence 45567788999999999999999999999999999999999999888766655443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=378.33 Aligned_cols=261 Identities=34% Similarity=0.589 Sum_probs=217.2
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEECC-ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWRG-SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
+.+...+|++.+.||+|+||+||+|.+.+ ..||||+++.... ..+.|.+|+.+|++++||||+++++++.
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 249 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAVVS 249 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---------CHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 34566789999999999999999999965 5699999875421 1356889999999999999999999986
Q ss_pred cCCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
+ ..+++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+
T Consensus 250 ~---~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~----~~~~~kl~ 322 (452)
T 1fmk_A 250 E---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVA 322 (452)
T ss_dssp S---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEEC
T ss_pred C---CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC----CCCCEEEC
Confidence 5 3689999999999999999653 34589999999999999999999999999999999999998 67899999
Q ss_pred eccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCC
Q 040257 1117 DFGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1117 DFGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
|||+++...... ......++..|+|||++.+. .++.++|||||||+||||++ |+.||......+....+... .+
T Consensus 323 DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~ 399 (452)
T 1fmk_A 323 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YR 399 (452)
T ss_dssp CCCTTC--------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CC
T ss_pred CCccceecCCCceecccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC
Confidence 999998654322 22334577889999999865 48999999999999999999 99999988877777666543 45
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
...+..+++.+.+||.+||+.||++|||+.+|++.|+.+....+.
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 566778999999999999999999999999999999988655444
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=354.65 Aligned_cols=260 Identities=24% Similarity=0.338 Sum_probs=207.9
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.+...+|++++.||+|+||.||++++ .++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--------EQQDREEAQREADMHRLFNHPNILRLVAYCL 96 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--------CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEE
Confidence 45667899999999999999999997 5788999998653 1234567889999999999999999999986
Q ss_pred cC--CCCceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCe
Q 040257 1038 DG--TGGTLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPI 1112 (1254)
Q Consensus 1038 Dd--n~~~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~ 1112 (1254)
.. ....+++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.
T Consensus 97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~----~~~~ 172 (317)
T 2buj_A 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG----DEGQ 172 (317)
T ss_dssp EEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSC
T ss_pred eccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc----CCCC
Confidence 32 33478999999999999998865 356799999999999999999999999999999999999998 7789
Q ss_pred EEEEeccccccccCccc----------cCCCCCCCCccCcccccCCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCh-
Q 040257 1113 CKVGDFGLSRIKRNTLV----------SGGVRGTLPWMAPELLNGSSN-RVSEKVDVFSFGISMWEILTGEEPYADMHC- 1180 (1254)
Q Consensus 1113 VKLiDFGLAr~~~~s~~----------sts~~GT~~YmAPEVLrG~~~-kyS~KSDIWSLGVILYELLTGk~PF~~~n~- 1180 (1254)
+||+|||++........ .....||+.|+|||++.+... .++.++|||||||++|+|++|+.||.....
T Consensus 173 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 252 (317)
T 2buj_A 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252 (317)
T ss_dssp EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT
T ss_pred EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc
Confidence 99999999875422110 112347999999999976532 368899999999999999999999964211
Q ss_pred -hhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1181 -GAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1181 -~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
.... ..............++.++.+||.+||+.||.+||++.+++++|+.+
T Consensus 253 ~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 253 GDSVA-LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp TSCHH-HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cchhh-HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 1111 12222333344567899999999999999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=345.14 Aligned_cols=258 Identities=25% Similarity=0.314 Sum_probs=217.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCc-hhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRS-SEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDG 1039 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~-~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Dd 1039 (1254)
.+|++.+.||+|+||.||+|.++ ++.||||++......... .......+.+.+|+.+++++. ||||+++++++.+.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 48999999999999999999984 678999999754321111 223455677899999999995 99999999999765
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
. .+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 97 ~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~dfg 169 (298)
T 1phk_A 97 T--FFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDFG 169 (298)
T ss_dssp S--EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCT
T ss_pred C--eEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc----CCCcEEEeccc
Confidence 4 899999999999999998654 5699999999999999999999999999999999999998 77899999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCC----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGS----SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~----~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
++.............|++.|+|||++.+. ...++.++||||||+++|+|++|+.||...........+........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 1phk_A 170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249 (298)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred chhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence 99876555445556799999999998521 22478899999999999999999999998887777776666554433
Q ss_pred CC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1196 IP--ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1196 ip--e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+ ..++..+.+||.+||+.||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 33 4578999999999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=346.30 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=214.3
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|++.+.||+|+||.||+|++. ++.||||++..... ........+.+|+.++++++||||+++++++.+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-----EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc-----chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 44458999999999999999999985 56799999975321 112224568899999999999999999999986
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. .+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 86 ~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~Df 158 (284)
T 2vgo_A 86 RK--RIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG----YKGELKIADF 158 (284)
T ss_dssp SS--EEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC----TTCCEEECCC
T ss_pred CC--EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc----CCCCEEEecc
Confidence 54 899999999999999998654 4689999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCC
Q 040257 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1119 GLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe 1198 (1254)
|++...... ......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+.... ...+.
T Consensus 159 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~ 233 (284)
T 2vgo_A 159 GWSVHAPSL-RRRTMCGTLDYLPPEMIEGKT--HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--LKFPP 233 (284)
T ss_dssp TTCEECSSS-CBCCCCSCGGGCCHHHHTTCC--BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCT
T ss_pred cccccCccc-ccccccCCCCcCCHHHhccCC--CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc--cCCCC
Confidence 998755433 234467999999999998764 7889999999999999999999999887777666665543 34567
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++.++++||.+||+.||.+||++.+++++
T Consensus 234 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 234 FLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred cCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 789999999999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=358.46 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=204.6
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-----CCceeEEe
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-----HPNVVAFY 1033 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-----HPNIVkLy 1033 (1254)
+...+|+++++||+|+||+||+|++ +++.||||+++.. ......+.+|+.+++.+. ||||++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---------KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---------HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---------hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 4456899999999999999999999 5778999999742 223456678999999886 99999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC-----
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD----- 1107 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd----- 1107 (1254)
+++.... .+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++...
T Consensus 103 ~~~~~~~--~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 103 GKFMYYD--HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEETT--EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred ceeeECC--eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 9998765 899999999 999999986543 3599999999999999999999999999999999999997211
Q ss_pred ----------------CCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcC
Q 040257 1108 ----------------PQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG 1171 (1254)
Q Consensus 1108 ----------------~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTG 1171 (1254)
...+.+||+|||+++..... .....||+.|+|||++.+.. ++.++|||||||+||+|++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLG--WDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHS
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCC--CCCccchHHHHHHHHHHHHC
Confidence 13678999999999864432 23467999999999998764 88999999999999999999
Q ss_pred CCCCCCCChhhHHHHhhhccCCC------------------------CCC--------------------CCCcHHHHHH
Q 040257 1172 EEPYADMHCGAIIGGIVKNTLRP------------------------TIP--------------------ERCDPEWRKL 1207 (1254)
Q Consensus 1172 k~PF~~~n~~eliqsIlk~~Lrp------------------------~ip--------------------e~iS~eLrdL 1207 (1254)
+.||......+.+..+....... ..+ ...++.+.+|
T Consensus 256 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 335 (360)
T 3llt_A 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDF 335 (360)
T ss_dssp SCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHH
T ss_pred CCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHH
Confidence 99998876655544433211100 000 1123678899
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 040257 1208 MEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1208 IkKCLqkDPeKRPSArELLe~ 1228 (1254)
|.+||+.||.+|||+.|+|++
T Consensus 336 i~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 336 LYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHhcCChhhCCCHHHHhcC
Confidence 999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=349.39 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=210.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||++++. ++.||||+++.... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--------FRDSSLENEIAVLKKIKHENIVTLEDIYESTT- 79 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------HHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--------cchHHHHHHHHHHHhCCCCCeeehhhhcccCC-
Confidence 37999999999999999999984 78899999985421 12346788999999999999999999998655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+...+ ..+.+||+|||++
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~-~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 80 -HYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE-ENSKIMITDFGLS 156 (304)
T ss_dssp -EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSS-TTCCEEBCSCSTT
T ss_pred -EEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCC-CCCCEEEccCCcc
Confidence 899999999999999988654 4689999999999999999999999999999999999994222 6789999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC--CCCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP--TIPER 1199 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp--~ipe~ 1199 (1254)
....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+....+.. .....
T Consensus 157 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (304)
T 2jam_A 157 KMEQNGI-MSTACGTPGYVAPEVLAQKP--YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDD 233 (304)
T ss_dssp CCCCCBT-THHHHSCCCBCCTTTBSSCS--CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTT
T ss_pred eecCCCc-cccccCCCCccChHHhccCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcccccc
Confidence 7544332 22345899999999998664 8999999999999999999999999888777777776654432 33456
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++.++.+||.+||+.||.+||++.+++++
T Consensus 234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 234 ISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp SCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 89999999999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=382.73 Aligned_cols=257 Identities=33% Similarity=0.610 Sum_probs=220.6
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf 1036 (1254)
+.+...+|++.+.||+|+||.||+|.++ +..||||+++.... ..+.|.+|+.+|++++||||+++++++
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~~ 285 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------EVEEFLKEAAVMKEIKHPNLVQLLGVC 285 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---------chHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4566678999999999999999999996 67899999875421 145688999999999999999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
.+.. .+++||||+.+|+|.+++... ...+++..++.|+.||+.||.|||+++|+||||||+||||+ .++.+||
T Consensus 286 ~~~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----~~~~~kl 359 (495)
T 1opk_A 286 TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG----ENHLVKV 359 (495)
T ss_dssp CSSS--SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----GGGCEEE
T ss_pred ecCC--cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC----CCCcEEE
Confidence 7655 789999999999999999753 34689999999999999999999999999999999999998 6789999
Q ss_pred EeccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccC
Q 040257 1116 GDFGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1116 iDFGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~L 1192 (1254)
+|||+++...... ......++..|+|||++.+.. ++.++|||||||+||||++ |..||...........+. ..+
T Consensus 360 ~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~ 436 (495)
T 1opk_A 360 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDY 436 (495)
T ss_dssp CCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTC
T ss_pred eecccceeccCCceeecCCCcCCcceeCHhHHhcCC--CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCC
Confidence 9999998654322 223345678899999998654 8999999999999999999 999999887776665544 345
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
+...+..+++++.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 56677889999999999999999999999999999998763
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=359.44 Aligned_cols=254 Identities=26% Similarity=0.335 Sum_probs=203.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|++. ++.||||+++..... .........+.+|+.++++++||||+++++++.+..
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 85 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS---EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS- 85 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcc---hhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC-
Confidence 47999999999999999999984 778999998754211 111223356789999999999999999999997654
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+ +|..++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 86 -~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~----~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 86 -NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLA 159 (346)
T ss_dssp -CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECCCGGG
T ss_pred -ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc----CCCCEEEEecccc
Confidence 78999999975 88888877667799999999999999999999999999999999999998 7789999999999
Q ss_pred ccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC-----
Q 040257 1122 RIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT----- 1195 (1254)
Q Consensus 1122 r~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~----- 1195 (1254)
+.... ........||+.|+|||++.+.. .++.++|||||||++|+|++|..||........+..+......+.
T Consensus 160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 160 KSFGSPNRAYTHQVVTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp STTTSCCCCCCCSCCCCTTCCHHHHTTCS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred eeccCCcccCCcccccccccCchHhhCCC-CCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 86533 22334567999999999997542 478999999999999999999999998877666665543211110
Q ss_pred ---------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1196 ---------------------IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1196 ---------------------ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
....++.++++||.+||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 013457899999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.50 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=204.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn 1040 (1254)
.+|++++.||+|+||+||+|++. ++.||||+++.... .......+.+|+.++..+ +||||+++++++.+..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA------GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT------TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc------ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 47999999999999999999994 78899999985421 112345678899999998 9999999999998765
Q ss_pred CCceEEEEEecccCchhhhhhcc---CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC----------
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKK---DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD---------- 1107 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kr---e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd---------- 1107 (1254)
.+++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 85 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 85 --HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp --EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred --eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccc
Confidence 899999999999999998653 25689999999999999999999999999999999999997332
Q ss_pred -----CCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 040257 1108 -----PQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA 1182 (1254)
Q Consensus 1108 -----~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e 1182 (1254)
.....+||+|||++....... ...||+.|+|||++.+. ..++.++|||||||++|+|++|..++.....
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-- 236 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ-- 236 (289)
T ss_dssp -------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred cccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence 144579999999998654432 24599999999999865 2467899999999999999999988765432
Q ss_pred HHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1183 IIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1183 liqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
...+... ..+..+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 237 -~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 -WHEIRQG-RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HHHHHTT-CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -HHHHHcC-CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 2233333 3355677889999999999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=382.19 Aligned_cols=253 Identities=26% Similarity=0.444 Sum_probs=219.6
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+...+|.+++.||+|+||+||+|++. ++.||||++.+.... .......+.+|+.+|+.++||||+++++++.+
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-----SLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-----HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34558999999999999999999984 788999999754211 12234678899999999999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
.. .+++||||+.+++|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 88 ~~--~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~----~~~~vkL~DF 160 (476)
T 2y94_A 88 PS--DIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD----AHMNAKIADF 160 (476)
T ss_dssp SS--EEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC----TTCCEEECCC
T ss_pred CC--EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe----cCCCeEEEec
Confidence 65 89999999999999999854 45699999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCC
Q 040257 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1119 GLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe 1198 (1254)
|+++...........+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...........+....+ ..+.
T Consensus 161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p~ 237 (476)
T 2y94_A 161 GLSNMMSDGEFLRTSCGSPNYAAPEVISGRL-YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF--YTPQ 237 (476)
T ss_dssp SSCEECCTTCCBCCCCSCSTTCCHHHHTTCC-BCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC--CCCT
T ss_pred cchhhccccccccccCCCcCeEChhhccCCC-CCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc--CCCc
Confidence 9998765555555678999999999998764 247899999999999999999999998887777777766543 3566
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+++++.+||++||+.||.+|||+.+++++
T Consensus 238 ~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 238 YLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred cCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 789999999999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=352.97 Aligned_cols=255 Identities=30% Similarity=0.542 Sum_probs=209.2
Q ss_pred cCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhc--CCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN--LHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkr--LnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++.+.||+|+||+||+++++++.||||++.... ...+.+|+++++. ++||||+++++++.....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----------ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 378999999999999999999999999999986431 2456778888876 799999999999876543
Q ss_pred --CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhh--------hCCcccccCCCCceEeccCCCCCC
Q 040257 1042 --GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLH--------SKNIVHFDLKCENLLVNLRDPQRP 1111 (1254)
Q Consensus 1042 --~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLH--------SkGIIHRDLKPeNILLDsdd~snG 1111 (1254)
..+++||||+.+++|.+++.+ ..+++..++.++.||+.||.||| +++|+||||||+|||++ .++
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~----~~~ 184 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNG 184 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC----TTS
T ss_pred ccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC----CCC
Confidence 378999999999999999954 36899999999999999999999 89999999999999998 778
Q ss_pred eEEEEeccccccccCcc-----ccCCCCCCCCccCcccccCCCC----CCCchhHHHHHHHHHHHHHcC----------C
Q 040257 1112 ICKVGDFGLSRIKRNTL-----VSGGVRGTLPWMAPELLNGSSN----RVSEKVDVFSFGISMWEILTG----------E 1172 (1254)
Q Consensus 1112 ~VKLiDFGLAr~~~~s~-----~sts~~GT~~YmAPEVLrG~~~----kyS~KSDIWSLGVILYELLTG----------k 1172 (1254)
.+||+|||+++...... ......||+.|+|||++.+... .++.++|||||||+||||++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999997654332 2344579999999999986532 234789999999999999999 7
Q ss_pred CCCCCCC-----hhhHHHHhhhccCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1173 EPYADMH-----CGAIIGGIVKNTLRPTIPE-----RCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1173 ~PF~~~n-----~~eliqsIlk~~Lrp~ipe-----~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
.||.... .......+....+++..+. .++..+.+||.+||+.||.+|||+.+++++|+.+..+
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 8887642 2333344444444444443 2346799999999999999999999999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=369.04 Aligned_cols=260 Identities=30% Similarity=0.546 Sum_probs=209.4
Q ss_pred CceEEEEEeeeCcEEEEEEEEC---C--ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR---G--SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r---G--s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
.|++.+.||+|+||+||+|++. + ..||||.++... .....+++.+|+.++++++||||+++++++.+.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-------CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 5788899999999999999873 1 248999886421 123356789999999999999999999987543
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
. ...++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 163 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~~~~kL~DFG 237 (373)
T 3c1x_A 163 E-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFG 237 (373)
T ss_dssp S-SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEECCC-
T ss_pred C-CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC----CCCCEEEeecc
Confidence 3 367899999999999999977777799999999999999999999999999999999999998 77899999999
Q ss_pred ccccccCcc-----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCC
Q 040257 1120 LSRIKRNTL-----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1120 LAr~~~~s~-----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
+++...... ......+|+.|+|||++.+. .++.++|||||||+||||++ |.+||......+....+.... .
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-~ 314 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-R 314 (373)
T ss_dssp --------------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-C
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-C
Confidence 997543221 12334578889999999865 48999999999999999999 788888776666555554433 3
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhc
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk 1239 (1254)
...+..++..+.+||.+||+.||++||++.++++.|+.+...+...
T Consensus 315 ~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 315 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 4556778999999999999999999999999999999998877654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=358.24 Aligned_cols=265 Identities=30% Similarity=0.400 Sum_probs=214.7
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
.+...+|++.+.||+|+||.||+|++.+ .+|+|+++...... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNE------DQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCC------CCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCH------HHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 4556689999999999999999999875 59999987542211 1123466799999999999999999999876
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
. .+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 102 ~--~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-----~~~~~l~Dfg 174 (319)
T 2y4i_B 102 P--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-----NGKVVITDFG 174 (319)
T ss_dssp S--CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-------CCEECCCS
T ss_pred C--ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-----CCCEEEeecC
Confidence 5 79999999999999999977666799999999999999999999999999999999999996 3589999999
Q ss_pred ccccccC------ccccCCCCCCCCccCcccccCC-------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHH
Q 040257 1120 LSRIKRN------TLVSGGVRGTLPWMAPELLNGS-------SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGG 1186 (1254)
Q Consensus 1120 LAr~~~~------s~~sts~~GT~~YmAPEVLrG~-------~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqs 1186 (1254)
+++.... ........||+.|+|||++.+. ...++.++|||||||++|+|++|+.||...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9864321 1122334589999999999752 23478999999999999999999999998887777766
Q ss_pred hhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1187 IVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1187 Ilk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
+............++.++.+||.+||..||.+|||+.++++.|+.+......
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred hccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 6655444444456888999999999999999999999999999998776543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=360.00 Aligned_cols=250 Identities=27% Similarity=0.382 Sum_probs=200.2
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|++. ++.||||+++.... ......+.+|+.+|++++||||+++++++.+..
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 73 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-------EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK- 73 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-------cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-
Confidence 37999999999999999999984 77899999974321 111223457999999999999999999998655
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 -~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 74 -SLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN----ERGELKLADFGLA 147 (324)
T ss_dssp -CEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC----TTCCEEECSSSEE
T ss_pred -EEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC----CCCCEEEccCccc
Confidence 7999999996 589998877777799999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC-----
Q 040257 1122 RIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT----- 1195 (1254)
Q Consensus 1122 r~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~----- 1195 (1254)
+..... .......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+....+......+.
T Consensus 148 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 148 RAKSIPTKTYDNEVVTLWYRPPDILLGST-DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226 (324)
T ss_dssp ECC------------CGGGCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccCCccccccccCcccccChhhhcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhch
Confidence 754322 2233456899999999997642 479999999999999999999999998877666555443211100
Q ss_pred -----------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1196 -----------------------IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1196 -----------------------ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
....+++++.+||.+||+.||.+|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 112467899999999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=349.35 Aligned_cols=248 Identities=23% Similarity=0.301 Sum_probs=203.5
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVP 1037 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~ 1037 (1254)
....+|++++.||+|+||+||+|++ .++.||||+++... .+.+.+|+.++++++ ||||+++++++.
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 101 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVK 101 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----------hHHHHHHHHHHHHcCCCCCEEEeeeeec
Confidence 3456899999999999999999988 47789999987431 356789999999997 999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCC-eEEEE
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRP-ICKVG 1116 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG-~VKLi 1116 (1254)
+......++||||+.+++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++ .++ .+||+
T Consensus 102 ~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~----~~~~~~kl~ 173 (330)
T 3nsz_A 102 DPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID----HEHRKLRLI 173 (330)
T ss_dssp CTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----TTTTEEEEC
T ss_pred cCCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc----CCCCEEEEE
Confidence 866668999999999999999873 489999999999999999999999999999999999998 444 89999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hhHHHHhh-------
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC-GAIIGGIV------- 1188 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~-~eliqsIl------- 1188 (1254)
|||+++............||..|+|||++.+.. .++.++|||||||+||+|++|+.||..... ...+..+.
T Consensus 174 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~ 252 (330)
T 3nsz_A 174 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252 (330)
T ss_dssp CCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred eCCCceEcCCCCccccccccccccChhhhcCCC-cCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCch
Confidence 999998765555555667999999999997632 489999999999999999999999954322 11111111
Q ss_pred ------hcc----------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1189 ------KNT----------------------LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1189 ------k~~----------------------Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
... ........+++++.+||.+||+.||.+|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 0111122378999999999999999999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=367.22 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=208.9
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC--CCceeEEeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH--HPNVVAFYGVV 1036 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn--HPNIVkLyGvf 1036 (1254)
.+...+|++++.||+|+||+||++.+. ++.||||++..... .....+.+.+|+.+|+++. ||||+++++++
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc------cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 344557999999999999999999884 67799999975421 2334577899999999996 59999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.... .+++||| +.+++|.+++... ..+++..++.|+.||+.||.|||+++|+||||||+||||+ ++.+||+
T Consensus 126 ~~~~--~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-----~~~~kl~ 196 (390)
T 2zmd_A 126 ITDQ--YIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLI 196 (390)
T ss_dssp ECSS--EEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-----SSCEEEC
T ss_pred ecCC--EEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-----CCeEEEE
Confidence 8765 7999999 5688999998654 4789999999999999999999999999999999999996 3689999
Q ss_pred eccccccccCcc---ccCCCCCCCCccCcccccCC---------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hhH
Q 040257 1117 DFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGS---------SNRVSEKVDVFSFGISMWEILTGEEPYADMHC-GAI 1183 (1254)
Q Consensus 1117 DFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~---------~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~-~el 1183 (1254)
|||+++...... .....+||+.|+|||++.+. ...++.++|||||||+||||++|+.||..... ...
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 276 (390)
T 2zmd_A 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276 (390)
T ss_dssp CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH
Confidence 999998654322 23456799999999999752 12489999999999999999999999987543 344
Q ss_pred HHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1184 IGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1184 iqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
+..+.........+...+.++.+||.+||+.||.+||++.|++++-
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 5555555555566777889999999999999999999999999763
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=356.47 Aligned_cols=250 Identities=27% Similarity=0.377 Sum_probs=214.8
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|.+++.||+|+||.||++++. ++.||+|++...... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-----KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc-----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 347999999999999999999985 667999999865322 2334567889999999999999999999998755
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 115 --~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~~kl~Dfg~ 187 (335)
T 2owb_A 115 --FVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN----EDLEVKIGDFGL 187 (335)
T ss_dssp --EEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCTT
T ss_pred --eEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc----CCCCEEEeeccC
Confidence 899999999999999988554 5699999999999999999999999999999999999998 778999999999
Q ss_pred cccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1121 SRIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1121 Ar~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
++.... ........||..|+|||++.+.. ++.++||||||+++|+|++|+.||......+....+.... ..++..
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~ 263 (335)
T 2owb_A 188 ATKVEYDGERKKVLCGTPNYIAPEVLSKKG--HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPKH 263 (335)
T ss_dssp CEECCSTTCCBCCCCSCCSSCCHHHHHTSC--BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCTT
T ss_pred ceecccCcccccccCCCccccCHHHhccCC--CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC--CCCCcc
Confidence 986542 22334467999999999998764 7889999999999999999999999887766666665543 345677
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++..+.+||.+||+.||.+||++.+++++
T Consensus 264 ~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 264 INPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=341.11 Aligned_cols=249 Identities=29% Similarity=0.388 Sum_probs=205.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||.||+|++. ++.||||++..... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 78 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-------VDCPENIKKEICINKMLNHENVVKFYGHRREGN-- 78 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-------TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-------hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC--
Confidence 7999999999999999999984 77899999975421 123467889999999999999999999998755
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
..++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~dfg~~~ 153 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLAT 153 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCTTCE
T ss_pred EEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc----cCCCEEEeeCCCcc
Confidence 88999999999999998854 35699999999999999999999999999999999999998 77899999999997
Q ss_pred cccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-hHHHHhhhccCCCCCCC
Q 040257 1123 IKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG-AIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1123 ~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~-eliqsIlk~~Lrp~ipe 1198 (1254)
..... .......||+.|+|||++.+.. .++.++||||||+++|+|++|+.||...... .....+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (276)
T 2yex_A 154 VFRYNNRERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232 (276)
T ss_dssp ECEETTEECCBCCCCSCGGGCCGGGGTCSS-BCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGG
T ss_pred ccCCCcchhcccCCccccCccChHHHhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchh
Confidence 54321 2234567999999999998653 2478999999999999999999999875543 22333333222222334
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++..+.+||.+||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 233 KIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 678999999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=361.21 Aligned_cols=254 Identities=30% Similarity=0.485 Sum_probs=201.9
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
..+|++.+.||+|+||+||+|++ +++.||||++...... .....+.+|+.++++++||||+++++++.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 100 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-------GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT- 100 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS-
T ss_pred hhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-------hHHHHHHHHHHHHHhccCCCccceEEEEecCC-
Confidence 45789999999999999999987 4778999998754211 11225788999999999999999999997655
Q ss_pred CceEEEEEecccCchhhhhhccC---CCCCHHHHHHHHHHhhhhhHHhhhC---CcccccCCCCceEeccCCCCCCeEEE
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKD---RSLDRRKKLIIAMDAAFGMEYLHSK---NIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre---~~LSe~~~lkIa~QIAeALaYLHSk---GIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||
T Consensus 101 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~----~~~~~kl 175 (326)
T 3uim_A 101 -ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD----EEFEAVV 175 (326)
T ss_dssp -CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC----TTCCEEE
T ss_pred -ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC----CCCCEEe
Confidence 7889999999999999986543 3489999999999999999999999 999999999999998 7789999
Q ss_pred EeccccccccC--ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----hhhHHHHhhh
Q 040257 1116 GDFGLSRIKRN--TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH----CGAIIGGIVK 1189 (1254)
Q Consensus 1116 iDFGLAr~~~~--s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n----~~eliqsIlk 1189 (1254)
+|||+++.... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.... ..........
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSE--ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCC--CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99999986532 22334456999999999997654 7999999999999999999999995211 1111111111
Q ss_pred c-------------cCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1190 N-------------TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1190 ~-------------~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
. .+....+...+..+.+|+.+||+.||.+|||+.+++++|+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 1 11111222234679999999999999999999999999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=364.56 Aligned_cols=264 Identities=17% Similarity=0.202 Sum_probs=199.5
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC-----CceEEEEEEeccccCCCchhHH-----HHHHHHHHHHHHHhcCCCCcee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR-----GSDVAIKRIKKSCFAGRSSEQE-----RLTKDFWREAHILSNLHHPNVV 1030 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r-----Gs~VAIKvIkk~~~~~~~~e~e-----e~~eqFlrEIeILkrLnHPNIV 1030 (1254)
+...+|++++.||+|+||+||+|++. +..+|||++...... ..... .....+.+|+.+++.++||||+
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP--LFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CH--HHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcc--hHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 44568999999999999999999984 467999998754210 00011 1123467889999999999999
Q ss_pred EEeeeeecC--CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCC
Q 040257 1031 AFYGVVPDG--TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDP 1108 (1254)
Q Consensus 1031 kLyGvf~Dd--n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~ 1108 (1254)
++++++.+. ....+++||||+ +++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++..
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-- 187 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-- 187 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS--
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC--
Confidence 999998762 234899999999 999999986543 79999999999999999999999999999999999999822
Q ss_pred CCCeEEEEeccccccccCcc--------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 040257 1109 QRPICKVGDFGLSRIKRNTL--------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC 1180 (1254)
Q Consensus 1109 snG~VKLiDFGLAr~~~~s~--------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~ 1180 (1254)
..+.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||.....
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 12389999999997543221 11345799999999999876 489999999999999999999999965322
Q ss_pred h-hHHHHhhhccCCCCC---------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1181 G-AIIGGIVKNTLRPTI---------PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1181 ~-eliqsIlk~~Lrp~i---------pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
. ........ ...... ...++.++.+||.+||+.||.+||++.+|++.|+.+.
T Consensus 266 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 266 DPVAVQTAKT-NLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp CHHHHHHHHH-HHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred ccHHHHHHHH-hhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1 11111111 111111 1268899999999999999999999999999998753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=378.82 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=198.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
.+|++++.||+|+||+||+|.+. ++.||||++.+.. ......+++.+|+.+|+.++||||+++++++....
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 135 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG------GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc------cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence 47999999999999999999884 7789999997542 12344567889999999999999999999997543
Q ss_pred ---CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1041 ---GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1041 ---~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
...+++||||+.++ |.+.+. ..+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|
T Consensus 136 ~~~~~~~~lv~E~~~~~-l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~----~~~~~kl~D 207 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILD 207 (464)
T ss_dssp TTTCCEEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECC
T ss_pred cccCCeEEEEEeCCCCC-HHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe----CCCCEEEEE
Confidence 24679999999654 655553 2489999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC---
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP--- 1194 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp--- 1194 (1254)
||+++...........+||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.+....+..+......+
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 208 FGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285 (464)
T ss_dssp CCCC-----CCCC----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred EEeeeecCCCcccCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999876655555667899999999999976 48899999999999999999999999887665555443321100
Q ss_pred -----------------CC---------CCC-----------CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 -----------------TI---------PER-----------CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 -----------------~i---------pe~-----------iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.. +.. .++++++||.+||++||++|||+.|++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000 15678999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=355.05 Aligned_cols=260 Identities=26% Similarity=0.371 Sum_probs=202.2
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||.||+|++. ++.||||++..................+.+|+.+|++++||||+++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--
Confidence 37999999999999999999984 67899999976532211111222345678999999999999999999998654
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+ ....+||+|||++
T Consensus 88 -~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 88 -DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGHS 164 (322)
T ss_dssp -SEEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-SSCCEEECCCTTC
T ss_pred -ceEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC-CCCeEEEccCccc
Confidence 38999999999999998854 45799999999999999999999999999999999999998332 3456999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccC-CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-hHHHHhhhccCC--CCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNG-SSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG-AIIGGIVKNTLR--PTIP 1197 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG-~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~-eliqsIlk~~Lr--p~ip 1197 (1254)
+............||+.|+|||++.+ ....++.++|||||||++|+|++|..||...... .....+...... +...
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 87655443344569999999999852 1235789999999999999999999999765443 233333333221 1122
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..++..+.+||.+||+.||.+||++.+++++
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 4678999999999999999999999999953
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=371.53 Aligned_cols=252 Identities=27% Similarity=0.305 Sum_probs=186.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
.+|++++.||+|+||+||+|++. ++.||||++.+.. ......+++.+|+.+|++++||||+++++++....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF------EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh------cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 47999999999999999999874 7789999997532 12334567899999999999999999999985432
Q ss_pred --CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1041 --GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1041 --~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
...+|+||||+ +++|..++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+||
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~----~~~~~kl~DF 200 (458)
T 3rp9_A 127 EKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN----QDCSVKVCDF 200 (458)
T ss_dssp TTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTCCEEECCC
T ss_pred ccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC----CCCCEeeccc
Confidence 24799999997 6789888854 45699999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCcc----------------------------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 040257 1119 GLSRIKRNTL----------------------------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT 1170 (1254)
Q Consensus 1119 GLAr~~~~s~----------------------------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT 1170 (1254)
|+++...... .....+||+.|+|||++.... .|+.++||||||||||||++
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE-NYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHT
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCC-CCCcHhHHHHHHHHHHHHHH
Confidence 9998643211 223457899999999875432 48999999999999999999
Q ss_pred -----------CCCCCCCCCh--------------------hhHHHHhhhc----------------------cCC----
Q 040257 1171 -----------GEEPYADMHC--------------------GAIIGGIVKN----------------------TLR---- 1193 (1254)
Q Consensus 1171 -----------Gk~PF~~~n~--------------------~eliqsIlk~----------------------~Lr---- 1193 (1254)
|+++|.+... ...+..+... .+.
T Consensus 280 g~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (458)
T 3rp9_A 280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREG 359 (458)
T ss_dssp TSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCC
T ss_pred hccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCC
Confidence 6677755431 0111111100 000
Q ss_pred ---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 ---PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 ---p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
......+++++.+||++||.+||.+|||+.|+|++
T Consensus 360 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 360 TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp CCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00113458899999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=356.71 Aligned_cols=259 Identities=24% Similarity=0.314 Sum_probs=202.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccCCCc---hhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec-
Q 040257 964 VDLEELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAGRS---SEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD- 1038 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~~~---~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D- 1038 (1254)
.+|++++.||+|+||.||+|.+ .++.||||++......... .......+.+.+|+.++++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 4899999999999999999987 4778999999754322111 1233445788999999999999999999999854
Q ss_pred --CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1039 --GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1039 --dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.....+++||||+. ++|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl~ 176 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA----DNNDITIC 176 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEEC
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc----CCCCEEEE
Confidence 23347899999996 688888877667899999999999999999999999999999999999998 77899999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC--
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP-- 1194 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp-- 1194 (1254)
|||+++............||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...........+......+
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFK-GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTTCT-TCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred ecCcccccccccccceecccceecCcHHhcCCC-CCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 999998655554555567999999999998632 48999999999999999999999999877665555443211100
Q ss_pred ----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 ----------------------------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 ----------------------------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0123467889999999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=343.97 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=214.3
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|++. ++.||||++....... .....+.+|+.++++++||||+++++++.+..
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN------KDTSTILREVELLKKLDHPNIMKLFEILEDSS- 94 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS------SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch------HHHHHHHHHHHHHHhccCCCccEEEEEEeCCC-
Confidence 37999999999999999999984 7789999997653221 12456889999999999999999999998654
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|||++
T Consensus 95 -~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~-~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 95 -SFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-KDCDIKIIDFGLS 171 (287)
T ss_dssp -EEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS-TTCCEEECSTTGG
T ss_pred -eEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCC-CcccEEEeccCcc
Confidence 899999999999999988654 4689999999999999999999999999999999999997332 3568999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCC--CC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP--ER 1199 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ip--e~ 1199 (1254)
.............||+.|+|||++.+. ++.++||||||+++|+|++|+.||...........+.........+ ..
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRGT---YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT 248 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTTC---CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTT
T ss_pred eeecCCCccccccCcccccChHHhcCC---CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhh
Confidence 865544444445688999999999864 7899999999999999999999999888777777776665544333 46
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++.++.+||.+||..||.+|||+.+++++
T Consensus 249 ~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 249 ISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 78999999999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=344.37 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=204.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|.....||+|+||+||+|++ +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 92 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--------SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG- 92 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--------C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--------hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC-
Confidence 3555566899999999999998 46789999987542 123466889999999999999999999998655
Q ss_pred CceEEEEEecccCchhhhhhccC--CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKD--RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre--~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. .++.+||+|||
T Consensus 93 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~~kl~Dfg 168 (295)
T 2clq_A 93 -FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT---YSGVLKISDFG 168 (295)
T ss_dssp -EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTCCEEECCTT
T ss_pred -cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC---CCCCEEEeecc
Confidence 8999999999999999986653 24678899999999999999999999999999999999981 26799999999
Q ss_pred ccccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh-HHHHhhhccCCCCCC
Q 040257 1120 LSRIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA-IIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1120 LAr~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e-liqsIlk~~Lrp~ip 1197 (1254)
++...... .......||+.|+|||++.+....++.++||||||+++|+|++|+.||....... ...........+..+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 2clq_A 169 TSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP 248 (295)
T ss_dssp TCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC
T ss_pred cccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc
Confidence 99765432 2234467999999999997654457899999999999999999999997654332 222222233455677
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..++.++.+||.+||+.||++||++.+++++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 8899999999999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=348.43 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=206.2
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Dd 1039 (1254)
..+|++++.||+|+||+||+|++ .++.||||++..... ....+.+|+.+++++ +||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---------EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---------cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 45799999999999999999999 578899999975321 124677899999998 899999999998764
Q ss_pred C----CCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1040 T----GGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1040 n----~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
. ...+++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~----~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----TTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc----CCCCEE
Confidence 3 45799999999999999998654 35689999999999999999999999999999999999998 778999
Q ss_pred EEeccccccccCc-cccCCCCCCCCccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc
Q 040257 1115 VGDFGLSRIKRNT-LVSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN 1190 (1254)
Q Consensus 1115 LiDFGLAr~~~~s-~~sts~~GT~~YmAPEVLrG~---~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~ 1190 (1254)
|+|||++...... .......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||...........+...
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 9999998754432 223345699999999999732 234789999999999999999999999888776666666555
Q ss_pred cCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1191 ~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.........++..+.+||.+||..||.+||++.+++++
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 54444556789999999999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=355.87 Aligned_cols=253 Identities=24% Similarity=0.303 Sum_probs=205.2
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
.+|++++.||+|+||+||+|++ +++.||||++....... .....+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS------SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc------cchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 4799999999999999999998 47789999986543221 12345678999999999999999999987643
Q ss_pred -----CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1041 -----GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1041 -----~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
...+++||||+.+ +|...+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~----~~~~~kl 165 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT----RDGVLKL 165 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEE
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc----CCCCEEE
Confidence 3478999999964 78777767667799999999999999999999999999999999999998 7789999
Q ss_pred EeccccccccC-----ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc
Q 040257 1116 GDFGLSRIKRN-----TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN 1190 (1254)
Q Consensus 1116 iDFGLAr~~~~-----s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~ 1190 (1254)
+|||+++.... ........||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...........+...
T Consensus 166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 244 (351)
T 3mi9_A 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244 (351)
T ss_dssp CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCC-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccchhcccccccccccccccCCcccccCccCchhhcCCC-CCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 99999975432 22234456899999999997642 4789999999999999999999999988776655554432
Q ss_pred cC--CCCCCCC----------------------------CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1191 TL--RPTIPER----------------------------CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1191 ~L--rp~ipe~----------------------------iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.. .+..... .++.+.+||.+||+.||.+|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11 1111000 26779999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=368.65 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=207.6
Q ss_pred cccCceEEEEEeeeCcEEEEEEEE-----CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeee
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKW-----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGV 1035 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~-----rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGv 1035 (1254)
...+|++++.||+|+||+||++++ .++.||||++++...... ....+.+.+|+.+|+++ +||||++++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----AKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE----ESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh----hhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 345899999999999999999998 577899999975432110 01123456789999999 69999999999
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
+.+.. .+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+||||+ .++.+||
T Consensus 128 ~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kl 200 (355)
T 1vzo_A 128 FQTET--KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVVL 200 (355)
T ss_dssp EEETT--EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEE
T ss_pred EeeCc--eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCcEEE
Confidence 98765 899999999999999998654 4699999999999999999999999999999999999998 7789999
Q ss_pred EeccccccccC--ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----hhHHHHhhh
Q 040257 1116 GDFGLSRIKRN--TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC----GAIIGGIVK 1189 (1254)
Q Consensus 1116 iDFGLAr~~~~--s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~----~eliqsIlk 1189 (1254)
+|||+++.... .......+||+.|+|||++.+....++.++|||||||+||||++|+.||..... ......+..
T Consensus 201 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 280 (355)
T 1vzo_A 201 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280 (355)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred eeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc
Confidence 99999975432 222344679999999999987555678999999999999999999999975432 223333332
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARP-----SFTEITSRL 1229 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRP-----SArELLe~L 1229 (1254)
..+..+..++..+.+||.+||..||.+|| ++.+++++.
T Consensus 281 --~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 281 --SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 23456778899999999999999999999 999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=363.66 Aligned_cols=248 Identities=22% Similarity=0.329 Sum_probs=205.8
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||+|++ +++.||||+++.................+.+|+.+|++++||||+++++++.+..
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-- 102 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG-- 102 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC--
Confidence 799999999999999999987 4778999999865432211001112345677999999999999999999998655
Q ss_pred ceEEEEEecccC-chhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1043 TLATVTEFMVNG-SLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1043 ~L~LVMEYm~GG-SL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+| +|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA----EDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc----CCCcEEEeecccc
Confidence 899999998776 89888854 45699999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
+............||+.|+|||++.+.. .++.++|||||||++|+|++|+.||..... .... ....+..++
T Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~--~~~~~~~~~ 248 (335)
T 3dls_A 178 AYLERGKLFYTFCGTIEYCAPEVLMGNP-YRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEA--AIHPPYLVS 248 (335)
T ss_dssp EECCTTCCBCEECSCGGGCCHHHHTTCC-BCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTT--CCCCSSCCC
T ss_pred eECCCCCceeccCCCccccChhhhcCCC-CCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhh--ccCCCcccC
Confidence 8766555555567999999999998764 238899999999999999999999976321 1111 223455689
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++.+||.+||+.||.+|||+.+++++
T Consensus 249 ~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 249 KELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=348.06 Aligned_cols=253 Identities=28% Similarity=0.445 Sum_probs=207.6
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
...+|++++.||+|+||+||+|++. ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--------EEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--------HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 3457999999999999999999995 7789999987532 11246788999999999999999999999875
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
. .+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 89 ~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~Dfg 162 (302)
T 2j7t_A 89 G--KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT----LEGDIRLADFG 162 (302)
T ss_dssp ---CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----TTSCEEECCCH
T ss_pred C--eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC----CCCCEEEEECC
Confidence 5 89999999999999999877667899999999999999999999999999999999999998 67899999999
Q ss_pred ccccccC-ccccCCCCCCCCccCcccccC---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC-
Q 040257 1120 LSRIKRN-TLVSGGVRGTLPWMAPELLNG---SSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP- 1194 (1254)
Q Consensus 1120 LAr~~~~-s~~sts~~GT~~YmAPEVLrG---~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp- 1194 (1254)
++..... ........||..|+|||++.. ....++.++||||||+++|+|++|+.||...........+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T 2j7t_A 163 VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL 242 (302)
T ss_dssp HHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred CCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc
Confidence 9753221 112234569999999999841 12247899999999999999999999999887776666655443322
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 2346678999999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=351.85 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=206.1
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||.||++++. ++.||||++..... ......+.+.+|+.++++++||||+++++++.++.
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~- 107 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-----SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG- 107 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-----GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-----cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC-
Confidence 48999999999999999999984 77899999875421 13445677899999999999999999999998755
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 108 -~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~----~~~~~kl~Dfg~~ 181 (309)
T 2h34_A 108 -QLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS----ADDFAYLVDFGIA 181 (309)
T ss_dssp -EEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECSCCC-
T ss_pred -eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc----CCCCEEEecCccC
Confidence 899999999999999998654 5699999999999999999999999999999999999998 6789999999998
Q ss_pred ccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC-CCCCC
Q 040257 1122 RIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR-PTIPE 1198 (1254)
Q Consensus 1122 r~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr-p~ipe 1198 (1254)
....... ......|++.|+|||++.+. .++.++||||||+++|+|++|+.||...........+...... ...+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (309)
T 2h34_A 182 SATTDEKLTQLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRP 259 (309)
T ss_dssp ---------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTST
T ss_pred ccccccccccccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCC
Confidence 7554322 22345689999999999865 4788999999999999999999999887655433333222111 13456
Q ss_pred CCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHHHHh
Q 040257 1199 RCDPEWRKLMEQCWAADPEARP-SFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRP-SArELLe~Le~Ll~eLE 1237 (1254)
.++.++.+||.+||+.||++|| ++.++++.|+.++....
T Consensus 260 ~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 260 GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 7889999999999999999999 99999999988755443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=355.14 Aligned_cols=253 Identities=22% Similarity=0.313 Sum_probs=207.3
Q ss_pred CceEE-EEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCC
Q 040257 965 DLEEL-RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 965 dYeiL-kkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn 1040 (1254)
+|.+. +.||+|+||+||+|.+. ++.||||+++..... ......+.+|+.+++.+ +||||+++++++.+..
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG------QDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT------EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc------hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 56666 88999999999999985 788999999864321 11245678899999998 5699999999998655
Q ss_pred CCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
.+++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++... ..+.+||+|||
T Consensus 103 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~-~~~~~kL~Dfg 179 (327)
T 3lm5_A 103 --EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY-PLGDIKIVDFG 179 (327)
T ss_dssp --EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT-TBCCEEECCGG
T ss_pred --eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC-CCCcEEEeeCc
Confidence 799999999999999998543 35699999999999999999999999999999999999998321 26789999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC--CCCC
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR--PTIP 1197 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr--p~ip 1197 (1254)
+++............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+...... ....
T Consensus 180 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 257 (327)
T 3lm5_A 180 MSRKIGHACELREIMGTPEYLAPEILNYDP--ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF 257 (327)
T ss_dssp GCEEC---------CCCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred cccccCCccccccccCCcCccCCeeecCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhh
Confidence 998765554455567999999999998664 889999999999999999999999988877776666544332 3334
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 5689999999999999999999999999876
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=362.22 Aligned_cols=256 Identities=23% Similarity=0.283 Sum_probs=207.0
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC-
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG- 1039 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd- 1039 (1254)
..+|++++.||+|+||+||+|++ +++.||||++..... ...+|+.+++.++||||++++++|...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------------~~~~E~~il~~l~hpnIv~l~~~~~~~~ 73 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------------YKNRELDIMKVLDHVNIIKLVDYFYTTG 73 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------------SCCHHHHHHTTCCCTTBCCEEEEEEEC-
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------------hHHHHHHHHHHcCCCCccchhheeeecC
Confidence 45899999999999999999998 478899999875421 123699999999999999999998542
Q ss_pred -----------------------------------CCCceEEEEEecccCchhhhhh---ccCCCCCHHHHHHHHHHhhh
Q 040257 1040 -----------------------------------TGGTLATVTEFMVNGSLKHVLL---KKDRSLDRRKKLIIAMDAAF 1081 (1254)
Q Consensus 1040 -----------------------------------n~~~L~LVMEYm~GGSL~d~L~---kre~~LSe~~~lkIa~QIAe 1081 (1254)
....+++||||+. ++|.+.+. .....+++..++.++.||+.
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp ------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 2235889999997 57776664 24567999999999999999
Q ss_pred hhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHH
Q 040257 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSF 1161 (1254)
Q Consensus 1082 ALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSL 1161 (1254)
||.|||++||+||||||+|||++ ..++.+||+|||+++............+|+.|+|||++.+.. .++.++|||||
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~Diwsl 228 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVN---SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGAT-EYTPSIDLWSI 228 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEE---TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCS-SCCTHHHHHHH
T ss_pred HHHHHHHCcCccCccCHHHEEEc---CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCC-CCCcchhhhhH
Confidence 99999999999999999999997 246799999999998765555555677999999999998643 47999999999
Q ss_pred HHHHHHHHcCCCCCCCCChhhHHHHhhhccC---------------------------CCCCCCCCcHHHHHHHHHhhhc
Q 040257 1162 GISMWEILTGEEPYADMHCGAIIGGIVKNTL---------------------------RPTIPERCDPEWRKLMEQCWAA 1214 (1254)
Q Consensus 1162 GVILYELLTGk~PF~~~n~~eliqsIlk~~L---------------------------rp~ipe~iS~eLrdLIkKCLqk 1214 (1254)
||++|||++|+.||.+....+.+..+..... ...++..+++++.+||.+||+.
T Consensus 229 G~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999999998877666555543110 0013455788999999999999
Q ss_pred CCCCCCCHHHHHHH--HHHHHHH
Q 040257 1215 DPEARPSFTEITSR--LRTISAA 1235 (1254)
Q Consensus 1215 DPeKRPSArELLe~--Le~Ll~e 1235 (1254)
||.+|||+.|++++ ++.+...
T Consensus 309 dP~~R~t~~e~l~hp~f~~~~~~ 331 (383)
T 3eb0_A 309 EPDLRINPYEAMAHPFFDHLRNS 331 (383)
T ss_dssp SGGGSCCHHHHHTSGGGHHHHHC
T ss_pred ChhhCCCHHHHhcCHHHHHHHhh
Confidence 99999999999964 5555443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.77 Aligned_cols=253 Identities=22% Similarity=0.288 Sum_probs=198.2
Q ss_pred cCceEE-EEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecC
Q 040257 964 VDLEEL-RELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 964 ~dYeiL-kkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Dd 1039 (1254)
..|++. +.||+|+||+||+|++ +++.||||++..... .....+.+|+.+++++ +||||+++++++.+.
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--------HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE 83 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--------CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--------hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 468875 6799999999999987 477899999975421 1235678999999885 799999999999876
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
. .+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++..+ ....+||+|||
T Consensus 84 ~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~~~kl~Dfg 159 (316)
T 2ac3_A 84 D--RFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPN-QVSPVKICDFD 159 (316)
T ss_dssp T--EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSS-SSCSEEECCTT
T ss_pred C--EEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCC-CcCceEEEEcc
Confidence 5 899999999999999998654 5689999999999999999999999999999999999998322 23459999999
Q ss_pred ccccccCc--------cccCCCCCCCCccCcccccCCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh--------
Q 040257 1120 LSRIKRNT--------LVSGGVRGTLPWMAPELLNGSS---NRVSEKVDVFSFGISMWEILTGEEPYADMHC-------- 1180 (1254)
Q Consensus 1120 LAr~~~~s--------~~sts~~GT~~YmAPEVLrG~~---~kyS~KSDIWSLGVILYELLTGk~PF~~~n~-------- 1180 (1254)
++...... ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 98754221 1122346999999999997421 1368899999999999999999999976532
Q ss_pred -------hhHHHHhhhccCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1181 -------GAIIGGIVKNTLRPTI--PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1181 -------~eliqsIlk~~Lrp~i--pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
......+....+.... ...++.++++||.+||+.||.+|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 2233344433332111 13578999999999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=383.89 Aligned_cols=261 Identities=34% Similarity=0.589 Sum_probs=221.8
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEECC-ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWRG-SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
+.+...+|++.++||+|+||+||+|++.+ ..||||+++.... ..+.|.+|+.+|++|+||||+++++++.
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~~~~~~~ 332 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAVVS 332 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---------CHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34666789999999999999999999964 5699999975421 1356889999999999999999999986
Q ss_pred cCCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
+ ..+++||||+.+|+|.+++... ...+++..++.|+.||+.||.|||+++||||||||+||||+ .++.+||+
T Consensus 333 ~---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----~~~~~kl~ 405 (535)
T 2h8h_A 333 E---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVA 405 (535)
T ss_dssp S---SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEEC
T ss_pred e---ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc----CCCcEEEc
Confidence 5 3689999999999999999653 34589999999999999999999999999999999999998 67899999
Q ss_pred eccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCC
Q 040257 1117 DFGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1117 DFGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
|||+++...... ......++..|+|||++.+. .++.++|||||||+||||++ |+.||......+.+..+... .+
T Consensus 406 DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~ 482 (535)
T 2h8h_A 406 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YR 482 (535)
T ss_dssp CTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT-CC
T ss_pred ccccceecCCCceecccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC
Confidence 999998654322 22334577889999999865 48999999999999999999 99999988877777666543 45
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
...+..++..+.+||.+||+.||++|||+.+|++.|+.+....+.
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 556778999999999999999999999999999999988655443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.96 Aligned_cols=250 Identities=29% Similarity=0.453 Sum_probs=213.6
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
...|++++.||+|+||+||+|.+. ++.||||++...... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-------DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 93 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-------TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-------HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 346999999999999999999884 778999999754211 12467889999999999999999999998755
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 94 --~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 94 --KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGV 165 (303)
T ss_dssp --EEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTT
T ss_pred --eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC----CCCCEEEeeccc
Confidence 89999999999999998843 5699999999999999999999999999999999999998 778999999999
Q ss_pred cccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1121 SRIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1121 Ar~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
+....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+... ..+..+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 242 (303)
T 3a7i_A 166 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSA--YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEGN 242 (303)
T ss_dssp CEECBTTBCCBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCCSS
T ss_pred ceecCccccccCccCCCcCccCHHHHhcCC--CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-CCCCCccc
Confidence 97654322 234567999999999998664 788999999999999999999999987766665555443 34456778
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
++..+.+||.+||+.||.+|||+.+++++..
T Consensus 243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 8999999999999999999999999998643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=355.87 Aligned_cols=255 Identities=17% Similarity=0.197 Sum_probs=206.0
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC----------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeE-
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR----------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVA- 1031 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r----------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVk- 1031 (1254)
..+|++.+.||+|+||+||+|++. ++.||||++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------~~~~~E~~~l~~l~h~niv~~ 107 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------GRLFNEQNFFQRAAKPLQVNK 107 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------STHHHHHHHHHHHCCHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------chHHHHHHHHHHhcccchhhh
Confidence 468999999999999999999984 567999998753 34678999999999999987
Q ss_pred --------------EeeeeecCCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccC
Q 040257 1032 --------------FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDL 1096 (1254)
Q Consensus 1032 --------------LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDL 1096 (1254)
+++++... ...+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||
T Consensus 108 ~~~~~~~~~~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Di 185 (352)
T 2jii_A 108 WKKLYSTPLLAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNV 185 (352)
T ss_dssp HHHHTTCTTCSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCC
T ss_pred hhhhccCCccCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 45555542 34889999999 99999999654 367999999999999999999999999999999
Q ss_pred CCCceEeccCCCCCC--eEEEEeccccccccCcc--------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHH
Q 040257 1097 KCENLLVNLRDPQRP--ICKVGDFGLSRIKRNTL--------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMW 1166 (1254)
Q Consensus 1097 KPeNILLDsdd~snG--~VKLiDFGLAr~~~~s~--------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILY 1166 (1254)
||+|||++ .++ .+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||+||
T Consensus 186 kp~NIl~~----~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ 259 (352)
T 2jii_A 186 TAENIFVD----PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCML 259 (352)
T ss_dssp CGGGEEEE----TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHH
T ss_pred CHHHEEEc----CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHH
Confidence 99999998 566 89999999997543321 12334799999999999876 4899999999999999
Q ss_pred HHHcCCCCCCCCC-hhhHHHHhhhc--cCCCCCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 040257 1167 EILTGEEPYADMH-CGAIIGGIVKN--TLRPTIP------ERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1167 ELLTGk~PF~~~n-~~eliqsIlk~--~Lrp~ip------e~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLE 1237 (1254)
+|++|+.||.... ....+...... .....+. ..++.++.+||.+||+.||.+||++.++++.|+.+..+..
T Consensus 260 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 260 KWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp HHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 9999999998764 22222222110 1111111 2468999999999999999999999999999999988765
Q ss_pred h
Q 040257 1238 S 1238 (1254)
Q Consensus 1238 s 1238 (1254)
.
T Consensus 340 ~ 340 (352)
T 2jii_A 340 V 340 (352)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=361.03 Aligned_cols=249 Identities=28% Similarity=0.393 Sum_probs=201.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|.+ +++.||||++.... ......+++.+|+.+|++++||||+++++++.....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF------QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT------SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc------cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 4799999999999999999998 47789999986532 123446778999999999999999999999876432
Q ss_pred ----CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1042 ----GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1042 ----~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
..+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~kl~D 171 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN----EDCELKILD 171 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECC
T ss_pred cccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc----CCCCEEEEe
Confidence 3579999999 8899998854 4689999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC----
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR---- 1193 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr---- 1193 (1254)
||+++..... .....+|+.|+|||++.+.. .++.++|||||||++|||++|+.||.+.+....+..+......
T Consensus 172 fg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 172 FGLARQADSE--MTGYVVTRWYRAPEVILNWM-RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp CTTCEECCSS--CCSSCSCGGGCCTHHHHTTT-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eecccccccc--cCcCcCCCCcCCHHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999865443 34467899999999998632 4899999999999999999999999987765555444321100
Q ss_pred -------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 -------------------------PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 -------------------------p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
......+++++.+||.+||+.||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 01224568999999999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=364.51 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=195.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|++. ++.||||+++... ......+++.+|+.+|++++||||+++++++.....
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF------EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT------TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh------cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 48999999999999999999984 6779999997532 123345678999999999999999999999876532
Q ss_pred ---CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1042 ---GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1042 ---~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
..+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+||
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~----~~~~~kL~DF 173 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN----QDCSVKVCDF 173 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCC
T ss_pred CcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC----CCCCEEEccC
Confidence 47899999985 699998854 45699999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCcc-----------------------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCC-
Q 040257 1119 GLSRIKRNTL-----------------------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEP- 1174 (1254)
Q Consensus 1119 GLAr~~~~s~-----------------------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~P- 1174 (1254)
|+++...... .....+||+.|+|||++.... .++.++|||||||+||||++|..|
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE-NYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTCS-CCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCC-CCCcccccchHHHHHHHHHhccccc
Confidence 9998654321 125567999999999975432 489999999999999999985444
Q ss_pred ----------CCCCCh-----------------hhHHHHhhh----------------------ccCCCCC-------CC
Q 040257 1175 ----------YADMHC-----------------GAIIGGIVK----------------------NTLRPTI-------PE 1198 (1254)
Q Consensus 1175 ----------F~~~n~-----------------~eliqsIlk----------------------~~Lrp~i-------pe 1198 (1254)
|.+... ...+..+.. ..+.... ..
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence 433221 011111100 0000011 13
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+++++.+||.+||+.||.+|||+.|+|++
T Consensus 333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 333 SISDDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 478999999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.28 Aligned_cols=248 Identities=30% Similarity=0.482 Sum_probs=205.9
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|++++.||+|+||.||+|.+. ++.||||++.... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT 97 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 457999999999999999999985 7889999997542 1246788999999999999999999998655
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||+
T Consensus 98 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~dfg~ 171 (314)
T 3com_A 98 --DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN----TEGHAKLADFGV 171 (314)
T ss_dssp --EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTT
T ss_pred --EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC----CCCCEEEeeccc
Confidence 78999999999999999976667899999999999999999999999999999999999998 678999999999
Q ss_pred cccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-CCCCCC
Q 040257 1121 SRIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL-RPTIPE 1198 (1254)
Q Consensus 1121 Ar~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L-rp~ipe 1198 (1254)
+...... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+..... ....+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T 3com_A 172 AGQLTDTMAKRNTVIGTPFWMAPEVIQEIG--YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPE 249 (314)
T ss_dssp CEECBTTBSCBCCCCSCGGGCCHHHHSSSC--BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGG
T ss_pred chhhhhhccccCccCCCCCccChhhcCCCC--CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcc
Confidence 9755432 2234456899999999998764 78899999999999999999999988776555544433321 122345
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.++..+.+||.+||..||.+|||+.+++++
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 678999999999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=346.66 Aligned_cols=255 Identities=28% Similarity=0.446 Sum_probs=192.4
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.+...+|++++.||+|+||+||++.+ +++.||||++.... .....+.+.+|+.++++++||||+++++++.
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 83 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-------CQTSMDELLKEIQAMSQCHHPNIVSYYTSFV 83 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-------cchhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence 35566899999999999999999987 57789999886432 1223466889999999999999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhc-------cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCC
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLK-------KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQR 1110 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~k-------re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~sn 1110 (1254)
... .+++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 84 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~ 157 (303)
T 2vwi_A 84 VKD--ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG----ED 157 (303)
T ss_dssp SSS--CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----TT
T ss_pred ecC--CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc----CC
Confidence 765 78999999999999999854 245689999999999999999999999999999999999998 77
Q ss_pred CeEEEEeccccccccCc------cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 040257 1111 PICKVGDFGLSRIKRNT------LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAII 1184 (1254)
Q Consensus 1111 G~VKLiDFGLAr~~~~s------~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eli 1184 (1254)
+.+||+|||++...... .......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.........
T Consensus 158 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 236 (303)
T 2vwi_A 158 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR-GYDFKADIWSFGITAIELATGAAPYHKYPPMKVL 236 (303)
T ss_dssp CCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHH-CCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH
T ss_pred CCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcccc-CCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH
Confidence 89999999998754321 1223456999999999987521 3789999999999999999999999887665555
Q ss_pred HHhhhccCC--------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1185 GGIVKNTLR--------PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1185 qsIlk~~Lr--------p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
......... ......++.++.+||.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 237 MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 444332211 12335678999999999999999999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=393.45 Aligned_cols=252 Identities=22% Similarity=0.367 Sum_probs=216.3
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVP 1037 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~ 1037 (1254)
+...+|+++++||+|+||+||++++. ++.||||++++.... .....+.+.+|..+|..+ +||+|++++++|.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-----~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~ 412 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-----QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 412 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-----HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-----cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence 44568999999999999999999985 567999999864221 112245677899999987 7999999999997
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. .+|+||||+.+|+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+||||+ .++++||+|
T Consensus 413 ~~~--~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~----~~g~ikL~D 485 (674)
T 3pfq_A 413 TMD--RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD----SEGHIKIAD 485 (674)
T ss_dssp CSS--EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC----SSSCEEECC
T ss_pred eCC--EEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc----CCCcEEEee
Confidence 655 899999999999999999654 5699999999999999999999999999999999999998 788999999
Q ss_pred ccccccc-cCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1118 FGLSRIK-RNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1118 FGLAr~~-~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
||+++.. .........+||+.|+|||++.+.. |+.++|||||||+||||++|+.||...+..+.+..+....+ .+
T Consensus 486 FGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--~~ 561 (674)
T 3pfq_A 486 FGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--AY 561 (674)
T ss_dssp CTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCC--BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC--CC
T ss_pred cceeeccccCCcccccccCCCcccCHhhhcCCC--CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC--CC
Confidence 9999853 2333455678999999999998764 79999999999999999999999999988888888877643 46
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSF-----TEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSA-----rELLe~ 1228 (1254)
+..+++++++||++||++||.+||++ ++|+++
T Consensus 562 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 562 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 77899999999999999999999987 777764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.44 Aligned_cols=248 Identities=25% Similarity=0.427 Sum_probs=198.4
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC--
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG-- 1039 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd-- 1039 (1254)
.+|++++.||+|+||+||+|++ +++.||||++... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 3799999999999999999998 4778999999642 23356788999999999999999999987653
Q ss_pred ---------CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCC
Q 040257 1040 ---------TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQR 1110 (1254)
Q Consensus 1040 ---------n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~sn 1110 (1254)
....+++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~----~~ 152 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID----ES 152 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TT
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc----CC
Confidence 23478999999999999999977666788999999999999999999999999999999999998 77
Q ss_pred CeEEEEeccccccccCc---------------cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 040257 1111 PICKVGDFGLSRIKRNT---------------LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY 1175 (1254)
Q Consensus 1111 G~VKLiDFGLAr~~~~s---------------~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF 1175 (1254)
+.+||+|||++...... .......||+.|+|||++.+.. .++.++|||||||++|+|++ ||
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG-HYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCS-CCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCC-CCcchhhHHHHHHHHHHHHh---cc
Confidence 89999999998754321 1223456899999999998642 47899999999999999998 55
Q ss_pred CCC-ChhhHHHHhhhc--cCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1176 ADM-HCGAIIGGIVKN--TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1176 ~~~-n~~eliqsIlk~--~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
... ........+... .+....+...+..+++||.+||+.||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 229 STGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp SSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 432 222333333222 23344556678889999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.70 Aligned_cols=255 Identities=16% Similarity=0.191 Sum_probs=204.6
Q ss_pred ccccCceEEEEEeeeCcEEEEEEE-----E--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC---CCcee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGK-----W--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH---HPNVV 1030 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk-----~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn---HPNIV 1030 (1254)
+...+|.+.+.||+|+||+||+|. . .++.||||+++... ...+.+|+.+++.++ |+||+
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~l~~~~~~~iv 130 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----------PWEFYIGTQLMERLKPSMQHMFM 130 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----------HHHHHHHHHHHHHSCGGGGGGBC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----------hhHHHHHHHHHHHhhhhhhhhhh
Confidence 445689999999999999999994 2 47789999997531 235667777777776 99999
Q ss_pred EEeeeeecCCCCceEEEEEecccCchhhhhhc----cCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccC
Q 040257 1031 AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLK----KDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLR 1106 (1254)
Q Consensus 1031 kLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~k----re~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsd 1106 (1254)
++++++.... ..++||||+.+|+|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+||||+..
T Consensus 131 ~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~ 208 (365)
T 3e7e_A 131 KFYSAHLFQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG 208 (365)
T ss_dssp CEEEEEECSS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGG
T ss_pred hhheeeecCC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccc
Confidence 9999998765 78999999999999999964 34569999999999999999999999999999999999999831
Q ss_pred -------CCCCCeEEEEeccccccc---cCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 040257 1107 -------DPQRPICKVGDFGLSRIK---RNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYA 1176 (1254)
Q Consensus 1107 -------d~snG~VKLiDFGLAr~~---~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~ 1176 (1254)
+...+.+||+|||+++.. .........+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP--WNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC--BSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC--CCccccHHHHHHHHHHHHhCCCccc
Confidence 112789999999999643 2333445677999999999998764 8999999999999999999999996
Q ss_pred CCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHHHHHH
Q 040257 1177 DMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEAR-PSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1177 ~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKR-PSArELLe~Le~Ll~eL 1236 (1254)
........ ....+ .....++.|.+++..||..+|.+| |++.++.+.|+.++...
T Consensus 287 ~~~~~~~~---~~~~~---~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 287 KNEGGECK---PEGLF---RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp EEETTEEE---ECSCC---TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred cCCCCcee---echhc---cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 53321100 01111 111347789999999999999998 68999999998887764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=368.23 Aligned_cols=249 Identities=24% Similarity=0.301 Sum_probs=200.2
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC-
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG- 1039 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd- 1039 (1254)
..+|++++.||+|+||+||+|++ +++.||||++.... ..+.+|+++|++++||||++++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------------RFKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------------TSCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------------hhHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 34799999999999999999999 47889999987532 1123699999999999999999988532
Q ss_pred ---CCCceEEEEEecccCchhhhhh---ccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1040 ---TGGTLATVTEFMVNGSLKHVLL---KKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1040 ---n~~~L~LVMEYm~GGSL~d~L~---kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
....+++||||+.+ +|.+.+. .....+++..++.++.||+.||.|||++||+||||||+||||+. ..+.+
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~~~~~ 196 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP---DTAVL 196 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET---TTTEE
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC---CCCeE
Confidence 22357899999975 5555543 23567999999999999999999999999999999999999982 34678
Q ss_pred EEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc--
Q 040257 1114 KVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT-- 1191 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~-- 1191 (1254)
||+|||+++............||+.|+|||++.+.. .++.++|||||||+||||++|+.||.+....+.+..+....
T Consensus 197 kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~ 275 (420)
T 1j1b_A 197 KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275 (420)
T ss_dssp EECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999998655444445567999999999997642 48999999999999999999999999877655554443210
Q ss_pred ------------C-CCC------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 ------------L-RPT------------IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 ------------L-rp~------------ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+ ... ++..+++++.+||.+||+.||.+||++.|++++
T Consensus 276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 000 223568899999999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=355.27 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=205.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
.+|++++.||+|+||+||++.+. ++.||||++.... .....+.+.+|+.+|++++||||+++++++....
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-------CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 47999999999999999999984 6779999987421 2334567889999999999999999999986543
Q ss_pred --CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1041 --GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1041 --~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
...+++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 100 ~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~~kl~Df 172 (364)
T 3qyz_A 100 EQMKDVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TTCDLKICDF 172 (364)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCC
T ss_pred cccceEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC----CCCCEEEEeC
Confidence 246899999996 589888854 4699999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCccc----cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC
Q 040257 1119 GLSRIKRNTLV----SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1119 GLAr~~~~s~~----sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp 1194 (1254)
|+++....... .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||........+..+......+
T Consensus 173 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251 (364)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBC-SCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC
T ss_pred cceEecCCCCCccccccccccccCCCCCHHhcCCC-CCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99986543221 23457999999999876542 47899999999999999999999998877666555543211000
Q ss_pred -----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 -----------------------------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 -----------------------------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.....++.++.+||.+||+.||.+|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0113568899999999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=348.75 Aligned_cols=258 Identities=21% Similarity=0.316 Sum_probs=211.2
Q ss_pred ccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCch---------hHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSS---------EQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~---------e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
..+|++++.||+|+||.||+|+++++.||||++.......... ......+.+.+|+.++++++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4589999999999999999999999999999998543211100 0001126788999999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhh------hhcc-CCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEecc
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHV------LLKK-DRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNL 1105 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~------L~kr-e~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDs 1105 (1254)
+++.+.. .+++||||+.+++|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 110 ~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~- 186 (348)
T 2pml_X 110 GIITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD- 186 (348)
T ss_dssp EEEESSS--EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC-
T ss_pred EEEeeCC--eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc-
Confidence 9998765 89999999999999998 5432 4679999999999999999999999 9999999999999998
Q ss_pred CCCCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCCh-hhH
Q 040257 1106 RDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSE-KVDVFSFGISMWEILTGEEPYADMHC-GAI 1183 (1254)
Q Consensus 1106 dd~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~-KSDIWSLGVILYELLTGk~PF~~~n~-~el 1183 (1254)
.++.+||+|||++...... ......||..|+|||++.+.. .++. ++|||||||++|+|++|+.||..... ...
T Consensus 187 ---~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 187 ---KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNES-SYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp ---TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCC-CEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred ---CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCC-CCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 7789999999999865443 334567999999999998652 2455 99999999999999999999988766 555
Q ss_pred HHHhhhccCCCCC-----------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1184 IGGIVKNTLRPTI-----------------PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1184 iqsIlk~~Lrp~i-----------------pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
...+......... ...++.++.+||.+||+.||.+||++.+++++
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 5555444332211 15688999999999999999999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=355.74 Aligned_cols=242 Identities=25% Similarity=0.350 Sum_probs=181.2
Q ss_pred EEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCCCCceEE
Q 040257 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
+.||+|+||+||+|.+. ++.||||++.+. ....+.+|+.+++.+. ||||+++++++.+.. .+++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~--~~~l 83 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL--HTFL 83 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEE
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-----------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC--EEEE
Confidence 67999999999999985 778999999753 1345678999999997 999999999998665 8999
Q ss_pred EEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccC
Q 040257 1047 VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN 1126 (1254)
Q Consensus 1047 VMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~ 1126 (1254)
||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++..+ ....+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~-~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN-DNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----CEEEECCCTTCEECCC
T ss_pred EEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC-CcccEEEeccccceecCC
Confidence 99999999999998654 5799999999999999999999999999999999999998322 344899999999985433
Q ss_pred c-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-------hhHHHHhhhccCCCCC--
Q 040257 1127 T-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC-------GAIIGGIVKNTLRPTI-- 1196 (1254)
Q Consensus 1127 s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~-------~eliqsIlk~~Lrp~i-- 1196 (1254)
. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... .+....+.........
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 162 DNQPLKTPCFTLHYAAPELLNQNG--YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp ----------------------CC--CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred CCCcccccCCCcCccCHHHhcCCC--CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 2 2334566899999999998664 89999999999999999999999976432 3344444443332211
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
...+++++++||.+||+.||.+|||+.+++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 13578999999999999999999999999855
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=340.74 Aligned_cols=251 Identities=27% Similarity=0.362 Sum_probs=198.8
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC-
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG- 1039 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd- 1039 (1254)
..+|++++.||+|+||+||+|.+. ++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--------DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--------ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 458999999999999999999985 778999998743 233456788999999999999999999987432
Q ss_pred -----------CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCC
Q 040257 1040 -----------TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDP 1108 (1254)
Q Consensus 1040 -----------n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~ 1108 (1254)
....+++||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--- 155 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--- 155 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET---
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC---
Confidence 2347899999997 699998843 56899999999999999999999999999999999999972
Q ss_pred CCCeEEEEeccccccccCc----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 040257 1109 QRPICKVGDFGLSRIKRNT----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAII 1184 (1254)
Q Consensus 1109 snG~VKLiDFGLAr~~~~s----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eli 1184 (1254)
.++.+||+|||+++..... .......+|..|+|||++.+. ..++.++|||||||++|+|++|+.||.........
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4578999999999865322 122334579999999998753 24899999999999999999999999987766555
Q ss_pred HHhhhccCC-----------------------C-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1185 GGIVKNTLR-----------------------P-----TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1185 qsIlk~~Lr-----------------------p-----~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+...... + .....++.++++||++||+.||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 544332110 0 0124578999999999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=361.85 Aligned_cols=259 Identities=14% Similarity=0.078 Sum_probs=189.4
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHH---HHHhcCCCCceeEEe-----
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREA---HILSNLHHPNVVAFY----- 1033 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEI---eILkrLnHPNIVkLy----- 1033 (1254)
..|++++.||+|+||+||+|++. ++.||||+++.... ......+.+.+|+ .+|+. +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~ 135 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-----NSRSELERLHEATFAAARLLG-ESPEEARDRRRLLL 135 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-----THHHHHHHHHHHHHHHHHHHC-----------CBCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-----ccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEe
Confidence 35999999999999999999984 77899999986532 1233455677784 45555 799988865
Q ss_pred --eeeecCCC---------------CceEEEEEecccCchhhhhhccCCCCCHHHH------HHHHHHhhhhhHHhhhCC
Q 040257 1034 --GVVPDGTG---------------GTLATVTEFMVNGSLKHVLLKKDRSLDRRKK------LIIAMDAAFGMEYLHSKN 1090 (1254)
Q Consensus 1034 --Gvf~Ddn~---------------~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~------lkIa~QIAeALaYLHSkG 1090 (1254)
+++..... ..+++||||+. ++|.+++......+.+..+ +.++.||+.||.|||++|
T Consensus 136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ 214 (371)
T 3q60_A 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG 214 (371)
T ss_dssp CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence 33332221 34899999998 8999999765555566666 778899999999999999
Q ss_pred cccccCCCCceEeccCCCCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 040257 1091 IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT 1170 (1254)
Q Consensus 1091 IIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT 1170 (1254)
|+||||||+||||+ .++.+||+|||+++....... ...+|+.|+|||++.+....++.++|||||||+||||++
T Consensus 215 ivHrDikp~NIll~----~~~~~kL~DFG~a~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 LVHGHFTPDNLFIM----PDGRLMLGDVSALWKVGTRGP--ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp EEETTCSGGGEEEC----TTSCEEECCGGGEEETTCEEE--GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CccCcCCHHHEEEC----CCCCEEEEecceeeecCCCcc--CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999998 778999999999986544321 344679999999998633458999999999999999999
Q ss_pred CCCCCCCCChhhH--HHH-----hhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHHH
Q 040257 1171 GEEPYADMHCGAI--IGG-----IVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITS--RLRTISAA 1235 (1254)
Q Consensus 1171 Gk~PF~~~n~~el--iqs-----Ilk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe--~Le~Ll~e 1235 (1254)
|+.||........ ... .....+.......+++.+.+||.+||+.||++|||+.++++ .++.+...
T Consensus 289 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 362 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE 362 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence 9999987633211 000 00111222233578999999999999999999999999986 34444333
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=364.50 Aligned_cols=256 Identities=14% Similarity=0.069 Sum_probs=197.0
Q ss_pred ccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHH---HHHhcCCCCceeEEe----
Q 040257 963 NVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREA---HILSNLHHPNVVAFY---- 1033 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEI---eILkrLnHPNIVkLy---- 1033 (1254)
..+|++.+.||+|+||+||+|++ +++.||||++....... ....+.+.+|+ .+|++++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-----SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC-----TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc-----hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 35799999999999999999996 47889999998543221 12346788999 455566899999998
Q ss_pred ---eeeecCCC----------C-----ceEEEEEecccCchhhhhhccCC------CCCHHHHHHHHHHhhhhhHHhhhC
Q 040257 1034 ---GVVPDGTG----------G-----TLATVTEFMVNGSLKHVLLKKDR------SLDRRKKLIIAMDAAFGMEYLHSK 1089 (1254)
Q Consensus 1034 ---Gvf~Ddn~----------~-----~L~LVMEYm~GGSL~d~L~kre~------~LSe~~~lkIa~QIAeALaYLHSk 1089 (1254)
+++.+... . ..++||||+ +|+|.+++..... .+++..++.|+.||+.||.|||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 55544321 0 378999999 6899999865421 233588888999999999999999
Q ss_pred CcccccCCCCceEeccCCCCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCC---------CCCCCchhHHHH
Q 040257 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGS---------SNRVSEKVDVFS 1160 (1254)
Q Consensus 1090 GIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~---------~~kyS~KSDIWS 1160 (1254)
||+||||||+||||+ .++.+||+|||+++.... .....+| +.|+|||++.+. ...++.++||||
T Consensus 226 ~ivHrDikp~NIll~----~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 226 GLVHTYLRPVDIVLD----QRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp TEECSCCCGGGEEEC----TTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred CeecCCCCHHHEEEc----CCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 999999999999998 678999999999986433 2334567 999999999865 013899999999
Q ss_pred HHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHHHHh
Q 040257 1161 FGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITS--RLRTISAAIE 1237 (1254)
Q Consensus 1161 LGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe--~Le~Ll~eLE 1237 (1254)
|||+||||++|+.||...........+.. ....+++++.+||.+||+.||.+||++.++++ .++.+...+.
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~ 371 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 371 (377)
T ss_dssp HHHHHHHHHHSSCCC------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCcccccccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHHH
Confidence 99999999999999987654443333322 23567899999999999999999999999997 5565555443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=342.58 Aligned_cols=252 Identities=28% Similarity=0.349 Sum_probs=204.3
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC---CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC---CCCceeEEeeeee
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR---GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL---HHPNVVAFYGVVP 1037 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r---Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL---nHPNIVkLyGvf~ 1037 (1254)
.+|++++.||+|+||+||+|++. ++.||||+++....... ....+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------MPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS------CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc------CCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 58999999999999999999983 67799999975432111 112344566666655 8999999999986
Q ss_pred c---CCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1038 D---GTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1038 D---dn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
. .....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~----~~~~~ 159 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQI 159 (326)
T ss_dssp EEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCE
T ss_pred ecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc----CCCCE
Confidence 2 23347899999996 69999886543 4589999999999999999999999999999999999998 77899
Q ss_pred EEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC
Q 040257 1114 KVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
||+|||+++............||..|+|||++.+.. ++.++|||||||++|+|++|+.||........+..+......
T Consensus 160 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (326)
T 1blx_A 160 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237 (326)
T ss_dssp EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEecCcccccccCCCCccccccccceeCHHHHhcCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence 999999998665544455677999999999998664 889999999999999999999999987776665555431100
Q ss_pred -------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 -------------------------PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 -------------------------p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
......++..+++||.+||+.||.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01234678999999999999999999999999964
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=354.06 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=194.4
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
.+|++++.||+|+||+||+|.+. ++.||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 98 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS------SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC------ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence 47999999999999999999884 77899999975421 2334567889999999999999999999987543
Q ss_pred ---CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1041 ---GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1041 ---~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
...+++||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 99 ~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl~D 170 (371)
T 2xrw_A 99 LEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILD 170 (371)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECC
T ss_pred cccccceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc----CCCCEEEEE
Confidence 236899999996 57877774 3589999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC----
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR---- 1193 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr---- 1193 (1254)
||+++............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 171 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 171 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 248 (371)
T ss_dssp CCC----------------CTTCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHH
T ss_pred eecccccccccccCCceecCCccCHHHhcCCC--CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99998665544445567999999999998764 789999999999999999999999987766555544432110
Q ss_pred ----------------CCC--------------CC------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 ----------------PTI--------------PE------RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 ----------------p~i--------------pe------~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+.. +. ..+.++++||.+||+.||.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000 00 015678999999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=343.01 Aligned_cols=251 Identities=21% Similarity=0.251 Sum_probs=201.6
Q ss_pred cccCceEEEEEeeeCcEEEEEEEE---CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCC------ceeEE
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKW---RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP------NVVAF 1032 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~---rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHP------NIVkL 1032 (1254)
...+|++++.||+|+||+||+|.+ .++.||||+++.. ....+.+.+|+.+++.++|+ +|+++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---------CchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 345899999999999999999987 4678999998742 23356678899999888655 59999
Q ss_pred eeeeecCCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCC---
Q 040257 1033 YGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDP--- 1108 (1254)
Q Consensus 1033 yGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~--- 1108 (1254)
++++.+.. .+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.
T Consensus 83 ~~~~~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 83 LEWFEHHG--HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp EEEEEETT--EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred ecccccCC--cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 99998665 899999999 899999886554 36899999999999999999999999999999999999983210
Q ss_pred ------------CCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 040257 1109 ------------QRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYA 1176 (1254)
Q Consensus 1109 ------------snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~ 1176 (1254)
..+.+||+|||+++..... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALG--WSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSC--CCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCC--CCcchhhHHHHHHHHHHHhCCCCCC
Confidence 0568999999999865433 23457999999999998764 8999999999999999999999998
Q ss_pred CCChhhHHHHhhhccCC------------------------------------------CCCCCCCcHHHHHHHHHhhhc
Q 040257 1177 DMHCGAIIGGIVKNTLR------------------------------------------PTIPERCDPEWRKLMEQCWAA 1214 (1254)
Q Consensus 1177 ~~n~~eliqsIlk~~Lr------------------------------------------p~ipe~iS~eLrdLIkKCLqk 1214 (1254)
..+..+....+...... .......++++.+||.+||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 87665544332211000 001122357789999999999
Q ss_pred CCCCCCCHHHHHHH
Q 040257 1215 DPEARPSFTEITSR 1228 (1254)
Q Consensus 1215 DPeKRPSArELLe~ 1228 (1254)
||.+|||+.|++++
T Consensus 316 dP~~Rpt~~ell~h 329 (339)
T 1z57_A 316 DPAKRITLREALKH 329 (339)
T ss_dssp STTTSCCHHHHTTS
T ss_pred CcccccCHHHHhcC
Confidence 99999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=352.65 Aligned_cols=252 Identities=28% Similarity=0.358 Sum_probs=203.0
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|++++.||+|+||+||+|++. ++.||||++.... ......+.+.+|+.++++++||||+++++++.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 97 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD------DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK 97 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC------CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence 347999999999999999999985 7789999987542 12334566789999999999999999999998665
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+.+++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 98 --~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 98 --RWYLVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS----QSGVVKLCDFGF 170 (331)
T ss_dssp --EEEEEEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECCCTT
T ss_pred --EEEEEEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc----CCCcEEEEeCCC
Confidence 8999999999988888764 345699999999999999999999999999999999999998 778999999999
Q ss_pred cccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc--------
Q 040257 1121 SRIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT-------- 1191 (1254)
Q Consensus 1121 Ar~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~-------- 1191 (1254)
++.... ........||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...........+....
T Consensus 171 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (331)
T 4aaa_A 171 ARTLAAPGEVYDDEVATRWYRAPELLVGDV-KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249 (331)
T ss_dssp C------------CCCCCTTCCHHHHTTCT-TCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceeecCCccccCCCcCCccccCcccccCCC-CcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence 975433 22334456999999999998642 47899999999999999999999998877655444332110
Q ss_pred ------------CCCC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 ------------LRPT---------IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 ------------Lrp~---------ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+. ....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 012468899999999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.35 Aligned_cols=253 Identities=22% Similarity=0.265 Sum_probs=196.5
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC--------CCceeE
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH--------HPNVVA 1031 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn--------HPNIVk 1031 (1254)
...+|+++++||+|+||+||+|++. ++.||||+++.. ....+.+.+|+.+|++++ |+||++
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---------CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 3468999999999999999999884 678999999743 234567889999999885 788999
Q ss_pred EeeeeecC--CCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhC-CcccccCCCCceEeccCC
Q 040257 1032 FYGVVPDG--TGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRD 1107 (1254)
Q Consensus 1032 LyGvf~Dd--n~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSk-GIIHRDLKPeNILLDsdd 1107 (1254)
+++++... ....+++||||+ +++|.+.+... ...+++..++.|+.||+.||.|||++ ||+||||||+||||+..+
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 99998622 334799999999 66666665443 36699999999999999999999998 999999999999998221
Q ss_pred ---------------------------------------------CCCCeEEEEeccccccccCccccCCCCCCCCccCc
Q 040257 1108 ---------------------------------------------PQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAP 1142 (1254)
Q Consensus 1108 ---------------------------------------------~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAP 1142 (1254)
.....+||+|||+++..... .....||+.|+||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aP 262 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCH
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCC
Confidence 01137999999999865443 3345699999999
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh------hHHHHhhhc--cC----------------------
Q 040257 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG------AIIGGIVKN--TL---------------------- 1192 (1254)
Q Consensus 1143 EVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~------eliqsIlk~--~L---------------------- 1192 (1254)
|++.+.. ++.++|||||||+||||++|+.||...... ..+..+... ..
T Consensus 263 E~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 263 EVLIGSG--YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp HHHHTSC--CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred hhhcCCC--CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 9998764 889999999999999999999999754421 111111110 00
Q ss_pred ----------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 ----------------RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 ----------------rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
....+...+..+.+||.+||+.||++|||+.|++++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 001122335678899999999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=383.24 Aligned_cols=250 Identities=32% Similarity=0.574 Sum_probs=210.3
Q ss_pred EEEeeeCcEEEEEEEEC----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceE
Q 040257 970 RELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~ 1045 (1254)
++||+|+||+||+|.+. ++.||||+++.... .....+++.+|+.+|++++||||+++++++.++ .++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~ 445 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN------DPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWM 445 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG------CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEE
Confidence 57999999999999762 45799999976421 122356789999999999999999999999643 588
Q ss_pred EEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1046 TVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
+||||+.+|+|.+++.. .+.+++..++.|+.||+.||.|||+++||||||||+||||+ .++.+||+|||+++...
T Consensus 446 lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~----~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFGLSKALR 520 (635)
T ss_dssp EEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEECCTTHHHHTT
T ss_pred EEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe----CCCCEEEEEcCCccccc
Confidence 99999999999999954 45699999999999999999999999999999999999999 77899999999998653
Q ss_pred Ccc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1126 NTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1126 ~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
... ......+|+.|+|||++.+. .++.++|||||||+||||++ |+.||......+....+... .....+..+
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~ 597 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGC 597 (635)
T ss_dssp C-------------CGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTC
T ss_pred cCccccccccCCCCceeeeChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCC
Confidence 321 22234467889999999865 48999999999999999998 99999998887777666544 455677889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
+.++.+||.+||+.||++||++.+|++.|+++...+
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999999998765
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=384.35 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=214.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.+...+|++++.||+|+||+||+|+++ ++.||||++.+.... .......+.+|+.+|++++||||+++++++.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh-----hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 356678999999999999999999984 788999999764221 1122356788999999999999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
+.. .+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+||||+ .++++||+
T Consensus 255 ~~~--~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld----~~g~vKL~ 328 (576)
T 2acx_A 255 TKD--ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD----DHGHIRIS 328 (576)
T ss_dssp CSS--EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEEEC
T ss_pred eCC--EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe----CCCCeEEE
Confidence 755 8999999999999999886543 3499999999999999999999999999999999999998 78899999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh----hhHHHHhhhccC
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC----GAIIGGIVKNTL 1192 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~----~eliqsIlk~~L 1192 (1254)
|||+++...........+||+.|+|||++.+.. ++.++|||||||+||||++|+.||..... ..+...+.. .
T Consensus 329 DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~--~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~ 404 (576)
T 2acx_A 329 DLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER--YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--V 404 (576)
T ss_dssp CCTTCEECCTTCCEECCCSCGGGCCHHHHTTCE--ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--C
T ss_pred ecccceecccCccccccCCCccccCHHHHcCCC--CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--c
Confidence 999998765544445568999999999998764 78999999999999999999999987542 233333332 2
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
...++..+++++++||.+||+.||.+|| ++.|+++|
T Consensus 405 ~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 3456678899999999999999999999 78999876
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=339.79 Aligned_cols=253 Identities=24% Similarity=0.427 Sum_probs=188.4
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
...+|++++.||+|+||+||+|++. ++.||||++..... .....+.+..+..+++.++||||+++++++.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 96 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN------KEENKRILMDLDVVLKSHDCPYIVQCFGTFITN 96 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC------HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc------chHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence 3458999999999999999999994 78899999975421 222334445555678889999999999999876
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC-CcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk-GIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
. .+++||||+ ++.+..++......+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+||
T Consensus 97 ~--~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~----~~~~~kl~df 169 (318)
T 2dyl_A 97 T--DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGQIKLCDF 169 (318)
T ss_dssp S--EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC----TTSCEEECCC
T ss_pred C--cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC----CCCCEEEEEC
Confidence 5 899999999 5566665555567799999999999999999999995 999999999999998 7789999999
Q ss_pred cccccccCccccCCCCCCCCccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hhhHHHHhhhccCCC
Q 040257 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTGEEPYADMH-CGAIIGGIVKNTLRP 1194 (1254)
Q Consensus 1119 GLAr~~~~s~~sts~~GT~~YmAPEVLrG~---~~kyS~KSDIWSLGVILYELLTGk~PF~~~n-~~eliqsIlk~~Lrp 1194 (1254)
|++.............||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.... ....+..+..... +
T Consensus 170 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~ 248 (318)
T 2dyl_A 170 GISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-P 248 (318)
T ss_dssp TTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-C
T ss_pred CCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-C
Confidence 999765544444456799999999999631 2347899999999999999999999998743 3444444444322 2
Q ss_pred CCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 TIP--ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 ~ip--e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+ ..++.++.+||.+||+.||.+||++.+++++
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 222 4578999999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=345.42 Aligned_cols=251 Identities=25% Similarity=0.324 Sum_probs=202.7
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|++.+.||+|+||+||+|++. ++.||||++.... .......+.+|+.++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-------KPLFALRTLREIKILKHFKHENIITIFNIQRPDS 82 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-------cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence 358999999999999999999985 7789999996421 2334567889999999999999999999876532
Q ss_pred ---CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1041 ---GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1041 ---~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
...+++||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 83 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~----~~~~~kl~D 155 (353)
T 2b9h_A 83 FENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN----SNCDLKVCD 155 (353)
T ss_dssp STTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECC
T ss_pred cCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc----CCCcEEEEe
Confidence 357899999996 689888854 4699999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCcc-----------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHH
Q 040257 1118 FGLSRIKRNTL-----------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGG 1186 (1254)
Q Consensus 1118 FGLAr~~~~s~-----------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqs 1186 (1254)
||+++...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........+..
T Consensus 156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp CTTCEECC----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccccccccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 99997543221 12235689999999998653 2489999999999999999999999988765544433
Q ss_pred hhhccCC----------------------C--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1187 IVKNTLR----------------------P--------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1187 Ilk~~Lr----------------------p--------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+....-. + .....+++++.+||.+||+.||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 3211000 0 0113578899999999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=360.09 Aligned_cols=250 Identities=23% Similarity=0.306 Sum_probs=200.8
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
..+|++++.||+|+||+||+|++. +..+|+|++..... ...+|+.+++.++||||++++++|....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------------~~~~E~~il~~l~h~niv~l~~~~~~~~~ 106 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------------FKNRELQIMRIVKHPNVVDLKAFFYSNGD 106 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------------SCCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------------hHHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence 347999999999999999999984 45599998865321 1126899999999999999999985432
Q ss_pred ---CCceEEEEEecccCchhhhh--hccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1041 ---GGTLATVTEFMVNGSLKHVL--LKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1041 ---~~~L~LVMEYm~GGSL~d~L--~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
...+++||||+.++.+.... ......+++..++.++.||+.||.|||++||+||||||+||||+ ..++.+||
T Consensus 107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~~kL 183 (394)
T 4e7w_A 107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD---PPSGVLKL 183 (394)
T ss_dssp SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---TTTTEEEE
T ss_pred CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc---CCCCcEEE
Confidence 22488999999765444332 12356799999999999999999999999999999999999997 24679999
Q ss_pred EeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC---
Q 040257 1116 GDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL--- 1192 (1254)
Q Consensus 1116 iDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L--- 1192 (1254)
+|||+++............||+.|+|||++.+.. .++.++|||||||+||||++|+.||.+......+..+....-
T Consensus 184 ~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGAT-NYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp CCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eeCCCcccccCCCCCcccccCcCccCHHHHcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999998765554555677999999999997643 489999999999999999999999998876655554433100
Q ss_pred ------------CC------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 ------------RP------------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 ------------rp------------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.. .++..+++++.+||.+||+.||.+|||+.|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 1223478899999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=347.77 Aligned_cols=251 Identities=24% Similarity=0.247 Sum_probs=191.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
.+|++.+.||+|+||+||+|++. ++.||||++...... ...+.+|+..++.++||||++++++|....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---------RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---------CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---------cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 37999999999999999999985 778999998654211 124556788888899999999999986422
Q ss_pred ----CCceEEEEEecccCchhhhhh---ccCCCCCHHHHHHHHHHhhhhhHHhh--hCCcccccCCCCceEeccCCCCCC
Q 040257 1041 ----GGTLATVTEFMVNGSLKHVLL---KKDRSLDRRKKLIIAMDAAFGMEYLH--SKNIVHFDLKCENLLVNLRDPQRP 1111 (1254)
Q Consensus 1041 ----~~~L~LVMEYm~GGSL~d~L~---kre~~LSe~~~lkIa~QIAeALaYLH--SkGIIHRDLKPeNILLDsdd~snG 1111 (1254)
...+++||||+.+ +|...+. .....+++..++.++.||+.||.||| ++||+||||||+|||++. .++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE---ADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET---TTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC---CCC
Confidence 2238899999975 5444432 24567899999999999999999999 999999999999999981 268
Q ss_pred eEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc
Q 040257 1112 ICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT 1191 (1254)
Q Consensus 1112 ~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~ 1191 (1254)
.+||+|||+++............||+.|+|||++.+.. .++.++|||||||++|+|++|+.||........+..+....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCC-CCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 99999999998766555555667999999999997543 47999999999999999999999999887766665554311
Q ss_pred C------------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 L------------------------------RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 L------------------------------rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
. ........+.++.+||.+||+.||.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 011222357899999999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=378.61 Aligned_cols=254 Identities=24% Similarity=0.405 Sum_probs=212.7
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
.+...+|++++.||+|+||+||+|+++ ++.||||++.+.... .......+.+|+.+|++++||||++++++|.
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 255 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-----KRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh-----hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 455678999999999999999999984 788999999764321 1122456789999999999999999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhcc---CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKK---DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kr---e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
+.. .+|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+ .++++|
T Consensus 256 ~~~--~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~----~~g~vk 329 (543)
T 3c4z_A 256 TKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD----DDGNVR 329 (543)
T ss_dssp CSS--EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEE
T ss_pred eCC--EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe----CCCCEE
Confidence 765 899999999999999988654 34699999999999999999999999999999999999998 788999
Q ss_pred EEeccccccccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----hhhHHHHhhh
Q 040257 1115 VGDFGLSRIKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH----CGAIIGGIVK 1189 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n----~~eliqsIlk 1189 (1254)
|+|||+++...... .....+||+.|+|||++.+. .++.++|||||||+||||++|+.||.... .......+..
T Consensus 330 L~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~ 407 (543)
T 3c4z_A 330 ISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE 407 (543)
T ss_dssp ECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH
T ss_pred EeecceeeeccCCCcccccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh
Confidence 99999998654432 23456899999999999876 48899999999999999999999998653 2344444544
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSF-----TEITSR 1228 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSA-----rELLe~ 1228 (1254)
.. ..++..+++++++||.+||++||.+||++ .+++++
T Consensus 408 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 408 QA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred cc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 33 34667889999999999999999999964 677754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=359.46 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=185.1
Q ss_pred CceE-EEEEeeeCcEEEEEEEEC----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 965 DLEE-LRELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 965 dYei-LkkLGeGsFGtVYlAk~r----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
.|++ .++||+|+||+||+|+++ ++.||||++..... ...+.+|+.+|++++||||+++++++...
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----------CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----------CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 3555 457999999999999974 56799999875421 23577899999999999999999999766
Q ss_pred CCCceEEEEEecccCchhhhhhcc--------CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCC
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKK--------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRP 1111 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kr--------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG 1111 (1254)
....+++||||+. ++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||||...+...+
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 6668999999985 5777776422 124899999999999999999999999999999999999954434778
Q ss_pred eEEEEeccccccccCc----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh------
Q 040257 1112 ICKVGDFGLSRIKRNT----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG------ 1181 (1254)
Q Consensus 1112 ~VKLiDFGLAr~~~~s----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~------ 1181 (1254)
.+||+|||+++..... ......+||+.|+|||++.+.. .++.++|||||||+||+|++|+.||......
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCC-SCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCC-cccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 9999999999865432 2234467999999999998643 4899999999999999999999999754331
Q ss_pred ---hHHHHhhhccCCC------------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 040257 1182 ---AIIGGIVKNTLRP------------------------------------TIPERCDPEWRKLMEQCWAADPEARPSF 1222 (1254)
Q Consensus 1182 ---eliqsIlk~~Lrp------------------------------------~ipe~iS~eLrdLIkKCLqkDPeKRPSA 1222 (1254)
..+..+....-.+ ......+..+.+||.+||+.||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 2222221110000 0011226788999999999999999999
Q ss_pred HHHHHH
Q 040257 1223 TEITSR 1228 (1254)
Q Consensus 1223 rELLe~ 1228 (1254)
.|+|++
T Consensus 329 ~e~L~h 334 (405)
T 3rgf_A 329 EQAMQD 334 (405)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.63 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=205.9
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC--CCceeEEeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH--HPNVVAFYGVV 1036 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn--HPNIVkLyGvf 1036 (1254)
.+...+|++++.||+|+||.||++.+. ++.||||++..... .....+.+.+|+.++++++ |+||+++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC------CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc------cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 455668999999999999999999884 67799999975421 2334577889999999997 59999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.+.. .+++||| +.+++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++ ++.+||+
T Consensus 98 ~~~~--~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-----~~~~kL~ 168 (313)
T 3cek_A 98 ITDQ--YIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLI 168 (313)
T ss_dssp ECSS--EEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-----TTEEEEC
T ss_pred ecCC--EEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-----CCeEEEe
Confidence 8765 7999999 5688999998654 5689999999999999999999999999999999999996 3789999
Q ss_pred eccccccccCcc---ccCCCCCCCCccCcccccCC---------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hhH
Q 040257 1117 DFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGS---------SNRVSEKVDVFSFGISMWEILTGEEPYADMHC-GAI 1183 (1254)
Q Consensus 1117 DFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~---------~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~-~el 1183 (1254)
|||+++...... ......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||..... ...
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH
Confidence 999997543322 22345689999999999752 12488999999999999999999999986543 334
Q ss_pred HHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1184 IGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1184 iqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
...+.........+...+.++.+||.+||+.||.+||++.+++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 249 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 4444444455566777889999999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.88 Aligned_cols=248 Identities=27% Similarity=0.383 Sum_probs=201.2
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|.+.+.||+|+||+||+|.+. ++.||||++.... ......+.+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc------cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 47999999999999999999984 7789999997542 123445778899999999999999999999976542
Q ss_pred ----CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1042 ----GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1042 ----~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
..+++||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~----~~~~~kl~D 169 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN----EDCELKILD 169 (353)
T ss_dssp GGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC----TTCCEEECS
T ss_pred cccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC----CCCcEEEee
Confidence 23589999996 68888773 3489999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc------
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT------ 1191 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~------ 1191 (1254)
||+++..... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+....+..+....
T Consensus 170 fg~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 170 FGLARHADAE--MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246 (353)
T ss_dssp TTCTTC----------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred cccccCCCCC--ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999765433 2345689999999999863 247899999999999999999999999877655444433210
Q ss_pred --------------------CC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 --------------------LR---PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 --------------------Lr---p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.. ......+++++.+||.+||+.||.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 12234578999999999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=342.63 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=182.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHH-HHhcCCCCceeEEeeee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH-ILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIe-ILkrLnHPNIVkLyGvf 1036 (1254)
.+...+|++++.||+|+||.||+|.++ ++.||||+++... ......++.+|+. +++.++||||+++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~ 90 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-------DEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL 90 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-------CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-------CchHHHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence 455668999999999999999999995 7889999997542 1122345556665 77888999999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhc----cCCCCCHHHHHHHHHHhhhhhHHhhhC-CcccccCCCCceEeccCCCCCC
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLK----KDRSLDRRKKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRP 1111 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~k----re~~LSe~~~lkIa~QIAeALaYLHSk-GIIHRDLKPeNILLDsdd~snG 1111 (1254)
.+.. .+++||||+.+ +|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+|||++ .++
T Consensus 91 ~~~~--~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~----~~~ 163 (327)
T 3aln_A 91 FREG--DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD----RSG 163 (327)
T ss_dssp ECSS--EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE----TTT
T ss_pred EeCC--ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc----CCC
Confidence 8765 89999999975 77777642 246789999999999999999999999 999999999999998 788
Q ss_pred eEEEEeccccccccCccccCCCCCCCCccCcccccCC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-hHHHHhh
Q 040257 1112 ICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGS--SNRVSEKVDVFSFGISMWEILTGEEPYADMHCG-AIIGGIV 1188 (1254)
Q Consensus 1112 ~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~--~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~-eliqsIl 1188 (1254)
.+||+|||+++............||+.|+|||++... ...++.++|||||||++|+|++|+.||...... ..+..+.
T Consensus 164 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 243 (327)
T 3aln_A 164 NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243 (327)
T ss_dssp EEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC
T ss_pred CEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh
Confidence 9999999999866554444445799999999998421 224789999999999999999999999865422 2222222
Q ss_pred hccC---CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1189 KNTL---RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1189 k~~L---rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.... .......+++.+.+||.+||+.||.+||++.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 2211 111224588999999999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=358.50 Aligned_cols=246 Identities=23% Similarity=0.310 Sum_probs=200.9
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC------CCCceeEEee
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL------HHPNVVAFYG 1034 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL------nHPNIVkLyG 1034 (1254)
..+|++++.||+|+||+||+|.+. ++.||||+++.. ......+.+|+.+++.+ +|+||+++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~ 166 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---------cchHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence 347999999999999999999984 678999999743 22345667788877776 6789999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCe-
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPI- 1112 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~- 1112 (1254)
++.... .+++||||+. ++|.+++.... ..+++..++.|+.||+.||.|||+++||||||||+||||+ ..+.
T Consensus 167 ~~~~~~--~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~----~~~~~ 239 (429)
T 3kvw_A 167 NFTFRN--HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK----QQGRS 239 (429)
T ss_dssp EEEETT--EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES----STTSC
T ss_pred ecccCC--eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc----cCCCc
Confidence 998765 8999999995 68988886543 4599999999999999999999999999999999999998 4444
Q ss_pred -EEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc
Q 040257 1113 -CKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT 1191 (1254)
Q Consensus 1113 -VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~ 1191 (1254)
+||+|||+++..... .....||+.|+|||++.+.. ++.++|||||||+||||++|+.||......+.+..+....
T Consensus 240 ~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~ 315 (429)
T 3kvw_A 240 GIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGAR--YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315 (429)
T ss_dssp CEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred ceEEeecccceecCCc--ccccCCCCCccChHHHhCCC--CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 999999999765433 23467999999999998764 8999999999999999999999999877665554443210
Q ss_pred CCC---------------------------------------------------------CCCCCCcHHHHHHHHHhhhc
Q 040257 1192 LRP---------------------------------------------------------TIPERCDPEWRKLMEQCWAA 1214 (1254)
Q Consensus 1192 Lrp---------------------------------------------------------~ipe~iS~eLrdLIkKCLqk 1214 (1254)
-.+ .+....++++.+||.+||++
T Consensus 316 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~ 395 (429)
T 3kvw_A 316 GMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEW 395 (429)
T ss_dssp CCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCS
T ss_pred CCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCC
Confidence 000 01123478899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 040257 1215 DPEARPSFTEITSR 1228 (1254)
Q Consensus 1215 DPeKRPSArELLe~ 1228 (1254)
||++|||+.|+|++
T Consensus 396 dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 396 DPAVRMTPGQALRH 409 (429)
T ss_dssp STTTSCCHHHHHTS
T ss_pred ChhhCCCHHHHhCC
Confidence 99999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=350.22 Aligned_cols=248 Identities=27% Similarity=0.382 Sum_probs=201.0
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|.+.+.||+|+||+||+|.+. ++.||||++.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc------cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 48999999999999999999984 7789999997542 123446778899999999999999999999976542
Q ss_pred C----ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1042 G----TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1042 ~----~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
. .+++||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~----~~~~~kL~D 187 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN----EDCELKILD 187 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEECS
T ss_pred cccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC----CCCCEEEEe
Confidence 1 2489999996 68887763 3499999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC---
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP--- 1194 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp--- 1194 (1254)
||+++..... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+......+
T Consensus 188 fg~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 188 FGLARHADAE--MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp TTCC----------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cCcccccccC--cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 9999865433 3346789999999999863 248899999999999999999999999877665555443211000
Q ss_pred --------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 --------------------------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 --------------------------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.....+++++.+||.+||+.||.+|||+.|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0123468999999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=356.04 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=188.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
.+|++++.||+|+||+||+|.+ +++.||||++.... ......+++.+|+.+|+.++||||+++++++....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc------cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 4899999999999999999987 47789999986532 12334567889999999999999999999986531
Q ss_pred ---CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1041 ---GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1041 ---~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
...+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~----~~~~~kL~D 175 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILD 175 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECC
T ss_pred cccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC----CCCCEEEee
Confidence 24689999998 7899988854 5699999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC----
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR---- 1193 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr---- 1193 (1254)
||+++..... .....||+.|+|||++.+.. .++.++|||||||++|||++|+.||.+.+....+..+......
T Consensus 176 FG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 176 FGLARHTADE--MTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCC-SCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cccccccccc--CCCcCcCcCccChHHHcCCc-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999865432 23467999999999998632 4889999999999999999999999987765555444321100
Q ss_pred -----------------CC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 -----------------PT--------IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 -----------------p~--------ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+. .....++++.+||.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00 012467889999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=339.95 Aligned_cols=250 Identities=19% Similarity=0.236 Sum_probs=198.9
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--C-ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCc------eeEEe
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--G-SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN------VVAFY 1033 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--G-s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPN------IVkLy 1033 (1254)
..+|++++.||+|+||+||+|.+. + +.||||+++.. ....+.+.+|+.++++++|++ ++.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---------GKYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---------ccchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 458999999999999999999984 3 57999999742 223466778999999887655 89999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC-----
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD----- 1107 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd----- 1107 (1254)
+++.... .+++||||+ +++|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 89 ~~~~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 89 DWFNFHG--HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp EEEEETT--EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eeeeeCC--eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence 9987655 899999999 667777665543 5699999999999999999999999999999999999994221
Q ss_pred ----------CCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 040257 1108 ----------PQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD 1177 (1254)
Q Consensus 1108 ----------~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~ 1177 (1254)
...+.+||+|||+++..... .....||+.|+|||++.+.. ++.++|||||||+||||++|+.||..
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELG--WAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCC--CCCccchHHHHHHHHHHHhCCCCCCC
Confidence 15788999999999864433 23467999999999998664 88999999999999999999999988
Q ss_pred CChhhHHHHhhhccCCC------------------------------------------CCCCCCcHHHHHHHHHhhhcC
Q 040257 1178 MHCGAIIGGIVKNTLRP------------------------------------------TIPERCDPEWRKLMEQCWAAD 1215 (1254)
Q Consensus 1178 ~n~~eliqsIlk~~Lrp------------------------------------------~ipe~iS~eLrdLIkKCLqkD 1215 (1254)
......+..+....... ......+.++.+||.+||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 76655443332211000 001112457899999999999
Q ss_pred CCCCCCHHHHHHH
Q 040257 1216 PEARPSFTEITSR 1228 (1254)
Q Consensus 1216 PeKRPSArELLe~ 1228 (1254)
|.+|||+.|++++
T Consensus 322 P~~Rpt~~e~l~h 334 (355)
T 2eu9_A 322 PAQRITLAEALLH 334 (355)
T ss_dssp TTTSCCHHHHTTS
T ss_pred hhhCcCHHHHhcC
Confidence 9999999999964
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=376.86 Aligned_cols=259 Identities=34% Similarity=0.608 Sum_probs=218.4
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC-----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR-----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGV 1035 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r-----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGv 1035 (1254)
+...+|++.+.||+|+||+||+|.+. +..||||+++... .....+.+.+|+.++++++||||++++++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 44568999999999999999999984 2358999876421 23445778999999999999999999999
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
+.+ ..+++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 460 ~~~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~----~~~~vkL 532 (656)
T 2j0j_A 460 ITE---NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVKL 532 (656)
T ss_dssp ECS---SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEE
T ss_pred Eec---CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe----CCCCEEE
Confidence 854 358999999999999999977666799999999999999999999999999999999999998 7789999
Q ss_pred EeccccccccCccc--cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccC
Q 040257 1116 GDFGLSRIKRNTLV--SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1116 iDFGLAr~~~~s~~--sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~L 1192 (1254)
+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|||++ |..||......+....+....
T Consensus 533 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~- 609 (656)
T 2j0j_A 533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE- 609 (656)
T ss_dssp CCCCCCCSCCC----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-
T ss_pred EecCCCeecCCCcceeccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-
Confidence 99999986543321 2234467899999999865 48999999999999999997 999999888877777665543
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
....+..+++.+.+||.+||..||.+||++.+|++.|+.++.+-
T Consensus 610 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 610 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 34567789999999999999999999999999999999997654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=364.96 Aligned_cols=258 Identities=21% Similarity=0.301 Sum_probs=207.9
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCC-ceeEEeeeeecC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP-NVVAFYGVVPDG 1039 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHP-NIVkLyGvf~Dd 1039 (1254)
..+|+++++||+|+||.||+|++. ++.||||++..... ..++.+|+++++.|.|+ +|..+..++.+.
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----------SCCHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 458999999999999999999984 78899998875421 12467899999999874 444555554443
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
...++||||+ +++|.+++......+++..++.|+.||+.||.|||+++||||||||+||||+..+ ..+.+||+|||
T Consensus 76 --~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~-~~~~vkL~DFG 151 (483)
T 3sv0_A 76 --DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFG 151 (483)
T ss_dssp --TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTTCEEECCCT
T ss_pred --CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCC-CCCeEEEEeCC
Confidence 3789999999 9999999976677899999999999999999999999999999999999994211 67899999999
Q ss_pred ccccccCccc--------cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh---hhHHHHhh
Q 040257 1120 LSRIKRNTLV--------SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC---GAIIGGIV 1188 (1254)
Q Consensus 1120 LAr~~~~s~~--------sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~---~eliqsIl 1188 (1254)
+++....... .....||..|+|||++.+.. ++.++|||||||+||||++|+.||..... ...+..+.
T Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (483)
T 3sv0_A 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (483)
T ss_dssp TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH
T ss_pred cceeccCCccccccccccccccCCCccccCHHHhcCCC--CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh
Confidence 9986543221 22567999999999998764 89999999999999999999999987543 22333332
Q ss_pred hccCCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1189 KNTLRP---TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1189 k~~Lrp---~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
...... .+...++.++.+||.+||+.+|++||++.+|++.|+.++...
T Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 230 EKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 222111 223567899999999999999999999999999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=346.65 Aligned_cols=255 Identities=20% Similarity=0.283 Sum_probs=199.6
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-----------C
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-----------H 1026 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-----------H 1026 (1254)
.+...+|++++.||+|+||+||+|++ .++.||||++... ....+.+.+|+.++++++ |
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~ 85 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---------KVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---------ccchhhhhHHHHHHHHhhcccccchhcccc
Confidence 34566899999999999999999997 4778999998743 123456778999998876 8
Q ss_pred CceeEEeeeeecCC--CCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhC-CcccccCCCCceE
Q 040257 1027 PNVVAFYGVVPDGT--GGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLL 1102 (1254)
Q Consensus 1027 PNIVkLyGvf~Ddn--~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSk-GIIHRDLKPeNIL 1102 (1254)
+||+++++++.... ...+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||
T Consensus 86 ~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIl 164 (373)
T 1q8y_A 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164 (373)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEE
T ss_pred chHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeE
Confidence 99999999987532 23789999999 89999998653 35599999999999999999999998 9999999999999
Q ss_pred eccCC--CCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 040257 1103 VNLRD--PQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC 1180 (1254)
Q Consensus 1103 LDsdd--~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~ 1180 (1254)
|+..+ ...+.+||+|||+++..... .....||+.|+|||++.+.. ++.++|||||||+||||++|+.||.....
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~pf~~~~~ 240 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP--WGCGADIWSTACLIFELITGDFLFEPDEG 240 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC--CCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC--CCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 96322 24558999999999865443 23456999999999998764 78999999999999999999999975432
Q ss_pred ------hhHHHHhhhc--c--------------------------------------CCCCCCCCCcHHHHHHHHHhhhc
Q 040257 1181 ------GAIIGGIVKN--T--------------------------------------LRPTIPERCDPEWRKLMEQCWAA 1214 (1254)
Q Consensus 1181 ------~eliqsIlk~--~--------------------------------------Lrp~ipe~iS~eLrdLIkKCLqk 1214 (1254)
...+..+... . ....++..++.++.+||.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 320 (373)
T 1q8y_A 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 320 (373)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence 1111111110 0 00112334567899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 040257 1215 DPEARPSFTEITSR 1228 (1254)
Q Consensus 1215 DPeKRPSArELLe~ 1228 (1254)
||.+|||+.|++++
T Consensus 321 dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 321 DPRKRADAGGLVNH 334 (373)
T ss_dssp STTTCBCHHHHHTC
T ss_pred CccccCCHHHHhhC
Confidence 99999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=341.30 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=175.6
Q ss_pred cCceEEE-EEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC-
Q 040257 964 VDLEELR-ELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG- 1039 (1254)
Q Consensus 964 ~dYeiLk-kLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd- 1039 (1254)
.+|++++ .||+|+||+||+|+++ ++.||||++... ..... .....++.+.||||+++++++...
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---------PKARQ---EVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---------HHHHH---HHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---------HHHHH---HHHHHHHhcCCCChHHHHHHHhhcc
Confidence 4799865 5999999999999995 788999998743 11111 222345677999999999998652
Q ss_pred -CCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1040 -TGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1040 -n~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
....+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~-~~~~~kl~D 174 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE-KDAVLKLTD 174 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-TTCCEEECC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC-CCceEEEec
Confidence 2336899999999999999997653 4699999999999999999999999999999999999997332 456799999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH----HhhhccC-
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIG----GIVKNTL- 1192 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliq----sIlk~~L- 1192 (1254)
||+++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.......... .+.....
T Consensus 175 fg~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T 3fhr_A 175 FGFAKETTQNA-LQTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251 (336)
T ss_dssp CTTCEEC-----------------------CH--HHHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred cccceeccccc-cccCCCCcCccChhhhCCCC--CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence 99997654332 23456899999999997654 7899999999999999999999997655433211 1111111
Q ss_pred -CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1193 -RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1193 -rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
.......++.++++||.+||+.||.+|||+.+++++-
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 2222356899999999999999999999999999853
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=344.77 Aligned_cols=247 Identities=23% Similarity=0.246 Sum_probs=198.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CC-----ceeEEeee
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HP-----NVVAFYGV 1035 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HP-----NIVkLyGv 1035 (1254)
.+|++++.||+|+||+||+|++. ++.||||+++.. ......+.+|+.+++.++ |+ +|++++++
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---------KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---------HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 48999999999999999999984 678999999743 233456777888888774 44 59999999
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhh--hCCcccccCCCCceEeccCCCCCCe
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLH--SKNIVHFDLKCENLLVNLRDPQRPI 1112 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLH--SkGIIHRDLKPeNILLDsdd~snG~ 1112 (1254)
+.... .+++||||+. ++|.+++.... ..+++..++.++.||+.||.||| +.|||||||||+||||+.+ ..+.
T Consensus 125 ~~~~~--~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~--~~~~ 199 (382)
T 2vx3_A 125 FMFRN--HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP--KRSA 199 (382)
T ss_dssp EEETT--EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST--TSCC
T ss_pred eccCC--ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC--CCCc
Confidence 98765 8999999995 59999886653 56999999999999999999999 5799999999999999521 4678
Q ss_pred EEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC
Q 040257 1113 CKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1113 VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L 1192 (1254)
+||+|||+++..... .....||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+....+..+.....
T Consensus 200 ~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMP--YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp EEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEEEeccCceecccc--cccccCCccccChHHHcCCC--CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999999865433 23467999999999998764 88999999999999999999999998776665555443110
Q ss_pred CCC----------------CCC----------------------------------------------CCcHHHHHHHHH
Q 040257 1193 RPT----------------IPE----------------------------------------------RCDPEWRKLMEQ 1210 (1254)
Q Consensus 1193 rp~----------------ipe----------------------------------------------~iS~eLrdLIkK 1210 (1254)
.+. ++. ...+++++||.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 000 000 001478999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 040257 1211 CWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1211 CLqkDPeKRPSArELLe~ 1228 (1254)
||++||++|||+.|+|++
T Consensus 356 mL~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQH 373 (382)
T ss_dssp HTCSCTTTSCCHHHHTTS
T ss_pred hcCCChhhCCCHHHHhcC
Confidence 999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=332.10 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=195.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC----CCCceeEEeeeee
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL----HHPNVVAFYGVVP 1037 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL----nHPNIVkLyGvf~ 1037 (1254)
.+|++.+.||+|+||.||+|++ +++.||||++......... .......+.+|+.+++++ +||||+++++++.
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS--PLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC----------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccc--cchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 4799999999999999999988 4778999999754322110 111223456788888888 8999999999997
Q ss_pred cCCCCceEEEEEe-cccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1038 DGTGGTLATVTEF-MVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1038 Ddn~~~L~LVMEY-m~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
+.. ..++|||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+||+
T Consensus 109 ~~~--~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~kl~ 182 (312)
T 2iwi_A 109 TQE--GFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID---LRRGCAKLI 182 (312)
T ss_dssp ------CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE---TTTTEEEEC
T ss_pred cCC--eEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe---CCCCeEEEE
Confidence 654 78899999 7899999998654 4699999999999999999999999999999999999997 246789999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
|||+++...... .....||..|+|||++.+.. ..+.++|||||||++|+|++|+.||.... .+... ....
T Consensus 183 dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~--~~~~ 252 (312)
T 2iwi_A 183 DFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQ-YHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA--ELHF 252 (312)
T ss_dssp CCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT--CCCC
T ss_pred EcchhhhcccCc-ccccCCcccccCceeeecCC-CCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh--ccCC
Confidence 999998665433 33456999999999987653 23568999999999999999999997532 12222 2345
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+..++..+.+||.+||+.||++||++.+++++
T Consensus 253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 66789999999999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=355.44 Aligned_cols=256 Identities=28% Similarity=0.418 Sum_probs=195.3
Q ss_pred ccccccCceEEEEEeeeCcEEE-EEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTV-YHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVV 1036 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtV-YlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf 1036 (1254)
..+...+|++.+.||+|+||+| |++..+++.||||++..... ..+.+|+.+|+++ +||||+++++++
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----------~~~~~E~~~l~~l~~HpnIv~l~~~~ 87 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----------SFADREVQLLRESDEHPNVIRYFCTE 87 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----------EECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----------HHHHHHHHHHHhccCCCCcCeEEEEE
Confidence 3455668999999999999985 55666889999999975421 1245799999998 799999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC-CCCCeEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD-PQRPICKV 1115 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd-~snG~VKL 1115 (1254)
.+.. .+++||||+. ++|.+++......+.+..++.++.||+.||.|||++||+||||||+||||+..+ .....+||
T Consensus 88 ~~~~--~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL 164 (432)
T 3p23_A 88 KDRQ--FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMI 164 (432)
T ss_dssp EETT--EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred ecCC--EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEE
Confidence 8665 8899999995 699999977665666667789999999999999999999999999999996322 23456889
Q ss_pred EeccccccccCc----cccCCCCCCCCccCcccccCC-CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhh
Q 040257 1116 GDFGLSRIKRNT----LVSGGVRGTLPWMAPELLNGS-SNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1116 iDFGLAr~~~~s----~~sts~~GT~~YmAPEVLrG~-~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk 1189 (1254)
+|||+++..... .......||+.|+|||++.+. ...++.++|||||||++|||++ |..||...........+..
T Consensus 165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~ 244 (432)
T 3p23_A 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA 244 (432)
T ss_dssp CCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTC
T ss_pred ecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhcc
Confidence 999999865432 223446799999999999753 2357889999999999999999 9999976544333222211
Q ss_pred ccCCCC-CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1190 NTLRPT-IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1190 ~~Lrp~-ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
...... .....+..+++||.+||+.||.+|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 245 CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 111111 122345678999999999999999999999953
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=335.93 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=202.3
Q ss_pred cccCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC--CCceeEEeeeee
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH--HPNVVAFYGVVP 1037 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn--HPNIVkLyGvf~ 1037 (1254)
...+|++++.||+|+||+||+|++ +++.||||+++......... ......+.+|+.++++++ |+||+++++++.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE--LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEE--CTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhh--hhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 345899999999999999999988 47789999998653321000 001234567899999986 599999999998
Q ss_pred cCCCCceEEEEEeccc-CchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1038 DGTGGTLATVTEFMVN-GSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~G-GSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
+.. .+++||||+.+ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ...+.+||+
T Consensus 119 ~~~--~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~~kL~ 192 (320)
T 3a99_A 119 RPD--SFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID---LNRGELKLI 192 (320)
T ss_dssp CSS--EEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTTTEEEEC
T ss_pred cCC--cEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe---CCCCCEEEe
Confidence 665 89999999976 8999988654 5689999999999999999999999999999999999997 245789999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
|||+++...... .....||+.|+|||++.+.. .++.++|||||||++|||++|+.||.... .+... ....
T Consensus 193 Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~--~~~~ 262 (320)
T 3a99_A 193 DFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--QVFF 262 (320)
T ss_dssp CCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--CCCC
T ss_pred eCcccccccccc-ccCCCCCccCCChHHhccCC-CCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc--cccc
Confidence 999998665433 33456999999999997653 24788999999999999999999997532 12222 2234
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+..+++++.+||.+||+.||.+||++.+++++
T Consensus 263 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 56789999999999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.62 Aligned_cols=247 Identities=13% Similarity=0.081 Sum_probs=188.4
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
...+|++++.||+|+||.||+|++. ++.||||++...... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 103 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL-----PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR 103 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc-----CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC
Confidence 3458999999999999999999995 788999999754321 234567789999999999999999999999876
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
. .+|+||||+.+++|.+++.. + .....+..|+.||+.||.|||++||+||||||+|||++ .++.+||++++
T Consensus 104 ~--~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~----~~g~~kl~~~~ 174 (286)
T 3uqc_A 104 A--GGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS----IDGDVVLAYPA 174 (286)
T ss_dssp T--EEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE----TTSCEEECSCC
T ss_pred C--cEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc----CCCCEEEEecc
Confidence 5 89999999999999999843 2 45667889999999999999999999999999999999 77889997443
Q ss_pred ccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH---HhhhccCCC--
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIG---GIVKNTLRP-- 1194 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliq---sIlk~~Lrp-- 1194 (1254)
|++| ++.++|||||||+||||++|+.||........+. .........
T Consensus 175 -------------------~~~~---------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T 3uqc_A 175 -------------------TMPD---------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA 226 (286)
T ss_dssp -------------------CCTT---------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHH
T ss_pred -------------------ccCC---------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChh
Confidence 3332 6889999999999999999999998765433221 111111111
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhcccCCCCCCCCCCC
Q 040257 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCINSEPKQTKPIV 1252 (1254)
Q Consensus 1195 ~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk~~k~~p~t~~Pi~ 1252 (1254)
.....+++++.+||.+||++||.+| |+.++++.|+.+...-.... ..++....|.+
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~~-~~~p~~~~~~~ 282 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRTE-VLGPIDEAPVS 282 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC------------------
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCccC-CCCCCCCCCcc
Confidence 1235688999999999999999999 99999999999876544332 22344444444
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=342.75 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=186.3
Q ss_pred cCceEEEEEeeeCcEEEEEE-EECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHG-KWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlA-k~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~ 1041 (1254)
..|...+.||+|+||+||.+ ..+++.||||++.... .+.+.+|+.+|+++ +||||+++++++.+..
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~- 82 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----------CDIALMEIKLLTESDDHPNVIRYYCSETTDR- 82 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS-
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC-
Confidence 35667789999999999754 4478899999987531 24567899999876 8999999999997654
Q ss_pred CceEEEEEecccCchhhhhhccCCC------CCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC--------
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRS------LDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD-------- 1107 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~------LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd-------- 1107 (1254)
.+++||||+. ++|.+++...... .++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 83 -~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 83 -FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp -EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred -eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence 8999999995 6999998654321 12334577999999999999999999999999999997321
Q ss_pred -CCCCeEEEEeccccccccCcc-----ccCCCCCCCCccCcccccCC-----CCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 040257 1108 -PQRPICKVGDFGLSRIKRNTL-----VSGGVRGTLPWMAPELLNGS-----SNRVSEKVDVFSFGISMWEILT-GEEPY 1175 (1254)
Q Consensus 1108 -~snG~VKLiDFGLAr~~~~s~-----~sts~~GT~~YmAPEVLrG~-----~~kyS~KSDIWSLGVILYELLT-Gk~PF 1175 (1254)
...+.+||+|||+++...... ......||+.|+|||++.+. ...++.++|||||||++|||++ |+.||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 245689999999998654322 12345799999999999762 2358999999999999999999 99999
Q ss_pred CCCChhhHHHHhhhccCCCCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040257 1176 ADMHCGAIIGGIVKNTLRPTI-----PERCDPEWRKLMEQCWAADPEARPSFTEITS 1227 (1254)
Q Consensus 1176 ~~~n~~eliqsIlk~~Lrp~i-----pe~iS~eLrdLIkKCLqkDPeKRPSArELLe 1227 (1254)
....... ..+......... ...++.++.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 241 GDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp CSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 7654332 223332222111 1234578999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=318.39 Aligned_cols=228 Identities=25% Similarity=0.356 Sum_probs=180.4
Q ss_pred CceEE-EEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHH-hcCCCCceeEEeeeeec--
Q 040257 965 DLEEL-RELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHIL-SNLHHPNVVAFYGVVPD-- 1038 (1254)
Q Consensus 965 dYeiL-kkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeIL-krLnHPNIVkLyGvf~D-- 1038 (1254)
+|.++ +.||+|+||+||++.+ +++.||||+++.. ..+.+|+.++ +.++||||+++++++..
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 67777 7799999999999998 4778999999742 3456788877 66699999999999865
Q ss_pred CCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
.....+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~~~kl~D 163 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTD 163 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-TTCCEEECC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCC-CCCcEEEec
Confidence 22347899999999999999997653 4699999999999999999999999999999999999998322 267899999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC--C
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP--T 1195 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp--~ 1195 (1254)
||++..... ..++.++|||||||++|+|++|+.||...........+....... .
T Consensus 164 fg~a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 164 FGFAKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220 (299)
T ss_dssp CTTCEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred ccccccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence 999864321 136789999999999999999999998765443322221111111 1
Q ss_pred CC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 040257 1196 IP----ERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229 (1254)
Q Consensus 1196 ip----e~iS~eLrdLIkKCLqkDPeKRPSArELLe~L 1229 (1254)
.+ ..+++++.+||.+||+.||.+|||+.+++++-
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 12 45789999999999999999999999999863
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=340.59 Aligned_cols=253 Identities=15% Similarity=0.083 Sum_probs=187.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCC-Ccee-----------
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH-PNVV----------- 1030 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnH-PNIV----------- 1030 (1254)
.|...+.||+|+||+||+|++. ++.||||+++..... .....+.+.+|+.+++.++| .|+.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~-----~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-----PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC---------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc-----cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 4788899999999999999985 889999998743211 22234668899999999977 2111
Q ss_pred ----E------EeeeeecCC---CCceEEEEEecccCchhhhhh------ccCCCCCHHHHHHHHHHhhhhhHHhhhCCc
Q 040257 1031 ----A------FYGVVPDGT---GGTLATVTEFMVNGSLKHVLL------KKDRSLDRRKKLIIAMDAAFGMEYLHSKNI 1091 (1254)
Q Consensus 1031 ----k------LyGvf~Ddn---~~~L~LVMEYm~GGSL~d~L~------kre~~LSe~~~lkIa~QIAeALaYLHSkGI 1091 (1254)
. ++.++.... ...++++|+++ +++|.+++. .....+++..++.++.||+.||.|||++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 232 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 232 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 1 111111111 22456677764 789998883 224558888999999999999999999999
Q ss_pred ccccCCCCceEeccCCCCCCeEEEEeccccccccCccccCCCCCCCCccCcccccC--------CCCCCCchhHHHHHHH
Q 040257 1092 VHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNG--------SSNRVSEKVDVFSFGI 1163 (1254)
Q Consensus 1092 IHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG--------~~~kyS~KSDIWSLGV 1163 (1254)
|||||||+||||+ .++.+||+|||+++..... ....+| +.|+|||++.+ ....++.++|||||||
T Consensus 233 iHrDiKp~NILl~----~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 233 VHTYLRPVDIVLD----QRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp ECSCCCGGGEEEC----TTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred ccCCcccceEEEe----cCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 9999999999999 7788999999998765443 344568 99999999931 1224788999999999
Q ss_pred HHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHHHHHH
Q 040257 1164 SMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR--LRTISAAI 1236 (1254)
Q Consensus 1164 ILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~--Le~Ll~eL 1236 (1254)
+||||++|+.||...........+.. ....+++++.+||.+||+.||++||++.+++++ ++.+...+
T Consensus 306 il~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~ 374 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 374 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHHH
T ss_pred HHHHHHHCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHHH
Confidence 99999999999987655444333322 123578999999999999999999999888765 44444433
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.09 Aligned_cols=252 Identities=16% Similarity=0.165 Sum_probs=186.5
Q ss_pred ccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC---------CCceeEEe
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH---------HPNVVAFY 1033 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn---------HPNIVkLy 1033 (1254)
..+|++++.||+|+||+||+|+++++.||||++................+.+.+|+.+|+.++ ||||++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 347889999999999999999999999999999865322111111222356778888888775 66666665
Q ss_pred ee-----------------eec-----------CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHH
Q 040257 1034 GV-----------------VPD-----------GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085 (1254)
Q Consensus 1034 Gv-----------------f~D-----------dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaY 1085 (1254)
++ |.+ .....+++||||+.+|++.+.+.+ +.+++..++.|+.||+.||.|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence 54 332 014589999999999987777743 568999999999999999999
Q ss_pred hh-hCCcccccCCCCceEeccCCC----------------CCCeEEEEeccccccccCccccCCCCCCCCccCcccccCC
Q 040257 1086 LH-SKNIVHFDLKCENLLVNLRDP----------------QRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGS 1148 (1254)
Q Consensus 1086 LH-SkGIIHRDLKPeNILLDsdd~----------------snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~ 1148 (1254)
|| ++|||||||||+||||+..+. ....+||+|||+|+..... ...||+.|+|||++.+.
T Consensus 177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCC
T ss_pred HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCC
Confidence 99 999999999999999983220 1128999999999866543 24699999999999876
Q ss_pred CCCCCchhHHHHHHHH-HHHHHcCCCCCCCCCh-hhHHHHhhhcc-CCCC----CCCCCcHHHHHHHHHhhhcCCCCCCC
Q 040257 1149 SNRVSEKVDVFSFGIS-MWEILTGEEPYADMHC-GAIIGGIVKNT-LRPT----IPERCDPEWRKLMEQCWAADPEARPS 1221 (1254)
Q Consensus 1149 ~~kyS~KSDIWSLGVI-LYELLTGk~PF~~~n~-~eliqsIlk~~-Lrp~----ipe~iS~eLrdLIkKCLqkDPeKRPS 1221 (1254)
. +.++|||||+++ .+++++|..||..... ......+.... .... ....+++++++||++||++| |
T Consensus 253 ~---~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s 324 (336)
T 2vuw_A 253 G---DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S 324 (336)
T ss_dssp S---SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred C---ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence 3 889999998777 7788999999964321 11222222111 1111 12246788999999999976 9
Q ss_pred HHHHH-HH
Q 040257 1222 FTEIT-SR 1228 (1254)
Q Consensus 1222 ArELL-e~ 1228 (1254)
+.|++ ++
T Consensus 325 a~e~l~~H 332 (336)
T 2vuw_A 325 ATDLLCQH 332 (336)
T ss_dssp HHHHHHHC
T ss_pred HHHHHhcC
Confidence 99998 54
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=358.24 Aligned_cols=247 Identities=19% Similarity=0.253 Sum_probs=198.3
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC---CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR---GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r---Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
..+|++++.||+|+||+||++.+. ++.||||++.... .......+.+|+.++++++||||+++++++.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-------DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-------CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-------CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 458999999999999999999984 6789999886431 223456788999999999999999999999765
Q ss_pred CCC---ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1040 TGG---TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1040 n~~---~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
... .+|+||||+.+++|.+++.. .+++..++.|+.||+.||.|||++|||||||||+|||++ . +.+||+
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~----~-~~~kl~ 223 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----E-EQLKLI 223 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----S-SCEEEC
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe----C-CcEEEE
Confidence 421 26999999999999987743 699999999999999999999999999999999999997 3 389999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
|||+++..... ....||+.|+|||++.+. ++.++|||||||+||+|++|..||........ .....
T Consensus 224 DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------~~~~~ 289 (681)
T 2pzi_A 224 DLGAVSRINSF---GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------PEDDP 289 (681)
T ss_dssp CCTTCEETTCC---SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------CTTCH
T ss_pred ecccchhcccC---CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCcccccccc--------ccccc
Confidence 99999865443 446799999999999765 58999999999999999999998875321100 00000
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHHHHhh
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARP-SFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRP-SArELLe~Le~Ll~eLEs 1238 (1254)
....++.+.+||.+||+.||.+|| +++++...|..+..++..
T Consensus 290 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~ 332 (681)
T 2pzi_A 290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVA 332 (681)
T ss_dssp HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHhhc
Confidence 012357899999999999999999 678888888887766543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=353.41 Aligned_cols=253 Identities=24% Similarity=0.325 Sum_probs=197.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec---
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD--- 1038 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D--- 1038 (1254)
.+|++.+.||+|+||+||+|.+ .++.||||+++... .....+.+.+|+.++++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-------~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-------SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-------CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-------CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 4799999999999999999987 47789999986531 23345678899999999999999999998765
Q ss_pred -CCCCceEEEEEecccCchhhhhhccC--CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1039 -GTGGTLATVTEFMVNGSLKHVLLKKD--RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1039 -dn~~~L~LVMEYm~GGSL~d~L~kre--~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
......++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ....+||
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g-~~~~vKL 165 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP-QRLIHKI 165 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS-SSCEEEE
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC-CceeEEE
Confidence 12457899999999999999986543 2589999999999999999999999999999999999998432 3456999
Q ss_pred EeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHH---------
Q 040257 1116 GDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGG--------- 1186 (1254)
Q Consensus 1116 iDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqs--------- 1186 (1254)
+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||...........
T Consensus 166 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 166 IDLGYAKELDQGELCTEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp CSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred cccccccccccccccccccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 999999876665555667899999999999865 488999999999999999999999976432211100
Q ss_pred -----hhhccC--------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 040257 1187 -----IVKNTL--------RPTIPERCDPEWRKLMEQCWAADPEARPSFTEIT 1226 (1254)
Q Consensus 1187 -----Ilk~~L--------rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELL 1226 (1254)
...+.. ...+...++..+.+||.+||.+||++|||+.+++
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000000 0112234678899999999999999999998854
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-29 Score=296.11 Aligned_cols=191 Identities=16% Similarity=0.067 Sum_probs=132.8
Q ss_pred EEeeeCcEEEEEEEE--CCceEEEEEEeccccCC--CchhHHHHHHHHHHHHHHHhcC-CCCceeEEeeeeecCCCCceE
Q 040257 971 ELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAG--RSSEQERLTKDFWREAHILSNL-HHPNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 971 kLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~--~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyGvf~Ddn~~~L~ 1045 (1254)
.++.|++|.+..++. .|+.||+|++.+..... .....+...++|.+|+++|+++ .|+||+++++++.++. .+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~--~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ--SGW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS--EEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC--EEE
Confidence 466777777765443 58899999998654322 2223445567899999999999 7999999999998765 899
Q ss_pred EEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1046 TVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
|||||++|++|.++|... +.+++. .|+.||+.||+|||++|||||||||+||||+ .+++|||+|||+|+...
T Consensus 319 LVMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~----~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD----ARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC----TTSCEEECCCTTEESCC
T ss_pred EEEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC----CCCCEEEeecccCeeCC
Confidence 999999999999999654 557654 4789999999999999999999999999998 78899999999998654
Q ss_pred Cc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCC
Q 040257 1126 NT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEP 1174 (1254)
Q Consensus 1126 ~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~P 1174 (1254)
.. ....+.+||+.|||||++.+. +..++|+|++|+++++|.++..+
T Consensus 391 ~~~~~~~t~vGTp~YmAPE~l~g~---~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCSWPTNLVQSFFVFVNELFAEN---KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred CCCccccCceechhhccHHHhCCC---CCCcccccccccchhhhccccch
Confidence 32 233456799999999999875 56789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-26 Score=271.68 Aligned_cols=191 Identities=18% Similarity=0.166 Sum_probs=148.7
Q ss_pred EEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceEEEE
Q 040257 969 LRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVT 1048 (1254)
Q Consensus 969 LkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~LVM 1048 (1254)
.+.||+|+||+||++++.++.+++|++................+++.+|+++|++++||||+++..++.+.. ..++||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--NKRIMM 418 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--TTEEEE
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--ccEEEE
Confidence 457999999999999888999999998654333222233444677899999999999999994444433333 569999
Q ss_pred EecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCcc
Q 040257 1049 EFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL 1128 (1254)
Q Consensus 1049 EYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~ 1128 (1254)
||+.+++|.+++.. ++.++.||+.||.|||+++|+||||||+|||++ . .+||+|||+++......
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~----~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD----K--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES----S--SEEECCCTTCEECCCHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC----C--eEEEEECccCEECCCcc
Confidence 99999999999854 568999999999999999999999999999998 4 89999999998765432
Q ss_pred c--------cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 040257 1129 V--------SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYA 1176 (1254)
Q Consensus 1129 ~--------sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~ 1176 (1254)
. ....+||+.|||||++.+....|+..+|+|+..+-..+.+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1 23567999999999998644457888999999998888887776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.9e-21 Score=207.31 Aligned_cols=151 Identities=17% Similarity=0.037 Sum_probs=115.9
Q ss_pred CceEEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccCCC--chhHH--------HHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 965 DLEELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAGR--SSEQE--------RLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~~--~~e~e--------e~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
.|.+.+.||+|+||.||+|.+ .++.||||+++....... ....+ .....+.+|+.+|++++ | ++++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 567779999999999999999 477899999974321100 00000 24567889999999998 4 6666
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
+++.. ...++||||+.+++|.+ +.. .....++.||+.||.|||++||+||||||+|||++ ++.+
T Consensus 168 ~~~~~---~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-----~~~v 231 (282)
T 1zar_A 168 KVYAW---EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-----EEGI 231 (282)
T ss_dssp CEEEE---ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-----TTEE
T ss_pred eEEec---cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-----CCcE
Confidence 65543 25799999999999998 421 12446999999999999999999999999999997 4689
Q ss_pred EEEeccccccccCccccCCCCCCCCccCccccc
Q 040257 1114 KVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLN 1146 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLr 1146 (1254)
||+|||+++. +..|+|||++.
T Consensus 232 kl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 232 WIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp EECCCTTCEE------------TTSTTHHHHHH
T ss_pred EEEECCCCeE------------CCCCCHHHHHH
Confidence 9999999862 34578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.2e-18 Score=182.58 Aligned_cols=144 Identities=17% Similarity=0.072 Sum_probs=106.7
Q ss_pred CceEEEEEeeeCcEEEEEEEE--CCce--EEEEEEeccccCCCc----------------hhHHHHHHHHHHHHHHHhcC
Q 040257 965 DLEELRELGSGTYGTVYHGKW--RGSD--VAIKRIKKSCFAGRS----------------SEQERLTKDFWREAHILSNL 1024 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~--rGs~--VAIKvIkk~~~~~~~----------------~e~ee~~eqFlrEIeILkrL 1024 (1254)
-|++.+.||+|+||.||+|.+ .++. ||||+++........ .........+.+|+.+|+++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999998 6888 999998643211000 00122234678899999999
Q ss_pred CCCce--eEEeeeeecCCCCceEEEEEeccc-C----chhhhhhccCCCCCHHHHHHHHHHhhhhhHHhh-hCCcccccC
Q 040257 1025 HHPNV--VAFYGVVPDGTGGTLATVTEFMVN-G----SLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLH-SKNIVHFDL 1096 (1254)
Q Consensus 1025 nHPNI--VkLyGvf~Ddn~~~L~LVMEYm~G-G----SL~d~L~kre~~LSe~~~lkIa~QIAeALaYLH-SkGIIHRDL 1096 (1254)
.|+++ +.++.+ ...++||||+.+ | +|.++... .++..+..++.||+.+|.||| +.|||||||
T Consensus 128 ~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 87754 444433 146899999943 4 55554422 234567889999999999999 999999999
Q ss_pred CCCceEeccCCCCCCeEEEEeccccccc
Q 040257 1097 KCENLLVNLRDPQRPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1097 KPeNILLDsdd~snG~VKLiDFGLAr~~ 1124 (1254)
||+|||++ . .++|+|||+|...
T Consensus 198 kp~NILl~----~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYI----D--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEES----S--SEEECCCTTCEET
T ss_pred CHHHEEEc----C--cEEEEECcccccC
Confidence 99999998 4 8999999999653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.1e-14 Score=166.69 Aligned_cols=147 Identities=12% Similarity=0.012 Sum_probs=100.2
Q ss_pred CceEEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccC------------CCchhH--HHHHHHHHHHHHHHhcCCCCce
Q 040257 965 DLEELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFA------------GRSSEQ--ERLTKDFWREAHILSNLHHPNV 1029 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~------------~~~~e~--ee~~eqFlrEIeILkrLnHPNI 1029 (1254)
-|++.+.||+|+||.||+|.. .|+.||||+++..... ...... ........+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 489999999999999999987 5888999998643211 000000 0111122456777777754443
Q ss_pred --eEEeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC
Q 040257 1030 --VAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD 1107 (1254)
Q Consensus 1030 --VkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd 1107 (1254)
...+++. ..++||||+.|+.|..+... .....++.||+.+|.+||++|||||||||.||||+.++
T Consensus 176 ~vp~p~~~~------~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQS------RHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEEE------TTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred CCCeeeecc------CceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence 2223221 23789999999888765421 12356788999999999999999999999999998322
Q ss_pred CC------CCeEEEEeccccccc
Q 040257 1108 PQ------RPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1108 ~s------nG~VKLiDFGLAr~~ 1124 (1254)
.. ...+.|+||+.+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 10 114899999987643
|
| >2cu1_A Mitogen-activated protein kinase kinase kinase 2; PB1 domain, MAPK/ERK kinase kinase 2, MEK kinase 2, MEKK 2, signaling protein; NMR {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=99.34 E-value=3.5e-12 Score=120.44 Aligned_cols=77 Identities=19% Similarity=0.321 Sum_probs=68.0
Q ss_pred ecCceEEEeccCCCChHHHHHHHHhhcCCCceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEEEEecC
Q 040257 205 VGGETRIISLRTNLSWEELVKKTSNICNQPHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRLFLIPL 284 (1254)
Q Consensus 205 vGG~triv~V~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~FLFp~ 284 (1254)
.+||+|||.|+|.++|.||..|+.+.||..+.|.|+ +++.||+++|+|||++.||+|||.. ...-||+||-+.
T Consensus 15 ~~GEkRIi~f~RPv~f~eL~~Kv~~~fGq~ldL~y~----n~EllIpl~sQeDLDkaIellDrss---~~kSLrIlL~~~ 87 (103)
T 2cu1_A 15 HRGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT----NNELVIPLTTQDDLDKAVELLDRSI---HMKSLKILLVIN 87 (103)
T ss_dssp ETTEEEEEEEESSCCHHHHHHHHHHHHSSCEEEEEC----SSSSCEECCSHHHHHHHHHHHHHCS---SCCSEEEEEEEC
T ss_pred ecCeEEEEeccCCccHHHHHHHHHHHhCCeeeEEEe----cceEEEeccCHHHHHHHHHHHccCC---cccceEEEEecC
Confidence 367899999999999999999999999999999999 9999999999999999999999963 233578898886
Q ss_pred CCCC
Q 040257 285 SESE 288 (1254)
Q Consensus 285 ~~~~ 288 (1254)
....
T Consensus 88 ~~~~ 91 (103)
T 2cu1_A 88 GSTQ 91 (103)
T ss_dssp CCCS
T ss_pred CCCc
Confidence 5443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=6.5e-11 Score=123.45 Aligned_cols=138 Identities=17% Similarity=0.058 Sum_probs=106.5
Q ss_pred CceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCCCCc
Q 040257 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn~~~ 1043 (1254)
.|++...++.|+++.||++...+..+++|+........ ...+.+|+.+++.+. +..+.++++++.+. +.
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~ 84 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHD--GW 84 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TE
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--------HHHHHHHHHHHHHHhcCCCCCeEEEEEecC--Cc
Confidence 57788889999999999998878899999987431110 124677888888874 66788899888754 37
Q ss_pred eEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-----------------------------------
Q 040257 1044 LATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS----------------------------------- 1088 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS----------------------------------- 1088 (1254)
.++||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred eEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 899999999999887641 112234678889999999998
Q ss_pred ------------------------CCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1089 ------------------------KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1089 ------------------------kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
..++|+|++|.|||++ ....+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~----~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK----DGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE----TTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE----CCcEEEEEEchhcc
Confidence 4589999999999997 44456799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.93 E-value=2.2e-09 Score=117.75 Aligned_cols=147 Identities=18% Similarity=0.218 Sum_probs=107.7
Q ss_pred eEEEEEeeeCcEEEEEEEECCceEEEEEEe--ccccCCCchhHHHHHHHHHHHHHHHhcCC--CCceeEEeeeeecCCC-
Q 040257 967 EELRELGSGTYGTVYHGKWRGSDVAIKRIK--KSCFAGRSSEQERLTKDFWREAHILSNLH--HPNVVAFYGVVPDGTG- 1041 (1254)
Q Consensus 967 eiLkkLGeGsFGtVYlAk~rGs~VAIKvIk--k~~~~~~~~e~ee~~eqFlrEIeILkrLn--HPNIVkLyGvf~Ddn~- 1041 (1254)
..++.|+.|.++.||+....+..+++|+.. .... ......+.+|..+++.|. +..+++++.++.+...
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~-------~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~ 113 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL-------LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI 113 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSCEEEEECCCC-----------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCC-------CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence 356789999999999998888889999765 3211 011245678999998886 4567888888765432
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh---------------------------------
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS--------------------------------- 1088 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS--------------------------------- 1088 (1254)
+..++||||++|..+.+.. ...++......++.+++..|..||+
T Consensus 114 g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (359)
T 3dxp_A 114 GRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE 190 (359)
T ss_dssp SSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred CCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence 4578999999988885432 1246788888999999999999997
Q ss_pred -------------------------CCcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1089 -------------------------KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1089 -------------------------kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
..++|+|+++.|||++.++ ...+.|+||+.+....
T Consensus 191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~--~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE--PRVLAVLDWELSTLGH 250 (359)
T ss_dssp CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS--SCEEEECCCTTCEEEC
T ss_pred CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC--CcEEEEECccccccCC
Confidence 3699999999999998221 1346999999987543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.89 E-value=2e-09 Score=110.17 Aligned_cols=132 Identities=17% Similarity=0.078 Sum_probs=91.0
Q ss_pred ceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCc--eeEEeeeeecCCCC
Q 040257 966 LEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN--VVAFYGVVPDGTGG 1042 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPN--IVkLyGvf~Ddn~~ 1042 (1254)
+.+....+.|..+.||++... ++.+++|+..... ...+.+|+.+++.+.+.+ +.+++++..++ +
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~ 88 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----------LNELQDEAARLSWLATTGVPCAAVLDVVTEA--G 88 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--S
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC--C
Confidence 444333345666999998764 5679999876431 123567888888875434 56688877654 3
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCC--------------------------------
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKN-------------------------------- 1090 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkG-------------------------------- 1090 (1254)
..++||||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 89 ~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp CEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 688999999998884 211 11 1245666777777777643
Q ss_pred --------------------------cccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1091 --------------------------IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1091 --------------------------IIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
++|+|++|.|||++ .+..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~----~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE----NGRFSGFIDCGRLGV 214 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE----TTEEEEECCCTTCEE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE----CCcEEEEEcchhccc
Confidence 99999999999997 445567999999753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=4e-09 Score=113.33 Aligned_cols=190 Identities=19% Similarity=0.175 Sum_probs=120.5
Q ss_pred EEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCc--eeEEeeeeecCC-CCce
Q 040257 969 LRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPN--VVAFYGVVPDGT-GGTL 1044 (1254)
Q Consensus 969 LkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPN--IVkLyGvf~Ddn-~~~L 1044 (1254)
++.++.|....||++. ..+++|+.... .....+.+|..+|+.+. +.. +.+++.+..... ....
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~----------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~ 91 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS----------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS 91 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH----------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc----------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence 4569999999999864 56888986421 23456788999998773 322 345554433222 1245
Q ss_pred EEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh------------------------------------
Q 040257 1045 ATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS------------------------------------ 1088 (1254)
Q Consensus 1045 ~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS------------------------------------ 1088 (1254)
|+||+|++|..|..... ..++......++.+++..|..||+
T Consensus 92 ~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 92 FAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp CEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred eEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 78999999988875432 246677777777788887777775
Q ss_pred ----------------------CCcccccCCCCceEeccCCCCCCeEEEEeccccccccCccccCCCCCCCCccCccccc
Q 040257 1089 ----------------------KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLN 1146 (1254)
Q Consensus 1089 ----------------------kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLr 1146 (1254)
..++|+|++|.|||++.+ ....+.|+||+.+.................-..|+...
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~--~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE--KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT--TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC--CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHH
Confidence 237999999999999821 14568899999987654322111111000002222211
Q ss_pred C---C-CC--------CCCchhHHHHHHHHHHHHHcCCCCCC
Q 040257 1147 G---S-SN--------RVSEKVDVFSFGISMWEILTGEEPYA 1176 (1254)
Q Consensus 1147 G---~-~~--------kyS~KSDIWSLGVILYELLTGk~PF~ 1176 (1254)
. . .. ......+.|+++.++|.+.+|..+|.
T Consensus 247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0 0 00 01223689999999999999988764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=1e-05 Score=88.06 Aligned_cols=140 Identities=21% Similarity=0.199 Sum_probs=91.3
Q ss_pred EEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCC---ceeEEeeeeecCCCCce
Q 040257 968 ELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP---NVVAFYGVVPDGTGGTL 1044 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHP---NIVkLyGvf~Ddn~~~L 1044 (1254)
.++.++.|....||+. +..+++|+... ......+.+|..+|+.|.+. .+.+++.+... ..+..
T Consensus 23 ~v~~l~~G~~n~v~~v---g~~~VlR~~~~----------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~ 88 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV---NGDWVFRFPKS----------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNP 88 (306)
T ss_dssp CEEEEEECSSEEEEEE---TTTEEEEEESS----------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCE
T ss_pred eeeecCCCcceeEEEE---CCEEEEEecCC----------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCce
Confidence 4567899999999987 67889997532 12345788999999988642 35566666542 23467
Q ss_pred EEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh------------------------------------
Q 040257 1045 ATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS------------------------------------ 1088 (1254)
Q Consensus 1045 ~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS------------------------------------ 1088 (1254)
++||+|++|..|..... ..++......++.++...|..||+
T Consensus 89 ~~v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~ 165 (306)
T 3tdw_A 89 FVGYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD 165 (306)
T ss_dssp EEEEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred EEEEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence 89999999988865321 112333334444444444444442
Q ss_pred ------------------------CCcccccCCCCceEeccCCCCCCeEEEEeccccccc
Q 040257 1089 ------------------------KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK 1124 (1254)
Q Consensus 1089 ------------------------kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~ 1124 (1254)
..++|+|+++.|||++..+.....+.|+||+.+...
T Consensus 166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 246999999999999831112344589999988654
|
| >1vd2_A Protein kinase C, IOTA type; PB1 domain, OPCA motif, APKC, ZIP/P62, MEK5, molecular recognition, transferase; NMR {Homo sapiens} SCOP: d.15.2.2 PDB: 1wmh_A | Back alignment and structure |
|---|
Probab=98.11 E-value=1.8e-05 Score=74.28 Aligned_cols=80 Identities=19% Similarity=0.343 Sum_probs=67.2
Q ss_pred CcEEEEeecCCccccCCCCCCceeecCceEEEeccCCCChHHHHHHHHhhcCC----CceEEEecCCCCcCcEEeecChH
Q 040257 181 GKMKFLCSFGGKILPRPSDGKLRYVGGETRIISLRTNLSWEELVKKTSNICNQ----PHLIKYQLPGEDLDALISVSSDD 256 (1254)
Q Consensus 181 ~kvklmcSyGG~I~pr~~d~~l~YvGG~triv~V~r~~~f~~l~~kl~~~~~~----~~~lkYqLP~edLD~LiSVt~De 256 (1254)
+.||+-..|+|. .|++.|+.+++|.+|..|+.++|+. ++++||- .|| ..+|.+++|+
T Consensus 5 ~~vkvK~~~~gd----------------i~~~~v~~~i~~~~L~~kv~~~~~~~~~~~f~lky~--DEe-GD~itisSd~ 65 (89)
T 1vd2_A 5 SQVRVKAYYRGD----------------IMITHFEPSISFEGLCNEVRDMCSFDNEQLFTMKWI--DEE-GDPCTVSSQL 65 (89)
T ss_dssp SCEEEEEESSSC----------------EEEEEECTTCCHHHHHHHHHHHTTCCSSCCEEEEEC--CSS-SCCEECCSHH
T ss_pred CeEEEEEEeCCe----------------EEEEECCCCCCHHHHHHHHHHHhCCCCCCeEEEEEE--CCC-CCcccccCHH
Confidence 356766666665 7899999999999999999999984 4889998 666 8899999999
Q ss_pred HHHHHHHHhhcccccCCCceEEEEEec
Q 040257 257 DLQNMIDEYCGLERLEGSQRLRLFLIP 283 (1254)
Q Consensus 257 DL~~m~~Eydr~~~~~~~~rlR~FLFp 283 (1254)
||+..+.-|... +.++|.+.+||
T Consensus 66 EL~eAl~l~~~n----~~~~l~ihvf~ 88 (89)
T 1vd2_A 66 ELEEAFRLYELN----KDSELLIHVFP 88 (89)
T ss_dssp HHHHHHHHHHHT----SCCCEEEEEEE
T ss_pred HHHHHHHHHHcc----CCCCEEEEEcc
Confidence 999999988763 33689999998
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=3.4e-05 Score=80.62 Aligned_cols=130 Identities=20% Similarity=0.140 Sum_probs=84.4
Q ss_pred EeeeCcE-EEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCCCCceEEE
Q 040257 972 LGSGTYG-TVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGTGGTLATV 1047 (1254)
Q Consensus 972 LGeGsFG-tVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn~~~L~LV 1047 (1254)
+..|..+ .||+.... +..+++|+-... ....+.+|..+|+.|. +--+.++++++.+.. ..++|
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~--~~~lv 98 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD--DAWLL 98 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT--EEEEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC--eEEEE
Confidence 4455544 68987653 557899986532 1345678888888774 333667888877654 78899
Q ss_pred EEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhC--------------------------------------
Q 040257 1048 TEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSK-------------------------------------- 1089 (1254)
Q Consensus 1048 MEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSk-------------------------------------- 1089 (1254)
||+++|.++.+..... ......++.++...|..||..
T Consensus 99 me~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp EECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred EEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 9999988776654211 111122333344444444421
Q ss_pred --------------------CcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1090 --------------------NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1090 --------------------GIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
.++|+|+.+.|||++ ..+.+-|+||+.+..
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~----~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD----EGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE----TTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEE----CCeEEEEEECccccc
Confidence 279999999999998 555667999999854
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=2.2e-05 Score=85.82 Aligned_cols=87 Identities=8% Similarity=-0.047 Sum_probs=54.8
Q ss_pred ceEEEEE-eeeCcEEEEEEEEC--------CceEEEEEEecccc-CCCchhHHHHHHHHHHHHHHHhcCC---CCceeEE
Q 040257 966 LEELREL-GSGTYGTVYHGKWR--------GSDVAIKRIKKSCF-AGRSSEQERLTKDFWREAHILSNLH---HPNVVAF 1032 (1254)
Q Consensus 966 YeiLkkL-GeGsFGtVYlAk~r--------Gs~VAIKvIkk~~~-~~~~~e~ee~~eqFlrEIeILkrLn---HPNIVkL 1032 (1254)
...++.| +.|....+|+.... +..+++|+...... .... ...+.+|+.+++.|. ...+.++
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~------~~~~~~E~~~l~~L~~~~~vpvP~v 95 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP------TYRLDHQFEVIRLVGELTDVPVPRV 95 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS------CCCHHHHHHHHHHHHHHCCSCCCCE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc------hhHHHHHHHHHHHHhhcCCCCCCcE
Confidence 3456778 88999999988765 66788887653210 0000 123456777777663 2346777
Q ss_pred eeeeecCC-CCceEEEEEecccCchhh
Q 040257 1033 YGVVPDGT-GGTLATVTEFMVNGSLKH 1058 (1254)
Q Consensus 1033 yGvf~Ddn-~~~L~LVMEYm~GGSL~d 1058 (1254)
+.++.+.. .+..++||||++|..+.+
T Consensus 96 ~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 96 RWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred EEEccCCCccCCceEEEEecCCCChhh
Confidence 77765432 135678999998876653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00014 Score=77.60 Aligned_cols=31 Identities=23% Similarity=0.213 Sum_probs=26.6
Q ss_pred CCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1089 kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
..++|+|+++.|||++ .++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~----~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLG----ENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEEC----GGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEe----CCCcEEEEehhhccc
Confidence 5799999999999997 456799999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00014 Score=80.95 Aligned_cols=81 Identities=19% Similarity=0.102 Sum_probs=48.0
Q ss_pred EEEEEeeeCcEEEEEEEE--CCceEEEEEEecccc-CCCchhHHHHHHHHHHHHHHHhcCCC--C-ceeEEeeeeecCCC
Q 040257 968 ELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCF-AGRSSEQERLTKDFWREAHILSNLHH--P-NVVAFYGVVPDGTG 1041 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~-~~~~~e~ee~~eqFlrEIeILkrLnH--P-NIVkLyGvf~Ddn~ 1041 (1254)
.++.||.|..+.||++.. .++.++||....... ... .......++..|.++|+.+.. + .+.+++.+. ..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~--~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~- 108 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE--SWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE- 108 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC---------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT-
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCC--CCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CC-
Confidence 467899999999999964 457899998653210 000 000012345668888876632 3 344666542 22
Q ss_pred CceEEEEEecccC
Q 040257 1042 GTLATVTEFMVNG 1054 (1254)
Q Consensus 1042 ~~L~LVMEYm~GG 1054 (1254)
..++||||+.+.
T Consensus 109 -~~~lvmE~l~g~ 120 (397)
T 2olc_A 109 -MAVTVMEDLSHL 120 (397)
T ss_dssp -TTEEEECCCTTS
T ss_pred -ccEEEEEeCCCc
Confidence 357899999764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.10 E-value=0.004 Score=67.20 Aligned_cols=138 Identities=13% Similarity=0.135 Sum_probs=93.0
Q ss_pred CchhhhhhccCCCCCHHHHHHHHHHhhhhhHHh-hhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCccccCC
Q 040257 1054 GSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL-HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGG 1132 (1254)
Q Consensus 1054 GSL~d~L~kre~~LSe~~~lkIa~QIAeALaYL-HSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~sts 1132 (1254)
-+|.+++..++.++++.++|.++.|.+.+|.-+ +...-..+=+.|..|+|. .+|.|-+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~----~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW----RDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE----TTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe----cCCceeccc-cccc----------
Confidence 489999999999999999999999999998776 211212333456888888 667776653 1110
Q ss_pred CCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhh
Q 040257 1133 VRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCW 1212 (1254)
Q Consensus 1133 ~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCL 1212 (1254)
.....+.+||.... ..+.+.=|||||++||..+--.. ....+..+++.+.+||..|.
T Consensus 98 -~~~~~~~~pe~~~~---~~te~~~IysLG~tLY~ALDygL-------------------~e~eE~eLS~~LE~LL~~Mt 154 (229)
T 2yle_A 98 -AGEPPPVAGKLGYS---QCMETEVIESLGIIIYKALDYGL-------------------KENEERELSPPLEQLIDHMA 154 (229)
T ss_dssp ----------CCSSS---SSCHHHHHHHHHHHHHHHHTTTC-------------------CTTEEECCCHHHHHHHHHHT
T ss_pred -ccccCCCChhhccc---cchHHHHHHHHHHHHHHHhhcCC-------------------CcccchhhCHHHHHHHHHHH
Confidence 12234678888742 35789999999999999986332 22334457889999998887
Q ss_pred hc-------------------------CCCCCCCHHHHHHHH
Q 040257 1213 AA-------------------------DPEARPSFTEITSRL 1229 (1254)
Q Consensus 1213 qk-------------------------DPeKRPSArELLe~L 1229 (1254)
.- .+..|.++++|++..
T Consensus 155 ~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C 196 (229)
T 2yle_A 155 NTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLC 196 (229)
T ss_dssp TCCC--------------------CCSCCCCCCSHHHHHHHH
T ss_pred hcccccccccccccccccccccccccccccCcCCHHHHHHHH
Confidence 55 245788898888664
|
| >2jrh_A Mitogen-activated protein kinase kinase kinase 3; kinase signaling domain, transferase; NMR {Homo sapiens} PDB: 2pph_A | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0042 Score=58.23 Aligned_cols=71 Identities=27% Similarity=0.461 Sum_probs=61.1
Q ss_pred cCceEEEeccCCCChHHHHHHHHhhcCCCceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEEEEec
Q 040257 206 GGETRIISLRTNLSWEELVKKTSNICNQPHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRLFLIP 283 (1254)
Q Consensus 206 GG~triv~V~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~FLFp 283 (1254)
-||.||+-++|.++|.||..|+...+|..+.+-|- + =.-+|.+.|.+||+.-++-.||.. .---||+.|.-
T Consensus 12 ~gEKRIi~f~RPvkf~dl~qkv~~afGq~ldl~y~--n--nEL~iPL~~Q~DLDkAvelLDrs~---~mkSLRIlL~~ 82 (94)
T 2jrh_A 12 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM--N--NELSILLKNQDDLDKAIDILDRSS---SMKSLRILLLS 82 (94)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHCSSEEEEEE--C--SSCEEECCSHHHHHHHHHHHHHST---TTTEEEEEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe--c--ceeEEeccCHHHHHHHHHHhccCc---cccceEEEEEc
Confidence 47899999999999999999999999999999998 3 336999999999999999988843 22357887765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0068 Score=67.23 Aligned_cols=78 Identities=22% Similarity=0.181 Sum_probs=59.1
Q ss_pred ceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC---CCceeEEeeeeecCCCC
Q 040257 966 LEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH---HPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn---HPNIVkLyGvf~Ddn~~ 1042 (1254)
...++.|+.|....+|+....+..+++|+.... ....+.+|...|+.|. ...+++++.+.... +
T Consensus 38 i~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g 104 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLINDEVQTVFVKINERS-----------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--G 104 (312)
T ss_dssp CCEEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--S
T ss_pred eeeeEEeCCccceeeeEEEECCCeEEEEeCCcc-----------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--C
Confidence 445678999999999999877788999987532 1345678888888773 35677888876554 4
Q ss_pred ceEEEEEecccCch
Q 040257 1043 TLATVTEFMVNGSL 1056 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL 1056 (1254)
..++||||+++..+
T Consensus 105 ~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 105 HSFLLLEALNKSKN 118 (312)
T ss_dssp EEEEEEECCCCCCC
T ss_pred ceEEEEEeccCCCC
Confidence 78999999998765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0013 Score=70.63 Aligned_cols=71 Identities=18% Similarity=0.105 Sum_probs=42.3
Q ss_pred EEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCce-eEEeeeeecCCCCceEEE
Q 040257 969 LRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV-VAFYGVVPDGTGGTLATV 1047 (1254)
Q Consensus 969 LkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNI-VkLyGvf~Ddn~~~L~LV 1047 (1254)
++.|+.|....+|++ ..+++|+........ ....+|+.+++.+....+ .++++++.+ .-++|
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~---------~~r~~E~~~l~~l~~~g~~P~~~~~~~~----~~~~v 85 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY---------INRANEAVAAREAAKAGVSPEVLHVDPA----TGVMV 85 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----C---------CCHHHHHHHHHHHHHTTSSCCEEEECTT----TCCEE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccce---------eCHHHHHHHHHHHHHcCCCCceEEEECC----CCEEE
Confidence 678999999999998 668889876421000 011346666665532122 466655432 23578
Q ss_pred EEec-ccCch
Q 040257 1048 TEFM-VNGSL 1056 (1254)
Q Consensus 1048 MEYm-~GGSL 1056 (1254)
+||+ .+..|
T Consensus 86 ~e~i~~g~~l 95 (301)
T 3dxq_A 86 TRYIAGAQTM 95 (301)
T ss_dssp EECCTTCEEC
T ss_pred EeecCCCccC
Confidence 9999 66554
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0021 Score=72.65 Aligned_cols=80 Identities=19% Similarity=0.182 Sum_probs=48.4
Q ss_pred hhCCcccccCCCCceEeccCCCCCCeEEEEeccccccccCccccCCCC--CCCCccCcccccCCCC-CCCchhHHHHHHH
Q 040257 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVR--GTLPWMAPELLNGSSN-RVSEKVDVFSFGI 1163 (1254)
Q Consensus 1087 HSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~~sts~~--GT~~YmAPEVLrG~~~-kyS~KSDIWSLGV 1163 (1254)
+...++|+|+++.|||++ .++ ++|+||+.+............. -...|++|+....... ......++..+..
T Consensus 230 ~~~~liHGDl~~~Nil~~----~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVT----QDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIE 304 (420)
T ss_dssp BCCEEECSCCSGGGEEEC----SSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEe----CCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHH
Confidence 456899999999999997 333 9999999987544322111111 1134666655531110 1123455567787
Q ss_pred HHHHHHcC
Q 040257 1164 SMWEILTG 1171 (1254)
Q Consensus 1164 ILYELLTG 1171 (1254)
.+|+.+.+
T Consensus 305 ~~~~~y~~ 312 (420)
T 2pyw_A 305 QTWNLFNK 312 (420)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 88877654
|
| >2c60_A Human mitogen-activated protein kinase kinase kinase 3 isoform 2; MAP3K3, MAP/ERK kinase kinase 3, MAPKKK3, MEKK3, serine threonine phosphorylation; HET: MSE; 1.25A {Homo sapiens} SCOP: d.15.2.2 PDB: 2o2v_B | Back alignment and structure |
|---|
Probab=96.70 E-value=0.006 Score=58.46 Aligned_cols=70 Identities=27% Similarity=0.471 Sum_probs=59.6
Q ss_pred cCceEEEeccCCCChHHHHHHHHhhcCCCceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEEEEe
Q 040257 206 GGETRIISLRTNLSWEELVKKTSNICNQPHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRLFLI 282 (1254)
Q Consensus 206 GG~triv~V~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~FLF 282 (1254)
-||.|||-++|.++|.||..|+...+|..+.+-|- .=.-+|.+.|.|||+.-++..||... ---||+.|.
T Consensus 39 ~gEKRIiqf~RPvkf~dl~qkv~~afGq~ldl~y~----nnEL~IPL~~Q~DLDkAvelLDrs~~---mkSLRIlL~ 108 (111)
T 2c60_A 39 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM----NNELSILLKNQDDLDKAIDILDRSSS---MKSLRILLL 108 (111)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHSSCCEEEEE----CSSCEEECCSHHHHHHHHHHHHHCSS---CCSEEEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe----cceEEEecccHHHHHHHHHHhccCcc---ccceEEEEe
Confidence 36899999999999999999999999999999998 33469999999999999999988432 224777764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0026 Score=68.29 Aligned_cols=144 Identities=13% Similarity=0.104 Sum_probs=76.6
Q ss_pred ceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCc--eeEEeeeeec----C
Q 040257 966 LEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN--VVAFYGVVPD----G 1039 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPN--IVkLyGvf~D----d 1039 (1254)
...++.|+.|....+|+....+..+++|+..... ....+..|+.+++.|.... +.+++..... .
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~----------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~ 93 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV----------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 93 (322)
T ss_dssp EEEEEEECC---EEEEEEEESSCCEEEEEECC-------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred ceEeeccCCCcccceEEEEeCCccEEEEEeCCCC----------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEE
Confidence 3456778889999999998876689999886421 0123345666666553111 2333321100 0
Q ss_pred CCCceEEEEEecccCchhhh--------------hhccC----CC----CC---HHHHHH------------HHHHhhhh
Q 040257 1040 TGGTLATVTEFMVNGSLKHV--------------LLKKD----RS----LD---RRKKLI------------IAMDAAFG 1082 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~--------------L~kre----~~----LS---e~~~lk------------Ia~QIAeA 1082 (1254)
..+..+++|+|++|..+... ++... .. .. +...+. +...+...
T Consensus 94 ~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~ 173 (322)
T 2ppq_A 94 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 173 (322)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred ECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHH
Confidence 11356889999987654210 11110 00 11 111000 00012333
Q ss_pred hHHhh-------hCCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1083 MEYLH-------SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1083 LaYLH-------SkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
+.+|+ ..+++|+|+.+.|||++ .+..+.|+||+.+..
T Consensus 174 ~~~l~~~~~~~~~~~liHgDl~~~Nil~~----~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 174 IDYLAAHWPKDLPAGVIHADLFQDNVFFL----GDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEE----TTEEEEECCCTTCEE
T ss_pred HHHHHhhCcccCCcccCCCCCCccCEEEe----CCceEEEecchhccC
Confidence 44444 24799999999999998 444557999998753
|
| >2npt_B Mitogen-activated protein kinase kinase kinase 2; MAP2K5, MEK5, MKK PRKMK5, MAP kinase kinase 5, PHOX, PHOX-domain; 1.75A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0052 Score=58.19 Aligned_cols=70 Identities=21% Similarity=0.372 Sum_probs=59.5
Q ss_pred cCceEEEeccCCCChHHHHHHHHhhcCCCceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEEEEe
Q 040257 206 GGETRIISLRTNLSWEELVKKTSNICNQPHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRLFLI 282 (1254)
Q Consensus 206 GG~triv~V~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~FLF 282 (1254)
-||.||+-++|.+.|.||..|+...||..+.+-|- + =.-+|.+.|.+||+.-|+-.||... ---||+.|.
T Consensus 28 ~gEkRIi~f~RPv~f~el~~kv~~afGq~ldl~y~--n--nEL~iPL~~Q~DLDkAvelLDrs~~---~kSLrIlL~ 97 (100)
T 2npt_B 28 RGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT--N--NELVIPLTTQDDLDKAVELLDRSIH---MKSLKILLV 97 (100)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHTSCEEEEEE--E--TTEEEECCCHHHHHHHHHHHHHCSS---CCSEEEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe--c--ceeEEecccHHHHHHHHHHhccCcc---ccceEEEEe
Confidence 36799999999999999999999999999999998 3 3369999999999999999988432 224777764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0077 Score=69.14 Aligned_cols=73 Identities=12% Similarity=0.253 Sum_probs=48.2
Q ss_pred EEEEEeeeCcEEEEEEEEC---------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCc-eeEEeeeee
Q 040257 968 ELRELGSGTYGTVYHGKWR---------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN-VVAFYGVVP 1037 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~r---------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPN-IVkLyGvf~ 1037 (1254)
.++.|+.|....||++... +..+++|+..... . ...+.+|..+++.|...+ ..++++.+.
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-------~---~~~li~E~~~l~~L~~~g~~P~l~~~~~ 146 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-------T---ESHLVAESVIFTLLSERHLGPKLYGIFS 146 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-------C---HHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-------c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC
Confidence 4567889999999999874 3678889874210 0 123446888887774222 367777663
Q ss_pred cCCCCceEEEEEecccCch
Q 040257 1038 DGTGGTLATVTEFMVNGSL 1056 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL 1056 (1254)
+ .+|+||++|..|
T Consensus 147 ~------g~v~e~l~G~~l 159 (429)
T 1nw1_A 147 G------GRLEEYIPSRPL 159 (429)
T ss_dssp T------EEEECCCCEEEC
T ss_pred C------CEEEEEeCCccc
Confidence 2 278999987544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.29 E-value=0.012 Score=62.83 Aligned_cols=78 Identities=19% Similarity=0.159 Sum_probs=52.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-C--CceeEEeeeeecC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-H--PNVVAFYGVVPDG 1039 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-H--PNIVkLyGvf~Dd 1039 (1254)
.+..-+..+|.|..+.||+.+. +|+.|++|+....... ....|.+|...|+.|. . --+.+++++.
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~--------~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA--------LDGLFRAEALGLDWLGRSFGSPVPQVAGWD--- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC--------CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc--------hhhHHHHHHHHHHHHHhhCCCCcceEEecc---
Confidence 3556678899999999999998 5788999976533111 0123567888887763 1 2345555542
Q ss_pred CCCceEEEEEecccCc
Q 040257 1040 TGGTLATVTEFMVNGS 1055 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGS 1055 (1254)
.-++||||+.++.
T Consensus 84 ---~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 84 ---DRTLAMEWVDERP 96 (288)
T ss_dssp ---TTEEEEECCCCCC
T ss_pred ---CceEEEEeecccC
Confidence 2367999987664
|
| >1q1o_A Cell division control protein 24; PB1 domain, PCCR, PC motif, OPCA motif, yeast, cell polarity, protein-protein interaction; NMR {Saccharomyces cerevisiae} SCOP: d.15.2.2 PDB: 2kfj_A 2kfk_B | Back alignment and structure |
|---|
Probab=96.01 E-value=0.019 Score=54.92 Aligned_cols=85 Identities=19% Similarity=0.271 Sum_probs=60.4
Q ss_pred CcEEEEeecCCccccCCCCCCceeecCceEEEeccCCCChHHHHHHHHhhcCC--------CceEEEecCCCCcC-cEEe
Q 040257 181 GKMKFLCSFGGKILPRPSDGKLRYVGGETRIISLRTNLSWEELVKKTSNICNQ--------PHLIKYQLPGEDLD-ALIS 251 (1254)
Q Consensus 181 ~kvklmcSyGG~I~pr~~d~~l~YvGG~triv~V~r~~~f~~l~~kl~~~~~~--------~~~lkYqLP~edLD-~LiS 251 (1254)
+.||+-++|+.- ..- -.-++++.+.|+.+|+|.+|..|+.+-++. .+.|||| |-| ..|.
T Consensus 4 ~sikVKv~y~~~-------~~~-~~~~d~~~i~V~~~i~f~~L~~kI~~Kl~~~~~~~i~~~~klkYk----DEdGD~Vt 71 (98)
T 1q1o_A 4 GSILFRISYNNN-------SNN-TSSSEIFTLLVEKVWNFDDLIMAINSKISNTHNNNISPITKIKYQ----DEDGDFVV 71 (98)
T ss_dssp SCEEEEEEECSS-------CSS-CCCCEEEEEEECTTCCHHHHHHHHHHHHHHHCSSCCCCCCCEEEE----CSSSCEEE
T ss_pred ccEEEEEEecCc-------ccc-cccCcEEEEEecCCCCHHHHHHHHHHHHcCCccccccceeEEEEE----cCCCCEEE
Confidence 357777777732 000 001588999999999999999999886652 3679999 334 6999
Q ss_pred ecChHHHHHHHHHhhcccccCCCceEEEEE
Q 040257 252 VSSDDDLQNMIDEYCGLERLEGSQRLRLFL 281 (1254)
Q Consensus 252 Vt~DeDL~~m~~Eydr~~~~~~~~rlR~FL 281 (1254)
+.+||||+-.+++.... +.++|-+.+
T Consensus 72 l~sddDl~~A~e~~~e~----~~~~l~Iwv 97 (98)
T 1q1o_A 72 LGSDEDWNVAKEMLAEN----NEKFLNIRL 97 (98)
T ss_dssp ECSHHHHHHHHHHHHHT----TCCEEEEEE
T ss_pred EcCHHHHHHHHHHHHhh----hcCeEEEEE
Confidence 99999999999887332 235555544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.93 E-value=0.019 Score=63.41 Aligned_cols=74 Identities=11% Similarity=0.168 Sum_probs=42.0
Q ss_pred EEEEEeeeCcEEEEEEEECC----------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCc-eeEEeeee
Q 040257 968 ELRELGSGTYGTVYHGKWRG----------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPN-VVAFYGVV 1036 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~rG----------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPN-IVkLyGvf 1036 (1254)
.+..|+.|....+|++...+ ..+++|+.....- .. .....|..+++.|...+ +.++++.+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--------~~-~~~~~E~~~l~~L~~~g~~P~~~~~~ 107 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--------EL-YNTISEFEVYKTMSKYKIAPQLLNTF 107 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--------GT-SCHHHHHHHHHHHHHTTSSCCEEEEE
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--------ce-ecHHHHHHHHHHHHhcCCCCceEEec
Confidence 35678889999999998754 5788887653210 00 01245677776663222 44666554
Q ss_pred ecCCCCceEEEEEecccCch
Q 040257 1037 PDGTGGTLATVTEFMVNGSL 1056 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL 1056 (1254)
. -++||+|++|..+
T Consensus 108 --~----~~~v~e~i~G~~l 121 (369)
T 3c5i_A 108 --N----GGRIEEWLYGDPL 121 (369)
T ss_dssp --T----TEEEEECCCSEEC
T ss_pred --C----CcEEEEEecCCcC
Confidence 1 1579999987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.90 E-value=0.01 Score=64.38 Aligned_cols=39 Identities=23% Similarity=0.196 Sum_probs=28.8
Q ss_pred hCCcccccCCCCceEeccCCCCCCeEEEEeccccccccC
Q 040257 1088 SKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN 1126 (1254)
Q Consensus 1088 SkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~ 1126 (1254)
...++|+|+.+.|||++.+......+.|+||+.+.....
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 357999999999999972111125789999999875443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.70 E-value=0.016 Score=66.16 Aligned_cols=150 Identities=14% Similarity=0.152 Sum_probs=82.6
Q ss_pred cccccccCceEEEEEeeeCcEEEEEEEEC---------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CC
Q 040257 958 LQIIKNVDLEELRELGSGTYGTVYHGKWR---------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HP 1027 (1254)
Q Consensus 958 lq~Ik~~dYeiLkkLGeGsFGtVYlAk~r---------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HP 1027 (1254)
+..+....++ ++.|..|....+|++... +..+++|+.-.. . .....+.+|..+++.|. +.
T Consensus 45 W~~~~~~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~--------~~~~~~~rE~~vl~~L~~~g 114 (379)
T 3feg_A 45 WRRVQPEELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L--------QGVDSLVLESVMFAILAERS 114 (379)
T ss_dssp GGGCCGGGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------------CCHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCcCceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c--------chHHHHHHHHHHHHHHHhcC
Confidence 3344444555 456878888999998863 357888875321 0 01234457888887773 22
Q ss_pred ceeEEeeeeecCCCCceEEEEEecccCchhhh-----------------hhcc----CCCCC--HHHHHHHHHHhhh---
Q 040257 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHV-----------------LLKK----DRSLD--RRKKLIIAMDAAF--- 1081 (1254)
Q Consensus 1028 NIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~-----------------L~kr----e~~LS--e~~~lkIa~QIAe--- 1081 (1254)
-..++++++.+ .+||||++|..|... ++.. .+... +.++..+..++..
T Consensus 115 v~P~ll~~~~~------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~ 188 (379)
T 3feg_A 115 LGPQLYGVFPE------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPP 188 (379)
T ss_dssp SSCCEEEEETT------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCC
T ss_pred CCCeEEEEcCC------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccC
Confidence 23667777642 279999988665421 0111 11122 3344445443321
Q ss_pred ----------------hhHHhh----h----CCcccccCCCCceEeccCCCCCCeEEEEecccccc
Q 040257 1082 ----------------GMEYLH----S----KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1082 ----------------ALaYLH----S----kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~ 1123 (1254)
.+..|. . ..++|+|+.+.|||++.++...+.+.|+||..+..
T Consensus 189 ~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 189 TGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred cccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 123332 2 25999999999999983211236899999998863
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.63 E-value=0.036 Score=59.65 Aligned_cols=75 Identities=15% Similarity=0.115 Sum_probs=44.7
Q ss_pred EEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCC--CceeEEeeeeecCC-----C
Q 040257 970 RELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH--PNVVAFYGVVPDGT-----G 1041 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnH--PNIVkLyGvf~Ddn-----~ 1041 (1254)
..|+ |....||++... ++.+++|+...... . ...+..|..+++.|.. -.+++++.. ++. .
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~------~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~ 99 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---T------ADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQ 99 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---C------HHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEET
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---C------HHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEEC
Confidence 4566 888899988764 55799999863211 0 1344557777666632 124444443 111 2
Q ss_pred CceEEEEEecccCch
Q 040257 1042 GTLATVTEFMVNGSL 1056 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL 1056 (1254)
+..+++|+|++|..+
T Consensus 100 g~~~~l~~~i~G~~~ 114 (328)
T 1zyl_A 100 GFYFAVFPSVGGRQF 114 (328)
T ss_dssp TEEEEEEECCCCEEC
T ss_pred CEEEEEEEecCCCCC
Confidence 356789999987544
|
| >2kkc_A Sequestosome-1; P62, PB1, autophagy, ubiquitin-proteasome system, NF-KB signaling, alternative splicing, apoptosis, cytoplasm, differentiation; NMR {Rattus norvegicus} PDB: 2ktr_B | Back alignment and structure |
|---|
Probab=95.12 E-value=0.057 Score=51.93 Aligned_cols=68 Identities=19% Similarity=0.281 Sum_probs=54.2
Q ss_pred ecCceEEEeccCC-----------CChHHHHHHHHhhc----CCCceEEEecCCCCcCcEEeecChHHHHHHHHHhhccc
Q 040257 205 VGGETRIISLRTN-----------LSWEELVKKTSNIC----NQPHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLE 269 (1254)
Q Consensus 205 vGG~triv~V~r~-----------~~f~~l~~kl~~~~----~~~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~ 269 (1254)
.|.|.|=.+++++ .+|.+|..++.++| +..+.|||. .| =.-||.+++||||...+..-
T Consensus 18 ~~~EiRRF~l~~~~~p~~~~~~~~~s~~~L~~~V~~lFp~l~~~~f~l~Y~--De-dGDlItiSsDeEL~~Al~~~---- 90 (102)
T 2kkc_A 18 AAREIRRFSFCFSPEPEAEAAAGPGPCERLLSRVAVLFPALRPGGFQAHYR--AE-RGDLVAFSSDEELTMAMSYV---- 90 (102)
T ss_dssp CEEEEEEEEEESSSCSCSSSCCSCCHHHHHHHHHHHHCTTSCSSCEEEEEE--CT-TCCEEEECSHHHHHHHHHHC----
T ss_pred CCCceEEEEeccCCCcccccccccccHHHHHHHHHHHccccCCCcEEEEEE--CC-CCCEEEecCHHHHHHHHHhc----
Confidence 4789999999874 48999999999998 456899999 22 24499999999999888753
Q ss_pred ccCCCceEEEEEe
Q 040257 270 RLEGSQRLRLFLI 282 (1254)
Q Consensus 270 ~~~~~~rlR~FLF 282 (1254)
...-||||+-
T Consensus 91 ---~~~~lRlyVk 100 (102)
T 2kkc_A 91 ---KDDIFRIYIK 100 (102)
T ss_dssp ---CSSEEEEEEE
T ss_pred ---CCCeEEEEEE
Confidence 1357899873
|
| >2ktr_A Sequestosome-1; autophagy, NF-KB signaling, HOMO-oligomer, PB1 dimer, signaling protein, transport protein; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=94.94 E-value=0.052 Score=53.36 Aligned_cols=68 Identities=19% Similarity=0.270 Sum_probs=53.9
Q ss_pred ecCceEEEeccCC-----------CChHHHHHHHHhhc----CCCceEEEecCCCCcCcEEeecChHHHHHHHHHhhccc
Q 040257 205 VGGETRIISLRTN-----------LSWEELVKKTSNIC----NQPHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLE 269 (1254)
Q Consensus 205 vGG~triv~V~r~-----------~~f~~l~~kl~~~~----~~~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~ 269 (1254)
.++|.|-.+++++ .+|..|..++.+++ +..+.|||. .| =.-||.+++||||..-+..-
T Consensus 33 ~~~EIRRF~l~~~~~p~~~~~~~~~s~~~L~~kV~~lFp~L~~~~f~l~Yk--DE-dGDlItISsDeEL~~Al~~~---- 105 (117)
T 2ktr_A 33 AAREIRRFSFCFSPEPEAEAAAGPGPSERLLSRVAVLFPALRPGGFQAHYR--AE-RGDLVAFSSDEELTMAMSYV---- 105 (117)
T ss_dssp CEEEEEEEEECSSSCSCSSSCCSCCHHHHHHHHHHHHCTTSCSSCEEEEEE--CT-TCCEEEECSHHHHHHHHHHC----
T ss_pred CCCcEEEEEeccCCCccccccccCCCHHHHHHHHHHHccccCCCcEEEEEE--CC-CCCEEEecCHHHHHHHHHhc----
Confidence 3589999999864 39999999999999 456899999 22 24499999999999888753
Q ss_pred ccCCCceEEEEEe
Q 040257 270 RLEGSQRLRLFLI 282 (1254)
Q Consensus 270 ~~~~~~rlR~FLF 282 (1254)
...-||||+-
T Consensus 106 ---~~~~lRlyVk 115 (117)
T 2ktr_A 106 ---KDDIFRIYIK 115 (117)
T ss_dssp ---CSSEEEEEEE
T ss_pred ---CCCeEEEEEE
Confidence 1357899873
|
| >1pqs_A Cell division control protein 24; alpha and beta protein, cell cycle; NMR {Saccharomyces cerevisiae} SCOP: d.15.2.2 PDB: 1tz1_A | Back alignment and structure |
|---|
Probab=94.86 E-value=0.05 Score=49.91 Aligned_cols=68 Identities=18% Similarity=0.224 Sum_probs=53.8
Q ss_pred ceEEEeccCCCChHHHHHHHHhhcCC--------CceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEE
Q 040257 208 ETRIISLRTNLSWEELVKKTSNICNQ--------PHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRL 279 (1254)
Q Consensus 208 ~triv~V~r~~~f~~l~~kl~~~~~~--------~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~ 279 (1254)
+++.|.|+.+|+|.+|..|+.+-++. .+.|||| .| =+..|++.+||||.--++..... +.++|-+
T Consensus 2 D~~~i~V~~~i~f~~L~~kI~~kl~~~~~~~~~~~~~lkYk--DE-dGD~Vti~sddDl~~A~~~~~~~----~~~~lei 74 (77)
T 1pqs_A 2 EIFTLLVEKVWNFDDLIMAINSKISNTHNNNISPITKIKYQ--DE-DGDFVVLGSDEDWNVAKEMLAEN----NEKFLNI 74 (77)
T ss_dssp CEEEEECTTCCCSHHHHHHHHHHTTTTTSSCSCSTTCCEEE--ET-TTEEEECCSTTHHHHHHHHHHHH----CCCEEEE
T ss_pred CEEEEEeCCCCCHHHHHHHHHHHHcccccccccceeEEEEE--cC-CCCEEEEcCHHHHHHHHHHHHhh----hcCeEEE
Confidence 68999999999999999999987762 3679999 33 34699999999999888876322 2467777
Q ss_pred EEe
Q 040257 280 FLI 282 (1254)
Q Consensus 280 FLF 282 (1254)
.+|
T Consensus 75 Wv~ 77 (77)
T 1pqs_A 75 RLY 77 (77)
T ss_dssp ECC
T ss_pred EEC
Confidence 665
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=94.12 E-value=0.29 Score=57.07 Aligned_cols=75 Identities=19% Similarity=0.152 Sum_probs=47.7
Q ss_pred eEEEEEeeeCcEEEEEEEECC--ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCce-eEEeeeeecCCCCc
Q 040257 967 EELRELGSGTYGTVYHGKWRG--SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV-VAFYGVVPDGTGGT 1043 (1254)
Q Consensus 967 eiLkkLGeGsFGtVYlAk~rG--s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNI-VkLyGvf~Ddn~~~ 1043 (1254)
-.++.|+.|....+|++...+ ..+++|+..... ... . .-.+|..+++.|...++ .++++++. +
T Consensus 111 ~~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~-------i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--- 176 (458)
T 2qg7_A 111 LEFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEI-------I-NREREKKISCILYNKNIAKKIYVFFT--N--- 176 (458)
T ss_dssp EEEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSC-------S-CHHHHHHHHHHHTTSSSBCCEEEEET--T---
T ss_pred eEEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhh-------c-CHHHHHHHHHHHHhcCCCCCEEEEeC--C---
Confidence 346679999999999999876 778899874321 000 0 01367888887754334 57777763 2
Q ss_pred eEEEEEecccCch
Q 040257 1044 LATVTEFMVNGSL 1056 (1254)
Q Consensus 1044 L~LVMEYm~GGSL 1056 (1254)
.+||||++|..|
T Consensus 177 -G~v~e~I~G~~l 188 (458)
T 2qg7_A 177 -GRIEEFMDGYAL 188 (458)
T ss_dssp -EEEEECCCSEEC
T ss_pred -eEEEEeeCCccC
Confidence 249999987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=93.70 E-value=0.21 Score=55.24 Aligned_cols=34 Identities=18% Similarity=0.234 Sum_probs=28.1
Q ss_pred CCcccccCCCCceEeccCCCCCCeEEEEeccccccccC
Q 040257 1089 KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN 1126 (1254)
Q Consensus 1089 kGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~ 1126 (1254)
..++|+|+.+.|||++ .++.+.|+||+.+.....
T Consensus 206 ~~~~HgD~~~~N~l~~----~~~~~~~iD~e~~~~~~~ 239 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVG----NEESIYIIDWDEPMLAPK 239 (339)
T ss_dssp CEEECSCCCGGGEEEC----GGGCEEECCCSSCEEECT
T ss_pred ceeEeCCCCcCCEEEe----CCCeEEEEECCCCeeCCH
Confidence 4699999999999997 456799999998875443
|
| >1oey_A P67-PHOX, neutrophil cytosol factor 2; immune system, PB1 heterodimer/complex, NADPH oxidase, PB1 D heterodimerization; 2.0A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=92.42 E-value=0.2 Score=46.65 Aligned_cols=69 Identities=16% Similarity=0.254 Sum_probs=52.9
Q ss_pred ceeecCceEEEeccCCCChHHHHHHHHhhcCCC---ceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEE
Q 040257 202 LRYVGGETRIISLRTNLSWEELVKKTSNICNQP---HLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLR 278 (1254)
Q Consensus 202 l~YvGG~triv~V~r~~~f~~l~~kl~~~~~~~---~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR 278 (1254)
.+|- .|..|.|+++++|++|..||++-.+.. ..|.|.=+ |=..++ +.+||||+.++..- +.+||+
T Consensus 10 V~~~--~tvairvp~~~~y~~L~~~l~~kL~l~~~~~~LsYk~~--~s~~~v-i~~d~dl~~aw~~~-------~n~~Lt 77 (83)
T 1oey_A 10 VHYK--YTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPR--DSNELV-PLSEDSMKDAWGQV-------KNYCLT 77 (83)
T ss_dssp EESS--SEEEEEECTTCCHHHHHHHHHHHTTCCGGGCCEEECCT--TCSSCE-ECCTTTHHHHHTTC-------BTTEEE
T ss_pred EEEE--EEEEEECCCCCCHHHHHHHHHHHhCCCcceeEEEeeCC--CCCCee-ccChHHHHHHHHhc-------cCCcEE
Confidence 3455 799999999999999999999988764 56888854 556677 99999999887431 224787
Q ss_pred EEEe
Q 040257 279 LFLI 282 (1254)
Q Consensus 279 ~FLF 282 (1254)
|+..
T Consensus 78 L~C~ 81 (83)
T 1oey_A 78 LWCE 81 (83)
T ss_dssp EEEC
T ss_pred EEEe
Confidence 7653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.32 E-value=0.46 Score=55.07 Aligned_cols=74 Identities=15% Similarity=0.094 Sum_probs=46.1
Q ss_pred EEEEEeeeCcEEEEEEEEC---------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeee
Q 040257 968 ELRELGSGTYGTVYHGKWR---------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVP 1037 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~r---------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~ 1037 (1254)
.++.|..|....+|++... +..+++|+.....-.. -...+|..+++.|. +.-..++++.+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~---------idR~~E~~~l~~L~~~gi~P~l~~~~~ 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF---------YDSKVELDVFRYLSNINIAPNIIADFP 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC---------CCHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh---------cCHHHHHHHHHHHHhcCCCCCEEEEcC
Confidence 4567888999999999876 5778988864321000 01135666666663 222456665442
Q ss_pred cCCCCceEEEEEecccCch
Q 040257 1038 DGTGGTLATVTEFMVNGSL 1056 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL 1056 (1254)
-++||+|++|..|
T Consensus 145 ------~~~I~efI~G~~l 157 (424)
T 3mes_A 145 ------EGRIEEFIDGEPL 157 (424)
T ss_dssp ------TEEEEECCCSEEC
T ss_pred ------CCEEEEEeCCccC
Confidence 2678999988654
|
| >1wmh_B Partitioning defective-6 homolog alpha; kinase, PB1 domain, OPCA motif, APKC, cell polarity, transferase/cell cycle complex; 1.50A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=90.96 E-value=0.64 Score=43.59 Aligned_cols=67 Identities=21% Similarity=0.365 Sum_probs=51.0
Q ss_pred eecCceEEEeccCC--CChHHHHHHHHhhcC---CCceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEE
Q 040257 204 YVGGETRIISLRTN--LSWEELVKKTSNICN---QPHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLR 278 (1254)
Q Consensus 204 YvGG~triv~V~r~--~~f~~l~~kl~~~~~---~~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR 278 (1254)
.-|+|.|=.+++|+ .+|.+|..++..+.. .++.|.|.= +| ..||.+++||+|..-+. .+.+-||
T Consensus 12 kf~aE~RRFs~d~~~~~~fe~f~~lv~~lh~L~~~~f~i~Y~D--~d-GDLlpInnDdnl~~Al~--------~a~plLR 80 (86)
T 1wmh_B 12 KFDAEFRRFALPRASVSGFQEFSRLLRAVHQIPGLDVLLGYTD--AH-GDLLPLTNDDSLHRALA--------SGPPPLR 80 (86)
T ss_dssp EETTEEEEEEEEGGGCCCHHHHHHHHHHHTTCTTCCCEEEEEC--TT-SCEEECCSHHHHHHHTT--------SSSSCEE
T ss_pred ecCCeeeEeEccCCCCCCHHHHHHHHHHHcCCCCCCEEEEEEC--CC-CCEeeecCHHHHHHHHH--------hCCCcEE
Confidence 45788899999877 899999999999874 458899993 33 45999999998864332 1234799
Q ss_pred EEE
Q 040257 279 LFL 281 (1254)
Q Consensus 279 ~FL 281 (1254)
||+
T Consensus 81 l~I 83 (86)
T 1wmh_B 81 LLV 83 (86)
T ss_dssp EEE
T ss_pred EEE
Confidence 987
|
| >2bkf_A Zinc-finger protein NBR1 (NEXT to breast cancer 1; PB1 domain, interaction domain, Z finger; 1.56A {Homo sapiens} SCOP: d.15.2.2 PDB: 2g4s_A | Back alignment and structure |
|---|
Probab=88.72 E-value=1.8 Score=40.69 Aligned_cols=69 Identities=14% Similarity=0.233 Sum_probs=50.7
Q ss_pred cCceEE--EeccCCCChHHHHHHHHhhcCCC-ceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEEEEe
Q 040257 206 GGETRI--ISLRTNLSWEELVKKTSNICNQP-HLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRLFLI 282 (1254)
Q Consensus 206 GG~tri--v~V~r~~~f~~l~~kl~~~~~~~-~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~FLF 282 (1254)
.|+++. |+-.|.++|.+|.+.+...||.+ +.|||- ++=+-.|+|+++++++.++.-+ .. ....||+++|
T Consensus 14 ~ge~~rf~vs~~~~~tweel~~mvk~~f~L~~~~ikY~---DEenD~v~i~Sq~E~eEAlkva----~k-~~n~L~m~v~ 85 (87)
T 2bkf_A 14 KNEIQSFLVSDPENTTWADIEAMVKVSFDLNTIQIKYL---DEENEEVSINSQGEYEEALKMA----VK-QGNQLQMQVH 85 (87)
T ss_dssp TTEEEEEEESCGGGCCHHHHHHHHHHHHTCSSEEEEEE---CTTSCEEEECSHHHHHHHHHHH----HH-TTTEEEEEEE
T ss_pred cCCeeEEEeccCCCCCHHHHHHHHHHHcCCCceEEEEE---cCCCCEEEEecHHHHHHHHHHh----cc-CCCEEEEEEe
Confidence 355666 44578999999999999999965 889997 3345699999999987776643 22 2235777765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.79 E-value=0.71 Score=52.22 Aligned_cols=34 Identities=21% Similarity=0.169 Sum_probs=26.3
Q ss_pred CcccccCCCCceEeccCC--CCCCeEEEEecccccc
Q 040257 1090 NIVHFDLKCENLLVNLRD--PQRPICKVGDFGLSRI 1123 (1254)
Q Consensus 1090 GIIHRDLKPeNILLDsdd--~snG~VKLiDFGLAr~ 1123 (1254)
.++|+|+.+.|||+.... .....++|+||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 368999999999995211 2456899999999864
|
| >1oey_J P40-PHOX, neutrophil cytosol factor 4; immune system, PB1 heterodimer/complex, NADPH oxidase, PB1 D heterodimerization; 2.0A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=87.68 E-value=1.2 Score=42.96 Aligned_cols=59 Identities=20% Similarity=0.305 Sum_probs=47.3
Q ss_pred cCceEEEeccCCC----ChHHHHHHHHhhcCCC-ceEEEecCCCCcCcEEeecChHHHHHHHHHhhc
Q 040257 206 GGETRIISLRTNL----SWEELVKKTSNICNQP-HLIKYQLPGEDLDALISVSSDDDLQNMIDEYCG 267 (1254)
Q Consensus 206 GG~triv~V~r~~----~f~~l~~kl~~~~~~~-~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr 267 (1254)
|-.+|=|+|.-++ +|.||+..+...+... +.|+|+=+..| ||-+-+|||+..|+.+-..
T Consensus 17 ~~~irdI~veedl~~~P~ykdLl~lmr~~F~~~DIaLNYrD~eGD---LIrilddeDv~lmi~~sr~ 80 (107)
T 1oey_J 17 ISTIKDIAVEEDLSSTPLLKDLLELTRREFQREDIALNYRDAEGD---LVRLLSDEDVALMVRQARG 80 (107)
T ss_dssp EEEEEEEEECSCTTCCCCHHHHHHHHHHHHCCSSEEEEEECTTSC---EEECCSHHHHHHHHHHCCC
T ss_pred CceeeeEEEccccccCCCHHHHHHHHHHHhcccceeeeeecCCCC---EEEEcchHHHHHHHHHhhc
Confidence 5567778886554 7999999999998765 88999944433 8999999999999998733
|
| >1ip9_A BEM1 protein; ubiquitin alpha/beta roll, signaling protein; NMR {Saccharomyces cerevisiae} SCOP: d.15.2.2 PDB: 1ipg_A 2kfk_A | Back alignment and structure |
|---|
Probab=87.10 E-value=2.8 Score=39.28 Aligned_cols=65 Identities=15% Similarity=0.252 Sum_probs=48.4
Q ss_pred CcEEEEeecCCccccCCCCCCceeecCceEEEeccCCCChHHHHHHHHhhcCC-CceEEEecCCCCcCcEEeecChHHHH
Q 040257 181 GKMKFLCSFGGKILPRPSDGKLRYVGGETRIISLRTNLSWEELVKKTSNICNQ-PHLIKYQLPGEDLDALISVSSDDDLQ 259 (1254)
Q Consensus 181 ~kvklmcSyGG~I~pr~~d~~l~YvGG~triv~V~r~~~f~~l~~kl~~~~~~-~~~lkYqLP~edLD~LiSVt~DeDL~ 259 (1254)
+++|+-..|.+-| -+|.||-+|+|.+|..||..-... .+.+.+-. +|.... .+.+|+||.
T Consensus 11 ~~~KVK~yy~DDI----------------iAIrvP~di~~~~L~dKi~~RLk~~~~~l~~yk-de~~g~--~i~sD~dl~ 71 (85)
T 1ip9_A 11 KTTKIKFYYKDDI----------------FALMLKGDTTYKELRSKIAPRIDTDNFKLQTKL-FDGSGE--EIKTDSQVS 71 (85)
T ss_dssp CCEEEEECBTTCC----------------EEEEECSCCCHHHHHHHHHHHHTSSCEEEEECC-SSSCCS--CCCSHHHHH
T ss_pred CceEEEEEecCcE----------------EEEECCCCCCHHHHHHHHHHHhcccceEEEEec-CCCCCC--cccCHHHHH
Confidence 4566666665555 489999999999999999997765 34433333 665655 999999999
Q ss_pred HHHHH
Q 040257 260 NMIDE 264 (1254)
Q Consensus 260 ~m~~E 264 (1254)
.-|..
T Consensus 72 ~aiqr 76 (85)
T 1ip9_A 72 NIIQA 76 (85)
T ss_dssp HHHHT
T ss_pred HHHHh
Confidence 98865
|
| >1wj6_A KIAA0049 protein, RSGI RUH-024; PB1 domain, protein binding, structural genomics, riken structural genomics/proteomics initiative; NMR {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=84.86 E-value=2.3 Score=40.98 Aligned_cols=85 Identities=14% Similarity=0.298 Sum_probs=62.6
Q ss_pred CCccccCCCCCcEEEEeecCCccccCCCCCCceeecCceEE--EeccCCCChHHHHHHHHhhcCCC-ceEEEecCCCCcC
Q 040257 171 GPRVLGRSQSGKMKFLCSFGGKILPRPSDGKLRYVGGETRI--ISLRTNLSWEELVKKTSNICNQP-HLIKYQLPGEDLD 247 (1254)
Q Consensus 171 ~p~~~~~~~~~kvklmcSyGG~I~pr~~d~~l~YvGG~tri--v~V~r~~~f~~l~~kl~~~~~~~-~~lkYqLP~edLD 247 (1254)
||++|+ ..|.|-+.|.|+ ++. |+-.|.++|.||.+.+...||.. +.|||- +|=+
T Consensus 7 ~~~~m~----~~v~lkV~f~ge----------------~~rF~Vs~~~~~tweel~~mvk~~f~L~~~~IkY~---DEen 63 (101)
T 1wj6_A 7 GPHSME----PQVTLNVTFKNE----------------IQSFLVSDPENTTWADIEAMVKVSFDLNTIQIKYL---DEEN 63 (101)
T ss_dssp CCCSSC----SCEEEEEEETTE----------------EEEEEESCTTTSCHHHHHHHHHHHHCCSSBCCEEE---CTTS
T ss_pred CccccC----ccEEEEEEEcCC----------------eeEEEecCCCCCCHHHHHHHHHHHcCCCceEEEEe---cCCC
Confidence 576654 367888888776 444 44578999999999999999965 889997 3345
Q ss_pred cEEeecChHHHHHHHHHhhcccccCCCceEEEEEec
Q 040257 248 ALISVSSDDDLQNMIDEYCGLERLEGSQRLRLFLIP 283 (1254)
Q Consensus 248 ~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~FLFp 283 (1254)
-.|+|+++++++.++--+.. . .-.|++++|=
T Consensus 64 D~V~i~Sq~E~eEAlkva~k----~-~n~L~m~V~~ 94 (101)
T 1wj6_A 64 EEVSINSQGEYEEALKMAVK----Q-GNQLQMQVHE 94 (101)
T ss_dssp CEECCCSHHHHHHHHHHHHH----H-TSEEEEECCB
T ss_pred CEEEEecHHHHHHHHHHhcc----C-CCEEEEEEee
Confidence 69999999998877664322 1 2368888874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1254 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-74 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-70 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-68 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-67 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-66 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-66 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-65 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-64 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-63 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-63 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-59 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-56 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-56 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-55 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-54 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-52 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-51 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-49 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-48 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-44 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-40 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 | |
| d1ip9a_ | 85 | d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker' | 2e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (628), Expect = 3e-74
Identities = 83/280 (29%), Positives = 144/280 (51%), Gaps = 22/280 (7%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ + +GSG++GTVY GKW G DVA+K + + + Q+ + F E +L
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT----APTPQQL--QAFKNEVGVLRKT 61
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
H N++ F G T LA VT++ SL H L + + K + IA A GM+
Sbjct: 62 RHVNILLFMGY---STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK---RNTLVSGGVRGTLPWMA 1141
YLH+K+I+H DLK N+ ++ + K+GDFGL+ +K + + G++ WMA
Sbjct: 119 YLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 1142 PELLNG-SSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR----PTI 1196
PE++ N S + DV++FGI ++E++TG+ PY++++ I +V +
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236
C ++LM +C + RP F +I + + ++ ++
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 4e-70
Identities = 91/270 (33%), Positives = 137/270 (50%), Gaps = 22/270 (8%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+L+ L+ +G G +G V G +RG+ VA+K IK + + F EA +++ L
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----------DATAQAFLAEASVMTQL 57
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS-LDRRKKLIIAMDAAFGM 1083
H N+V GV+ + G L VTE+M GSL L + RS L L ++D M
Sbjct: 58 RHSNLVQLLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 1084 EYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPE 1143
EYL N VH DL N+LV+ + + KV DFGL++ +T +G + + W APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASSTQDTG--KLPVKWTAPE 170
Query: 1144 LLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDP 1202
L + S K DV+SFGI +WEI + G PY + ++ + K + P+ C P
Sbjct: 171 ALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPP 227
Query: 1203 EWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
++M+ CW D RPSF ++ +L I
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 8e-68
Identities = 90/276 (32%), Positives = 129/276 (46%), Gaps = 22/276 (7%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
I DL L+ELG+G +G V +GKWR DVAIK IK+ +F EA
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG---------SMSEDEFIEEAK 51
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
++ NL H +V YGV + +TE+M NG L + L + ++ L + D
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 109
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--KRNTLVSGGVRGTL 1137
MEYL SK +H DL N LVN + + KV DFGLSR S G + +
Sbjct: 110 CEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTI 1196
W PE+L ++ S K D+++FG+ MWEI + G+ PY I + LR
Sbjct: 166 RWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYR 222
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
P + +M CW + RP+F + S + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 3e-67
Identities = 77/263 (29%), Positives = 132/263 (50%), Gaps = 21/263 (7%)
Query: 970 RELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHP 1027
E+G G++ TVY G +VA ++ + ++ ER + F EA +L L HP
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDR----KLTKSER--QRFKEEAEMLKGLQHP 68
Query: 1028 NVVAFYGVVPDGT--GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
N+V FY + VTE M +G+LK LK+ + + + G+++
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQF 127
Query: 1086 LHSKN--IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPE 1143
LH++ I+H DLKC+N+ + K+GD GL+ +KR + + V GT +MAPE
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASF-AKAVIGTPEFMAPE 183
Query: 1144 LLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP-TIPERCDP 1202
+ + E VDV++FG+ M E+ T E PY++ A I V + ++P + + P
Sbjct: 184 MYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 1203 EWRKLMEQCWAADPEARPSFTEI 1225
E ++++E C + + R S ++
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 1e-66
Identities = 91/281 (32%), Positives = 127/281 (45%), Gaps = 24/281 (8%)
Query: 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDF 1014
+I DL L +LG G++G V G+W VA+K +K Q DF
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-----SQPEAMDDF 58
Query: 1015 WREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI 1074
RE + + +L H N++ YGVV + VTE GSL L K
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 115
Query: 1075 IAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI----KRNTLVS 1130
A+ A GM YL SK +H DL NLL+ RD + K+GDFGL R + ++
Sbjct: 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQ 171
Query: 1131 GGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189
+ W APE L S D + FG+++WE+ T G+EP+ ++ I+ I K
Sbjct: 172 EHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229
Query: 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230
R PE C + +M QCWA PE RP+F + L
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 1e-66
Identities = 88/286 (30%), Positives = 131/286 (45%), Gaps = 27/286 (9%)
Query: 963 NVDLEELRELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
N+ + ++ ELG G +G+V G +R DVAIK +K+ ++ T++ REA
Sbjct: 9 NLLIADI-ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-------TEKADTEEMMREA 60
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
I+ L +P +V GV L V E G L L+ K + +
Sbjct: 61 QIMHQLDNPYIVRLIGV---CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI----KRNTLVSGGVR 1134
+ GM+YL KN VH DL N+L+ R K+ DFGLS+ +
Sbjct: 118 VSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLR 1193
L W APE +N + S + DV+S+G++MWE L+ G++PY M ++ I + R
Sbjct: 174 WPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KR 230
Query: 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESK 1239
P C PE LM CW E RP F + R+R ++ SK
Sbjct: 231 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 2e-66
Identities = 69/278 (24%), Positives = 127/278 (45%), Gaps = 25/278 (8%)
Query: 959 QIIKNVDLEE----LRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTK 1012
+ ++++ E+ + ELG G +G VY + + + A K I SE+E +
Sbjct: 3 HVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK------SEEEL--E 54
Query: 1013 DFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKK 1072
D+ E IL++ HPN+V L + EF G++ V+L+ +R L +
Sbjct: 55 DYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQI 112
Query: 1073 LIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSG 1131
++ + YLH I+H DLK N+L K+ DFG+S R
Sbjct: 113 QVVCKQTLDALNYLHDNKIIHRDLKAGNILFT----LDGDIKLADFGVSAKNTRTIQRRD 168
Query: 1132 GVRGTLPWMAPELLNGSSNR---VSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIV 1188
GT WMAPE++ +++ K DV+S GI++ E+ E P+ +++ ++ I
Sbjct: 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 228
Query: 1189 KN-TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
K+ P R ++ +++C + +AR + +++
Sbjct: 229 KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 3e-66
Identities = 82/277 (29%), Positives = 124/277 (44%), Gaps = 22/277 (7%)
Query: 965 DLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
L+ + LG+G +G V+ G + + VA+K +K+ F EA+++
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG---------SMSPDAFLAEANLMKQ 64
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR-SLDRRKKLIIAMDAAFG 1082
L H +V Y VV + +TE+M NGSL L L K L +A A G
Sbjct: 65 LQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--KRNTLVSGGVRGTLPWM 1140
M ++ +N +H DL+ N+LV+ CK+ DFGL+R+ G + + W
Sbjct: 122 MAFIEERNYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
APE +N + K DV+SFGI + EI+T + ++ R P+ C
Sbjct: 178 APEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237
E +LM CW PE RP+F + S L A E
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 224 bits (571), Expect = 3e-66
Identities = 68/262 (25%), Positives = 117/262 (44%), Gaps = 18/262 (6%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+LRE+G G++G VY + VAIK++ S + +D +E L L
Sbjct: 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS-----GKQSNEKWQDIIKEVRFLQKL 72
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
HPN + + G T V E+ + + + + K + L + + A G+
Sbjct: 73 RHPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLA 129
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPEL 1144
YLHS N++H D+K N+L++ + + K+GDFG + I GT WMAPE+
Sbjct: 130 YLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEV 182
Query: 1145 LNGSSN-RVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPE 1203
+ + KVDV+S GI+ E+ + P +M+ + + I +N
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242
Query: 1204 WRKLMEQCWAADPEARPSFTEI 1225
+R ++ C P+ RP+ +
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 2e-65
Identities = 70/272 (25%), Positives = 118/272 (43%), Gaps = 24/272 (8%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E L +G+G+YG + + G + K + S E + E ++L
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG------SMTEAEKQMLVSEVNLLR 58
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS---LDRRKKLIIAMDA 1079
L HPN+V +Y + D T TL V E+ G L V+ K + LD L +
Sbjct: 59 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118
Query: 1080 AFGMEYLHSKN-----IVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSGGV 1133
++ H ++ ++H DLK N+ ++ + K+GDFGL+R + +T +
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQNVKLGDFGLARILNHDTSFAKAF 174
Query: 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193
GT +M+PE +N +EK D++S G ++E+ P+ + G I +
Sbjct: 175 VGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-F 231
Query: 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
IP R E +++ + RPS EI
Sbjct: 232 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 3e-65
Identities = 79/277 (28%), Positives = 126/277 (45%), Gaps = 20/277 (7%)
Query: 960 IIKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
+I +L ++E+GSG +G V+ G W VAIK I++ +DF EA
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG---------AMSEEDFIEEA 51
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
++ L HP +V YGV + + V EFM +G L L + L + +D
Sbjct: 52 EVMMKLSHPKLVQLYGVCLEQ--APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 109
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--KRNTLVSGGVRGT 1136
GM YL ++H DL N LV + + KV DFG++R S G +
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 165
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196
+ W +PE+ + +R S K DV+SFG+ MWE+ + + + + + + R
Sbjct: 166 VKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 223
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233
P ++M CW PE RP+F+ + +L I+
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 5e-65
Identities = 82/280 (29%), Positives = 126/280 (45%), Gaps = 27/280 (9%)
Query: 962 KNVDLEELRELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
K + LE+ +ELGSG +GTV G ++ VA+K +K + L + E
Sbjct: 6 KLLTLED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE------ANDPALKDELLAE 58
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM 1077
A+++ L +P +V G+ + V E G L L+++R + + + +
Sbjct: 59 ANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAELGPLNK-YLQQNRHVKDKNIIELVH 114
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI----KRNTLVSGGV 1133
+ GM+YL N VH DL N+L+ + K+ DFGLS+ +
Sbjct: 115 QVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTL 1192
+ + W APE +N + S K DV+SFG+ MWE + G++PY M + + K
Sbjct: 171 KWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-E 227
Query: 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
R P C E LM CW D E RP F + RLR
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (550), Expect = 5e-64
Identities = 72/263 (27%), Positives = 119/263 (45%), Gaps = 19/263 (7%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D E R LG G +G VY + + S +A+K + K+ E+ + RE I S
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-----QLEKAGVEHQLRREVEIQS 61
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
+L HPN++ YG D + + E+ G++ L+K D ++ + A
Sbjct: 62 HLRHPNILRLYGYFHDA--TRVYLILEYAPLGTVYR-ELQKLSKFDEQRTATYITELANA 118
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAP 1142
+ Y HSK ++H D+K ENLL+ K+ DFG S ++ + GTL ++ P
Sbjct: 119 LSYCHSKRVIHRDIKPENLLLG----SAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPP 173
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDP 1202
E++ G EKVD++S G+ +E L G+ P+ I + + T P+
Sbjct: 174 EMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTE 229
Query: 1203 EWRKLMEQCWAADPEARPSFTEI 1225
R L+ + +P RP E+
Sbjct: 230 GARDLISRLLKHNPSQRPMLREV 252
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 3e-63
Identities = 86/276 (31%), Positives = 129/276 (46%), Gaps = 25/276 (9%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
+E R +G G +G V+ G + + VAIK K + + + F +EA
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-------TSDSVREKFLQEAL 60
Query: 1020 ILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDA 1079
+ HP++V GV+ + + + E G L+ L + SLD ++ A
Sbjct: 61 TMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 1080 AFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--KRNTLVSGGVRGTL 1137
+ + YL SK VH D+ N+LV+ K+GDFGLSR + + +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVS----SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTI 1196
WMAPE +N R + DV+ FG+ MWEIL G +P+ + +IG I R +
Sbjct: 174 KWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPM 230
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
P C P LM +CWA DP RP FTE+ ++L TI
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 8e-63
Identities = 74/285 (25%), Positives = 138/285 (48%), Gaps = 27/285 (9%)
Query: 958 LQIIKNVDLEELRELGSGTYGTVYHGKWRGSD------VAIKRIKKSCFAGRSSEQERLT 1011
L+I+K + ++++ LGSG +GTVY G W VAIK ++++ +
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-------TSPKAN 55
Query: 1012 KDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRK 1071
K+ EA++++++ +P+V G+ T + +T+ M G L + + ++ +
Sbjct: 56 KEILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQY 112
Query: 1072 KLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI---KRNTL 1128
L + A GM YL + +VH DL N+LV K+ DFGL+++ +
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLGAEEKEY 168
Query: 1129 VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGI 1187
+ G + + WMA E + + + DV+S+G+++WE++T G +PY + I I
Sbjct: 169 HAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-I 225
Query: 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
++ R P C + +M +CW D ++RP F E+ +
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-62
Identities = 87/299 (29%), Positives = 126/299 (42%), Gaps = 49/299 (16%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
+LE + LGSG +G V + G VA+K +K+ ++ ER + E
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-----KADSSER--EALMSE 90
Query: 1018 AHILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS---------- 1066
+++ L H N+V G G + + E+ G L + L K
Sbjct: 91 LKMMTQLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 1067 ------------LDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114
L L A A GME+L K+ VH DL N+LV + K
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT----HGKVVK 204
Query: 1115 VGDFGLSRI---KRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170
+ DFGL+R N +V G R + WMAPE L + K DV+S+GI +WEI +
Sbjct: 205 ICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSL 262
Query: 1171 GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRL 1229
G PY + A +++N + P E +M+ CWA D RPSF +TS L
Sbjct: 263 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (533), Expect = 2e-61
Identities = 86/277 (31%), Positives = 128/277 (46%), Gaps = 22/277 (7%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
++ D+ +LG G YG VY G W+ VA+K +K+ ++F +EA
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---------TMEVEEFLKEA 64
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDR-SLDRRKKLIIAM 1077
++ + HPN+V GV +TEFM G+L L + +R + L +A
Sbjct: 65 AVMKEIKHPNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN--TLVSGGVRG 1135
+ MEYL KN +H DL N LV + + KV DFGLSR+ G +
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 1136 TLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT 1195
+ W APE L N+ S K DV++FG+ +WEI T + + +++ R
Sbjct: 179 PIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236
Query: 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
PE C + +LM CW +P RPSF EI T+
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 3e-61
Identities = 86/284 (30%), Positives = 124/284 (43%), Gaps = 22/284 (7%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
L +LG G +G V+ G W G+ VAIK +K + F +EA ++
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG---------TMSPEAFLQEAQVMKK 68
Query: 1024 LHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLI-IAMDAAFG 1082
L H +V Y VV + + VTE+M GSL L + R +L+ +A A G
Sbjct: 69 LRHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI--KRNTLVSGGVRGTLPWM 1140
M Y+ N VH DL+ N+LV + +CKV DFGL+R+ G + + W
Sbjct: 126 MAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
APE R + K DV+SFGI + E+ T + V+ R P C
Sbjct: 182 APEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 239
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCINSE 1244
LM QCW +PE RP+F + + L + E + E
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (530), Expect = 9e-61
Identities = 92/284 (32%), Positives = 133/284 (46%), Gaps = 28/284 (9%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDFW 1015
I ++ + +G+G +G V G + VAIK +K +E++R +DF
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-----YTEKQR--RDFL 75
Query: 1016 REAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLII 1075
EA I+ HPNV+ GVV + +TEFM NGSL L + D + + +
Sbjct: 76 SEASIMGQFDHPNVIHLEGVVTKS--TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM 133
Query: 1076 AMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI------KRNTLV 1129
A GM+YL N VH DL N+LVN +CKV DFGLSR
Sbjct: 134 LRGIAAGMKYLADMNYVHRDLAARNILVN----SNLVCKVSDFGLSRFLEDDTSDPTYTS 189
Query: 1130 SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIV 1188
+ G + + W APE + + + DV+S+GI MWE+++ GE PY DM +I I
Sbjct: 190 ALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247
Query: 1189 KNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
++ R P C +LM CW D RP F +I + L +
Sbjct: 248 QD-YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 9e-61
Identities = 88/284 (30%), Positives = 133/284 (46%), Gaps = 25/284 (8%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD------VAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
+ + +G+G +G VY G + S VAIK +K +E++R DF EA
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-----YTEKQR--VDFLGEA 60
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
I+ H N++ GV+ + +TE+M NG+L L +KD + + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI----KRNTLVSGGVR 1134
A GM+YL + N VH DL N+LVN +CKV DFGLSR+ T + G +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 1135 GTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP 1194
+ W APE ++ + + DV+SFGI MWE++T E + + + R
Sbjct: 175 IPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232
Query: 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238
P C +LM QCW + RP F +I S L + A +S
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-60
Identities = 77/274 (28%), Positives = 129/274 (47%), Gaps = 26/274 (9%)
Query: 970 RELGSGTYGTVYHGKWRGSD-----VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+G G +G VYHG +D A+K + + F E I+ +
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-------TDIGEVSQFLTEGIIMKDF 85
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
HPNV++ G+ + G+ V +M +G L++ + + + + + + A GM+
Sbjct: 86 SHPNVLSLLGICLR-SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN-----TLVSGGVRGTLPW 1139
+L SK VH DL N +++ ++ KV DFGL+R + G + + W
Sbjct: 145 FLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPE 1198
MA E L + + K DV+SFG+ +WE++T G PY D++ I +++ R PE
Sbjct: 201 MALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPE 257
Query: 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
C ++M +CW E RPSF+E+ SR+ I
Sbjct: 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-60
Identities = 67/263 (25%), Positives = 112/263 (42%), Gaps = 22/263 (8%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
++G G GTVY G +VAI+++ +Q+ + E ++
Sbjct: 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL--------QQQPKKELIINEILVMREN 74
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
+PN+V + G L V E++ GSL V+ + + + + +E
Sbjct: 75 KNPNIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAA--VCRECLQALE 130
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSGGVRGTLPWMAPE 1143
+LHS ++H D+K +N+L+ K+ DFG I + GT WMAPE
Sbjct: 131 FLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 1144 LLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN-TLRPTIPERCDP 1202
++ KVD++S GI E++ GE PY + + + I N T PE+
Sbjct: 187 VVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244
Query: 1203 EWRKLMEQCWAADPEARPSFTEI 1225
+R + +C D E R S E+
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (526), Expect = 3e-60
Identities = 83/302 (27%), Positives = 125/302 (41%), Gaps = 50/302 (16%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
++E +R++G G +G V+ + G VA+K +K+ + DF RE
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-------ASADMQADFQRE 66
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS----------- 1066
A +++ +PN+V GV G + + E+M G L L
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 1067 ------------LDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114
L ++L IA A GM YL + VH DL N LV + + K
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG----ENMVVK 180
Query: 1115 VGDFGLSRI---KRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT- 1170
+ DFGLSR G + WM PE + NR + + DV+++G+ +WEI +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSY 238
Query: 1171 GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230
G +PY M +I + PE C E LM CW+ P RPSF I L+
Sbjct: 239 GLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
Query: 1231 TI 1232
+
Sbjct: 298 RM 299
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-59
Identities = 80/313 (25%), Positives = 132/313 (42%), Gaps = 56/313 (17%)
Query: 960 IIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
I + + L+E +G G +G V+ GKWRG +VA+K +E + E +
Sbjct: 1 IARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSS---------REERSWFREAEIY 49
Query: 1020 ILSNLHHPNVVAFYGVV--PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM 1077
L H N++ F +GT L V+++ +GSL L + +++ K +A+
Sbjct: 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK--LAL 107
Query: 1078 DAAFGMEYLHS--------KNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN--- 1126
A G+ +LH I H DLK +N+LV + C + D GL+ +
Sbjct: 108 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVRHDSATD 163
Query: 1127 --TLVSGGVRGTLPWMAPELLNGSSN----RVSEKVDVFSFGISMWEILTG--------- 1171
+ GT +MAPE+L+ S N ++ D+++ G+ WEI
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223
Query: 1172 -EEPYADMHCG-----AIIGGIVKNTLRPTIPER-----CDPEWRKLMEQCWAADPEARP 1220
+ PY D+ + + + LRP IP R K+M +CW A+ AR
Sbjct: 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
Query: 1221 SFTEITSRLRTIS 1233
+ I L +S
Sbjct: 284 TALRIKKTLSQLS 296
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-59
Identities = 89/289 (30%), Positives = 131/289 (45%), Gaps = 37/289 (12%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGS----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHI 1020
D++ +G G +G V + + D AIKR+K+ +S+ + +DF E +
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----ASKDDH--RDFAGELEV 63
Query: 1021 LSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD--------------- 1064
L L HHPN++ G G L E+ +G+L L K
Sbjct: 64 LCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 1065 RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIK 1124
+L ++ L A D A GM+YL K +H DL N+LV + + K+ DFGLSR +
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSRGQ 177
Query: 1125 RNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAI 1183
+ R + WMA E LN S + DV+S+G+ +WEI++ G PY M C +
Sbjct: 178 EVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235
Query: 1184 IGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+ + R P CD E LM QCW P RPSF +I L +
Sbjct: 236 YEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 203 bits (517), Expect = 2e-58
Identities = 53/263 (20%), Positives = 105/263 (39%), Gaps = 18/263 (6%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ L ELGSG +G V+ + G K I ++ E I++ L
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTP------YPLDK--YTVKNEISIMNQL 83
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
HHP ++ + D + + EF+ G L + +D + + + A G++
Sbjct: 84 HHPKLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPEL 1144
++H +IVH D+K EN++ + K+ DFGL+ + T + APE+
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKA--SSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 199
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN--TLRPTIPERCDP 1202
++ V D+++ G+ + +L+G P+A + + + P
Sbjct: 200 VDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257
Query: 1203 EWRKLMEQCWAADPEARPSFTEI 1225
E + ++ +P R + +
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-58
Identities = 81/294 (27%), Positives = 121/294 (41%), Gaps = 38/294 (12%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
L + LG+G +G V G VA+K +K S + ER + E
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----AHLTER--EALMSE 76
Query: 1018 AHILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK------------- 1063
+LS L +H N+V G G G +TE+ G L + L +K
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 1064 ----DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119
+ +LD L + A GM +L SKN +H DL N+L+ IC G
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLAR 193
Query: 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEP-YADM 1178
+ N +V G R + WMAPE + + + DV+S+GI +WE+ + Y M
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 1179 HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+ ++K R PE E +M+ CW ADP RP+F +I +
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 201 bits (513), Expect = 7e-58
Identities = 55/263 (20%), Positives = 102/263 (38%), Gaps = 18/263 (6%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ ELG+G +G V+ R G++ A K + E + +E +S L
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--------PHESDKETVRKEIQTMSVL 80
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
HP +V + D + + EFM G L + + + + + G+
Sbjct: 81 RHPTLVNLHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPEL 1144
++H N VH DLK EN++ + K+ DFGL+ GT + APE+
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNE--LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN--TLRPTIPERCDP 1202
G V D++S G+ + +L+G P+ + + + + +
Sbjct: 197 AEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254
Query: 1203 EWRKLMEQCWAADPEARPSFTEI 1225
+ + + + ADP R + +
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-57
Identities = 70/267 (26%), Positives = 110/267 (41%), Gaps = 21/267 (7%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D + ++ LG G YG V R ++ VA+K + ++ +E I
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-------RAVDCPENIKKEICINK 58
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
L+H NVV FYG +G E+ G L ++ D + G
Sbjct: 59 MLNHENVVKFYGHRREG--NIQYLFLEYCSGGELFD-RIEPDIGMPEPDAQRFFHQLMAG 115
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR---NTLVSGGVRGTLPW 1139
+ YLH I H D+K ENLL++ +R K+ DFGL+ + R + + GTLP+
Sbjct: 116 VVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGE-EPYADMHCGAIIGGIVKNTLRPTIPE 1198
+APELL +E VDV+S GI + +L GE + +
Sbjct: 172 VAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 230
Query: 1199 RCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ D L+ + +P AR + +I
Sbjct: 231 KIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 3e-57
Identities = 68/266 (25%), Positives = 115/266 (43%), Gaps = 21/266 (7%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D + + LG G++ TV + + AIK ++K R +E RE ++S
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEK-----RHIIKENKVPYVTRERDVMS 63
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
L HP V Y D L + NG L ++K S D +
Sbjct: 64 RLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLK-YIRKIGSFDETCTRFYTAEIVSA 120
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI---KRNTLVSGGVRGTLPW 1139
+EYLH K I+H DLK EN+L+N + ++ DFG +++ + + GT +
Sbjct: 121 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 1140 MAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199
++PELL + D+++ G +++++ G P+ + I I+K L PE+
Sbjct: 177 VSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEK 232
Query: 1200 CDPEWRKLMEQCWAADPEARPSFTEI 1225
P+ R L+E+ D R E+
Sbjct: 233 FFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 6e-57
Identities = 72/310 (23%), Positives = 120/310 (38%), Gaps = 62/310 (20%)
Query: 961 IKNVDLEELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREA 1018
+K+ D E++ ELG+G G V+ + S +A K I + + RE
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-------IKPAIRNQIIREL 55
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
+L + P +V FYG G ++ E M GSL VL K R + + +++
Sbjct: 56 QVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIA 112
Query: 1079 AAFGMEYLHSKN-IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTL 1137
G+ YL K+ I+H D+K N+LVN R K+ DFG+S +++ + V GT
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMANSFV-GTR 167
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD-------------------- 1177
+M+PE L G S + D++S G+S+ E+ G P
Sbjct: 168 SYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 1178 ----------------------MHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAAD 1215
M ++ IV E++ + +C +
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 1216 PEARPSFTEI 1225
P R ++
Sbjct: 286 PAERADLKQL 295
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 3e-56
Identities = 68/263 (25%), Positives = 108/263 (41%), Gaps = 17/263 (6%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ LG+G + V + + VAIK I K G+ E +L +
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-------GSMENEIAVLHKI 64
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
HPN+VA + G G L + + + G L +++K R + ++
Sbjct: 65 KHPNIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVK 121
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPEL 1144
YLH IVH DLK ENLL D I + DFGLS+++ V GT ++APE+
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKI-MISDFGLSKMEDPGSVLSTACGTPGYVAPEV 180
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIP--ERCDP 1202
L S+ VD +S G+ + +L G P+ D + + I+K P +
Sbjct: 181 LAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238
Query: 1203 EWRKLMEQCWAADPEARPSFTEI 1225
+ + DPE R + +
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 5e-56
Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 15/274 (5%)
Query: 960 IIKNVDLEE----LRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKD 1013
+ + ++++ ELGSG + V + + G A K IKK +SS + +D
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT--KSSRRGVSRED 59
Query: 1014 FWREAHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKL 1073
RE IL + HPNV+ + V + + + E + G L L +K+ L +
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKES-LTEEEAT 116
Query: 1074 IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGV 1133
G+ YLHS I HFDLK EN+++ R+ +P K+ DFGL+ +
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGI--VKNT 1191
GT ++APE++N + + D++S G+ + +L+G P+ + + V
Sbjct: 177 FGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ + + DP+ R + +
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 192 bits (489), Expect = 1e-55
Identities = 65/271 (23%), Positives = 109/271 (40%), Gaps = 17/271 (6%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQ-ERLTKDFWREAHIL 1021
+ E LG G V + + A+K I + S+E+ + L + +E IL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 1022 SNLH-HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
+ HPN++ T V + M G L L + +L ++ I
Sbjct: 64 RKVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFD-YLTEKVTLSEKETRKIMRALL 120
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWM 1140
+ LH NIVH DLK EN+L++ K+ DFG S V GT ++
Sbjct: 121 EVICALHKLNIVHRDLKPENILLD----DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176
Query: 1141 APELLNGSSNR----VSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196
APE++ S N ++VD++S G+ M+ +L G P+ ++ I+ +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236
Query: 1197 PE--RCDPEWRKLMEQCWAADPEARPSFTEI 1225
PE + L+ + P+ R + E
Sbjct: 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-55
Identities = 52/261 (19%), Positives = 103/261 (39%), Gaps = 19/261 (7%)
Query: 969 LRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
+LG G +G V+ S K +K + ++Q +E IL+ H
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVL----VKKEISILNIARH 60
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
N++ + L + EF+ + + L+ R+ + +++L
Sbjct: 61 RNILHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLN 1146
HS NI HFD++ EN++ R K+ +FG +R + + + APE+
Sbjct: 119 HSHNIGHFDIRPENIIYQTRR--SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 1147 GSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN--TLRPTIPERCDPEW 1204
+ VS D++S G ++ +L+G P+ II I+ T + E
Sbjct: 177 H--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 1205 RKLMEQCWAADPEARPSFTEI 1225
+++ + ++R + +E
Sbjct: 235 MDFVDRLLVKERKSRMTASEA 255
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-54
Identities = 78/296 (26%), Positives = 116/296 (39%), Gaps = 39/296 (13%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD---------VAIKRIKKSCFAGRSSEQERLTKDFW 1015
L + LG G +G V + G D VA+K +K ++E++ D
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKDL--SDLI 66
Query: 1016 REAHILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVL-------------- 1060
E ++ + H N++ G G L + E+ G+L+ L
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 1061 -LKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119
+ L + + A A GMEYL SK +H DL N+LV D I G
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLAR 183
Query: 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADM 1178
+ R + WMAPE L + + DV+SFG+ +WEI T G PY +
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 1179 HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234
+ ++K R P C E +M CW A P RP+F ++ L I A
Sbjct: 242 PVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 188 bits (479), Expect = 2e-54
Identities = 57/273 (20%), Positives = 115/273 (42%), Gaps = 15/273 (5%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E LG G V+ + DVA+K ++ + F REA + L
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD-----LARDPSFYLRFRREAQNAAAL 64
Query: 1025 HHPNVVAFYGVV--PDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
+HP +VA Y G V E++ +L+ ++ + + ++ + + DA
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVIADACQA 123
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAP 1142
+ + H I+H D+K N++++ + + + ++ + + V GT +++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP--TIPERC 1200
E G + V + DV+S G ++E+LTGE P+ ++ V+ P E
Sbjct: 184 EQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241
Query: 1201 DPEWRKLMEQCWAADPEARP-SFTEITSRLRTI 1232
+ ++ + A +PE R + E+ + L +
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-54
Identities = 77/294 (26%), Positives = 119/294 (40%), Gaps = 39/294 (13%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
L+ + LG G +G V G D VA+K +K+ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG------ATHSEHRALMSEL 67
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS----------- 1066
++ HH NVV G GG L + EF G+L L K
Sbjct: 68 KILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 1067 ----LDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122
L + + A GME+L S+ +H DL N+L++ ++ + K+ DFGL+R
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLAR 182
Query: 1123 I---KRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEE-PYADM 1178
+ + G R L WMAPE + + + DV+SFG+ +WEI + PY +
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240
Query: 1179 HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+K R P+ PE + M CW +P RP+F+E+ L +
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 7e-53
Identities = 63/264 (23%), Positives = 116/264 (43%), Gaps = 20/264 (7%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D + LG G++G V+ +++ AIK +KK + + E +LS
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKD-----VVLMDDDVECTMVEKRVLS 57
Query: 1023 -NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
HP + + L V E++ G L + ++ D + A +
Sbjct: 58 LAWEHPFLTHMFCTFQTK--ENLFFVMEYLNGGDLMY-HIQSCHKFDLSRATFYAAEIIL 114
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSGGVRGTLPWM 1140
G+++LHSK IV+ DLK +N+L++ + K+ DFG+ + + GT ++
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLD----KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYI 170
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
APE+L G + + VD +SFG+ ++E+L G+ P+ + I + P P
Sbjct: 171 APEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWL 226
Query: 1201 DPEWRKLMEQCWAADPEARPSFTE 1224
+ E + L+ + + +PE R
Sbjct: 227 EKEAKDLLVKLFVREPEKRLGVRG 250
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-52
Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 36/286 (12%)
Query: 965 DLEELRELGSGTYGTVYHGKWRGSD-------VAIKRIKKSCFAGRSSEQERLTKDFWRE 1017
+ RELG G++G VY G +G VAIK + ++ +S +ER +F E
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-----ASMRER--IEFLNE 73
Query: 1018 AHILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRS---------LD 1068
A ++ + +VV GVV G + E M G LK L +
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 1069 RRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI---KR 1125
K + +A + A GM YL++ VH DL N +V + K+GDFG++R
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRDIYETD 187
Query: 1126 NTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEE-PYADMHCGAII 1184
G + WM+PE L + DV+SFG+ +WEI T E PY + ++
Sbjct: 188 YYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245
Query: 1185 GGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230
+++ L P+ C +LM CW +P+ RPSF EI S ++
Sbjct: 246 RFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 5e-52
Identities = 67/285 (23%), Positives = 109/285 (38%), Gaps = 32/285 (11%)
Query: 957 GLQIIKNVDLEE----LRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERL 1010
GLQI KN +++ + LG G G V + A+K ++
Sbjct: 1 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------ 48
Query: 1011 TKDFWREAHILSNL-HHPNVVAFYGVVPDG--TGGTLATVTEFMVNGSLKHVLLKK-DRS 1066
RE + P++V V + L V E + G L + + D++
Sbjct: 49 -PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA 107
Query: 1067 LDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN 1126
R+ I ++YLHS NI H D+K ENLL + P I K+ DFG ++ +
Sbjct: 108 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTS 166
Query: 1127 TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGG 1186
T ++APE+L + + D++S G+ M+ +L G P+ H AI G
Sbjct: 167 HNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 224
Query: 1187 IVKNTLRPTI------PERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ E + L+ +P R + TE
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-51
Identities = 56/261 (21%), Positives = 98/261 (37%), Gaps = 21/261 (8%)
Query: 969 LRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH- 1025
LGSG +G+VY G VAIK ++K + E +L +
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG--TRVPMEVVLLKKVSS 66
Query: 1026 -HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
V+ + + E + + +L +
Sbjct: 67 GFSGVIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPEL 1144
+ H+ ++H D+K EN+L+ D R K+ DFG + ++T+ + GT + PE
Sbjct: 125 HCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYT-DFDGTRVYSPPEW 180
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEW 1204
+ V+S GI +++++ G+ P+ II G + +R E
Sbjct: 181 IRYHRYH-GRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRG------QVFFRQRVSSEC 231
Query: 1205 RKLMEQCWAADPEARPSFTEI 1225
+ L+ C A P RP+F EI
Sbjct: 232 QHLIRWCLALRPSDRPTFEEI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (459), Expect = 2e-51
Identities = 53/280 (18%), Positives = 102/280 (36%), Gaps = 31/280 (11%)
Query: 969 LRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
R++GSG++G +Y G G +VAIK + E+ I +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECV----------KTKHPQLHIESKIYKMMQG 61
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
+ G V E + SL+ + R + L++A +EY+
Sbjct: 62 GVGIPTIRWCGA-EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT--------LVSGGVRGTLP 1138
HSKN +H D+K +N L+ L + + DFGL++ R+ + + GT
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVK------NTL 1192
+ + G S + D+ S G + G P+ + + +T
Sbjct: 179 YASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+ + E+ + C + + +P ++ + R +
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 175 bits (444), Expect = 2e-49
Identities = 53/281 (18%), Positives = 104/281 (37%), Gaps = 31/281 (11%)
Query: 969 LRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH 1026
R +G G++G ++ G VAIK + S+ +L +D +R +L+
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR------SDAPQL-RDEYRTYKLLAGCTG 62
Query: 1027 PNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYL 1086
V ++G G V + + SL+ +L R + + A ++ +
Sbjct: 63 IPNVYYFGQ----EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 1087 HSKNIVHFDLKCENLLVNLRDPQRPIC-KVGDFGLSRIKRNTLVS--------GGVRGTL 1137
H K++V+ D+K +N L+ + + V DFG+ + R+ + + GT
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAI------IGGIVKNT 1191
+M+ G S + D+ + G L G P+ + IG ++T
Sbjct: 178 RYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232
+ E+ K M +A P + + +
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 177 bits (449), Expect = 3e-49
Identities = 57/260 (21%), Positives = 100/260 (38%), Gaps = 14/260 (5%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D R +G G +G VY + G A+K + K + + E L + ++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI--KMKQGETLALNERIMLSLVS 62
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
P +V L+ + + M G L + L + + + A G
Sbjct: 63 TGDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-IILG 119
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAP 1142
+E++H++ +V+ DLK N+L++ + ++ D GL+ GT +MAP
Sbjct: 120 LEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKKK-PHASVGTHGYMAP 174
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN-TLRPTIPERCD 1201
E+L D FS G ++++L G P+ T+ +P+
Sbjct: 175 EVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233
Query: 1202 PEWRKLMEQCWAADPEARPS 1221
PE R L+E D R
Sbjct: 234 PELRSLLEGLLQRDVNRRLG 253
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 174 bits (443), Expect = 5e-49
Identities = 65/264 (24%), Positives = 124/264 (46%), Gaps = 20/264 (7%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D + LR LG+G++G V+ + R G A+K +KK + + + E +LS
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-----EIVVRLKQVEHTNDERLMLS 59
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
+ HP ++ +G D + + +++ G L +L K R + K A +
Sbjct: 60 IVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLA 116
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAP 1142
+EYLHSK+I++ DLK EN+L++ + K+ DFG ++ + + + GT ++AP
Sbjct: 117 LEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFAKYVPDVTYT--LCGTPDYIAP 170
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDP 1202
E+++ ++ +D +SFGI ++E+L G P+ D + I+ P +
Sbjct: 171 EVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNE 226
Query: 1203 EWRKLMEQCWAADPEARPSFTEIT 1226
+ + L+ + D R +
Sbjct: 227 DVKDLLSRLITRDLSQRLGNLQNG 250
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 4e-48
Identities = 67/293 (22%), Positives = 109/293 (37%), Gaps = 46/293 (15%)
Query: 967 EELRELGSGTYGTVYHGKWR---GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN 1023
E + E+G G YG V+ + G VA+KR++ + +E + RE +L +
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ------TGEEGMPLSTIREVAVLRH 63
Query: 1024 L---HHPNVVAFYGVVPDG---TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAM 1077
L HPNVV + V L V E + ++ + + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 1078 DAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTL 1137
G+++LHS +VH DLK +N+LV K+ DFGL+RI + V TL
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYSFQMALTSVVVTL 179
Query: 1138 PWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT-- 1195
+ APE+L S + VD++S G E+ + + +G I+ P
Sbjct: 180 WYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 1196 -----------------------IPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
D + L+ +C +P R S
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-46
Identities = 64/265 (24%), Positives = 110/265 (41%), Gaps = 19/265 (7%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D + L+ LG GT+G V + + G A+K ++K + E+ +L
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH-----TVTESRVLQ 60
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
N HP + A L V E+ G L L ++ + R + A +
Sbjct: 61 NTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSA 117
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSGGVRGTLPWMA 1141
+EYLHS+++V+ D+K ENL+++ + K+ DFGL + + GT ++A
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201
PE+L N VD + G+ M+E++ G P+ + + I+ P
Sbjct: 174 PEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLS 229
Query: 1202 PEWRKLMEQCWAADPEARPSFTEIT 1226
PE + L+ DP+ R
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSD 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 6e-45
Identities = 68/291 (23%), Positives = 109/291 (37%), Gaps = 43/291 (14%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
+ +++ ++G GTYG VY + + G VA+K+I+ +E E + RE +L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD------TETEGVPSTAIREISLLK 56
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
L+HPN+V V+ L V EF+ K + + G
Sbjct: 57 ELNHPNIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPW-MA 1141
+ + HS ++H DLK +NLL+N K+ DFGL+R + + W A
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT------ 1195
PE+L G S VD++S G E++T + + I + P
Sbjct: 171 PEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 1196 ---------------------IPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ D + R L+ Q DP R S
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 161 bits (407), Expect = 1e-44
Identities = 61/287 (21%), Positives = 101/287 (35%), Gaps = 41/287 (14%)
Query: 967 EELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH 1025
L ++G GTYG VY + G A+K+I+ E E + RE IL L
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLE------KEDEGIPSTTIREISILKELK 58
Query: 1026 HPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEY 1085
H N+V Y V+ L ++ LK +L + L+ + G+ Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVL---VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 1086 LHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELL 1145
H + ++H DLK +NLL+N K+ DFGL+R + W +
Sbjct: 116 CHDRRVLHRDLKPQNLLINREG----ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 1146 NGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT---------- 1195
S + S +D++S G E++ G + + + I + P
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 1196 -----------------IPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ D L+ + DP R + +
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-44
Identities = 63/272 (23%), Positives = 123/272 (45%), Gaps = 21/272 (7%)
Query: 965 DLEELRELGSGTYGTVY-----HGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
+ E L+ LG+G YG V+ G G A+K +KK+ ++ + T+ E
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA----TIVQKAKTTEHTRTERQ 80
Query: 1020 ILSNL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
+L ++ P +V + L + +++ G L L +++R + ++ + +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-E 137
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR--IKRNTLVSGGVRGT 1136
+E+LH I++ D+K EN+L++ + DFGLS+ + T + GT
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLD----SNGHVVLTDFGLSKEFVADETERAYDFCGT 193
Query: 1137 LPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR--P 1194
+ +MAP+++ G + + VD +S G+ M+E+LTG P+ I + L+ P
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253
Query: 1195 TIPERCDPEWRKLMEQCWAADPEARPSFTEIT 1226
P+ + L+++ DP+ R
Sbjct: 254 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRD 285
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-44
Identities = 68/288 (23%), Positives = 112/288 (38%), Gaps = 40/288 (13%)
Query: 967 EELRELGSGTYGTVYHGKWRGSD--VAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E+L LG G + TVY + + ++ VAIK+IK RS ++ + + RE +L L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLG---HRSEAKDGINRTALREIKLLQEL 57
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
HPN++ G ++ V +FM + K + M G+E
Sbjct: 58 SHPNIIGLLDA--FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM-TLQGLE 114
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR-IKRNTLVSGGVRGTLPWMAPE 1143
YLH I+H DLK NLL++ + + K+ DFGL++ T + APE
Sbjct: 115 YLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 1144 LLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT-------- 1195
LL G+ VD+++ G + E+L + I + PT
Sbjct: 171 LLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 1196 ------------------IPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
I + L++ + +P AR + T+
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 8e-44
Identities = 60/296 (20%), Positives = 106/296 (35%), Gaps = 51/296 (17%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
L +G G YG V VAIK+I E + + RE IL
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-------EHQTYCQRTLREIKILLRF 63
Query: 1025 HHPNVVAFYGVVPDGTGGTLAT--VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
H N++ ++ T + + ++ L +L K + L G
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQILRG 121
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRI----KRNTLVSGGVRGTLP 1138
++Y+HS N++H DLK NLL+N K+ DFGL+R+ +T T
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLN----TTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 1139 WMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT--- 1195
+ APE++ S ++ +D++S G + E+L+ + H + I+ P+
Sbjct: 178 YRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 1196 --------------------------IPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ D + L+++ +P R +
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (403), Expect = 2e-43
Identities = 57/264 (21%), Positives = 109/264 (41%), Gaps = 20/264 (7%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
+ ++ LG+G++G V K + G+ A+K + K + + + + E IL
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRILQ 96
Query: 1023 NLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFG 1082
++ P +V D + L V E++ G + L + R A
Sbjct: 97 AVNFPFLVKLEFSFKDNS--NLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLT 153
Query: 1083 MEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAP 1142
EYLHS ++++ DLK ENLL++ + +V DFG ++ + + + GT +AP
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQG----YIQVTDFGFAKRVKGRTWT--LCGTPEALAP 207
Query: 1143 ELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCDP 1202
E++ ++ VD ++ G+ ++E+ G P+ I IV + P
Sbjct: 208 EIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSS 263
Query: 1203 EWRKLMEQCWAADPEARPSFTEIT 1226
+ + L+ D R +
Sbjct: 264 DLKDLLRNLLQVDLTKRFGNLKNG 287
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-43
Identities = 62/299 (20%), Positives = 108/299 (36%), Gaps = 51/299 (17%)
Query: 962 KNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAH 1019
+ V + + +G+G++G VY K G VAIK++ + + RE
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------------KRFKNRELQ 65
Query: 1020 ILSNLHHPNVVAFYGVV----PDGTGGTLATVTEFMVNGSLKHVL--LKKDRSLDRRKKL 1073
I+ L H N+V L V +++ + + ++L
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 1074 IIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGV 1133
+ + Y+HS I H D+K +NLL+ DP + K+ DFG ++ +
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193
+ + APEL+ G + + +DV+S G + E+L G+ + + I+K
Sbjct: 183 ICSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 1194 PT---------------------------IPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
PT R PE L + P AR + E
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-42
Identities = 64/302 (21%), Positives = 106/302 (35%), Gaps = 55/302 (18%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E+L ++G GT+G V+ + R G VA+K++ +E+E RE IL L
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME------NEKEGFPITALREIKILQLL 66
Query: 1025 HHPNVVAFYGVVPDGT------GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
H NVV + G++ V +F + + + K ++ M
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM- 125
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVS-----GGV 1133
G+ Y+H I+H D+K N+L+ + + K+ DFGL+R S
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 1134 RGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193
TL + PELL G + +D++ G M E+ T + I +
Sbjct: 182 VVTLWYRPPELLLGERD-YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 1194 PT------------------------------IPERCDPEWRKLMEQCWAADPEARPSFT 1223
T DP L+++ DP R
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 1224 EI 1225
+
Sbjct: 301 DA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 9e-41
Identities = 65/289 (22%), Positives = 107/289 (37%), Gaps = 43/289 (14%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
E+L ++G GTYGTV+ K R VA+KR++ + E + RE +L L
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD------DDDEGVPSSALREICLLKEL 58
Query: 1025 HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGME 1084
H N+V + V+ TL V EF K+ K + G+
Sbjct: 59 KHKNIVRLHDVLHSDKKLTL--VFEFCDQDLKKYFDSCNGDLDPEIVKSFLF-QLLKGLG 115
Query: 1085 YLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPEL 1144
+ HS+N++H DLK +NLL+N + K+ +FGL+R + W P
Sbjct: 116 FCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171
Query: 1145 LNGSSNRVSEKVDVFSFGISMWEILTGEEP-YADMHCGAIIGGIVKNTLRPT-------- 1195
+ + S +D++S G E+ P + + I + PT
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 1196 -------------------IPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ + + R L++ +P R S E
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-40
Identities = 72/294 (24%), Positives = 117/294 (39%), Gaps = 51/294 (17%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+L+ +GSG YG V G+ VAIK++ + + E K +RE +L ++
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHM 74
Query: 1025 HHPNVVAFYGVVPDGTGGTLAT----VTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
H NV+ V T V FM G+ L+K ++ L + +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGEDRIQFLVYQML 131
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWM 1140
G+ Y+H+ I+H DLK NL VN + K+ DFGL+R + + T +
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQADSEMTG--YVVTRWYR 185
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP------ 1194
APE++ R ++ VD++S G M E++TG+ + + I+K T P
Sbjct: 186 APEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 1195 -----------------------TIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+I P L+E+ D E R + E
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 149 bits (378), Expect = 3e-40
Identities = 56/300 (18%), Positives = 100/300 (33%), Gaps = 58/300 (19%)
Query: 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS 1022
D + +R+LG G Y V+ V +K +K K RE IL
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----------KKKKIKREIKILE 84
Query: 1023 NL-HHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
NL PN++ +V D T A V E + N K + ++L +
Sbjct: 85 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILK 140
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMA 1141
++Y HS I+H D+K N+++ D + ++ D+GL+ + +
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 197
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMH---------------------- 1179
PELL +D++S G + ++ +EP+ H
Sbjct: 198 PELLVDYQM-YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256
Query: 1180 --------------CGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
G + + PE +++ D ++R + E
Sbjct: 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-34
Identities = 61/293 (20%), Positives = 110/293 (37%), Gaps = 49/293 (16%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ L +GSG YG+V G VA+K++ + + K +RE +L ++
Sbjct: 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP------FQSIIHAKRTYRELRLLKHM 74
Query: 1025 HHPNVVAFYGVVPDGTG---GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAF 1081
H NV+ V + ++ L + + K + L +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIYQILR 132
Query: 1082 GMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMA 1141
G++Y+HS +I+H DLK NL VN + K+ DFGL+R + + T + A
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDDEMTG--YVATRWYRA 186
Query: 1142 PELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT------ 1195
PE++ ++ VD++S G M E+LTG + + I++ P
Sbjct: 187 PEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245
Query: 1196 -----------------------IPERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ +P L+E+ D + R + +
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 3e-34
Identities = 56/286 (19%), Positives = 111/286 (38%), Gaps = 23/286 (8%)
Query: 967 EELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL 1024
+ L+ +GSG G V +VAIK++ + + + K +RE ++ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCV 73
Query: 1025 HHPNVVAFYGVVPDG----TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAA 1080
+H N+++ V + V E M + ++ + +R +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV--IQMELDHERMSY--LLYQML 129
Query: 1081 FGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWM 1140
G+++LHS I+H DLK N++V K+ DFGL+R + + T +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 1141 APELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200
APE++ G E VD++S G M E++ + + +++ P PE
Sbjct: 186 APEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC-PEFM 242
Query: 1201 DPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCINSEPK 1246
+ A +F ++ + + +K S+ +
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR 288
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (281), Expect = 3e-27
Identities = 49/329 (14%), Positives = 104/329 (31%), Gaps = 73/329 (22%)
Query: 959 QIIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWR 1016
+ K+ +R+LG G + TV+ K + VA+K ++ + T+
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---------KVYTEAAED 58
Query: 1017 EAHILSNLHHPNVVA-------------FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKK 1063
E +L ++ + + G + V E + L + +
Sbjct: 59 EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE 118
Query: 1064 DRSLDRRKKLIIAMDAAFGMEYLHSK-NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122
R + I+ G++Y+H + I+H D+K EN+L+ + D + ++ L
Sbjct: 119 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 178
Query: 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD----- 1177
T + +PE+L G+ D++S ++E++TG+ +
Sbjct: 179 ACWYDEHYTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHS 236
Query: 1178 ------------MHCGAIIGGIVKN-----------------------------TLRPTI 1196
G + +++N T +
Sbjct: 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 296
Query: 1197 PERCDPEWRKLMEQCWAADPEARPSFTEI 1225
+ E + DP R +
Sbjct: 297 SKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.8 bits (209), Expect = 3e-19
Identities = 31/217 (14%), Positives = 61/217 (28%), Gaps = 50/217 (23%)
Query: 970 RELGSGTYGTVYHGK-WRGSDVAIKRIKKSCFAGRSSEQERLTKD----------FWREA 1018
+ +G G V++ + + +K K + + +++R D E
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 1019 HILSNLHHPNVVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMD 1078
L L V Y + A + E + L V ++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN------AVLMELIDAKELYRVRVENPDE--------VLDM 111
Query: 1079 AAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLP 1138
+ + + IVH DL N+LV+ + DF S
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-----WIIDFPQSVEVGEE----------- 155
Query: 1139 WMAPELLNGSSNRVSE--------KVDVFSFGISMWE 1167
E+L + + D+ S + +
Sbjct: 156 -GWREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 85 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 39.4 bits (92), Expect = 2e-04
Identities = 9/69 (13%), Positives = 27/69 (39%), Gaps = 5/69 (7%)
Query: 201 KLRYVGGETRIISLRTNLSWEELVKKTSNICN-QPHLIKYQLPGEDLDALISVSSDDDLQ 259
K Y + + L+ + +++EL K + + ++ + + + +D +
Sbjct: 16 KFYY-KDDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTK---LFDGSGEEIKTDSQVS 71
Query: 260 NMIDEYCGL 268
N+I +
Sbjct: 72 NIIQAKLKI 80
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1254 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.06 | |
| d1ip9a_ | 85 | Bud emergence mediator Bemp1 {Baker's yeast (Sacch | 97.96 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.26 | |
| d2c60a1 | 80 | Mitogen-activated protein kinase kinase kinase 3, | 97.03 | |
| d2nptb1 | 82 | Mitogen-activated protein kinase kinase kinase 2, | 96.68 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.61 | |
| d2bkfa1 | 85 | Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Hum | 96.28 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.15 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.97 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.93 | |
| d1wmha_ | 83 | Protein kinase C, iota type {Human (Homo sapiens) | 91.69 | |
| d2npta1 | 105 | Mitogen activated protein kinase kinase 5, Map2k5 | 81.33 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=433.66 Aligned_cols=264 Identities=32% Similarity=0.571 Sum_probs=219.4
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
++|...+|++++.||+|+||+||+|++++ .||||+++..... ....+.|.+|+.+|++++|||||++++++.+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPT------PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCC------TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCC------HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence 45777899999999999999999998765 5999998754322 1235678999999999999999999999754
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
+ .+++||||+.+|+|.+++......+++..++.|+.||+.||+|||+++||||||||+||||+ .++++||+||
T Consensus 76 ~---~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~----~~~~~Kl~DF 148 (276)
T d1uwha_ 76 P---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDF 148 (276)
T ss_dssp S---SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----TTSSEEECCC
T ss_pred c---EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc----CCCCEEEccc
Confidence 3 58999999999999999977777899999999999999999999999999999999999999 7889999999
Q ss_pred cccccccCc---cccCCCCCCCCccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc-CC
Q 040257 1119 GLSRIKRNT---LVSGGVRGTLPWMAPELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT-LR 1193 (1254)
Q Consensus 1119 GLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~-~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~-Lr 1193 (1254)
|+|+..... .......||+.|||||++.+.. ..|+.++|||||||+||||+||+.||.+......+....... ..
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 228 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 228 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC
T ss_pred cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence 999765332 2334567999999999997643 358999999999999999999999999876655444444333 22
Q ss_pred C---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1194 P---TIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1194 p---~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
+ ..+..+++++.+||.+||+.||.+|||+.+|+++|+.+..++
T Consensus 229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 2 345678999999999999999999999999999999887643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=420.90 Aligned_cols=257 Identities=32% Similarity=0.611 Sum_probs=212.8
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
|...+|++++.||+|+||+||+|++. ++.||||+++..... .++|.+|++++++++||||+++++++.++
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---------HHHHHHHHHHHHhcCCCCcccccceeccC
Confidence 45678999999999999999999995 567999998754211 25688999999999999999999999765
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
. .+++||||+.+|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+||||+ .++.+||+|||
T Consensus 73 ~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~----~~~~~Kl~DFG 146 (263)
T d1sm2a_ 73 A--PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFG 146 (263)
T ss_dssp S--SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC----GGGCEEECSCC
T ss_pred C--ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec----CCCCeEecccc
Confidence 5 78999999999999999877777899999999999999999999999999999999999999 77899999999
Q ss_pred ccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1120 LSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1120 LAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
+++...... ......||+.|+|||++.+.. |+.++|||||||+||||+| |.+||......+.+..+.. ..+...
T Consensus 147 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~ 223 (263)
T d1sm2a_ 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYK 223 (263)
T ss_dssp ------------------CTTSCCHHHHTTCC--CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCC
T ss_pred hheeccCCCceeecceecCcccCChHHhcCCC--CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-cCCCCC
Confidence 998654332 223456899999999998764 8999999999999999999 5666766666666666554 455667
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
+..+++++.+||.+||+.||++|||+++|+++|+++.++
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 788899999999999999999999999999999998653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=426.74 Aligned_cols=252 Identities=28% Similarity=0.461 Sum_probs=207.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
++|++++.||+|+||+||+|+++ ++.||||++..... .+...+.+.+|+++|++++||||+++++++.+...
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM------TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS------CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC------CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence 47999999999999999999984 77899999976532 12335678999999999999999999999987666
Q ss_pred CceEEEEEecccCchhhhhhc---cCCCCCHHHHHHHHHHhhhhhHHhhhCC-----cccccCCCCceEeccCCCCCCeE
Q 040257 1042 GTLATVTEFMVNGSLKHVLLK---KDRSLDRRKKLIIAMDAAFGMEYLHSKN-----IVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~k---re~~LSe~~~lkIa~QIAeALaYLHSkG-----IIHRDLKPeNILLDsdd~snG~V 1113 (1254)
..+++|||||.+|+|.+++.+ ....+++..++.++.||+.||.|||+++ ||||||||+||||+ .++.+
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~----~~~~v 153 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQNV 153 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC----TTSCE
T ss_pred CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC----CCCcE
Confidence 689999999999999999854 2457999999999999999999999976 99999999999998 77899
Q ss_pred EEEeccccccccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC
Q 040257 1114 KVGDFGLSRIKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL 1192 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L 1192 (1254)
||+|||+++..... ......+||+.|+|||++.+.. |+.++|||||||+||||+||+.||...+..+....+.....
T Consensus 154 kl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~ 231 (269)
T d2java1 154 KLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS--YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 231 (269)
T ss_dssp EECCHHHHHHC-----------CCCSCCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred EEeeccceeecccCCCccccCCCCcccCCHHHHcCCC--CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999999865433 3345578999999999998764 89999999999999999999999999888888877776654
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
. .++..+++++++||.+||+.||.+|||+.|++++
T Consensus 232 ~-~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 R-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 3 5677899999999999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-50 Score=425.16 Aligned_cols=248 Identities=29% Similarity=0.472 Sum_probs=217.4
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|+++ ++.||||++.+... ......+.+.+|+.++++++||||+++++++.++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~- 79 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT- 79 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc-----cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC-
Confidence 47999999999999999999985 67899999975422 12233567889999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+|+|.+++.+. ..+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|
T Consensus 80 -~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~~kl~DFG~a 153 (263)
T d2j4za1 80 -RVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG----SAGELKIADFGWS 153 (263)
T ss_dssp -EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECCCCSC
T ss_pred -EEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec----CCCCEeeccccee
Confidence 899999999999999998654 5699999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
+...... ....+||+.|+|||++.+.. |+.++|||||||+||||++|+.||...+..+.+..+.... ..++..++
T Consensus 154 ~~~~~~~-~~~~~Gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s 228 (263)
T d2j4za1 154 VHAPSSR-RTTLCGTLDYLPPEMIEGRM--HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVT 228 (263)
T ss_dssp SCCCCCC-CEETTEEGGGCCHHHHTTCC--CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--CCCCTTSC
T ss_pred eecCCCc-ccccCCCCcccCHHHHcCCC--CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCccCC
Confidence 8655443 23467999999999999864 7899999999999999999999999988888877776654 34677899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++++||.+||+.||.+|||++|++++
T Consensus 229 ~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 229 EGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 999999999999999999999999974
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.5e-49 Score=424.15 Aligned_cols=259 Identities=36% Similarity=0.620 Sum_probs=212.8
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--Cc---eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GS---DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs---~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
.+...+|++.++||+|+||+||+|+++ ++ .||||++.... .....+.|.+|+.+|++++|||||++++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~g 94 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNVIHLEG 94 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-------CHHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 355568999999999999999999984 22 47888776431 2234567999999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
++.+.. .+++|||||.+|+|.+++....+.+++..++.|+.||+.||.|||+++||||||||+||||+ .++++|
T Consensus 95 ~~~~~~--~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~----~~~~~K 168 (299)
T d1jpaa_ 95 VVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN----SNLVCK 168 (299)
T ss_dssp EECSSS--SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEE
T ss_pred EEeeCC--EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC----CCCcEE
Confidence 997655 79999999999999999877777899999999999999999999999999999999999998 788999
Q ss_pred EEeccccccccCccc------cCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHh
Q 040257 1115 VGDFGLSRIKRNTLV------SGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGI 1187 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~~------sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsI 1187 (1254)
|+|||+++....... .....||+.|||||++.+. .++.++|||||||+||||+| |+.||.+....+.+..+
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i 246 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 246 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ECCcccceEccCCCCcceeeecccccCCccccCHHHHhcC--CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999986543221 1224578999999999865 48999999999999999998 89999998887777766
Q ss_pred hhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1188 lk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
..+ .++..+..++.++.+||.+||+.||.+|||+.||++.|+.++.
T Consensus 247 ~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 247 EQD-YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HTT-CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HcC-CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 544 4556778899999999999999999999999999999998865
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=423.61 Aligned_cols=250 Identities=28% Similarity=0.384 Sum_probs=207.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|+++ ++.||||++.+... ....+.+.+|+.+|++++||||+++++++.+++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~- 76 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-------VDCPENIKKEICINKMLNHENVVKFYGHRREGN- 76 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-------chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc-
Confidence 37999999999999999999985 77899999976421 123456889999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|
T Consensus 77 -~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~----~~~~~KL~DFG~a 150 (271)
T d1nvra_ 77 -IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLA 150 (271)
T ss_dssp -EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCTTC
T ss_pred -eeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC----CCCCEEEccchhh
Confidence 89999999999999999854 45799999999999999999999999999999999999998 6789999999999
Q ss_pred ccccC---ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh-HHHHhhhccCCCCCC
Q 040257 1122 RIKRN---TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA-IIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1122 r~~~~---s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e-liqsIlk~~Lrp~ip 1197 (1254)
+.... .......+||+.|||||++.+..+ ++.++|||||||+||||++|+.||....... ....+..........
T Consensus 151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 229 (271)
T d1nvra_ 151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREF-HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229 (271)
T ss_dssp EECEETTEECCBCCCCSCGGGSCTHHHHCSSB-CHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTG
T ss_pred eeeccCCccccccceeeCcCccCHhHhcCCCC-CCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 86432 223455789999999999987642 4788999999999999999999997655433 333333333333334
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+++++++||.+||+.||++|||++|++++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 5689999999999999999999999999764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=417.91 Aligned_cols=259 Identities=33% Similarity=0.581 Sum_probs=219.2
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
++|...+|++++.||+|+||+||+|+++ ++.||||+++.... ..+.|.+|+.+|++++|||||++++++.
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~---------~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---------SPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC---------CHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 4566779999999999999999999996 46799999975421 1356899999999999999999999986
Q ss_pred cCCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
++ .+++||||+.+|+|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+||||+ .++.+||+
T Consensus 79 ~~---~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~----~~~~~Kl~ 151 (272)
T d1qpca_ 79 QE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIA 151 (272)
T ss_dssp SS---SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEEC
T ss_pred cC---CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee----cccceeec
Confidence 43 5789999999999998775433 3589999999999999999999999999999999999998 78899999
Q ss_pred eccccccccCc--cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChhhHHHHhhhccCC
Q 040257 1117 DFGLSRIKRNT--LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG-EEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1117 DFGLAr~~~~s--~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTG-k~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
|||+|+..... .......||+.|+|||++.+.. ++.++|||||||+||||+|| .+||......+.+..+.. ..+
T Consensus 152 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~-~~~ 228 (272)
T d1qpca_ 152 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYR 228 (272)
T ss_dssp CCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCC
T ss_pred cccceEEccCCccccccccCCcccccChHHHhCCC--CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCC
Confidence 99999865443 2334567899999999998654 89999999999999999995 555555555566555544 456
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
+..+..+++++.+||.+||+.||++|||+.+|++.|+++..+.
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 6678889999999999999999999999999999999987653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=428.54 Aligned_cols=257 Identities=32% Similarity=0.501 Sum_probs=219.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECC-------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVA 1031 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVk 1031 (1254)
.|..++|+++++||+|+||+||+|++.+ ..||+|++.... .......+.+|+.+|+++ +|||||+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~HpnIv~ 105 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-------DSSEREALMSELKMMTQLGSHENIVN 105 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-------CHHHHHHHHHHHHHHHHhcCCCcEeE
Confidence 4666789999999999999999999843 248999886432 222346788999999988 8999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccC----------------------CCCCHHHHHHHHHHhhhhhHHhhhC
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD----------------------RSLDRRKKLIIAMDAAFGMEYLHSK 1089 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre----------------------~~LSe~~~lkIa~QIAeALaYLHSk 1089 (1254)
+++++.+.. .+++|||||++|+|.+++..+. ..+++..++.|+.||+.||.|||++
T Consensus 106 l~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~ 183 (325)
T d1rjba_ 106 LLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 183 (325)
T ss_dssp EEEEECSSS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEeeCC--eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 999998765 7999999999999999996543 2478999999999999999999999
Q ss_pred CcccccCCCCceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHH
Q 040257 1090 NIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMW 1166 (1254)
Q Consensus 1090 GIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILY 1166 (1254)
+||||||||+|||++ .++++||+|||+|+...... ......||+.|||||++.+. .|+.++|||||||+||
T Consensus 184 ~IiHRDlKp~Nill~----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil~ 257 (325)
T d1rjba_ 184 SCVHRDLAARNVLVT----HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLW 257 (325)
T ss_dssp TEEETTCSGGGEEEE----TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHH
T ss_pred CeeeccCchhccccc----cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC--CCCcceeccchhHHHH
Confidence 999999999999999 78899999999998543322 23345689999999999865 4899999999999999
Q ss_pred HHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1167 EILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1167 ELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
||+| |+.||.+......+..++....++..+..+++++++||.+||+.||++|||++||+++|..
T Consensus 258 emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 258 EIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 9998 8999998877777777777778888888999999999999999999999999999999863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=425.00 Aligned_cols=247 Identities=27% Similarity=0.438 Sum_probs=214.2
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|+++++||+|+||+||+|+++ ++.||||+++..... ..+.+.+|+.+|++++||||++++++|.+++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLVGD- 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--------CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--------HHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-
Confidence 37999999999999999999974 788999999864321 1356889999999999999999999998766
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+|+|.+++.+ +.+++..++.|+.||+.||.|||++|||||||||+|||++ .++++||+|||+|
T Consensus 91 -~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~vkl~DFG~a 163 (293)
T d1yhwa1 91 -ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFC 163 (293)
T ss_dssp -EEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred -EEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC----CCCcEeeccchhh
Confidence 89999999999999998754 4699999999999999999999999999999999999998 6789999999999
Q ss_pred ccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc-cCCCCCCCC
Q 040257 1122 RIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN-TLRPTIPER 1199 (1254)
Q Consensus 1122 r~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~-~Lrp~ipe~ 1199 (1254)
+.... .......+||+.|+|||++.+.. |+.++|||||||+||+|++|+.||.+.+....+..+... ......+..
T Consensus 164 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T d1yhwa1 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (293)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHSSSC--BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGG
T ss_pred eeeccccccccccccCCCccChhhhcCCC--CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Confidence 86543 33445667999999999999764 789999999999999999999999988776666655544 333455677
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++++++||.+||+.||.+|||+.|+++|
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=425.70 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=215.8
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|++++.||+|+||+||+|+++ ++.||||++++... ...+.+.+|+++|++++|||||++++++.++.
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-- 82 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--------EELEDYMVEIDILASCDHPNIVKLLDAFYYEN-- 82 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--------GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--------HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--
Confidence 5899999999999999999984 67899999975421 12356789999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++|||||.+|+|.+++.+..+.+++..++.++.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~----~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT----LDGDIKLADFGVSA 158 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTTCE
T ss_pred eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC----CCCCEEEEechhhh
Confidence 89999999999999999877777899999999999999999999999999999999999998 77899999999997
Q ss_pred cccCc-cccCCCCCCCCccCcccccCC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC-CCCC
Q 040257 1123 IKRNT-LVSGGVRGTLPWMAPELLNGS---SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR-PTIP 1197 (1254)
Q Consensus 1123 ~~~~s-~~sts~~GT~~YmAPEVLrG~---~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr-p~ip 1197 (1254)
..... ......+||+.|+|||++.+. ...|+.++|||||||+||||++|+.||.+.+..+.+..+...... ...+
T Consensus 159 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (288)
T d2jfla1 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238 (288)
T ss_dssp ECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSG
T ss_pred ccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 54332 233457799999999998642 224789999999999999999999999998888877777765432 2345
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+++++++||.+||+.||.+|||+.|++++
T Consensus 239 ~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 6789999999999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=418.25 Aligned_cols=265 Identities=33% Similarity=0.565 Sum_probs=226.4
Q ss_pred ccccCceEEEE-EeeeCcEEEEEEEEC----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeee
Q 040257 961 IKNVDLEELRE-LGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGV 1035 (1254)
Q Consensus 961 Ik~~dYeiLkk-LGeGsFGtVYlAk~r----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGv 1035 (1254)
++..+|.+... ||+|+||+||+|.++ +..||||+++... .....++|.+|+++|++++|||||+++++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-------CHHHHHHHHHHHHHHHhCCCCCEeeEeee
Confidence 45567888874 999999999999874 3469999997532 22345679999999999999999999999
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
+.++ .+++||||+++|+|.+++......+++..++.|+.||+.||.|||+++||||||||+||||+ .++.+||
T Consensus 78 ~~~~---~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~----~~~~~Kl 150 (285)
T d1u59a_ 78 CQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKI 150 (285)
T ss_dssp EESS---SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----ETTEEEE
T ss_pred eccC---eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec----cCCceee
Confidence 9653 58999999999999999877667899999999999999999999999999999999999999 7889999
Q ss_pred EeccccccccCc----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhc
Q 040257 1116 GDFGLSRIKRNT----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKN 1190 (1254)
Q Consensus 1116 iDFGLAr~~~~s----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~ 1190 (1254)
+|||+++..... .......||+.|+|||++.+.. ++.++|||||||+||||+| |+.||......+....+..+
T Consensus 151 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~ 228 (285)
T d1u59a_ 151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 228 (285)
T ss_dssp CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT
T ss_pred ccchhhhcccccccccccccccccCccccChHHHhCCC--CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999999865332 1223456899999999998664 8999999999999999998 99999988877776666543
Q ss_pred cCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhcccC
Q 040257 1191 TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKCIN 1242 (1254)
Q Consensus 1191 ~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk~~k 1242 (1254)
.++..+..+++++.+||.+||+.||++|||+.+|++.|+.+..++..+...
T Consensus 229 -~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~~ 279 (285)
T d1u59a_ 229 -KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279 (285)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccch
Confidence 456678889999999999999999999999999999999998887765544
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=414.59 Aligned_cols=260 Identities=33% Similarity=0.590 Sum_probs=214.3
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECC------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRG------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rG------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
+|...+|++.++||+|+||+||+|++++ ..||||+++... ......+|.+|+.+|++++|||||+++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~il~~l~H~nIv~~~ 75 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-------TEKQRVDFLGEAGIMGQFSHHNIIRLE 75 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-------ChHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 4566789999999999999999998853 359999986532 122345789999999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
+++.+.. .+++||||+.+++|.+++......+++..++.++.||+.||.|||+++||||||||+||||+ .++.+
T Consensus 76 g~~~~~~--~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~----~~~~~ 149 (283)
T d1mqba_ 76 GVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVC 149 (283)
T ss_dssp EEECSSS--SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCE
T ss_pred EEEecCC--ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEEC----CCCeE
Confidence 9997655 78999999999999998877777899999999999999999999999999999999999999 78899
Q ss_pred EEEeccccccccCc----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCChhhHHHHhh
Q 040257 1114 KVGDFGLSRIKRNT----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEP-YADMHCGAIIGGIV 1188 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~P-F~~~n~~eliqsIl 1188 (1254)
||+|||+++..... .......||+.|+|||++.+. .++.++|||||||+||||++|..| |......+....+
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i- 226 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI- 226 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-
T ss_pred EEcccchhhcccCCCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH-
Confidence 99999999864332 122345689999999999876 489999999999999999996555 5555555555544
Q ss_pred hccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1189 KNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1189 k~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
....++..+..++.++.+||.+||+.||++|||+.+|++.|+.+.+.
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 44556677888999999999999999999999999999999988763
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-49 Score=422.89 Aligned_cols=258 Identities=33% Similarity=0.560 Sum_probs=219.5
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVV 1036 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf 1036 (1254)
++|...+|++.++||+|+||+||+|+++ ++.||||+++.... ..++|.+|+.+|++++|||||+++++|
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---------~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------EVEEFLKEAAVMKEIKHPNLVQLLGVC 82 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---------hHHHHHHHHHHHHhCCCCCEecCCccE
Confidence 4677789999999999999999999994 67899999875421 135688999999999999999999999
Q ss_pred ecCCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1037 PDGTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1037 ~Ddn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
.++. .+++||||+.+|+|.+++.+. ...+++..++.|+.||+.||+|||+++||||||||+||||+ .++.+||
T Consensus 83 ~~~~--~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~----~~~~~Kl 156 (287)
T d1opja_ 83 TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKV 156 (287)
T ss_dssp CSSS--SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEE
T ss_pred eeCC--eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC----CCCcEEE
Confidence 8655 789999999999999998653 45789999999999999999999999999999999999998 7789999
Q ss_pred EeccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC
Q 040257 1116 GDFGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1116 iDFGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr 1193 (1254)
+|||+|+...... ......|++.|+|||++.+. .|+.++|||||||+||||++|..||........+..++....+
T Consensus 157 ~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~ 234 (287)
T d1opja_ 157 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 234 (287)
T ss_dssp CCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ccccceeecCCCCceeeccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC
Confidence 9999998654332 23344588999999999866 4899999999999999999977666544444444445555667
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
+..+..+++++++||.+||+.||++|||+.+|++.|+.+.
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 7788899999999999999999999999999999998763
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-48 Score=425.02 Aligned_cols=248 Identities=27% Similarity=0.458 Sum_probs=216.4
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
.|+.++.||+|+||+||+|++. ++.||||++..... ......+.+.+|+.+|++++|||||++++++.++.
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-- 88 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-- 88 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-----cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC--
Confidence 4899999999999999999984 67799999986432 13344677899999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++|||||.+|+|..++. ..+.+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+
T Consensus 89 ~~~iv~E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSAS 163 (309)
T ss_dssp EEEEEEECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE----TTTEEEECCCTTCB
T ss_pred EEEEEEEecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC----CCCCEEEeeccccc
Confidence 8999999999999876654 446799999999999999999999999999999999999999 78899999999998
Q ss_pred cccCccccCCCCCCCCccCcccccCCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSS-NRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~-~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
..... ...+||+.|||||++.+.. ..|+.++|||||||+||||++|+.||.+......+..+.........+..++
T Consensus 164 ~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 240 (309)
T d1u5ra_ 164 IMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240 (309)
T ss_dssp SSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSC
T ss_pred ccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCC
Confidence 65432 3467999999999997642 3589999999999999999999999998888887777777766655667789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARPSFTEITS 1227 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRPSArELLe 1227 (1254)
+++++||.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 241 EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 99999999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-49 Score=426.90 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=202.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
..|++++.||+|+||+||+|+++ ++.||||++.+.... .....+.+|+.+|++++||||+++++++.++.
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~- 80 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-------GKEGSMENEIAVLHKIKHPNIVALDDIYESGG- 80 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-------hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 36999999999999999999985 778999999865321 12356789999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++|||||.+|+|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+|||+...+ .++.+||+|||+|
T Consensus 81 -~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~-~~~~vkl~DFG~a 157 (307)
T d1a06a_ 81 -HLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLS 157 (307)
T ss_dssp -EEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCCEEECCC---
T ss_pred -EEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccC-CCceEEEecccee
Confidence 89999999999999999855 45799999999999999999999999999999999999996332 5689999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC--CCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT--IPER 1199 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~--ipe~ 1199 (1254)
+...........+||+.|||||++.+.. |+.++|||||||+||||++|+.||.+.........+........ ....
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQKP--YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235 (307)
T ss_dssp ---------------CTTSCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTT
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCCC--CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccC
Confidence 8766655556678999999999999764 78999999999999999999999999888888888877655433 3467
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++++++||.+||++||.+|||+.|++++
T Consensus 236 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 89999999999999999999999999985
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=417.90 Aligned_cols=258 Identities=25% Similarity=0.351 Sum_probs=222.2
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|+++ ++.||||++++....... .....+.+.+|+.+|++++|||||+++++|.+..
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 86 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR--RGVSREDIEREVSILKEIQHPNVITLHEVYENKT- 86 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhh--hhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 47999999999999999999985 778999999865433211 1122467889999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++|||||.+|+|.+++... +.+++..++.++.||+.||+|||+++||||||||+|||++..+.....+||+|||++
T Consensus 87 -~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 87 -DVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp -EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred -EEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 899999999999999998654 569999999999999999999999999999999999999855545567999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC--CCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT--IPER 1199 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~--ipe~ 1199 (1254)
+............||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.+..+.+..+........ .+..
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred hhcCCCccccccCCCCcccCHHHHcCCC--CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCC
Confidence 8776655566678999999999998764 78999999999999999999999999888888877766554322 2356
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++++++||++||+.||.+|||++|++++
T Consensus 243 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=428.56 Aligned_cols=250 Identities=28% Similarity=0.463 Sum_probs=206.7
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+++++|+++++||+|+||+||+|+++ ++.||||+++... ......++.+|+.+|++++|||||+++++|.+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-------CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 56779999999999999999999984 7789999997542 11234678899999999999999999999987
Q ss_pred CCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+. .+++||||+.+|+|.+++.+. +.+++..++.++.||+.||.|||+ +|||||||||+||||+ .++++||+|
T Consensus 76 ~~--~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~----~~~~vkl~D 148 (322)
T d1s9ja_ 76 DG--EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCD 148 (322)
T ss_dssp SS--EEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC----TTCCEEECC
T ss_pred CC--EEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC----CCCCEEEee
Confidence 65 899999999999999998654 569999999999999999999997 5999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH------------
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIG------------ 1185 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliq------------ 1185 (1254)
||+|+..... .....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||...+......
T Consensus 149 FGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~--y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
T d1s9ja_ 149 FGVSGQLIDS-MANSFVGTRSYMSPERLQGTH--YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225 (322)
T ss_dssp CCCCHHHHHH-TC---CCSSCCCCHHHHHCSC--CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred CCCccccCCC-ccccccCCccccCchHHcCCC--CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCccc
Confidence 9999865433 234568999999999999864 8899999999999999999999997654322110
Q ss_pred ------------------------------HhhhccCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1186 ------------------------------GIVKNTLRPTIP-ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1186 ------------------------------sIlk~~Lrp~ip-e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+... ..+..+ ..++.++++||.+||+.||.+|||++|+|+|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE-PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------------------CCCCHHHHHHHHHTS-CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCcccccccccccccccccccchhHHHHHhhhhcc-CCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 01111 111122 3467899999999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.2e-48 Score=430.76 Aligned_cols=250 Identities=22% Similarity=0.343 Sum_probs=219.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||+|+++ ++.||||++.+.. ....+.+.+|+.+|++|+|||||+++++|.++.
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-- 96 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-- 96 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT--
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--------hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 7999999999999999999984 7789999997542 223467889999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++|||||.+|+|.+++....+.+++..++.|+.||+.||.|||++|||||||||+||||+.+ .++.+||+|||+++
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~--~~~~vkL~DFG~a~ 174 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--RSNELKLIDFGLTA 174 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC--CCCeEEEeecchhe
Confidence 8999999999999999997666779999999999999999999999999999999999999622 35789999999998
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC--CCCCC
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT--IPERC 1200 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~--ipe~i 1200 (1254)
............||+.|||||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..+....+... ....+
T Consensus 175 ~~~~~~~~~~~~gT~~Y~aPEv~~~~~--~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 252 (350)
T d1koaa2 175 HLDPKQSVKVTTGTAEFAAPEVAEGKP--VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252 (350)
T ss_dssp ECCTTSCEEEECSCTTTCCHHHHHTCC--BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGC
T ss_pred ecccccccceecCcccccCHHHHcCCC--CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCC
Confidence 776655556678999999999999764 78999999999999999999999999888888888776654332 23568
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++++++||.+||+.||++|||+.|++++
T Consensus 253 s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 253 SEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=411.66 Aligned_cols=252 Identities=36% Similarity=0.602 Sum_probs=221.0
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
...+|+++++||+|+||+||+|+++ ++.||||++++.... .++|.+|+.++++++||||+++++++.++.
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---------HHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---------HHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 3468999999999999999999996 557999999864321 246889999999999999999999997654
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+.+|+|.+++......+++..++.|+.||++||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 73 --~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~----~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 73 --PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGL 146 (258)
T ss_dssp --SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC----TTCCEEECCCSS
T ss_pred --ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc----CCCcEEECcchh
Confidence 79999999999999999877777899999999999999999999999999999999999998 788999999999
Q ss_pred cccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCC
Q 040257 1121 SRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIP 1197 (1254)
Q Consensus 1121 Ar~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ip 1197 (1254)
++...... ......||+.|+|||++.+.. ++.++|||||||++|||+| |+.||......+....+.. ..+...+
T Consensus 147 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p 223 (258)
T d1k2pa_ 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRP 223 (258)
T ss_dssp CCBCSSSSCCCCCCSCCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCC
T ss_pred heeccCCCceeecccCCCCCcCCcHHhcCCC--CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-CCCCCCc
Confidence 97544332 223456899999999998664 8999999999999999998 8999999988887777665 4466778
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 040257 1198 ERCDPEWRKLMEQCWAADPEARPSFTEITSRLRT 1231 (1254)
Q Consensus 1198 e~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~ 1231 (1254)
..+++++.+||.+||+.||++|||+.+++++|.+
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 8899999999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=424.56 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=216.9
Q ss_pred cccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC
Q 040257 962 KNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG 1039 (1254)
Q Consensus 962 k~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd 1039 (1254)
..++|++++.||+|+||+||+|+++ ++.||||++.+.... .....+.+.+|+++|++++||||++++++|.++
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 80 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-----KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 80 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-----CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence 3468999999999999999999984 778999999754221 222346788999999999999999999999876
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
. .+|+||||+.+|+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||
T Consensus 81 ~--~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~----~~~~vkl~DFG 153 (288)
T d1uu3a_ 81 E--KLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDFG 153 (288)
T ss_dssp S--EEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCCT
T ss_pred C--EEEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC----CCceEEecccc
Confidence 5 899999999999999988554 5699999999999999999999999999999999999998 77899999999
Q ss_pred ccccccC---ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1120 LSRIKRN---TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1120 LAr~~~~---s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
+|+.... .......+||+.|+|||++.+.. |+.++|||||||+||||++|+.||...+.......+....+ .+
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--~~ 229 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKS--ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY--DF 229 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC--CC
T ss_pred cceecccCCcccccccccCCccccCceeeccCC--CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC--CC
Confidence 9986532 22334567999999999998764 89999999999999999999999999888888887776543 46
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLR 1230 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le 1230 (1254)
+..+++++++||.+||+.||.+|||++|++++..
T Consensus 230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 7789999999999999999999999999876543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=409.96 Aligned_cols=261 Identities=33% Similarity=0.597 Sum_probs=214.8
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECC-----ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRG-----SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-----s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
.|...+|++++.||+|+||+||+|++.. ..||||.++... .....+.|.+|+.+|++++||||+++++
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 75 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLIG 75 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------SHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 4666789999999999999999998842 347888775321 2344577999999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
++.+ ..+++||||+.+|+|.+++......+++..++.++.||+.||.|||+++||||||||+|||++ ..+.+|
T Consensus 76 ~~~~---~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~----~~~~~K 148 (273)
T d1mp8a_ 76 VITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVK 148 (273)
T ss_dssp EECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEE
T ss_pred EEec---CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec----CCCcEE
Confidence 9964 368999999999999998877777899999999999999999999999999999999999999 778999
Q ss_pred EEeccccccccCc--cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhcc
Q 040257 1115 VGDFGLSRIKRNT--LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNT 1191 (1254)
Q Consensus 1115 LiDFGLAr~~~~s--~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~ 1191 (1254)
|+|||+++..... .......||+.|+|||++.+.. ++.++|||||||+||||++ |.+||......+....+..+.
T Consensus 149 l~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~--~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~ 226 (273)
T d1mp8a_ 149 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 226 (273)
T ss_dssp ECC-------------------CCGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EccchhheeccCCcceeccceecCcccchhhHhccCC--CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999865432 2334456899999999998664 8999999999999999998 899999988888877776543
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 040257 1192 LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1192 Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLE 1237 (1254)
.+..+..+++++.+||.+||+.||++|||+.||+++|+.++++-+
T Consensus 227 -~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 227 -RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 456778899999999999999999999999999999999877643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.4e-48 Score=427.92 Aligned_cols=250 Identities=21% Similarity=0.339 Sum_probs=219.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|++++.||+|+||+||+|+++ ++.||||++++.. ....+.+.+|+.+|++|+|||||+++++|.++.
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-- 99 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--------PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-- 99 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS--
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--------hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 6999999999999999999984 7889999997542 112356789999999999999999999998765
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+|+|||||.+|+|.+.+......+++..++.|+.||+.||.|||++|||||||||+||||+.. ..+.+||+|||+|+
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~--~~~~vkL~DFGla~ 177 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK--KASSVKIIDFGLAT 177 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TCCCEEECCCTTCE
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc--CCCeEEEeecccce
Confidence 8999999999999999887777789999999999999999999999999999999999999732 45789999999998
Q ss_pred cccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC--CCCCCC
Q 040257 1123 IKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP--TIPERC 1200 (1254)
Q Consensus 1123 ~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp--~ipe~i 1200 (1254)
............||+.|+|||++.+.. |+.++|||||||+||+|++|+.||.+......+..+....... .....+
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 255 (352)
T d1koba_ 178 KLNPDEIVKVTTATAEFAAPEIVDREP--VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255 (352)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTTCC--BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTS
T ss_pred ecCCCCceeeccCcccccCHHHHcCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCC
Confidence 776655555677999999999998764 8999999999999999999999999988888888877665433 344678
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
++++++||.+||++||.+|||+.|++++
T Consensus 256 s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 256 SPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=412.29 Aligned_cols=249 Identities=29% Similarity=0.501 Sum_probs=208.3
Q ss_pred ceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC--CC
Q 040257 966 LEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG--TG 1041 (1254)
Q Consensus 966 YeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd--n~ 1041 (1254)
|++.++||+|+||+||+|+++ +..||+|++..... .....+.+.+|+++|++++|||||+++++|.+. ..
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL------TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC------CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 366778999999999999985 66799999976532 122356789999999999999999999998642 33
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCC--cccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKN--IVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkG--IIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
..+++||||+++|+|.+++.+. ..+++..++.|+.||+.||.|||+++ ||||||||+||||+. .++.+||+|||
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~---~~~~~Kl~DFG 160 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLG 160 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS---TTSCEEECCTT
T ss_pred CEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC---CCCCEEEeecC
Confidence 4689999999999999998654 56999999999999999999999998 999999999999961 46789999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hhHHHHhhhccCCCCCCC
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC-GAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~-~eliqsIlk~~Lrp~ipe 1198 (1254)
+++...... ....+||+.|||||++.+. |+.++|||||||+||||++|+.||..... ......+.....+...+.
T Consensus 161 la~~~~~~~-~~~~~GT~~Y~aPE~~~~~---~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 236 (270)
T d1t4ha_ 161 LATLKRASF-AKAVIGTPEFMAPEMYEEK---YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236 (270)
T ss_dssp GGGGCCTTS-BEESCSSCCCCCGGGGGTC---CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred cceeccCCc-cCCcccCccccCHHHhCCC---CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCc
Confidence 998654433 3456799999999999753 89999999999999999999999987554 444455554444445566
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+++++++||.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 788999999999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=410.71 Aligned_cols=254 Identities=31% Similarity=0.564 Sum_probs=213.1
Q ss_pred EEEeeeCcEEEEEEEEC----CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceE
Q 040257 970 RELGSGTYGTVYHGKWR----GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 970 kkLGeGsFGtVYlAk~r----Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~ 1045 (1254)
++||+|+||+||+|.++ ++.||||+++... ......++|.+|+.+|++++|||||++++++.++ .++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~ 83 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA------NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWM 83 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh------CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---CEE
Confidence 57999999999999874 3469999997542 1234457899999999999999999999999653 478
Q ss_pred EEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1046 TVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
+||||+++|+|.+++.+ ...+++..++.|+.||+.||.|||+++||||||||+||||+ .++.+||+|||+++...
T Consensus 84 lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~----~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFGLSKALR 158 (277)
T ss_dssp EEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc----ccCcccccchhhhhhcc
Confidence 99999999999998854 45699999999999999999999999999999999999999 78899999999998543
Q ss_pred Cc----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1126 NT----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1126 ~s----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
.. .......||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.+....+....+.. ..++..+..+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~ 235 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGC 235 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTC
T ss_pred ccccccccccccCCCceecCchhhcCCC--CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc-CCCCCCCccc
Confidence 32 1223456899999999998654 8999999999999999998 8999999887776665554 3456778889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhhcc
Q 040257 1201 DPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIESKC 1240 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEsk~ 1240 (1254)
++++++||.+||+.||.+|||+.+|++.|+.....+-.+.
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~e~ 275 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCCCC
Confidence 9999999999999999999999999999998877665543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=423.17 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=219.4
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
-.+|++++.||+|+||+||+|+++ ++.||||++++.... .....+.+.+|+.+|++++||||++++++|.+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc-----CHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence 348999999999999999999984 778999999865321 1223467889999999999999999999998765
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+|+|||||.+|+|..++.+. +.+++..++.++.||+.||+|||++|||||||||+||||+ .++++||+|||+
T Consensus 79 --~~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~----~~g~vkl~DFG~ 151 (337)
T d1o6la_ 79 --RLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGL 151 (337)
T ss_dssp --EEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCCTT
T ss_pred --ccccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec----CCCCEEEeeccc
Confidence 899999999999999988554 5699999999999999999999999999999999999998 788999999999
Q ss_pred cccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1121 SRIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1121 Ar~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
|+.... .......+||+.|+|||++.+.. |+.++|||||||+||||++|+.||...+..++...+.... ..+|..
T Consensus 152 a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~--y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~~~p~~ 227 (337)
T d1o6la_ 152 CKEGISDGATMKTFCGTPEYLAPEVLEDND--YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRT 227 (337)
T ss_dssp CBCSCCTTCCBCCCEECGGGCCGGGGSSSC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTT
T ss_pred ccccccCCcccccceeCHHHhhhhhccCCC--CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--CCCCcc
Confidence 986533 33445678999999999999875 7889999999999999999999999999888888877765 456788
Q ss_pred CcHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPS-----FTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPS-----ArELLe~ 1228 (1254)
+++++++||++||++||.+|++ +.++++|
T Consensus 228 ~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 9999999999999999999994 8888875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=414.98 Aligned_cols=261 Identities=29% Similarity=0.573 Sum_probs=219.1
Q ss_pred cccccccCceEEEEEeeeCcEEEEEEEEC--Cc----eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeE
Q 040257 958 LQIIKNVDLEELRELGSGTYGTVYHGKWR--GS----DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVA 1031 (1254)
Q Consensus 958 lq~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs----~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVk 1031 (1254)
++.++..+|+++++||+|+||+||+|++. ++ .||+|+++... .....++|.+|+.+|++++|||||+
T Consensus 3 ~~~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~ 75 (317)
T d1xkka_ 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCR 75 (317)
T ss_dssp SEECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------CTHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCEee
Confidence 35677789999999999999999999984 33 47888776431 1223567899999999999999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCC
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRP 1111 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG 1111 (1254)
++++|.++ ..+++|||+.+++|.+.+......+++..++.|+.||+.||.|||+++||||||||+||||+ .++
T Consensus 76 l~g~~~~~---~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~----~~~ 148 (317)
T d1xkka_ 76 LLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQ 148 (317)
T ss_dssp EEEEEESS---SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETT
T ss_pred EEEEEecC---CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC----CCC
Confidence 99999864 47789999999999999888888899999999999999999999999999999999999999 788
Q ss_pred eEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHh
Q 040257 1112 ICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGI 1187 (1254)
Q Consensus 1112 ~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsI 1187 (1254)
++||+|||+++...... ......||+.|+|||++.+. .|+.++|||||||+||||+| |..||......++...+
T Consensus 149 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i 226 (317)
T d1xkka_ 149 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226 (317)
T ss_dssp EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH
T ss_pred CeEeeccccceecccccccccccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 99999999998653322 22334689999999999876 48999999999999999998 89999988777766555
Q ss_pred hhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1188 VKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1188 lk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
.. ..++..+..+++++.+||.+||..||.+|||+.||+++|..+...
T Consensus 227 ~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 227 EK-GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HH-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred Hc-CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 44 455667788999999999999999999999999999999988654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=409.11 Aligned_cols=262 Identities=30% Similarity=0.503 Sum_probs=212.2
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeE
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVA 1031 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVk 1031 (1254)
.|...+|+++++||+|+||+||+|++. ++.||||+++... .....+.+.+|..++.++ +|+||+.
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-------CcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 466678999999999999999999974 2469999987432 122345677888877766 6899999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccC
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDL 1096 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDL 1096 (1254)
+++++.+.. ..+++|||||.+|+|.+++..+. ..+++..++.++.||+.||.|||+++||||||
T Consensus 82 ~~~~~~~~~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDl 160 (299)
T d1ywna1 82 LLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 160 (299)
T ss_dssp EEEEECSTT-SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred eeeeeccCC-CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcC
Confidence 999886543 46899999999999999986432 34899999999999999999999999999999
Q ss_pred CCCceEeccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcC-C
Q 040257 1097 KCENLLVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG-E 1172 (1254)
Q Consensus 1097 KPeNILLDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTG-k 1172 (1254)
||+||||+ .++++||+|||+|+..... .......||+.|+|||++.+. .++.++|||||||++|||++| .
T Consensus 161 Kp~NILl~----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~ 234 (299)
T d1ywna1 161 AARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGA 234 (299)
T ss_dssp CGGGEEEC----GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccceeEC----CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCC
Confidence 99999998 7789999999999754332 233456799999999999875 489999999999999999986 5
Q ss_pred CCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1173 EPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1173 ~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
.||........+...+....++..+..+++++++||.+||+.||++|||+.|++++|+.++++
T Consensus 235 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 235 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 688877766666666666667788888999999999999999999999999999999998754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=410.15 Aligned_cols=259 Identities=35% Similarity=0.596 Sum_probs=215.9
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEECC-----ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWRG-----SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYG 1034 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-----s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyG 1034 (1254)
.|...+|++++.||+|+||+||+|++.. ..||||++++.... .....+.|.+|+.+|++++||||+++++
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~~~g 78 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPEAMDDFIREVNAMHSLDHRNLIRLYG 78 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC-----CHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3566789999999999999999998742 25899998754321 2344578999999999999999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEE
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICK 1114 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VK 1114 (1254)
++.++ .+++||||+.+++|.+.+..+...+++..++.++.||+.||.|||+++|+||||||+||||+ .++.+|
T Consensus 79 ~~~~~---~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~----~~~~vk 151 (273)
T d1u46a_ 79 VVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA----TRDLVK 151 (273)
T ss_dssp EECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTEEE
T ss_pred EEeec---chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc----ccccee
Confidence 99653 57899999999999999877777899999999999999999999999999999999999999 678999
Q ss_pred EEeccccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhh
Q 040257 1115 VGDFGLSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVK 1189 (1254)
Q Consensus 1115 LiDFGLAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk 1189 (1254)
|+|||+++...... ......|+..|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..+....+..
T Consensus 152 l~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~ 229 (273)
T d1u46a_ 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229 (273)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred eccchhhhhcccCCCcceecCccccCcccCCHHHHhCCC--CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh
Confidence 99999998653322 223445788999999999764 8999999999999999998 8999999999998888888
Q ss_pred ccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 040257 1190 NTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTI 1232 (1254)
Q Consensus 1190 ~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~L 1232 (1254)
...++..+..++.++++||.+||..||++|||+.+|++.|+++
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 8888888888999999999999999999999999999988764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.3e-47 Score=401.53 Aligned_cols=258 Identities=25% Similarity=0.372 Sum_probs=213.3
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
++|++++.||+|+||+||+|++. ++.||||++++.... .......+.+|+.+|++++||||+++++++.....
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc-----CHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 47999999999999999999984 788999999865321 23445779999999999999999999999876443
Q ss_pred --CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1042 --GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1042 --~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
..+|+||||+.+++|.+++... +.+++..++.|+.||+.||+|||++|||||||||+||||+ ..+.++|+|||
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~----~~~~~~l~d~~ 156 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS----ATNAVKVMDFG 156 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----TTSCEEECCCT
T ss_pred CCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC----ccccceeehhh
Confidence 3588999999999999988554 5699999999999999999999999999999999999999 78899999999
Q ss_pred ccccccCc----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC-
Q 040257 1120 LSRIKRNT----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP- 1194 (1254)
Q Consensus 1120 LAr~~~~s----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp- 1194 (1254)
.+...... ......+||+.|+|||++.+.. ++.++|||||||+||||+||+.||...+..+....+......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS--VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCCC--CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC
Confidence 98643222 2334567999999999998764 8999999999999999999999999888777777666654432
Q ss_pred -CCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHH
Q 040257 1195 -TIPERCDPEWRKLMEQCWAADPEARP-SFTEITSRLRTIS 1233 (1254)
Q Consensus 1195 -~ipe~iS~eLrdLIkKCLqkDPeKRP-SArELLe~Le~Ll 1233 (1254)
.....+++++.+||.+||++||.+|| |+++++..|..+.
T Consensus 235 ~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 23467899999999999999999999 8999999988774
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.1e-47 Score=406.09 Aligned_cols=258 Identities=24% Similarity=0.295 Sum_probs=223.3
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCch-hHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSS-EQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDG 1039 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~-e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Dd 1039 (1254)
.+|++++.||+|+||+||+|++ +++.||||++.+........ ..+...+.+.+|+.+|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5899999999999999999998 47889999998765433222 33456678999999999997 99999999999876
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
. .+|+||||+.+|+|.+++..+ +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 83 ~--~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----~~~~~kl~DFG 155 (277)
T d1phka_ 83 T--FFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDFG 155 (277)
T ss_dssp S--EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCT
T ss_pred c--ceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc----CCCCeEEccch
Confidence 5 899999999999999999654 5799999999999999999999999999999999999998 78899999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCC----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGS----SNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~----~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ 1195 (1254)
+++............||+.|+|||++.+. ...++.++|||||||+||+|++|+.||.+.........+........
T Consensus 156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred heeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 99876665555667899999999998642 22478899999999999999999999999888887777777655433
Q ss_pred C--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1196 I--PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1196 i--pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
. ...+++++++||.+||+.||.+|||+.|++++
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 3 34689999999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-47 Score=414.54 Aligned_cols=247 Identities=26% Similarity=0.449 Sum_probs=216.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|++++.||+|+||+||+|+++ ++.||||++++.... .....+.+.+|+.+|++++||||+++++++.+..
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 77 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-----RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ- 77 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-----CHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC-
Confidence 37999999999999999999985 788999999864321 1223567889999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.+|+|..++.. ...+++..++.++.||+.||.|||++|||||||||+||||+ .++.+||+|||+|
T Consensus 78 -~~~ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~----~~g~vkL~DFG~a 151 (316)
T d1fota_ 78 -QIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFA 151 (316)
T ss_dssp -EEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTSCEEECCCSSC
T ss_pred -eeeeEeeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc----CCCCEEEecCccc
Confidence 89999999999999988854 45689999999999999999999999999999999999998 7889999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCCc
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERCD 1201 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS 1201 (1254)
+..... ....+||+.|+|||++.+.. |+.++|||||||+||||++|+.||.+.+..+....+..... .++..++
T Consensus 152 ~~~~~~--~~~~~Gt~~Y~APE~l~~~~--y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s 225 (316)
T d1fota_ 152 KYVPDV--TYTLCGTPDYIAPEVVSTKP--YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--RFPPFFN 225 (316)
T ss_dssp EECSSC--BCCCCSCTTTCCHHHHTTCC--BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--CCCTTSC
T ss_pred eEeccc--cccccCcccccCHHHHcCCC--CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC--CCCCCCC
Confidence 876543 33578999999999998764 78899999999999999999999999988888888877643 4667889
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1202 PEWRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1202 ~eLrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
++++++|.+||.+||.+|+ |++++++|
T Consensus 226 ~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 9999999999999999996 89999885
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=404.27 Aligned_cols=256 Identities=34% Similarity=0.626 Sum_probs=215.9
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD 1038 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D 1038 (1254)
+.|...+|++++.||+|+||.||+|+++++.||||++++.. ..+.|.+|++++++++||||+++++++.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVE 71 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----------HHHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence 35666789999999999999999999999999999997532 23568899999999999999999999865
Q ss_pred CCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
.. ..+++||||+++|+|.+++.++. ..+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 72 ~~-~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~----~~~~~kl~d 146 (262)
T d1byga_ 72 EK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSD 146 (262)
T ss_dssp C---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTSCEEECC
T ss_pred cC-CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec----CCCCEeecc
Confidence 43 36899999999999999986543 3589999999999999999999999999999999999999 788999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHHhhhccCCCCC
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT-GEEPYADMHCGAIIGGIVKNTLRPTI 1196 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT-Gk~PF~~~n~~eliqsIlk~~Lrp~i 1196 (1254)
||+++...... ....+|..|+|||++.+. .++.++|||||||++|||+| |++||......+....+.. ..++..
T Consensus 147 fg~s~~~~~~~--~~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-~~~~~~ 221 (262)
T d1byga_ 147 FGLTKEASSTQ--DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDA 221 (262)
T ss_dssp CCC--------------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCC
T ss_pred cccceecCCCC--ccccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCC
Confidence 99998654432 335689999999999865 48999999999999999998 7999988877777777654 456677
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1197 PERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1197 pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
+..+++++++||.+||..||.+|||+.+|+++|+.+..
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 88899999999999999999999999999999998854
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-46 Score=405.22 Aligned_cols=257 Identities=31% Similarity=0.569 Sum_probs=218.8
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEECC-------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWRG-------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY 1033 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~rG-------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy 1033 (1254)
+..++|++++.||+|+||+||+|++++ +.||||+++... .....++|.+|+.+|++++||||++++
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~il~~l~h~niv~~~ 82 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDNPNIVKLL 82 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-------ChHHHHHHHHHHHHHHhcCCCCcccce
Confidence 445689999999999999999999853 569999987432 233457899999999999999999999
Q ss_pred eeeecCCCCceEEEEEecccCchhhhhhccC-----------------------CCCCHHHHHHHHHHhhhhhHHhhhCC
Q 040257 1034 GVVPDGTGGTLATVTEFMVNGSLKHVLLKKD-----------------------RSLDRRKKLIIAMDAAFGMEYLHSKN 1090 (1254)
Q Consensus 1034 Gvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre-----------------------~~LSe~~~lkIa~QIAeALaYLHSkG 1090 (1254)
+++.+.. .++++|||+.+|+|.+++.... ..+++..++.|+.||+.||+|||+++
T Consensus 83 ~~~~~~~--~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 160 (301)
T d1lufa_ 83 GVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160 (301)
T ss_dssp EEECSSS--SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeeccCC--ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence 9997654 7899999999999999985432 24889999999999999999999999
Q ss_pred cccccCCCCceEeccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHH
Q 040257 1091 IVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWE 1167 (1254)
Q Consensus 1091 IIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYE 1167 (1254)
||||||||+||||+ .++.+||+|||+|+..... .......||+.|+|||++.+.. |+.++|||||||+|||
T Consensus 161 ivHrDlKp~NILld----~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~t~ksDVwS~Gvvl~e 234 (301)
T d1lufa_ 161 FVHRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWE 234 (301)
T ss_dssp CCCSCCSGGGEEEC----GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHH
T ss_pred eEeeEEcccceEEC----CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC--CChhhhhccchhhHHH
Confidence 99999999999999 7789999999999754332 2334467889999999998764 8999999999999999
Q ss_pred HHcCC-CCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 040257 1168 ILTGE-EPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTIS 1233 (1254)
Q Consensus 1168 LLTGk-~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll 1233 (1254)
|++|. +||......+....+..+. .+..+..+++++.+||.+||+.+|.+|||+.||+++|+.+.
T Consensus 235 ll~~~~~p~~~~~~~e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 235 IFSYGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHccCCCCCCCCCHHHHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 99985 6888888888877776654 45678889999999999999999999999999999998763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-47 Score=411.73 Aligned_cols=250 Identities=20% Similarity=0.238 Sum_probs=217.8
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
++|++++.||+|+||+||+|.++ ++.||||++++.. .....+.+|+++|++++||||++++++|.++.
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~- 74 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---------TDQVLVKKEISILNIARHRNILHLHESFESME- 74 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-
Confidence 37999999999999999999984 7789999997642 11245789999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+|+|||||.+|+|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++.+ ....+||+|||++
T Consensus 75 -~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~--~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 75 -ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKIIEFGQA 151 (321)
T ss_dssp -EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECCCTTC
T ss_pred -EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC--CceEEEEcccchh
Confidence 8999999999999999997766679999999999999999999999999999999999999732 3468999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCC--CCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPT--IPER 1199 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~--ipe~ 1199 (1254)
+............+|+.|+|||.+.+.. |+.++|||||||+||+|++|+.||...+..+.+..+....+... ....
T Consensus 152 ~~~~~~~~~~~~~~t~~y~ape~~~~~~--~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (321)
T d1tkia_ 152 RQLKPGDNFRLLFTAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229 (321)
T ss_dssp EECCTTCEEEEEESCGGGSCHHHHTTCE--ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred hccccCCcccccccccccccchhccCCC--CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccC
Confidence 8765554455567999999999998764 78999999999999999999999999988888888877654432 1246
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
+++++++||.+||.+||.+|||+.|++++
T Consensus 230 ~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 230 ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=405.96 Aligned_cols=259 Identities=32% Similarity=0.552 Sum_probs=211.8
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEECC-ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWRG-SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVP 1037 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~rG-s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~ 1037 (1254)
+.|...+|++.+.||+|+||+||+|++++ +.||||+++.... ..+.|.+|+.+|++++|||||++++++.
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---------~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 82 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAVVS 82 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---------CHHHHHHHHHHHHhcccCCEeEEEEEEe
Confidence 45667799999999999999999999964 5699999875421 1256889999999999999999999986
Q ss_pred cCCCCceEEEEEecccCchhhhhhcc-CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKK-DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kr-e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
++ .+++||||+.+|+|..++... ...+++..++.|+.||+.||+|||+++|+||||||+||||+ .++.+||+
T Consensus 83 ~~---~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~----~~~~~kl~ 155 (285)
T d1fmka3 83 EE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVA 155 (285)
T ss_dssp SS---SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEEC
T ss_pred cC---CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC----CCCcEEEc
Confidence 43 578999999999999887643 35699999999999999999999999999999999999998 67899999
Q ss_pred eccccccccCcc--ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCC-CCCChhhHHHHhhhccCC
Q 040257 1117 DFGLSRIKRNTL--VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPY-ADMHCGAIIGGIVKNTLR 1193 (1254)
Q Consensus 1117 DFGLAr~~~~s~--~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF-~~~n~~eliqsIlk~~Lr 1193 (1254)
|||+++...... ......||+.|+|||++... .++.++|||||||+||||++|..|| ......+.+..+.. ..+
T Consensus 156 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~-~~~ 232 (285)
T d1fmka3 156 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYR 232 (285)
T ss_dssp CCCTTC--------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCC
T ss_pred ccchhhhccCCCceeeccccccccccChHHHhCC--CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCC
Confidence 999998653322 23345689999999999865 4899999999999999999965554 55555555555544 455
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
...+..+++++++||.+||+.||++||++.+|++.|+......
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 6678889999999999999999999999999999988766443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-46 Score=414.72 Aligned_cols=248 Identities=23% Similarity=0.382 Sum_probs=217.1
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
-.+|++++.||+|+||+||+|+++ ++.||||++.+.... .....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-----KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-----CHHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence 357999999999999999999984 788999999754221 1223467889999999999999999999998765
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+++||||+.+|+|..++.+. +.+++..++.|+.||+.||.|||+++||||||||+||||+ .++++||+|||+
T Consensus 115 --~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~----~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 115 --NLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFGF 187 (350)
T ss_dssp --EEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTT
T ss_pred --ccccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC----CCCCEEeeecee
Confidence 899999999999999998654 4699999999999999999999999999999999999998 778999999999
Q ss_pred cccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCCC
Q 040257 1121 SRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPERC 1200 (1254)
Q Consensus 1121 Ar~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~i 1200 (1254)
|+..... ....+||+.|||||++.+.. |+.++|||||||+||||+||+.||.+.+....+..+..... ..+..+
T Consensus 188 a~~~~~~--~~~~~Gt~~Y~APE~~~~~~--~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~ 261 (350)
T d1rdqe_ 188 AKRVKGR--TWTLCGTPEALAPEIILSKG--YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--RFPSHF 261 (350)
T ss_dssp CEECSSC--BCCCEECGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTC
T ss_pred eeecccc--cccccCccccCCHHHHcCCC--CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC--CCCccC
Confidence 9876543 23467999999999999764 78999999999999999999999999888888888776643 456789
Q ss_pred cHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
++++.+||++||++||.+|+ |+.++++|
T Consensus 262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 99999999999999999994 89999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=405.65 Aligned_cols=260 Identities=33% Similarity=0.573 Sum_probs=218.6
Q ss_pred cccccCceEEEEEeeeCcEEEEEEEEC--Cc--eEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCceeEEee
Q 040257 960 IIKNVDLEELRELGSGTYGTVYHGKWR--GS--DVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVVAFYG 1034 (1254)
Q Consensus 960 ~Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs--~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIVkLyG 1034 (1254)
.|...+|++.++||+|+||+||+|+++ +. .||||+++... .....+.|.+|+++|+++ +|||||++++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~HpnIv~~~~ 78 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLG 78 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-------ChHHHHHHHHHHHHHHhccCCCCEeeEEE
Confidence 355678999999999999999999985 33 47788876432 122346789999999998 7999999999
Q ss_pred eeecCCCCceEEEEEecccCchhhhhhcc---------------CCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCC
Q 040257 1035 VVPDGTGGTLATVTEFMVNGSLKHVLLKK---------------DRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCE 1099 (1254)
Q Consensus 1035 vf~Ddn~~~L~LVMEYm~GGSL~d~L~kr---------------e~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPe 1099 (1254)
++.+.. .+++||||+++|+|.+++.+. ...+++..++.++.||+.||.|||+++||||||||+
T Consensus 79 ~~~~~~--~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~ 156 (309)
T d1fvra_ 79 ACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 156 (309)
T ss_dssp EEEETT--EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEecCC--eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccc
Confidence 998765 899999999999999998643 356999999999999999999999999999999999
Q ss_pred ceEeccCCCCCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCC-CCCCCC
Q 040257 1100 NLLVNLRDPQRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGE-EPYADM 1178 (1254)
Q Consensus 1100 NILLDsdd~snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk-~PF~~~ 1178 (1254)
|||++ ..+.+||+|||+++............||..|+|||.+.+.. ++.++|||||||++|||++|. +||...
T Consensus 157 NIL~~----~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 157 NILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp GEEEC----GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eEEEc----CCCceEEccccccccccccccccceecCCcccchHHhccCC--CCccceeehhHHHHHHHHhcCCCCCCCC
Confidence 99998 77899999999998665554445567999999999998664 899999999999999999965 678888
Q ss_pred ChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1179 HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1179 n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
+..+....+..+ .++..+..+++++++||.+||+.||++|||+.||+++|+.++++
T Consensus 231 ~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 231 TCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp CHHHHHHHGGGT-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CHHHHHHHHHhc-CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 887877776554 55677888999999999999999999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=401.83 Aligned_cols=250 Identities=25% Similarity=0.316 Sum_probs=201.4
Q ss_pred EEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCCceE
Q 040257 968 ELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGGTLA 1045 (1254)
Q Consensus 968 iLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~~L~ 1045 (1254)
.+++||+|+||+||+|+++ ++.||||+++..... .......+.+.+|+.+|++++|||||++++++.++. .++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS---EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhh---hhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--cee
Confidence 5688999999999999984 778999999754321 112233457889999999999999999999998765 799
Q ss_pred EEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccccccc
Q 040257 1046 TVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSRIKR 1125 (1254)
Q Consensus 1046 LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr~~~ 1125 (1254)
+||||+.++++..++ .....+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+|||+++...
T Consensus 77 ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~----~~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECCCGGGSTTT
T ss_pred ehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec----CCCccccccCccccccC
Confidence 999999887777655 4556799999999999999999999999999999999999998 78899999999997654
Q ss_pred Cc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC----------
Q 040257 1126 NT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP---------- 1194 (1254)
Q Consensus 1126 ~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp---------- 1194 (1254)
.. ......+||+.|+|||++.+.. .|+.++|||||||+||||++|+.||......+.+..+......+
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred CCcccccceecChhhccHHHHccCC-CCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence 32 3334567999999999987543 47999999999999999999999999887777666554321100
Q ss_pred --------C--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 --------T--------IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 --------~--------ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
. ....+++++.+||.+||+.||++|||++|+|+|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 012467899999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=410.43 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=203.1
Q ss_pred cCceEEE-EEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhc-CCCCceeEEeeeeec-
Q 040257 964 VDLEELR-ELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSN-LHHPNVVAFYGVVPD- 1038 (1254)
Q Consensus 964 ~dYeiLk-kLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkr-LnHPNIVkLyGvf~D- 1038 (1254)
.+|++++ .||+|+||+||+|++. ++.||||++++. ..+.+|+.++.+ ++|||||+++++|.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 3798886 5999999999999984 778999999743 346679988654 589999999999865
Q ss_pred -CCCCceEEEEEecccCchhhhhhccC-CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1039 -GTGGTLATVTEFMVNGSLKHVLLKKD-RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1039 -dn~~~L~LVMEYm~GGSL~d~L~kre-~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
.....+|+|||||+||+|.+++.++. ..+++..++.|+.||+.||+|||++||+||||||+|||++..+ ..+.+||+
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~-~~~~~Kl~ 156 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLT 156 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS-TTCCEEEC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccc-cccccccc
Confidence 23347999999999999999997653 5699999999999999999999999999999999999998433 46789999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC--
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP-- 1194 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp-- 1194 (1254)
|||+++...........+||+.|+|||++.+.. |+.++|||||||+||+|+||+.||.+.+.......+.......
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234 (335)
T ss_dssp CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGG--GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS
T ss_pred ccceeeeccCCCccccccCCcccCCcHHHcCCC--CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC
Confidence 999998766655566678999999999998764 8999999999999999999999998765544433332221111
Q ss_pred CCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 TIP----ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 ~ip----e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
..+ ..+++++++||.+||++||++|||+.|++++
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 112 2478999999999999999999999999885
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-46 Score=399.55 Aligned_cols=260 Identities=30% Similarity=0.521 Sum_probs=217.5
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEECC---------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCc
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWRG---------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPN 1028 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~rG---------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPN 1028 (1254)
+.|..++|++++.||+|+||.||+|++.+ ..||||++++.. ......++.+|...+.++ +|||
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-------ChHHHHHHHHHHHHHHHhcCCCe
Confidence 45667799999999999999999998632 359999987542 223356788899988888 8999
Q ss_pred eeEEeeeeecCCCCceEEEEEecccCchhhhhhccC---------------CCCCHHHHHHHHHHhhhhhHHhhhCCccc
Q 040257 1029 VVAFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVH 1093 (1254)
Q Consensus 1029 IVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------------~~LSe~~~lkIa~QIAeALaYLHSkGIIH 1093 (1254)
||+++++|.++. .+++||||+.+|+|.+++..+. ..+++..++.++.||+.||+|||+++|||
T Consensus 81 Iv~~~~~~~~~~--~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivH 158 (299)
T d1fgka_ 81 IINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 158 (299)
T ss_dssp BCCEEEEECSSS--SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEecccccccCC--eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEe
Confidence 999999998654 7999999999999999996543 35899999999999999999999999999
Q ss_pred ccCCCCceEeccCCCCCCeEEEEeccccccccCcc---ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 040257 1094 FDLKCENLLVNLRDPQRPICKVGDFGLSRIKRNTL---VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT 1170 (1254)
Q Consensus 1094 RDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~s~---~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT 1170 (1254)
|||||+|||++ .++.+||+|||+++...... ......||+.|+|||.+.+. .|+.++|||||||+||||++
T Consensus 159 rDiKp~NiLl~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~ 232 (299)
T d1fgka_ 159 RDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFT 232 (299)
T ss_dssp SCCSGGGEEEC----TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHT
T ss_pred eeecccceeec----CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhcc
Confidence 99999999998 77899999999998554332 23446789999999999865 48999999999999999998
Q ss_pred -CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1171 -GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1171 -Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
|.+||.+.........+. ...++..+..+++++++||.+||+.||.+|||+.||++.|+.+..
T Consensus 233 ~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 233 LGGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp TSCCSSTTCCHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 799998888777666554 456677888999999999999999999999999999999998854
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=398.96 Aligned_cols=262 Identities=32% Similarity=0.518 Sum_probs=225.1
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC-CCCcee
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL-HHPNVV 1030 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL-nHPNIV 1030 (1254)
+.+...+|++.++||+|+||.||+|++. ++.||||+++... .......|.+|+.+++++ +|||||
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~~~~~l~~HpnIv 90 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-------HLTEREALMSELKVLSYLGNHMNIV 90 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-------CHHHHHHHHHHHHHHHhccCCCCEE
Confidence 3466678999999999999999999873 3469999997542 123346788999999999 699999
Q ss_pred EEeeeeecCCCCceEEEEEecccCchhhhhhccC-----------------CCCCHHHHHHHHHHhhhhhHHhhhCCccc
Q 040257 1031 AFYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD-----------------RSLDRRKKLIIAMDAAFGMEYLHSKNIVH 1093 (1254)
Q Consensus 1031 kLyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre-----------------~~LSe~~~lkIa~QIAeALaYLHSkGIIH 1093 (1254)
++++++.+.. .+++|||||.+|+|.+++.+.. ..+++..++.|+.||+.||+|||+++|||
T Consensus 91 ~~~g~~~~~~--~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivH 168 (311)
T d1t46a_ 91 NLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH 168 (311)
T ss_dssp CEEEEECSSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEEEEeeCC--EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 9999997665 7899999999999999986532 25899999999999999999999999999
Q ss_pred ccCCCCceEeccCCCCCCeEEEEeccccccccC---ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHc
Q 040257 1094 FDLKCENLLVNLRDPQRPICKVGDFGLSRIKRN---TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILT 1170 (1254)
Q Consensus 1094 RDLKPeNILLDsdd~snG~VKLiDFGLAr~~~~---s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLT 1170 (1254)
|||||+|||++ ..+.+||+|||+++.... .......+||+.|+|||++.+. .++.++|||||||+||||+|
T Consensus 169 rDLKp~NIl~~----~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~ellt 242 (311)
T d1t46a_ 169 RDLAARNILLT----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFS 242 (311)
T ss_dssp SCCSGGGEEEE----TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccc----ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC--CCCCcccccchHHHHHHHHh
Confidence 99999999999 788999999999986543 2333456789999999999865 48999999999999999999
Q ss_pred -CCCCCCCCChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1171 -GEEPYADMHCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1171 -Gk~PF~~~n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
|.+||........+..++....++..+..++.++.+||.+||+.||++|||+.||++.|++.+.+
T Consensus 243 ~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 243 LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp TTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 67777777777777777777788888888999999999999999999999999999999987665
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.9e-46 Score=411.32 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=207.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|+++++||+|+||+||+|+++ ++.||||++.+..+... ..........+|+.+++.++|||||+++++|.+..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~--~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~- 80 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD- 80 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH--TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS-
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchh--hHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC-
Confidence 47999999999999999999984 77899999975432111 11122233345678888999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+|+||||+.+|+|.+++.+. ..+++..++.|+.||+.||.|||++|||||||||+||||+ ..+.+||+|||+|
T Consensus 81 -~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~----~~g~iKl~DFGla 154 (364)
T d1omwa3 81 -KLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLA 154 (364)
T ss_dssp -EEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----SSSCEEECCCTTC
T ss_pred -EEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc----CCCcEEEeeecee
Confidence 899999999999999998654 5689999999999999999999999999999999999998 7789999999999
Q ss_pred ccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhh-hccCCCCCCCCC
Q 040257 1122 RIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIV-KNTLRPTIPERC 1200 (1254)
Q Consensus 1122 r~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIl-k~~Lrp~ipe~i 1200 (1254)
+...... ....+||+.|+|||++.+.. .|+.++|||||||+||||+||+.||............. ........+..+
T Consensus 155 ~~~~~~~-~~~~~GT~~y~APE~~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (364)
T d1omwa3 155 CDFSKKK-PHASVGTHGYMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232 (364)
T ss_dssp EECSSSC-CCSCCSCGGGCCHHHHSTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSS
T ss_pred eecCCCc-ccccccccccchhHHhhcCC-CCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Confidence 8665443 34567999999999997432 47899999999999999999999998755433322111 122334567789
Q ss_pred cHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 040257 1201 DPEWRKLMEQCWAADPEARPS-----FTEITSR 1228 (1254)
Q Consensus 1201 S~eLrdLIkKCLqkDPeKRPS-----ArELLe~ 1228 (1254)
++++++||.+||++||.+||| ++|+++|
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 999999999999999999999 7899875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=394.30 Aligned_cols=254 Identities=26% Similarity=0.329 Sum_probs=208.0
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC---CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcC---CCCceeEEeeee
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR---GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNL---HHPNVVAFYGVV 1036 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r---Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrL---nHPNIVkLyGvf 1036 (1254)
+.+|+++++||+|+||+||+|++. ++.||||+++........ ...+.+|+.+|+.| +||||++++++|
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------BCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH------HHHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence 358999999999999999999984 456999999765322111 12344666666555 899999999998
Q ss_pred ecC---CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeE
Q 040257 1037 PDG---TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1037 ~Dd---n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
... ....++++|||+.++.+..........+++..++.++.||+.||+|||+++||||||||+|||++ ..+.+
T Consensus 80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~----~~~~~ 155 (305)
T d1blxa_ 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQI 155 (305)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCE
T ss_pred cccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc----CCCCe
Confidence 532 23478999999988877766666667799999999999999999999999999999999999998 77899
Q ss_pred EEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC-
Q 040257 1114 KVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL- 1192 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L- 1192 (1254)
||+|||+++............||+.|+|||++.+.. |+.++|||||||+||||++|+.||...+..+.+..+.....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~--y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 156 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC--CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred eecchhhhhhhcccccCCCcccChhhcCcchhcCCC--CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 999999998766666667788999999999998764 89999999999999999999999998877666555432110
Q ss_pred ------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 ------------------------RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 ------------------------rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.......+++.+++||.+||++||++|||+.|+|+|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 011234578899999999999999999999999885
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=407.11 Aligned_cols=248 Identities=26% Similarity=0.438 Sum_probs=212.9
Q ss_pred cCceEEEEEeeeCcEEEEEEEE--CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHh-cCCCCceeEEeeeeecCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKW--RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILS-NLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~--rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILk-rLnHPNIVkLyGvf~Ddn 1040 (1254)
.+|++++.||+|+||+||+|++ +++.||||++++.... .....+.+.+|..++. .++||||+++++++.++.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~-----~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-----MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhcc-----ChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence 3799999999999999999999 4778999999864321 1122345667777665 689999999999998765
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
.+|+||||+.+|+|.+++... ..+++..++.++.||+.||+|||+++||||||||+|||++ ..+++||+|||+
T Consensus 77 --~~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~----~~~~~kl~DFG~ 149 (320)
T d1xjda_ 77 --NLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIKIADFGM 149 (320)
T ss_dssp --EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCCTT
T ss_pred --ceeEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec----CCCceeccccch
Confidence 899999999999999998654 5689999999999999999999999999999999999998 788999999999
Q ss_pred cccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCCC
Q 040257 1121 SRIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPER 1199 (1254)
Q Consensus 1121 Ar~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe~ 1199 (1254)
++.... .......+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+.......+.... +.++..
T Consensus 150 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~~ 225 (320)
T d1xjda_ 150 CKENMLGDAKTNTFCGTPDYIAPEILLGQK--YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRW 225 (320)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTTCC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTT
T ss_pred hhhcccccccccccCCCCCcCCHHHHcCCC--CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCcc
Confidence 985433 33344567999999999999764 7899999999999999999999999988888887776654 456788
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 040257 1200 CDPEWRKLMEQCWAADPEARPSFT-EITS 1227 (1254)
Q Consensus 1200 iS~eLrdLIkKCLqkDPeKRPSAr-ELLe 1227 (1254)
+++++++||.+||++||.+||++. ++++
T Consensus 226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 999999999999999999999995 7765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=394.57 Aligned_cols=252 Identities=27% Similarity=0.352 Sum_probs=205.2
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
++|+++++||+|+||+||+|++. ++.||||+++.... .+...+++.+|+++|++++||||++++++|.+..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~- 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE------TEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN- 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc------ChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-
Confidence 37999999999999999999984 78899999975421 2223467889999999999999999999998765
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
.+++||||+.++.+..........+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|
T Consensus 75 -~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~----~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 75 -KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLA 149 (298)
T ss_dssp -EEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECSTTHH
T ss_pred -ceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec----ccCcceeccCCcc
Confidence 89999999976555544444556799999999999999999999999999999999999998 7789999999999
Q ss_pred ccccC-ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC-------
Q 040257 1122 RIKRN-TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR------- 1193 (1254)
Q Consensus 1122 r~~~~-s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr------- 1193 (1254)
+.... ........||+.|+|||++.... .++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 150 ~~~~~~~~~~~~~~gt~~y~apE~~~~~~-~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 150 RAFGVPVRTYTHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp HHHCCCSBCTTCCBCCCTTCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred eeccCCcccceeecccceeeehhhhcccc-CCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence 86543 23344567999999999987664 3688999999999999999999999887766655544321100
Q ss_pred ---------CCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 ---------PTI-----------PERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 ---------p~i-----------pe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
... ...+++++++||.+||+.||.+|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 12467889999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-45 Score=394.46 Aligned_cols=257 Identities=28% Similarity=0.494 Sum_probs=212.0
Q ss_pred eEEEEEeeeCcEEEEEEEECC-----ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 967 EELRELGSGTYGTVYHGKWRG-----SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 967 eiLkkLGeGsFGtVYlAk~rG-----s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
...++||+|+||+||+|++.. ..||||++++.. .....++|.+|+++|++++||||+++++++.+..
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~- 101 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE- 101 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-------CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-------CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-
Confidence 345789999999999999842 258999986431 2334578999999999999999999999986533
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecccc
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLS 1121 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLA 1121 (1254)
..+++|||||.+++|.+++......+++..++.++.|++.||.|||+.+|+||||||+||||+ +++.+||+|||++
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~----~~~~~kL~DFG~~ 177 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGLA 177 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECSSGGG
T ss_pred CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC----CCCCEEEecccch
Confidence 378999999999999999987777889999999999999999999999999999999999998 7889999999999
Q ss_pred ccccCcc-----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hhHHHHhhhccCCCC
Q 040257 1122 RIKRNTL-----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHC-GAIIGGIVKNTLRPT 1195 (1254)
Q Consensus 1122 r~~~~s~-----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~-~eliqsIlk~~Lrp~ 1195 (1254)
+...... ......||+.|+|||++... .++.++||||||++||||+||..||..... .+....+.. ..++.
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~-g~~~~ 254 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLL 254 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT-TCCCC
T ss_pred hhccccccccceecccccccccccChHHHhcC--CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCC
Confidence 8643321 22335689999999999865 489999999999999999998777765433 333333333 34566
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHhh
Q 040257 1196 IPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIES 1238 (1254)
Q Consensus 1196 ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLEs 1238 (1254)
.+..+++++.+||.+||..||++||++.||+++|+.++..+..
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 7788999999999999999999999999999999999876544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.5e-45 Score=385.87 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=204.1
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
++|+++++||+|+||+||+|+++ ++.||||+++.... .+...+++.+|+.+|++++||||++++++|.+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-- 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE------DEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-- 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG------GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc------ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--
Confidence 37999999999999999999985 67899999976432 1223467889999999999999999999998766
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.++++|||+.++.+..+. ...+.+++..++.++.||+.||+|||+++||||||||+||||+ .++.+||+|||++.
T Consensus 74 ~~~i~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~----~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLAR 148 (286)
T ss_dssp CEEEEEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECCTTHHH
T ss_pred ceeEEEEeehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc----CCCCEEecccccce
Confidence 789999999776666554 5557799999999999999999999999999999999999998 77899999999997
Q ss_pred cccCc-cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC--------
Q 040257 1123 IKRNT-LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR-------- 1193 (1254)
Q Consensus 1123 ~~~~s-~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr-------- 1193 (1254)
..... .......+++.|+|||.+.+.. .++.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 149 AFGIPVRKYTHEIVTLWYRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp HHCC---------CCCTTCCHHHHTTCC-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ecccCccccceecccchhhhHHHHhCCC-CCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 65433 2234456899999999998654 4789999999999999999999999887766555543321100
Q ss_pred -------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 -------------------PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 -------------------p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
......+++++++||++||++||++|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01234568899999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-45 Score=392.38 Aligned_cols=260 Identities=31% Similarity=0.524 Sum_probs=221.0
Q ss_pred ccccccCceEEEEEeeeCcEEEEEEEEC-------CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeE
Q 040257 959 QIIKNVDLEELRELGSGTYGTVYHGKWR-------GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVA 1031 (1254)
Q Consensus 959 q~Ik~~dYeiLkkLGeGsFGtVYlAk~r-------Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVk 1031 (1254)
++|...+|++++.||+|+||+||+|.+. ++.||||+++... .......|.+|++++++++||||++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-------~~~~~~~~~~E~~il~~l~h~nIv~ 87 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHVVR 87 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-------CHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-------ChHHHHHHHHHHHHHHHcCCCCEee
Confidence 4566779999999999999999999874 3579999987431 1223467899999999999999999
Q ss_pred EeeeeecCCCCceEEEEEecccCchhhhhhccC---------CCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceE
Q 040257 1032 FYGVVPDGTGGTLATVTEFMVNGSLKHVLLKKD---------RSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLL 1102 (1254)
Q Consensus 1032 LyGvf~Ddn~~~L~LVMEYm~GGSL~d~L~kre---------~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNIL 1102 (1254)
+++++..+. .+++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||
T Consensus 88 ~~~~~~~~~--~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiL 165 (308)
T d1p4oa_ 88 LLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 165 (308)
T ss_dssp EEEEECSSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred eeeEEecCC--ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCcee
Confidence 999997655 7899999999999999885431 34688999999999999999999999999999999999
Q ss_pred eccCCCCCCeEEEEeccccccccCc---cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcC-CCCCCCC
Q 040257 1103 VNLRDPQRPICKVGDFGLSRIKRNT---LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTG-EEPYADM 1178 (1254)
Q Consensus 1103 LDsdd~snG~VKLiDFGLAr~~~~s---~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTG-k~PF~~~ 1178 (1254)
|+ .++++||+|||+++..... .......||+.|+|||.+.+.. ++.++|||||||+||||+|| ..||...
T Consensus 166 ld----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~--~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 166 VA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp EC----TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ec----CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCC--CCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 98 7889999999999854332 2233446899999999998764 88999999999999999998 5888888
Q ss_pred ChhhHHHHhhhccCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 040257 1179 HCGAIIGGIVKNTLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISA 1234 (1254)
Q Consensus 1179 n~~eliqsIlk~~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~ 1234 (1254)
...+.+..+.... .+..+..+++.+.+||.+||+.+|.+|||+.+|+++|+..++
T Consensus 240 ~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 240 SNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CHHHHHHHHHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 8888887776544 456778899999999999999999999999999999876644
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=391.12 Aligned_cols=247 Identities=22% Similarity=0.329 Sum_probs=202.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC--CCceeEEeeeeecC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH--HPNVVAFYGVVPDG 1039 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn--HPNIVkLyGvf~Dd 1039 (1254)
.+|++.+.||+|+||+||+|++. ++.||||++++........ .....++.+|+.+|++++ ||||+++++++.++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE--LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEE--CTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhh--hhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 47999999999999999999984 7789999998654332111 011234567999999986 89999999999876
Q ss_pred CCCceEEEEEeccc-CchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1040 TGGTLATVTEFMVN-GSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1040 n~~~L~LVMEYm~G-GSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
+ .+++||||+.+ +++.+++.+ ...+++..++.++.||+.||.|||++|||||||||+|||++ .+.+.+||+||
T Consensus 82 ~--~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~---~~~~~vkl~DF 155 (273)
T d1xwsa_ 82 D--SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID---LNRGELKLIDF 155 (273)
T ss_dssp S--EEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---TTTTEEEECCC
T ss_pred C--eEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe---cCCCeEEECcc
Confidence 5 89999999976 566676644 45799999999999999999999999999999999999998 23478999999
Q ss_pred cccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCCCCCC
Q 040257 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRPTIPE 1198 (1254)
Q Consensus 1119 GLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp~ipe 1198 (1254)
|+|+...... .....||+.|+|||++.+.. .++.++|||||||+||||++|+.||.... .+.... ..++.
T Consensus 156 G~a~~~~~~~-~~~~~GT~~y~aPE~~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~--~~~~~ 225 (273)
T d1xwsa_ 156 GSGALLKDTV-YTDFDGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ--VFFRQ 225 (273)
T ss_dssp TTCEECCSSC-BCCCCSCGGGSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC--CCCSS
T ss_pred ccceeccccc-ccccccCCCcCCHHHHcCCC-CCCcccccccceeeehhHhhCCCCCCCch------HHhhcc--cCCCC
Confidence 9998654443 34567999999999998654 24778999999999999999999997632 222322 34567
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1199 RCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1199 ~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.+++++++||++||++||++|||++|++++
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 789999999999999999999999999885
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=393.57 Aligned_cols=247 Identities=23% Similarity=0.279 Sum_probs=200.9
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeec----
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPD---- 1038 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~D---- 1038 (1254)
+|+.+++||+|+||+||+|++. ++.||||++++... .+.+|+.+|++++||||++++++|..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------------SCCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------------HHHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 6899999999999999999994 77899999976421 12369999999999999999999853
Q ss_pred CCCCceEEEEEecccCchhhhhh--ccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCC-CeEEE
Q 040257 1039 GTGGTLATVTEFMVNGSLKHVLL--KKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQR-PICKV 1115 (1254)
Q Consensus 1039 dn~~~L~LVMEYm~GGSL~d~L~--kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~sn-G~VKL 1115 (1254)
.+..++++||||+.++.+..+.. .....+++..++.|+.||+.||+|||++|||||||||+||||+ .+ ..+||
T Consensus 89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~----~~~~~~kl 164 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD----PDTAVLKL 164 (350)
T ss_dssp CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTTCCEEE
T ss_pred CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe----cCCCceeE
Confidence 23346899999997664443322 3455799999999999999999999999999999999999998 44 48999
Q ss_pred EeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc----
Q 040257 1116 GDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT---- 1191 (1254)
Q Consensus 1116 iDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~---- 1191 (1254)
+|||+++............||..|+|||++.+.. .|+.++|||||||++|||++|+.||........+..+....
T Consensus 165 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~ 243 (350)
T d1q5ka_ 165 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243 (350)
T ss_dssp CCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ecccchhhccCCcccccccccccccChHHhhccc-CCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCCh
Confidence 9999998765555555678999999999987643 48999999999999999999999998877665554443210
Q ss_pred -----------CC------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 -----------LR------------PTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 -----------Lr------------p~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.. ......+++++.+||.+||++||++|||+.|+|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 01123478899999999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-43 Score=383.13 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=203.7
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDG 1039 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Dd 1039 (1254)
.++|+++++||+|+||+||+|++. ++.||||+++... .+++.+|+.+|++++ ||||++++++|...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----------HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 357999999999999999999984 7789999997531 356788999999995 99999999999877
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
....+++||||+.+++|..+. +.+++..++.++.||+.||.|||++|||||||||+||||+. .+..+||+|||
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~---~~~~vkl~DFG 175 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH---EHRKLRLIDWG 175 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTTEEEECCGG
T ss_pred CCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC---CCCeeeecccc
Confidence 667899999999999998764 46999999999999999999999999999999999999982 34579999999
Q ss_pred ccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh-HHHHhhh---------
Q 040257 1120 LSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGA-IIGGIVK--------- 1189 (1254)
Q Consensus 1120 LAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~e-liqsIlk--------- 1189 (1254)
+|+............+|+.|+|||++.+.. .++.++|||||||++|||++|+.||....... ....+..
T Consensus 176 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 176 LAEFYHPGQEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp GCEECCTTCCCCSCCSCGGGCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred cceeccCCCcccccccCccccCcccccCCC-CCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence 998776655566678999999999988653 47899999999999999999999997654321 1111100
Q ss_pred ----c----------------------cCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1190 ----N----------------------TLRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1190 ----~----------------------~Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
. .........+++++++||++||++||++|||++|+|+|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00111223468899999999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=383.69 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=202.2
Q ss_pred cCceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC--
Q 040257 964 VDLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG-- 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~-- 1041 (1254)
.+|.+.++||+|+||+||+|+++++.||||+++... .. ......|+..+++++||||+++++++.+...
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-------~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-------ER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-------HH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-------hh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 368888999999999999999999999999986431 11 1122345666678899999999999976543
Q ss_pred CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhh--------CCcccccCCCCceEeccCCCCCCeE
Q 040257 1042 GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHS--------KNIVHFDLKCENLLVNLRDPQRPIC 1113 (1254)
Q Consensus 1042 ~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHS--------kGIIHRDLKPeNILLDsdd~snG~V 1113 (1254)
..+++||||+.+|+|.+++.+. .+++..++.++.|++.||.|||+ ++||||||||+||||+ .++.+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~----~~~~~ 147 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTC 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC----TTSCE
T ss_pred eEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc----CCCCe
Confidence 3689999999999999999653 68999999999999999999996 5999999999999998 78899
Q ss_pred EEEeccccccccCcc-----ccCCCCCCCCccCcccccCCCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCC-----
Q 040257 1114 KVGDFGLSRIKRNTL-----VSGGVRGTLPWMAPELLNGSSN----RVSEKVDVFSFGISMWEILTGEEPYADMH----- 1179 (1254)
Q Consensus 1114 KLiDFGLAr~~~~s~-----~sts~~GT~~YmAPEVLrG~~~----kyS~KSDIWSLGVILYELLTGk~PF~~~n----- 1179 (1254)
||+|||+++...... ......||+.|+|||++.+... .++.++|||||||+||||+||..||....
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence 999999998653321 2344679999999999976432 25778999999999999999988874211
Q ss_pred ----------hhhHHHHhhhccCCCCCCCCC-----cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 040257 1180 ----------CGAIIGGIVKNTLRPTIPERC-----DPEWRKLMEQCWAADPEARPSFTEITSRLRTISAA 1235 (1254)
Q Consensus 1180 ----------~~eliqsIlk~~Lrp~ipe~i-----S~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~e 1235 (1254)
............+++.++... ...+.+|+.+||+.||++|||+.||++.|+++..+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 122333333444545444332 34688999999999999999999999999988754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=385.09 Aligned_cols=254 Identities=27% Similarity=0.378 Sum_probs=202.7
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT 1040 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn 1040 (1254)
..+|+++++||+|+||+||+|+++ ++.||||++++... .....+.+.+|+.+|++++|||||+++++|....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS------SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc------ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 358999999999999999999984 78899999975421 2344677899999999999999999999987543
Q ss_pred ----CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEE
Q 040257 1041 ----GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVG 1116 (1254)
Q Consensus 1041 ----~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLi 1116 (1254)
...+|+||||+ +.+|..++.. ..+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~----~~~~~kl~ 163 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN----EDCELKIL 163 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEEC
T ss_pred cccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc----cccccccc
Confidence 23579999998 6677776633 4699999999999999999999999999999999999998 78899999
Q ss_pred eccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccC----
Q 040257 1117 DFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTL---- 1192 (1254)
Q Consensus 1117 DFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~L---- 1192 (1254)
|||+|+..... .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...+....+..+.....
T Consensus 164 Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 164 DFGLARQADSE--MTGYVVTRWYRAPEVILNWM-RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp CCTTCEECCSS--CCSSCSCGGGCCTHHHHTTT-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cccceeccCCc--cccccccccccCHHHHcCCC-CCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 99999866543 24467999999999998653 468999999999999999999999988765554433221110
Q ss_pred -------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 040257 1193 -------------------------RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR--LRTI 1232 (1254)
Q Consensus 1193 -------------------------rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~--Le~L 1232 (1254)
.......+++++.+||.+||..||.+|||+.|+|+| |+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 011234578999999999999999999999999986 5544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-43 Score=375.43 Aligned_cols=257 Identities=20% Similarity=0.291 Sum_probs=203.2
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEe-eeeecCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFY-GVVPDGT 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLy-Gvf~Ddn 1040 (1254)
.+|++++.||+|+||+||+|++. ++.||||++..... ..++.+|+++++.++|++++.++ .++.+..
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----------SCCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----------CHHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 36999999999999999999985 77899999875421 12467899999999877655554 4444443
Q ss_pred CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccc
Q 040257 1041 GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGL 1120 (1254)
Q Consensus 1041 ~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGL 1120 (1254)
..++||||+ +++|...+....+.+++..++.++.||+.||+|||++|||||||||+|||++..+ ....+||+|||+
T Consensus 77 --~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~-~~~~vkl~DFG~ 152 (299)
T d1ckia_ 77 --YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFGL 152 (299)
T ss_dssp --EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-GTTCEEECCCSS
T ss_pred --EEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccC-CCceeeeeccCc
Confidence 788999998 6777777767777899999999999999999999999999999999999987433 456899999999
Q ss_pred cccccCcc--------ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHh---hh
Q 040257 1121 SRIKRNTL--------VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGI---VK 1189 (1254)
Q Consensus 1121 Ar~~~~s~--------~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsI---lk 1189 (1254)
|+...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+ ..
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC--CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHhCCC--CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence 98654321 234567999999999999764 899999999999999999999999875543322221 11
Q ss_pred ccC---CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 040257 1190 NTL---RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAI 1236 (1254)
Q Consensus 1190 ~~L---rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eL 1236 (1254)
... .+.....+++++.+||.+||+.+|.+||++.++.+.|+.+..+.
T Consensus 231 ~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 111 11234578999999999999999999999999999998886543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=377.69 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=199.7
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
.+|+++++||+|+||+||+|+++ ++.||||++...... +....++.+|+.+|++++||||+++++++....
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK------EGFPITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT------TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc------hHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 47999999999999999999984 778999998754321 223456789999999999999999999886532
Q ss_pred -----CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1041 -----GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1041 -----~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
...+++||||+.++.+.... .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~----~~~~~kl 158 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT----RDGVLKL 158 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEEE
T ss_pred cccccCceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec----CCCcEEe
Confidence 34689999999777665444 4556799999999999999999999999999999999999998 7889999
Q ss_pred EeccccccccCc-----cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc
Q 040257 1116 GDFGLSRIKRNT-----LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN 1190 (1254)
Q Consensus 1116 iDFGLAr~~~~s-----~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~ 1190 (1254)
+|||+++..... ......+||+.|+|||++.+.. .++.++|||||||++|||++|+.||.+.........+...
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred eecceeeecccccccccccccceecCHHHhhHHHHcCCC-CCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence 999999754321 1223457999999999998653 4789999999999999999999999887766655544332
Q ss_pred cCCC--CCC----------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1191 TLRP--TIP----------------------------ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1191 ~Lrp--~ip----------------------------e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
...+ ... ...++++++||.+||++||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1110 000 0135678899999999999999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=382.70 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=199.4
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCC
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTG 1041 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~ 1041 (1254)
.+|+++++||+|+||+||+|+++ ++.||||++.+.. .....+++.+|+.+|++|+||||+++++++.....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-------ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 36999999999999999999984 8889999997531 23445678999999999999999999999865432
Q ss_pred --CceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEecc
Q 040257 1042 --GTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFG 1119 (1254)
Q Consensus 1042 --~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFG 1119 (1254)
...+++++|+.+++|.+++.. +.+++..++.++.||+.||+|||++|||||||||+||||+ ..+.+||+|||
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~----~~~~~kl~DfG 154 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TTCDLKICDFG 154 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCT
T ss_pred cccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC----CCCCEEEcccC
Confidence 123455666779999999854 3699999999999999999999999999999999999998 77899999999
Q ss_pred ccccccCcc----ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhcc----
Q 040257 1120 LSRIKRNTL----VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNT---- 1191 (1254)
Q Consensus 1120 LAr~~~~s~----~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~---- 1191 (1254)
+++...... .....+||+.|+|||++.... .++.++||||+||++|+|++|+.||................
T Consensus 155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233 (345)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBC-SCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred ceeeccCCCccceeeccccccceechHHHhhcCC-CCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCC
Confidence 997543322 234567999999999986543 47899999999999999999999998766543333221110
Q ss_pred ------------------CCC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1192 ------------------LRP-------TIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1192 ------------------Lrp-------~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
... .....++.++++||.+||+.||.+|||+.|+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0123467889999999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=366.97 Aligned_cols=250 Identities=26% Similarity=0.335 Sum_probs=204.4
Q ss_pred CceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCCCC
Q 040257 965 DLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn~~ 1042 (1254)
+|+++++||+|+||+||+|++. ++.||||+++.... ......++.+|+.+|++++||||+++++++.+..
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-- 74 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-- 74 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS------STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC------ChHHHHHHHHHHHHHHhcCcCCEEeecccccccc--
Confidence 7999999999999999999984 67799999976532 2234577889999999999999999999998766
Q ss_pred ceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEeccccc
Q 040257 1043 TLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDFGLSR 1122 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDFGLAr 1122 (1254)
.+++|++++.+++|..++. ..+.+++..++.++.|++.||+|||++|||||||||+|||++ ..+.+||+|||.++
T Consensus 75 ~~~iv~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~----~~~~~kl~DFG~a~ 149 (292)
T d1unla_ 75 KLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLAR 149 (292)
T ss_dssp EEEEEEECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTCE
T ss_pred ceeEEeeeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc----cCCceeeeecchhh
Confidence 8899999998888877764 456789999999999999999999999999999999999998 67899999999998
Q ss_pred cccCcc-ccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChhhHHHHhhhccC--------
Q 040257 1123 IKRNTL-VSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYAD-MHCGAIIGGIVKNTL-------- 1192 (1254)
Q Consensus 1123 ~~~~s~-~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~-~n~~eliqsIlk~~L-------- 1192 (1254)
...... ......++..|+|||++.+.. .++.++|||||||++|||++|+.||.. .+..+.+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp ECCSCCSCCCSCCSCGGGCCHHHHTTCS-CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred cccCCCccceeeccccchhhhhHhccCC-CCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhh
Confidence 654432 333445788899999988654 368999999999999999999999644 333433333221100
Q ss_pred -------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1193 -------------------RPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1193 -------------------rp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
.......+++++++||++||+.||.+|||++|+|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112234568899999999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=385.29 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=208.4
Q ss_pred cCceEEEEEeeeCcEEEEEEEE-----CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCC-CceeEEeeeee
Q 040257 964 VDLEELRELGSGTYGTVYHGKW-----RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH-PNVVAFYGVVP 1037 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~-----rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnH-PNIVkLyGvf~ 1037 (1254)
.+|++++.||+|+||+||+|++ +++.||||++++...... ....+.+.+|+++|++++| |||+++++++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~----~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE----ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc----hHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 4799999999999999999987 367899999976532211 1123557789999999976 89999999998
Q ss_pred cCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1038 DGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1038 Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
+.. .++++|||+.+++|.+++... +.+++..++.++.||+.||.|||+++|+||||||+||||+ .++.+||+|
T Consensus 100 ~~~--~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~vkL~D 172 (322)
T d1vzoa_ 100 TET--KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVVLTD 172 (322)
T ss_dssp ETT--EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEESC
T ss_pred cCC--ceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec----CCCCEEEee
Confidence 766 899999999999999998654 4578999999999999999999999999999999999998 778999999
Q ss_pred ccccccccC--ccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhc--cCC
Q 040257 1118 FGLSRIKRN--TLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKN--TLR 1193 (1254)
Q Consensus 1118 FGLAr~~~~--s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~--~Lr 1193 (1254)
||+++.... ........|++.|+|||.+.+..+.++.++|||||||+||+|++|+.||...........+... ...
T Consensus 173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252 (322)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC
Confidence 999975432 2234456799999999999887667899999999999999999999999876554433333322 223
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 040257 1194 PTIPERCDPEWRKLMEQCWAADPEARP-----SFTEITSR 1228 (1254)
Q Consensus 1194 p~ipe~iS~eLrdLIkKCLqkDPeKRP-----SArELLe~ 1228 (1254)
+.++..+++++++||++||..||.+|| +++|+++|
T Consensus 253 ~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 456678999999999999999999999 48999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.3e-42 Score=367.33 Aligned_cols=260 Identities=18% Similarity=0.257 Sum_probs=210.6
Q ss_pred ccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCC-CceeEEeeeeecC
Q 040257 963 NVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHH-PNVVAFYGVVPDG 1039 (1254)
Q Consensus 963 ~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnH-PNIVkLyGvf~Dd 1039 (1254)
..+|+++++||+|+||+||+|++. ++.||||++..... ...+.+|+++++.|.| +|++.+++++.+.
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 73 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG 73 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----------cHHHHHHHHHHHHhcCCCCCCEEEEEeecC
Confidence 458999999999999999999984 77899999865421 1235678888888865 8999999998765
Q ss_pred CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCC-CCCCeEEEEec
Q 040257 1040 TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRD-PQRPICKVGDF 1118 (1254)
Q Consensus 1040 n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd-~snG~VKLiDF 1118 (1254)
. ..++||||+ +++|.+++......+++..++.++.|++.||+|||++|||||||||+|||++... ...+.+||+||
T Consensus 74 ~--~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 74 L--HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp T--EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred C--ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccc
Confidence 5 889999998 7899999877777899999999999999999999999999999999999997422 23578999999
Q ss_pred cccccccCc--------cccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh---hHHHHh
Q 040257 1119 GLSRIKRNT--------LVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG---AIIGGI 1187 (1254)
Q Consensus 1119 GLAr~~~~s--------~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~---eliqsI 1187 (1254)
|+|+..... .......||+.|||||++.+.. ++.++|||||||++|||++|+.||...... .....+
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~--~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i 228 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE--QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCC--CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence 999864322 1234467999999999999764 899999999999999999999999865432 222222
Q ss_pred hhcc---CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHh
Q 040257 1188 VKNT---LRPTIPERCDPEWRKLMEQCWAADPEARPSFTEITSRLRTISAAIE 1237 (1254)
Q Consensus 1188 lk~~---Lrp~ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~Le~Ll~eLE 1237 (1254)
.... ....+...+++++.+|+..|++.+|++||+++.+.+.|++++.+..
T Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 2111 1112345688999999999999999999999999999998876553
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=377.57 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=201.6
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecCC-
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDGT- 1040 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Ddn- 1040 (1254)
.+|+++++||+|+||+||+|++. ++.||||++++... .....+++.+|+++|++++||||+++++++....
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc------ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 57999999999999999999984 78899999975421 2233467889999999999999999999986432
Q ss_pred --CCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEec
Q 040257 1041 --GGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDF 1118 (1254)
Q Consensus 1041 --~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiDF 1118 (1254)
....+++|+|+.+|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~----~~~~~kl~df 165 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILDF 165 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECCC
T ss_pred cccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc----cccccccccc
Confidence 1234566778889999998843 4699999999999999999999999999999999999998 7789999999
Q ss_pred cccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCCC----
Q 040257 1119 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLRP---- 1194 (1254)
Q Consensus 1119 GLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lrp---- 1194 (1254)
|++...... .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 166 g~a~~~~~~--~~~~~g~~~y~apE~~~~~~-~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 166 GLARHTDDE--MTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp ----CCTGG--GSSSCHHHHTSCHHHHTTCS-CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred chhcccCcc--cccccccccccCchhhcCCc-cCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 999755433 34467899999999987653 46889999999999999999999998877665555443321111
Q ss_pred -----------------C--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1195 -----------------T--------IPERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1195 -----------------~--------ipe~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
. ....+++++++||.+||+.||.+|||+.|+|+|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0 013468899999999999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=379.27 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=191.5
Q ss_pred cCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCceeEEeeeeecC--
Q 040257 964 VDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNVVAFYGVVPDG-- 1039 (1254)
Q Consensus 964 ~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGvf~Dd-- 1039 (1254)
.+|+++++||+|+||+||+|+++ ++.||||++++... ......++.+|+.+|++++||||++++++|...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc------CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 36999999999999999999985 78899999986532 233456788999999999999999999998654
Q ss_pred --CCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEEEe
Q 040257 1040 --TGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGD 1117 (1254)
Q Consensus 1040 --n~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKLiD 1117 (1254)
....+|+||||+.++.+. .+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 91 ~~~~~~~~iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~----~~~~~kl~d 162 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILD 162 (355)
T ss_dssp TTTCCEEEEEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEECC
T ss_pred cccCceeEEEEeccchHHHH-hhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc----cccceeeec
Confidence 335899999999665544 442 4589999999999999999999999999999999999998 778999999
Q ss_pred ccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHHhhhccCC----
Q 040257 1118 FGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCGAIIGGIVKNTLR---- 1193 (1254)
Q Consensus 1118 FGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~eliqsIlk~~Lr---- 1193 (1254)
||+++...........++|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+......
T Consensus 163 f~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp CCC---------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred hhhhhccccccccccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence 9999877666666667899999999999876 4788999999999999999999999877655444433211100
Q ss_pred ------------------C------------CCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 040257 1194 ------------------P------------TIP------ERCDPEWRKLMEQCWAADPEARPSFTEITSR 1228 (1254)
Q Consensus 1194 ------------------p------------~ip------e~iS~eLrdLIkKCLqkDPeKRPSArELLe~ 1228 (1254)
. ..+ ...++++.+||++||++||++|||++|+|+|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000 1135678999999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.7e-38 Score=339.61 Aligned_cols=255 Identities=20% Similarity=0.266 Sum_probs=190.8
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEEC--CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-----------CC
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWR--GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-----------HP 1027 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-----------HP 1027 (1254)
+.+.+|+++++||+|+||+||+|++. ++.||||++++. ....+.+.+|+.+++.++ |+
T Consensus 10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---------KVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred ccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---------ccchHHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence 44557999999999999999999984 788999999753 223456778888888775 57
Q ss_pred ceeEEeeeeecCCCCceEEEEEecccCchhhh--hhccCCCCCHHHHHHHHHHhhhhhHHhhh-CCcccccCCCCceEec
Q 040257 1028 NVVAFYGVVPDGTGGTLATVTEFMVNGSLKHV--LLKKDRSLDRRKKLIIAMDAAFGMEYLHS-KNIVHFDLKCENLLVN 1104 (1254)
Q Consensus 1028 NIVkLyGvf~Ddn~~~L~LVMEYm~GGSL~d~--L~kre~~LSe~~~lkIa~QIAeALaYLHS-kGIIHRDLKPeNILLD 1104 (1254)
||+++++++........+++|+++..+..... .......+++..++.++.||+.||.|||+ .||+||||||+||||+
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred ceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeee
Confidence 89999999876555577778877655543333 23344678999999999999999999998 8999999999999998
Q ss_pred cCCC--CCCeEEEEeccccccccCccccCCCCCCCCccCcccccCCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-
Q 040257 1105 LRDP--QRPICKVGDFGLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEKVDVFSFGISMWEILTGEEPYADMHCG- 1181 (1254)
Q Consensus 1105 sdd~--snG~VKLiDFGLAr~~~~s~~sts~~GT~~YmAPEVLrG~~~kyS~KSDIWSLGVILYELLTGk~PF~~~n~~- 1181 (1254)
..+. ....+||+|||.+...... .....||+.|+|||++.+.. ++.++|||||||++++|++|+.||......
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP--WGCGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC--CCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred ccCcccccceeeEeecccccccccc--cccccccccccChhhccccC--CCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 3321 2235999999999755433 34567999999999999764 789999999999999999999999743321
Q ss_pred -----hHHHHhhh--c------------------------cC--------------CCCCCCCCcHHHHHHHHHhhhcCC
Q 040257 1182 -----AIIGGIVK--N------------------------TL--------------RPTIPERCDPEWRKLMEQCWAADP 1216 (1254)
Q Consensus 1182 -----eliqsIlk--~------------------------~L--------------rp~ipe~iS~eLrdLIkKCLqkDP 1216 (1254)
..+..... + .. ........++++++||.+||++||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 11110000 0 00 001122346788999999999999
Q ss_pred CCCCCHHHHHHH
Q 040257 1217 EARPSFTEITSR 1228 (1254)
Q Consensus 1217 eKRPSArELLe~ 1228 (1254)
.+|||++|+|+|
T Consensus 317 ~~Rpta~e~L~H 328 (362)
T d1q8ya_ 317 RKRADAGGLVNH 328 (362)
T ss_dssp TTCBCHHHHHTC
T ss_pred hHCcCHHHHhcC
Confidence 999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=3.3e-22 Score=200.32 Aligned_cols=170 Identities=15% Similarity=0.014 Sum_probs=120.0
Q ss_pred eEEEEEeeeCcEEEEEEEE-CCceEEEEEEeccccCC----------CchhHHHHHHHHHHHHHHHhcCCCCceeEEeee
Q 040257 967 EELRELGSGTYGTVYHGKW-RGSDVAIKRIKKSCFAG----------RSSEQERLTKDFWREAHILSNLHHPNVVAFYGV 1035 (1254)
Q Consensus 967 eiLkkLGeGsFGtVYlAk~-rGs~VAIKvIkk~~~~~----------~~~e~ee~~eqFlrEIeILkrLnHPNIVkLyGv 1035 (1254)
.+.++||+|+||+||+|++ +++.||||+++...... ...........+.+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4678999999999999987 57889999876321110 000112223455678999999999999998876
Q ss_pred eecCCCCceEEEEEecccCchhhhhhccCCCCCHHHHHHHHHHhhhhhHHhhhCCcccccCCCCceEeccCCCCCCeEEE
Q 040257 1036 VPDGTGGTLATVTEFMVNGSLKHVLLKKDRSLDRRKKLIIAMDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKV 1115 (1254)
Q Consensus 1036 f~Ddn~~~L~LVMEYm~GGSL~d~L~kre~~LSe~~~lkIa~QIAeALaYLHSkGIIHRDLKPeNILLDsdd~snG~VKL 1115 (1254)
. ..+++|||+.+..+.. ++......++.||+.+|.|||++||+||||||+|||++ . ..++|
T Consensus 83 ~------~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~-~~~~l 143 (191)
T d1zara2 83 E------GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----E-EGIWI 143 (191)
T ss_dssp E------TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----T-TEEEE
T ss_pred c------CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----C-CCEEE
Confidence 4 2378999998765543 23344567899999999999999999999999999998 3 35899
Q ss_pred EeccccccccCccccCCCCCCCCccC------cccccCCCCCCCchhHHHHHHHHH
Q 040257 1116 GDFGLSRIKRNTLVSGGVRGTLPWMA------PELLNGSSNRVSEKVDVFSFGISM 1165 (1254)
Q Consensus 1116 iDFGLAr~~~~s~~sts~~GT~~YmA------PEVLrG~~~kyS~KSDIWSLGVIL 1165 (1254)
+|||+|+....+... .|.. .+.+.. .|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r---~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR-------EILERDVRNIITYFSR---TYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH-------HHHHHHHHHHHHHHHH---HHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH-------HHHHHHHHHHHHHHcC---CCCCcccHHHHHHHH
Confidence 999999755433211 1211 122322 367789999986443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.06 E-value=3e-06 Score=85.70 Aligned_cols=86 Identities=10% Similarity=-0.040 Sum_probs=56.5
Q ss_pred CceEEEEEeeeCcEEEEEEEECCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCceeEEeeeeecCCCCc
Q 040257 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVVAFYGVVPDGTGGT 1043 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIVkLyGvf~Ddn~~~ 1043 (1254)
.|+..+..+.++.+.||+....+..+.||+........ ...+.+|..++..|. +--+.+++.+..++. .
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~--~ 84 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHDG--W 84 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT--E
T ss_pred ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--------hhhHHHHHHHHHHHhccCCCCcEEEEEecCC--c
Confidence 45655555555567999988888889999886442111 123456777776653 333567777765543 7
Q ss_pred eEEEEEecccCchhhhh
Q 040257 1044 LATVTEFMVNGSLKHVL 1060 (1254)
Q Consensus 1044 L~LVMEYm~GGSL~d~L 1060 (1254)
.++||++++|..+....
T Consensus 85 ~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEY 101 (263)
T ss_dssp EEEEEECCSSEEHHHHT
T ss_pred eEEEEEecccccccccc
Confidence 88999999888775543
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.96 E-value=9e-06 Score=73.06 Aligned_cols=71 Identities=13% Similarity=0.112 Sum_probs=58.2
Q ss_pred CCCCcEEEEeecCCccccCCCCCCceeecCceEEEeccCCCChHHHHHHHHhhcC-CCceEEEecCCCCcCcEEeecChH
Q 040257 178 SQSGKMKFLCSFGGKILPRPSDGKLRYVGGETRIISLRTNLSWEELVKKTSNICN-QPHLIKYQLPGEDLDALISVSSDD 256 (1254)
Q Consensus 178 ~~~~kvklmcSyGG~I~pr~~d~~l~YvGG~triv~V~r~~~f~~l~~kl~~~~~-~~~~lkYqLP~edLD~LiSVt~De 256 (1254)
++..+||+-+.|+ +++|++.|+.+++|.+|+.++.+.++ ..+.|||+ . |-+.+|+++||+
T Consensus 8 ~~~~~ikVKv~~~----------------~D~~~~~l~~~it~~dL~~kI~~rf~~~~~~lkY~--D-edgd~v~i~sD~ 68 (85)
T d1ip9a_ 8 SGLKTTKIKFYYK----------------DDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTK--L-FDGSGEEIKTDS 68 (85)
T ss_dssp CCCCCEEEEECBT----------------TCCEEEEECSCCCHHHHHHHHHHHHTSSCEEEEEC--C-SSSCCSCCCSHH
T ss_pred CCCCCEEEEEEEC----------------CcEEEEEeCCCCCHHHHHHHHHHHhCCCceEEEEE--c-CCCCEEEEeCHH
Confidence 4455788888876 46789999999999999999999887 44889999 3 336679999999
Q ss_pred HHHHHHHHhhc
Q 040257 257 DLQNMIDEYCG 267 (1254)
Q Consensus 257 DL~~m~~Eydr 267 (1254)
||+.+|++..+
T Consensus 69 Dl~~ai~~~~k 79 (85)
T d1ip9a_ 69 QVSNIIQAKLK 79 (85)
T ss_dssp HHHHHHHTTCC
T ss_pred HHHHHHHhcCc
Confidence 99999985543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.26 E-value=0.00037 Score=69.59 Aligned_cols=75 Identities=16% Similarity=0.052 Sum_probs=47.2
Q ss_pred EEeeeCc-EEEEEEEEC-CceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC--CCceeEEeeeeecCCCCceEE
Q 040257 971 ELGSGTY-GTVYHGKWR-GSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH--HPNVVAFYGVVPDGTGGTLAT 1046 (1254)
Q Consensus 971 kLGeGsF-GtVYlAk~r-Gs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn--HPNIVkLyGvf~Ddn~~~L~L 1046 (1254)
.+..|.. +.||+.... +..+++|....... ..+..|...|+.|. .-.+.+++.+..++. ..++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~--~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----------NELQDEAARLSWLATTGVPCAAVLDVVTEAG--RDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSS--CEEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----------hHHHHHHHHHHHHHhcCCCCCceeeeccccc--ceEE
Confidence 3455553 689998875 44578887654321 12445666666553 233567777766543 7889
Q ss_pred EEEecccCchhh
Q 040257 1047 VTEFMVNGSLKH 1058 (1254)
Q Consensus 1047 VMEYm~GGSL~d 1058 (1254)
||+|++|.++..
T Consensus 84 v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 84 LLGEVPGQDLLS 95 (255)
T ss_dssp EEECCSSEETTT
T ss_pred EEEeeecccccc
Confidence 999998866543
|
| >d2c60a1 d.15.2.2 (A:43-122) Mitogen-activated protein kinase kinase kinase 3, MEKK 3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 3, MEKK 3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.03 E-value=0.0012 Score=58.22 Aligned_cols=70 Identities=27% Similarity=0.488 Sum_probs=59.7
Q ss_pred cCceEEEeccCCCChHHHHHHHHhhcCCCceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEEEEe
Q 040257 206 GGETRIISLRTNLSWEELVKKTSNICNQPHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRLFLI 282 (1254)
Q Consensus 206 GG~triv~V~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~FLF 282 (1254)
-||.||+-++|.++|.||..|+...||..+.+-|- +. .-+|.+++.+||+.-++-.||...- + -||+.|.
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~--n~--El~IPl~~Q~DLDkAvellDrs~~~-k--sLrilL~ 79 (80)
T d2c60a1 10 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM--NN--ELSILLKNQDDLDKAIDILDRSSSM-K--SLRILLL 79 (80)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHSSCCEEEEE--CS--SCEEECCSHHHHHHHHHHHHHCSSC-C--SEEEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe--cC--eEEEecccHHHHHHHHHHHccCccc-c--eeEEEEe
Confidence 48999999999999999999999999999999998 33 3579999999999999999985432 2 2777663
|
| >d2nptb1 d.15.2.2 (B:42-123) Mitogen-activated protein kinase kinase kinase 2, MEKK 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 2, MEKK 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.68 E-value=0.0028 Score=56.10 Aligned_cols=70 Identities=23% Similarity=0.386 Sum_probs=59.4
Q ss_pred cCceEEEeccCCCChHHHHHHHHhhcCCCceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEEEEe
Q 040257 206 GGETRIISLRTNLSWEELVKKTSNICNQPHLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRLFLI 282 (1254)
Q Consensus 206 GG~triv~V~r~~~f~~l~~kl~~~~~~~~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~FLF 282 (1254)
-||.||+-++|.+.|.||..|+...||..+.+-|- +. .-+|.+++.+||+.-++-.||... -++ ||+.|.
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~--n~--EL~IPl~~Q~DLDkAvellDrs~~-~ks--LrilL~ 79 (82)
T d2nptb1 10 RGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT--NN--ELVIPLTTQDDLDKAVELLDRSIH-MKS--LKILLV 79 (82)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHTSCEEEEEE--ET--TEEEECCCHHHHHHHHHHHHHCSS-CCS--EEEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeEEEe--cC--eEEEecccHHHHHHHHHHHccCcc-ccc--eEEEEE
Confidence 48999999999999999999999999999999998 32 469999999999999999998543 222 666553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.61 E-value=0.0015 Score=71.24 Aligned_cols=82 Identities=18% Similarity=0.102 Sum_probs=46.9
Q ss_pred EEEEeeeCcEEEEEEEEC--CceEEEEEEeccc-cCCCchhHHHHHHHHHHHHHHHhcCC---CCceeEEeeeeecCCCC
Q 040257 969 LRELGSGTYGTVYHGKWR--GSDVAIKRIKKSC-FAGRSSEQERLTKDFWREAHILSNLH---HPNVVAFYGVVPDGTGG 1042 (1254)
Q Consensus 969 LkkLGeGsFGtVYlAk~r--Gs~VAIKvIkk~~-~~~~~~e~ee~~eqFlrEIeILkrLn---HPNIVkLyGvf~Ddn~~ 1042 (1254)
.+.||.|....||++... ++.++||.-.... ..+.. ......+...|...|+.+. ...+++++.+.. .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~--~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~-- 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGES--WPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--E-- 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CC--CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--T--
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCC--CCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--C--
Confidence 567999999999998763 5678888654211 00000 0001123445777776552 234666766542 2
Q ss_pred ceEEEEEecccCch
Q 040257 1043 TLATVTEFMVNGSL 1056 (1254)
Q Consensus 1043 ~L~LVMEYm~GGSL 1056 (1254)
..++||||+.+..+
T Consensus 105 ~~~lvmE~L~~~~~ 118 (392)
T d2pula1 105 MAVTVMEDLSHLKI 118 (392)
T ss_dssp TTEEEECCCTTSEE
T ss_pred CCEEEEeccCCccc
Confidence 34689999976543
|
| >d2bkfa1 d.15.2.2 (A:1-85) Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.28 E-value=0.0052 Score=55.20 Aligned_cols=63 Identities=14% Similarity=0.260 Sum_probs=48.3
Q ss_pred EeccCCCChHHHHHHHHhhcCCC-ceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEEEEe
Q 040257 212 ISLRTNLSWEELVKKTSNICNQP-HLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRLFLI 282 (1254)
Q Consensus 212 v~V~r~~~f~~l~~kl~~~~~~~-~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~FLF 282 (1254)
|++++..+|.+|.++++..++.. +.|||. +|=+-.|.++||+||+.-++-+.+ ....||+++.
T Consensus 20 ls~~~~~~~~~L~~~i~~rf~l~~~~lkY~---Ddd~e~v~l~~d~dl~E~~~~a~~-----~~~~irl~v~ 83 (85)
T d2bkfa1 20 VSDPENTTWADIEAMVKVSFDLNTIQIKYL---DEENEEVSINSQGEYEEALKMAVK-----QGNQLQMQVH 83 (85)
T ss_dssp ESCGGGCCHHHHHHHHHHHHTCSSEEEEEE---CTTSCEEEECSHHHHHHHHHHHHH-----TTTEEEEEEE
T ss_pred ecCCCCCcHHHHHHHHHHhcCcccceEEEE---cCCCCEEEEecHHHHHHHHHHHhc-----CCCEEEEEEe
Confidence 56789999999999999999854 889998 344568999999999876665422 2245776664
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.15 E-value=0.041 Score=59.19 Aligned_cols=80 Identities=13% Similarity=0.212 Sum_probs=49.3
Q ss_pred ccccCceEEEEEeeeCcEEEEEEEECC---------ceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCC-CCcee
Q 040257 961 IKNVDLEELRELGSGTYGTVYHGKWRG---------SDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLH-HPNVV 1030 (1254)
Q Consensus 961 Ik~~dYeiLkkLGeGsFGtVYlAk~rG---------s~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLn-HPNIV 1030 (1254)
+...++++ +.|+.|-.-.+|++.... ..|.+++.-.. .. . ....+|..+++.+. +.-..
T Consensus 40 ~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~-----~-idr~~E~~i~~~ls~~gl~P 108 (395)
T d1nw1a_ 40 VPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET-----E-SHLVAESVIFTLLSERHLGP 108 (395)
T ss_dssp CCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC-----H-HHHHHHHHHHHHHHHTTSSS
T ss_pred CCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----ch-----h-hHHHHHHHHHHHHHhCCCCC
Confidence 34444444 678889999999998742 33566554321 01 1 12346788887774 33345
Q ss_pred EEeeeeecCCCCceEEEEEecccCchh
Q 040257 1031 AFYGVVPDGTGGTLATVTEFMVNGSLK 1057 (1254)
Q Consensus 1031 kLyGvf~Ddn~~~L~LVMEYm~GGSL~ 1057 (1254)
++++++.+ .+||||+.|..|.
T Consensus 109 kll~~~~~------g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 109 KLYGIFSG------GRLEEYIPSRPLS 129 (395)
T ss_dssp CEEEEETT------EEEECCCCEEECC
T ss_pred eEEEEcCC------ceEEEEeccccCC
Confidence 88888742 5689999876543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.97 E-value=0.022 Score=58.80 Aligned_cols=33 Identities=9% Similarity=0.137 Sum_probs=23.5
Q ss_pred CceEEEEEeeeCcEEEEEEEECCceEEEEEEec
Q 040257 965 DLEELRELGSGTYGTVYHGKWRGSDVAIKRIKK 997 (1254)
Q Consensus 965 dYeiLkkLGeGsFGtVYlAk~rGs~VAIKvIkk 997 (1254)
.+.-++.|..|.--+.|+.+..+..+++|++..
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~ 51 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEK 51 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC
T ss_pred CceEeecCCCCcccCeEEEEECCCcEEEEEcCC
Confidence 344556677888899999998877899999864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.93 E-value=0.019 Score=60.50 Aligned_cols=69 Identities=13% Similarity=0.071 Sum_probs=39.9
Q ss_pred eCcEEEEEEEE-CCceEEEEEEeccccCCCchhHHHHHHHHHHHHHHHhcCCCCce--eEEee-----eeecCCCCceEE
Q 040257 975 GTYGTVYHGKW-RGSDVAIKRIKKSCFAGRSSEQERLTKDFWREAHILSNLHHPNV--VAFYG-----VVPDGTGGTLAT 1046 (1254)
Q Consensus 975 GsFGtVYlAk~-rGs~VAIKvIkk~~~~~~~~e~ee~~eqFlrEIeILkrLnHPNI--VkLyG-----vf~Ddn~~~L~L 1046 (1254)
+.--.||+++. +|+.|++|+....... .+++..|...+..|....| +..+. .+. .....+.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s---------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~--~~~~~~~ 101 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWT---------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLN--HQGFYFA 101 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSC---------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEE--ETTEEEE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCCC---------HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeee--eeeEEEE
Confidence 44568999987 5778999998644211 2445567777766632211 11111 111 1236778
Q ss_pred EEEecccC
Q 040257 1047 VTEFMVNG 1054 (1254)
Q Consensus 1047 VMEYm~GG 1054 (1254)
+++++.|.
T Consensus 102 l~~~~~G~ 109 (325)
T d1zyla1 102 VFPSVGGR 109 (325)
T ss_dssp EEECCCCE
T ss_pred EEeecCCc
Confidence 89998764
|
| >d1wmha_ d.15.2.2 (A:) Protein kinase C, iota type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Protein kinase C, iota type species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.69 E-value=0.72 Score=40.72 Aligned_cols=70 Identities=23% Similarity=0.379 Sum_probs=54.2
Q ss_pred CceEEEeccCCCChHHHHHHHHhhcCCC----ceEEEecCCCCcCcEEeecChHHHHHHHHHhhcccccCCCceEEEEEe
Q 040257 207 GETRIISLRTNLSWEELVKKTSNICNQP----HLIKYQLPGEDLDALISVSSDDDLQNMIDEYCGLERLEGSQRLRLFLI 282 (1254)
Q Consensus 207 G~triv~V~r~~~f~~l~~kl~~~~~~~----~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr~~~~~~~~rlR~FLF 282 (1254)
|+--|..++.+|+|.+|...+..+|+.+ +++|+= .|+=| =++|+++.+|+.-+-.|... +..-|-+-+|
T Consensus 10 G~i~it~~~~~it~e~l~~evr~~C~f~~~q~fT~KWi--DeEGD-PCTISSQmEL~EA~RLye~n----~dseL~iHVF 82 (83)
T d1wmha_ 10 GDIMITHFEPSISFEGLCNEVRDMCSFDNEQLFTMKWI--DEEGD-PCTVSSQLELEEAFRLYELN----KDSELLIHVF 82 (83)
T ss_dssp TEEEEEEECTTCCHHHHHHHHHHHTTCCTTCCCEEEEE--CTTSC-EEECCSHHHHHHHHHHHHHT----TCSCEEEEEE
T ss_pred CeEEEEecCCCccHHHHHHHHHHHhCCCcCCcEEEEEE--cCCCC-ceeeecHHHHHHHHHHHHcc----CCcceEEEec
Confidence 3344889999999999999999999865 788985 44444 58999999998888888653 2345666677
Q ss_pred c
Q 040257 283 P 283 (1254)
Q Consensus 283 p 283 (1254)
|
T Consensus 83 P 83 (83)
T d1wmha_ 83 P 83 (83)
T ss_dssp C
T ss_pred C
Confidence 6
|
| >d2npta1 d.15.2.2 (A:4-108) Mitogen activated protein kinase kinase 5, Map2k5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen activated protein kinase kinase 5, Map2k5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.33 E-value=1.5 Score=39.92 Aligned_cols=51 Identities=22% Similarity=0.434 Sum_probs=39.8
Q ss_pred ccCCCChHHHHHHHHhhcCCC--ceEEEecCCCCcCcEEeecChHHHHHHHHHhhc
Q 040257 214 LRTNLSWEELVKKTSNICNQP--HLIKYQLPGEDLDALISVSSDDDLQNMIDEYCG 267 (1254)
Q Consensus 214 V~r~~~f~~l~~kl~~~~~~~--~~lkYqLP~edLD~LiSVt~DeDL~~m~~Eydr 267 (1254)
-++.++|.++...++....-. ..++|- .||=| =|.|.+||+|..||.=|..
T Consensus 32 ~~~~l~F~dvL~~i~q~~p~at~taFEYE--DEdGD-RITVRSDEEl~AMisyy~~ 84 (105)
T d2npta1 32 SGPQLLFRDVLDVIGQVLPEATTTAFEYE--DEDGD-RITVRSDEEMKAMLSYYYS 84 (105)
T ss_dssp C--CCCHHHHHHHHHHHSTTSCCSEEEEE--CTTSC-EEEECSHHHHHHHHHHHHH
T ss_pred CCceeeHHHHHHHHHHhcccccccceeec--cccCC-EeEEccHHHHHHHHHHHHH
Confidence 357899999999999988543 558885 55555 4899999999999999843
|